data_2jrf_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jrf _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 52.6 mt . . . . . 0 CA--C 1.542 0.636 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 70.17 -70.42 0.15 Allowed 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -56.46 -45.28 89.68 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 121.455 -0.403 . . . . 0.0 113.315 -177.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.646 HD22 ' SG ' ' A' ' 100' ' ' CYS . 45.3 tp -57.57 -46.14 84.34 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.232 0.539 . . . . 0.0 110.836 175.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.411 ' HG2' ' HH ' ' A' ' 72' ' ' TYR . 37.2 mt-10 -61.42 -34.45 75.4 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.06 178.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -66.43 -50.89 61.89 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.614 177.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.6 m -60.28 -34.18 73.39 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.36 177.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -57.67 -49.99 74.66 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.793 0.33 . . . . 0.0 110.154 174.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.54 ' O ' HG12 ' A' ' 19' ' ' ILE . 76.6 mtm-85 -57.16 -47.1 82.02 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.299 176.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -44.93 -48.46 11.32 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 176.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -84.82 -26.97 27.11 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.9 -53.05 23.27 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.976 0.417 . . . . 0.0 111.938 -178.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.54 HG12 ' O ' ' A' ' 15' ' ' ARG . 29.9 pt -77.95 7.33 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -178.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -62.13 89.91 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.232 0.539 . . . . 0.0 110.596 176.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 125.23 -54.48 0.75 Allowed Glycine 0 CA--C 1.527 0.785 0 CA-C-N 115.888 -0.597 . . . . 0.0 112.64 -176.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -127.03 109.79 21.79 Favored Pre-proline 0 CA--C 1.547 0.835 0 O-C-N 122.626 -0.338 . . . . 0.0 110.933 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -76.39 -5.78 16.48 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 122.845 2.363 . . . . 0.0 113.644 -178.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 30.7 mtmm -89.5 -11.77 41.97 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.932 0.396 . . . . 0.0 110.945 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.86 -20.34 66.2 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.607 176.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 59.9 m 73.11 -53.72 0.7 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.582 0.753 . . . . 0.0 112.213 177.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 137.86 47.25 0.07 OUTLIER Glycine 0 CA--C 1.524 0.609 0 CA-C-N 116.41 -0.359 . . . . 0.0 112.309 -177.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -95.16 -34.78 12.13 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.643 0.259 . . . . 0.0 111.506 -178.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.08 178.92 6.59 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.341 0.591 . . . . 0.0 112.488 -175.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 52.7 ttm -157.41 133.9 9.81 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.63 176.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -86.38 167.75 14.45 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.094 0.473 . . . . 0.0 112.134 -178.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -58.13 -33.19 68.87 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-N 115.749 -0.659 . . . . 0.0 114.432 -176.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -69.22 -54.12 16.38 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.331 0.586 . . . . 0.0 110.976 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -60.57 -40.29 91.12 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.425 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 30.5 t-105 -63.51 -42.84 98.46 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 120.998 0.428 . . . . 0.0 111.492 175.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.18 -44.63 96.99 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 121.001 0.429 . . . . 0.0 111.183 176.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 43.2 tttm -66.36 -39.43 89.14 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.784 177.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.7 tt -51.69 -47.5 63.86 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.084 0.469 . . . . 0.0 110.792 178.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 79.5 m -63.44 -41.26 98.66 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.324 176.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -62.7 -57.3 11.48 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.815 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -53.69 -39.42 65.14 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 122.731 0.412 . . . . 0.0 111.795 178.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.572 ' SG ' HG12 ' A' ' 103' ' ' VAL . 57.0 m -91.85 -0.7 57.53 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.662 ' HB2' ' HZ1' ' A' ' 43' ' ' LYS . 9.7 mtmp? 50.15 31.75 5.32 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.1 t -68.78 -38.14 78.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-O 121.263 0.554 . . . . 0.0 109.586 171.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.47 79.69 3.97 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.02 171.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.0 p30 -76.79 -14.28 59.93 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.914 -173.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.61 -27.43 7.14 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 121.168 -0.539 . . . . 0.0 113.23 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -85.01 -37.81 19.96 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 122.478 -0.425 . . . . 0.0 111.448 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.8 t -112.46 -51.13 2.86 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.128 0.49 . . . . 0.0 110.549 176.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 34.1 t -112.81 110.46 32.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.065 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.496 ' O ' HG23 ' A' ' 55' ' ' VAL . 81.9 p -97.52 166.72 11.38 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.527 179.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -50.02 -55.49 15.02 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 121.368 -0.444 . . . . 0.0 113.079 178.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.545 ' O ' HG12 ' A' ' 57' ' ' ILE . 94.0 m -53.08 -48.56 67.66 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.599 0.237 . . . . 0.0 111.493 178.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.456 ' O ' HG21 ' A' ' 58' ' ' VAL . 18.0 t70 -58.48 -36.82 74.32 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 120.726 0.298 . . . . 0.0 110.872 -178.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 51' ' ' THR . 88.6 t -61.87 -37.92 79.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.375 175.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -73.52 -34.73 65.39 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.399 0.619 . . . . 0.0 110.137 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.545 HG12 ' O ' ' A' ' 53' ' ' THR . 8.0 mm -60.48 -52.73 58.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.999 176.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.456 HG21 ' O ' ' A' ' 54' ' ' ASP . 91.8 t -52.49 -48.5 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 121.04 0.448 . . . . 0.0 111.12 177.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -59.94 -41.28 91.49 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.009 178.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 28.3 t -72.95 -20.22 61.09 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 116.156 -0.474 . . . . 0.0 112.051 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.453 ' HG3' ' O ' ' A' ' 57' ' ' ILE . 53.6 mtmt -84.49 -57.12 3.28 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.087 0.47 . . . . 0.0 111.953 178.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.3 m -61.19 -31.95 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 -173.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.633 ' HD3' ' O ' ' A' ' 66' ' ' SER . 17.2 ptpt -56.55 -52.44 64.78 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -175.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 72.74 -64.78 1.48 Allowed Glycine 0 CA--C 1.537 1.46 0 N-CA-C 114.55 0.58 . . . . 0.0 114.55 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.591 ' HG2' ' HB2' ' A' ' 67' ' ' ALA . 0.0 OUTLIER -78.52 53.43 1.3 Allowed 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -172.569 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.633 ' O ' ' HD3' ' A' ' 63' ' ' LYS . 88.5 p 54.23 -77.61 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.148 0.579 . . . . 0.0 110.928 -173.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.591 ' HB2' ' HG2' ' A' ' 65' ' ' LYS . . . 46.88 117.88 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 115.859 1.799 . . . . 0.0 115.859 164.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 57.2 ttp180 -66.52 -18.3 65.29 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 121.355 0.598 . . . . 0.0 110.684 169.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 33.8 m -135.15 159.21 41.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.902 -173.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 39.3 pt -115.27 147.56 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-O 120.699 0.285 . . . . 0.0 110.929 174.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -86.47 157.55 19.77 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.411 ' HH ' ' HG2' ' A' ' 11' ' ' GLU . 86.7 t80 -40.25 -48.6 2.63 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 -175.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.532 ' HA ' ' HE3' ' A' ' 76' ' ' LYS . 46.5 mm-40 -52.15 -46.42 65.43 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 120.935 0.398 . . . . 0.0 111.77 178.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -76.56 -19.36 57.98 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 120.97 0.414 . . . . 0.0 110.99 -178.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -70.56 -49.68 45.42 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.118 174.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.532 ' HE3' ' HA ' ' A' ' 73' ' ' GLU . 22.8 pttp -69.58 -22.54 63.51 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.322 177.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -71.81 -41.35 68.35 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.165 0.507 . . . . 0.0 110.251 170.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.455 ' O ' ' HB3' ' A' ' 81' ' ' GLU . . . -63.61 -37.8 88.72 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.33 175.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 84.9 mt -59.69 -43.44 94.04 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.326 175.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -54.85 -43.97 73.55 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 121.029 0.443 . . . . 0.0 110.891 174.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.455 ' HB3' ' O ' ' A' ' 78' ' ' ALA . 6.9 tp10 -54.28 -64.33 0.86 Allowed 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.057 175.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.476 ' HA ' ' HG3' ' A' ' 85' ' ' LYS . 9.1 mp -57.71 -33.25 68.22 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.153 0.502 . . . . 0.0 111.936 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.84 -48.47 81.66 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.146 175.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.468 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 76.1 p -70.41 -19.06 63.02 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 120.827 0.346 . . . . 0.0 111.699 179.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.476 ' HG3' ' HA ' ' A' ' 82' ' ' LEU . 46.9 mmtt -67.29 -41.64 85.1 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 121.088 0.471 . . . . 0.0 111.013 174.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 23.4 mtp180 -106.25 -57.38 2.06 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -176.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -88.85 29.33 1.04 Allowed 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -171.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.468 ' HB3' ' O ' ' A' ' 84' ' ' THR . 22.7 pttp -71.8 150.58 44.22 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.079 0.466 . . . . 0.0 111.406 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 98.84 -28.5 14.86 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.908 -178.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -86.62 -177.48 6.15 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.05 0.453 . . . . 0.0 111.423 176.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 35.6 t -63.7 135.13 56.48 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.058 177.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -48.76 -48.03 41.25 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 122.98 0.512 . . . . 0.0 111.856 -178.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.427 ' HG3' ' N ' ' A' ' 94' ' ' GLU . 9.9 pt-20 -60.9 -48.45 81.77 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.461 178.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.427 ' N ' ' HG3' ' A' ' 93' ' ' GLU . 63.5 tt0 -58.58 -47.15 85.24 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.635 0.255 . . . . 0.0 111.354 -178.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.81 -44.81 86.61 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 120.951 0.405 . . . . 0.0 111.711 178.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -68.37 -50.29 54.15 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.422 -178.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -62.01 -31.55 71.94 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 120.725 0.298 . . . . 0.0 111.57 177.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -66.65 -54.94 17.86 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 11.5 tt -58.43 -39.75 75.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 120.929 0.395 . . . . 0.0 110.99 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' CYS . . . . . 0.646 ' SG ' HD22 ' A' ' 10' ' ' LEU . 79.0 m -64.17 -37.58 87.96 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.847 0.356 . . . . 0.0 110.998 175.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -60.15 -29.31 68.57 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.536 177.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 79.0 mt -77.18 -13.46 59.94 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 177.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.572 HG12 ' SG ' ' A' ' 42' ' ' CYS . 58.3 t -110.62 -54.18 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -175.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -41.36 126.21 2.74 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 -172.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 109.11 -32.84 6.54 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 121.321 -0.466 . . . . 0.0 114.219 173.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 38.0 mtmm -82.06 169.12 17.07 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -174.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.529 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 12.1 pt-20 -126.89 165.37 29.12 Favored Pre-proline 0 CA--C 1.55 0.967 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.464 -178.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.529 ' HD2' ' HB2' ' A' ' 107' ' ' GLU . 55.5 Cg_endo -68.37 71.97 0.91 Allowed 'Trans proline' 0 CA--C 1.545 1.031 0 C-N-CA 122.635 2.223 . . . . 0.0 113.889 -178.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.673 0 C-N-CA 122.672 0.389 . . . . 0.0 111.8 -179.061 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.0 mt . . . . . 0 N--CA 1.472 0.654 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.55 -31.07 69.04 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.382 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.73 -17.06 48.48 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 121.225 -0.512 . . . . 0.0 113.164 175.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 53.0 tp -71.85 -58.44 3.46 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.783 0.291 . . . . 0.0 110.899 177.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -55.43 -39.63 70.5 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 177.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -61.47 -57.08 13.61 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.573 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.3 t -57.32 -44.91 84.59 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.134 0.492 . . . . 0.0 110.868 178.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -58.34 -40.97 83.59 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.435 176.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.48 ' O ' HG12 ' A' ' 19' ' ' ILE . 58.4 ttt180 -67.48 -44.21 79.1 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 120.678 0.275 . . . . 0.0 110.985 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -62.8 -34.37 77.15 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.237 178.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.484 ' HB3' ' HE1' ' A' ' 30' ' ' MET . 5.6 m-85 -72.28 -49.72 32.56 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.365 173.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.73 -46.96 81.0 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -176.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.48 HG12 ' O ' ' A' ' 15' ' ' ARG . 23.1 pt -83.58 5.58 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-O 121.018 0.437 . . . . 0.0 111.974 -177.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 37.1 t60 -78.96 105.22 10.13 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.937 0.399 . . . . 0.0 110.291 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.446 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . 88.82 -64.31 3.42 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.27 -174.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -90.13 97.33 1.07 Allowed Pre-proline 0 CA--C 1.547 0.839 0 CA-C-O 120.865 0.364 . . . . 0.0 110.608 175.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.446 ' HD3' ' O ' ' A' ' 21' ' ' GLY . 74.4 Cg_endo -73.33 -30.79 9.91 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 122.546 2.164 . . . . 0.0 114.183 -170.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.66 ' HB2' ' HZ2' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -76.46 2.42 13.75 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -173.211 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.412 ' HB2' ' O ' ' A' ' 29' ' ' GLU . . . -65.79 -37.16 85.54 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.974 0.416 . . . . 0.0 111.288 176.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 27.1 t 55.76 16.43 2.01 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 175.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 75.86 13.95 82.61 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 120.883 -0.675 . . . . 0.0 113.87 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -95.78 -36.65 11.08 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.268 0.556 . . . . 0.0 110.461 175.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.412 ' O ' ' HB2' ' A' ' 25' ' ' ALA . 26.3 mt-10 -137.44 142.74 41.6 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.926 -178.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.484 ' HE1' ' HB3' ' A' ' 17' ' ' PHE . 27.2 ttt -123.97 142.51 51.1 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.983 0.421 . . . . 0.0 111.667 -175.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -103.46 164.79 11.43 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -174.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -58.71 -32.27 69.25 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-N 115.725 -0.67 . . . . 0.0 113.7 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.506 ' HB2' ' HZ2' ' A' ' 33' ' ' LYS . 3.6 ttmp? -47.75 -61.9 1.72 Allowed 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 121.62 0.724 . . . . 0.0 111.395 176.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -79.81 -20.36 46.31 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.125 -175.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 62.0 t-105 -69.91 -50.22 44.36 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 120.882 0.373 . . . . 0.0 111.218 177.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.13 -43.85 95.35 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-O 121.403 0.62 . . . . 0.0 110.203 174.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 41.3 tttm -57.16 -46.73 82.52 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.593 174.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.478 HD11 ' HE3' ' A' ' 30' ' ' MET . 8.4 tt -51.91 -46.82 64.76 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 122.895 0.478 . . . . 0.0 111.057 -179.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.65 ' SG ' HG11 ' A' ' 55' ' ' VAL . 73.7 m -56.29 -50.5 71.21 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.218 177.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -71.73 -28.99 64.04 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 121.113 0.482 . . . . 0.0 111.914 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.406 ' OD1' ' NZ ' ' A' ' 106' ' ' LYS . 5.8 t70 -75.37 -44.8 42.99 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.427 0.632 . . . . 0.0 111.158 -173.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 65.4 m -103.08 2.25 34.48 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.68 178.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp 62.36 34.95 15.34 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.321 0.581 . . . . 0.0 111.348 178.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 59.9 t -68.21 -42.21 84.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.443 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.09 91.91 2.12 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.266 0.555 . . . . 0.0 111.123 178.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.62 ' HB2' ' HG2' ' A' ' 86' ' ' ARG . 26.9 t70 -51.86 -26.61 10.44 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.72 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.11 -55.99 4.59 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 121.302 -0.475 . . . . 0.0 112.27 -177.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.776 ' HB3' ' HZ3' ' A' ' 48' ' ' LYS . 5.9 ttpm? -64.08 -32.97 74.73 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 121.124 0.487 . . . . 0.0 111.128 176.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 13.8 m -110.15 -19.47 13.02 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.52 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 5.8 p -160.3 113.88 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-O 121.005 0.431 . . . . 0.0 112.131 -176.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 58.5 p -95.69 172.48 8.02 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 120.818 0.342 . . . . 0.0 111.768 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -51.65 -36.42 39.96 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-N 116.19 -0.459 . . . . 0.0 113.686 177.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.517 ' O ' HG13 ' A' ' 57' ' ' ILE . 21.6 p -62.06 -54.38 42.29 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.972 0.415 . . . . 0.0 110.234 177.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -58.2 -38.48 76.82 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.52 -176.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.65 HG11 ' SG ' ' A' ' 39' ' ' CYS . 88.6 t -58.21 -39.1 72.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.595 174.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -70.42 -36.17 73.86 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 121.296 0.57 . . . . 0.0 110.318 178.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.566 ' O ' ' HG3' ' A' ' 61' ' ' LYS . 8.7 mt -61.49 -46.43 96.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.578 176.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 89.7 t -60.91 -45.13 98.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-O 121.08 0.467 . . . . 0.0 110.73 177.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.509 ' O ' ' HB2' ' A' ' 63' ' ' LYS . 76.5 t80 -59.39 -30.92 68.78 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.874 175.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.548 ' HA ' ' HE3' ' A' ' 63' ' ' LYS . 67.8 m -82.5 -25.15 33.74 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.722 177.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.566 ' HG3' ' O ' ' A' ' 57' ' ' ILE . 95.4 mttt -66.47 -55.3 16.28 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 120.98 0.419 . . . . 0.0 111.338 177.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.529 ' HB ' ' HB3' ' A' ' 74' ' ' GLU . 27.6 m -83.72 6.99 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 CA-C-N 116.064 -0.516 . . . . 0.0 112.198 -177.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.548 ' HE3' ' HA ' ' A' ' 60' ' ' SER . 39.6 ttmt -78.01 143.86 37.17 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.766 -179.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -73.01 177.98 41.24 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 121.022 -0.609 . . . . 0.0 113.203 177.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -50.98 100.35 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -177.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 60.6 p 52.04 23.95 2.45 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.368 0.667 . . . . 0.0 112.335 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.452 ' O ' ' HD3' ' A' ' 63' ' ' LYS . . . -70.29 176.23 4.08 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -177.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.51 ' HG3' HG12 ' A' ' 69' ' ' VAL . 16.8 ptt180 -116.48 -9.48 11.43 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.51 HG12 ' HG3' ' A' ' 68' ' ' ARG . 33.1 m -136.57 172.18 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-O 121.084 0.469 . . . . 0.0 112.0 -178.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 37.8 pt -128.18 145.61 35.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.097 175.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 -79.92 158.89 26.54 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 120.736 0.303 . . . . 0.0 111.729 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.524 ' O ' ' HB3' ' A' ' 75' ' ' PHE . 30.1 t80 -48.4 -46.8 37.73 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -175.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 22.7 mp0 -60.81 -43.96 97.49 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 122.113 -0.367 . . . . 0.0 111.418 -178.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.529 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 32.5 mm-40 -71.96 -27.19 62.61 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.887 0.375 . . . . 0.0 111.078 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.524 ' HB3' ' O ' ' A' ' 72' ' ' TYR . 61.6 t80 -57.22 -39.67 75.93 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.396 0.617 . . . . 0.0 110.349 170.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.511 ' HG3' ' O ' ' A' ' 72' ' ' TYR . 32.3 mtpt -67.12 -35.62 80.14 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.825 177.082 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.412 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 15.1 tppt? -66.88 -39.65 87.54 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.346 0.593 . . . . 0.0 110.653 176.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.09 -46.47 90.51 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.807 174.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 79.4 mt -60.75 -32.32 71.62 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.114 174.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.412 ' HB3' ' O ' ' A' ' 77' ' ' LYS . 32.9 tt0 -56.66 -51.32 69.19 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 120.704 0.288 . . . . 0.0 110.934 177.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -61.68 -53.71 52.52 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.408 175.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 82.0 mt -54.21 -38.36 65.59 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -178.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.76 -52.16 40.61 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.907 0.384 . . . . 0.0 111.62 177.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 70.1 p -66.65 -16.14 63.98 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -90.5 -49.3 6.58 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 122.077 -0.39 . . . . 0.0 111.02 173.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.62 ' HG2' ' HB2' ' A' ' 46' ' ' ASP . 2.2 tmt_? -59.77 -51.2 70.78 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.003 0.43 . . . . 0.0 110.687 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -94.24 24.18 4.58 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.145 0.498 . . . . 0.0 111.923 -177.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 56.0 mttm 59.46 -179.81 0.08 Allowed 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.925 178.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -77.25 58.69 3.64 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 121.309 -0.472 . . . . 0.0 114.051 -175.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -98.43 -162.16 0.93 Allowed 'General case' 0 CA--C 1.543 0.697 0 O-C-N 122.618 -0.342 . . . . 0.0 110.634 176.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.406 ' HB3' ' HB3' ' A' ' 94' ' ' GLU . 28.5 t -56.28 120.56 7.79 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 122.182 -0.323 . . . . 0.0 111.402 176.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -57.59 -44.56 85.5 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.877 0.37 . . . . 0.0 111.373 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.5 mp0 -59.1 -50.01 75.68 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.933 177.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.406 ' HB3' ' HB3' ' A' ' 91' ' ' SER . 36.3 tt0 -58.25 -47.05 84.79 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.667 177.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.54 -36.73 83.54 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.917 0.389 . . . . 0.0 111.448 178.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -65.87 -42.75 89.96 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.83 178.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -60.94 -42.79 98.87 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.195 0.521 . . . . 0.0 110.591 175.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.531 ' O ' ' HB3' ' A' ' 101' ' ' GLN . . . -61.44 -49.34 77.24 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 179.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.1 tt -64.51 -33.37 62.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 O-C-N 121.886 -0.508 . . . . 0.0 110.937 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 97.6 m -66.12 -38.55 88.46 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.88 0.371 . . . . 0.0 110.581 172.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.531 ' HB3' ' O ' ' A' ' 98' ' ' ALA . 6.7 tt0 -54.95 -34.09 62.93 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 121.045 0.45 . . . . 0.0 111.409 174.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 75.6 mt -78.09 -36.68 47.81 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 112.694 0.628 . . . . 0.0 112.694 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 54.9 t -100.71 -49.73 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -172.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.17 134.34 56.9 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -174.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 68.66 33.39 76.03 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.292 -0.48 . . . . 0.0 113.037 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.406 ' NZ ' ' OD1' ' A' ' 41' ' ' ASP . 14.2 tmtt? -142.91 133.71 25.37 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 122.922 0.489 . . . . 0.0 110.807 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -85.94 154.6 58.19 Favored Pre-proline 0 N--CA 1.474 0.767 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -175.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -65.9 84.64 0.24 Allowed 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 123.076 2.518 . . . . 0.0 112.866 176.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.784 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 174.715 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.9 mm . . . . . 0 CA--C 1.539 0.541 0 CA-C-O 121.122 0.487 . . . . 0.0 110.959 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.42 -38.45 66.28 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.18 -177.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -69.02 -26.69 74.52 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 121.144 -0.551 . . . . 0.0 113.257 177.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 50.7 tp -74.9 -51.29 14.21 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 122.523 -0.398 . . . . 0.0 110.882 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -62.33 -30.22 71.01 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.719 0.295 . . . . 0.0 111.047 176.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -63.56 -51.94 63.21 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.837 0.351 . . . . 0.0 110.377 175.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.5 m -62.78 -39.47 94.31 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.57 177.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -54.14 -51.66 63.57 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.862 0.363 . . . . 0.0 110.492 176.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.598 ' O ' HG12 ' A' ' 19' ' ' ILE . 81.6 mtt85 -63.26 -44.2 95.81 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.962 0.411 . . . . 0.0 111.232 175.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.631 ' HD2' ' HA ' ' A' ' 107' ' ' GLU . 26.9 ttmt -52.43 -34.32 48.03 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.414 -178.058 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -93.04 -38.8 11.44 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 116.167 -0.47 . . . . 0.0 112.098 173.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.07 -41.7 83.95 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -175.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.598 HG12 ' O ' ' A' ' 15' ' ' ARG . 46.5 pt -83.73 10.58 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -178.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 22.8 t60 -82.64 129.15 34.9 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 120.894 0.378 . . . . 0.0 110.8 177.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.49 -49.29 4.2 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.548 -177.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -93.19 100.78 4.57 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-O 120.741 0.305 . . . . 0.0 111.242 175.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -76.85 4.64 5.52 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 122.584 2.189 . . . . 0.0 113.229 -177.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -113.83 4.26 15.82 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.708 0.29 . . . . 0.0 111.707 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -74.99 132.05 41.09 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.788 0.328 . . . . 0.0 111.72 -179.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.6 m -76.81 -36.05 57.19 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.865 0.364 . . . . 0.0 111.473 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.515 ' HA3' ' HG2' ' A' ' 15' ' ' ARG . . . 126.71 15.67 2.61 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 120.881 -0.676 . . . . 0.0 114.229 176.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -113.95 -7.84 13.13 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 117.228 0.514 . . . . 0.0 111.833 177.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -123.79 137.13 54.73 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 122.418 0.287 . . . . 0.0 110.995 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 51.2 ttm -133.54 137.43 45.55 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.867 0.365 . . . . 0.0 111.404 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 31.0 p30 -92.12 171.22 9.23 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.261 0.553 . . . . 0.0 112.267 -179.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.55 -29.1 72.57 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-N 115.885 -0.598 . . . . 0.0 113.603 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -60.13 -55.06 38.54 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.031 0.443 . . . . 0.0 111.356 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -69.99 -29.16 66.18 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.496 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 53.8 t-105 -61.59 -42.63 99.13 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.275 0.559 . . . . 0.0 110.605 173.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.404 ' O ' ' SG ' ' A' ' 39' ' ' CYS . . . -61.61 -42.62 99.13 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.119 174.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.406 ' HE2' ' OD2' ' A' ' 41' ' ' ASP . 13.2 mmmm -61.87 -44.05 97.61 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.205 175.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.492 HD12 ' HE1' ' A' ' 75' ' ' PHE . 11.1 mt -48.83 -54.28 15.84 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 177.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.404 ' SG ' ' O ' ' A' ' 36' ' ' ALA . 24.6 p -62.06 -45.88 91.57 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.664 -178.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.5 ttpm? -68.72 -49.2 60.82 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.074 0.464 . . . . 0.0 111.661 -176.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.406 ' OD2' ' HE2' ' A' ' 37' ' ' LYS . 12.4 m-20 -69.14 -38.37 78.78 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.563 -176.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.46 ' SG ' ' HA ' ' A' ' 103' ' ' VAL . 73.4 m -85.35 -4.04 59.03 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 176.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt 62.0 35.53 16.03 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.265 0.555 . . . . 0.0 112.284 175.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 41.7 t -80.04 -23.84 11.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.472 174.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -92.62 96.92 10.48 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.574 179.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -56.73 -30.43 63.52 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.946 0.403 . . . . 0.0 111.532 178.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 98.04 -48.63 1.43 Allowed Glycine 0 CA--C 1.524 0.63 0 C-N-CA 121.536 -0.364 . . . . 0.0 112.655 -178.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -84.87 -21.11 29.9 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.965 0.412 . . . . 0.0 111.704 178.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 78.7 p -113.7 -72.53 0.7 Allowed 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.957 0.408 . . . . 0.0 110.551 176.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 59.3 t -88.14 122.03 39.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.172 174.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.5 t -140.6 178.56 7.24 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.416 -176.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -44.83 -52.36 7.82 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 114.189 0.436 . . . . 0.0 114.189 -175.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.568 ' O ' HG12 ' A' ' 57' ' ' ILE . 84.7 m -57.88 -51.67 68.65 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 122.561 -0.376 . . . . 0.0 111.303 177.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -55.86 -42.99 76.68 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 121.263 0.554 . . . . 0.0 111.123 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 83.7 t -65.8 -29.19 46.18 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.562 177.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -78.05 -33.84 50.73 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.592 0.711 . . . . 0.0 109.732 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.568 HG12 ' O ' ' A' ' 53' ' ' THR . 11.0 mm -64.13 -47.36 90.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.684 175.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.535 ' HA ' ' HD2' ' A' ' 61' ' ' LYS . 80.8 t -57.63 -45.91 86.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.323 175.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -57.36 -43.35 83.42 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.145 0.498 . . . . 0.0 110.579 174.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 23.0 t -65.48 -34.36 78.08 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.766 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.535 ' HD2' ' HA ' ' A' ' 58' ' ' VAL . 64.6 mttm -58.75 -51.96 67.74 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.333 0.587 . . . . 0.0 111.308 176.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.507 ' HB ' ' HB3' ' A' ' 74' ' ' GLU . 25.9 m -84.31 -6.6 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.039 -177.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.725 ' HZ1' ' HB3' ' A' ' 63' ' ' LYS . 6.3 ttpm? -65.69 153.55 41.38 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 120.922 0.392 . . . . 0.0 111.83 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -79.37 -161.46 21.87 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.683 175.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -62.38 -38.63 90.36 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 122.48 -0.424 . . . . 0.0 111.918 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 21.2 t -154.08 17.44 0.49 Allowed 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 120.824 0.345 . . . . 0.0 111.235 177.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.06 138.81 58.56 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -179.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 62.4 mtt180 -94.12 -8.58 39.15 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.232 178.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 36.0 m -132.17 152.03 35.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.807 -178.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.469 HG22 HG22 ' A' ' 62' ' ' VAL . 35.2 pt -117.58 151.63 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.087 176.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -100.38 173.03 6.78 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -177.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.497 ' O ' ' HB3' ' A' ' 75' ' ' PHE . 34.5 t80 -53.17 -50.65 64.18 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -170.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -63.43 -42.82 98.71 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -176.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.507 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 0.8 OUTLIER -69.93 -30.72 68.18 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.984 0.421 . . . . 0.0 110.537 176.653 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.497 ' HB3' ' O ' ' A' ' 72' ' ' TYR . 50.5 t80 -58.53 -43.25 89.14 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.163 0.506 . . . . 0.0 110.55 171.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.484 ' HG3' ' O ' ' A' ' 72' ' ' TYR . 55.2 mtpt -60.95 -40.14 92.17 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.7 175.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -70.01 -28.26 65.36 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.528 175.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.85 -42.74 80.91 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.036 0.446 . . . . 0.0 110.546 173.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 79.9 mt -64.71 -41.72 95.79 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.716 173.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -56.95 -45.07 83.07 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.319 0.58 . . . . 0.0 110.665 174.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.421 ' O ' ' HG3' ' A' ' 85' ' ' LYS . 16.4 tp10 -58.65 -59.82 4.79 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.029 176.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.409 ' O ' ' HG3' ' A' ' 86' ' ' ARG . 87.6 mt -56.13 -36.69 68.51 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.556 178.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.99 -58.31 9.23 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.72 -0.218 . . . . 0.0 111.276 177.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 80.5 p -53.79 -33.8 57.12 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.421 ' HG3' ' O ' ' A' ' 81' ' ' GLU . 7.2 mtpm? -72.71 -35.62 67.62 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.518 178.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.409 ' HG3' ' O ' ' A' ' 82' ' ' LEU . 48.1 mtp180 -96.82 -65.91 0.94 Allowed 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 120.88 0.372 . . . . 0.0 111.528 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -87.37 111.63 21.3 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.859 0.361 . . . . 0.0 110.436 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 15.5 pttm -141.93 31.64 1.6 Allowed 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -171.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -78.85 43.04 2.35 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 120.97 -0.634 . . . . 0.0 113.182 175.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.5 ttpp 72.04 -45.92 0.63 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.036 0.935 . . . . 0.0 112.964 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.4 m -72.62 110.4 6.95 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 122.071 -0.393 . . . . 0.0 111.759 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -81.62 -34.52 30.85 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 178.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -47.12 -70.55 0.09 Allowed 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 120.994 0.426 . . . . 0.0 111.409 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -66.64 -28.82 68.78 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -177.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.2 -42.88 91.95 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.307 0.575 . . . . 0.0 110.696 174.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -68.16 -40.3 82.37 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.539 176.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -57.78 -40.31 79.52 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.791 0.329 . . . . 0.0 111.513 174.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.565 ' O ' ' HB3' ' A' ' 101' ' ' GLN . . . -63.8 -47.45 80.81 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.036 0.446 . . . . 0.0 112.093 -178.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.9 tt -70.46 -31.14 45.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 O-C-N 121.998 -0.439 . . . . 0.0 110.752 178.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 84.8 m -68.06 -33.88 75.4 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.788 0.328 . . . . 0.0 110.613 171.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.565 ' HB3' ' O ' ' A' ' 98' ' ' ALA . 28.2 tt0 -56.53 -39.93 74.22 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.284 0.564 . . . . 0.0 110.526 173.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 88.8 mt -68.18 -39.15 82.59 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.405 176.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.46 ' HA ' ' SG ' ' A' ' 42' ' ' CYS . 67.7 t -93.53 -59.08 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -174.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -51.28 125.02 13.03 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 112.546 0.572 . . . . 0.0 112.546 -177.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.67 -42.13 2.81 Favored Glycine 0 CA--C 1.528 0.869 0 CA-C-N 116.172 -0.467 . . . . 0.0 112.745 -177.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -51.44 132.64 29.8 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -176.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.631 ' HA ' ' HD2' ' A' ' 16' ' ' LYS . 10.4 pt-20 -95.76 155.05 38.91 Favored Pre-proline 0 CA--C 1.542 0.657 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.902 174.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -56.87 130.14 38.27 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.545 2.163 . . . . 0.0 113.025 -178.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.737 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.224 -177.045 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 48.3 mm . . . . . 0 CA--C 1.538 0.51 0 CA-C-O 120.749 0.309 . . . . 0.0 110.709 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.94 -47.97 81.32 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -178.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.05 -29.83 59.88 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 121.1 -0.572 . . . . 0.0 113.047 177.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 50.6 tp -71.78 -45.1 62.7 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.778 0.323 . . . . 0.0 110.705 177.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -59.08 -46.72 87.57 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.017 0.437 . . . . 0.0 111.282 177.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.539 ' HG3' ' HE2' ' A' ' 16' ' ' LYS . 14.1 tp10 -56.91 -47.59 80.21 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.128 179.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.5 m -64.35 -42.44 96.23 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.795 177.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -53.97 -46.06 71.54 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.265 176.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.542 ' O ' HG12 ' A' ' 19' ' ' ILE . 94.5 mtt180 -59.28 -55.74 30.97 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.61 176.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.539 ' HE2' ' HG3' ' A' ' 12' ' ' GLU . 50.4 mttm -55.43 -32.5 62.76 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -175.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.458 ' HB3' ' HE1' ' A' ' 30' ' ' MET . 11.7 m-85 -81.68 -48.65 11.42 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 122.192 -0.317 . . . . 0.0 111.443 173.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.489 ' HA ' ' HG3' ' A' ' 30' ' ' MET . . . -55.39 -40.47 71.43 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -177.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.542 HG12 ' O ' ' A' ' 15' ' ' ARG . 16.6 pt -99.41 12.82 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 121.426 0.631 . . . . 0.0 110.957 -177.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 37.4 t-80 -58.64 92.93 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.014 -176.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.73 -6.3 57.1 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 121.11 -0.567 . . . . 0.0 113.376 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -134.9 92.85 18.27 Favored Pre-proline 0 CA--C 1.539 0.552 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -63.6 -12.95 33.66 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.348 2.032 . . . . 0.0 111.667 170.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -96.05 7.24 46.93 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.174 178.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.6 -97.25 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -176.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 59.1 m -164.12 -72.05 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 120.913 0.387 . . . . 0.0 111.092 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.59 -31.44 5.57 Favored Glycine 0 N--CA 1.464 0.537 0 C-N-CA 121.185 -0.531 . . . . 0.0 112.052 179.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -100.74 -11.97 19.49 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 120.663 0.268 . . . . 0.0 111.435 174.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -126.5 140.14 52.68 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.827 178.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.489 ' HG3' ' HA ' ' A' ' 18' ' ' ALA . 26.7 ttt -126.15 148.4 49.41 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.765 -173.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -98.15 174.9 6.3 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 120.933 0.396 . . . . 0.0 111.964 -177.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.4 -26.13 64.24 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 121.368 -0.444 . . . . 0.0 114.119 -176.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -63.83 -58.05 8.01 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 122.385 -0.479 . . . . 0.0 111.65 -177.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -74.03 -18.7 60.81 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 120.753 0.311 . . . . 0.0 111.603 178.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.441 ' NE1' HG13 ' A' ' 55' ' ' VAL . 58.8 t-105 -65.75 -47.6 74.69 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 121.142 0.496 . . . . 0.0 110.927 172.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.34 -36.97 79.21 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.181 0.515 . . . . 0.0 110.771 174.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 25.2 tptp -66.57 -44.73 81.46 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.842 176.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.483 HD12 ' HE3' ' A' ' 30' ' ' MET . 5.0 tt -53.86 -56.44 17.59 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.625 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.707 ' HA ' ' SG ' ' A' ' 42' ' ' CYS . 23.9 p -64.45 -32.64 74.35 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.694 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.461 ' HZ1' ' CG ' ' A' ' 46' ' ' ASP . 50.5 tptt -72.7 -36.7 67.89 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 120.589 0.233 . . . . 0.0 111.481 -179.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -73.45 -40.09 64.44 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 120.614 0.245 . . . . 0.0 111.473 177.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.707 ' SG ' ' HA ' ' A' ' 39' ' ' CYS . 27.6 p -79.27 -4.72 52.07 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.403 0.62 . . . . 0.0 110.386 172.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 22.4 mtpp 57.51 23.4 9.11 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.147 -0.933 . . . . 0.0 113.463 173.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.553 HG22 ' SG ' ' A' ' 42' ' ' CYS . 93.9 t -57.08 -42.9 80.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 168.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.576 ' HB2' HG22 ' A' ' 55' ' ' VAL . . . -86.59 65.86 9.22 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.637 177.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.461 ' CG ' ' HZ1' ' A' ' 40' ' ' LYS . 1.9 m-20 -155.62 11.09 0.31 Allowed 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.316 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -92.22 37.17 3.45 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 114.683 0.633 . . . . 0.0 114.683 -170.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt 54.2 13.29 0.58 Allowed 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 117.402 0.601 . . . . 0.0 112.337 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 42.8 t -156.75 -57.03 0.09 Allowed 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.277 0.561 . . . . 0.0 109.578 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.416 HG21 ' HB3' ' A' ' 85' ' ' LYS . 9.3 t -70.88 110.24 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.59 170.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 68.5 p -135.67 176.1 8.99 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.004 -177.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -48.19 -42.66 24.77 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 121.339 -0.458 . . . . 0.0 113.468 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.553 ' O ' HG12 ' A' ' 57' ' ' ILE . 99.0 m -64.41 -51.18 64.49 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 122.506 -0.408 . . . . 0.0 111.243 177.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -56.94 -39.26 74.21 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.17 0.509 . . . . 0.0 111.18 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.576 HG22 ' HB2' ' A' ' 45' ' ' ALA . 64.0 t -72.68 -23.89 21.13 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.684 178.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -79.14 -32.51 44.42 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.601 0.715 . . . . 0.0 109.565 178.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.553 HG12 ' O ' ' A' ' 53' ' ' THR . 16.1 mm -58.51 -47.99 86.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.276 171.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 55.5 t -60.45 -42.85 92.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.849 175.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -57.21 -39.99 76.56 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.083 0.468 . . . . 0.0 110.64 174.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 33.5 t -69.4 -35.82 76.16 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.941 177.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.413 ' HG2' ' O ' ' A' ' 57' ' ' ILE . 11.9 mmmm -61.29 -31.44 71.27 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.234 0.54 . . . . 0.0 111.535 177.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.498 HG21 ' HB1' ' A' ' 78' ' ' ALA . 20.0 m -113.11 20.82 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.943 -178.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.476 ' HA ' HG21 ' A' ' 70' ' ' ILE . 40.1 ttmt -73.84 123.17 23.68 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 120.895 0.379 . . . . 0.0 111.991 -178.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -57.74 86.66 0.01 OUTLIER Glycine 0 CA--C 1.529 0.928 0 CA-C-N 116.057 -0.52 . . . . 0.0 113.121 176.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 61.3 mttm 64.95 -78.33 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.275 0.63 . . . . 0.0 111.464 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 81.1 p -146.54 3.93 0.88 Allowed 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.447 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -69.82 151.04 46.2 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -173.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.503 ' HG3' HG12 ' A' ' 69' ' ' VAL . 1.8 ptm180 -73.13 -6.98 49.27 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.187 174.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.503 HG12 ' HG3' ' A' ' 68' ' ' ARG . 30.6 m -125.71 142.84 41.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-O 121.113 0.482 . . . . 0.0 112.221 -178.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.476 HG21 ' HA ' ' A' ' 63' ' ' LYS . 35.3 pt -113.3 151.49 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.595 176.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -86.9 169.83 12.16 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.075 0.464 . . . . 0.0 111.868 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.428 ' O ' ' HB3' ' A' ' 75' ' ' PHE . 86.9 t80 -52.07 -38.36 56.93 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -175.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.477 ' O ' ' HG3' ' A' ' 77' ' ' LYS . 33.7 tt0 -70.14 -41.36 73.99 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.445 -0.784 . . . . 0.0 110.765 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -64.78 -33.28 75.61 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.248 0.547 . . . . 0.0 110.341 177.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.428 ' HB3' ' O ' ' A' ' 72' ' ' TYR . 67.7 t80 -55.86 -46.35 78.25 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.987 171.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 23.0 mtmt -64.36 -39.37 93.74 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.886 0.374 . . . . 0.0 111.455 176.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.477 ' HG3' ' O ' ' A' ' 73' ' ' GLU . 60.7 mttm -60.18 -39.83 87.85 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.314 0.578 . . . . 0.0 110.363 176.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.498 ' HB1' HG21 ' A' ' 62' ' ' VAL . . . -63.53 -46.88 83.98 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.136 176.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 86.2 mt -58.61 -34.17 70.84 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.86 0.362 . . . . 0.0 111.228 175.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.441 ' HB3' ' O ' ' A' ' 77' ' ' LYS . 10.4 tp10 -55.47 -59.82 4.29 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.533 0.682 . . . . 0.0 110.838 176.012 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.567 ' O ' ' HG2' ' A' ' 85' ' ' LYS . 47.2 mt-10 -61.18 -47.98 83.65 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.409 178.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 69.5 mt -56.8 -33.75 67.0 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 178.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.36 -48.58 81.12 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 120.906 0.384 . . . . 0.0 110.86 175.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 31.0 p -72.72 -8.56 56.0 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 116.194 -0.457 . . . . 0.0 112.072 177.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.567 ' HG2' ' O ' ' A' ' 81' ' ' GLU . 73.1 mmtt -79.82 -51.58 8.97 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.133 0.492 . . . . 0.0 110.697 174.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 8.2 mmt180 -82.55 -58.07 3.07 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -178.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -86.59 56.88 4.2 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -170.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 66.3 mttm 61.81 175.85 0.12 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.357 0.599 . . . . 0.0 111.989 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -96.87 29.53 10.41 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.669 176.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -143.44 169.19 18.14 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 122.75 0.42 . . . . 0.0 110.861 -178.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 46.4 t 55.62 47.0 21.66 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.153 0.502 . . . . 0.0 111.529 177.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.427 ' HA ' ' HB1' ' A' ' 95' ' ' ALA . 22.0 pttp -64.19 -20.22 65.87 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -174.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -63.08 -59.53 4.67 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.296 0.57 . . . . 0.0 109.871 172.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -57.3 -43.75 83.49 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.452 175.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.427 ' HB1' ' HA ' ' A' ' 92' ' ' LYS . . . -58.51 -46.2 87.24 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.026 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -61.04 -53.79 52.81 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.944 0.402 . . . . 0.0 111.212 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -57.15 -37.9 72.75 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 120.808 0.337 . . . . 0.0 111.842 176.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.24 -49.82 68.2 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -179.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 12.5 tt -63.7 -39.94 87.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-O 121.111 0.481 . . . . 0.0 110.874 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 36.5 t -61.3 -39.33 90.07 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.037 0.446 . . . . 0.0 110.927 174.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -60.75 -39.35 88.39 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.677 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 93.1 mt -66.8 -36.02 81.41 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.706 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 49.9 t -83.15 -37.07 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -178.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -57.21 104.09 0.15 Allowed 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -174.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 94.81 13.56 52.83 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-N 116.154 -0.475 . . . . 0.0 113.678 174.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 46.2 tttp -86.3 161.35 18.79 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.973 0.416 . . . . 0.0 111.273 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -73.28 136.11 78.99 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.777 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.61 73.46 2.3 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.468 2.112 . . . . 0.0 112.015 175.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.49 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.781 -175.149 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.7 tp . . . . . 0 CA--C 1.544 0.713 0 CA-C-O 120.895 0.378 . . . . 0.0 110.925 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -49.49 -37.67 27.28 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -176.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.35 -29.92 60.87 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 121.417 -0.42 . . . . 0.0 113.74 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 30.9 tp -73.75 -48.38 32.18 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 122.324 -0.515 . . . . 0.0 111.031 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -65.87 -30.05 70.59 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.766 0.317 . . . . 0.0 110.642 176.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -59.27 -55.24 37.33 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.743 0.306 . . . . 0.0 110.444 174.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.7 m -57.94 -42.28 84.54 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.236 176.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.407 ' CD1' ' HE3' ' A' ' 30' ' ' MET . 86.6 t80 -55.73 -56.07 24.87 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.875 0.369 . . . . 0.0 111.064 176.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 57.3 ttt180 -56.19 -51.13 69.14 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.396 0.617 . . . . 0.0 110.87 177.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -52.91 -37.11 60.36 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 114.903 -1.044 . . . . 0.0 112.213 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -85.51 -32.51 22.17 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.697 176.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.76 -39.61 65.51 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -175.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.49 HG22 ' HB2' ' A' ' 25' ' ' ALA . 0.2 OUTLIER -103.74 7.45 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -178.927 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 60.0 t60 -35.46 -48.7 0.5 Allowed 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -174.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -138.27 22.44 3.06 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 120.286 -0.959 . . . . 0.0 113.604 -178.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.519 ' HB2' ' HB3' ' A' ' 25' ' ' ALA . 8.9 m-20 -121.55 118.7 29.6 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 116.886 0.343 . . . . 0.0 110.863 -176.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -46.02 -46.49 15.95 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 123.406 2.737 . . . . 0.0 114.102 -176.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -105.29 -34.09 7.99 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.703 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.519 ' HB3' ' HB2' ' A' ' 22' ' ' ASP . . . 36.99 -90.11 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -172.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 28.0 t 167.76 -45.36 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.825 0.85 . . . . 0.0 110.099 -174.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 88.28 -52.18 4.04 Favored Glycine 0 C--N 1.334 0.462 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.257 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 20.4 tp60 -91.26 -13.26 33.04 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 120.818 0.342 . . . . 0.0 111.376 178.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -128.03 143.99 51.09 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.788 175.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.407 ' HE3' ' CD1' ' A' ' 14' ' ' PHE . 49.2 ttm -115.24 143.39 45.32 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.285 0.564 . . . . 0.0 112.324 -175.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.44 HD21 ' HB2' ' A' ' 33' ' ' LYS . 0.8 OUTLIER -93.78 154.75 17.59 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.892 175.23 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -55.52 -26.64 45.92 Favored Glycine 0 CA--C 1.53 0.97 0 CA-C-N 116.122 -0.49 . . . . 0.0 114.104 -176.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.44 ' HB2' HD21 ' A' ' 31' ' ' ASN . 91.1 mttt -51.07 -60.86 2.65 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 122.026 0.917 . . . . 0.0 110.809 175.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 63.4 m-20 -73.1 -33.97 65.9 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 114.51 -1.223 . . . . 0.0 111.553 -174.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 41.1 t-105 -58.62 -45.21 89.7 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.054 0.454 . . . . 0.0 111.341 174.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.509 ' HA ' HG11 ' A' ' 55' ' ' VAL . . . -60.52 -47.99 83.74 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 120.974 0.416 . . . . 0.0 111.337 176.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -60.7 -37.32 81.26 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.492 176.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.3 tt -59.23 -45.42 91.18 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.336 178.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.656 ' SG ' ' HB ' ' A' ' 44' ' ' VAL . 44.4 t -54.33 -44.41 72.07 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.945 0.402 . . . . 0.0 111.038 175.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.828 ' HZ3' ' HB3' ' A' ' 40' ' ' LYS . 4.5 ttpm? -58.98 -54.64 44.8 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.746 176.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -65.55 -35.77 81.84 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -175.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.559 ' SG ' ' HB3' ' A' ' 102' ' ' LEU . 6.0 t -77.84 -9.87 59.27 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 120.799 0.333 . . . . 0.0 111.452 173.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm 69.05 26.95 5.48 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.197 0.599 . . . . 0.0 112.139 174.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.656 ' HB ' ' SG ' ' A' ' 39' ' ' CYS . 60.1 t -68.15 -35.77 72.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 121.054 0.454 . . . . 0.0 111.212 178.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.63 100.39 7.8 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.007 0.432 . . . . 0.0 111.683 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -99.91 -25.67 14.26 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.679 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 134.89 -78.99 0.33 Allowed Glycine 0 CA--C 1.529 0.921 0 C-N-CA 120.964 -0.636 . . . . 0.0 113.624 178.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -92.06 -7.32 49.06 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -174.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.4 t -102.35 -49.55 3.85 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.181 0.515 . . . . 0.0 110.041 173.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.423 HG12 HG12 ' A' ' 44' ' ' VAL . 99.1 t -139.65 130.94 33.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.948 176.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.447 ' O ' HG23 ' A' ' 55' ' ' VAL . 8.9 t -139.19 -177.86 5.1 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 116.766 -0.197 . . . . 0.0 110.68 173.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -46.19 -46.46 15.75 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 121.579 -0.344 . . . . 0.0 113.847 -177.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.513 ' O ' HG12 ' A' ' 57' ' ' ILE . 41.6 m -51.52 -54.81 23.4 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.035 0.445 . . . . 0.0 111.517 176.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -58.93 -34.56 71.86 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.392 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.509 HG11 ' HA ' ' A' ' 36' ' ' ALA . 65.5 t -60.21 -35.72 63.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.286 177.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -74.48 -38.5 62.9 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.562 0.696 . . . . 0.0 110.17 178.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.519 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 12.1 mm -61.41 -51.82 68.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.903 178.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 87.8 t -57.69 -41.87 80.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-O 120.912 0.387 . . . . 0.0 111.125 177.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -56.76 -42.26 79.06 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 120.915 0.388 . . . . 0.0 110.563 175.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 47.6 t -69.33 -36.76 77.26 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.392 177.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.519 ' HG2' ' O ' ' A' ' 57' ' ' ILE . 1.8 mmmp? -56.33 -35.67 67.86 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.875 0.369 . . . . 0.0 111.261 178.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.48 HG22 ' HB2' ' A' ' 78' ' ' ALA . 22.4 m -107.42 -2.7 10.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -177.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -70.74 101.5 2.1 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.024 0.44 . . . . 0.0 112.142 -178.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -133.98 -146.9 5.55 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-N 116.216 -0.447 . . . . 0.0 113.285 177.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 62.1 mttp 53.37 -103.05 0.15 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.842 0.457 . . . . 0.0 112.031 -176.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 88.0 p -109.0 -1.87 18.63 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.735 0.302 . . . . 0.0 110.899 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 66.0 -168.89 0.2 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.641 -177.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 20.3 tpp180 73.06 -51.56 0.71 Allowed 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.375 0.607 . . . . 0.0 111.034 -176.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 12.6 m -132.51 149.07 31.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.862 -178.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 37.5 pt -113.13 140.6 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-O 120.668 0.271 . . . . 0.0 111.113 177.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -85.37 177.73 7.7 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.9 -0.5 . . . . 0.0 111.341 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -55.1 -37.05 66.35 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -177.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.548 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 42.5 mt-10 -61.08 -53.34 58.34 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.189 0.519 . . . . 0.0 111.497 177.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -69.43 -20.77 63.77 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.243 0.544 . . . . 0.0 110.791 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -69.84 -54.87 11.56 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.959 173.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.548 ' HE2' ' HA ' ' A' ' 73' ' ' GLU . 63.8 pttt -62.54 -30.4 71.27 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.091 0.472 . . . . 0.0 110.533 177.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -64.42 -40.56 96.0 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.851 173.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.48 ' HB2' HG22 ' A' ' 62' ' ' VAL . . . -67.73 -38.73 83.95 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.03 0.443 . . . . 0.0 111.374 175.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 80.7 mt -59.98 -41.09 91.23 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.103 176.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -60.29 -42.49 95.58 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 120.664 0.269 . . . . 0.0 111.021 176.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -54.14 -62.81 1.42 Allowed 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.041 0.448 . . . . 0.0 110.769 174.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.507 HD12 HG13 ' A' ' 44' ' ' VAL . 90.5 mt -52.43 -43.98 65.18 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.434 178.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.13 -54.33 47.17 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.85 -0.613 . . . . 0.0 112.21 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.457 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 63.4 p -64.18 -20.55 66.09 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -177.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -96.72 -23.1 16.59 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 65.5 mtp85 -97.1 -50.63 4.52 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 121.797 -0.564 . . . . 0.0 111.744 175.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -86.75 31.45 0.69 Allowed 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.029 0.442 . . . . 0.0 111.331 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.457 ' HB3' ' O ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -71.63 172.55 9.47 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -177.857 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 78.62 24.36 62.85 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 121.063 -0.589 . . . . 0.0 113.183 -178.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -168.86 -168.75 0.9 Allowed 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 120.826 0.346 . . . . 0.0 111.155 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 65.8 m -56.07 120.72 7.94 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -177.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -55.96 -33.21 64.56 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.321 175.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -54.76 -56.11 22.8 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.204 0.526 . . . . 0.0 110.97 174.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -63.91 -29.75 70.9 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.537 -178.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.53 -57.44 12.67 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.961 0.41 . . . . 0.0 111.017 176.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.521 ' O ' HG23 ' A' ' 99' ' ' ILE . 80.8 t80 -64.94 -35.99 82.95 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.218 0.532 . . . . 0.0 110.791 177.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -55.08 -47.5 74.8 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.461 0.648 . . . . 0.0 111.052 176.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -71.78 -42.08 67.57 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.518 -177.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.521 HG23 ' O ' ' A' ' 96' ' ' PHE . 7.3 tp -61.62 -34.02 60.01 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 CA-C-O 121.351 0.596 . . . . 0.0 110.214 178.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 35.8 t -64.67 -42.71 95.19 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.946 173.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -55.41 -35.12 65.01 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.123 0.487 . . . . 0.0 111.846 176.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.559 ' HB3' ' SG ' ' A' ' 42' ' ' CYS . 97.5 mt -73.29 -48.02 37.97 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 49.1 t -86.67 -53.59 9.93 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -173.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.22 127.39 24.27 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -171.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.59 -39.32 3.1 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-N 116.035 -0.529 . . . . 0.0 113.841 176.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 58.9 tttp -63.05 162.19 11.94 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-O 121.504 0.668 . . . . 0.0 112.799 -174.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.466 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 0.3 OUTLIER -124.48 161.94 45.2 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.679 175.019 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.466 ' HD2' ' HB2' ' A' ' 107' ' ' GLU . 19.0 Cg_endo -58.17 155.69 33.33 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.515 2.143 . . . . 0.0 112.922 176.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.56 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -179.105 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.504 ' HB ' ' HB2' ' A' ' 10' ' ' LEU . 42.6 mm . . . . . 0 CA--C 1.545 0.755 0 CA-C-O 120.629 0.252 . . . . 0.0 111.512 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 72.37 -58.93 0.58 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.463 0.705 . . . . 0.0 110.812 -175.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -63.79 -16.73 59.61 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 120.955 -0.641 . . . . 0.0 112.393 172.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.504 ' HB2' ' HB ' ' A' ' 7' ' ' ILE . 53.7 tp -70.95 -54.7 10.41 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 122.693 -0.298 . . . . 0.0 111.198 178.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.453 ' HG3' ' N ' ' A' ' 12' ' ' GLU . 7.7 pt-20 -61.33 -42.22 98.32 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.788 0.328 . . . . 0.0 110.82 177.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.453 ' N ' ' HG3' ' A' ' 11' ' ' GLU . 1.7 tm-20 -64.5 -34.24 77.75 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-O 120.962 0.411 . . . . 0.0 110.921 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.543 ' HG ' HG11 ' A' ' 103' ' ' VAL . 23.2 t -72.4 -44.12 62.93 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 120.744 0.307 . . . . 0.0 111.143 176.227 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -56.1 -50.5 70.87 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.141 0.496 . . . . 0.0 110.067 175.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.491 ' O ' HG12 ' A' ' 19' ' ' ILE . 11.2 ttt85 -53.55 -43.04 68.13 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.706 172.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 9.6 tppt? -54.0 -46.21 71.68 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.053 0.454 . . . . 0.0 111.581 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -79.93 -33.63 39.53 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 177.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.13 -38.41 91.08 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.893 0.377 . . . . 0.0 111.781 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.491 HG12 ' O ' ' A' ' 15' ' ' ARG . 23.8 pt -83.26 -7.86 11.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 121.016 0.436 . . . . 0.0 111.689 178.178 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -64.69 86.7 0.05 Allowed 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.295 0.569 . . . . 0.0 110.748 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 142.02 -40.25 1.31 Allowed Glycine 0 CA--C 1.524 0.613 0 CA-C-N 115.685 -0.688 . . . . 0.0 112.048 -178.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -128.63 111.39 19.09 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-O 120.727 0.298 . . . . 0.0 110.806 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.46 -0.19 9.83 Favored 'Trans proline' 0 CA--C 1.546 1.079 0 C-N-CA 122.5 2.133 . . . . 0.0 114.425 -176.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.417 ' HE2' ' HB2' ' A' ' 24' ' ' LYS . 2.8 mppt? -100.35 -28.38 12.98 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 121.855 -0.528 . . . . 0.0 111.04 178.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.69 134.96 55.17 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 43.1 m -65.54 -35.21 80.19 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.73 178.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.07 45.88 2.52 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-N 116.203 -0.453 . . . . 0.0 113.81 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -103.56 -16.32 15.56 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 122.374 -0.486 . . . . 0.0 111.326 179.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -136.56 154.23 50.76 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.008 -174.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 49.1 ttm -143.6 143.59 31.56 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 120.92 0.39 . . . . 0.0 112.003 -174.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 23.5 p30 -90.09 166.02 13.66 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.063 0.459 . . . . 0.0 111.52 177.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.42 -20.31 61.0 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 121.251 -0.499 . . . . 0.0 113.236 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.1 mmtm -69.07 -55.38 10.95 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.729 0.3 . . . . 0.0 111.619 177.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -65.67 -34.78 79.02 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.156 176.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 41.2 t-105 -62.45 -48.28 80.34 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 122.602 0.361 . . . . 0.0 111.597 175.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.46 -46.48 89.94 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.117 0.484 . . . . 0.0 111.112 177.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 57.6 tttp -64.46 -35.03 79.62 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.975 178.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.3 tt -59.16 -45.06 91.98 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.311 175.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 73.9 m -60.08 -46.01 91.0 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.407 177.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -60.33 -52.43 65.3 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.578 0.228 . . . . 0.0 111.586 177.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -53.66 -41.68 67.09 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.102 0.477 . . . . 0.0 111.012 177.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.706 ' SG ' ' HA ' ' A' ' 103' ' ' VAL . 58.7 m -89.73 1.09 56.52 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.983 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp 55.56 33.25 20.74 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 122.88 0.472 . . . . 0.0 112.104 177.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.445 ' HA ' ' NH1' ' A' ' 86' ' ' ARG . 55.5 t -72.69 -29.52 30.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.735 178.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -97.36 102.54 14.33 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.815 0.341 . . . . 0.0 111.778 -179.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -57.59 -50.46 73.05 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.484 0.659 . . . . 0.0 112.194 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.02 -16.72 60.62 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 -166.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.743 ' HZ2' ' HB3' ' A' ' 48' ' ' LYS . 6.8 ttpm? -96.44 -64.09 1.08 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.239 0.616 . . . . 0.0 110.618 176.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 45.6 p -95.75 -66.53 0.9 Allowed 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.692 177.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 52.3 t -82.92 98.9 5.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 170.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 80.9 p -89.65 -84.54 0.22 Allowed 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -169.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -152.89 -39.05 0.03 OUTLIER Glycine 0 C--O 1.236 0.229 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.638 ' O ' HG13 ' A' ' 57' ' ' ILE . 26.9 p -48.95 -53.96 17.58 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.012 0.434 . . . . 0.0 109.911 172.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.469 ' O ' HG23 ' A' ' 58' ' ' VAL . 6.2 m-20 -48.43 -49.17 36.25 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.231 -175.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.3 t -60.5 -40.08 83.21 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.277 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -75.35 -43.74 48.94 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.582 0.706 . . . . 0.0 110.196 -176.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.638 HG13 ' O ' ' A' ' 53' ' ' THR . 8.0 mt -62.49 -45.24 99.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.117 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 54' ' ' ASP . 79.4 t -59.66 -41.88 86.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-O 120.554 0.216 . . . . 0.0 111.183 176.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.415 ' O ' ' HG3' ' A' ' 63' ' ' LYS . 76.1 t80 -55.2 -40.93 71.35 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.898 0.38 . . . . 0.0 111.5 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 51.6 p -80.77 -34.13 34.44 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.206 0.527 . . . . 0.0 110.998 177.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 55.3 tttp -65.81 -31.3 72.19 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.234 -174.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.7 m -88.33 -3.7 9.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.565 ' HD3' ' O ' ' A' ' 66' ' ' SER . 96.7 mttt -72.12 163.28 28.18 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -178.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -105.07 -98.92 2.57 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.981 176.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -80.08 75.46 6.84 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 122.44 -0.447 . . . . 0.0 111.132 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.565 ' O ' ' HD3' ' A' ' 63' ' ' LYS . 55.0 m 59.76 -79.09 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 122.334 0.254 . . . . 0.0 110.819 -175.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 64.28 129.3 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 114.09 1.144 . . . . 0.0 114.09 173.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.2 ptm85 -81.95 -21.67 37.1 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.255 173.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 28.3 m -136.41 151.72 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.076 -178.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 39.4 pt -99.6 161.46 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-O 120.589 0.233 . . . . 0.0 110.776 176.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -110.79 166.97 10.59 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.09 0.471 . . . . 0.0 111.49 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -46.46 -36.79 6.96 Favored 'General case' 0 CA--C 1.554 1.133 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -177.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -73.3 -36.67 66.32 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 121.619 -0.676 . . . . 0.0 112.029 -178.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -72.28 -29.91 64.33 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.356 0.598 . . . . 0.0 109.981 174.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -58.64 -44.31 90.04 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.587 176.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -47.7 -61.05 2.13 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.162 0.506 . . . . 0.0 111.604 174.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -64.88 -29.38 70.33 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.309 -176.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.26 -49.86 75.38 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.25 0.548 . . . . 0.0 110.98 173.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 62.2 mt -64.5 -41.7 96.28 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.486 176.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.502 ' O ' HG22 ' A' ' 84' ' ' THR . 31.8 tt0 -60.33 -40.74 91.7 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.54 -178.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -62.31 -59.2 5.35 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 120.85 0.357 . . . . 0.0 110.347 177.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 90.4 mt -57.03 -29.52 63.44 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.974 0.416 . . . . 0.0 111.394 178.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.41 -39.34 90.36 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.648 174.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.502 HG22 ' O ' ' A' ' 80' ' ' GLU . 8.6 p -68.63 -34.56 75.95 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 121.066 0.46 . . . . 0.0 110.986 178.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -69.53 -36.26 76.22 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.71 175.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.445 ' NH1' ' HA ' ' A' ' 44' ' ' VAL . 3.3 tpt180 -85.58 -62.24 1.57 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.341 0.591 . . . . 0.0 111.494 -177.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -96.67 93.44 6.73 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.387 -176.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -92.12 27.92 2.03 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 121.231 0.538 . . . . 0.0 110.653 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -60.03 -78.73 0.13 Allowed Glycine 0 CA--C 1.529 0.921 0 CA-C-N 116.028 -0.533 . . . . 0.0 113.957 -175.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.9 pttp -162.79 -60.62 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -177.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 54.7 m -91.32 132.9 35.86 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -173.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -64.95 -34.92 79.57 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.031 0.443 . . . . 0.0 110.718 176.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -57.2 -52.92 63.37 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.238 0.542 . . . . 0.0 110.484 171.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -55.73 -46.26 77.82 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.287 177.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.48 -48.94 79.13 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.97 0.414 . . . . 0.0 111.274 177.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -65.49 -36.54 84.15 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.022 178.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.463 ' O ' ' HG3' ' A' ' 101' ' ' GLN . 23.6 t70 -57.02 -62.18 1.93 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.391 0.615 . . . . 0.0 110.964 176.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -53.47 -46.85 70.09 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.607 -178.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.458 ' O ' HG21 ' A' ' 103' ' ' VAL . 16.7 tt -66.53 -38.45 81.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 O-C-N 122.056 -0.403 . . . . 0.0 111.232 -179.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 93.5 m -64.46 -35.96 82.62 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.783 0.325 . . . . 0.0 111.043 176.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.463 ' HG3' ' O ' ' A' ' 97' ' ' ASP . 88.1 mt-30 -63.69 -31.87 73.18 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 120.985 0.422 . . . . 0.0 111.09 176.014 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.9 mt -77.7 -9.62 59.09 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.918 177.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.706 ' HA ' ' SG ' ' A' ' 42' ' ' CYS . 69.4 t -108.79 -43.79 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -177.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -50.03 87.37 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 -170.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 48.1 65.27 2.58 Favored Glycine 0 CA--C 1.531 1.035 0 N-CA-C 115.084 0.794 . . . . 0.0 115.084 170.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm -79.22 -82.33 0.1 Allowed 'General case' 0 N--CA 1.471 0.612 0 O-C-N 122.273 -0.545 . . . . 0.0 111.845 178.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.514 ' N ' ' HD3' ' A' ' 108' ' ' PRO . 10.9 pt-20 -149.65 32.38 0.07 OUTLIER Pre-proline 0 CA--C 1.554 1.128 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.514 ' HD3' ' N ' ' A' ' 107' ' ' GLU . 71.7 Cg_endo -76.32 149.75 31.87 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.001 1.801 . . . . 0.0 113.424 -173.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.759 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 178.754 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.4 ' O ' ' HB1' ' A' ' 8' ' ' ALA . 36.3 pt . . . . . 0 N--CA 1.468 0.457 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.4 ' HB1' ' O ' ' A' ' 7' ' ' ILE . . . 74.81 -48.56 0.65 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.205 0.602 . . . . 0.0 111.424 -176.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.2 -22.89 45.29 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 121.445 -0.407 . . . . 0.0 113.091 175.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.676 HD22 ' SG ' ' A' ' 100' ' ' CYS . 56.6 tp -74.65 -43.1 56.99 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 122.477 -0.425 . . . . 0.0 110.602 176.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -59.26 -42.32 90.89 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.307 0.575 . . . . 0.0 110.26 175.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.498 ' HG2' ' HE2' ' A' ' 16' ' ' LYS . 34.1 tt0 -61.38 -55.31 32.96 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.141 174.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.8 t -58.39 -35.14 71.55 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.439 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -59.49 -46.44 88.81 Favored 'General case' 0 C--O 1.225 -0.231 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.859 177.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.514 ' O ' HG12 ' A' ' 19' ' ' ILE . 97.8 mtt180 -60.48 -45.63 93.04 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.561 176.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.498 ' HE2' ' HG2' ' A' ' 12' ' ' GLU . 67.7 mttm -54.87 -37.72 66.6 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.891 0.377 . . . . 0.0 111.774 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -83.17 -36.56 24.6 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.599 174.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.03 -51.55 67.55 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -175.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.514 HG12 ' O ' ' A' ' 15' ' ' ARG . 29.1 pt -82.62 4.49 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 CA-C-O 121.056 0.455 . . . . 0.0 111.609 -178.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 39.5 t-80 -65.08 107.1 1.43 Allowed 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.903 177.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 115.51 -14.63 17.81 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 121.295 -0.478 . . . . 0.0 112.997 -177.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -154.68 118.1 2.53 Favored Pre-proline 0 CA--C 1.542 0.649 0 O-C-N 122.547 -0.384 . . . . 0.0 110.577 176.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -66.09 -14.55 44.91 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.459 2.106 . . . . 0.0 113.992 -174.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -100.07 -52.85 3.3 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 120.74 0.305 . . . . 0.0 110.923 178.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.472 ' HB1' HG22 ' A' ' 19' ' ' ILE . . . 33.56 -115.14 0.07 Allowed 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.897 -175.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 63.8 m -157.93 -56.5 0.07 Allowed 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 122.768 0.427 . . . . 0.0 110.674 176.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.43 7.7 8.11 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 120.635 -0.793 . . . . 0.0 114.687 173.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -136.65 7.35 3.01 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 117.533 0.666 . . . . 0.0 111.531 178.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.431 ' HB3' HG22 ' A' ' 69' ' ' VAL . 33.9 mp0 -122.4 148.21 45.37 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 122.893 0.477 . . . . 0.0 111.536 -175.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.515 ' SD ' ' HB2' ' A' ' 34' ' ' ASN . 39.0 tpp -137.74 131.68 31.67 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.974 178.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 22.1 p30 -92.14 163.3 13.99 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.77 0.319 . . . . 0.0 111.59 178.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -55.88 -29.04 54.33 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 121.163 -0.542 . . . . 0.0 113.111 178.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -57.8 -61.35 2.59 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.072 0.463 . . . . 0.0 111.886 176.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.515 ' HB2' ' SD ' ' A' ' 30' ' ' MET . 24.7 m-20 -68.71 -34.37 75.53 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.358 -179.068 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.438 ' CD1' ' HB2' ' A' ' 59' ' ' PHE . 56.1 t-105 -60.11 -49.38 77.89 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.976 0.417 . . . . 0.0 111.631 178.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.92 -43.7 94.73 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 121.032 0.444 . . . . 0.0 111.228 177.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -66.57 -38.72 87.67 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.003 177.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.2 tt -56.38 -55.01 38.88 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.282 0.563 . . . . 0.0 110.592 -178.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 26.7 p -66.81 -40.88 88.22 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.782 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 58.0 tttp -76.35 -20.61 57.05 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-O 121.008 0.432 . . . . 0.0 111.715 -177.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -80.29 -41.72 24.43 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.326 0.584 . . . . 0.0 110.478 177.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.632 ' SG ' ' HA ' ' A' ' 103' ' ' VAL . 33.9 m -89.98 -6.83 55.23 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.689 -178.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.5 55.67 2.76 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.634 0.731 . . . . 0.0 111.418 -178.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 56.2 t -92.54 -36.77 7.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.476 173.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.467 ' HA ' HG21 ' A' ' 50' ' ' VAL . . . -107.18 78.44 1.22 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.221 0.534 . . . . 0.0 111.108 177.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.8 p-10 -152.66 4.03 0.35 Allowed 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.21 -174.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -79.79 47.04 3.22 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 121.094 -0.574 . . . . 0.0 113.534 -178.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt 50.53 21.53 0.88 Allowed 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 177.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 60.2 p -146.93 -63.44 0.29 Allowed 'General case' 0 N--CA 1.469 0.499 0 O-C-N 121.775 -0.578 . . . . 0.0 110.633 -176.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.467 HG21 ' HA ' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -48.24 -83.31 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.887 0 CA-C-N 115.221 -0.9 . . . . 0.0 112.514 174.039 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.51 ' O ' HG23 ' A' ' 55' ' ' VAL . 12.4 p 58.33 -174.94 0.08 Allowed 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.418 0.687 . . . . 0.0 112.455 177.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -56.79 -29.5 58.57 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 121.35 -0.452 . . . . 0.0 113.279 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.529 ' O ' HG13 ' A' ' 57' ' ' ILE . 83.7 m -58.01 -58.92 6.27 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 122.626 -0.338 . . . . 0.0 111.377 178.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -63.3 -39.04 93.46 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.616 -0.265 . . . . 0.0 110.927 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 51' ' ' THR . 74.5 t -48.3 -41.13 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 N-CA-C 112.249 0.462 . . . . 0.0 112.249 175.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -74.17 -38.21 63.74 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.01 0.433 . . . . 0.0 110.591 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.529 HG13 ' O ' ' A' ' 53' ' ' THR . 10.1 mt -62.06 -45.41 98.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.102 178.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.472 HG21 ' HG2' ' A' ' 81' ' ' GLU . 86.9 t -63.19 -49.69 82.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.89 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.438 ' HB2' ' CD1' ' A' ' 35' ' ' TRP . 77.2 t80 -58.11 -48.34 80.5 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.188 0.518 . . . . 0.0 110.853 -179.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 90.5 p -68.15 -30.19 69.26 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.146 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -64.58 -46.64 81.83 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.574 177.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.434 HG22 HG22 ' A' ' 70' ' ' ILE . 35.7 m -88.58 -13.77 9.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -178.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -74.71 138.91 43.08 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.92 0.39 . . . . 0.0 111.562 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -66.96 167.05 39.44 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.836 176.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -64.77 -47.97 76.21 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 122.531 -0.394 . . . . 0.0 111.921 -178.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.5 m -99.53 3.75 45.64 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 120.85 0.357 . . . . 0.0 111.584 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -80.26 135.29 36.21 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 120.947 0.403 . . . . 0.0 111.808 -178.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? -87.01 -20.01 27.85 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.057 0.456 . . . . 0.0 110.85 175.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.431 HG22 ' HB3' ' A' ' 29' ' ' GLU . 29.3 m -137.62 174.54 11.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.579 -176.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.434 HG22 HG22 ' A' ' 62' ' ' VAL . 36.4 pt -111.6 144.12 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.711 173.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -94.01 156.61 16.51 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 120.858 0.361 . . . . 0.0 111.777 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.473 ' O ' ' HB3' ' A' ' 75' ' ' PHE . 49.9 t80 -49.04 -39.86 28.95 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -173.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -60.94 -41.91 97.17 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 122.11 -0.369 . . . . 0.0 111.659 178.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -73.18 -28.1 62.02 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.213 0.53 . . . . 0.0 110.519 176.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.473 ' HB3' ' O ' ' A' ' 72' ' ' TYR . 85.3 t80 -58.99 -36.55 75.08 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.969 175.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -61.29 -43.41 98.93 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.462 0.172 . . . . 0.0 111.17 175.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 28.3 mtmm -64.07 -38.1 89.85 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.997 0.427 . . . . 0.0 110.947 175.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.71 -41.07 97.12 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.256 176.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 86.4 mt -64.09 -44.42 92.41 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.105 175.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -56.48 -45.99 80.67 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.173 0.511 . . . . 0.0 110.555 176.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.472 ' HG2' HG21 ' A' ' 58' ' ' VAL . 37.7 tp10 -55.45 -58.74 6.51 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.573 176.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 86.4 mt -62.68 -44.84 95.22 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -178.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.26 -44.27 92.41 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.659 ' HA ' ' HE3' ' A' ' 90' ' ' LYS . 40.1 p -64.54 -35.4 80.86 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -89.93 -20.08 23.77 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 112.991 0.738 . . . . 0.0 112.991 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 33.5 tpt85 -82.97 -53.6 5.71 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.689 0.757 . . . . 0.0 110.826 178.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -94.52 117.89 30.82 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.156 175.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -82.05 -62.64 1.57 Allowed 'General case' 0 CA--C 1.539 0.557 0 O-C-N 122.292 -0.255 . . . . 0.0 111.386 -177.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -82.16 94.53 1.69 Allowed Glycine 0 CA--C 1.528 0.901 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.463 176.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.659 ' HE3' ' HA ' ' A' ' 84' ' ' THR . 0.3 OUTLIER -157.51 171.7 19.88 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -174.725 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 46.7 t -110.53 179.45 4.07 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.182 169.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -59.95 -76.43 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 120.946 0.403 . . . . 0.0 111.841 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 -60.87 -36.21 78.58 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.882 -176.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -56.78 -47.4 80.23 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.829 0.347 . . . . 0.0 111.577 177.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.56 -40.31 73.43 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.868 0.366 . . . . 0.0 111.315 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -63.37 -47.33 82.52 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.907 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -56.38 -49.56 74.11 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.452 0.168 . . . . 0.0 111.063 172.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -53.62 -54.39 38.36 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 15.2 tt -62.33 -33.35 58.59 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-O 120.94 0.4 . . . . 0.0 111.435 -179.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' CYS . . . . . 0.676 ' SG ' HD22 ' A' ' 10' ' ' LEU . 97.2 m -68.6 -38.06 80.31 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.925 0.393 . . . . 0.0 111.083 176.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -67.53 -31.19 71.13 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.706 179.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 96.7 mt -60.86 -35.46 76.65 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.255 0.55 . . . . 0.0 110.774 176.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.632 ' HA ' ' SG ' ' A' ' 42' ' ' CYS . 19.3 t -87.69 -78.07 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.785 178.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 41.05 26.72 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 178.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 61.1 45.59 96.25 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 121.282 -0.485 . . . . 0.0 113.798 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.542 ' HG3' ' HG2' ' A' ' 107' ' ' GLU . 21.9 pttp -70.85 -40.75 72.18 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.754 0.649 . . . . 0.0 112.754 -177.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.542 ' HG2' ' HG3' ' A' ' 106' ' ' LYS . 14.7 pt-20 -167.88 50.44 0.19 Allowed Pre-proline 0 N--CA 1.477 0.884 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -177.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.483 ' HD3' ' N ' ' A' ' 107' ' ' GLU . 64.1 Cg_exo -42.87 120.86 2.01 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 123.225 2.617 . . . . 0.0 113.634 -174.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.653 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.732 -172.331 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.415 ' O ' ' HB1' ' A' ' 8' ' ' ALA . 26.3 pt . . . . . 0 CA--C 1.534 0.334 0 CA-C-O 120.412 0.148 . . . . 0.0 111.037 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.415 ' HB1' ' O ' ' A' ' 7' ' ' ILE . . . 71.26 -43.22 0.56 Allowed 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 120.792 0.329 . . . . 0.0 110.464 -166.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -73.82 -34.84 55.6 Favored Glycine 0 C--N 1.337 0.613 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 171.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.559 HD21 ' SG ' ' A' ' 100' ' ' CYS . 59.1 tp -62.66 -37.28 85.76 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.091 -0.555 . . . . 0.0 110.273 170.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -68.06 -40.92 82.67 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.821 176.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -54.07 -58.17 8.33 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.032 0.444 . . . . 0.0 110.577 173.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.6 m -59.83 -42.37 93.4 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.511 178.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 94.0 t80 -53.79 -46.75 71.13 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.059 176.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.526 ' O ' HG12 ' A' ' 19' ' ' ILE . 21.7 ttt180 -66.3 -46.19 77.78 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.224 178.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 39.4 mtpt -57.84 -27.06 62.85 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 116.301 -0.408 . . . . 0.0 112.067 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -86.34 -44.66 11.9 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.495 172.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.08 -43.69 74.15 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -177.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.526 HG12 ' O ' ' A' ' 15' ' ' ARG . 29.0 pt -101.05 14.91 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-O 120.976 0.417 . . . . 0.0 111.594 -178.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.413 ' CD2' ' HG2' ' A' ' 108' ' ' PRO . 27.4 t-80 -66.5 -33.31 75.4 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -175.133 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -135.54 22.9 3.47 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.838 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.455 ' CG ' ' HZ1' ' A' ' 33' ' ' LYS . 12.0 m-20 -138.3 101.6 8.29 Favored Pre-proline 0 CA--C 1.542 0.654 0 CA-C-O 120.871 0.367 . . . . 0.0 110.878 -177.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.21 -19.96 43.88 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 122.683 2.255 . . . . 0.0 113.955 -174.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 49.2 mmtm -100.6 6.6 44.18 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -178.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -81.5 138.46 35.47 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.13 0.49 . . . . 0.0 111.736 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 93.2 p -70.2 -60.43 2.29 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.437 0.637 . . . . 0.0 111.1 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 145.99 -26.73 1.75 Allowed Glycine 0 CA--C 1.522 0.48 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.245 -178.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -85.84 -15.55 41.53 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 111.752 0.278 . . . . 0.0 111.752 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.494 ' HB3' HG21 ' A' ' 69' ' ' VAL . 50.3 mt-10 -111.13 116.46 31.15 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.747 0.308 . . . . 0.0 111.375 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 48.1 ttm -107.22 139.49 41.59 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.179 0.514 . . . . 0.0 111.846 178.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.596 ' OD1' ' HB3' ' A' ' 33' ' ' LYS . 7.6 p30 -95.58 165.74 12.18 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.351 177.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.46 -30.22 73.81 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 121.562 -0.352 . . . . 0.0 113.842 -177.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.596 ' HB3' ' OD1' ' A' ' 31' ' ' ASN . 29.7 ttpt -58.39 -61.21 2.75 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.036 0.446 . . . . 0.0 111.565 177.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 64.2 m-20 -68.24 -31.96 71.82 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 122.281 -0.262 . . . . 0.0 111.57 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 32.2 t-105 -61.99 -38.89 90.31 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-O 120.953 0.406 . . . . 0.0 111.273 175.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.504 ' HA ' HG11 ' A' ' 55' ' ' VAL . . . -61.59 -48.85 79.07 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 120.984 0.421 . . . . 0.0 110.897 175.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.3 mtpp -67.6 -30.55 70.17 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.957 177.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.9 tt -56.9 -46.68 81.79 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.98 0.419 . . . . 0.0 110.169 177.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 79.0 m -64.32 -44.93 90.0 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.049 0.452 . . . . 0.0 111.623 176.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -68.17 -58.31 4.66 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -177.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.31 -23.84 64.51 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 178.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 86.0 m -95.86 -5.05 42.53 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 122.044 -0.41 . . . . 0.0 111.471 173.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt 62.41 28.94 17.1 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 173.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 43.2 t -78.79 -32.99 16.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.439 177.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.452 ' HA ' HG12 ' A' ' 50' ' ' VAL . . . -91.54 102.47 15.12 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.833 0.349 . . . . 0.0 111.9 -178.174 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -77.31 -44.99 27.68 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.699 0.762 . . . . 0.0 111.687 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.63 -37.63 3.73 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 -163.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.9 ttpm? -43.11 -56.16 3.52 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.66 0.784 . . . . 0.0 112.199 173.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 78.4 p -125.91 -0.85 7.25 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 120.878 0.37 . . . . 0.0 111.755 178.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.452 HG12 ' HA ' ' A' ' 45' ' ' ALA . 3.8 p -156.74 111.75 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-O 121.1 0.476 . . . . 0.0 111.868 -174.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.419 ' O ' HG22 ' A' ' 55' ' ' VAL . 68.6 p -106.23 -177.78 3.46 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.104 178.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -55.64 -38.46 71.97 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.531 175.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.515 ' O ' HG12 ' A' ' 57' ' ' ILE . 88.8 m -58.0 -49.94 75.11 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 122.703 -0.292 . . . . 0.0 110.627 176.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.425 ' O ' HG21 ' A' ' 58' ' ' VAL . 7.1 m-20 -53.76 -38.61 64.59 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.991 0.424 . . . . 0.0 111.266 175.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.504 HG11 ' HA ' ' A' ' 36' ' ' ALA . 95.9 t -59.67 -39.6 80.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.507 178.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -76.02 -34.04 59.67 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.454 0.645 . . . . 0.0 110.535 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.515 HG12 ' O ' ' A' ' 53' ' ' THR . 9.9 mm -59.05 -53.16 51.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.059 175.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.425 HG21 ' O ' ' A' ' 54' ' ' ASP . 56.5 t -61.12 -42.42 93.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.286 178.181 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -55.22 -40.63 71.05 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.147 0.499 . . . . 0.0 111.289 175.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 50.6 m -78.38 -29.23 47.22 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.387 178.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -69.33 -56.91 6.14 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.903 -178.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.9 m -65.0 -34.15 68.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -173.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.602 ' HZ2' ' HB3' ' A' ' 63' ' ' LYS . 0.1 OUTLIER -65.94 -21.87 66.46 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.91 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 64.22 25.56 69.81 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 121.27 -0.49 . . . . 0.0 113.056 -178.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.615 ' HZ2' ' HB3' ' A' ' 65' ' ' LYS . 9.7 mtpm? 68.22 167.74 0.26 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.187 0.595 . . . . 0.0 111.889 -176.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 65.5 m 72.47 -47.95 0.67 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.324 0.65 . . . . 0.0 112.335 -178.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.457 ' O ' ' HD3' ' A' ' 63' ' ' LYS . . . -74.72 107.72 7.01 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 122.22 -0.3 . . . . 0.0 111.166 175.181 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -62.88 -48.71 77.82 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 121.378 0.609 . . . . 0.0 111.289 -177.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.494 HG21 ' HB3' ' A' ' 29' ' ' GLU . 30.2 m -93.23 -166.06 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.271 178.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 31.5 pt -134.93 144.7 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 122.417 0.287 . . . . 0.0 111.102 174.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -97.94 -179.57 4.46 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 120.815 0.34 . . . . 0.0 111.559 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -57.62 -43.38 84.73 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -175.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.595 ' HA ' ' HG3' ' A' ' 76' ' ' LYS . 15.7 pt-20 -80.25 -28.73 38.42 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.529 -0.732 . . . . 0.0 111.881 -176.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -69.03 -30.06 68.35 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.501 0.667 . . . . 0.0 109.43 170.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -69.17 -49.38 57.31 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.47 176.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.595 ' HG3' ' HA ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -64.97 -27.57 68.93 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 120.753 0.311 . . . . 0.0 111.289 177.948 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -68.75 -39.35 80.33 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.8 0.333 . . . . 0.0 110.336 170.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.02 -43.76 86.93 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.184 0.516 . . . . 0.0 110.61 173.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 80.8 mt -58.97 -37.07 75.95 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.3 176.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -62.69 -47.39 83.83 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.862 0.363 . . . . 0.0 111.352 175.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -57.59 -55.93 28.41 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.893 0.378 . . . . 0.0 110.828 176.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 11.3 mp -54.4 -49.54 69.67 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.279 176.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -52.34 -48.5 65.46 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 75.3 p -62.58 -33.97 76.03 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 -179.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -94.77 -2.08 51.65 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 176.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 31.4 tpt85 -104.8 -63.76 1.19 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.043 0.449 . . . . 0.0 111.727 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -103.77 118.85 37.66 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.721 -177.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -79.01 58.68 2.48 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 121.429 0.633 . . . . 0.0 110.868 176.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -90.16 -11.21 63.32 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-N 115.817 -0.629 . . . . 0.0 114.024 -176.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp 59.74 23.4 12.28 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 177.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 48.2 t -149.17 155.77 41.15 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 122.059 -0.401 . . . . 0.0 111.09 176.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -83.1 -58.57 2.8 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.549 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -52.57 -58.14 7.74 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.584 0.586 . . . . 0.0 112.584 -176.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -57.37 -55.13 38.74 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -176.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.7 -36.36 74.11 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.771 0.319 . . . . 0.0 111.766 179.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -67.28 -52.62 38.41 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.326 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.477 ' O ' ' HG3' ' A' ' 101' ' ' GLN . 7.1 m-20 -58.0 -39.48 78.39 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 120.488 0.185 . . . . 0.0 111.421 176.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.16 -60.21 4.23 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 120.817 0.341 . . . . 0.0 111.593 176.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 17.6 tt -63.16 -28.84 45.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-O 121.039 0.447 . . . . 0.0 111.077 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' CYS . . . . . 0.559 ' SG ' HD21 ' A' ' 10' ' ' LEU . 39.6 t -66.54 -44.95 80.98 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.019 173.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.477 ' HG3' ' O ' ' A' ' 97' ' ' ASP . 46.2 mt-30 -60.71 -29.0 69.08 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 179.101 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 83.3 mt -63.69 -23.67 67.47 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 120.799 0.333 . . . . 0.0 111.833 176.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 43.3 t -112.98 -34.39 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -177.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.58 115.1 3.98 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -174.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 85.01 14.42 69.51 Favored Glycine 0 CA--C 1.523 0.561 0 CA-C-N 116.103 -0.499 . . . . 0.0 112.531 -178.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 24.3 tptm -102.77 156.31 17.73 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.344 0.592 . . . . 0.0 111.268 -178.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -132.3 158.24 76.14 Favored Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.248 174.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.413 ' HG2' ' CD2' ' A' ' 20' ' ' HIS . 25.6 Cg_exo -62.68 -179.06 0.44 Allowed 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.111 1.874 . . . . 0.0 112.537 178.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.53 0 CA-C-O 121.017 0.437 . . . . 0.0 111.025 174.756 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.4 HG12 ' H ' ' A' ' 9' ' ' GLY . 13.4 tt . . . . . 0 CA--C 1.541 0.623 0 N-CA-C 111.801 0.296 . . . . 0.0 111.801 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -49.16 -36.01 18.23 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.4 ' H ' HG12 ' A' ' 7' ' ' ILE . . . -57.94 -33.6 69.26 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 121.274 -0.488 . . . . 0.0 113.131 176.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 50.0 tp -70.88 -40.68 72.09 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.943 0.401 . . . . 0.0 110.546 177.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -63.27 -36.31 83.25 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.697 175.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -60.03 -56.51 20.79 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.025 0.44 . . . . 0.0 110.895 175.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.3 m -53.15 -51.24 62.62 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.46 178.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -56.12 -50.07 72.12 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.458 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 29.9 ttt180 -62.94 -42.56 99.84 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.875 0.369 . . . . 0.0 111.677 -176.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -65.22 -34.32 78.08 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.498 ' HA ' ' HB2' ' A' ' 20' ' ' HIS . 41.0 m-85 -79.84 -23.61 41.86 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 120.826 0.346 . . . . 0.0 111.28 173.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.47 -11.56 60.26 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.172 0.511 . . . . 0.0 111.278 175.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.428 HG21 ' HA2' ' A' ' 27' ' ' GLY . 32.8 pt -117.79 15.78 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-O 121.055 0.455 . . . . 0.0 110.67 171.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.498 ' HB2' ' HA ' ' A' ' 17' ' ' PHE . 48.8 t-80 -63.24 100.73 0.25 Allowed 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 120.94 0.4 . . . . 0.0 111.448 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 126.88 -46.9 1.05 Allowed Glycine 0 CA--C 1.526 0.753 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.089 -176.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.426 ' HB2' ' HB3' ' A' ' 25' ' ' ALA . 19.7 m-20 -138.98 127.87 14.02 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 122.757 0.423 . . . . 0.0 110.815 179.15 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_exo -47.54 -32.64 16.17 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 123.215 2.61 . . . . 0.0 114.232 -178.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -120.9 31.42 6.41 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.875 0.369 . . . . 0.0 111.566 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.426 ' HB3' ' HB2' ' A' ' 22' ' ' ASP . . . -53.44 -60.1 3.73 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 67.5 m -152.9 -43.85 0.1 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.071 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.428 ' HA2' HG21 ' A' ' 19' ' ' ILE . . . 79.1 -34.83 1.94 Allowed Glycine 0 CA--C 1.528 0.904 0 C-N-CA 121.168 -0.539 . . . . 0.0 114.358 173.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -125.72 -21.59 4.4 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 117.033 0.417 . . . . 0.0 111.667 -178.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -99.16 138.66 35.95 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 122.113 -0.367 . . . . 0.0 110.519 173.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 49.8 ttm -125.55 131.19 52.81 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.843 0.354 . . . . 0.0 111.929 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.489 ' ND2' ' HB2' ' A' ' 33' ' ' LYS . 17.8 p-10 -91.71 158.43 16.38 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.89 0.376 . . . . 0.0 111.592 178.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -56.64 -29.17 57.58 Favored Glycine 0 N--CA 1.465 0.626 0 CA-C-N 116.302 -0.408 . . . . 0.0 113.253 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.489 ' HB2' ' ND2' ' A' ' 31' ' ' ASN . 98.7 mttt -57.93 -56.06 26.85 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 120.938 0.399 . . . . 0.0 111.464 175.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -71.21 -29.15 64.8 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 122.342 -0.224 . . . . 0.0 111.412 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.462 ' CD1' ' HB2' ' A' ' 59' ' ' PHE . 25.8 t-105 -64.32 -45.27 88.63 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 120.879 0.371 . . . . 0.0 111.26 175.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.432 ' HA ' HG11 ' A' ' 55' ' ' VAL . . . -58.74 -46.3 87.73 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.183 0.516 . . . . 0.0 111.007 177.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -66.94 -39.25 87.24 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.779 176.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.2 tt -49.88 -45.26 50.46 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.24 0.543 . . . . 0.0 110.618 177.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 64.6 m -70.44 -38.58 74.55 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.715 178.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -70.96 -47.92 56.27 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -176.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -53.46 -48.86 68.46 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.065 0.46 . . . . 0.0 111.073 172.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 63.3 m -77.09 -6.07 51.39 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.722 178.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 47.0 mttp 59.45 26.41 15.34 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 175.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 42.8 t -74.24 -32.63 32.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 121.397 0.618 . . . . 0.0 110.347 173.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.531 ' HB3' ' HA ' ' A' ' 51' ' ' THR . . . -87.85 91.96 8.95 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.669 -176.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -174.52 17.55 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.831 0 CA-C-O 120.971 0.415 . . . . 0.0 111.688 175.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -86.93 18.93 32.61 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.69 -0.767 . . . . 0.0 113.446 -175.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.485 ' HD2' ' N ' ' A' ' 48' ' ' LYS . 12.0 mptt 57.51 20.05 5.79 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 121.738 0.78 . . . . 0.0 111.51 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 65.4 m -147.0 -30.92 0.34 Allowed 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.494 175.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.631 HG12 ' HG ' ' A' ' 82' ' ' LEU . 93.3 t -125.46 96.71 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.95 166.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.531 ' HA ' ' HB3' ' A' ' 45' ' ' ALA . 5.0 t -156.55 125.06 5.79 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.803 0.335 . . . . 0.0 111.854 176.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 50.47 -90.6 0.01 OUTLIER Glycine 0 CA--C 1.53 0.995 0 CA-C-N 116.413 -0.358 . . . . 0.0 113.776 178.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.576 ' O ' HG13 ' A' ' 57' ' ' ILE . 58.0 m -52.04 -55.01 23.27 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.788 0.328 . . . . 0.0 111.199 179.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.478 ' HB2' ' HA ' ' A' ' 50' ' ' VAL . 9.2 m-20 -57.53 -34.02 68.69 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.553 -177.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.432 HG11 ' HA ' ' A' ' 36' ' ' ALA . 43.8 t -64.06 -38.2 81.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-O 120.939 0.4 . . . . 0.0 111.032 178.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -72.12 -31.25 65.85 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.171 0.51 . . . . 0.0 110.004 177.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.576 HG13 ' O ' ' A' ' 53' ' ' THR . 9.8 mt -68.01 -48.31 75.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.896 176.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 76.1 t -54.04 -51.32 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-O 121.022 0.439 . . . . 0.0 110.849 174.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.462 ' HB2' ' CD1' ' A' ' 35' ' ' TRP . 72.0 t80 -53.06 -51.19 62.58 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.763 175.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.563 ' HA ' ' HE3' ' A' ' 63' ' ' LYS . 59.3 m -68.23 -21.65 64.83 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.028 -178.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 43.9 tttp -83.11 -39.87 20.55 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 120.747 0.308 . . . . 0.0 111.402 -178.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 26.9 m -82.22 -24.88 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 CA-C-O 120.783 0.325 . . . . 0.0 111.377 177.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.563 ' HE3' ' HA ' ' A' ' 60' ' ' SER . 26.3 ttpp -53.84 126.83 23.68 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.964 178.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -45.78 -62.26 3.41 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-N 116.088 -0.505 . . . . 0.0 113.294 179.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.462 ' O ' ' NZ ' ' A' ' 63' ' ' LYS . 48.4 tptt -152.02 -86.3 0.07 Allowed 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 117.085 0.442 . . . . 0.0 111.782 174.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 88.4 p -110.09 -7.04 14.96 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -173.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.43 107.1 1.03 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.725 0.297 . . . . 0.0 111.2 178.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 83.8 mtm-85 -72.48 2.32 6.49 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -176.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 28.2 m -125.71 132.98 70.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-O 120.894 0.378 . . . . 0.0 110.73 174.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.518 ' HB ' ' HB2' ' A' ' 74' ' ' GLU . 30.6 pt -100.63 148.06 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 121.077 0.465 . . . . 0.0 111.878 179.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.446 ' ND2' ' HB2' ' A' ' 73' ' ' GLU . 1.7 p-10 -89.18 167.93 12.71 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.153 174.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.492 ' O ' ' HG3' ' A' ' 76' ' ' LYS . 24.9 t80 -52.12 -37.46 54.34 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.922 0.391 . . . . 0.0 111.866 -173.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.446 ' HB2' ' ND2' ' A' ' 71' ' ' ASN . 19.5 mp0 -60.4 -47.98 83.75 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.288 178.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.518 ' HB2' ' HB ' ' A' ' 70' ' ' ILE . 48.7 mt-10 -65.4 -37.3 86.54 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.18 0.514 . . . . 0.0 110.296 176.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -59.6 -41.11 89.57 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.222 175.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.492 ' HG3' ' O ' ' A' ' 72' ' ' TYR . 27.7 mtpp -55.75 -47.85 76.28 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.691 0.281 . . . . 0.0 110.969 176.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.442 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 54.9 tttp -68.91 -32.99 73.02 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.384 177.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.427 ' O ' HD13 ' A' ' 82' ' ' LEU . . . -56.9 -40.84 77.02 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.111 0.481 . . . . 0.0 110.407 173.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 88.2 mt -67.79 -43.26 80.13 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.87 173.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -49.4 -47.62 47.74 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 120.975 0.417 . . . . 0.0 111.104 175.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.627 ' O ' ' HG2' ' A' ' 85' ' ' LYS . 32.0 mm-40 -58.94 -68.67 0.25 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.916 177.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.631 ' HG ' HG12 ' A' ' 50' ' ' VAL . 11.0 mp -47.77 -43.73 27.71 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -178.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.01 -48.02 83.1 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.692 177.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 74.0 p -75.01 -7.24 53.11 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -178.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.627 ' HG2' ' O ' ' A' ' 81' ' ' GLU . 54.7 mmtt -97.75 -35.4 10.56 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.292 0.568 . . . . 0.0 110.172 172.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 9.9 mmt180 -78.35 -70.2 0.51 Allowed 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.722 176.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -98.83 86.47 3.52 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.192 0.52 . . . . 0.0 111.144 -172.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.685 ' HZ1' ' HB2' ' A' ' 88' ' ' LYS . 9.4 mtmp? -94.07 36.29 1.13 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.3 0.571 . . . . 0.0 110.999 -177.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -78.53 35.95 1.81 Allowed Glycine 0 CA--C 1.531 1.054 0 CA-C-N 116.044 -0.526 . . . . 0.0 113.853 -177.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 76.9 tttt 70.83 -60.87 0.49 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.666 0.786 . . . . 0.0 112.253 178.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 53.5 m -63.73 105.69 0.85 Allowed 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 120.824 0.345 . . . . 0.0 111.558 176.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.402 ' HE2' ' OE2' ' A' ' 93' ' ' GLU . 11.3 ttpt -73.6 -49.05 28.13 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -173.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.402 ' OE2' ' HE2' ' A' ' 92' ' ' LYS . 2.8 mp0 -53.17 -49.59 66.33 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 111.671 0.248 . . . . 0.0 111.671 -178.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -60.71 -33.46 72.91 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.889 0.376 . . . . 0.0 111.402 178.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.21 -39.56 94.97 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.139 0.495 . . . . 0.0 110.645 173.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -63.41 -39.04 93.43 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.326 175.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.46 ' O ' ' HB3' ' A' ' 100' ' ' CYS . 20.2 m-20 -60.25 -49.81 76.14 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.654 0.264 . . . . 0.0 111.057 172.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -53.58 -50.57 65.32 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -177.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 17.3 tt -65.6 -30.56 50.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-O 121.083 0.468 . . . . 0.0 110.819 177.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' CYS . . . . . 0.46 ' HB3' ' O ' ' A' ' 97' ' ' ASP . 35.8 t -63.41 -42.01 98.75 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.968 173.174 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -57.4 -39.54 76.35 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.776 0.322 . . . . 0.0 111.128 175.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 96.6 mt -65.96 -44.6 84.5 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 178.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 60.9 t -97.8 -54.2 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -172.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.77 127.82 33.53 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -171.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 100.24 -8.78 59.12 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 115.888 -0.596 . . . . 0.0 113.62 177.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -105.08 173.98 6.07 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.467 0.651 . . . . 0.0 112.15 -179.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.51 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 10.9 pt-20 -143.83 160.92 48.47 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.657 179.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.51 ' HD2' ' HB2' ' A' ' 107' ' ' GLU . 42.2 Cg_exo -32.38 106.6 0.04 OUTLIER 'Trans proline' 0 C--N 1.36 1.158 0 C-N-CA 123.711 2.94 . . . . 0.0 114.622 -177.024 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.432 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.817 -177.203 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.573 HG12 ' H ' ' A' ' 9' ' ' GLY . 7.9 tt . . . . . 0 CA--C 1.547 0.848 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.04 -27.9 48.07 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -178.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.573 ' H ' HG12 ' A' ' 7' ' ' ILE . . . -60.06 -28.42 66.36 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 121.229 -0.51 . . . . 0.0 113.049 177.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 44.8 tp -73.24 -35.28 66.22 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.116 0.484 . . . . 0.0 110.524 177.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -62.69 -45.46 92.66 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.849 175.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.488 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 35.1 tt0 -65.89 -45.85 80.51 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.53 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 79.6 p -58.0 -46.41 85.27 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.045 0.45 . . . . 0.0 110.818 178.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -54.14 -48.71 70.53 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.219 0.533 . . . . 0.0 110.685 172.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.406 ' HG3' ' HA3' ' A' ' 27' ' ' GLY . 49.4 ttt180 -58.51 -37.21 75.12 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.37 -179.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.488 ' HG2' ' O ' ' A' ' 12' ' ' GLU . 75.6 mmtt -60.39 -50.19 74.58 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.823 178.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.474 ' HB2' ' HE1' ' A' ' 30' ' ' MET . 81.7 m-85 -72.89 -21.1 60.97 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.739 0.304 . . . . 0.0 111.524 177.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.68 -54.31 12.34 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 120.862 0.363 . . . . 0.0 111.877 179.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 32.8 pt -73.78 -10.68 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-O 120.989 0.423 . . . . 0.0 111.882 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 -58.85 87.95 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.12 0.486 . . . . 0.0 111.745 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 132.84 -34.4 2.47 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-N 116.136 -0.484 . . . . 0.0 113.125 -179.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -133.04 114.59 13.9 Favored Pre-proline 0 CA--C 1.544 0.746 0 O-C-N 122.462 -0.434 . . . . 0.0 111.337 -177.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -80.86 0.03 10.29 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.585 2.19 . . . . 0.0 113.562 -179.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.672 ' HZ2' ' HB2' ' A' ' 24' ' ' LYS . 9.5 mtmp? -93.91 -16.77 23.68 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.97 0.414 . . . . 0.0 111.368 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -82.54 137.72 34.5 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.396 177.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 47.0 m -68.98 -22.66 64.09 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 120.77 0.319 . . . . 0.0 111.463 179.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.406 ' HA3' ' HG3' ' A' ' 15' ' ' ARG . . . 108.44 23.5 6.59 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 121.274 -0.488 . . . . 0.0 114.194 177.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -104.51 6.22 34.6 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 117.388 0.594 . . . . 0.0 111.799 178.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -130.79 130.76 44.11 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.011 -178.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.474 ' HE1' ' HB2' ' A' ' 17' ' ' PHE . 48.2 ttm -125.81 133.88 51.86 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.987 0.422 . . . . 0.0 111.99 -179.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.484 HD22 ' ND2' ' A' ' 34' ' ' ASN . 9.8 p30 -90.93 168.35 11.75 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.987 0.422 . . . . 0.0 111.605 178.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -66.04 -28.72 73.9 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-N 116.164 -0.471 . . . . 0.0 114.041 -179.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.433 ' HB3' ' OD1' ' A' ' 31' ' ' ASN . 39.6 ttmt -67.46 -48.8 66.14 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 117.006 0.403 . . . . 0.0 111.316 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.484 ' ND2' HD22 ' A' ' 31' ' ' ASN . 87.4 m-20 -68.71 -35.22 76.88 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.803 0.335 . . . . 0.0 111.013 175.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 47.5 t-105 -58.43 -45.48 88.41 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.283 174.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.52 -38.26 83.83 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.193 0.521 . . . . 0.0 111.528 176.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -70.72 -35.58 72.79 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.364 175.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.7 tt -59.57 -54.45 46.4 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.083 0.468 . . . . 0.0 110.588 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 26.2 p -60.51 -44.42 96.04 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.646 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -67.89 -38.16 82.67 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.847 0.356 . . . . 0.0 111.525 -178.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -67.31 -49.91 62.27 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.236 178.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.55 ' SG ' HG22 ' A' ' 103' ' ' VAL . 68.8 m -80.61 1.43 29.85 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.503 178.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp 69.03 20.23 7.82 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.033 0.533 . . . . 0.0 112.144 172.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.543 ' HA ' ' NH1' ' A' ' 86' ' ' ARG . 40.0 t -70.04 -26.94 30.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 120.926 0.394 . . . . 0.0 110.561 175.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.16 78.04 0.51 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.651 0.739 . . . . 0.0 109.972 172.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.406 ' HB3' ' H ' ' A' ' 50' ' ' VAL . 38.7 t70 -54.99 -30.12 58.62 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 114.601 -1.181 . . . . 0.0 113.978 -169.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.26 -36.44 1.53 Allowed Glycine 0 CA--C 1.531 1.065 0 C-N-CA 121.227 -0.511 . . . . 0.0 113.31 -177.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.7 mttp -82.59 -46.94 12.69 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.161 0.505 . . . . 0.0 110.093 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 73.1 m -108.55 -50.43 3.03 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.564 174.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.406 ' H ' ' HB3' ' A' ' 46' ' ' ASP . 43.1 t -93.76 110.25 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -178.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 76.5 p -96.44 173.93 7.12 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 120.689 0.281 . . . . 0.0 111.519 177.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -58.06 -44.05 94.85 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 121.083 -0.58 . . . . 0.0 112.443 177.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.544 ' O ' HG13 ' A' ' 57' ' ' ILE . 44.5 p -51.21 -50.64 58.71 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.325 0.583 . . . . 0.0 110.361 172.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.06 -38.42 70.61 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.04 -176.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.2 t -59.22 -40.56 81.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.173 176.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -68.06 -37.66 81.55 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.98 0.419 . . . . 0.0 110.84 175.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.544 HG13 ' O ' ' A' ' 53' ' ' THR . 6.5 mt -62.73 -46.76 95.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.146 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 76.5 t -59.99 -42.48 89.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 120.979 0.419 . . . . 0.0 111.07 177.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -62.36 -23.32 66.73 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-O 121.153 0.502 . . . . 0.0 110.999 176.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 23.1 t -87.0 -34.79 19.13 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.836 0.35 . . . . 0.0 111.254 175.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -60.86 -44.69 96.69 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 29.4 m -78.97 -22.64 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -177.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? -73.97 150.01 41.02 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.905 0.383 . . . . 0.0 111.789 -175.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -70.18 -98.67 0.05 OUTLIER Glycine 0 CA--C 1.53 0.993 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.161 174.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -141.88 -64.73 0.43 Allowed 'General case' 0 N--CA 1.471 0.607 0 O-C-N 122.423 -0.457 . . . . 0.0 111.216 174.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 43.5 t -92.77 91.3 7.42 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.862 0.363 . . . . 0.0 110.825 177.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -160.57 146.56 15.08 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.231 0.538 . . . . 0.0 112.089 -178.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 68' ' ' ARG . 32.5 mtm-85 -104.36 -37.76 7.1 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.393 0.616 . . . . 0.0 110.716 177.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.3 m -124.82 158.56 32.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.208 -178.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 42.1 pt -118.49 159.77 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.091 177.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -103.61 177.81 4.73 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 84.7 t80 -54.01 -40.62 67.17 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -174.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -56.22 -51.47 67.95 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.266 0.555 . . . . 0.0 111.281 178.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -64.52 -32.87 74.69 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.068 177.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -58.82 -43.72 90.68 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.025 174.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp -54.95 -49.53 71.14 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.186 0.517 . . . . 0.0 111.066 173.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -61.18 -35.13 76.32 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.173 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.47 -43.38 81.16 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.012 0.434 . . . . 0.0 111.449 176.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 80.8 mt -64.89 -35.4 81.01 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.103 177.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -59.94 -49.94 75.7 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.134 0.492 . . . . 0.0 110.325 176.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -57.4 -56.7 18.43 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.152 175.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 87.1 mt -60.27 -35.24 75.08 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -178.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.476 ' HB1' HG21 ' A' ' 99' ' ' ILE . . . -64.15 -48.04 77.58 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.108 0.48 . . . . 0.0 111.057 178.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 65.7 p -74.67 -9.26 58.39 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.846 -0.616 . . . . 0.0 112.161 -179.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -101.6 -28.32 12.58 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 173.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.543 ' NH1' ' HA ' ' A' ' 44' ' ' VAL . 14.3 tpt180 -83.26 -54.26 5.14 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.695 0.76 . . . . 0.0 110.575 178.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -86.55 144.58 27.14 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.752 178.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.739 ' HZ1' ' HB3' ' A' ' 88' ' ' LYS . 0.5 OUTLIER -81.64 -164.71 0.82 Allowed 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -178.555 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -55.3 81.97 0.01 OUTLIER Glycine 0 CA--C 1.531 1.035 0 N-CA-C 114.633 0.613 . . . . 0.0 114.633 -176.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -126.3 177.15 6.6 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 122.885 0.474 . . . . 0.0 110.749 176.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 65.9 m -62.72 125.44 23.96 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 120.767 0.318 . . . . 0.0 111.161 176.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -54.84 -40.31 69.48 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 116.134 -0.485 . . . . 0.0 112.303 -174.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -62.59 -59.93 4.23 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.653 0.263 . . . . 0.0 110.98 178.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -53.82 -39.47 65.57 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 120.725 0.297 . . . . 0.0 111.432 -179.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.24 -42.73 95.91 Favored 'General case' 0 CA--C 1.541 0.635 0 CA-C-O 120.706 0.288 . . . . 0.0 111.468 177.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -67.59 -50.2 59.44 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.222 178.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -57.32 -42.03 81.07 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 120.727 0.298 . . . . 0.0 111.456 178.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.67 -54.22 45.71 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 112.041 0.385 . . . . 0.0 112.041 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.476 HG21 ' HB1' ' A' ' 83' ' ' ALA . 12.7 tt -59.29 -36.12 61.84 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-O 121.096 0.474 . . . . 0.0 110.793 179.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 81.6 m -68.04 -38.69 82.8 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.135 176.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -58.42 -31.49 67.76 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.061 0.458 . . . . 0.0 111.486 177.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 92.9 mt -60.79 -41.11 94.96 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.879 176.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.55 HG22 ' SG ' ' A' ' 42' ' ' CYS . 16.3 t -96.76 -31.63 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 CA-C-O 121.044 0.449 . . . . 0.0 112.176 -174.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.03 124.67 21.7 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -173.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 85.78 -11.56 61.73 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 116.123 -0.49 . . . . 0.0 113.44 177.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -86.67 153.33 21.83 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 122.5 -0.412 . . . . 0.0 111.293 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.53 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 0.4 OUTLIER -86.42 163.27 42.79 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.294 173.901 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.53 ' HD2' ' HB2' ' A' ' 107' ' ' GLU . 59.3 Cg_endo -69.73 -149.38 0.02 OUTLIER 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.052 1.835 . . . . 0.0 111.922 177.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.376 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 169.805 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.407 HG12 ' H ' ' A' ' 9' ' ' GLY . 10.8 tt . . . . . 0 CA--C 1.542 0.642 0 CA-C-O 121.138 0.494 . . . . 0.0 112.014 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -53.19 -34.3 56.39 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -177.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.407 ' H ' HG12 ' A' ' 7' ' ' ILE . . . -60.75 -34.48 86.9 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 121.41 -0.424 . . . . 0.0 113.487 177.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 38.8 tp -73.76 -43.69 58.32 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.363 0.601 . . . . 0.0 110.656 178.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -59.17 -36.25 74.98 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.501 174.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -66.9 -51.03 60.34 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.457 174.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.5 p -60.74 -43.24 98.16 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -177.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -57.61 -55.96 28.08 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.026 0.441 . . . . 0.0 110.492 175.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.455 ' O ' HG12 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -56.91 -34.65 68.14 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.541 177.198 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -63.89 -48.28 77.25 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 120.901 0.381 . . . . 0.0 111.765 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.421 ' HA ' ' HB2' ' A' ' 20' ' ' HIS . 49.9 m-85 -77.72 -23.17 49.48 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.725 -0.216 . . . . 0.0 111.479 176.071 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.78 -47.79 71.04 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 120.913 0.387 . . . . 0.0 111.09 176.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.455 HG12 ' O ' ' A' ' 15' ' ' ARG . 26.3 pt -86.47 1.61 5.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.869 178.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.421 ' HB2' ' HA ' ' A' ' 17' ' ' PHE . 34.6 t-80 -51.8 96.91 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.41 0.624 . . . . 0.0 111.737 -178.106 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 135.31 -50.32 0.86 Allowed Glycine 0 CA--C 1.525 0.705 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.068 -175.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -126.97 111.04 21.9 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 122.443 0.297 . . . . 0.0 111.283 179.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -68.4 -5.08 14.19 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 122.569 2.179 . . . . 0.0 112.417 178.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.3 pttt -93.36 0.06 56.77 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.844 177.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.86 158.94 26.62 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.052 0.454 . . . . 0.0 111.842 -178.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 31.2 p -67.14 -71.23 0.21 Allowed 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.077 -178.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 109.75 14.34 14.21 Favored Glycine 0 CA--C 1.532 1.099 0 N-CA-C 114.674 0.63 . . . . 0.0 114.674 175.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 -97.86 4.19 49.7 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 117.617 0.709 . . . . 0.0 111.468 176.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.484 ' HB3' HG22 ' A' ' 69' ' ' VAL . 31.8 mt-10 -144.9 143.53 30.62 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.042 0.537 . . . . 0.0 110.888 177.429 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.508 ' O ' ' HB ' ' A' ' 69' ' ' VAL . 49.4 ttm -128.8 140.69 51.59 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.06 0.457 . . . . 0.0 111.997 -177.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 27.2 p30 -93.18 164.21 13.33 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.084 0.469 . . . . 0.0 111.868 178.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.456 ' HA2' ' HB3' ' A' ' 35' ' ' TRP . . . -61.72 -25.96 66.25 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 121.386 -0.435 . . . . 0.0 113.224 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -59.08 -57.38 13.32 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 121.196 0.522 . . . . 0.0 111.474 177.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -75.94 -26.37 56.83 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.49 179.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.456 ' HB3' ' HA2' ' A' ' 32' ' ' GLY . 51.7 t-105 -62.52 -45.5 92.71 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.136 0.493 . . . . 0.0 110.875 173.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.72 -45.25 94.78 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.111 176.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -68.71 -31.25 70.2 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.653 177.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.543 HD23 ' HG ' ' A' ' 42' ' ' CYS . 8.2 tt -58.44 -56.79 17.58 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.171 0.51 . . . . 0.0 110.522 178.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.624 ' HA ' ' SG ' ' A' ' 42' ' ' CYS . 28.9 p -63.98 -35.9 82.22 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.613 -179.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -68.42 -41.42 80.42 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.804 0.335 . . . . 0.0 111.443 178.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -73.59 -31.86 63.82 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.624 ' SG ' ' HA ' ' A' ' 39' ' ' CYS . 27.9 p -89.8 -5.97 56.38 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.96 0.409 . . . . 0.0 110.711 173.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt 55.94 25.66 8.93 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.299 0.852 . . . . 0.0 113.299 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.507 HG22 ' SG ' ' A' ' 42' ' ' CYS . 79.1 t -67.54 -37.32 78.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 169.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.92 115.46 7.46 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.925 171.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -131.43 84.53 2.18 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.393 -173.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -33.18 -30.69 0.01 OUTLIER Glycine 0 CA--C 1.537 1.458 0 N-CA-C 116.011 1.165 . . . . 0.0 116.011 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -62.89 -44.6 95.67 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 118.042 0.921 . . . . 0.0 111.1 175.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.5 t -107.61 -55.66 2.32 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.026 176.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 40.9 t -109.37 109.46 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 122.788 0.435 . . . . 0.0 111.788 -177.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 66.1 p -79.58 151.91 30.38 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -56.41 -30.69 58.94 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 121.395 -0.431 . . . . 0.0 112.59 176.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.576 ' O ' HG13 ' A' ' 57' ' ' ILE . 89.2 m -61.92 -50.58 71.58 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 122.867 -0.196 . . . . 0.0 110.845 174.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.432 ' O ' HG23 ' A' ' 58' ' ' VAL . 26.7 t70 -58.22 -41.42 84.07 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.876 0.369 . . . . 0.0 110.951 179.255 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.1 t -58.64 -35.14 53.74 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 CA-C-O 121.183 0.516 . . . . 0.0 111.408 175.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -73.3 -38.28 65.91 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.205 0.526 . . . . 0.0 110.305 179.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.576 HG13 ' O ' ' A' ' 53' ' ' THR . 9.1 mt -62.5 -45.72 98.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.777 177.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 54' ' ' ASP . 94.2 t -58.03 -42.13 82.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.794 177.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -54.91 -43.88 73.67 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 121.178 0.514 . . . . 0.0 111.252 176.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 60.1 p -80.65 -17.48 51.09 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.834 -177.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.433 ' HD3' ' HA ' ' A' ' 61' ' ' LYS . 31.7 mmtp -84.54 -33.12 23.53 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 178.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.502 ' HB ' ' HB3' ' A' ' 74' ' ' GLU . 34.5 m -82.82 -19.63 10.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-O 121.135 0.493 . . . . 0.0 110.729 173.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.4 ttmm -61.2 127.27 30.71 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.285 177.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -71.85 152.12 48.48 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 120.94 -0.648 . . . . 0.0 111.919 171.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -53.53 -44.13 68.94 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -175.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 95.0 p -93.4 4.95 53.13 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 120.849 0.357 . . . . 0.0 111.806 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -88.66 117.58 27.72 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 120.865 0.364 . . . . 0.0 111.671 -178.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 66.3 mtp180 -70.25 -34.37 72.75 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.565 0.698 . . . . 0.0 110.227 178.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.508 ' HB ' ' O ' ' A' ' 30' ' ' MET . 32.4 m -124.82 -160.99 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.486 177.226 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 47.4 pt -119.9 150.02 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 O-C-N 122.051 -0.406 . . . . 0.0 111.28 173.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.482 ' ND2' ' HB2' ' A' ' 73' ' ' GLU . 4.2 p-10 -102.57 169.62 8.54 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 120.778 0.323 . . . . 0.0 111.461 179.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -54.19 -40.68 67.81 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -175.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.482 ' HB2' ' ND2' ' A' ' 71' ' ' ASN . 43.0 mt-10 -55.81 -43.53 76.98 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.819 0.342 . . . . 0.0 111.353 176.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.607 ' HA ' ' HD3' ' A' ' 77' ' ' LYS . 11.0 mm-40 -71.99 -31.69 66.49 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.009 0.433 . . . . 0.0 110.75 178.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -58.09 -43.7 87.23 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.098 176.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -54.9 -49.49 71.11 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.524 0.678 . . . . 0.0 110.987 173.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.607 ' HD3' ' HA ' ' A' ' 74' ' ' GLU . 51.0 mtpt -62.97 -36.66 84.23 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.684 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.7 -47.05 70.49 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.581 178.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 75.8 mt -59.35 -47.47 85.31 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.817 0.341 . . . . 0.0 111.195 177.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -54.22 -40.89 68.08 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 121.114 0.483 . . . . 0.0 111.224 178.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -61.18 -61.42 2.57 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.016 0.436 . . . . 0.0 111.164 176.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 80.9 mt -58.29 -30.87 66.97 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.963 0.411 . . . . 0.0 111.54 -179.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.03 -51.36 67.08 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.983 176.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 68.0 p -65.65 -17.21 64.43 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -72.22 -55.81 6.6 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 120.756 0.313 . . . . 0.0 111.593 174.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 62.5 mtp180 -81.35 -47.26 13.51 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.872 0.368 . . . . 0.0 111.668 -178.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -84.9 144.91 28.07 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.793 0.33 . . . . 0.0 110.519 177.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 41.6 mtpt -81.53 157.55 24.77 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.308 0.575 . . . . 0.0 112.096 -177.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -78.22 60.89 3.88 Favored Glycine 0 CA--C 1.528 0.897 0 CA-C-N 116.019 -0.537 . . . . 0.0 114.298 -173.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 58.7 pttt -96.3 -34.79 11.47 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.239 0.543 . . . . 0.0 110.488 173.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 32.3 t -167.26 115.8 0.81 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.141 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -65.68 -25.86 67.53 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 120.783 0.325 . . . . 0.0 110.707 174.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -57.22 -58.46 8.11 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.145 177.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -70.12 -37.7 75.39 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.305 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.51 -41.79 95.08 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.847 0.356 . . . . 0.0 111.54 178.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -67.8 -40.49 83.91 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.441 178.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -55.16 -52.67 62.57 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.421 0.629 . . . . 0.0 110.776 174.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.33 -52.62 62.92 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 115.166 -0.925 . . . . 0.0 112.581 -176.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.0 tt -59.65 -38.01 73.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 O-C-N 121.903 -0.498 . . . . 0.0 110.772 178.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 83.0 m -73.68 -24.15 59.92 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.177 175.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.94 -34.29 77.17 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.503 0.668 . . . . 0.0 109.81 175.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 94.4 mt -80.3 -25.99 39.07 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.487 177.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 76.6 t -100.57 -53.62 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -175.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -51.56 125.99 16.2 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -176.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 69.93 0.65 28.08 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-N 115.861 -0.609 . . . . 0.0 114.257 178.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.475 ' HD3' ' N ' ' A' ' 107' ' ' GLU . 11.7 tmtt? -87.79 134.63 33.64 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 121.382 0.61 . . . . 0.0 111.057 -176.04 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.475 ' N ' ' HD3' ' A' ' 106' ' ' LYS . 0.9 OUTLIER -89.12 154.61 49.49 Favored Pre-proline 0 CA--C 1.547 0.854 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -174.347 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -62.62 120.21 7.63 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 122.526 2.151 . . . . 0.0 112.37 175.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.389 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -175.116 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.486 ' N ' HD12 ' A' ' 7' ' ' ILE . 2.9 mp . . . . . 0 CA--C 1.544 0.733 0 CA-C-O 120.788 0.328 . . . . 0.0 111.004 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.64 -26.4 65.32 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.264 0.554 . . . . 0.0 111.404 179.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -55.76 -28.46 52.36 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.381 175.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 34.4 tp -58.33 -38.79 77.84 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.954 0.407 . . . . 0.0 110.704 178.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -67.85 -44.11 77.92 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 120.865 0.364 . . . . 0.0 110.246 173.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 20.5 tp10 -54.75 -47.0 74.39 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 178.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.501 ' HB3' ' HA2' ' A' ' 105' ' ' GLY . 53.9 p -67.49 -52.34 40.34 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -53.04 -47.13 68.62 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.273 0.559 . . . . 0.0 111.211 175.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -60.38 -36.14 77.36 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.261 177.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -73.34 -38.17 65.85 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.552 -178.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -74.28 -38.3 63.45 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 120.609 0.243 . . . . 0.0 111.388 176.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.401 ' HB2' ' HA2' ' A' ' 27' ' ' GLY . . . -55.94 -49.81 72.47 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.502 ' HA ' ' HB3' ' A' ' 25' ' ' ALA . 33.9 pt -78.67 6.06 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -178.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -90.73 146.07 24.29 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.984 0.421 . . . . 0.0 111.837 -177.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 79.15 -60.88 4.2 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 121.164 -0.541 . . . . 0.0 112.533 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -96.59 105.66 24.52 Favored Pre-proline 0 CA--C 1.542 0.657 0 CA-C-O 120.892 0.377 . . . . 0.0 111.115 177.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.14 -7.31 20.53 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.596 2.197 . . . . 0.0 113.387 -178.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -97.88 11.76 36.3 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 178.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.502 ' HB3' ' HA ' ' A' ' 19' ' ' ILE . . . -77.21 161.08 28.44 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.288 0.566 . . . . 0.0 112.356 -178.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 96.6 p -87.95 -45.15 10.48 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.978 -178.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.401 ' HA2' ' HB2' ' A' ' 18' ' ' ALA . . . 108.05 -19.93 31.79 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 121.393 -0.432 . . . . 0.0 112.481 -175.009 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 56.4 tp60 -96.54 -21.36 17.73 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.95 0.405 . . . . 0.0 110.841 177.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -125.25 129.49 50.15 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.54 178.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.423 ' HE2' HD12 ' A' ' 38' ' ' LEU . 54.7 ttp -125.29 148.91 48.5 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.118 0.485 . . . . 0.0 112.196 -177.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.479 ' OD1' ' HB3' ' A' ' 33' ' ' LYS . 16.9 p30 -93.07 172.09 8.53 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -177.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.533 ' HA2' ' HB3' ' A' ' 35' ' ' TRP . . . -60.83 -27.06 66.11 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-N 116.21 -0.45 . . . . 0.0 112.871 176.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.479 ' HB3' ' OD1' ' A' ' 31' ' ' ASN . 87.1 tttt -50.81 -64.47 0.8 Allowed 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 123.941 0.897 . . . . 0.0 112.117 175.393 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -77.42 -25.08 50.38 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.972 -0.455 . . . . 0.0 111.51 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.533 ' HB3' ' HA2' ' A' ' 32' ' ' GLY . 55.8 t-105 -59.76 -38.61 82.27 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.203 0.525 . . . . 0.0 110.462 171.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.92 -43.62 87.58 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.75 174.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -53.6 -48.75 68.97 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.647 174.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.423 HD12 ' HE2' ' A' ' 30' ' ' MET . 7.6 mt -52.59 -49.65 64.59 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.027 0.441 . . . . 0.0 111.644 177.059 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 73.8 m -55.9 -42.55 76.19 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.674 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -75.34 -39.86 58.91 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.071 0.462 . . . . 0.0 111.92 -178.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.48 ' CG ' ' HZ3' ' A' ' 106' ' ' LYS . 24.7 t0 -70.83 -42.51 70.1 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 122.144 -0.348 . . . . 0.0 111.277 -177.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.572 ' SG ' HG22 ' A' ' 103' ' ' VAL . 62.9 m -83.41 -12.38 56.5 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.44 176.081 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? 64.7 37.94 7.26 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.179 0.592 . . . . 0.0 111.957 179.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.459 HG12 HD13 ' A' ' 82' ' ' LEU . 51.6 t -75.32 -34.93 31.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-O 121.155 0.503 . . . . 0.0 110.079 173.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.72 82.09 2.08 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.481 0.657 . . . . 0.0 111.054 177.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -65.47 -40.26 92.94 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.483 -178.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.97 -38.55 3.23 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 121.392 -0.432 . . . . 0.0 112.806 -176.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -96.52 -48.08 5.69 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.18 0.514 . . . . 0.0 111.15 178.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.4 t -90.17 -44.54 9.7 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.318 178.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 54.0 t -121.51 108.88 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.499 177.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.401 ' O ' HG22 ' A' ' 55' ' ' VAL . 68.2 p -94.06 163.31 13.53 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -175.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -56.15 -44.41 88.74 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 121.19 -0.528 . . . . 0.0 112.744 176.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.563 ' O ' HG12 ' A' ' 57' ' ' ILE . 7.8 t -61.86 -41.04 97.35 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 122.53 -0.394 . . . . 0.0 110.69 175.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -59.85 -37.71 80.02 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.009 0.433 . . . . 0.0 110.584 176.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.401 HG22 ' O ' ' A' ' 51' ' ' THR . 76.3 t -59.39 -35.16 56.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.147 174.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -76.26 -34.39 59.15 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.817 0.817 . . . . 0.0 109.754 178.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.563 HG12 ' O ' ' A' ' 53' ' ' THR . 9.7 mm -60.61 -54.51 34.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.009 175.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 74.3 t -57.96 -40.3 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-O 120.728 0.299 . . . . 0.0 111.557 178.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -61.71 -44.13 97.51 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.045 0.45 . . . . 0.0 110.512 178.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 78.3 p -80.33 -15.06 57.77 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.108 0.48 . . . . 0.0 111.452 178.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 24.8 tptp -74.78 -49.98 18.92 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.166 0.587 . . . . 0.0 111.709 178.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.7 m -85.02 -24.56 7.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -179.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -57.7 131.54 50.57 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 179.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -77.68 -162.86 19.01 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-O 121.291 0.384 . . . . 0.0 113.994 179.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 21.3 ttpp -82.06 148.16 28.75 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -177.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 48.5 p 51.18 17.91 0.53 Allowed 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 173.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -110.64 146.49 36.08 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.878 0.371 . . . . 0.0 110.811 177.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 7.4 ptp85 -114.97 15.37 17.26 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.271 0.557 . . . . 0.0 110.862 178.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 22.2 m -145.72 169.86 6.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.661 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 37.2 pt -122.37 143.09 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-O 120.681 0.277 . . . . 0.0 110.885 175.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -100.72 177.79 4.89 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 120.888 0.375 . . . . 0.0 111.467 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -55.76 -27.33 50.23 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 113.159 0.799 . . . . 0.0 113.159 -175.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -70.7 -59.79 2.62 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.782 -0.574 . . . . 0.0 111.076 174.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -56.82 -32.42 65.7 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.436 0.636 . . . . 0.0 110.627 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -60.61 -51.54 68.98 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.733 176.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 37.5 mtmm -60.95 -42.72 98.78 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -59.43 -40.9 88.25 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 120.997 0.427 . . . . 0.0 110.839 175.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.02 -43.37 98.98 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.42 177.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 85.0 mt -57.7 -43.12 84.94 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.725 178.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -60.11 -46.42 89.69 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 120.722 0.296 . . . . 0.0 111.241 177.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.464 ' O ' ' HG3' ' A' ' 85' ' ' LYS . 52.5 mt-10 -59.24 -50.56 73.53 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.548 0.213 . . . . 0.0 111.274 177.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.459 HD13 HG12 ' A' ' 44' ' ' VAL . 95.9 mt -58.88 -40.32 84.02 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.023 0.439 . . . . 0.0 111.381 176.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.87 -51.41 70.16 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.807 178.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 56.2 p -65.99 -22.17 66.45 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -178.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' A' ' 81' ' ' GLU . 96.9 mttt -78.23 -43.24 28.86 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 120.887 0.375 . . . . 0.0 111.225 174.338 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 26.7 tpt180 -81.32 -63.93 1.29 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.026 0.441 . . . . 0.0 111.133 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -79.16 88.18 4.87 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.361 0.6 . . . . 0.0 110.527 178.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 53.1 mttm -80.01 87.86 5.39 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.421 -173.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -156.46 4.53 0.19 Allowed Glycine 0 CA--C 1.533 1.212 0 C-N-CA 120.86 -0.686 . . . . 0.0 114.468 178.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 82.8 tttt 72.86 -43.71 0.57 Allowed 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 33.7 p -46.19 105.04 0.06 Allowed 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -175.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 46.4 mttm -60.37 -63.15 1.4 Allowed 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -176.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -54.32 -48.06 71.77 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -175.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -66.71 -44.38 81.79 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -178.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.65 -41.01 93.06 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.011 0.434 . . . . 0.0 111.426 179.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -68.75 -37.18 79.2 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.043 178.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -62.17 -49.37 76.11 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.373 0.606 . . . . 0.0 110.001 174.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -58.87 -49.89 76.07 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.296 -0.866 . . . . 0.0 112.669 -179.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.4 tp -60.89 -38.69 79.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-O 121.149 0.499 . . . . 0.0 110.904 178.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 75.0 m -73.65 -25.36 60.24 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.105 176.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -72.75 -32.4 65.64 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.024 0.44 . . . . 0.0 110.616 177.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 90.4 mt -64.16 -55.2 23.48 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.077 0.465 . . . . 0.0 110.924 173.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.572 HG22 ' SG ' ' A' ' 42' ' ' CYS . 41.2 t -69.34 -65.15 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.004 178.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 48.95 -100.46 0.07 Allowed 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.494 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.501 ' HA2' ' HB3' ' A' ' 13' ' ' SER . . . -151.13 44.18 0.68 Allowed Glycine 0 CA--C 1.523 0.54 0 C-N-CA 121.199 -0.524 . . . . 0.0 112.407 -179.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.48 ' HZ3' ' CG ' ' A' ' 41' ' ' ASP . 49.6 tttm -74.37 155.33 38.24 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-O 121.141 0.496 . . . . 0.0 112.337 -177.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -66.56 137.55 95.23 Favored Pre-proline 0 CA--C 1.545 0.756 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.769 173.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -66.54 147.14 81.69 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.564 2.176 . . . . 0.0 113.898 -173.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.716 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.686 177.15 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.404 ' N ' HD12 ' A' ' 7' ' ' ILE . 3.5 mp . . . . . 0 CA--C 1.546 0.796 0 CA-C-O 121.181 0.515 . . . . 0.0 111.696 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.16 -34.95 78.72 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-O 121.329 0.585 . . . . 0.0 111.607 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -59.98 -19.95 52.13 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.698 176.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.647 HD22 ' SG ' ' A' ' 100' ' ' CYS . 43.6 tp -74.9 -38.85 61.75 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 120.713 0.292 . . . . 0.0 110.405 177.412 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -59.09 -41.23 87.55 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.009 173.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.542 ' O ' ' HG3' ' A' ' 16' ' ' LYS . 42.5 mt-10 -55.34 -54.45 43.5 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.207 175.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 41.7 t -55.37 -54.94 37.35 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.752 -178.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.432 ' CE1' ' HE2' ' A' ' 30' ' ' MET . 90.8 t80 -53.55 -43.33 68.34 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.28 0.562 . . . . 0.0 110.771 176.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 63.8 ttt180 -62.36 -32.74 73.57 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.112 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.542 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 95.8 mttt -74.83 -39.37 61.67 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.564 178.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.847 ' HB3' ' SD ' ' A' ' 30' ' ' MET . 18.2 m-85 -69.67 -38.78 77.2 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 120.896 0.379 . . . . 0.0 111.43 175.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.2 -40.46 97.56 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -178.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.459 HG22 ' O ' ' A' ' 25' ' ' ALA . 29.2 pt -86.85 13.13 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-O 120.874 0.369 . . . . 0.0 111.839 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 37.6 t-80 -109.13 95.69 5.8 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.812 0.339 . . . . 0.0 111.652 -175.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 108.78 -46.55 1.15 Allowed Glycine 0 CA--C 1.521 0.457 0 C-N-CA 121.147 -0.549 . . . . 0.0 111.895 -175.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -74.3 108.34 4.97 Favored Pre-proline 0 CA--C 1.544 0.741 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 171.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -56.92 -38.73 95.26 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.752 2.301 . . . . 0.0 114.298 -169.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.5 mtpt -124.79 28.78 6.39 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -172.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.459 ' O ' HG22 ' A' ' 19' ' ' ILE . . . -74.93 123.56 25.32 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.772 0.32 . . . . 0.0 111.272 179.428 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 55.4 m -69.45 -2.02 10.03 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.52 -1.53 66.57 Favored Glycine 0 CA--C 1.523 0.593 0 C-N-CA 121.402 -0.428 . . . . 0.0 112.94 -178.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -86.35 -37.77 18.12 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.99 0.424 . . . . 0.0 111.775 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -116.66 131.58 56.91 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.86 -175.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.847 ' SD ' ' HB3' ' A' ' 17' ' ' PHE . 58.2 ttp -127.64 140.75 51.9 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.988 0.423 . . . . 0.0 111.801 178.28 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.451 ' OD1' ' HB3' ' A' ' 33' ' ' LYS . 10.9 p30 -74.79 167.69 21.34 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 121.249 0.547 . . . . 0.0 112.241 -178.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -70.95 -21.59 78.27 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-N 116.075 -0.511 . . . . 0.0 114.033 -178.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.451 ' HB3' ' OD1' ' A' ' 31' ' ' ASN . 61.5 tttp -70.88 -44.22 66.77 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 117.314 0.557 . . . . 0.0 111.052 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -72.34 -26.43 61.93 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 122.179 -0.326 . . . . 0.0 110.938 174.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 49.7 t-105 -65.45 -52.35 53.75 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 120.885 0.374 . . . . 0.0 111.167 173.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.428 ' O ' ' SG ' ' A' ' 39' ' ' CYS . . . -57.93 -42.54 85.06 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.411 0.624 . . . . 0.0 110.583 174.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -61.04 -40.12 92.39 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.985 174.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.6 tt -55.22 -46.95 75.95 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.713 -178.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.58 ' SG ' HG21 ' A' ' 55' ' ' VAL . 15.7 p -66.1 -49.33 67.9 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.671 0.272 . . . . 0.0 111.467 -179.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.439 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 88.7 tttt -67.64 -34.62 77.31 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 120.904 0.383 . . . . 0.0 111.525 -175.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 49.0 t0 -77.8 -36.96 49.72 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 120.869 0.366 . . . . 0.0 110.824 179.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.566 ' SG ' ' HD3' ' A' ' 106' ' ' LYS . 77.7 m -87.12 4.11 43.54 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 178.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm 74.61 15.01 3.38 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 172.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 55.3 t -69.04 -32.67 55.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-O 120.788 0.328 . . . . 0.0 111.087 178.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.1 98.12 6.41 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 120.919 0.39 . . . . 0.0 111.32 178.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -90.79 -37.75 13.44 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -178.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 111.97 -25.87 12.3 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 121.286 -0.483 . . . . 0.0 113.608 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -88.87 -53.47 4.59 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.102 0.477 . . . . 0.0 110.72 178.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 64.6 m -98.22 -41.58 7.82 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.226 179.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.3 t -111.37 102.5 14.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 121.108 0.48 . . . . 0.0 110.691 175.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 48.5 p -93.4 15.02 16.74 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -176.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.6 -52.37 4.69 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.573 -173.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.578 ' O ' HG13 ' A' ' 57' ' ' ILE . 49.1 m -50.53 -46.44 57.35 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.131 0.491 . . . . 0.0 109.949 172.477 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -53.31 -35.31 60.01 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.109 176.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.58 HG21 ' SG ' ' A' ' 39' ' ' CYS . 56.3 t -66.01 -36.88 78.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 120.895 0.378 . . . . 0.0 110.74 177.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -69.79 -37.93 76.49 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.37 0.605 . . . . 0.0 109.886 175.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.578 HG13 ' O ' ' A' ' 53' ' ' THR . 6.8 mt -63.89 -50.42 77.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.191 178.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 71.3 t -58.55 -38.15 69.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-O 120.87 0.367 . . . . 0.0 111.34 177.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -59.11 -45.31 91.21 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.215 0.531 . . . . 0.0 110.022 176.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.438 ' HA ' ' HE2' ' A' ' 63' ' ' LYS . 80.7 p -79.14 -12.64 59.99 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.574 177.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.414 ' HE3' ' OE2' ' A' ' 81' ' ' GLU . 61.0 tttp -85.53 -21.96 28.36 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 121.303 0.573 . . . . 0.0 110.763 178.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.492 ' HB ' ' HB3' ' A' ' 74' ' ' GLU . 28.4 m -103.52 -18.85 6.49 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.564 171.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.438 ' HE2' ' HA ' ' A' ' 60' ' ' SER . 37.7 ttpt -71.77 93.37 1.29 Allowed 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 120.974 0.416 . . . . 0.0 111.53 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -93.72 -12.53 56.73 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 121.356 -0.449 . . . . 0.0 113.187 -177.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.525 ' HG2' ' N ' ' A' ' 66' ' ' SER . 22.6 ttmm -111.83 164.7 12.79 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 122.622 0.369 . . . . 0.0 110.359 178.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.525 ' N ' ' HG2' ' A' ' 65' ' ' LYS . 86.0 p -74.55 59.6 0.84 Allowed 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.373 0.606 . . . . 0.0 109.649 169.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.481 ' HB1' ' HD2' ' A' ' 65' ' ' LYS . . . -114.72 150.23 35.61 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.446 -171.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 35.0 mtp180 -90.98 -2.7 57.67 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.305 174.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 27.0 m -135.96 144.43 33.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -173.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 27.6 pt -103.21 158.86 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.964 173.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -103.42 179.42 4.28 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.172 0.511 . . . . 0.0 111.743 -178.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -67.47 -36.3 80.87 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -64.55 -57.11 10.07 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 179.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.492 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 0.9 OUTLIER -64.96 -20.46 66.49 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 122.123 -0.361 . . . . 0.0 111.312 177.034 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -63.94 -43.15 96.72 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 120.781 0.324 . . . . 0.0 110.962 173.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -55.16 -46.32 75.74 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 121.178 0.514 . . . . 0.0 110.594 174.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.43 ' O ' ' HG3' ' A' ' 81' ' ' GLU . 59.7 tttm -61.49 -50.85 71.09 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.402 177.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -53.2 -43.71 67.41 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.119 -178.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.484 HD11 HD23 ' A' ' 10' ' ' LEU . 79.9 mt -68.26 -39.86 82.09 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 178.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.5 ' O ' HG22 ' A' ' 84' ' ' THR . 38.0 tt0 -55.51 -47.2 76.62 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.309 0.576 . . . . 0.0 110.748 176.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 77' ' ' LYS . 38.0 mt-10 -65.41 -52.84 50.53 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.444 -179.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 58.9 mt -55.55 -36.72 67.09 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 122.252 -0.28 . . . . 0.0 111.428 174.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.16 -45.64 84.11 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 111.661 0.245 . . . . 0.0 111.661 179.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.5 HG22 ' O ' ' A' ' 80' ' ' GLU . 70.7 p -61.19 -29.5 69.84 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 38.4 mtpt -84.57 -48.47 9.5 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 122.026 -0.421 . . . . 0.0 111.967 173.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 32.4 tpt85 -60.05 -56.99 14.79 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.355 0.598 . . . . 0.0 111.873 -176.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -86.06 172.72 10.4 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.055 -178.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -79.58 171.43 15.16 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.259 -0.428 . . . . 0.0 112.137 -174.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -71.79 67.48 1.06 Allowed Glycine 0 CA--C 1.528 0.858 0 CA-C-N 116.034 -0.53 . . . . 0.0 113.186 178.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -119.81 174.6 6.34 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 45.9 t -44.97 123.32 3.76 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 178.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -52.2 -35.48 49.26 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.662 -178.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 -50.06 -62.84 1.34 Allowed 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.327 177.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -58.64 -42.04 87.37 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.787 0.327 . . . . 0.0 111.435 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.76 -37.41 81.74 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.079 0.466 . . . . 0.0 111.59 179.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -73.51 -46.49 47.51 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.759 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -58.45 -33.65 69.96 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.855 0.36 . . . . 0.0 110.832 174.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.448 ' O ' ' HB3' ' A' ' 101' ' ' GLN . . . -64.45 -55.34 21.49 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.867 178.112 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 19.1 tt -63.94 -34.03 65.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-O 121.033 0.445 . . . . 0.0 110.856 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' CYS . . . . . 0.647 ' SG ' HD22 ' A' ' 10' ' ' LEU . 99.2 m -66.77 -36.75 83.16 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.809 0.337 . . . . 0.0 110.858 173.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.448 ' HB3' ' O ' ' A' ' 98' ' ' ALA . 8.4 tt0 -55.95 -38.64 70.61 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.197 0.522 . . . . 0.0 110.791 175.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 91.1 mt -68.04 -50.97 51.97 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.322 177.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 39.0 t -83.98 -45.97 18.18 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -171.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -52.58 136.89 31.69 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 -173.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 79.44 -35.2 2.01 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-N 116.282 -0.417 . . . . 0.0 113.763 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.566 ' HD3' ' SG ' ' A' ' 42' ' ' CYS . 63.4 tttp -59.77 159.51 8.74 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.349 0.66 . . . . 0.0 112.669 -177.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -124.77 151.02 67.45 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.989 179.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -64.47 120.84 8.25 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 122.573 2.182 . . . . 0.0 113.231 178.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.498 0 CA-C-O 121.214 0.53 . . . . 0.0 112.154 178.786 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 41.3 mm . . . . . 0 N--CA 1.478 0.927 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.42 -45.86 57.76 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.012 0.434 . . . . 0.0 111.485 178.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.24 -18.45 35.37 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 121.223 -0.513 . . . . 0.0 112.863 177.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.412 HD11 HD11 ' A' ' 79' ' ' LEU . 34.1 tp -74.48 -36.83 63.3 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.895 0.379 . . . . 0.0 110.132 175.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -59.03 -43.18 91.58 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.437 0.637 . . . . 0.0 109.533 173.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 56.3 tt0 -58.53 -55.87 29.5 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.236 176.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 73.7 m -54.58 -47.44 73.3 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.628 179.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -58.38 -44.16 88.77 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.005 0.431 . . . . 0.0 110.781 176.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 47.9 ttt180 -60.85 -47.41 86.5 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.719 -179.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -65.25 -40.28 93.78 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.619 178.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.47 ' HB3' ' HE1' ' A' ' 30' ' ' MET . 6.2 m-85 -73.07 -29.69 63.14 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 177.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.09 -47.03 78.68 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.112 0.482 . . . . 0.0 111.078 178.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 17.7 pt -88.88 5.94 4.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-O 121.208 0.527 . . . . 0.0 111.798 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -69.45 93.12 0.64 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.03 0.443 . . . . 0.0 110.806 177.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 81.26 45.89 7.25 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 -170.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.462 ' CB ' ' HB2' ' A' ' 25' ' ' ALA . 11.3 p-10 -64.16 120.83 67.89 Favored Pre-proline 0 CA--C 1.542 0.649 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -168.172 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -84.63 -26.39 1.66 Allowed 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.107 1.871 . . . . 0.0 111.96 166.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 47.7 mttp -157.02 67.14 0.53 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.596 0.758 . . . . 0.0 110.095 176.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.462 ' HB2' ' CB ' ' A' ' 22' ' ' ASP . . . -55.34 91.29 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 179.047 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 66.4 m -104.31 -29.39 10.8 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 120.968 0.413 . . . . 0.0 110.202 169.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.43 22.73 6.94 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 121.214 -0.517 . . . . 0.0 114.243 173.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -146.11 0.78 0.84 Allowed 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 117.363 0.582 . . . . 0.0 112.213 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 20.5 mp0 -114.29 121.48 43.78 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 120.683 0.278 . . . . 0.0 111.74 -175.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.47 ' HE1' ' HB3' ' A' ' 17' ' ' PHE . 52.0 ttm -119.85 134.34 55.27 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.876 0.369 . . . . 0.0 111.406 175.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 18.5 p30 -95.22 165.32 12.45 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.065 0.46 . . . . 0.0 111.702 178.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.78 -31.92 77.35 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 121.321 -0.466 . . . . 0.0 113.255 178.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -58.41 -53.62 56.22 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 177.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -70.42 -33.73 71.68 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 111.595 0.22 . . . . 0.0 111.595 179.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 40.0 t-105 -58.07 -47.13 84.09 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.122 0.487 . . . . 0.0 111.565 175.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.25 -49.37 72.15 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.982 0.42 . . . . 0.0 111.351 178.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -68.28 -22.35 64.74 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 178.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.6 tt -62.55 -52.39 63.6 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.542 0.687 . . . . 0.0 109.475 172.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 81.9 m -58.34 -38.6 77.49 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.211 177.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.436 ' HB2' ' HZ2' ' A' ' 40' ' ' LYS . 4.1 ttmp? -68.69 -44.08 74.73 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 111.919 0.341 . . . . 0.0 111.919 177.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -67.85 -33.19 74.29 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -173.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.945 ' SG ' ' HB3' ' A' ' 102' ' ' LEU . 52.2 t -107.45 1.04 23.25 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-O 121.104 0.478 . . . . 0.0 110.75 175.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.439 ' N ' ' HD2' ' A' ' 43' ' ' LYS . 0.1 OUTLIER 63.09 38.2 10.95 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.793 -0.639 . . . . 0.0 112.155 175.83 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 48.5 t -62.89 -27.7 43.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-O 121.343 0.592 . . . . 0.0 110.386 173.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.51 ' HB1' HG11 ' A' ' 50' ' ' VAL . . . -57.58 115.75 2.96 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.101 170.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.556 ' C ' HG23 ' A' ' 50' ' ' VAL . 11.0 t70 -144.22 -50.14 0.29 Allowed 'General case' 0 C--O 1.221 -0.444 0 CA-C-O 119.311 -0.376 . . . . 0.0 111.662 -170.26 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -2.45 47.81 0.0 OUTLIER Glycine 0 N--CA 1.475 1.239 0 N-CA-C 116.389 1.316 . . . . 0.0 116.389 -164.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.546 ' N ' ' O ' ' A' ' 46' ' ' ASP . 25.0 ttpp 56.42 3.75 0.12 Allowed 'General case' 0 CA--C 1.552 1.046 0 CA-C-O 121.297 0.57 . . . . 0.0 111.704 -177.334 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.8 m 171.98 -27.35 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.92 1.288 . . . . 0.0 109.163 -168.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.556 HG23 ' C ' ' A' ' 46' ' ' ASP . 0.2 OUTLIER 63.58 158.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 124.994 1.317 . . . . 0.0 111.855 -179.541 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.22 -12.32 6.31 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.67 -177.582 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.79 -67.89 1.63 Allowed Glycine 0 CA--C 1.526 0.759 0 C-N-CA 121.361 -0.447 . . . . 0.0 112.47 -175.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.52 ' O ' HG12 ' A' ' 57' ' ' ILE . 51.8 m -48.57 -38.45 20.62 Favored 'General case' 0 C--O 1.223 -0.309 0 C-N-CA 122.275 0.23 . . . . 0.0 111.138 175.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.422 ' O ' HG23 ' A' ' 58' ' ' VAL . 24.1 t70 -51.87 -47.4 64.52 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.991 0.424 . . . . 0.0 111.148 176.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.6 t -61.74 -35.45 67.64 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 CA-C-O 121.186 0.517 . . . . 0.0 110.788 177.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -73.42 -30.24 63.1 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.6 0.714 . . . . 0.0 110.244 178.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.52 HG12 ' O ' ' A' ' 53' ' ' THR . 5.5 mm -70.31 -41.94 78.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.02 177.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 54' ' ' ASP . 88.8 t -58.83 -43.8 89.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 120.777 0.322 . . . . 0.0 110.9 176.172 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -58.13 -41.69 84.23 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.206 0.527 . . . . 0.0 110.44 174.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 28.9 t -73.63 -24.01 59.96 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.769 176.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 55.3 tttp -71.88 -38.57 70.0 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 122.901 0.48 . . . . 0.0 111.248 -176.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.3 m -91.1 -9.52 10.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-O 121.018 0.437 . . . . 0.0 111.34 174.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.551 ' HG3' ' HB3' ' A' ' 67' ' ' ALA . 39.7 ttmt -68.92 118.86 12.38 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.776 179.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -75.52 63.47 2.63 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 121.306 -0.473 . . . . 0.0 113.318 178.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.6 mttt 60.66 101.93 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 178.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.0 t 63.66 11.96 6.18 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 175.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.551 ' HB3' ' HG3' ' A' ' 63' ' ' LYS . . . -69.39 98.75 1.12 Allowed 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.983 0.42 . . . . 0.0 110.912 177.031 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 58.3 mtm180 -64.5 -16.42 62.48 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -177.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 31.2 m -136.14 148.65 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-O 120.793 0.33 . . . . 0.0 111.318 177.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 35.3 pt -115.23 166.07 9.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 121.024 0.44 . . . . 0.0 111.864 178.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -111.52 172.15 7.06 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.187 179.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.508 ' O ' ' HG3' ' A' ' 76' ' ' LYS . 59.6 t80 -61.62 -42.99 99.66 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -178.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -55.54 -55.57 30.39 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -177.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.57 -30.62 68.45 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 122.276 -0.265 . . . . 0.0 111.664 177.179 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -55.1 -38.71 68.49 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.059 0.457 . . . . 0.0 111.032 175.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.528 ' HB3' ' HZ1' ' A' ' 76' ' ' LYS . 6.5 mtpm? -55.95 -47.82 76.9 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.979 175.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.413 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 4.3 mptp? -67.46 -34.36 77.02 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.477 178.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.6 -39.73 92.27 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.125 0.488 . . . . 0.0 111.113 175.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.412 HD11 HD11 ' A' ' 10' ' ' LEU . 69.8 mt -66.64 -41.06 88.87 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.408 175.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -51.94 -44.9 64.13 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 120.966 0.413 . . . . 0.0 111.357 176.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.584 ' O ' ' HG2' ' A' ' 85' ' ' LYS . 1.2 tm-20 -60.98 -66.5 0.52 Allowed 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.442 177.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.417 ' O ' ' HG3' ' A' ' 86' ' ' ARG . 73.6 mt -52.37 -31.52 34.15 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.47 ' HB3' HG21 ' A' ' 99' ' ' ILE . . . -62.95 -51.92 65.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.934 0.397 . . . . 0.0 111.114 177.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.573 ' HB ' ' HA2' ' A' ' 89' ' ' GLY . 69.3 p -62.45 -31.55 72.29 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.244 178.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.584 ' HG2' ' O ' ' A' ' 81' ' ' GLU . 6.2 mmmm -61.71 -29.22 69.96 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.356 176.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.417 ' HG3' ' O ' ' A' ' 82' ' ' LEU . 60.6 mtp180 -96.02 -63.83 1.11 Allowed 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.371 0.605 . . . . 0.0 111.915 179.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.425 ' O ' ' HB2' ' A' ' 88' ' ' LYS . 64.3 m-85 -84.83 46.18 1.23 Allowed 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.839 -0.618 . . . . 0.0 112.39 -170.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.706 ' HZ1' ' HB2' ' A' ' 88' ' ' LYS . 8.4 mtmp? 70.79 114.89 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.962 0.505 . . . . 0.0 111.725 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.573 ' HA2' ' HB ' ' A' ' 84' ' ' THR . . . -65.69 78.81 0.09 OUTLIER Glycine 0 CA--C 1.526 0.778 0 CA-C-N 116.018 -0.537 . . . . 0.0 113.604 -178.473 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 47.0 tttm -159.51 -77.27 0.07 Allowed 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 48.1 m -75.22 108.2 7.82 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -172.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 20.0 ttmm -60.35 -45.6 92.89 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.778 177.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 21.6 mp0 -60.86 -57.67 11.68 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.313 0.578 . . . . 0.0 111.108 -175.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -55.87 -52.01 65.56 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.761 179.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.38 -45.32 91.8 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.987 -178.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -65.6 -48.09 73.46 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.651 -0.249 . . . . 0.0 111.524 -178.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -55.56 -47.34 76.53 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.902 0.382 . . . . 0.0 111.702 177.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.42 -51.42 65.82 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.47 HG21 ' HB3' ' A' ' 83' ' ' ALA . 16.5 tt -63.57 -33.97 64.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 O-C-N 122.006 -0.434 . . . . 0.0 111.385 -178.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 96.5 m -68.7 -37.08 79.27 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.86 0.362 . . . . 0.0 110.593 173.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -59.12 -28.23 66.34 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 121.216 0.532 . . . . 0.0 110.734 176.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.945 ' HB3' ' SG ' ' A' ' 42' ' ' CYS . 53.6 mt -79.74 -58.11 3.34 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.86 175.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.6 t -79.22 -51.11 17.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -173.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.53 119.4 7.45 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -172.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 93.89 -16.34 61.08 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-N 116.183 -0.462 . . . . 0.0 113.825 179.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.427 ' O ' ' HG2' ' A' ' 107' ' ' GLU . 60.1 tttm -74.01 -49.12 25.75 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 117.183 0.491 . . . . 0.0 112.173 -178.092 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.427 ' HG2' ' O ' ' A' ' 106' ' ' LYS . 7.1 pt-20 54.4 161.16 0.06 OUTLIER Pre-proline 0 CA--C 1.557 1.228 0 C-N-CA 124.295 1.038 . . . . 0.0 112.397 -174.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -51.48 118.56 4.5 Favored 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 122.414 2.076 . . . . 0.0 113.641 -176.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.488 0 CA-C-O 121.312 0.577 . . . . 0.0 111.968 179.586 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.5 mp . . . . . 0 N--CA 1.475 0.812 0 CA-C-O 120.903 0.383 . . . . 0.0 110.677 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.96 -44.88 78.91 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.039 0.447 . . . . 0.0 111.543 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.44 -25.78 63.4 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 121.127 -0.559 . . . . 0.0 113.168 177.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 45.4 tp -72.57 -42.6 64.44 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 122.535 -0.391 . . . . 0.0 110.659 178.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -57.56 -47.47 81.96 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.909 0.385 . . . . 0.0 110.783 175.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.581 ' O ' ' HD3' ' A' ' 16' ' ' LYS . 44.6 mt-10 -62.79 -43.28 99.22 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.491 177.035 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.505 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . 38.7 t -54.65 -54.07 46.52 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 120.768 0.318 . . . . 0.0 111.428 178.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -56.73 -42.83 79.9 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.212 0.529 . . . . 0.0 110.844 175.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 33.5 ttt180 -56.57 -45.91 81.03 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.712 -179.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.581 ' HD3' ' O ' ' A' ' 12' ' ' GLU . 5.0 mptp? -66.52 -55.64 14.6 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 178.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -64.04 -28.37 69.75 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -178.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.08 -54.15 45.39 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.986 0.422 . . . . 0.0 111.333 177.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 29.1 pt -80.81 4.56 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 CA-C-N 116.147 -0.478 . . . . 0.0 112.026 -178.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -61.83 -36.39 81.04 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -175.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -125.89 0.1 7.75 Favored Glycine 0 N--CA 1.465 0.58 0 C-N-CA 120.852 -0.689 . . . . 0.0 113.079 -179.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -155.43 89.89 2.95 Favored Pre-proline 0 CA--C 1.542 0.653 0 CA-C-O 121.192 0.52 . . . . 0.0 111.006 -178.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -52.23 -29.71 38.97 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.086 2.524 . . . . 0.0 113.965 -177.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -80.41 3.83 20.03 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.083 0.468 . . . . 0.0 111.654 -176.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.413 ' HB1' ' O ' ' A' ' 29' ' ' GLU . . . -63.9 -31.8 73.1 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.71 170.04 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 30.6 t 58.69 20.12 7.48 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.499 176.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 70.25 11.82 68.15 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.793 -176.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -93.44 -38.31 11.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.231 0.539 . . . . 0.0 110.834 177.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.443 ' HB3' ' CG2' ' A' ' 69' ' ' VAL . 39.3 mt-10 -131.53 154.24 49.0 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.425 -172.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 52.1 ttm -137.88 136.31 36.98 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.809 0.338 . . . . 0.0 111.176 177.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.52 HD22 ' ND2' ' A' ' 34' ' ' ASN . 10.8 p30 -89.73 166.44 13.57 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.134 0.492 . . . . 0.0 111.916 -179.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.62 -21.86 69.34 Favored Glycine 0 CA--C 1.531 1.046 0 CA-C-N 116.024 -0.535 . . . . 0.0 114.283 -177.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.425 ' HB3' ' OD1' ' A' ' 31' ' ' ASN . 62.8 tttp -74.22 -52.43 12.42 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 117.413 0.607 . . . . 0.0 111.151 179.305 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.52 ' ND2' HD22 ' A' ' 31' ' ' ASN . 71.8 m-20 -63.67 -38.36 90.82 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.811 0.338 . . . . 0.0 110.687 176.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.433 ' CD1' ' HB2' ' A' ' 59' ' ' PHE . 43.3 t-105 -60.24 -38.78 84.5 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.425 174.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.21 -45.45 93.14 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.482 177.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -74.13 -32.72 63.29 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 120.866 -0.334 . . . . 0.0 111.102 176.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.7 tt -51.33 -51.35 55.19 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.035 0.445 . . . . 0.0 110.399 177.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 75.0 m -69.13 -49.94 52.42 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.11 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -64.7 -47.55 77.94 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 112.041 0.385 . . . . 0.0 112.041 -176.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -64.88 -34.64 78.87 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 121.033 0.444 . . . . 0.0 110.956 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.79 ' HA ' ' HE2' ' A' ' 106' ' ' LYS . 68.5 m -90.07 1.61 56.16 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.352 174.408 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 52.1 mttm 53.07 34.39 17.08 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 176.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.604 ' HA ' HH11 ' A' ' 86' ' ' ARG . 49.0 t -64.89 -37.58 80.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 121.566 0.698 . . . . 0.0 109.556 167.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -98.83 51.36 0.97 Allowed 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.51 173.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -64.99 -27.92 69.16 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 116.072 -0.513 . . . . 0.0 112.023 -175.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 138.2 -62.51 0.57 Allowed Glycine 0 CA--C 1.527 0.823 0 C-N-CA 121.046 -0.597 . . . . 0.0 113.497 -178.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.62 ' HD2' ' H ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -71.19 20.03 0.05 Allowed 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -175.653 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 49.2 m -153.71 -64.58 0.14 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.214 0.531 . . . . 0.0 110.887 176.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.565 HG13 HD23 ' A' ' 82' ' ' LEU . 58.8 t -121.18 151.92 24.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.863 -179.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 71.4 p -118.59 154.32 32.82 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 122.343 0.257 . . . . 0.0 111.121 177.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -52.18 -41.64 54.1 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 121.398 -0.429 . . . . 0.0 113.349 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 63.0 m -55.84 -49.31 73.65 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.097 0.475 . . . . 0.0 110.834 176.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -62.01 -37.33 84.47 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.928 178.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 70.0 t -57.34 -36.3 52.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.85 176.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -69.27 -43.91 72.95 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 122.01 0.91 . . . . 0.0 109.583 178.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.9 mm -62.22 -45.53 98.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-N 114.584 -1.189 . . . . 0.0 111.621 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.467 ' O ' HG12 ' A' ' 62' ' ' VAL . 73.9 t -56.91 -47.82 82.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.525 177.051 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.433 ' HB2' ' CD1' ' A' ' 35' ' ' TRP . 80.0 t80 -50.85 -51.05 55.03 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.026 0.441 . . . . 0.0 111.183 177.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 29.2 t -71.01 -29.34 65.26 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.572 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -64.78 -36.95 85.96 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.536 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.479 HG23 ' HB2' ' A' ' 77' ' ' LYS . 3.7 p -94.93 -22.14 5.49 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 178.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -56.45 134.79 54.2 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -67.96 83.49 0.17 Allowed Glycine 0 CA--C 1.532 1.113 0 C-N-CA 121.333 -0.461 . . . . 0.0 113.816 176.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 61.9 mttp 53.13 -90.47 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 175.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 36.5 t -128.22 29.62 5.33 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.983 0.42 . . . . 0.0 111.212 -174.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -73.97 5.76 3.96 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 179.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 44.5 mtp180 68.36 -64.48 0.3 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.531 0.733 . . . . 0.0 112.125 -176.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.517 HG13 ' HA ' ' A' ' 31' ' ' ASN . 24.4 m -117.92 170.04 7.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.134 -172.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 39.4 pt -109.75 152.79 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.293 178.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -92.36 178.45 5.83 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.045 0.45 . . . . 0.0 111.381 175.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.492 ' O ' ' HB3' ' A' ' 75' ' ' PHE . 75.5 t80 -58.45 -41.87 86.09 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -174.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -70.51 -34.05 71.88 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.993 -0.442 . . . . 0.0 111.384 -178.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -68.9 -34.29 75.18 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.434 0.635 . . . . 0.0 110.012 174.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.492 ' HB3' ' O ' ' A' ' 72' ' ' TYR . 61.1 t80 -58.22 -43.03 87.52 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.823 170.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.468 ' HG3' ' O ' ' A' ' 72' ' ' TYR . 47.0 mtpt -60.03 -37.86 81.02 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.743 0.306 . . . . 0.0 111.021 176.042 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.479 ' HB2' HG23 ' A' ' 62' ' ' VAL . 94.6 mttt -65.0 -38.45 91.01 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.159 0.504 . . . . 0.0 110.89 177.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.98 -39.73 93.91 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.058 176.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 84.2 mt -61.36 -49.78 75.55 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.832 175.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -51.56 -44.39 62.71 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.2 0.524 . . . . 0.0 111.605 175.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -60.53 -63.7 1.21 Allowed 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.511 178.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.565 HD23 HG13 ' A' ' 50' ' ' VAL . 75.1 mt -58.71 -38.18 77.76 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -178.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.78 -47.74 83.8 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.607 0.241 . . . . 0.0 111.546 178.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 50.5 p -65.84 -19.56 65.93 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 178.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -81.28 -38.41 26.89 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 120.774 0.321 . . . . 0.0 111.444 172.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.604 HH11 ' HA ' ' A' ' 44' ' ' VAL . 36.7 mtp180 -79.28 -58.73 3.07 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -98.3 -164.46 1.14 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.393 -173.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -62.71 119.58 9.56 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -178.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -72.34 61.56 1.47 Allowed Glycine 0 CA--C 1.528 0.901 0 C-N-CA 120.902 -0.666 . . . . 0.0 111.555 171.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -163.29 -50.68 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.93 0.395 . . . . 0.0 111.099 -169.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 48.4 t -94.45 120.95 35.47 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.611 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -75.82 -60.77 2.17 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -178.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -61.76 -36.74 81.9 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -174.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -62.21 -60.15 3.99 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.088 0.471 . . . . 0.0 111.428 177.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.07 -42.39 85.43 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.913 -178.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -70.52 -40.37 73.52 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.412 -177.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -62.79 -53.52 53.04 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.125 0.488 . . . . 0.0 110.354 177.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -55.94 -52.54 63.77 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.644 -178.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 14.4 tt -60.92 -39.84 83.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 O-C-N 122.115 -0.366 . . . . 0.0 111.23 -179.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 95.9 m -70.56 -30.24 66.91 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.829 0.347 . . . . 0.0 111.042 176.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -64.42 -30.27 71.31 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.231 0.539 . . . . 0.0 110.762 178.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 82.8 mt -77.82 -18.42 56.35 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 177.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.497 HG13 ' HG ' ' A' ' 13' ' ' SER . 41.3 t -114.56 -54.54 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -172.03 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.505 ' HA ' ' HB2' ' A' ' 13' ' ' SER . . . -52.12 112.08 0.73 Allowed 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -172.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 81.98 -2.99 82.24 Favored Glycine 0 CA--C 1.527 0.814 0 CA-C-N 115.908 -0.587 . . . . 0.0 114.463 173.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.79 ' HE2' ' HA ' ' A' ' 42' ' ' CYS . 22.1 ttpp -70.64 -28.05 64.52 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 117.602 0.701 . . . . 0.0 112.22 -178.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.522 ' HG2' ' O ' ' A' ' 106' ' ' LYS . 1.5 pt-20 72.7 155.46 0.16 Allowed Pre-proline 0 N--CA 1.481 1.079 0 C-N-CA 124.049 0.94 . . . . 0.0 111.904 -178.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -73.08 113.04 3.67 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 122.808 2.338 . . . . 0.0 111.628 174.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.62 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -174.411 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.2 tp . . . . . 0 CA--C 1.547 0.828 0 CA-C-O 121.225 0.535 . . . . 0.0 111.255 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -49.22 -41.46 37.36 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -175.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.84 -36.59 80.64 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 121.03 -0.605 . . . . 0.0 113.51 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.553 HD12 ' HB3' ' A' ' 104' ' ' ALA . 24.7 tp -78.24 -39.99 38.59 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 122.46 -0.435 . . . . 0.0 110.868 -179.37 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.577 ' HB3' ' NH2' ' A' ' 15' ' ' ARG . 45.3 mt-10 -55.77 -42.26 75.22 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.428 0.632 . . . . 0.0 110.657 173.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.468 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 8.7 tp10 -57.13 -55.57 33.08 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.389 177.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.415 ' HB3' ' O ' ' A' ' 108' ' ' PRO . 75.0 m -47.06 -51.23 18.06 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.324 174.132 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.404 ' N ' ' HB3' ' A' ' 109' ' ' ALA . 62.4 t80 -51.32 -46.35 62.56 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.696 -0.627 . . . . 0.0 111.196 -178.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.577 ' NH2' ' HB3' ' A' ' 11' ' ' GLU . 0.5 OUTLIER -70.02 -46.15 65.69 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 111.849 0.315 . . . . 0.0 111.849 177.838 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.52 ' O ' ' HB2' ' A' ' 20' ' ' HIS . 75.8 mmtt -53.99 -42.78 69.41 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.164 0.507 . . . . 0.0 110.854 178.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.668 ' CD1' ' HA ' ' A' ' 108' ' ' PRO . 0.2 OUTLIER -73.58 -34.39 65.09 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.859 -177.114 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.681 ' HA ' ' SD ' ' A' ' 30' ' ' MET . . . -66.98 -58.13 5.54 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.155 0.502 . . . . 0.0 112.048 -177.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 30.7 pt -80.49 -0.09 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 121.432 0.634 . . . . 0.0 111.052 -178.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.52 ' HB2' ' O ' ' A' ' 16' ' ' LYS . 37.2 t-80 -52.16 -45.59 65.11 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.316 -0.856 . . . . 0.0 112.289 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -112.14 10.03 26.94 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.771 -0.728 . . . . 0.0 114.516 -173.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -157.23 127.31 3.34 Favored Pre-proline 0 CA--C 1.545 0.78 0 CA-C-N 117.628 0.714 . . . . 0.0 111.438 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.54 -26.65 13.8 Favored 'Trans proline' 0 CA--C 1.544 0.992 0 C-N-CA 122.754 2.303 . . . . 0.0 113.611 -178.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -96.3 0.98 51.59 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -176.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.73 134.25 51.37 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 120.832 0.349 . . . . 0.0 111.846 178.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.4 t -57.43 -34.46 68.96 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.474 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.72 15.1 76.45 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 121.246 -0.502 . . . . 0.0 113.126 177.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -124.85 -26.15 3.81 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.199 0.523 . . . . 0.0 110.987 178.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -122.81 128.25 50.19 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.694 -178.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.681 ' SD ' ' HA ' ' A' ' 18' ' ' ALA . 10.9 tpp -114.08 152.29 31.28 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -176.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.513 ' ND2' ' HB2' ' A' ' 33' ' ' LYS . 13.7 p-10 -97.27 164.4 12.49 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -179.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.75 -29.03 69.15 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-N 116.069 -0.514 . . . . 0.0 113.959 -179.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.513 ' HB2' ' ND2' ' A' ' 31' ' ' ASN . 5.2 mmmm -51.75 -45.05 63.54 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 175.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.516 ' ND2' ' SD ' ' A' ' 30' ' ' MET . 4.5 m-20 -72.94 -25.71 61.13 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.777 -179.158 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 40.0 t-105 -66.88 -45.0 79.42 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.042 0.448 . . . . 0.0 111.0 175.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.2 -47.76 84.65 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.233 0.539 . . . . 0.0 110.945 175.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -63.83 -32.79 74.42 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.689 177.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.55 HD13 ' HA ' ' A' ' 109' ' ' ALA . 2.6 tt -58.16 -55.22 37.82 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.221 0.534 . . . . 0.0 110.263 179.06 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.596 ' SG ' ' HB3' ' A' ' 45' ' ' ALA . 45.9 t -58.86 -43.95 90.95 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.529 -179.417 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 28.9 ttpp -66.78 -41.51 87.53 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 120.878 0.37 . . . . 0.0 111.562 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -63.0 -48.59 78.17 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.274 0.559 . . . . 0.0 110.822 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.429 ' SG ' HG22 ' A' ' 103' ' ' VAL . 83.9 m -82.32 -3.28 55.04 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.675 179.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt 59.92 28.3 17.78 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.199 0.523 . . . . 0.0 112.02 175.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 47.9 t -67.36 -33.35 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.695 174.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.596 ' HB3' ' SG ' ' A' ' 39' ' ' CYS . . . -61.95 86.77 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.395 0.616 . . . . 0.0 111.079 175.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -63.69 -47.45 81.12 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.473 -178.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 125.13 -33.51 3.65 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 121.126 -0.559 . . . . 0.0 113.186 -178.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.5 pttt -129.32 -28.64 2.31 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 177.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 90.9 p -88.55 -39.82 13.86 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 121.055 0.455 . . . . 0.0 110.377 171.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 91.2 t -132.99 116.62 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.776 174.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 27.1 p -111.8 175.72 5.31 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.874 0.369 . . . . 0.0 111.088 178.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -58.92 -29.11 64.41 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.105 172.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.622 ' O ' HG13 ' A' ' 57' ' ' ILE . 44.3 m -61.51 -57.72 11.0 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 110.318 -0.253 . . . . 0.0 110.318 174.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -48.61 -42.51 34.26 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.96 0.41 . . . . 0.0 111.618 178.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 95.5 t -56.35 -45.71 81.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.625 177.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -71.79 -32.76 67.96 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 120.837 0.351 . . . . 0.0 111.275 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.622 HG13 ' O ' ' A' ' 53' ' ' THR . 9.3 mt -66.23 -54.44 26.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.721 178.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.427 HG11 ' CD1' ' A' ' 82' ' ' LEU . 93.9 t -54.2 -47.37 67.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 120.805 0.336 . . . . 0.0 111.68 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.513 ' O ' ' HG2' ' A' ' 63' ' ' LYS . 55.2 t80 -56.99 -38.28 72.83 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 120.803 0.335 . . . . 0.0 110.638 178.277 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 37.5 m -81.33 -18.78 44.51 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 178.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.427 ' HG2' ' O ' ' A' ' 57' ' ' ILE . 32.4 mmtp -73.26 -43.88 60.34 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 179.05 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.467 HG11 ' HB2' ' A' ' 78' ' ' ALA . 7.1 m -70.03 -45.0 77.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.513 ' HG2' ' O ' ' A' ' 59' ' ' PHE . 22.2 ptmt -81.2 166.34 20.69 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.369 0.604 . . . . 0.0 112.509 -176.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -104.18 -94.36 2.32 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.165 174.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -131.84 -57.56 0.98 Allowed 'General case' 0 N--CA 1.473 0.706 0 O-C-N 122.426 -0.455 . . . . 0.0 111.832 176.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 37.8 m -77.45 65.27 2.96 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -176.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -160.79 111.86 1.82 Allowed 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.977 0.418 . . . . 0.0 111.676 179.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.86 -26.9 17.44 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.794 0.33 . . . . 0.0 110.822 175.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 26.0 m -120.57 174.07 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 121.102 0.477 . . . . 0.0 111.955 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.9 pp -135.39 165.76 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -172.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.593 ' OD1' ' HB2' ' A' ' 74' ' ' GLU . 24.7 p-10 -111.79 -179.82 3.81 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.231 -178.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.606 ' O ' ' HB3' ' A' ' 75' ' ' PHE . 65.9 t80 -85.84 -46.18 10.87 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -176.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -62.05 -31.5 71.92 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.462 -0.774 . . . . 0.0 111.472 -175.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.593 ' HB2' ' OD1' ' A' ' 71' ' ' ASN . 0.4 OUTLIER -73.12 -36.27 66.68 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.751 -0.204 . . . . 0.0 111.134 171.822 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.606 ' HB3' ' O ' ' A' ' 72' ' ' TYR . 41.7 t80 -46.09 -41.95 12.95 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 172.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -57.84 -41.74 82.95 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 121.238 0.542 . . . . 0.0 111.658 174.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -72.09 -43.6 64.54 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 121.13 0.49 . . . . 0.0 111.082 -179.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.467 ' HB2' HG11 ' A' ' 62' ' ' VAL . . . -60.92 -44.61 96.96 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.843 177.21 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.456 HD12 ' CZ ' ' A' ' 75' ' ' PHE . 34.1 mt -52.32 -46.0 65.83 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 122.079 -0.388 . . . . 0.0 111.61 172.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -54.15 -38.25 65.3 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 121.094 0.473 . . . . 0.0 110.94 177.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.426 ' HB3' ' O ' ' A' ' 78' ' ' ALA . 16.6 tp10 -59.47 -51.23 70.76 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.995 174.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.427 ' CD1' HG11 ' A' ' 58' ' ' VAL . 8.8 mp -60.63 -47.62 85.42 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 111.841 0.312 . . . . 0.0 111.841 178.386 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.36 -46.28 69.51 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.851 0.358 . . . . 0.0 111.867 -178.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 69.2 p -67.55 -34.59 77.37 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.19 -0.459 . . . . 0.0 112.115 179.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.727 ' HB3' ' HZ1' ' A' ' 85' ' ' LYS . 8.3 mtpm? -80.11 -28.55 38.98 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 179.177 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -85.85 -55.26 4.05 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.07 0.462 . . . . 0.0 110.73 -176.319 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -96.75 50.52 1.12 Allowed 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.45 -177.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -59.64 99.82 0.07 Allowed 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.304 0.573 . . . . 0.0 111.483 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 136.14 -30.61 2.71 Favored Glycine 0 CA--C 1.521 0.43 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.774 -176.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -86.01 144.04 27.8 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 122.796 0.439 . . . . 0.0 110.585 176.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 43.6 t -59.07 134.78 57.29 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 122.412 -0.18 . . . . 0.0 111.345 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -52.2 -36.69 52.75 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -174.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -66.03 -51.61 56.7 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 120.869 0.366 . . . . 0.0 111.242 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -64.39 -37.21 86.71 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 121.072 0.463 . . . . 0.0 111.366 176.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.69 -43.97 91.81 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.994 0.425 . . . . 0.0 111.561 178.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -62.81 -39.28 93.81 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.114 0.483 . . . . 0.0 110.758 177.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -60.16 -51.62 68.81 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.534 176.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.82 -51.87 67.46 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.247 -178.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.3 tt -58.73 -42.97 86.74 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 CA-C-O 120.808 0.337 . . . . 0.0 111.119 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 74.7 m -68.96 -28.72 66.88 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.727 0.299 . . . . 0.0 111.267 177.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -64.41 -33.0 74.85 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.07 0.462 . . . . 0.0 110.989 178.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 81.0 mt -77.12 -20.41 55.67 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 116.176 -0.465 . . . . 0.0 112.062 178.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.429 HG22 ' SG ' ' A' ' 42' ' ' CYS . 60.2 t -105.91 -61.5 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -173.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.553 ' HB3' HD12 ' A' ' 10' ' ' LEU . . . -57.73 147.9 26.46 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -175.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 98.01 -35.9 4.28 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 121.157 -0.544 . . . . 0.0 113.265 177.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -79.04 -77.33 0.17 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 117.029 0.414 . . . . 0.0 111.525 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.526 ' CG ' ' HD3' ' A' ' 108' ' ' PRO . 11.1 pt-20 -176.29 -33.65 0.0 OUTLIER Pre-proline 0 CA--C 1.553 1.088 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 -179.367 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.668 ' HA ' ' CD1' ' A' ' 17' ' ' PHE . 50.6 Cg_exo -68.08 142.77 57.29 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 122.553 2.169 . . . . 0.0 115.646 176.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.55 ' HA ' HD13 ' A' ' 38' ' ' LEU . . . . . . . . 0 N--CA 1.489 1.501 0 CA-C-N 115.054 -0.975 . . . . 0.0 112.107 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.54 HD11 ' HB3' ' A' ' 100' ' ' CYS . 30.3 pt . . . . . 0 N--CA 1.472 0.642 0 CA-C-O 121.226 0.536 . . . . 0.0 111.681 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.77 -31.92 70.12 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.909 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.8 -31.76 64.81 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 121.215 -0.517 . . . . 0.0 113.028 177.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 36.8 tp -70.89 -43.77 67.67 Favored 'General case' 0 N--CA 1.467 0.383 0 O-C-N 122.73 -0.277 . . . . 0.0 110.773 178.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.2 tm-20 -57.78 -46.87 83.99 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.273 175.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.402 ' O ' ' HB2' ' A' ' 16' ' ' LYS . 33.5 tt0 -57.24 -49.61 75.5 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.575 177.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 56.9 m -63.36 -50.02 71.57 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -178.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -54.88 -48.53 72.85 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.216 0.531 . . . . 0.0 110.558 176.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.472 ' HG3' ' HA3' ' A' ' 27' ' ' GLY . 23.2 ttt180 -63.7 -37.95 89.27 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.084 178.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 12' ' ' GLU . 32.6 ttmt -59.32 -42.12 90.65 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.041 -178.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.412 ' CZ ' ' HA ' ' A' ' 108' ' ' PRO . 31.1 m-85 -79.9 -32.2 40.25 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 174.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.52 -34.35 75.38 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -178.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 27.9 pt -95.7 14.22 3.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-O 120.98 0.419 . . . . 0.0 111.685 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 75.1 t60 -64.75 -16.81 63.49 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -176.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -105.35 -38.57 2.42 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 120.959 -0.639 . . . . 0.0 113.396 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -162.18 148.98 11.05 Favored Pre-proline 0 CA--C 1.541 0.618 0 O-C-N 122.688 -0.301 . . . . 0.0 111.652 -175.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.12 -2.9 12.74 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.651 2.234 . . . . 0.0 113.401 -178.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -85.97 -18.74 31.78 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.068 0.461 . . . . 0.0 110.862 178.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -76.54 54.19 0.92 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.353 170.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 38.0 t -25.58 -53.43 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 -170.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.472 ' HA3' ' HG3' ' A' ' 15' ' ' ARG . . . 147.95 58.93 0.01 OUTLIER Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.629 -179.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -134.95 -19.17 1.79 Allowed 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 120.751 0.31 . . . . 0.0 111.5 -178.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -152.72 151.87 31.03 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -171.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.412 ' O ' HD11 ' A' ' 70' ' ' ILE . 42.8 ttm -136.58 149.63 48.16 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.61 -179.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -97.36 168.35 10.46 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.119 0.485 . . . . 0.0 111.948 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.08 -32.77 81.56 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-N 116.185 -0.461 . . . . 0.0 114.181 -177.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -62.51 -52.26 64.16 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 117.053 0.426 . . . . 0.0 111.732 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -69.13 -40.3 78.35 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.594 0.235 . . . . 0.0 110.999 177.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.49 ' NE1' ' HB2' ' A' ' 59' ' ' PHE . 24.9 t-105 -56.36 -42.27 77.52 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.113 0.482 . . . . 0.0 111.747 175.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.07 -51.93 65.97 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.572 179.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -69.32 -27.41 65.35 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.19 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.0 tt -57.38 -56.91 15.77 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.058 0.456 . . . . 0.0 110.198 176.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 86.3 m -60.49 -47.83 84.4 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.997 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -67.48 -41.71 84.15 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -176.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.407 ' OD2' ' NZ ' ' A' ' 106' ' ' LYS . 37.5 t70 -77.51 -29.96 52.7 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 120.741 0.305 . . . . 0.0 111.623 -178.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 62.2 m -90.7 -0.44 57.7 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 120.697 0.284 . . . . 0.0 111.429 176.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt 71.47 22.06 4.31 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 173.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 50.7 t -68.02 -28.45 41.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 CA-C-O 121.144 0.497 . . . . 0.0 110.99 174.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -89.65 121.03 31.45 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.254 174.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -79.48 -66.19 0.9 Allowed 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -173.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.437 ' O ' ' HB2' ' A' ' 48' ' ' LYS . . . 130.34 119.46 2.13 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 -168.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.437 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 75.2 mmtt 80.74 -15.94 0.7 Allowed 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.646 0.779 . . . . 0.0 111.936 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 42.4 t -122.03 -83.23 0.66 Allowed 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 173.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 84.1 t -87.56 111.7 22.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 120.894 0.378 . . . . 0.0 110.617 172.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.433 ' O ' HG21 ' A' ' 55' ' ' VAL . 72.8 p -125.58 -179.93 4.86 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.935 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -50.78 -35.44 31.11 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 121.031 -0.604 . . . . 0.0 113.195 178.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.561 ' O ' HG13 ' A' ' 57' ' ' ILE . 27.6 m -60.8 -58.41 8.57 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.738 0.304 . . . . 0.0 110.797 176.62 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -53.34 -41.45 65.78 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.976 179.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.433 HG21 ' O ' ' A' ' 51' ' ' THR . 93.6 t -56.91 -39.51 65.67 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.74 177.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -73.82 -37.84 64.75 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.292 0.568 . . . . 0.0 110.4 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.561 HG13 ' O ' ' A' ' 53' ' ' THR . 11.4 mt -60.33 -48.42 88.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.943 178.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 89.7 t -62.48 -43.69 98.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.64 177.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.49 ' HB2' ' NE1' ' A' ' 35' ' ' TRP . 86.7 t80 -50.23 -47.66 54.9 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.109 0.481 . . . . 0.0 111.938 178.368 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 35.8 t -82.04 -16.7 49.29 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.06 0.457 . . . . 0.0 111.614 -179.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -76.09 -38.22 57.24 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.95 -179.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.1 m -87.07 -5.92 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -176.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.6 pttp -119.88 -176.92 3.28 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.09 0.472 . . . . 0.0 111.692 -178.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -105.1 -178.03 24.36 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-N 116.291 -0.413 . . . . 0.0 113.424 177.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -75.49 -39.79 58.1 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -178.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 43.4 t -66.47 -35.95 81.54 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 120.917 0.389 . . . . 0.0 111.868 -178.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -93.4 122.44 35.82 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 120.967 0.413 . . . . 0.0 111.327 178.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 70.7 mtp180 -94.25 5.64 51.14 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.112 0.482 . . . . 0.0 110.683 175.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.9 m -129.63 159.91 41.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.921 179.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.412 HD11 ' O ' ' A' ' 30' ' ' MET . 0.2 OUTLIER -114.4 150.7 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-O 120.967 0.413 . . . . 0.0 111.297 175.946 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.413 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 2.9 p-10 -104.78 172.25 6.89 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.296 178.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -46.49 -54.18 9.78 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -169.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.46 -44.86 89.76 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 120.983 0.421 . . . . 0.0 111.347 -176.035 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -65.71 -33.96 77.1 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.203 0.525 . . . . 0.0 110.838 179.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -57.62 -44.09 85.25 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.6 172.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -69.08 -33.7 73.94 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.231 176.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -60.54 -37.92 82.79 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.251 0.548 . . . . 0.0 110.292 173.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.08 -41.91 97.15 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.745 172.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 88.6 mt -62.31 -33.7 75.19 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.398 175.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -61.07 -49.64 76.52 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 120.735 0.302 . . . . 0.0 110.833 175.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -55.56 -58.01 9.54 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.111 0.482 . . . . 0.0 111.085 174.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 94.0 mt -56.71 -44.46 81.6 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.036 -179.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.69 -45.2 87.64 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -179.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 81.8 p -72.44 -12.29 61.04 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -178.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -93.72 -47.45 6.78 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 120.685 0.279 . . . . 0.0 111.502 172.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 76.7 mtp180 -70.63 -49.87 42.88 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 121.176 0.512 . . . . 0.0 111.85 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -106.55 38.59 2.02 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.881 -177.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -57.87 90.97 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.97 -178.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -160.8 44.81 0.41 Allowed Glycine 0 CA--C 1.526 0.772 0 C-N-CA 121.076 -0.583 . . . . 0.0 113.446 179.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 60.9 mttm 70.71 -60.68 0.5 Allowed 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 177.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 25.6 m -56.78 87.91 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -175.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -66.36 -43.48 85.88 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.703 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -54.03 -61.07 2.54 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.836 0.35 . . . . 0.0 110.886 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -56.72 -41.6 77.74 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.691 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.24 -43.5 92.39 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.924 0.393 . . . . 0.0 111.282 177.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -68.69 -49.06 62.01 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.963 -179.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.52 ' O ' ' HG3' ' A' ' 101' ' ' GLN . 1.5 m-20 -55.5 -44.54 76.66 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 111.545 0.202 . . . . 0.0 111.545 175.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.67 -57.55 11.55 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.019 0.437 . . . . 0.0 112.108 -179.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.0 tt -57.62 -29.74 35.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-O 121.245 0.545 . . . . 0.0 110.474 178.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' CYS . . . . . 0.54 ' HB3' HD11 ' A' ' 7' ' ' ILE . 90.6 m -82.26 -18.98 40.53 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.963 175.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.52 ' HG3' ' O ' ' A' ' 97' ' ' ASP . 24.4 mt-30 -64.91 -33.94 77.23 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 121.669 -0.644 . . . . 0.0 109.853 171.259 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 81.1 mt -75.58 -11.1 59.95 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.557 177.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 64.5 t -121.48 -51.16 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -173.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -49.45 113.8 0.9 Allowed 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -175.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.39 -31.25 5.85 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 121.401 -0.428 . . . . 0.0 113.293 -179.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.407 ' NZ ' ' OD2' ' A' ' 41' ' ' ASP . 26.3 tptp -47.02 133.21 11.52 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.571 0.748 . . . . 0.0 112.602 -178.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -83.48 155.82 65.82 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.319 178.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.412 ' HA ' ' CZ ' ' A' ' 17' ' ' PHE . 83.2 Cg_endo -79.83 139.34 13.82 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.589 2.193 . . . . 0.0 113.17 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.509 0 CA-C-O 121.214 0.531 . . . . 0.0 111.301 178.913 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.459 ' N ' HD12 ' A' ' 7' ' ' ILE . 2.3 mp . . . . . 0 CA--C 1.543 0.683 0 CA-C-O 121.264 0.554 . . . . 0.0 110.797 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.41 -35.65 72.36 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.329 -177.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -56.66 -31.4 60.47 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 121.131 -0.557 . . . . 0.0 113.131 179.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.423 HD11 ' HE2' ' A' ' 75' ' ' PHE . 54.7 tp -70.45 -53.73 15.22 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 120.776 0.322 . . . . 0.0 111.314 178.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -63.36 -39.01 93.36 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 122.185 -0.322 . . . . 0.0 111.533 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -57.79 -56.52 20.92 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.831 0.348 . . . . 0.0 111.095 175.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.673 ' HB3' ' HB2' ' A' ' 107' ' ' GLU . 65.7 m -67.79 -44.34 77.61 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -176.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -50.01 -51.94 38.0 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 121.187 0.518 . . . . 0.0 111.145 171.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 15' ' ' ARG . 32.1 ttt180 -60.55 -44.23 96.35 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.832 179.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.539 ' HD3' HD11 ' A' ' 19' ' ' ILE . 0.1 OUTLIER -68.85 -27.89 66.22 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.844 -179.441 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -78.52 -33.12 48.25 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.177 0.513 . . . . 0.0 110.199 177.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.38 -38.35 77.98 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.447 177.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.539 HD11 ' HD3' ' A' ' 16' ' ' LYS . 27.0 pt -94.11 14.45 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 120.877 0.37 . . . . 0.0 111.039 178.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -52.85 97.3 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.101 0.477 . . . . 0.0 111.477 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 120.73 -36.2 3.44 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.656 -176.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.436 ' O ' ' HB ' ' A' ' 19' ' ' ILE . 11.7 m-20 -121.54 91.4 48.41 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 122.76 0.424 . . . . 0.0 111.946 -178.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -71.35 -2.87 11.9 Favored 'Trans proline' 0 CA--C 1.545 1.026 0 C-N-CA 122.517 2.145 . . . . 0.0 113.549 -178.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.658 ' HZ2' ' HB3' ' A' ' 24' ' ' LYS . 8.7 mtpm? -88.35 -7.0 57.38 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -178.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.449 ' HB3' HG22 ' A' ' 19' ' ' ILE . . . -93.73 157.57 16.09 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.615 0.245 . . . . 0.0 111.321 178.163 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 28.3 t -88.36 -19.16 27.02 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 120.989 0.423 . . . . 0.0 110.776 177.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.427 ' HA3' HG21 ' A' ' 19' ' ' ILE . . . 63.87 56.6 17.82 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 115.606 1.002 . . . . 0.0 115.606 170.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -96.57 -8.56 31.53 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.518 0.675 . . . . 0.0 109.793 169.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.509 ' HB3' HG21 ' A' ' 69' ' ' VAL . 50.9 mt-10 -113.08 111.61 22.42 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.432 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 42.3 ttm -98.86 133.32 43.32 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.146 0.498 . . . . 0.0 111.553 176.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.416 ' ND2' ' HB2' ' A' ' 33' ' ' LYS . 13.9 p-10 -86.86 156.92 19.67 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.531 179.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -58.25 -28.2 61.32 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-N 116.24 -0.437 . . . . 0.0 113.212 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.416 ' HB2' ' ND2' ' A' ' 31' ' ' ASN . 47.4 mmtm -57.7 -59.5 5.11 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.045 0.45 . . . . 0.0 111.336 176.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -64.66 -38.76 92.1 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.872 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 45.5 t-105 -56.17 -49.06 75.06 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 120.901 0.382 . . . . 0.0 111.798 177.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.04 -47.08 86.33 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.205 0.526 . . . . 0.0 111.751 178.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.612 ' HZ2' ' HB3' ' A' ' 37' ' ' LYS . 7.8 mtpm? -67.26 -29.98 69.74 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.336 179.33 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.462 HD23 ' HG ' ' A' ' 42' ' ' CYS . 5.1 tt -62.3 -49.3 76.18 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.169 0.509 . . . . 0.0 110.081 177.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 78.9 m -58.53 -44.28 89.52 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.442 178.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -69.9 -33.66 72.48 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 120.992 0.425 . . . . 0.0 111.388 179.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -64.1 -38.66 91.88 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.418 0.628 . . . . 0.0 110.822 177.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.472 ' HA ' ' HE2' ' A' ' 106' ' ' LYS . 59.1 m -99.2 0.76 43.98 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.039 -177.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.428 ' N ' ' HD2' ' A' ' 43' ' ' LYS . 3.3 mptp? 59.2 31.28 21.1 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.337 176.26 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.446 HG11 ' HB3' ' A' ' 82' ' ' LEU . 32.5 t -70.3 -37.44 71.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-O 121.486 0.66 . . . . 0.0 109.39 170.098 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.19 85.46 6.8 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.505 169.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -169.76 78.68 0.1 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.785 -171.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -176.72 37.29 0.09 OUTLIER Glycine 0 CA--C 1.522 0.506 0 C-N-CA 120.708 -0.758 . . . . 0.0 113.434 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.1 mtpm? 50.23 14.67 0.16 Allowed 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 178.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.7 m -150.54 -60.08 0.19 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.885 0.374 . . . . 0.0 110.509 -175.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 41.0 t -68.29 90.36 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 172.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 49.2 p -129.0 -171.09 2.39 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.103 -178.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -48.04 -36.86 15.58 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 121.476 -0.392 . . . . 0.0 113.686 -178.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.55 ' O ' HG12 ' A' ' 57' ' ' ILE . 4.8 t -64.32 -55.85 18.49 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 122.334 -0.51 . . . . 0.0 111.358 178.37 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -62.7 -40.03 95.87 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.04 0.448 . . . . 0.0 110.994 -177.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 84.3 t -61.69 -31.03 49.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.417 176.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -82.03 -30.91 31.23 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.334 0.588 . . . . 0.0 109.55 179.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.55 HG12 ' O ' ' A' ' 53' ' ' THR . 10.4 mm -61.24 -52.38 62.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.9 174.233 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.8 t -58.53 -42.74 85.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 120.919 0.39 . . . . 0.0 110.945 176.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -57.82 -40.82 80.9 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.355 0.598 . . . . 0.0 110.869 175.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 37.3 m -82.59 -11.72 58.21 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.486 178.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.667 ' HA ' ' HE2' ' A' ' 61' ' ' LYS . 0.6 OUTLIER -76.95 -50.41 13.28 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.838 176.972 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 31.4 m -67.63 -25.94 34.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.548 175.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.404 ' NZ ' ' O ' ' A' ' 67' ' ' ALA . 23.0 ttmm -69.34 104.98 2.4 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.829 174.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -91.15 -61.35 1.27 Allowed Glycine 0 CA--C 1.526 0.778 0 C-N-CA 121.081 -0.581 . . . . 0.0 113.299 -178.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.581 ' HB2' ' HZ2' ' A' ' 65' ' ' LYS . 10.3 mtmp? -121.55 -152.63 0.52 Allowed 'General case' 0 CA--C 1.542 0.66 0 O-C-N 122.524 -0.398 . . . . 0.0 111.014 -178.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 39.3 t -62.72 91.19 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.425 0.631 . . . . 0.0 111.917 -176.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.404 ' O ' ' NZ ' ' A' ' 63' ' ' LYS . . . -160.12 108.51 1.7 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.771 178.492 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.7 ttm-85 -70.36 -44.64 67.71 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.349 0.595 . . . . 0.0 111.113 -177.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.509 HG21 ' HB3' ' A' ' 29' ' ' GLU . 27.6 m -95.64 170.92 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.385 -175.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 34.6 pt -121.22 149.63 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.394 176.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -99.46 171.4 7.97 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.93 0.395 . . . . 0.0 111.389 178.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -57.99 -35.49 71.3 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -176.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.471 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 39.5 mm-40 -61.39 -53.27 58.81 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.799 0.333 . . . . 0.0 111.499 178.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -65.97 -28.06 68.62 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.907 0.384 . . . . 0.0 110.939 178.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.423 ' HE2' HD11 ' A' ' 10' ' ' LEU . 88.5 t80 -60.7 -47.99 83.78 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.183 175.05 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.471 ' HE2' ' HA ' ' A' ' 73' ' ' GLU . 53.4 mtmt -58.01 -47.08 84.1 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.919 0.39 . . . . 0.0 110.782 176.325 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -56.75 -42.9 80.13 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.154 0.502 . . . . 0.0 111.249 175.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.21 -42.87 99.35 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.375 177.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 88.2 mt -58.32 -41.57 84.83 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.294 177.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -63.76 -36.6 84.41 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 120.88 0.372 . . . . 0.0 111.192 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -63.76 -61.06 2.55 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 120.634 0.254 . . . . 0.0 111.122 172.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.446 ' HB3' HG11 ' A' ' 44' ' ' VAL . 11.2 mp -50.71 -40.49 54.3 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.196 0.522 . . . . 0.0 111.851 179.001 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.96 -53.33 59.29 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.743 175.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 69.2 p -74.32 -10.4 59.55 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -86.96 -45.86 10.4 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.105 0.479 . . . . 0.0 111.414 174.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.4 -49.04 9.05 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.882 -176.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -82.61 -178.45 7.08 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.156 0.503 . . . . 0.0 111.068 179.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -93.96 142.02 27.85 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.848 177.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -76.19 56.33 3.21 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 121.356 -0.449 . . . . 0.0 114.177 -176.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 29.0 ttpp -83.59 -31.78 26.12 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.208 0.527 . . . . 0.0 110.323 175.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.521 ' HB3' ' HB3' ' A' ' 94' ' ' GLU . 30.8 t -162.37 126.16 3.06 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.812 178.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 50.7 tttm -69.31 -47.09 65.5 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.777 0.323 . . . . 0.0 111.811 -178.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -64.47 -40.9 96.57 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 120.78 0.324 . . . . 0.0 110.986 178.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.521 ' HB3' ' HB3' ' A' ' 91' ' ' SER . 34.5 tt0 -65.67 -43.48 89.2 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.803 0.335 . . . . 0.0 111.257 177.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.95 -35.52 73.28 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.885 0.374 . . . . 0.0 110.978 175.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -64.87 -42.66 94.64 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.864 176.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -64.69 -38.51 91.26 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 120.933 0.396 . . . . 0.0 110.972 176.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.59 -51.31 60.65 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.679 179.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 16.5 tt -62.6 -33.2 58.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-O 120.941 0.4 . . . . 0.0 110.343 177.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' CYS . . . . . 0.449 ' SG ' ' HB1' ' A' ' 104' ' ' ALA . 39.7 t -65.43 -34.12 77.55 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.82 0.343 . . . . 0.0 110.851 172.154 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -69.7 -22.32 63.42 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.506 178.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 80.4 mt -95.55 -36.61 11.21 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.059 0.457 . . . . 0.0 111.987 175.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 81.9 t -96.8 -65.69 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 112.554 0.575 . . . . 0.0 112.554 -174.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.449 ' HB1' ' SG ' ' A' ' 100' ' ' CYS . . . -51.38 109.38 0.34 Allowed 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -168.074 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 107.25 -38.09 3.5 Favored Glycine 0 CA--C 1.522 0.479 0 C-N-CA 121.174 -0.536 . . . . 0.0 112.849 178.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.472 ' HE2' ' HA ' ' A' ' 42' ' ' CYS . 14.7 ttpp -78.86 -63.37 1.43 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.836 0.35 . . . . 0.0 110.549 178.281 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.673 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 25.6 mt-10 29.72 -88.03 0.0 OUTLIER Pre-proline 0 CA--C 1.557 1.219 0 N-CA-C 115.161 1.541 . . . . 0.0 115.161 177.121 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.583 ' HD3' ' HB2' ' A' ' 107' ' ' GLU . 6.8 Cg_exo -74.22 79.22 2.45 Favored 'Trans proline' 0 C--N 1.367 1.552 0 CA-C-N 123.306 2.216 . . . . 0.0 112.004 177.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.763 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -177.067 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.7 mm . . . . . 0 CA--C 1.539 0.522 0 CA-C-O 120.745 0.307 . . . . 0.0 110.465 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 66.23 -68.41 0.13 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.166 0.586 . . . . 0.0 112.098 -178.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -51.15 -28.56 18.89 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 121.615 -0.326 . . . . 0.0 113.496 178.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 51.6 tp -64.56 -38.48 91.17 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 120.719 0.295 . . . . 0.0 111.052 176.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.598 ' O ' ' HD3' ' A' ' 15' ' ' ARG . 39.9 tt0 -67.09 -46.14 75.14 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 177.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.453 ' O ' ' HG3' ' A' ' 16' ' ' LYS . 1.1 mp0 -51.79 -46.22 64.13 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.744 0.307 . . . . 0.0 111.156 172.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 70.6 m -58.95 -41.68 88.04 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.684 -0.234 . . . . 0.0 111.253 176.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -58.29 -46.85 85.32 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.645 176.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.598 ' HD3' ' O ' ' A' ' 11' ' ' GLU . 1.8 mpt_? -54.93 -55.85 26.1 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.121 175.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.453 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 67.1 mttm -54.32 -45.14 72.56 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -176.037 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -69.75 -39.49 76.69 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 111.728 0.27 . . . . 0.0 111.728 176.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.69 -53.6 38.83 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -177.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.522 HG12 ' O ' ' A' ' 15' ' ' ARG . 25.8 pt -78.8 -1.84 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 -176.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -56.06 -33.98 65.51 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.082 0.467 . . . . 0.0 110.656 175.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.57 59.83 4.93 Favored Glycine 0 CA--C 1.522 0.516 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.838 175.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 68.57 124.05 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 123.199 0.6 . . . . 0.0 111.338 -173.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.512 ' HA ' ' HB ' ' A' ' 19' ' ' ILE . 81.8 Cg_exo -47.57 -30.62 12.45 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 123.145 2.564 . . . . 0.0 114.237 -178.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -75.35 3.33 9.25 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 178.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.36 -52.04 66.97 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 111.868 0.321 . . . . 0.0 111.868 179.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 99.7 p 177.74 -70.55 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.004 0.431 . . . . 0.0 111.563 -179.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 107.46 -26.08 19.44 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 111.925 -0.47 . . . . 0.0 111.925 -174.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -115.88 -15.91 11.2 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.028 0.531 . . . . 0.0 111.101 178.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.426 ' HB3' HG21 ' A' ' 69' ' ' VAL . 8.7 mm-40 -111.9 145.7 39.07 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.715 -176.198 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 53.1 ttm -133.87 135.29 43.59 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 120.556 0.217 . . . . 0.0 111.146 178.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 36.1 p30 -94.13 168.85 10.67 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.17 0.51 . . . . 0.0 112.277 -178.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.15 -27.6 70.81 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-N 116.033 -0.531 . . . . 0.0 113.768 -179.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -62.89 -58.94 5.66 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.39 0.614 . . . . 0.0 111.199 178.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -64.18 -35.83 82.09 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.164 178.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 50.3 t-105 -62.2 -42.92 99.73 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.625 175.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.11 -45.72 86.77 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 121.131 0.491 . . . . 0.0 111.309 177.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.4 mtpp -64.83 -45.04 87.83 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.298 175.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.3 tt -46.02 -43.88 14.71 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.134 0.492 . . . . 0.0 111.182 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 79.3 m -68.48 -46.4 69.8 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 120.979 0.418 . . . . 0.0 111.588 176.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -65.91 -52.86 46.29 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.785 0.326 . . . . 0.0 111.84 -177.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.411 ' O ' ' NZ ' ' A' ' 43' ' ' LYS . 1.2 m-20 -55.27 -38.47 68.62 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 122.954 0.502 . . . . 0.0 111.257 176.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.688 ' SG ' ' HA ' ' A' ' 103' ' ' VAL . 83.4 m -85.94 -4.12 59.09 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 175.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.411 ' NZ ' ' O ' ' A' ' 41' ' ' ASP . 19.9 mtmm 52.76 41.3 31.56 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 178.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 57.9 t -78.34 -35.4 19.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 121.316 0.579 . . . . 0.0 110.32 171.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -102.56 79.22 1.79 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.637 178.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -60.35 -27.09 67.1 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.5 -29.33 12.75 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 121.196 -0.526 . . . . 0.0 111.977 -172.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -74.05 -61.65 1.78 Allowed 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 120.937 0.398 . . . . 0.0 110.9 176.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 69.0 p -90.05 -74.01 0.5 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.088 0.471 . . . . 0.0 110.506 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 89.0 t -89.19 135.27 26.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.365 174.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 43.6 p -124.05 173.53 8.21 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 120.883 0.373 . . . . 0.0 111.538 -177.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -54.84 -34.29 56.95 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 121.24 -0.505 . . . . 0.0 112.753 177.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.635 ' O ' HG13 ' A' ' 57' ' ' ILE . 89.3 m -53.61 -57.56 10.33 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 122.382 0.273 . . . . 0.0 111.102 176.443 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -52.43 -42.99 64.59 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.252 179.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 80.1 t -55.93 -43.96 76.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.851 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -73.55 -33.31 64.62 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.04 0.448 . . . . 0.0 111.115 -179.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.635 HG13 ' O ' ' A' ' 53' ' ' THR . 7.8 mt -64.42 -49.13 82.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.626 177.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 93.0 t -60.84 -43.38 95.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-O 120.786 0.327 . . . . 0.0 111.435 178.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -58.15 -35.16 71.13 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.17 0.509 . . . . 0.0 111.261 178.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 38.9 t -87.83 -21.84 24.81 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.743 177.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -68.13 -41.22 81.99 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 122.631 0.372 . . . . 0.0 111.969 -176.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.6 m -82.44 -21.26 9.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-O 121.245 0.545 . . . . 0.0 111.533 177.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.462 ' HD3' ' O ' ' A' ' 67' ' ' ALA . 39.4 ttmt -74.08 156.7 37.17 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -175.566 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -91.58 -128.02 4.11 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 121.538 -0.363 . . . . 0.0 113.184 175.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -100.54 -77.79 0.53 Allowed 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 81.2 p -76.94 -4.92 46.42 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -172.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.462 ' O ' ' HD3' ' A' ' 63' ' ' LYS . . . -68.88 121.06 15.8 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.106 0.479 . . . . 0.0 111.501 178.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 67.3 mtt180 -85.3 -32.31 22.58 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.198 0.523 . . . . 0.0 110.882 178.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.426 HG21 ' HB3' ' A' ' 29' ' ' GLU . 30.9 m -127.34 171.46 15.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.706 -176.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 36.3 pt -117.49 170.58 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 CA-C-O 120.581 0.229 . . . . 0.0 111.032 177.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -126.82 -179.97 5.08 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 -179.405 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.489 ' O ' ' HB3' ' A' ' 75' ' ' PHE . 70.6 t80 -34.73 -62.66 0.35 Allowed 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 -174.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -64.61 -38.57 91.46 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 121.798 -0.564 . . . . 0.0 112.014 -175.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -62.41 -37.22 84.97 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.219 0.533 . . . . 0.0 110.333 176.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.489 ' HB3' ' O ' ' A' ' 72' ' ' TYR . 60.8 t80 -57.03 -45.98 82.72 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.586 176.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.421 ' HE3' ' CZ ' ' A' ' 72' ' ' TYR . 81.2 mttt -61.39 -38.74 88.15 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.859 0.361 . . . . 0.0 111.7 178.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -71.69 -30.46 65.7 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.712 0.292 . . . . 0.0 111.531 176.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.31 -46.71 85.41 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.123 0.487 . . . . 0.0 110.687 173.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 86.9 mt -63.74 -34.95 79.01 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.107 175.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -62.0 -43.62 98.45 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 121.089 0.471 . . . . 0.0 110.93 178.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -59.79 -58.98 6.23 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.028 0.442 . . . . 0.0 111.284 173.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 90.9 mt -56.12 -42.01 76.17 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.949 -178.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.58 -51.78 68.44 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.799 0.333 . . . . 0.0 111.633 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 68.6 p -66.37 -20.7 66.14 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -178.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -102.38 -13.97 17.08 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 48.7 tpt85 -98.38 -60.79 1.48 Allowed 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.196 0.522 . . . . 0.0 110.975 177.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -77.38 -178.98 5.46 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.918 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 19.8 tptm -62.29 133.87 55.73 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.612 177.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -77.07 61.72 3.39 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 121.174 -0.536 . . . . 0.0 114.129 -173.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -165.77 153.52 10.67 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.979 0.389 . . . . 0.0 111.51 176.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 44.1 t 65.47 86.76 0.13 Allowed 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.91 -175.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 55.0 tttp -45.73 -41.78 11.07 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.295 175.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -57.38 -60.83 3.05 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.7 178.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -59.97 -43.75 94.88 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.82 0.343 . . . . 0.0 111.845 -176.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.61 -48.21 80.41 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -66.69 -48.11 70.3 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.278 -178.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.463 ' O ' ' HG3' ' A' ' 101' ' ' GLN . 4.2 m-20 -54.58 -49.36 70.57 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.748 0.309 . . . . 0.0 111.376 176.266 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -55.32 -51.94 65.1 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -178.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.8 tt -66.67 -33.16 61.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 CA-C-O 120.885 0.374 . . . . 0.0 111.235 -179.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 86.5 m -65.27 -34.82 79.24 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.824 0.345 . . . . 0.0 110.8 173.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.463 ' HG3' ' O ' ' A' ' 97' ' ' ASP . 28.9 mt-30 -64.78 -31.09 72.16 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.33 175.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 87.8 mt -72.91 -38.38 66.9 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 176.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.688 ' HA ' ' SG ' ' A' ' 42' ' ' CYS . 58.4 t -92.18 -57.4 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -174.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.91 98.41 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -170.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 85.17 5.39 85.68 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 114.99 0.756 . . . . 0.0 114.99 170.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 50.5 tttp -83.41 -2.04 54.89 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 118.015 0.908 . . . . 0.0 111.856 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 74.04 148.34 0.12 Allowed Pre-proline 0 N--CA 1.478 0.964 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 173.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -74.92 81.95 2.09 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.844 2.363 . . . . 0.0 112.168 176.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.718 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.863 179.676 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.4 HG21 ' HB2' ' A' ' 10' ' ' LEU . 9.0 tt . . . . . 0 CA--C 1.541 0.623 0 CA-C-O 120.941 0.4 . . . . 0.0 111.158 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -52.62 -33.81 48.28 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.2 -37.08 92.39 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 121.224 -0.513 . . . . 0.0 112.921 178.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.4 ' HB2' HG21 ' A' ' 7' ' ' ILE . 46.7 tp -60.89 -42.72 98.53 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.947 0.403 . . . . 0.0 110.522 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -57.33 -44.95 84.67 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.133 174.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.605 ' O ' ' HG3' ' A' ' 16' ' ' LYS . 32.3 mt-10 -61.44 -49.38 77.06 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.594 0.235 . . . . 0.0 110.954 179.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.462 ' HA ' ' HD2' ' A' ' 16' ' ' LYS . 47.4 m -57.48 -45.97 84.23 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.065 0.459 . . . . 0.0 111.312 178.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -58.77 -44.64 90.68 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.175 0.512 . . . . 0.0 110.408 175.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.715 HH11 ' HA3' ' A' ' 27' ' ' GLY . 3.0 tpt180 -56.16 -43.4 78.29 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.202 177.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.605 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 88.7 mttt -58.88 -54.67 44.49 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.036 -178.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -70.51 -33.4 71.17 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.93 -15.92 63.83 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -177.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.44 HG12 ' O ' ' A' ' 15' ' ' ARG . 31.9 pt -113.95 20.12 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-O 121.468 0.652 . . . . 0.0 111.126 175.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 50.0 t60 -67.9 -17.37 64.45 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -177.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -101.1 -42.83 2.33 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 120.933 -0.651 . . . . 0.0 113.558 -179.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.51 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . 5.0 m-20 -116.41 157.26 46.06 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 122.733 0.413 . . . . 0.0 110.893 -177.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -69.91 -13.73 34.69 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.306 2.004 . . . . 0.0 113.198 -178.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -132.79 -38.85 0.99 Allowed 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.006 0.432 . . . . 0.0 110.374 172.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.51 ' HB1' ' HB2' ' A' ' 22' ' ' ASP . . . 47.07 -87.68 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -179.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 70.0 m -163.69 -56.73 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.384 0.612 . . . . 0.0 110.433 -175.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.715 ' HA3' HH11 ' A' ' 15' ' ' ARG . . . 92.26 -34.51 4.41 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-N 115.934 -0.576 . . . . 0.0 113.238 -178.454 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -99.97 0.92 42.04 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 121.079 0.466 . . . . 0.0 111.001 177.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.449 ' HB3' HG22 ' A' ' 69' ' ' VAL . 44.9 mt-10 -124.88 112.34 16.52 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.162 -179.299 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 50.6 ttm -107.68 145.08 33.86 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.78 0.324 . . . . 0.0 111.109 178.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -109.73 168.63 9.27 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.154 0.502 . . . . 0.0 112.095 -177.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -59.88 -37.24 92.28 Favored Glycine 0 CA--C 1.529 0.936 0 N-CA-C 114.555 0.582 . . . . 0.0 114.555 -174.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -64.21 -53.69 45.22 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -174.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 13.1 p30 -74.33 -28.94 61.38 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 29.0 t-105 -60.42 -44.86 95.34 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.091 0.472 . . . . 0.0 111.231 170.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.43 -49.08 78.28 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.928 0.394 . . . . 0.0 111.135 176.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -64.81 -31.65 72.98 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.425 178.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.9 tt -58.21 -54.81 42.72 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.049 0.452 . . . . 0.0 110.147 177.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 67.4 m -58.07 -45.98 86.2 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.192 178.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -66.34 -33.2 75.19 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -74.23 -47.09 37.48 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.146 0.498 . . . . 0.0 110.188 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 85.7 m -75.19 -2.21 26.83 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.233 173.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt 54.78 35.65 24.59 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 175.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 61.7 t -68.55 -28.12 39.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.784 174.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.39 124.22 21.68 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.21 0.529 . . . . 0.0 111.622 178.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -75.29 -22.99 57.31 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.929 -176.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.12 -47.63 3.87 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 121.252 -0.499 . . . . 0.0 112.853 -179.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 42.0 mtmt -77.69 -57.83 3.6 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.465 0.65 . . . . 0.0 110.745 176.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.7 p -97.26 -72.07 0.66 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.497 179.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 49.4 t -76.43 114.29 16.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-O 121.067 0.461 . . . . 0.0 111.475 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.7 t -140.59 -175.16 4.18 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.623 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -45.23 -45.82 10.55 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 113.793 0.277 . . . . 0.0 113.793 -177.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.573 ' O ' HG12 ' A' ' 57' ' ' ILE . 67.8 m -53.88 -56.6 16.19 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.823 0.344 . . . . 0.0 111.37 175.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -58.16 -43.26 87.3 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 121.129 0.49 . . . . 0.0 111.016 -178.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 71.4 t -61.85 -26.92 41.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-O 121.224 0.535 . . . . 0.0 111.438 178.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -82.88 -39.36 21.67 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.522 0.677 . . . . 0.0 109.989 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.573 HG12 ' O ' ' A' ' 53' ' ' THR . 16.4 mm -55.95 -46.76 80.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.593 174.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 87.1 t -61.62 -47.48 93.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.294 176.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -54.5 -44.28 72.56 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.068 0.461 . . . . 0.0 111.617 178.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 35.6 t -74.92 -35.23 62.2 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.044 0.449 . . . . 0.0 111.636 178.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -62.9 -55.66 24.07 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -177.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 22.6 m -66.49 -24.38 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-O 121.124 0.488 . . . . 0.0 111.6 -178.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.51 ' HB2' HG21 ' A' ' 70' ' ' ILE . 22.0 ttpp -105.64 82.86 1.86 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.634 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -101.45 -10.58 41.01 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 121.049 -0.596 . . . . 0.0 114.586 -173.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 48.2 tptt -84.76 45.66 1.17 Allowed 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 117.81 0.805 . . . . 0.0 112.035 -177.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 39.6 t 53.68 16.02 0.9 Allowed 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 176.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -76.5 166.75 22.97 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.027 0.441 . . . . 0.0 111.647 -178.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 68' ' ' ARG . 40.6 ttp-105 -105.13 -36.56 7.23 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.045 0.45 . . . . 0.0 111.252 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.449 HG22 ' HB3' ' A' ' 29' ' ' GLU . 33.9 m -110.36 165.0 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.805 178.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.51 HG21 ' HB2' ' A' ' 63' ' ' LYS . 33.5 pt -111.93 146.53 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.012 175.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 30.1 p30 -100.46 -179.81 4.22 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.609 0.242 . . . . 0.0 111.379 177.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -56.45 -39.07 72.54 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -174.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -66.57 -49.25 66.99 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.792 0.33 . . . . 0.0 111.24 179.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -62.42 -35.37 79.01 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.058 0.456 . . . . 0.0 110.885 178.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.41 ' O ' ' HG ' ' A' ' 79' ' ' LEU . 89.1 t80 -58.63 -45.24 89.68 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.495 172.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -60.88 -41.81 96.71 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.542 176.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -60.05 -40.76 90.53 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.237 0.541 . . . . 0.0 110.727 174.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.76 -40.32 96.91 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.227 177.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 75' ' ' PHE . 76.5 mt -62.23 -37.64 86.14 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.233 177.043 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -61.66 -42.72 99.29 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.085 0.469 . . . . 0.0 110.672 176.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.438 ' O ' ' HG2' ' A' ' 85' ' ' LYS . 61.7 mm-40 -59.92 -55.08 38.57 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.202 175.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 91.5 mt -59.68 -37.81 79.79 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.862 0.363 . . . . 0.0 111.448 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.67 -55.02 40.43 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.878 0.37 . . . . 0.0 111.424 177.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 36.3 p -63.52 -24.01 67.63 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.044 178.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.438 ' HG2' ' O ' ' A' ' 81' ' ' GLU . 33.3 mmtp -73.97 -42.26 60.75 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 120.884 0.373 . . . . 0.0 111.728 174.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 30.9 mmm180 -90.63 -57.32 2.87 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -174.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -99.37 25.76 6.66 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -171.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt 62.7 -175.06 0.15 Allowed 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.834 -178.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -98.05 17.58 58.48 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 121.042 -0.599 . . . . 0.0 113.36 178.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -74.77 96.42 3.06 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 122.421 -0.458 . . . . 0.0 111.077 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 24.6 t 65.3 110.09 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.009 0.523 . . . . 0.0 112.327 -178.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -57.21 -34.63 68.72 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.589 0.233 . . . . 0.0 111.417 175.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -60.19 -52.69 64.23 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 120.696 0.284 . . . . 0.0 111.684 -178.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -69.2 -42.61 75.56 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 120.711 0.291 . . . . 0.0 111.641 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.62 -47.36 86.58 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 120.955 0.407 . . . . 0.0 111.649 177.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.439 ' HA ' HG23 ' A' ' 99' ' ' ILE . 49.0 t80 -66.39 -37.04 84.35 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.017 0.437 . . . . 0.0 110.74 179.11 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -58.23 -51.76 68.43 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.508 0.67 . . . . 0.0 110.566 174.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.3 -41.46 94.08 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.814 -176.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.439 HG23 ' HA ' ' A' ' 96' ' ' PHE . 10.1 tp -64.87 -37.68 80.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 O-C-N 121.936 -0.478 . . . . 0.0 110.42 177.292 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 87.1 m -69.75 -30.07 67.58 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.673 172.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 3.6 tp-100 -60.12 -35.56 75.52 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.104 0.478 . . . . 0.0 111.028 178.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 88.3 mt -67.85 -22.58 65.13 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.944 177.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 47.7 t -111.45 -70.02 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-O 120.775 0.321 . . . . 0.0 111.241 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 53.7 -86.74 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 177.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -143.57 27.71 2.07 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.739 -176.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -73.3 -172.59 1.16 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.575 0.702 . . . . 0.0 112.745 -176.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -136.51 151.71 73.43 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.374 178.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -57.6 95.7 0.07 OUTLIER 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 122.219 1.946 . . . . 0.0 113.077 -179.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.737 0 C-N-CA 123.443 0.697 . . . . 0.0 112.221 -177.891 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.614 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 120.43 0.157 . . . . 0.0 111.103 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 64.07 96.07 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 120.981 0.419 . . . . 0.0 112.032 -177.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -74.08 68.8 1.44 Allowed 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.231 0.539 . . . . 0.0 111.874 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 66.1 p 176.98 -68.25 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.375 -177.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 62.7 p -101.38 74.65 1.56 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.485 0.659 . . . . 0.0 110.605 174.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -72.97 -63.02 1.26 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.412 -0.813 . . . . 0.0 113.06 -172.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 52.6 mt -110.54 -31.13 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -170.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 70.17 -70.42 0.15 Allowed 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -56.46 -45.28 89.68 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 121.455 -0.403 . . . . 0.0 113.315 -177.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.646 HD22 ' SG ' ' A' ' 100' ' ' CYS . 45.3 tp -57.57 -46.14 84.34 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.232 0.539 . . . . 0.0 110.836 175.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.411 ' HG2' ' HH ' ' A' ' 72' ' ' TYR . 37.2 mt-10 -61.42 -34.45 75.4 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.06 178.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -66.43 -50.89 61.89 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.614 177.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.6 m -60.28 -34.18 73.39 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.36 177.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -57.67 -49.99 74.66 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.793 0.33 . . . . 0.0 110.154 174.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.54 ' O ' HG12 ' A' ' 19' ' ' ILE . 76.6 mtm-85 -57.16 -47.1 82.02 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.299 176.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -44.93 -48.46 11.32 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 176.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -84.82 -26.97 27.11 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.9 -53.05 23.27 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.976 0.417 . . . . 0.0 111.938 -178.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.54 HG12 ' O ' ' A' ' 15' ' ' ARG . 29.9 pt -77.95 7.33 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -178.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -62.13 89.91 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.232 0.539 . . . . 0.0 110.596 176.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 125.23 -54.48 0.75 Allowed Glycine 0 CA--C 1.527 0.785 0 CA-C-N 115.888 -0.597 . . . . 0.0 112.64 -176.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -127.03 109.79 21.79 Favored Pre-proline 0 CA--C 1.547 0.835 0 O-C-N 122.626 -0.338 . . . . 0.0 110.933 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -76.39 -5.78 16.48 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 122.845 2.363 . . . . 0.0 113.644 -178.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 30.7 mtmm -89.5 -11.77 41.97 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.932 0.396 . . . . 0.0 110.945 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.86 -20.34 66.2 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.607 176.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 59.9 m 73.11 -53.72 0.7 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.582 0.753 . . . . 0.0 112.213 177.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 137.86 47.25 0.07 OUTLIER Glycine 0 CA--C 1.524 0.609 0 CA-C-N 116.41 -0.359 . . . . 0.0 112.309 -177.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -95.16 -34.78 12.13 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.643 0.259 . . . . 0.0 111.506 -178.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.08 178.92 6.59 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.341 0.591 . . . . 0.0 112.488 -175.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 52.7 ttm -157.41 133.9 9.81 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.63 176.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -86.38 167.75 14.45 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.094 0.473 . . . . 0.0 112.134 -178.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -58.13 -33.19 68.87 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-N 115.749 -0.659 . . . . 0.0 114.432 -176.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -69.22 -54.12 16.38 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.331 0.586 . . . . 0.0 110.976 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -60.57 -40.29 91.12 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.425 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 30.5 t-105 -63.51 -42.84 98.46 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 120.998 0.428 . . . . 0.0 111.492 175.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.18 -44.63 96.99 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 121.001 0.429 . . . . 0.0 111.183 176.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 43.2 tttm -66.36 -39.43 89.14 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.784 177.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.7 tt -51.69 -47.5 63.86 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.084 0.469 . . . . 0.0 110.792 178.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 79.5 m -63.44 -41.26 98.66 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.324 176.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -62.7 -57.3 11.48 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.815 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.537 ' HA ' HD22 ' A' ' 110' ' ' ASN . 2.1 m-20 -53.69 -39.42 65.14 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 122.731 0.412 . . . . 0.0 111.795 178.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.572 ' SG ' HG12 ' A' ' 103' ' ' VAL . 57.0 m -91.85 -0.7 57.53 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.662 ' HB2' ' HZ1' ' A' ' 43' ' ' LYS . 9.7 mtmp? 50.15 31.75 5.32 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.1 t -68.78 -38.14 78.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-O 121.263 0.554 . . . . 0.0 109.586 171.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.47 79.69 3.97 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.02 171.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.0 p30 -76.79 -14.28 59.93 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.914 -173.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.61 -27.43 7.14 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 121.168 -0.539 . . . . 0.0 113.23 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -85.01 -37.81 19.96 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 122.478 -0.425 . . . . 0.0 111.448 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.8 t -112.46 -51.13 2.86 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.128 0.49 . . . . 0.0 110.549 176.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 34.1 t -112.81 110.46 32.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.065 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.496 ' O ' HG23 ' A' ' 55' ' ' VAL . 81.9 p -97.52 166.72 11.38 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.527 179.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -50.02 -55.49 15.02 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 121.368 -0.444 . . . . 0.0 113.079 178.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.545 ' O ' HG12 ' A' ' 57' ' ' ILE . 94.0 m -53.08 -48.56 67.66 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.599 0.237 . . . . 0.0 111.493 178.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.456 ' O ' HG21 ' A' ' 58' ' ' VAL . 18.0 t70 -58.48 -36.82 74.32 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 120.726 0.298 . . . . 0.0 110.872 -178.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 51' ' ' THR . 88.6 t -61.87 -37.92 79.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.375 175.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -73.52 -34.73 65.39 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.399 0.619 . . . . 0.0 110.137 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.545 HG12 ' O ' ' A' ' 53' ' ' THR . 8.0 mm -60.48 -52.73 58.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.999 176.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.456 HG21 ' O ' ' A' ' 54' ' ' ASP . 91.8 t -52.49 -48.5 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 121.04 0.448 . . . . 0.0 111.12 177.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -59.94 -41.28 91.49 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.009 178.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 28.3 t -72.95 -20.22 61.09 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 116.156 -0.474 . . . . 0.0 112.051 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.453 ' HG3' ' O ' ' A' ' 57' ' ' ILE . 53.6 mtmt -84.49 -57.12 3.28 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.087 0.47 . . . . 0.0 111.953 178.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.3 m -61.19 -31.95 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 -173.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.633 ' HD3' ' O ' ' A' ' 66' ' ' SER . 17.2 ptpt -56.55 -52.44 64.78 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -175.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 72.74 -64.78 1.48 Allowed Glycine 0 CA--C 1.537 1.46 0 N-CA-C 114.55 0.58 . . . . 0.0 114.55 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.591 ' HG2' ' HB2' ' A' ' 67' ' ' ALA . 0.0 OUTLIER -78.52 53.43 1.3 Allowed 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -172.569 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.633 ' O ' ' HD3' ' A' ' 63' ' ' LYS . 88.5 p 54.23 -77.61 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.148 0.579 . . . . 0.0 110.928 -173.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.591 ' HB2' ' HG2' ' A' ' 65' ' ' LYS . . . 46.88 117.88 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 115.859 1.799 . . . . 0.0 115.859 164.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 57.2 ttp180 -66.52 -18.3 65.29 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 121.355 0.598 . . . . 0.0 110.684 169.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 33.8 m -135.15 159.21 41.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.902 -173.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 39.3 pt -115.27 147.56 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-O 120.699 0.285 . . . . 0.0 110.929 174.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -86.47 157.55 19.77 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.411 ' HH ' ' HG2' ' A' ' 11' ' ' GLU . 86.7 t80 -40.25 -48.6 2.63 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 -175.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.532 ' HA ' ' HE3' ' A' ' 76' ' ' LYS . 46.5 mm-40 -52.15 -46.42 65.43 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 120.935 0.398 . . . . 0.0 111.77 178.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -76.56 -19.36 57.98 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 120.97 0.414 . . . . 0.0 110.99 -178.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -70.56 -49.68 45.42 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.118 174.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.532 ' HE3' ' HA ' ' A' ' 73' ' ' GLU . 22.8 pttp -69.58 -22.54 63.51 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.322 177.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -71.81 -41.35 68.35 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.165 0.507 . . . . 0.0 110.251 170.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.455 ' O ' ' HB3' ' A' ' 81' ' ' GLU . . . -63.61 -37.8 88.72 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.33 175.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 84.9 mt -59.69 -43.44 94.04 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.326 175.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -54.85 -43.97 73.55 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 121.029 0.443 . . . . 0.0 110.891 174.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.455 ' HB3' ' O ' ' A' ' 78' ' ' ALA . 6.9 tp10 -54.28 -64.33 0.86 Allowed 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.057 175.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.476 ' HA ' ' HG3' ' A' ' 85' ' ' LYS . 9.1 mp -57.71 -33.25 68.22 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.153 0.502 . . . . 0.0 111.936 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.84 -48.47 81.66 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.146 175.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.468 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 76.1 p -70.41 -19.06 63.02 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 120.827 0.346 . . . . 0.0 111.699 179.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.476 ' HG3' ' HA ' ' A' ' 82' ' ' LEU . 46.9 mmtt -67.29 -41.64 85.1 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 121.088 0.471 . . . . 0.0 111.013 174.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 23.4 mtp180 -106.25 -57.38 2.06 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -176.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -88.85 29.33 1.04 Allowed 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -171.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.468 ' HB3' ' O ' ' A' ' 84' ' ' THR . 22.7 pttp -71.8 150.58 44.22 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.079 0.466 . . . . 0.0 111.406 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 98.84 -28.5 14.86 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.908 -178.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -86.62 -177.48 6.15 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.05 0.453 . . . . 0.0 111.423 176.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 35.6 t -63.7 135.13 56.48 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.058 177.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -48.76 -48.03 41.25 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 122.98 0.512 . . . . 0.0 111.856 -178.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.427 ' HG3' ' N ' ' A' ' 94' ' ' GLU . 9.9 pt-20 -60.9 -48.45 81.77 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.461 178.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.427 ' N ' ' HG3' ' A' ' 93' ' ' GLU . 63.5 tt0 -58.58 -47.15 85.24 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.635 0.255 . . . . 0.0 111.354 -178.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.81 -44.81 86.61 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 120.951 0.405 . . . . 0.0 111.711 178.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -68.37 -50.29 54.15 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.422 -178.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -62.01 -31.55 71.94 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 120.725 0.298 . . . . 0.0 111.57 177.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -66.65 -54.94 17.86 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 11.5 tt -58.43 -39.75 75.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 120.929 0.395 . . . . 0.0 110.99 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . 0.646 ' SG ' HD22 ' A' ' 10' ' ' LEU . 79.0 m -64.17 -37.58 87.96 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.847 0.356 . . . . 0.0 110.998 175.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -60.15 -29.31 68.57 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.536 177.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 79.0 mt -77.18 -13.46 59.94 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 177.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.572 HG12 ' SG ' ' A' ' 42' ' ' CYS . 58.3 t -110.62 -54.18 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -175.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -41.36 126.21 2.74 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 -172.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 109.11 -32.84 6.54 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 121.321 -0.466 . . . . 0.0 114.219 173.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 38.0 mtmm -82.06 169.12 17.07 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -174.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.529 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 12.1 pt-20 -126.89 165.37 29.12 Favored Pre-proline 0 CA--C 1.55 0.967 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.464 -178.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.529 ' HD2' ' HB2' ' A' ' 107' ' ' GLU . 55.5 Cg_endo -68.37 71.97 0.91 Allowed 'Trans proline' 0 CA--C 1.545 1.031 0 C-N-CA 122.635 2.223 . . . . 0.0 113.889 -178.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 177.28 112.98 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 122.672 0.389 . . . . 0.0 111.8 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.537 HD22 ' HA ' ' A' ' 41' ' ' ASP . 18.5 m120 -77.93 82.21 4.3 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 122.313 -0.242 . . . . 0.0 110.389 174.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 76.5 t 65.77 -67.45 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.205 -174.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -89.54 146.86 19.14 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 121.41 -0.424 . . . . 0.0 112.79 175.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 33.1 m -81.63 156.88 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-O 121.154 0.502 . . . . 0.0 111.532 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 73.2 p -83.31 109.36 17.2 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -178.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -64.0 111.42 2.51 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.743 175.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -130.6 10.34 5.16 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -177.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -67.64 100.03 0.85 Allowed 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.633 0.73 . . . . 0.0 111.518 -178.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.5 t 178.57 -28.52 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.716 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -71.94 114.13 4.88 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.399 175.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -60.02 105.12 0.7 Allowed Glycine 0 CA--C 1.526 0.763 0 C-N-CA 121.354 -0.451 . . . . 0.0 113.166 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -103.99 20.49 18.11 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.206 0.527 . . . . 0.0 111.24 177.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 35.5 m -87.51 14.6 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.138 -177.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -75.04 27.68 0.09 Allowed 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -177.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 54.7 mtm-85 -66.35 84.07 0.09 Allowed 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.373 0.606 . . . . 0.0 111.435 -177.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 26.8 tp -97.13 10.37 39.56 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.093 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 11.2 p 70.84 -49.03 0.67 Allowed 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.609 1.163 . . . . 0.0 111.885 -174.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -53.15 -35.23 59.51 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 120.907 0.384 . . . . 0.0 111.65 172.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 43.4 p -60.18 111.85 1.68 Allowed 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.786 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.423 ' C ' ' H ' ' A' ' 131' ' ' TYR . 27.7 t 66.2 -67.53 0.15 Allowed 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.194 0.597 . . . . 0.0 110.636 -172.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 70.88 -26.1 0.17 Allowed 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 174.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.423 ' H ' ' C ' ' A' ' 129' ' ' SER . 52.1 m-85 54.16 -85.6 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 122.867 0.467 . . . . 0.0 111.968 -175.049 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 24.4 m -77.38 93.84 4.13 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.172 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 133.84 -20.37 4.08 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 120.965 -0.636 . . . . 0.0 113.987 178.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 81.9 p -82.41 -85.94 0.11 Allowed 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 117.592 0.696 . . . . 0.0 111.565 -178.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 43.7 p-80 -171.61 142.95 1.66 Allowed 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.054 0.454 . . . . 0.0 111.895 178.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -124.89 157.83 35.0 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 174.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -60.51 122.23 14.12 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 121.201 0.524 . . . . 0.0 112.133 -178.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 53.2 ttp180 -73.1 153.78 40.65 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.906 178.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -67.46 80.42 0.16 Allowed 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.634 0.731 . . . . 0.0 112.051 -178.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -126.55 26.08 6.37 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.73 0.776 . . . . 0.0 109.619 172.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.571 ' HA ' ' NZ ' ' A' ' 144' ' ' LYS . 50.6 mt-10 -75.61 -28.92 59.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.87 -178.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 61.8 p -77.9 -53.02 7.94 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.514 178.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -104.62 82.47 0.36 Allowed Glycine 0 CA--C 1.53 0.994 0 C-N-CA 120.887 -0.673 . . . . 0.0 114.08 -178.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.571 ' NZ ' ' HA ' ' A' ' 141' ' ' GLU . 50.8 mttp -102.39 171.58 7.37 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.291 0.567 . . . . 0.0 111.723 174.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -84.54 119.43 4.98 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-N 115.932 -0.576 . . . . 0.0 113.324 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -68.49 106.8 2.67 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 120.963 0.411 . . . . 0.0 110.296 176.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 72.11 36.57 60.35 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.161 -171.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 81.5 mt 64.44 -71.93 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 123.448 0.699 . . . . 0.0 111.999 -179.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -150.42 -71.86 0.17 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.98 0.419 . . . . 0.0 110.921 178.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -108.99 32.16 7.11 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 121.103 -0.57 . . . . 0.0 113.593 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.441 HH11 ' HD2' ' A' ' 151' ' ' ARG . 42.8 ttm180 72.77 -53.54 0.7 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.12 0.568 . . . . 0.0 111.875 178.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 40.64 97.72 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 169.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -116.9 -82.71 0.63 Allowed 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.863 174.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 18.6 pt -137.09 134.24 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-O 121.083 0.468 . . . . 0.0 111.743 -179.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 90.2 mt -113.44 32.44 5.78 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.146 0.498 . . . . 0.0 110.988 178.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -62.72 133.06 54.24 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.116 -177.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -117.85 165.98 13.02 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 121.177 0.513 . . . . 0.0 111.449 -179.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 55.4 p -57.52 -25.64 60.16 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 176.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 137.16 11.41 1.04 Allowed Glycine 0 CA--C 1.529 0.959 0 C-N-CA 120.969 -0.634 . . . . 0.0 113.835 178.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 59.1 93.79 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 122.862 0.465 . . . . 0.0 112.219 178.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 42.0 t -95.6 126.17 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-O 120.848 0.356 . . . . 0.0 111.867 -177.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 85.0 p -103.11 139.71 38.27 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.309 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -62.21 113.42 2.87 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -177.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 58.18 23.39 10.19 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 177.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 97.4 mttt 62.65 -164.47 0.25 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 122.612 0.365 . . . . 0.0 111.618 -176.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 11.5 m120 66.72 -75.61 0.06 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 122.833 0.453 . . . . 0.0 111.656 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 55.86 -80.54 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.336 0.655 . . . . 0.0 112.742 178.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -146.65 85.31 0.17 Allowed Glycine 0 CA--C 1.521 0.415 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' THR . . . . . 0.405 ' O ' ' HB2' ' A' ' 170' ' ' TYR . 44.0 p 51.57 50.69 18.26 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 121.193 0.52 . . . . 0.0 111.201 -172.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . 0.405 ' HB2' ' O ' ' A' ' 169' ' ' THR . 41.4 m-85 72.4 -175.82 0.17 Allowed 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.905 -179.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -70.42 75.44 0.55 Allowed 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.648 0.737 . . . . 0.0 112.54 -175.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.405 ' HB2' ' HB3' ' A' ' 175' ' ' LYS . . . -79.41 71.14 5.96 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.279 177.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -65.83 103.44 0.91 Allowed 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.34 -178.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 22.7 m 42.55 34.96 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 123.716 0.806 . . . . 0.0 112.184 -175.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.405 ' HB3' ' HB2' ' A' ' 172' ' ' ALA . 86.9 tttt -75.68 85.18 2.7 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.601 -178.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm 58.29 -76.54 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.266 0.626 . . . . 0.0 112.409 178.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.423 HD12 ' N ' ' A' ' 177' ' ' LEU . 6.9 mp -79.49 116.9 19.98 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.963 0.411 . . . . 0.0 110.769 178.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.545 0.751 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.395 -174.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.7 mmt . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 120.532 0.206 . . . . 0.0 110.92 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 63.16 -77.44 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 174.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.16 -32.71 72.23 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -178.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 30.2 t 59.45 -166.17 0.18 Allowed 'General case' 0 N--CA 1.475 0.824 0 CA-C-O 121.104 0.478 . . . . 0.0 111.849 179.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 96.1 m -119.12 106.35 12.3 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.793 0.33 . . . . 0.0 111.027 178.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -56.61 129.07 39.41 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.794 178.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.0 mt -56.71 124.31 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -170.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.55 -31.07 69.04 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.382 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.73 -17.06 48.48 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 121.225 -0.512 . . . . 0.0 113.164 175.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 53.0 tp -71.85 -58.44 3.46 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.783 0.291 . . . . 0.0 110.899 177.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -55.43 -39.63 70.5 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 177.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -61.47 -57.08 13.61 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.573 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.3 t -57.32 -44.91 84.59 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.134 0.492 . . . . 0.0 110.868 178.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -58.34 -40.97 83.59 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.435 176.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.48 ' O ' HG12 ' A' ' 19' ' ' ILE . 58.4 ttt180 -67.48 -44.21 79.1 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 120.678 0.275 . . . . 0.0 110.985 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -62.8 -34.37 77.15 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.237 178.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.484 ' HB3' ' HE1' ' A' ' 30' ' ' MET . 5.6 m-85 -72.28 -49.72 32.56 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.365 173.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.73 -46.96 81.0 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -176.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.48 HG12 ' O ' ' A' ' 15' ' ' ARG . 23.1 pt -83.58 5.58 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-O 121.018 0.437 . . . . 0.0 111.974 -177.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 37.1 t60 -78.96 105.22 10.13 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.937 0.399 . . . . 0.0 110.291 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.446 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . 88.82 -64.31 3.42 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.27 -174.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -90.13 97.33 1.07 Allowed Pre-proline 0 CA--C 1.547 0.839 0 CA-C-O 120.865 0.364 . . . . 0.0 110.608 175.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.446 ' HD3' ' O ' ' A' ' 21' ' ' GLY . 74.4 Cg_endo -73.33 -30.79 9.91 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 122.546 2.164 . . . . 0.0 114.183 -170.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.66 ' HB2' ' HZ2' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -76.46 2.42 13.75 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -173.211 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.412 ' HB2' ' O ' ' A' ' 29' ' ' GLU . . . -65.79 -37.16 85.54 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.974 0.416 . . . . 0.0 111.288 176.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 27.1 t 55.76 16.43 2.01 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 175.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 75.86 13.95 82.61 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 120.883 -0.675 . . . . 0.0 113.87 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -95.78 -36.65 11.08 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.268 0.556 . . . . 0.0 110.461 175.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.412 ' O ' ' HB2' ' A' ' 25' ' ' ALA . 26.3 mt-10 -137.44 142.74 41.6 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.926 -178.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.484 ' HE1' ' HB3' ' A' ' 17' ' ' PHE . 27.2 ttt -123.97 142.51 51.1 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.983 0.421 . . . . 0.0 111.667 -175.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -103.46 164.79 11.43 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -174.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -58.71 -32.27 69.25 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-N 115.725 -0.67 . . . . 0.0 113.7 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.506 ' HB2' ' HZ2' ' A' ' 33' ' ' LYS . 3.6 ttmp? -47.75 -61.9 1.72 Allowed 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 121.62 0.724 . . . . 0.0 111.395 176.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -79.81 -20.36 46.31 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.125 -175.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 62.0 t-105 -69.91 -50.22 44.36 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 120.882 0.373 . . . . 0.0 111.218 177.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.13 -43.85 95.35 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-O 121.403 0.62 . . . . 0.0 110.203 174.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 41.3 tttm -57.16 -46.73 82.52 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.593 174.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.478 HD11 ' HE3' ' A' ' 30' ' ' MET . 8.4 tt -51.91 -46.82 64.76 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 122.895 0.478 . . . . 0.0 111.057 -179.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.65 ' SG ' HG11 ' A' ' 55' ' ' VAL . 73.7 m -56.29 -50.5 71.21 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.218 177.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -71.73 -28.99 64.04 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 121.113 0.482 . . . . 0.0 111.914 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.406 ' OD1' ' NZ ' ' A' ' 106' ' ' LYS . 5.8 t70 -75.37 -44.8 42.99 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.427 0.632 . . . . 0.0 111.158 -173.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 65.4 m -103.08 2.25 34.48 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.68 178.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp 62.36 34.95 15.34 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.321 0.581 . . . . 0.0 111.348 178.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 59.9 t -68.21 -42.21 84.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.443 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.09 91.91 2.12 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.266 0.555 . . . . 0.0 111.123 178.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.62 ' HB2' ' HG2' ' A' ' 86' ' ' ARG . 26.9 t70 -51.86 -26.61 10.44 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.72 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.11 -55.99 4.59 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 121.302 -0.475 . . . . 0.0 112.27 -177.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.776 ' HB3' ' HZ3' ' A' ' 48' ' ' LYS . 5.9 ttpm? -64.08 -32.97 74.73 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 121.124 0.487 . . . . 0.0 111.128 176.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 13.8 m -110.15 -19.47 13.02 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.52 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 5.8 p -160.3 113.88 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-O 121.005 0.431 . . . . 0.0 112.131 -176.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 58.5 p -95.69 172.48 8.02 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 120.818 0.342 . . . . 0.0 111.768 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -51.65 -36.42 39.96 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-N 116.19 -0.459 . . . . 0.0 113.686 177.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.517 ' O ' HG13 ' A' ' 57' ' ' ILE . 21.6 p -62.06 -54.38 42.29 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.972 0.415 . . . . 0.0 110.234 177.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -58.2 -38.48 76.82 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.52 -176.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.65 HG11 ' SG ' ' A' ' 39' ' ' CYS . 88.6 t -58.21 -39.1 72.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.595 174.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -70.42 -36.17 73.86 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 121.296 0.57 . . . . 0.0 110.318 178.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.566 ' O ' ' HG3' ' A' ' 61' ' ' LYS . 8.7 mt -61.49 -46.43 96.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.578 176.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 89.7 t -60.91 -45.13 98.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-O 121.08 0.467 . . . . 0.0 110.73 177.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.509 ' O ' ' HB2' ' A' ' 63' ' ' LYS . 76.5 t80 -59.39 -30.92 68.78 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.874 175.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.548 ' HA ' ' HE3' ' A' ' 63' ' ' LYS . 67.8 m -82.5 -25.15 33.74 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.722 177.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.566 ' HG3' ' O ' ' A' ' 57' ' ' ILE . 95.4 mttt -66.47 -55.3 16.28 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 120.98 0.419 . . . . 0.0 111.338 177.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.529 ' HB ' ' HB3' ' A' ' 74' ' ' GLU . 27.6 m -83.72 6.99 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 CA-C-N 116.064 -0.516 . . . . 0.0 112.198 -177.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.548 ' HE3' ' HA ' ' A' ' 60' ' ' SER . 39.6 ttmt -78.01 143.86 37.17 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.766 -179.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -73.01 177.98 41.24 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 121.022 -0.609 . . . . 0.0 113.203 177.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -50.98 100.35 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -177.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 60.6 p 52.04 23.95 2.45 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.368 0.667 . . . . 0.0 112.335 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.452 ' O ' ' HD3' ' A' ' 63' ' ' LYS . . . -70.29 176.23 4.08 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -177.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.51 ' HG3' HG12 ' A' ' 69' ' ' VAL . 16.8 ptt180 -116.48 -9.48 11.43 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.51 HG12 ' HG3' ' A' ' 68' ' ' ARG . 33.1 m -136.57 172.18 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-O 121.084 0.469 . . . . 0.0 112.0 -178.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 37.8 pt -128.18 145.61 35.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.097 175.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 -79.92 158.89 26.54 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 120.736 0.303 . . . . 0.0 111.729 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.524 ' O ' ' HB3' ' A' ' 75' ' ' PHE . 30.1 t80 -48.4 -46.8 37.73 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -175.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 22.7 mp0 -60.81 -43.96 97.49 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 122.113 -0.367 . . . . 0.0 111.418 -178.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.529 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 32.5 mm-40 -71.96 -27.19 62.61 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.887 0.375 . . . . 0.0 111.078 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.524 ' HB3' ' O ' ' A' ' 72' ' ' TYR . 61.6 t80 -57.22 -39.67 75.93 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.396 0.617 . . . . 0.0 110.349 170.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.511 ' HG3' ' O ' ' A' ' 72' ' ' TYR . 32.3 mtpt -67.12 -35.62 80.14 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.825 177.082 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.412 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 15.1 tppt? -66.88 -39.65 87.54 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.346 0.593 . . . . 0.0 110.653 176.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.09 -46.47 90.51 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.807 174.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 79.4 mt -60.75 -32.32 71.62 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.114 174.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.412 ' HB3' ' O ' ' A' ' 77' ' ' LYS . 32.9 tt0 -56.66 -51.32 69.19 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 120.704 0.288 . . . . 0.0 110.934 177.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -61.68 -53.71 52.52 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.408 175.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 82.0 mt -54.21 -38.36 65.59 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -178.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.76 -52.16 40.61 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.907 0.384 . . . . 0.0 111.62 177.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 70.1 p -66.65 -16.14 63.98 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -90.5 -49.3 6.58 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 122.077 -0.39 . . . . 0.0 111.02 173.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.62 ' HG2' ' HB2' ' A' ' 46' ' ' ASP . 2.2 tmt_? -59.77 -51.2 70.78 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.003 0.43 . . . . 0.0 110.687 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -94.24 24.18 4.58 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.145 0.498 . . . . 0.0 111.923 -177.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 56.0 mttm 59.46 -179.81 0.08 Allowed 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.925 178.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -77.25 58.69 3.64 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 121.309 -0.472 . . . . 0.0 114.051 -175.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -98.43 -162.16 0.93 Allowed 'General case' 0 CA--C 1.543 0.697 0 O-C-N 122.618 -0.342 . . . . 0.0 110.634 176.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.406 ' HB3' ' HB3' ' A' ' 94' ' ' GLU . 28.5 t -56.28 120.56 7.79 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 122.182 -0.323 . . . . 0.0 111.402 176.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -57.59 -44.56 85.5 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.877 0.37 . . . . 0.0 111.373 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.5 mp0 -59.1 -50.01 75.68 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.933 177.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.406 ' HB3' ' HB3' ' A' ' 91' ' ' SER . 36.3 tt0 -58.25 -47.05 84.79 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.667 177.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.54 -36.73 83.54 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.917 0.389 . . . . 0.0 111.448 178.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -65.87 -42.75 89.96 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.83 178.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -60.94 -42.79 98.87 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.195 0.521 . . . . 0.0 110.591 175.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.531 ' O ' ' HB3' ' A' ' 101' ' ' GLN . . . -61.44 -49.34 77.24 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 179.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.1 tt -64.51 -33.37 62.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 O-C-N 121.886 -0.508 . . . . 0.0 110.937 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 97.6 m -66.12 -38.55 88.46 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.88 0.371 . . . . 0.0 110.581 172.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.531 ' HB3' ' O ' ' A' ' 98' ' ' ALA . 6.7 tt0 -54.95 -34.09 62.93 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 121.045 0.45 . . . . 0.0 111.409 174.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 75.6 mt -78.09 -36.68 47.81 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 112.694 0.628 . . . . 0.0 112.694 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 54.9 t -100.71 -49.73 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -172.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.17 134.34 56.9 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -174.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 68.66 33.39 76.03 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.292 -0.48 . . . . 0.0 113.037 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.406 ' NZ ' ' OD1' ' A' ' 41' ' ' ASP . 14.2 tmtt? -142.91 133.71 25.37 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 122.922 0.489 . . . . 0.0 110.807 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -85.94 154.6 58.19 Favored Pre-proline 0 N--CA 1.474 0.767 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -175.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -65.9 84.64 0.24 Allowed 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 123.076 2.518 . . . . 0.0 112.866 176.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 64.86 25.19 12.83 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 174.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -112.09 158.26 19.81 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 110.251 -0.278 . . . . 0.0 110.251 174.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 61.0 t -63.39 88.24 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 121.399 0.618 . . . . 0.0 111.005 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -178.54 92.36 0.08 OUTLIER Glycine 0 CA--C 1.526 0.72 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.338 -178.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.433 HG11 ' N ' ' A' ' 114' ' ' THR . 4.0 p -162.9 -53.2 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 122.581 0.352 . . . . 0.0 111.141 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.433 ' N ' HG11 ' A' ' 113' ' ' VAL . 76.4 p -78.09 113.87 16.43 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.957 0.408 . . . . 0.0 110.772 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 16.8 pttm -136.05 146.68 47.35 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 120.734 0.302 . . . . 0.0 111.812 -175.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 72.44 -73.65 0.1 Allowed 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.299 0.64 . . . . 0.0 112.424 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -179.22 -40.85 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 120.987 0.422 . . . . 0.0 111.077 -179.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.8 t -80.01 -178.06 6.32 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.89 0.376 . . . . 0.0 111.062 175.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 79.49 -58.29 4.44 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.527 -177.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -64.03 -22.0 66.36 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 121.32 -0.467 . . . . 0.0 112.616 175.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -138.48 153.55 48.8 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 122.595 0.358 . . . . 0.0 110.892 178.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 11.4 p -128.44 145.71 35.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 121.054 0.454 . . . . 0.0 111.81 -177.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -88.0 151.79 22.52 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.873 177.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 17.7 ttm180 -80.95 109.99 16.06 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.25 0.548 . . . . 0.0 111.938 -179.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 8.7 mp -83.15 58.94 4.69 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.059 175.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 15.2 t 38.47 37.58 0.18 Allowed 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 124.112 0.965 . . . . 0.0 113.398 -176.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -68.04 135.99 53.13 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.168 0.508 . . . . 0.0 111.596 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 6.7 t -119.03 142.56 47.72 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.839 177.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.483 ' O ' HG23 ' A' ' 132' ' ' THR . 47.9 t -81.65 -69.6 0.6 Allowed 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.692 0.282 . . . . 0.0 111.44 -178.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 62.34 3.29 1.02 Allowed 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 176.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 42.6 t80 56.83 28.32 14.27 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 121.457 0.646 . . . . 0.0 110.686 -175.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' THR . . . . . 0.483 HG23 ' O ' ' A' ' 129' ' ' SER . 5.0 t -71.1 76.62 0.68 Allowed 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.47 0.652 . . . . 0.0 112.632 -176.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -81.16 70.5 3.07 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 121.048 -0.596 . . . . 0.0 111.662 173.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 34.0 t 64.7 -166.38 0.23 Allowed 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 120.865 0.364 . . . . 0.0 110.647 -173.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -149.96 46.02 0.92 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.377 0.608 . . . . 0.0 110.864 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -81.52 63.51 5.84 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.073 -176.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 67.15 -79.69 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.2 0.6 . . . . 0.0 112.31 176.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 19.9 tpt180 -177.4 -48.36 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.978 -175.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -112.78 157.88 20.8 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.411 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -84.65 -64.68 1.11 Allowed 'General case' 0 CA--C 1.545 0.786 0 CA-C-O 120.756 0.312 . . . . 0.0 111.4 177.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -155.75 4.08 0.18 Allowed 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 122.323 0.249 . . . . 0.0 111.275 -179.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 94.7 p 53.35 -85.26 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.335 0.654 . . . . 0.0 111.073 -168.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.437 ' O ' ' HB3' ' A' ' 144' ' ' LYS . . . 77.38 -51.03 3.25 Favored Glycine 0 CA--C 1.53 1.003 0 N-CA-C 114.363 0.505 . . . . 0.0 114.363 176.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.437 ' HB3' ' O ' ' A' ' 143' ' ' GLY . 23.6 ttmm 70.71 -61.11 0.48 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.262 0.625 . . . . 0.0 111.084 -174.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -115.53 79.7 0.29 Allowed Glycine 0 CA--C 1.527 0.817 0 C-N-CA 121.25 -0.5 . . . . 0.0 112.627 176.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -66.77 90.25 0.17 Allowed 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 116.806 0.303 . . . . 0.0 111.192 178.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 142.85 143.65 4.18 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 121.05 -0.595 . . . . 0.0 113.663 177.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 48.9 mm -105.0 124.95 60.0 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 O-C-N 122.524 -0.398 . . . . 0.0 112.03 -178.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . 61.23 14.73 5.8 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 175.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -86.7 82.2 1.65 Allowed Glycine 0 CA--C 1.524 0.594 0 C-N-CA 121.015 -0.612 . . . . 0.0 113.682 -177.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.418 HH11 ' HD3' ' A' ' 151' ' ' ARG . 24.5 ttm-85 -145.84 -55.35 0.29 Allowed 'General case' 0 CA--C 1.54 0.586 0 O-C-N 122.481 -0.423 . . . . 0.0 111.553 177.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -71.09 146.63 49.13 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.538 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -108.74 -163.52 0.88 Allowed 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.498 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 41.2 pt -66.94 126.88 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-O 121.192 0.52 . . . . 0.0 112.069 -178.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 75.5 mt -135.48 86.67 2.26 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.6 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 17.3 t70 75.91 -48.75 0.6 Allowed 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 169.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -53.84 121.26 7.57 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -174.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 26.7 p -83.03 -33.17 26.55 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.192 177.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 124.21 107.01 1.73 Allowed Glycine 0 CA--C 1.527 0.786 0 C-N-CA 121.031 -0.604 . . . . 0.0 113.616 175.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -65.66 162.98 17.3 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.231 0.539 . . . . 0.0 112.14 175.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.434 ' O ' ' HB3' ' A' ' 162' ' ' SER . 11.8 p -112.73 26.57 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.928 0 CA-C-O 121.451 0.643 . . . . 0.0 110.409 177.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.434 ' HB3' ' O ' ' A' ' 161' ' ' VAL . 28.9 t 73.06 132.82 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.198 -176.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -58.12 136.12 57.16 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.955 178.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -81.04 59.73 3.94 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.375 0.607 . . . . 0.0 111.531 -176.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -94.77 -77.85 0.46 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.991 -0.549 . . . . 0.0 112.189 177.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 22.2 p-10 -158.41 -55.15 0.07 Allowed 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -176.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.87 109.31 0.62 Allowed 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -174.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -85.56 73.3 2.6 Favored Glycine 0 CA--C 1.524 0.596 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.766 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 59.1 m -67.09 83.62 0.13 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.216 0.531 . . . . 0.0 111.226 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -105.79 134.54 48.75 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.719 178.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -78.18 84.21 4.41 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.758 0.79 . . . . 0.0 111.917 -177.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -120.03 -62.26 1.5 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.037 176.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 51.6 tttp -84.52 31.7 0.52 Allowed 'General case' 0 CA--C 1.548 0.887 0 CA-C-O 121.395 0.617 . . . . 0.0 111.3 -178.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 54.1 t -80.02 87.54 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-O 121.462 0.648 . . . . 0.0 110.826 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 57.5 tttm -151.56 55.53 0.86 Allowed 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.833 0.825 . . . . 0.0 109.248 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 34.1 mtmt -105.37 -83.23 0.51 Allowed 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.601 -171.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.414 HD11 ' N ' ' A' ' 177' ' ' LEU . 6.7 mp -84.19 -79.88 0.2 Allowed 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 178.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 . . . . . 0 N--CA 1.476 0.861 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 166.806 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.4 tpt . . . . . 0 N--CA 1.488 1.44 0 CA-C-O 120.683 0.278 . . . . 0.0 110.861 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.62 102.34 0.9 Allowed 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -176.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -84.8 85.97 7.4 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.27 0.557 . . . . 0.0 110.764 174.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.0 t -66.05 149.81 49.68 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -176.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 75.6 p -84.03 94.77 8.38 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.303 173.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.7 t70 62.31 -164.36 0.25 Allowed 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.518 -176.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.9 mm -75.15 104.42 3.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 O-C-N 121.904 -0.497 . . . . 0.0 110.959 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.42 -38.45 66.28 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.18 -177.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -69.02 -26.69 74.52 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 121.144 -0.551 . . . . 0.0 113.257 177.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 50.7 tp -74.9 -51.29 14.21 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 122.523 -0.398 . . . . 0.0 110.882 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -62.33 -30.22 71.01 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.719 0.295 . . . . 0.0 111.047 176.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -63.56 -51.94 63.21 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.837 0.351 . . . . 0.0 110.377 175.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.5 m -62.78 -39.47 94.31 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.57 177.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -54.14 -51.66 63.57 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.862 0.363 . . . . 0.0 110.492 176.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.598 ' O ' HG12 ' A' ' 19' ' ' ILE . 81.6 mtt85 -63.26 -44.2 95.81 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.962 0.411 . . . . 0.0 111.232 175.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.631 ' HD2' ' HA ' ' A' ' 107' ' ' GLU . 26.9 ttmt -52.43 -34.32 48.03 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.414 -178.058 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -93.04 -38.8 11.44 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 116.167 -0.47 . . . . 0.0 112.098 173.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.07 -41.7 83.95 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -175.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.598 HG12 ' O ' ' A' ' 15' ' ' ARG . 46.5 pt -83.73 10.58 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -178.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 22.8 t60 -82.64 129.15 34.9 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 120.894 0.378 . . . . 0.0 110.8 177.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.49 -49.29 4.2 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.548 -177.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -93.19 100.78 4.57 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-O 120.741 0.305 . . . . 0.0 111.242 175.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -76.85 4.64 5.52 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 122.584 2.189 . . . . 0.0 113.229 -177.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -113.83 4.26 15.82 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.708 0.29 . . . . 0.0 111.707 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -74.99 132.05 41.09 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.788 0.328 . . . . 0.0 111.72 -179.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.6 m -76.81 -36.05 57.19 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.865 0.364 . . . . 0.0 111.473 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.515 ' HA3' ' HG2' ' A' ' 15' ' ' ARG . . . 126.71 15.67 2.61 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 120.881 -0.676 . . . . 0.0 114.229 176.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -113.95 -7.84 13.13 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 117.228 0.514 . . . . 0.0 111.833 177.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -123.79 137.13 54.73 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 122.418 0.287 . . . . 0.0 110.995 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 51.2 ttm -133.54 137.43 45.55 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.867 0.365 . . . . 0.0 111.404 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 31.0 p30 -92.12 171.22 9.23 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.261 0.553 . . . . 0.0 112.267 -179.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.55 -29.1 72.57 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-N 115.885 -0.598 . . . . 0.0 113.603 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -60.13 -55.06 38.54 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.031 0.443 . . . . 0.0 111.356 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -69.99 -29.16 66.18 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.496 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 53.8 t-105 -61.59 -42.63 99.13 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.275 0.559 . . . . 0.0 110.605 173.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.404 ' O ' ' SG ' ' A' ' 39' ' ' CYS . . . -61.61 -42.62 99.13 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.119 174.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.406 ' HE2' ' OD2' ' A' ' 41' ' ' ASP . 13.2 mmmm -61.87 -44.05 97.61 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.205 175.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.492 HD12 ' HE1' ' A' ' 75' ' ' PHE . 11.1 mt -48.83 -54.28 15.84 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 177.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.404 ' SG ' ' O ' ' A' ' 36' ' ' ALA . 24.6 p -62.06 -45.88 91.57 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.664 -178.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.5 ttpm? -68.72 -49.2 60.82 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.074 0.464 . . . . 0.0 111.661 -176.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.406 ' OD2' ' HE2' ' A' ' 37' ' ' LYS . 12.4 m-20 -69.14 -38.37 78.78 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.563 -176.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.46 ' SG ' ' HA ' ' A' ' 103' ' ' VAL . 73.4 m -85.35 -4.04 59.03 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 176.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt 62.0 35.53 16.03 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.265 0.555 . . . . 0.0 112.284 175.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 41.7 t -80.04 -23.84 11.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.472 174.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -92.62 96.92 10.48 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.574 179.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -56.73 -30.43 63.52 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.946 0.403 . . . . 0.0 111.532 178.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 98.04 -48.63 1.43 Allowed Glycine 0 CA--C 1.524 0.63 0 C-N-CA 121.536 -0.364 . . . . 0.0 112.655 -178.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -84.87 -21.11 29.9 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.965 0.412 . . . . 0.0 111.704 178.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 78.7 p -113.7 -72.53 0.7 Allowed 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.957 0.408 . . . . 0.0 110.551 176.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 59.3 t -88.14 122.03 39.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.172 174.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.5 t -140.6 178.56 7.24 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.416 -176.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -44.83 -52.36 7.82 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 114.189 0.436 . . . . 0.0 114.189 -175.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.568 ' O ' HG12 ' A' ' 57' ' ' ILE . 84.7 m -57.88 -51.67 68.65 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 122.561 -0.376 . . . . 0.0 111.303 177.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -55.86 -42.99 76.68 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 121.263 0.554 . . . . 0.0 111.123 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 83.7 t -65.8 -29.19 46.18 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.562 177.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -78.05 -33.84 50.73 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.592 0.711 . . . . 0.0 109.732 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.568 HG12 ' O ' ' A' ' 53' ' ' THR . 11.0 mm -64.13 -47.36 90.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.684 175.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.535 ' HA ' ' HD2' ' A' ' 61' ' ' LYS . 80.8 t -57.63 -45.91 86.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.323 175.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -57.36 -43.35 83.42 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.145 0.498 . . . . 0.0 110.579 174.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 23.0 t -65.48 -34.36 78.08 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.766 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.535 ' HD2' ' HA ' ' A' ' 58' ' ' VAL . 64.6 mttm -58.75 -51.96 67.74 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.333 0.587 . . . . 0.0 111.308 176.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.507 ' HB ' ' HB3' ' A' ' 74' ' ' GLU . 25.9 m -84.31 -6.6 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.039 -177.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.725 ' HB3' ' HZ1' ' A' ' 63' ' ' LYS . 6.3 ttpm? -65.69 153.55 41.38 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 120.922 0.392 . . . . 0.0 111.83 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -79.37 -161.46 21.87 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.683 175.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -62.38 -38.63 90.36 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 122.48 -0.424 . . . . 0.0 111.918 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 21.2 t -154.08 17.44 0.49 Allowed 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 120.824 0.345 . . . . 0.0 111.235 177.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.06 138.81 58.56 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -179.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 62.4 mtt180 -94.12 -8.58 39.15 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.232 178.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 36.0 m -132.17 152.03 35.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.807 -178.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.469 HG22 HG22 ' A' ' 62' ' ' VAL . 35.2 pt -117.58 151.63 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.087 176.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -100.38 173.03 6.78 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -177.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.497 ' O ' ' HB3' ' A' ' 75' ' ' PHE . 34.5 t80 -53.17 -50.65 64.18 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -170.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -63.43 -42.82 98.71 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -176.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.507 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 0.8 OUTLIER -69.93 -30.72 68.18 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.984 0.421 . . . . 0.0 110.537 176.653 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.497 ' HB3' ' O ' ' A' ' 72' ' ' TYR . 50.5 t80 -58.53 -43.25 89.14 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.163 0.506 . . . . 0.0 110.55 171.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.484 ' HG3' ' O ' ' A' ' 72' ' ' TYR . 55.2 mtpt -60.95 -40.14 92.17 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.7 175.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -70.01 -28.26 65.36 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.528 175.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.85 -42.74 80.91 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.036 0.446 . . . . 0.0 110.546 173.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 79.9 mt -64.71 -41.72 95.79 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.716 173.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -56.95 -45.07 83.07 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.319 0.58 . . . . 0.0 110.665 174.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.421 ' O ' ' HG3' ' A' ' 85' ' ' LYS . 16.4 tp10 -58.65 -59.82 4.79 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.029 176.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.409 ' O ' ' HG3' ' A' ' 86' ' ' ARG . 87.6 mt -56.13 -36.69 68.51 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.556 178.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.99 -58.31 9.23 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.72 -0.218 . . . . 0.0 111.276 177.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 80.5 p -53.79 -33.8 57.12 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.421 ' HG3' ' O ' ' A' ' 81' ' ' GLU . 7.2 mtpm? -72.71 -35.62 67.62 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.518 178.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.409 ' HG3' ' O ' ' A' ' 82' ' ' LEU . 48.1 mtp180 -96.82 -65.91 0.94 Allowed 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 120.88 0.372 . . . . 0.0 111.528 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -87.37 111.63 21.3 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.859 0.361 . . . . 0.0 110.436 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 15.5 pttm -141.93 31.64 1.6 Allowed 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -171.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -78.85 43.04 2.35 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 120.97 -0.634 . . . . 0.0 113.182 175.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.5 ttpp 72.04 -45.92 0.63 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.036 0.935 . . . . 0.0 112.964 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.4 m -72.62 110.4 6.95 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 122.071 -0.393 . . . . 0.0 111.759 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -81.62 -34.52 30.85 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 178.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -47.12 -70.55 0.09 Allowed 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 120.994 0.426 . . . . 0.0 111.409 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -66.64 -28.82 68.78 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -177.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.2 -42.88 91.95 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.307 0.575 . . . . 0.0 110.696 174.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -68.16 -40.3 82.37 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.539 176.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -57.78 -40.31 79.52 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.791 0.329 . . . . 0.0 111.513 174.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.565 ' O ' ' HB3' ' A' ' 101' ' ' GLN . . . -63.8 -47.45 80.81 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.036 0.446 . . . . 0.0 112.093 -178.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.9 tt -70.46 -31.14 45.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 O-C-N 121.998 -0.439 . . . . 0.0 110.752 178.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 84.8 m -68.06 -33.88 75.4 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.788 0.328 . . . . 0.0 110.613 171.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.565 ' HB3' ' O ' ' A' ' 98' ' ' ALA . 28.2 tt0 -56.53 -39.93 74.22 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.284 0.564 . . . . 0.0 110.526 173.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 88.8 mt -68.18 -39.15 82.59 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.405 176.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.46 ' HA ' ' SG ' ' A' ' 42' ' ' CYS . 67.7 t -93.53 -59.08 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -174.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -51.28 125.02 13.03 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 112.546 0.572 . . . . 0.0 112.546 -177.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.67 -42.13 2.81 Favored Glycine 0 CA--C 1.528 0.869 0 CA-C-N 116.172 -0.467 . . . . 0.0 112.745 -177.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -51.44 132.64 29.8 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -176.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.631 ' HA ' ' HD2' ' A' ' 16' ' ' LYS . 10.4 pt-20 -95.76 155.05 38.91 Favored Pre-proline 0 CA--C 1.542 0.657 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.902 174.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -56.87 130.14 38.27 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.545 2.163 . . . . 0.0 113.025 -178.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 60.27 -105.24 0.21 Allowed 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.224 -177.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 8.4 t30 59.01 122.1 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 121.304 0.573 . . . . 0.0 112.313 -175.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 41.0 t -73.81 75.65 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-O 121.5 0.667 . . . . 0.0 111.001 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -112.53 83.47 0.33 Allowed Glycine 0 CA--C 1.521 0.439 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.989 178.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 62.0 t -100.79 119.28 48.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -176.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 70.4 m -70.19 100.96 1.76 Allowed 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 172.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -74.99 125.87 29.82 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.296 0.57 . . . . 0.0 112.482 -173.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -100.62 -70.79 0.73 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.012 174.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -114.09 99.8 7.91 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.081 0.467 . . . . 0.0 112.137 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 41.7 p -78.2 -173.04 3.04 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.315 176.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 96.13 134.54 7.99 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.348 -177.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 154.72 -89.16 0.12 Allowed Glycine 0 CA--C 1.523 0.544 0 C-N-CA 121.269 -0.491 . . . . 0.0 112.421 -178.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.2 172.37 18.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.96 0.41 . . . . 0.0 111.416 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 28.8 m -76.7 128.29 37.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-O 121.071 0.463 . . . . 0.0 110.923 176.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -104.38 92.73 4.45 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 120.964 0.412 . . . . 0.0 110.918 -179.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 66.3 mtm180 57.84 16.62 3.71 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 175.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 7.5 mp 62.54 87.02 0.11 Allowed 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.116 0.484 . . . . 0.0 111.782 -177.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 53.2 p -116.84 12.12 14.68 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -86.77 21.12 2.32 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -175.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 66.2 p -79.71 69.19 5.98 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 122.093 -0.38 . . . . 0.0 111.302 178.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.51 ' HB3' ' HB3' ' A' ' 135' ' ' HIS . 82.8 p 50.12 106.33 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.827 0.851 . . . . 0.0 112.593 -176.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 63.9 mtt180 -55.46 -42.52 74.42 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.773 -176.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -171.66 29.41 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.888 0.851 . . . . 0.0 109.827 172.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 24.3 m -82.55 -25.73 33.07 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.603 -178.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 78.03 -61.32 3.77 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 121.156 -0.545 . . . . 0.0 112.02 -172.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 49.5 m -67.52 114.2 5.98 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 122.359 0.264 . . . . 0.0 110.957 175.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.51 ' HB3' ' HB3' ' A' ' 129' ' ' SER . 39.4 p-80 -140.03 -2.83 1.45 Allowed 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -178.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -77.54 -18.73 56.7 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.733 0.777 . . . . 0.0 109.733 173.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.52 ' O ' ' N ' ' A' ' 139' ' ' PHE . 0.0 OUTLIER -138.68 -175.39 4.12 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.555 172.652 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.645 ' HG3' ' H ' ' A' ' 139' ' ' PHE . 13.7 ptm180 34.17 -73.85 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.189 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 -174.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.645 ' H ' ' HG3' ' A' ' 138' ' ' ARG . 36.3 p90 46.42 177.14 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -178.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -90.46 151.29 21.46 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.785 -176.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -74.66 142.6 44.5 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.059 174.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 22.9 t -62.92 98.02 0.12 Allowed 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.101 0.477 . . . . 0.0 111.06 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -61.91 -29.04 71.32 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-N 116.008 -0.542 . . . . 0.0 113.316 -178.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 96.2 mttt 59.28 101.08 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.388 0.613 . . . . 0.0 111.658 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -90.7 -173.81 44.28 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 121.074 -0.584 . . . . 0.0 113.552 -176.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -107.05 144.95 32.97 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.759 0.314 . . . . 0.0 110.708 177.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -68.56 78.97 0.24 Allowed Glycine 0 CA--C 1.527 0.83 0 C-N-CA 121.426 -0.416 . . . . 0.0 113.506 -177.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.412 HG12 ' O ' ' A' ' 148' ' ' ILE . 15.4 tt -146.91 9.56 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 CA-C-O 121.391 0.615 . . . . 0.0 111.384 179.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -73.26 82.3 1.35 Allowed 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.12 0.486 . . . . 0.0 111.648 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 145.58 123.93 1.62 Allowed Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.235 -0.507 . . . . 0.0 112.899 178.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 62.7 ttt-85 -118.63 95.99 5.09 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 120.884 0.373 . . . . 0.0 110.993 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -109.58 20.49 18.09 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.003 0.43 . . . . 0.0 111.025 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 62.53 -166.65 0.22 Allowed 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.19 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.442 HG13 ' H ' ' A' ' 156' ' ' ASP . 35.5 pt -91.46 176.67 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-O 121.079 0.466 . . . . 0.0 111.71 178.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 75.2 mt -89.64 19.35 4.69 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.814 -179.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . 0.523 ' O ' ' N ' ' A' ' 158' ' ' SER . 10.1 m-20 63.85 -84.44 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.114 0.566 . . . . 0.0 111.938 -177.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 3.9 p30 40.37 -67.5 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -177.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.523 ' N ' ' O ' ' A' ' 156' ' ' ASP . 50.9 m -57.76 87.26 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.223 0.609 . . . . 0.0 112.19 -178.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 159.44 108.91 0.25 Allowed Glycine 0 CA--C 1.526 0.74 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.667 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -68.15 112.55 5.16 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 117.109 0.455 . . . . 0.0 111.951 -173.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 11.2 p -135.4 19.77 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 CA-C-O 121.527 0.679 . . . . 0.0 111.146 177.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 76.7 p -95.19 20.14 9.61 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -69.67 108.57 3.93 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 122.139 -0.35 . . . . 0.0 111.656 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 35.9 t80 73.19 -53.39 0.7 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.96 0.904 . . . . 0.0 111.317 -178.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 62.6 tttm 72.88 -57.24 0.64 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.101 0.96 . . . . 0.0 113.349 174.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -60.88 91.65 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -175.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -176.52 167.26 2.73 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.385 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -87.32 -44.69 5.52 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.288 175.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 95.9 m 72.82 -41.03 0.49 Allowed 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 176.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . 0.439 ' HA ' ' HE3' ' A' ' 175' ' ' LYS . 80.3 m-85 -73.18 94.18 1.93 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.308 0.575 . . . . 0.0 111.413 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -95.53 -8.04 36.29 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.527 -0.761 . . . . 0.0 112.257 -178.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . 75.31 -42.15 0.47 Allowed 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -178.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 44.2 mmtm -62.16 -63.99 1.07 Allowed 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -176.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 9.1 p -166.33 146.02 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 120.782 0.325 . . . . 0.0 111.621 -175.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.439 ' HE3' ' HA ' ' A' ' 170' ' ' TYR . 41.2 mmtm -97.04 52.37 1.15 Allowed 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -179.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp 60.36 106.91 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 176.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.708 HD23 ' H ' ' A' ' 177' ' ' LEU . 2.3 pt? -87.64 14.57 8.18 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 . . . . . 0 N--CA 1.471 0.618 0 CA-C-O 121.175 0.512 . . . . 0.0 111.357 176.664 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.3 mtt . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 120.671 0.272 . . . . 0.0 111.129 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.23 -58.77 2.8 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.19 0.519 . . . . 0.0 110.194 173.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -86.18 97.18 10.2 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.766 173.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 95.4 p -80.67 -59.06 2.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.48 -177.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.3 m 55.15 58.35 4.78 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.555 0.693 . . . . 0.0 111.032 -178.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -82.98 -170.92 3.27 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.56 -177.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 48.3 mm -98.32 113.34 32.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-O 120.749 0.309 . . . . 0.0 110.709 177.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.94 -47.97 81.32 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -178.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.05 -29.83 59.88 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 121.1 -0.572 . . . . 0.0 113.047 177.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 50.6 tp -71.78 -45.1 62.7 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.778 0.323 . . . . 0.0 110.705 177.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -59.08 -46.72 87.57 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.017 0.437 . . . . 0.0 111.282 177.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.539 ' HG3' ' HE2' ' A' ' 16' ' ' LYS . 14.1 tp10 -56.91 -47.59 80.21 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.128 179.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.5 m -64.35 -42.44 96.23 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.795 177.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -53.97 -46.06 71.54 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.265 176.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.542 ' O ' HG12 ' A' ' 19' ' ' ILE . 94.5 mtt180 -59.28 -55.74 30.97 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.61 176.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.539 ' HE2' ' HG3' ' A' ' 12' ' ' GLU . 50.4 mttm -55.43 -32.5 62.76 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -175.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.458 ' HB3' ' HE1' ' A' ' 30' ' ' MET . 11.7 m-85 -81.68 -48.65 11.42 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 122.192 -0.317 . . . . 0.0 111.443 173.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.489 ' HA ' ' HG3' ' A' ' 30' ' ' MET . . . -55.39 -40.47 71.43 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -177.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.542 HG12 ' O ' ' A' ' 15' ' ' ARG . 16.6 pt -99.41 12.82 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 121.426 0.631 . . . . 0.0 110.957 -177.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 37.4 t-80 -58.64 92.93 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.014 -176.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.73 -6.3 57.1 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 121.11 -0.567 . . . . 0.0 113.376 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -134.9 92.85 18.27 Favored Pre-proline 0 CA--C 1.539 0.552 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -63.6 -12.95 33.66 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.348 2.032 . . . . 0.0 111.667 170.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -96.05 7.24 46.93 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.174 178.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.6 -97.25 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -176.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 59.1 m -164.12 -72.05 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 120.913 0.387 . . . . 0.0 111.092 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.59 -31.44 5.57 Favored Glycine 0 N--CA 1.464 0.537 0 C-N-CA 121.185 -0.531 . . . . 0.0 112.052 179.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -100.74 -11.97 19.49 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 120.663 0.268 . . . . 0.0 111.435 174.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -126.5 140.14 52.68 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.827 178.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.489 ' HG3' ' HA ' ' A' ' 18' ' ' ALA . 26.7 ttt -126.15 148.4 49.41 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.765 -173.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -98.15 174.9 6.3 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 120.933 0.396 . . . . 0.0 111.964 -177.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.4 -26.13 64.24 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 121.368 -0.444 . . . . 0.0 114.119 -176.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -63.83 -58.05 8.01 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 122.385 -0.479 . . . . 0.0 111.65 -177.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -74.03 -18.7 60.81 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 120.753 0.311 . . . . 0.0 111.603 178.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.441 ' NE1' HG13 ' A' ' 55' ' ' VAL . 58.8 t-105 -65.75 -47.6 74.69 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 121.142 0.496 . . . . 0.0 110.927 172.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.34 -36.97 79.21 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.181 0.515 . . . . 0.0 110.771 174.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 25.2 tptp -66.57 -44.73 81.46 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.842 176.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.483 HD12 ' HE3' ' A' ' 30' ' ' MET . 5.0 tt -53.86 -56.44 17.59 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.625 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.707 ' HA ' ' SG ' ' A' ' 42' ' ' CYS . 23.9 p -64.45 -32.64 74.35 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.694 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.461 ' HZ1' ' CG ' ' A' ' 46' ' ' ASP . 50.5 tptt -72.7 -36.7 67.89 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 120.589 0.233 . . . . 0.0 111.481 -179.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -73.45 -40.09 64.44 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 120.614 0.245 . . . . 0.0 111.473 177.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.707 ' SG ' ' HA ' ' A' ' 39' ' ' CYS . 27.6 p -79.27 -4.72 52.07 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.403 0.62 . . . . 0.0 110.386 172.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 22.4 mtpp 57.51 23.4 9.11 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.147 -0.933 . . . . 0.0 113.463 173.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.553 HG22 ' SG ' ' A' ' 42' ' ' CYS . 93.9 t -57.08 -42.9 80.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 168.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.576 ' HB2' HG22 ' A' ' 55' ' ' VAL . . . -86.59 65.86 9.22 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.637 177.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.461 ' CG ' ' HZ1' ' A' ' 40' ' ' LYS . 1.9 m-20 -155.62 11.09 0.31 Allowed 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.316 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -92.22 37.17 3.45 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 114.683 0.633 . . . . 0.0 114.683 -170.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt 54.2 13.29 0.58 Allowed 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 117.402 0.601 . . . . 0.0 112.337 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 42.8 t -156.75 -57.03 0.09 Allowed 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.277 0.561 . . . . 0.0 109.578 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.416 HG21 ' HB3' ' A' ' 85' ' ' LYS . 9.3 t -70.88 110.24 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.59 170.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 68.5 p -135.67 176.1 8.99 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.004 -177.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -48.19 -42.66 24.77 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 121.339 -0.458 . . . . 0.0 113.468 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.553 ' O ' HG12 ' A' ' 57' ' ' ILE . 99.0 m -64.41 -51.18 64.49 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 122.506 -0.408 . . . . 0.0 111.243 177.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -56.94 -39.26 74.21 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.17 0.509 . . . . 0.0 111.18 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.576 HG22 ' HB2' ' A' ' 45' ' ' ALA . 64.0 t -72.68 -23.89 21.13 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.684 178.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -79.14 -32.51 44.42 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.601 0.715 . . . . 0.0 109.565 178.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.553 HG12 ' O ' ' A' ' 53' ' ' THR . 16.1 mm -58.51 -47.99 86.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.276 171.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 55.5 t -60.45 -42.85 92.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.849 175.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -57.21 -39.99 76.56 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.083 0.468 . . . . 0.0 110.64 174.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 33.5 t -69.4 -35.82 76.16 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.941 177.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.413 ' HG2' ' O ' ' A' ' 57' ' ' ILE . 11.9 mmmm -61.29 -31.44 71.27 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.234 0.54 . . . . 0.0 111.535 177.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.498 HG21 ' HB1' ' A' ' 78' ' ' ALA . 20.0 m -113.11 20.82 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.943 -178.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.476 ' HA ' HG21 ' A' ' 70' ' ' ILE . 40.1 ttmt -73.84 123.17 23.68 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 120.895 0.379 . . . . 0.0 111.991 -178.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -57.74 86.66 0.01 OUTLIER Glycine 0 CA--C 1.529 0.928 0 CA-C-N 116.057 -0.52 . . . . 0.0 113.121 176.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 61.3 mttm 64.95 -78.33 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.275 0.63 . . . . 0.0 111.464 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 81.1 p -146.54 3.93 0.88 Allowed 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.447 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -69.82 151.04 46.2 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -173.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.503 ' HG3' HG12 ' A' ' 69' ' ' VAL . 1.8 ptm180 -73.13 -6.98 49.27 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.187 174.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.503 HG12 ' HG3' ' A' ' 68' ' ' ARG . 30.6 m -125.71 142.84 41.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-O 121.113 0.482 . . . . 0.0 112.221 -178.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.476 HG21 ' HA ' ' A' ' 63' ' ' LYS . 35.3 pt -113.3 151.49 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.595 176.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -86.9 169.83 12.16 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.075 0.464 . . . . 0.0 111.868 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.428 ' O ' ' HB3' ' A' ' 75' ' ' PHE . 86.9 t80 -52.07 -38.36 56.93 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -175.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.477 ' O ' ' HG3' ' A' ' 77' ' ' LYS . 33.7 tt0 -70.14 -41.36 73.99 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.445 -0.784 . . . . 0.0 110.765 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -64.78 -33.28 75.61 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.248 0.547 . . . . 0.0 110.341 177.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.428 ' HB3' ' O ' ' A' ' 72' ' ' TYR . 67.7 t80 -55.86 -46.35 78.25 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.987 171.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 23.0 mtmt -64.36 -39.37 93.74 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.886 0.374 . . . . 0.0 111.455 176.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.477 ' HG3' ' O ' ' A' ' 73' ' ' GLU . 60.7 mttm -60.18 -39.83 87.85 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.314 0.578 . . . . 0.0 110.363 176.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.498 ' HB1' HG21 ' A' ' 62' ' ' VAL . . . -63.53 -46.88 83.98 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.136 176.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 86.2 mt -58.61 -34.17 70.84 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.86 0.362 . . . . 0.0 111.228 175.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.441 ' HB3' ' O ' ' A' ' 77' ' ' LYS . 10.4 tp10 -55.47 -59.82 4.29 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.533 0.682 . . . . 0.0 110.838 176.012 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.567 ' O ' ' HG2' ' A' ' 85' ' ' LYS . 47.2 mt-10 -61.18 -47.98 83.65 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.409 178.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 69.5 mt -56.8 -33.75 67.0 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 178.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.36 -48.58 81.12 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 120.906 0.384 . . . . 0.0 110.86 175.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 31.0 p -72.72 -8.56 56.0 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 116.194 -0.457 . . . . 0.0 112.072 177.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.567 ' HG2' ' O ' ' A' ' 81' ' ' GLU . 73.1 mmtt -79.82 -51.58 8.97 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.133 0.492 . . . . 0.0 110.697 174.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 8.2 mmt180 -82.55 -58.07 3.07 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -178.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -86.59 56.88 4.2 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -170.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 66.3 mttm 61.81 175.85 0.12 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.357 0.599 . . . . 0.0 111.989 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -96.87 29.53 10.41 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.669 176.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -143.44 169.19 18.14 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 122.75 0.42 . . . . 0.0 110.861 -178.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 46.4 t 55.62 47.0 21.66 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.153 0.502 . . . . 0.0 111.529 177.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.427 ' HA ' ' HB1' ' A' ' 95' ' ' ALA . 22.0 pttp -64.19 -20.22 65.87 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -174.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -63.08 -59.53 4.67 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.296 0.57 . . . . 0.0 109.871 172.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -57.3 -43.75 83.49 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.452 175.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.427 ' HB1' ' HA ' ' A' ' 92' ' ' LYS . . . -58.51 -46.2 87.24 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.026 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -61.04 -53.79 52.81 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.944 0.402 . . . . 0.0 111.212 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -57.15 -37.9 72.75 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 120.808 0.337 . . . . 0.0 111.842 176.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.24 -49.82 68.2 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -179.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 12.5 tt -63.7 -39.94 87.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-O 121.111 0.481 . . . . 0.0 110.874 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 36.5 t -61.3 -39.33 90.07 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.037 0.446 . . . . 0.0 110.927 174.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -60.75 -39.35 88.39 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.677 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 93.1 mt -66.8 -36.02 81.41 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.706 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 49.9 t -83.15 -37.07 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -178.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -57.21 104.09 0.15 Allowed 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -174.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 94.81 13.56 52.83 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-N 116.154 -0.475 . . . . 0.0 113.678 174.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 46.2 tttp -86.3 161.35 18.79 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.973 0.416 . . . . 0.0 111.273 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -73.28 136.11 78.99 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.777 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.61 73.46 2.3 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.468 2.112 . . . . 0.0 112.015 175.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 62.65 93.18 0.05 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.781 -175.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 14.8 p30 -75.59 73.49 2.59 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 121.855 0.836 . . . . 0.0 111.973 -178.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 7.4 p -166.37 -36.81 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.718 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -63.03 122.26 27.03 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 121.251 -0.499 . . . . 0.0 112.951 176.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 50.0 t -88.74 110.66 21.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 O-C-N 122.471 -0.429 . . . . 0.0 111.584 -178.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 91.2 m -127.19 -49.48 1.44 Allowed 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.683 176.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 67.2 mttm 66.01 -78.45 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.612 176.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.45 157.69 36.61 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -172.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -133.49 108.02 8.39 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.482 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 89.6 m -87.23 -77.78 0.32 Allowed 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -174.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -133.74 166.78 23.83 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 120.466 -0.873 . . . . 0.0 114.109 -173.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -89.74 -24.79 29.32 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 121.552 -0.356 . . . . 0.0 113.484 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 63.56 15.26 8.72 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 177.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.414 ' O ' ' HB2' ' A' ' 123' ' ' ASP . 22.6 m -94.7 -167.07 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -177.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.414 ' HB2' ' O ' ' A' ' 122' ' ' VAL . 16.2 m-20 76.07 -33.08 0.21 Allowed 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 178.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 63.8 ttt180 -59.16 -55.36 36.03 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -91.58 38.48 0.98 Allowed 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -173.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.1 t -151.68 96.37 2.24 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.175 0.512 . . . . 0.0 112.312 179.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -54.25 142.94 24.5 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.601 174.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 79.8 p -58.34 106.2 0.36 Allowed 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.005 0.431 . . . . 0.0 111.246 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 96.2 p -160.1 145.7 15.29 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.885 -178.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? -90.1 -14.36 33.87 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.852 -176.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -109.92 -84.37 0.55 Allowed 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 -177.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 8.8 t -153.36 21.56 0.55 Allowed 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 121.007 0.432 . . . . 0.0 112.049 -175.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 148.09 166.88 13.06 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 121.128 -0.558 . . . . 0.0 112.611 -176.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 82.7 p -147.35 -168.99 3.2 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 122.764 -0.256 . . . . 0.0 110.785 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 12.2 m80 68.84 -77.27 0.05 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 122.738 0.415 . . . . 0.0 111.045 -177.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -141.99 130.97 23.11 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.912 0.387 . . . . 0.0 110.433 176.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -79.15 -51.89 8.92 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.312 0.577 . . . . 0.0 111.897 -173.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 85.2 mtt180 -120.05 112.89 19.7 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.497 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -82.64 179.83 7.66 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 120.473 0.178 . . . . 0.0 110.526 174.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -72.69 136.75 45.66 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 122.166 -0.334 . . . . 0.0 110.592 177.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -67.02 101.72 0.89 Allowed 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -174.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 32.0 t -91.19 -153.3 0.31 Allowed 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.159 175.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -75.6 48.12 2.2 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 120.968 -0.634 . . . . 0.0 113.602 177.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -89.76 113.69 25.27 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 122.401 -0.47 . . . . 0.0 110.533 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 78.78 -66.37 3.35 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.133 -177.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 12.1 ptmm? -58.73 -45.19 90.16 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.021 0.439 . . . . 0.0 111.26 175.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 68.1 142.01 0.08 OUTLIER Glycine 0 CA--C 1.529 0.958 0 N-CA-C 115.058 0.783 . . . . 0.0 115.058 175.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 49.6 mm -82.64 -50.86 15.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 169.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -98.48 105.38 17.51 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 166.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -128.04 -96.08 0.87 Allowed Glycine 0 CA--C 1.525 0.7 0 C-N-CA 120.466 -0.874 . . . . 0.0 115.019 -168.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 23.1 ttp180 -92.77 122.58 35.3 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -168.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -79.67 148.49 31.58 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 165.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -53.1 127.23 23.41 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -171.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 37.6 pt -120.63 175.75 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.328 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 78.6 mt -79.84 80.88 6.19 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.979 0.419 . . . . 0.0 111.752 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -74.06 53.81 0.5 Allowed 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.49 175.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -75.31 83.3 2.44 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.01 0.433 . . . . 0.0 111.827 -174.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 26.8 m -172.75 156.31 3.45 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.402 0.681 . . . . 0.0 110.489 177.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.403 ' O ' ' N ' ' A' ' 161' ' ' VAL . . . -54.97 117.98 9.17 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 120.322 -0.942 . . . . 0.0 110.953 169.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -59.05 82.7 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 -170.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.403 ' N ' ' O ' ' A' ' 159' ' ' GLY . 7.5 p -111.19 -40.03 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.953 171.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 36.8 t -176.37 -177.91 0.9 Allowed 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.133 178.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -68.0 -37.25 81.25 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.731 0.301 . . . . 0.0 111.363 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 85.4 t80 74.35 -55.18 0.66 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.864 0.865 . . . . 0.0 112.767 175.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -58.17 -40.3 81.09 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.03 0.443 . . . . 0.0 111.688 -176.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -105.95 122.18 45.62 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.525 177.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -58.87 123.27 15.92 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.002 0.429 . . . . 0.0 111.525 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -93.97 -155.44 31.76 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 121.221 -0.514 . . . . 0.0 113.543 -175.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 71.2 p -109.5 -166.71 1.12 Allowed 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 120.988 0.423 . . . . 0.0 111.488 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -79.23 18.03 0.73 Allowed 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 112.554 0.575 . . . . 0.0 112.554 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 37.9 t70 69.47 116.34 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.308 0.575 . . . . 0.0 111.627 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -125.3 87.79 2.76 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.122 0.487 . . . . 0.0 112.138 -177.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 49.7 mttp -86.18 -11.55 52.21 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.715 174.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 16.2 m 46.84 14.59 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 N-CA-C 115.441 1.645 . . . . 0.0 115.441 171.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.645 ' HD3' ' HG3' ' A' ' 178' ' ' GLU . 74.7 mmtt -76.46 66.66 2.53 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 121.681 -0.637 . . . . 0.0 110.886 176.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -133.09 -64.38 0.74 Allowed 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.256 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -104.1 17.92 23.11 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.378 0.609 . . . . 0.0 109.968 173.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.645 ' HG3' ' HD3' ' A' ' 175' ' ' LYS . 1.8 tm-20 . . . . . 0 CA--C 1.546 0.812 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.433 -171.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.4 mtt . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 120.684 0.278 . . . . 0.0 110.462 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -54.89 143.16 26.87 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -179.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 63.48 -90.94 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.451 178.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 39.0 t 176.93 -64.01 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 120.904 0.383 . . . . 0.0 111.935 -175.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.0 t -101.42 -174.87 2.7 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -173.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -83.47 123.77 30.04 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -175.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.7 tp -61.6 118.81 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-O 120.895 0.378 . . . . 0.0 110.925 173.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -49.49 -37.67 27.28 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -176.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.35 -29.92 60.87 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 121.417 -0.42 . . . . 0.0 113.74 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 30.9 tp -73.75 -48.38 32.18 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 122.324 -0.515 . . . . 0.0 111.031 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -65.87 -30.05 70.59 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.766 0.317 . . . . 0.0 110.642 176.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -59.27 -55.24 37.33 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.743 0.306 . . . . 0.0 110.444 174.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.7 m -57.94 -42.28 84.54 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.236 176.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.407 ' CD1' ' HE3' ' A' ' 30' ' ' MET . 86.6 t80 -55.73 -56.07 24.87 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.875 0.369 . . . . 0.0 111.064 176.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 57.3 ttt180 -56.19 -51.13 69.14 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.396 0.617 . . . . 0.0 110.87 177.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -52.91 -37.11 60.36 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 114.903 -1.044 . . . . 0.0 112.213 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -85.51 -32.51 22.17 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.697 176.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.76 -39.61 65.51 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -175.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.49 HG22 ' HB2' ' A' ' 25' ' ' ALA . 0.2 OUTLIER -103.74 7.45 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -178.927 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 60.0 t60 -35.46 -48.7 0.5 Allowed 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -174.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -138.27 22.44 3.06 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 120.286 -0.959 . . . . 0.0 113.604 -178.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.519 ' HB2' ' HB3' ' A' ' 25' ' ' ALA . 8.9 m-20 -121.55 118.7 29.6 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 116.886 0.343 . . . . 0.0 110.863 -176.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -46.02 -46.49 15.95 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 123.406 2.737 . . . . 0.0 114.102 -176.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -105.29 -34.09 7.99 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.703 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.519 ' HB3' ' HB2' ' A' ' 22' ' ' ASP . . . 36.99 -90.11 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -172.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 28.0 t 167.76 -45.36 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.825 0.85 . . . . 0.0 110.099 -174.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 88.28 -52.18 4.04 Favored Glycine 0 C--N 1.334 0.462 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.257 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 20.4 tp60 -91.26 -13.26 33.04 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 120.818 0.342 . . . . 0.0 111.376 178.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -128.03 143.99 51.09 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.788 175.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.407 ' HE3' ' CD1' ' A' ' 14' ' ' PHE . 49.2 ttm -115.24 143.39 45.32 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.285 0.564 . . . . 0.0 112.324 -175.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.44 HD21 ' HB2' ' A' ' 33' ' ' LYS . 0.8 OUTLIER -93.78 154.75 17.59 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.892 175.23 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -55.52 -26.64 45.92 Favored Glycine 0 CA--C 1.53 0.97 0 CA-C-N 116.122 -0.49 . . . . 0.0 114.104 -176.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.44 ' HB2' HD21 ' A' ' 31' ' ' ASN . 91.1 mttt -51.07 -60.86 2.65 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 122.026 0.917 . . . . 0.0 110.809 175.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 63.4 m-20 -73.1 -33.97 65.9 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 114.51 -1.223 . . . . 0.0 111.553 -174.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 41.1 t-105 -58.62 -45.21 89.7 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.054 0.454 . . . . 0.0 111.341 174.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.509 ' HA ' HG11 ' A' ' 55' ' ' VAL . . . -60.52 -47.99 83.74 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 120.974 0.416 . . . . 0.0 111.337 176.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -60.7 -37.32 81.26 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.492 176.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.3 tt -59.23 -45.42 91.18 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.336 178.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.656 ' SG ' ' HB ' ' A' ' 44' ' ' VAL . 44.4 t -54.33 -44.41 72.07 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.945 0.402 . . . . 0.0 111.038 175.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.828 ' HB3' ' HZ3' ' A' ' 40' ' ' LYS . 4.5 ttpm? -58.98 -54.64 44.8 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.746 176.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -65.55 -35.77 81.84 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -175.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.559 ' SG ' ' HB3' ' A' ' 102' ' ' LEU . 6.0 t -77.84 -9.87 59.27 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 120.799 0.333 . . . . 0.0 111.452 173.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm 69.05 26.95 5.48 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.197 0.599 . . . . 0.0 112.139 174.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.656 ' HB ' ' SG ' ' A' ' 39' ' ' CYS . 60.1 t -68.15 -35.77 72.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 121.054 0.454 . . . . 0.0 111.212 178.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.63 100.39 7.8 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.007 0.432 . . . . 0.0 111.683 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -99.91 -25.67 14.26 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.679 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 134.89 -78.99 0.33 Allowed Glycine 0 CA--C 1.529 0.921 0 C-N-CA 120.964 -0.636 . . . . 0.0 113.624 178.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -92.06 -7.32 49.06 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -174.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.4 t -102.35 -49.55 3.85 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.181 0.515 . . . . 0.0 110.041 173.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.423 HG12 HG12 ' A' ' 44' ' ' VAL . 99.1 t -139.65 130.94 33.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.948 176.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.447 ' O ' HG23 ' A' ' 55' ' ' VAL . 8.9 t -139.19 -177.86 5.1 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 116.766 -0.197 . . . . 0.0 110.68 173.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -46.19 -46.46 15.75 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 121.579 -0.344 . . . . 0.0 113.847 -177.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.513 ' O ' HG12 ' A' ' 57' ' ' ILE . 41.6 m -51.52 -54.81 23.4 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.035 0.445 . . . . 0.0 111.517 176.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -58.93 -34.56 71.86 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.392 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.509 HG11 ' HA ' ' A' ' 36' ' ' ALA . 65.5 t -60.21 -35.72 63.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.286 177.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -74.48 -38.5 62.9 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.562 0.696 . . . . 0.0 110.17 178.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.519 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 12.1 mm -61.41 -51.82 68.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.903 178.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 87.8 t -57.69 -41.87 80.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-O 120.912 0.387 . . . . 0.0 111.125 177.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -56.76 -42.26 79.06 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 120.915 0.388 . . . . 0.0 110.563 175.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 47.6 t -69.33 -36.76 77.26 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.392 177.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.519 ' HG2' ' O ' ' A' ' 57' ' ' ILE . 1.8 mmmp? -56.33 -35.67 67.86 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.875 0.369 . . . . 0.0 111.261 178.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.48 HG22 ' HB2' ' A' ' 78' ' ' ALA . 22.4 m -107.42 -2.7 10.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -177.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -70.74 101.5 2.1 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.024 0.44 . . . . 0.0 112.142 -178.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -133.98 -146.9 5.55 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-N 116.216 -0.447 . . . . 0.0 113.285 177.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 62.1 mttp 53.37 -103.05 0.15 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.842 0.457 . . . . 0.0 112.031 -176.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 88.0 p -109.0 -1.87 18.63 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.735 0.302 . . . . 0.0 110.899 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 66.0 -168.89 0.2 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.641 -177.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 20.3 tpp180 73.06 -51.56 0.71 Allowed 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.375 0.607 . . . . 0.0 111.034 -176.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 12.6 m -132.51 149.07 31.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.862 -178.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 37.5 pt -113.13 140.6 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-O 120.668 0.271 . . . . 0.0 111.113 177.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -85.37 177.73 7.7 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.9 -0.5 . . . . 0.0 111.341 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -55.1 -37.05 66.35 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -177.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.548 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 42.5 mt-10 -61.08 -53.34 58.34 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.189 0.519 . . . . 0.0 111.497 177.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -69.43 -20.77 63.77 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.243 0.544 . . . . 0.0 110.791 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -69.84 -54.87 11.56 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.959 173.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.548 ' HE2' ' HA ' ' A' ' 73' ' ' GLU . 63.8 pttt -62.54 -30.4 71.27 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.091 0.472 . . . . 0.0 110.533 177.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -64.42 -40.56 96.0 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.851 173.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.48 ' HB2' HG22 ' A' ' 62' ' ' VAL . . . -67.73 -38.73 83.95 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.03 0.443 . . . . 0.0 111.374 175.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 80.7 mt -59.98 -41.09 91.23 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.103 176.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -60.29 -42.49 95.58 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 120.664 0.269 . . . . 0.0 111.021 176.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -54.14 -62.81 1.42 Allowed 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.041 0.448 . . . . 0.0 110.769 174.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.507 HD12 HG13 ' A' ' 44' ' ' VAL . 90.5 mt -52.43 -43.98 65.18 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.434 178.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.13 -54.33 47.17 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.85 -0.613 . . . . 0.0 112.21 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.457 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 63.4 p -64.18 -20.55 66.09 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -177.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -96.72 -23.1 16.59 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 65.5 mtp85 -97.1 -50.63 4.52 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 121.797 -0.564 . . . . 0.0 111.744 175.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -86.75 31.45 0.69 Allowed 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.029 0.442 . . . . 0.0 111.331 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.457 ' HB3' ' O ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -71.63 172.55 9.47 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -177.857 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 78.62 24.36 62.85 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 121.063 -0.589 . . . . 0.0 113.183 -178.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -168.86 -168.75 0.9 Allowed 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 120.826 0.346 . . . . 0.0 111.155 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 65.8 m -56.07 120.72 7.94 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -177.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -55.96 -33.21 64.56 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.321 175.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -54.76 -56.11 22.8 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.204 0.526 . . . . 0.0 110.97 174.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -63.91 -29.75 70.9 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.537 -178.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.53 -57.44 12.67 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.961 0.41 . . . . 0.0 111.017 176.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.521 ' O ' HG23 ' A' ' 99' ' ' ILE . 80.8 t80 -64.94 -35.99 82.95 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.218 0.532 . . . . 0.0 110.791 177.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -55.08 -47.5 74.8 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.461 0.648 . . . . 0.0 111.052 176.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -71.78 -42.08 67.57 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.518 -177.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.521 HG23 ' O ' ' A' ' 96' ' ' PHE . 7.3 tp -61.62 -34.02 60.01 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 CA-C-O 121.351 0.596 . . . . 0.0 110.214 178.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 35.8 t -64.67 -42.71 95.19 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.946 173.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -55.41 -35.12 65.01 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.123 0.487 . . . . 0.0 111.846 176.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.559 ' HB3' ' SG ' ' A' ' 42' ' ' CYS . 97.5 mt -73.29 -48.02 37.97 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 49.1 t -86.67 -53.59 9.93 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -173.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.22 127.39 24.27 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -171.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.59 -39.32 3.1 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-N 116.035 -0.529 . . . . 0.0 113.841 176.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 58.9 tttp -63.05 162.19 11.94 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-O 121.504 0.668 . . . . 0.0 112.799 -174.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.466 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 0.3 OUTLIER -124.48 161.94 45.2 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.679 175.019 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.466 ' HD2' ' HB2' ' A' ' 107' ' ' GLU . 19.0 Cg_endo -58.17 155.69 33.33 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.515 2.143 . . . . 0.0 112.922 176.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -54.74 98.64 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -179.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.495 ' N ' HD21 ' A' ' 110' ' ' ASN . 0.8 OUTLIER 70.01 103.98 0.06 Allowed 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.556 0.693 . . . . 0.0 112.757 175.47 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.9 t -70.31 -25.96 28.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.814 176.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 65.21 -134.65 36.63 Favored Glycine 0 CA--C 1.525 0.659 0 CA-C-N 116.129 -0.487 . . . . 0.0 113.124 177.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 6.3 p -65.84 109.94 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-O 121.384 0.611 . . . . 0.0 111.444 177.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 62.1 p -66.91 116.43 7.76 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.372 -176.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 52.4 mttp -98.03 107.06 19.45 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.256 179.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -87.71 108.36 19.07 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -172.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.562 ' HD3' ' O ' ' A' ' 117' ' ' LYS . 7.8 tmtm? -92.97 -19.14 21.91 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.453 175.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 69.6 p -48.98 -57.57 6.29 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -176.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -77.95 48.19 2.96 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 121.253 -0.498 . . . . 0.0 113.425 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -112.06 26.6 11.19 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 121.355 -0.45 . . . . 0.0 113.018 177.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.499 ' O ' HG23 ' A' ' 122' ' ' VAL . . . 67.7 -6.59 0.67 Allowed 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 176.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 121' ' ' ALA . 2.9 m 53.76 156.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 C-N-CA 124.489 1.116 . . . . 0.0 113.53 -178.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -138.35 132.47 31.58 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.846 -0.534 . . . . 0.0 112.067 -177.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.62 57.83 3.93 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.568 0.699 . . . . 0.0 111.309 176.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.3 pp -77.34 21.69 0.25 Allowed 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -176.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 62.7 p -74.62 102.27 4.51 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.801 0.334 . . . . 0.0 110.79 176.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -53.74 132.78 41.74 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 121.114 0.483 . . . . 0.0 111.965 178.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.2 t -73.65 75.74 1.52 Allowed 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.362 0.601 . . . . 0.0 111.798 178.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.472 ' HB3' ' HD2' ' A' ' 131' ' ' TYR . 66.9 m -63.68 -52.37 60.96 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.871 -179.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.43 ' HB3' ' OG ' ' A' ' 134' ' ' SER . 9.8 mtp180 68.91 -15.18 0.26 Allowed 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 174.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.472 ' HD2' ' HB3' ' A' ' 129' ' ' SER . 98.7 m-85 -45.01 122.01 3.09 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -177.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 32.1 p 70.19 -33.29 0.26 Allowed 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.446 1.099 . . . . 0.0 113.093 178.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -67.36 -25.69 73.64 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.654 176.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.487 ' O ' ' HB2' ' A' ' 135' ' ' HIS . 81.9 p -133.13 52.53 2.08 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 122.604 0.362 . . . . 0.0 110.658 175.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.487 ' HB2' ' O ' ' A' ' 134' ' ' SER . 82.8 m-70 71.72 -168.36 0.14 Allowed 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.219 0.533 . . . . 0.0 111.725 -175.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -82.13 107.84 15.14 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.527 178.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -70.84 65.51 0.34 Allowed 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.477 0.656 . . . . 0.0 110.366 174.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -92.97 -81.58 0.35 Allowed 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.902 -171.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 58.33 96.11 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.151 0.581 . . . . 0.0 112.313 177.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -101.51 -63.76 1.11 Allowed 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 121.133 0.492 . . . . 0.0 111.745 -176.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.616 ' HG2' ' HG ' ' A' ' 142' ' ' SER . 33.0 tt0 62.01 -83.07 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.726 -174.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.616 ' HG ' ' HG2' ' A' ' 141' ' ' GLU . 72.7 p 179.27 -37.52 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 120.843 0.354 . . . . 0.0 111.56 -174.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -57.35 134.71 52.22 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-N 116.354 -0.385 . . . . 0.0 114.039 -177.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.417 ' HE2' ' HB3' ' A' ' 144' ' ' LYS . 38.6 mtpt 63.86 32.74 13.14 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 178.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -71.69 73.22 0.81 Allowed Glycine 0 CA--C 1.532 1.121 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.629 174.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm 62.68 -73.77 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.719 0.808 . . . . 0.0 112.35 -175.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 72.74 -166.22 54.33 Favored Glycine 0 CA--C 1.529 0.906 0 C-N-CA 121.366 -0.445 . . . . 0.0 113.249 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.426 HD11 ' N ' ' A' ' 148' ' ' ILE . 2.8 mp 59.76 122.03 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 CA-C-O 121.391 0.615 . . . . 0.0 112.177 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -80.46 94.58 6.23 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 122.05 -0.406 . . . . 0.0 111.478 179.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 61.85 -139.89 46.77 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 121.256 -0.497 . . . . 0.0 112.697 -178.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 47.0 mtt180 59.42 30.08 19.72 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 174.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -87.53 173.86 8.83 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.176 0.512 . . . . 0.0 111.925 -176.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -65.04 115.04 5.02 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 -176.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 67.1 mt -76.99 131.43 34.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 170.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.474 HD12 ' N ' ' A' ' 155' ' ' LEU . 5.5 mp -83.2 40.27 0.7 Allowed 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -173.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 63.22 -72.21 0.05 Allowed 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -61.18 85.64 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.254 0.549 . . . . 0.0 111.795 -178.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 57.3 p -94.11 -11.15 31.14 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.703 178.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 102.87 -107.56 3.11 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 121.263 -0.494 . . . . 0.0 113.044 178.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 81.1 t80 66.96 156.18 0.11 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.148 0.579 . . . . 0.0 112.058 178.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 57.1 t -56.08 96.43 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 121.366 0.603 . . . . 0.0 111.225 177.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 68.1 m -112.56 25.33 11.58 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.004 -175.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -55.25 -35.48 65.02 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.338 0.589 . . . . 0.0 111.313 174.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -98.92 10.58 41.09 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.429 176.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.492 ' HG3' ' OH ' ' A' ' 170' ' ' TYR . 75.5 mmtt 67.26 123.07 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.438 0.695 . . . . 0.0 112.362 -177.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -82.87 133.67 35.12 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 120.808 0.337 . . . . 0.0 111.137 178.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 68.81 -4.71 1.13 Allowed 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 176.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 54.87 37.57 62.57 Favored Glycine 0 CA--C 1.531 1.077 0 N-CA-C 114.418 0.527 . . . . 0.0 114.418 177.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 86.9 m -76.74 85.97 3.36 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.279 0.561 . . . . 0.0 111.799 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . 0.492 ' OH ' ' HG3' ' A' ' 165' ' ' LYS . 65.1 m-85 -107.96 -9.22 15.72 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.677 172.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 31.6 t70 56.74 71.64 0.56 Allowed 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.145 -177.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -129.72 16.11 5.86 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.613 0.72 . . . . 0.0 109.944 172.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 46.5 mttm -91.31 25.46 2.55 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.608 -171.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 14.6 p -62.52 -24.52 35.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -176.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -66.59 83.64 0.1 Allowed 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.485 0.659 . . . . 0.0 111.915 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -96.48 -27.16 15.01 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.974 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 85.2 mt -64.56 -53.34 49.35 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -172.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.526 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -176.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.0 mmt . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 120.574 0.226 . . . . 0.0 111.136 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.41 -63.17 1.16 Allowed 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -176.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 55.04 -152.82 0.34 Allowed 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.071 -177.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 67.6 m -63.02 88.94 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.098 0.475 . . . . 0.0 110.123 171.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 71.1 p -58.24 116.33 3.51 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 113.415 0.895 . . . . 0.0 113.415 -172.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -129.36 163.31 26.04 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.517 173.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.504 ' HB ' ' HB2' ' A' ' 10' ' ' LEU . 42.6 mm -86.78 -10.38 11.12 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 CA-C-O 120.629 0.252 . . . . 0.0 111.512 -178.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 72.37 -58.93 0.58 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.463 0.705 . . . . 0.0 110.812 -175.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -63.79 -16.73 59.61 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 120.955 -0.641 . . . . 0.0 112.393 172.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.504 ' HB2' ' HB ' ' A' ' 7' ' ' ILE . 53.7 tp -70.95 -54.7 10.41 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 122.693 -0.298 . . . . 0.0 111.198 178.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.453 ' HG3' ' N ' ' A' ' 12' ' ' GLU . 7.7 pt-20 -61.33 -42.22 98.32 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.788 0.328 . . . . 0.0 110.82 177.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.453 ' N ' ' HG3' ' A' ' 11' ' ' GLU . 1.7 tm-20 -64.5 -34.24 77.75 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-O 120.962 0.411 . . . . 0.0 110.921 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.543 ' HG ' HG11 ' A' ' 103' ' ' VAL . 23.2 t -72.4 -44.12 62.93 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 120.744 0.307 . . . . 0.0 111.143 176.227 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -56.1 -50.5 70.87 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.141 0.496 . . . . 0.0 110.067 175.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.491 ' O ' HG12 ' A' ' 19' ' ' ILE . 11.2 ttt85 -53.55 -43.04 68.13 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.706 172.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 9.6 tppt? -54.0 -46.21 71.68 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.053 0.454 . . . . 0.0 111.581 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -79.93 -33.63 39.53 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 177.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.13 -38.41 91.08 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.893 0.377 . . . . 0.0 111.781 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.579 HD11 ' HD2' ' A' ' 115' ' ' LYS . 23.8 pt -83.26 -7.86 11.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 121.016 0.436 . . . . 0.0 111.689 178.178 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -64.69 86.7 0.05 Allowed 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.295 0.569 . . . . 0.0 110.748 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 142.02 -40.25 1.31 Allowed Glycine 0 CA--C 1.524 0.613 0 CA-C-N 115.685 -0.688 . . . . 0.0 112.048 -178.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -128.63 111.39 19.09 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-O 120.727 0.298 . . . . 0.0 110.806 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.46 -0.19 9.83 Favored 'Trans proline' 0 CA--C 1.546 1.079 0 C-N-CA 122.5 2.133 . . . . 0.0 114.425 -176.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.417 ' HE2' ' HB2' ' A' ' 24' ' ' LYS . 2.8 mppt? -100.35 -28.38 12.98 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 121.855 -0.528 . . . . 0.0 111.04 178.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.69 134.96 55.17 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 43.1 m -65.54 -35.21 80.19 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.73 178.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.07 45.88 2.52 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-N 116.203 -0.453 . . . . 0.0 113.81 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -103.56 -16.32 15.56 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 122.374 -0.486 . . . . 0.0 111.326 179.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -136.56 154.23 50.76 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.008 -174.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 49.1 ttm -143.6 143.59 31.56 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 120.92 0.39 . . . . 0.0 112.003 -174.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 23.5 p30 -90.09 166.02 13.66 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.063 0.459 . . . . 0.0 111.52 177.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.42 -20.31 61.0 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 121.251 -0.499 . . . . 0.0 113.236 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.1 mmtm -69.07 -55.38 10.95 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.729 0.3 . . . . 0.0 111.619 177.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -65.67 -34.78 79.02 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.156 176.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 41.2 t-105 -62.45 -48.28 80.34 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 122.602 0.361 . . . . 0.0 111.597 175.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.46 -46.48 89.94 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.117 0.484 . . . . 0.0 111.112 177.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 57.6 tttp -64.46 -35.03 79.62 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.975 178.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.3 tt -59.16 -45.06 91.98 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.311 175.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 73.9 m -60.08 -46.01 91.0 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.407 177.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -60.33 -52.43 65.3 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.578 0.228 . . . . 0.0 111.586 177.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -53.66 -41.68 67.09 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.102 0.477 . . . . 0.0 111.012 177.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.706 ' SG ' ' HA ' ' A' ' 103' ' ' VAL . 58.7 m -89.73 1.09 56.52 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.983 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp 55.56 33.25 20.74 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 122.88 0.472 . . . . 0.0 112.104 177.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.445 ' HA ' ' NH1' ' A' ' 86' ' ' ARG . 55.5 t -72.69 -29.52 30.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.735 178.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -97.36 102.54 14.33 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.815 0.341 . . . . 0.0 111.778 -179.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -57.59 -50.46 73.05 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.484 0.659 . . . . 0.0 112.194 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.02 -16.72 60.62 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 -166.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.743 ' HZ2' ' HB3' ' A' ' 48' ' ' LYS . 6.8 ttpm? -96.44 -64.09 1.08 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.239 0.616 . . . . 0.0 110.618 176.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 45.6 p -95.75 -66.53 0.9 Allowed 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.692 177.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 52.3 t -82.92 98.9 5.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 170.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 80.9 p -89.65 -84.54 0.22 Allowed 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -169.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -152.89 -39.05 0.03 OUTLIER Glycine 0 C--O 1.236 0.229 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.638 ' O ' HG13 ' A' ' 57' ' ' ILE . 26.9 p -48.95 -53.96 17.58 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.012 0.434 . . . . 0.0 109.911 172.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.469 ' O ' HG23 ' A' ' 58' ' ' VAL . 6.2 m-20 -48.43 -49.17 36.25 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.231 -175.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.3 t -60.5 -40.08 83.21 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.277 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -75.35 -43.74 48.94 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.582 0.706 . . . . 0.0 110.196 -176.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.638 HG13 ' O ' ' A' ' 53' ' ' THR . 8.0 mt -62.49 -45.24 99.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.117 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 54' ' ' ASP . 79.4 t -59.66 -41.88 86.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-O 120.554 0.216 . . . . 0.0 111.183 176.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.415 ' O ' ' HG3' ' A' ' 63' ' ' LYS . 76.1 t80 -55.2 -40.93 71.35 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.898 0.38 . . . . 0.0 111.5 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 51.6 p -80.77 -34.13 34.44 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.206 0.527 . . . . 0.0 110.998 177.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 55.3 tttp -65.81 -31.3 72.19 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.234 -174.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.7 m -88.33 -3.7 9.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.565 ' HD3' ' O ' ' A' ' 66' ' ' SER . 96.7 mttt -72.12 163.28 28.18 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -178.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -105.07 -98.92 2.57 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.981 176.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -80.08 75.46 6.84 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 122.44 -0.447 . . . . 0.0 111.132 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.565 ' O ' ' HD3' ' A' ' 63' ' ' LYS . 55.0 m 59.76 -79.09 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 122.334 0.254 . . . . 0.0 110.819 -175.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 64.28 129.3 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 114.09 1.144 . . . . 0.0 114.09 173.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.2 ptm85 -81.95 -21.67 37.1 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.255 173.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 28.3 m -136.41 151.72 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.076 -178.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 39.4 pt -99.6 161.46 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-O 120.589 0.233 . . . . 0.0 110.776 176.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -110.79 166.97 10.59 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.09 0.471 . . . . 0.0 111.49 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -46.46 -36.79 6.96 Favored 'General case' 0 CA--C 1.554 1.133 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -177.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -73.3 -36.67 66.32 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 121.619 -0.676 . . . . 0.0 112.029 -178.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -72.28 -29.91 64.33 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.356 0.598 . . . . 0.0 109.981 174.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -58.64 -44.31 90.04 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.587 176.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -47.7 -61.05 2.13 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.162 0.506 . . . . 0.0 111.604 174.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -64.88 -29.38 70.33 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.309 -176.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.26 -49.86 75.38 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.25 0.548 . . . . 0.0 110.98 173.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 62.2 mt -64.5 -41.7 96.28 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.486 176.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.502 ' O ' HG22 ' A' ' 84' ' ' THR . 31.8 tt0 -60.33 -40.74 91.7 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.54 -178.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -62.31 -59.2 5.35 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 120.85 0.357 . . . . 0.0 110.347 177.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 90.4 mt -57.03 -29.52 63.44 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.974 0.416 . . . . 0.0 111.394 178.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.41 -39.34 90.36 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.648 174.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.502 HG22 ' O ' ' A' ' 80' ' ' GLU . 8.6 p -68.63 -34.56 75.95 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 121.066 0.46 . . . . 0.0 110.986 178.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -69.53 -36.26 76.22 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.71 175.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.445 ' NH1' ' HA ' ' A' ' 44' ' ' VAL . 3.3 tpt180 -85.58 -62.24 1.57 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.341 0.591 . . . . 0.0 111.494 -177.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -96.67 93.44 6.73 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.387 -176.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -92.12 27.92 2.03 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 121.231 0.538 . . . . 0.0 110.653 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -60.03 -78.73 0.13 Allowed Glycine 0 CA--C 1.529 0.921 0 CA-C-N 116.028 -0.533 . . . . 0.0 113.957 -175.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.9 pttp -162.79 -60.62 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -177.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 54.7 m -91.32 132.9 35.86 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -173.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -64.95 -34.92 79.57 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.031 0.443 . . . . 0.0 110.718 176.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -57.2 -52.92 63.37 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.238 0.542 . . . . 0.0 110.484 171.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -55.73 -46.26 77.82 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.287 177.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.48 -48.94 79.13 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.97 0.414 . . . . 0.0 111.274 177.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -65.49 -36.54 84.15 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.022 178.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.463 ' O ' ' HG3' ' A' ' 101' ' ' GLN . 23.6 t70 -57.02 -62.18 1.93 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.391 0.615 . . . . 0.0 110.964 176.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -53.47 -46.85 70.09 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.607 -178.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.458 ' O ' HG21 ' A' ' 103' ' ' VAL . 16.7 tt -66.53 -38.45 81.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 O-C-N 122.056 -0.403 . . . . 0.0 111.232 -179.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 93.5 m -64.46 -35.96 82.62 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.783 0.325 . . . . 0.0 111.043 176.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.463 ' HG3' ' O ' ' A' ' 97' ' ' ASP . 88.1 mt-30 -63.69 -31.87 73.18 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 120.985 0.422 . . . . 0.0 111.09 176.014 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.9 mt -77.7 -9.62 59.09 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.918 177.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.706 ' HA ' ' SG ' ' A' ' 42' ' ' CYS . 69.4 t -108.79 -43.79 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -177.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -50.03 87.37 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 -170.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 48.1 65.27 2.58 Favored Glycine 0 CA--C 1.531 1.035 0 N-CA-C 115.084 0.794 . . . . 0.0 115.084 170.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm -79.22 -82.33 0.1 Allowed 'General case' 0 N--CA 1.471 0.612 0 O-C-N 122.273 -0.545 . . . . 0.0 111.845 178.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.514 ' N ' ' HD3' ' A' ' 108' ' ' PRO . 10.9 pt-20 -149.65 32.38 0.07 OUTLIER Pre-proline 0 CA--C 1.554 1.128 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.514 ' HD3' ' N ' ' A' ' 107' ' ' GLU . 71.7 Cg_endo -76.32 149.75 31.87 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.001 1.801 . . . . 0.0 113.424 -173.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 72.83 -54.83 0.69 Allowed 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.468 HD21 HG22 ' A' ' 111' ' ' VAL . 8.2 t30 68.0 166.26 0.24 Allowed 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.111 0.564 . . . . 0.0 111.07 -176.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.468 HG22 HD21 ' A' ' 110' ' ' ASN . 60.8 t 60.12 88.12 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-O 121.382 0.611 . . . . 0.0 110.258 -172.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -68.92 77.68 0.28 Allowed Glycine 0 CA--C 1.527 0.782 0 CA-C-N 115.85 -0.613 . . . . 0.0 114.393 -172.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 30.9 m -70.17 130.21 34.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 CA-C-O 121.022 0.439 . . . . 0.0 110.707 172.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 77.3 p -62.57 161.76 11.55 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.223 0.535 . . . . 0.0 112.443 -175.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.579 ' HD2' HD11 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -147.2 153.92 40.43 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.038 0.447 . . . . 0.0 111.714 -177.961 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.408 ' N ' ' HG3' ' A' ' 115' ' ' LYS . . . -65.99 152.89 43.6 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 178.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -60.7 142.81 55.4 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.196 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 90.0 m -75.31 134.4 41.06 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.069 175.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 146.75 -170.18 27.77 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 121.042 -0.599 . . . . 0.0 113.028 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 115.93 -51.78 0.7 Allowed Glycine 0 CA--C 1.527 0.806 0 C-N-CA 121.467 -0.397 . . . . 0.0 113.074 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 66.34 177.73 0.22 Allowed 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 121.108 0.48 . . . . 0.0 112.168 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 33.1 m -87.83 135.77 24.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.426 177.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -101.21 -38.72 7.98 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -177.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 53.7 ttt180 -72.76 83.08 1.17 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.714 0.769 . . . . 0.0 112.647 -173.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 90.7 mt -131.37 18.9 4.83 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.188 168.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 71.3 p -92.35 13.18 20.16 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.857 -176.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -74.51 48.13 0.33 Allowed 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 121.173 0.511 . . . . 0.0 111.011 174.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 78.0 p -89.97 -10.41 45.11 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.249 -0.432 . . . . 0.0 112.13 -175.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 38.8 m -66.93 86.81 0.13 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.032 0.444 . . . . 0.0 110.853 177.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 -59.56 -28.76 67.41 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.344 -176.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -106.79 4.34 27.46 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 120.665 0.269 . . . . 0.0 111.304 -178.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 92.9 m 62.7 -69.5 0.06 Allowed 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 122.98 0.512 . . . . 0.0 111.277 -171.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -118.25 148.54 18.51 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 121.533 -0.365 . . . . 0.0 112.51 176.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 87.8 p -118.21 -60.81 1.75 Allowed 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.097 0.475 . . . . 0.0 110.895 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -78.35 -33.14 49.24 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.149 0.5 . . . . 0.0 110.081 173.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -104.13 134.45 47.37 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.186 172.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -70.55 -51.64 27.21 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.843 0.83 . . . . 0.0 110.943 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 17.7 ptt-85 -110.39 -178.68 3.56 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.669 -1.15 . . . . 0.0 110.914 -178.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -63.41 138.78 58.65 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 167.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -59.46 91.46 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.73 0 CA-C-O 121.207 0.527 . . . . 0.0 112.378 -173.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 59.96 -179.77 0.09 Allowed 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.259 -0.882 . . . . 0.0 113.083 178.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.401 ' O ' ' NZ ' ' A' ' 175' ' ' LYS . 23.0 t -126.53 -14.38 5.8 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.775 -179.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.92 123.73 1.69 Allowed Glycine 0 CA--C 1.528 0.871 0 C-N-CA 121.028 -0.606 . . . . 0.0 113.152 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.44 ' HD2' ' N ' ' A' ' 144' ' ' LYS . 12.0 mptt -83.06 83.19 7.93 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.248 0.547 . . . . 0.0 110.66 178.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 169.28 129.58 1.11 Allowed Glycine 0 CA--C 1.527 0.835 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.611 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -157.34 -27.88 0.09 Allowed 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -49.15 100.6 0.03 OUTLIER Glycine 0 CA--C 1.529 0.936 0 C-N-CA 121.511 -0.376 . . . . 0.0 113.653 -177.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 2.0 mp 71.83 -17.11 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.11 0 C-N-CA 123.399 0.679 . . . . 0.0 112.469 177.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -63.34 138.93 58.7 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -178.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -154.65 63.51 0.34 Allowed Glycine 0 CA--C 1.531 1.054 0 C-N-CA 120.897 -0.668 . . . . 0.0 113.702 -179.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 14.7 mtm-85 64.51 -82.96 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.149 0.579 . . . . 0.0 111.26 178.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -99.55 98.68 9.54 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 171.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -68.56 78.93 0.28 Allowed 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.221 0.534 . . . . 0.0 111.553 -174.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 34.8 pt -106.73 -179.68 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.775 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 45.8 tp -89.73 -27.1 20.29 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.903 -177.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -73.16 85.59 1.37 Allowed 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -178.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 26.3 t70 55.22 -101.4 0.13 Allowed 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.801 172.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 56.5 m -166.92 -36.87 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.272 0.629 . . . . 0.0 109.925 -174.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 136.91 -111.04 0.82 Allowed Glycine 0 CA--C 1.527 0.841 0 C-N-CA 120.938 -0.648 . . . . 0.0 113.59 176.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 62.0 t80 67.46 -62.34 0.33 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.668 0.787 . . . . 0.0 111.467 -173.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.493 ' O ' ' HE2' ' A' ' 165' ' ' LYS . 33.9 m -61.18 -23.47 30.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 121.086 0.469 . . . . 0.0 111.026 174.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 37.7 t -114.79 173.67 6.36 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.067 172.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 73.61 -49.75 0.69 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.132 0.573 . . . . 0.0 111.949 -176.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -76.48 49.02 0.57 Allowed 'General case' 0 CA--C 1.545 0.773 0 CA-C-O 121.207 0.527 . . . . 0.0 111.2 175.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.493 ' HE2' ' O ' ' A' ' 161' ' ' VAL . 74.9 mmtt -104.9 179.91 4.13 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.081 0.467 . . . . 0.0 111.375 -178.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -75.91 128.49 35.19 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.624 174.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 61.75 18.1 9.36 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 120.959 0.409 . . . . 0.0 112.06 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.19 62.24 4.66 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 121.311 -0.471 . . . . 0.0 112.795 -179.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 9.7 t -93.64 25.96 3.29 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.938 0.399 . . . . 0.0 112.062 -177.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -59.36 -30.52 68.46 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 121.236 0.541 . . . . 0.0 110.737 174.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -138.48 139.09 38.66 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 172.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -61.97 159.46 14.17 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -175.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -56.62 111.85 1.12 Allowed 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.572 176.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 5.2 p -41.75 119.93 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-O 121.827 0.822 . . . . 0.0 112.969 -173.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.406 ' O ' ' HB2' ' A' ' 176' ' ' LYS . 29.1 pttt -51.37 146.18 7.41 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 114.803 -1.089 . . . . 0.0 113.001 -178.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . 0.406 ' HB2' ' O ' ' A' ' 175' ' ' LYS . 48.1 mmtm 75.18 -12.68 0.93 Allowed 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 177.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 60.9 tp -73.1 -52.52 13.95 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.901 -0.5 . . . . 0.0 111.38 176.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 . . . . . 0 N--CA 1.471 0.621 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.644 179.766 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ptm . . . . . 0 N--CA 1.493 1.714 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.88 174.39 15.58 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.727 0.299 . . . . 0.0 111.669 -178.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -148.42 -81.46 0.13 Allowed 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 120.824 0.345 . . . . 0.0 111.615 178.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 42.8 t -72.93 85.17 1.26 Allowed 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.201 0.524 . . . . 0.0 111.314 177.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.2 t -170.86 -4.79 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.983 179.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.3 t70 71.96 163.0 0.26 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.496 0.719 . . . . 0.0 111.785 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.4 ' O ' ' HB1' ' A' ' 8' ' ' ALA . 36.3 pt -86.71 -4.4 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.9 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.4 ' HB1' ' O ' ' A' ' 7' ' ' ILE . . . 74.81 -48.56 0.65 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.205 0.602 . . . . 0.0 111.424 -176.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.2 -22.89 45.29 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 121.445 -0.407 . . . . 0.0 113.091 175.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.676 HD22 ' SG ' ' A' ' 100' ' ' CYS . 56.6 tp -74.65 -43.1 56.99 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 122.477 -0.425 . . . . 0.0 110.602 176.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -59.26 -42.32 90.89 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.307 0.575 . . . . 0.0 110.26 175.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.498 ' HG2' ' HE2' ' A' ' 16' ' ' LYS . 34.1 tt0 -61.38 -55.31 32.96 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.141 174.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.8 t -58.39 -35.14 71.55 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.439 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -59.49 -46.44 88.81 Favored 'General case' 0 C--O 1.225 -0.231 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.859 177.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.514 ' O ' HG12 ' A' ' 19' ' ' ILE . 97.8 mtt180 -60.48 -45.63 93.04 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.561 176.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.498 ' HE2' ' HG2' ' A' ' 12' ' ' GLU . 67.7 mttm -54.87 -37.72 66.6 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.891 0.377 . . . . 0.0 111.774 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -83.17 -36.56 24.6 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.599 174.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.03 -51.55 67.55 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -175.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.514 HG12 ' O ' ' A' ' 15' ' ' ARG . 29.1 pt -82.62 4.49 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 CA-C-O 121.056 0.455 . . . . 0.0 111.609 -178.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 39.5 t-80 -65.08 107.1 1.43 Allowed 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.903 177.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 115.51 -14.63 17.81 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 121.295 -0.478 . . . . 0.0 112.997 -177.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -154.68 118.1 2.53 Favored Pre-proline 0 CA--C 1.542 0.649 0 O-C-N 122.547 -0.384 . . . . 0.0 110.577 176.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -66.09 -14.55 44.91 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.459 2.106 . . . . 0.0 113.992 -174.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -100.07 -52.85 3.3 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 120.74 0.305 . . . . 0.0 110.923 178.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.472 ' HB1' HG22 ' A' ' 19' ' ' ILE . . . 33.56 -115.14 0.07 Allowed 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.897 -175.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 63.8 m -157.93 -56.5 0.07 Allowed 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 122.768 0.427 . . . . 0.0 110.674 176.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.43 7.7 8.11 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 120.635 -0.793 . . . . 0.0 114.687 173.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -136.65 7.35 3.01 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 117.533 0.666 . . . . 0.0 111.531 178.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.431 ' HB3' HG22 ' A' ' 69' ' ' VAL . 33.9 mp0 -122.4 148.21 45.37 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 122.893 0.477 . . . . 0.0 111.536 -175.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.515 ' SD ' ' HB2' ' A' ' 34' ' ' ASN . 39.0 tpp -137.74 131.68 31.67 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.974 178.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 22.1 p30 -92.14 163.3 13.99 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.77 0.319 . . . . 0.0 111.59 178.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -55.88 -29.04 54.33 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 121.163 -0.542 . . . . 0.0 113.111 178.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -57.8 -61.35 2.59 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.072 0.463 . . . . 0.0 111.886 176.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.515 ' HB2' ' SD ' ' A' ' 30' ' ' MET . 24.7 m-20 -68.71 -34.37 75.53 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.358 -179.068 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.438 ' CD1' ' HB2' ' A' ' 59' ' ' PHE . 56.1 t-105 -60.11 -49.38 77.89 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.976 0.417 . . . . 0.0 111.631 178.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.92 -43.7 94.73 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 121.032 0.444 . . . . 0.0 111.228 177.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -66.57 -38.72 87.67 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.003 177.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.2 tt -56.38 -55.01 38.88 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.282 0.563 . . . . 0.0 110.592 -178.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 26.7 p -66.81 -40.88 88.22 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.782 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 58.0 tttp -76.35 -20.61 57.05 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-O 121.008 0.432 . . . . 0.0 111.715 -177.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -80.29 -41.72 24.43 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.326 0.584 . . . . 0.0 110.478 177.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.632 ' SG ' ' HA ' ' A' ' 103' ' ' VAL . 33.9 m -89.98 -6.83 55.23 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.689 -178.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.5 55.67 2.76 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.634 0.731 . . . . 0.0 111.418 -178.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 56.2 t -92.54 -36.77 7.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.476 173.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.467 ' HA ' HG21 ' A' ' 50' ' ' VAL . . . -107.18 78.44 1.22 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.221 0.534 . . . . 0.0 111.108 177.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.8 p-10 -152.66 4.03 0.35 Allowed 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.21 -174.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -79.79 47.04 3.22 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 121.094 -0.574 . . . . 0.0 113.534 -178.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt 50.53 21.53 0.88 Allowed 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 177.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 60.2 p -146.93 -63.44 0.29 Allowed 'General case' 0 N--CA 1.469 0.499 0 O-C-N 121.775 -0.578 . . . . 0.0 110.633 -176.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.467 HG21 ' HA ' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -48.24 -83.31 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.887 0 CA-C-N 115.221 -0.9 . . . . 0.0 112.514 174.039 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.51 ' O ' HG23 ' A' ' 55' ' ' VAL . 12.4 p 58.33 -174.94 0.08 Allowed 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.418 0.687 . . . . 0.0 112.455 177.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -56.79 -29.5 58.57 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 121.35 -0.452 . . . . 0.0 113.279 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.529 ' O ' HG13 ' A' ' 57' ' ' ILE . 83.7 m -58.01 -58.92 6.27 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 122.626 -0.338 . . . . 0.0 111.377 178.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -63.3 -39.04 93.46 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.616 -0.265 . . . . 0.0 110.927 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 51' ' ' THR . 74.5 t -48.3 -41.13 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 N-CA-C 112.249 0.462 . . . . 0.0 112.249 175.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -74.17 -38.21 63.74 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.01 0.433 . . . . 0.0 110.591 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.529 HG13 ' O ' ' A' ' 53' ' ' THR . 10.1 mt -62.06 -45.41 98.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.102 178.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.472 HG21 ' HG2' ' A' ' 81' ' ' GLU . 86.9 t -63.19 -49.69 82.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.89 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.438 ' HB2' ' CD1' ' A' ' 35' ' ' TRP . 77.2 t80 -58.11 -48.34 80.5 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.188 0.518 . . . . 0.0 110.853 -179.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 90.5 p -68.15 -30.19 69.26 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.146 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -64.58 -46.64 81.83 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.574 177.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.434 HG22 HG22 ' A' ' 70' ' ' ILE . 35.7 m -88.58 -13.77 9.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -178.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -74.71 138.91 43.08 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.92 0.39 . . . . 0.0 111.562 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -66.96 167.05 39.44 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.836 176.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -64.77 -47.97 76.21 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 122.531 -0.394 . . . . 0.0 111.921 -178.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.5 m -99.53 3.75 45.64 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 120.85 0.357 . . . . 0.0 111.584 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -80.26 135.29 36.21 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 120.947 0.403 . . . . 0.0 111.808 -178.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? -87.01 -20.01 27.85 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.057 0.456 . . . . 0.0 110.85 175.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.431 HG22 ' HB3' ' A' ' 29' ' ' GLU . 29.3 m -137.62 174.54 11.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.579 -176.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.434 HG22 HG22 ' A' ' 62' ' ' VAL . 36.4 pt -111.6 144.12 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.711 173.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -94.01 156.61 16.51 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 120.858 0.361 . . . . 0.0 111.777 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.473 ' O ' ' HB3' ' A' ' 75' ' ' PHE . 49.9 t80 -49.04 -39.86 28.95 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -173.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -60.94 -41.91 97.17 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 122.11 -0.369 . . . . 0.0 111.659 178.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -73.18 -28.1 62.02 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.213 0.53 . . . . 0.0 110.519 176.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.473 ' HB3' ' O ' ' A' ' 72' ' ' TYR . 85.3 t80 -58.99 -36.55 75.08 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.969 175.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -61.29 -43.41 98.93 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.462 0.172 . . . . 0.0 111.17 175.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 28.3 mtmm -64.07 -38.1 89.85 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.997 0.427 . . . . 0.0 110.947 175.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.71 -41.07 97.12 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.256 176.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 86.4 mt -64.09 -44.42 92.41 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.105 175.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -56.48 -45.99 80.67 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.173 0.511 . . . . 0.0 110.555 176.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.472 ' HG2' HG21 ' A' ' 58' ' ' VAL . 37.7 tp10 -55.45 -58.74 6.51 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.573 176.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 86.4 mt -62.68 -44.84 95.22 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -178.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.26 -44.27 92.41 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.659 ' HA ' ' HE3' ' A' ' 90' ' ' LYS . 40.1 p -64.54 -35.4 80.86 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -89.93 -20.08 23.77 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 112.991 0.738 . . . . 0.0 112.991 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 33.5 tpt85 -82.97 -53.6 5.71 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.689 0.757 . . . . 0.0 110.826 178.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -94.52 117.89 30.82 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.156 175.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -82.05 -62.64 1.57 Allowed 'General case' 0 CA--C 1.539 0.557 0 O-C-N 122.292 -0.255 . . . . 0.0 111.386 -177.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -82.16 94.53 1.69 Allowed Glycine 0 CA--C 1.528 0.901 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.463 176.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.659 ' HE3' ' HA ' ' A' ' 84' ' ' THR . 0.3 OUTLIER -157.51 171.7 19.88 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -174.725 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 46.7 t -110.53 179.45 4.07 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.182 169.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -59.95 -76.43 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 120.946 0.403 . . . . 0.0 111.841 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 -60.87 -36.21 78.58 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.882 -176.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -56.78 -47.4 80.23 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.829 0.347 . . . . 0.0 111.577 177.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.56 -40.31 73.43 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.868 0.366 . . . . 0.0 111.315 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -63.37 -47.33 82.52 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.907 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -56.38 -49.56 74.11 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.452 0.168 . . . . 0.0 111.063 172.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -53.62 -54.39 38.36 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 15.2 tt -62.33 -33.35 58.59 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-O 120.94 0.4 . . . . 0.0 111.435 -179.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . 0.676 ' SG ' HD22 ' A' ' 10' ' ' LEU . 97.2 m -68.6 -38.06 80.31 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.925 0.393 . . . . 0.0 111.083 176.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -67.53 -31.19 71.13 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.706 179.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 96.7 mt -60.86 -35.46 76.65 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.255 0.55 . . . . 0.0 110.774 176.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.632 ' HA ' ' SG ' ' A' ' 42' ' ' CYS . 19.3 t -87.69 -78.07 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.785 178.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 41.05 26.72 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 178.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 61.1 45.59 96.25 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 121.282 -0.485 . . . . 0.0 113.798 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.542 ' HG3' ' HG2' ' A' ' 107' ' ' GLU . 21.9 pttp -70.85 -40.75 72.18 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.754 0.649 . . . . 0.0 112.754 -177.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.542 ' HG2' ' HG3' ' A' ' 106' ' ' LYS . 14.7 pt-20 -167.88 50.44 0.19 Allowed Pre-proline 0 N--CA 1.477 0.884 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -177.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.483 ' HD3' ' N ' ' A' ' 107' ' ' GLU . 64.1 Cg_exo -42.87 120.86 2.01 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 123.225 2.617 . . . . 0.0 113.634 -174.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 69.41 -69.03 0.17 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.732 -172.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 177.61 116.59 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.716 174.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 18.3 m -113.59 1.77 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-O 121.077 0.465 . . . . 0.0 110.679 171.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 154.67 -125.44 1.7 Allowed Glycine 0 CA--C 1.527 0.797 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.75 -178.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 11.8 p -164.04 144.8 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 120.681 0.277 . . . . 0.0 110.989 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 5.9 t -75.4 127.26 32.73 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.213 0.53 . . . . 0.0 111.696 179.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -92.19 -8.33 45.81 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.296 -0.411 . . . . 0.0 112.09 -179.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -178.78 -25.76 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -63.56 107.82 1.23 Allowed 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.164 0.507 . . . . 0.0 111.859 -176.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 62.0 p -109.57 -177.03 3.17 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.398 179.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -131.13 -77.77 0.16 Allowed Glycine 0 CA--C 1.53 0.988 0 C-N-CA 120.894 -0.67 . . . . 0.0 113.591 -176.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -66.84 84.06 0.11 Allowed Glycine 0 CA--C 1.529 0.937 0 C-N-CA 121.215 -0.517 . . . . 0.0 113.435 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -73.33 -8.26 55.1 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 60.0 t 70.6 135.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.249 0.62 . . . . 0.0 112.181 -179.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -83.39 175.61 9.72 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-O 120.858 0.361 . . . . 0.0 110.842 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.594 ' HD3' ' H ' ' A' ' 124' ' ' ARG . 0.0 OUTLIER -113.65 -26.99 8.0 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -175.746 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 60.9 tp 65.44 133.77 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 176.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 67.7 p -119.83 -43.06 2.58 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -78.47 38.19 0.3 Allowed 'General case' 0 CA--C 1.547 0.835 0 CA-C-O 121.199 0.523 . . . . 0.0 112.372 -177.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.8 t -68.5 88.41 0.33 Allowed 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -179.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 34.0 t -108.41 -177.63 3.38 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.006 0.432 . . . . 0.0 111.495 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 71.6 mtp180 -80.02 -18.55 49.88 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.739 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -151.04 89.17 1.5 Allowed 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.193 0.521 . . . . 0.0 110.956 -179.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 41.0 p -83.5 70.09 10.18 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.271 0.557 . . . . 0.0 111.586 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -152.3 54.75 0.46 Allowed Glycine 0 CA--C 1.524 0.638 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.602 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 15.2 m -76.13 163.6 26.93 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.872 0.367 . . . . 0.0 111.955 -178.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 69.0 m-70 67.32 82.09 0.19 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.161 0.585 . . . . 0.0 111.132 -177.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.596 ' HD3' ' HG3' ' A' ' 141' ' ' GLU . 94.3 mttt -101.63 -58.19 1.93 Allowed 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.058 -176.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.701 ' HG3' ' HG3' ' A' ' 138' ' ' ARG . 9.3 tp10 60.62 -85.83 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.171 -172.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.701 ' HG3' ' HG3' ' A' ' 137' ' ' GLU . 51.7 mtt-85 -112.01 -92.55 0.47 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 122.953 0.501 . . . . 0.0 110.958 177.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 47.31 26.52 0.73 Allowed 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 172.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 46.34 31.17 1.18 Allowed 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 175.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.596 ' HG3' ' HD3' ' A' ' 136' ' ' LYS . 0.9 OUTLIER -61.43 123.69 18.53 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.055 0.455 . . . . 0.0 111.433 -176.068 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 47.0 t -165.0 -28.89 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.426 -177.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 97.89 19.48 24.2 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 121.216 -0.516 . . . . 0.0 113.198 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 61.2 mttm 62.56 -79.64 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -141.09 131.94 5.13 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 121.186 -0.531 . . . . 0.0 112.756 -177.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm -72.45 77.39 1.04 Allowed 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.247 0.546 . . . . 0.0 111.271 -178.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.447 ' O ' ' N ' ' A' ' 149' ' ' ALA . . . 145.37 -51.45 0.6 Allowed Glycine 0 CA--C 1.53 0.978 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.035 -178.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 12.2 tt 43.79 -71.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 N-CA-C 115.506 1.669 . . . . 0.0 115.506 175.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.447 ' N ' ' O ' ' A' ' 147' ' ' GLY . . . -113.77 111.06 21.16 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 121.558 -0.713 . . . . 0.0 112.834 -170.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -97.87 5.64 61.87 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 121.43 -0.414 . . . . 0.0 113.011 173.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -90.78 157.52 17.35 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.037 0.446 . . . . 0.0 111.787 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -66.51 -43.28 85.71 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.64 0.733 . . . . 0.0 110.0 171.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -138.29 132.95 32.45 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.946 174.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 9.5 tt -145.33 131.62 14.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-O 121.261 0.553 . . . . 0.0 111.696 -177.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 92.0 mt -88.34 64.09 7.42 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.092 0.472 . . . . 0.0 111.229 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -90.11 0.75 57.0 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.733 176.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 37.2 t70 76.01 -36.0 0.27 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.646 0.778 . . . . 0.0 112.132 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 56.5 m 57.1 39.51 29.02 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.978 0.418 . . . . 0.0 112.053 178.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -69.22 86.3 0.24 Allowed Glycine 0 CA--C 1.527 0.801 0 C-N-CA 121.172 -0.537 . . . . 0.0 112.859 176.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -65.59 162.69 17.72 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.741 0.305 . . . . 0.0 111.69 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 67.4 t 71.46 -57.8 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.183 0.593 . . . . 0.0 111.994 -177.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 91.7 p 52.5 33.73 13.94 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 177.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -95.37 41.89 1.09 Allowed 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 178.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -82.33 -0.52 46.1 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -177.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -88.69 -5.94 57.79 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -175.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -83.17 -39.61 20.8 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -172.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 61.37 102.07 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 121.113 0.482 . . . . 0.0 112.232 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -66.28 171.44 28.5 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 121.318 -0.468 . . . . 0.0 114.046 -178.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' THR . . . . . 0.414 ' O ' HG21 ' A' ' 169' ' ' THR . 12.3 m -72.76 2.59 6.38 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -177.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 66.7 t80 64.68 9.5 5.23 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 121.999 -0.438 . . . . 0.0 111.788 178.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 59.13 21.77 9.84 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 122.747 0.419 . . . . 0.0 111.82 179.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -53.93 118.52 4.06 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.689 0.625 . . . . 0.0 112.689 -176.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 64.6 mmtt -84.84 94.12 8.66 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 120.982 0.42 . . . . 0.0 111.812 177.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.408 ' O ' ' HB3' ' A' ' 175' ' ' LYS . 7.5 p -84.43 119.23 33.05 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.265 173.137 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.647 ' HB2' ' HZ3' ' A' ' 175' ' ' LYS . 5.0 ttmp? 71.71 90.17 0.09 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.482 0.713 . . . . 0.0 110.52 -168.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -91.47 1.12 57.35 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.555 -178.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 56.0 tp 68.87 111.13 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.033 0.533 . . . . 0.0 111.298 -177.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 . . . . . 0 CA--C 1.544 0.718 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.202 179.866 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptm . . . . . 0 N--CA 1.492 1.626 0 N-CA-C 111.438 0.162 . . . . 0.0 111.438 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 58.04 96.25 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 177.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -175.15 -86.83 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 122.473 0.309 . . . . 0.0 110.994 178.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.1 m -117.72 -3.63 11.25 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 121.142 0.496 . . . . 0.0 110.658 175.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 40.1 p -118.0 98.25 6.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.859 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -70.65 -24.31 62.68 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.493 -177.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.415 ' O ' ' HB1' ' A' ' 8' ' ' ALA . 26.3 pt -57.08 158.11 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.037 173.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.415 ' HB1' ' O ' ' A' ' 7' ' ' ILE . . . 71.26 -43.22 0.56 Allowed 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 120.792 0.329 . . . . 0.0 110.464 -166.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -73.82 -34.84 55.6 Favored Glycine 0 C--N 1.337 0.613 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 171.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.559 HD21 ' SG ' ' A' ' 100' ' ' CYS . 59.1 tp -62.66 -37.28 85.76 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.091 -0.555 . . . . 0.0 110.273 170.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -68.06 -40.92 82.67 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.821 176.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -54.07 -58.17 8.33 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.032 0.444 . . . . 0.0 110.577 173.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.6 m -59.83 -42.37 93.4 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.511 178.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 94.0 t80 -53.79 -46.75 71.13 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.059 176.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.526 ' O ' HG12 ' A' ' 19' ' ' ILE . 21.7 ttt180 -66.3 -46.19 77.78 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.224 178.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 39.4 mtpt -57.84 -27.06 62.85 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 116.301 -0.408 . . . . 0.0 112.067 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -86.34 -44.66 11.9 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.495 172.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.08 -43.69 74.15 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -177.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.526 HG12 ' O ' ' A' ' 15' ' ' ARG . 29.0 pt -101.05 14.91 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-O 120.976 0.417 . . . . 0.0 111.594 -178.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.413 ' CD2' ' HG2' ' A' ' 108' ' ' PRO . 27.4 t-80 -66.5 -33.31 75.4 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -175.133 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -135.54 22.9 3.47 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.838 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.455 ' CG ' ' HZ1' ' A' ' 33' ' ' LYS . 12.0 m-20 -138.3 101.6 8.29 Favored Pre-proline 0 CA--C 1.542 0.654 0 CA-C-O 120.871 0.367 . . . . 0.0 110.878 -177.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.21 -19.96 43.88 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 122.683 2.255 . . . . 0.0 113.955 -174.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 49.2 mmtm -100.6 6.6 44.18 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -178.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -81.5 138.46 35.47 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.13 0.49 . . . . 0.0 111.736 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 93.2 p -70.2 -60.43 2.29 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.437 0.637 . . . . 0.0 111.1 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 145.99 -26.73 1.75 Allowed Glycine 0 CA--C 1.522 0.48 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.245 -178.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -85.84 -15.55 41.53 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 111.752 0.278 . . . . 0.0 111.752 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.494 ' HB3' HG21 ' A' ' 69' ' ' VAL . 50.3 mt-10 -111.13 116.46 31.15 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.747 0.308 . . . . 0.0 111.375 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 48.1 ttm -107.22 139.49 41.59 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.179 0.514 . . . . 0.0 111.846 178.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.596 ' OD1' ' HB3' ' A' ' 33' ' ' LYS . 7.6 p30 -95.58 165.74 12.18 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.351 177.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.46 -30.22 73.81 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 121.562 -0.352 . . . . 0.0 113.842 -177.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.596 ' HB3' ' OD1' ' A' ' 31' ' ' ASN . 29.7 ttpt -58.39 -61.21 2.75 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.036 0.446 . . . . 0.0 111.565 177.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 64.2 m-20 -68.24 -31.96 71.82 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 122.281 -0.262 . . . . 0.0 111.57 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 32.2 t-105 -61.99 -38.89 90.31 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-O 120.953 0.406 . . . . 0.0 111.273 175.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.504 ' HA ' HG11 ' A' ' 55' ' ' VAL . . . -61.59 -48.85 79.07 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 120.984 0.421 . . . . 0.0 110.897 175.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.3 mtpp -67.6 -30.55 70.17 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.957 177.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.9 tt -56.9 -46.68 81.79 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.98 0.419 . . . . 0.0 110.169 177.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 79.0 m -64.32 -44.93 90.0 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.049 0.452 . . . . 0.0 111.623 176.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -68.17 -58.31 4.66 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -177.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.31 -23.84 64.51 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 178.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 86.0 m -95.86 -5.05 42.53 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 122.044 -0.41 . . . . 0.0 111.471 173.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt 62.41 28.94 17.1 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 173.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 43.2 t -78.79 -32.99 16.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.439 177.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.452 ' HA ' HG12 ' A' ' 50' ' ' VAL . . . -91.54 102.47 15.12 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.833 0.349 . . . . 0.0 111.9 -178.174 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -77.31 -44.99 27.68 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.699 0.762 . . . . 0.0 111.687 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.63 -37.63 3.73 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 -163.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.9 ttpm? -43.11 -56.16 3.52 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.66 0.784 . . . . 0.0 112.199 173.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 78.4 p -125.91 -0.85 7.25 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 120.878 0.37 . . . . 0.0 111.755 178.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.452 HG12 ' HA ' ' A' ' 45' ' ' ALA . 3.8 p -156.74 111.75 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-O 121.1 0.476 . . . . 0.0 111.868 -174.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.419 ' O ' HG22 ' A' ' 55' ' ' VAL . 68.6 p -106.23 -177.78 3.46 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.104 178.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -55.64 -38.46 71.97 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.531 175.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.515 ' O ' HG12 ' A' ' 57' ' ' ILE . 88.8 m -58.0 -49.94 75.11 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 122.703 -0.292 . . . . 0.0 110.627 176.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.425 ' O ' HG21 ' A' ' 58' ' ' VAL . 7.1 m-20 -53.76 -38.61 64.59 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.991 0.424 . . . . 0.0 111.266 175.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.504 HG11 ' HA ' ' A' ' 36' ' ' ALA . 95.9 t -59.67 -39.6 80.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.507 178.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -76.02 -34.04 59.67 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.454 0.645 . . . . 0.0 110.535 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.515 HG12 ' O ' ' A' ' 53' ' ' THR . 9.9 mm -59.05 -53.16 51.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.059 175.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.425 HG21 ' O ' ' A' ' 54' ' ' ASP . 56.5 t -61.12 -42.42 93.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.286 178.181 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -55.22 -40.63 71.05 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.147 0.499 . . . . 0.0 111.289 175.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 50.6 m -78.38 -29.23 47.22 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.387 178.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -69.33 -56.91 6.14 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.903 -178.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.9 m -65.0 -34.15 68.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -173.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.602 ' HZ2' ' HB3' ' A' ' 63' ' ' LYS . 0.1 OUTLIER -65.94 -21.87 66.46 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.91 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 64.22 25.56 69.81 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 121.27 -0.49 . . . . 0.0 113.056 -178.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.615 ' HZ2' ' HB3' ' A' ' 65' ' ' LYS . 9.7 mtpm? 68.22 167.74 0.26 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.187 0.595 . . . . 0.0 111.889 -176.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 65.5 m 72.47 -47.95 0.67 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.324 0.65 . . . . 0.0 112.335 -178.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.457 ' O ' ' HD3' ' A' ' 63' ' ' LYS . . . -74.72 107.72 7.01 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 122.22 -0.3 . . . . 0.0 111.166 175.181 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -62.88 -48.71 77.82 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 121.378 0.609 . . . . 0.0 111.289 -177.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.494 HG21 ' HB3' ' A' ' 29' ' ' GLU . 30.2 m -93.23 -166.06 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.271 178.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 31.5 pt -134.93 144.7 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 122.417 0.287 . . . . 0.0 111.102 174.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -97.94 -179.57 4.46 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 120.815 0.34 . . . . 0.0 111.559 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -57.62 -43.38 84.73 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -175.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.595 ' HA ' ' HG3' ' A' ' 76' ' ' LYS . 15.7 pt-20 -80.25 -28.73 38.42 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.529 -0.732 . . . . 0.0 111.881 -176.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -69.03 -30.06 68.35 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.501 0.667 . . . . 0.0 109.43 170.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -69.17 -49.38 57.31 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.47 176.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.595 ' HG3' ' HA ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -64.97 -27.57 68.93 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 120.753 0.311 . . . . 0.0 111.289 177.948 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -68.75 -39.35 80.33 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.8 0.333 . . . . 0.0 110.336 170.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.02 -43.76 86.93 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.184 0.516 . . . . 0.0 110.61 173.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 80.8 mt -58.97 -37.07 75.95 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.3 176.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -62.69 -47.39 83.83 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.862 0.363 . . . . 0.0 111.352 175.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -57.59 -55.93 28.41 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.893 0.378 . . . . 0.0 110.828 176.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 11.3 mp -54.4 -49.54 69.67 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.279 176.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -52.34 -48.5 65.46 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 75.3 p -62.58 -33.97 76.03 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 -179.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -94.77 -2.08 51.65 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 176.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 31.4 tpt85 -104.8 -63.76 1.19 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.043 0.449 . . . . 0.0 111.727 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -103.77 118.85 37.66 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.721 -177.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -79.01 58.68 2.48 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 121.429 0.633 . . . . 0.0 110.868 176.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -90.16 -11.21 63.32 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-N 115.817 -0.629 . . . . 0.0 114.024 -176.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp 59.74 23.4 12.28 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 177.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 48.2 t -149.17 155.77 41.15 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 122.059 -0.401 . . . . 0.0 111.09 176.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -83.1 -58.57 2.8 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.549 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -52.57 -58.14 7.74 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.584 0.586 . . . . 0.0 112.584 -176.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -57.37 -55.13 38.74 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -176.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.7 -36.36 74.11 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.771 0.319 . . . . 0.0 111.766 179.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -67.28 -52.62 38.41 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.326 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.477 ' O ' ' HG3' ' A' ' 101' ' ' GLN . 7.1 m-20 -58.0 -39.48 78.39 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 120.488 0.185 . . . . 0.0 111.421 176.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.16 -60.21 4.23 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 120.817 0.341 . . . . 0.0 111.593 176.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 17.6 tt -63.16 -28.84 45.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-O 121.039 0.447 . . . . 0.0 111.077 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . 0.559 ' SG ' HD21 ' A' ' 10' ' ' LEU . 39.6 t -66.54 -44.95 80.98 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.019 173.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.477 ' HG3' ' O ' ' A' ' 97' ' ' ASP . 46.2 mt-30 -60.71 -29.0 69.08 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 179.101 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 83.3 mt -63.69 -23.67 67.47 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 120.799 0.333 . . . . 0.0 111.833 176.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 43.3 t -112.98 -34.39 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -177.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.58 115.1 3.98 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -174.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 85.01 14.42 69.51 Favored Glycine 0 CA--C 1.523 0.561 0 CA-C-N 116.103 -0.499 . . . . 0.0 112.531 -178.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 24.3 tptm -102.77 156.31 17.73 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.344 0.592 . . . . 0.0 111.268 -178.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -132.3 158.24 76.14 Favored Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.248 174.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.413 ' HG2' ' CD2' ' A' ' 20' ' ' HIS . 25.6 Cg_exo -62.68 -179.06 0.44 Allowed 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.111 1.874 . . . . 0.0 112.537 178.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -53.75 -60.73 2.94 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.017 0.437 . . . . 0.0 111.025 174.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.501 ' N ' HD21 ' A' ' 110' ' ' ASN . 0.8 OUTLIER -97.53 135.6 39.14 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.453 173.075 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 14.3 p -134.56 154.98 38.1 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-O 120.794 0.33 . . . . 0.0 111.428 -177.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.21 -165.28 41.13 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 121.147 -0.549 . . . . 0.0 113.13 178.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.6 p -101.8 121.32 52.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-O 121.071 0.462 . . . . 0.0 111.582 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 10.0 t -101.36 173.8 6.28 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 121.232 0.539 . . . . 0.0 112.284 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -98.76 -161.85 0.91 Allowed 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.833 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -76.65 163.4 26.9 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.138 173.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -70.71 80.24 0.61 Allowed 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.143 0.497 . . . . 0.0 111.74 -178.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 82.3 p -103.25 -30.51 10.61 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.918 177.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -77.12 52.93 3.4 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 113.975 0.35 . . . . 0.0 113.975 -177.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -90.03 98.24 2.42 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 121.168 -0.539 . . . . 0.0 112.221 176.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -55.3 140.53 39.04 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -177.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.8 p -144.39 6.96 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 CA-C-O 121.52 0.676 . . . . 0.0 111.023 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -75.65 -174.33 2.5 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.922 -177.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 124' ' ' ARG . 11.0 ptp180 -132.7 172.78 12.1 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 120.668 0.271 . . . . 0.0 111.107 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.408 ' O ' HD13 ' A' ' 125' ' ' LEU . 4.1 pp -74.66 145.4 43.22 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 120.912 0.386 . . . . 0.0 111.299 177.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 8.8 t -159.74 23.66 0.18 Allowed 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.416 0.627 . . . . 0.0 110.987 -179.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -78.13 179.49 6.82 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.184 -177.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 8.0 t -146.8 125.78 12.81 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.749 178.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 59.8 m 50.75 93.66 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.433 HH11 ' HD2' ' A' ' 130' ' ' ARG . 48.3 mtm180 -107.41 0.56 23.0 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.884 174.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.439 ' O ' ' N ' ' A' ' 133' ' ' GLY . 8.9 t80 63.83 -81.73 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.915 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 82.0 p 48.55 -75.66 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 174.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 131' ' ' TYR . . . -56.67 157.29 11.03 Favored Glycine 0 CA--C 1.532 1.105 0 N-CA-C 115.153 0.821 . . . . 0.0 115.153 -173.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 89.5 p -111.23 -163.02 0.82 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 122.951 0.5 . . . . 0.0 110.779 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -89.33 66.0 7.37 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.187 0.518 . . . . 0.0 110.843 178.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.423 ' O ' ' HB3' ' A' ' 137' ' ' GLU . 59.5 mttp 61.34 -80.88 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -178.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.423 ' HB3' ' O ' ' A' ' 136' ' ' LYS . 43.5 tt0 71.99 -46.39 0.64 Allowed 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.345 0.658 . . . . 0.0 110.698 -168.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 28.9 ttt180 -53.58 141.46 25.62 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.209 173.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -83.29 -173.02 4.47 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.375 0.607 . . . . 0.0 112.474 -176.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -74.92 -177.02 3.13 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 121.806 0.812 . . . . 0.0 112.858 -175.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -64.29 143.51 57.83 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.246 -0.888 . . . . 0.0 112.077 178.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 22.1 m -86.58 32.55 0.65 Allowed 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 120.829 0.347 . . . . 0.0 111.7 178.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -75.22 -30.15 59.27 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 114.11 0.404 . . . . 0.0 114.11 -176.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 96.6 mttt 69.39 19.1 7.77 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 122.863 0.465 . . . . 0.0 112.083 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 98.95 -62.57 0.77 Allowed Glycine 0 CA--C 1.527 0.798 0 C-N-CA 121.272 -0.49 . . . . 0.0 113.064 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -155.5 179.05 9.55 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 122.575 -0.368 . . . . 0.0 111.093 178.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -66.29 76.38 0.13 Allowed Glycine 0 CA--C 1.528 0.868 0 C-N-CA 121.39 -0.433 . . . . 0.0 113.142 178.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 61.8 mt -66.07 -34.36 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 121.335 0.588 . . . . 0.0 110.812 178.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -89.3 163.21 15.45 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.622 171.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -73.62 64.83 1.79 Allowed Glycine 0 CA--C 1.528 0.903 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.862 178.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 18.9 mmm180 -132.66 168.41 18.33 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.107 0.479 . . . . 0.0 111.98 -175.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -73.86 -178.25 3.15 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.798 177.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -97.34 166.89 11.33 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.793 176.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 48.1 mm -83.13 87.42 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-O 121.477 0.656 . . . . 0.0 110.798 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 79.1 mt -87.75 80.97 7.75 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.617 -176.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -111.22 115.42 29.32 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.992 0.425 . . . . 0.0 111.586 178.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -89.58 100.07 12.94 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.056 0.455 . . . . 0.0 109.972 173.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 70.6 m -72.38 -167.43 0.33 Allowed 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 116.015 -0.539 . . . . 0.0 112.291 -176.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -72.9 66.94 1.4 Allowed Glycine 0 CA--C 1.53 1.011 0 N-CA-C 114.371 0.509 . . . . 0.0 114.371 -175.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -92.07 103.64 16.12 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 122.552 -0.381 . . . . 0.0 110.093 174.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 49.3 t 57.58 76.79 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 121.58 0.705 . . . . 0.0 110.204 -170.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 31.8 t 61.91 -87.39 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.551 -173.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 58.38 17.53 4.86 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -177.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -94.0 66.28 3.57 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.455 0.645 . . . . 0.0 111.371 -177.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 21.4 pttm -61.33 141.29 57.69 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.788 175.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -68.51 122.83 19.28 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.949 0.405 . . . . 0.0 111.859 -177.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -106.71 97.21 7.03 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.08 0.467 . . . . 0.0 111.537 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 106.48 154.33 20.48 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 121.137 -0.554 . . . . 0.0 113.173 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 16.2 p 55.84 -176.24 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.893 0.877 . . . . 0.0 112.423 -178.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 9.8 t80 63.29 24.82 14.45 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-O 121.547 0.689 . . . . 0.0 110.719 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -62.18 -56.92 13.88 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.726 -175.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -78.49 31.49 0.19 Allowed 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -175.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.512 ' HG3' HG11 ' A' ' 174' ' ' VAL . 61.4 pttt -60.88 -51.74 68.03 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.512 HG11 ' HG3' ' A' ' 173' ' ' LYS . 34.2 m -71.81 -32.2 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -174.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 55.5 mttp 68.9 -66.59 0.24 Allowed 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 177.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 96.7 mttt 67.88 -71.45 0.11 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.521 0.728 . . . . 0.0 111.556 -178.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 42.0 tp -144.09 70.95 1.3 Allowed 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.137 0.494 . . . . 0.0 111.099 178.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 . . . . . 0 CA--C 1.545 0.762 0 CA-C-N 115.503 -0.771 . . . . 0.0 113.073 175.968 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.0 mmt . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 120.597 0.237 . . . . 0.0 110.967 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.85 81.87 1.64 Allowed 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.208 0.528 . . . . 0.0 110.839 174.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -72.67 -48.05 42.36 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.782 -177.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 61.4 p -110.83 102.61 11.12 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.216 0.532 . . . . 0.0 112.028 -178.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 89.8 m -69.83 -23.54 63.32 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.313 0.577 . . . . 0.0 110.277 173.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -67.49 92.71 0.31 Allowed 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.187 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.4 HG12 ' H ' ' A' ' 9' ' ' GLY . 13.4 tt -62.47 150.08 9.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.801 -179.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -49.16 -36.01 18.23 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.4 ' H ' HG12 ' A' ' 7' ' ' ILE . . . -57.94 -33.6 69.26 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 121.274 -0.488 . . . . 0.0 113.131 176.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 50.0 tp -70.88 -40.68 72.09 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.943 0.401 . . . . 0.0 110.546 177.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -63.27 -36.31 83.25 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.697 175.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -60.03 -56.51 20.79 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.025 0.44 . . . . 0.0 110.895 175.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.3 m -53.15 -51.24 62.62 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.46 178.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -56.12 -50.07 72.12 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.458 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 29.9 ttt180 -62.94 -42.56 99.84 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.875 0.369 . . . . 0.0 111.677 -176.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -65.22 -34.32 78.08 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.498 ' HA ' ' HB2' ' A' ' 20' ' ' HIS . 41.0 m-85 -79.84 -23.61 41.86 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 120.826 0.346 . . . . 0.0 111.28 173.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.47 -11.56 60.26 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.172 0.511 . . . . 0.0 111.278 175.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.428 HG21 ' HA2' ' A' ' 27' ' ' GLY . 32.8 pt -117.79 15.78 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-O 121.055 0.455 . . . . 0.0 110.67 171.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.498 ' HB2' ' HA ' ' A' ' 17' ' ' PHE . 48.8 t-80 -63.24 100.73 0.25 Allowed 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 120.94 0.4 . . . . 0.0 111.448 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 126.88 -46.9 1.05 Allowed Glycine 0 CA--C 1.526 0.753 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.089 -176.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.426 ' HB2' ' HB3' ' A' ' 25' ' ' ALA . 19.7 m-20 -138.98 127.87 14.02 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 122.757 0.423 . . . . 0.0 110.815 179.15 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_exo -47.54 -32.64 16.17 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 123.215 2.61 . . . . 0.0 114.232 -178.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -120.9 31.42 6.41 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.875 0.369 . . . . 0.0 111.566 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.426 ' HB3' ' HB2' ' A' ' 22' ' ' ASP . . . -53.44 -60.1 3.73 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 67.5 m -152.9 -43.85 0.1 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.071 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.428 ' HA2' HG21 ' A' ' 19' ' ' ILE . . . 79.1 -34.83 1.94 Allowed Glycine 0 CA--C 1.528 0.904 0 C-N-CA 121.168 -0.539 . . . . 0.0 114.358 173.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -125.72 -21.59 4.4 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 117.033 0.417 . . . . 0.0 111.667 -178.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -99.16 138.66 35.95 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 122.113 -0.367 . . . . 0.0 110.519 173.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 49.8 ttm -125.55 131.19 52.81 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.843 0.354 . . . . 0.0 111.929 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.489 ' ND2' ' HB2' ' A' ' 33' ' ' LYS . 17.8 p-10 -91.71 158.43 16.38 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.89 0.376 . . . . 0.0 111.592 178.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -56.64 -29.17 57.58 Favored Glycine 0 N--CA 1.465 0.626 0 CA-C-N 116.302 -0.408 . . . . 0.0 113.253 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.489 ' HB2' ' ND2' ' A' ' 31' ' ' ASN . 98.7 mttt -57.93 -56.06 26.85 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 120.938 0.399 . . . . 0.0 111.464 175.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -71.21 -29.15 64.8 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 122.342 -0.224 . . . . 0.0 111.412 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.462 ' CD1' ' HB2' ' A' ' 59' ' ' PHE . 25.8 t-105 -64.32 -45.27 88.63 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 120.879 0.371 . . . . 0.0 111.26 175.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.432 ' HA ' HG11 ' A' ' 55' ' ' VAL . . . -58.74 -46.3 87.73 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.183 0.516 . . . . 0.0 111.007 177.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -66.94 -39.25 87.24 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.779 176.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.2 tt -49.88 -45.26 50.46 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.24 0.543 . . . . 0.0 110.618 177.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 64.6 m -70.44 -38.58 74.55 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.715 178.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -70.96 -47.92 56.27 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -176.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -53.46 -48.86 68.46 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.065 0.46 . . . . 0.0 111.073 172.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 63.3 m -77.09 -6.07 51.39 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.722 178.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 47.0 mttp 59.45 26.41 15.34 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 175.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 42.8 t -74.24 -32.63 32.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 121.397 0.618 . . . . 0.0 110.347 173.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.531 ' HB3' ' HA ' ' A' ' 51' ' ' THR . . . -87.85 91.96 8.95 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.669 -176.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -174.52 17.55 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.831 0 CA-C-O 120.971 0.415 . . . . 0.0 111.688 175.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -86.93 18.93 32.61 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.69 -0.767 . . . . 0.0 113.446 -175.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.485 ' HD2' ' N ' ' A' ' 48' ' ' LYS . 12.0 mptt 57.51 20.05 5.79 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 121.738 0.78 . . . . 0.0 111.51 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 65.4 m -147.0 -30.92 0.34 Allowed 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.494 175.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.631 HG12 ' HG ' ' A' ' 82' ' ' LEU . 93.3 t -125.46 96.71 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.95 166.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.531 ' HA ' ' HB3' ' A' ' 45' ' ' ALA . 5.0 t -156.55 125.06 5.79 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.803 0.335 . . . . 0.0 111.854 176.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 50.47 -90.6 0.01 OUTLIER Glycine 0 CA--C 1.53 0.995 0 CA-C-N 116.413 -0.358 . . . . 0.0 113.776 178.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.576 ' O ' HG13 ' A' ' 57' ' ' ILE . 58.0 m -52.04 -55.01 23.27 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.788 0.328 . . . . 0.0 111.199 179.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.478 ' HB2' ' HA ' ' A' ' 50' ' ' VAL . 9.2 m-20 -57.53 -34.02 68.69 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.553 -177.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.432 HG11 ' HA ' ' A' ' 36' ' ' ALA . 43.8 t -64.06 -38.2 81.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-O 120.939 0.4 . . . . 0.0 111.032 178.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -72.12 -31.25 65.85 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.171 0.51 . . . . 0.0 110.004 177.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.576 HG13 ' O ' ' A' ' 53' ' ' THR . 9.8 mt -68.01 -48.31 75.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.896 176.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 76.1 t -54.04 -51.32 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-O 121.022 0.439 . . . . 0.0 110.849 174.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.462 ' HB2' ' CD1' ' A' ' 35' ' ' TRP . 72.0 t80 -53.06 -51.19 62.58 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.763 175.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.563 ' HA ' ' HE3' ' A' ' 63' ' ' LYS . 59.3 m -68.23 -21.65 64.83 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.028 -178.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 43.9 tttp -83.11 -39.87 20.55 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 120.747 0.308 . . . . 0.0 111.402 -178.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 26.9 m -82.22 -24.88 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 CA-C-O 120.783 0.325 . . . . 0.0 111.377 177.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.563 ' HE3' ' HA ' ' A' ' 60' ' ' SER . 26.3 ttpp -53.84 126.83 23.68 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.964 178.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -45.78 -62.26 3.41 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-N 116.088 -0.505 . . . . 0.0 113.294 179.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.462 ' O ' ' NZ ' ' A' ' 63' ' ' LYS . 48.4 tptt -152.02 -86.3 0.07 Allowed 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 117.085 0.442 . . . . 0.0 111.782 174.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 88.4 p -110.09 -7.04 14.96 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -173.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.43 107.1 1.03 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.725 0.297 . . . . 0.0 111.2 178.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 83.8 mtm-85 -72.48 2.32 6.49 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -176.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 28.2 m -125.71 132.98 70.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-O 120.894 0.378 . . . . 0.0 110.73 174.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.518 ' HB ' ' HB2' ' A' ' 74' ' ' GLU . 30.6 pt -100.63 148.06 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 121.077 0.465 . . . . 0.0 111.878 179.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.446 ' ND2' ' HB2' ' A' ' 73' ' ' GLU . 1.7 p-10 -89.18 167.93 12.71 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.153 174.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.492 ' O ' ' HG3' ' A' ' 76' ' ' LYS . 24.9 t80 -52.12 -37.46 54.34 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.922 0.391 . . . . 0.0 111.866 -173.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.446 ' HB2' ' ND2' ' A' ' 71' ' ' ASN . 19.5 mp0 -60.4 -47.98 83.75 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.288 178.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.518 ' HB2' ' HB ' ' A' ' 70' ' ' ILE . 48.7 mt-10 -65.4 -37.3 86.54 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.18 0.514 . . . . 0.0 110.296 176.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -59.6 -41.11 89.57 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.222 175.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.492 ' HG3' ' O ' ' A' ' 72' ' ' TYR . 27.7 mtpp -55.75 -47.85 76.28 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.691 0.281 . . . . 0.0 110.969 176.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.442 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 54.9 tttp -68.91 -32.99 73.02 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.384 177.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.427 ' O ' HD13 ' A' ' 82' ' ' LEU . . . -56.9 -40.84 77.02 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.111 0.481 . . . . 0.0 110.407 173.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 88.2 mt -67.79 -43.26 80.13 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.87 173.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -49.4 -47.62 47.74 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 120.975 0.417 . . . . 0.0 111.104 175.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.627 ' O ' ' HG2' ' A' ' 85' ' ' LYS . 32.0 mm-40 -58.94 -68.67 0.25 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.916 177.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.631 ' HG ' HG12 ' A' ' 50' ' ' VAL . 11.0 mp -47.77 -43.73 27.71 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -178.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.01 -48.02 83.1 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.692 177.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 74.0 p -75.01 -7.24 53.11 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -178.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.627 ' HG2' ' O ' ' A' ' 81' ' ' GLU . 54.7 mmtt -97.75 -35.4 10.56 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.292 0.568 . . . . 0.0 110.172 172.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 9.9 mmt180 -78.35 -70.2 0.51 Allowed 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.722 176.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -98.83 86.47 3.52 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.192 0.52 . . . . 0.0 111.144 -172.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.685 ' HZ1' ' HB2' ' A' ' 88' ' ' LYS . 9.4 mtmp? -94.07 36.29 1.13 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.3 0.571 . . . . 0.0 110.999 -177.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -78.53 35.95 1.81 Allowed Glycine 0 CA--C 1.531 1.054 0 CA-C-N 116.044 -0.526 . . . . 0.0 113.853 -177.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 76.9 tttt 70.83 -60.87 0.49 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.666 0.786 . . . . 0.0 112.253 178.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 53.5 m -63.73 105.69 0.85 Allowed 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 120.824 0.345 . . . . 0.0 111.558 176.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.402 ' HE2' ' OE2' ' A' ' 93' ' ' GLU . 11.3 ttpt -73.6 -49.05 28.13 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -173.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.402 ' OE2' ' HE2' ' A' ' 92' ' ' LYS . 2.8 mp0 -53.17 -49.59 66.33 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 111.671 0.248 . . . . 0.0 111.671 -178.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -60.71 -33.46 72.91 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.889 0.376 . . . . 0.0 111.402 178.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.21 -39.56 94.97 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.139 0.495 . . . . 0.0 110.645 173.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -63.41 -39.04 93.43 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.326 175.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.46 ' O ' ' HB3' ' A' ' 100' ' ' CYS . 20.2 m-20 -60.25 -49.81 76.14 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.654 0.264 . . . . 0.0 111.057 172.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -53.58 -50.57 65.32 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -177.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 17.3 tt -65.6 -30.56 50.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-O 121.083 0.468 . . . . 0.0 110.819 177.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . 0.46 ' HB3' ' O ' ' A' ' 97' ' ' ASP . 35.8 t -63.41 -42.01 98.75 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.968 173.174 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -57.4 -39.54 76.35 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.776 0.322 . . . . 0.0 111.128 175.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 96.6 mt -65.96 -44.6 84.5 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 178.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 60.9 t -97.8 -54.2 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -172.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.77 127.82 33.53 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -171.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 100.24 -8.78 59.12 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 115.888 -0.596 . . . . 0.0 113.62 177.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -105.08 173.98 6.07 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.467 0.651 . . . . 0.0 112.15 -179.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.51 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 10.9 pt-20 -143.83 160.92 48.47 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.657 179.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.51 ' HD2' ' HB2' ' A' ' 107' ' ' GLU . 42.2 Cg_exo -32.38 106.6 0.04 OUTLIER 'Trans proline' 0 C--N 1.36 1.158 0 C-N-CA 123.711 2.94 . . . . 0.0 114.622 -177.024 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -93.62 -24.5 17.89 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.817 -177.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -98.22 100.92 12.25 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.095 0.474 . . . . 0.0 111.032 178.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 60.6 t -83.55 -48.16 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 121.07 0.462 . . . . 0.0 111.662 -177.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -174.53 107.0 0.23 Allowed Glycine 0 CA--C 1.525 0.697 0 C-N-CA 121.329 -0.462 . . . . 0.0 112.549 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 49.0 t -75.34 -64.67 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 O-C-N 122.604 -0.351 . . . . 0.0 111.882 -178.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 90.5 m 70.02 -61.73 0.45 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.215 0.606 . . . . 0.0 112.235 -178.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -68.25 176.67 2.63 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -178.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 69.26 -67.43 0.22 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.315 0.646 . . . . 0.0 112.714 178.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -67.8 -30.16 69.52 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -177.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.5 t -51.35 130.95 28.14 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.27 0.557 . . . . 0.0 112.276 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 136.93 -124.67 3.18 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.175 -177.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -75.78 70.95 1.95 Allowed Glycine 0 CA--C 1.529 0.964 0 C-N-CA 121.405 -0.426 . . . . 0.0 113.052 178.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -136.66 153.3 50.95 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 122.545 0.338 . . . . 0.0 111.057 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 24.3 m -96.59 111.49 26.77 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 CA-C-O 121.726 0.774 . . . . 0.0 112.526 -177.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -89.28 -42.99 11.27 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.493 0.663 . . . . 0.0 109.274 172.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 53.9 ttt85 -97.43 117.99 32.92 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.979 172.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.666 ' H ' HD23 ' A' ' 125' ' ' LEU . 1.9 pt? -121.34 137.83 54.52 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.113 0.483 . . . . 0.0 111.801 -174.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 76.5 p -88.91 3.42 51.45 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.586 0.588 . . . . 0.0 112.586 -177.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -160.25 155.76 25.37 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-O 120.7 0.286 . . . . 0.0 110.638 -178.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 10.0 t -114.73 0.1 13.74 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 121.155 0.502 . . . . 0.0 111.307 178.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 41.1 t -142.37 -55.69 0.44 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.26 -178.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 12.6 tpt180 64.71 7.27 3.72 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 121.289 0.566 . . . . 0.0 111.234 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -145.85 161.34 40.22 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.635 -176.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 94.3 m -125.18 123.49 39.73 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 120.924 0.392 . . . . 0.0 111.908 178.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -74.51 114.23 4.36 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 121.364 -0.446 . . . . 0.0 113.412 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 41.1 t -160.18 110.68 1.86 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 122.624 0.37 . . . . 0.0 110.48 177.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 38.3 m80 60.53 175.28 0.1 Allowed 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 120.989 0.423 . . . . 0.0 111.831 -175.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt 71.66 -26.41 0.17 Allowed 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 172.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -49.0 -49.35 41.28 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -177.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? 61.28 101.09 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.425 -175.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 25.3 p90 -128.33 135.4 49.55 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.011 0.434 . . . . 0.0 111.585 -176.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -84.54 126.67 33.51 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.178 0.513 . . . . 0.0 111.123 177.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -63.96 91.77 0.07 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.547 0.689 . . . . 0.0 111.463 -178.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 78.4 p -104.94 26.39 9.29 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.254 -176.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -179.1 -158.98 22.5 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 120.046 -1.073 . . . . 0.0 114.088 -178.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 64.5 tttp 63.48 -87.11 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.278 0.631 . . . . 0.0 111.631 -176.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 42.94 -119.91 2.41 Favored Glycine 0 CA--C 1.531 1.057 0 N-CA-C 114.34 0.496 . . . . 0.0 114.34 177.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -122.3 35.09 4.97 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.953 0.406 . . . . 0.0 110.958 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -72.57 40.0 0.76 Allowed Glycine 0 CA--C 1.536 1.363 0 N-CA-C 114.777 0.671 . . . . 0.0 114.777 -175.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 34.2 mm -98.48 -14.19 7.84 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-O 121.225 0.536 . . . . 0.0 111.078 178.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -73.03 115.39 12.28 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 120.99 0.424 . . . . 0.0 111.918 -177.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 105.29 100.87 2.66 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 121.415 -0.421 . . . . 0.0 112.598 -178.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -123.52 87.44 2.74 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 122.53 -0.394 . . . . 0.0 111.994 -176.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -173.95 -28.93 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.601 175.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 65.13 -77.41 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.206 0.602 . . . . 0.0 112.232 178.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 32.4 pt -133.61 151.34 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-O 120.979 0.419 . . . . 0.0 111.521 -177.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 74.5 mt -98.31 37.13 1.49 Allowed 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 120.893 0.378 . . . . 0.0 111.222 -178.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 60.14 24.8 14.1 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.601 -177.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -60.16 120.99 10.81 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.358 0.599 . . . . 0.0 111.338 179.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 19.6 t -71.05 128.74 36.98 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.146 -172.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -74.32 127.54 10.01 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 121.181 -0.533 . . . . 0.0 112.844 178.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -69.6 128.49 36.65 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 120.893 0.377 . . . . 0.0 111.691 -177.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 35.0 m -76.67 142.5 14.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-O 121.145 0.497 . . . . 0.0 111.804 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 73.0 p -76.32 108.55 9.35 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.034 177.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 67.01 -165.37 0.22 Allowed 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.027 0.441 . . . . 0.0 111.703 -178.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -83.01 14.93 3.01 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -177.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp 68.72 -59.34 0.46 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.16 0.584 . . . . 0.0 111.638 -175.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -103.57 179.25 4.32 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.102 0.477 . . . . 0.0 110.919 175.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -70.0 92.99 0.75 Allowed 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.143 0.497 . . . . 0.0 111.379 177.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -80.8 42.4 2.67 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 121.3 -0.476 . . . . 0.0 113.205 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 73.7 p -139.25 176.54 8.62 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.023 0.439 . . . . 0.0 110.858 -179.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -86.1 48.72 1.65 Allowed 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 121.075 0.464 . . . . 0.0 111.04 178.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 10.6 t70 65.79 -72.91 0.07 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.688 0.795 . . . . 0.0 112.617 178.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -59.45 161.28 5.93 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -177.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -64.03 127.67 32.45 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.82 173.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 58.0 t -50.16 91.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-O 121.098 0.475 . . . . 0.0 112.127 -176.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 51.5 mtpt 54.18 31.07 13.29 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.009 178.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 58.8 mttm 62.17 17.86 9.57 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 122.956 0.502 . . . . 0.0 112.277 178.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 84.1 mt 68.02 98.95 0.05 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.132 0.573 . . . . 0.0 111.726 -178.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 . . . . . 0 N--CA 1.476 0.868 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -178.497 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.6 tpt . . . . . 0 N--CA 1.487 1.425 0 CA-C-O 120.552 0.215 . . . . 0.0 110.759 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.15 165.34 3.48 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 177.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 69.82 101.14 0.06 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.006 0.523 . . . . 0.0 111.309 -176.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.8 t -81.33 126.47 31.62 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.993 0.425 . . . . 0.0 112.093 -174.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.433 ' O ' ' HB2' ' A' ' 6' ' ' ASP . 74.6 p -70.27 114.73 8.69 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.177 172.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.456 ' CG ' ' HZ2' ' A' ' 76' ' ' LYS . 2.1 m-20 68.45 101.48 0.05 Allowed 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.193 0.52 . . . . 0.0 111.25 -174.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.573 HG12 ' H ' ' A' ' 9' ' ' GLY . 7.9 tt -49.28 129.06 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 CA-C-N 115.947 -0.569 . . . . 0.0 112.308 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.04 -27.9 48.07 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -178.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.573 ' H ' HG12 ' A' ' 7' ' ' ILE . . . -60.06 -28.42 66.36 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 121.229 -0.51 . . . . 0.0 113.049 177.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 44.8 tp -73.24 -35.28 66.22 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.116 0.484 . . . . 0.0 110.524 177.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -62.69 -45.46 92.66 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.849 175.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.488 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 35.1 tt0 -65.89 -45.85 80.51 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.53 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 79.6 p -58.0 -46.41 85.27 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.045 0.45 . . . . 0.0 110.818 178.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -54.14 -48.71 70.53 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.219 0.533 . . . . 0.0 110.685 172.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.406 ' HG3' ' HA3' ' A' ' 27' ' ' GLY . 49.4 ttt180 -58.51 -37.21 75.12 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.37 -179.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.488 ' HG2' ' O ' ' A' ' 12' ' ' GLU . 75.6 mmtt -60.39 -50.19 74.58 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.823 178.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.474 ' HB2' ' HE1' ' A' ' 30' ' ' MET . 81.7 m-85 -72.89 -21.1 60.97 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.739 0.304 . . . . 0.0 111.524 177.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.68 -54.31 12.34 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 120.862 0.363 . . . . 0.0 111.877 179.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 32.8 pt -73.78 -10.68 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-O 120.989 0.423 . . . . 0.0 111.882 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 -58.85 87.95 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.12 0.486 . . . . 0.0 111.745 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 132.84 -34.4 2.47 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-N 116.136 -0.484 . . . . 0.0 113.125 -179.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -133.04 114.59 13.9 Favored Pre-proline 0 CA--C 1.544 0.746 0 O-C-N 122.462 -0.434 . . . . 0.0 111.337 -177.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -80.86 0.03 10.29 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.585 2.19 . . . . 0.0 113.562 -179.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.672 ' HB2' ' HZ2' ' A' ' 24' ' ' LYS . 9.5 mtmp? -93.91 -16.77 23.68 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.97 0.414 . . . . 0.0 111.368 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -82.54 137.72 34.5 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.396 177.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 47.0 m -68.98 -22.66 64.09 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 120.77 0.319 . . . . 0.0 111.463 179.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.406 ' HA3' ' HG3' ' A' ' 15' ' ' ARG . . . 108.44 23.5 6.59 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 121.274 -0.488 . . . . 0.0 114.194 177.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -104.51 6.22 34.6 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 117.388 0.594 . . . . 0.0 111.799 178.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -130.79 130.76 44.11 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.011 -178.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.474 ' HE1' ' HB2' ' A' ' 17' ' ' PHE . 48.2 ttm -125.81 133.88 51.86 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.987 0.422 . . . . 0.0 111.99 -179.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.484 HD22 ' ND2' ' A' ' 34' ' ' ASN . 9.8 p30 -90.93 168.35 11.75 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.987 0.422 . . . . 0.0 111.605 178.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -66.04 -28.72 73.9 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-N 116.164 -0.471 . . . . 0.0 114.041 -179.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.433 ' HB3' ' OD1' ' A' ' 31' ' ' ASN . 39.6 ttmt -67.46 -48.8 66.14 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 117.006 0.403 . . . . 0.0 111.316 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.484 ' ND2' HD22 ' A' ' 31' ' ' ASN . 87.4 m-20 -68.71 -35.22 76.88 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.803 0.335 . . . . 0.0 111.013 175.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 47.5 t-105 -58.43 -45.48 88.41 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.283 174.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.52 -38.26 83.83 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.193 0.521 . . . . 0.0 111.528 176.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -70.72 -35.58 72.79 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.364 175.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.7 tt -59.57 -54.45 46.4 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.083 0.468 . . . . 0.0 110.588 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 26.2 p -60.51 -44.42 96.04 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.646 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -67.89 -38.16 82.67 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.847 0.356 . . . . 0.0 111.525 -178.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -67.31 -49.91 62.27 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.236 178.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.55 ' SG ' HG22 ' A' ' 103' ' ' VAL . 68.8 m -80.61 1.43 29.85 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.503 178.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp 69.03 20.23 7.82 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.033 0.533 . . . . 0.0 112.144 172.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.543 ' HA ' ' NH1' ' A' ' 86' ' ' ARG . 40.0 t -70.04 -26.94 30.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 120.926 0.394 . . . . 0.0 110.561 175.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.16 78.04 0.51 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.651 0.739 . . . . 0.0 109.972 172.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.406 ' HB3' ' H ' ' A' ' 50' ' ' VAL . 38.7 t70 -54.99 -30.12 58.62 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 114.601 -1.181 . . . . 0.0 113.978 -169.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.26 -36.44 1.53 Allowed Glycine 0 CA--C 1.531 1.065 0 C-N-CA 121.227 -0.511 . . . . 0.0 113.31 -177.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.7 mttp -82.59 -46.94 12.69 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.161 0.505 . . . . 0.0 110.093 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 73.1 m -108.55 -50.43 3.03 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.564 174.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.406 ' H ' ' HB3' ' A' ' 46' ' ' ASP . 43.1 t -93.76 110.25 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -178.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 76.5 p -96.44 173.93 7.12 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 120.689 0.281 . . . . 0.0 111.519 177.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -58.06 -44.05 94.85 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 121.083 -0.58 . . . . 0.0 112.443 177.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.544 ' O ' HG13 ' A' ' 57' ' ' ILE . 44.5 p -51.21 -50.64 58.71 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.325 0.583 . . . . 0.0 110.361 172.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.06 -38.42 70.61 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.04 -176.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.2 t -59.22 -40.56 81.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.173 176.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -68.06 -37.66 81.55 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.98 0.419 . . . . 0.0 110.84 175.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.544 HG13 ' O ' ' A' ' 53' ' ' THR . 6.5 mt -62.73 -46.76 95.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.146 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 76.5 t -59.99 -42.48 89.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 120.979 0.419 . . . . 0.0 111.07 177.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -62.36 -23.32 66.73 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-O 121.153 0.502 . . . . 0.0 110.999 176.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 23.1 t -87.0 -34.79 19.13 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.836 0.35 . . . . 0.0 111.254 175.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -60.86 -44.69 96.69 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 29.4 m -78.97 -22.64 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -177.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? -73.97 150.01 41.02 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.905 0.383 . . . . 0.0 111.789 -175.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -70.18 -98.67 0.05 OUTLIER Glycine 0 CA--C 1.53 0.993 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.161 174.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -141.88 -64.73 0.43 Allowed 'General case' 0 N--CA 1.471 0.607 0 O-C-N 122.423 -0.457 . . . . 0.0 111.216 174.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 43.5 t -92.77 91.3 7.42 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.862 0.363 . . . . 0.0 110.825 177.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -160.57 146.56 15.08 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.231 0.538 . . . . 0.0 112.089 -178.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 68' ' ' ARG . 32.5 mtm-85 -104.36 -37.76 7.1 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.393 0.616 . . . . 0.0 110.716 177.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.3 m -124.82 158.56 32.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.208 -178.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 42.1 pt -118.49 159.77 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.091 177.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -103.61 177.81 4.73 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.404 ' OH ' ' HB3' ' A' ' 6' ' ' ASP . 84.7 t80 -54.01 -40.62 67.17 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -174.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -56.22 -51.47 67.95 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.266 0.555 . . . . 0.0 111.281 178.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -64.52 -32.87 74.69 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.068 177.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -58.82 -43.72 90.68 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.025 174.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.456 ' HZ2' ' CG ' ' A' ' 6' ' ' ASP . 24.1 mtpp -54.95 -49.53 71.14 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.186 0.517 . . . . 0.0 111.066 173.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -61.18 -35.13 76.32 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.173 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.47 -43.38 81.16 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.012 0.434 . . . . 0.0 111.449 176.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 80.8 mt -64.89 -35.4 81.01 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.103 177.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -59.94 -49.94 75.7 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.134 0.492 . . . . 0.0 110.325 176.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -57.4 -56.7 18.43 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.152 175.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 87.1 mt -60.27 -35.24 75.08 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -178.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.476 ' HB1' HG21 ' A' ' 99' ' ' ILE . . . -64.15 -48.04 77.58 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.108 0.48 . . . . 0.0 111.057 178.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 65.7 p -74.67 -9.26 58.39 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.846 -0.616 . . . . 0.0 112.161 -179.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -101.6 -28.32 12.58 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 173.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.543 ' NH1' ' HA ' ' A' ' 44' ' ' VAL . 14.3 tpt180 -83.26 -54.26 5.14 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.695 0.76 . . . . 0.0 110.575 178.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -86.55 144.58 27.14 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.752 178.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.739 ' HZ1' ' HB3' ' A' ' 88' ' ' LYS . 0.5 OUTLIER -81.64 -164.71 0.82 Allowed 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -178.555 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -55.3 81.97 0.01 OUTLIER Glycine 0 CA--C 1.531 1.035 0 N-CA-C 114.633 0.613 . . . . 0.0 114.633 -176.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -126.3 177.15 6.6 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 122.885 0.474 . . . . 0.0 110.749 176.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 65.9 m -62.72 125.44 23.96 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 120.767 0.318 . . . . 0.0 111.161 176.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -54.84 -40.31 69.48 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 116.134 -0.485 . . . . 0.0 112.303 -174.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -62.59 -59.93 4.23 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.653 0.263 . . . . 0.0 110.98 178.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -53.82 -39.47 65.57 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 120.725 0.297 . . . . 0.0 111.432 -179.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.24 -42.73 95.91 Favored 'General case' 0 CA--C 1.541 0.635 0 CA-C-O 120.706 0.288 . . . . 0.0 111.468 177.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -67.59 -50.2 59.44 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.222 178.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -57.32 -42.03 81.07 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 120.727 0.298 . . . . 0.0 111.456 178.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.67 -54.22 45.71 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 112.041 0.385 . . . . 0.0 112.041 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.476 HG21 ' HB1' ' A' ' 83' ' ' ALA . 12.7 tt -59.29 -36.12 61.84 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-O 121.096 0.474 . . . . 0.0 110.793 179.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 81.6 m -68.04 -38.69 82.8 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.135 176.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -58.42 -31.49 67.76 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.061 0.458 . . . . 0.0 111.486 177.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 92.9 mt -60.79 -41.11 94.96 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.879 176.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.55 HG22 ' SG ' ' A' ' 42' ' ' CYS . 16.3 t -96.76 -31.63 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 CA-C-O 121.044 0.449 . . . . 0.0 112.176 -174.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.03 124.67 21.7 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -173.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 85.78 -11.56 61.73 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 116.123 -0.49 . . . . 0.0 113.44 177.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -86.67 153.33 21.83 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 122.5 -0.412 . . . . 0.0 111.293 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.53 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 0.4 OUTLIER -86.42 163.27 42.79 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.294 173.901 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.53 ' HD2' ' HB2' ' A' ' 107' ' ' GLU . 59.3 Cg_endo -69.73 -149.38 0.02 OUTLIER 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.052 1.835 . . . . 0.0 111.922 177.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' A' ' 111' ' ' VAL . . . -48.53 118.94 2.74 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 169.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.467 ' O ' ' HB ' ' A' ' 111' ' ' VAL . 19.4 p30 -53.49 72.09 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -170.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.518 ' N ' ' O ' ' A' ' 109' ' ' ALA . 12.4 p 166.63 -36.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.614 0.766 . . . . 0.0 110.684 -178.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 94.47 -67.19 1.4 Allowed Glycine 0 CA--C 1.526 0.725 0 CA-C-N 116.336 -0.393 . . . . 0.0 112.193 -176.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 11.4 p -106.09 150.22 8.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 122.385 0.274 . . . . 0.0 110.638 175.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 58.3 m -49.96 144.5 6.6 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.464 0.173 . . . . 0.0 111.314 178.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -50.98 93.0 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.614 0.721 . . . . 0.0 112.645 -174.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.42 ' C ' ' H ' ' A' ' 118' ' ' THR . . . -152.25 -81.33 0.1 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.36 173.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 64.9 tttp 66.21 -21.75 0.1 Allowed 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 170.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.42 ' H ' ' C ' ' A' ' 116' ' ' ALA . 78.9 p -79.84 30.92 0.25 Allowed 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -175.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -66.03 -76.2 0.36 Allowed Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.843 179.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 53.02 32.15 41.67 Favored Glycine 0 CA--C 1.529 0.936 0 N-CA-C 114.478 0.551 . . . . 0.0 114.478 176.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -150.77 161.54 42.44 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 117.004 0.402 . . . . 0.0 111.677 -178.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 65.0 t 69.17 -61.99 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 123.014 0.526 . . . . 0.0 111.785 -178.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 22.3 t70 67.62 -73.68 0.08 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.113 0.565 . . . . 0.0 111.894 176.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 46.2 ttp180 68.17 73.78 0.29 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.476 0.711 . . . . 0.0 111.914 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.69 -5.75 55.8 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.668 171.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 15.2 m -59.56 95.48 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.6 -0.727 . . . . 0.0 112.446 -178.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -77.43 178.54 7.11 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.161 175.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 13.5 t -61.68 176.69 0.49 Allowed 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.114 0.412 . . . . 0.0 112.114 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 45.2 t -49.58 127.62 15.96 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -177.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 130' ' ' ARG . 61.6 mtt180 -72.31 -16.23 61.89 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.266 178.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -81.57 63.52 5.89 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.24 0.543 . . . . 0.0 110.491 177.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 81.0 p 45.84 79.93 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.274 -0.875 . . . . 0.0 113.078 -176.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -81.97 67.64 3.64 Favored Glycine 0 CA--C 1.523 0.538 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.156 175.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 39.6 t -49.16 152.49 1.14 Allowed 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -175.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 74.6 m-70 71.13 -64.38 0.38 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.728 0.811 . . . . 0.0 111.582 -176.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 89.1 tttt 57.26 -93.23 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 122.773 0.429 . . . . 0.0 111.439 -178.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.416 ' O ' ' HB3' ' A' ' 138' ' ' ARG . 18.2 mm-40 -135.96 124.59 23.72 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 122.188 0.195 . . . . 0.0 110.95 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.416 ' HB3' ' O ' ' A' ' 137' ' ' GLU . 30.8 ttt180 72.66 -42.11 0.52 Allowed 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 176.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -76.26 155.43 34.37 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -172.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 61.55 98.8 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.458 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -55.57 122.47 11.39 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.551 176.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 66.8 m -69.26 80.8 0.36 Allowed 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -171.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 51.59 -137.41 30.73 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-N 115.892 -0.594 . . . . 0.0 114.543 173.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.508 ' HE3' ' HA3' ' A' ' 147' ' ' GLY . 46.8 tttp -110.15 108.92 19.24 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 122.58 0.352 . . . . 0.0 110.449 179.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.451 ' O ' ' NZ ' ' A' ' 175' ' ' LYS . . . -55.67 -81.32 0.07 OUTLIER Glycine 0 CA--C 1.526 0.761 0 C-N-CA 121.203 -0.522 . . . . 0.0 112.853 178.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -122.49 -44.52 2.24 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 122.431 -0.452 . . . . 0.0 110.895 172.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.508 ' HA3' ' HE3' ' A' ' 144' ' ' LYS . . . 67.65 35.69 86.43 Favored Glycine 0 CA--C 1.521 0.453 0 C-N-CA 121.195 -0.526 . . . . 0.0 112.717 -178.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 10.4 tt -84.98 122.8 38.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-O 121.128 0.49 . . . . 0.0 111.702 -177.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -84.86 78.06 9.97 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.31 0.576 . . . . 0.0 110.856 177.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . 0.447 ' C ' ' HD2' ' A' ' 151' ' ' ARG . . . -159.73 177.42 36.24 Favored Glycine 0 CA--C 1.524 0.637 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.84 -179.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.447 ' HD2' ' C ' ' A' ' 150' ' ' GLY . 3.5 mpt_? -116.51 138.23 51.55 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.985 0.421 . . . . 0.0 111.418 178.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -77.86 85.04 4.14 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.409 178.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -74.99 -12.85 60.43 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.947 0.403 . . . . 0.0 111.375 176.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 7.7 tt -61.73 104.94 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 121.277 0.56 . . . . 0.0 110.554 172.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 92.0 mt -91.57 86.3 5.98 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.939 0.4 . . . . 0.0 111.518 -176.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -70.7 129.55 39.44 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.76 175.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -72.2 77.46 0.97 Allowed 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.794 0.807 . . . . 0.0 110.676 175.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 39.5 t -81.53 94.5 6.89 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.429 -178.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -139.04 -72.45 0.05 OUTLIER Glycine 0 CA--C 1.524 0.636 0 C-N-CA 121.417 -0.421 . . . . 0.0 112.33 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -117.61 120.55 38.39 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.865 0.364 . . . . 0.0 111.072 178.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 16.7 m -78.1 99.52 2.81 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-O 121.402 0.62 . . . . 0.0 111.956 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 62.9 p -90.48 126.9 36.06 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.425 175.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 72.02 113.18 0.06 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.115 0.566 . . . . 0.0 111.081 -174.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -97.11 -83.61 0.39 Allowed 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -172.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 30.5 mmtm 57.92 -89.56 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -174.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 7.4 t30 47.95 76.36 0.11 Allowed 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.133 0.492 . . . . 0.0 111.243 -174.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -74.06 -31.96 63.08 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -174.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 69.35 46.78 55.28 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.119 -176.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' THR . . . . . 0.519 HG22 ' HD2' ' A' ' 170' ' ' TYR . 35.1 m -51.76 105.12 0.1 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.493 0.717 . . . . 0.0 112.688 -175.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . 0.519 ' HD2' HG22 ' A' ' 169' ' ' THR . 93.9 m-85 58.34 16.39 4.04 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 179.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 17.5 t70 67.56 161.92 0.18 Allowed 'General case' 0 CA--C 1.547 0.859 0 CA-C-O 121.372 0.606 . . . . 0.0 111.565 -178.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -83.99 9.7 11.7 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.427 0.528 . . . . 0.0 112.427 -178.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.752 ' HZ2' ' HB3' ' A' ' 173' ' ' LYS . 5.8 ttpm? -77.52 51.65 0.91 Allowed 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 121.565 0.697 . . . . 0.0 111.691 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 35.1 m -76.96 -2.84 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-O 121.454 0.645 . . . . 0.0 110.785 173.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.451 ' NZ ' ' O ' ' A' ' 145' ' ' GLY . 11.9 mmmm -83.3 38.02 0.59 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.589 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 7.9 ptmm? -52.29 139.19 24.83 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -172.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 86.8 mt -78.74 1.73 22.12 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.96 -177.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 . . . . . 0 CA--C 1.542 0.671 0 CA-C-O 120.845 0.355 . . . . 0.0 110.276 176.843 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.7 mmt . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 64.78 -74.44 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 178.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -58.24 104.82 0.23 Allowed 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -176.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 42.7 t 64.9 100.58 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.07 0.548 . . . . 0.0 111.516 -177.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 94.4 m -128.96 99.06 5.14 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.578 178.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -78.98 118.08 20.64 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.948 176.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.407 HG12 ' H ' ' A' ' 9' ' ' GLY . 10.8 tt -56.72 131.33 20.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 CA-C-O 121.138 0.494 . . . . 0.0 112.014 -178.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -53.19 -34.3 56.39 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -177.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.407 ' H ' HG12 ' A' ' 7' ' ' ILE . . . -60.75 -34.48 86.9 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 121.41 -0.424 . . . . 0.0 113.487 177.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 38.8 tp -73.76 -43.69 58.32 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.363 0.601 . . . . 0.0 110.656 178.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -59.17 -36.25 74.98 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.501 174.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -66.9 -51.03 60.34 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.457 174.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.5 p -60.74 -43.24 98.16 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -177.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -57.61 -55.96 28.08 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.026 0.441 . . . . 0.0 110.492 175.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.455 ' O ' HG12 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -56.91 -34.65 68.14 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.541 177.198 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -63.89 -48.28 77.25 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 120.901 0.381 . . . . 0.0 111.765 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.421 ' HA ' ' HB2' ' A' ' 20' ' ' HIS . 49.9 m-85 -77.72 -23.17 49.48 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.725 -0.216 . . . . 0.0 111.479 176.071 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.78 -47.79 71.04 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 120.913 0.387 . . . . 0.0 111.09 176.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.455 HG12 ' O ' ' A' ' 15' ' ' ARG . 26.3 pt -86.47 1.61 5.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.869 178.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.421 ' HB2' ' HA ' ' A' ' 17' ' ' PHE . 34.6 t-80 -51.8 96.91 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.41 0.624 . . . . 0.0 111.737 -178.106 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 135.31 -50.32 0.86 Allowed Glycine 0 CA--C 1.525 0.705 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.068 -175.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -126.97 111.04 21.9 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 122.443 0.297 . . . . 0.0 111.283 179.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -68.4 -5.08 14.19 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 122.569 2.179 . . . . 0.0 112.417 178.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.3 pttt -93.36 0.06 56.77 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.844 177.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.86 158.94 26.62 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.052 0.454 . . . . 0.0 111.842 -178.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 31.2 p -67.14 -71.23 0.21 Allowed 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.077 -178.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 109.75 14.34 14.21 Favored Glycine 0 CA--C 1.532 1.099 0 N-CA-C 114.674 0.63 . . . . 0.0 114.674 175.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 -97.86 4.19 49.7 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 117.617 0.709 . . . . 0.0 111.468 176.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.484 ' HB3' HG22 ' A' ' 69' ' ' VAL . 31.8 mt-10 -144.9 143.53 30.62 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.042 0.537 . . . . 0.0 110.888 177.429 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.508 ' O ' ' HB ' ' A' ' 69' ' ' VAL . 49.4 ttm -128.8 140.69 51.59 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.06 0.457 . . . . 0.0 111.997 -177.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 27.2 p30 -93.18 164.21 13.33 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.084 0.469 . . . . 0.0 111.868 178.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.456 ' HA2' ' HB3' ' A' ' 35' ' ' TRP . . . -61.72 -25.96 66.25 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 121.386 -0.435 . . . . 0.0 113.224 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -59.08 -57.38 13.32 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 121.196 0.522 . . . . 0.0 111.474 177.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -75.94 -26.37 56.83 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.49 179.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.456 ' HB3' ' HA2' ' A' ' 32' ' ' GLY . 51.7 t-105 -62.52 -45.5 92.71 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.136 0.493 . . . . 0.0 110.875 173.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.72 -45.25 94.78 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.111 176.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -68.71 -31.25 70.2 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.653 177.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.543 HD23 ' HG ' ' A' ' 42' ' ' CYS . 8.2 tt -58.44 -56.79 17.58 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.171 0.51 . . . . 0.0 110.522 178.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.624 ' HA ' ' SG ' ' A' ' 42' ' ' CYS . 28.9 p -63.98 -35.9 82.22 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.613 -179.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -68.42 -41.42 80.42 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.804 0.335 . . . . 0.0 111.443 178.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -73.59 -31.86 63.82 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.624 ' SG ' ' HA ' ' A' ' 39' ' ' CYS . 27.9 p -89.8 -5.97 56.38 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.96 0.409 . . . . 0.0 110.711 173.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt 55.94 25.66 8.93 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.299 0.852 . . . . 0.0 113.299 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.507 HG22 ' SG ' ' A' ' 42' ' ' CYS . 79.1 t -67.54 -37.32 78.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 169.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.92 115.46 7.46 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.925 171.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -131.43 84.53 2.18 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.393 -173.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -33.18 -30.69 0.01 OUTLIER Glycine 0 CA--C 1.537 1.458 0 N-CA-C 116.011 1.165 . . . . 0.0 116.011 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -62.89 -44.6 95.67 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 118.042 0.921 . . . . 0.0 111.1 175.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.5 t -107.61 -55.66 2.32 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.026 176.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 40.9 t -109.37 109.46 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 122.788 0.435 . . . . 0.0 111.788 -177.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 66.1 p -79.58 151.91 30.38 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -56.41 -30.69 58.94 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 121.395 -0.431 . . . . 0.0 112.59 176.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.576 ' O ' HG13 ' A' ' 57' ' ' ILE . 89.2 m -61.92 -50.58 71.58 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 122.867 -0.196 . . . . 0.0 110.845 174.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.432 ' O ' HG23 ' A' ' 58' ' ' VAL . 26.7 t70 -58.22 -41.42 84.07 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.876 0.369 . . . . 0.0 110.951 179.255 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.1 t -58.64 -35.14 53.74 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 CA-C-O 121.183 0.516 . . . . 0.0 111.408 175.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -73.3 -38.28 65.91 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.205 0.526 . . . . 0.0 110.305 179.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.576 HG13 ' O ' ' A' ' 53' ' ' THR . 9.1 mt -62.5 -45.72 98.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.777 177.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 54' ' ' ASP . 94.2 t -58.03 -42.13 82.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.794 177.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -54.91 -43.88 73.67 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 121.178 0.514 . . . . 0.0 111.252 176.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 60.1 p -80.65 -17.48 51.09 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.834 -177.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.433 ' HD3' ' HA ' ' A' ' 61' ' ' LYS . 31.7 mmtp -84.54 -33.12 23.53 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 178.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.502 ' HB ' ' HB3' ' A' ' 74' ' ' GLU . 34.5 m -82.82 -19.63 10.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-O 121.135 0.493 . . . . 0.0 110.729 173.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.4 ttmm -61.2 127.27 30.71 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.285 177.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -71.85 152.12 48.48 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 120.94 -0.648 . . . . 0.0 111.919 171.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -53.53 -44.13 68.94 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -175.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 95.0 p -93.4 4.95 53.13 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 120.849 0.357 . . . . 0.0 111.806 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -88.66 117.58 27.72 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 120.865 0.364 . . . . 0.0 111.671 -178.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 66.3 mtp180 -70.25 -34.37 72.75 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.565 0.698 . . . . 0.0 110.227 178.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.508 ' HB ' ' O ' ' A' ' 30' ' ' MET . 32.4 m -124.82 -160.99 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.486 177.226 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 47.4 pt -119.9 150.02 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 O-C-N 122.051 -0.406 . . . . 0.0 111.28 173.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.482 ' ND2' ' HB2' ' A' ' 73' ' ' GLU . 4.2 p-10 -102.57 169.62 8.54 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 120.778 0.323 . . . . 0.0 111.461 179.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -54.19 -40.68 67.81 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -175.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.482 ' HB2' ' ND2' ' A' ' 71' ' ' ASN . 43.0 mt-10 -55.81 -43.53 76.98 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.819 0.342 . . . . 0.0 111.353 176.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.607 ' HA ' ' HD3' ' A' ' 77' ' ' LYS . 11.0 mm-40 -71.99 -31.69 66.49 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.009 0.433 . . . . 0.0 110.75 178.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -58.09 -43.7 87.23 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.098 176.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -54.9 -49.49 71.11 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.524 0.678 . . . . 0.0 110.987 173.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.607 ' HD3' ' HA ' ' A' ' 74' ' ' GLU . 51.0 mtpt -62.97 -36.66 84.23 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.684 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.7 -47.05 70.49 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.581 178.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 75.8 mt -59.35 -47.47 85.31 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.817 0.341 . . . . 0.0 111.195 177.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -54.22 -40.89 68.08 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 121.114 0.483 . . . . 0.0 111.224 178.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -61.18 -61.42 2.57 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.016 0.436 . . . . 0.0 111.164 176.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 80.9 mt -58.29 -30.87 66.97 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.963 0.411 . . . . 0.0 111.54 -179.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.03 -51.36 67.08 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.983 176.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 68.0 p -65.65 -17.21 64.43 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -72.22 -55.81 6.6 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 120.756 0.313 . . . . 0.0 111.593 174.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 62.5 mtp180 -81.35 -47.26 13.51 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.872 0.368 . . . . 0.0 111.668 -178.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -84.9 144.91 28.07 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.793 0.33 . . . . 0.0 110.519 177.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 41.6 mtpt -81.53 157.55 24.77 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.308 0.575 . . . . 0.0 112.096 -177.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -78.22 60.89 3.88 Favored Glycine 0 CA--C 1.528 0.897 0 CA-C-N 116.019 -0.537 . . . . 0.0 114.298 -173.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 58.7 pttt -96.3 -34.79 11.47 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.239 0.543 . . . . 0.0 110.488 173.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 32.3 t -167.26 115.8 0.81 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.141 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -65.68 -25.86 67.53 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 120.783 0.325 . . . . 0.0 110.707 174.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -57.22 -58.46 8.11 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.145 177.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -70.12 -37.7 75.39 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.305 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.51 -41.79 95.08 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.847 0.356 . . . . 0.0 111.54 178.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -67.8 -40.49 83.91 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.441 178.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -55.16 -52.67 62.57 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.421 0.629 . . . . 0.0 110.776 174.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.33 -52.62 62.92 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 115.166 -0.925 . . . . 0.0 112.581 -176.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.0 tt -59.65 -38.01 73.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 O-C-N 121.903 -0.498 . . . . 0.0 110.772 178.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 83.0 m -73.68 -24.15 59.92 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.177 175.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.94 -34.29 77.17 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.503 0.668 . . . . 0.0 109.81 175.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 94.4 mt -80.3 -25.99 39.07 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.487 177.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 76.6 t -100.57 -53.62 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -175.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -51.56 125.99 16.2 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -176.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 69.93 0.65 28.08 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-N 115.861 -0.609 . . . . 0.0 114.257 178.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.475 ' HD3' ' N ' ' A' ' 107' ' ' GLU . 11.7 tmtt? -87.79 134.63 33.64 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 121.382 0.61 . . . . 0.0 111.057 -176.04 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.475 ' N ' ' HD3' ' A' ' 106' ' ' LYS . 0.9 OUTLIER -89.12 154.61 49.49 Favored Pre-proline 0 CA--C 1.547 0.854 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -174.347 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -62.62 120.21 7.63 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 122.526 2.151 . . . . 0.0 112.37 175.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -98.04 -53.75 3.29 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -175.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.501 ' N ' HD21 ' A' ' 110' ' ' ASN . 0.8 OUTLIER 62.52 97.93 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 122.664 0.385 . . . . 0.0 111.024 -176.02 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 66.8 t 71.87 -58.44 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 123.246 0.619 . . . . 0.0 110.965 -174.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 109.07 74.89 0.84 Allowed Glycine 0 CA--C 1.525 0.658 0 C-N-CA 121.238 -0.506 . . . . 0.0 113.477 175.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.6 p -74.44 -39.88 48.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 O-C-N 122.555 -0.379 . . . . 0.0 110.947 176.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 40.2 m -68.02 102.19 1.26 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.942 176.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.854 ' HZ1' ' HB3' ' A' ' 115' ' ' LYS . 0.3 OUTLIER -137.84 7.71 2.74 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.816 0.341 . . . . 0.0 111.731 178.699 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.422 ' O ' ' HB2' ' A' ' 117' ' ' LYS . . . -64.39 102.29 0.52 Allowed 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.83 176.18 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.708 ' HZ3' ' HB2' ' A' ' 117' ' ' LYS . 8.3 mtmp? 71.95 81.22 0.15 Allowed 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.238 0.542 . . . . 0.0 110.686 -174.128 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 82.4 m -75.14 126.41 30.96 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.507 -177.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -81.41 150.95 30.59 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 121.205 -0.521 . . . . 0.0 113.601 -179.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 83.38 -55.61 5.03 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 121.275 -0.488 . . . . 0.0 113.574 177.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 69.93 172.73 0.3 Allowed 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.1 p -78.53 135.29 26.27 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 CA-C-O 121.33 0.586 . . . . 0.0 112.354 -178.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -83.72 45.99 1.12 Allowed 'General case' 0 CA--C 1.548 0.878 0 CA-C-O 121.245 0.545 . . . . 0.0 111.518 178.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -77.24 115.43 17.01 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -177.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 9.6 mp -112.67 -53.54 2.7 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.52 170.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 26.2 p 62.42 -65.69 0.09 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.611 1.164 . . . . 0.0 112.972 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -76.62 151.65 36.15 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.051 0.453 . . . . 0.0 111.715 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 74.3 p -77.3 95.38 4.35 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 120.942 0.401 . . . . 0.0 112.009 -176.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 29.0 t -59.23 137.62 57.9 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.575 174.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 9.2 mmm-85 -65.47 -18.21 65.15 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -176.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -84.69 90.3 7.68 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.538 0.685 . . . . 0.0 110.958 175.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 9.1 t -111.31 3.89 18.66 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.487 -0.778 . . . . 0.0 111.625 -178.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 129.36 -86.45 0.31 Allowed Glycine 0 CA--C 1.523 0.585 0 C-N-CA 121.411 -0.423 . . . . 0.0 112.766 -176.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 21.2 t 62.26 -76.1 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.012 0.525 . . . . 0.0 111.579 179.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -157.81 86.69 0.92 Allowed 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.071 0.462 . . . . 0.0 111.511 172.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 50.6 pttt -72.35 136.34 46.13 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.979 171.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -116.58 100.98 8.22 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -173.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.44 HH11 ' HD3' ' A' ' 138' ' ' ARG . 7.3 tpp180 -117.9 20.64 13.25 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-O 121.576 0.703 . . . . 0.0 110.414 175.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -83.28 32.7 0.45 Allowed 'General case' 0 CA--C 1.545 0.787 0 CA-C-O 121.501 0.667 . . . . 0.0 111.329 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -85.11 106.82 16.85 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.516 0.674 . . . . 0.0 111.141 177.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -94.33 45.52 1.13 Allowed 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.38 -177.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 46.6 t -90.37 148.63 22.71 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 120.862 0.363 . . . . 0.0 111.936 -176.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -89.87 -138.6 7.14 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 121.46 -0.4 . . . . 0.0 113.355 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -88.65 78.58 7.71 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 122.219 -0.577 . . . . 0.0 111.197 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -98.0 -159.43 30.43 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.159 -0.543 . . . . 0.0 113.308 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -78.61 -16.55 57.24 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 122.362 -0.493 . . . . 0.0 111.804 -179.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -79.81 20.35 5.5 Favored Glycine 0 CA--C 1.53 1.01 0 N-CA-C 114.341 0.496 . . . . 0.0 114.341 -175.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 37.1 pt -77.25 32.39 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 O-C-N 122.243 -0.563 . . . . 0.0 112.481 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -82.17 16.95 1.77 Allowed 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -176.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -158.1 146.53 13.49 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 121.334 -0.46 . . . . 0.0 112.621 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 75.8 mtm180 -134.36 163.77 28.92 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.873 0.368 . . . . 0.0 111.45 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 9.0 mm100 -86.18 -167.61 1.93 Allowed 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.291 0.567 . . . . 0.0 111.895 179.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -53.6 -28.85 34.68 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.355 176.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 9.2 tt -54.45 123.11 4.8 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 179.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -110.69 -44.95 3.57 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.287 0.565 . . . . 0.0 109.987 176.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -75.75 157.62 33.29 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.832 177.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 15.6 t70 71.35 164.63 0.28 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 122.65 0.38 . . . . 0.0 110.803 -175.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 51.7 m 73.06 -43.84 0.57 Allowed 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 179.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -59.0 108.85 1.76 Allowed Glycine 0 CA--C 1.531 1.087 0 C-N-CA 121.527 -0.368 . . . . 0.0 113.581 178.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 39.8 t80 60.63 103.47 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.169 0.587 . . . . 0.0 111.851 -177.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.559 HG22 ' HB2' ' A' ' 164' ' ' TYR . 7.2 p -79.24 121.51 32.59 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -177.116 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 72.4 m -139.11 92.53 2.6 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.145 170.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 64.55 77.26 0.32 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.22 -172.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . 0.559 ' HB2' HG22 ' A' ' 161' ' ' VAL . 0.9 OUTLIER -83.36 56.82 3.71 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.572 0.701 . . . . 0.0 110.587 -176.931 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -130.4 141.67 50.54 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.217 -176.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -62.99 134.13 55.68 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -178.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -153.22 -60.46 0.14 Allowed 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.163 177.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 73.26 -69.56 1.34 Allowed Glycine 0 CA--C 1.528 0.872 0 C-N-CA 121.195 -0.526 . . . . 0.0 113.244 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 8.9 t -99.64 159.44 15.04 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.988 0.423 . . . . 0.0 111.425 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -118.75 168.64 10.54 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.891 0.377 . . . . 0.0 111.728 -177.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -70.37 125.28 26.35 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.117 0.484 . . . . 0.0 111.482 -177.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -148.45 124.32 10.6 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.621 177.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.402 ' O ' HG21 ' A' ' 174' ' ' VAL . 37.4 mtmm 63.65 32.66 13.72 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.108 -175.378 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.402 HG21 ' O ' ' A' ' 173' ' ' LYS . 15.6 m 52.79 127.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 125.186 1.394 . . . . 0.0 114.41 179.073 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -98.5 126.88 44.21 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.544 179.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 30.3 mtpp -74.83 124.39 26.76 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 122.185 -0.322 . . . . 0.0 111.198 176.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 81.0 mt -87.91 167.47 13.73 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.976 0.417 . . . . 0.0 111.765 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 . . . . . 0 N--CA 1.47 0.558 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.702 179.709 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.2 mtt . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.07 0.462 . . . . 0.0 111.313 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -139.93 130.08 25.09 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.133 -178.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -175.72 -53.96 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.192 0.52 . . . . 0.0 111.346 -177.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 75.6 m -144.96 -21.53 0.5 Allowed 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.633 177.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 44.2 p -75.04 0.9 14.45 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 177.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -65.37 -171.03 0.07 Allowed 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 121.103 0.477 . . . . 0.0 111.958 177.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.486 ' N ' HD12 ' A' ' 7' ' ' ILE . 2.9 mp -73.91 96.65 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 CA-C-O 120.788 0.328 . . . . 0.0 111.004 -177.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.64 -26.4 65.32 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.264 0.554 . . . . 0.0 111.404 179.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -55.76 -28.46 52.36 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.381 175.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 34.4 tp -58.33 -38.79 77.84 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.954 0.407 . . . . 0.0 110.704 178.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -67.85 -44.11 77.92 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 120.865 0.364 . . . . 0.0 110.246 173.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 20.5 tp10 -54.75 -47.0 74.39 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 178.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.501 ' HB3' ' HA2' ' A' ' 105' ' ' GLY . 53.9 p -67.49 -52.34 40.34 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -53.04 -47.13 68.62 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.273 0.559 . . . . 0.0 111.211 175.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -60.38 -36.14 77.36 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.261 177.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -73.34 -38.17 65.85 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.552 -178.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -74.28 -38.3 63.45 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 120.609 0.243 . . . . 0.0 111.388 176.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.401 ' HB2' ' HA2' ' A' ' 27' ' ' GLY . . . -55.94 -49.81 72.47 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.502 ' HA ' ' HB3' ' A' ' 25' ' ' ALA . 33.9 pt -78.67 6.06 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -178.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -90.73 146.07 24.29 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.984 0.421 . . . . 0.0 111.837 -177.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 79.15 -60.88 4.2 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 121.164 -0.541 . . . . 0.0 112.533 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -96.59 105.66 24.52 Favored Pre-proline 0 CA--C 1.542 0.657 0 CA-C-O 120.892 0.377 . . . . 0.0 111.115 177.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.14 -7.31 20.53 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.596 2.197 . . . . 0.0 113.387 -178.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -97.88 11.76 36.3 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 178.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.502 ' HB3' ' HA ' ' A' ' 19' ' ' ILE . . . -77.21 161.08 28.44 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.288 0.566 . . . . 0.0 112.356 -178.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 96.6 p -87.95 -45.15 10.48 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.978 -178.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.401 ' HA2' ' HB2' ' A' ' 18' ' ' ALA . . . 108.05 -19.93 31.79 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 121.393 -0.432 . . . . 0.0 112.481 -175.009 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 56.4 tp60 -96.54 -21.36 17.73 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.95 0.405 . . . . 0.0 110.841 177.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -125.25 129.49 50.15 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.54 178.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.423 ' HE2' HD12 ' A' ' 38' ' ' LEU . 54.7 ttp -125.29 148.91 48.5 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.118 0.485 . . . . 0.0 112.196 -177.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.479 ' OD1' ' HB3' ' A' ' 33' ' ' LYS . 16.9 p30 -93.07 172.09 8.53 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -177.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.533 ' HA2' ' HB3' ' A' ' 35' ' ' TRP . . . -60.83 -27.06 66.11 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-N 116.21 -0.45 . . . . 0.0 112.871 176.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.479 ' HB3' ' OD1' ' A' ' 31' ' ' ASN . 87.1 tttt -50.81 -64.47 0.8 Allowed 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 123.941 0.897 . . . . 0.0 112.117 175.393 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -77.42 -25.08 50.38 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.972 -0.455 . . . . 0.0 111.51 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.533 ' HB3' ' HA2' ' A' ' 32' ' ' GLY . 55.8 t-105 -59.76 -38.61 82.27 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.203 0.525 . . . . 0.0 110.462 171.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.92 -43.62 87.58 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.75 174.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -53.6 -48.75 68.97 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.647 174.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.423 HD12 ' HE2' ' A' ' 30' ' ' MET . 7.6 mt -52.59 -49.65 64.59 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.027 0.441 . . . . 0.0 111.644 177.059 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 73.8 m -55.9 -42.55 76.19 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.674 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -75.34 -39.86 58.91 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.071 0.462 . . . . 0.0 111.92 -178.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.554 ' HA ' HD22 ' A' ' 110' ' ' ASN . 24.7 t0 -70.83 -42.51 70.1 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 122.144 -0.348 . . . . 0.0 111.277 -177.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.572 ' SG ' HG22 ' A' ' 103' ' ' VAL . 62.9 m -83.41 -12.38 56.5 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.44 176.081 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? 64.7 37.94 7.26 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.179 0.592 . . . . 0.0 111.957 179.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.459 HG12 HD13 ' A' ' 82' ' ' LEU . 51.6 t -75.32 -34.93 31.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-O 121.155 0.503 . . . . 0.0 110.079 173.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.72 82.09 2.08 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.481 0.657 . . . . 0.0 111.054 177.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -65.47 -40.26 92.94 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.483 -178.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.97 -38.55 3.23 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 121.392 -0.432 . . . . 0.0 112.806 -176.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -96.52 -48.08 5.69 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.18 0.514 . . . . 0.0 111.15 178.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.4 t -90.17 -44.54 9.7 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.318 178.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 54.0 t -121.51 108.88 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.499 177.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.401 ' O ' HG22 ' A' ' 55' ' ' VAL . 68.2 p -94.06 163.31 13.53 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -175.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -56.15 -44.41 88.74 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 121.19 -0.528 . . . . 0.0 112.744 176.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.563 ' O ' HG12 ' A' ' 57' ' ' ILE . 7.8 t -61.86 -41.04 97.35 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 122.53 -0.394 . . . . 0.0 110.69 175.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -59.85 -37.71 80.02 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.009 0.433 . . . . 0.0 110.584 176.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.401 HG22 ' O ' ' A' ' 51' ' ' THR . 76.3 t -59.39 -35.16 56.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.147 174.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -76.26 -34.39 59.15 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.817 0.817 . . . . 0.0 109.754 178.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.563 HG12 ' O ' ' A' ' 53' ' ' THR . 9.7 mm -60.61 -54.51 34.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.009 175.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 74.3 t -57.96 -40.3 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-O 120.728 0.299 . . . . 0.0 111.557 178.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -61.71 -44.13 97.51 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.045 0.45 . . . . 0.0 110.512 178.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 78.3 p -80.33 -15.06 57.77 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.108 0.48 . . . . 0.0 111.452 178.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 24.8 tptp -74.78 -49.98 18.92 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.166 0.587 . . . . 0.0 111.709 178.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.7 m -85.02 -24.56 7.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -179.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -57.7 131.54 50.57 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 179.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -77.68 -162.86 19.01 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-O 121.291 0.384 . . . . 0.0 113.994 179.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 21.3 ttpp -82.06 148.16 28.75 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -177.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 48.5 p 51.18 17.91 0.53 Allowed 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 173.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -110.64 146.49 36.08 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.878 0.371 . . . . 0.0 110.811 177.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 7.4 ptp85 -114.97 15.37 17.26 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.271 0.557 . . . . 0.0 110.862 178.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 22.2 m -145.72 169.86 6.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.661 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 37.2 pt -122.37 143.09 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-O 120.681 0.277 . . . . 0.0 110.885 175.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -100.72 177.79 4.89 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 120.888 0.375 . . . . 0.0 111.467 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -55.76 -27.33 50.23 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 113.159 0.799 . . . . 0.0 113.159 -175.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -70.7 -59.79 2.62 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.782 -0.574 . . . . 0.0 111.076 174.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -56.82 -32.42 65.7 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.436 0.636 . . . . 0.0 110.627 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -60.61 -51.54 68.98 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.733 176.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 37.5 mtmm -60.95 -42.72 98.78 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -59.43 -40.9 88.25 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 120.997 0.427 . . . . 0.0 110.839 175.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.02 -43.37 98.98 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.42 177.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 85.0 mt -57.7 -43.12 84.94 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.725 178.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -60.11 -46.42 89.69 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 120.722 0.296 . . . . 0.0 111.241 177.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.464 ' O ' ' HG3' ' A' ' 85' ' ' LYS . 52.5 mt-10 -59.24 -50.56 73.53 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.548 0.213 . . . . 0.0 111.274 177.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.459 HD13 HG12 ' A' ' 44' ' ' VAL . 95.9 mt -58.88 -40.32 84.02 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.023 0.439 . . . . 0.0 111.381 176.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.87 -51.41 70.16 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.807 178.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 56.2 p -65.99 -22.17 66.45 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -178.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' A' ' 81' ' ' GLU . 96.9 mttt -78.23 -43.24 28.86 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 120.887 0.375 . . . . 0.0 111.225 174.338 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 26.7 tpt180 -81.32 -63.93 1.29 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.026 0.441 . . . . 0.0 111.133 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -79.16 88.18 4.87 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.361 0.6 . . . . 0.0 110.527 178.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 53.1 mttm -80.01 87.86 5.39 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.421 -173.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -156.46 4.53 0.19 Allowed Glycine 0 CA--C 1.533 1.212 0 C-N-CA 120.86 -0.686 . . . . 0.0 114.468 178.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 82.8 tttt 72.86 -43.71 0.57 Allowed 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 33.7 p -46.19 105.04 0.06 Allowed 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -175.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 46.4 mttm -60.37 -63.15 1.4 Allowed 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -176.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -54.32 -48.06 71.77 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -175.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -66.71 -44.38 81.79 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -178.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.65 -41.01 93.06 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.011 0.434 . . . . 0.0 111.426 179.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -68.75 -37.18 79.2 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.043 178.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -62.17 -49.37 76.11 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.373 0.606 . . . . 0.0 110.001 174.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -58.87 -49.89 76.07 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.296 -0.866 . . . . 0.0 112.669 -179.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.4 tp -60.89 -38.69 79.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-O 121.149 0.499 . . . . 0.0 110.904 178.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 75.0 m -73.65 -25.36 60.24 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.105 176.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -72.75 -32.4 65.64 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.024 0.44 . . . . 0.0 110.616 177.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 90.4 mt -64.16 -55.2 23.48 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.077 0.465 . . . . 0.0 110.924 173.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.572 HG22 ' SG ' ' A' ' 42' ' ' CYS . 41.2 t -69.34 -65.15 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.004 178.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 48.95 -100.46 0.07 Allowed 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.494 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.501 ' HA2' ' HB3' ' A' ' 13' ' ' SER . . . -151.13 44.18 0.68 Allowed Glycine 0 CA--C 1.523 0.54 0 C-N-CA 121.199 -0.524 . . . . 0.0 112.407 -179.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.48 ' HZ3' ' CG ' ' A' ' 41' ' ' ASP . 49.6 tttm -74.37 155.33 38.24 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-O 121.141 0.496 . . . . 0.0 112.337 -177.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -66.56 137.55 95.23 Favored Pre-proline 0 CA--C 1.545 0.756 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.769 173.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -66.54 147.14 81.69 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.564 2.176 . . . . 0.0 113.898 -173.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 75.64 162.65 0.25 Allowed 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.686 177.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.554 HD22 ' HA ' ' A' ' 41' ' ' ASP . 4.0 m120 -92.88 117.07 29.63 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.728 -174.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 31.0 m -87.08 134.13 28.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 170.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 80.85 64.24 1.82 Allowed Glycine 0 CA--C 1.528 0.871 0 C-N-CA 120.697 -0.763 . . . . 0.0 111.582 -173.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 49.0 t -59.73 -43.66 92.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -172.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 87.0 m -114.82 108.28 16.54 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.19 0.519 . . . . 0.0 112.051 -177.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.569 ' HA ' ' NH2' ' A' ' 124' ' ' ARG . 58.8 pttt -115.76 -35.9 4.36 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.011 174.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.504 ' HA ' HG21 ' A' ' 122' ' ' VAL . . . -166.2 105.46 0.66 Allowed 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.229 178.043 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -125.78 -63.16 1.14 Allowed 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.992 0.425 . . . . 0.0 111.107 179.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 91.8 m -86.28 95.77 9.73 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.084 0.468 . . . . 0.0 110.416 176.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 97.72 144.12 16.35 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.347 -176.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -68.0 -40.42 88.77 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 120.817 -0.706 . . . . 0.0 113.253 -179.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -106.34 85.14 2.13 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.166 0.507 . . . . 0.0 111.726 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.504 HG21 ' HA ' ' A' ' 116' ' ' ALA . 59.3 t -83.02 161.76 3.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.517 175.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -56.84 91.36 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -175.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.569 ' NH2' ' HA ' ' A' ' 115' ' ' LYS . 48.9 mmt-85 -120.72 -171.97 2.29 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.855 171.204 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 34.5 tp 66.12 15.78 10.2 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.852 0.834 . . . . 0.0 109.73 -170.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 65.4 p -99.54 -38.73 8.65 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.572 -176.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 66.29 -65.36 0.19 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.157 0.583 . . . . 0.0 111.834 -176.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 59.4 m 66.83 93.64 0.07 Allowed 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 174.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 63.8 p -96.64 135.82 38.03 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.994 173.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -91.87 -6.28 51.81 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -172.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 22.3 p90 39.1 35.66 0.14 Allowed 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 175.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 93.8 m -143.11 -55.41 0.4 Allowed 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.838 0.351 . . . . 0.0 111.198 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -172.63 163.04 34.91 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 120.918 -0.658 . . . . 0.0 113.27 -179.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 73.9 p -80.15 -177.63 6.16 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.25 0.548 . . . . 0.0 111.865 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 77.5 m-70 -78.08 80.37 4.51 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.079 0.466 . . . . 0.0 110.99 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -84.66 144.89 28.28 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.058 0.456 . . . . 0.0 111.91 -177.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -155.92 95.58 1.65 Allowed 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.432 176.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -84.95 106.73 16.67 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.296 179.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -56.5 128.78 37.83 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 174.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -57.77 -22.94 49.7 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -171.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -84.48 -67.87 0.76 Allowed 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 120.525 0.203 . . . . 0.0 111.082 175.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 75.7 m 71.65 -47.43 0.66 Allowed 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 112.848 0.685 . . . . 0.0 112.848 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -60.44 125.96 39.97 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 121.495 -0.383 . . . . 0.0 113.313 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -67.77 107.93 2.77 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.212 0.53 . . . . 0.0 110.817 178.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -81.64 65.5 4.01 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 114.716 0.646 . . . . 0.0 114.716 -170.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 43.2 tttm -91.22 126.8 36.42 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 122.273 -0.545 . . . . 0.0 111.069 173.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -74.09 143.63 32.31 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.725 178.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 14.3 tt -65.14 -30.59 50.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 121.176 0.512 . . . . 0.0 111.571 -178.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -83.08 -13.67 55.26 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.408 177.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -81.66 87.06 1.4 Allowed Glycine 0 CA--C 1.526 0.751 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.185 177.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 151' ' ' ARG . 41.3 mtt180 -84.37 141.3 30.97 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -174.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -116.93 61.04 0.74 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.29 0.566 . . . . 0.0 110.418 173.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -68.11 129.57 40.31 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.543 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 46.6 mm -88.1 94.98 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-O 121.364 0.602 . . . . 0.0 111.213 -177.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 27.2 tp -128.41 4.81 5.68 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.097 175.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -67.92 157.48 34.87 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.897 -177.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -88.01 96.09 10.38 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -175.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 37.5 t -92.92 137.6 32.22 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.593 174.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.419 ' C ' ' H ' ' A' ' 161' ' ' VAL . . . 173.42 -27.62 0.09 OUTLIER Glycine 0 CA--C 1.525 0.692 0 C-N-CA 120.253 -0.975 . . . . 0.0 113.969 -178.03 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 70.56 -24.02 0.17 Allowed 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 178.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.419 ' H ' ' C ' ' A' ' 159' ' ' GLY . 31.5 m -59.58 126.92 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -176.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 34.9 t 176.2 -22.5 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.157 178.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -69.02 74.37 0.3 Allowed 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.32 0.581 . . . . 0.0 111.872 178.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -102.99 -16.46 15.81 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.357 178.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -99.13 125.86 44.77 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.11 -178.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -86.32 121.03 28.33 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 120.924 0.393 . . . . 0.0 111.691 -178.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -109.69 82.86 1.66 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.114 0.483 . . . . 0.0 111.084 177.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -93.52 -138.58 9.0 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 121.09 -0.576 . . . . 0.0 113.724 -177.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 68.8 p -95.09 116.91 29.33 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.897 0.379 . . . . 0.0 111.877 -177.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -142.04 144.73 33.76 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.066 178.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -71.83 72.95 0.83 Allowed 'General case' 0 CA--C 1.546 0.799 0 CA-C-O 121.663 0.744 . . . . 0.0 111.217 177.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.49 -26.65 62.77 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -175.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -159.94 -36.29 0.06 Allowed 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.465 0.542 . . . . 0.0 112.465 -176.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 88.8 t 70.15 -65.06 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 122.843 0.457 . . . . 0.0 112.178 -179.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -73.26 161.43 30.53 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.361 0.6 . . . . 0.0 111.991 -178.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -127.99 117.01 20.94 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.761 175.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 58.0 tp -52.42 97.69 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -173.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 . . . . . 0 CA--C 1.539 0.531 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 175.792 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.4 mtm . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.489 0.185 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.08 149.64 33.88 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.759 0.314 . . . . 0.0 111.742 179.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -104.5 142.67 34.21 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.363 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 37.6 m -81.75 172.55 13.25 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.466 0.651 . . . . 0.0 112.179 -177.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 77.4 p -97.02 -160.06 0.78 Allowed 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.476 177.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -69.45 -152.4 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.956 0 CA-C-O 120.702 0.287 . . . . 0.0 111.434 175.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.404 ' N ' HD12 ' A' ' 7' ' ' ILE . 3.5 mp -71.69 97.66 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 CA-C-O 121.181 0.515 . . . . 0.0 111.696 -172.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.16 -34.95 78.72 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-O 121.329 0.585 . . . . 0.0 111.607 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -59.98 -19.95 52.13 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.698 176.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.647 HD22 ' SG ' ' A' ' 100' ' ' CYS . 43.6 tp -74.9 -38.85 61.75 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 120.713 0.292 . . . . 0.0 110.405 177.412 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -59.09 -41.23 87.55 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.009 173.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.542 ' O ' ' HG3' ' A' ' 16' ' ' LYS . 42.5 mt-10 -55.34 -54.45 43.5 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.207 175.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 41.7 t -55.37 -54.94 37.35 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.752 -178.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.432 ' CE1' ' HE2' ' A' ' 30' ' ' MET . 90.8 t80 -53.55 -43.33 68.34 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.28 0.562 . . . . 0.0 110.771 176.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 63.8 ttt180 -62.36 -32.74 73.57 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.112 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.542 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 95.8 mttt -74.83 -39.37 61.67 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.564 178.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.847 ' HB3' ' SD ' ' A' ' 30' ' ' MET . 18.2 m-85 -69.67 -38.78 77.2 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 120.896 0.379 . . . . 0.0 111.43 175.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.2 -40.46 97.56 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -178.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.459 HG22 ' O ' ' A' ' 25' ' ' ALA . 29.2 pt -86.85 13.13 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-O 120.874 0.369 . . . . 0.0 111.839 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 37.6 t-80 -109.13 95.69 5.8 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.812 0.339 . . . . 0.0 111.652 -175.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 108.78 -46.55 1.15 Allowed Glycine 0 CA--C 1.521 0.457 0 C-N-CA 121.147 -0.549 . . . . 0.0 111.895 -175.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -74.3 108.34 4.97 Favored Pre-proline 0 CA--C 1.544 0.741 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 171.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -56.92 -38.73 95.26 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.752 2.301 . . . . 0.0 114.298 -169.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.5 mtpt -124.79 28.78 6.39 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -172.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.459 ' O ' HG22 ' A' ' 19' ' ' ILE . . . -74.93 123.56 25.32 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.772 0.32 . . . . 0.0 111.272 179.428 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 55.4 m -69.45 -2.02 10.03 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.52 -1.53 66.57 Favored Glycine 0 CA--C 1.523 0.593 0 C-N-CA 121.402 -0.428 . . . . 0.0 112.94 -178.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -86.35 -37.77 18.12 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.99 0.424 . . . . 0.0 111.775 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -116.66 131.58 56.91 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.86 -175.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.847 ' SD ' ' HB3' ' A' ' 17' ' ' PHE . 58.2 ttp -127.64 140.75 51.9 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.988 0.423 . . . . 0.0 111.801 178.28 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.451 ' OD1' ' HB3' ' A' ' 33' ' ' LYS . 10.9 p30 -74.79 167.69 21.34 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 121.249 0.547 . . . . 0.0 112.241 -178.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -70.95 -21.59 78.27 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-N 116.075 -0.511 . . . . 0.0 114.033 -178.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.451 ' HB3' ' OD1' ' A' ' 31' ' ' ASN . 61.5 tttp -70.88 -44.22 66.77 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 117.314 0.557 . . . . 0.0 111.052 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -72.34 -26.43 61.93 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 122.179 -0.326 . . . . 0.0 110.938 174.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 49.7 t-105 -65.45 -52.35 53.75 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 120.885 0.374 . . . . 0.0 111.167 173.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.428 ' O ' ' SG ' ' A' ' 39' ' ' CYS . . . -57.93 -42.54 85.06 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.411 0.624 . . . . 0.0 110.583 174.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -61.04 -40.12 92.39 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.985 174.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.6 tt -55.22 -46.95 75.95 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.713 -178.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.58 ' SG ' HG21 ' A' ' 55' ' ' VAL . 15.7 p -66.1 -49.33 67.9 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.671 0.272 . . . . 0.0 111.467 -179.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.439 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 88.7 tttt -67.64 -34.62 77.31 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 120.904 0.383 . . . . 0.0 111.525 -175.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 49.0 t0 -77.8 -36.96 49.72 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 120.869 0.366 . . . . 0.0 110.824 179.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.566 ' SG ' ' HD3' ' A' ' 106' ' ' LYS . 77.7 m -87.12 4.11 43.54 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 178.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm 74.61 15.01 3.38 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 172.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 55.3 t -69.04 -32.67 55.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-O 120.788 0.328 . . . . 0.0 111.087 178.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.1 98.12 6.41 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 120.919 0.39 . . . . 0.0 111.32 178.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -90.79 -37.75 13.44 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -178.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 111.97 -25.87 12.3 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 121.286 -0.483 . . . . 0.0 113.608 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -88.87 -53.47 4.59 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.102 0.477 . . . . 0.0 110.72 178.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 64.6 m -98.22 -41.58 7.82 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.226 179.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.3 t -111.37 102.5 14.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 121.108 0.48 . . . . 0.0 110.691 175.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 48.5 p -93.4 15.02 16.74 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -176.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.6 -52.37 4.69 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.573 -173.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.578 ' O ' HG13 ' A' ' 57' ' ' ILE . 49.1 m -50.53 -46.44 57.35 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.131 0.491 . . . . 0.0 109.949 172.477 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -53.31 -35.31 60.01 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.109 176.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.58 HG21 ' SG ' ' A' ' 39' ' ' CYS . 56.3 t -66.01 -36.88 78.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 120.895 0.378 . . . . 0.0 110.74 177.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -69.79 -37.93 76.49 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.37 0.605 . . . . 0.0 109.886 175.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.578 HG13 ' O ' ' A' ' 53' ' ' THR . 6.8 mt -63.89 -50.42 77.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.191 178.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 71.3 t -58.55 -38.15 69.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-O 120.87 0.367 . . . . 0.0 111.34 177.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -59.11 -45.31 91.21 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.215 0.531 . . . . 0.0 110.022 176.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.438 ' HA ' ' HE2' ' A' ' 63' ' ' LYS . 80.7 p -79.14 -12.64 59.99 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.574 177.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.414 ' HE3' ' OE2' ' A' ' 81' ' ' GLU . 61.0 tttp -85.53 -21.96 28.36 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 121.303 0.573 . . . . 0.0 110.763 178.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.492 ' HB ' ' HB3' ' A' ' 74' ' ' GLU . 28.4 m -103.52 -18.85 6.49 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.564 171.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.438 ' HE2' ' HA ' ' A' ' 60' ' ' SER . 37.7 ttpt -71.77 93.37 1.29 Allowed 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 120.974 0.416 . . . . 0.0 111.53 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -93.72 -12.53 56.73 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 121.356 -0.449 . . . . 0.0 113.187 -177.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.525 ' HG2' ' N ' ' A' ' 66' ' ' SER . 22.6 ttmm -111.83 164.7 12.79 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 122.622 0.369 . . . . 0.0 110.359 178.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.525 ' N ' ' HG2' ' A' ' 65' ' ' LYS . 86.0 p -74.55 59.6 0.84 Allowed 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.373 0.606 . . . . 0.0 109.649 169.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.481 ' HB1' ' HD2' ' A' ' 65' ' ' LYS . . . -114.72 150.23 35.61 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.446 -171.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 35.0 mtp180 -90.98 -2.7 57.67 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.305 174.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 27.0 m -135.96 144.43 33.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -173.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 27.6 pt -103.21 158.86 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.964 173.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -103.42 179.42 4.28 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.172 0.511 . . . . 0.0 111.743 -178.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -67.47 -36.3 80.87 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -64.55 -57.11 10.07 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 179.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.492 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 0.9 OUTLIER -64.96 -20.46 66.49 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 122.123 -0.361 . . . . 0.0 111.312 177.034 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -63.94 -43.15 96.72 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 120.781 0.324 . . . . 0.0 110.962 173.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -55.16 -46.32 75.74 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 121.178 0.514 . . . . 0.0 110.594 174.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.43 ' O ' ' HG3' ' A' ' 81' ' ' GLU . 59.7 tttm -61.49 -50.85 71.09 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.402 177.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -53.2 -43.71 67.41 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.119 -178.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.484 HD11 HD23 ' A' ' 10' ' ' LEU . 79.9 mt -68.26 -39.86 82.09 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 178.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.5 ' O ' HG22 ' A' ' 84' ' ' THR . 38.0 tt0 -55.51 -47.2 76.62 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.309 0.576 . . . . 0.0 110.748 176.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 77' ' ' LYS . 38.0 mt-10 -65.41 -52.84 50.53 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.444 -179.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 58.9 mt -55.55 -36.72 67.09 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 122.252 -0.28 . . . . 0.0 111.428 174.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.16 -45.64 84.11 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 111.661 0.245 . . . . 0.0 111.661 179.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.5 HG22 ' O ' ' A' ' 80' ' ' GLU . 70.7 p -61.19 -29.5 69.84 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 38.4 mtpt -84.57 -48.47 9.5 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 122.026 -0.421 . . . . 0.0 111.967 173.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 32.4 tpt85 -60.05 -56.99 14.79 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.355 0.598 . . . . 0.0 111.873 -176.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -86.06 172.72 10.4 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.055 -178.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -79.58 171.43 15.16 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.259 -0.428 . . . . 0.0 112.137 -174.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -71.79 67.48 1.06 Allowed Glycine 0 CA--C 1.528 0.858 0 CA-C-N 116.034 -0.53 . . . . 0.0 113.186 178.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -119.81 174.6 6.34 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 45.9 t -44.97 123.32 3.76 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 178.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -52.2 -35.48 49.26 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.662 -178.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 -50.06 -62.84 1.34 Allowed 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.327 177.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -58.64 -42.04 87.37 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.787 0.327 . . . . 0.0 111.435 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.76 -37.41 81.74 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.079 0.466 . . . . 0.0 111.59 179.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -73.51 -46.49 47.51 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.759 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -58.45 -33.65 69.96 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.855 0.36 . . . . 0.0 110.832 174.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.448 ' O ' ' HB3' ' A' ' 101' ' ' GLN . . . -64.45 -55.34 21.49 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.867 178.112 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 19.1 tt -63.94 -34.03 65.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-O 121.033 0.445 . . . . 0.0 110.856 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . 0.647 ' SG ' HD22 ' A' ' 10' ' ' LEU . 99.2 m -66.77 -36.75 83.16 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.809 0.337 . . . . 0.0 110.858 173.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.448 ' HB3' ' O ' ' A' ' 98' ' ' ALA . 8.4 tt0 -55.95 -38.64 70.61 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.197 0.522 . . . . 0.0 110.791 175.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 91.1 mt -68.04 -50.97 51.97 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.322 177.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 39.0 t -83.98 -45.97 18.18 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -171.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -52.58 136.89 31.69 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 -173.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 79.44 -35.2 2.01 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-N 116.282 -0.417 . . . . 0.0 113.763 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.566 ' HD3' ' SG ' ' A' ' 42' ' ' CYS . 63.4 tttp -59.77 159.51 8.74 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.349 0.66 . . . . 0.0 112.669 -177.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -124.77 151.02 67.45 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.989 179.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -64.47 120.84 8.25 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 122.573 2.182 . . . . 0.0 113.231 178.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.11 149.29 48.85 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.214 0.53 . . . . 0.0 112.154 178.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -144.0 163.54 33.2 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.987 177.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 13.1 p -161.48 -30.71 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -177.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 101.61 98.86 2.38 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 121.373 -0.441 . . . . 0.0 112.385 -177.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 35.9 m -85.3 140.78 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-O 121.045 0.45 . . . . 0.0 111.902 -177.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 31.1 m -126.62 96.17 4.58 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.23 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 47.0 mtpt 69.46 -61.25 0.44 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.478 0.711 . . . . 0.0 112.64 178.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 74.6 -57.57 0.61 Allowed 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 176.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -74.58 19.67 0.13 Allowed 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -175.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 58.1 m -69.6 101.3 1.6 Allowed 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.09 0.471 . . . . 0.0 110.112 175.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -76.59 65.66 2.79 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 116.039 -0.528 . . . . 0.0 114.409 -173.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -84.36 55.19 4.99 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 121.185 -0.531 . . . . 0.0 112.833 177.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.36 133.45 50.53 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.738 0.304 . . . . 0.0 111.789 -178.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 33.9 m -111.68 -13.6 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -176.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -141.58 140.44 33.37 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.136 0.493 . . . . 0.0 112.129 -178.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 36.7 mtm180 -104.75 -14.89 15.4 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.688 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 97.7 mt -78.84 104.99 9.85 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.454 0.645 . . . . 0.0 112.547 -172.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 5.9 t -138.25 45.65 2.08 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.912 178.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -65.24 -12.32 50.26 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.432 -176.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 85.0 m 76.52 -45.53 0.5 Allowed 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 177.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 71.5 m 65.19 97.27 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 121.039 0.447 . . . . 0.0 111.07 -174.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 90.4 mtt-85 -55.81 -33.66 64.64 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -172.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -87.01 -13.72 43.66 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -179.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' THR . . . . . 0.443 HG22 ' O ' ' A' ' 132' ' ' THR . 8.4 m -127.5 20.63 6.67 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 121.071 0.462 . . . . 0.0 111.629 -175.198 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -74.47 -55.89 5.34 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.814 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 73.3 m -90.7 109.52 20.7 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.876 0.37 . . . . 0.0 110.555 176.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -88.73 -174.72 4.64 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.982 0.42 . . . . 0.0 111.715 -176.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.692 ' HZ2' ' HB3' ' A' ' 136' ' ' LYS . 9.6 mtpm? -93.51 -163.16 1.01 Allowed 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 120.873 0.368 . . . . 0.0 111.805 -179.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -57.99 121.87 11.63 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -176.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.55 123.78 41.36 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 176.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -60.03 139.9 57.15 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.112 0.482 . . . . 0.0 111.73 -177.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -64.99 88.72 0.07 Allowed 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -171.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.419 ' O ' ' HG3' ' A' ' 141' ' ' GLU . 5.5 pt-20 -98.22 103.74 15.71 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.216 0.532 . . . . 0.0 111.014 172.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 42.1 m -65.24 -15.76 62.82 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.912 0.387 . . . . 0.0 111.216 176.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.8 -155.39 48.1 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 121.283 -0.484 . . . . 0.0 112.969 179.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 40.2 mmtm -126.37 19.04 7.53 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 120.971 0.415 . . . . 0.0 110.516 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 81.22 57.46 2.79 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 111.13 -0.788 . . . . 0.0 111.13 -169.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -101.74 126.28 48.57 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -172.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 60.41 18.32 50.09 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-N 115.797 -0.638 . . . . 0.0 114.291 176.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.477 ' O ' HG22 ' A' ' 148' ' ' ILE . 37.8 mm 52.85 15.44 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.22 0 CA-C-O 121.399 0.619 . . . . 0.0 111.7 -177.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . 62.57 18.23 10.3 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.046 0.539 . . . . 0.0 112.37 -176.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -119.6 132.03 9.28 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 121.223 -0.513 . . . . 0.0 113.637 -177.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 47.5 mtp180 -104.81 -18.69 14.15 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 120.982 0.42 . . . . 0.0 111.293 177.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -152.93 -9.98 0.17 Allowed 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.64 -179.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 66.47 166.27 0.21 Allowed 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.458 0.647 . . . . 0.0 112.548 -174.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 29.6 pt -109.11 137.4 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.184 175.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 86.9 mt -82.0 88.72 6.38 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.156 0.503 . . . . 0.0 111.694 -178.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -46.48 136.09 7.8 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.991 170.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -54.52 102.38 0.06 Allowed 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.468 0.651 . . . . 0.0 112.193 -177.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 24.5 t -109.77 -157.91 0.63 Allowed 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.271 -177.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -59.34 179.23 1.86 Allowed Glycine 0 CA--C 1.532 1.101 0 N-CA-C 114.544 0.578 . . . . 0.0 114.544 -178.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -76.93 84.82 3.47 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.223 0.535 . . . . 0.0 112.106 -175.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 27.6 m -108.43 -27.58 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.257 175.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 49.6 m -87.1 -20.92 26.4 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.052 0.453 . . . . 0.0 110.904 176.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -121.48 130.88 53.83 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.75 176.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -102.65 15.41 29.37 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 120.956 0.408 . . . . 0.0 111.669 -176.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -77.47 147.34 35.94 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.025 0.44 . . . . 0.0 111.886 -176.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -104.22 154.05 20.23 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -171.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 66.73 88.07 0.11 Allowed 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.733 0.813 . . . . 0.0 112.965 178.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -69.8 88.57 0.29 Allowed Glycine 0 CA--C 1.528 0.872 0 C-N-CA 121.096 -0.573 . . . . 0.0 112.54 176.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 82.5 p 52.1 64.29 1.91 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.257 0.623 . . . . 0.0 111.825 -177.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 4.1 t80 72.06 130.15 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.501 0.72 . . . . 0.0 111.506 -177.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -94.51 10.61 33.94 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 113.982 1.104 . . . . 0.0 113.982 -169.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -83.06 -105.0 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.832 0 O-C-N 121.834 -0.541 . . . . 0.0 111.643 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 87.6 mttt 59.1 24.76 13.12 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 174.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 7.9 p -91.84 131.47 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 O-C-N 122.119 -0.363 . . . . 0.0 111.563 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.414 ' HG2' ' O ' ' A' ' 175' ' ' LYS . 25.1 ttpp 68.66 -0.3 2.36 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.004 0.521 . . . . 0.0 112.011 179.137 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -74.93 -97.68 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.919 0 O-C-N 122.166 -0.334 . . . . 0.0 111.844 -173.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 87.5 mt 41.32 -118.63 0.39 Allowed 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 176.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 . . . . . 0 N--CA 1.476 0.839 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 173.113 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 120.696 0.284 . . . . 0.0 111.119 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.18 84.06 1.35 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.443 178.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -162.26 117.52 1.91 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 43.3 t -80.74 104.73 11.46 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 170.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.4 t -95.97 16.33 18.11 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -170.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -123.95 -101.53 0.39 Allowed 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.906 -0.496 . . . . 0.0 112.29 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 41.3 mm -134.41 122.97 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 O-C-N 121.969 -0.457 . . . . 0.0 112.063 -173.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.42 -45.86 57.76 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.012 0.434 . . . . 0.0 111.485 178.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.24 -18.45 35.37 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 121.223 -0.513 . . . . 0.0 112.863 177.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.412 HD11 HD11 ' A' ' 79' ' ' LEU . 34.1 tp -74.48 -36.83 63.3 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.895 0.379 . . . . 0.0 110.132 175.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -59.03 -43.18 91.58 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.437 0.637 . . . . 0.0 109.533 173.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 56.3 tt0 -58.53 -55.87 29.5 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.236 176.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 73.7 m -54.58 -47.44 73.3 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.628 179.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -58.38 -44.16 88.77 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.005 0.431 . . . . 0.0 110.781 176.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 47.9 ttt180 -60.85 -47.41 86.5 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.719 -179.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -65.25 -40.28 93.78 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.619 178.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.47 ' HB3' ' HE1' ' A' ' 30' ' ' MET . 6.2 m-85 -73.07 -29.69 63.14 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 177.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.09 -47.03 78.68 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.112 0.482 . . . . 0.0 111.078 178.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 17.7 pt -88.88 5.94 4.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-O 121.208 0.527 . . . . 0.0 111.798 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -69.45 93.12 0.64 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.03 0.443 . . . . 0.0 110.806 177.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 81.26 45.89 7.25 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 -170.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.462 ' CB ' ' HB2' ' A' ' 25' ' ' ALA . 11.3 p-10 -64.16 120.83 67.89 Favored Pre-proline 0 CA--C 1.542 0.649 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -168.172 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -84.63 -26.39 1.66 Allowed 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.107 1.871 . . . . 0.0 111.96 166.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 47.7 mttp -157.02 67.14 0.53 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.596 0.758 . . . . 0.0 110.095 176.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.462 ' HB2' ' CB ' ' A' ' 22' ' ' ASP . . . -55.34 91.29 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 179.047 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 66.4 m -104.31 -29.39 10.8 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 120.968 0.413 . . . . 0.0 110.202 169.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.43 22.73 6.94 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 121.214 -0.517 . . . . 0.0 114.243 173.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -146.11 0.78 0.84 Allowed 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 117.363 0.582 . . . . 0.0 112.213 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 20.5 mp0 -114.29 121.48 43.78 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 120.683 0.278 . . . . 0.0 111.74 -175.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.47 ' HE1' ' HB3' ' A' ' 17' ' ' PHE . 52.0 ttm -119.85 134.34 55.27 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.876 0.369 . . . . 0.0 111.406 175.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 18.5 p30 -95.22 165.32 12.45 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.065 0.46 . . . . 0.0 111.702 178.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.78 -31.92 77.35 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 121.321 -0.466 . . . . 0.0 113.255 178.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -58.41 -53.62 56.22 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 177.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -70.42 -33.73 71.68 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 111.595 0.22 . . . . 0.0 111.595 179.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 40.0 t-105 -58.07 -47.13 84.09 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.122 0.487 . . . . 0.0 111.565 175.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.25 -49.37 72.15 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.982 0.42 . . . . 0.0 111.351 178.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -68.28 -22.35 64.74 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 178.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.6 tt -62.55 -52.39 63.6 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.542 0.687 . . . . 0.0 109.475 172.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 81.9 m -58.34 -38.6 77.49 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.211 177.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.436 ' HB2' ' HZ2' ' A' ' 40' ' ' LYS . 4.1 ttmp? -68.69 -44.08 74.73 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 111.919 0.341 . . . . 0.0 111.919 177.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -67.85 -33.19 74.29 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -173.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.945 ' SG ' ' HB3' ' A' ' 102' ' ' LEU . 52.2 t -107.45 1.04 23.25 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-O 121.104 0.478 . . . . 0.0 110.75 175.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.439 ' N ' ' HD2' ' A' ' 43' ' ' LYS . 0.1 OUTLIER 63.09 38.2 10.95 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.793 -0.639 . . . . 0.0 112.155 175.83 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 48.5 t -62.89 -27.7 43.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-O 121.343 0.592 . . . . 0.0 110.386 173.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.51 ' HB1' HG11 ' A' ' 50' ' ' VAL . . . -57.58 115.75 2.96 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.101 170.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.556 ' C ' HG23 ' A' ' 50' ' ' VAL . 11.0 t70 -144.22 -50.14 0.29 Allowed 'General case' 0 C--O 1.221 -0.444 0 CA-C-O 119.311 -0.376 . . . . 0.0 111.662 -170.26 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -2.45 47.81 0.0 OUTLIER Glycine 0 N--CA 1.475 1.239 0 N-CA-C 116.389 1.316 . . . . 0.0 116.389 -164.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.546 ' N ' ' O ' ' A' ' 46' ' ' ASP . 25.0 ttpp 56.42 3.75 0.12 Allowed 'General case' 0 CA--C 1.552 1.046 0 CA-C-O 121.297 0.57 . . . . 0.0 111.704 -177.334 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.8 m 171.98 -27.35 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.92 1.288 . . . . 0.0 109.163 -168.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.556 HG23 ' C ' ' A' ' 46' ' ' ASP . 0.2 OUTLIER 63.58 158.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 124.994 1.317 . . . . 0.0 111.855 -179.541 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.22 -12.32 6.31 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.67 -177.582 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.79 -67.89 1.63 Allowed Glycine 0 CA--C 1.526 0.759 0 C-N-CA 121.361 -0.447 . . . . 0.0 112.47 -175.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.52 ' O ' HG12 ' A' ' 57' ' ' ILE . 51.8 m -48.57 -38.45 20.62 Favored 'General case' 0 C--O 1.223 -0.309 0 C-N-CA 122.275 0.23 . . . . 0.0 111.138 175.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.422 ' O ' HG23 ' A' ' 58' ' ' VAL . 24.1 t70 -51.87 -47.4 64.52 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.991 0.424 . . . . 0.0 111.148 176.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.6 t -61.74 -35.45 67.64 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 CA-C-O 121.186 0.517 . . . . 0.0 110.788 177.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -73.42 -30.24 63.1 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.6 0.714 . . . . 0.0 110.244 178.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.52 HG12 ' O ' ' A' ' 53' ' ' THR . 5.5 mm -70.31 -41.94 78.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.02 177.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 54' ' ' ASP . 88.8 t -58.83 -43.8 89.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 120.777 0.322 . . . . 0.0 110.9 176.172 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -58.13 -41.69 84.23 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.206 0.527 . . . . 0.0 110.44 174.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 28.9 t -73.63 -24.01 59.96 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.769 176.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 55.3 tttp -71.88 -38.57 70.0 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 122.901 0.48 . . . . 0.0 111.248 -176.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.3 m -91.1 -9.52 10.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-O 121.018 0.437 . . . . 0.0 111.34 174.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.551 ' HG3' ' HB3' ' A' ' 67' ' ' ALA . 39.7 ttmt -68.92 118.86 12.38 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.776 179.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -75.52 63.47 2.63 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 121.306 -0.473 . . . . 0.0 113.318 178.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.6 mttt 60.66 101.93 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 178.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.0 t 63.66 11.96 6.18 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 175.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.551 ' HB3' ' HG3' ' A' ' 63' ' ' LYS . . . -69.39 98.75 1.12 Allowed 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.983 0.42 . . . . 0.0 110.912 177.031 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 58.3 mtm180 -64.5 -16.42 62.48 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -177.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 31.2 m -136.14 148.65 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-O 120.793 0.33 . . . . 0.0 111.318 177.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 35.3 pt -115.23 166.07 9.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 121.024 0.44 . . . . 0.0 111.864 178.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -111.52 172.15 7.06 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.187 179.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.508 ' O ' ' HG3' ' A' ' 76' ' ' LYS . 59.6 t80 -61.62 -42.99 99.66 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -178.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -55.54 -55.57 30.39 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -177.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.57 -30.62 68.45 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 122.276 -0.265 . . . . 0.0 111.664 177.179 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -55.1 -38.71 68.49 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.059 0.457 . . . . 0.0 111.032 175.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.528 ' HB3' ' HZ1' ' A' ' 76' ' ' LYS . 6.5 mtpm? -55.95 -47.82 76.9 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.979 175.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.413 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 4.3 mptp? -67.46 -34.36 77.02 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.477 178.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.6 -39.73 92.27 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.125 0.488 . . . . 0.0 111.113 175.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.412 HD11 HD11 ' A' ' 10' ' ' LEU . 69.8 mt -66.64 -41.06 88.87 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.408 175.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -51.94 -44.9 64.13 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 120.966 0.413 . . . . 0.0 111.357 176.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.584 ' O ' ' HG2' ' A' ' 85' ' ' LYS . 1.2 tm-20 -60.98 -66.5 0.52 Allowed 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.442 177.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.417 ' O ' ' HG3' ' A' ' 86' ' ' ARG . 73.6 mt -52.37 -31.52 34.15 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.47 ' HB3' HG21 ' A' ' 99' ' ' ILE . . . -62.95 -51.92 65.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.934 0.397 . . . . 0.0 111.114 177.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.573 ' HB ' ' HA2' ' A' ' 89' ' ' GLY . 69.3 p -62.45 -31.55 72.29 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.244 178.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.584 ' HG2' ' O ' ' A' ' 81' ' ' GLU . 6.2 mmmm -61.71 -29.22 69.96 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.356 176.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.417 ' HG3' ' O ' ' A' ' 82' ' ' LEU . 60.6 mtp180 -96.02 -63.83 1.11 Allowed 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.371 0.605 . . . . 0.0 111.915 179.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.425 ' O ' ' HB2' ' A' ' 88' ' ' LYS . 64.3 m-85 -84.83 46.18 1.23 Allowed 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.839 -0.618 . . . . 0.0 112.39 -170.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.706 ' HZ1' ' HB2' ' A' ' 88' ' ' LYS . 8.4 mtmp? 70.79 114.89 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.962 0.505 . . . . 0.0 111.725 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.573 ' HA2' ' HB ' ' A' ' 84' ' ' THR . . . -65.69 78.81 0.09 OUTLIER Glycine 0 CA--C 1.526 0.778 0 CA-C-N 116.018 -0.537 . . . . 0.0 113.604 -178.473 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 47.0 tttm -159.51 -77.27 0.07 Allowed 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 48.1 m -75.22 108.2 7.82 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -172.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 20.0 ttmm -60.35 -45.6 92.89 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.778 177.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 21.6 mp0 -60.86 -57.67 11.68 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.313 0.578 . . . . 0.0 111.108 -175.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -55.87 -52.01 65.56 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.761 179.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.38 -45.32 91.8 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.987 -178.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -65.6 -48.09 73.46 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.651 -0.249 . . . . 0.0 111.524 -178.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -55.56 -47.34 76.53 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.902 0.382 . . . . 0.0 111.702 177.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.42 -51.42 65.82 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.47 HG21 ' HB3' ' A' ' 83' ' ' ALA . 16.5 tt -63.57 -33.97 64.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 O-C-N 122.006 -0.434 . . . . 0.0 111.385 -178.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 96.5 m -68.7 -37.08 79.27 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.86 0.362 . . . . 0.0 110.593 173.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -59.12 -28.23 66.34 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 121.216 0.532 . . . . 0.0 110.734 176.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.945 ' HB3' ' SG ' ' A' ' 42' ' ' CYS . 53.6 mt -79.74 -58.11 3.34 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.86 175.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.6 t -79.22 -51.11 17.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -173.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.53 119.4 7.45 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -172.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 93.89 -16.34 61.08 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-N 116.183 -0.462 . . . . 0.0 113.825 179.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.427 ' O ' ' HG2' ' A' ' 107' ' ' GLU . 60.1 tttm -74.01 -49.12 25.75 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 117.183 0.491 . . . . 0.0 112.173 -178.092 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.427 ' HG2' ' O ' ' A' ' 106' ' ' LYS . 7.1 pt-20 54.4 161.16 0.06 OUTLIER Pre-proline 0 CA--C 1.557 1.228 0 C-N-CA 124.295 1.038 . . . . 0.0 112.397 -174.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -51.48 118.56 4.5 Favored 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 122.414 2.076 . . . . 0.0 113.641 -176.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -65.59 95.71 0.24 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.312 0.577 . . . . 0.0 111.968 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -98.01 28.36 4.02 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.398 0.618 . . . . 0.0 110.988 176.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 61.2 t -65.12 -50.09 76.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.104 -177.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -119.68 138.09 12.97 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 120.993 -0.622 . . . . 0.0 113.286 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 32.6 m -109.53 165.08 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-O 121.07 0.462 . . . . 0.0 111.945 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 61.1 p -77.19 114.84 16.43 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.555 179.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -85.84 40.53 0.86 Allowed 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 121.08 0.467 . . . . 0.0 111.809 -177.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -145.83 -177.51 5.63 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.27 -178.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.493 ' O ' ' HD2' ' A' ' 117' ' ' LYS . 0.0 OUTLIER -141.67 142.55 33.37 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -179.4 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.8 t 39.91 98.88 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.703 1.201 . . . . 0.0 113.821 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -67.34 -51.78 35.51 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-N 116.031 -0.531 . . . . 0.0 113.766 -177.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -110.9 11.5 29.62 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.847 -176.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 65.26 17.18 10.91 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 120.995 0.426 . . . . 0.0 111.936 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 30.8 m -142.2 17.28 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 CA-C-O 121.183 0.515 . . . . 0.0 110.74 178.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -76.07 -40.12 53.9 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -171.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 51.3 ttp180 73.43 -34.9 0.3 Allowed 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.604 0.762 . . . . 0.0 111.062 -171.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.67 HD23 HG21 ' A' ' 126' ' ' THR . 8.9 tt -67.56 146.1 54.24 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 167.349 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.67 HG21 HD23 ' A' ' 125' ' ' LEU . 31.3 p 54.63 38.68 30.37 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -173.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -73.59 -161.51 0.11 Allowed 'General case' 0 CA--C 1.547 0.832 0 CA-C-O 120.741 0.305 . . . . 0.0 110.52 169.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 79.8 p -65.18 78.57 0.05 Allowed 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.201 0.524 . . . . 0.0 111.313 174.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 70.9 m -145.24 146.63 31.77 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.976 0.417 . . . . 0.0 111.732 -177.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 48.7 ttt180 -73.38 -43.58 60.31 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.38 176.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -117.82 128.53 54.94 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.304 172.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 8.9 t -98.63 21.74 10.89 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.036 0.446 . . . . 0.0 111.557 178.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -167.98 -169.5 31.55 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 121.135 -0.555 . . . . 0.0 113.063 -178.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 67.2 m 68.88 154.4 0.11 Allowed 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 121.317 0.579 . . . . 0.0 112.088 -178.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 79.0 m-70 -124.2 104.39 8.8 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.155 0.502 . . . . 0.0 111.87 176.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 47.2 tttp -106.71 5.26 28.61 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.64 0.733 . . . . 0.0 109.928 178.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -80.41 43.4 0.64 Allowed 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.981 -175.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -83.62 49.61 1.63 Allowed 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -175.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 62.44 122.38 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 175.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.459 ' O ' ' HB3' ' A' ' 141' ' ' GLU . 4.9 t70 -68.31 154.86 40.93 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 172.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.663 ' HG2' ' H ' ' A' ' 143' ' ' GLY . 40.5 tt0 73.62 145.16 0.08 Allowed 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 121.263 0.554 . . . . 0.0 111.478 -174.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 84.8 p -85.58 7.6 22.54 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -177.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.663 ' H ' ' HG2' ' A' ' 141' ' ' GLU . . . -69.51 169.94 43.44 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 121.402 -0.428 . . . . 0.0 113.36 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 61.8 mttp 70.75 -34.86 0.31 Allowed 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.7 111.66 3.93 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 121.246 -0.502 . . . . 0.0 112.871 177.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 63.9 pttt 43.53 -156.42 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.057 0.943 . . . . 0.0 112.993 -177.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 73.51 -78.3 0.86 Allowed Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 -170.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 14.8 tt -108.58 -20.35 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 CA-C-O 121.121 0.486 . . . . 0.0 109.988 166.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . 67.79 -179.15 0.22 Allowed 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.545 179.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -68.95 78.62 0.27 Allowed Glycine 0 CA--C 1.528 0.861 0 C-N-CA 121.19 -0.529 . . . . 0.0 112.889 178.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 26.5 tpt180 -72.99 103.35 3.75 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.313 0.577 . . . . 0.0 111.664 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -132.12 -165.69 1.62 Allowed 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.072 179.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -87.24 117.87 26.29 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.575 175.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.471 HD11 ' N ' ' A' ' 154' ' ' ILE . 2.3 mp -82.28 106.93 13.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-O 121.02 0.438 . . . . 0.0 111.319 -178.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.481 ' O ' HD23 ' A' ' 155' ' ' LEU . 6.0 tt -80.2 -38.56 30.92 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.134 0.492 . . . . 0.0 110.57 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -65.95 135.83 55.26 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.415 0.626 . . . . 0.0 112.613 -176.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -124.5 92.19 3.61 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.39 168.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 49.6 p -37.11 106.74 0.05 Allowed 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -174.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.476 ' O ' ' N ' ' A' ' 161' ' ' VAL . . . 152.89 -33.6 0.8 Allowed Glycine 0 CA--C 1.527 0.798 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.822 -177.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 37.1 p90 44.65 -72.4 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 178.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.476 ' N ' ' O ' ' A' ' 159' ' ' GLY . 59.1 t 65.25 100.36 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 123.634 0.773 . . . . 0.0 112.178 -176.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 98.1 p -104.24 -65.0 1.05 Allowed 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.126 0.488 . . . . 0.0 110.775 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -91.74 124.8 36.15 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.457 175.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -77.23 53.99 1.05 Allowed 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -177.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.664 ' HB3' ' HZ2' ' A' ' 165' ' ' LYS . 7.2 mtpm? 53.79 34.57 19.46 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 173.377 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -104.05 -178.97 3.81 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 73.59 127.69 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.304 0.641 . . . . 0.0 112.075 -178.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -129.37 -46.53 0.17 Allowed Glycine 0 CA--C 1.527 0.826 0 C-N-CA 121.336 -0.459 . . . . 0.0 113.573 -177.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 72.4 p -68.71 88.2 0.36 Allowed 'General case' 0 N--CA 1.47 0.555 0 O-C-N 122.397 -0.473 . . . . 0.0 111.596 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 79.7 t80 -110.37 -24.34 10.68 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.979 0.419 . . . . 0.0 111.631 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -73.18 -12.2 60.8 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.253 -0.431 . . . . 0.0 112.102 -177.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -81.19 145.51 30.95 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.024 0.44 . . . . 0.0 112.034 -178.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.431 ' HG2' ' O ' ' A' ' 173' ' ' LYS . 54.8 tttm 70.72 7.96 6.4 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 174.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 85.7 t -63.33 -29.0 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 O-C-N 121.961 -0.462 . . . . 0.0 111.536 177.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt 73.1 116.68 0.05 Allowed 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.333 0.653 . . . . 0.0 112.521 178.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 57.5 pttt -98.86 145.03 27.4 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.733 174.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.416 ' N ' HD22 ' A' ' 177' ' ' LEU . 2.6 mm? -92.17 128.56 38.07 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.995 0.426 . . . . 0.0 111.76 -176.385 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 23.6 mp0 . . . . . 0 CA--C 1.54 0.56 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.605 178.736 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.592 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.551 0.215 . . . . 0.0 110.714 . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.83 53.27 1.62 Allowed 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.114 0.483 . . . . 0.0 111.953 -178.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -163.69 152.31 13.73 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.118 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 43.7 t -135.0 -46.92 0.72 Allowed 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.104 0.478 . . . . 0.0 111.405 179.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.4 t -132.8 46.12 2.66 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.485 0.66 . . . . 0.0 110.999 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 63.34 -97.61 0.06 Allowed 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.113 -175.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.5 mp -138.82 110.37 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-O 120.903 0.383 . . . . 0.0 110.677 176.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.96 -44.88 78.91 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.039 0.447 . . . . 0.0 111.543 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.44 -25.78 63.4 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 121.127 -0.559 . . . . 0.0 113.168 177.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 45.4 tp -72.57 -42.6 64.44 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 122.535 -0.391 . . . . 0.0 110.659 178.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -57.56 -47.47 81.96 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.909 0.385 . . . . 0.0 110.783 175.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.581 ' O ' ' HD3' ' A' ' 16' ' ' LYS . 44.6 mt-10 -62.79 -43.28 99.22 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.491 177.035 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.505 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . 38.7 t -54.65 -54.07 46.52 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 120.768 0.318 . . . . 0.0 111.428 178.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -56.73 -42.83 79.9 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.212 0.529 . . . . 0.0 110.844 175.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 33.5 ttt180 -56.57 -45.91 81.03 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.712 -179.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.581 ' HD3' ' O ' ' A' ' 12' ' ' GLU . 5.0 mptp? -66.52 -55.64 14.6 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 178.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -64.04 -28.37 69.75 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -178.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.08 -54.15 45.39 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.986 0.422 . . . . 0.0 111.333 177.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 29.1 pt -80.81 4.56 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 CA-C-N 116.147 -0.478 . . . . 0.0 112.026 -178.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -61.83 -36.39 81.04 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -175.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -125.89 0.1 7.75 Favored Glycine 0 N--CA 1.465 0.58 0 C-N-CA 120.852 -0.689 . . . . 0.0 113.079 -179.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -155.43 89.89 2.95 Favored Pre-proline 0 CA--C 1.542 0.653 0 CA-C-O 121.192 0.52 . . . . 0.0 111.006 -178.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -52.23 -29.71 38.97 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.086 2.524 . . . . 0.0 113.965 -177.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -80.41 3.83 20.03 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.083 0.468 . . . . 0.0 111.654 -176.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.413 ' HB1' ' O ' ' A' ' 29' ' ' GLU . . . -63.9 -31.8 73.1 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.71 170.04 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 30.6 t 58.69 20.12 7.48 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.499 176.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 70.25 11.82 68.15 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.793 -176.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -93.44 -38.31 11.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.231 0.539 . . . . 0.0 110.834 177.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.443 ' HB3' ' CG2' ' A' ' 69' ' ' VAL . 39.3 mt-10 -131.53 154.24 49.0 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.425 -172.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 52.1 ttm -137.88 136.31 36.98 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.809 0.338 . . . . 0.0 111.176 177.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.52 HD22 ' ND2' ' A' ' 34' ' ' ASN . 10.8 p30 -89.73 166.44 13.57 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.134 0.492 . . . . 0.0 111.916 -179.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.62 -21.86 69.34 Favored Glycine 0 CA--C 1.531 1.046 0 CA-C-N 116.024 -0.535 . . . . 0.0 114.283 -177.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.425 ' HB3' ' OD1' ' A' ' 31' ' ' ASN . 62.8 tttp -74.22 -52.43 12.42 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 117.413 0.607 . . . . 0.0 111.151 179.305 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.52 ' ND2' HD22 ' A' ' 31' ' ' ASN . 71.8 m-20 -63.67 -38.36 90.82 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.811 0.338 . . . . 0.0 110.687 176.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.433 ' CD1' ' HB2' ' A' ' 59' ' ' PHE . 43.3 t-105 -60.24 -38.78 84.5 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.425 174.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.21 -45.45 93.14 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.482 177.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -74.13 -32.72 63.29 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 120.866 -0.334 . . . . 0.0 111.102 176.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.7 tt -51.33 -51.35 55.19 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.035 0.445 . . . . 0.0 110.399 177.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 75.0 m -69.13 -49.94 52.42 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.11 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -64.7 -47.55 77.94 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 112.041 0.385 . . . . 0.0 112.041 -176.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -64.88 -34.64 78.87 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 121.033 0.444 . . . . 0.0 110.956 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.79 ' HA ' ' HE2' ' A' ' 106' ' ' LYS . 68.5 m -90.07 1.61 56.16 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.352 174.408 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 52.1 mttm 53.07 34.39 17.08 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 176.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.604 ' HA ' HH11 ' A' ' 86' ' ' ARG . 49.0 t -64.89 -37.58 80.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 121.566 0.698 . . . . 0.0 109.556 167.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -98.83 51.36 0.97 Allowed 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.51 173.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -64.99 -27.92 69.16 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 116.072 -0.513 . . . . 0.0 112.023 -175.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 138.2 -62.51 0.57 Allowed Glycine 0 CA--C 1.527 0.823 0 C-N-CA 121.046 -0.597 . . . . 0.0 113.497 -178.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.62 ' HD2' ' H ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -71.19 20.03 0.05 Allowed 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -175.653 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 49.2 m -153.71 -64.58 0.14 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.214 0.531 . . . . 0.0 110.887 176.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.565 HG13 HD23 ' A' ' 82' ' ' LEU . 58.8 t -121.18 151.92 24.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.863 -179.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 71.4 p -118.59 154.32 32.82 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 122.343 0.257 . . . . 0.0 111.121 177.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -52.18 -41.64 54.1 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 121.398 -0.429 . . . . 0.0 113.349 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 63.0 m -55.84 -49.31 73.65 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.097 0.475 . . . . 0.0 110.834 176.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -62.01 -37.33 84.47 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.928 178.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 70.0 t -57.34 -36.3 52.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.85 176.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -69.27 -43.91 72.95 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 122.01 0.91 . . . . 0.0 109.583 178.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.9 mm -62.22 -45.53 98.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-N 114.584 -1.189 . . . . 0.0 111.621 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.467 ' O ' HG12 ' A' ' 62' ' ' VAL . 73.9 t -56.91 -47.82 82.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.525 177.051 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.433 ' HB2' ' CD1' ' A' ' 35' ' ' TRP . 80.0 t80 -50.85 -51.05 55.03 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.026 0.441 . . . . 0.0 111.183 177.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 29.2 t -71.01 -29.34 65.26 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.572 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -64.78 -36.95 85.96 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.536 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.479 HG23 ' HB2' ' A' ' 77' ' ' LYS . 3.7 p -94.93 -22.14 5.49 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 178.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -56.45 134.79 54.2 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -67.96 83.49 0.17 Allowed Glycine 0 CA--C 1.532 1.113 0 C-N-CA 121.333 -0.461 . . . . 0.0 113.816 176.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 61.9 mttp 53.13 -90.47 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 175.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 36.5 t -128.22 29.62 5.33 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.983 0.42 . . . . 0.0 111.212 -174.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -73.97 5.76 3.96 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 179.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 44.5 mtp180 68.36 -64.48 0.3 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.531 0.733 . . . . 0.0 112.125 -176.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.517 HG13 ' HA ' ' A' ' 31' ' ' ASN . 24.4 m -117.92 170.04 7.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.134 -172.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 39.4 pt -109.75 152.79 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.293 178.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -92.36 178.45 5.83 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.045 0.45 . . . . 0.0 111.381 175.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.492 ' O ' ' HB3' ' A' ' 75' ' ' PHE . 75.5 t80 -58.45 -41.87 86.09 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -174.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -70.51 -34.05 71.88 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.993 -0.442 . . . . 0.0 111.384 -178.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -68.9 -34.29 75.18 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.434 0.635 . . . . 0.0 110.012 174.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.492 ' HB3' ' O ' ' A' ' 72' ' ' TYR . 61.1 t80 -58.22 -43.03 87.52 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.823 170.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.468 ' HG3' ' O ' ' A' ' 72' ' ' TYR . 47.0 mtpt -60.03 -37.86 81.02 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.743 0.306 . . . . 0.0 111.021 176.042 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.479 ' HB2' HG23 ' A' ' 62' ' ' VAL . 94.6 mttt -65.0 -38.45 91.01 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.159 0.504 . . . . 0.0 110.89 177.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.98 -39.73 93.91 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.058 176.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 84.2 mt -61.36 -49.78 75.55 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.832 175.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -51.56 -44.39 62.71 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.2 0.524 . . . . 0.0 111.605 175.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -60.53 -63.7 1.21 Allowed 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.511 178.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.565 HD23 HG13 ' A' ' 50' ' ' VAL . 75.1 mt -58.71 -38.18 77.76 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -178.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.78 -47.74 83.8 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.607 0.241 . . . . 0.0 111.546 178.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 50.5 p -65.84 -19.56 65.93 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 178.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -81.28 -38.41 26.89 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 120.774 0.321 . . . . 0.0 111.444 172.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.604 HH11 ' HA ' ' A' ' 44' ' ' VAL . 36.7 mtp180 -79.28 -58.73 3.07 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -98.3 -164.46 1.14 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.393 -173.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -62.71 119.58 9.56 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -178.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -72.34 61.56 1.47 Allowed Glycine 0 CA--C 1.528 0.901 0 C-N-CA 120.902 -0.666 . . . . 0.0 111.555 171.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -163.29 -50.68 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.93 0.395 . . . . 0.0 111.099 -169.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 48.4 t -94.45 120.95 35.47 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.611 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -75.82 -60.77 2.17 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -178.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -61.76 -36.74 81.9 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -174.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -62.21 -60.15 3.99 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.088 0.471 . . . . 0.0 111.428 177.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.07 -42.39 85.43 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.913 -178.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -70.52 -40.37 73.52 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.412 -177.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -62.79 -53.52 53.04 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.125 0.488 . . . . 0.0 110.354 177.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -55.94 -52.54 63.77 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.644 -178.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 14.4 tt -60.92 -39.84 83.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 O-C-N 122.115 -0.366 . . . . 0.0 111.23 -179.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 95.9 m -70.56 -30.24 66.91 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.829 0.347 . . . . 0.0 111.042 176.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -64.42 -30.27 71.31 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.231 0.539 . . . . 0.0 110.762 178.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 82.8 mt -77.82 -18.42 56.35 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 177.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.497 HG13 ' HG ' ' A' ' 13' ' ' SER . 41.3 t -114.56 -54.54 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -172.03 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.505 ' HA ' ' HB2' ' A' ' 13' ' ' SER . . . -52.12 112.08 0.73 Allowed 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -172.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 81.98 -2.99 82.24 Favored Glycine 0 CA--C 1.527 0.814 0 CA-C-N 115.908 -0.587 . . . . 0.0 114.463 173.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.79 ' HE2' ' HA ' ' A' ' 42' ' ' CYS . 22.1 ttpp -70.64 -28.05 64.52 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 117.602 0.701 . . . . 0.0 112.22 -178.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.522 ' HG2' ' O ' ' A' ' 106' ' ' LYS . 1.5 pt-20 72.7 155.46 0.16 Allowed Pre-proline 0 N--CA 1.481 1.079 0 C-N-CA 124.049 0.94 . . . . 0.0 111.904 -178.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -73.08 113.04 3.67 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 122.808 2.338 . . . . 0.0 111.628 174.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -172.29 -28.93 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -174.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 8.2 t30 65.37 173.51 0.22 Allowed 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 -169.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 6.1 p -59.24 88.1 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 CA-C-O 121.793 0.806 . . . . 0.0 112.436 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -92.37 -33.05 7.82 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.607 174.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.425 ' O ' ' N ' ' A' ' 115' ' ' LYS . 60.9 t -74.29 136.42 25.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 122.287 0.235 . . . . 0.0 111.586 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.401 HG21 ' N ' ' A' ' 115' ' ' LYS . 12.9 t 53.7 -60.12 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 125.403 1.481 . . . . 0.0 114.602 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.425 ' N ' ' O ' ' A' ' 113' ' ' VAL . 88.4 tttt 73.48 -24.87 0.2 Allowed 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.309 0.644 . . . . 0.0 112.556 177.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.36 -23.91 58.3 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -178.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 51.6 pttt -72.92 81.61 1.19 Allowed 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 121.5 0.667 . . . . 0.0 111.645 178.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 66.8 p -115.18 173.87 6.28 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.805 -178.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 103.63 -59.93 0.48 Allowed Glycine 0 CA--C 1.526 0.728 0 C-N-CA 121.219 -0.515 . . . . 0.0 112.83 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 84.47 31.67 24.24 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 121.173 -0.537 . . . . 0.0 112.979 179.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -80.78 107.43 13.59 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 121.019 0.438 . . . . 0.0 111.487 -179.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.6 p -120.28 106.41 18.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-O 121.263 0.554 . . . . 0.0 111.873 -179.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -91.81 141.58 28.52 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.061 176.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -113.23 101.74 9.7 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.924 0.392 . . . . 0.0 111.378 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 83.5 mt -98.29 11.19 38.74 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.05 0.452 . . . . 0.0 111.076 176.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 28.5 m -64.62 101.15 0.43 Allowed 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.375 178.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -52.74 142.21 19.27 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-O 120.82 0.343 . . . . 0.0 110.418 173.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 11.7 t -137.81 9.29 2.83 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -176.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 77.7 p -70.15 -65.82 0.68 Allowed 'General case' 0 N--CA 1.473 0.701 0 O-C-N 122.141 -0.349 . . . . 0.0 111.064 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 31.4 ttm180 71.96 -51.69 0.7 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.74 0.816 . . . . 0.0 113.14 177.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 59.62 -159.3 0.3 Allowed 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 120.766 0.317 . . . . 0.0 110.398 -170.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 11.5 m -113.9 -17.93 11.9 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 121.914 -0.491 . . . . 0.0 111.014 173.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -85.28 -150.04 12.56 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 121.34 -0.457 . . . . 0.0 113.645 -179.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 19.5 m -94.86 143.56 26.36 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.012 0.434 . . . . 0.0 111.72 -176.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -121.76 123.43 41.8 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.883 178.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.624 ' HB2' ' HZ3' ' A' ' 136' ' ' LYS . 3.2 ttmp? -63.45 123.18 18.09 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.013 0.435 . . . . 0.0 111.973 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -78.44 105.21 9.54 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.733 175.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 36.2 ttp-105 -116.8 7.06 13.28 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 120.941 0.4 . . . . 0.0 111.445 -177.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -107.77 -177.73 3.42 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 120.901 0.382 . . . . 0.0 111.789 -178.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -124.95 149.28 47.82 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.996 179.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -149.38 67.76 1.02 Allowed 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.516 0.674 . . . . 0.0 110.656 178.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 63.2 m -81.32 64.01 5.88 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.234 -175.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 63.89 -84.29 0.05 OUTLIER Glycine 0 CA--C 1.527 0.829 0 CA-C-N 116.27 -0.423 . . . . 0.0 113.542 179.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.618 ' HZ1' ' HB2' ' A' ' 144' ' ' LYS . 4.9 ttmp? -163.62 78.43 0.41 Allowed 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 120.844 0.354 . . . . 0.0 111.731 -179.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 73.89 -65.32 1.86 Allowed Glycine 0 CA--C 1.534 1.24 0 N-CA-C 114.942 0.737 . . . . 0.0 114.942 171.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -54.29 -25.68 24.99 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -173.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 85.39 136.88 3.96 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.628 -177.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 11.5 tt -123.56 135.38 63.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-O 121.139 0.495 . . . . 0.0 112.04 -176.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -124.29 -10.63 7.51 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.491 175.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -169.33 167.94 40.87 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-N 116.335 -0.393 . . . . 0.0 112.475 179.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 28.3 ptt180 -88.88 84.88 6.65 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.536 0.684 . . . . 0.0 111.808 -178.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -90.63 -13.17 34.86 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.497 178.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -70.61 2.12 4.43 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -173.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 11.0 tt -68.08 98.24 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 CA-C-O 121.589 0.709 . . . . 0.0 111.794 -179.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 31.1 tp -117.01 25.54 10.43 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-O 121.118 0.485 . . . . 0.0 111.097 -178.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 34.1 t0 53.97 32.2 14.93 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.838 0.828 . . . . 0.0 110.981 -176.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -76.66 36.99 0.17 Allowed 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.561 177.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 60.1 p -76.56 88.97 3.28 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.455 0.645 . . . . 0.0 111.29 -177.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -80.78 -45.46 7.76 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 114.335 0.494 . . . . 0.0 114.335 -174.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -76.52 11.42 1.63 Allowed 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -173.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 87.4 t -63.12 134.64 28.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-O 121.049 0.452 . . . . 0.0 111.891 179.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 48.8 p -71.86 82.83 0.92 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.234 0.54 . . . . 0.0 111.495 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -90.97 16.28 9.84 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -178.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 57.27 52.48 8.78 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -62.22 111.7 2.08 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.088 0.47 . . . . 0.0 110.973 177.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . 0.571 ' ND2' ' HB3' ' A' ' 170' ' ' TYR . 54.8 t30 65.8 19.3 11.33 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.646 -177.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 64.26 25.52 13.57 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 174.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 137.27 -102.98 0.4 Allowed Glycine 0 CA--C 1.526 0.735 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.942 178.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 66.8 p -121.72 -76.66 0.58 Allowed 'General case' 0 N--CA 1.473 0.689 0 O-C-N 122.502 -0.411 . . . . 0.0 110.864 176.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . 0.571 ' HB3' ' ND2' ' A' ' 166' ' ' ASN . 50.3 t80 67.2 -58.35 0.41 Allowed 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.75 0.82 . . . . 0.0 112.459 -179.413 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -52.68 116.66 2.42 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 176.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -75.7 119.03 19.16 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.776 0.322 . . . . 0.0 110.646 175.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -68.23 -17.0 64.19 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 -172.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.426 HG12 ' N ' ' A' ' 175' ' ' LYS . 7.3 p -156.13 -55.45 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 175.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.56 ' HD3' ' HA ' ' A' ' 178' ' ' GLU . 57.7 tttm -178.47 137.9 0.17 Allowed 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 122.32 0.248 . . . . 0.0 111.039 -176.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . 0.67 ' HB3' ' HZ1' ' A' ' 176' ' ' LYS . 7.7 mtpm? -59.05 -42.4 90.21 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 120.976 0.417 . . . . 0.0 111.598 -179.24 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 63.2 tp -138.35 105.38 5.43 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.41 174.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.56 ' HA ' ' HD3' ' A' ' 175' ' ' LYS . 1.2 tm-20 . . . . . 0 CA--C 1.539 0.547 0 CA-C-O 121.41 0.624 . . . . 0.0 111.851 -175.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.626 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.486 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.06 76.1 8.96 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.967 0.413 . . . . 0.0 110.922 178.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 57.74 69.74 0.71 Allowed 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.866 -176.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.411 ' O ' HG21 ' A' ' 5' ' ' THR . 68.4 m -81.91 43.16 0.75 Allowed 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 -176.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.411 HG21 ' O ' ' A' ' 4' ' ' SER . 5.4 t 48.35 -166.09 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 175.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -71.63 175.95 5.21 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -177.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.2 tp -100.1 118.12 46.29 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 CA-C-O 121.225 0.535 . . . . 0.0 111.255 177.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -49.22 -41.46 37.36 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -175.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.84 -36.59 80.64 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 121.03 -0.605 . . . . 0.0 113.51 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.553 HD12 ' HB3' ' A' ' 104' ' ' ALA . 24.7 tp -78.24 -39.99 38.59 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 122.46 -0.435 . . . . 0.0 110.868 -179.37 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.577 ' HB3' ' NH2' ' A' ' 15' ' ' ARG . 45.3 mt-10 -55.77 -42.26 75.22 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.428 0.632 . . . . 0.0 110.657 173.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.468 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 8.7 tp10 -57.13 -55.57 33.08 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.389 177.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.415 ' HB3' ' O ' ' A' ' 108' ' ' PRO . 75.0 m -47.06 -51.23 18.06 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.324 174.132 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.404 ' N ' ' HB3' ' A' ' 109' ' ' ALA . 62.4 t80 -51.32 -46.35 62.56 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.696 -0.627 . . . . 0.0 111.196 -178.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.577 ' NH2' ' HB3' ' A' ' 11' ' ' GLU . 0.5 OUTLIER -70.02 -46.15 65.69 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 111.849 0.315 . . . . 0.0 111.849 177.838 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.52 ' O ' ' HB2' ' A' ' 20' ' ' HIS . 75.8 mmtt -53.99 -42.78 69.41 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.164 0.507 . . . . 0.0 110.854 178.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.668 ' CD1' ' HA ' ' A' ' 108' ' ' PRO . 0.2 OUTLIER -73.58 -34.39 65.09 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.859 -177.114 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.681 ' HA ' ' SD ' ' A' ' 30' ' ' MET . . . -66.98 -58.13 5.54 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.155 0.502 . . . . 0.0 112.048 -177.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 30.7 pt -80.49 -0.09 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 121.432 0.634 . . . . 0.0 111.052 -178.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.52 ' HB2' ' O ' ' A' ' 16' ' ' LYS . 37.2 t-80 -52.16 -45.59 65.11 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.316 -0.856 . . . . 0.0 112.289 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -112.14 10.03 26.94 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.771 -0.728 . . . . 0.0 114.516 -173.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -157.23 127.31 3.34 Favored Pre-proline 0 CA--C 1.545 0.78 0 CA-C-N 117.628 0.714 . . . . 0.0 111.438 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.54 -26.65 13.8 Favored 'Trans proline' 0 CA--C 1.544 0.992 0 C-N-CA 122.754 2.303 . . . . 0.0 113.611 -178.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -96.3 0.98 51.59 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -176.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.73 134.25 51.37 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 120.832 0.349 . . . . 0.0 111.846 178.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.4 t -57.43 -34.46 68.96 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.474 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.72 15.1 76.45 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 121.246 -0.502 . . . . 0.0 113.126 177.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -124.85 -26.15 3.81 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.199 0.523 . . . . 0.0 110.987 178.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -122.81 128.25 50.19 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.694 -178.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.681 ' SD ' ' HA ' ' A' ' 18' ' ' ALA . 10.9 tpp -114.08 152.29 31.28 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -176.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.513 ' ND2' ' HB2' ' A' ' 33' ' ' LYS . 13.7 p-10 -97.27 164.4 12.49 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -179.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.75 -29.03 69.15 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-N 116.069 -0.514 . . . . 0.0 113.959 -179.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.513 ' HB2' ' ND2' ' A' ' 31' ' ' ASN . 5.2 mmmm -51.75 -45.05 63.54 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 175.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.516 ' ND2' ' SD ' ' A' ' 30' ' ' MET . 4.5 m-20 -72.94 -25.71 61.13 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.777 -179.158 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.413 ' CE3' ' O ' ' A' ' 110' ' ' ASN . 40.0 t-105 -66.88 -45.0 79.42 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.042 0.448 . . . . 0.0 111.0 175.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.2 -47.76 84.65 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.233 0.539 . . . . 0.0 110.945 175.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -63.83 -32.79 74.42 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.689 177.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.55 HD13 ' HA ' ' A' ' 109' ' ' ALA . 2.6 tt -58.16 -55.22 37.82 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.221 0.534 . . . . 0.0 110.263 179.06 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.596 ' SG ' ' HB3' ' A' ' 45' ' ' ALA . 45.9 t -58.86 -43.95 90.95 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.529 -179.417 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 28.9 ttpp -66.78 -41.51 87.53 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 120.878 0.37 . . . . 0.0 111.562 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -63.0 -48.59 78.17 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.274 0.559 . . . . 0.0 110.822 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.429 ' SG ' HG22 ' A' ' 103' ' ' VAL . 83.9 m -82.32 -3.28 55.04 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.675 179.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt 59.92 28.3 17.78 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.199 0.523 . . . . 0.0 112.02 175.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 47.9 t -67.36 -33.35 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.695 174.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.596 ' HB3' ' SG ' ' A' ' 39' ' ' CYS . . . -61.95 86.77 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.395 0.616 . . . . 0.0 111.079 175.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -63.69 -47.45 81.12 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.473 -178.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 125.13 -33.51 3.65 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 121.126 -0.559 . . . . 0.0 113.186 -178.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.5 pttt -129.32 -28.64 2.31 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 177.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 90.9 p -88.55 -39.82 13.86 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 121.055 0.455 . . . . 0.0 110.377 171.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 91.2 t -132.99 116.62 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.776 174.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 27.1 p -111.8 175.72 5.31 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.874 0.369 . . . . 0.0 111.088 178.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -58.92 -29.11 64.41 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.105 172.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.622 ' O ' HG13 ' A' ' 57' ' ' ILE . 44.3 m -61.51 -57.72 11.0 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 110.318 -0.253 . . . . 0.0 110.318 174.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -48.61 -42.51 34.26 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.96 0.41 . . . . 0.0 111.618 178.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 95.5 t -56.35 -45.71 81.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.625 177.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -71.79 -32.76 67.96 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 120.837 0.351 . . . . 0.0 111.275 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.622 HG13 ' O ' ' A' ' 53' ' ' THR . 9.3 mt -66.23 -54.44 26.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.721 178.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.427 HG11 ' CD1' ' A' ' 82' ' ' LEU . 93.9 t -54.2 -47.37 67.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 120.805 0.336 . . . . 0.0 111.68 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.513 ' O ' ' HG2' ' A' ' 63' ' ' LYS . 55.2 t80 -56.99 -38.28 72.83 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 120.803 0.335 . . . . 0.0 110.638 178.277 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 37.5 m -81.33 -18.78 44.51 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 178.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.427 ' HG2' ' O ' ' A' ' 57' ' ' ILE . 32.4 mmtp -73.26 -43.88 60.34 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 179.05 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.467 HG11 ' HB2' ' A' ' 78' ' ' ALA . 7.1 m -70.03 -45.0 77.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.513 ' HG2' ' O ' ' A' ' 59' ' ' PHE . 22.2 ptmt -81.2 166.34 20.69 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.369 0.604 . . . . 0.0 112.509 -176.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -104.18 -94.36 2.32 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.165 174.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -131.84 -57.56 0.98 Allowed 'General case' 0 N--CA 1.473 0.706 0 O-C-N 122.426 -0.455 . . . . 0.0 111.832 176.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 37.8 m -77.45 65.27 2.96 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -176.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -160.79 111.86 1.82 Allowed 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.977 0.418 . . . . 0.0 111.676 179.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.86 -26.9 17.44 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.794 0.33 . . . . 0.0 110.822 175.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.676 HG22 HG23 ' A' ' 114' ' ' THR . 26.0 m -120.57 174.07 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 121.102 0.477 . . . . 0.0 111.955 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.793 HD12 ' HB2' ' A' ' 110' ' ' ASN . 2.9 pp -135.39 165.76 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -172.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.593 ' OD1' ' HB2' ' A' ' 74' ' ' GLU . 24.7 p-10 -111.79 -179.82 3.81 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.231 -178.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.606 ' O ' ' HB3' ' A' ' 75' ' ' PHE . 65.9 t80 -85.84 -46.18 10.87 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -176.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -62.05 -31.5 71.92 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.462 -0.774 . . . . 0.0 111.472 -175.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.593 ' HB2' ' OD1' ' A' ' 71' ' ' ASN . 0.4 OUTLIER -73.12 -36.27 66.68 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.751 -0.204 . . . . 0.0 111.134 171.822 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.669 ' HD1' HG12 ' A' ' 111' ' ' VAL . 41.7 t80 -46.09 -41.95 12.95 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 172.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -57.84 -41.74 82.95 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 121.238 0.542 . . . . 0.0 111.658 174.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -72.09 -43.6 64.54 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 121.13 0.49 . . . . 0.0 111.082 -179.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.629 ' HB1' HG11 ' A' ' 111' ' ' VAL . . . -60.92 -44.61 96.96 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.843 177.21 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.456 HD12 ' CZ ' ' A' ' 75' ' ' PHE . 34.1 mt -52.32 -46.0 65.83 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 122.079 -0.388 . . . . 0.0 111.61 172.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -54.15 -38.25 65.3 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 121.094 0.473 . . . . 0.0 110.94 177.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.426 ' HB3' ' O ' ' A' ' 78' ' ' ALA . 16.6 tp10 -59.47 -51.23 70.76 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.995 174.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.427 ' CD1' HG11 ' A' ' 58' ' ' VAL . 8.8 mp -60.63 -47.62 85.42 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 111.841 0.312 . . . . 0.0 111.841 178.386 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.36 -46.28 69.51 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.851 0.358 . . . . 0.0 111.867 -178.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 69.2 p -67.55 -34.59 77.37 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.19 -0.459 . . . . 0.0 112.115 179.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.727 ' HB3' ' HZ1' ' A' ' 85' ' ' LYS . 8.3 mtpm? -80.11 -28.55 38.98 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 179.177 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -85.85 -55.26 4.05 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.07 0.462 . . . . 0.0 110.73 -176.319 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -96.75 50.52 1.12 Allowed 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.45 -177.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -59.64 99.82 0.07 Allowed 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.304 0.573 . . . . 0.0 111.483 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 136.14 -30.61 2.71 Favored Glycine 0 CA--C 1.521 0.43 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.774 -176.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -86.01 144.04 27.8 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 122.796 0.439 . . . . 0.0 110.585 176.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 43.6 t -59.07 134.78 57.29 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 122.412 -0.18 . . . . 0.0 111.345 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -52.2 -36.69 52.75 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -174.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -66.03 -51.61 56.7 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 120.869 0.366 . . . . 0.0 111.242 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -64.39 -37.21 86.71 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 121.072 0.463 . . . . 0.0 111.366 176.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.69 -43.97 91.81 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.994 0.425 . . . . 0.0 111.561 178.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -62.81 -39.28 93.81 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.114 0.483 . . . . 0.0 110.758 177.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -60.16 -51.62 68.81 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.534 176.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.82 -51.87 67.46 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.247 -178.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.3 tt -58.73 -42.97 86.74 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 CA-C-O 120.808 0.337 . . . . 0.0 111.119 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 74.7 m -68.96 -28.72 66.88 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.727 0.299 . . . . 0.0 111.267 177.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -64.41 -33.0 74.85 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.07 0.462 . . . . 0.0 110.989 178.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 81.0 mt -77.12 -20.41 55.67 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 116.176 -0.465 . . . . 0.0 112.062 178.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.429 HG22 ' SG ' ' A' ' 42' ' ' CYS . 60.2 t -105.91 -61.5 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -173.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.553 ' HB3' HD12 ' A' ' 10' ' ' LEU . . . -57.73 147.9 26.46 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -175.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 98.01 -35.9 4.28 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 121.157 -0.544 . . . . 0.0 113.265 177.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -79.04 -77.33 0.17 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 117.029 0.414 . . . . 0.0 111.525 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.526 ' CG ' ' HD3' ' A' ' 108' ' ' PRO . 11.1 pt-20 -176.29 -33.65 0.0 OUTLIER Pre-proline 0 CA--C 1.553 1.088 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 -179.367 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.668 ' HA ' ' CD1' ' A' ' 17' ' ' PHE . 50.6 Cg_exo -68.08 142.77 57.29 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 122.553 2.169 . . . . 0.0 115.646 176.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.55 ' HA ' HD13 ' A' ' 38' ' ' LEU . . . 168.35 115.52 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 115.054 -0.975 . . . . 0.0 112.107 179.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.793 ' HB2' HD12 ' A' ' 70' ' ' ILE . 7.9 p30 170.06 127.93 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 177.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.669 HG12 ' HD1' ' A' ' 75' ' ' PHE . 4.3 p 170.27 135.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 C-N-CA 123.926 0.891 . . . . 0.0 110.73 166.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.517 ' H ' HG22 ' A' ' 70' ' ' ILE . . . 164.66 -130.98 2.29 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 119.739 -1.219 . . . . 0.0 115.261 -176.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.466 HG13 ' N ' ' A' ' 114' ' ' THR . 11.8 t -137.77 165.01 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 O-C-N 122.564 -0.374 . . . . 0.0 111.638 -175.36 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.676 HG23 HG22 ' A' ' 69' ' ' VAL . 12.3 p -140.27 87.14 2.12 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 121.118 0.485 . . . . 0.0 111.92 173.011 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -148.37 -60.96 0.25 Allowed 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.873 175.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.485 ' O ' ' HB2' ' A' ' 117' ' ' LYS . . . 59.08 -161.55 0.26 Allowed 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 173.483 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 116' ' ' ALA . 34.1 mtmm 89.39 59.29 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.915 1.286 . . . . 0.0 112.364 -177.325 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 34.1 m 61.66 -75.58 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 173.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 177.43 -50.13 0.1 Allowed Glycine 0 CA--C 1.525 0.705 0 C-N-CA 121.026 -0.607 . . . . 0.0 113.245 -176.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -78.4 47.45 2.96 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 121.266 -0.492 . . . . 0.0 112.994 177.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.483 ' HB3' ' HE2' ' A' ' 117' ' ' LYS . . . -89.86 96.34 10.64 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 122.541 -0.388 . . . . 0.0 111.725 -177.119 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 35.1 m -91.11 -2.56 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-O 120.726 0.298 . . . . 0.0 111.296 175.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 62.87 -176.65 0.14 Allowed 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.876 -178.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -96.06 -82.04 0.4 Allowed 'General case' 0 CA--C 1.539 0.522 0 O-C-N 122.09 -0.381 . . . . 0.0 111.909 -176.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 5.1 tt -178.7 -77.73 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 120.846 0.355 . . . . 0.0 110.503 -176.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 52.4 m -95.22 -14.09 24.36 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 120.922 0.392 . . . . 0.0 111.551 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 66.72 170.55 0.25 Allowed 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.753 0.787 . . . . 0.0 112.628 -178.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 81.7 p -127.88 175.13 8.59 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.367 176.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 63.1 m -59.81 126.85 29.18 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.717 0.294 . . . . 0.0 110.696 175.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 33.4 mmt180 -61.27 -17.12 51.88 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -176.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -52.94 -25.41 11.78 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.166 0.586 . . . . 0.0 111.571 174.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 8.5 t -121.57 30.32 6.78 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.301 0.572 . . . . 0.0 111.333 178.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -70.63 -0.47 32.18 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 121.281 -0.485 . . . . 0.0 114.125 -178.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.454 ' O ' ' HG3' ' A' ' 136' ' ' LYS . 40.6 t 63.7 -86.53 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 179.054 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 52.9 t-80 63.5 1.31 0.98 Allowed 'General case' 0 CA--C 1.549 0.932 0 CA-C-O 120.957 0.408 . . . . 0.0 111.809 -175.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.454 ' HG3' ' O ' ' A' ' 134' ' ' SER . 54.7 mtpt -87.43 12.9 11.05 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -172.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -118.15 88.75 2.98 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.959 0.409 . . . . 0.0 111.77 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 57.2 ttp180 -88.37 107.41 18.83 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.906 0.384 . . . . 0.0 110.781 176.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -73.24 118.98 16.85 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.043 0.449 . . . . 0.0 111.322 -179.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -68.66 89.07 0.37 Allowed 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.562 0.696 . . . . 0.0 110.806 175.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -60.13 -46.43 89.67 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.516 -178.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 55.6 m 65.88 -74.77 0.06 Allowed 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.24 178.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -67.31 96.83 0.35 Allowed Glycine 0 CA--C 1.528 0.864 0 C-N-CA 121.33 -0.462 . . . . 0.0 113.704 -178.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -121.57 145.8 47.61 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.794 0.331 . . . . 0.0 111.177 175.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -78.05 111.65 3.3 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 121.266 -0.492 . . . . 0.0 113.861 -175.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.702 ' HZ3' ' HB2' ' A' ' 146' ' ' LYS . 10.0 mtmp? -81.65 30.42 0.36 Allowed 'General case' 0 N--CA 1.473 0.723 0 O-C-N 122.377 -0.484 . . . . 0.0 111.46 177.154 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 75.28 56.06 4.88 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.886 -176.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 8.8 tt -49.99 -44.01 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-O 121.109 0.48 . . . . 0.0 111.97 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -172.27 -74.93 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.013 178.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -159.33 49.97 0.4 Allowed Glycine 0 CA--C 1.521 0.411 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 175.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 20.7 mtt180 60.68 -156.38 0.35 Allowed 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -171.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 86.3 mm-40 -72.53 115.73 12.15 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 167.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -49.58 107.75 0.16 Allowed 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -171.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 61.3 mt -68.27 130.44 33.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.319 178.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.403 ' N ' HD13 ' A' ' 155' ' ' LEU . 6.9 mp -85.21 84.72 7.59 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.145 177.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -51.5 139.87 19.18 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.916 -179.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -61.34 -41.54 97.21 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.449 0.642 . . . . 0.0 110.62 175.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 48.1 t -141.96 109.68 5.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.963 171.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -76.06 63.82 2.8 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 121.177 -0.535 . . . . 0.0 113.56 -177.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 50.9 t80 64.05 10.05 5.1 Favored 'General case' 0 CA--C 1.551 0.992 0 CA-C-O 121.199 0.523 . . . . 0.0 112.399 176.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 26.9 m -88.59 -33.38 6.34 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -176.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.465 ' O ' ' NZ ' ' A' ' 175' ' ' LYS . 66.2 m -77.06 104.71 7.71 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 121.991 -0.443 . . . . 0.0 112.145 -176.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 60.36 98.45 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 176.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -78.57 -63.51 1.39 Allowed 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.519 0.676 . . . . 0.0 110.322 174.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -89.68 94.5 9.87 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.203 175.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -68.22 116.03 8.35 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.014 0.435 . . . . 0.0 111.782 -178.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -88.65 -16.95 31.1 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.874 178.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -76.65 65.85 2.79 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 121.312 -0.471 . . . . 0.0 113.444 -178.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 40.4 m -65.99 -52.91 45.21 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.118 0.485 . . . . 0.0 111.975 -176.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -111.55 10.67 21.24 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.289 0.566 . . . . 0.0 111.065 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -89.53 23.09 2.72 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.053 -176.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . 69.82 -6.58 1.03 Allowed 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -82.05 76.35 8.94 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.579 0.704 . . . . 0.0 109.519 176.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 34.4 m -78.12 29.09 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -168.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.465 ' NZ ' ' O ' ' A' ' 162' ' ' SER . 87.4 tttt -73.2 95.12 2.06 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.942 -0.473 . . . . 0.0 110.798 176.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 47.3 mttp -97.77 95.67 7.71 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.683 0.278 . . . . 0.0 110.674 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 42.9 tp -74.09 87.11 1.88 Allowed 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.484 0.659 . . . . 0.0 111.743 -177.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 . . . . . 0 N--CA 1.467 0.419 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.607 175.588 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.5 mtt . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 120.484 0.183 . . . . 0.0 110.799 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.63 116.53 6.3 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 169.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 64.25 -168.89 0.2 Allowed 'General case' 0 CA--C 1.542 0.643 0 O-C-N 123.212 0.32 . . . . 0.0 110.954 -171.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 66.5 m -67.42 161.74 24.61 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.08 0.467 . . . . 0.0 111.436 178.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.5 t -68.08 178.76 1.73 Allowed 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.624 177.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -39.98 -69.44 0.13 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.207 0.603 . . . . 0.0 112.306 178.064 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.54 HD11 ' HB3' ' A' ' 100' ' ' CYS . 30.3 pt -143.28 128.31 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-O 121.226 0.536 . . . . 0.0 111.681 174.022 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.77 -31.92 70.12 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.909 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.8 -31.76 64.81 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 121.215 -0.517 . . . . 0.0 113.028 177.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 36.8 tp -70.89 -43.77 67.67 Favored 'General case' 0 N--CA 1.467 0.383 0 O-C-N 122.73 -0.277 . . . . 0.0 110.773 178.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.2 tm-20 -57.78 -46.87 83.99 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.273 175.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.402 ' O ' ' HB2' ' A' ' 16' ' ' LYS . 33.5 tt0 -57.24 -49.61 75.5 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.575 177.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 56.9 m -63.36 -50.02 71.57 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -178.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -54.88 -48.53 72.85 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.216 0.531 . . . . 0.0 110.558 176.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.472 ' HG3' ' HA3' ' A' ' 27' ' ' GLY . 23.2 ttt180 -63.7 -37.95 89.27 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.084 178.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 12' ' ' GLU . 32.6 ttmt -59.32 -42.12 90.65 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.041 -178.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.412 ' CZ ' ' HA ' ' A' ' 108' ' ' PRO . 31.1 m-85 -79.9 -32.2 40.25 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 174.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.52 -34.35 75.38 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -178.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 27.9 pt -95.7 14.22 3.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-O 120.98 0.419 . . . . 0.0 111.685 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 75.1 t60 -64.75 -16.81 63.49 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -176.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -105.35 -38.57 2.42 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 120.959 -0.639 . . . . 0.0 113.396 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -162.18 148.98 11.05 Favored Pre-proline 0 CA--C 1.541 0.618 0 O-C-N 122.688 -0.301 . . . . 0.0 111.652 -175.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.12 -2.9 12.74 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.651 2.234 . . . . 0.0 113.401 -178.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -85.97 -18.74 31.78 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.068 0.461 . . . . 0.0 110.862 178.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -76.54 54.19 0.92 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.353 170.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 38.0 t -25.58 -53.43 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 -170.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.472 ' HA3' ' HG3' ' A' ' 15' ' ' ARG . . . 147.95 58.93 0.01 OUTLIER Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.629 -179.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -134.95 -19.17 1.79 Allowed 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 120.751 0.31 . . . . 0.0 111.5 -178.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -152.72 151.87 31.03 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -171.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.412 ' O ' HD11 ' A' ' 70' ' ' ILE . 42.8 ttm -136.58 149.63 48.16 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.61 -179.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -97.36 168.35 10.46 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.119 0.485 . . . . 0.0 111.948 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.08 -32.77 81.56 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-N 116.185 -0.461 . . . . 0.0 114.181 -177.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -62.51 -52.26 64.16 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 117.053 0.426 . . . . 0.0 111.732 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -69.13 -40.3 78.35 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.594 0.235 . . . . 0.0 110.999 177.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.49 ' NE1' ' HB2' ' A' ' 59' ' ' PHE . 24.9 t-105 -56.36 -42.27 77.52 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.113 0.482 . . . . 0.0 111.747 175.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.07 -51.93 65.97 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.572 179.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -69.32 -27.41 65.35 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.19 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.0 tt -57.38 -56.91 15.77 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.058 0.456 . . . . 0.0 110.198 176.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 86.3 m -60.49 -47.83 84.4 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.997 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -67.48 -41.71 84.15 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -176.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.407 ' OD2' ' NZ ' ' A' ' 106' ' ' LYS . 37.5 t70 -77.51 -29.96 52.7 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 120.741 0.305 . . . . 0.0 111.623 -178.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 62.2 m -90.7 -0.44 57.7 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 120.697 0.284 . . . . 0.0 111.429 176.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt 71.47 22.06 4.31 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 173.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 50.7 t -68.02 -28.45 41.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 CA-C-O 121.144 0.497 . . . . 0.0 110.99 174.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -89.65 121.03 31.45 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.254 174.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -79.48 -66.19 0.9 Allowed 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -173.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.437 ' O ' ' HB2' ' A' ' 48' ' ' LYS . . . 130.34 119.46 2.13 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 -168.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.437 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 75.2 mmtt 80.74 -15.94 0.7 Allowed 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.646 0.779 . . . . 0.0 111.936 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 42.4 t -122.03 -83.23 0.66 Allowed 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 173.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 84.1 t -87.56 111.7 22.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 120.894 0.378 . . . . 0.0 110.617 172.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.433 ' O ' HG21 ' A' ' 55' ' ' VAL . 72.8 p -125.58 -179.93 4.86 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.935 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -50.78 -35.44 31.11 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 121.031 -0.604 . . . . 0.0 113.195 178.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.561 ' O ' HG13 ' A' ' 57' ' ' ILE . 27.6 m -60.8 -58.41 8.57 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.738 0.304 . . . . 0.0 110.797 176.62 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -53.34 -41.45 65.78 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.976 179.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.433 HG21 ' O ' ' A' ' 51' ' ' THR . 93.6 t -56.91 -39.51 65.67 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.74 177.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -73.82 -37.84 64.75 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.292 0.568 . . . . 0.0 110.4 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.561 HG13 ' O ' ' A' ' 53' ' ' THR . 11.4 mt -60.33 -48.42 88.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.943 178.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 89.7 t -62.48 -43.69 98.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.64 177.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.49 ' HB2' ' NE1' ' A' ' 35' ' ' TRP . 86.7 t80 -50.23 -47.66 54.9 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.109 0.481 . . . . 0.0 111.938 178.368 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 35.8 t -82.04 -16.7 49.29 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.06 0.457 . . . . 0.0 111.614 -179.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -76.09 -38.22 57.24 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.95 -179.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.1 m -87.07 -5.92 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -176.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.6 pttp -119.88 -176.92 3.28 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.09 0.472 . . . . 0.0 111.692 -178.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -105.1 -178.03 24.36 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-N 116.291 -0.413 . . . . 0.0 113.424 177.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -75.49 -39.79 58.1 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -178.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 43.4 t -66.47 -35.95 81.54 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 120.917 0.389 . . . . 0.0 111.868 -178.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -93.4 122.44 35.82 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 120.967 0.413 . . . . 0.0 111.327 178.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 70.7 mtp180 -94.25 5.64 51.14 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.112 0.482 . . . . 0.0 110.683 175.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.9 m -129.63 159.91 41.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.921 179.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.412 HD11 ' O ' ' A' ' 30' ' ' MET . 0.2 OUTLIER -114.4 150.7 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-O 120.967 0.413 . . . . 0.0 111.297 175.946 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.413 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 2.9 p-10 -104.78 172.25 6.89 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.296 178.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -46.49 -54.18 9.78 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -169.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.46 -44.86 89.76 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 120.983 0.421 . . . . 0.0 111.347 -176.035 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -65.71 -33.96 77.1 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.203 0.525 . . . . 0.0 110.838 179.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -57.62 -44.09 85.25 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.6 172.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -69.08 -33.7 73.94 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.231 176.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -60.54 -37.92 82.79 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.251 0.548 . . . . 0.0 110.292 173.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.08 -41.91 97.15 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.745 172.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 88.6 mt -62.31 -33.7 75.19 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.398 175.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -61.07 -49.64 76.52 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 120.735 0.302 . . . . 0.0 110.833 175.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -55.56 -58.01 9.54 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.111 0.482 . . . . 0.0 111.085 174.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 94.0 mt -56.71 -44.46 81.6 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.036 -179.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.69 -45.2 87.64 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -179.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 81.8 p -72.44 -12.29 61.04 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -178.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -93.72 -47.45 6.78 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 120.685 0.279 . . . . 0.0 111.502 172.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 76.7 mtp180 -70.63 -49.87 42.88 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 121.176 0.512 . . . . 0.0 111.85 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -106.55 38.59 2.02 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.881 -177.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -57.87 90.97 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.97 -178.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -160.8 44.81 0.41 Allowed Glycine 0 CA--C 1.526 0.772 0 C-N-CA 121.076 -0.583 . . . . 0.0 113.446 179.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 60.9 mttm 70.71 -60.68 0.5 Allowed 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 177.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 25.6 m -56.78 87.91 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -175.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -66.36 -43.48 85.88 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.703 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -54.03 -61.07 2.54 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.836 0.35 . . . . 0.0 110.886 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -56.72 -41.6 77.74 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.691 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.24 -43.5 92.39 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.924 0.393 . . . . 0.0 111.282 177.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -68.69 -49.06 62.01 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.963 -179.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.52 ' O ' ' HG3' ' A' ' 101' ' ' GLN . 1.5 m-20 -55.5 -44.54 76.66 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 111.545 0.202 . . . . 0.0 111.545 175.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.67 -57.55 11.55 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.019 0.437 . . . . 0.0 112.108 -179.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.0 tt -57.62 -29.74 35.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-O 121.245 0.545 . . . . 0.0 110.474 178.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . 0.54 ' HB3' HD11 ' A' ' 7' ' ' ILE . 90.6 m -82.26 -18.98 40.53 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.963 175.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.52 ' HG3' ' O ' ' A' ' 97' ' ' ASP . 24.4 mt-30 -64.91 -33.94 77.23 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 121.669 -0.644 . . . . 0.0 109.853 171.259 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 81.1 mt -75.58 -11.1 59.95 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.557 177.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 64.5 t -121.48 -51.16 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -173.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -49.45 113.8 0.9 Allowed 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -175.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.39 -31.25 5.85 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 121.401 -0.428 . . . . 0.0 113.293 -179.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.407 ' NZ ' ' OD2' ' A' ' 41' ' ' ASP . 26.3 tptp -47.02 133.21 11.52 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.571 0.748 . . . . 0.0 112.602 -178.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -83.48 155.82 65.82 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.319 178.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.412 ' HA ' ' CZ ' ' A' ' 17' ' ' PHE . 83.2 Cg_endo -79.83 139.34 13.82 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.589 2.193 . . . . 0.0 113.17 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 57.24 54.47 6.73 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.214 0.531 . . . . 0.0 111.301 178.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -80.25 29.34 0.29 Allowed 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.366 0.603 . . . . 0.0 111.86 -174.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 5.3 p -104.55 -53.12 7.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.902 176.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 49.41 73.05 0.39 Allowed Glycine 0 C--N 1.339 0.728 0 C-N-CA 121.505 -0.379 . . . . 0.0 112.822 -178.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 47.3 t -61.59 93.73 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-O 121.398 0.618 . . . . 0.0 111.459 -177.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 60.5 m -133.54 141.35 47.69 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.196 -177.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 25.8 ttpp -68.18 104.74 1.88 Allowed 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.317 178.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 67.16 91.68 0.09 Allowed 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 121.22 0.533 . . . . 0.0 111.699 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -139.34 39.56 2.08 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.297 -176.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 33.5 m -59.68 -39.9 86.05 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 121.158 0.504 . . . . 0.0 111.234 178.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -80.26 105.03 2.31 Favored Glycine 0 CA--C 1.526 0.768 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.561 176.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -73.78 68.2 1.6 Allowed Glycine 0 CA--C 1.531 1.051 0 C-N-CA 121.395 -0.431 . . . . 0.0 113.604 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 58.62 -84.95 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 20.8 m -102.88 112.17 35.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 121.437 0.637 . . . . 0.0 112.04 -175.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -85.82 -2.82 58.62 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -178.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 53.4 mtm180 -57.73 126.11 25.96 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 120.891 0.377 . . . . 0.0 111.55 176.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.453 HD12 ' N ' ' A' ' 125' ' ' LEU . 6.4 mp -79.59 69.03 5.8 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 121.345 0.593 . . . . 0.0 111.562 -177.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 8.8 t -113.96 3.65 15.45 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.136 0.493 . . . . 0.0 111.348 177.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -88.69 143.34 26.99 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.534 -178.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 24.5 m -83.92 65.91 8.88 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.436 0.636 . . . . 0.0 111.187 -178.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.421 ' C ' ' H ' ' A' ' 131' ' ' TYR . 33.7 t -83.1 -47.66 11.41 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.962 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 19.8 mtp180 70.63 -21.69 0.19 Allowed 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.421 ' H ' ' C ' ' A' ' 129' ' ' SER . 93.1 m-85 68.96 -11.86 0.42 Allowed 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 177.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' THR . . . . . 0.543 ' OG1' ' HB2' ' A' ' 135' ' ' HIS . 46.6 p 52.46 18.95 1.04 Allowed 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 174.01 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 48.09 -110.33 0.64 Allowed Glycine 0 CA--C 1.531 1.08 0 N-CA-C 115.471 0.949 . . . . 0.0 115.471 173.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 42.2 m -65.96 -3.6 5.54 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -173.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.543 ' HB2' ' OG1' ' A' ' 132' ' ' THR . 73.4 m80 -83.0 6.71 17.84 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 120.834 0.35 . . . . 0.0 111.554 178.102 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 34.1 ttmt -69.69 73.72 0.4 Allowed 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.355 0.597 . . . . 0.0 110.62 175.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -85.44 92.61 8.54 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.268 0.556 . . . . 0.0 111.621 -177.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -110.8 113.16 25.54 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.96 173.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 59.9 t80 54.63 72.98 0.43 Allowed 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.423 0.63 . . . . 0.0 111.526 -174.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -86.82 127.87 35.02 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.13 -0.487 . . . . 0.0 109.825 178.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -57.29 130.17 45.03 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -170.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 48.8 m 65.6 -74.24 0.06 Allowed 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.641 175.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 102.55 -139.82 14.59 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 121.19 -0.528 . . . . 0.0 113.319 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -105.46 -8.4 18.12 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -176.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -68.75 77.52 0.28 Allowed Glycine 0 CA--C 1.533 1.158 0 N-CA-C 114.677 0.631 . . . . 0.0 114.677 -175.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -147.42 133.82 19.65 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 120.993 0.425 . . . . 0.0 110.977 174.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 69.58 -163.31 51.73 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 121.254 -0.498 . . . . 0.0 113.011 -177.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.496 ' N ' HD11 ' A' ' 148' ' ' ILE . 2.7 mp -80.32 -46.73 21.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 120.805 0.336 . . . . 0.0 110.122 175.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . 60.32 -80.43 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 172.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -57.61 -44.25 93.99 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 114.552 0.581 . . . . 0.0 114.552 -171.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 151' ' ' ARG . 4.1 ptp85 -118.6 -178.07 3.45 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 122.448 -0.443 . . . . 0.0 111.457 -177.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -100.49 142.99 31.19 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.954 0.407 . . . . 0.0 111.462 -178.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -82.03 -69.45 0.62 Allowed 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.037 0.446 . . . . 0.0 111.191 179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 7.3 tp -82.62 136.29 23.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.731 176.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 87.9 mt -75.89 65.99 2.06 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.709 0.29 . . . . 0.0 111.718 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.9 p30 39.56 25.27 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 178.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -62.47 -31.97 72.79 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 121.078 0.466 . . . . 0.0 111.352 179.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 80.4 p -75.68 14.13 0.69 Allowed 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -97.27 -8.07 56.71 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 121.478 -0.391 . . . . 0.0 112.691 173.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -106.8 -54.52 2.46 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.094 0.473 . . . . 0.0 111.953 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 7.1 p -99.65 126.09 53.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -172.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 61.5 m 65.27 139.71 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 173.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 61.2 85.05 0.12 Allowed 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.034 -176.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -74.67 -20.99 59.65 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.947 -173.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 73.7 mttt 60.49 -164.61 0.23 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.066 0.46 . . . . 0.0 111.804 174.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -118.88 163.87 16.27 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.809 0.338 . . . . 0.0 110.718 174.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -79.48 15.99 1.15 Allowed 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -177.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 93.29 65.8 1.07 Allowed Glycine 0 CA--C 1.524 0.625 0 C-N-CA 121.252 -0.499 . . . . 0.0 112.401 -177.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' THR . . . . . 0.478 HG23 ' HA ' ' A' ' 173' ' ' LYS . 2.7 t -91.51 128.07 37.2 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.054 0.454 . . . . 0.0 111.959 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -88.74 -14.92 36.06 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.878 178.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -77.27 82.71 3.74 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 121.13 0.49 . . . . 0.0 111.513 -178.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . 56.64 9.52 0.58 Allowed 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 175.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.478 ' HA ' HG23 ' A' ' 169' ' ' THR . 66.9 mttm 56.86 82.69 0.11 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 122.401 0.28 . . . . 0.0 111.283 -176.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 9.7 p 41.25 93.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 CA-C-O 121.989 0.899 . . . . 0.0 112.703 -176.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 51.4 tttp -89.41 86.0 6.69 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.66 -175.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -107.64 -39.8 5.5 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 116.554 -0.293 . . . . 0.0 111.356 -179.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.451 ' O ' ' HB3' ' A' ' 178' ' ' GLU . 8.4 mp 73.87 -59.3 0.56 Allowed 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 176.181 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.451 ' HB3' ' O ' ' A' ' 177' ' ' LEU . 40.5 tt0 . . . . . 0 N--CA 1.475 0.803 0 C-N-CA 123.331 0.653 . . . . 0.0 110.825 -169.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.6 tpt . . . . . 0 N--CA 1.489 1.486 0 CA-C-O 120.712 0.292 . . . . 0.0 111.414 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.4 175.87 9.22 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.223 0.535 . . . . 0.0 112.223 -178.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -92.21 -156.75 0.48 Allowed 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.363 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 69.4 m -57.47 101.34 0.07 Allowed 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 120.996 0.427 . . . . 0.0 111.287 175.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 71.9 p -78.03 -177.11 4.86 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.716 0.635 . . . . 0.0 112.716 -176.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -68.19 -179.34 1.24 Allowed 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.866 176.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.459 ' N ' HD12 ' A' ' 7' ' ' ILE . 2.3 mp -66.43 96.13 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-O 121.264 0.554 . . . . 0.0 110.797 178.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.41 -35.65 72.36 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.329 -177.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -56.66 -31.4 60.47 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 121.131 -0.557 . . . . 0.0 113.131 179.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.423 HD11 ' HE2' ' A' ' 75' ' ' PHE . 54.7 tp -70.45 -53.73 15.22 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 120.776 0.322 . . . . 0.0 111.314 178.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -63.36 -39.01 93.36 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 122.185 -0.322 . . . . 0.0 111.533 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -57.79 -56.52 20.92 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.831 0.348 . . . . 0.0 111.095 175.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.673 ' HB3' ' HB2' ' A' ' 107' ' ' GLU . 65.7 m -67.79 -44.34 77.61 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -176.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -50.01 -51.94 38.0 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 121.187 0.518 . . . . 0.0 111.145 171.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 15' ' ' ARG . 32.1 ttt180 -60.55 -44.23 96.35 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.832 179.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.539 ' HD3' HD11 ' A' ' 19' ' ' ILE . 0.1 OUTLIER -68.85 -27.89 66.22 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.844 -179.441 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -78.52 -33.12 48.25 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.177 0.513 . . . . 0.0 110.199 177.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.38 -38.35 77.98 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.447 177.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.539 HD11 ' HD3' ' A' ' 16' ' ' LYS . 27.0 pt -94.11 14.45 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 120.877 0.37 . . . . 0.0 111.039 178.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -52.85 97.3 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.101 0.477 . . . . 0.0 111.477 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 120.73 -36.2 3.44 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.656 -176.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.436 ' O ' ' HB ' ' A' ' 19' ' ' ILE . 11.7 m-20 -121.54 91.4 48.41 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 122.76 0.424 . . . . 0.0 111.946 -178.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -71.35 -2.87 11.9 Favored 'Trans proline' 0 CA--C 1.545 1.026 0 C-N-CA 122.517 2.145 . . . . 0.0 113.549 -178.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.658 ' HZ2' ' HB3' ' A' ' 24' ' ' LYS . 8.7 mtpm? -88.35 -7.0 57.38 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -178.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.449 ' HB3' HG22 ' A' ' 19' ' ' ILE . . . -93.73 157.57 16.09 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.615 0.245 . . . . 0.0 111.321 178.163 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 28.3 t -88.36 -19.16 27.02 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 120.989 0.423 . . . . 0.0 110.776 177.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.427 ' HA3' HG21 ' A' ' 19' ' ' ILE . . . 63.87 56.6 17.82 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 115.606 1.002 . . . . 0.0 115.606 170.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -96.57 -8.56 31.53 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.518 0.675 . . . . 0.0 109.793 169.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.509 ' HB3' HG21 ' A' ' 69' ' ' VAL . 50.9 mt-10 -113.08 111.61 22.42 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.432 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 42.3 ttm -98.86 133.32 43.32 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.146 0.498 . . . . 0.0 111.553 176.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.416 ' ND2' ' HB2' ' A' ' 33' ' ' LYS . 13.9 p-10 -86.86 156.92 19.67 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.531 179.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -58.25 -28.2 61.32 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-N 116.24 -0.437 . . . . 0.0 113.212 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.416 ' HB2' ' ND2' ' A' ' 31' ' ' ASN . 47.4 mmtm -57.7 -59.5 5.11 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.045 0.45 . . . . 0.0 111.336 176.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -64.66 -38.76 92.1 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.872 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 45.5 t-105 -56.17 -49.06 75.06 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 120.901 0.382 . . . . 0.0 111.798 177.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.04 -47.08 86.33 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.205 0.526 . . . . 0.0 111.751 178.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.612 ' HZ2' ' HB3' ' A' ' 37' ' ' LYS . 7.8 mtpm? -67.26 -29.98 69.74 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.336 179.33 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.462 HD23 ' HG ' ' A' ' 42' ' ' CYS . 5.1 tt -62.3 -49.3 76.18 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.169 0.509 . . . . 0.0 110.081 177.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 78.9 m -58.53 -44.28 89.52 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.442 178.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -69.9 -33.66 72.48 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 120.992 0.425 . . . . 0.0 111.388 179.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -64.1 -38.66 91.88 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.418 0.628 . . . . 0.0 110.822 177.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.472 ' HA ' ' HE2' ' A' ' 106' ' ' LYS . 59.1 m -99.2 0.76 43.98 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.039 -177.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.428 ' N ' ' HD2' ' A' ' 43' ' ' LYS . 3.3 mptp? 59.2 31.28 21.1 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.337 176.26 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.446 HG11 ' HB3' ' A' ' 82' ' ' LEU . 32.5 t -70.3 -37.44 71.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-O 121.486 0.66 . . . . 0.0 109.39 170.098 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.19 85.46 6.8 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.505 169.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -169.76 78.68 0.1 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.785 -171.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -176.72 37.29 0.09 OUTLIER Glycine 0 CA--C 1.522 0.506 0 C-N-CA 120.708 -0.758 . . . . 0.0 113.434 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.1 mtpm? 50.23 14.67 0.16 Allowed 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 178.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.7 m -150.54 -60.08 0.19 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.885 0.374 . . . . 0.0 110.509 -175.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 41.0 t -68.29 90.36 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 172.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 49.2 p -129.0 -171.09 2.39 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.103 -178.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -48.04 -36.86 15.58 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 121.476 -0.392 . . . . 0.0 113.686 -178.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.55 ' O ' HG12 ' A' ' 57' ' ' ILE . 4.8 t -64.32 -55.85 18.49 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 122.334 -0.51 . . . . 0.0 111.358 178.37 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -62.7 -40.03 95.87 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.04 0.448 . . . . 0.0 110.994 -177.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 84.3 t -61.69 -31.03 49.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.417 176.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -82.03 -30.91 31.23 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.334 0.588 . . . . 0.0 109.55 179.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.55 HG12 ' O ' ' A' ' 53' ' ' THR . 10.4 mm -61.24 -52.38 62.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.9 174.233 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.8 t -58.53 -42.74 85.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 120.919 0.39 . . . . 0.0 110.945 176.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -57.82 -40.82 80.9 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.355 0.598 . . . . 0.0 110.869 175.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 37.3 m -82.59 -11.72 58.21 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.486 178.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.667 ' HA ' ' HE2' ' A' ' 61' ' ' LYS . 0.6 OUTLIER -76.95 -50.41 13.28 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.838 176.972 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 31.4 m -67.63 -25.94 34.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.548 175.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.404 ' NZ ' ' O ' ' A' ' 67' ' ' ALA . 23.0 ttmm -69.34 104.98 2.4 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.829 174.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -91.15 -61.35 1.27 Allowed Glycine 0 CA--C 1.526 0.778 0 C-N-CA 121.081 -0.581 . . . . 0.0 113.299 -178.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.581 ' HB2' ' HZ2' ' A' ' 65' ' ' LYS . 10.3 mtmp? -121.55 -152.63 0.52 Allowed 'General case' 0 CA--C 1.542 0.66 0 O-C-N 122.524 -0.398 . . . . 0.0 111.014 -178.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 39.3 t -62.72 91.19 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.425 0.631 . . . . 0.0 111.917 -176.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.404 ' O ' ' NZ ' ' A' ' 63' ' ' LYS . . . -160.12 108.51 1.7 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.771 178.492 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.7 ttm-85 -70.36 -44.64 67.71 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.349 0.595 . . . . 0.0 111.113 -177.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.509 HG21 ' HB3' ' A' ' 29' ' ' GLU . 27.6 m -95.64 170.92 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.385 -175.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 34.6 pt -121.22 149.63 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.394 176.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -99.46 171.4 7.97 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.93 0.395 . . . . 0.0 111.389 178.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -57.99 -35.49 71.3 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -176.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.471 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 39.5 mm-40 -61.39 -53.27 58.81 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.799 0.333 . . . . 0.0 111.499 178.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -65.97 -28.06 68.62 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.907 0.384 . . . . 0.0 110.939 178.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.423 ' HE2' HD11 ' A' ' 10' ' ' LEU . 88.5 t80 -60.7 -47.99 83.78 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.183 175.05 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.471 ' HE2' ' HA ' ' A' ' 73' ' ' GLU . 53.4 mtmt -58.01 -47.08 84.1 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.919 0.39 . . . . 0.0 110.782 176.325 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -56.75 -42.9 80.13 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.154 0.502 . . . . 0.0 111.249 175.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.21 -42.87 99.35 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.375 177.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 88.2 mt -58.32 -41.57 84.83 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.294 177.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -63.76 -36.6 84.41 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 120.88 0.372 . . . . 0.0 111.192 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -63.76 -61.06 2.55 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 120.634 0.254 . . . . 0.0 111.122 172.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.446 ' HB3' HG11 ' A' ' 44' ' ' VAL . 11.2 mp -50.71 -40.49 54.3 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.196 0.522 . . . . 0.0 111.851 179.001 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.96 -53.33 59.29 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.743 175.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 69.2 p -74.32 -10.4 59.55 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -86.96 -45.86 10.4 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.105 0.479 . . . . 0.0 111.414 174.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.4 -49.04 9.05 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.882 -176.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -82.61 -178.45 7.08 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.156 0.503 . . . . 0.0 111.068 179.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -93.96 142.02 27.85 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.848 177.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -76.19 56.33 3.21 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 121.356 -0.449 . . . . 0.0 114.177 -176.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 29.0 ttpp -83.59 -31.78 26.12 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.208 0.527 . . . . 0.0 110.323 175.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.521 ' HB3' ' HB3' ' A' ' 94' ' ' GLU . 30.8 t -162.37 126.16 3.06 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.812 178.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 50.7 tttm -69.31 -47.09 65.5 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.777 0.323 . . . . 0.0 111.811 -178.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -64.47 -40.9 96.57 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 120.78 0.324 . . . . 0.0 110.986 178.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.521 ' HB3' ' HB3' ' A' ' 91' ' ' SER . 34.5 tt0 -65.67 -43.48 89.2 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.803 0.335 . . . . 0.0 111.257 177.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.95 -35.52 73.28 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.885 0.374 . . . . 0.0 110.978 175.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -64.87 -42.66 94.64 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.864 176.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -64.69 -38.51 91.26 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 120.933 0.396 . . . . 0.0 110.972 176.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.59 -51.31 60.65 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.679 179.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 16.5 tt -62.6 -33.2 58.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-O 120.941 0.4 . . . . 0.0 110.343 177.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . 0.449 ' SG ' ' HB1' ' A' ' 104' ' ' ALA . 39.7 t -65.43 -34.12 77.55 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.82 0.343 . . . . 0.0 110.851 172.154 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -69.7 -22.32 63.42 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.506 178.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 80.4 mt -95.55 -36.61 11.21 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.059 0.457 . . . . 0.0 111.987 175.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 81.9 t -96.8 -65.69 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 112.554 0.575 . . . . 0.0 112.554 -174.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.449 ' HB1' ' SG ' ' A' ' 100' ' ' CYS . . . -51.38 109.38 0.34 Allowed 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -168.074 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 107.25 -38.09 3.5 Favored Glycine 0 CA--C 1.522 0.479 0 C-N-CA 121.174 -0.536 . . . . 0.0 112.849 178.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.472 ' HE2' ' HA ' ' A' ' 42' ' ' CYS . 14.7 ttpp -78.86 -63.37 1.43 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.836 0.35 . . . . 0.0 110.549 178.281 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.673 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 25.6 mt-10 29.72 -88.03 0.0 OUTLIER Pre-proline 0 CA--C 1.557 1.219 0 N-CA-C 115.161 1.541 . . . . 0.0 115.161 177.121 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.583 ' HD3' ' HB2' ' A' ' 107' ' ' GLU . 6.8 Cg_exo -74.22 79.22 2.45 Favored 'Trans proline' 0 C--N 1.367 1.552 0 CA-C-N 123.306 2.216 . . . . 0.0 112.004 177.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -127.56 -51.31 1.38 Allowed 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -177.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -77.92 73.58 4.48 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 121.702 0.763 . . . . 0.0 112.143 -172.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 35.3 m -90.28 -4.3 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-O 121.314 0.578 . . . . 0.0 110.824 173.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -172.66 -107.76 0.21 Allowed Glycine 0 CA--C 1.527 0.834 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.848 178.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 65.0 t -113.55 130.72 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-O 120.99 0.424 . . . . 0.0 111.356 177.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 9.6 t -81.54 135.15 35.58 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.895 0.379 . . . . 0.0 111.181 177.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 44.6 tptt -84.32 163.93 19.3 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.652 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 68.28 122.63 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 122.913 0.485 . . . . 0.0 111.868 -177.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt 66.58 16.14 10.31 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 122.954 0.502 . . . . 0.0 111.66 -176.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 18.6 m -58.69 -40.55 83.92 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.932 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 148.41 -125.33 2.05 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 121.394 -0.432 . . . . 0.0 112.598 -178.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 88.34 -81.84 1.56 Allowed Glycine 0 CA--C 1.525 0.686 0 C-N-CA 121.333 -0.46 . . . . 0.0 112.842 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -72.65 146.43 46.57 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.939 0.399 . . . . 0.0 111.629 178.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.471 HG22 ' HB2' ' A' ' 125' ' ' LEU . 15.5 m -67.01 81.33 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -178.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 58.86 -81.13 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.913 175.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -159.91 18.34 0.16 Allowed 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 121.196 0.522 . . . . 0.0 110.339 -178.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.471 ' HB2' HG22 ' A' ' 122' ' ' VAL . 88.4 mt -81.8 139.28 34.88 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.48 0.657 . . . . 0.0 112.457 -173.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 87.8 m -119.97 85.19 2.34 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.546 175.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -71.85 151.67 43.23 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.301 174.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 93.5 m 67.33 110.03 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 112.451 0.538 . . . . 0.0 112.451 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 54.8 m 66.87 111.48 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 121.14 0.495 . . . . 0.0 111.894 178.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 14.5 mmt85 -107.83 12.78 26.95 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -173.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -63.61 -6.06 4.81 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -179.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 75.3 p -74.26 149.91 40.51 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -177.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.83 74.66 1.24 Allowed Glycine 0 CA--C 1.528 0.857 0 C-N-CA 121.21 -0.519 . . . . 0.0 113.069 179.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 50.7 m -107.94 13.8 25.87 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -177.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 10.0 p-80 -163.37 131.17 3.61 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -178.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 55.8 tttm -80.25 -41.33 25.25 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.069 0.461 . . . . 0.0 111.028 177.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -75.06 141.87 43.79 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 120.79 0.328 . . . . 0.0 110.589 175.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 34.2 tpt85 -176.82 -35.5 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.12 0.486 . . . . 0.0 111.164 -170.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -124.6 163.93 20.91 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.281 -176.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -66.67 -165.15 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 121.47 0.652 . . . . 0.0 111.807 176.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -82.65 -179.05 7.31 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 120.959 0.409 . . . . 0.0 110.888 174.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 49.7 m -65.76 143.56 57.44 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.379 174.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -63.71 90.88 0.08 OUTLIER Glycine 0 CA--C 1.528 0.895 0 C-N-CA 121.157 -0.544 . . . . 0.0 113.692 -175.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -73.15 -36.5 66.67 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.082 0.468 . . . . 0.0 110.725 176.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 71.58 -120.66 8.35 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.817 -178.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -161.93 24.17 0.11 Allowed 'General case' 0 CA--C 1.545 0.752 0 CA-C-O 121.282 0.563 . . . . 0.0 110.822 179.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 105.8 82.18 1.52 Allowed Glycine 0 CA--C 1.522 0.474 0 C-N-CA 121.224 -0.512 . . . . 0.0 112.117 -176.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 45.6 mm 64.17 -68.31 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 123.222 0.609 . . . . 0.0 111.615 -174.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -139.8 -54.5 0.55 Allowed 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 78.34 65.08 1.9 Allowed Glycine 0 CA--C 1.526 0.775 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.913 -174.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.423 ' HG3' ' H ' ' A' ' 152' ' ' GLN . 12.2 ptm180 53.9 -59.75 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 125.592 1.557 . . . . 0.0 113.585 -172.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . 0.423 ' H ' ' HG3' ' A' ' 151' ' ' ARG . 25.6 tp60 71.74 107.26 0.07 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.447 0.641 . . . . 0.0 112.033 176.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -102.9 144.53 31.09 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.082 173.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 2.7 pp -92.32 162.69 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -174.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 48.3 tp 73.21 -47.64 0.67 Allowed 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 176.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -55.41 -56.1 24.07 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 120.804 0.335 . . . . 0.0 111.689 -178.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.431 ' O ' ' HB3' ' A' ' 158' ' ' SER . 28.6 t0 -129.25 165.25 21.77 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.493 176.188 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.431 ' HB3' ' O ' ' A' ' 157' ' ' ASP . 37.5 t 73.62 -49.87 0.69 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.173 0.589 . . . . 0.0 111.864 -176.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -55.36 105.04 0.34 Allowed Glycine 0 CA--C 1.528 0.875 0 C-N-CA 121.614 -0.327 . . . . 0.0 113.318 179.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -67.81 96.88 0.6 Allowed 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.361 0.6 . . . . 0.0 111.764 -178.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 7.9 p -162.9 140.46 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.513 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 91.8 p -136.5 124.0 22.17 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.867 -0.419 . . . . 0.0 109.867 176.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -150.43 127.87 11.45 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -175.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 76.7 t80 -147.47 87.24 1.64 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.92 174.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 83.7 tttt 55.12 39.9 31.65 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-O 121.725 0.774 . . . . 0.0 110.783 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -83.76 -172.12 3.98 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.172 -175.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -64.89 98.76 0.3 Allowed 'General case' 0 CA--C 1.539 0.522 0 O-C-N 122.085 -0.384 . . . . 0.0 111.493 177.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -66.08 -69.27 1.39 Allowed Glycine 0 CA--C 1.526 0.731 0 C-N-CA 121.338 -0.458 . . . . 0.0 112.836 178.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 39.5 p 48.43 48.98 18.76 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.024 0.53 . . . . 0.0 112.298 178.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -84.92 37.55 0.67 Allowed 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -175.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -94.44 127.85 40.61 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 122.101 -0.374 . . . . 0.0 110.153 176.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -89.32 -10.27 47.37 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -174.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -70.49 -42.91 70.74 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.044 0.45 . . . . 0.0 111.342 -177.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 4.9 p -74.28 94.71 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 CA-C-O 121.462 0.649 . . . . 0.0 111.437 178.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -84.64 120.68 26.66 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.709 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . 0.685 ' HG3' ' H ' ' A' ' 177' ' ' LEU . 38.7 tptt -109.88 -161.52 0.76 Allowed 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 173.4 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.685 ' H ' ' HG3' ' A' ' 176' ' ' LYS . 87.3 mt -75.0 67.17 1.67 Allowed 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -174.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 . . . . . 0 N--CA 1.484 1.23 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 172.46 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.583 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 120.723 0.296 . . . . 0.0 111.277 . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.41 80.73 0.25 Allowed 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.002 0.43 . . . . 0.0 111.649 -178.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -176.16 -23.21 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.408 -177.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 32.9 m -71.06 -56.99 4.98 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.979 0.419 . . . . 0.0 111.827 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.623 HG22 ' HB3' ' A' ' 8' ' ' ALA . 84.8 m -108.79 98.83 8.26 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.031 0.443 . . . . 0.0 111.703 -178.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -83.63 -63.39 1.36 Allowed 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.205 0.526 . . . . 0.0 111.067 176.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.7 mm -122.17 -31.41 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.465 175.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.623 ' HB3' HG22 ' A' ' 5' ' ' THR . . . 66.23 -68.41 0.13 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.166 0.586 . . . . 0.0 112.098 -178.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -51.15 -28.56 18.89 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 121.615 -0.326 . . . . 0.0 113.496 178.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 51.6 tp -64.56 -38.48 91.17 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 120.719 0.295 . . . . 0.0 111.052 176.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.598 ' O ' ' HD3' ' A' ' 15' ' ' ARG . 39.9 tt0 -67.09 -46.14 75.14 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 177.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.453 ' O ' ' HG3' ' A' ' 16' ' ' LYS . 1.1 mp0 -51.79 -46.22 64.13 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.744 0.307 . . . . 0.0 111.156 172.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 70.6 m -58.95 -41.68 88.04 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.684 -0.234 . . . . 0.0 111.253 176.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -58.29 -46.85 85.32 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.645 176.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.598 ' HD3' ' O ' ' A' ' 11' ' ' GLU . 1.8 mpt_? -54.93 -55.85 26.1 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.121 175.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.453 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 67.1 mttm -54.32 -45.14 72.56 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -176.037 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -69.75 -39.49 76.69 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 111.728 0.27 . . . . 0.0 111.728 176.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.69 -53.6 38.83 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -177.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.522 HG12 ' O ' ' A' ' 15' ' ' ARG . 25.8 pt -78.8 -1.84 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 -176.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -56.06 -33.98 65.51 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.082 0.467 . . . . 0.0 110.656 175.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.57 59.83 4.93 Favored Glycine 0 CA--C 1.522 0.516 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.838 175.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 68.57 124.05 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 123.199 0.6 . . . . 0.0 111.338 -173.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.512 ' HA ' ' HB ' ' A' ' 19' ' ' ILE . 81.8 Cg_exo -47.57 -30.62 12.45 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 123.145 2.564 . . . . 0.0 114.237 -178.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -75.35 3.33 9.25 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 178.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.36 -52.04 66.97 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 111.868 0.321 . . . . 0.0 111.868 179.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 99.7 p 177.74 -70.55 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.004 0.431 . . . . 0.0 111.563 -179.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 107.46 -26.08 19.44 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 111.925 -0.47 . . . . 0.0 111.925 -174.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -115.88 -15.91 11.2 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.028 0.531 . . . . 0.0 111.101 178.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.426 ' HB3' HG21 ' A' ' 69' ' ' VAL . 8.7 mm-40 -111.9 145.7 39.07 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.715 -176.198 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 53.1 ttm -133.87 135.29 43.59 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 120.556 0.217 . . . . 0.0 111.146 178.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 36.1 p30 -94.13 168.85 10.67 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.17 0.51 . . . . 0.0 112.277 -178.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.15 -27.6 70.81 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-N 116.033 -0.531 . . . . 0.0 113.768 -179.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -62.89 -58.94 5.66 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.39 0.614 . . . . 0.0 111.199 178.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -64.18 -35.83 82.09 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.164 178.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 50.3 t-105 -62.2 -42.92 99.73 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.625 175.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.11 -45.72 86.77 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 121.131 0.491 . . . . 0.0 111.309 177.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.4 mtpp -64.83 -45.04 87.83 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.298 175.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.3 tt -46.02 -43.88 14.71 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.134 0.492 . . . . 0.0 111.182 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 79.3 m -68.48 -46.4 69.8 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 120.979 0.418 . . . . 0.0 111.588 176.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -65.91 -52.86 46.29 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.785 0.326 . . . . 0.0 111.84 -177.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.411 ' O ' ' NZ ' ' A' ' 43' ' ' LYS . 1.2 m-20 -55.27 -38.47 68.62 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 122.954 0.502 . . . . 0.0 111.257 176.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.688 ' SG ' ' HA ' ' A' ' 103' ' ' VAL . 83.4 m -85.94 -4.12 59.09 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 175.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.411 ' NZ ' ' O ' ' A' ' 41' ' ' ASP . 19.9 mtmm 52.76 41.3 31.56 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 178.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 57.9 t -78.34 -35.4 19.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 121.316 0.579 . . . . 0.0 110.32 171.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -102.56 79.22 1.79 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.637 178.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -60.35 -27.09 67.1 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.5 -29.33 12.75 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 121.196 -0.526 . . . . 0.0 111.977 -172.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -74.05 -61.65 1.78 Allowed 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 120.937 0.398 . . . . 0.0 110.9 176.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 69.0 p -90.05 -74.01 0.5 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.088 0.471 . . . . 0.0 110.506 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 89.0 t -89.19 135.27 26.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.365 174.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 43.6 p -124.05 173.53 8.21 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 120.883 0.373 . . . . 0.0 111.538 -177.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -54.84 -34.29 56.95 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 121.24 -0.505 . . . . 0.0 112.753 177.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.635 ' O ' HG13 ' A' ' 57' ' ' ILE . 89.3 m -53.61 -57.56 10.33 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 122.382 0.273 . . . . 0.0 111.102 176.443 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -52.43 -42.99 64.59 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.252 179.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 80.1 t -55.93 -43.96 76.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.851 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -73.55 -33.31 64.62 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.04 0.448 . . . . 0.0 111.115 -179.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.635 HG13 ' O ' ' A' ' 53' ' ' THR . 7.8 mt -64.42 -49.13 82.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.626 177.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 93.0 t -60.84 -43.38 95.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-O 120.786 0.327 . . . . 0.0 111.435 178.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -58.15 -35.16 71.13 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.17 0.509 . . . . 0.0 111.261 178.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 38.9 t -87.83 -21.84 24.81 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.743 177.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -68.13 -41.22 81.99 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 122.631 0.372 . . . . 0.0 111.969 -176.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.6 m -82.44 -21.26 9.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-O 121.245 0.545 . . . . 0.0 111.533 177.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.462 ' HD3' ' O ' ' A' ' 67' ' ' ALA . 39.4 ttmt -74.08 156.7 37.17 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -175.566 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -91.58 -128.02 4.11 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 121.538 -0.363 . . . . 0.0 113.184 175.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -100.54 -77.79 0.53 Allowed 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 81.2 p -76.94 -4.92 46.42 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -172.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.462 ' O ' ' HD3' ' A' ' 63' ' ' LYS . . . -68.88 121.06 15.8 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.106 0.479 . . . . 0.0 111.501 178.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 67.3 mtt180 -85.3 -32.31 22.58 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.198 0.523 . . . . 0.0 110.882 178.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.426 HG21 ' HB3' ' A' ' 29' ' ' GLU . 30.9 m -127.34 171.46 15.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.706 -176.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 36.3 pt -117.49 170.58 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 CA-C-O 120.581 0.229 . . . . 0.0 111.032 177.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -126.82 -179.97 5.08 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 -179.405 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.489 ' O ' ' HB3' ' A' ' 75' ' ' PHE . 70.6 t80 -34.73 -62.66 0.35 Allowed 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 -174.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -64.61 -38.57 91.46 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 121.798 -0.564 . . . . 0.0 112.014 -175.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -62.41 -37.22 84.97 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.219 0.533 . . . . 0.0 110.333 176.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.489 ' HB3' ' O ' ' A' ' 72' ' ' TYR . 60.8 t80 -57.03 -45.98 82.72 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.586 176.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.421 ' HE3' ' CZ ' ' A' ' 72' ' ' TYR . 81.2 mttt -61.39 -38.74 88.15 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.859 0.361 . . . . 0.0 111.7 178.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -71.69 -30.46 65.7 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.712 0.292 . . . . 0.0 111.531 176.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.31 -46.71 85.41 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.123 0.487 . . . . 0.0 110.687 173.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 86.9 mt -63.74 -34.95 79.01 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.107 175.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -62.0 -43.62 98.45 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 121.089 0.471 . . . . 0.0 110.93 178.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -59.79 -58.98 6.23 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.028 0.442 . . . . 0.0 111.284 173.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 90.9 mt -56.12 -42.01 76.17 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.949 -178.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.58 -51.78 68.44 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.799 0.333 . . . . 0.0 111.633 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 68.6 p -66.37 -20.7 66.14 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -178.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -102.38 -13.97 17.08 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 48.7 tpt85 -98.38 -60.79 1.48 Allowed 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.196 0.522 . . . . 0.0 110.975 177.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -77.38 -178.98 5.46 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.918 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 19.8 tptm -62.29 133.87 55.73 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.612 177.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -77.07 61.72 3.39 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 121.174 -0.536 . . . . 0.0 114.129 -173.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -165.77 153.52 10.67 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.979 0.389 . . . . 0.0 111.51 176.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 44.1 t 65.47 86.76 0.13 Allowed 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.91 -175.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 55.0 tttp -45.73 -41.78 11.07 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.295 175.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -57.38 -60.83 3.05 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.7 178.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -59.97 -43.75 94.88 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.82 0.343 . . . . 0.0 111.845 -176.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.61 -48.21 80.41 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -66.69 -48.11 70.3 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.278 -178.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.463 ' O ' ' HG3' ' A' ' 101' ' ' GLN . 4.2 m-20 -54.58 -49.36 70.57 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.748 0.309 . . . . 0.0 111.376 176.266 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -55.32 -51.94 65.1 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -178.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.8 tt -66.67 -33.16 61.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 CA-C-O 120.885 0.374 . . . . 0.0 111.235 -179.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 86.5 m -65.27 -34.82 79.24 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.824 0.345 . . . . 0.0 110.8 173.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.463 ' HG3' ' O ' ' A' ' 97' ' ' ASP . 28.9 mt-30 -64.78 -31.09 72.16 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.33 175.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 87.8 mt -72.91 -38.38 66.9 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 176.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.688 ' HA ' ' SG ' ' A' ' 42' ' ' CYS . 58.4 t -92.18 -57.4 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -174.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.91 98.41 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -170.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 85.17 5.39 85.68 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 114.99 0.756 . . . . 0.0 114.99 170.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 50.5 tttp -83.41 -2.04 54.89 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 118.015 0.908 . . . . 0.0 111.856 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 74.04 148.34 0.12 Allowed Pre-proline 0 N--CA 1.478 0.964 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 173.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -74.92 81.95 2.09 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.844 2.363 . . . . 0.0 112.168 176.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 53.28 -149.68 0.39 Allowed 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.863 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -69.49 105.58 2.68 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.732 0.301 . . . . 0.0 110.397 176.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 10.7 p -66.74 -35.91 75.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -178.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -118.81 -100.11 1.94 Allowed Glycine 0 CA--C 1.526 0.732 0 C-N-CA 121.354 -0.451 . . . . 0.0 112.646 179.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 8.2 p -74.71 135.38 27.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-O 121.014 0.435 . . . . 0.0 111.349 176.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 11.3 t -79.93 155.41 27.73 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.062 0.458 . . . . 0.0 112.227 -178.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.453 ' O ' HG23 ' A' ' 118' ' ' THR . 73.0 mmtt 64.6 -80.77 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 178.046 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 69.22 -61.07 0.44 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 122.765 0.426 . . . . 0.0 110.682 -169.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 55.8 tttp -164.57 -57.33 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 120.652 0.263 . . . . 0.0 110.967 173.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.453 HG23 ' O ' ' A' ' 115' ' ' LYS . 73.0 p 51.36 23.44 1.74 Allowed 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 175.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 78.11 11.96 84.84 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 120.892 -0.67 . . . . 0.0 113.98 178.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -60.63 -14.15 34.61 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 121.48 -0.39 . . . . 0.0 113.882 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -83.63 -43.06 16.01 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 120.802 0.334 . . . . 0.0 111.753 178.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 34.7 m -96.19 11.22 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -177.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -57.2 118.63 5.26 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.4 178.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 21.7 mtm180 -91.89 -174.32 3.77 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.566 0.698 . . . . 0.0 112.03 -177.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 85.4 mt -114.14 -149.84 0.45 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.614 178.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 48.8 p -64.45 93.09 0.09 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.349 0.595 . . . . 0.0 112.078 -177.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -67.45 158.3 32.13 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.097 175.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 80.6 p -85.98 -63.35 1.33 Allowed 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.323 0.582 . . . . 0.0 110.576 174.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 84.6 p -150.68 138.39 19.81 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.686 172.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 49.5 mtm-85 -66.78 -49.49 65.71 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.476 0.655 . . . . 0.0 110.55 -178.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -174.59 24.12 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 114.904 -1.043 . . . . 0.0 108.759 176.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 14.8 m -103.08 122.83 45.47 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.109 -0.95 . . . . 0.0 113.355 -163.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -98.8 167.29 21.88 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 166.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 66.0 m -57.72 96.11 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 117.677 0.738 . . . . 0.0 111.229 178.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 44.7 t-80 -78.4 90.37 4.42 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -175.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -111.62 -10.29 14.11 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.369 0.604 . . . . 0.0 109.702 167.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -58.36 152.34 17.86 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.612 178.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.669 ' HG3' ' H ' ' A' ' 139' ' ' PHE . 24.4 tpt180 -112.73 -173.28 2.22 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.94 -178.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.669 ' H ' ' HG3' ' A' ' 138' ' ' ARG . 95.1 m-85 76.89 23.63 0.97 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.827 0.851 . . . . 0.0 112.073 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -84.02 -12.19 55.59 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.963 172.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -72.9 144.96 47.18 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.08 -0.964 . . . . 0.0 112.433 -175.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 30.1 t -149.47 -57.07 0.19 Allowed 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.03 178.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 96.28 -56.03 1.49 Allowed Glycine 0 CA--C 1.528 0.858 0 C-N-CA 121.135 -0.555 . . . . 0.0 113.571 177.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -102.88 -166.84 1.32 Allowed 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 120.848 0.356 . . . . 0.0 111.296 -178.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -61.87 165.53 19.81 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.659 174.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 22.1 tptp -67.11 -22.11 65.82 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 122.265 -0.55 . . . . 0.0 111.911 -176.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -128.14 174.27 18.79 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-N 116.502 -0.317 . . . . 0.0 112.529 179.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 9.5 tt -146.19 137.94 19.44 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 O-C-N 122.263 -0.551 . . . . 0.0 112.171 -177.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . 74.36 -57.85 0.6 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.575 0.75 . . . . 0.0 112.996 175.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -59.91 -83.86 0.05 OUTLIER Glycine 0 CA--C 1.528 0.874 0 C-N-CA 121.353 -0.451 . . . . 0.0 114.087 -176.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -82.25 119.9 24.69 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 122.301 -0.529 . . . . 0.0 111.245 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -85.86 134.07 33.93 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.552 0.215 . . . . 0.0 111.184 177.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 37.62 -94.76 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -174.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 9.8 tt -160.56 116.9 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-O 121.295 0.569 . . . . 0.0 112.236 -176.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 86.1 mt -95.58 -35.95 11.45 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.178 0.513 . . . . 0.0 111.477 176.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -94.08 117.69 30.47 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.3 0.572 . . . . 0.0 112.135 -176.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -95.26 173.34 7.59 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.909 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 51.1 m -56.3 115.06 2.25 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -178.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -121.61 -141.17 6.04 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.364 176.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 63.84 -74.33 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.969 0 CA-C-O 121.389 0.614 . . . . 0.0 112.429 178.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 85.5 t -89.39 138.04 20.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.28 -175.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 38.4 t -77.45 58.54 1.73 Allowed 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.199 0.523 . . . . 0.0 111.046 177.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -80.57 34.22 0.32 Allowed 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -176.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 64.65 86.87 0.12 Allowed 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.29 0.567 . . . . 0.0 112.169 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -72.18 152.71 42.08 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.516 176.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -86.91 -172.76 4.14 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 120.926 0.393 . . . . 0.0 111.433 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -55.85 119.46 5.83 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -179.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.0 173.67 52.36 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 121.142 -0.552 . . . . 0.0 112.936 177.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 4.4 m -78.39 38.87 0.31 Allowed 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -175.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 57.12 18.41 4.09 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 173.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 31.3 t70 64.09 105.61 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 121.248 0.547 . . . . 0.0 111.537 -178.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.19 93.62 1.47 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.101 0.477 . . . . 0.0 111.18 178.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 36.1 tttp -91.12 95.19 9.95 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.608 -177.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 31.5 m -137.19 161.93 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -175.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.521 ' HD3' ' O ' ' A' ' 175' ' ' LYS . 6.0 tmtm? -80.7 -18.35 48.17 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 121.006 0.432 . . . . 0.0 110.544 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -42.32 129.96 3.82 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.411 HD11 ' N ' ' A' ' 177' ' ' LEU . 6.3 mp -59.63 -84.11 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.549 -178.357 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 . . . . . 0 CA--C 1.534 0.336 0 CA-C-O 121.006 0.431 . . . . 0.0 112.146 178.436 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.529 ' SD ' ' N ' ' A' ' 2' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.529 ' N ' ' SD ' ' A' ' 1' ' ' MET . . . -100.6 -37.43 8.78 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.003 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -173.85 -36.21 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.777 -177.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 73.4 m 75.09 -33.11 0.23 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.227 0.611 . . . . 0.0 112.37 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 55.9 m 65.99 98.21 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 122.765 0.426 . . . . 0.0 111.2 -179.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 67.69 -69.32 0.14 Allowed 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.142 0.577 . . . . 0.0 111.14 -175.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.4 HG21 ' HB2' ' A' ' 10' ' ' LEU . 9.0 tt -163.4 124.35 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.158 176.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -52.62 -33.81 48.28 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.2 -37.08 92.39 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 121.224 -0.513 . . . . 0.0 112.921 178.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.4 ' HB2' HG21 ' A' ' 7' ' ' ILE . 46.7 tp -60.89 -42.72 98.53 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.947 0.403 . . . . 0.0 110.522 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -57.33 -44.95 84.67 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.133 174.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.605 ' O ' ' HG3' ' A' ' 16' ' ' LYS . 32.3 mt-10 -61.44 -49.38 77.06 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.594 0.235 . . . . 0.0 110.954 179.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.462 ' HA ' ' HD2' ' A' ' 16' ' ' LYS . 47.4 m -57.48 -45.97 84.23 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.065 0.459 . . . . 0.0 111.312 178.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -58.77 -44.64 90.68 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.175 0.512 . . . . 0.0 110.408 175.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.715 HH11 ' HA3' ' A' ' 27' ' ' GLY . 3.0 tpt180 -56.16 -43.4 78.29 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.202 177.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.605 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 88.7 mttt -58.88 -54.67 44.49 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.036 -178.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -70.51 -33.4 71.17 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.93 -15.92 63.83 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -177.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.44 HG12 ' O ' ' A' ' 15' ' ' ARG . 31.9 pt -113.95 20.12 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-O 121.468 0.652 . . . . 0.0 111.126 175.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 50.0 t60 -67.9 -17.37 64.45 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -177.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -101.1 -42.83 2.33 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 120.933 -0.651 . . . . 0.0 113.558 -179.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.51 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . 5.0 m-20 -116.41 157.26 46.06 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 122.733 0.413 . . . . 0.0 110.893 -177.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -69.91 -13.73 34.69 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.306 2.004 . . . . 0.0 113.198 -178.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -132.79 -38.85 0.99 Allowed 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.006 0.432 . . . . 0.0 110.374 172.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.51 ' HB1' ' HB2' ' A' ' 22' ' ' ASP . . . 47.07 -87.68 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -179.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 70.0 m -163.69 -56.73 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.384 0.612 . . . . 0.0 110.433 -175.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.715 ' HA3' HH11 ' A' ' 15' ' ' ARG . . . 92.26 -34.51 4.41 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-N 115.934 -0.576 . . . . 0.0 113.238 -178.454 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -99.97 0.92 42.04 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 121.079 0.466 . . . . 0.0 111.001 177.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.449 ' HB3' HG22 ' A' ' 69' ' ' VAL . 44.9 mt-10 -124.88 112.34 16.52 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.162 -179.299 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 50.6 ttm -107.68 145.08 33.86 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.78 0.324 . . . . 0.0 111.109 178.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -109.73 168.63 9.27 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.154 0.502 . . . . 0.0 112.095 -177.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -59.88 -37.24 92.28 Favored Glycine 0 CA--C 1.529 0.936 0 N-CA-C 114.555 0.582 . . . . 0.0 114.555 -174.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -64.21 -53.69 45.22 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -174.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 13.1 p30 -74.33 -28.94 61.38 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 29.0 t-105 -60.42 -44.86 95.34 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.091 0.472 . . . . 0.0 111.231 170.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.43 -49.08 78.28 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.928 0.394 . . . . 0.0 111.135 176.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -64.81 -31.65 72.98 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.425 178.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.9 tt -58.21 -54.81 42.72 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.049 0.452 . . . . 0.0 110.147 177.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 67.4 m -58.07 -45.98 86.2 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.192 178.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -66.34 -33.2 75.19 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -74.23 -47.09 37.48 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.146 0.498 . . . . 0.0 110.188 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 85.7 m -75.19 -2.21 26.83 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.233 173.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt 54.78 35.65 24.59 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 175.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 61.7 t -68.55 -28.12 39.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.784 174.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.39 124.22 21.68 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.21 0.529 . . . . 0.0 111.622 178.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -75.29 -22.99 57.31 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.929 -176.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.12 -47.63 3.87 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 121.252 -0.499 . . . . 0.0 112.853 -179.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 42.0 mtmt -77.69 -57.83 3.6 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.465 0.65 . . . . 0.0 110.745 176.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.7 p -97.26 -72.07 0.66 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.497 179.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 49.4 t -76.43 114.29 16.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-O 121.067 0.461 . . . . 0.0 111.475 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.7 t -140.59 -175.16 4.18 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.623 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -45.23 -45.82 10.55 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 113.793 0.277 . . . . 0.0 113.793 -177.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.573 ' O ' HG12 ' A' ' 57' ' ' ILE . 67.8 m -53.88 -56.6 16.19 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.823 0.344 . . . . 0.0 111.37 175.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -58.16 -43.26 87.3 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 121.129 0.49 . . . . 0.0 111.016 -178.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 71.4 t -61.85 -26.92 41.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-O 121.224 0.535 . . . . 0.0 111.438 178.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -82.88 -39.36 21.67 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.522 0.677 . . . . 0.0 109.989 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.573 HG12 ' O ' ' A' ' 53' ' ' THR . 16.4 mm -55.95 -46.76 80.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.593 174.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 87.1 t -61.62 -47.48 93.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.294 176.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -54.5 -44.28 72.56 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.068 0.461 . . . . 0.0 111.617 178.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 35.6 t -74.92 -35.23 62.2 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.044 0.449 . . . . 0.0 111.636 178.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -62.9 -55.66 24.07 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -177.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 22.6 m -66.49 -24.38 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-O 121.124 0.488 . . . . 0.0 111.6 -178.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.51 ' HB2' HG21 ' A' ' 70' ' ' ILE . 22.0 ttpp -105.64 82.86 1.86 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.634 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -101.45 -10.58 41.01 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 121.049 -0.596 . . . . 0.0 114.586 -173.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 48.2 tptt -84.76 45.66 1.17 Allowed 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 117.81 0.805 . . . . 0.0 112.035 -177.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 39.6 t 53.68 16.02 0.9 Allowed 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 176.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -76.5 166.75 22.97 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.027 0.441 . . . . 0.0 111.647 -178.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 68' ' ' ARG . 40.6 ttp-105 -105.13 -36.56 7.23 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.045 0.45 . . . . 0.0 111.252 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.449 HG22 ' HB3' ' A' ' 29' ' ' GLU . 33.9 m -110.36 165.0 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.805 178.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.51 HG21 ' HB2' ' A' ' 63' ' ' LYS . 33.5 pt -111.93 146.53 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.012 175.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 30.1 p30 -100.46 -179.81 4.22 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.609 0.242 . . . . 0.0 111.379 177.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -56.45 -39.07 72.54 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -174.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -66.57 -49.25 66.99 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.792 0.33 . . . . 0.0 111.24 179.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -62.42 -35.37 79.01 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.058 0.456 . . . . 0.0 110.885 178.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.41 ' O ' ' HG ' ' A' ' 79' ' ' LEU . 89.1 t80 -58.63 -45.24 89.68 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.495 172.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -60.88 -41.81 96.71 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.542 176.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -60.05 -40.76 90.53 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.237 0.541 . . . . 0.0 110.727 174.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.76 -40.32 96.91 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.227 177.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 75' ' ' PHE . 76.5 mt -62.23 -37.64 86.14 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.233 177.043 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -61.66 -42.72 99.29 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.085 0.469 . . . . 0.0 110.672 176.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.438 ' O ' ' HG2' ' A' ' 85' ' ' LYS . 61.7 mm-40 -59.92 -55.08 38.57 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.202 175.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 91.5 mt -59.68 -37.81 79.79 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.862 0.363 . . . . 0.0 111.448 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.67 -55.02 40.43 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.878 0.37 . . . . 0.0 111.424 177.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 36.3 p -63.52 -24.01 67.63 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.044 178.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.438 ' HG2' ' O ' ' A' ' 81' ' ' GLU . 33.3 mmtp -73.97 -42.26 60.75 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 120.884 0.373 . . . . 0.0 111.728 174.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 30.9 mmm180 -90.63 -57.32 2.87 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -174.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -99.37 25.76 6.66 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -171.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt 62.7 -175.06 0.15 Allowed 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.834 -178.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -98.05 17.58 58.48 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 121.042 -0.599 . . . . 0.0 113.36 178.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -74.77 96.42 3.06 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 122.421 -0.458 . . . . 0.0 111.077 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 24.6 t 65.3 110.09 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.009 0.523 . . . . 0.0 112.327 -178.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -57.21 -34.63 68.72 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.589 0.233 . . . . 0.0 111.417 175.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -60.19 -52.69 64.23 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 120.696 0.284 . . . . 0.0 111.684 -178.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -69.2 -42.61 75.56 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 120.711 0.291 . . . . 0.0 111.641 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.62 -47.36 86.58 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 120.955 0.407 . . . . 0.0 111.649 177.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.439 ' HA ' HG23 ' A' ' 99' ' ' ILE . 49.0 t80 -66.39 -37.04 84.35 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.017 0.437 . . . . 0.0 110.74 179.11 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -58.23 -51.76 68.43 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.508 0.67 . . . . 0.0 110.566 174.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.3 -41.46 94.08 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.814 -176.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.439 HG23 ' HA ' ' A' ' 96' ' ' PHE . 10.1 tp -64.87 -37.68 80.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 O-C-N 121.936 -0.478 . . . . 0.0 110.42 177.292 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 87.1 m -69.75 -30.07 67.58 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.673 172.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 3.6 tp-100 -60.12 -35.56 75.52 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.104 0.478 . . . . 0.0 111.028 178.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 88.3 mt -67.85 -22.58 65.13 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.944 177.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 47.7 t -111.45 -70.02 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-O 120.775 0.321 . . . . 0.0 111.241 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 53.7 -86.74 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 177.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -143.57 27.71 2.07 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.739 -176.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -73.3 -172.59 1.16 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.575 0.702 . . . . 0.0 112.745 -176.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -136.51 151.71 73.43 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.374 178.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -57.6 95.7 0.07 OUTLIER 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 122.219 1.946 . . . . 0.0 113.077 -179.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 61.98 -79.13 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.443 0.697 . . . . 0.0 112.221 -177.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -165.18 114.01 1.04 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 122.684 0.394 . . . . 0.0 110.259 -178.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 17.4 m -96.6 174.46 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-O 120.917 0.389 . . . . 0.0 111.593 -177.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -60.12 150.36 40.37 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.773 175.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.7 m -70.26 -6.0 6.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -178.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 6.6 t -55.28 127.06 27.61 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.935 0.397 . . . . 0.0 111.362 176.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.425 ' HE3' ' HA ' ' A' ' 118' ' ' THR . 65.1 tttp -75.26 113.04 12.17 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.036 0.446 . . . . 0.0 111.911 -175.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -80.86 160.29 24.81 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.341 178.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 60.2 tttm 66.06 -70.61 0.1 Allowed 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 122.798 0.439 . . . . 0.0 111.232 -178.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.425 ' HA ' ' HE3' ' A' ' 115' ' ' LYS . 68.2 m 51.35 -95.34 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 176.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 50.9 -150.24 6.38 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.158 -170.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -80.89 -68.83 1.44 Allowed Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 166.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -137.37 -63.72 0.58 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 169.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.5 p -108.09 10.18 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.162 174.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 18.5 t70 76.86 152.55 0.13 Allowed 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.362 -177.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.4 tpm_? -76.22 104.28 6.67 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 112.735 0.642 . . . . 0.0 112.735 -172.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 97.7 mt -114.5 -161.56 0.78 Allowed 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.266 173.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 48.0 p 54.33 21.09 2.99 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 175.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -87.95 -154.96 0.28 Allowed 'General case' 0 CA--C 1.547 0.832 0 CA-C-O 121.109 0.481 . . . . 0.0 111.879 -175.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 37.1 m -74.45 -36.35 63.35 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -176.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 90.5 p -56.16 122.44 11.72 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -174.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -76.34 -47.56 23.05 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.486 174.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 81.0 t80 70.2 -42.55 0.52 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.743 0.817 . . . . 0.0 112.986 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 13.9 t -58.45 -11.01 2.46 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -178.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -161.82 121.15 1.0 Allowed Glycine 0 CA--C 1.523 0.54 0 C-N-CA 121.538 -0.363 . . . . 0.0 112.732 177.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 66.2 m -67.4 -25.26 65.86 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.01 0.434 . . . . 0.0 111.106 178.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -83.11 71.49 10.15 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.322 0.582 . . . . 0.0 109.767 172.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 56.8 pttt -65.81 -43.96 87.06 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.774 -176.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -98.32 79.63 2.56 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.79 0.805 . . . . 0.0 110.759 177.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.446 ' O ' ' HB2' ' A' ' 139' ' ' PHE . 33.8 ttp-105 -98.43 -77.96 0.5 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.506 -177.104 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.446 ' HB2' ' O ' ' A' ' 138' ' ' ARG . 68.2 t80 170.57 81.63 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.828 177.202 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -72.83 130.77 41.19 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 120.916 0.389 . . . . 0.0 111.04 178.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.476 ' O ' ' N ' ' A' ' 143' ' ' GLY . 1.5 tm-20 -147.54 -86.6 0.09 Allowed 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.309 -178.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 86.0 p 40.48 -81.21 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.743 0.817 . . . . 0.0 113.059 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 141' ' ' GLU . . . -136.02 -25.45 0.48 Allowed Glycine 0 CA--C 1.529 0.933 0 CA-C-N 116.368 -0.378 . . . . 0.0 112.715 177.388 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 88.2 tttt 63.98 -66.71 0.11 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.591 0.756 . . . . 0.0 112.085 -176.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -82.72 61.36 4.76 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 121.266 -0.493 . . . . 0.0 112.502 176.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -69.57 136.87 51.85 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 122.757 -0.261 . . . . 0.0 111.396 179.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 82.33 62.26 1.9 Allowed Glycine 0 CA--C 1.524 0.605 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.339 -178.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 10.7 tt -72.72 137.43 23.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 120.933 0.397 . . . . 0.0 111.516 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -67.14 94.27 0.34 Allowed 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.08 0.467 . . . . 0.0 111.559 178.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -154.36 -133.09 1.73 Allowed Glycine 0 CA--C 1.524 0.612 0 CA-C-N 116.196 -0.456 . . . . 0.0 112.93 179.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -122.04 163.11 19.96 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.032 0.444 . . . . 0.0 111.576 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.43 110.84 16.26 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 173.319 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -91.79 171.52 9.09 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 121.343 0.592 . . . . 0.0 112.085 -172.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 2.5 pp -97.33 178.87 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.055 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 48.1 tp 63.22 92.65 0.06 Allowed 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 176.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -76.59 147.69 37.47 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.378 169.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -62.88 139.81 58.76 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.267 0.556 . . . . 0.0 111.915 -173.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 71.5 m -98.31 54.98 1.1 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.126 0.489 . . . . 0.0 110.685 174.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -66.85 -33.29 83.63 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-N 116.079 -0.51 . . . . 0.0 113.443 179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -75.19 81.69 2.33 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.372 0.606 . . . . 0.0 110.981 178.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 25.7 m -87.3 32.88 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -177.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 36.3 m -66.88 -13.91 62.17 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 122.301 -0.25 . . . . 0.0 111.613 178.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 63.88 -76.63 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 175.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -89.11 -38.06 14.62 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.287 0.565 . . . . 0.0 111.216 -177.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -87.2 135.66 33.22 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.768 -172.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . 0.536 HD21 ' N ' ' A' ' 166' ' ' ASN . 0.8 OUTLIER -85.8 155.67 20.9 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.845 0.355 . . . . 0.0 111.385 179.177 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -70.89 -36.65 72.85 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -63.62 122.09 25.57 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 121.41 -0.424 . . . . 0.0 113.232 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 6.1 t -149.32 144.93 26.76 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.235 0.54 . . . . 0.0 112.405 -176.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -143.23 108.47 5.0 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.842 175.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . 0.496 ' HB2' ' H ' ' A' ' 178' ' ' GLU . 5.6 p-10 -68.26 -33.51 74.5 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -173.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . 77.99 -174.99 0.09 Allowed 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 176.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -109.91 -55.77 2.4 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -177.089 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 47.8 t -66.6 98.8 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -170.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.0 mttt 66.76 -64.6 0.23 Allowed 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.543 0.737 . . . . 0.0 112.223 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 38.1 mtmm -60.05 114.89 3.08 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.399 174.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 5.7 tt -169.58 124.27 0.81 Allowed 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.07 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.496 ' H ' ' HB2' ' A' ' 171' ' ' ASP . 3.4 tm-20 . . . . . 0 CA--C 1.542 0.636 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.41 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 52.6 mt . . . . . 0 CA--C 1.542 0.636 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 70.17 -70.42 0.15 Allowed 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -56.46 -45.28 89.68 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 121.455 -0.403 . . . . 0.0 113.315 -177.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.64 HD22 ' SG ' ' A' ' 100' ' ' CYS . 45.3 tp -57.57 -46.14 84.34 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.232 0.539 . . . . 0.0 110.836 175.056 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -61.42 -34.45 75.4 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.06 178.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -66.43 -50.89 61.89 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.614 177.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.6 m -60.28 -34.18 73.39 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.36 177.077 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -57.67 -49.99 74.66 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.793 0.33 . . . . 0.0 110.154 174.017 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.551 ' O ' HG12 ' A' ' 19' ' ' ILE . 76.6 mtm-85 -57.16 -47.1 82.02 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.299 176.608 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.412 ' HB3' ' HD3' ' A' ' 108' ' ' PRO . 75.3 mmtt -44.93 -48.46 11.32 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 176.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -84.82 -26.97 27.11 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.9 -53.05 23.27 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.976 0.417 . . . . 0.0 111.938 -178.493 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.551 HG12 ' O ' ' A' ' 15' ' ' ARG . 29.9 pt -77.95 7.33 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -178.055 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -62.13 89.91 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.232 0.539 . . . . 0.0 110.596 176.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 125.23 -54.48 0.75 Allowed Glycine 0 CA--C 1.527 0.785 0 CA-C-N 115.888 -0.597 . . . . 0.0 112.64 -176.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -127.03 109.79 21.79 Favored Pre-proline 0 CA--C 1.547 0.835 0 O-C-N 122.626 -0.338 . . . . 0.0 110.933 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -76.39 -5.78 16.48 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 122.845 2.363 . . . . 0.0 113.644 -178.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 30.7 mtmm -89.5 -11.77 41.97 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.932 0.396 . . . . 0.0 110.945 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.86 -20.34 66.2 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.607 176.337 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 59.9 m 73.11 -53.72 0.7 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.582 0.753 . . . . 0.0 112.213 177.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 137.86 47.25 0.07 OUTLIER Glycine 0 CA--C 1.524 0.609 0 CA-C-N 116.41 -0.359 . . . . 0.0 112.309 -177.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -95.16 -34.78 12.13 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.643 0.259 . . . . 0.0 111.506 -178.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.08 178.92 6.59 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.341 0.591 . . . . 0.0 112.488 -175.467 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 52.7 ttm -157.41 133.9 9.81 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.63 176.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -86.38 167.75 14.45 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.094 0.473 . . . . 0.0 112.134 -178.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -58.13 -33.19 68.87 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-N 115.749 -0.659 . . . . 0.0 114.432 -176.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -69.22 -54.12 16.38 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.331 0.586 . . . . 0.0 110.976 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -60.57 -40.29 91.12 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.425 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 30.5 t-105 -63.51 -42.84 98.46 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 120.998 0.428 . . . . 0.0 111.492 175.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.18 -44.63 96.99 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 121.001 0.429 . . . . 0.0 111.183 176.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 43.2 tttm -66.36 -39.43 89.14 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.784 177.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.7 tt -51.69 -47.5 63.86 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.084 0.469 . . . . 0.0 110.792 178.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 79.5 m -63.44 -41.26 98.66 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.324 176.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -62.7 -57.3 11.48 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.815 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -53.69 -39.42 65.14 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 122.731 0.412 . . . . 0.0 111.795 178.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.587 ' SG ' HG13 ' A' ' 103' ' ' VAL . 57.0 m -91.85 -0.7 57.53 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? 50.15 31.75 5.32 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.1 t -68.78 -38.14 78.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-O 121.263 0.554 . . . . 0.0 109.586 171.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.47 79.69 3.97 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.02 171.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.0 p30 -76.79 -14.28 59.93 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.914 -173.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.61 -27.43 7.14 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 121.168 -0.539 . . . . 0.0 113.23 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -85.01 -37.81 19.96 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 122.478 -0.425 . . . . 0.0 111.448 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.8 t -112.46 -51.13 2.86 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.128 0.49 . . . . 0.0 110.549 176.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 34.1 t -112.81 110.46 32.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.065 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.504 ' O ' HG23 ' A' ' 55' ' ' VAL . 81.9 p -97.52 166.72 11.38 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.527 179.076 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -50.02 -55.49 15.02 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 121.368 -0.444 . . . . 0.0 113.079 178.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.574 ' O ' HG12 ' A' ' 57' ' ' ILE . 94.0 m -53.08 -48.56 67.66 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.599 0.237 . . . . 0.0 111.493 178.111 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.488 ' O ' HG23 ' A' ' 58' ' ' VAL . 18.0 t70 -58.48 -36.82 74.32 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 120.726 0.298 . . . . 0.0 110.872 -178.494 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 51' ' ' THR . 88.6 t -61.87 -37.92 79.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.375 175.584 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -73.52 -34.73 65.39 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.399 0.619 . . . . 0.0 110.137 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.574 HG12 ' O ' ' A' ' 53' ' ' THR . 8.0 mm -60.48 -52.73 58.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.999 176.331 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 54' ' ' ASP . 91.8 t -52.49 -48.5 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 121.04 0.448 . . . . 0.0 111.12 177.392 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -59.94 -41.28 91.49 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.009 178.067 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 28.3 t -72.95 -20.22 61.09 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 116.156 -0.474 . . . . 0.0 112.051 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.456 ' HG3' ' O ' ' A' ' 57' ' ' ILE . 53.6 mtmt -84.49 -57.12 3.28 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.087 0.47 . . . . 0.0 111.953 178.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.3 m -61.19 -31.95 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 -173.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.646 ' HD3' ' O ' ' A' ' 66' ' ' SER . 17.2 ptpt -56.55 -52.44 64.78 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -175.363 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 72.74 -64.78 1.48 Allowed Glycine 0 CA--C 1.537 1.46 0 N-CA-C 114.55 0.58 . . . . 0.0 114.55 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.622 ' HD2' ' H ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -78.52 53.43 1.3 Allowed 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -172.569 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.646 ' O ' ' HD3' ' A' ' 63' ' ' LYS . 88.5 p 54.23 -77.61 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.148 0.579 . . . . 0.0 110.928 -173.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.559 ' HB2' ' HG2' ' A' ' 65' ' ' LYS . . . 46.88 117.88 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 115.859 1.799 . . . . 0.0 115.859 164.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 57.2 ttp180 -66.52 -18.3 65.29 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 121.355 0.598 . . . . 0.0 110.684 169.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.413 ' O ' ' HB1' ' A' ' 67' ' ' ALA . 33.8 m -135.15 159.21 41.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.902 -173.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 39.3 pt -115.27 147.56 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-O 120.699 0.285 . . . . 0.0 110.929 174.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -86.47 157.55 19.77 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -40.25 -48.6 2.63 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 -175.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.529 ' HA ' ' HE3' ' A' ' 76' ' ' LYS . 46.5 mm-40 -52.15 -46.42 65.43 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 120.935 0.398 . . . . 0.0 111.77 178.198 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -76.56 -19.36 57.98 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 120.97 0.414 . . . . 0.0 110.99 -178.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -70.56 -49.68 45.42 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.118 174.139 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.529 ' HE3' ' HA ' ' A' ' 73' ' ' GLU . 22.8 pttp -69.58 -22.54 63.51 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.322 177.21 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -71.81 -41.35 68.35 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.165 0.507 . . . . 0.0 110.251 170.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.467 ' O ' ' HB3' ' A' ' 81' ' ' GLU . . . -63.61 -37.8 88.72 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.33 175.32 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 84.9 mt -59.69 -43.44 94.04 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.326 175.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -54.85 -43.97 73.55 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 121.029 0.443 . . . . 0.0 110.891 174.216 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.467 ' HB3' ' O ' ' A' ' 78' ' ' ALA . 6.9 tp10 -54.28 -64.33 0.86 Allowed 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.057 175.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.5 ' HA ' ' HG3' ' A' ' 85' ' ' LYS . 9.1 mp -57.71 -33.25 68.22 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.153 0.502 . . . . 0.0 111.936 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.422 ' HB2' HG21 ' A' ' 99' ' ' ILE . . . -60.84 -48.47 81.66 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.146 175.669 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.47 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 76.1 p -70.41 -19.06 63.02 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 120.827 0.346 . . . . 0.0 111.699 179.071 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.5 ' HG3' ' HA ' ' A' ' 82' ' ' LEU . 46.9 mmtt -67.29 -41.64 85.1 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 121.088 0.471 . . . . 0.0 111.013 174.288 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 23.4 mtp180 -106.25 -57.38 2.06 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -176.238 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -88.85 29.33 1.04 Allowed 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -171.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.47 ' HB3' ' O ' ' A' ' 84' ' ' THR . 22.7 pttp -71.8 150.58 44.22 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.079 0.466 . . . . 0.0 111.406 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 98.84 -28.5 14.86 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.908 -178.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -86.62 -177.48 6.15 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.05 0.453 . . . . 0.0 111.423 176.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 35.6 t -63.7 135.13 56.48 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.058 177.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -48.76 -48.03 41.25 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 122.98 0.512 . . . . 0.0 111.856 -178.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.432 ' HG3' ' N ' ' A' ' 94' ' ' GLU . 9.9 pt-20 -60.9 -48.45 81.77 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.461 178.203 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.432 ' N ' ' HG3' ' A' ' 93' ' ' GLU . 63.5 tt0 -58.58 -47.15 85.24 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.635 0.255 . . . . 0.0 111.354 -178.55 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.81 -44.81 86.61 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 120.951 0.405 . . . . 0.0 111.711 178.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -68.37 -50.29 54.15 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.422 -178.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -62.01 -31.55 71.94 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 120.725 0.298 . . . . 0.0 111.57 177.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -66.65 -54.94 17.86 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.422 HG21 ' HB2' ' A' ' 83' ' ' ALA . 11.5 tt -58.43 -39.75 75.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 120.929 0.395 . . . . 0.0 110.99 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' CYS . . . . . 0.64 ' SG ' HD22 ' A' ' 10' ' ' LEU . 79.0 m -64.17 -37.58 87.96 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.847 0.356 . . . . 0.0 110.998 175.076 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -60.15 -29.31 68.57 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.536 177.356 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 79.0 mt -77.18 -13.46 59.94 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 177.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.587 HG13 ' SG ' ' A' ' 42' ' ' CYS . 58.3 t -110.62 -54.18 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -175.506 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -41.36 126.21 2.74 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 -172.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 109.11 -32.84 6.54 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 121.321 -0.466 . . . . 0.0 114.219 173.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 38.0 mtmm -82.06 169.12 17.07 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -174.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.547 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 12.1 pt-20 -126.89 165.37 29.12 Favored Pre-proline 0 CA--C 1.55 0.967 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.464 -178.008 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.547 ' HD2' ' HB2' ' A' ' 107' ' ' GLU . 55.5 Cg_endo -68.37 71.97 0.91 Allowed 'Trans proline' 0 CA--C 1.545 1.031 0 C-N-CA 122.635 2.223 . . . . 0.0 113.889 -178.552 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.673 0 C-N-CA 122.672 0.389 . . . . 0.0 111.8 -179.061 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.0 mt . . . . . 0 N--CA 1.472 0.654 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.55 -31.07 69.04 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.382 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.73 -17.06 48.48 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 121.225 -0.512 . . . . 0.0 113.164 175.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 53.0 tp -71.85 -58.44 3.46 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.783 0.291 . . . . 0.0 110.899 177.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -55.43 -39.63 70.5 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 177.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -61.47 -57.08 13.61 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.573 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.3 t -57.32 -44.91 84.59 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.134 0.492 . . . . 0.0 110.868 178.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -58.34 -40.97 83.59 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.435 176.049 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.482 ' O ' HG12 ' A' ' 19' ' ' ILE . 58.4 ttt180 -67.48 -44.21 79.1 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 120.678 0.275 . . . . 0.0 110.985 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -62.8 -34.37 77.15 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.237 178.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -72.28 -49.72 32.56 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.365 173.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.73 -46.96 81.0 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -176.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.482 HG12 ' O ' ' A' ' 15' ' ' ARG . 23.1 pt -83.58 5.58 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-O 121.018 0.437 . . . . 0.0 111.974 -177.556 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 37.1 t60 -78.96 105.22 10.13 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.937 0.399 . . . . 0.0 110.291 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.461 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . 88.82 -64.31 3.42 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.27 -174.55 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -90.13 97.33 1.07 Allowed Pre-proline 0 CA--C 1.547 0.839 0 CA-C-O 120.865 0.364 . . . . 0.0 110.608 175.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' A' ' 21' ' ' GLY . 74.4 Cg_endo -73.33 -30.79 9.91 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 122.546 2.164 . . . . 0.0 114.183 -170.287 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.46 2.42 13.75 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -173.211 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.405 ' HB1' ' O ' ' A' ' 29' ' ' GLU . . . -65.79 -37.16 85.54 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.974 0.416 . . . . 0.0 111.288 176.47 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 27.1 t 55.76 16.43 2.01 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 175.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 75.86 13.95 82.61 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 120.883 -0.675 . . . . 0.0 113.87 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -95.78 -36.65 11.08 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.268 0.556 . . . . 0.0 110.461 175.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.405 ' O ' ' HB1' ' A' ' 25' ' ' ALA . 26.3 mt-10 -137.44 142.74 41.6 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.926 -178.141 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.41 ' HE2' ' HA ' ' A' ' 35' ' ' TRP . 27.2 ttt -123.97 142.51 51.1 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.983 0.421 . . . . 0.0 111.667 -175.63 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -103.46 164.79 11.43 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -174.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -58.71 -32.27 69.25 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-N 115.725 -0.67 . . . . 0.0 113.7 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.522 ' HB2' ' HZ2' ' A' ' 33' ' ' LYS . 3.6 ttmp? -47.75 -61.9 1.72 Allowed 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 121.62 0.724 . . . . 0.0 111.395 176.505 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -79.81 -20.36 46.31 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.125 -175.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.41 ' HA ' ' HE2' ' A' ' 30' ' ' MET . 62.0 t-105 -69.91 -50.22 44.36 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 120.882 0.373 . . . . 0.0 111.218 177.013 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.13 -43.85 95.35 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-O 121.403 0.62 . . . . 0.0 110.203 174.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.405 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 41.3 tttm -57.16 -46.73 82.52 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.593 174.353 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.4 tt -51.91 -46.82 64.76 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 122.895 0.478 . . . . 0.0 111.057 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.704 ' SG ' HG11 ' A' ' 55' ' ' VAL . 73.7 m -56.29 -50.5 71.21 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.218 177.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -71.73 -28.99 64.04 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 121.113 0.482 . . . . 0.0 111.914 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.405 ' HB2' ' O ' ' A' ' 37' ' ' LYS . 5.8 t70 -75.37 -44.8 42.99 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.427 0.632 . . . . 0.0 111.158 -173.655 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 65.4 m -103.08 2.25 34.48 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.68 178.409 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp 62.36 34.95 15.34 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.321 0.581 . . . . 0.0 111.348 178.327 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 59.9 t -68.21 -42.21 84.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.443 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.09 91.91 2.12 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.266 0.555 . . . . 0.0 111.123 178.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.634 ' HB2' ' HG2' ' A' ' 86' ' ' ARG . 26.9 t70 -51.86 -26.61 10.44 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.72 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.11 -55.99 4.59 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 121.302 -0.475 . . . . 0.0 112.27 -177.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.506 ' NZ ' ' HB3' ' A' ' 48' ' ' LYS . 5.9 ttpm? -64.08 -32.97 74.73 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 121.124 0.487 . . . . 0.0 111.128 176.486 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 13.8 m -110.15 -19.47 13.02 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.52 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 5.8 p -160.3 113.88 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-O 121.005 0.431 . . . . 0.0 112.131 -176.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.4 ' O ' HG23 ' A' ' 55' ' ' VAL . 58.5 p -95.69 172.48 8.02 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 120.818 0.342 . . . . 0.0 111.768 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -51.65 -36.42 39.96 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-N 116.19 -0.459 . . . . 0.0 113.686 177.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.537 ' O ' HG13 ' A' ' 57' ' ' ILE . 21.6 p -62.06 -54.38 42.29 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.972 0.415 . . . . 0.0 110.234 177.354 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -58.2 -38.48 76.82 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.52 -176.065 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.704 HG11 ' SG ' ' A' ' 39' ' ' CYS . 88.6 t -58.21 -39.1 72.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.595 174.708 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -70.42 -36.17 73.86 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 121.296 0.57 . . . . 0.0 110.318 178.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.572 ' O ' ' HG3' ' A' ' 61' ' ' LYS . 8.7 mt -61.49 -46.43 96.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.578 176.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 89.7 t -60.91 -45.13 98.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-O 121.08 0.467 . . . . 0.0 110.73 177.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.522 ' O ' ' HB2' ' A' ' 63' ' ' LYS . 76.5 t80 -59.39 -30.92 68.78 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.874 175.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.552 ' HA ' ' HE3' ' A' ' 63' ' ' LYS . 67.8 m -82.5 -25.15 33.74 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.722 177.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.572 ' HG3' ' O ' ' A' ' 57' ' ' ILE . 95.4 mttt -66.47 -55.3 16.28 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 120.98 0.419 . . . . 0.0 111.338 177.549 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.537 ' HB ' ' HB3' ' A' ' 74' ' ' GLU . 27.6 m -83.72 6.99 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 CA-C-N 116.064 -0.516 . . . . 0.0 112.198 -177.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.552 ' HE3' ' HA ' ' A' ' 60' ' ' SER . 39.6 ttmt -78.01 143.86 37.17 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.766 -179.105 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -73.01 177.98 41.24 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 121.022 -0.609 . . . . 0.0 113.203 177.196 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -50.98 100.35 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -177.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 60.6 p 52.04 23.95 2.45 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.368 0.667 . . . . 0.0 112.335 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.454 ' O ' ' HD3' ' A' ' 63' ' ' LYS . . . -70.29 176.23 4.08 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -177.676 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.523 ' HG3' HG13 ' A' ' 69' ' ' VAL . 16.8 ptt180 -116.48 -9.48 11.43 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.523 HG13 ' HG3' ' A' ' 68' ' ' ARG . 33.1 m -136.57 172.18 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-O 121.084 0.469 . . . . 0.0 112.0 -178.184 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 37.8 pt -128.18 145.61 35.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.097 175.269 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 -79.92 158.89 26.54 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 120.736 0.303 . . . . 0.0 111.729 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.532 ' O ' ' HB3' ' A' ' 75' ' ' PHE . 30.1 t80 -48.4 -46.8 37.73 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -175.269 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 22.7 mp0 -60.81 -43.96 97.49 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 122.113 -0.367 . . . . 0.0 111.418 -178.111 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.537 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 32.5 mm-40 -71.96 -27.19 62.61 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.887 0.375 . . . . 0.0 111.078 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.532 ' HB3' ' O ' ' A' ' 72' ' ' TYR . 61.6 t80 -57.22 -39.67 75.93 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.396 0.617 . . . . 0.0 110.349 170.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.529 ' HG3' ' O ' ' A' ' 72' ' ' TYR . 32.3 mtpt -67.12 -35.62 80.14 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.825 177.082 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.429 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 15.1 tppt? -66.88 -39.65 87.54 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.346 0.593 . . . . 0.0 110.653 176.345 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.09 -46.47 90.51 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.807 174.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 79.4 mt -60.75 -32.32 71.62 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.114 174.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.429 ' HB3' ' O ' ' A' ' 77' ' ' LYS . 32.9 tt0 -56.66 -51.32 69.19 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 120.704 0.288 . . . . 0.0 110.934 177.377 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -61.68 -53.71 52.52 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.408 175.286 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 82.0 mt -54.21 -38.36 65.59 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -178.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.76 -52.16 40.61 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.907 0.384 . . . . 0.0 111.62 177.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 70.1 p -66.65 -16.14 63.98 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -90.5 -49.3 6.58 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 122.077 -0.39 . . . . 0.0 111.02 173.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.634 ' HG2' ' HB2' ' A' ' 46' ' ' ASP . 2.2 tmt_? -59.77 -51.2 70.78 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.003 0.43 . . . . 0.0 110.687 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -94.24 24.18 4.58 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.145 0.498 . . . . 0.0 111.923 -177.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 56.0 mttm 59.46 -179.81 0.08 Allowed 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.925 178.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -77.25 58.69 3.64 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 121.309 -0.472 . . . . 0.0 114.051 -175.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -98.43 -162.16 0.93 Allowed 'General case' 0 CA--C 1.543 0.697 0 O-C-N 122.618 -0.342 . . . . 0.0 110.634 176.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.417 ' HB3' ' HB3' ' A' ' 94' ' ' GLU . 28.5 t -56.28 120.56 7.79 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 122.182 -0.323 . . . . 0.0 111.402 176.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -57.59 -44.56 85.5 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.877 0.37 . . . . 0.0 111.373 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.5 mp0 -59.1 -50.01 75.68 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.933 177.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.417 ' HB3' ' HB3' ' A' ' 91' ' ' SER . 36.3 tt0 -58.25 -47.05 84.79 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.667 177.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.54 -36.73 83.54 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.917 0.389 . . . . 0.0 111.448 178.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -65.87 -42.75 89.96 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.83 178.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -60.94 -42.79 98.87 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.195 0.521 . . . . 0.0 110.591 175.162 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.541 ' O ' ' HB3' ' A' ' 101' ' ' GLN . . . -61.44 -49.34 77.24 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 179.211 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.1 tt -64.51 -33.37 62.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 O-C-N 121.886 -0.508 . . . . 0.0 110.937 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 97.6 m -66.12 -38.55 88.46 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.88 0.371 . . . . 0.0 110.581 172.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.541 ' HB3' ' O ' ' A' ' 98' ' ' ALA . 49.8 tt0 -54.95 -34.09 62.93 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 121.045 0.45 . . . . 0.0 111.409 174.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 75.6 mt -78.09 -36.68 47.81 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 112.694 0.628 . . . . 0.0 112.694 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 54.9 t -100.71 -49.73 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -172.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.17 134.34 56.9 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -174.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 68.66 33.39 76.03 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.292 -0.48 . . . . 0.0 113.037 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -142.91 133.71 25.37 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 122.922 0.489 . . . . 0.0 110.807 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.406 ' HA ' ' HD3' ' A' ' 108' ' ' PRO . 38.9 mt-10 -85.94 154.6 58.19 Favored Pre-proline 0 N--CA 1.474 0.767 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -175.655 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 107' ' ' GLU . 22.8 Cg_exo -65.9 84.64 0.24 Allowed 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 123.076 2.518 . . . . 0.0 112.866 176.299 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.784 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 174.715 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.9 mm . . . . . 0 CA--C 1.539 0.541 0 CA-C-O 121.122 0.487 . . . . 0.0 110.959 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.42 -38.45 66.28 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.18 -177.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -69.02 -26.69 74.52 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 121.144 -0.551 . . . . 0.0 113.257 177.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 50.7 tp -74.9 -51.29 14.21 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 122.523 -0.398 . . . . 0.0 110.882 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -62.33 -30.22 71.01 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.719 0.295 . . . . 0.0 111.047 176.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -63.56 -51.94 63.21 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.837 0.351 . . . . 0.0 110.377 175.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.5 m -62.78 -39.47 94.31 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.57 177.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -54.14 -51.66 63.57 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.862 0.363 . . . . 0.0 110.492 176.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.607 ' O ' HG12 ' A' ' 19' ' ' ILE . 81.6 mtt85 -63.26 -44.2 95.81 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.962 0.411 . . . . 0.0 111.232 175.124 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.657 ' HD2' ' HA ' ' A' ' 107' ' ' GLU . 26.9 ttmt -52.43 -34.32 48.03 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.414 -178.058 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -93.04 -38.8 11.44 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 116.167 -0.47 . . . . 0.0 112.098 173.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.07 -41.7 83.95 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -175.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.607 HG12 ' O ' ' A' ' 15' ' ' ARG . 46.5 pt -83.73 10.58 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -178.592 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 22.8 t60 -82.64 129.15 34.9 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 120.894 0.378 . . . . 0.0 110.8 177.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.408 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . 83.49 -49.29 4.2 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.548 -177.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -93.19 100.78 4.57 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-O 120.741 0.305 . . . . 0.0 111.242 175.302 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 21' ' ' GLY . 89.8 Cg_endo -76.85 4.64 5.52 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 122.584 2.189 . . . . 0.0 113.229 -177.145 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -113.83 4.26 15.82 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.708 0.29 . . . . 0.0 111.707 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.405 ' HB3' ' HA ' ' A' ' 19' ' ' ILE . . . -74.99 132.05 41.09 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.788 0.328 . . . . 0.0 111.72 -179.144 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.6 m -76.81 -36.05 57.19 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.865 0.364 . . . . 0.0 111.473 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.524 ' HA3' ' HG2' ' A' ' 15' ' ' ARG . . . 126.71 15.67 2.61 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 120.881 -0.676 . . . . 0.0 114.229 176.397 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -113.95 -7.84 13.13 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 117.228 0.514 . . . . 0.0 111.833 177.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -123.79 137.13 54.73 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 122.418 0.287 . . . . 0.0 110.995 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 51.2 ttm -133.54 137.43 45.55 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.867 0.365 . . . . 0.0 111.404 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 31.0 p30 -92.12 171.22 9.23 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.261 0.553 . . . . 0.0 112.267 -179.048 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.55 -29.1 72.57 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-N 115.885 -0.598 . . . . 0.0 113.603 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -60.13 -55.06 38.54 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.031 0.443 . . . . 0.0 111.356 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -69.99 -29.16 66.18 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.496 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 53.8 t-105 -61.59 -42.63 99.13 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.275 0.559 . . . . 0.0 110.605 173.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.61 -42.62 99.13 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.119 174.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.421 ' HE2' ' OD2' ' A' ' 41' ' ' ASP . 13.2 mmmm -61.87 -44.05 97.61 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.205 175.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.498 HD13 ' HE1' ' A' ' 75' ' ' PHE . 11.1 mt -48.83 -54.28 15.84 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 177.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 24.6 p -62.06 -45.88 91.57 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.664 -178.364 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.5 ttpm? -68.72 -49.2 60.82 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.074 0.464 . . . . 0.0 111.661 -176.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.421 ' OD2' ' HE2' ' A' ' 37' ' ' LYS . 12.4 m-20 -69.14 -38.37 78.78 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.563 -176.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.472 ' SG ' ' HA ' ' A' ' 103' ' ' VAL . 73.4 m -85.35 -4.04 59.03 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 176.47 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt 62.0 35.53 16.03 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.265 0.555 . . . . 0.0 112.284 175.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 41.7 t -80.04 -23.84 11.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.472 174.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -92.62 96.92 10.48 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.574 179.052 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -56.73 -30.43 63.52 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.946 0.403 . . . . 0.0 111.532 178.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 98.04 -48.63 1.43 Allowed Glycine 0 CA--C 1.524 0.63 0 C-N-CA 121.536 -0.364 . . . . 0.0 112.655 -178.002 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -84.87 -21.11 29.9 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.965 0.412 . . . . 0.0 111.704 178.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 78.7 p -113.7 -72.53 0.7 Allowed 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.957 0.408 . . . . 0.0 110.551 176.026 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 59.3 t -88.14 122.03 39.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.172 174.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.408 ' O ' HG23 ' A' ' 55' ' ' VAL . 5.5 t -140.6 178.56 7.24 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.416 -176.505 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -44.83 -52.36 7.82 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 114.189 0.436 . . . . 0.0 114.189 -175.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.597 ' O ' HG12 ' A' ' 57' ' ' ILE . 84.7 m -57.88 -51.67 68.65 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 122.561 -0.376 . . . . 0.0 111.303 177.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -55.86 -42.99 76.68 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 121.263 0.554 . . . . 0.0 111.123 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 51' ' ' THR . 83.7 t -65.8 -29.19 46.18 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.562 177.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -78.05 -33.84 50.73 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.592 0.711 . . . . 0.0 109.732 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.597 HG12 ' O ' ' A' ' 53' ' ' THR . 11.0 mm -64.13 -47.36 90.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.684 175.403 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.537 ' HA ' ' HD2' ' A' ' 61' ' ' LYS . 80.8 t -57.63 -45.91 86.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.323 175.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -57.36 -43.35 83.42 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.145 0.498 . . . . 0.0 110.579 174.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 23.0 t -65.48 -34.36 78.08 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.766 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.537 ' HD2' ' HA ' ' A' ' 58' ' ' VAL . 64.6 mttm -58.75 -51.96 67.74 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.333 0.587 . . . . 0.0 111.308 176.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.515 ' HB ' ' HB3' ' A' ' 74' ' ' GLU . 25.9 m -84.31 -6.6 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.039 -177.625 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.42 ' HB3' ' NZ ' ' A' ' 63' ' ' LYS . 6.3 ttpm? -65.69 153.55 41.38 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 120.922 0.392 . . . . 0.0 111.83 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -79.37 -161.46 21.87 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.683 175.23 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -62.38 -38.63 90.36 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 122.48 -0.424 . . . . 0.0 111.918 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 21.2 t -154.08 17.44 0.49 Allowed 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 120.824 0.345 . . . . 0.0 111.235 177.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.06 138.81 58.56 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -179.053 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 62.4 mtt180 -94.12 -8.58 39.15 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.232 178.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 36.0 m -132.17 152.03 35.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.807 -178.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.494 HG21 HG23 ' A' ' 62' ' ' VAL . 35.2 pt -117.58 151.63 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.087 176.38 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -100.38 173.03 6.78 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -177.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.501 ' O ' ' HB3' ' A' ' 75' ' ' PHE . 34.5 t80 -53.17 -50.65 64.18 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -170.053 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -63.43 -42.82 98.71 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -176.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.515 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 0.8 OUTLIER -69.93 -30.72 68.18 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.984 0.421 . . . . 0.0 110.537 176.653 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.501 ' HB3' ' O ' ' A' ' 72' ' ' TYR . 50.5 t80 -58.53 -43.25 89.14 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.163 0.506 . . . . 0.0 110.55 171.168 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.486 ' HG3' ' O ' ' A' ' 72' ' ' TYR . 55.2 mtpt -60.95 -40.14 92.17 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.7 175.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.401 ' HD3' ' HA ' ' A' ' 77' ' ' LYS . 72.1 mmtt -70.01 -28.26 65.36 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.528 175.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.85 -42.74 80.91 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.036 0.446 . . . . 0.0 110.546 173.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 79.9 mt -64.71 -41.72 95.79 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.716 173.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -56.95 -45.07 83.07 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.319 0.58 . . . . 0.0 110.665 174.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.418 ' O ' ' HG3' ' A' ' 85' ' ' LYS . 16.4 tp10 -58.65 -59.82 4.79 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.029 176.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.409 ' O ' ' HG3' ' A' ' 86' ' ' ARG . 87.6 mt -56.13 -36.69 68.51 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.556 178.284 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.99 -58.31 9.23 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.72 -0.218 . . . . 0.0 111.276 177.353 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 80.5 p -53.79 -33.8 57.12 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.418 ' HG3' ' O ' ' A' ' 81' ' ' GLU . 7.2 mtpm? -72.71 -35.62 67.62 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.518 178.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.409 ' HG3' ' O ' ' A' ' 82' ' ' LEU . 48.1 mtp180 -96.82 -65.91 0.94 Allowed 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 120.88 0.372 . . . . 0.0 111.528 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.41 ' HB2' ' HB1' ' A' ' 95' ' ' ALA . 51.7 m-85 -87.37 111.63 21.3 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.859 0.361 . . . . 0.0 110.436 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 15.5 pttm -141.93 31.64 1.6 Allowed 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -171.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -78.85 43.04 2.35 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 120.97 -0.634 . . . . 0.0 113.182 175.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.5 ttpp 72.04 -45.92 0.63 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.036 0.935 . . . . 0.0 112.964 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.4 m -72.62 110.4 6.95 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 122.071 -0.393 . . . . 0.0 111.759 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -81.62 -34.52 30.85 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 178.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -47.12 -70.55 0.09 Allowed 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 120.994 0.426 . . . . 0.0 111.409 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -66.64 -28.82 68.78 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -177.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.41 ' HB1' ' HB2' ' A' ' 87' ' ' PHE . . . -59.2 -42.88 91.95 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.307 0.575 . . . . 0.0 110.696 174.535 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -68.16 -40.3 82.37 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.539 176.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -57.78 -40.31 79.52 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.791 0.329 . . . . 0.0 111.513 174.04 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.574 ' O ' ' HB3' ' A' ' 101' ' ' GLN . . . -63.8 -47.45 80.81 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.036 0.446 . . . . 0.0 112.093 -178.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.9 tt -70.46 -31.14 45.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 O-C-N 121.998 -0.439 . . . . 0.0 110.752 178.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 84.8 m -68.06 -33.88 75.4 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.788 0.328 . . . . 0.0 110.613 171.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.574 ' HB3' ' O ' ' A' ' 98' ' ' ALA . 28.2 tt0 -56.53 -39.93 74.22 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.284 0.564 . . . . 0.0 110.526 173.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 88.8 mt -68.18 -39.15 82.59 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.405 176.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.472 ' HA ' ' SG ' ' A' ' 42' ' ' CYS . 67.7 t -93.53 -59.08 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -174.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -51.28 125.02 13.03 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 112.546 0.572 . . . . 0.0 112.546 -177.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.67 -42.13 2.81 Favored Glycine 0 CA--C 1.528 0.869 0 CA-C-N 116.172 -0.467 . . . . 0.0 112.745 -177.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -51.44 132.64 29.8 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -176.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.657 ' HA ' ' HD2' ' A' ' 16' ' ' LYS . 10.4 pt-20 -95.76 155.05 38.91 Favored Pre-proline 0 CA--C 1.542 0.657 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.902 174.311 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -56.87 130.14 38.27 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.545 2.163 . . . . 0.0 113.025 -178.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.737 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.224 -177.045 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 48.3 mm . . . . . 0 CA--C 1.538 0.51 0 CA-C-O 120.749 0.309 . . . . 0.0 110.709 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.94 -47.97 81.32 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -178.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.05 -29.83 59.88 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 121.1 -0.572 . . . . 0.0 113.047 177.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 50.6 tp -71.78 -45.1 62.7 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.778 0.323 . . . . 0.0 110.705 177.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -59.08 -46.72 87.57 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.017 0.437 . . . . 0.0 111.282 177.176 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.557 ' HG3' ' HE2' ' A' ' 16' ' ' LYS . 14.1 tp10 -56.91 -47.59 80.21 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.128 179.574 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.5 m -64.35 -42.44 96.23 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.795 177.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -53.97 -46.06 71.54 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.265 176.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.55 ' O ' HG12 ' A' ' 19' ' ' ILE . 94.5 mtt180 -59.28 -55.74 30.97 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.61 176.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.557 ' HE2' ' HG3' ' A' ' 12' ' ' GLU . 50.4 mttm -55.43 -32.5 62.76 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -175.094 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.713 ' HB3' ' HE3' ' A' ' 30' ' ' MET . 11.7 m-85 -81.68 -48.65 11.42 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 122.192 -0.317 . . . . 0.0 111.443 173.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.474 ' HA ' ' HG3' ' A' ' 30' ' ' MET . . . -55.39 -40.47 71.43 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -177.679 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.55 HG12 ' O ' ' A' ' 15' ' ' ARG . 16.6 pt -99.41 12.82 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 121.426 0.631 . . . . 0.0 110.957 -177.691 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 37.4 t-80 -58.64 92.93 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.014 -176.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.73 -6.3 57.1 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 121.11 -0.567 . . . . 0.0 113.376 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -134.9 92.85 18.27 Favored Pre-proline 0 CA--C 1.539 0.552 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -63.6 -12.95 33.66 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.348 2.032 . . . . 0.0 111.667 170.172 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -96.05 7.24 46.93 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.174 178.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.6 -97.25 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -176.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 59.1 m -164.12 -72.05 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 120.913 0.387 . . . . 0.0 111.092 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.59 -31.44 5.57 Favored Glycine 0 N--CA 1.464 0.537 0 C-N-CA 121.185 -0.531 . . . . 0.0 112.052 179.116 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -100.74 -11.97 19.49 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 120.663 0.268 . . . . 0.0 111.435 174.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -126.5 140.14 52.68 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.827 178.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.713 ' HE3' ' HB3' ' A' ' 17' ' ' PHE . 26.7 ttt -126.15 148.4 49.41 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.765 -173.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.403 ' OD1' ' HB3' ' A' ' 33' ' ' LYS . 10.4 p30 -98.15 174.9 6.3 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 120.933 0.396 . . . . 0.0 111.964 -177.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.4 -26.13 64.24 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 121.368 -0.444 . . . . 0.0 114.119 -176.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.403 ' HB3' ' OD1' ' A' ' 31' ' ' ASN . 39.2 ttpt -63.83 -58.05 8.01 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 122.385 -0.479 . . . . 0.0 111.65 -177.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -74.03 -18.7 60.81 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 120.753 0.311 . . . . 0.0 111.603 178.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.45 ' NE1' HG12 ' A' ' 55' ' ' VAL . 58.8 t-105 -65.75 -47.6 74.69 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 121.142 0.496 . . . . 0.0 110.927 172.093 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.34 -36.97 79.21 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.181 0.515 . . . . 0.0 110.771 174.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 25.2 tptp -66.57 -44.73 81.46 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.842 176.159 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.429 HD12 ' HE1' ' A' ' 30' ' ' MET . 5.0 tt -53.86 -56.44 17.59 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.625 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.721 ' HA ' ' SG ' ' A' ' 42' ' ' CYS . 23.9 p -64.45 -32.64 74.35 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.694 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 50.5 tptt -72.7 -36.7 67.89 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 120.589 0.233 . . . . 0.0 111.481 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -73.45 -40.09 64.44 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 120.614 0.245 . . . . 0.0 111.473 177.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.721 ' SG ' ' HA ' ' A' ' 39' ' ' CYS . 27.6 p -79.27 -4.72 52.07 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.403 0.62 . . . . 0.0 110.386 172.183 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 22.4 mtpp 57.51 23.4 9.11 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.147 -0.933 . . . . 0.0 113.463 173.048 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.563 HG23 ' SG ' ' A' ' 42' ' ' CYS . 93.9 t -57.08 -42.9 80.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 168.585 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.599 ' HB2' HG21 ' A' ' 55' ' ' VAL . . . -86.59 65.86 9.22 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.637 177.538 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -155.62 11.09 0.31 Allowed 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.316 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -92.22 37.17 3.45 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 114.683 0.633 . . . . 0.0 114.683 -170.263 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt 54.2 13.29 0.58 Allowed 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 117.402 0.601 . . . . 0.0 112.337 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 42.8 t -156.75 -57.03 0.09 Allowed 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.277 0.561 . . . . 0.0 109.578 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.461 HG22 ' HB3' ' A' ' 85' ' ' LYS . 9.3 t -70.88 110.24 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.59 170.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.423 ' H ' ' HB3' ' A' ' 54' ' ' ASP . 68.5 p -135.67 176.1 8.99 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.004 -177.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -48.19 -42.66 24.77 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 121.339 -0.458 . . . . 0.0 113.468 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.578 ' O ' HG12 ' A' ' 57' ' ' ILE . 99.0 m -64.41 -51.18 64.49 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 122.506 -0.408 . . . . 0.0 111.243 177.408 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.423 ' HB3' ' H ' ' A' ' 51' ' ' THR . 37.1 t70 -56.94 -39.26 74.21 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.17 0.509 . . . . 0.0 111.18 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.599 HG21 ' HB2' ' A' ' 45' ' ' ALA . 64.0 t -72.68 -23.89 21.13 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.684 178.305 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -79.14 -32.51 44.42 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.601 0.715 . . . . 0.0 109.565 178.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.578 HG12 ' O ' ' A' ' 53' ' ' THR . 16.1 mm -58.51 -47.99 86.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.276 171.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 55.5 t -60.45 -42.85 92.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.849 175.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -57.21 -39.99 76.56 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.083 0.468 . . . . 0.0 110.64 174.028 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 33.5 t -69.4 -35.82 76.16 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.941 177.094 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.425 ' HG2' ' O ' ' A' ' 57' ' ' ILE . 11.9 mmmm -61.29 -31.44 71.27 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.234 0.54 . . . . 0.0 111.535 177.27 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.533 HG21 ' HB2' ' A' ' 78' ' ' ALA . 20.0 m -113.11 20.82 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.943 -178.039 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.506 ' HA ' HG22 ' A' ' 70' ' ' ILE . 40.1 ttmt -73.84 123.17 23.68 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 120.895 0.379 . . . . 0.0 111.991 -178.708 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -57.74 86.66 0.01 OUTLIER Glycine 0 CA--C 1.529 0.928 0 CA-C-N 116.057 -0.52 . . . . 0.0 113.121 176.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 61.3 mttm 64.95 -78.33 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.275 0.63 . . . . 0.0 111.464 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 81.1 p -146.54 3.93 0.88 Allowed 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.447 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -69.82 151.04 46.2 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -173.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.542 ' HG3' HG13 ' A' ' 69' ' ' VAL . 1.8 ptm180 -73.13 -6.98 49.27 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.187 174.481 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.542 HG13 ' HG3' ' A' ' 68' ' ' ARG . 30.6 m -125.71 142.84 41.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-O 121.113 0.482 . . . . 0.0 112.221 -178.092 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.506 HG22 ' HA ' ' A' ' 63' ' ' LYS . 35.3 pt -113.3 151.49 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.595 176.111 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -86.9 169.83 12.16 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.075 0.464 . . . . 0.0 111.868 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.438 ' O ' ' HB3' ' A' ' 75' ' ' PHE . 86.9 t80 -52.07 -38.36 56.93 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -175.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.484 ' O ' ' HG3' ' A' ' 77' ' ' LYS . 33.7 tt0 -70.14 -41.36 73.99 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.445 -0.784 . . . . 0.0 110.765 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -64.78 -33.28 75.61 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.248 0.547 . . . . 0.0 110.341 177.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.438 ' HB3' ' O ' ' A' ' 72' ' ' TYR . 67.7 t80 -55.86 -46.35 78.25 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.987 171.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 23.0 mtmt -64.36 -39.37 93.74 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.886 0.374 . . . . 0.0 111.455 176.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.484 ' HG3' ' O ' ' A' ' 73' ' ' GLU . 60.7 mttm -60.18 -39.83 87.85 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.314 0.578 . . . . 0.0 110.363 176.266 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.533 ' HB2' HG21 ' A' ' 62' ' ' VAL . . . -63.53 -46.88 83.98 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.136 176.183 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 86.2 mt -58.61 -34.17 70.84 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.86 0.362 . . . . 0.0 111.228 175.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.457 ' HB3' ' O ' ' A' ' 77' ' ' LYS . 10.4 tp10 -55.47 -59.82 4.29 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.533 0.682 . . . . 0.0 110.838 176.012 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.58 ' O ' ' HG2' ' A' ' 85' ' ' LYS . 47.2 mt-10 -61.18 -47.98 83.65 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.409 178.476 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 69.5 mt -56.8 -33.75 67.0 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 178.016 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.36 -48.58 81.12 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 120.906 0.384 . . . . 0.0 110.86 175.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 31.0 p -72.72 -8.56 56.0 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 116.194 -0.457 . . . . 0.0 112.072 177.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.58 ' HG2' ' O ' ' A' ' 81' ' ' GLU . 73.1 mmtt -79.82 -51.58 8.97 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.133 0.492 . . . . 0.0 110.697 174.137 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 8.2 mmt180 -82.55 -58.07 3.07 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -178.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -86.59 56.88 4.2 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -170.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 66.3 mttm 61.81 175.85 0.12 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.357 0.599 . . . . 0.0 111.989 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -96.87 29.53 10.41 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.669 176.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -143.44 169.19 18.14 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 122.75 0.42 . . . . 0.0 110.861 -178.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 46.4 t 55.62 47.0 21.66 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.153 0.502 . . . . 0.0 111.529 177.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.469 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 22.0 pttp -64.19 -20.22 65.87 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -174.03 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -63.08 -59.53 4.67 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.296 0.57 . . . . 0.0 109.871 172.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -57.3 -43.75 83.49 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.452 175.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.469 ' HB3' ' HA ' ' A' ' 92' ' ' LYS . . . -58.51 -46.2 87.24 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.026 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -61.04 -53.79 52.81 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.944 0.402 . . . . 0.0 111.212 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -57.15 -37.9 72.75 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 120.808 0.337 . . . . 0.0 111.842 176.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.24 -49.82 68.2 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -179.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 12.5 tt -63.7 -39.94 87.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-O 121.111 0.481 . . . . 0.0 110.874 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 36.5 t -61.3 -39.33 90.07 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.037 0.446 . . . . 0.0 110.927 174.294 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -60.75 -39.35 88.39 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.677 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 93.1 mt -66.8 -36.02 81.41 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.706 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 49.9 t -83.15 -37.07 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -178.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -57.21 104.09 0.15 Allowed 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -174.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 94.81 13.56 52.83 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-N 116.154 -0.475 . . . . 0.0 113.678 174.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 46.2 tttp -86.3 161.35 18.79 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.973 0.416 . . . . 0.0 111.273 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -73.28 136.11 78.99 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.777 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.61 73.46 2.3 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.468 2.112 . . . . 0.0 112.015 175.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.49 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.781 -175.149 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.7 tp . . . . . 0 CA--C 1.544 0.713 0 CA-C-O 120.895 0.378 . . . . 0.0 110.925 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -49.49 -37.67 27.28 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -176.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.35 -29.92 60.87 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 121.417 -0.42 . . . . 0.0 113.74 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 30.9 tp -73.75 -48.38 32.18 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 122.324 -0.515 . . . . 0.0 111.031 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -65.87 -30.05 70.59 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.766 0.317 . . . . 0.0 110.642 176.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -59.27 -55.24 37.33 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.743 0.306 . . . . 0.0 110.444 174.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.7 m -57.94 -42.28 84.54 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.236 176.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -55.73 -56.07 24.87 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.875 0.369 . . . . 0.0 111.064 176.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 57.3 ttt180 -56.19 -51.13 69.14 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.396 0.617 . . . . 0.0 110.87 177.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -52.91 -37.11 60.36 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 114.903 -1.044 . . . . 0.0 112.213 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -85.51 -32.51 22.17 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.697 176.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.76 -39.61 65.51 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -175.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.522 ' H ' HD13 ' A' ' 19' ' ' ILE . 0.2 OUTLIER -103.74 7.45 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -178.927 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 60.0 t60 -35.46 -48.7 0.5 Allowed 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -174.173 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -138.27 22.44 3.06 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 120.286 -0.959 . . . . 0.0 113.604 -178.116 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.573 ' HB2' ' HB2' ' A' ' 25' ' ' ALA . 8.9 m-20 -121.55 118.7 29.6 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 116.886 0.343 . . . . 0.0 110.863 -176.619 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -46.02 -46.49 15.95 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 123.406 2.737 . . . . 0.0 114.102 -176.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -105.29 -34.09 7.99 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.703 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.573 ' HB2' ' HB2' ' A' ' 22' ' ' ASP . . . 36.99 -90.11 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -172.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 28.0 t 167.76 -45.36 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.825 0.85 . . . . 0.0 110.099 -174.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 88.28 -52.18 4.04 Favored Glycine 0 C--N 1.334 0.462 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.257 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 20.4 tp60 -91.26 -13.26 33.04 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 120.818 0.342 . . . . 0.0 111.376 178.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -128.03 143.99 51.09 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.788 175.266 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 49.2 ttm -115.24 143.39 45.32 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.285 0.564 . . . . 0.0 112.324 -175.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -93.78 154.75 17.59 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.892 175.23 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -55.52 -26.64 45.92 Favored Glycine 0 CA--C 1.53 0.97 0 CA-C-N 116.122 -0.49 . . . . 0.0 114.104 -176.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -51.07 -60.86 2.65 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 122.026 0.917 . . . . 0.0 110.809 175.025 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 63.4 m-20 -73.1 -33.97 65.9 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 114.51 -1.223 . . . . 0.0 111.553 -174.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 41.1 t-105 -58.62 -45.21 89.7 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.054 0.454 . . . . 0.0 111.341 174.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.518 ' HA ' HG11 ' A' ' 55' ' ' VAL . . . -60.52 -47.99 83.74 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 120.974 0.416 . . . . 0.0 111.337 176.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -60.7 -37.32 81.26 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.492 176.004 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.3 tt -59.23 -45.42 91.18 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.336 178.201 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.665 ' SG ' ' HB ' ' A' ' 44' ' ' VAL . 44.4 t -54.33 -44.41 72.07 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.945 0.402 . . . . 0.0 111.038 175.061 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.535 ' HB3' ' NZ ' ' A' ' 40' ' ' LYS . 4.5 ttpm? -58.98 -54.64 44.8 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.746 176.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -65.55 -35.77 81.84 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -175.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.571 ' SG ' ' HB3' ' A' ' 102' ' ' LEU . 6.0 t -77.84 -9.87 59.27 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 120.799 0.333 . . . . 0.0 111.452 173.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm 69.05 26.95 5.48 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.197 0.599 . . . . 0.0 112.139 174.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.665 ' HB ' ' SG ' ' A' ' 39' ' ' CYS . 60.1 t -68.15 -35.77 72.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 121.054 0.454 . . . . 0.0 111.212 178.01 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.63 100.39 7.8 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.007 0.432 . . . . 0.0 111.683 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -99.91 -25.67 14.26 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.679 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 134.89 -78.99 0.33 Allowed Glycine 0 CA--C 1.529 0.921 0 C-N-CA 120.964 -0.636 . . . . 0.0 113.624 178.432 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -92.06 -7.32 49.06 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -174.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.4 t -102.35 -49.55 3.85 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.181 0.515 . . . . 0.0 110.041 173.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.457 HG11 HG12 ' A' ' 44' ' ' VAL . 99.1 t -139.65 130.94 33.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.948 176.48 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.459 ' O ' HG23 ' A' ' 55' ' ' VAL . 8.9 t -139.19 -177.86 5.1 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 116.766 -0.197 . . . . 0.0 110.68 173.054 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -46.19 -46.46 15.75 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 121.579 -0.344 . . . . 0.0 113.847 -177.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.54 ' O ' HG12 ' A' ' 57' ' ' ILE . 41.6 m -51.52 -54.81 23.4 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.035 0.445 . . . . 0.0 111.517 176.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -58.93 -34.56 71.86 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.392 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.518 HG11 ' HA ' ' A' ' 36' ' ' ALA . 65.5 t -60.21 -35.72 63.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.286 177.436 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -74.48 -38.5 62.9 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.562 0.696 . . . . 0.0 110.17 178.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.54 HG12 ' O ' ' A' ' 53' ' ' THR . 12.1 mm -61.41 -51.82 68.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.903 178.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 87.8 t -57.69 -41.87 80.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-O 120.912 0.387 . . . . 0.0 111.125 177.201 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -56.76 -42.26 79.06 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 120.915 0.388 . . . . 0.0 110.563 175.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.403 ' HA ' ' HE3' ' A' ' 63' ' ' LYS . 47.6 t -69.33 -36.76 77.26 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.392 177.519 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.534 ' HG2' ' O ' ' A' ' 57' ' ' ILE . 1.8 mmmp? -56.33 -35.67 67.86 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.875 0.369 . . . . 0.0 111.261 178.504 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.506 HG21 ' HB2' ' A' ' 78' ' ' ALA . 22.4 m -107.42 -2.7 10.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -177.666 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.403 ' HE3' ' HA ' ' A' ' 60' ' ' SER . 26.3 ttpp -70.74 101.5 2.1 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.024 0.44 . . . . 0.0 112.142 -178.366 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -133.98 -146.9 5.55 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-N 116.216 -0.447 . . . . 0.0 113.285 177.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 62.1 mttp 53.37 -103.05 0.15 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.842 0.457 . . . . 0.0 112.031 -176.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 88.0 p -109.0 -1.87 18.63 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.735 0.302 . . . . 0.0 110.899 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 66.0 -168.89 0.2 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.641 -177.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 20.3 tpp180 73.06 -51.56 0.71 Allowed 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.375 0.607 . . . . 0.0 111.034 -176.149 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 12.6 m -132.51 149.07 31.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.862 -178.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 37.5 pt -113.13 140.6 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-O 120.668 0.271 . . . . 0.0 111.113 177.274 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -85.37 177.73 7.7 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.9 -0.5 . . . . 0.0 111.341 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -55.1 -37.05 66.35 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -177.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.572 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 42.5 mt-10 -61.08 -53.34 58.34 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.189 0.519 . . . . 0.0 111.497 177.64 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -69.43 -20.77 63.77 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.243 0.544 . . . . 0.0 110.791 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -69.84 -54.87 11.56 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.959 173.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.572 ' HE2' ' HA ' ' A' ' 73' ' ' GLU . 63.8 pttt -62.54 -30.4 71.27 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.091 0.472 . . . . 0.0 110.533 177.01 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -64.42 -40.56 96.0 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.851 173.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.506 ' HB2' HG21 ' A' ' 62' ' ' VAL . . . -67.73 -38.73 83.95 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.03 0.443 . . . . 0.0 111.374 175.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 80.7 mt -59.98 -41.09 91.23 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.103 176.05 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -60.29 -42.49 95.58 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 120.664 0.269 . . . . 0.0 111.021 176.188 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -54.14 -62.81 1.42 Allowed 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.041 0.448 . . . . 0.0 110.769 174.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.537 HD13 HG11 ' A' ' 44' ' ' VAL . 90.5 mt -52.43 -43.98 65.18 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.434 178.3 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.13 -54.33 47.17 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.85 -0.613 . . . . 0.0 112.21 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.461 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 63.4 p -64.18 -20.55 66.09 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -177.296 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -96.72 -23.1 16.59 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 65.5 mtp85 -97.1 -50.63 4.52 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 121.797 -0.564 . . . . 0.0 111.744 175.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -86.75 31.45 0.69 Allowed 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.029 0.442 . . . . 0.0 111.331 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.461 ' HB3' ' O ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -71.63 172.55 9.47 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -177.857 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 78.62 24.36 62.85 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 121.063 -0.589 . . . . 0.0 113.183 -178.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -168.86 -168.75 0.9 Allowed 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 120.826 0.346 . . . . 0.0 111.155 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 65.8 m -56.07 120.72 7.94 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -177.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -55.96 -33.21 64.56 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.321 175.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -54.76 -56.11 22.8 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.204 0.526 . . . . 0.0 110.97 174.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -63.91 -29.75 70.9 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.537 -178.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.53 -57.44 12.67 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.961 0.41 . . . . 0.0 111.017 176.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.523 ' O ' HG22 ' A' ' 99' ' ' ILE . 80.8 t80 -64.94 -35.99 82.95 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.218 0.532 . . . . 0.0 110.791 177.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -55.08 -47.5 74.8 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.461 0.648 . . . . 0.0 111.052 176.575 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -71.78 -42.08 67.57 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.518 -177.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.523 HG22 ' O ' ' A' ' 96' ' ' PHE . 7.3 tp -61.62 -34.02 60.01 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 CA-C-O 121.351 0.596 . . . . 0.0 110.214 178.265 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 35.8 t -64.67 -42.71 95.19 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.946 173.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -55.41 -35.12 65.01 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.123 0.487 . . . . 0.0 111.846 176.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.571 ' HB3' ' SG ' ' A' ' 42' ' ' CYS . 97.5 mt -73.29 -48.02 37.97 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 49.1 t -86.67 -53.59 9.93 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -173.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.22 127.39 24.27 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -171.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.59 -39.32 3.1 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-N 116.035 -0.529 . . . . 0.0 113.841 176.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 58.9 tttp -63.05 162.19 11.94 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-O 121.504 0.668 . . . . 0.0 112.799 -174.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.463 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 0.3 OUTLIER -124.48 161.94 45.2 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.679 175.019 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.463 ' HD2' ' HB2' ' A' ' 107' ' ' GLU . 19.0 Cg_endo -58.17 155.69 33.33 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.515 2.143 . . . . 0.0 112.922 176.511 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.56 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -179.105 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.522 ' HB ' ' HB2' ' A' ' 10' ' ' LEU . 42.6 mm . . . . . 0 CA--C 1.545 0.755 0 CA-C-O 120.629 0.252 . . . . 0.0 111.512 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 72.37 -58.93 0.58 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.463 0.705 . . . . 0.0 110.812 -175.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -63.79 -16.73 59.61 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 120.955 -0.641 . . . . 0.0 112.393 172.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.522 ' HB2' ' HB ' ' A' ' 7' ' ' ILE . 53.7 tp -70.95 -54.7 10.41 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 122.693 -0.298 . . . . 0.0 111.198 178.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.462 ' HG3' ' N ' ' A' ' 12' ' ' GLU . 7.7 pt-20 -61.33 -42.22 98.32 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.788 0.328 . . . . 0.0 110.82 177.675 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.462 ' N ' ' HG3' ' A' ' 11' ' ' GLU . 1.7 tm-20 -64.5 -34.24 77.75 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-O 120.962 0.411 . . . . 0.0 110.921 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.2 t -72.4 -44.12 62.93 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 120.744 0.307 . . . . 0.0 111.143 176.227 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -56.1 -50.5 70.87 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.141 0.496 . . . . 0.0 110.067 175.063 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.489 ' O ' HG12 ' A' ' 19' ' ' ILE . 11.2 ttt85 -53.55 -43.04 68.13 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.706 172.747 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.436 ' HB2' ' HE2' ' A' ' 16' ' ' LYS . 9.6 tppt? -54.0 -46.21 71.68 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.053 0.454 . . . . 0.0 111.581 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -79.93 -33.63 39.53 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 177.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.13 -38.41 91.08 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.893 0.377 . . . . 0.0 111.781 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.489 HG12 ' O ' ' A' ' 15' ' ' ARG . 23.8 pt -83.26 -7.86 11.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 121.016 0.436 . . . . 0.0 111.689 178.178 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -64.69 86.7 0.05 Allowed 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.295 0.569 . . . . 0.0 110.748 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 142.02 -40.25 1.31 Allowed Glycine 0 CA--C 1.524 0.613 0 CA-C-N 115.685 -0.688 . . . . 0.0 112.048 -178.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -128.63 111.39 19.09 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-O 120.727 0.298 . . . . 0.0 110.806 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.46 -0.19 9.83 Favored 'Trans proline' 0 CA--C 1.546 1.079 0 C-N-CA 122.5 2.133 . . . . 0.0 114.425 -176.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.419 ' HE2' ' HB2' ' A' ' 24' ' ' LYS . 2.8 mppt? -100.35 -28.38 12.98 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 121.855 -0.528 . . . . 0.0 111.04 178.328 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.69 134.96 55.17 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 43.1 m -65.54 -35.21 80.19 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.73 178.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.07 45.88 2.52 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-N 116.203 -0.453 . . . . 0.0 113.81 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -103.56 -16.32 15.56 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 122.374 -0.486 . . . . 0.0 111.326 179.074 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -136.56 154.23 50.76 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.008 -174.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 49.1 ttm -143.6 143.59 31.56 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 120.92 0.39 . . . . 0.0 112.003 -174.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 23.5 p30 -90.09 166.02 13.66 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.063 0.459 . . . . 0.0 111.52 177.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.42 -20.31 61.0 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 121.251 -0.499 . . . . 0.0 113.236 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.433 ' HA ' ' HD3' ' A' ' 33' ' ' LYS . 41.1 mmtm -69.07 -55.38 10.95 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.729 0.3 . . . . 0.0 111.619 177.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -65.67 -34.78 79.02 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.156 176.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 41.2 t-105 -62.45 -48.28 80.34 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 122.602 0.361 . . . . 0.0 111.597 175.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.46 -46.48 89.94 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.117 0.484 . . . . 0.0 111.112 177.374 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 57.6 tttp -64.46 -35.03 79.62 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.975 178.078 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.3 tt -59.16 -45.06 91.98 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.311 175.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 73.9 m -60.08 -46.01 91.0 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.407 177.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -60.33 -52.43 65.3 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.578 0.228 . . . . 0.0 111.586 177.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -53.66 -41.68 67.09 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.102 0.477 . . . . 0.0 111.012 177.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.703 ' SG ' ' HA ' ' A' ' 103' ' ' VAL . 58.7 m -89.73 1.09 56.52 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.983 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp 55.56 33.25 20.74 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 122.88 0.472 . . . . 0.0 112.104 177.096 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.46 ' HA ' ' NH1' ' A' ' 86' ' ' ARG . 55.5 t -72.69 -29.52 30.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.735 178.436 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -97.36 102.54 14.33 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.815 0.341 . . . . 0.0 111.778 -179.046 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -57.59 -50.46 73.05 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.484 0.659 . . . . 0.0 112.194 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.02 -16.72 60.62 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 -166.251 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.42 ' HB3' ' NZ ' ' A' ' 48' ' ' LYS . 6.8 ttpm? -96.44 -64.09 1.08 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.239 0.616 . . . . 0.0 110.618 176.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 45.6 p -95.75 -66.53 0.9 Allowed 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.692 177.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 52.3 t -82.92 98.9 5.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 170.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 80.9 p -89.65 -84.54 0.22 Allowed 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -169.11 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -152.89 -39.05 0.03 OUTLIER Glycine 0 C--O 1.236 0.229 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.651 ' O ' HG13 ' A' ' 57' ' ' ILE . 26.9 p -48.95 -53.96 17.58 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.012 0.434 . . . . 0.0 109.911 172.614 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.504 ' O ' HG23 ' A' ' 58' ' ' VAL . 6.2 m-20 -48.43 -49.17 36.25 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.231 -175.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.3 t -60.5 -40.08 83.21 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.277 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -75.35 -43.74 48.94 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.582 0.706 . . . . 0.0 110.196 -176.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.651 HG13 ' O ' ' A' ' 53' ' ' THR . 8.0 mt -62.49 -45.24 99.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.117 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 54' ' ' ASP . 79.4 t -59.66 -41.88 86.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-O 120.554 0.216 . . . . 0.0 111.183 176.524 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.43 ' O ' ' HG3' ' A' ' 63' ' ' LYS . 76.1 t80 -55.2 -40.93 71.35 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.898 0.38 . . . . 0.0 111.5 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 51.6 p -80.77 -34.13 34.44 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.206 0.527 . . . . 0.0 110.998 177.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 55.3 tttp -65.81 -31.3 72.19 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.234 -174.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.7 m -88.33 -3.7 9.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.582 ' HD3' ' O ' ' A' ' 66' ' ' SER . 96.7 mttt -72.12 163.28 28.18 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -178.144 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -105.07 -98.92 2.57 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.981 176.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -80.08 75.46 6.84 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 122.44 -0.447 . . . . 0.0 111.132 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.582 ' O ' ' HD3' ' A' ' 63' ' ' LYS . 55.0 m 59.76 -79.09 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 122.334 0.254 . . . . 0.0 110.819 -175.482 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 64.28 129.3 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 114.09 1.144 . . . . 0.0 114.09 173.078 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.2 ptm85 -81.95 -21.67 37.1 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.255 173.001 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 28.3 m -136.41 151.72 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.076 -178.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 39.4 pt -99.6 161.46 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-O 120.589 0.233 . . . . 0.0 110.776 176.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -110.79 166.97 10.59 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.09 0.471 . . . . 0.0 111.49 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.404 ' O ' ' HB3' ' A' ' 75' ' ' PHE . 16.6 t80 -46.46 -36.79 6.96 Favored 'General case' 0 CA--C 1.554 1.133 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -177.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -73.3 -36.67 66.32 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 121.619 -0.676 . . . . 0.0 112.029 -178.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -72.28 -29.91 64.33 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.356 0.598 . . . . 0.0 109.981 174.152 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.404 ' HB3' ' O ' ' A' ' 72' ' ' TYR . 73.2 t80 -58.64 -44.31 90.04 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.587 176.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -47.7 -61.05 2.13 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.162 0.506 . . . . 0.0 111.604 174.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -64.88 -29.38 70.33 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.309 -176.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.26 -49.86 75.38 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.25 0.548 . . . . 0.0 110.98 173.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 62.2 mt -64.5 -41.7 96.28 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.486 176.174 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.521 ' O ' HG23 ' A' ' 84' ' ' THR . 31.8 tt0 -60.33 -40.74 91.7 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.54 -178.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -62.31 -59.2 5.35 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 120.85 0.357 . . . . 0.0 110.347 177.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 90.4 mt -57.03 -29.52 63.44 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.974 0.416 . . . . 0.0 111.394 178.118 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.41 -39.34 90.36 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.648 174.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.521 HG23 ' O ' ' A' ' 80' ' ' GLU . 8.6 p -68.63 -34.56 75.95 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 121.066 0.46 . . . . 0.0 110.986 178.245 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -69.53 -36.26 76.22 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.71 175.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.46 ' NH1' ' HA ' ' A' ' 44' ' ' VAL . 3.3 tpt180 -85.58 -62.24 1.57 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.341 0.591 . . . . 0.0 111.494 -177.555 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -96.67 93.44 6.73 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.387 -176.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -92.12 27.92 2.03 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 121.231 0.538 . . . . 0.0 110.653 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -60.03 -78.73 0.13 Allowed Glycine 0 CA--C 1.529 0.921 0 CA-C-N 116.028 -0.533 . . . . 0.0 113.957 -175.188 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.9 pttp -162.79 -60.62 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -177.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 54.7 m -91.32 132.9 35.86 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -173.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -64.95 -34.92 79.57 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.031 0.443 . . . . 0.0 110.718 176.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -57.2 -52.92 63.37 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.238 0.542 . . . . 0.0 110.484 171.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -55.73 -46.26 77.82 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.287 177.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.48 -48.94 79.13 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.97 0.414 . . . . 0.0 111.274 177.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -65.49 -36.54 84.15 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.022 178.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.465 ' O ' ' HG3' ' A' ' 101' ' ' GLN . 23.6 t70 -57.02 -62.18 1.93 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.391 0.615 . . . . 0.0 110.964 176.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -53.47 -46.85 70.09 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.607 -178.159 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.482 ' O ' HG23 ' A' ' 103' ' ' VAL . 16.7 tt -66.53 -38.45 81.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 O-C-N 122.056 -0.403 . . . . 0.0 111.232 -179.253 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 93.5 m -64.46 -35.96 82.62 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.783 0.325 . . . . 0.0 111.043 176.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.465 ' HG3' ' O ' ' A' ' 97' ' ' ASP . 88.1 mt-30 -63.69 -31.87 73.18 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 120.985 0.422 . . . . 0.0 111.09 176.014 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.9 mt -77.7 -9.62 59.09 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.918 177.144 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.703 ' HA ' ' SG ' ' A' ' 42' ' ' CYS . 69.4 t -108.79 -43.79 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -177.359 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -50.03 87.37 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 -170.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 48.1 65.27 2.58 Favored Glycine 0 CA--C 1.531 1.035 0 N-CA-C 115.084 0.794 . . . . 0.0 115.084 170.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm -79.22 -82.33 0.1 Allowed 'General case' 0 N--CA 1.471 0.612 0 O-C-N 122.273 -0.545 . . . . 0.0 111.845 178.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.532 ' N ' ' HD3' ' A' ' 108' ' ' PRO . 10.9 pt-20 -149.65 32.38 0.07 OUTLIER Pre-proline 0 CA--C 1.554 1.128 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.532 ' HD3' ' N ' ' A' ' 107' ' ' GLU . 71.7 Cg_endo -76.32 149.75 31.87 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.001 1.801 . . . . 0.0 113.424 -173.21 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.759 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 178.754 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.441 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 36.3 pt . . . . . 0 N--CA 1.468 0.457 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 7' ' ' ILE . . . 74.81 -48.56 0.65 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.205 0.602 . . . . 0.0 111.424 -176.401 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.2 -22.89 45.29 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 121.445 -0.407 . . . . 0.0 113.091 175.057 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.687 HD22 ' SG ' ' A' ' 100' ' ' CYS . 56.6 tp -74.65 -43.1 56.99 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 122.477 -0.425 . . . . 0.0 110.602 176.527 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -59.26 -42.32 90.89 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.307 0.575 . . . . 0.0 110.26 175.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.521 ' HG2' ' HE2' ' A' ' 16' ' ' LYS . 34.1 tt0 -61.38 -55.31 32.96 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.141 174.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.8 t -58.39 -35.14 71.55 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.439 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -59.49 -46.44 88.81 Favored 'General case' 0 C--O 1.225 -0.231 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.859 177.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.522 ' O ' HG12 ' A' ' 19' ' ' ILE . 97.8 mtt180 -60.48 -45.63 93.04 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.561 176.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.521 ' HE2' ' HG2' ' A' ' 12' ' ' GLU . 67.7 mttm -54.87 -37.72 66.6 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.891 0.377 . . . . 0.0 111.774 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -83.17 -36.56 24.6 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.599 174.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.03 -51.55 67.55 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -175.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.522 HG12 ' O ' ' A' ' 15' ' ' ARG . 29.1 pt -82.62 4.49 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 CA-C-O 121.056 0.455 . . . . 0.0 111.609 -178.09 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 39.5 t-80 -65.08 107.1 1.43 Allowed 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.903 177.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 115.51 -14.63 17.81 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 121.295 -0.478 . . . . 0.0 112.997 -177.248 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -154.68 118.1 2.53 Favored Pre-proline 0 CA--C 1.542 0.649 0 O-C-N 122.547 -0.384 . . . . 0.0 110.577 176.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -66.09 -14.55 44.91 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.459 2.106 . . . . 0.0 113.992 -174.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.401 ' HE3' ' HB2' ' A' ' 24' ' ' LYS . 45.3 mtmt -100.07 -52.85 3.3 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 120.74 0.305 . . . . 0.0 110.923 178.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.498 ' HB3' HG22 ' A' ' 19' ' ' ILE . . . 33.56 -115.14 0.07 Allowed 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.897 -175.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 63.8 m -157.93 -56.5 0.07 Allowed 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 122.768 0.427 . . . . 0.0 110.674 176.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.43 7.7 8.11 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 120.635 -0.793 . . . . 0.0 114.687 173.088 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -136.65 7.35 3.01 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 117.533 0.666 . . . . 0.0 111.531 178.164 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.447 ' HB3' HG21 ' A' ' 69' ' ' VAL . 33.9 mp0 -122.4 148.21 45.37 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 122.893 0.477 . . . . 0.0 111.536 -175.344 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.536 ' SD ' ' HB2' ' A' ' 34' ' ' ASN . 39.0 tpp -137.74 131.68 31.67 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.974 178.503 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 22.1 p30 -92.14 163.3 13.99 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.77 0.319 . . . . 0.0 111.59 178.292 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -55.88 -29.04 54.33 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 121.163 -0.542 . . . . 0.0 113.111 178.334 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -57.8 -61.35 2.59 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.072 0.463 . . . . 0.0 111.886 176.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.536 ' HB2' ' SD ' ' A' ' 30' ' ' MET . 24.7 m-20 -68.71 -34.37 75.53 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.358 -179.068 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.441 ' CD1' ' HB2' ' A' ' 59' ' ' PHE . 56.1 t-105 -60.11 -49.38 77.89 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.976 0.417 . . . . 0.0 111.631 178.13 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.92 -43.7 94.73 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 121.032 0.444 . . . . 0.0 111.228 177.052 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -66.57 -38.72 87.67 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.003 177.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.2 tt -56.38 -55.01 38.88 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.282 0.563 . . . . 0.0 110.592 -178.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 26.7 p -66.81 -40.88 88.22 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.782 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 58.0 tttp -76.35 -20.61 57.05 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-O 121.008 0.432 . . . . 0.0 111.715 -177.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -80.29 -41.72 24.43 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.326 0.584 . . . . 0.0 110.478 177.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.637 ' SG ' ' HA ' ' A' ' 103' ' ' VAL . 33.9 m -89.98 -6.83 55.23 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.689 -178.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.5 55.67 2.76 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.634 0.731 . . . . 0.0 111.418 -178.148 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 56.2 t -92.54 -36.77 7.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.476 173.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -107.18 78.44 1.22 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.221 0.534 . . . . 0.0 111.108 177.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.8 p-10 -152.66 4.03 0.35 Allowed 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.21 -174.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -79.79 47.04 3.22 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 121.094 -0.574 . . . . 0.0 113.534 -178.103 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt 50.53 21.53 0.88 Allowed 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 177.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 60.2 p -146.93 -63.44 0.29 Allowed 'General case' 0 N--CA 1.469 0.499 0 O-C-N 121.775 -0.578 . . . . 0.0 110.633 -176.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.421 HG22 ' H ' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -48.24 -83.31 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.887 0 CA-C-N 115.221 -0.9 . . . . 0.0 112.514 174.039 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.535 ' O ' HG23 ' A' ' 55' ' ' VAL . 12.4 p 58.33 -174.94 0.08 Allowed 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.418 0.687 . . . . 0.0 112.455 177.166 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -56.79 -29.5 58.57 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 121.35 -0.452 . . . . 0.0 113.279 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.542 ' O ' HG13 ' A' ' 57' ' ' ILE . 83.7 m -58.01 -58.92 6.27 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 122.626 -0.338 . . . . 0.0 111.377 178.008 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -63.3 -39.04 93.46 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.616 -0.265 . . . . 0.0 110.927 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 51' ' ' THR . 74.5 t -48.3 -41.13 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 N-CA-C 112.249 0.462 . . . . 0.0 112.249 175.189 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -74.17 -38.21 63.74 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.01 0.433 . . . . 0.0 110.591 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.542 HG13 ' O ' ' A' ' 53' ' ' THR . 10.1 mt -62.06 -45.41 98.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.102 178.484 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.515 HG22 ' HG2' ' A' ' 81' ' ' GLU . 86.9 t -63.19 -49.69 82.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.89 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.441 ' HB2' ' CD1' ' A' ' 35' ' ' TRP . 77.2 t80 -58.11 -48.34 80.5 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.188 0.518 . . . . 0.0 110.853 -179.425 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 90.5 p -68.15 -30.19 69.26 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.146 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -64.58 -46.64 81.83 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.574 177.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.432 HG23 HG21 ' A' ' 70' ' ' ILE . 35.7 m -88.58 -13.77 9.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -178.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -74.71 138.91 43.08 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.92 0.39 . . . . 0.0 111.562 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -66.96 167.05 39.44 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.836 176.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -64.77 -47.97 76.21 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 122.531 -0.394 . . . . 0.0 111.921 -178.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.5 m -99.53 3.75 45.64 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 120.85 0.357 . . . . 0.0 111.584 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -80.26 135.29 36.21 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 120.947 0.403 . . . . 0.0 111.808 -178.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? -87.01 -20.01 27.85 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.057 0.456 . . . . 0.0 110.85 175.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.447 HG21 ' HB3' ' A' ' 29' ' ' GLU . 29.3 m -137.62 174.54 11.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.579 -176.212 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.432 HG21 HG23 ' A' ' 62' ' ' VAL . 36.4 pt -111.6 144.12 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.711 173.349 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -94.01 156.61 16.51 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 120.858 0.361 . . . . 0.0 111.777 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.484 ' O ' ' HB3' ' A' ' 75' ' ' PHE . 49.9 t80 -49.04 -39.86 28.95 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -173.454 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -60.94 -41.91 97.17 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 122.11 -0.369 . . . . 0.0 111.659 178.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -73.18 -28.1 62.02 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.213 0.53 . . . . 0.0 110.519 176.192 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.484 ' HB3' ' O ' ' A' ' 72' ' ' TYR . 85.3 t80 -58.99 -36.55 75.08 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.969 175.032 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -61.29 -43.41 98.93 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.462 0.172 . . . . 0.0 111.17 175.334 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 28.3 mtmm -64.07 -38.1 89.85 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.997 0.427 . . . . 0.0 110.947 175.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.404 ' HB1' ' CH2' ' A' ' 35' ' ' TRP . . . -61.71 -41.07 97.12 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.256 176.109 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 86.4 mt -64.09 -44.42 92.41 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.105 175.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -56.48 -45.99 80.67 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.173 0.511 . . . . 0.0 110.555 176.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.515 ' HG2' HG22 ' A' ' 58' ' ' VAL . 37.7 tp10 -55.45 -58.74 6.51 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.573 176.199 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 86.4 mt -62.68 -44.84 95.22 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -178.316 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.26 -44.27 92.41 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.672 ' HA ' ' HE3' ' A' ' 90' ' ' LYS . 40.1 p -64.54 -35.4 80.86 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -89.93 -20.08 23.77 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 112.991 0.738 . . . . 0.0 112.991 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 33.5 tpt85 -82.97 -53.6 5.71 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.689 0.757 . . . . 0.0 110.826 178.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -94.52 117.89 30.82 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.156 175.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -82.05 -62.64 1.57 Allowed 'General case' 0 CA--C 1.539 0.557 0 O-C-N 122.292 -0.255 . . . . 0.0 111.386 -177.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -82.16 94.53 1.69 Allowed Glycine 0 CA--C 1.528 0.901 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.463 176.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.672 ' HE3' ' HA ' ' A' ' 84' ' ' THR . 0.3 OUTLIER -157.51 171.7 19.88 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -174.725 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 46.7 t -110.53 179.45 4.07 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.182 169.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -59.95 -76.43 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 120.946 0.403 . . . . 0.0 111.841 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 -60.87 -36.21 78.58 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.882 -176.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -56.78 -47.4 80.23 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.829 0.347 . . . . 0.0 111.577 177.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.56 -40.31 73.43 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.868 0.366 . . . . 0.0 111.315 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -63.37 -47.33 82.52 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.907 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -56.38 -49.56 74.11 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.452 0.168 . . . . 0.0 111.063 172.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -53.62 -54.39 38.36 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 15.2 tt -62.33 -33.35 58.59 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-O 120.94 0.4 . . . . 0.0 111.435 -179.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' CYS . . . . . 0.687 ' SG ' HD22 ' A' ' 10' ' ' LEU . 97.2 m -68.6 -38.06 80.31 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.925 0.393 . . . . 0.0 111.083 176.12 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -67.53 -31.19 71.13 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.706 179.028 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 96.7 mt -60.86 -35.46 76.65 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.255 0.55 . . . . 0.0 110.774 176.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.637 ' HA ' ' SG ' ' A' ' 42' ' ' CYS . 19.3 t -87.69 -78.07 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.785 178.508 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 41.05 26.72 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 178.033 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 61.1 45.59 96.25 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 121.282 -0.485 . . . . 0.0 113.798 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.554 ' HG3' ' HG2' ' A' ' 107' ' ' GLU . 21.9 pttp -70.85 -40.75 72.18 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.754 0.649 . . . . 0.0 112.754 -177.381 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.554 ' HG2' ' HG3' ' A' ' 106' ' ' LYS . 14.7 pt-20 -167.88 50.44 0.19 Allowed Pre-proline 0 N--CA 1.477 0.884 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -177.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.488 ' HD3' ' N ' ' A' ' 107' ' ' GLU . 64.1 Cg_exo -42.87 120.86 2.01 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 123.225 2.617 . . . . 0.0 113.634 -174.535 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.653 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.732 -172.331 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.453 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 26.3 pt . . . . . 0 CA--C 1.534 0.334 0 CA-C-O 120.412 0.148 . . . . 0.0 111.037 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 7' ' ' ILE . . . 71.26 -43.22 0.56 Allowed 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 120.792 0.329 . . . . 0.0 110.464 -166.237 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -73.82 -34.84 55.6 Favored Glycine 0 C--N 1.337 0.613 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 171.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.567 HD22 ' SG ' ' A' ' 100' ' ' CYS . 59.1 tp -62.66 -37.28 85.76 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.091 -0.555 . . . . 0.0 110.273 170.411 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -68.06 -40.92 82.67 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.821 176.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -54.07 -58.17 8.33 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.032 0.444 . . . . 0.0 110.577 173.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.6 m -59.83 -42.37 93.4 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.511 178.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 94.0 t80 -53.79 -46.75 71.13 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.059 176.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.54 ' O ' HG12 ' A' ' 19' ' ' ILE . 21.7 ttt180 -66.3 -46.19 77.78 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.224 178.359 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 39.4 mtpt -57.84 -27.06 62.85 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 116.301 -0.408 . . . . 0.0 112.067 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -86.34 -44.66 11.9 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.495 172.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.08 -43.69 74.15 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -177.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.54 HG12 ' O ' ' A' ' 15' ' ' ARG . 29.0 pt -101.05 14.91 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-O 120.976 0.417 . . . . 0.0 111.594 -178.184 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 77.5 t60 -66.5 -33.31 75.4 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -175.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -135.54 22.9 3.47 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.838 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -138.3 101.6 8.29 Favored Pre-proline 0 CA--C 1.542 0.654 0 CA-C-O 120.871 0.367 . . . . 0.0 110.878 -177.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.21 -19.96 43.88 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 122.683 2.255 . . . . 0.0 113.955 -174.052 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 49.2 mmtm -100.6 6.6 44.18 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -178.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -81.5 138.46 35.47 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.13 0.49 . . . . 0.0 111.736 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 93.2 p -70.2 -60.43 2.29 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.437 0.637 . . . . 0.0 111.1 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 145.99 -26.73 1.75 Allowed Glycine 0 CA--C 1.522 0.48 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.245 -178.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -85.84 -15.55 41.53 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 111.752 0.278 . . . . 0.0 111.752 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.533 ' HB3' HG21 ' A' ' 69' ' ' VAL . 50.3 mt-10 -111.13 116.46 31.15 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.747 0.308 . . . . 0.0 111.375 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 48.1 ttm -107.22 139.49 41.59 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.179 0.514 . . . . 0.0 111.846 178.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.602 ' OD1' ' HB3' ' A' ' 33' ' ' LYS . 7.6 p30 -95.58 165.74 12.18 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.351 177.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.46 -30.22 73.81 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 121.562 -0.352 . . . . 0.0 113.842 -177.134 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.602 ' HB3' ' OD1' ' A' ' 31' ' ' ASN . 29.7 ttpt -58.39 -61.21 2.75 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.036 0.446 . . . . 0.0 111.565 177.729 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 64.2 m-20 -68.24 -31.96 71.82 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 122.281 -0.262 . . . . 0.0 111.57 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 32.2 t-105 -61.99 -38.89 90.31 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-O 120.953 0.406 . . . . 0.0 111.273 175.001 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.533 ' HA ' HG11 ' A' ' 55' ' ' VAL . . . -61.59 -48.85 79.07 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 120.984 0.421 . . . . 0.0 110.897 175.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.3 mtpp -67.6 -30.55 70.17 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.957 177.055 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.9 tt -56.9 -46.68 81.79 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.98 0.419 . . . . 0.0 110.169 177.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 79.0 m -64.32 -44.93 90.0 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.049 0.452 . . . . 0.0 111.623 176.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -68.17 -58.31 4.66 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -177.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.31 -23.84 64.51 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 178.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 86.0 m -95.86 -5.05 42.53 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 122.044 -0.41 . . . . 0.0 111.471 173.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt 62.41 28.94 17.1 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 173.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 43.2 t -78.79 -32.99 16.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.439 177.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.425 ' HA ' HG13 ' A' ' 50' ' ' VAL . . . -91.54 102.47 15.12 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.833 0.349 . . . . 0.0 111.9 -178.174 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -77.31 -44.99 27.68 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.699 0.762 . . . . 0.0 111.687 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.422 ' HA2' HG22 ' A' ' 51' ' ' THR . . . 107.63 -37.63 3.73 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 -163.454 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.9 ttpm? -43.11 -56.16 3.52 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.66 0.784 . . . . 0.0 112.199 173.094 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 78.4 p -125.91 -0.85 7.25 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 120.878 0.37 . . . . 0.0 111.755 178.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.425 HG13 ' HA ' ' A' ' 45' ' ' ALA . 3.8 p -156.74 111.75 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-O 121.1 0.476 . . . . 0.0 111.868 -174.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.43 ' O ' HG23 ' A' ' 55' ' ' VAL . 68.6 p -106.23 -177.78 3.46 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.104 178.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -55.64 -38.46 71.97 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.531 175.278 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.543 ' O ' HG12 ' A' ' 57' ' ' ILE . 88.8 m -58.0 -49.94 75.11 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 122.703 -0.292 . . . . 0.0 110.627 176.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.435 ' O ' HG23 ' A' ' 58' ' ' VAL . 7.1 m-20 -53.76 -38.61 64.59 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.991 0.424 . . . . 0.0 111.266 175.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.533 HG11 ' HA ' ' A' ' 36' ' ' ALA . 95.9 t -59.67 -39.6 80.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.507 178.431 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -76.02 -34.04 59.67 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.454 0.645 . . . . 0.0 110.535 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.543 HG12 ' O ' ' A' ' 53' ' ' THR . 9.9 mm -59.05 -53.16 51.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.059 175.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 54' ' ' ASP . 56.5 t -61.12 -42.42 93.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.286 178.181 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -55.22 -40.63 71.05 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.147 0.499 . . . . 0.0 111.289 175.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 50.6 m -78.38 -29.23 47.22 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.387 178.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -69.33 -56.91 6.14 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.903 -178.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.418 HG12 ' HG3' ' A' ' 77' ' ' LYS . 33.9 m -65.0 -34.15 68.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -173.597 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.602 ' HG3' ' H ' ' A' ' 65' ' ' LYS . 0.1 OUTLIER -65.94 -21.87 66.46 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.91 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 64.22 25.56 69.81 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 121.27 -0.49 . . . . 0.0 113.056 -178.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.602 ' H ' ' HG3' ' A' ' 63' ' ' LYS . 9.7 mtpm? 68.22 167.74 0.26 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.187 0.595 . . . . 0.0 111.889 -176.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 65.5 m 72.47 -47.95 0.67 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.324 0.65 . . . . 0.0 112.335 -178.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.452 ' O ' ' HD3' ' A' ' 63' ' ' LYS . . . -74.72 107.72 7.01 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 122.22 -0.3 . . . . 0.0 111.166 175.181 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -62.88 -48.71 77.82 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 121.378 0.609 . . . . 0.0 111.289 -177.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.533 HG21 ' HB3' ' A' ' 29' ' ' GLU . 30.2 m -93.23 -166.06 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.271 178.065 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 31.5 pt -134.93 144.7 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 122.417 0.287 . . . . 0.0 111.102 174.014 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -97.94 -179.57 4.46 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 120.815 0.34 . . . . 0.0 111.559 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -57.62 -43.38 84.73 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -175.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.623 ' HA ' ' HG3' ' A' ' 76' ' ' LYS . 15.7 pt-20 -80.25 -28.73 38.42 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.529 -0.732 . . . . 0.0 111.881 -176.495 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -69.03 -30.06 68.35 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.501 0.667 . . . . 0.0 109.43 170.372 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -69.17 -49.38 57.31 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.47 176.15 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.623 ' HG3' ' HA ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -64.97 -27.57 68.93 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 120.753 0.311 . . . . 0.0 111.289 177.948 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.418 ' HG3' HG12 ' A' ' 62' ' ' VAL . 17.7 tppt? -68.75 -39.35 80.33 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.8 0.333 . . . . 0.0 110.336 170.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.02 -43.76 86.93 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.184 0.516 . . . . 0.0 110.61 173.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 80.8 mt -58.97 -37.07 75.95 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.3 176.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.409 ' O ' HG23 ' A' ' 84' ' ' THR . 54.9 mt-10 -62.69 -47.39 83.83 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.862 0.363 . . . . 0.0 111.352 175.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -57.59 -55.93 28.41 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.893 0.378 . . . . 0.0 110.828 176.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 11.3 mp -54.4 -49.54 69.67 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.279 176.188 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -52.34 -48.5 65.46 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.409 HG23 ' O ' ' A' ' 80' ' ' GLU . 75.3 p -62.58 -33.97 76.03 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 -179.126 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -94.77 -2.08 51.65 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 176.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 31.4 tpt85 -104.8 -63.76 1.19 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.043 0.449 . . . . 0.0 111.727 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -103.77 118.85 37.66 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.721 -177.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -79.01 58.68 2.48 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 121.429 0.633 . . . . 0.0 110.868 176.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -90.16 -11.21 63.32 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-N 115.817 -0.629 . . . . 0.0 114.024 -176.064 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp 59.74 23.4 12.28 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 177.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 48.2 t -149.17 155.77 41.15 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 122.059 -0.401 . . . . 0.0 111.09 176.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -83.1 -58.57 2.8 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.549 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -52.57 -58.14 7.74 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.584 0.586 . . . . 0.0 112.584 -176.075 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -57.37 -55.13 38.74 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -176.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.7 -36.36 74.11 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.771 0.319 . . . . 0.0 111.766 179.027 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -67.28 -52.62 38.41 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.326 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.47 ' O ' ' HG3' ' A' ' 101' ' ' GLN . 7.1 m-20 -58.0 -39.48 78.39 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 120.488 0.185 . . . . 0.0 111.421 176.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.16 -60.21 4.23 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 120.817 0.341 . . . . 0.0 111.593 176.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 17.6 tt -63.16 -28.84 45.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-O 121.039 0.447 . . . . 0.0 111.077 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' CYS . . . . . 0.567 ' SG ' HD22 ' A' ' 10' ' ' LEU . 39.6 t -66.54 -44.95 80.98 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.019 173.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.47 ' HG3' ' O ' ' A' ' 97' ' ' ASP . 46.2 mt-30 -60.71 -29.0 69.08 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 179.101 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 83.3 mt -63.69 -23.67 67.47 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 120.799 0.333 . . . . 0.0 111.833 176.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 43.3 t -112.98 -34.39 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -177.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.58 115.1 3.98 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -174.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 85.01 14.42 69.51 Favored Glycine 0 CA--C 1.523 0.561 0 CA-C-N 116.103 -0.499 . . . . 0.0 112.531 -178.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 24.3 tptm -102.77 156.31 17.73 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.344 0.592 . . . . 0.0 111.268 -178.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -132.3 158.24 76.14 Favored Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.248 174.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -62.68 -179.06 0.44 Allowed 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.111 1.874 . . . . 0.0 112.537 178.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.53 0 CA-C-O 121.017 0.437 . . . . 0.0 111.025 174.756 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.432 HG12 ' H ' ' A' ' 9' ' ' GLY . 13.4 tt . . . . . 0 CA--C 1.541 0.623 0 N-CA-C 111.801 0.296 . . . . 0.0 111.801 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -49.16 -36.01 18.23 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.432 ' H ' HG12 ' A' ' 7' ' ' ILE . . . -57.94 -33.6 69.26 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 121.274 -0.488 . . . . 0.0 113.131 176.555 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 50.0 tp -70.88 -40.68 72.09 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.943 0.401 . . . . 0.0 110.546 177.257 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -63.27 -36.31 83.25 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.697 175.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -60.03 -56.51 20.79 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.025 0.44 . . . . 0.0 110.895 175.283 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.3 m -53.15 -51.24 62.62 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.46 178.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -56.12 -50.07 72.12 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.458 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 29.9 ttt180 -62.94 -42.56 99.84 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.875 0.369 . . . . 0.0 111.677 -176.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.407 ' HD3' ' HB3' ' A' ' 107' ' ' GLU . 99.0 mttt -65.22 -34.32 78.08 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.515 ' HA ' ' HB2' ' A' ' 20' ' ' HIS . 41.0 m-85 -79.84 -23.61 41.86 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 120.826 0.346 . . . . 0.0 111.28 173.376 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.47 -11.56 60.26 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.172 0.511 . . . . 0.0 111.278 175.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.448 HG23 ' HA2' ' A' ' 27' ' ' GLY . 32.8 pt -117.79 15.78 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-O 121.055 0.455 . . . . 0.0 110.67 171.02 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.515 ' HB2' ' HA ' ' A' ' 17' ' ' PHE . 48.8 t-80 -63.24 100.73 0.25 Allowed 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 120.94 0.4 . . . . 0.0 111.448 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 126.88 -46.9 1.05 Allowed Glycine 0 CA--C 1.526 0.753 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.089 -176.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.478 ' HB2' ' HB2' ' A' ' 25' ' ' ALA . 19.7 m-20 -138.98 127.87 14.02 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 122.757 0.423 . . . . 0.0 110.815 179.15 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_exo -47.54 -32.64 16.17 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 123.215 2.61 . . . . 0.0 114.232 -178.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -120.9 31.42 6.41 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.875 0.369 . . . . 0.0 111.566 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.478 ' HB2' ' HB2' ' A' ' 22' ' ' ASP . . . -53.44 -60.1 3.73 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 67.5 m -152.9 -43.85 0.1 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.071 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.448 ' HA2' HG23 ' A' ' 19' ' ' ILE . . . 79.1 -34.83 1.94 Allowed Glycine 0 CA--C 1.528 0.904 0 C-N-CA 121.168 -0.539 . . . . 0.0 114.358 173.214 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -125.72 -21.59 4.4 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 117.033 0.417 . . . . 0.0 111.667 -178.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -99.16 138.66 35.95 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 122.113 -0.367 . . . . 0.0 110.519 173.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 49.8 ttm -125.55 131.19 52.81 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.843 0.354 . . . . 0.0 111.929 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.494 ' ND2' ' HB2' ' A' ' 33' ' ' LYS . 17.8 p-10 -91.71 158.43 16.38 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.89 0.376 . . . . 0.0 111.592 178.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -56.64 -29.17 57.58 Favored Glycine 0 N--CA 1.465 0.626 0 CA-C-N 116.302 -0.408 . . . . 0.0 113.253 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.494 ' HB2' ' ND2' ' A' ' 31' ' ' ASN . 98.7 mttt -57.93 -56.06 26.85 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 120.938 0.399 . . . . 0.0 111.464 175.326 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -71.21 -29.15 64.8 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 122.342 -0.224 . . . . 0.0 111.412 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.467 ' CD1' ' HB2' ' A' ' 59' ' ' PHE . 25.8 t-105 -64.32 -45.27 88.63 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 120.879 0.371 . . . . 0.0 111.26 175.22 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.472 ' HA ' HG11 ' A' ' 55' ' ' VAL . . . -58.74 -46.3 87.73 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.183 0.516 . . . . 0.0 111.007 177.342 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -66.94 -39.25 87.24 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.779 176.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.2 tt -49.88 -45.26 50.46 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.24 0.543 . . . . 0.0 110.618 177.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 64.6 m -70.44 -38.58 74.55 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.715 178.009 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -70.96 -47.92 56.27 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -176.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -53.46 -48.86 68.46 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.065 0.46 . . . . 0.0 111.073 172.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 63.3 m -77.09 -6.07 51.39 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.722 178.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 47.0 mttp 59.45 26.41 15.34 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 175.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 42.8 t -74.24 -32.63 32.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 121.397 0.618 . . . . 0.0 110.347 173.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.545 ' HB1' ' HA ' ' A' ' 51' ' ' THR . . . -87.85 91.96 8.95 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.669 -176.603 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -174.52 17.55 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.831 0 CA-C-O 120.971 0.415 . . . . 0.0 111.688 175.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -86.93 18.93 32.61 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.69 -0.767 . . . . 0.0 113.446 -175.076 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.5 ' HD2' ' N ' ' A' ' 48' ' ' LYS . 12.0 mptt 57.51 20.05 5.79 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 121.738 0.78 . . . . 0.0 111.51 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 65.4 m -147.0 -30.92 0.34 Allowed 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.494 175.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.655 HG11 ' HG ' ' A' ' 82' ' ' LEU . 93.3 t -125.46 96.71 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.95 166.498 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.545 ' HA ' ' HB1' ' A' ' 45' ' ' ALA . 5.0 t -156.55 125.06 5.79 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.803 0.335 . . . . 0.0 111.854 176.243 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 50.47 -90.6 0.01 OUTLIER Glycine 0 CA--C 1.53 0.995 0 CA-C-N 116.413 -0.358 . . . . 0.0 113.776 178.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.595 ' O ' HG13 ' A' ' 57' ' ' ILE . 58.0 m -52.04 -55.01 23.27 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.788 0.328 . . . . 0.0 111.199 179.037 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.49 ' HB2' ' HA ' ' A' ' 50' ' ' VAL . 9.2 m-20 -57.53 -34.02 68.69 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.553 -177.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.472 HG11 ' HA ' ' A' ' 36' ' ' ALA . 43.8 t -64.06 -38.2 81.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-O 120.939 0.4 . . . . 0.0 111.032 178.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -72.12 -31.25 65.85 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.171 0.51 . . . . 0.0 110.004 177.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.595 HG13 ' O ' ' A' ' 53' ' ' THR . 9.8 mt -68.01 -48.31 75.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.896 176.597 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 76.1 t -54.04 -51.32 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-O 121.022 0.439 . . . . 0.0 110.849 174.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.467 ' HB2' ' CD1' ' A' ' 35' ' ' TRP . 72.0 t80 -53.06 -51.19 62.58 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.763 175.49 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.595 ' HA ' ' HE3' ' A' ' 63' ' ' LYS . 59.3 m -68.23 -21.65 64.83 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.028 -178.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 43.9 tttp -83.11 -39.87 20.55 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 120.747 0.308 . . . . 0.0 111.402 -178.13 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 26.9 m -82.22 -24.88 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 CA-C-O 120.783 0.325 . . . . 0.0 111.377 177.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.595 ' HE3' ' HA ' ' A' ' 60' ' ' SER . 26.3 ttpp -53.84 126.83 23.68 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.964 178.471 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -45.78 -62.26 3.41 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-N 116.088 -0.505 . . . . 0.0 113.294 179.103 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 48.4 tptt -152.02 -86.3 0.07 Allowed 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 117.085 0.442 . . . . 0.0 111.782 174.033 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 88.4 p -110.09 -7.04 14.96 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -173.055 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.43 107.1 1.03 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.725 0.297 . . . . 0.0 111.2 178.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 83.8 mtm-85 -72.48 2.32 6.49 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -176.399 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 28.2 m -125.71 132.98 70.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-O 120.894 0.378 . . . . 0.0 110.73 174.125 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.54 ' HB ' ' HB2' ' A' ' 74' ' ' GLU . 30.6 pt -100.63 148.06 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 121.077 0.465 . . . . 0.0 111.878 179.136 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.445 ' ND2' ' HB2' ' A' ' 73' ' ' GLU . 1.7 p-10 -89.18 167.93 12.71 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.153 174.584 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.492 ' O ' ' HG3' ' A' ' 76' ' ' LYS . 24.9 t80 -52.12 -37.46 54.34 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.922 0.391 . . . . 0.0 111.866 -173.619 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.445 ' HB2' ' ND2' ' A' ' 71' ' ' ASN . 19.5 mp0 -60.4 -47.98 83.75 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.288 178.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.54 ' HB2' ' HB ' ' A' ' 70' ' ' ILE . 48.7 mt-10 -65.4 -37.3 86.54 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.18 0.514 . . . . 0.0 110.296 176.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -59.6 -41.11 89.57 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.222 175.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.492 ' HG3' ' O ' ' A' ' 72' ' ' TYR . 27.7 mtpp -55.75 -47.85 76.28 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.691 0.281 . . . . 0.0 110.969 176.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.444 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 54.9 tttp -68.91 -32.99 73.02 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.384 177.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.446 ' O ' HD13 ' A' ' 82' ' ' LEU . . . -56.9 -40.84 77.02 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.111 0.481 . . . . 0.0 110.407 173.418 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 88.2 mt -67.79 -43.26 80.13 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.87 173.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -49.4 -47.62 47.74 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 120.975 0.417 . . . . 0.0 111.104 175.026 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.634 ' O ' ' HG2' ' A' ' 85' ' ' LYS . 32.0 mm-40 -58.94 -68.67 0.25 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.916 177.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.655 ' HG ' HG11 ' A' ' 50' ' ' VAL . 11.0 mp -47.77 -43.73 27.71 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -178.411 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.01 -48.02 83.1 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.692 177.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 74.0 p -75.01 -7.24 53.11 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -178.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.634 ' HG2' ' O ' ' A' ' 81' ' ' GLU . 54.7 mmtt -97.75 -35.4 10.56 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.292 0.568 . . . . 0.0 110.172 172.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 9.9 mmt180 -78.35 -70.2 0.51 Allowed 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.722 176.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -98.83 86.47 3.52 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.192 0.52 . . . . 0.0 111.144 -172.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.559 ' NZ ' ' HB2' ' A' ' 88' ' ' LYS . 9.4 mtmp? -94.07 36.29 1.13 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.3 0.571 . . . . 0.0 110.999 -177.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -78.53 35.95 1.81 Allowed Glycine 0 CA--C 1.531 1.054 0 CA-C-N 116.044 -0.526 . . . . 0.0 113.853 -177.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 76.9 tttt 70.83 -60.87 0.49 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.666 0.786 . . . . 0.0 112.253 178.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 53.5 m -63.73 105.69 0.85 Allowed 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 120.824 0.345 . . . . 0.0 111.558 176.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.407 ' HE2' ' OE2' ' A' ' 93' ' ' GLU . 11.3 ttpt -73.6 -49.05 28.13 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -173.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.407 ' OE2' ' HE2' ' A' ' 92' ' ' LYS . 2.8 mp0 -53.17 -49.59 66.33 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 111.671 0.248 . . . . 0.0 111.671 -178.614 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -60.71 -33.46 72.91 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.889 0.376 . . . . 0.0 111.402 178.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.21 -39.56 94.97 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.139 0.495 . . . . 0.0 110.645 173.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -63.41 -39.04 93.43 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.326 175.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.47 ' O ' ' HB3' ' A' ' 100' ' ' CYS . 20.2 m-20 -60.25 -49.81 76.14 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.654 0.264 . . . . 0.0 111.057 172.388 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -53.58 -50.57 65.32 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -177.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 17.3 tt -65.6 -30.56 50.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-O 121.083 0.468 . . . . 0.0 110.819 177.233 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' CYS . . . . . 0.47 ' HB3' ' O ' ' A' ' 97' ' ' ASP . 35.8 t -63.41 -42.01 98.75 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.968 173.174 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -57.4 -39.54 76.35 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.776 0.322 . . . . 0.0 111.128 175.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 96.6 mt -65.96 -44.6 84.5 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 178.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 60.9 t -97.8 -54.2 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -172.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.77 127.82 33.53 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -171.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 100.24 -8.78 59.12 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 115.888 -0.596 . . . . 0.0 113.62 177.223 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -105.08 173.98 6.07 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.467 0.651 . . . . 0.0 112.15 -179.153 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.523 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 10.9 pt-20 -143.83 160.92 48.47 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.657 179.196 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.523 ' HD2' ' HB2' ' A' ' 107' ' ' GLU . 42.2 Cg_exo -32.38 106.6 0.04 OUTLIER 'Trans proline' 0 C--N 1.36 1.158 0 C-N-CA 123.711 2.94 . . . . 0.0 114.622 -177.024 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.432 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.817 -177.203 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.638 HG12 ' H ' ' A' ' 9' ' ' GLY . 7.9 tt . . . . . 0 CA--C 1.547 0.848 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.04 -27.9 48.07 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -178.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.638 ' H ' HG12 ' A' ' 7' ' ' ILE . . . -60.06 -28.42 66.36 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 121.229 -0.51 . . . . 0.0 113.049 177.171 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 44.8 tp -73.24 -35.28 66.22 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.116 0.484 . . . . 0.0 110.524 177.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -62.69 -45.46 92.66 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.849 175.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.498 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 35.1 tt0 -65.89 -45.85 80.51 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.53 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 79.6 p -58.0 -46.41 85.27 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.045 0.45 . . . . 0.0 110.818 178.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -54.14 -48.71 70.53 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.219 0.533 . . . . 0.0 110.685 172.05 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.435 ' HG3' ' HA3' ' A' ' 27' ' ' GLY . 49.4 ttt180 -58.51 -37.21 75.12 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.37 -179.105 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.498 ' HG2' ' O ' ' A' ' 12' ' ' GLU . 75.6 mmtt -60.39 -50.19 74.58 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.823 178.093 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.464 ' HB2' ' HE2' ' A' ' 30' ' ' MET . 81.7 m-85 -72.89 -21.1 60.97 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.739 0.304 . . . . 0.0 111.524 177.555 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.68 -54.31 12.34 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 120.862 0.363 . . . . 0.0 111.877 179.09 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 32.8 pt -73.78 -10.68 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-O 120.989 0.423 . . . . 0.0 111.882 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 -58.85 87.95 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.12 0.486 . . . . 0.0 111.745 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 132.84 -34.4 2.47 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-N 116.136 -0.484 . . . . 0.0 113.125 -179.175 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.502 ' CG ' ' HZ2' ' A' ' 24' ' ' LYS . 12.2 t70 -133.04 114.59 13.9 Favored Pre-proline 0 CA--C 1.544 0.746 0 O-C-N 122.462 -0.434 . . . . 0.0 111.337 -177.271 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -80.86 0.03 10.29 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.585 2.19 . . . . 0.0 113.562 -179.305 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.502 ' HZ2' ' CG ' ' A' ' 22' ' ' ASP . 9.5 mtmp? -93.91 -16.77 23.68 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.97 0.414 . . . . 0.0 111.368 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -82.54 137.72 34.5 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.396 177.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 47.0 m -68.98 -22.66 64.09 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 120.77 0.319 . . . . 0.0 111.463 179.031 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.435 ' HA3' ' HG3' ' A' ' 15' ' ' ARG . . . 108.44 23.5 6.59 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 121.274 -0.488 . . . . 0.0 114.194 177.081 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -104.51 6.22 34.6 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 117.388 0.594 . . . . 0.0 111.799 178.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -130.79 130.76 44.11 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.011 -178.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.464 ' HE2' ' HB2' ' A' ' 17' ' ' PHE . 48.2 ttm -125.81 133.88 51.86 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.987 0.422 . . . . 0.0 111.99 -179.156 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.445 ' OD1' ' HB3' ' A' ' 33' ' ' LYS . 9.8 p30 -90.93 168.35 11.75 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.987 0.422 . . . . 0.0 111.605 178.563 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -66.04 -28.72 73.9 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-N 116.164 -0.471 . . . . 0.0 114.041 -179.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.445 ' HB3' ' OD1' ' A' ' 31' ' ' ASN . 39.6 ttmt -67.46 -48.8 66.14 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 117.006 0.403 . . . . 0.0 111.316 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -68.71 -35.22 76.88 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.803 0.335 . . . . 0.0 111.013 175.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 47.5 t-105 -58.43 -45.48 88.41 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.283 174.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.52 -38.26 83.83 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.193 0.521 . . . . 0.0 111.528 176.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -70.72 -35.58 72.79 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.364 175.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.7 tt -59.57 -54.45 46.4 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.083 0.468 . . . . 0.0 110.588 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 26.2 p -60.51 -44.42 96.04 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.646 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -67.89 -38.16 82.67 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.847 0.356 . . . . 0.0 111.525 -178.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -67.31 -49.91 62.27 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.236 178.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.557 ' SG ' HG22 ' A' ' 103' ' ' VAL . 68.8 m -80.61 1.43 29.85 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.503 178.097 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp 69.03 20.23 7.82 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.033 0.533 . . . . 0.0 112.144 172.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.543 ' HA ' ' NH1' ' A' ' 86' ' ' ARG . 40.0 t -70.04 -26.94 30.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 120.926 0.394 . . . . 0.0 110.561 175.196 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.16 78.04 0.51 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.651 0.739 . . . . 0.0 109.972 172.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.486 ' HB3' ' H ' ' A' ' 50' ' ' VAL . 38.7 t70 -54.99 -30.12 58.62 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 114.601 -1.181 . . . . 0.0 113.978 -169.221 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.26 -36.44 1.53 Allowed Glycine 0 CA--C 1.531 1.065 0 C-N-CA 121.227 -0.511 . . . . 0.0 113.31 -177.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.7 mttp -82.59 -46.94 12.69 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.161 0.505 . . . . 0.0 110.093 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 73.1 m -108.55 -50.43 3.03 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.564 174.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.486 ' H ' ' HB3' ' A' ' 46' ' ' ASP . 43.1 t -93.76 110.25 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -178.22 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 76.5 p -96.44 173.93 7.12 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 120.689 0.281 . . . . 0.0 111.519 177.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -58.06 -44.05 94.85 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 121.083 -0.58 . . . . 0.0 112.443 177.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.562 ' O ' HG13 ' A' ' 57' ' ' ILE . 44.5 p -51.21 -50.64 58.71 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.325 0.583 . . . . 0.0 110.361 172.69 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.06 -38.42 70.61 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.04 -176.655 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.2 t -59.22 -40.56 81.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.173 176.063 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -68.06 -37.66 81.55 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.98 0.419 . . . . 0.0 110.84 175.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.562 HG13 ' O ' ' A' ' 53' ' ' THR . 6.5 mt -62.73 -46.76 95.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.146 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 76.5 t -59.99 -42.48 89.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 120.979 0.419 . . . . 0.0 111.07 177.073 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -62.36 -23.32 66.73 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-O 121.153 0.502 . . . . 0.0 110.999 176.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 23.1 t -87.0 -34.79 19.13 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.836 0.35 . . . . 0.0 111.254 175.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -60.86 -44.69 96.69 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 29.4 m -78.97 -22.64 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -177.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? -73.97 150.01 41.02 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.905 0.383 . . . . 0.0 111.789 -175.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -70.18 -98.67 0.05 OUTLIER Glycine 0 CA--C 1.53 0.993 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.161 174.063 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -141.88 -64.73 0.43 Allowed 'General case' 0 N--CA 1.471 0.607 0 O-C-N 122.423 -0.457 . . . . 0.0 111.216 174.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 43.5 t -92.77 91.3 7.42 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.862 0.363 . . . . 0.0 110.825 177.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -160.57 146.56 15.08 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.231 0.538 . . . . 0.0 112.089 -178.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 68' ' ' ARG . 32.5 mtm-85 -104.36 -37.76 7.1 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.393 0.616 . . . . 0.0 110.716 177.551 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.3 m -124.82 158.56 32.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.208 -178.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 42.1 pt -118.49 159.77 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.091 177.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 18.0 p30 -103.61 177.81 4.73 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.407 ' O ' ' HB3' ' A' ' 75' ' ' PHE . 84.7 t80 -54.01 -40.62 67.17 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -174.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -56.22 -51.47 67.95 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.266 0.555 . . . . 0.0 111.281 178.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -64.52 -32.87 74.69 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.068 177.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.407 ' HB3' ' O ' ' A' ' 72' ' ' TYR . 61.0 t80 -58.82 -43.72 90.68 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.025 174.761 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp -54.95 -49.53 71.14 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.186 0.517 . . . . 0.0 111.066 173.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -61.18 -35.13 76.32 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.173 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.47 -43.38 81.16 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.012 0.434 . . . . 0.0 111.449 176.036 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 80.8 mt -64.89 -35.4 81.01 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.103 177.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -59.94 -49.94 75.7 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.134 0.492 . . . . 0.0 110.325 176.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -57.4 -56.7 18.43 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.152 175.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 87.1 mt -60.27 -35.24 75.08 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -178.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.5 ' HB2' HG21 ' A' ' 99' ' ' ILE . . . -64.15 -48.04 77.58 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.108 0.48 . . . . 0.0 111.057 178.279 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 65.7 p -74.67 -9.26 58.39 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.846 -0.616 . . . . 0.0 112.161 -179.428 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -101.6 -28.32 12.58 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 173.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.543 ' NH1' ' HA ' ' A' ' 44' ' ' VAL . 14.3 tpt180 -83.26 -54.26 5.14 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.695 0.76 . . . . 0.0 110.575 178.639 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -86.55 144.58 27.14 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.752 178.033 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.464 ' NZ ' ' HB3' ' A' ' 88' ' ' LYS . 0.5 OUTLIER -81.64 -164.71 0.82 Allowed 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -178.555 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -55.3 81.97 0.01 OUTLIER Glycine 0 CA--C 1.531 1.035 0 N-CA-C 114.633 0.613 . . . . 0.0 114.633 -176.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -126.3 177.15 6.6 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 122.885 0.474 . . . . 0.0 110.749 176.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 65.9 m -62.72 125.44 23.96 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 120.767 0.318 . . . . 0.0 111.161 176.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -54.84 -40.31 69.48 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 116.134 -0.485 . . . . 0.0 112.303 -174.081 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -62.59 -59.93 4.23 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.653 0.263 . . . . 0.0 110.98 178.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -53.82 -39.47 65.57 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 120.725 0.297 . . . . 0.0 111.432 -179.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.24 -42.73 95.91 Favored 'General case' 0 CA--C 1.541 0.635 0 CA-C-O 120.706 0.288 . . . . 0.0 111.468 177.043 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -67.59 -50.2 59.44 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.222 178.14 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -57.32 -42.03 81.07 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 120.727 0.298 . . . . 0.0 111.456 178.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.67 -54.22 45.71 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 112.041 0.385 . . . . 0.0 112.041 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.5 HG21 ' HB2' ' A' ' 83' ' ' ALA . 12.7 tt -59.29 -36.12 61.84 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-O 121.096 0.474 . . . . 0.0 110.793 179.252 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 81.6 m -68.04 -38.69 82.8 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.135 176.081 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -58.42 -31.49 67.76 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.061 0.458 . . . . 0.0 111.486 177.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 92.9 mt -60.79 -41.11 94.96 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.879 176.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.557 HG22 ' SG ' ' A' ' 42' ' ' CYS . 16.3 t -96.76 -31.63 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 CA-C-O 121.044 0.449 . . . . 0.0 112.176 -174.666 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.03 124.67 21.7 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -173.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 85.78 -11.56 61.73 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 116.123 -0.49 . . . . 0.0 113.44 177.332 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -86.67 153.33 21.83 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 122.5 -0.412 . . . . 0.0 111.293 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.538 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 0.4 OUTLIER -86.42 163.27 42.79 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.294 173.901 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.538 ' HD2' ' HB2' ' A' ' 107' ' ' GLU . 59.3 Cg_endo -69.73 -149.38 0.02 OUTLIER 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.052 1.835 . . . . 0.0 111.922 177.119 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.376 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 169.805 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.479 HG12 ' H ' ' A' ' 9' ' ' GLY . 10.8 tt . . . . . 0 CA--C 1.542 0.642 0 CA-C-O 121.138 0.494 . . . . 0.0 112.014 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -53.19 -34.3 56.39 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -177.116 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.479 ' H ' HG12 ' A' ' 7' ' ' ILE . . . -60.75 -34.48 86.9 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 121.41 -0.424 . . . . 0.0 113.487 177.767 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 38.8 tp -73.76 -43.69 58.32 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.363 0.601 . . . . 0.0 110.656 178.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -59.17 -36.25 74.98 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.501 174.653 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -66.9 -51.03 60.34 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.457 174.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.5 p -60.74 -43.24 98.16 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -177.324 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -57.61 -55.96 28.08 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.026 0.441 . . . . 0.0 110.492 175.072 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.46 ' O ' HG12 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -56.91 -34.65 68.14 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.541 177.198 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -63.89 -48.28 77.25 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 120.901 0.381 . . . . 0.0 111.765 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.443 ' HA ' ' HB2' ' A' ' 20' ' ' HIS . 49.9 m-85 -77.72 -23.17 49.48 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.725 -0.216 . . . . 0.0 111.479 176.071 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.78 -47.79 71.04 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 120.913 0.387 . . . . 0.0 111.09 176.517 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.46 HG12 ' O ' ' A' ' 15' ' ' ARG . 26.3 pt -86.47 1.61 5.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.869 178.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.443 ' HB2' ' HA ' ' A' ' 17' ' ' PHE . 34.6 t-80 -51.8 96.91 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.41 0.624 . . . . 0.0 111.737 -178.106 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 135.31 -50.32 0.86 Allowed Glycine 0 CA--C 1.525 0.705 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.068 -175.56 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -126.97 111.04 21.9 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 122.443 0.297 . . . . 0.0 111.283 179.001 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -68.4 -5.08 14.19 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 122.569 2.179 . . . . 0.0 112.417 178.362 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.3 pttt -93.36 0.06 56.77 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.844 177.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.86 158.94 26.62 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.052 0.454 . . . . 0.0 111.842 -178.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 31.2 p -67.14 -71.23 0.21 Allowed 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.077 -178.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 109.75 14.34 14.21 Favored Glycine 0 CA--C 1.532 1.099 0 N-CA-C 114.674 0.63 . . . . 0.0 114.674 175.372 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 -97.86 4.19 49.7 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 117.617 0.709 . . . . 0.0 111.468 176.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.585 ' HB3' HG21 ' A' ' 69' ' ' VAL . 31.8 mt-10 -144.9 143.53 30.62 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.042 0.537 . . . . 0.0 110.888 177.429 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.518 ' O ' ' HB ' ' A' ' 69' ' ' VAL . 49.4 ttm -128.8 140.69 51.59 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.06 0.457 . . . . 0.0 111.997 -177.398 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 27.2 p30 -93.18 164.21 13.33 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.084 0.469 . . . . 0.0 111.868 178.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.455 ' HA2' ' HB3' ' A' ' 35' ' ' TRP . . . -61.72 -25.96 66.25 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 121.386 -0.435 . . . . 0.0 113.224 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -59.08 -57.38 13.32 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 121.196 0.522 . . . . 0.0 111.474 177.24 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -75.94 -26.37 56.83 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.49 179.291 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.455 ' HB3' ' HA2' ' A' ' 32' ' ' GLY . 51.7 t-105 -62.52 -45.5 92.71 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.136 0.493 . . . . 0.0 110.875 173.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.72 -45.25 94.78 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.111 176.487 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -68.71 -31.25 70.2 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.653 177.274 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.2 tt -58.44 -56.79 17.58 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.171 0.51 . . . . 0.0 110.522 178.132 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.637 ' HA ' ' SG ' ' A' ' 42' ' ' CYS . 28.9 p -63.98 -35.9 82.22 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.613 -179.303 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -68.42 -41.42 80.42 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.804 0.335 . . . . 0.0 111.443 178.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -73.59 -31.86 63.82 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.637 ' SG ' ' HA ' ' A' ' 39' ' ' CYS . 27.9 p -89.8 -5.97 56.38 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.96 0.409 . . . . 0.0 110.711 173.703 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt 55.94 25.66 8.93 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.299 0.852 . . . . 0.0 113.299 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.525 HG23 ' SG ' ' A' ' 42' ' ' CYS . 79.1 t -67.54 -37.32 78.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 169.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.92 115.46 7.46 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.925 171.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -131.43 84.53 2.18 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.393 -173.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -33.18 -30.69 0.01 OUTLIER Glycine 0 CA--C 1.537 1.458 0 N-CA-C 116.011 1.165 . . . . 0.0 116.011 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -62.89 -44.6 95.67 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 118.042 0.921 . . . . 0.0 111.1 175.151 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.5 t -107.61 -55.66 2.32 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.026 176.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 40.9 t -109.37 109.46 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 122.788 0.435 . . . . 0.0 111.788 -177.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 66.1 p -79.58 151.91 30.38 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -56.41 -30.69 58.94 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 121.395 -0.431 . . . . 0.0 112.59 176.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.596 ' O ' HG13 ' A' ' 57' ' ' ILE . 89.2 m -61.92 -50.58 71.58 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 122.867 -0.196 . . . . 0.0 110.845 174.546 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.442 ' O ' HG23 ' A' ' 58' ' ' VAL . 26.7 t70 -58.22 -41.42 84.07 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.876 0.369 . . . . 0.0 110.951 179.255 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.1 t -58.64 -35.14 53.74 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 CA-C-O 121.183 0.516 . . . . 0.0 111.408 175.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -73.3 -38.28 65.91 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.205 0.526 . . . . 0.0 110.305 179.415 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.596 HG13 ' O ' ' A' ' 53' ' ' THR . 9.1 mt -62.5 -45.72 98.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.777 177.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 54' ' ' ASP . 94.2 t -58.03 -42.13 82.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.794 177.522 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -54.91 -43.88 73.67 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 121.178 0.514 . . . . 0.0 111.252 176.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 60.1 p -80.65 -17.48 51.09 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.834 -177.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.433 ' HD3' ' HA ' ' A' ' 61' ' ' LYS . 31.7 mmtp -84.54 -33.12 23.53 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 178.371 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.515 ' HB ' ' HB3' ' A' ' 74' ' ' GLU . 34.5 m -82.82 -19.63 10.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-O 121.135 0.493 . . . . 0.0 110.729 173.82 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.4 ttmm -61.2 127.27 30.71 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.285 177.618 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -71.85 152.12 48.48 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 120.94 -0.648 . . . . 0.0 111.919 171.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -53.53 -44.13 68.94 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -175.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 95.0 p -93.4 4.95 53.13 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 120.849 0.357 . . . . 0.0 111.806 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -88.66 117.58 27.72 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 120.865 0.364 . . . . 0.0 111.671 -178.488 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 66.3 mtp180 -70.25 -34.37 72.75 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.565 0.698 . . . . 0.0 110.227 178.252 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.585 HG21 ' HB3' ' A' ' 29' ' ' GLU . 32.4 m -124.82 -160.99 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.486 177.226 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 47.4 pt -119.9 150.02 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 O-C-N 122.051 -0.406 . . . . 0.0 111.28 173.385 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -102.57 169.62 8.54 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 120.778 0.323 . . . . 0.0 111.461 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -54.19 -40.68 67.81 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -175.265 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -55.81 -43.53 76.98 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.819 0.342 . . . . 0.0 111.353 176.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.621 ' HA ' ' HD3' ' A' ' 77' ' ' LYS . 11.0 mm-40 -71.99 -31.69 66.49 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.009 0.433 . . . . 0.0 110.75 178.441 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -58.09 -43.7 87.23 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.098 176.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -54.9 -49.49 71.11 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.524 0.678 . . . . 0.0 110.987 173.456 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.621 ' HD3' ' HA ' ' A' ' 74' ' ' GLU . 51.0 mtpt -62.97 -36.66 84.23 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.684 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.7 -47.05 70.49 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.581 178.015 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 75.8 mt -59.35 -47.47 85.31 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.817 0.341 . . . . 0.0 111.195 177.375 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -54.22 -40.89 68.08 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 121.114 0.483 . . . . 0.0 111.224 178.552 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -61.18 -61.42 2.57 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.016 0.436 . . . . 0.0 111.164 176.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 80.9 mt -58.29 -30.87 66.97 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.963 0.411 . . . . 0.0 111.54 -179.36 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.03 -51.36 67.08 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.983 176.215 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 68.0 p -65.65 -17.21 64.43 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -72.22 -55.81 6.6 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 120.756 0.313 . . . . 0.0 111.593 174.573 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 62.5 mtp180 -81.35 -47.26 13.51 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.872 0.368 . . . . 0.0 111.668 -178.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -84.9 144.91 28.07 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.793 0.33 . . . . 0.0 110.519 177.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 41.6 mtpt -81.53 157.55 24.77 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.308 0.575 . . . . 0.0 112.096 -177.21 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -78.22 60.89 3.88 Favored Glycine 0 CA--C 1.528 0.897 0 CA-C-N 116.019 -0.537 . . . . 0.0 114.298 -173.216 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 58.7 pttt -96.3 -34.79 11.47 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.239 0.543 . . . . 0.0 110.488 173.113 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 32.3 t -167.26 115.8 0.81 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.141 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -65.68 -25.86 67.53 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 120.783 0.325 . . . . 0.0 110.707 174.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -57.22 -58.46 8.11 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.145 177.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -70.12 -37.7 75.39 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.305 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.51 -41.79 95.08 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.847 0.356 . . . . 0.0 111.54 178.166 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -67.8 -40.49 83.91 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.441 178.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -55.16 -52.67 62.57 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.421 0.629 . . . . 0.0 110.776 174.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.33 -52.62 62.92 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 115.166 -0.925 . . . . 0.0 112.581 -176.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.0 tt -59.65 -38.01 73.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 O-C-N 121.903 -0.498 . . . . 0.0 110.772 178.289 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 83.0 m -73.68 -24.15 59.92 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.177 175.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -62.94 -34.29 77.17 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.503 0.668 . . . . 0.0 109.81 175.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 94.4 mt -80.3 -25.99 39.07 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.487 177.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 76.6 t -100.57 -53.62 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -175.566 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -51.56 125.99 16.2 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -176.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 69.93 0.65 28.08 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-N 115.861 -0.609 . . . . 0.0 114.257 178.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.48 ' HD3' ' N ' ' A' ' 107' ' ' GLU . 11.7 tmtt? -87.79 134.63 33.64 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 121.382 0.61 . . . . 0.0 111.057 -176.04 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.48 ' N ' ' HD3' ' A' ' 106' ' ' LYS . 0.9 OUTLIER -89.12 154.61 49.49 Favored Pre-proline 0 CA--C 1.547 0.854 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -174.347 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -62.62 120.21 7.63 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 122.526 2.151 . . . . 0.0 112.37 175.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.389 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -175.116 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.521 ' N ' HD12 ' A' ' 7' ' ' ILE . 2.9 mp . . . . . 0 CA--C 1.544 0.733 0 CA-C-O 120.788 0.328 . . . . 0.0 111.004 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.64 -26.4 65.32 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.264 0.554 . . . . 0.0 111.404 179.047 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -55.76 -28.46 52.36 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.381 175.382 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 34.4 tp -58.33 -38.79 77.84 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.954 0.407 . . . . 0.0 110.704 178.179 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -67.85 -44.11 77.92 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 120.865 0.364 . . . . 0.0 110.246 173.375 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 20.5 tp10 -54.75 -47.0 74.39 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 178.336 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.505 ' HB3' ' HA2' ' A' ' 105' ' ' GLY . 53.9 p -67.49 -52.34 40.34 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -53.04 -47.13 68.62 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.273 0.559 . . . . 0.0 111.211 175.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -60.38 -36.14 77.36 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.261 177.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -73.34 -38.17 65.85 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.552 -178.516 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -74.28 -38.3 63.45 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 120.609 0.243 . . . . 0.0 111.388 176.37 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.94 -49.81 72.47 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.517 ' HA ' ' HB3' ' A' ' 25' ' ' ALA . 33.9 pt -78.67 6.06 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -178.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -90.73 146.07 24.29 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.984 0.421 . . . . 0.0 111.837 -177.324 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 79.15 -60.88 4.2 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 121.164 -0.541 . . . . 0.0 112.533 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -96.59 105.66 24.52 Favored Pre-proline 0 CA--C 1.542 0.657 0 CA-C-O 120.892 0.377 . . . . 0.0 111.115 177.476 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.14 -7.31 20.53 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.596 2.197 . . . . 0.0 113.387 -178.433 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -97.88 11.76 36.3 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 178.353 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.517 ' HB3' ' HA ' ' A' ' 19' ' ' ILE . . . -77.21 161.08 28.44 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.288 0.566 . . . . 0.0 112.356 -178.444 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 96.6 p -87.95 -45.15 10.48 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.978 -178.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.05 -19.93 31.79 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 121.393 -0.432 . . . . 0.0 112.481 -175.009 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 56.4 tp60 -96.54 -21.36 17.73 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.95 0.405 . . . . 0.0 110.841 177.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -125.25 129.49 50.15 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.54 178.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 54.7 ttp -125.29 148.91 48.5 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.118 0.485 . . . . 0.0 112.196 -177.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.489 ' OD1' ' HB3' ' A' ' 33' ' ' LYS . 16.9 p30 -93.07 172.09 8.53 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -177.661 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.547 ' HA2' ' HB3' ' A' ' 35' ' ' TRP . . . -60.83 -27.06 66.11 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-N 116.21 -0.45 . . . . 0.0 112.871 176.729 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.489 ' HB3' ' OD1' ' A' ' 31' ' ' ASN . 87.1 tttt -50.81 -64.47 0.8 Allowed 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 123.941 0.897 . . . . 0.0 112.117 175.393 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -77.42 -25.08 50.38 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.972 -0.455 . . . . 0.0 111.51 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.547 ' HB3' ' HA2' ' A' ' 32' ' ' GLY . 55.8 t-105 -59.76 -38.61 82.27 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.203 0.525 . . . . 0.0 110.462 171.158 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.92 -43.62 87.58 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.75 174.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -53.6 -48.75 68.97 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.647 174.003 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.6 mt -52.59 -49.65 64.59 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.027 0.441 . . . . 0.0 111.644 177.059 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 73.8 m -55.9 -42.55 76.19 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.674 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -75.34 -39.86 58.91 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.071 0.462 . . . . 0.0 111.92 -178.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -70.83 -42.51 70.1 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 122.144 -0.348 . . . . 0.0 111.277 -177.443 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.592 ' SG ' HG22 ' A' ' 103' ' ' VAL . 62.9 m -83.41 -12.38 56.5 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.44 176.081 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? 64.7 37.94 7.26 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.179 0.592 . . . . 0.0 111.957 179.016 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.484 HG11 HD13 ' A' ' 82' ' ' LEU . 51.6 t -75.32 -34.93 31.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-O 121.155 0.503 . . . . 0.0 110.079 173.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.72 82.09 2.08 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.481 0.657 . . . . 0.0 111.054 177.269 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -65.47 -40.26 92.94 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.483 -178.501 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.97 -38.55 3.23 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 121.392 -0.432 . . . . 0.0 112.806 -176.7 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -96.52 -48.08 5.69 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.18 0.514 . . . . 0.0 111.15 178.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.4 t -90.17 -44.54 9.7 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.318 178.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 54.0 t -121.51 108.88 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.499 177.348 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.412 ' O ' HG23 ' A' ' 55' ' ' VAL . 68.2 p -94.06 163.31 13.53 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -175.559 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -56.15 -44.41 88.74 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 121.19 -0.528 . . . . 0.0 112.744 176.31 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.592 ' O ' HG12 ' A' ' 57' ' ' ILE . 7.8 t -61.86 -41.04 97.35 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 122.53 -0.394 . . . . 0.0 110.69 175.719 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -59.85 -37.71 80.02 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.009 0.433 . . . . 0.0 110.584 176.518 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 51' ' ' THR . 76.3 t -59.39 -35.16 56.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.147 174.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -76.26 -34.39 59.15 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.817 0.817 . . . . 0.0 109.754 178.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.592 HG12 ' O ' ' A' ' 53' ' ' THR . 9.7 mm -60.61 -54.51 34.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.009 175.591 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.411 ' HA ' ' HB3' ' A' ' 61' ' ' LYS . 74.3 t -57.96 -40.3 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-O 120.728 0.299 . . . . 0.0 111.557 178.545 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -61.71 -44.13 97.51 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.045 0.45 . . . . 0.0 110.512 178.37 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 78.3 p -80.33 -15.06 57.77 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.108 0.48 . . . . 0.0 111.452 178.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.411 ' HB3' ' HA ' ' A' ' 58' ' ' VAL . 24.8 tptp -74.78 -49.98 18.92 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.166 0.587 . . . . 0.0 111.709 178.048 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.7 m -85.02 -24.56 7.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -179.102 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -57.7 131.54 50.57 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 179.614 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -77.68 -162.86 19.01 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-O 121.291 0.384 . . . . 0.0 113.994 179.358 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 21.3 ttpp -82.06 148.16 28.75 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -177.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 48.5 p 51.18 17.91 0.53 Allowed 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 173.739 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -110.64 146.49 36.08 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.878 0.371 . . . . 0.0 110.811 177.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 7.4 ptp85 -114.97 15.37 17.26 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.271 0.557 . . . . 0.0 110.862 178.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 22.2 m -145.72 169.86 6.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.661 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 37.2 pt -122.37 143.09 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-O 120.681 0.277 . . . . 0.0 110.885 175.421 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -100.72 177.79 4.89 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 120.888 0.375 . . . . 0.0 111.467 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -55.76 -27.33 50.23 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 113.159 0.799 . . . . 0.0 113.159 -175.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -70.7 -59.79 2.62 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.782 -0.574 . . . . 0.0 111.076 174.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -56.82 -32.42 65.7 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.436 0.636 . . . . 0.0 110.627 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -60.61 -51.54 68.98 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.733 176.349 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 37.5 mtmm -60.95 -42.72 98.78 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -59.43 -40.9 88.25 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 120.997 0.427 . . . . 0.0 110.839 175.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.02 -43.37 98.98 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.42 177.237 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 85.0 mt -57.7 -43.12 84.94 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.725 178.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -60.11 -46.42 89.69 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 120.722 0.296 . . . . 0.0 111.241 177.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.466 ' O ' ' HG3' ' A' ' 85' ' ' LYS . 52.5 mt-10 -59.24 -50.56 73.53 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.548 0.213 . . . . 0.0 111.274 177.601 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.484 HD13 HG11 ' A' ' 44' ' ' VAL . 95.9 mt -58.88 -40.32 84.02 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.023 0.439 . . . . 0.0 111.381 176.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.87 -51.41 70.16 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.807 178.468 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 56.2 p -65.99 -22.17 66.45 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -178.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.466 ' HG3' ' O ' ' A' ' 81' ' ' GLU . 96.9 mttt -78.23 -43.24 28.86 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 120.887 0.375 . . . . 0.0 111.225 174.338 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 26.7 tpt180 -81.32 -63.93 1.29 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.026 0.441 . . . . 0.0 111.133 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -79.16 88.18 4.87 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.361 0.6 . . . . 0.0 110.527 178.355 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 53.1 mttm -80.01 87.86 5.39 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.421 -173.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.402 ' O ' ' HB3' ' A' ' 90' ' ' LYS . . . -156.46 4.53 0.19 Allowed Glycine 0 CA--C 1.533 1.212 0 C-N-CA 120.86 -0.686 . . . . 0.0 114.468 178.518 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.402 ' HB3' ' O ' ' A' ' 89' ' ' GLY . 82.8 tttt 72.86 -43.71 0.57 Allowed 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 33.7 p -46.19 105.04 0.06 Allowed 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -175.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 46.4 mttm -60.37 -63.15 1.4 Allowed 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -176.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -54.32 -48.06 71.77 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -175.03 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -66.71 -44.38 81.79 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -178.534 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.65 -41.01 93.06 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.011 0.434 . . . . 0.0 111.426 179.415 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -68.75 -37.18 79.2 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.043 178.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -62.17 -49.37 76.11 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.373 0.606 . . . . 0.0 110.001 174.435 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -58.87 -49.89 76.07 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.296 -0.866 . . . . 0.0 112.669 -179.033 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.4 tp -60.89 -38.69 79.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-O 121.149 0.499 . . . . 0.0 110.904 178.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 75.0 m -73.65 -25.36 60.24 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.105 176.155 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -72.75 -32.4 65.64 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.024 0.44 . . . . 0.0 110.616 177.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 90.4 mt -64.16 -55.2 23.48 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.077 0.465 . . . . 0.0 110.924 173.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.592 HG22 ' SG ' ' A' ' 42' ' ' CYS . 41.2 t -69.34 -65.15 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.004 178.36 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 48.95 -100.46 0.07 Allowed 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.494 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.505 ' HA2' ' HB3' ' A' ' 13' ' ' SER . . . -151.13 44.18 0.68 Allowed Glycine 0 CA--C 1.523 0.54 0 C-N-CA 121.199 -0.524 . . . . 0.0 112.407 -179.36 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 49.6 tttm -74.37 155.33 38.24 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-O 121.141 0.496 . . . . 0.0 112.337 -177.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -66.56 137.55 95.23 Favored Pre-proline 0 CA--C 1.545 0.756 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.769 173.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -66.54 147.14 81.69 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.564 2.176 . . . . 0.0 113.898 -173.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.716 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.686 177.15 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.484 ' N ' HD12 ' A' ' 7' ' ' ILE . 3.5 mp . . . . . 0 CA--C 1.546 0.796 0 CA-C-O 121.181 0.515 . . . . 0.0 111.696 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.16 -34.95 78.72 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-O 121.329 0.585 . . . . 0.0 111.607 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -59.98 -19.95 52.13 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.698 176.327 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.646 HD22 ' SG ' ' A' ' 100' ' ' CYS . 43.6 tp -74.9 -38.85 61.75 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 120.713 0.292 . . . . 0.0 110.405 177.412 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -59.09 -41.23 87.55 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.009 173.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.542 ' O ' ' HG3' ' A' ' 16' ' ' LYS . 42.5 mt-10 -55.34 -54.45 43.5 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.207 175.391 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 41.7 t -55.37 -54.94 37.35 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.752 -178.517 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -53.55 -43.33 68.34 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.28 0.562 . . . . 0.0 110.771 176.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 63.8 ttt180 -62.36 -32.74 73.57 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.112 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.542 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 95.8 mttt -74.83 -39.37 61.67 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.564 178.719 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.864 ' HB3' ' SD ' ' A' ' 30' ' ' MET . 18.2 m-85 -69.67 -38.78 77.2 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 120.896 0.379 . . . . 0.0 111.43 175.669 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.2 -40.46 97.56 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -178.532 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.47 HG22 ' O ' ' A' ' 25' ' ' ALA . 29.2 pt -86.85 13.13 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-O 120.874 0.369 . . . . 0.0 111.839 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 37.6 t-80 -109.13 95.69 5.8 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.812 0.339 . . . . 0.0 111.652 -175.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 108.78 -46.55 1.15 Allowed Glycine 0 CA--C 1.521 0.457 0 C-N-CA 121.147 -0.549 . . . . 0.0 111.895 -175.383 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -74.3 108.34 4.97 Favored Pre-proline 0 CA--C 1.544 0.741 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 171.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -56.92 -38.73 95.26 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.752 2.301 . . . . 0.0 114.298 -169.027 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.5 mtpt -124.79 28.78 6.39 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -172.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.47 ' O ' HG22 ' A' ' 19' ' ' ILE . . . -74.93 123.56 25.32 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.772 0.32 . . . . 0.0 111.272 179.428 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 55.4 m -69.45 -2.02 10.03 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.52 -1.53 66.57 Favored Glycine 0 CA--C 1.523 0.593 0 C-N-CA 121.402 -0.428 . . . . 0.0 112.94 -178.688 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -86.35 -37.77 18.12 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.99 0.424 . . . . 0.0 111.775 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -116.66 131.58 56.91 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.86 -175.178 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.864 ' SD ' ' HB3' ' A' ' 17' ' ' PHE . 58.2 ttp -127.64 140.75 51.9 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.988 0.423 . . . . 0.0 111.801 178.28 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.463 ' OD1' ' HB3' ' A' ' 33' ' ' LYS . 10.9 p30 -74.79 167.69 21.34 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 121.249 0.547 . . . . 0.0 112.241 -178.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -70.95 -21.59 78.27 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-N 116.075 -0.511 . . . . 0.0 114.033 -178.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.463 ' HB3' ' OD1' ' A' ' 31' ' ' ASN . 61.5 tttp -70.88 -44.22 66.77 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 117.314 0.557 . . . . 0.0 111.052 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -72.34 -26.43 61.93 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 122.179 -0.326 . . . . 0.0 110.938 174.708 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 49.7 t-105 -65.45 -52.35 53.75 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 120.885 0.374 . . . . 0.0 111.167 173.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.93 -42.54 85.06 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.411 0.624 . . . . 0.0 110.583 174.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -61.04 -40.12 92.39 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.985 174.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.6 tt -55.22 -46.95 75.95 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.713 -178.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.595 ' SG ' HG21 ' A' ' 55' ' ' VAL . 15.7 p -66.1 -49.33 67.9 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.671 0.272 . . . . 0.0 111.467 -179.747 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.439 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 88.7 tttt -67.64 -34.62 77.31 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 120.904 0.383 . . . . 0.0 111.525 -175.808 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 49.0 t0 -77.8 -36.96 49.72 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 120.869 0.366 . . . . 0.0 110.824 179.023 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.575 ' SG ' ' HD3' ' A' ' 106' ' ' LYS . 77.7 m -87.12 4.11 43.54 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 178.801 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm 74.61 15.01 3.38 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 172.053 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 55.3 t -69.04 -32.67 55.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-O 120.788 0.328 . . . . 0.0 111.087 178.125 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.1 98.12 6.41 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 120.919 0.39 . . . . 0.0 111.32 178.552 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -90.79 -37.75 13.44 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -178.182 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 111.97 -25.87 12.3 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 121.286 -0.483 . . . . 0.0 113.608 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -88.87 -53.47 4.59 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.102 0.477 . . . . 0.0 110.72 178.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 64.6 m -98.22 -41.58 7.82 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.226 179.272 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.3 t -111.37 102.5 14.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 121.108 0.48 . . . . 0.0 110.691 175.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 48.5 p -93.4 15.02 16.74 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -176.291 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.6 -52.37 4.69 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.573 -173.122 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.595 ' O ' HG13 ' A' ' 57' ' ' ILE . 49.1 m -50.53 -46.44 57.35 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.131 0.491 . . . . 0.0 109.949 172.477 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -53.31 -35.31 60.01 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.109 176.193 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.595 HG21 ' SG ' ' A' ' 39' ' ' CYS . 56.3 t -66.01 -36.88 78.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 120.895 0.378 . . . . 0.0 110.74 177.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -69.79 -37.93 76.49 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.37 0.605 . . . . 0.0 109.886 175.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.595 HG13 ' O ' ' A' ' 53' ' ' THR . 6.8 mt -63.89 -50.42 77.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.191 178.138 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 71.3 t -58.55 -38.15 69.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-O 120.87 0.367 . . . . 0.0 111.34 177.46 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -59.11 -45.31 91.21 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.215 0.531 . . . . 0.0 110.022 176.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.441 ' HA ' ' HE2' ' A' ' 63' ' ' LYS . 80.7 p -79.14 -12.64 59.99 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.574 177.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.421 ' HE3' ' OE2' ' A' ' 81' ' ' GLU . 61.0 tttp -85.53 -21.96 28.36 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 121.303 0.573 . . . . 0.0 110.763 178.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.492 ' HB ' ' HB3' ' A' ' 74' ' ' GLU . 28.4 m -103.52 -18.85 6.49 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.564 171.749 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.441 ' HE2' ' HA ' ' A' ' 60' ' ' SER . 37.7 ttpt -71.77 93.37 1.29 Allowed 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 120.974 0.416 . . . . 0.0 111.53 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -93.72 -12.53 56.73 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 121.356 -0.449 . . . . 0.0 113.187 -177.207 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.534 ' HG2' ' N ' ' A' ' 66' ' ' SER . 22.6 ttmm -111.83 164.7 12.79 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 122.622 0.369 . . . . 0.0 110.359 178.548 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.534 ' N ' ' HG2' ' A' ' 65' ' ' LYS . 86.0 p -74.55 59.6 0.84 Allowed 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.373 0.606 . . . . 0.0 109.649 169.658 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.499 ' HB2' ' HD2' ' A' ' 65' ' ' LYS . . . -114.72 150.23 35.61 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.446 -171.42 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 35.0 mtp180 -90.98 -2.7 57.67 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.305 174.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 27.0 m -135.96 144.43 33.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -173.419 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 27.6 pt -103.21 158.86 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.964 173.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -103.42 179.42 4.28 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.172 0.511 . . . . 0.0 111.743 -178.703 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -67.47 -36.3 80.87 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -64.55 -57.11 10.07 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 179.153 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.492 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 0.9 OUTLIER -64.96 -20.46 66.49 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 122.123 -0.361 . . . . 0.0 111.312 177.034 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -63.94 -43.15 96.72 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 120.781 0.324 . . . . 0.0 110.962 173.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -55.16 -46.32 75.74 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 121.178 0.514 . . . . 0.0 110.594 174.106 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.431 ' O ' ' HG3' ' A' ' 81' ' ' GLU . 59.7 tttm -61.49 -50.85 71.09 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.402 177.665 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -53.2 -43.71 67.41 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.119 -178.173 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.512 HD12 HD21 ' A' ' 10' ' ' LEU . 79.9 mt -68.26 -39.86 82.09 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 178.496 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.512 ' O ' HG23 ' A' ' 84' ' ' THR . 38.0 tt0 -55.51 -47.2 76.62 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.309 0.576 . . . . 0.0 110.748 176.291 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.431 ' HG3' ' O ' ' A' ' 77' ' ' LYS . 38.0 mt-10 -65.41 -52.84 50.53 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.444 -179.13 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 58.9 mt -55.55 -36.72 67.09 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 122.252 -0.28 . . . . 0.0 111.428 174.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.16 -45.64 84.11 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 111.661 0.245 . . . . 0.0 111.661 179.244 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.512 HG23 ' O ' ' A' ' 80' ' ' GLU . 70.7 p -61.19 -29.5 69.84 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 38.4 mtpt -84.57 -48.47 9.5 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 122.026 -0.421 . . . . 0.0 111.967 173.405 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 32.4 tpt85 -60.05 -56.99 14.79 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.355 0.598 . . . . 0.0 111.873 -176.016 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -86.06 172.72 10.4 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.055 -178.068 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -79.58 171.43 15.16 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.259 -0.428 . . . . 0.0 112.137 -174.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -71.79 67.48 1.06 Allowed Glycine 0 CA--C 1.528 0.858 0 CA-C-N 116.034 -0.53 . . . . 0.0 113.186 178.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -119.81 174.6 6.34 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 45.9 t -44.97 123.32 3.76 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 178.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -52.2 -35.48 49.26 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.662 -178.077 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 -50.06 -62.84 1.34 Allowed 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.327 177.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -58.64 -42.04 87.37 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.787 0.327 . . . . 0.0 111.435 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.76 -37.41 81.74 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.079 0.466 . . . . 0.0 111.59 179.312 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -73.51 -46.49 47.51 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.759 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -58.45 -33.65 69.96 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.855 0.36 . . . . 0.0 110.832 174.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.457 ' O ' ' HB3' ' A' ' 101' ' ' GLN . . . -64.45 -55.34 21.49 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.867 178.112 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 19.1 tt -63.94 -34.03 65.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-O 121.033 0.445 . . . . 0.0 110.856 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' CYS . . . . . 0.646 ' SG ' HD22 ' A' ' 10' ' ' LEU . 99.2 m -66.77 -36.75 83.16 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.809 0.337 . . . . 0.0 110.858 173.611 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.457 ' HB3' ' O ' ' A' ' 98' ' ' ALA . 59.9 tt0 -55.95 -38.64 70.61 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.197 0.522 . . . . 0.0 110.791 175.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 91.1 mt -68.04 -50.97 51.97 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.322 177.687 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 39.0 t -83.98 -45.97 18.18 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -171.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -52.58 136.89 31.69 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 -173.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 79.44 -35.2 2.01 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-N 116.282 -0.417 . . . . 0.0 113.763 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.575 ' HD3' ' SG ' ' A' ' 42' ' ' CYS . 63.4 tttp -59.77 159.51 8.74 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.349 0.66 . . . . 0.0 112.669 -177.731 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -124.77 151.02 67.45 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.989 179.123 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -64.47 120.84 8.25 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 122.573 2.182 . . . . 0.0 113.231 178.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.498 0 CA-C-O 121.214 0.53 . . . . 0.0 112.154 178.786 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.428 HG22 ' H ' ' A' ' 10' ' ' LEU . 41.3 mm . . . . . 0 N--CA 1.478 0.927 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.42 -45.86 57.76 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.012 0.434 . . . . 0.0 111.485 178.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.24 -18.45 35.37 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 121.223 -0.513 . . . . 0.0 112.863 177.139 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.438 HD11 HD11 ' A' ' 79' ' ' LEU . 34.1 tp -74.48 -36.83 63.3 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.895 0.379 . . . . 0.0 110.132 175.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -59.03 -43.18 91.58 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.437 0.637 . . . . 0.0 109.533 173.304 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 56.3 tt0 -58.53 -55.87 29.5 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.236 176.568 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 73.7 m -54.58 -47.44 73.3 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.628 179.159 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.409 ' CD1' ' HE3' ' A' ' 30' ' ' MET . 73.4 t80 -58.38 -44.16 88.77 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.005 0.431 . . . . 0.0 110.781 176.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 47.9 ttt180 -60.85 -47.41 86.5 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.719 -179.133 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -65.25 -40.28 93.78 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.619 178.381 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.429 ' HB3' ' HE2' ' A' ' 30' ' ' MET . 6.2 m-85 -73.07 -29.69 63.14 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 177.53 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.09 -47.03 78.68 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.112 0.482 . . . . 0.0 111.078 178.011 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 17.7 pt -88.88 5.94 4.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-O 121.208 0.527 . . . . 0.0 111.798 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -69.45 93.12 0.64 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.03 0.443 . . . . 0.0 110.806 177.391 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 81.26 45.89 7.25 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 -170.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.471 ' CB ' ' HB2' ' A' ' 25' ' ' ALA . 11.3 p-10 -64.16 120.83 67.89 Favored Pre-proline 0 CA--C 1.542 0.649 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -168.172 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -84.63 -26.39 1.66 Allowed 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.107 1.871 . . . . 0.0 111.96 166.671 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 47.7 mttp -157.02 67.14 0.53 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.596 0.758 . . . . 0.0 110.095 176.087 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.471 ' HB2' ' CB ' ' A' ' 22' ' ' ASP . . . -55.34 91.29 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 179.047 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 66.4 m -104.31 -29.39 10.8 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 120.968 0.413 . . . . 0.0 110.202 169.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.43 22.73 6.94 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 121.214 -0.517 . . . . 0.0 114.243 173.249 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -146.11 0.78 0.84 Allowed 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 117.363 0.582 . . . . 0.0 112.213 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 20.5 mp0 -114.29 121.48 43.78 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 120.683 0.278 . . . . 0.0 111.74 -175.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.429 ' HE2' ' HB3' ' A' ' 17' ' ' PHE . 52.0 ttm -119.85 134.34 55.27 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.876 0.369 . . . . 0.0 111.406 175.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 18.5 p30 -95.22 165.32 12.45 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.065 0.46 . . . . 0.0 111.702 178.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.78 -31.92 77.35 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 121.321 -0.466 . . . . 0.0 113.255 178.485 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -58.41 -53.62 56.22 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 177.278 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -70.42 -33.73 71.68 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 111.595 0.22 . . . . 0.0 111.595 179.103 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 40.0 t-105 -58.07 -47.13 84.09 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.122 0.487 . . . . 0.0 111.565 175.186 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.25 -49.37 72.15 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.982 0.42 . . . . 0.0 111.351 178.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -68.28 -22.35 64.74 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 178.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.6 tt -62.55 -52.39 63.6 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.542 0.687 . . . . 0.0 109.475 172.062 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 81.9 m -58.34 -38.6 77.49 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.211 177.215 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.1 ttmp? -68.69 -44.08 74.73 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 111.919 0.341 . . . . 0.0 111.919 177.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -67.85 -33.19 74.29 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -173.045 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.964 ' SG ' ' HB3' ' A' ' 102' ' ' LEU . 52.2 t -107.45 1.04 23.25 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-O 121.104 0.478 . . . . 0.0 110.75 175.526 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.446 ' N ' ' HD2' ' A' ' 43' ' ' LYS . 0.1 OUTLIER 63.09 38.2 10.95 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.793 -0.639 . . . . 0.0 112.155 175.83 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 48.5 t -62.89 -27.7 43.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-O 121.343 0.592 . . . . 0.0 110.386 173.186 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.563 ' HB1' HG11 ' A' ' 50' ' ' VAL . . . -57.58 115.75 2.96 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.101 170.696 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.564 ' C ' HG22 ' A' ' 50' ' ' VAL . 11.0 t70 -144.22 -50.14 0.29 Allowed 'General case' 0 C--O 1.221 -0.444 0 CA-C-O 119.311 -0.376 . . . . 0.0 111.662 -170.26 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -2.45 47.81 0.0 OUTLIER Glycine 0 N--CA 1.475 1.239 0 N-CA-C 116.389 1.316 . . . . 0.0 116.389 -164.374 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.546 ' N ' ' O ' ' A' ' 46' ' ' ASP . 25.0 ttpp 56.42 3.75 0.12 Allowed 'General case' 0 CA--C 1.552 1.046 0 CA-C-O 121.297 0.57 . . . . 0.0 111.704 -177.334 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.8 m 171.98 -27.35 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.92 1.288 . . . . 0.0 109.163 -168.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.564 HG22 ' C ' ' A' ' 46' ' ' ASP . 0.2 OUTLIER 63.58 158.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 124.994 1.317 . . . . 0.0 111.855 -179.541 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.22 -12.32 6.31 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.67 -177.582 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.79 -67.89 1.63 Allowed Glycine 0 CA--C 1.526 0.759 0 C-N-CA 121.361 -0.447 . . . . 0.0 112.47 -175.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.555 ' O ' HG12 ' A' ' 57' ' ' ILE . 51.8 m -48.57 -38.45 20.62 Favored 'General case' 0 C--O 1.223 -0.309 0 C-N-CA 122.275 0.23 . . . . 0.0 111.138 175.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.435 ' O ' HG23 ' A' ' 58' ' ' VAL . 24.1 t70 -51.87 -47.4 64.52 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.991 0.424 . . . . 0.0 111.148 176.821 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.6 t -61.74 -35.45 67.64 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 CA-C-O 121.186 0.517 . . . . 0.0 110.788 177.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -73.42 -30.24 63.1 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.6 0.714 . . . . 0.0 110.244 178.522 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.555 HG12 ' O ' ' A' ' 53' ' ' THR . 5.5 mm -70.31 -41.94 78.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.02 177.297 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 54' ' ' ASP . 88.8 t -58.83 -43.8 89.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 120.777 0.322 . . . . 0.0 110.9 176.172 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -58.13 -41.69 84.23 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.206 0.527 . . . . 0.0 110.44 174.29 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 28.9 t -73.63 -24.01 59.96 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.769 176.644 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 55.3 tttp -71.88 -38.57 70.0 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 122.901 0.48 . . . . 0.0 111.248 -176.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.3 m -91.1 -9.52 10.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-O 121.018 0.437 . . . . 0.0 111.34 174.425 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.582 ' HG3' ' HB3' ' A' ' 67' ' ' ALA . 39.7 ttmt -68.92 118.86 12.38 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.776 179.386 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -75.52 63.47 2.63 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 121.306 -0.473 . . . . 0.0 113.318 178.08 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.6 mttt 60.66 101.93 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 178.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.0 t 63.66 11.96 6.18 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 175.078 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.582 ' HB3' ' HG3' ' A' ' 63' ' ' LYS . . . -69.39 98.75 1.12 Allowed 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.983 0.42 . . . . 0.0 110.912 177.031 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 58.3 mtm180 -64.5 -16.42 62.48 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -177.482 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 31.2 m -136.14 148.65 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-O 120.793 0.33 . . . . 0.0 111.318 177.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 35.3 pt -115.23 166.07 9.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 121.024 0.44 . . . . 0.0 111.864 178.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.404 ' OD1' ' HB2' ' A' ' 73' ' ' GLU . 8.5 p30 -111.52 172.15 7.06 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.187 179.566 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.513 ' O ' ' HG3' ' A' ' 76' ' ' LYS . 59.6 t80 -61.62 -42.99 99.66 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -178.463 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.404 ' HB2' ' OD1' ' A' ' 71' ' ' ASN . 6.4 mp0 -55.54 -55.57 30.39 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -177.558 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.57 -30.62 68.45 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 122.276 -0.265 . . . . 0.0 111.664 177.179 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -55.1 -38.71 68.49 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.059 0.457 . . . . 0.0 111.032 175.047 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.513 ' HG3' ' O ' ' A' ' 72' ' ' TYR . 6.5 mtpm? -55.95 -47.82 76.9 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.979 175.508 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.428 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 4.3 mptp? -67.46 -34.36 77.02 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.477 178.597 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.6 -39.73 92.27 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.125 0.488 . . . . 0.0 111.113 175.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.438 HD11 HD11 ' A' ' 10' ' ' LEU . 69.8 mt -66.64 -41.06 88.87 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.408 175.646 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -51.94 -44.9 64.13 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 120.966 0.413 . . . . 0.0 111.357 176.577 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.595 ' O ' ' HG2' ' A' ' 85' ' ' LYS . 1.2 tm-20 -60.98 -66.5 0.52 Allowed 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.442 177.661 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.422 ' O ' ' HG3' ' A' ' 86' ' ' ARG . 73.6 mt -52.37 -31.52 34.15 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.476 ' HB2' HG21 ' A' ' 99' ' ' ILE . . . -62.95 -51.92 65.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.934 0.397 . . . . 0.0 111.114 177.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.6 ' HB ' ' HA2' ' A' ' 89' ' ' GLY . 69.3 p -62.45 -31.55 72.29 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.244 178.762 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.595 ' HG2' ' O ' ' A' ' 81' ' ' GLU . 6.2 mmmm -61.71 -29.22 69.96 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.356 176.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.422 ' HG3' ' O ' ' A' ' 82' ' ' LEU . 60.6 mtp180 -96.02 -63.83 1.11 Allowed 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.371 0.605 . . . . 0.0 111.915 179.589 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.422 ' O ' ' HB2' ' A' ' 88' ' ' LYS . 64.3 m-85 -84.83 46.18 1.23 Allowed 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.839 -0.618 . . . . 0.0 112.39 -170.731 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.524 ' NZ ' ' HB2' ' A' ' 88' ' ' LYS . 8.4 mtmp? 70.79 114.89 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.962 0.505 . . . . 0.0 111.725 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.6 ' HA2' ' HB ' ' A' ' 84' ' ' THR . . . -65.69 78.81 0.09 OUTLIER Glycine 0 CA--C 1.526 0.778 0 CA-C-N 116.018 -0.537 . . . . 0.0 113.604 -178.473 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 47.0 tttm -159.51 -77.27 0.07 Allowed 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 48.1 m -75.22 108.2 7.82 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -172.107 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 20.0 ttmm -60.35 -45.6 92.89 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.778 177.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.46 ' H ' ' CD ' ' A' ' 93' ' ' GLU . 21.6 mp0 -60.86 -57.67 11.68 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.313 0.578 . . . . 0.0 111.108 -175.035 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -55.87 -52.01 65.56 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.761 179.077 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.38 -45.32 91.8 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.987 -178.246 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -65.6 -48.09 73.46 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.651 -0.249 . . . . 0.0 111.524 -178.387 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -55.56 -47.34 76.53 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.902 0.382 . . . . 0.0 111.702 177.236 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.42 -51.42 65.82 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.476 HG21 ' HB2' ' A' ' 83' ' ' ALA . 16.5 tt -63.57 -33.97 64.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 O-C-N 122.006 -0.434 . . . . 0.0 111.385 -178.151 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 96.5 m -68.7 -37.08 79.27 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.86 0.362 . . . . 0.0 110.593 173.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -59.12 -28.23 66.34 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 121.216 0.532 . . . . 0.0 110.734 176.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.964 ' HB3' ' SG ' ' A' ' 42' ' ' CYS . 53.6 mt -79.74 -58.11 3.34 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.86 175.483 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.6 t -79.22 -51.11 17.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -173.201 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.53 119.4 7.45 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -172.171 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 93.89 -16.34 61.08 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-N 116.183 -0.462 . . . . 0.0 113.825 179.099 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.443 ' O ' ' HG2' ' A' ' 107' ' ' GLU . 60.1 tttm -74.01 -49.12 25.75 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 117.183 0.491 . . . . 0.0 112.173 -178.092 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.443 ' HG2' ' O ' ' A' ' 106' ' ' LYS . 7.1 pt-20 54.4 161.16 0.06 OUTLIER Pre-proline 0 CA--C 1.557 1.228 0 C-N-CA 124.295 1.038 . . . . 0.0 112.397 -174.147 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -51.48 118.56 4.5 Favored 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 122.414 2.076 . . . . 0.0 113.641 -176.369 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.488 0 CA-C-O 121.312 0.577 . . . . 0.0 111.968 179.586 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.5 mp . . . . . 0 N--CA 1.475 0.812 0 CA-C-O 120.903 0.383 . . . . 0.0 110.677 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.96 -44.88 78.91 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.039 0.447 . . . . 0.0 111.543 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.44 -25.78 63.4 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 121.127 -0.559 . . . . 0.0 113.168 177.467 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 45.4 tp -72.57 -42.6 64.44 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 122.535 -0.391 . . . . 0.0 110.659 178.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -57.56 -47.47 81.96 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.909 0.385 . . . . 0.0 110.783 175.432 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.603 ' O ' ' HD3' ' A' ' 16' ' ' LYS . 44.6 mt-10 -62.79 -43.28 99.22 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.491 177.035 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.533 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . 38.7 t -54.65 -54.07 46.52 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 120.768 0.318 . . . . 0.0 111.428 178.456 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -56.73 -42.83 79.9 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.212 0.529 . . . . 0.0 110.844 175.182 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 33.5 ttt180 -56.57 -45.91 81.03 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.712 -179.235 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.603 ' HD3' ' O ' ' A' ' 12' ' ' GLU . 5.0 mptp? -66.52 -55.64 14.6 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 178.483 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -64.04 -28.37 69.75 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -178.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.08 -54.15 45.39 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.986 0.422 . . . . 0.0 111.333 177.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 29.1 pt -80.81 4.56 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 CA-C-N 116.147 -0.478 . . . . 0.0 112.026 -178.419 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -61.83 -36.39 81.04 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -175.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -125.89 0.1 7.75 Favored Glycine 0 N--CA 1.465 0.58 0 C-N-CA 120.852 -0.689 . . . . 0.0 113.079 -179.183 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -155.43 89.89 2.95 Favored Pre-proline 0 CA--C 1.542 0.653 0 CA-C-O 121.192 0.52 . . . . 0.0 111.006 -178.273 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -52.23 -29.71 38.97 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.086 2.524 . . . . 0.0 113.965 -177.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -80.41 3.83 20.03 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.083 0.468 . . . . 0.0 111.654 -176.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.409 ' HB1' ' O ' ' A' ' 29' ' ' GLU . . . -63.9 -31.8 73.1 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.71 170.04 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 30.6 t 58.69 20.12 7.48 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.499 176.105 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 70.25 11.82 68.15 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.793 -176.599 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -93.44 -38.31 11.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.231 0.539 . . . . 0.0 110.834 177.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.453 ' HB3' ' CG2' ' A' ' 69' ' ' VAL . 39.3 mt-10 -131.53 154.24 49.0 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.425 -172.706 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 52.1 ttm -137.88 136.31 36.98 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.809 0.338 . . . . 0.0 111.176 177.253 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.537 ' HA ' HG12 ' A' ' 69' ' ' VAL . 10.8 p30 -89.73 166.44 13.57 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.134 0.492 . . . . 0.0 111.916 -179.492 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.62 -21.86 69.34 Favored Glycine 0 CA--C 1.531 1.046 0 CA-C-N 116.024 -0.535 . . . . 0.0 114.283 -177.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.434 ' HB3' ' OD1' ' A' ' 31' ' ' ASN . 62.8 tttp -74.22 -52.43 12.42 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 117.413 0.607 . . . . 0.0 111.151 179.305 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -63.67 -38.36 90.82 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.811 0.338 . . . . 0.0 110.687 176.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.439 ' CD1' ' HB2' ' A' ' 59' ' ' PHE . 43.3 t-105 -60.24 -38.78 84.5 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.425 174.585 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.21 -45.45 93.14 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.482 177.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -74.13 -32.72 63.29 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 120.866 -0.334 . . . . 0.0 111.102 176.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.7 tt -51.33 -51.35 55.19 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.035 0.445 . . . . 0.0 110.399 177.604 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 75.0 m -69.13 -49.94 52.42 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.11 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -64.7 -47.55 77.94 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 112.041 0.385 . . . . 0.0 112.041 -176.431 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -64.88 -34.64 78.87 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 121.033 0.444 . . . . 0.0 110.956 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.809 ' HA ' ' HE2' ' A' ' 106' ' ' LYS . 68.5 m -90.07 1.61 56.16 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.352 174.408 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 52.1 mttm 53.07 34.39 17.08 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 176.561 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.616 ' HA ' HH11 ' A' ' 86' ' ' ARG . 49.0 t -64.89 -37.58 80.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 121.566 0.698 . . . . 0.0 109.556 167.795 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -98.83 51.36 0.97 Allowed 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.51 173.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -64.99 -27.92 69.16 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 116.072 -0.513 . . . . 0.0 112.023 -175.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 138.2 -62.51 0.57 Allowed Glycine 0 CA--C 1.527 0.823 0 C-N-CA 121.046 -0.597 . . . . 0.0 113.497 -178.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.677 ' HD2' ' H ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -71.19 20.03 0.05 Allowed 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -175.653 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 49.2 m -153.71 -64.58 0.14 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.214 0.531 . . . . 0.0 110.887 176.419 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.58 HG11 HD22 ' A' ' 82' ' ' LEU . 58.8 t -121.18 151.92 24.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.863 -179.768 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 71.4 p -118.59 154.32 32.82 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 122.343 0.257 . . . . 0.0 111.121 177.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -52.18 -41.64 54.1 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 121.398 -0.429 . . . . 0.0 113.349 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.412 ' O ' HG12 ' A' ' 57' ' ' ILE . 63.0 m -55.84 -49.31 73.65 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.097 0.475 . . . . 0.0 110.834 176.004 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.4 ' O ' HG23 ' A' ' 58' ' ' VAL . 24.6 t70 -62.01 -37.33 84.47 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.928 178.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 70.0 t -57.34 -36.3 52.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.85 176.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -69.27 -43.91 72.95 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 122.01 0.91 . . . . 0.0 109.583 178.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.412 HG12 ' O ' ' A' ' 53' ' ' THR . 7.9 mm -62.22 -45.53 98.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-N 114.584 -1.189 . . . . 0.0 111.621 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.478 ' O ' HG12 ' A' ' 62' ' ' VAL . 73.9 t -56.91 -47.82 82.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.525 177.051 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.439 ' HB2' ' CD1' ' A' ' 35' ' ' TRP . 80.0 t80 -50.85 -51.05 55.03 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.026 0.441 . . . . 0.0 111.183 177.657 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 29.2 t -71.01 -29.34 65.26 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.572 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -64.78 -36.95 85.96 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.536 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.508 HG21 ' HB2' ' A' ' 77' ' ' LYS . 3.7 p -94.93 -22.14 5.49 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 178.328 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -56.45 134.79 54.2 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -67.96 83.49 0.17 Allowed Glycine 0 CA--C 1.532 1.113 0 C-N-CA 121.333 -0.461 . . . . 0.0 113.816 176.604 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 61.9 mttp 53.13 -90.47 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 175.418 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 36.5 t -128.22 29.62 5.33 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.983 0.42 . . . . 0.0 111.212 -174.386 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -73.97 5.76 3.96 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 179.287 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 44.5 mtp180 68.36 -64.48 0.3 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.531 0.733 . . . . 0.0 112.125 -176.001 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.537 HG12 ' HA ' ' A' ' 31' ' ' ASN . 24.4 m -117.92 170.04 7.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.134 -172.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.417 ' HB ' ' HB2' ' A' ' 74' ' ' GLU . 39.4 pt -109.75 152.79 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.293 178.073 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -92.36 178.45 5.83 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.045 0.45 . . . . 0.0 111.381 175.395 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.5 ' O ' ' HB3' ' A' ' 75' ' ' PHE . 75.5 t80 -58.45 -41.87 86.09 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -174.823 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -70.51 -34.05 71.88 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.993 -0.442 . . . . 0.0 111.384 -178.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.417 ' HB2' ' HB ' ' A' ' 70' ' ' ILE . 52.3 mt-10 -68.9 -34.29 75.18 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.434 0.635 . . . . 0.0 110.012 174.765 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.5 ' HB3' ' O ' ' A' ' 72' ' ' TYR . 61.1 t80 -58.22 -43.03 87.52 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.823 170.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.481 ' HG3' ' O ' ' A' ' 72' ' ' TYR . 47.0 mtpt -60.03 -37.86 81.02 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.743 0.306 . . . . 0.0 111.021 176.042 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.508 ' HB2' HG21 ' A' ' 62' ' ' VAL . 94.6 mttt -65.0 -38.45 91.01 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.159 0.504 . . . . 0.0 110.89 177.424 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.98 -39.73 93.91 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.058 176.442 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 84.2 mt -61.36 -49.78 75.55 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.832 175.512 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -51.56 -44.39 62.71 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.2 0.524 . . . . 0.0 111.605 175.132 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -60.53 -63.7 1.21 Allowed 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.511 178.006 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.58 HD22 HG11 ' A' ' 50' ' ' VAL . 75.1 mt -58.71 -38.18 77.76 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -178.077 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.4 ' HB1' ' HB1' ' A' ' 95' ' ' ALA . . . -61.78 -47.74 83.8 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.607 0.241 . . . . 0.0 111.546 178.598 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 50.5 p -65.84 -19.56 65.93 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 178.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -81.28 -38.41 26.89 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 120.774 0.321 . . . . 0.0 111.444 172.183 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.616 HH11 ' HA ' ' A' ' 44' ' ' VAL . 36.7 mtp180 -79.28 -58.73 3.07 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.407 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -98.3 -164.46 1.14 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.393 -173.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -62.71 119.58 9.56 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -178.172 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -72.34 61.56 1.47 Allowed Glycine 0 CA--C 1.528 0.901 0 C-N-CA 120.902 -0.666 . . . . 0.0 111.555 171.332 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -163.29 -50.68 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.93 0.395 . . . . 0.0 111.099 -169.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 48.4 t -94.45 120.95 35.47 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.611 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -75.82 -60.77 2.17 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -178.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -61.76 -36.74 81.9 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -174.445 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -62.21 -60.15 3.99 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.088 0.471 . . . . 0.0 111.428 177.04 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.4 ' HB1' ' HB1' ' A' ' 83' ' ' ALA . . . -58.07 -42.39 85.43 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.913 -178.384 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -70.52 -40.37 73.52 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.412 -177.465 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -62.79 -53.52 53.04 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.125 0.488 . . . . 0.0 110.354 177.474 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -55.94 -52.54 63.77 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.644 -178.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 14.4 tt -60.92 -39.84 83.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 O-C-N 122.115 -0.366 . . . . 0.0 111.23 -179.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 95.9 m -70.56 -30.24 66.91 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.829 0.347 . . . . 0.0 111.042 176.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -64.42 -30.27 71.31 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.231 0.539 . . . . 0.0 110.762 178.413 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 82.8 mt -77.82 -18.42 56.35 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 177.413 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.464 HG13 ' SG ' ' A' ' 42' ' ' CYS . 41.3 t -114.56 -54.54 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -172.03 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.533 ' HA ' ' HB2' ' A' ' 13' ' ' SER . . . -52.12 112.08 0.73 Allowed 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -172.722 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 81.98 -2.99 82.24 Favored Glycine 0 CA--C 1.527 0.814 0 CA-C-N 115.908 -0.587 . . . . 0.0 114.463 173.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.809 ' HE2' ' HA ' ' A' ' 42' ' ' CYS . 22.1 ttpp -70.64 -28.05 64.52 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 117.602 0.701 . . . . 0.0 112.22 -178.454 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.521 ' HG2' ' O ' ' A' ' 106' ' ' LYS . 1.5 pt-20 72.7 155.46 0.16 Allowed Pre-proline 0 N--CA 1.481 1.079 0 C-N-CA 124.049 0.94 . . . . 0.0 111.904 -178.581 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -73.08 113.04 3.67 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 122.808 2.338 . . . . 0.0 111.628 174.463 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.62 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -174.411 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.2 tp . . . . . 0 CA--C 1.547 0.828 0 CA-C-O 121.225 0.535 . . . . 0.0 111.255 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -49.22 -41.46 37.36 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -175.123 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.84 -36.59 80.64 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 121.03 -0.605 . . . . 0.0 113.51 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.589 HD13 ' HB2' ' A' ' 104' ' ' ALA . 24.7 tp -78.24 -39.99 38.59 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 122.46 -0.435 . . . . 0.0 110.868 -179.37 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.584 ' HB3' ' NH2' ' A' ' 15' ' ' ARG . 45.3 mt-10 -55.77 -42.26 75.22 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.428 0.632 . . . . 0.0 110.657 173.665 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.481 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 8.7 tp10 -57.13 -55.57 33.08 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.389 177.721 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.429 ' HB3' ' O ' ' A' ' 108' ' ' PRO . 75.0 m -47.06 -51.23 18.06 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.324 174.132 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.413 ' N ' ' HB3' ' A' ' 109' ' ' ALA . 62.4 t80 -51.32 -46.35 62.56 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.696 -0.627 . . . . 0.0 111.196 -178.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.584 ' NH2' ' HB3' ' A' ' 11' ' ' GLU . 0.5 OUTLIER -70.02 -46.15 65.69 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 111.849 0.315 . . . . 0.0 111.849 177.838 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.524 ' O ' ' HB2' ' A' ' 20' ' ' HIS . 75.8 mmtt -53.99 -42.78 69.41 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.164 0.507 . . . . 0.0 110.854 178.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.624 ' CD1' ' HA ' ' A' ' 108' ' ' PRO . 0.2 OUTLIER -73.58 -34.39 65.09 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.859 -177.114 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.672 ' HA ' ' SD ' ' A' ' 30' ' ' MET . . . -66.98 -58.13 5.54 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.155 0.502 . . . . 0.0 112.048 -177.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 30.7 pt -80.49 -0.09 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 121.432 0.634 . . . . 0.0 111.052 -178.576 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.524 ' HB2' ' O ' ' A' ' 16' ' ' LYS . 37.2 t-80 -52.16 -45.59 65.11 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.316 -0.856 . . . . 0.0 112.289 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -112.14 10.03 26.94 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.771 -0.728 . . . . 0.0 114.516 -173.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -157.23 127.31 3.34 Favored Pre-proline 0 CA--C 1.545 0.78 0 CA-C-N 117.628 0.714 . . . . 0.0 111.438 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.54 -26.65 13.8 Favored 'Trans proline' 0 CA--C 1.544 0.992 0 C-N-CA 122.754 2.303 . . . . 0.0 113.611 -178.349 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -96.3 0.98 51.59 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -176.201 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.73 134.25 51.37 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 120.832 0.349 . . . . 0.0 111.846 178.477 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.4 t -57.43 -34.46 68.96 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.474 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.72 15.1 76.45 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 121.246 -0.502 . . . . 0.0 113.126 177.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 -124.85 -26.15 3.81 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.199 0.523 . . . . 0.0 110.987 178.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -122.81 128.25 50.19 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.694 -178.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.672 ' SD ' ' HA ' ' A' ' 18' ' ' ALA . 10.9 tpp -114.08 152.29 31.28 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -176.3 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.522 ' ND2' ' HB2' ' A' ' 33' ' ' LYS . 13.7 p-10 -97.27 164.4 12.49 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -179.617 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.75 -29.03 69.15 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-N 116.069 -0.514 . . . . 0.0 113.959 -179.087 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.522 ' HB2' ' ND2' ' A' ' 31' ' ' ASN . 5.2 mmmm -51.75 -45.05 63.54 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 175.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.516 ' ND2' ' SD ' ' A' ' 30' ' ' MET . 4.5 m-20 -72.94 -25.71 61.13 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.777 -179.158 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 40.0 t-105 -66.88 -45.0 79.42 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.042 0.448 . . . . 0.0 111.0 175.291 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.2 -47.76 84.65 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.233 0.539 . . . . 0.0 110.945 175.303 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -63.83 -32.79 74.42 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.689 177.094 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.597 HD11 ' HA ' ' A' ' 109' ' ' ALA . 2.6 tt -58.16 -55.22 37.82 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.221 0.534 . . . . 0.0 110.263 179.06 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.58 ' SG ' ' HB2' ' A' ' 45' ' ' ALA . 45.9 t -58.86 -43.95 90.95 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.529 -179.417 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 28.9 ttpp -66.78 -41.51 87.53 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 120.878 0.37 . . . . 0.0 111.562 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -63.0 -48.59 78.17 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.274 0.559 . . . . 0.0 110.822 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.44 ' SG ' HG22 ' A' ' 103' ' ' VAL . 83.9 m -82.32 -3.28 55.04 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.675 179.329 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt 59.92 28.3 17.78 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.199 0.523 . . . . 0.0 112.02 175.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 47.9 t -67.36 -33.35 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.695 174.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.58 ' HB2' ' SG ' ' A' ' 39' ' ' CYS . . . -61.95 86.77 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.395 0.616 . . . . 0.0 111.079 175.651 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -63.69 -47.45 81.12 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.473 -178.318 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 125.13 -33.51 3.65 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 121.126 -0.559 . . . . 0.0 113.186 -178.447 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.5 pttt -129.32 -28.64 2.31 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 177.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 90.9 p -88.55 -39.82 13.86 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 121.055 0.455 . . . . 0.0 110.377 171.481 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 91.2 t -132.99 116.62 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.776 174.007 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 27.1 p -111.8 175.72 5.31 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.874 0.369 . . . . 0.0 111.088 178.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -58.92 -29.11 64.41 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.105 172.677 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.64 ' O ' HG13 ' A' ' 57' ' ' ILE . 44.3 m -61.51 -57.72 11.0 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 110.318 -0.253 . . . . 0.0 110.318 174.689 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -48.61 -42.51 34.26 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.96 0.41 . . . . 0.0 111.618 178.238 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 95.5 t -56.35 -45.71 81.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.625 177.202 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -71.79 -32.76 67.96 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 120.837 0.351 . . . . 0.0 111.275 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.64 HG13 ' O ' ' A' ' 53' ' ' THR . 9.3 mt -66.23 -54.44 26.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.721 178.642 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.442 HG11 ' CD1' ' A' ' 82' ' ' LEU . 93.9 t -54.2 -47.37 67.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 120.805 0.336 . . . . 0.0 111.68 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.513 ' O ' ' HG2' ' A' ' 63' ' ' LYS . 55.2 t80 -56.99 -38.28 72.83 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 120.803 0.335 . . . . 0.0 110.638 178.277 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 37.5 m -81.33 -18.78 44.51 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 178.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.435 ' HG2' ' O ' ' A' ' 57' ' ' ILE . 32.4 mmtp -73.26 -43.88 60.34 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 179.05 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.51 HG11 ' HB2' ' A' ' 78' ' ' ALA . 7.1 m -70.03 -45.0 77.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.513 ' HG2' ' O ' ' A' ' 59' ' ' PHE . 22.2 ptmt -81.2 166.34 20.69 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.369 0.604 . . . . 0.0 112.509 -176.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -104.18 -94.36 2.32 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.165 174.051 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -131.84 -57.56 0.98 Allowed 'General case' 0 N--CA 1.473 0.706 0 O-C-N 122.426 -0.455 . . . . 0.0 111.832 176.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 37.8 m -77.45 65.27 2.96 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -176.084 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -160.79 111.86 1.82 Allowed 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.977 0.418 . . . . 0.0 111.676 179.44 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.86 -26.9 17.44 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.794 0.33 . . . . 0.0 110.822 175.682 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 26.0 m -120.57 174.07 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 121.102 0.477 . . . . 0.0 111.955 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.9 pp -135.39 165.76 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -172.368 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.6 ' OD1' ' HB2' ' A' ' 74' ' ' GLU . 24.7 p-10 -111.79 -179.82 3.81 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.231 -178.365 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.622 ' O ' ' HB3' ' A' ' 75' ' ' PHE . 65.9 t80 -85.84 -46.18 10.87 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -176.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -62.05 -31.5 71.92 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.462 -0.774 . . . . 0.0 111.472 -175.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.6 ' HB2' ' OD1' ' A' ' 71' ' ' ASN . 0.4 OUTLIER -73.12 -36.27 66.68 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.751 -0.204 . . . . 0.0 111.134 171.822 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.622 ' HB3' ' O ' ' A' ' 72' ' ' TYR . 41.7 t80 -46.09 -41.95 12.95 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 172.378 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -57.84 -41.74 82.95 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 121.238 0.542 . . . . 0.0 111.658 174.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -72.09 -43.6 64.54 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 121.13 0.49 . . . . 0.0 111.082 -179.161 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.51 ' HB2' HG11 ' A' ' 62' ' ' VAL . . . -60.92 -44.61 96.96 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.843 177.21 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.468 HD11 ' CZ ' ' A' ' 75' ' ' PHE . 34.1 mt -52.32 -46.0 65.83 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 122.079 -0.388 . . . . 0.0 111.61 172.599 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -54.15 -38.25 65.3 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 121.094 0.473 . . . . 0.0 110.94 177.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.439 ' HB3' ' O ' ' A' ' 78' ' ' ALA . 16.6 tp10 -59.47 -51.23 70.76 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.995 174.779 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.442 ' CD1' HG11 ' A' ' 58' ' ' VAL . 8.8 mp -60.63 -47.62 85.42 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 111.841 0.312 . . . . 0.0 111.841 178.386 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.36 -46.28 69.51 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.851 0.358 . . . . 0.0 111.867 -178.345 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 69.2 p -67.55 -34.59 77.37 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.19 -0.459 . . . . 0.0 112.115 179.584 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.452 ' HZ2' ' HB3' ' A' ' 85' ' ' LYS . 8.3 mtpm? -80.11 -28.55 38.98 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 179.177 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -85.85 -55.26 4.05 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.07 0.462 . . . . 0.0 110.73 -176.319 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -96.75 50.52 1.12 Allowed 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.45 -177.033 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -59.64 99.82 0.07 Allowed 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.304 0.573 . . . . 0.0 111.483 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 136.14 -30.61 2.71 Favored Glycine 0 CA--C 1.521 0.43 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.774 -176.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -86.01 144.04 27.8 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 122.796 0.439 . . . . 0.0 110.585 176.444 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 43.6 t -59.07 134.78 57.29 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 122.412 -0.18 . . . . 0.0 111.345 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -52.2 -36.69 52.75 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -174.395 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -66.03 -51.61 56.7 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 120.869 0.366 . . . . 0.0 111.242 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -64.39 -37.21 86.71 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 121.072 0.463 . . . . 0.0 111.366 176.173 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.69 -43.97 91.81 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.994 0.425 . . . . 0.0 111.561 178.595 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -62.81 -39.28 93.81 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.114 0.483 . . . . 0.0 110.758 177.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -60.16 -51.62 68.81 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.534 176.343 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.82 -51.87 67.46 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.247 -178.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.3 tt -58.73 -42.97 86.74 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 CA-C-O 120.808 0.337 . . . . 0.0 111.119 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 74.7 m -68.96 -28.72 66.88 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.727 0.299 . . . . 0.0 111.267 177.387 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -64.41 -33.0 74.85 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.07 0.462 . . . . 0.0 110.989 178.072 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 81.0 mt -77.12 -20.41 55.67 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 116.176 -0.465 . . . . 0.0 112.062 178.082 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.44 HG22 ' SG ' ' A' ' 42' ' ' CYS . 60.2 t -105.91 -61.5 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -173.513 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.589 ' HB2' HD13 ' A' ' 10' ' ' LEU . . . -57.73 147.9 26.46 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -175.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 98.01 -35.9 4.28 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 121.157 -0.544 . . . . 0.0 113.265 177.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -79.04 -77.33 0.17 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 117.029 0.414 . . . . 0.0 111.525 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.524 ' CG ' ' HD3' ' A' ' 108' ' ' PRO . 11.1 pt-20 -176.29 -33.65 0.0 OUTLIER Pre-proline 0 CA--C 1.553 1.088 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 -179.367 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.624 ' HA ' ' CD1' ' A' ' 17' ' ' PHE . 50.6 Cg_exo -68.08 142.77 57.29 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 122.553 2.169 . . . . 0.0 115.646 176.613 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.597 ' HA ' HD11 ' A' ' 38' ' ' LEU . . . . . . . . 0 N--CA 1.489 1.501 0 CA-C-N 115.054 -0.975 . . . . 0.0 112.107 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.553 HD11 ' HB3' ' A' ' 100' ' ' CYS . 30.3 pt . . . . . 0 N--CA 1.472 0.642 0 CA-C-O 121.226 0.536 . . . . 0.0 111.681 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.77 -31.92 70.12 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.909 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.8 -31.76 64.81 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 121.215 -0.517 . . . . 0.0 113.028 177.107 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 36.8 tp -70.89 -43.77 67.67 Favored 'General case' 0 N--CA 1.467 0.383 0 O-C-N 122.73 -0.277 . . . . 0.0 110.773 178.706 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.2 tm-20 -57.78 -46.87 83.99 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.273 175.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.419 ' O ' ' HB2' ' A' ' 16' ' ' LYS . 33.5 tt0 -57.24 -49.61 75.5 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.575 177.504 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 56.9 m -63.36 -50.02 71.57 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -178.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -54.88 -48.53 72.85 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.216 0.531 . . . . 0.0 110.558 176.579 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.484 ' HG3' ' HA3' ' A' ' 27' ' ' GLY . 23.2 ttt180 -63.7 -37.95 89.27 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.084 178.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.419 ' HB2' ' O ' ' A' ' 12' ' ' GLU . 32.6 ttmt -59.32 -42.12 90.65 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.041 -178.802 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -79.9 -32.2 40.25 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 174.532 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.52 -34.35 75.38 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -178.149 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 27.9 pt -95.7 14.22 3.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-O 120.98 0.419 . . . . 0.0 111.685 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 75.1 t60 -64.75 -16.81 63.49 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -176.467 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -105.35 -38.57 2.42 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 120.959 -0.639 . . . . 0.0 113.396 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -162.18 148.98 11.05 Favored Pre-proline 0 CA--C 1.541 0.618 0 O-C-N 122.688 -0.301 . . . . 0.0 111.652 -175.368 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.12 -2.9 12.74 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.651 2.234 . . . . 0.0 113.401 -178.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -85.97 -18.74 31.78 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.068 0.461 . . . . 0.0 110.862 178.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -76.54 54.19 0.92 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.353 170.315 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 38.0 t -25.58 -53.43 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 -170.528 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.484 ' HA3' ' HG3' ' A' ' 15' ' ' ARG . . . 147.95 58.93 0.01 OUTLIER Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.629 -179.408 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 19.4 tm0? -134.95 -19.17 1.79 Allowed 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 120.751 0.31 . . . . 0.0 111.5 -178.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -152.72 151.87 31.03 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -171.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.441 ' O ' HD13 ' A' ' 70' ' ' ILE . 42.8 ttm -136.58 149.63 48.16 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.61 -179.569 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -97.36 168.35 10.46 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.119 0.485 . . . . 0.0 111.948 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.08 -32.77 81.56 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-N 116.185 -0.461 . . . . 0.0 114.181 -177.053 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -62.51 -52.26 64.16 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 117.053 0.426 . . . . 0.0 111.732 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -69.13 -40.3 78.35 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.594 0.235 . . . . 0.0 110.999 177.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.498 ' NE1' ' HB2' ' A' ' 59' ' ' PHE . 24.9 t-105 -56.36 -42.27 77.52 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.113 0.482 . . . . 0.0 111.747 175.34 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.07 -51.93 65.97 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.572 179.028 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -69.32 -27.41 65.35 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.19 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.0 tt -57.38 -56.91 15.77 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.058 0.456 . . . . 0.0 110.198 176.129 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 86.3 m -60.49 -47.83 84.4 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.997 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -67.48 -41.71 84.15 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -176.26 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.407 ' OD2' ' NZ ' ' A' ' 106' ' ' LYS . 37.5 t70 -77.51 -29.96 52.7 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 120.741 0.305 . . . . 0.0 111.623 -178.641 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 62.2 m -90.7 -0.44 57.7 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 120.697 0.284 . . . . 0.0 111.429 176.431 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt 71.47 22.06 4.31 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 173.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 50.7 t -68.02 -28.45 41.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 CA-C-O 121.144 0.497 . . . . 0.0 110.99 174.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -89.65 121.03 31.45 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.254 174.366 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -79.48 -66.19 0.9 Allowed 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -173.545 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.432 ' O ' ' HB2' ' A' ' 48' ' ' LYS . . . 130.34 119.46 2.13 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 -168.653 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.432 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 75.2 mmtt 80.74 -15.94 0.7 Allowed 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.646 0.779 . . . . 0.0 111.936 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 42.4 t -122.03 -83.23 0.66 Allowed 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 173.246 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 84.1 t -87.56 111.7 22.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 120.894 0.378 . . . . 0.0 110.617 172.377 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.442 ' O ' HG23 ' A' ' 55' ' ' VAL . 72.8 p -125.58 -179.93 4.86 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.935 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -50.78 -35.44 31.11 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 121.031 -0.604 . . . . 0.0 113.195 178.496 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.578 ' O ' HG13 ' A' ' 57' ' ' ILE . 27.6 m -60.8 -58.41 8.57 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.738 0.304 . . . . 0.0 110.797 176.62 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -53.34 -41.45 65.78 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.976 179.193 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 51' ' ' THR . 93.6 t -56.91 -39.51 65.67 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.74 177.549 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -73.82 -37.84 64.75 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.292 0.568 . . . . 0.0 110.4 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.578 HG13 ' O ' ' A' ' 53' ' ' THR . 11.4 mt -60.33 -48.42 88.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.943 178.603 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 89.7 t -62.48 -43.69 98.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.64 177.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.498 ' HB2' ' NE1' ' A' ' 35' ' ' TRP . 86.7 t80 -50.23 -47.66 54.9 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.109 0.481 . . . . 0.0 111.938 178.368 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 35.8 t -82.04 -16.7 49.29 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.06 0.457 . . . . 0.0 111.614 -179.167 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -76.09 -38.22 57.24 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.95 -179.114 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.1 m -87.07 -5.92 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -176.029 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.6 pttp -119.88 -176.92 3.28 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.09 0.472 . . . . 0.0 111.692 -178.534 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -105.1 -178.03 24.36 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-N 116.291 -0.413 . . . . 0.0 113.424 177.638 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -75.49 -39.79 58.1 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -178.564 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 43.4 t -66.47 -35.95 81.54 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 120.917 0.389 . . . . 0.0 111.868 -178.14 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -93.4 122.44 35.82 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 120.967 0.413 . . . . 0.0 111.327 178.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 70.7 mtp180 -94.25 5.64 51.14 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.112 0.482 . . . . 0.0 110.683 175.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.9 m -129.63 159.91 41.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.921 179.161 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.502 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -114.4 150.7 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-O 120.967 0.413 . . . . 0.0 111.297 175.946 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.413 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 2.9 p-10 -104.78 172.25 6.89 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.296 178.517 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -46.49 -54.18 9.78 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -169.021 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.403 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 0.7 OUTLIER -64.46 -44.86 89.76 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 120.983 0.421 . . . . 0.0 111.347 -176.035 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -65.71 -33.96 77.1 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.203 0.525 . . . . 0.0 110.838 179.378 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -57.62 -44.09 85.25 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.6 172.527 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.403 ' HE2' ' HA ' ' A' ' 73' ' ' GLU . 52.8 mtmt -69.08 -33.7 73.94 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.231 176.649 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -60.54 -37.92 82.79 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.251 0.548 . . . . 0.0 110.292 173.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.08 -41.91 97.15 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.745 172.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 88.6 mt -62.31 -33.7 75.19 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.398 175.571 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -61.07 -49.64 76.52 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 120.735 0.302 . . . . 0.0 110.833 175.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -55.56 -58.01 9.54 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.111 0.482 . . . . 0.0 111.085 174.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 94.0 mt -56.71 -44.46 81.6 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.036 -179.129 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.69 -45.2 87.64 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -179.189 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 81.8 p -72.44 -12.29 61.04 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -178.697 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -93.72 -47.45 6.78 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 120.685 0.279 . . . . 0.0 111.502 172.169 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 76.7 mtp180 -70.63 -49.87 42.88 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 121.176 0.512 . . . . 0.0 111.85 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -106.55 38.59 2.02 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.881 -177.559 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -57.87 90.97 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.97 -178.507 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -160.8 44.81 0.41 Allowed Glycine 0 CA--C 1.526 0.772 0 C-N-CA 121.076 -0.583 . . . . 0.0 113.446 179.067 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 60.9 mttm 70.71 -60.68 0.5 Allowed 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 177.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 25.6 m -56.78 87.91 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -175.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -66.36 -43.48 85.88 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.703 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -54.03 -61.07 2.54 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.836 0.35 . . . . 0.0 110.886 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -56.72 -41.6 77.74 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.691 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.24 -43.5 92.39 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.924 0.393 . . . . 0.0 111.282 177.437 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -68.69 -49.06 62.01 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.963 -179.441 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.532 ' O ' ' HG3' ' A' ' 101' ' ' GLN . 1.5 m-20 -55.5 -44.54 76.66 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 111.545 0.202 . . . . 0.0 111.545 175.772 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.67 -57.55 11.55 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.019 0.437 . . . . 0.0 112.108 -179.193 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.0 tt -57.62 -29.74 35.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-O 121.245 0.545 . . . . 0.0 110.474 178.132 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' CYS . . . . . 0.553 ' HB3' HD11 ' A' ' 7' ' ' ILE . 90.6 m -82.26 -18.98 40.53 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.963 175.503 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.532 ' HG3' ' O ' ' A' ' 97' ' ' ASP . 73.2 mt-30 -64.91 -33.94 77.23 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 121.669 -0.644 . . . . 0.0 109.853 171.259 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 81.1 mt -75.58 -11.1 59.95 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.557 177.183 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.411 ' O ' ' HB3' ' A' ' 106' ' ' LYS . 64.5 t -121.48 -51.16 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -173.276 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -49.45 113.8 0.9 Allowed 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -175.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.39 -31.25 5.85 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 121.401 -0.428 . . . . 0.0 113.293 -179.264 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.411 ' HB3' ' O ' ' A' ' 103' ' ' VAL . 26.3 tptp -47.02 133.21 11.52 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.571 0.748 . . . . 0.0 112.602 -178.429 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -83.48 155.82 65.82 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.319 178.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -79.83 139.34 13.82 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.589 2.193 . . . . 0.0 113.17 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.509 0 CA-C-O 121.214 0.531 . . . . 0.0 111.301 178.913 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.474 ' N ' HD12 ' A' ' 7' ' ' ILE . 2.3 mp . . . . . 0 CA--C 1.543 0.683 0 CA-C-O 121.264 0.554 . . . . 0.0 110.797 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.41 -35.65 72.36 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.329 -177.23 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -56.66 -31.4 60.47 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 121.131 -0.557 . . . . 0.0 113.131 179.215 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.453 HD11 ' HE2' ' A' ' 75' ' ' PHE . 54.7 tp -70.45 -53.73 15.22 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 120.776 0.322 . . . . 0.0 111.314 178.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -63.36 -39.01 93.36 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 122.185 -0.322 . . . . 0.0 111.533 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -57.79 -56.52 20.92 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.831 0.348 . . . . 0.0 111.095 175.167 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.707 ' HB3' ' HB2' ' A' ' 107' ' ' GLU . 65.7 m -67.79 -44.34 77.61 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -176.625 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -50.01 -51.94 38.0 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 121.187 0.518 . . . . 0.0 111.145 171.716 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.418 HH11 ' HD3' ' A' ' 15' ' ' ARG . 32.1 ttt180 -60.55 -44.23 96.35 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.832 179.542 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.569 ' HD3' HD11 ' A' ' 19' ' ' ILE . 0.1 OUTLIER -68.85 -27.89 66.22 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.844 -179.441 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -78.52 -33.12 48.25 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.177 0.513 . . . . 0.0 110.199 177.775 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.38 -38.35 77.98 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.447 177.246 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.569 HD11 ' HD3' ' A' ' 16' ' ' LYS . 27.0 pt -94.11 14.45 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 120.877 0.37 . . . . 0.0 111.039 178.236 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -52.85 97.3 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.101 0.477 . . . . 0.0 111.477 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 120.73 -36.2 3.44 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.656 -176.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.445 ' O ' ' HB ' ' A' ' 19' ' ' ILE . 11.7 m-20 -121.54 91.4 48.41 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 122.76 0.424 . . . . 0.0 111.946 -178.413 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -71.35 -2.87 11.9 Favored 'Trans proline' 0 CA--C 1.545 1.026 0 C-N-CA 122.517 2.145 . . . . 0.0 113.549 -178.223 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 8.7 mtpm? -88.35 -7.0 57.38 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -178.582 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.414 ' HB3' HG22 ' A' ' 19' ' ' ILE . . . -93.73 157.57 16.09 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.615 0.245 . . . . 0.0 111.321 178.163 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 28.3 t -88.36 -19.16 27.02 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 120.989 0.423 . . . . 0.0 110.776 177.656 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.438 ' HA3' HG23 ' A' ' 19' ' ' ILE . . . 63.87 56.6 17.82 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 115.606 1.002 . . . . 0.0 115.606 170.693 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -96.57 -8.56 31.53 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.518 0.675 . . . . 0.0 109.793 169.78 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.583 ' HB3' HG21 ' A' ' 69' ' ' VAL . 50.9 mt-10 -113.08 111.61 22.42 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.432 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 42.3 ttm -98.86 133.32 43.32 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.146 0.498 . . . . 0.0 111.553 176.011 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.416 ' ND2' ' HB2' ' A' ' 33' ' ' LYS . 13.9 p-10 -86.86 156.92 19.67 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.531 179.664 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -58.25 -28.2 61.32 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-N 116.24 -0.437 . . . . 0.0 113.212 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.416 ' HB2' ' ND2' ' A' ' 31' ' ' ASN . 47.4 mmtm -57.7 -59.5 5.11 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.045 0.45 . . . . 0.0 111.336 176.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.403 ' O ' ' HB2' ' A' ' 38' ' ' LEU . 87.7 m-20 -64.66 -38.76 92.1 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.872 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 45.5 t-105 -56.17 -49.06 75.06 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 120.901 0.382 . . . . 0.0 111.798 177.4 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.04 -47.08 86.33 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.205 0.526 . . . . 0.0 111.751 178.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.455 ' HB3' ' NZ ' ' A' ' 37' ' ' LYS . 7.8 mtpm? -67.26 -29.98 69.74 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.336 179.33 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.403 ' HB2' ' O ' ' A' ' 34' ' ' ASN . 5.1 tt -62.3 -49.3 76.18 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.169 0.509 . . . . 0.0 110.081 177.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 78.9 m -58.53 -44.28 89.52 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.442 178.365 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -69.9 -33.66 72.48 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 120.992 0.425 . . . . 0.0 111.388 179.008 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -64.1 -38.66 91.88 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.418 0.628 . . . . 0.0 110.822 177.257 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.491 ' HA ' ' HE2' ' A' ' 106' ' ' LYS . 59.1 m -99.2 0.76 43.98 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.039 -177.812 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.432 ' N ' ' HD2' ' A' ' 43' ' ' LYS . 3.3 mptp? 59.2 31.28 21.1 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.337 176.26 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.455 HG11 ' HB3' ' A' ' 82' ' ' LEU . 32.5 t -70.3 -37.44 71.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-O 121.486 0.66 . . . . 0.0 109.39 170.098 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.19 85.46 6.8 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.505 169.249 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -169.76 78.68 0.1 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.785 -171.156 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -176.72 37.29 0.09 OUTLIER Glycine 0 CA--C 1.522 0.506 0 C-N-CA 120.708 -0.758 . . . . 0.0 113.434 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.1 mtpm? 50.23 14.67 0.16 Allowed 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 178.371 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.7 m -150.54 -60.08 0.19 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.885 0.374 . . . . 0.0 110.509 -175.496 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 41.0 t -68.29 90.36 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 172.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 49.2 p -129.0 -171.09 2.39 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.103 -178.165 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -48.04 -36.86 15.58 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 121.476 -0.392 . . . . 0.0 113.686 -178.347 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.58 ' O ' HG12 ' A' ' 57' ' ' ILE . 4.8 t -64.32 -55.85 18.49 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 122.334 -0.51 . . . . 0.0 111.358 178.37 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.414 ' N ' HG23 ' A' ' 53' ' ' THR . 12.9 t70 -62.7 -40.03 95.87 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.04 0.448 . . . . 0.0 110.994 -177.845 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 84.3 t -61.69 -31.03 49.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.417 176.772 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -82.03 -30.91 31.23 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.334 0.588 . . . . 0.0 109.55 179.095 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.58 HG12 ' O ' ' A' ' 53' ' ' THR . 10.4 mm -61.24 -52.38 62.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.9 174.233 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.8 t -58.53 -42.74 85.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 120.919 0.39 . . . . 0.0 110.945 176.218 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -57.82 -40.82 80.9 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.355 0.598 . . . . 0.0 110.869 175.142 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 37.3 m -82.59 -11.72 58.21 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.486 178.413 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.678 ' HA ' ' HE2' ' A' ' 61' ' ' LYS . 0.6 OUTLIER -76.95 -50.41 13.28 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.838 176.972 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 31.4 m -67.63 -25.94 34.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.548 175.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -69.34 104.98 2.4 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.829 174.528 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -91.15 -61.35 1.27 Allowed Glycine 0 CA--C 1.526 0.778 0 C-N-CA 121.081 -0.581 . . . . 0.0 113.299 -178.534 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 10.3 mtmp? -121.55 -152.63 0.52 Allowed 'General case' 0 CA--C 1.542 0.66 0 O-C-N 122.524 -0.398 . . . . 0.0 111.014 -178.6 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 39.3 t -62.72 91.19 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.425 0.631 . . . . 0.0 111.917 -176.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -160.12 108.51 1.7 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.771 178.492 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.7 ttm-85 -70.36 -44.64 67.71 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.349 0.595 . . . . 0.0 111.113 -177.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.583 HG21 ' HB3' ' A' ' 29' ' ' GLU . 27.6 m -95.64 170.92 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.385 -175.398 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 34.6 pt -121.22 149.63 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.394 176.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -99.46 171.4 7.97 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.93 0.395 . . . . 0.0 111.389 178.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -57.99 -35.49 71.3 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -176.292 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.5 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 39.5 mm-40 -61.39 -53.27 58.81 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.799 0.333 . . . . 0.0 111.499 178.66 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -65.97 -28.06 68.62 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.907 0.384 . . . . 0.0 110.939 178.008 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.453 ' HE2' HD11 ' A' ' 10' ' ' LEU . 88.5 t80 -60.7 -47.99 83.78 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.183 175.05 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.5 ' HE2' ' HA ' ' A' ' 73' ' ' GLU . 53.4 mtmt -58.01 -47.08 84.1 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.919 0.39 . . . . 0.0 110.782 176.325 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -56.75 -42.9 80.13 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.154 0.502 . . . . 0.0 111.249 175.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.21 -42.87 99.35 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.375 177.225 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 88.2 mt -58.32 -41.57 84.83 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.294 177.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -63.76 -36.6 84.41 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 120.88 0.372 . . . . 0.0 111.192 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -63.76 -61.06 2.55 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 120.634 0.254 . . . . 0.0 111.122 172.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.455 ' HB3' HG11 ' A' ' 44' ' ' VAL . 11.2 mp -50.71 -40.49 54.3 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.196 0.522 . . . . 0.0 111.851 179.001 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.96 -53.33 59.29 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.743 175.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 69.2 p -74.32 -10.4 59.55 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -86.96 -45.86 10.4 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.105 0.479 . . . . 0.0 111.414 174.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.4 -49.04 9.05 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.882 -176.494 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -82.61 -178.45 7.08 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.156 0.503 . . . . 0.0 111.068 179.322 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -93.96 142.02 27.85 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.848 177.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -76.19 56.33 3.21 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 121.356 -0.449 . . . . 0.0 114.177 -176.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 29.0 ttpp -83.59 -31.78 26.12 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.208 0.527 . . . . 0.0 110.323 175.103 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.529 ' HB3' ' HB3' ' A' ' 94' ' ' GLU . 30.8 t -162.37 126.16 3.06 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.812 178.587 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 50.7 tttm -69.31 -47.09 65.5 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.777 0.323 . . . . 0.0 111.811 -178.451 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -64.47 -40.9 96.57 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 120.78 0.324 . . . . 0.0 110.986 178.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.529 ' HB3' ' HB3' ' A' ' 91' ' ' SER . 34.5 tt0 -65.67 -43.48 89.2 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.803 0.335 . . . . 0.0 111.257 177.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.95 -35.52 73.28 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.885 0.374 . . . . 0.0 110.978 175.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -64.87 -42.66 94.64 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.864 176.08 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -64.69 -38.51 91.26 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 120.933 0.396 . . . . 0.0 110.972 176.265 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.59 -51.31 60.65 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.679 179.398 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 16.5 tt -62.6 -33.2 58.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-O 120.941 0.4 . . . . 0.0 110.343 177.028 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' CYS . . . . . 0.506 ' SG ' ' HB3' ' A' ' 104' ' ' ALA . 39.7 t -65.43 -34.12 77.55 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.82 0.343 . . . . 0.0 110.851 172.154 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -69.7 -22.32 63.42 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.506 178.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 80.4 mt -95.55 -36.61 11.21 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.059 0.457 . . . . 0.0 111.987 175.405 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 81.9 t -96.8 -65.69 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 112.554 0.575 . . . . 0.0 112.554 -174.157 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.506 ' HB3' ' SG ' ' A' ' 100' ' ' CYS . . . -51.38 109.38 0.34 Allowed 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -168.074 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 107.25 -38.09 3.5 Favored Glycine 0 CA--C 1.522 0.479 0 C-N-CA 121.174 -0.536 . . . . 0.0 112.849 178.671 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.491 ' HE2' ' HA ' ' A' ' 42' ' ' CYS . 14.7 ttpp -78.86 -63.37 1.43 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.836 0.35 . . . . 0.0 110.549 178.281 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.707 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 25.6 mt-10 29.72 -88.03 0.0 OUTLIER Pre-proline 0 CA--C 1.557 1.219 0 N-CA-C 115.161 1.541 . . . . 0.0 115.161 177.121 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.65 ' HD3' ' HB2' ' A' ' 107' ' ' GLU . 6.8 Cg_exo -74.22 79.22 2.45 Favored 'Trans proline' 0 C--N 1.367 1.552 0 CA-C-N 123.306 2.216 . . . . 0.0 112.004 177.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.763 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -177.067 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.7 mm . . . . . 0 CA--C 1.539 0.522 0 CA-C-O 120.745 0.307 . . . . 0.0 110.465 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 66.23 -68.41 0.13 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.166 0.586 . . . . 0.0 112.098 -178.454 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -51.15 -28.56 18.89 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 121.615 -0.326 . . . . 0.0 113.496 178.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 51.6 tp -64.56 -38.48 91.17 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 120.719 0.295 . . . . 0.0 111.052 176.298 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.615 ' O ' ' HD3' ' A' ' 15' ' ' ARG . 39.9 tt0 -67.09 -46.14 75.14 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 177.806 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.454 ' O ' ' HG3' ' A' ' 16' ' ' LYS . 1.1 mp0 -51.79 -46.22 64.13 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.744 0.307 . . . . 0.0 111.156 172.64 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 70.6 m -58.95 -41.68 88.04 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.684 -0.234 . . . . 0.0 111.253 176.308 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -58.29 -46.85 85.32 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.645 176.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.615 ' HD3' ' O ' ' A' ' 11' ' ' GLU . 1.8 mpt_? -54.93 -55.85 26.1 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.121 175.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.454 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 67.1 mttm -54.32 -45.14 72.56 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -176.037 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -69.75 -39.49 76.69 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 111.728 0.27 . . . . 0.0 111.728 176.394 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.69 -53.6 38.83 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -177.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.53 HG12 ' O ' ' A' ' 15' ' ' ARG . 25.8 pt -78.8 -1.84 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 -176.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -56.06 -33.98 65.51 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.082 0.467 . . . . 0.0 110.656 175.281 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.57 59.83 4.93 Favored Glycine 0 CA--C 1.522 0.516 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.838 175.295 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 68.57 124.05 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 123.199 0.6 . . . . 0.0 111.338 -173.7 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.522 ' HA ' ' HB ' ' A' ' 19' ' ' ILE . 81.8 Cg_exo -47.57 -30.62 12.45 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 123.145 2.564 . . . . 0.0 114.237 -178.463 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -75.35 3.33 9.25 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 178.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.36 -52.04 66.97 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 111.868 0.321 . . . . 0.0 111.868 179.123 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 99.7 p 177.74 -70.55 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.004 0.431 . . . . 0.0 111.563 -179.218 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 107.46 -26.08 19.44 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 111.925 -0.47 . . . . 0.0 111.925 -174.226 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -115.88 -15.91 11.2 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.028 0.531 . . . . 0.0 111.101 178.386 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.456 ' HB3' HG21 ' A' ' 69' ' ' VAL . 8.7 mm-40 -111.9 145.7 39.07 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.715 -176.198 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 53.1 ttm -133.87 135.29 43.59 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 120.556 0.217 . . . . 0.0 111.146 178.087 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 36.1 p30 -94.13 168.85 10.67 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.17 0.51 . . . . 0.0 112.277 -178.389 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.15 -27.6 70.81 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-N 116.033 -0.531 . . . . 0.0 113.768 -179.058 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -62.89 -58.94 5.66 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.39 0.614 . . . . 0.0 111.199 178.634 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -64.18 -35.83 82.09 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.164 178.145 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 50.3 t-105 -62.2 -42.92 99.73 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.625 175.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.11 -45.72 86.77 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 121.131 0.491 . . . . 0.0 111.309 177.348 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.4 mtpp -64.83 -45.04 87.83 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.298 175.32 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.3 tt -46.02 -43.88 14.71 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.134 0.492 . . . . 0.0 111.182 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 79.3 m -68.48 -46.4 69.8 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 120.979 0.418 . . . . 0.0 111.588 176.464 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -65.91 -52.86 46.29 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.785 0.326 . . . . 0.0 111.84 -177.029 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -55.27 -38.47 68.62 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 122.954 0.502 . . . . 0.0 111.257 176.803 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.687 ' SG ' ' HA ' ' A' ' 103' ' ' VAL . 83.4 m -85.94 -4.12 59.09 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 175.639 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.9 mtmm 52.76 41.3 31.56 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 178.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 57.9 t -78.34 -35.4 19.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 121.316 0.579 . . . . 0.0 110.32 171.121 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -102.56 79.22 1.79 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.637 178.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -60.35 -27.09 67.1 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.5 -29.33 12.75 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 121.196 -0.526 . . . . 0.0 111.977 -172.726 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -74.05 -61.65 1.78 Allowed 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 120.937 0.398 . . . . 0.0 110.9 176.435 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 69.0 p -90.05 -74.01 0.5 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.088 0.471 . . . . 0.0 110.506 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 89.0 t -89.19 135.27 26.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.365 174.618 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 43.6 p -124.05 173.53 8.21 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 120.883 0.373 . . . . 0.0 111.538 -177.53 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -54.84 -34.29 56.95 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 121.24 -0.505 . . . . 0.0 112.753 177.158 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.655 ' O ' HG13 ' A' ' 57' ' ' ILE . 89.3 m -53.61 -57.56 10.33 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 122.382 0.273 . . . . 0.0 111.102 176.443 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -52.43 -42.99 64.59 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.252 179.152 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 80.1 t -55.93 -43.96 76.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.851 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -73.55 -33.31 64.62 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.04 0.448 . . . . 0.0 111.115 -179.378 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.655 HG13 ' O ' ' A' ' 53' ' ' THR . 7.8 mt -64.42 -49.13 82.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.626 177.736 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 93.0 t -60.84 -43.38 95.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-O 120.786 0.327 . . . . 0.0 111.435 178.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -58.15 -35.16 71.13 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.17 0.509 . . . . 0.0 111.261 178.092 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 38.9 t -87.83 -21.84 24.81 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.743 177.474 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -68.13 -41.22 81.99 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 122.631 0.372 . . . . 0.0 111.969 -176.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.6 m -82.44 -21.26 9.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-O 121.245 0.545 . . . . 0.0 111.533 177.431 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.452 ' HD3' ' O ' ' A' ' 67' ' ' ALA . 39.4 ttmt -74.08 156.7 37.17 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -175.566 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -91.58 -128.02 4.11 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 121.538 -0.363 . . . . 0.0 113.184 175.258 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -100.54 -77.79 0.53 Allowed 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 81.2 p -76.94 -4.92 46.42 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -172.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.452 ' O ' ' HD3' ' A' ' 63' ' ' LYS . . . -68.88 121.06 15.8 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.106 0.479 . . . . 0.0 111.501 178.814 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 67.3 mtt180 -85.3 -32.31 22.58 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.198 0.523 . . . . 0.0 110.882 178.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.456 HG21 ' HB3' ' A' ' 29' ' ' GLU . 30.9 m -127.34 171.46 15.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.706 -176.526 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 36.3 pt -117.49 170.58 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 CA-C-O 120.581 0.229 . . . . 0.0 111.032 177.672 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 14.9 p30 -126.82 -179.97 5.08 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 -179.405 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.502 ' O ' ' HB3' ' A' ' 75' ' ' PHE . 70.6 t80 -34.73 -62.66 0.35 Allowed 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 -174.567 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -64.61 -38.57 91.46 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 121.798 -0.564 . . . . 0.0 112.014 -175.372 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -62.41 -37.22 84.97 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.219 0.533 . . . . 0.0 110.333 176.29 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.502 ' HB3' ' O ' ' A' ' 72' ' ' TYR . 60.8 t80 -57.03 -45.98 82.72 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.586 176.719 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.438 ' HE3' ' CZ ' ' A' ' 72' ' ' TYR . 81.2 mttt -61.39 -38.74 88.15 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.859 0.361 . . . . 0.0 111.7 178.243 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -71.69 -30.46 65.7 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.712 0.292 . . . . 0.0 111.531 176.441 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.31 -46.71 85.41 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.123 0.487 . . . . 0.0 110.687 173.709 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 86.9 mt -63.74 -34.95 79.01 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.107 175.332 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -62.0 -43.62 98.45 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 121.089 0.471 . . . . 0.0 110.93 178.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -59.79 -58.98 6.23 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.028 0.442 . . . . 0.0 111.284 173.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 90.9 mt -56.12 -42.01 76.17 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.949 -178.194 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.58 -51.78 68.44 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.799 0.333 . . . . 0.0 111.633 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 68.6 p -66.37 -20.7 66.14 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -178.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -102.38 -13.97 17.08 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 48.7 tpt85 -98.38 -60.79 1.48 Allowed 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.196 0.522 . . . . 0.0 110.975 177.597 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -77.38 -178.98 5.46 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.918 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 19.8 tptm -62.29 133.87 55.73 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.612 177.625 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -77.07 61.72 3.39 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 121.174 -0.536 . . . . 0.0 114.129 -173.65 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -165.77 153.52 10.67 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.979 0.389 . . . . 0.0 111.51 176.043 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 44.1 t 65.47 86.76 0.13 Allowed 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.91 -175.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 55.0 tttp -45.73 -41.78 11.07 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.295 175.116 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -57.38 -60.83 3.05 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.7 178.374 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -59.97 -43.75 94.88 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.82 0.343 . . . . 0.0 111.845 -176.583 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.61 -48.21 80.41 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.038 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -66.69 -48.11 70.3 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.278 -178.583 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.461 ' O ' ' HG3' ' A' ' 101' ' ' GLN . 4.2 m-20 -54.58 -49.36 70.57 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.748 0.309 . . . . 0.0 111.376 176.266 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -55.32 -51.94 65.1 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -178.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.8 tt -66.67 -33.16 61.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 CA-C-O 120.885 0.374 . . . . 0.0 111.235 -179.368 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 86.5 m -65.27 -34.82 79.24 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.824 0.345 . . . . 0.0 110.8 173.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.461 ' HG3' ' O ' ' A' ' 97' ' ' ASP . 78.4 mt-30 -64.78 -31.09 72.16 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.33 175.731 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 87.8 mt -72.91 -38.38 66.9 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 176.757 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.687 ' HA ' ' SG ' ' A' ' 42' ' ' CYS . 58.4 t -92.18 -57.4 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -174.81 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.91 98.41 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -170.273 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 85.17 5.39 85.68 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 114.99 0.756 . . . . 0.0 114.99 170.407 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 50.5 tttp -83.41 -2.04 54.89 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 118.015 0.908 . . . . 0.0 111.856 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 74.04 148.34 0.12 Allowed Pre-proline 0 N--CA 1.478 0.964 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 173.574 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -74.92 81.95 2.09 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.844 2.363 . . . . 0.0 112.168 176.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.718 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.863 179.676 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.429 HG12 ' H ' ' A' ' 9' ' ' GLY . 9.0 tt . . . . . 0 CA--C 1.541 0.623 0 CA-C-O 120.941 0.4 . . . . 0.0 111.158 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -52.62 -33.81 48.28 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.022 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.429 ' H ' HG12 ' A' ' 7' ' ' ILE . . . -60.2 -37.08 92.39 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 121.224 -0.513 . . . . 0.0 112.921 178.644 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.423 ' HB2' HG23 ' A' ' 7' ' ' ILE . 46.7 tp -60.89 -42.72 98.53 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.947 0.403 . . . . 0.0 110.522 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -57.33 -44.95 84.67 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.133 174.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.608 ' O ' ' HG3' ' A' ' 16' ' ' LYS . 32.3 mt-10 -61.44 -49.38 77.06 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.594 0.235 . . . . 0.0 110.954 179.285 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.457 ' HA ' ' HD2' ' A' ' 16' ' ' LYS . 47.4 m -57.48 -45.97 84.23 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.065 0.459 . . . . 0.0 111.312 178.703 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -58.77 -44.64 90.68 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.175 0.512 . . . . 0.0 110.408 175.175 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.742 HH11 ' HA3' ' A' ' 27' ' ' GLY . 3.0 tpt180 -56.16 -43.4 78.29 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.202 177.569 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.608 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 88.7 mttt -58.88 -54.67 44.49 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.036 -178.674 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -70.51 -33.4 71.17 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.93 -15.92 63.83 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -177.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.442 HG12 ' O ' ' A' ' 15' ' ' ARG . 31.9 pt -113.95 20.12 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-O 121.468 0.652 . . . . 0.0 111.126 175.811 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 50.0 t60 -67.9 -17.37 64.45 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -177.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -101.1 -42.83 2.33 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 120.933 -0.651 . . . . 0.0 113.558 -179.377 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.53 ' HB2' ' HB2' ' A' ' 25' ' ' ALA . 5.0 m-20 -116.41 157.26 46.06 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 122.733 0.413 . . . . 0.0 110.893 -177.591 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -69.91 -13.73 34.69 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.306 2.004 . . . . 0.0 113.198 -178.613 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -132.79 -38.85 0.99 Allowed 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.006 0.432 . . . . 0.0 110.374 172.165 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.53 ' HB2' ' HB2' ' A' ' 22' ' ' ASP . . . 47.07 -87.68 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -179.548 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 70.0 m -163.69 -56.73 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.384 0.612 . . . . 0.0 110.433 -175.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.742 ' HA3' HH11 ' A' ' 15' ' ' ARG . . . 92.26 -34.51 4.41 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-N 115.934 -0.576 . . . . 0.0 113.238 -178.454 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -99.97 0.92 42.04 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 121.079 0.466 . . . . 0.0 111.001 177.167 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.46 ' HB3' HG21 ' A' ' 69' ' ' VAL . 44.9 mt-10 -124.88 112.34 16.52 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.162 -179.299 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 50.6 ttm -107.68 145.08 33.86 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.78 0.324 . . . . 0.0 111.109 178.128 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -109.73 168.63 9.27 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.154 0.502 . . . . 0.0 112.095 -177.065 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -59.88 -37.24 92.28 Favored Glycine 0 CA--C 1.529 0.936 0 N-CA-C 114.555 0.582 . . . . 0.0 114.555 -174.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -64.21 -53.69 45.22 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -174.597 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 13.1 p30 -74.33 -28.94 61.38 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 29.0 t-105 -60.42 -44.86 95.34 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.091 0.472 . . . . 0.0 111.231 170.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.43 -49.08 78.28 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.928 0.394 . . . . 0.0 111.135 176.509 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -64.81 -31.65 72.98 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.425 178.587 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.9 tt -58.21 -54.81 42.72 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.049 0.452 . . . . 0.0 110.147 177.05 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 67.4 m -58.07 -45.98 86.2 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.192 178.054 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -66.34 -33.2 75.19 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -74.23 -47.09 37.48 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.146 0.498 . . . . 0.0 110.188 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 85.7 m -75.19 -2.21 26.83 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.233 173.034 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt 54.78 35.65 24.59 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 175.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 61.7 t -68.55 -28.12 39.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.784 174.429 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.39 124.22 21.68 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.21 0.529 . . . . 0.0 111.622 178.124 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.443 ' H ' ' HB ' ' A' ' 50' ' ' VAL . 32.0 t70 -75.29 -22.99 57.31 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.929 -176.462 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.12 -47.63 3.87 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 121.252 -0.499 . . . . 0.0 112.853 -179.269 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 42.0 mtmt -77.69 -57.83 3.6 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.465 0.65 . . . . 0.0 110.745 176.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.7 p -97.26 -72.07 0.66 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.497 179.354 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.443 ' HB ' ' H ' ' A' ' 46' ' ' ASP . 49.4 t -76.43 114.29 16.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-O 121.067 0.461 . . . . 0.0 111.475 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.7 t -140.59 -175.16 4.18 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.623 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -45.23 -45.82 10.55 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 113.793 0.277 . . . . 0.0 113.793 -177.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.599 ' O ' HG12 ' A' ' 57' ' ' ILE . 67.8 m -53.88 -56.6 16.19 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.823 0.344 . . . . 0.0 111.37 175.697 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -58.16 -43.26 87.3 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 121.129 0.49 . . . . 0.0 111.016 -178.213 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 71.4 t -61.85 -26.92 41.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-O 121.224 0.535 . . . . 0.0 111.438 178.5 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -82.88 -39.36 21.67 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.522 0.677 . . . . 0.0 109.989 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.599 HG12 ' O ' ' A' ' 53' ' ' THR . 16.4 mm -55.95 -46.76 80.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.593 174.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 87.1 t -61.62 -47.48 93.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.294 176.685 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -54.5 -44.28 72.56 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.068 0.461 . . . . 0.0 111.617 178.488 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 35.6 t -74.92 -35.23 62.2 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.044 0.449 . . . . 0.0 111.636 178.286 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -62.9 -55.66 24.07 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -177.199 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 22.6 m -66.49 -24.38 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-O 121.124 0.488 . . . . 0.0 111.6 -178.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.527 ' HB2' HG22 ' A' ' 70' ' ' ILE . 22.0 ttpp -105.64 82.86 1.86 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.634 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -101.45 -10.58 41.01 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 121.049 -0.596 . . . . 0.0 114.586 -173.063 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 48.2 tptt -84.76 45.66 1.17 Allowed 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 117.81 0.805 . . . . 0.0 112.035 -177.228 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 39.6 t 53.68 16.02 0.9 Allowed 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 176.469 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -76.5 166.75 22.97 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.027 0.441 . . . . 0.0 111.647 -178.555 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.432 HH11 ' HD3' ' A' ' 68' ' ' ARG . 40.6 ttp-105 -105.13 -36.56 7.23 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.045 0.45 . . . . 0.0 111.252 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.46 HG21 ' HB3' ' A' ' 29' ' ' GLU . 33.9 m -110.36 165.0 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.805 178.356 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.527 HG22 ' HB2' ' A' ' 63' ' ' LYS . 33.5 pt -111.93 146.53 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.012 175.649 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 30.1 p30 -100.46 -179.81 4.22 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.609 0.242 . . . . 0.0 111.379 177.499 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -56.45 -39.07 72.54 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -174.005 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -66.57 -49.25 66.99 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.792 0.33 . . . . 0.0 111.24 179.11 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -62.42 -35.37 79.01 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.058 0.456 . . . . 0.0 110.885 178.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.423 ' O ' ' HG ' ' A' ' 79' ' ' LEU . 89.1 t80 -58.63 -45.24 89.68 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.495 172.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -60.88 -41.81 96.71 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.542 176.06 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -60.05 -40.76 90.53 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.237 0.541 . . . . 0.0 110.727 174.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.76 -40.32 96.91 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.227 177.175 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' A' ' 75' ' ' PHE . 76.5 mt -62.23 -37.64 86.14 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.233 177.043 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -61.66 -42.72 99.29 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.085 0.469 . . . . 0.0 110.672 176.171 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.449 ' O ' ' HG2' ' A' ' 85' ' ' LYS . 61.7 mm-40 -59.92 -55.08 38.57 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.202 175.655 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 91.5 mt -59.68 -37.81 79.79 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.862 0.363 . . . . 0.0 111.448 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.424 ' HB1' ' HB1' ' A' ' 95' ' ' ALA . . . -58.67 -55.02 40.43 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.878 0.37 . . . . 0.0 111.424 177.684 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 36.3 p -63.52 -24.01 67.63 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.044 178.415 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.449 ' HG2' ' O ' ' A' ' 81' ' ' GLU . 33.3 mmtp -73.97 -42.26 60.75 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 120.884 0.373 . . . . 0.0 111.728 174.409 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 30.9 mmm180 -90.63 -57.32 2.87 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -174.573 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -99.37 25.76 6.66 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -171.358 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt 62.7 -175.06 0.15 Allowed 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.834 -178.239 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -98.05 17.58 58.48 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 121.042 -0.599 . . . . 0.0 113.36 178.692 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -74.77 96.42 3.06 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 122.421 -0.458 . . . . 0.0 111.077 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 24.6 t 65.3 110.09 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.009 0.523 . . . . 0.0 112.327 -178.17 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -57.21 -34.63 68.72 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.589 0.233 . . . . 0.0 111.417 175.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -60.19 -52.69 64.23 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 120.696 0.284 . . . . 0.0 111.684 -178.293 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -69.2 -42.61 75.56 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 120.711 0.291 . . . . 0.0 111.641 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.424 ' HB1' ' HB1' ' A' ' 83' ' ' ALA . . . -60.62 -47.36 86.58 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 120.955 0.407 . . . . 0.0 111.649 177.346 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.47 ' HA ' HG22 ' A' ' 99' ' ' ILE . 49.0 t80 -66.39 -37.04 84.35 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.017 0.437 . . . . 0.0 110.74 179.11 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -58.23 -51.76 68.43 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.508 0.67 . . . . 0.0 110.566 174.523 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.3 -41.46 94.08 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.814 -176.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.47 HG22 ' HA ' ' A' ' 96' ' ' PHE . 10.1 tp -64.87 -37.68 80.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 O-C-N 121.936 -0.478 . . . . 0.0 110.42 177.292 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 87.1 m -69.75 -30.07 67.58 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.673 172.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 3.6 tp-100 -60.12 -35.56 75.52 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.104 0.478 . . . . 0.0 111.028 178.444 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 88.3 mt -67.85 -22.58 65.13 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.944 177.704 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 47.7 t -111.45 -70.02 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-O 120.775 0.321 . . . . 0.0 111.241 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 53.7 -86.74 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 177.09 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -143.57 27.71 2.07 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.739 -176.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -73.3 -172.59 1.16 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.575 0.702 . . . . 0.0 112.745 -176.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -136.51 151.71 73.43 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.374 178.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -57.6 95.7 0.07 OUTLIER 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 122.219 1.946 . . . . 0.0 113.077 -179.21 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.737 0 C-N-CA 123.443 0.697 . . . . 0.0 112.221 -177.891 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.582 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 120.43 0.157 . . . . 0.0 111.103 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 64.07 96.07 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 120.981 0.419 . . . . 0.0 112.032 -177.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -74.08 68.8 1.44 Allowed 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.231 0.539 . . . . 0.0 111.874 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 66.1 p 176.98 -68.25 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.375 -177.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 62.7 p -101.38 74.65 1.56 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.485 0.659 . . . . 0.0 110.605 174.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -72.97 -63.02 1.26 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.412 -0.813 . . . . 0.0 113.06 -172.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 52.6 mt -110.54 -31.13 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -170.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 70.17 -70.42 0.15 Allowed 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -56.46 -45.28 89.68 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 121.455 -0.403 . . . . 0.0 113.315 -177.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.64 HD22 ' SG ' ' A' ' 100' ' ' CYS . 45.3 tp -57.57 -46.14 84.34 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.232 0.539 . . . . 0.0 110.836 175.056 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -61.42 -34.45 75.4 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.06 178.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -66.43 -50.89 61.89 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.614 177.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.6 m -60.28 -34.18 73.39 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.36 177.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -57.67 -49.99 74.66 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.793 0.33 . . . . 0.0 110.154 174.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.551 ' O ' HG12 ' A' ' 19' ' ' ILE . 76.6 mtm-85 -57.16 -47.1 82.02 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.299 176.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.412 ' HB3' ' HD3' ' A' ' 108' ' ' PRO . 75.3 mmtt -44.93 -48.46 11.32 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 176.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -84.82 -26.97 27.11 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.9 -53.05 23.27 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.976 0.417 . . . . 0.0 111.938 -178.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.551 HG12 ' O ' ' A' ' 15' ' ' ARG . 29.9 pt -77.95 7.33 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -178.055 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -62.13 89.91 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.232 0.539 . . . . 0.0 110.596 176.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 125.23 -54.48 0.75 Allowed Glycine 0 CA--C 1.527 0.785 0 CA-C-N 115.888 -0.597 . . . . 0.0 112.64 -176.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -127.03 109.79 21.79 Favored Pre-proline 0 CA--C 1.547 0.835 0 O-C-N 122.626 -0.338 . . . . 0.0 110.933 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -76.39 -5.78 16.48 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 122.845 2.363 . . . . 0.0 113.644 -178.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 30.7 mtmm -89.5 -11.77 41.97 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.932 0.396 . . . . 0.0 110.945 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.86 -20.34 66.2 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.607 176.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 59.9 m 73.11 -53.72 0.7 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.582 0.753 . . . . 0.0 112.213 177.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 137.86 47.25 0.07 OUTLIER Glycine 0 CA--C 1.524 0.609 0 CA-C-N 116.41 -0.359 . . . . 0.0 112.309 -177.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -95.16 -34.78 12.13 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.643 0.259 . . . . 0.0 111.506 -178.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.08 178.92 6.59 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.341 0.591 . . . . 0.0 112.488 -175.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 52.7 ttm -157.41 133.9 9.81 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.63 176.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -86.38 167.75 14.45 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.094 0.473 . . . . 0.0 112.134 -178.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -58.13 -33.19 68.87 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-N 115.749 -0.659 . . . . 0.0 114.432 -176.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -69.22 -54.12 16.38 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.331 0.586 . . . . 0.0 110.976 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -60.57 -40.29 91.12 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.425 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 30.5 t-105 -63.51 -42.84 98.46 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 120.998 0.428 . . . . 0.0 111.492 175.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.18 -44.63 96.99 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 121.001 0.429 . . . . 0.0 111.183 176.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 43.2 tttm -66.36 -39.43 89.14 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.784 177.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.7 tt -51.69 -47.5 63.86 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.084 0.469 . . . . 0.0 110.792 178.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 79.5 m -63.44 -41.26 98.66 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.324 176.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -62.7 -57.3 11.48 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.815 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -53.69 -39.42 65.14 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 122.731 0.412 . . . . 0.0 111.795 178.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.587 ' SG ' HG13 ' A' ' 103' ' ' VAL . 57.0 m -91.85 -0.7 57.53 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? 50.15 31.75 5.32 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.1 t -68.78 -38.14 78.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-O 121.263 0.554 . . . . 0.0 109.586 171.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.47 79.69 3.97 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.02 171.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.0 p30 -76.79 -14.28 59.93 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.914 -173.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.61 -27.43 7.14 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 121.168 -0.539 . . . . 0.0 113.23 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -85.01 -37.81 19.96 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 122.478 -0.425 . . . . 0.0 111.448 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.8 t -112.46 -51.13 2.86 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.128 0.49 . . . . 0.0 110.549 176.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 34.1 t -112.81 110.46 32.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.065 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.504 ' O ' HG23 ' A' ' 55' ' ' VAL . 81.9 p -97.52 166.72 11.38 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.527 179.076 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -50.02 -55.49 15.02 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 121.368 -0.444 . . . . 0.0 113.079 178.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.574 ' O ' HG12 ' A' ' 57' ' ' ILE . 94.0 m -53.08 -48.56 67.66 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.599 0.237 . . . . 0.0 111.493 178.111 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.488 ' O ' HG23 ' A' ' 58' ' ' VAL . 18.0 t70 -58.48 -36.82 74.32 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 120.726 0.298 . . . . 0.0 110.872 -178.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 51' ' ' THR . 88.6 t -61.87 -37.92 79.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.375 175.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -73.52 -34.73 65.39 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.399 0.619 . . . . 0.0 110.137 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.574 HG12 ' O ' ' A' ' 53' ' ' THR . 8.0 mm -60.48 -52.73 58.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.999 176.331 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 54' ' ' ASP . 91.8 t -52.49 -48.5 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 121.04 0.448 . . . . 0.0 111.12 177.392 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -59.94 -41.28 91.49 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.009 178.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 28.3 t -72.95 -20.22 61.09 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 116.156 -0.474 . . . . 0.0 112.051 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.456 ' HG3' ' O ' ' A' ' 57' ' ' ILE . 53.6 mtmt -84.49 -57.12 3.28 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.087 0.47 . . . . 0.0 111.953 178.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.3 m -61.19 -31.95 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 -173.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.646 ' HD3' ' O ' ' A' ' 66' ' ' SER . 17.2 ptpt -56.55 -52.44 64.78 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -175.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 72.74 -64.78 1.48 Allowed Glycine 0 CA--C 1.537 1.46 0 N-CA-C 114.55 0.58 . . . . 0.0 114.55 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.622 ' HD2' ' H ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -78.52 53.43 1.3 Allowed 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -172.569 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.646 ' O ' ' HD3' ' A' ' 63' ' ' LYS . 88.5 p 54.23 -77.61 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.148 0.579 . . . . 0.0 110.928 -173.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.559 ' HB2' ' HG2' ' A' ' 65' ' ' LYS . . . 46.88 117.88 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 115.859 1.799 . . . . 0.0 115.859 164.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 57.2 ttp180 -66.52 -18.3 65.29 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 121.355 0.598 . . . . 0.0 110.684 169.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.413 ' O ' ' HB1' ' A' ' 67' ' ' ALA . 33.8 m -135.15 159.21 41.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.902 -173.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 39.3 pt -115.27 147.56 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-O 120.699 0.285 . . . . 0.0 110.929 174.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -86.47 157.55 19.77 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -40.25 -48.6 2.63 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 -175.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.529 ' HA ' ' HE3' ' A' ' 76' ' ' LYS . 46.5 mm-40 -52.15 -46.42 65.43 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 120.935 0.398 . . . . 0.0 111.77 178.198 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -76.56 -19.36 57.98 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 120.97 0.414 . . . . 0.0 110.99 -178.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -70.56 -49.68 45.42 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.118 174.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.529 ' HE3' ' HA ' ' A' ' 73' ' ' GLU . 22.8 pttp -69.58 -22.54 63.51 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.322 177.21 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -71.81 -41.35 68.35 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.165 0.507 . . . . 0.0 110.251 170.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.467 ' O ' ' HB3' ' A' ' 81' ' ' GLU . . . -63.61 -37.8 88.72 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.33 175.32 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 84.9 mt -59.69 -43.44 94.04 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.326 175.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -54.85 -43.97 73.55 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 121.029 0.443 . . . . 0.0 110.891 174.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.467 ' HB3' ' O ' ' A' ' 78' ' ' ALA . 6.9 tp10 -54.28 -64.33 0.86 Allowed 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.057 175.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.5 ' HA ' ' HG3' ' A' ' 85' ' ' LYS . 9.1 mp -57.71 -33.25 68.22 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.153 0.502 . . . . 0.0 111.936 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.422 ' HB2' HG21 ' A' ' 99' ' ' ILE . . . -60.84 -48.47 81.66 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.146 175.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.47 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 76.1 p -70.41 -19.06 63.02 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 120.827 0.346 . . . . 0.0 111.699 179.071 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.5 ' HG3' ' HA ' ' A' ' 82' ' ' LEU . 46.9 mmtt -67.29 -41.64 85.1 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 121.088 0.471 . . . . 0.0 111.013 174.288 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 23.4 mtp180 -106.25 -57.38 2.06 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -176.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -88.85 29.33 1.04 Allowed 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -171.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.47 ' HB3' ' O ' ' A' ' 84' ' ' THR . 22.7 pttp -71.8 150.58 44.22 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.079 0.466 . . . . 0.0 111.406 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 98.84 -28.5 14.86 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.908 -178.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -86.62 -177.48 6.15 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.05 0.453 . . . . 0.0 111.423 176.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 35.6 t -63.7 135.13 56.48 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.058 177.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -48.76 -48.03 41.25 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 122.98 0.512 . . . . 0.0 111.856 -178.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.432 ' HG3' ' N ' ' A' ' 94' ' ' GLU . 9.9 pt-20 -60.9 -48.45 81.77 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.461 178.203 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.432 ' N ' ' HG3' ' A' ' 93' ' ' GLU . 63.5 tt0 -58.58 -47.15 85.24 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.635 0.255 . . . . 0.0 111.354 -178.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.81 -44.81 86.61 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 120.951 0.405 . . . . 0.0 111.711 178.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -68.37 -50.29 54.15 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.422 -178.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -62.01 -31.55 71.94 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 120.725 0.298 . . . . 0.0 111.57 177.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -66.65 -54.94 17.86 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.422 HG21 ' HB2' ' A' ' 83' ' ' ALA . 11.5 tt -58.43 -39.75 75.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 120.929 0.395 . . . . 0.0 110.99 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' CYS . . . . . 0.64 ' SG ' HD22 ' A' ' 10' ' ' LEU . 79.0 m -64.17 -37.58 87.96 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.847 0.356 . . . . 0.0 110.998 175.076 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -60.15 -29.31 68.57 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.536 177.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 79.0 mt -77.18 -13.46 59.94 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 177.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.587 HG13 ' SG ' ' A' ' 42' ' ' CYS . 58.3 t -110.62 -54.18 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -175.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -41.36 126.21 2.74 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 -172.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 109.11 -32.84 6.54 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 121.321 -0.466 . . . . 0.0 114.219 173.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 38.0 mtmm -82.06 169.12 17.07 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -174.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.547 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 12.1 pt-20 -126.89 165.37 29.12 Favored Pre-proline 0 CA--C 1.55 0.967 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.464 -178.008 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.547 ' HD2' ' HB2' ' A' ' 107' ' ' GLU . 55.5 Cg_endo -68.37 71.97 0.91 Allowed 'Trans proline' 0 CA--C 1.545 1.031 0 C-N-CA 122.635 2.223 . . . . 0.0 113.889 -178.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 177.28 112.98 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 122.672 0.389 . . . . 0.0 111.8 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -77.93 82.21 4.3 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 122.313 -0.242 . . . . 0.0 110.389 174.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 76.5 t 65.77 -67.45 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.205 -174.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -89.54 146.86 19.14 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 121.41 -0.424 . . . . 0.0 112.79 175.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 33.1 m -81.63 156.88 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-O 121.154 0.502 . . . . 0.0 111.532 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 73.2 p -83.31 109.36 17.2 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -178.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -64.0 111.42 2.51 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.743 175.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -130.6 10.34 5.16 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -177.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -67.64 100.03 0.85 Allowed 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.633 0.73 . . . . 0.0 111.518 -178.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.5 t 178.57 -28.52 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.716 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -71.94 114.13 4.88 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.399 175.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -60.02 105.12 0.7 Allowed Glycine 0 CA--C 1.526 0.763 0 C-N-CA 121.354 -0.451 . . . . 0.0 113.166 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -103.99 20.49 18.11 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.206 0.527 . . . . 0.0 111.24 177.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 35.5 m -87.51 14.6 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.138 -177.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -75.04 27.68 0.09 Allowed 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -177.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 54.7 mtm-85 -66.35 84.07 0.09 Allowed 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.373 0.606 . . . . 0.0 111.435 -177.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 26.8 tp -97.13 10.37 39.56 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.093 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 11.2 p 70.84 -49.03 0.67 Allowed 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.609 1.163 . . . . 0.0 111.885 -174.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -53.15 -35.23 59.51 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 120.907 0.384 . . . . 0.0 111.65 172.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 43.4 p -60.18 111.85 1.68 Allowed 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.786 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 27.7 t 66.2 -67.53 0.15 Allowed 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.194 0.597 . . . . 0.0 110.636 -172.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 70.88 -26.1 0.17 Allowed 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 174.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 54.16 -85.6 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 122.867 0.467 . . . . 0.0 111.968 -175.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 24.4 m -77.38 93.84 4.13 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.172 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 133.84 -20.37 4.08 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 120.965 -0.636 . . . . 0.0 113.987 178.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 81.9 p -82.41 -85.94 0.11 Allowed 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 117.592 0.696 . . . . 0.0 111.565 -178.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 43.7 p-80 -171.61 142.95 1.66 Allowed 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.054 0.454 . . . . 0.0 111.895 178.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -124.89 157.83 35.0 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 174.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -60.51 122.23 14.12 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 121.201 0.524 . . . . 0.0 112.133 -178.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 53.2 ttp180 -73.1 153.78 40.65 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.906 178.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -67.46 80.42 0.16 Allowed 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.634 0.731 . . . . 0.0 112.051 -178.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -126.55 26.08 6.37 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.73 0.776 . . . . 0.0 109.619 172.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.574 ' HA ' ' NZ ' ' A' ' 144' ' ' LYS . 50.6 mt-10 -75.61 -28.92 59.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.87 -178.483 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 61.8 p -77.9 -53.02 7.94 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.514 178.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -104.62 82.47 0.36 Allowed Glycine 0 CA--C 1.53 0.994 0 C-N-CA 120.887 -0.673 . . . . 0.0 114.08 -178.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.574 ' NZ ' ' HA ' ' A' ' 141' ' ' GLU . 50.8 mttp -102.39 171.58 7.37 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.291 0.567 . . . . 0.0 111.723 174.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -84.54 119.43 4.98 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-N 115.932 -0.576 . . . . 0.0 113.324 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -68.49 106.8 2.67 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 120.963 0.411 . . . . 0.0 110.296 176.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 72.11 36.57 60.35 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.161 -171.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 81.5 mt 64.44 -71.93 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 123.448 0.699 . . . . 0.0 111.999 -179.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -150.42 -71.86 0.17 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.98 0.419 . . . . 0.0 110.921 178.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -108.99 32.16 7.11 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 121.103 -0.57 . . . . 0.0 113.593 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.454 HH11 ' HD2' ' A' ' 151' ' ' ARG . 42.8 ttm180 72.77 -53.54 0.7 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.12 0.568 . . . . 0.0 111.875 178.013 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 40.64 97.72 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 169.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -116.9 -82.71 0.63 Allowed 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.863 174.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 18.6 pt -137.09 134.24 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-O 121.083 0.468 . . . . 0.0 111.743 -179.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 90.2 mt -113.44 32.44 5.78 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.146 0.498 . . . . 0.0 110.988 178.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -62.72 133.06 54.24 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.116 -177.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -117.85 165.98 13.02 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 121.177 0.513 . . . . 0.0 111.449 -179.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 55.4 p -57.52 -25.64 60.16 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 176.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 137.16 11.41 1.04 Allowed Glycine 0 CA--C 1.529 0.959 0 C-N-CA 120.969 -0.634 . . . . 0.0 113.835 178.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 59.1 93.79 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 122.862 0.465 . . . . 0.0 112.219 178.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 42.0 t -95.6 126.17 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-O 120.848 0.356 . . . . 0.0 111.867 -177.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 85.0 p -103.11 139.71 38.27 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.309 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -62.21 113.42 2.87 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -177.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 58.18 23.39 10.19 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 177.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 97.4 mttt 62.65 -164.47 0.25 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 122.612 0.365 . . . . 0.0 111.618 -176.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 66.72 -75.61 0.06 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 122.833 0.453 . . . . 0.0 111.656 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 55.86 -80.54 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.336 0.655 . . . . 0.0 112.742 178.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -146.65 85.31 0.17 Allowed Glycine 0 CA--C 1.521 0.415 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.407 ' O ' ' HB2' ' A' ' 170' ' ' TYR . 44.0 p 51.57 50.69 18.26 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 121.193 0.52 . . . . 0.0 111.201 -172.333 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' TYR . . . . . 0.407 ' HB2' ' O ' ' A' ' 169' ' ' THR . 41.4 m-85 72.4 -175.82 0.17 Allowed 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.905 -179.179 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -70.42 75.44 0.55 Allowed 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.648 0.737 . . . . 0.0 112.54 -175.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.424 ' HB1' ' HB3' ' A' ' 175' ' ' LYS . . . -79.41 71.14 5.96 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.279 177.064 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -65.83 103.44 0.91 Allowed 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.34 -178.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 22.7 m 42.55 34.96 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 123.716 0.806 . . . . 0.0 112.184 -175.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.424 ' HB3' ' HB1' ' A' ' 172' ' ' ALA . 86.9 tttt -75.68 85.18 2.7 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.601 -178.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm 58.29 -76.54 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.266 0.626 . . . . 0.0 112.409 178.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.414 HD12 ' N ' ' A' ' 177' ' ' LEU . 6.9 mp -79.49 116.9 19.98 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.963 0.411 . . . . 0.0 110.769 178.33 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.545 0.751 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.395 -174.148 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.7 mmt . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 120.532 0.206 . . . . 0.0 110.92 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 63.16 -77.44 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 174.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.16 -32.71 72.23 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -178.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 30.2 t 59.45 -166.17 0.18 Allowed 'General case' 0 N--CA 1.475 0.824 0 CA-C-O 121.104 0.478 . . . . 0.0 111.849 179.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 96.1 m -119.12 106.35 12.3 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.793 0.33 . . . . 0.0 111.027 178.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -56.61 129.07 39.41 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.794 178.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.0 mt -56.71 124.31 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -170.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.55 -31.07 69.04 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.382 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.73 -17.06 48.48 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 121.225 -0.512 . . . . 0.0 113.164 175.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 53.0 tp -71.85 -58.44 3.46 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.783 0.291 . . . . 0.0 110.899 177.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -55.43 -39.63 70.5 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 177.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -61.47 -57.08 13.61 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.573 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.3 t -57.32 -44.91 84.59 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.134 0.492 . . . . 0.0 110.868 178.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -58.34 -40.97 83.59 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.435 176.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.482 ' O ' HG12 ' A' ' 19' ' ' ILE . 58.4 ttt180 -67.48 -44.21 79.1 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 120.678 0.275 . . . . 0.0 110.985 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -62.8 -34.37 77.15 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.237 178.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -72.28 -49.72 32.56 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.365 173.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.73 -46.96 81.0 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -176.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.482 HG12 ' O ' ' A' ' 15' ' ' ARG . 23.1 pt -83.58 5.58 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-O 121.018 0.437 . . . . 0.0 111.974 -177.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 37.1 t60 -78.96 105.22 10.13 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.937 0.399 . . . . 0.0 110.291 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.461 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . 88.82 -64.31 3.42 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.27 -174.55 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -90.13 97.33 1.07 Allowed Pre-proline 0 CA--C 1.547 0.839 0 CA-C-O 120.865 0.364 . . . . 0.0 110.608 175.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' A' ' 21' ' ' GLY . 74.4 Cg_endo -73.33 -30.79 9.91 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 122.546 2.164 . . . . 0.0 114.183 -170.287 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.46 2.42 13.75 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -173.211 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.405 ' HB1' ' O ' ' A' ' 29' ' ' GLU . . . -65.79 -37.16 85.54 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.974 0.416 . . . . 0.0 111.288 176.47 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 27.1 t 55.76 16.43 2.01 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 175.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 75.86 13.95 82.61 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 120.883 -0.675 . . . . 0.0 113.87 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -95.78 -36.65 11.08 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.268 0.556 . . . . 0.0 110.461 175.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.405 ' O ' ' HB1' ' A' ' 25' ' ' ALA . 26.3 mt-10 -137.44 142.74 41.6 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.926 -178.141 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.41 ' HE2' ' HA ' ' A' ' 35' ' ' TRP . 27.2 ttt -123.97 142.51 51.1 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.983 0.421 . . . . 0.0 111.667 -175.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -103.46 164.79 11.43 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -174.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -58.71 -32.27 69.25 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-N 115.725 -0.67 . . . . 0.0 113.7 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.522 ' HB2' ' HZ2' ' A' ' 33' ' ' LYS . 3.6 ttmp? -47.75 -61.9 1.72 Allowed 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 121.62 0.724 . . . . 0.0 111.395 176.505 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -79.81 -20.36 46.31 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.125 -175.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.41 ' HA ' ' HE2' ' A' ' 30' ' ' MET . 62.0 t-105 -69.91 -50.22 44.36 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 120.882 0.373 . . . . 0.0 111.218 177.013 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.13 -43.85 95.35 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-O 121.403 0.62 . . . . 0.0 110.203 174.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.405 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 41.3 tttm -57.16 -46.73 82.52 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.593 174.353 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.4 tt -51.91 -46.82 64.76 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 122.895 0.478 . . . . 0.0 111.057 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.704 ' SG ' HG11 ' A' ' 55' ' ' VAL . 73.7 m -56.29 -50.5 71.21 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.218 177.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -71.73 -28.99 64.04 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 121.113 0.482 . . . . 0.0 111.914 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.405 ' HB2' ' O ' ' A' ' 37' ' ' LYS . 5.8 t70 -75.37 -44.8 42.99 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.427 0.632 . . . . 0.0 111.158 -173.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 65.4 m -103.08 2.25 34.48 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.68 178.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp 62.36 34.95 15.34 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.321 0.581 . . . . 0.0 111.348 178.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 59.9 t -68.21 -42.21 84.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.443 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.09 91.91 2.12 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.266 0.555 . . . . 0.0 111.123 178.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.634 ' HB2' ' HG2' ' A' ' 86' ' ' ARG . 26.9 t70 -51.86 -26.61 10.44 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.72 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.11 -55.99 4.59 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 121.302 -0.475 . . . . 0.0 112.27 -177.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.506 ' NZ ' ' HB3' ' A' ' 48' ' ' LYS . 5.9 ttpm? -64.08 -32.97 74.73 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 121.124 0.487 . . . . 0.0 111.128 176.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 13.8 m -110.15 -19.47 13.02 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.52 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 5.8 p -160.3 113.88 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-O 121.005 0.431 . . . . 0.0 112.131 -176.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.4 ' O ' HG23 ' A' ' 55' ' ' VAL . 58.5 p -95.69 172.48 8.02 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 120.818 0.342 . . . . 0.0 111.768 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -51.65 -36.42 39.96 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-N 116.19 -0.459 . . . . 0.0 113.686 177.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.537 ' O ' HG13 ' A' ' 57' ' ' ILE . 21.6 p -62.06 -54.38 42.29 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.972 0.415 . . . . 0.0 110.234 177.354 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -58.2 -38.48 76.82 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.52 -176.065 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.704 HG11 ' SG ' ' A' ' 39' ' ' CYS . 88.6 t -58.21 -39.1 72.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.595 174.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -70.42 -36.17 73.86 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 121.296 0.57 . . . . 0.0 110.318 178.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.572 ' O ' ' HG3' ' A' ' 61' ' ' LYS . 8.7 mt -61.49 -46.43 96.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.578 176.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 89.7 t -60.91 -45.13 98.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-O 121.08 0.467 . . . . 0.0 110.73 177.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.522 ' O ' ' HB2' ' A' ' 63' ' ' LYS . 76.5 t80 -59.39 -30.92 68.78 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.874 175.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.552 ' HA ' ' HE3' ' A' ' 63' ' ' LYS . 67.8 m -82.5 -25.15 33.74 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.722 177.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.572 ' HG3' ' O ' ' A' ' 57' ' ' ILE . 95.4 mttt -66.47 -55.3 16.28 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 120.98 0.419 . . . . 0.0 111.338 177.549 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.537 ' HB ' ' HB3' ' A' ' 74' ' ' GLU . 27.6 m -83.72 6.99 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 CA-C-N 116.064 -0.516 . . . . 0.0 112.198 -177.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.552 ' HE3' ' HA ' ' A' ' 60' ' ' SER . 39.6 ttmt -78.01 143.86 37.17 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.766 -179.105 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -73.01 177.98 41.24 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 121.022 -0.609 . . . . 0.0 113.203 177.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -50.98 100.35 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -177.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 60.6 p 52.04 23.95 2.45 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.368 0.667 . . . . 0.0 112.335 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.454 ' O ' ' HD3' ' A' ' 63' ' ' LYS . . . -70.29 176.23 4.08 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -177.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.523 ' HG3' HG13 ' A' ' 69' ' ' VAL . 16.8 ptt180 -116.48 -9.48 11.43 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.523 HG13 ' HG3' ' A' ' 68' ' ' ARG . 33.1 m -136.57 172.18 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-O 121.084 0.469 . . . . 0.0 112.0 -178.184 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 37.8 pt -128.18 145.61 35.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.097 175.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 -79.92 158.89 26.54 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 120.736 0.303 . . . . 0.0 111.729 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.532 ' O ' ' HB3' ' A' ' 75' ' ' PHE . 30.1 t80 -48.4 -46.8 37.73 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -175.269 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 22.7 mp0 -60.81 -43.96 97.49 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 122.113 -0.367 . . . . 0.0 111.418 -178.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.537 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 32.5 mm-40 -71.96 -27.19 62.61 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.887 0.375 . . . . 0.0 111.078 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.532 ' HB3' ' O ' ' A' ' 72' ' ' TYR . 61.6 t80 -57.22 -39.67 75.93 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.396 0.617 . . . . 0.0 110.349 170.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.529 ' HG3' ' O ' ' A' ' 72' ' ' TYR . 32.3 mtpt -67.12 -35.62 80.14 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.825 177.082 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.429 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 15.1 tppt? -66.88 -39.65 87.54 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.346 0.593 . . . . 0.0 110.653 176.345 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.09 -46.47 90.51 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.807 174.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 79.4 mt -60.75 -32.32 71.62 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.114 174.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.429 ' HB3' ' O ' ' A' ' 77' ' ' LYS . 32.9 tt0 -56.66 -51.32 69.19 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 120.704 0.288 . . . . 0.0 110.934 177.377 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -61.68 -53.71 52.52 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.408 175.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 82.0 mt -54.21 -38.36 65.59 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -178.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.76 -52.16 40.61 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.907 0.384 . . . . 0.0 111.62 177.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 70.1 p -66.65 -16.14 63.98 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -90.5 -49.3 6.58 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 122.077 -0.39 . . . . 0.0 111.02 173.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.634 ' HG2' ' HB2' ' A' ' 46' ' ' ASP . 2.2 tmt_? -59.77 -51.2 70.78 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.003 0.43 . . . . 0.0 110.687 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -94.24 24.18 4.58 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.145 0.498 . . . . 0.0 111.923 -177.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 56.0 mttm 59.46 -179.81 0.08 Allowed 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.925 178.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -77.25 58.69 3.64 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 121.309 -0.472 . . . . 0.0 114.051 -175.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -98.43 -162.16 0.93 Allowed 'General case' 0 CA--C 1.543 0.697 0 O-C-N 122.618 -0.342 . . . . 0.0 110.634 176.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.417 ' HB3' ' HB3' ' A' ' 94' ' ' GLU . 28.5 t -56.28 120.56 7.79 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 122.182 -0.323 . . . . 0.0 111.402 176.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -57.59 -44.56 85.5 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.877 0.37 . . . . 0.0 111.373 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.5 mp0 -59.1 -50.01 75.68 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.933 177.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.417 ' HB3' ' HB3' ' A' ' 91' ' ' SER . 36.3 tt0 -58.25 -47.05 84.79 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.667 177.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.54 -36.73 83.54 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.917 0.389 . . . . 0.0 111.448 178.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -65.87 -42.75 89.96 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.83 178.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -60.94 -42.79 98.87 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.195 0.521 . . . . 0.0 110.591 175.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.541 ' O ' ' HB3' ' A' ' 101' ' ' GLN . . . -61.44 -49.34 77.24 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 179.211 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.1 tt -64.51 -33.37 62.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 O-C-N 121.886 -0.508 . . . . 0.0 110.937 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 97.6 m -66.12 -38.55 88.46 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.88 0.371 . . . . 0.0 110.581 172.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.541 ' HB3' ' O ' ' A' ' 98' ' ' ALA . 49.8 tt0 -54.95 -34.09 62.93 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 121.045 0.45 . . . . 0.0 111.409 174.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 75.6 mt -78.09 -36.68 47.81 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 112.694 0.628 . . . . 0.0 112.694 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 54.9 t -100.71 -49.73 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -172.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.17 134.34 56.9 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -174.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 68.66 33.39 76.03 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.292 -0.48 . . . . 0.0 113.037 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -142.91 133.71 25.37 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 122.922 0.489 . . . . 0.0 110.807 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.406 ' HA ' ' HD3' ' A' ' 108' ' ' PRO . 38.9 mt-10 -85.94 154.6 58.19 Favored Pre-proline 0 N--CA 1.474 0.767 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -175.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 107' ' ' GLU . 22.8 Cg_exo -65.9 84.64 0.24 Allowed 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 123.076 2.518 . . . . 0.0 112.866 176.299 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 64.86 25.19 12.83 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 174.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -112.09 158.26 19.81 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 110.251 -0.278 . . . . 0.0 110.251 174.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 61.0 t -63.39 88.24 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 121.399 0.618 . . . . 0.0 111.005 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -178.54 92.36 0.08 OUTLIER Glycine 0 CA--C 1.526 0.72 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.338 -178.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.442 HG13 ' N ' ' A' ' 114' ' ' THR . 4.0 p -162.9 -53.2 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 122.581 0.352 . . . . 0.0 111.141 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.442 ' N ' HG13 ' A' ' 113' ' ' VAL . 76.4 p -78.09 113.87 16.43 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.957 0.408 . . . . 0.0 110.772 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 16.8 pttm -136.05 146.68 47.35 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 120.734 0.302 . . . . 0.0 111.812 -175.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 72.44 -73.65 0.1 Allowed 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.299 0.64 . . . . 0.0 112.424 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -179.22 -40.85 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 120.987 0.422 . . . . 0.0 111.077 -179.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.8 t -80.01 -178.06 6.32 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.89 0.376 . . . . 0.0 111.062 175.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 79.49 -58.29 4.44 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.527 -177.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -64.03 -22.0 66.36 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 121.32 -0.467 . . . . 0.0 112.616 175.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -138.48 153.55 48.8 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 122.595 0.358 . . . . 0.0 110.892 178.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 11.4 p -128.44 145.71 35.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 121.054 0.454 . . . . 0.0 111.81 -177.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -88.0 151.79 22.52 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.873 177.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 17.7 ttm180 -80.95 109.99 16.06 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.25 0.548 . . . . 0.0 111.938 -179.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 8.7 mp -83.15 58.94 4.69 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.059 175.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 15.2 t 38.47 37.58 0.18 Allowed 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 124.112 0.965 . . . . 0.0 113.398 -176.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -68.04 135.99 53.13 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.168 0.508 . . . . 0.0 111.596 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 6.7 t -119.03 142.56 47.72 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.839 177.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.51 ' O ' HG22 ' A' ' 132' ' ' THR . 47.9 t -81.65 -69.6 0.6 Allowed 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.692 0.282 . . . . 0.0 111.44 -178.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 62.34 3.29 1.02 Allowed 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 176.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 42.6 t80 56.83 28.32 14.27 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 121.457 0.646 . . . . 0.0 110.686 -175.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.51 HG22 ' O ' ' A' ' 129' ' ' SER . 5.0 t -71.1 76.62 0.68 Allowed 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.47 0.652 . . . . 0.0 112.632 -176.478 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -81.16 70.5 3.07 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 121.048 -0.596 . . . . 0.0 111.662 173.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 34.0 t 64.7 -166.38 0.23 Allowed 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 120.865 0.364 . . . . 0.0 110.647 -173.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -149.96 46.02 0.92 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.377 0.608 . . . . 0.0 110.864 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -81.52 63.51 5.84 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.073 -176.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 67.15 -79.69 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.2 0.6 . . . . 0.0 112.31 176.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 19.9 tpt180 -177.4 -48.36 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.978 -175.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -112.78 157.88 20.8 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.411 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -84.65 -64.68 1.11 Allowed 'General case' 0 CA--C 1.545 0.786 0 CA-C-O 120.756 0.312 . . . . 0.0 111.4 177.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -155.75 4.08 0.18 Allowed 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 122.323 0.249 . . . . 0.0 111.275 -179.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 94.7 p 53.35 -85.26 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.335 0.654 . . . . 0.0 111.073 -168.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.443 ' O ' ' HB3' ' A' ' 144' ' ' LYS . . . 77.38 -51.03 3.25 Favored Glycine 0 CA--C 1.53 1.003 0 N-CA-C 114.363 0.505 . . . . 0.0 114.363 176.418 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.443 ' HB3' ' O ' ' A' ' 143' ' ' GLY . 23.6 ttmm 70.71 -61.11 0.48 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.262 0.625 . . . . 0.0 111.084 -174.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -115.53 79.7 0.29 Allowed Glycine 0 CA--C 1.527 0.817 0 C-N-CA 121.25 -0.5 . . . . 0.0 112.627 176.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -66.77 90.25 0.17 Allowed 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 116.806 0.303 . . . . 0.0 111.192 178.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 142.85 143.65 4.18 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 121.05 -0.595 . . . . 0.0 113.663 177.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 48.9 mm -105.0 124.95 60.0 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 O-C-N 122.524 -0.398 . . . . 0.0 112.03 -178.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . 61.23 14.73 5.8 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 175.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -86.7 82.2 1.65 Allowed Glycine 0 CA--C 1.524 0.594 0 C-N-CA 121.015 -0.612 . . . . 0.0 113.682 -177.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 151' ' ' ARG . 24.5 ttm-85 -145.84 -55.35 0.29 Allowed 'General case' 0 CA--C 1.54 0.586 0 O-C-N 122.481 -0.423 . . . . 0.0 111.553 177.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -71.09 146.63 49.13 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.538 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -108.74 -163.52 0.88 Allowed 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.498 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 41.2 pt -66.94 126.88 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-O 121.192 0.52 . . . . 0.0 112.069 -178.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 75.5 mt -135.48 86.67 2.26 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.6 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 17.3 t70 75.91 -48.75 0.6 Allowed 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 169.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -53.84 121.26 7.57 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -174.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 26.7 p -83.03 -33.17 26.55 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.192 177.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 124.21 107.01 1.73 Allowed Glycine 0 CA--C 1.527 0.786 0 C-N-CA 121.031 -0.604 . . . . 0.0 113.616 175.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -65.66 162.98 17.3 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.231 0.539 . . . . 0.0 112.14 175.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.444 ' O ' ' HB3' ' A' ' 162' ' ' SER . 11.8 p -112.73 26.57 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.928 0 CA-C-O 121.451 0.643 . . . . 0.0 110.409 177.547 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.444 ' HB3' ' O ' ' A' ' 161' ' ' VAL . 28.9 t 73.06 132.82 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.198 -176.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -58.12 136.12 57.16 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.955 178.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -81.04 59.73 3.94 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.375 0.607 . . . . 0.0 111.531 -176.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -94.77 -77.85 0.46 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.991 -0.549 . . . . 0.0 112.189 177.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 22.2 p-10 -158.41 -55.15 0.07 Allowed 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -176.025 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.87 109.31 0.62 Allowed 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -174.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -85.56 73.3 2.6 Favored Glycine 0 CA--C 1.524 0.596 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.766 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 59.1 m -67.09 83.62 0.13 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.216 0.531 . . . . 0.0 111.226 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -105.79 134.54 48.75 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.719 178.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -78.18 84.21 4.41 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.758 0.79 . . . . 0.0 111.917 -177.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -120.03 -62.26 1.5 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.037 176.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 51.6 tttp -84.52 31.7 0.52 Allowed 'General case' 0 CA--C 1.548 0.887 0 CA-C-O 121.395 0.617 . . . . 0.0 111.3 -178.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 54.1 t -80.02 87.54 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-O 121.462 0.648 . . . . 0.0 110.826 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 57.5 tttm -151.56 55.53 0.86 Allowed 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.833 0.825 . . . . 0.0 109.248 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 34.1 mtmt -105.37 -83.23 0.51 Allowed 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.601 -171.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.426 HD12 ' N ' ' A' ' 177' ' ' LEU . 6.7 mp -84.19 -79.88 0.2 Allowed 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 178.161 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 . . . . . 0 N--CA 1.476 0.861 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 166.806 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.4 tpt . . . . . 0 N--CA 1.488 1.44 0 CA-C-O 120.683 0.278 . . . . 0.0 110.861 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.62 102.34 0.9 Allowed 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -176.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -84.8 85.97 7.4 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.27 0.557 . . . . 0.0 110.764 174.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.0 t -66.05 149.81 49.68 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -176.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 75.6 p -84.03 94.77 8.38 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.303 173.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.7 t70 62.31 -164.36 0.25 Allowed 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.518 -176.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.9 mm -75.15 104.42 3.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 O-C-N 121.904 -0.497 . . . . 0.0 110.959 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.42 -38.45 66.28 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.18 -177.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -69.02 -26.69 74.52 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 121.144 -0.551 . . . . 0.0 113.257 177.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 50.7 tp -74.9 -51.29 14.21 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 122.523 -0.398 . . . . 0.0 110.882 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -62.33 -30.22 71.01 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.719 0.295 . . . . 0.0 111.047 176.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -63.56 -51.94 63.21 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.837 0.351 . . . . 0.0 110.377 175.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.5 m -62.78 -39.47 94.31 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.57 177.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -54.14 -51.66 63.57 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.862 0.363 . . . . 0.0 110.492 176.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.607 ' O ' HG12 ' A' ' 19' ' ' ILE . 81.6 mtt85 -63.26 -44.2 95.81 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.962 0.411 . . . . 0.0 111.232 175.124 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.657 ' HD2' ' HA ' ' A' ' 107' ' ' GLU . 26.9 ttmt -52.43 -34.32 48.03 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.414 -178.058 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -93.04 -38.8 11.44 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 116.167 -0.47 . . . . 0.0 112.098 173.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.07 -41.7 83.95 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -175.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.607 HG12 ' O ' ' A' ' 15' ' ' ARG . 46.5 pt -83.73 10.58 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -178.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 22.8 t60 -82.64 129.15 34.9 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 120.894 0.378 . . . . 0.0 110.8 177.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.408 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . 83.49 -49.29 4.2 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.548 -177.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -93.19 100.78 4.57 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-O 120.741 0.305 . . . . 0.0 111.242 175.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 21' ' ' GLY . 89.8 Cg_endo -76.85 4.64 5.52 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 122.584 2.189 . . . . 0.0 113.229 -177.145 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -113.83 4.26 15.82 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.708 0.29 . . . . 0.0 111.707 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.405 ' HB3' ' HA ' ' A' ' 19' ' ' ILE . . . -74.99 132.05 41.09 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.788 0.328 . . . . 0.0 111.72 -179.144 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.6 m -76.81 -36.05 57.19 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.865 0.364 . . . . 0.0 111.473 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.524 ' HA3' ' HG2' ' A' ' 15' ' ' ARG . . . 126.71 15.67 2.61 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 120.881 -0.676 . . . . 0.0 114.229 176.397 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -113.95 -7.84 13.13 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 117.228 0.514 . . . . 0.0 111.833 177.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -123.79 137.13 54.73 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 122.418 0.287 . . . . 0.0 110.995 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 51.2 ttm -133.54 137.43 45.55 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.867 0.365 . . . . 0.0 111.404 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 31.0 p30 -92.12 171.22 9.23 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.261 0.553 . . . . 0.0 112.267 -179.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.55 -29.1 72.57 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-N 115.885 -0.598 . . . . 0.0 113.603 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -60.13 -55.06 38.54 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.031 0.443 . . . . 0.0 111.356 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -69.99 -29.16 66.18 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.496 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 53.8 t-105 -61.59 -42.63 99.13 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.275 0.559 . . . . 0.0 110.605 173.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.61 -42.62 99.13 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.119 174.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.421 ' HE2' ' OD2' ' A' ' 41' ' ' ASP . 13.2 mmmm -61.87 -44.05 97.61 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.205 175.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.498 HD13 ' HE1' ' A' ' 75' ' ' PHE . 11.1 mt -48.83 -54.28 15.84 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 177.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 24.6 p -62.06 -45.88 91.57 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.664 -178.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.5 ttpm? -68.72 -49.2 60.82 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.074 0.464 . . . . 0.0 111.661 -176.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.421 ' OD2' ' HE2' ' A' ' 37' ' ' LYS . 12.4 m-20 -69.14 -38.37 78.78 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.563 -176.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.472 ' SG ' ' HA ' ' A' ' 103' ' ' VAL . 73.4 m -85.35 -4.04 59.03 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 176.47 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt 62.0 35.53 16.03 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.265 0.555 . . . . 0.0 112.284 175.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 41.7 t -80.04 -23.84 11.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.472 174.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -92.62 96.92 10.48 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.574 179.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -56.73 -30.43 63.52 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.946 0.403 . . . . 0.0 111.532 178.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 98.04 -48.63 1.43 Allowed Glycine 0 CA--C 1.524 0.63 0 C-N-CA 121.536 -0.364 . . . . 0.0 112.655 -178.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -84.87 -21.11 29.9 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.965 0.412 . . . . 0.0 111.704 178.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 78.7 p -113.7 -72.53 0.7 Allowed 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.957 0.408 . . . . 0.0 110.551 176.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 59.3 t -88.14 122.03 39.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.172 174.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.408 ' O ' HG23 ' A' ' 55' ' ' VAL . 5.5 t -140.6 178.56 7.24 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.416 -176.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -44.83 -52.36 7.82 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 114.189 0.436 . . . . 0.0 114.189 -175.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.597 ' O ' HG12 ' A' ' 57' ' ' ILE . 84.7 m -57.88 -51.67 68.65 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 122.561 -0.376 . . . . 0.0 111.303 177.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -55.86 -42.99 76.68 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 121.263 0.554 . . . . 0.0 111.123 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 51' ' ' THR . 83.7 t -65.8 -29.19 46.18 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.562 177.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -78.05 -33.84 50.73 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.592 0.711 . . . . 0.0 109.732 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.597 HG12 ' O ' ' A' ' 53' ' ' THR . 11.0 mm -64.13 -47.36 90.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.684 175.403 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.537 ' HA ' ' HD2' ' A' ' 61' ' ' LYS . 80.8 t -57.63 -45.91 86.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.323 175.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -57.36 -43.35 83.42 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.145 0.498 . . . . 0.0 110.579 174.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 23.0 t -65.48 -34.36 78.08 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.766 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.537 ' HD2' ' HA ' ' A' ' 58' ' ' VAL . 64.6 mttm -58.75 -51.96 67.74 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.333 0.587 . . . . 0.0 111.308 176.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.515 ' HB ' ' HB3' ' A' ' 74' ' ' GLU . 25.9 m -84.31 -6.6 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.039 -177.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.42 ' HB3' ' NZ ' ' A' ' 63' ' ' LYS . 6.3 ttpm? -65.69 153.55 41.38 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 120.922 0.392 . . . . 0.0 111.83 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -79.37 -161.46 21.87 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.683 175.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -62.38 -38.63 90.36 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 122.48 -0.424 . . . . 0.0 111.918 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 21.2 t -154.08 17.44 0.49 Allowed 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 120.824 0.345 . . . . 0.0 111.235 177.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.06 138.81 58.56 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -179.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 62.4 mtt180 -94.12 -8.58 39.15 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.232 178.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 36.0 m -132.17 152.03 35.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.807 -178.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.494 HG21 HG23 ' A' ' 62' ' ' VAL . 35.2 pt -117.58 151.63 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.087 176.38 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -100.38 173.03 6.78 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -177.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.501 ' O ' ' HB3' ' A' ' 75' ' ' PHE . 34.5 t80 -53.17 -50.65 64.18 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -170.053 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -63.43 -42.82 98.71 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -176.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.515 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 0.8 OUTLIER -69.93 -30.72 68.18 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.984 0.421 . . . . 0.0 110.537 176.653 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.501 ' HB3' ' O ' ' A' ' 72' ' ' TYR . 50.5 t80 -58.53 -43.25 89.14 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.163 0.506 . . . . 0.0 110.55 171.168 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.486 ' HG3' ' O ' ' A' ' 72' ' ' TYR . 55.2 mtpt -60.95 -40.14 92.17 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.7 175.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.401 ' HD3' ' HA ' ' A' ' 77' ' ' LYS . 72.1 mmtt -70.01 -28.26 65.36 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.528 175.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.85 -42.74 80.91 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.036 0.446 . . . . 0.0 110.546 173.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 79.9 mt -64.71 -41.72 95.79 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.716 173.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -56.95 -45.07 83.07 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.319 0.58 . . . . 0.0 110.665 174.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.418 ' O ' ' HG3' ' A' ' 85' ' ' LYS . 16.4 tp10 -58.65 -59.82 4.79 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.029 176.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.409 ' O ' ' HG3' ' A' ' 86' ' ' ARG . 87.6 mt -56.13 -36.69 68.51 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.556 178.284 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.99 -58.31 9.23 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.72 -0.218 . . . . 0.0 111.276 177.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 80.5 p -53.79 -33.8 57.12 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.418 ' HG3' ' O ' ' A' ' 81' ' ' GLU . 7.2 mtpm? -72.71 -35.62 67.62 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.518 178.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.409 ' HG3' ' O ' ' A' ' 82' ' ' LEU . 48.1 mtp180 -96.82 -65.91 0.94 Allowed 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 120.88 0.372 . . . . 0.0 111.528 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.41 ' HB2' ' HB1' ' A' ' 95' ' ' ALA . 51.7 m-85 -87.37 111.63 21.3 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.859 0.361 . . . . 0.0 110.436 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 15.5 pttm -141.93 31.64 1.6 Allowed 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -171.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -78.85 43.04 2.35 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 120.97 -0.634 . . . . 0.0 113.182 175.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.5 ttpp 72.04 -45.92 0.63 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.036 0.935 . . . . 0.0 112.964 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.4 m -72.62 110.4 6.95 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 122.071 -0.393 . . . . 0.0 111.759 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -81.62 -34.52 30.85 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 178.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -47.12 -70.55 0.09 Allowed 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 120.994 0.426 . . . . 0.0 111.409 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -66.64 -28.82 68.78 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -177.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.41 ' HB1' ' HB2' ' A' ' 87' ' ' PHE . . . -59.2 -42.88 91.95 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.307 0.575 . . . . 0.0 110.696 174.535 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -68.16 -40.3 82.37 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.539 176.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -57.78 -40.31 79.52 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.791 0.329 . . . . 0.0 111.513 174.04 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.574 ' O ' ' HB3' ' A' ' 101' ' ' GLN . . . -63.8 -47.45 80.81 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.036 0.446 . . . . 0.0 112.093 -178.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.9 tt -70.46 -31.14 45.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 O-C-N 121.998 -0.439 . . . . 0.0 110.752 178.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 84.8 m -68.06 -33.88 75.4 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.788 0.328 . . . . 0.0 110.613 171.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.574 ' HB3' ' O ' ' A' ' 98' ' ' ALA . 28.2 tt0 -56.53 -39.93 74.22 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.284 0.564 . . . . 0.0 110.526 173.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 88.8 mt -68.18 -39.15 82.59 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.405 176.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.472 ' HA ' ' SG ' ' A' ' 42' ' ' CYS . 67.7 t -93.53 -59.08 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -174.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -51.28 125.02 13.03 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 112.546 0.572 . . . . 0.0 112.546 -177.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.67 -42.13 2.81 Favored Glycine 0 CA--C 1.528 0.869 0 CA-C-N 116.172 -0.467 . . . . 0.0 112.745 -177.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -51.44 132.64 29.8 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -176.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.657 ' HA ' ' HD2' ' A' ' 16' ' ' LYS . 10.4 pt-20 -95.76 155.05 38.91 Favored Pre-proline 0 CA--C 1.542 0.657 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.902 174.311 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -56.87 130.14 38.27 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.545 2.163 . . . . 0.0 113.025 -178.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 60.27 -105.24 0.21 Allowed 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.224 -177.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 8.4 t30 59.01 122.1 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 121.304 0.573 . . . . 0.0 112.313 -175.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 41.0 t -73.81 75.65 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-O 121.5 0.667 . . . . 0.0 111.001 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -112.53 83.47 0.33 Allowed Glycine 0 CA--C 1.521 0.439 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.989 178.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 62.0 t -100.79 119.28 48.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -176.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 70.4 m -70.19 100.96 1.76 Allowed 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 172.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -74.99 125.87 29.82 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.296 0.57 . . . . 0.0 112.482 -173.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -100.62 -70.79 0.73 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.012 174.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -114.09 99.8 7.91 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.081 0.467 . . . . 0.0 112.137 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 41.7 p -78.2 -173.04 3.04 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.315 176.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 96.13 134.54 7.99 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.348 -177.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 154.72 -89.16 0.12 Allowed Glycine 0 CA--C 1.523 0.544 0 C-N-CA 121.269 -0.491 . . . . 0.0 112.421 -178.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.2 172.37 18.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.96 0.41 . . . . 0.0 111.416 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 28.8 m -76.7 128.29 37.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-O 121.071 0.463 . . . . 0.0 110.923 176.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -104.38 92.73 4.45 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 120.964 0.412 . . . . 0.0 110.918 -179.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 66.3 mtm180 57.84 16.62 3.71 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 175.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 7.5 mp 62.54 87.02 0.11 Allowed 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.116 0.484 . . . . 0.0 111.782 -177.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 53.2 p -116.84 12.12 14.68 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -86.77 21.12 2.32 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -175.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 66.2 p -79.71 69.19 5.98 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 122.093 -0.38 . . . . 0.0 111.302 178.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.52 ' HB3' ' HB3' ' A' ' 135' ' ' HIS . 82.8 p 50.12 106.33 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.827 0.851 . . . . 0.0 112.593 -176.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 63.9 mtt180 -55.46 -42.52 74.42 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.773 -176.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -171.66 29.41 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.888 0.851 . . . . 0.0 109.827 172.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 24.3 m -82.55 -25.73 33.07 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.603 -178.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 78.03 -61.32 3.77 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 121.156 -0.545 . . . . 0.0 112.02 -172.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 49.5 m -67.52 114.2 5.98 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 122.359 0.264 . . . . 0.0 110.957 175.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.52 ' HB3' ' HB3' ' A' ' 129' ' ' SER . 39.4 p-80 -140.03 -2.83 1.45 Allowed 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -178.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -77.54 -18.73 56.7 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.733 0.777 . . . . 0.0 109.733 173.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.52 ' O ' ' N ' ' A' ' 139' ' ' PHE . 0.0 OUTLIER -138.68 -175.39 4.12 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.555 172.652 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.693 ' HG3' ' H ' ' A' ' 139' ' ' PHE . 13.7 ptm180 34.17 -73.85 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.189 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 -174.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.693 ' H ' ' HG3' ' A' ' 138' ' ' ARG . 36.3 p90 46.42 177.14 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -178.425 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -90.46 151.29 21.46 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.785 -176.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -74.66 142.6 44.5 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.059 174.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 22.9 t -62.92 98.02 0.12 Allowed 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.101 0.477 . . . . 0.0 111.06 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -61.91 -29.04 71.32 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-N 116.008 -0.542 . . . . 0.0 113.316 -178.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 96.2 mttt 59.28 101.08 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.388 0.613 . . . . 0.0 111.658 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -90.7 -173.81 44.28 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 121.074 -0.584 . . . . 0.0 113.552 -176.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -107.05 144.95 32.97 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.759 0.314 . . . . 0.0 110.708 177.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -68.56 78.97 0.24 Allowed Glycine 0 CA--C 1.527 0.83 0 C-N-CA 121.426 -0.416 . . . . 0.0 113.506 -177.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.435 HG12 ' O ' ' A' ' 148' ' ' ILE . 15.4 tt -146.91 9.56 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 CA-C-O 121.391 0.615 . . . . 0.0 111.384 179.185 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -73.26 82.3 1.35 Allowed 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.12 0.486 . . . . 0.0 111.648 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 145.58 123.93 1.62 Allowed Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.235 -0.507 . . . . 0.0 112.899 178.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 62.7 ttt-85 -118.63 95.99 5.09 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 120.884 0.373 . . . . 0.0 110.993 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -109.58 20.49 18.09 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.003 0.43 . . . . 0.0 111.025 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 62.53 -166.65 0.22 Allowed 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.19 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.524 HG13 ' H ' ' A' ' 156' ' ' ASP . 35.5 pt -91.46 176.67 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-O 121.079 0.466 . . . . 0.0 111.71 178.333 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 75.2 mt -89.64 19.35 4.69 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.814 -179.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.524 ' H ' HG13 ' A' ' 154' ' ' ILE . 10.1 m-20 63.85 -84.44 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.114 0.566 . . . . 0.0 111.938 -177.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 3.9 p30 40.37 -67.5 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -177.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.523 ' N ' ' O ' ' A' ' 156' ' ' ASP . 50.9 m -57.76 87.26 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.223 0.609 . . . . 0.0 112.19 -178.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 159.44 108.91 0.25 Allowed Glycine 0 CA--C 1.526 0.74 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.667 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -68.15 112.55 5.16 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 117.109 0.455 . . . . 0.0 111.951 -173.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.411 ' O ' HG22 ' A' ' 161' ' ' VAL . 11.2 p -135.4 19.77 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 CA-C-O 121.527 0.679 . . . . 0.0 111.146 177.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 76.7 p -95.19 20.14 9.61 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -69.67 108.57 3.93 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 122.139 -0.35 . . . . 0.0 111.656 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 35.9 t80 73.19 -53.39 0.7 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.96 0.904 . . . . 0.0 111.317 -178.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 62.6 tttm 72.88 -57.24 0.64 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.101 0.96 . . . . 0.0 113.349 174.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -60.88 91.65 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -175.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -176.52 167.26 2.73 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.385 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -87.32 -44.69 5.52 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.288 175.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 95.9 m 72.82 -41.03 0.49 Allowed 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 176.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' TYR . . . . . 0.45 ' HA ' ' HE3' ' A' ' 175' ' ' LYS . 80.3 m-85 -73.18 94.18 1.93 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.308 0.575 . . . . 0.0 111.413 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ASP . . . . . 0.406 ' O ' ' HB3' ' A' ' 172' ' ' ALA . 12.1 p-10 -95.53 -8.04 36.29 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.527 -0.761 . . . . 0.0 112.257 -178.228 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.406 ' HB3' ' O ' ' A' ' 171' ' ' ASP . . . 75.31 -42.15 0.47 Allowed 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -178.008 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 44.2 mmtm -62.16 -63.99 1.07 Allowed 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -176.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 9.1 p -166.33 146.02 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 120.782 0.325 . . . . 0.0 111.621 -175.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.45 ' HE3' ' HA ' ' A' ' 170' ' ' TYR . 41.2 mmtm -97.04 52.37 1.15 Allowed 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -179.438 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp 60.36 106.91 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 176.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.782 HD23 ' H ' ' A' ' 177' ' ' LEU . 2.3 pt? -87.64 14.57 8.18 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 . . . . . 0 N--CA 1.471 0.618 0 CA-C-O 121.175 0.512 . . . . 0.0 111.357 176.664 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.3 mtt . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 120.671 0.272 . . . . 0.0 111.129 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.23 -58.77 2.8 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.19 0.519 . . . . 0.0 110.194 173.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -86.18 97.18 10.2 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.766 173.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 95.4 p -80.67 -59.06 2.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.48 -177.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.3 m 55.15 58.35 4.78 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.555 0.693 . . . . 0.0 111.032 -178.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -82.98 -170.92 3.27 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.56 -177.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 48.3 mm -98.32 113.34 32.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-O 120.749 0.309 . . . . 0.0 110.709 177.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.94 -47.97 81.32 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -178.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.05 -29.83 59.88 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 121.1 -0.572 . . . . 0.0 113.047 177.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 50.6 tp -71.78 -45.1 62.7 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.778 0.323 . . . . 0.0 110.705 177.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -59.08 -46.72 87.57 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.017 0.437 . . . . 0.0 111.282 177.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.557 ' HG3' ' HE2' ' A' ' 16' ' ' LYS . 14.1 tp10 -56.91 -47.59 80.21 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.128 179.574 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.5 m -64.35 -42.44 96.23 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.795 177.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -53.97 -46.06 71.54 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.265 176.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.55 ' O ' HG12 ' A' ' 19' ' ' ILE . 94.5 mtt180 -59.28 -55.74 30.97 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.61 176.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.557 ' HE2' ' HG3' ' A' ' 12' ' ' GLU . 50.4 mttm -55.43 -32.5 62.76 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -175.094 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.713 ' HB3' ' HE3' ' A' ' 30' ' ' MET . 11.7 m-85 -81.68 -48.65 11.42 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 122.192 -0.317 . . . . 0.0 111.443 173.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.474 ' HA ' ' HG3' ' A' ' 30' ' ' MET . . . -55.39 -40.47 71.43 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -177.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.55 HG12 ' O ' ' A' ' 15' ' ' ARG . 16.6 pt -99.41 12.82 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 121.426 0.631 . . . . 0.0 110.957 -177.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 37.4 t-80 -58.64 92.93 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.014 -176.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.73 -6.3 57.1 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 121.11 -0.567 . . . . 0.0 113.376 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -134.9 92.85 18.27 Favored Pre-proline 0 CA--C 1.539 0.552 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -63.6 -12.95 33.66 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.348 2.032 . . . . 0.0 111.667 170.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -96.05 7.24 46.93 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.174 178.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.6 -97.25 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -176.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 59.1 m -164.12 -72.05 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 120.913 0.387 . . . . 0.0 111.092 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.59 -31.44 5.57 Favored Glycine 0 N--CA 1.464 0.537 0 C-N-CA 121.185 -0.531 . . . . 0.0 112.052 179.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -100.74 -11.97 19.49 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 120.663 0.268 . . . . 0.0 111.435 174.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -126.5 140.14 52.68 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.827 178.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.713 ' HE3' ' HB3' ' A' ' 17' ' ' PHE . 26.7 ttt -126.15 148.4 49.41 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.765 -173.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.403 ' OD1' ' HB3' ' A' ' 33' ' ' LYS . 10.4 p30 -98.15 174.9 6.3 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 120.933 0.396 . . . . 0.0 111.964 -177.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.4 -26.13 64.24 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 121.368 -0.444 . . . . 0.0 114.119 -176.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.403 ' HB3' ' OD1' ' A' ' 31' ' ' ASN . 39.2 ttpt -63.83 -58.05 8.01 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 122.385 -0.479 . . . . 0.0 111.65 -177.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -74.03 -18.7 60.81 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 120.753 0.311 . . . . 0.0 111.603 178.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.45 ' NE1' HG12 ' A' ' 55' ' ' VAL . 58.8 t-105 -65.75 -47.6 74.69 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 121.142 0.496 . . . . 0.0 110.927 172.093 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.34 -36.97 79.21 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.181 0.515 . . . . 0.0 110.771 174.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 25.2 tptp -66.57 -44.73 81.46 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.842 176.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.429 HD12 ' HE1' ' A' ' 30' ' ' MET . 5.0 tt -53.86 -56.44 17.59 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.625 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.721 ' HA ' ' SG ' ' A' ' 42' ' ' CYS . 23.9 p -64.45 -32.64 74.35 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.694 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 50.5 tptt -72.7 -36.7 67.89 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 120.589 0.233 . . . . 0.0 111.481 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -73.45 -40.09 64.44 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 120.614 0.245 . . . . 0.0 111.473 177.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.721 ' SG ' ' HA ' ' A' ' 39' ' ' CYS . 27.6 p -79.27 -4.72 52.07 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.403 0.62 . . . . 0.0 110.386 172.183 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 22.4 mtpp 57.51 23.4 9.11 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.147 -0.933 . . . . 0.0 113.463 173.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.563 HG23 ' SG ' ' A' ' 42' ' ' CYS . 93.9 t -57.08 -42.9 80.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 168.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.599 ' HB2' HG21 ' A' ' 55' ' ' VAL . . . -86.59 65.86 9.22 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.637 177.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -155.62 11.09 0.31 Allowed 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.316 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -92.22 37.17 3.45 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 114.683 0.633 . . . . 0.0 114.683 -170.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt 54.2 13.29 0.58 Allowed 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 117.402 0.601 . . . . 0.0 112.337 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 42.8 t -156.75 -57.03 0.09 Allowed 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.277 0.561 . . . . 0.0 109.578 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.461 HG22 ' HB3' ' A' ' 85' ' ' LYS . 9.3 t -70.88 110.24 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.59 170.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.423 ' H ' ' HB3' ' A' ' 54' ' ' ASP . 68.5 p -135.67 176.1 8.99 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.004 -177.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -48.19 -42.66 24.77 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 121.339 -0.458 . . . . 0.0 113.468 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.578 ' O ' HG12 ' A' ' 57' ' ' ILE . 99.0 m -64.41 -51.18 64.49 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 122.506 -0.408 . . . . 0.0 111.243 177.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.423 ' HB3' ' H ' ' A' ' 51' ' ' THR . 37.1 t70 -56.94 -39.26 74.21 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.17 0.509 . . . . 0.0 111.18 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.599 HG21 ' HB2' ' A' ' 45' ' ' ALA . 64.0 t -72.68 -23.89 21.13 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.684 178.305 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -79.14 -32.51 44.42 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.601 0.715 . . . . 0.0 109.565 178.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.578 HG12 ' O ' ' A' ' 53' ' ' THR . 16.1 mm -58.51 -47.99 86.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.276 171.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 55.5 t -60.45 -42.85 92.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.849 175.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -57.21 -39.99 76.56 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.083 0.468 . . . . 0.0 110.64 174.028 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 33.5 t -69.4 -35.82 76.16 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.941 177.094 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.425 ' HG2' ' O ' ' A' ' 57' ' ' ILE . 11.9 mmmm -61.29 -31.44 71.27 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.234 0.54 . . . . 0.0 111.535 177.27 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.533 HG21 ' HB2' ' A' ' 78' ' ' ALA . 20.0 m -113.11 20.82 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.943 -178.039 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.506 ' HA ' HG22 ' A' ' 70' ' ' ILE . 40.1 ttmt -73.84 123.17 23.68 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 120.895 0.379 . . . . 0.0 111.991 -178.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -57.74 86.66 0.01 OUTLIER Glycine 0 CA--C 1.529 0.928 0 CA-C-N 116.057 -0.52 . . . . 0.0 113.121 176.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 61.3 mttm 64.95 -78.33 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.275 0.63 . . . . 0.0 111.464 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 81.1 p -146.54 3.93 0.88 Allowed 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.447 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -69.82 151.04 46.2 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -173.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.542 ' HG3' HG13 ' A' ' 69' ' ' VAL . 1.8 ptm180 -73.13 -6.98 49.27 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.187 174.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.542 HG13 ' HG3' ' A' ' 68' ' ' ARG . 30.6 m -125.71 142.84 41.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-O 121.113 0.482 . . . . 0.0 112.221 -178.092 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.506 HG22 ' HA ' ' A' ' 63' ' ' LYS . 35.3 pt -113.3 151.49 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.595 176.111 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -86.9 169.83 12.16 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.075 0.464 . . . . 0.0 111.868 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.438 ' O ' ' HB3' ' A' ' 75' ' ' PHE . 86.9 t80 -52.07 -38.36 56.93 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -175.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.484 ' O ' ' HG3' ' A' ' 77' ' ' LYS . 33.7 tt0 -70.14 -41.36 73.99 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.445 -0.784 . . . . 0.0 110.765 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -64.78 -33.28 75.61 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.248 0.547 . . . . 0.0 110.341 177.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.438 ' HB3' ' O ' ' A' ' 72' ' ' TYR . 67.7 t80 -55.86 -46.35 78.25 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.987 171.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 23.0 mtmt -64.36 -39.37 93.74 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.886 0.374 . . . . 0.0 111.455 176.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.484 ' HG3' ' O ' ' A' ' 73' ' ' GLU . 60.7 mttm -60.18 -39.83 87.85 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.314 0.578 . . . . 0.0 110.363 176.266 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.533 ' HB2' HG21 ' A' ' 62' ' ' VAL . . . -63.53 -46.88 83.98 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.136 176.183 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 86.2 mt -58.61 -34.17 70.84 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.86 0.362 . . . . 0.0 111.228 175.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.457 ' HB3' ' O ' ' A' ' 77' ' ' LYS . 10.4 tp10 -55.47 -59.82 4.29 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.533 0.682 . . . . 0.0 110.838 176.012 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.58 ' O ' ' HG2' ' A' ' 85' ' ' LYS . 47.2 mt-10 -61.18 -47.98 83.65 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.409 178.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 69.5 mt -56.8 -33.75 67.0 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 178.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.36 -48.58 81.12 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 120.906 0.384 . . . . 0.0 110.86 175.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 31.0 p -72.72 -8.56 56.0 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 116.194 -0.457 . . . . 0.0 112.072 177.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.58 ' HG2' ' O ' ' A' ' 81' ' ' GLU . 73.1 mmtt -79.82 -51.58 8.97 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.133 0.492 . . . . 0.0 110.697 174.137 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 8.2 mmt180 -82.55 -58.07 3.07 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -178.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -86.59 56.88 4.2 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -170.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 66.3 mttm 61.81 175.85 0.12 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.357 0.599 . . . . 0.0 111.989 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -96.87 29.53 10.41 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.669 176.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -143.44 169.19 18.14 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 122.75 0.42 . . . . 0.0 110.861 -178.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 46.4 t 55.62 47.0 21.66 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.153 0.502 . . . . 0.0 111.529 177.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.469 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 22.0 pttp -64.19 -20.22 65.87 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -174.03 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -63.08 -59.53 4.67 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.296 0.57 . . . . 0.0 109.871 172.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -57.3 -43.75 83.49 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.452 175.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.469 ' HB3' ' HA ' ' A' ' 92' ' ' LYS . . . -58.51 -46.2 87.24 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.026 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -61.04 -53.79 52.81 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.944 0.402 . . . . 0.0 111.212 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -57.15 -37.9 72.75 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 120.808 0.337 . . . . 0.0 111.842 176.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.24 -49.82 68.2 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -179.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 12.5 tt -63.7 -39.94 87.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-O 121.111 0.481 . . . . 0.0 110.874 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 36.5 t -61.3 -39.33 90.07 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.037 0.446 . . . . 0.0 110.927 174.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -60.75 -39.35 88.39 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.677 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 93.1 mt -66.8 -36.02 81.41 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.706 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 49.9 t -83.15 -37.07 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -178.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -57.21 104.09 0.15 Allowed 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -174.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 94.81 13.56 52.83 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-N 116.154 -0.475 . . . . 0.0 113.678 174.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 46.2 tttp -86.3 161.35 18.79 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.973 0.416 . . . . 0.0 111.273 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -73.28 136.11 78.99 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.777 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.61 73.46 2.3 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.468 2.112 . . . . 0.0 112.015 175.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 62.65 93.18 0.05 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.781 -175.149 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 14.8 p30 -75.59 73.49 2.59 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 121.855 0.836 . . . . 0.0 111.973 -178.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 7.4 p -166.37 -36.81 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.718 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -63.03 122.26 27.03 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 121.251 -0.499 . . . . 0.0 112.951 176.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 50.0 t -88.74 110.66 21.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 O-C-N 122.471 -0.429 . . . . 0.0 111.584 -178.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 91.2 m -127.19 -49.48 1.44 Allowed 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.683 176.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 67.2 mttm 66.01 -78.45 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.612 176.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.45 157.69 36.61 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -172.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -133.49 108.02 8.39 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.482 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 89.6 m -87.23 -77.78 0.32 Allowed 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -174.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -133.74 166.78 23.83 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 120.466 -0.873 . . . . 0.0 114.109 -173.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -89.74 -24.79 29.32 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 121.552 -0.356 . . . . 0.0 113.484 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 63.56 15.26 8.72 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 177.168 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.41 ' O ' ' HB2' ' A' ' 123' ' ' ASP . 22.6 m -94.7 -167.07 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -177.399 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.41 ' HB2' ' O ' ' A' ' 122' ' ' VAL . 16.2 m-20 76.07 -33.08 0.21 Allowed 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 178.545 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 63.8 ttt180 -59.16 -55.36 36.03 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -91.58 38.48 0.98 Allowed 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -173.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.1 t -151.68 96.37 2.24 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.175 0.512 . . . . 0.0 112.312 179.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -54.25 142.94 24.5 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.601 174.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 79.8 p -58.34 106.2 0.36 Allowed 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.005 0.431 . . . . 0.0 111.246 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 96.2 p -160.1 145.7 15.29 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.885 -178.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? -90.1 -14.36 33.87 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.852 -176.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -109.92 -84.37 0.55 Allowed 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 -177.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 8.8 t -153.36 21.56 0.55 Allowed 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 121.007 0.432 . . . . 0.0 112.049 -175.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 148.09 166.88 13.06 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 121.128 -0.558 . . . . 0.0 112.611 -176.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 82.7 p -147.35 -168.99 3.2 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 122.764 -0.256 . . . . 0.0 110.785 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 12.2 m80 68.84 -77.27 0.05 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 122.738 0.415 . . . . 0.0 111.045 -177.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -141.99 130.97 23.11 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.912 0.387 . . . . 0.0 110.433 176.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -79.15 -51.89 8.92 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.312 0.577 . . . . 0.0 111.897 -173.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 85.2 mtt180 -120.05 112.89 19.7 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.497 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -82.64 179.83 7.66 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 120.473 0.178 . . . . 0.0 110.526 174.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -72.69 136.75 45.66 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 122.166 -0.334 . . . . 0.0 110.592 177.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -67.02 101.72 0.89 Allowed 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -174.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 32.0 t -91.19 -153.3 0.31 Allowed 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.159 175.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -75.6 48.12 2.2 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 120.968 -0.634 . . . . 0.0 113.602 177.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -89.76 113.69 25.27 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 122.401 -0.47 . . . . 0.0 110.533 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 78.78 -66.37 3.35 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.133 -177.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 12.1 ptmm? -58.73 -45.19 90.16 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.021 0.439 . . . . 0.0 111.26 175.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 68.1 142.01 0.08 OUTLIER Glycine 0 CA--C 1.529 0.958 0 N-CA-C 115.058 0.783 . . . . 0.0 115.058 175.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 49.6 mm -82.64 -50.86 15.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 169.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -98.48 105.38 17.51 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 166.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -128.04 -96.08 0.87 Allowed Glycine 0 CA--C 1.525 0.7 0 C-N-CA 120.466 -0.874 . . . . 0.0 115.019 -168.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 23.1 ttp180 -92.77 122.58 35.3 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -168.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -79.67 148.49 31.58 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 165.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -53.1 127.23 23.41 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -171.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 37.6 pt -120.63 175.75 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.328 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 78.6 mt -79.84 80.88 6.19 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.979 0.419 . . . . 0.0 111.752 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -74.06 53.81 0.5 Allowed 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.49 175.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -75.31 83.3 2.44 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.01 0.433 . . . . 0.0 111.827 -174.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 26.8 m -172.75 156.31 3.45 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.402 0.681 . . . . 0.0 110.489 177.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.403 ' O ' ' N ' ' A' ' 161' ' ' VAL . . . -54.97 117.98 9.17 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 120.322 -0.942 . . . . 0.0 110.953 169.399 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -59.05 82.7 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 -170.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.403 ' N ' ' O ' ' A' ' 159' ' ' GLY . 7.5 p -111.19 -40.03 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.953 171.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 36.8 t -176.37 -177.91 0.9 Allowed 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.133 178.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -68.0 -37.25 81.25 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.731 0.301 . . . . 0.0 111.363 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 85.4 t80 74.35 -55.18 0.66 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.864 0.865 . . . . 0.0 112.767 175.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -58.17 -40.3 81.09 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.03 0.443 . . . . 0.0 111.688 -176.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -105.95 122.18 45.62 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.525 177.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -58.87 123.27 15.92 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.002 0.429 . . . . 0.0 111.525 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -93.97 -155.44 31.76 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 121.221 -0.514 . . . . 0.0 113.543 -175.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 71.2 p -109.5 -166.71 1.12 Allowed 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 120.988 0.423 . . . . 0.0 111.488 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -79.23 18.03 0.73 Allowed 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 112.554 0.575 . . . . 0.0 112.554 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 37.9 t70 69.47 116.34 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.308 0.575 . . . . 0.0 111.627 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -125.3 87.79 2.76 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.122 0.487 . . . . 0.0 112.138 -177.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 49.7 mttp -86.18 -11.55 52.21 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.715 174.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 16.2 m 46.84 14.59 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 N-CA-C 115.441 1.645 . . . . 0.0 115.441 171.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.663 ' HD3' ' HG3' ' A' ' 178' ' ' GLU . 74.7 mmtt -76.46 66.66 2.53 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 121.681 -0.637 . . . . 0.0 110.886 176.31 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -133.09 -64.38 0.74 Allowed 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.256 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.494 HD23 ' H ' ' A' ' 177' ' ' LEU . 1.9 pt? -104.1 17.92 23.11 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.378 0.609 . . . . 0.0 109.968 173.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.663 ' HG3' ' HD3' ' A' ' 175' ' ' LYS . 1.8 tm-20 . . . . . 0 CA--C 1.546 0.812 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.433 -171.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.4 mtt . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 120.684 0.278 . . . . 0.0 110.462 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -54.89 143.16 26.87 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -179.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 63.48 -90.94 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.451 178.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 39.0 t 176.93 -64.01 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 120.904 0.383 . . . . 0.0 111.935 -175.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.0 t -101.42 -174.87 2.7 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -173.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -83.47 123.77 30.04 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -175.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.7 tp -61.6 118.81 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-O 120.895 0.378 . . . . 0.0 110.925 173.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -49.49 -37.67 27.28 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -176.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.35 -29.92 60.87 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 121.417 -0.42 . . . . 0.0 113.74 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 30.9 tp -73.75 -48.38 32.18 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 122.324 -0.515 . . . . 0.0 111.031 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -65.87 -30.05 70.59 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.766 0.317 . . . . 0.0 110.642 176.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -59.27 -55.24 37.33 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.743 0.306 . . . . 0.0 110.444 174.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.7 m -57.94 -42.28 84.54 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.236 176.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -55.73 -56.07 24.87 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.875 0.369 . . . . 0.0 111.064 176.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 57.3 ttt180 -56.19 -51.13 69.14 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.396 0.617 . . . . 0.0 110.87 177.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -52.91 -37.11 60.36 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 114.903 -1.044 . . . . 0.0 112.213 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -85.51 -32.51 22.17 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.697 176.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.76 -39.61 65.51 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -175.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.522 ' H ' HD13 ' A' ' 19' ' ' ILE . 0.2 OUTLIER -103.74 7.45 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -178.927 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 60.0 t60 -35.46 -48.7 0.5 Allowed 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -174.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -138.27 22.44 3.06 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 120.286 -0.959 . . . . 0.0 113.604 -178.116 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.573 ' HB2' ' HB2' ' A' ' 25' ' ' ALA . 8.9 m-20 -121.55 118.7 29.6 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 116.886 0.343 . . . . 0.0 110.863 -176.619 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -46.02 -46.49 15.95 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 123.406 2.737 . . . . 0.0 114.102 -176.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -105.29 -34.09 7.99 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.703 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.573 ' HB2' ' HB2' ' A' ' 22' ' ' ASP . . . 36.99 -90.11 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -172.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 28.0 t 167.76 -45.36 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.825 0.85 . . . . 0.0 110.099 -174.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 88.28 -52.18 4.04 Favored Glycine 0 C--N 1.334 0.462 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.257 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 20.4 tp60 -91.26 -13.26 33.04 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 120.818 0.342 . . . . 0.0 111.376 178.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -128.03 143.99 51.09 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.788 175.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 49.2 ttm -115.24 143.39 45.32 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.285 0.564 . . . . 0.0 112.324 -175.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -93.78 154.75 17.59 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.892 175.23 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -55.52 -26.64 45.92 Favored Glycine 0 CA--C 1.53 0.97 0 CA-C-N 116.122 -0.49 . . . . 0.0 114.104 -176.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -51.07 -60.86 2.65 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 122.026 0.917 . . . . 0.0 110.809 175.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 63.4 m-20 -73.1 -33.97 65.9 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 114.51 -1.223 . . . . 0.0 111.553 -174.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 41.1 t-105 -58.62 -45.21 89.7 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.054 0.454 . . . . 0.0 111.341 174.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.518 ' HA ' HG11 ' A' ' 55' ' ' VAL . . . -60.52 -47.99 83.74 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 120.974 0.416 . . . . 0.0 111.337 176.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -60.7 -37.32 81.26 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.492 176.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.3 tt -59.23 -45.42 91.18 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.336 178.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.665 ' SG ' ' HB ' ' A' ' 44' ' ' VAL . 44.4 t -54.33 -44.41 72.07 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.945 0.402 . . . . 0.0 111.038 175.061 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.535 ' HB3' ' NZ ' ' A' ' 40' ' ' LYS . 4.5 ttpm? -58.98 -54.64 44.8 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.746 176.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -65.55 -35.77 81.84 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -175.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.571 ' SG ' ' HB3' ' A' ' 102' ' ' LEU . 6.0 t -77.84 -9.87 59.27 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 120.799 0.333 . . . . 0.0 111.452 173.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm 69.05 26.95 5.48 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.197 0.599 . . . . 0.0 112.139 174.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.665 ' HB ' ' SG ' ' A' ' 39' ' ' CYS . 60.1 t -68.15 -35.77 72.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 121.054 0.454 . . . . 0.0 111.212 178.01 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.63 100.39 7.8 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.007 0.432 . . . . 0.0 111.683 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -99.91 -25.67 14.26 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.679 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 134.89 -78.99 0.33 Allowed Glycine 0 CA--C 1.529 0.921 0 C-N-CA 120.964 -0.636 . . . . 0.0 113.624 178.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -92.06 -7.32 49.06 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -174.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.4 t -102.35 -49.55 3.85 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.181 0.515 . . . . 0.0 110.041 173.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.457 HG11 HG12 ' A' ' 44' ' ' VAL . 99.1 t -139.65 130.94 33.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.948 176.48 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.459 ' O ' HG23 ' A' ' 55' ' ' VAL . 8.9 t -139.19 -177.86 5.1 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 116.766 -0.197 . . . . 0.0 110.68 173.054 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -46.19 -46.46 15.75 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 121.579 -0.344 . . . . 0.0 113.847 -177.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.54 ' O ' HG12 ' A' ' 57' ' ' ILE . 41.6 m -51.52 -54.81 23.4 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.035 0.445 . . . . 0.0 111.517 176.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -58.93 -34.56 71.86 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.392 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.518 HG11 ' HA ' ' A' ' 36' ' ' ALA . 65.5 t -60.21 -35.72 63.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.286 177.436 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -74.48 -38.5 62.9 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.562 0.696 . . . . 0.0 110.17 178.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.54 HG12 ' O ' ' A' ' 53' ' ' THR . 12.1 mm -61.41 -51.82 68.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.903 178.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 87.8 t -57.69 -41.87 80.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-O 120.912 0.387 . . . . 0.0 111.125 177.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -56.76 -42.26 79.06 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 120.915 0.388 . . . . 0.0 110.563 175.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.403 ' HA ' ' HE3' ' A' ' 63' ' ' LYS . 47.6 t -69.33 -36.76 77.26 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.392 177.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.534 ' HG2' ' O ' ' A' ' 57' ' ' ILE . 1.8 mmmp? -56.33 -35.67 67.86 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.875 0.369 . . . . 0.0 111.261 178.504 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.506 HG21 ' HB2' ' A' ' 78' ' ' ALA . 22.4 m -107.42 -2.7 10.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -177.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.403 ' HE3' ' HA ' ' A' ' 60' ' ' SER . 26.3 ttpp -70.74 101.5 2.1 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.024 0.44 . . . . 0.0 112.142 -178.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -133.98 -146.9 5.55 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-N 116.216 -0.447 . . . . 0.0 113.285 177.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 62.1 mttp 53.37 -103.05 0.15 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.842 0.457 . . . . 0.0 112.031 -176.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 88.0 p -109.0 -1.87 18.63 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.735 0.302 . . . . 0.0 110.899 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 66.0 -168.89 0.2 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.641 -177.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 20.3 tpp180 73.06 -51.56 0.71 Allowed 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.375 0.607 . . . . 0.0 111.034 -176.149 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 12.6 m -132.51 149.07 31.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.862 -178.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 37.5 pt -113.13 140.6 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-O 120.668 0.271 . . . . 0.0 111.113 177.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -85.37 177.73 7.7 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.9 -0.5 . . . . 0.0 111.341 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -55.1 -37.05 66.35 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -177.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.572 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 42.5 mt-10 -61.08 -53.34 58.34 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.189 0.519 . . . . 0.0 111.497 177.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -69.43 -20.77 63.77 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.243 0.544 . . . . 0.0 110.791 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -69.84 -54.87 11.56 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.959 173.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.572 ' HE2' ' HA ' ' A' ' 73' ' ' GLU . 63.8 pttt -62.54 -30.4 71.27 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.091 0.472 . . . . 0.0 110.533 177.01 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -64.42 -40.56 96.0 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.851 173.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.506 ' HB2' HG21 ' A' ' 62' ' ' VAL . . . -67.73 -38.73 83.95 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.03 0.443 . . . . 0.0 111.374 175.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 80.7 mt -59.98 -41.09 91.23 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.103 176.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -60.29 -42.49 95.58 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 120.664 0.269 . . . . 0.0 111.021 176.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -54.14 -62.81 1.42 Allowed 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.041 0.448 . . . . 0.0 110.769 174.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.537 HD13 HG11 ' A' ' 44' ' ' VAL . 90.5 mt -52.43 -43.98 65.18 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.434 178.3 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.13 -54.33 47.17 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.85 -0.613 . . . . 0.0 112.21 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.461 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 63.4 p -64.18 -20.55 66.09 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -177.296 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -96.72 -23.1 16.59 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 65.5 mtp85 -97.1 -50.63 4.52 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 121.797 -0.564 . . . . 0.0 111.744 175.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -86.75 31.45 0.69 Allowed 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.029 0.442 . . . . 0.0 111.331 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.461 ' HB3' ' O ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -71.63 172.55 9.47 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -177.857 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 78.62 24.36 62.85 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 121.063 -0.589 . . . . 0.0 113.183 -178.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -168.86 -168.75 0.9 Allowed 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 120.826 0.346 . . . . 0.0 111.155 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 65.8 m -56.07 120.72 7.94 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -177.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -55.96 -33.21 64.56 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.321 175.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -54.76 -56.11 22.8 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.204 0.526 . . . . 0.0 110.97 174.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -63.91 -29.75 70.9 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.537 -178.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.53 -57.44 12.67 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.961 0.41 . . . . 0.0 111.017 176.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.523 ' O ' HG22 ' A' ' 99' ' ' ILE . 80.8 t80 -64.94 -35.99 82.95 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.218 0.532 . . . . 0.0 110.791 177.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -55.08 -47.5 74.8 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.461 0.648 . . . . 0.0 111.052 176.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -71.78 -42.08 67.57 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.518 -177.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.523 HG22 ' O ' ' A' ' 96' ' ' PHE . 7.3 tp -61.62 -34.02 60.01 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 CA-C-O 121.351 0.596 . . . . 0.0 110.214 178.265 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 35.8 t -64.67 -42.71 95.19 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.946 173.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -55.41 -35.12 65.01 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.123 0.487 . . . . 0.0 111.846 176.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.571 ' HB3' ' SG ' ' A' ' 42' ' ' CYS . 97.5 mt -73.29 -48.02 37.97 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 49.1 t -86.67 -53.59 9.93 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -173.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.22 127.39 24.27 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -171.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.59 -39.32 3.1 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-N 116.035 -0.529 . . . . 0.0 113.841 176.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 58.9 tttp -63.05 162.19 11.94 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-O 121.504 0.668 . . . . 0.0 112.799 -174.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.463 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 0.3 OUTLIER -124.48 161.94 45.2 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.679 175.019 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.463 ' HD2' ' HB2' ' A' ' 107' ' ' GLU . 19.0 Cg_endo -58.17 155.69 33.33 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.515 2.143 . . . . 0.0 112.922 176.511 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -54.74 98.64 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -179.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 70.01 103.98 0.06 Allowed 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.556 0.693 . . . . 0.0 112.757 175.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.9 t -70.31 -25.96 28.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.814 176.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 65.21 -134.65 36.63 Favored Glycine 0 CA--C 1.525 0.659 0 CA-C-N 116.129 -0.487 . . . . 0.0 113.124 177.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 6.3 p -65.84 109.94 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-O 121.384 0.611 . . . . 0.0 111.444 177.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 62.1 p -66.91 116.43 7.76 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.372 -176.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 52.4 mttp -98.03 107.06 19.45 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.256 179.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -87.71 108.36 19.07 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -172.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.569 ' HD3' ' O ' ' A' ' 117' ' ' LYS . 7.8 tmtm? -92.97 -19.14 21.91 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.453 175.48 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 69.6 p -48.98 -57.57 6.29 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -176.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -77.95 48.19 2.96 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 121.253 -0.498 . . . . 0.0 113.425 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -112.06 26.6 11.19 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 121.355 -0.45 . . . . 0.0 113.018 177.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.537 ' O ' HG22 ' A' ' 122' ' ' VAL . . . 67.7 -6.59 0.67 Allowed 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 176.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.537 HG22 ' O ' ' A' ' 121' ' ' ALA . 2.9 m 53.76 156.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 C-N-CA 124.489 1.116 . . . . 0.0 113.53 -178.344 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -138.35 132.47 31.58 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.846 -0.534 . . . . 0.0 112.067 -177.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.62 57.83 3.93 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.568 0.699 . . . . 0.0 111.309 176.276 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.432 ' HG ' ' H ' ' A' ' 125' ' ' LEU . 1.3 pp -77.34 21.69 0.25 Allowed 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -176.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 62.7 p -74.62 102.27 4.51 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.801 0.334 . . . . 0.0 110.79 176.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -53.74 132.78 41.74 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 121.114 0.483 . . . . 0.0 111.965 178.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.2 t -73.65 75.74 1.52 Allowed 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.362 0.601 . . . . 0.0 111.798 178.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.482 ' HB3' ' HD2' ' A' ' 131' ' ' TYR . 66.9 m -63.68 -52.37 60.96 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.871 -179.069 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.429 ' HB3' ' OG ' ' A' ' 134' ' ' SER . 9.8 mtp180 68.91 -15.18 0.26 Allowed 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 174.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.482 ' HD2' ' HB3' ' A' ' 129' ' ' SER . 98.7 m-85 -45.01 122.01 3.09 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -177.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 32.1 p 70.19 -33.29 0.26 Allowed 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.446 1.099 . . . . 0.0 113.093 178.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -67.36 -25.69 73.64 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.654 176.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.494 ' O ' ' HB2' ' A' ' 135' ' ' HIS . 81.9 p -133.13 52.53 2.08 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 122.604 0.362 . . . . 0.0 110.658 175.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.494 ' HB2' ' O ' ' A' ' 134' ' ' SER . 82.8 m-70 71.72 -168.36 0.14 Allowed 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.219 0.533 . . . . 0.0 111.725 -175.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -82.13 107.84 15.14 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.527 178.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -70.84 65.51 0.34 Allowed 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.477 0.656 . . . . 0.0 110.366 174.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -92.97 -81.58 0.35 Allowed 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.902 -171.039 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 58.33 96.11 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.151 0.581 . . . . 0.0 112.313 177.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -101.51 -63.76 1.11 Allowed 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 121.133 0.492 . . . . 0.0 111.745 -176.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 62.01 -83.07 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.726 -174.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 72.7 p 179.27 -37.52 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 120.843 0.354 . . . . 0.0 111.56 -174.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -57.35 134.71 52.22 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-N 116.354 -0.385 . . . . 0.0 114.039 -177.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.434 ' HE2' ' HB3' ' A' ' 144' ' ' LYS . 38.6 mtpt 63.86 32.74 13.14 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 178.399 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -71.69 73.22 0.81 Allowed Glycine 0 CA--C 1.532 1.121 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.629 174.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm 62.68 -73.77 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.719 0.808 . . . . 0.0 112.35 -175.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 72.74 -166.22 54.33 Favored Glycine 0 CA--C 1.529 0.906 0 C-N-CA 121.366 -0.445 . . . . 0.0 113.249 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.447 ' N ' HD12 ' A' ' 148' ' ' ILE . 2.8 mp 59.76 122.03 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 CA-C-O 121.391 0.615 . . . . 0.0 112.177 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -80.46 94.58 6.23 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 122.05 -0.406 . . . . 0.0 111.478 179.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 61.85 -139.89 46.77 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 121.256 -0.497 . . . . 0.0 112.697 -178.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 47.0 mtt180 59.42 30.08 19.72 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 174.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -87.53 173.86 8.83 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.176 0.512 . . . . 0.0 111.925 -176.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -65.04 115.04 5.02 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 -176.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 67.1 mt -76.99 131.43 34.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 170.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.493 HD12 ' N ' ' A' ' 155' ' ' LEU . 5.5 mp -83.2 40.27 0.7 Allowed 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -173.197 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 63.22 -72.21 0.05 Allowed 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -61.18 85.64 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.254 0.549 . . . . 0.0 111.795 -178.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 57.3 p -94.11 -11.15 31.14 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.703 178.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 102.87 -107.56 3.11 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 121.263 -0.494 . . . . 0.0 113.044 178.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 81.1 t80 66.96 156.18 0.11 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.148 0.579 . . . . 0.0 112.058 178.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 57.1 t -56.08 96.43 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 121.366 0.603 . . . . 0.0 111.225 177.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 68.1 m -112.56 25.33 11.58 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.004 -175.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -55.25 -35.48 65.02 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.338 0.589 . . . . 0.0 111.313 174.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -98.92 10.58 41.09 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.429 176.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.504 ' HG3' ' OH ' ' A' ' 170' ' ' TYR . 75.5 mmtt 67.26 123.07 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.438 0.695 . . . . 0.0 112.362 -177.225 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -82.87 133.67 35.12 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 120.808 0.337 . . . . 0.0 111.137 178.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 68.81 -4.71 1.13 Allowed 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 176.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 54.87 37.57 62.57 Favored Glycine 0 CA--C 1.531 1.077 0 N-CA-C 114.418 0.527 . . . . 0.0 114.418 177.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 86.9 m -76.74 85.97 3.36 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.279 0.561 . . . . 0.0 111.799 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' TYR . . . . . 0.504 ' OH ' ' HG3' ' A' ' 165' ' ' LYS . 65.1 m-85 -107.96 -9.22 15.72 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.677 172.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 31.6 t70 56.74 71.64 0.56 Allowed 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.145 -177.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -129.72 16.11 5.86 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.613 0.72 . . . . 0.0 109.944 172.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 46.5 mttm -91.31 25.46 2.55 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.608 -171.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 14.6 p -62.52 -24.52 35.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -176.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -66.59 83.64 0.1 Allowed 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.485 0.659 . . . . 0.0 111.915 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -96.48 -27.16 15.01 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.974 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 85.2 mt -64.56 -53.34 49.35 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -172.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.526 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -176.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.0 mmt . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 120.574 0.226 . . . . 0.0 111.136 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.41 -63.17 1.16 Allowed 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -176.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 55.04 -152.82 0.34 Allowed 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.071 -177.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 67.6 m -63.02 88.94 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.098 0.475 . . . . 0.0 110.123 171.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 71.1 p -58.24 116.33 3.51 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 113.415 0.895 . . . . 0.0 113.415 -172.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -129.36 163.31 26.04 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.517 173.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.522 ' HB ' ' HB2' ' A' ' 10' ' ' LEU . 42.6 mm -86.78 -10.38 11.12 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 CA-C-O 120.629 0.252 . . . . 0.0 111.512 -178.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 72.37 -58.93 0.58 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.463 0.705 . . . . 0.0 110.812 -175.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -63.79 -16.73 59.61 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 120.955 -0.641 . . . . 0.0 112.393 172.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.522 ' HB2' ' HB ' ' A' ' 7' ' ' ILE . 53.7 tp -70.95 -54.7 10.41 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 122.693 -0.298 . . . . 0.0 111.198 178.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.462 ' HG3' ' N ' ' A' ' 12' ' ' GLU . 7.7 pt-20 -61.33 -42.22 98.32 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.788 0.328 . . . . 0.0 110.82 177.675 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.462 ' N ' ' HG3' ' A' ' 11' ' ' GLU . 1.7 tm-20 -64.5 -34.24 77.75 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-O 120.962 0.411 . . . . 0.0 110.921 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.2 t -72.4 -44.12 62.93 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 120.744 0.307 . . . . 0.0 111.143 176.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -56.1 -50.5 70.87 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.141 0.496 . . . . 0.0 110.067 175.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.489 ' O ' HG12 ' A' ' 19' ' ' ILE . 11.2 ttt85 -53.55 -43.04 68.13 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.706 172.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.436 ' HB2' ' HE2' ' A' ' 16' ' ' LYS . 9.6 tppt? -54.0 -46.21 71.68 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.053 0.454 . . . . 0.0 111.581 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -79.93 -33.63 39.53 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 177.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.13 -38.41 91.08 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.893 0.377 . . . . 0.0 111.781 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.604 HD12 ' HD2' ' A' ' 115' ' ' LYS . 23.8 pt -83.26 -7.86 11.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 121.016 0.436 . . . . 0.0 111.689 178.178 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -64.69 86.7 0.05 Allowed 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.295 0.569 . . . . 0.0 110.748 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 142.02 -40.25 1.31 Allowed Glycine 0 CA--C 1.524 0.613 0 CA-C-N 115.685 -0.688 . . . . 0.0 112.048 -178.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -128.63 111.39 19.09 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-O 120.727 0.298 . . . . 0.0 110.806 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.46 -0.19 9.83 Favored 'Trans proline' 0 CA--C 1.546 1.079 0 C-N-CA 122.5 2.133 . . . . 0.0 114.425 -176.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.419 ' HE2' ' HB2' ' A' ' 24' ' ' LYS . 2.8 mppt? -100.35 -28.38 12.98 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 121.855 -0.528 . . . . 0.0 111.04 178.328 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.69 134.96 55.17 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 43.1 m -65.54 -35.21 80.19 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.73 178.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.07 45.88 2.52 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-N 116.203 -0.453 . . . . 0.0 113.81 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -103.56 -16.32 15.56 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 122.374 -0.486 . . . . 0.0 111.326 179.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -136.56 154.23 50.76 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.008 -174.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 49.1 ttm -143.6 143.59 31.56 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 120.92 0.39 . . . . 0.0 112.003 -174.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 23.5 p30 -90.09 166.02 13.66 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.063 0.459 . . . . 0.0 111.52 177.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.42 -20.31 61.0 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 121.251 -0.499 . . . . 0.0 113.236 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.433 ' HA ' ' HD3' ' A' ' 33' ' ' LYS . 41.1 mmtm -69.07 -55.38 10.95 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.729 0.3 . . . . 0.0 111.619 177.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -65.67 -34.78 79.02 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.156 176.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 41.2 t-105 -62.45 -48.28 80.34 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 122.602 0.361 . . . . 0.0 111.597 175.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.46 -46.48 89.94 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.117 0.484 . . . . 0.0 111.112 177.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 57.6 tttp -64.46 -35.03 79.62 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.975 178.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.3 tt -59.16 -45.06 91.98 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.311 175.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 73.9 m -60.08 -46.01 91.0 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.407 177.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -60.33 -52.43 65.3 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.578 0.228 . . . . 0.0 111.586 177.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -53.66 -41.68 67.09 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.102 0.477 . . . . 0.0 111.012 177.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.703 ' SG ' ' HA ' ' A' ' 103' ' ' VAL . 58.7 m -89.73 1.09 56.52 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.983 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp 55.56 33.25 20.74 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 122.88 0.472 . . . . 0.0 112.104 177.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.46 ' HA ' ' NH1' ' A' ' 86' ' ' ARG . 55.5 t -72.69 -29.52 30.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.735 178.436 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -97.36 102.54 14.33 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.815 0.341 . . . . 0.0 111.778 -179.046 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -57.59 -50.46 73.05 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.484 0.659 . . . . 0.0 112.194 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.02 -16.72 60.62 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 -166.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.42 ' NZ ' ' HB3' ' A' ' 48' ' ' LYS . 6.8 ttpm? -96.44 -64.09 1.08 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.239 0.616 . . . . 0.0 110.618 176.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 45.6 p -95.75 -66.53 0.9 Allowed 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.692 177.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 52.3 t -82.92 98.9 5.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 170.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 80.9 p -89.65 -84.54 0.22 Allowed 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -169.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -152.89 -39.05 0.03 OUTLIER Glycine 0 C--O 1.236 0.229 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.651 ' O ' HG13 ' A' ' 57' ' ' ILE . 26.9 p -48.95 -53.96 17.58 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.012 0.434 . . . . 0.0 109.911 172.614 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.504 ' O ' HG23 ' A' ' 58' ' ' VAL . 6.2 m-20 -48.43 -49.17 36.25 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.231 -175.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.3 t -60.5 -40.08 83.21 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.277 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -75.35 -43.74 48.94 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.582 0.706 . . . . 0.0 110.196 -176.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.651 HG13 ' O ' ' A' ' 53' ' ' THR . 8.0 mt -62.49 -45.24 99.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.117 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 54' ' ' ASP . 79.4 t -59.66 -41.88 86.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-O 120.554 0.216 . . . . 0.0 111.183 176.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.43 ' O ' ' HG3' ' A' ' 63' ' ' LYS . 76.1 t80 -55.2 -40.93 71.35 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.898 0.38 . . . . 0.0 111.5 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 51.6 p -80.77 -34.13 34.44 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.206 0.527 . . . . 0.0 110.998 177.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 55.3 tttp -65.81 -31.3 72.19 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.234 -174.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.7 m -88.33 -3.7 9.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.582 ' HD3' ' O ' ' A' ' 66' ' ' SER . 96.7 mttt -72.12 163.28 28.18 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -178.144 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -105.07 -98.92 2.57 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.981 176.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -80.08 75.46 6.84 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 122.44 -0.447 . . . . 0.0 111.132 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.582 ' O ' ' HD3' ' A' ' 63' ' ' LYS . 55.0 m 59.76 -79.09 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 122.334 0.254 . . . . 0.0 110.819 -175.482 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 64.28 129.3 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 114.09 1.144 . . . . 0.0 114.09 173.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.2 ptm85 -81.95 -21.67 37.1 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.255 173.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 28.3 m -136.41 151.72 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.076 -178.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 39.4 pt -99.6 161.46 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-O 120.589 0.233 . . . . 0.0 110.776 176.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -110.79 166.97 10.59 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.09 0.471 . . . . 0.0 111.49 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.404 ' O ' ' HB3' ' A' ' 75' ' ' PHE . 16.6 t80 -46.46 -36.79 6.96 Favored 'General case' 0 CA--C 1.554 1.133 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -177.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -73.3 -36.67 66.32 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 121.619 -0.676 . . . . 0.0 112.029 -178.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -72.28 -29.91 64.33 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.356 0.598 . . . . 0.0 109.981 174.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.404 ' HB3' ' O ' ' A' ' 72' ' ' TYR . 73.2 t80 -58.64 -44.31 90.04 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.587 176.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -47.7 -61.05 2.13 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.162 0.506 . . . . 0.0 111.604 174.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -64.88 -29.38 70.33 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.309 -176.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.26 -49.86 75.38 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.25 0.548 . . . . 0.0 110.98 173.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 62.2 mt -64.5 -41.7 96.28 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.486 176.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.521 ' O ' HG23 ' A' ' 84' ' ' THR . 31.8 tt0 -60.33 -40.74 91.7 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.54 -178.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -62.31 -59.2 5.35 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 120.85 0.357 . . . . 0.0 110.347 177.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 90.4 mt -57.03 -29.52 63.44 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.974 0.416 . . . . 0.0 111.394 178.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.41 -39.34 90.36 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.648 174.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.521 HG23 ' O ' ' A' ' 80' ' ' GLU . 8.6 p -68.63 -34.56 75.95 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 121.066 0.46 . . . . 0.0 110.986 178.245 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -69.53 -36.26 76.22 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.71 175.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.46 ' NH1' ' HA ' ' A' ' 44' ' ' VAL . 3.3 tpt180 -85.58 -62.24 1.57 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.341 0.591 . . . . 0.0 111.494 -177.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -96.67 93.44 6.73 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.387 -176.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -92.12 27.92 2.03 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 121.231 0.538 . . . . 0.0 110.653 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -60.03 -78.73 0.13 Allowed Glycine 0 CA--C 1.529 0.921 0 CA-C-N 116.028 -0.533 . . . . 0.0 113.957 -175.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.9 pttp -162.79 -60.62 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -177.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 54.7 m -91.32 132.9 35.86 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -173.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -64.95 -34.92 79.57 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.031 0.443 . . . . 0.0 110.718 176.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -57.2 -52.92 63.37 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.238 0.542 . . . . 0.0 110.484 171.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -55.73 -46.26 77.82 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.287 177.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.48 -48.94 79.13 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.97 0.414 . . . . 0.0 111.274 177.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -65.49 -36.54 84.15 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.022 178.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.465 ' O ' ' HG3' ' A' ' 101' ' ' GLN . 23.6 t70 -57.02 -62.18 1.93 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.391 0.615 . . . . 0.0 110.964 176.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -53.47 -46.85 70.09 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.607 -178.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.482 ' O ' HG23 ' A' ' 103' ' ' VAL . 16.7 tt -66.53 -38.45 81.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 O-C-N 122.056 -0.403 . . . . 0.0 111.232 -179.253 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 93.5 m -64.46 -35.96 82.62 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.783 0.325 . . . . 0.0 111.043 176.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.465 ' HG3' ' O ' ' A' ' 97' ' ' ASP . 88.1 mt-30 -63.69 -31.87 73.18 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 120.985 0.422 . . . . 0.0 111.09 176.014 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.9 mt -77.7 -9.62 59.09 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.918 177.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.703 ' HA ' ' SG ' ' A' ' 42' ' ' CYS . 69.4 t -108.79 -43.79 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -177.359 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -50.03 87.37 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 -170.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 48.1 65.27 2.58 Favored Glycine 0 CA--C 1.531 1.035 0 N-CA-C 115.084 0.794 . . . . 0.0 115.084 170.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm -79.22 -82.33 0.1 Allowed 'General case' 0 N--CA 1.471 0.612 0 O-C-N 122.273 -0.545 . . . . 0.0 111.845 178.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.532 ' N ' ' HD3' ' A' ' 108' ' ' PRO . 10.9 pt-20 -149.65 32.38 0.07 OUTLIER Pre-proline 0 CA--C 1.554 1.128 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.532 ' HD3' ' N ' ' A' ' 107' ' ' GLU . 71.7 Cg_endo -76.32 149.75 31.87 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.001 1.801 . . . . 0.0 113.424 -173.21 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 72.83 -54.83 0.69 Allowed 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 68.0 166.26 0.24 Allowed 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.111 0.564 . . . . 0.0 111.07 -176.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 60.8 t 60.12 88.12 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-O 121.382 0.611 . . . . 0.0 110.258 -172.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -68.92 77.68 0.28 Allowed Glycine 0 CA--C 1.527 0.782 0 CA-C-N 115.85 -0.613 . . . . 0.0 114.393 -172.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 30.9 m -70.17 130.21 34.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 CA-C-O 121.022 0.439 . . . . 0.0 110.707 172.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 77.3 p -62.57 161.76 11.55 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.223 0.535 . . . . 0.0 112.443 -175.242 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.604 ' HD2' HD12 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -147.2 153.92 40.43 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.038 0.447 . . . . 0.0 111.714 -177.961 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.413 ' N ' ' HG3' ' A' ' 115' ' ' LYS . . . -65.99 152.89 43.6 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 178.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -60.7 142.81 55.4 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.196 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 90.0 m -75.31 134.4 41.06 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.069 175.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 146.75 -170.18 27.77 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 121.042 -0.599 . . . . 0.0 113.028 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 115.93 -51.78 0.7 Allowed Glycine 0 CA--C 1.527 0.806 0 C-N-CA 121.467 -0.397 . . . . 0.0 113.074 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 66.34 177.73 0.22 Allowed 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 121.108 0.48 . . . . 0.0 112.168 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 33.1 m -87.83 135.77 24.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.426 177.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -101.21 -38.72 7.98 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -177.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 53.7 ttt180 -72.76 83.08 1.17 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.714 0.769 . . . . 0.0 112.647 -173.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 90.7 mt -131.37 18.9 4.83 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.188 168.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 71.3 p -92.35 13.18 20.16 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.857 -176.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -74.51 48.13 0.33 Allowed 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 121.173 0.511 . . . . 0.0 111.011 174.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 78.0 p -89.97 -10.41 45.11 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.249 -0.432 . . . . 0.0 112.13 -175.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 38.8 m -66.93 86.81 0.13 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.032 0.444 . . . . 0.0 110.853 177.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 -59.56 -28.76 67.41 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.344 -176.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -106.79 4.34 27.46 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 120.665 0.269 . . . . 0.0 111.304 -178.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 92.9 m 62.7 -69.5 0.06 Allowed 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 122.98 0.512 . . . . 0.0 111.277 -171.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -118.25 148.54 18.51 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 121.533 -0.365 . . . . 0.0 112.51 176.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 87.8 p -118.21 -60.81 1.75 Allowed 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.097 0.475 . . . . 0.0 110.895 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -78.35 -33.14 49.24 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.149 0.5 . . . . 0.0 110.081 173.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -104.13 134.45 47.37 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.186 172.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -70.55 -51.64 27.21 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.843 0.83 . . . . 0.0 110.943 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 17.7 ptt-85 -110.39 -178.68 3.56 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.669 -1.15 . . . . 0.0 110.914 -178.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -63.41 138.78 58.65 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 167.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -59.46 91.46 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.73 0 CA-C-O 121.207 0.527 . . . . 0.0 112.378 -173.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 59.96 -179.77 0.09 Allowed 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.259 -0.882 . . . . 0.0 113.083 178.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 23.0 t -126.53 -14.38 5.8 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.775 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.92 123.73 1.69 Allowed Glycine 0 CA--C 1.528 0.871 0 C-N-CA 121.028 -0.606 . . . . 0.0 113.152 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.453 ' HD2' ' N ' ' A' ' 144' ' ' LYS . 12.0 mptt -83.06 83.19 7.93 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.248 0.547 . . . . 0.0 110.66 178.082 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 169.28 129.58 1.11 Allowed Glycine 0 CA--C 1.527 0.835 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.611 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -157.34 -27.88 0.09 Allowed 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -49.15 100.6 0.03 OUTLIER Glycine 0 CA--C 1.529 0.936 0 C-N-CA 121.511 -0.376 . . . . 0.0 113.653 -177.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.402 ' N ' HD12 ' A' ' 148' ' ' ILE . 2.0 mp 71.83 -17.11 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.11 0 C-N-CA 123.399 0.679 . . . . 0.0 112.469 177.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -63.34 138.93 58.7 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -178.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -154.65 63.51 0.34 Allowed Glycine 0 CA--C 1.531 1.054 0 C-N-CA 120.897 -0.668 . . . . 0.0 113.702 -179.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 14.7 mtm-85 64.51 -82.96 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.149 0.579 . . . . 0.0 111.26 178.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -99.55 98.68 9.54 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 171.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -68.56 78.93 0.28 Allowed 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.221 0.534 . . . . 0.0 111.553 -174.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 34.8 pt -106.73 -179.68 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.775 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 45.8 tp -89.73 -27.1 20.29 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.903 -177.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -73.16 85.59 1.37 Allowed 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -178.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 26.3 t70 55.22 -101.4 0.13 Allowed 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.801 172.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 56.5 m -166.92 -36.87 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.272 0.629 . . . . 0.0 109.925 -174.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 136.91 -111.04 0.82 Allowed Glycine 0 CA--C 1.527 0.841 0 C-N-CA 120.938 -0.648 . . . . 0.0 113.59 176.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 62.0 t80 67.46 -62.34 0.33 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.668 0.787 . . . . 0.0 111.467 -173.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.49 ' O ' ' HE2' ' A' ' 165' ' ' LYS . 33.9 m -61.18 -23.47 30.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 121.086 0.469 . . . . 0.0 111.026 174.481 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.421 ' O ' ' HB3' ' A' ' 163' ' ' ALA . 37.7 t -114.79 173.67 6.36 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.067 172.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 162' ' ' SER . . . 73.61 -49.75 0.69 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.132 0.573 . . . . 0.0 111.949 -176.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -76.48 49.02 0.57 Allowed 'General case' 0 CA--C 1.545 0.773 0 CA-C-O 121.207 0.527 . . . . 0.0 111.2 175.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.49 ' HE2' ' O ' ' A' ' 161' ' ' VAL . 74.9 mmtt -104.9 179.91 4.13 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.081 0.467 . . . . 0.0 111.375 -178.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -75.91 128.49 35.19 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.624 174.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 61.75 18.1 9.36 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 120.959 0.409 . . . . 0.0 112.06 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.19 62.24 4.66 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 121.311 -0.471 . . . . 0.0 112.795 -179.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 9.7 t -93.64 25.96 3.29 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.938 0.399 . . . . 0.0 112.062 -177.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -59.36 -30.52 68.46 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 121.236 0.541 . . . . 0.0 110.737 174.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -138.48 139.09 38.66 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 172.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -61.97 159.46 14.17 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -175.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -56.62 111.85 1.12 Allowed 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.572 176.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 5.2 p -41.75 119.93 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-O 121.827 0.822 . . . . 0.0 112.969 -173.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.401 ' O ' ' HB2' ' A' ' 176' ' ' LYS . 29.1 pttt -51.37 146.18 7.41 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 114.803 -1.089 . . . . 0.0 113.001 -178.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 175' ' ' LYS . 48.1 mmtm 75.18 -12.68 0.93 Allowed 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 177.388 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 60.9 tp -73.1 -52.52 13.95 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.901 -0.5 . . . . 0.0 111.38 176.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 . . . . . 0 N--CA 1.471 0.621 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.644 179.766 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ptm . . . . . 0 N--CA 1.493 1.714 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.88 174.39 15.58 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.727 0.299 . . . . 0.0 111.669 -178.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -148.42 -81.46 0.13 Allowed 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 120.824 0.345 . . . . 0.0 111.615 178.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 42.8 t -72.93 85.17 1.26 Allowed 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.201 0.524 . . . . 0.0 111.314 177.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.2 t -170.86 -4.79 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.983 179.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.3 t70 71.96 163.0 0.26 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.496 0.719 . . . . 0.0 111.785 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.441 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 36.3 pt -86.71 -4.4 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.9 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 7' ' ' ILE . . . 74.81 -48.56 0.65 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.205 0.602 . . . . 0.0 111.424 -176.401 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.2 -22.89 45.29 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 121.445 -0.407 . . . . 0.0 113.091 175.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.687 HD22 ' SG ' ' A' ' 100' ' ' CYS . 56.6 tp -74.65 -43.1 56.99 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 122.477 -0.425 . . . . 0.0 110.602 176.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -59.26 -42.32 90.89 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.307 0.575 . . . . 0.0 110.26 175.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.521 ' HG2' ' HE2' ' A' ' 16' ' ' LYS . 34.1 tt0 -61.38 -55.31 32.96 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.141 174.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.8 t -58.39 -35.14 71.55 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.439 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -59.49 -46.44 88.81 Favored 'General case' 0 C--O 1.225 -0.231 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.859 177.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.522 ' O ' HG12 ' A' ' 19' ' ' ILE . 97.8 mtt180 -60.48 -45.63 93.04 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.561 176.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.521 ' HE2' ' HG2' ' A' ' 12' ' ' GLU . 67.7 mttm -54.87 -37.72 66.6 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.891 0.377 . . . . 0.0 111.774 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -83.17 -36.56 24.6 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.599 174.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.03 -51.55 67.55 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -175.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.522 HG12 ' O ' ' A' ' 15' ' ' ARG . 29.1 pt -82.62 4.49 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 CA-C-O 121.056 0.455 . . . . 0.0 111.609 -178.09 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 39.5 t-80 -65.08 107.1 1.43 Allowed 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.903 177.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 115.51 -14.63 17.81 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 121.295 -0.478 . . . . 0.0 112.997 -177.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -154.68 118.1 2.53 Favored Pre-proline 0 CA--C 1.542 0.649 0 O-C-N 122.547 -0.384 . . . . 0.0 110.577 176.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -66.09 -14.55 44.91 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.459 2.106 . . . . 0.0 113.992 -174.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.401 ' HE3' ' HB2' ' A' ' 24' ' ' LYS . 45.3 mtmt -100.07 -52.85 3.3 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 120.74 0.305 . . . . 0.0 110.923 178.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.498 ' HB3' HG22 ' A' ' 19' ' ' ILE . . . 33.56 -115.14 0.07 Allowed 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.897 -175.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 63.8 m -157.93 -56.5 0.07 Allowed 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 122.768 0.427 . . . . 0.0 110.674 176.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.43 7.7 8.11 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 120.635 -0.793 . . . . 0.0 114.687 173.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -136.65 7.35 3.01 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 117.533 0.666 . . . . 0.0 111.531 178.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.447 ' HB3' HG21 ' A' ' 69' ' ' VAL . 33.9 mp0 -122.4 148.21 45.37 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 122.893 0.477 . . . . 0.0 111.536 -175.344 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.536 ' SD ' ' HB2' ' A' ' 34' ' ' ASN . 39.0 tpp -137.74 131.68 31.67 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.974 178.503 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 22.1 p30 -92.14 163.3 13.99 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.77 0.319 . . . . 0.0 111.59 178.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -55.88 -29.04 54.33 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 121.163 -0.542 . . . . 0.0 113.111 178.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -57.8 -61.35 2.59 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.072 0.463 . . . . 0.0 111.886 176.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.536 ' HB2' ' SD ' ' A' ' 30' ' ' MET . 24.7 m-20 -68.71 -34.37 75.53 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.358 -179.068 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.441 ' CD1' ' HB2' ' A' ' 59' ' ' PHE . 56.1 t-105 -60.11 -49.38 77.89 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.976 0.417 . . . . 0.0 111.631 178.13 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.92 -43.7 94.73 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 121.032 0.444 . . . . 0.0 111.228 177.052 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -66.57 -38.72 87.67 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.003 177.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.2 tt -56.38 -55.01 38.88 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.282 0.563 . . . . 0.0 110.592 -178.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 26.7 p -66.81 -40.88 88.22 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.782 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 58.0 tttp -76.35 -20.61 57.05 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-O 121.008 0.432 . . . . 0.0 111.715 -177.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -80.29 -41.72 24.43 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.326 0.584 . . . . 0.0 110.478 177.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.637 ' SG ' ' HA ' ' A' ' 103' ' ' VAL . 33.9 m -89.98 -6.83 55.23 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.689 -178.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.5 55.67 2.76 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.634 0.731 . . . . 0.0 111.418 -178.148 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 56.2 t -92.54 -36.77 7.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.476 173.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -107.18 78.44 1.22 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.221 0.534 . . . . 0.0 111.108 177.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.8 p-10 -152.66 4.03 0.35 Allowed 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.21 -174.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -79.79 47.04 3.22 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 121.094 -0.574 . . . . 0.0 113.534 -178.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt 50.53 21.53 0.88 Allowed 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 177.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 60.2 p -146.93 -63.44 0.29 Allowed 'General case' 0 N--CA 1.469 0.499 0 O-C-N 121.775 -0.578 . . . . 0.0 110.633 -176.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.421 HG22 ' H ' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -48.24 -83.31 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.887 0 CA-C-N 115.221 -0.9 . . . . 0.0 112.514 174.039 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.535 ' O ' HG23 ' A' ' 55' ' ' VAL . 12.4 p 58.33 -174.94 0.08 Allowed 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.418 0.687 . . . . 0.0 112.455 177.166 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -56.79 -29.5 58.57 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 121.35 -0.452 . . . . 0.0 113.279 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.542 ' O ' HG13 ' A' ' 57' ' ' ILE . 83.7 m -58.01 -58.92 6.27 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 122.626 -0.338 . . . . 0.0 111.377 178.008 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -63.3 -39.04 93.46 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.616 -0.265 . . . . 0.0 110.927 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 51' ' ' THR . 74.5 t -48.3 -41.13 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 N-CA-C 112.249 0.462 . . . . 0.0 112.249 175.189 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -74.17 -38.21 63.74 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.01 0.433 . . . . 0.0 110.591 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.542 HG13 ' O ' ' A' ' 53' ' ' THR . 10.1 mt -62.06 -45.41 98.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.102 178.484 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.515 HG22 ' HG2' ' A' ' 81' ' ' GLU . 86.9 t -63.19 -49.69 82.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.89 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.441 ' HB2' ' CD1' ' A' ' 35' ' ' TRP . 77.2 t80 -58.11 -48.34 80.5 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.188 0.518 . . . . 0.0 110.853 -179.425 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 90.5 p -68.15 -30.19 69.26 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.146 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -64.58 -46.64 81.83 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.574 177.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.432 HG23 HG21 ' A' ' 70' ' ' ILE . 35.7 m -88.58 -13.77 9.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -178.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -74.71 138.91 43.08 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.92 0.39 . . . . 0.0 111.562 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -66.96 167.05 39.44 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.836 176.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -64.77 -47.97 76.21 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 122.531 -0.394 . . . . 0.0 111.921 -178.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.5 m -99.53 3.75 45.64 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 120.85 0.357 . . . . 0.0 111.584 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -80.26 135.29 36.21 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 120.947 0.403 . . . . 0.0 111.808 -178.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? -87.01 -20.01 27.85 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.057 0.456 . . . . 0.0 110.85 175.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.447 HG21 ' HB3' ' A' ' 29' ' ' GLU . 29.3 m -137.62 174.54 11.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.579 -176.212 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.432 HG21 HG23 ' A' ' 62' ' ' VAL . 36.4 pt -111.6 144.12 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.711 173.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -94.01 156.61 16.51 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 120.858 0.361 . . . . 0.0 111.777 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.484 ' O ' ' HB3' ' A' ' 75' ' ' PHE . 49.9 t80 -49.04 -39.86 28.95 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -173.454 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -60.94 -41.91 97.17 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 122.11 -0.369 . . . . 0.0 111.659 178.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -73.18 -28.1 62.02 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.213 0.53 . . . . 0.0 110.519 176.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.484 ' HB3' ' O ' ' A' ' 72' ' ' TYR . 85.3 t80 -58.99 -36.55 75.08 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.969 175.032 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -61.29 -43.41 98.93 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.462 0.172 . . . . 0.0 111.17 175.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 28.3 mtmm -64.07 -38.1 89.85 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.997 0.427 . . . . 0.0 110.947 175.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.404 ' HB1' ' CH2' ' A' ' 35' ' ' TRP . . . -61.71 -41.07 97.12 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.256 176.109 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 86.4 mt -64.09 -44.42 92.41 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.105 175.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -56.48 -45.99 80.67 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.173 0.511 . . . . 0.0 110.555 176.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.515 ' HG2' HG22 ' A' ' 58' ' ' VAL . 37.7 tp10 -55.45 -58.74 6.51 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.573 176.199 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 86.4 mt -62.68 -44.84 95.22 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -178.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.26 -44.27 92.41 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.672 ' HA ' ' HE3' ' A' ' 90' ' ' LYS . 40.1 p -64.54 -35.4 80.86 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -89.93 -20.08 23.77 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 112.991 0.738 . . . . 0.0 112.991 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 33.5 tpt85 -82.97 -53.6 5.71 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.689 0.757 . . . . 0.0 110.826 178.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -94.52 117.89 30.82 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.156 175.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -82.05 -62.64 1.57 Allowed 'General case' 0 CA--C 1.539 0.557 0 O-C-N 122.292 -0.255 . . . . 0.0 111.386 -177.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -82.16 94.53 1.69 Allowed Glycine 0 CA--C 1.528 0.901 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.463 176.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.672 ' HE3' ' HA ' ' A' ' 84' ' ' THR . 0.3 OUTLIER -157.51 171.7 19.88 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -174.725 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 46.7 t -110.53 179.45 4.07 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.182 169.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -59.95 -76.43 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 120.946 0.403 . . . . 0.0 111.841 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 -60.87 -36.21 78.58 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.882 -176.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -56.78 -47.4 80.23 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.829 0.347 . . . . 0.0 111.577 177.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.56 -40.31 73.43 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.868 0.366 . . . . 0.0 111.315 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -63.37 -47.33 82.52 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.907 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -56.38 -49.56 74.11 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.452 0.168 . . . . 0.0 111.063 172.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -53.62 -54.39 38.36 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 15.2 tt -62.33 -33.35 58.59 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-O 120.94 0.4 . . . . 0.0 111.435 -179.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' CYS . . . . . 0.687 ' SG ' HD22 ' A' ' 10' ' ' LEU . 97.2 m -68.6 -38.06 80.31 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.925 0.393 . . . . 0.0 111.083 176.12 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -67.53 -31.19 71.13 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.706 179.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 96.7 mt -60.86 -35.46 76.65 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.255 0.55 . . . . 0.0 110.774 176.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.637 ' HA ' ' SG ' ' A' ' 42' ' ' CYS . 19.3 t -87.69 -78.07 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.785 178.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 41.05 26.72 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 178.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 61.1 45.59 96.25 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 121.282 -0.485 . . . . 0.0 113.798 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.554 ' HG3' ' HG2' ' A' ' 107' ' ' GLU . 21.9 pttp -70.85 -40.75 72.18 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.754 0.649 . . . . 0.0 112.754 -177.381 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.554 ' HG2' ' HG3' ' A' ' 106' ' ' LYS . 14.7 pt-20 -167.88 50.44 0.19 Allowed Pre-proline 0 N--CA 1.477 0.884 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -177.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.488 ' HD3' ' N ' ' A' ' 107' ' ' GLU . 64.1 Cg_exo -42.87 120.86 2.01 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 123.225 2.617 . . . . 0.0 113.634 -174.535 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 69.41 -69.03 0.17 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.732 -172.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 177.61 116.59 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.716 174.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 18.3 m -113.59 1.77 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-O 121.077 0.465 . . . . 0.0 110.679 171.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 154.67 -125.44 1.7 Allowed Glycine 0 CA--C 1.527 0.797 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.75 -178.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 11.8 p -164.04 144.8 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 120.681 0.277 . . . . 0.0 110.989 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 5.9 t -75.4 127.26 32.73 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.213 0.53 . . . . 0.0 111.696 179.105 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -92.19 -8.33 45.81 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.296 -0.411 . . . . 0.0 112.09 -179.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -178.78 -25.76 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -63.56 107.82 1.23 Allowed 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.164 0.507 . . . . 0.0 111.859 -176.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 62.0 p -109.57 -177.03 3.17 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.398 179.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -131.13 -77.77 0.16 Allowed Glycine 0 CA--C 1.53 0.988 0 C-N-CA 120.894 -0.67 . . . . 0.0 113.591 -176.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -66.84 84.06 0.11 Allowed Glycine 0 CA--C 1.529 0.937 0 C-N-CA 121.215 -0.517 . . . . 0.0 113.435 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -73.33 -8.26 55.1 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 60.0 t 70.6 135.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.249 0.62 . . . . 0.0 112.181 -179.131 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -83.39 175.61 9.72 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-O 120.858 0.361 . . . . 0.0 110.842 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.661 ' HD3' ' H ' ' A' ' 124' ' ' ARG . 0.0 OUTLIER -113.65 -26.99 8.0 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -175.746 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 60.9 tp 65.44 133.77 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 176.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 67.7 p -119.83 -43.06 2.58 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -78.47 38.19 0.3 Allowed 'General case' 0 CA--C 1.547 0.835 0 CA-C-O 121.199 0.523 . . . . 0.0 112.372 -177.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.8 t -68.5 88.41 0.33 Allowed 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -179.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 34.0 t -108.41 -177.63 3.38 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.006 0.432 . . . . 0.0 111.495 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 71.6 mtp180 -80.02 -18.55 49.88 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.739 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -151.04 89.17 1.5 Allowed 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.193 0.521 . . . . 0.0 110.956 -179.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 41.0 p -83.5 70.09 10.18 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.271 0.557 . . . . 0.0 111.586 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -152.3 54.75 0.46 Allowed Glycine 0 CA--C 1.524 0.638 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.602 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 15.2 m -76.13 163.6 26.93 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.872 0.367 . . . . 0.0 111.955 -178.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 69.0 m-70 67.32 82.09 0.19 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.161 0.585 . . . . 0.0 111.132 -177.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.576 ' HD3' ' HG3' ' A' ' 141' ' ' GLU . 94.3 mttt -101.63 -58.19 1.93 Allowed 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.058 -176.055 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.737 ' HG3' ' HG3' ' A' ' 138' ' ' ARG . 9.3 tp10 60.62 -85.83 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.171 -172.237 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.737 ' HG3' ' HG3' ' A' ' 137' ' ' GLU . 51.7 mtt-85 -112.01 -92.55 0.47 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 122.953 0.501 . . . . 0.0 110.958 177.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 47.31 26.52 0.73 Allowed 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 172.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 46.34 31.17 1.18 Allowed 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 175.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.576 ' HG3' ' HD3' ' A' ' 136' ' ' LYS . 0.9 OUTLIER -61.43 123.69 18.53 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.055 0.455 . . . . 0.0 111.433 -176.068 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 47.0 t -165.0 -28.89 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.426 -177.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 97.89 19.48 24.2 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 121.216 -0.516 . . . . 0.0 113.198 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 61.2 mttm 62.56 -79.64 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.272 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -141.09 131.94 5.13 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 121.186 -0.531 . . . . 0.0 112.756 -177.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm -72.45 77.39 1.04 Allowed 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.247 0.546 . . . . 0.0 111.271 -178.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.447 ' O ' ' N ' ' A' ' 149' ' ' ALA . . . 145.37 -51.45 0.6 Allowed Glycine 0 CA--C 1.53 0.978 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.035 -178.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.515 HG23 ' H ' ' A' ' 149' ' ' ALA . 12.2 tt 43.79 -71.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 N-CA-C 115.506 1.669 . . . . 0.0 115.506 175.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.515 ' H ' HG23 ' A' ' 148' ' ' ILE . . . -113.77 111.06 21.16 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 121.558 -0.713 . . . . 0.0 112.834 -170.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -97.87 5.64 61.87 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 121.43 -0.414 . . . . 0.0 113.011 173.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -90.78 157.52 17.35 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.037 0.446 . . . . 0.0 111.787 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -66.51 -43.28 85.71 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.64 0.733 . . . . 0.0 110.0 171.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -138.29 132.95 32.45 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.946 174.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 9.5 tt -145.33 131.62 14.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-O 121.261 0.553 . . . . 0.0 111.696 -177.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 92.0 mt -88.34 64.09 7.42 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.092 0.472 . . . . 0.0 111.229 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -90.11 0.75 57.0 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.733 176.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 37.2 t70 76.01 -36.0 0.27 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.646 0.778 . . . . 0.0 112.132 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 56.5 m 57.1 39.51 29.02 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.978 0.418 . . . . 0.0 112.053 178.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -69.22 86.3 0.24 Allowed Glycine 0 CA--C 1.527 0.801 0 C-N-CA 121.172 -0.537 . . . . 0.0 112.859 176.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -65.59 162.69 17.72 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.741 0.305 . . . . 0.0 111.69 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 67.4 t 71.46 -57.8 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.183 0.593 . . . . 0.0 111.994 -177.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 91.7 p 52.5 33.73 13.94 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 177.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -95.37 41.89 1.09 Allowed 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 178.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -82.33 -0.52 46.1 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -177.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -88.69 -5.94 57.79 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -175.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -83.17 -39.61 20.8 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -172.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 61.37 102.07 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 121.113 0.482 . . . . 0.0 112.232 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -66.28 171.44 28.5 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 121.318 -0.468 . . . . 0.0 114.046 -178.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.446 ' O ' HG22 ' A' ' 169' ' ' THR . 12.3 m -72.76 2.59 6.38 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -177.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 66.7 t80 64.68 9.5 5.23 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 121.999 -0.438 . . . . 0.0 111.788 178.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 59.13 21.77 9.84 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 122.747 0.419 . . . . 0.0 111.82 179.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -53.93 118.52 4.06 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.689 0.625 . . . . 0.0 112.689 -176.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 64.6 mmtt -84.84 94.12 8.66 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 120.982 0.42 . . . . 0.0 111.812 177.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.421 ' O ' ' HB3' ' A' ' 175' ' ' LYS . 7.5 p -84.43 119.23 33.05 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.265 173.137 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.421 ' HB3' ' O ' ' A' ' 174' ' ' VAL . 5.0 ttmp? 71.71 90.17 0.09 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.482 0.713 . . . . 0.0 110.52 -168.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -91.47 1.12 57.35 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.555 -178.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 56.0 tp 68.87 111.13 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.033 0.533 . . . . 0.0 111.298 -177.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 . . . . . 0 CA--C 1.544 0.718 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.202 179.866 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptm . . . . . 0 N--CA 1.492 1.626 0 N-CA-C 111.438 0.162 . . . . 0.0 111.438 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 58.04 96.25 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 177.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -175.15 -86.83 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 122.473 0.309 . . . . 0.0 110.994 178.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.1 m -117.72 -3.63 11.25 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 121.142 0.496 . . . . 0.0 110.658 175.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 40.1 p -118.0 98.25 6.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.859 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -70.65 -24.31 62.68 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.493 -177.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.453 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 26.3 pt -57.08 158.11 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.037 173.193 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 7' ' ' ILE . . . 71.26 -43.22 0.56 Allowed 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 120.792 0.329 . . . . 0.0 110.464 -166.237 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -73.82 -34.84 55.6 Favored Glycine 0 C--N 1.337 0.613 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 171.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.567 HD22 ' SG ' ' A' ' 100' ' ' CYS . 59.1 tp -62.66 -37.28 85.76 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.091 -0.555 . . . . 0.0 110.273 170.411 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -68.06 -40.92 82.67 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.821 176.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -54.07 -58.17 8.33 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.032 0.444 . . . . 0.0 110.577 173.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.6 m -59.83 -42.37 93.4 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.511 178.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 94.0 t80 -53.79 -46.75 71.13 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.059 176.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.54 ' O ' HG12 ' A' ' 19' ' ' ILE . 21.7 ttt180 -66.3 -46.19 77.78 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.224 178.359 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 39.4 mtpt -57.84 -27.06 62.85 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 116.301 -0.408 . . . . 0.0 112.067 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -86.34 -44.66 11.9 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.495 172.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.08 -43.69 74.15 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -177.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.54 HG12 ' O ' ' A' ' 15' ' ' ARG . 29.0 pt -101.05 14.91 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-O 120.976 0.417 . . . . 0.0 111.594 -178.184 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.42 ' CD2' ' HG2' ' A' ' 108' ' ' PRO . 27.4 t-80 -66.5 -33.31 75.4 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -175.133 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -135.54 22.9 3.47 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.838 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -138.3 101.6 8.29 Favored Pre-proline 0 CA--C 1.542 0.654 0 CA-C-O 120.871 0.367 . . . . 0.0 110.878 -177.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.21 -19.96 43.88 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 122.683 2.255 . . . . 0.0 113.955 -174.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 49.2 mmtm -100.6 6.6 44.18 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -178.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -81.5 138.46 35.47 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.13 0.49 . . . . 0.0 111.736 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 93.2 p -70.2 -60.43 2.29 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.437 0.637 . . . . 0.0 111.1 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 145.99 -26.73 1.75 Allowed Glycine 0 CA--C 1.522 0.48 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.245 -178.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -85.84 -15.55 41.53 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 111.752 0.278 . . . . 0.0 111.752 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.533 ' HB3' HG21 ' A' ' 69' ' ' VAL . 50.3 mt-10 -111.13 116.46 31.15 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.747 0.308 . . . . 0.0 111.375 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 48.1 ttm -107.22 139.49 41.59 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.179 0.514 . . . . 0.0 111.846 178.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.602 ' OD1' ' HB3' ' A' ' 33' ' ' LYS . 7.6 p30 -95.58 165.74 12.18 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.351 177.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.46 -30.22 73.81 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 121.562 -0.352 . . . . 0.0 113.842 -177.134 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.602 ' HB3' ' OD1' ' A' ' 31' ' ' ASN . 29.7 ttpt -58.39 -61.21 2.75 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.036 0.446 . . . . 0.0 111.565 177.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 64.2 m-20 -68.24 -31.96 71.82 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 122.281 -0.262 . . . . 0.0 111.57 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 32.2 t-105 -61.99 -38.89 90.31 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-O 120.953 0.406 . . . . 0.0 111.273 175.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.533 ' HA ' HG11 ' A' ' 55' ' ' VAL . . . -61.59 -48.85 79.07 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 120.984 0.421 . . . . 0.0 110.897 175.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.3 mtpp -67.6 -30.55 70.17 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.957 177.055 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.9 tt -56.9 -46.68 81.79 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.98 0.419 . . . . 0.0 110.169 177.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 79.0 m -64.32 -44.93 90.0 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.049 0.452 . . . . 0.0 111.623 176.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -68.17 -58.31 4.66 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -177.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.31 -23.84 64.51 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 178.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 86.0 m -95.86 -5.05 42.53 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 122.044 -0.41 . . . . 0.0 111.471 173.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt 62.41 28.94 17.1 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 173.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 43.2 t -78.79 -32.99 16.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.439 177.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.425 ' HA ' HG13 ' A' ' 50' ' ' VAL . . . -91.54 102.47 15.12 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.833 0.349 . . . . 0.0 111.9 -178.174 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -77.31 -44.99 27.68 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.699 0.762 . . . . 0.0 111.687 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.422 ' HA2' HG22 ' A' ' 51' ' ' THR . . . 107.63 -37.63 3.73 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 -163.454 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.9 ttpm? -43.11 -56.16 3.52 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.66 0.784 . . . . 0.0 112.199 173.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 78.4 p -125.91 -0.85 7.25 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 120.878 0.37 . . . . 0.0 111.755 178.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.425 HG13 ' HA ' ' A' ' 45' ' ' ALA . 3.8 p -156.74 111.75 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-O 121.1 0.476 . . . . 0.0 111.868 -174.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.43 ' O ' HG23 ' A' ' 55' ' ' VAL . 68.6 p -106.23 -177.78 3.46 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.104 178.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -55.64 -38.46 71.97 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.531 175.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.543 ' O ' HG12 ' A' ' 57' ' ' ILE . 88.8 m -58.0 -49.94 75.11 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 122.703 -0.292 . . . . 0.0 110.627 176.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.435 ' O ' HG23 ' A' ' 58' ' ' VAL . 7.1 m-20 -53.76 -38.61 64.59 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.991 0.424 . . . . 0.0 111.266 175.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.533 HG11 ' HA ' ' A' ' 36' ' ' ALA . 95.9 t -59.67 -39.6 80.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.507 178.431 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -76.02 -34.04 59.67 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.454 0.645 . . . . 0.0 110.535 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.543 HG12 ' O ' ' A' ' 53' ' ' THR . 9.9 mm -59.05 -53.16 51.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.059 175.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 54' ' ' ASP . 56.5 t -61.12 -42.42 93.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.286 178.181 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -55.22 -40.63 71.05 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.147 0.499 . . . . 0.0 111.289 175.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 50.6 m -78.38 -29.23 47.22 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.387 178.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -69.33 -56.91 6.14 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.903 -178.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.418 HG12 ' HG3' ' A' ' 77' ' ' LYS . 33.9 m -65.0 -34.15 68.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -173.597 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.602 ' HG3' ' H ' ' A' ' 65' ' ' LYS . 0.1 OUTLIER -65.94 -21.87 66.46 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.91 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 64.22 25.56 69.81 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 121.27 -0.49 . . . . 0.0 113.056 -178.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.602 ' H ' ' HG3' ' A' ' 63' ' ' LYS . 9.7 mtpm? 68.22 167.74 0.26 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.187 0.595 . . . . 0.0 111.889 -176.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 65.5 m 72.47 -47.95 0.67 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.324 0.65 . . . . 0.0 112.335 -178.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.452 ' O ' ' HD3' ' A' ' 63' ' ' LYS . . . -74.72 107.72 7.01 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 122.22 -0.3 . . . . 0.0 111.166 175.181 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -62.88 -48.71 77.82 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 121.378 0.609 . . . . 0.0 111.289 -177.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.533 HG21 ' HB3' ' A' ' 29' ' ' GLU . 30.2 m -93.23 -166.06 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.271 178.065 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 31.5 pt -134.93 144.7 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 122.417 0.287 . . . . 0.0 111.102 174.014 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -97.94 -179.57 4.46 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 120.815 0.34 . . . . 0.0 111.559 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -57.62 -43.38 84.73 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -175.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.623 ' HA ' ' HG3' ' A' ' 76' ' ' LYS . 15.7 pt-20 -80.25 -28.73 38.42 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.529 -0.732 . . . . 0.0 111.881 -176.495 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -69.03 -30.06 68.35 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.501 0.667 . . . . 0.0 109.43 170.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -69.17 -49.38 57.31 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.47 176.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.623 ' HG3' ' HA ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -64.97 -27.57 68.93 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 120.753 0.311 . . . . 0.0 111.289 177.948 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.418 ' HG3' HG12 ' A' ' 62' ' ' VAL . 17.7 tppt? -68.75 -39.35 80.33 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.8 0.333 . . . . 0.0 110.336 170.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.02 -43.76 86.93 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.184 0.516 . . . . 0.0 110.61 173.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 80.8 mt -58.97 -37.07 75.95 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.3 176.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.409 ' O ' HG23 ' A' ' 84' ' ' THR . 54.9 mt-10 -62.69 -47.39 83.83 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.862 0.363 . . . . 0.0 111.352 175.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -57.59 -55.93 28.41 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.893 0.378 . . . . 0.0 110.828 176.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 11.3 mp -54.4 -49.54 69.67 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.279 176.188 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -52.34 -48.5 65.46 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.409 HG23 ' O ' ' A' ' 80' ' ' GLU . 75.3 p -62.58 -33.97 76.03 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 -179.126 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -94.77 -2.08 51.65 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 176.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 31.4 tpt85 -104.8 -63.76 1.19 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.043 0.449 . . . . 0.0 111.727 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -103.77 118.85 37.66 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.721 -177.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -79.01 58.68 2.48 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 121.429 0.633 . . . . 0.0 110.868 176.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -90.16 -11.21 63.32 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-N 115.817 -0.629 . . . . 0.0 114.024 -176.064 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp 59.74 23.4 12.28 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 177.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 48.2 t -149.17 155.77 41.15 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 122.059 -0.401 . . . . 0.0 111.09 176.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -83.1 -58.57 2.8 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.549 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -52.57 -58.14 7.74 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.584 0.586 . . . . 0.0 112.584 -176.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -57.37 -55.13 38.74 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -176.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.7 -36.36 74.11 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.771 0.319 . . . . 0.0 111.766 179.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -67.28 -52.62 38.41 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.326 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.47 ' O ' ' HG3' ' A' ' 101' ' ' GLN . 7.1 m-20 -58.0 -39.48 78.39 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 120.488 0.185 . . . . 0.0 111.421 176.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.16 -60.21 4.23 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 120.817 0.341 . . . . 0.0 111.593 176.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 17.6 tt -63.16 -28.84 45.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-O 121.039 0.447 . . . . 0.0 111.077 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' CYS . . . . . 0.567 ' SG ' HD22 ' A' ' 10' ' ' LEU . 39.6 t -66.54 -44.95 80.98 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.019 173.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.47 ' HG3' ' O ' ' A' ' 97' ' ' ASP . 46.2 mt-30 -60.71 -29.0 69.08 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 179.101 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 83.3 mt -63.69 -23.67 67.47 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 120.799 0.333 . . . . 0.0 111.833 176.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 43.3 t -112.98 -34.39 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -177.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.58 115.1 3.98 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -174.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 85.01 14.42 69.51 Favored Glycine 0 CA--C 1.523 0.561 0 CA-C-N 116.103 -0.499 . . . . 0.0 112.531 -178.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 24.3 tptm -102.77 156.31 17.73 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.344 0.592 . . . . 0.0 111.268 -178.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -132.3 158.24 76.14 Favored Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.248 174.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.42 ' HG2' ' CD2' ' A' ' 20' ' ' HIS . 25.6 Cg_exo -62.68 -179.06 0.44 Allowed 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.111 1.874 . . . . 0.0 112.537 178.28 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -53.75 -60.73 2.94 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.017 0.437 . . . . 0.0 111.025 174.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -97.53 135.6 39.14 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.453 173.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 14.3 p -134.56 154.98 38.1 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-O 120.794 0.33 . . . . 0.0 111.428 -177.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.21 -165.28 41.13 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 121.147 -0.549 . . . . 0.0 113.13 178.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.6 p -101.8 121.32 52.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-O 121.071 0.462 . . . . 0.0 111.582 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 10.0 t -101.36 173.8 6.28 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 121.232 0.539 . . . . 0.0 112.284 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -98.76 -161.85 0.91 Allowed 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.833 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -76.65 163.4 26.9 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.138 173.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -70.71 80.24 0.61 Allowed 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.143 0.497 . . . . 0.0 111.74 -178.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 82.3 p -103.25 -30.51 10.61 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.918 177.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -77.12 52.93 3.4 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 113.975 0.35 . . . . 0.0 113.975 -177.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -90.03 98.24 2.42 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 121.168 -0.539 . . . . 0.0 112.221 176.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -55.3 140.53 39.04 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -177.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.8 p -144.39 6.96 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 CA-C-O 121.52 0.676 . . . . 0.0 111.023 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -75.65 -174.33 2.5 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.922 -177.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 124' ' ' ARG . 11.0 ptp180 -132.7 172.78 12.1 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 120.668 0.271 . . . . 0.0 111.107 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.417 ' O ' HD12 ' A' ' 125' ' ' LEU . 4.1 pp -74.66 145.4 43.22 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 120.912 0.386 . . . . 0.0 111.299 177.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 8.8 t -159.74 23.66 0.18 Allowed 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.416 0.627 . . . . 0.0 110.987 -179.14 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -78.13 179.49 6.82 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.184 -177.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 8.0 t -146.8 125.78 12.81 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.749 178.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 59.8 m 50.75 93.66 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' A' ' 130' ' ' ARG . 48.3 mtm180 -107.41 0.56 23.0 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.884 174.35 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.439 ' O ' ' N ' ' A' ' 133' ' ' GLY . 8.9 t80 63.83 -81.73 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.915 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 82.0 p 48.55 -75.66 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 174.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 131' ' ' TYR . . . -56.67 157.29 11.03 Favored Glycine 0 CA--C 1.532 1.105 0 N-CA-C 115.153 0.821 . . . . 0.0 115.153 -173.098 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 89.5 p -111.23 -163.02 0.82 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 122.951 0.5 . . . . 0.0 110.779 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -89.33 66.0 7.37 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.187 0.518 . . . . 0.0 110.843 178.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.433 ' O ' ' HB3' ' A' ' 137' ' ' GLU . 59.5 mttp 61.34 -80.88 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -178.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.433 ' HB3' ' O ' ' A' ' 136' ' ' LYS . 43.5 tt0 71.99 -46.39 0.64 Allowed 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.345 0.658 . . . . 0.0 110.698 -168.433 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 28.9 ttt180 -53.58 141.46 25.62 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.209 173.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -83.29 -173.02 4.47 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.375 0.607 . . . . 0.0 112.474 -176.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -74.92 -177.02 3.13 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 121.806 0.812 . . . . 0.0 112.858 -175.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -64.29 143.51 57.83 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.246 -0.888 . . . . 0.0 112.077 178.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 22.1 m -86.58 32.55 0.65 Allowed 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 120.829 0.347 . . . . 0.0 111.7 178.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -75.22 -30.15 59.27 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 114.11 0.404 . . . . 0.0 114.11 -176.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 96.6 mttt 69.39 19.1 7.77 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 122.863 0.465 . . . . 0.0 112.083 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 98.95 -62.57 0.77 Allowed Glycine 0 CA--C 1.527 0.798 0 C-N-CA 121.272 -0.49 . . . . 0.0 113.064 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -155.5 179.05 9.55 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 122.575 -0.368 . . . . 0.0 111.093 178.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -66.29 76.38 0.13 Allowed Glycine 0 CA--C 1.528 0.868 0 C-N-CA 121.39 -0.433 . . . . 0.0 113.142 178.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 61.8 mt -66.07 -34.36 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 121.335 0.588 . . . . 0.0 110.812 178.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -89.3 163.21 15.45 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.622 171.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -73.62 64.83 1.79 Allowed Glycine 0 CA--C 1.528 0.903 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.862 178.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 18.9 mmm180 -132.66 168.41 18.33 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.107 0.479 . . . . 0.0 111.98 -175.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -73.86 -178.25 3.15 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.798 177.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -97.34 166.89 11.33 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.793 176.37 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 48.1 mm -83.13 87.42 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-O 121.477 0.656 . . . . 0.0 110.798 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 79.1 mt -87.75 80.97 7.75 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.617 -176.138 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -111.22 115.42 29.32 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.992 0.425 . . . . 0.0 111.586 178.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -89.58 100.07 12.94 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.056 0.455 . . . . 0.0 109.972 173.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 70.6 m -72.38 -167.43 0.33 Allowed 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 116.015 -0.539 . . . . 0.0 112.291 -176.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -72.9 66.94 1.4 Allowed Glycine 0 CA--C 1.53 1.011 0 N-CA-C 114.371 0.509 . . . . 0.0 114.371 -175.191 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -92.07 103.64 16.12 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 122.552 -0.381 . . . . 0.0 110.093 174.084 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 49.3 t 57.58 76.79 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 121.58 0.705 . . . . 0.0 110.204 -170.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 31.8 t 61.91 -87.39 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.551 -173.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 58.38 17.53 4.86 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -177.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -94.0 66.28 3.57 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.455 0.645 . . . . 0.0 111.371 -177.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 21.4 pttm -61.33 141.29 57.69 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.788 175.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -68.51 122.83 19.28 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.949 0.405 . . . . 0.0 111.859 -177.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -106.71 97.21 7.03 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.08 0.467 . . . . 0.0 111.537 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 106.48 154.33 20.48 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 121.137 -0.554 . . . . 0.0 113.173 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 16.2 p 55.84 -176.24 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.893 0.877 . . . . 0.0 112.423 -178.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 9.8 t80 63.29 24.82 14.45 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-O 121.547 0.689 . . . . 0.0 110.719 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -62.18 -56.92 13.88 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.726 -175.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -78.49 31.49 0.19 Allowed 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -175.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.526 ' HG3' HG13 ' A' ' 174' ' ' VAL . 61.4 pttt -60.88 -51.74 68.03 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.526 HG13 ' HG3' ' A' ' 173' ' ' LYS . 34.2 m -71.81 -32.2 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -174.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 55.5 mttp 68.9 -66.59 0.24 Allowed 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 177.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 96.7 mttt 67.88 -71.45 0.11 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.521 0.728 . . . . 0.0 111.556 -178.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 42.0 tp -144.09 70.95 1.3 Allowed 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.137 0.494 . . . . 0.0 111.099 178.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 . . . . . 0 CA--C 1.545 0.762 0 CA-C-N 115.503 -0.771 . . . . 0.0 113.073 175.968 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.0 mmt . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 120.597 0.237 . . . . 0.0 110.967 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.85 81.87 1.64 Allowed 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.208 0.528 . . . . 0.0 110.839 174.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -72.67 -48.05 42.36 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.782 -177.157 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 61.4 p -110.83 102.61 11.12 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.216 0.532 . . . . 0.0 112.028 -178.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 89.8 m -69.83 -23.54 63.32 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.313 0.577 . . . . 0.0 110.277 173.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -67.49 92.71 0.31 Allowed 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.187 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.432 HG12 ' H ' ' A' ' 9' ' ' GLY . 13.4 tt -62.47 150.08 9.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.801 -179.31 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -49.16 -36.01 18.23 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.432 ' H ' HG12 ' A' ' 7' ' ' ILE . . . -57.94 -33.6 69.26 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 121.274 -0.488 . . . . 0.0 113.131 176.555 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 50.0 tp -70.88 -40.68 72.09 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.943 0.401 . . . . 0.0 110.546 177.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -63.27 -36.31 83.25 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.697 175.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -60.03 -56.51 20.79 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.025 0.44 . . . . 0.0 110.895 175.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.3 m -53.15 -51.24 62.62 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.46 178.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -56.12 -50.07 72.12 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.458 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 29.9 ttt180 -62.94 -42.56 99.84 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.875 0.369 . . . . 0.0 111.677 -176.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.407 ' HD3' ' HB3' ' A' ' 107' ' ' GLU . 99.0 mttt -65.22 -34.32 78.08 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.515 ' HA ' ' HB2' ' A' ' 20' ' ' HIS . 41.0 m-85 -79.84 -23.61 41.86 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 120.826 0.346 . . . . 0.0 111.28 173.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.47 -11.56 60.26 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.172 0.511 . . . . 0.0 111.278 175.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.448 HG23 ' HA2' ' A' ' 27' ' ' GLY . 32.8 pt -117.79 15.78 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-O 121.055 0.455 . . . . 0.0 110.67 171.02 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.515 ' HB2' ' HA ' ' A' ' 17' ' ' PHE . 48.8 t-80 -63.24 100.73 0.25 Allowed 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 120.94 0.4 . . . . 0.0 111.448 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 126.88 -46.9 1.05 Allowed Glycine 0 CA--C 1.526 0.753 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.089 -176.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.478 ' HB2' ' HB2' ' A' ' 25' ' ' ALA . 19.7 m-20 -138.98 127.87 14.02 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 122.757 0.423 . . . . 0.0 110.815 179.15 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_exo -47.54 -32.64 16.17 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 123.215 2.61 . . . . 0.0 114.232 -178.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -120.9 31.42 6.41 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.875 0.369 . . . . 0.0 111.566 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.478 ' HB2' ' HB2' ' A' ' 22' ' ' ASP . . . -53.44 -60.1 3.73 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 67.5 m -152.9 -43.85 0.1 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.071 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.448 ' HA2' HG23 ' A' ' 19' ' ' ILE . . . 79.1 -34.83 1.94 Allowed Glycine 0 CA--C 1.528 0.904 0 C-N-CA 121.168 -0.539 . . . . 0.0 114.358 173.214 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -125.72 -21.59 4.4 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 117.033 0.417 . . . . 0.0 111.667 -178.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -99.16 138.66 35.95 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 122.113 -0.367 . . . . 0.0 110.519 173.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 49.8 ttm -125.55 131.19 52.81 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.843 0.354 . . . . 0.0 111.929 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.494 ' ND2' ' HB2' ' A' ' 33' ' ' LYS . 17.8 p-10 -91.71 158.43 16.38 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.89 0.376 . . . . 0.0 111.592 178.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -56.64 -29.17 57.58 Favored Glycine 0 N--CA 1.465 0.626 0 CA-C-N 116.302 -0.408 . . . . 0.0 113.253 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.494 ' HB2' ' ND2' ' A' ' 31' ' ' ASN . 98.7 mttt -57.93 -56.06 26.85 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 120.938 0.399 . . . . 0.0 111.464 175.326 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -71.21 -29.15 64.8 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 122.342 -0.224 . . . . 0.0 111.412 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.467 ' CD1' ' HB2' ' A' ' 59' ' ' PHE . 25.8 t-105 -64.32 -45.27 88.63 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 120.879 0.371 . . . . 0.0 111.26 175.22 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.472 ' HA ' HG11 ' A' ' 55' ' ' VAL . . . -58.74 -46.3 87.73 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.183 0.516 . . . . 0.0 111.007 177.342 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -66.94 -39.25 87.24 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.779 176.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.2 tt -49.88 -45.26 50.46 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.24 0.543 . . . . 0.0 110.618 177.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 64.6 m -70.44 -38.58 74.55 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.715 178.009 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -70.96 -47.92 56.27 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -176.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -53.46 -48.86 68.46 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.065 0.46 . . . . 0.0 111.073 172.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 63.3 m -77.09 -6.07 51.39 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.722 178.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 47.0 mttp 59.45 26.41 15.34 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 175.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 42.8 t -74.24 -32.63 32.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 121.397 0.618 . . . . 0.0 110.347 173.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.545 ' HB1' ' HA ' ' A' ' 51' ' ' THR . . . -87.85 91.96 8.95 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.669 -176.603 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -174.52 17.55 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.831 0 CA-C-O 120.971 0.415 . . . . 0.0 111.688 175.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -86.93 18.93 32.61 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.69 -0.767 . . . . 0.0 113.446 -175.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.5 ' HD2' ' N ' ' A' ' 48' ' ' LYS . 12.0 mptt 57.51 20.05 5.79 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 121.738 0.78 . . . . 0.0 111.51 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 65.4 m -147.0 -30.92 0.34 Allowed 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.494 175.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.655 HG11 ' HG ' ' A' ' 82' ' ' LEU . 93.3 t -125.46 96.71 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.95 166.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.545 ' HA ' ' HB1' ' A' ' 45' ' ' ALA . 5.0 t -156.55 125.06 5.79 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.803 0.335 . . . . 0.0 111.854 176.243 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 50.47 -90.6 0.01 OUTLIER Glycine 0 CA--C 1.53 0.995 0 CA-C-N 116.413 -0.358 . . . . 0.0 113.776 178.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.595 ' O ' HG13 ' A' ' 57' ' ' ILE . 58.0 m -52.04 -55.01 23.27 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.788 0.328 . . . . 0.0 111.199 179.037 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.49 ' HB2' ' HA ' ' A' ' 50' ' ' VAL . 9.2 m-20 -57.53 -34.02 68.69 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.553 -177.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.472 HG11 ' HA ' ' A' ' 36' ' ' ALA . 43.8 t -64.06 -38.2 81.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-O 120.939 0.4 . . . . 0.0 111.032 178.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -72.12 -31.25 65.85 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.171 0.51 . . . . 0.0 110.004 177.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.595 HG13 ' O ' ' A' ' 53' ' ' THR . 9.8 mt -68.01 -48.31 75.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.896 176.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 76.1 t -54.04 -51.32 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-O 121.022 0.439 . . . . 0.0 110.849 174.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.467 ' HB2' ' CD1' ' A' ' 35' ' ' TRP . 72.0 t80 -53.06 -51.19 62.58 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.763 175.49 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.595 ' HA ' ' HE3' ' A' ' 63' ' ' LYS . 59.3 m -68.23 -21.65 64.83 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.028 -178.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 43.9 tttp -83.11 -39.87 20.55 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 120.747 0.308 . . . . 0.0 111.402 -178.13 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 26.9 m -82.22 -24.88 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 CA-C-O 120.783 0.325 . . . . 0.0 111.377 177.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.595 ' HE3' ' HA ' ' A' ' 60' ' ' SER . 26.3 ttpp -53.84 126.83 23.68 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.964 178.471 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -45.78 -62.26 3.41 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-N 116.088 -0.505 . . . . 0.0 113.294 179.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 48.4 tptt -152.02 -86.3 0.07 Allowed 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 117.085 0.442 . . . . 0.0 111.782 174.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 88.4 p -110.09 -7.04 14.96 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -173.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.43 107.1 1.03 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.725 0.297 . . . . 0.0 111.2 178.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 83.8 mtm-85 -72.48 2.32 6.49 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -176.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 28.2 m -125.71 132.98 70.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-O 120.894 0.378 . . . . 0.0 110.73 174.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.54 ' HB ' ' HB2' ' A' ' 74' ' ' GLU . 30.6 pt -100.63 148.06 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 121.077 0.465 . . . . 0.0 111.878 179.136 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.445 ' ND2' ' HB2' ' A' ' 73' ' ' GLU . 1.7 p-10 -89.18 167.93 12.71 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.153 174.584 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.492 ' O ' ' HG3' ' A' ' 76' ' ' LYS . 24.9 t80 -52.12 -37.46 54.34 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.922 0.391 . . . . 0.0 111.866 -173.619 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.445 ' HB2' ' ND2' ' A' ' 71' ' ' ASN . 19.5 mp0 -60.4 -47.98 83.75 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.288 178.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.54 ' HB2' ' HB ' ' A' ' 70' ' ' ILE . 48.7 mt-10 -65.4 -37.3 86.54 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.18 0.514 . . . . 0.0 110.296 176.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -59.6 -41.11 89.57 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.222 175.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.492 ' HG3' ' O ' ' A' ' 72' ' ' TYR . 27.7 mtpp -55.75 -47.85 76.28 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.691 0.281 . . . . 0.0 110.969 176.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.444 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 54.9 tttp -68.91 -32.99 73.02 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.384 177.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.446 ' O ' HD13 ' A' ' 82' ' ' LEU . . . -56.9 -40.84 77.02 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.111 0.481 . . . . 0.0 110.407 173.418 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 88.2 mt -67.79 -43.26 80.13 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.87 173.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -49.4 -47.62 47.74 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 120.975 0.417 . . . . 0.0 111.104 175.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.634 ' O ' ' HG2' ' A' ' 85' ' ' LYS . 32.0 mm-40 -58.94 -68.67 0.25 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.916 177.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.655 ' HG ' HG11 ' A' ' 50' ' ' VAL . 11.0 mp -47.77 -43.73 27.71 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -178.411 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.01 -48.02 83.1 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.692 177.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 74.0 p -75.01 -7.24 53.11 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -178.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.634 ' HG2' ' O ' ' A' ' 81' ' ' GLU . 54.7 mmtt -97.75 -35.4 10.56 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.292 0.568 . . . . 0.0 110.172 172.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 9.9 mmt180 -78.35 -70.2 0.51 Allowed 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.722 176.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -98.83 86.47 3.52 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.192 0.52 . . . . 0.0 111.144 -172.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.559 ' NZ ' ' HB2' ' A' ' 88' ' ' LYS . 9.4 mtmp? -94.07 36.29 1.13 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.3 0.571 . . . . 0.0 110.999 -177.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -78.53 35.95 1.81 Allowed Glycine 0 CA--C 1.531 1.054 0 CA-C-N 116.044 -0.526 . . . . 0.0 113.853 -177.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 76.9 tttt 70.83 -60.87 0.49 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.666 0.786 . . . . 0.0 112.253 178.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 53.5 m -63.73 105.69 0.85 Allowed 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 120.824 0.345 . . . . 0.0 111.558 176.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.407 ' HE2' ' OE2' ' A' ' 93' ' ' GLU . 11.3 ttpt -73.6 -49.05 28.13 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -173.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.407 ' OE2' ' HE2' ' A' ' 92' ' ' LYS . 2.8 mp0 -53.17 -49.59 66.33 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 111.671 0.248 . . . . 0.0 111.671 -178.614 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -60.71 -33.46 72.91 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.889 0.376 . . . . 0.0 111.402 178.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.21 -39.56 94.97 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.139 0.495 . . . . 0.0 110.645 173.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -63.41 -39.04 93.43 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.326 175.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.47 ' O ' ' HB3' ' A' ' 100' ' ' CYS . 20.2 m-20 -60.25 -49.81 76.14 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.654 0.264 . . . . 0.0 111.057 172.388 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -53.58 -50.57 65.32 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -177.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 17.3 tt -65.6 -30.56 50.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-O 121.083 0.468 . . . . 0.0 110.819 177.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' CYS . . . . . 0.47 ' HB3' ' O ' ' A' ' 97' ' ' ASP . 35.8 t -63.41 -42.01 98.75 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.968 173.174 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -57.4 -39.54 76.35 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.776 0.322 . . . . 0.0 111.128 175.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 96.6 mt -65.96 -44.6 84.5 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 178.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 60.9 t -97.8 -54.2 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -172.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.77 127.82 33.53 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -171.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 100.24 -8.78 59.12 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 115.888 -0.596 . . . . 0.0 113.62 177.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -105.08 173.98 6.07 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.467 0.651 . . . . 0.0 112.15 -179.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.523 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 10.9 pt-20 -143.83 160.92 48.47 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.657 179.196 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.523 ' HD2' ' HB2' ' A' ' 107' ' ' GLU . 42.2 Cg_exo -32.38 106.6 0.04 OUTLIER 'Trans proline' 0 C--N 1.36 1.158 0 C-N-CA 123.711 2.94 . . . . 0.0 114.622 -177.024 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -93.62 -24.5 17.89 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.817 -177.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -98.22 100.92 12.25 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.095 0.474 . . . . 0.0 111.032 178.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 60.6 t -83.55 -48.16 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 121.07 0.462 . . . . 0.0 111.662 -177.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -174.53 107.0 0.23 Allowed Glycine 0 CA--C 1.525 0.697 0 C-N-CA 121.329 -0.462 . . . . 0.0 112.549 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 49.0 t -75.34 -64.67 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 O-C-N 122.604 -0.351 . . . . 0.0 111.882 -178.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 90.5 m 70.02 -61.73 0.45 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.215 0.606 . . . . 0.0 112.235 -178.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -68.25 176.67 2.63 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -178.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 69.26 -67.43 0.22 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.315 0.646 . . . . 0.0 112.714 178.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -67.8 -30.16 69.52 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -177.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.5 t -51.35 130.95 28.14 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.27 0.557 . . . . 0.0 112.276 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 136.93 -124.67 3.18 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.175 -177.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -75.78 70.95 1.95 Allowed Glycine 0 CA--C 1.529 0.964 0 C-N-CA 121.405 -0.426 . . . . 0.0 113.052 178.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -136.66 153.3 50.95 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 122.545 0.338 . . . . 0.0 111.057 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 24.3 m -96.59 111.49 26.77 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 CA-C-O 121.726 0.774 . . . . 0.0 112.526 -177.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -89.28 -42.99 11.27 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.493 0.663 . . . . 0.0 109.274 172.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 53.9 ttt85 -97.43 117.99 32.92 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.979 172.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.764 ' H ' HD23 ' A' ' 125' ' ' LEU . 1.9 pt? -121.34 137.83 54.52 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.113 0.483 . . . . 0.0 111.801 -174.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 76.5 p -88.91 3.42 51.45 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.586 0.588 . . . . 0.0 112.586 -177.078 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -160.25 155.76 25.37 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-O 120.7 0.286 . . . . 0.0 110.638 -178.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 10.0 t -114.73 0.1 13.74 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 121.155 0.502 . . . . 0.0 111.307 178.031 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 41.1 t -142.37 -55.69 0.44 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.26 -178.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 12.6 tpt180 64.71 7.27 3.72 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 121.289 0.566 . . . . 0.0 111.234 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -145.85 161.34 40.22 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.635 -176.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 94.3 m -125.18 123.49 39.73 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 120.924 0.392 . . . . 0.0 111.908 178.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -74.51 114.23 4.36 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 121.364 -0.446 . . . . 0.0 113.412 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 41.1 t -160.18 110.68 1.86 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 122.624 0.37 . . . . 0.0 110.48 177.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 38.3 m80 60.53 175.28 0.1 Allowed 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 120.989 0.423 . . . . 0.0 111.831 -175.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt 71.66 -26.41 0.17 Allowed 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 172.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -49.0 -49.35 41.28 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -177.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 138' ' ' ARG . 2.8 tmm_? 61.28 101.09 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.425 -175.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 25.3 p90 -128.33 135.4 49.55 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.011 0.434 . . . . 0.0 111.585 -176.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -84.54 126.67 33.51 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.178 0.513 . . . . 0.0 111.123 177.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -63.96 91.77 0.07 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.547 0.689 . . . . 0.0 111.463 -178.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 78.4 p -104.94 26.39 9.29 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.254 -176.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -179.1 -158.98 22.5 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 120.046 -1.073 . . . . 0.0 114.088 -178.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 64.5 tttp 63.48 -87.11 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.278 0.631 . . . . 0.0 111.631 -176.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 42.94 -119.91 2.41 Favored Glycine 0 CA--C 1.531 1.057 0 N-CA-C 114.34 0.496 . . . . 0.0 114.34 177.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -122.3 35.09 4.97 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.953 0.406 . . . . 0.0 110.958 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -72.57 40.0 0.76 Allowed Glycine 0 CA--C 1.536 1.363 0 N-CA-C 114.777 0.671 . . . . 0.0 114.777 -175.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 34.2 mm -98.48 -14.19 7.84 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-O 121.225 0.536 . . . . 0.0 111.078 178.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -73.03 115.39 12.28 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 120.99 0.424 . . . . 0.0 111.918 -177.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 105.29 100.87 2.66 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 121.415 -0.421 . . . . 0.0 112.598 -178.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -123.52 87.44 2.74 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 122.53 -0.394 . . . . 0.0 111.994 -176.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -173.95 -28.93 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.601 175.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 65.13 -77.41 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.206 0.602 . . . . 0.0 112.232 178.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 32.4 pt -133.61 151.34 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-O 120.979 0.419 . . . . 0.0 111.521 -177.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 74.5 mt -98.31 37.13 1.49 Allowed 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 120.893 0.378 . . . . 0.0 111.222 -178.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 60.14 24.8 14.1 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.601 -177.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -60.16 120.99 10.81 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.358 0.599 . . . . 0.0 111.338 179.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 19.6 t -71.05 128.74 36.98 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.146 -172.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -74.32 127.54 10.01 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 121.181 -0.533 . . . . 0.0 112.844 178.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -69.6 128.49 36.65 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 120.893 0.377 . . . . 0.0 111.691 -177.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 35.0 m -76.67 142.5 14.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-O 121.145 0.497 . . . . 0.0 111.804 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 73.0 p -76.32 108.55 9.35 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.034 177.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 67.01 -165.37 0.22 Allowed 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.027 0.441 . . . . 0.0 111.703 -178.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -83.01 14.93 3.01 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -177.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp 68.72 -59.34 0.46 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.16 0.584 . . . . 0.0 111.638 -175.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -103.57 179.25 4.32 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.102 0.477 . . . . 0.0 110.919 175.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -70.0 92.99 0.75 Allowed 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.143 0.497 . . . . 0.0 111.379 177.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -80.8 42.4 2.67 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 121.3 -0.476 . . . . 0.0 113.205 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 73.7 p -139.25 176.54 8.62 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.023 0.439 . . . . 0.0 110.858 -179.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -86.1 48.72 1.65 Allowed 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 121.075 0.464 . . . . 0.0 111.04 178.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 10.6 t70 65.79 -72.91 0.07 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.688 0.795 . . . . 0.0 112.617 178.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -59.45 161.28 5.93 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -177.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -64.03 127.67 32.45 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.82 173.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 58.0 t -50.16 91.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-O 121.098 0.475 . . . . 0.0 112.127 -176.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 51.5 mtpt 54.18 31.07 13.29 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.009 178.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 58.8 mttm 62.17 17.86 9.57 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 122.956 0.502 . . . . 0.0 112.277 178.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 84.1 mt 68.02 98.95 0.05 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.132 0.573 . . . . 0.0 111.726 -178.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 . . . . . 0 N--CA 1.476 0.868 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -178.497 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.6 tpt . . . . . 0 N--CA 1.487 1.425 0 CA-C-O 120.552 0.215 . . . . 0.0 110.759 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.15 165.34 3.48 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 177.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 69.82 101.14 0.06 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.006 0.523 . . . . 0.0 111.309 -176.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.8 t -81.33 126.47 31.62 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.993 0.425 . . . . 0.0 112.093 -174.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.432 ' O ' ' HB2' ' A' ' 6' ' ' ASP . 74.6 p -70.27 114.73 8.69 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.177 172.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.432 ' HB2' ' O ' ' A' ' 5' ' ' THR . 2.1 m-20 68.45 101.48 0.05 Allowed 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.193 0.52 . . . . 0.0 111.25 -174.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.638 HG12 ' H ' ' A' ' 9' ' ' GLY . 7.9 tt -49.28 129.06 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 CA-C-N 115.947 -0.569 . . . . 0.0 112.308 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.04 -27.9 48.07 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -178.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.638 ' H ' HG12 ' A' ' 7' ' ' ILE . . . -60.06 -28.42 66.36 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 121.229 -0.51 . . . . 0.0 113.049 177.171 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 44.8 tp -73.24 -35.28 66.22 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.116 0.484 . . . . 0.0 110.524 177.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -62.69 -45.46 92.66 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.849 175.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.498 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 35.1 tt0 -65.89 -45.85 80.51 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.53 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 79.6 p -58.0 -46.41 85.27 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.045 0.45 . . . . 0.0 110.818 178.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -54.14 -48.71 70.53 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.219 0.533 . . . . 0.0 110.685 172.05 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.435 ' HG3' ' HA3' ' A' ' 27' ' ' GLY . 49.4 ttt180 -58.51 -37.21 75.12 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.37 -179.105 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.498 ' HG2' ' O ' ' A' ' 12' ' ' GLU . 75.6 mmtt -60.39 -50.19 74.58 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.823 178.093 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.464 ' HB2' ' HE2' ' A' ' 30' ' ' MET . 81.7 m-85 -72.89 -21.1 60.97 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.739 0.304 . . . . 0.0 111.524 177.555 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.68 -54.31 12.34 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 120.862 0.363 . . . . 0.0 111.877 179.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 32.8 pt -73.78 -10.68 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-O 120.989 0.423 . . . . 0.0 111.882 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 -58.85 87.95 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.12 0.486 . . . . 0.0 111.745 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 132.84 -34.4 2.47 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-N 116.136 -0.484 . . . . 0.0 113.125 -179.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.502 ' CG ' ' HZ2' ' A' ' 24' ' ' LYS . 12.2 t70 -133.04 114.59 13.9 Favored Pre-proline 0 CA--C 1.544 0.746 0 O-C-N 122.462 -0.434 . . . . 0.0 111.337 -177.271 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -80.86 0.03 10.29 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.585 2.19 . . . . 0.0 113.562 -179.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.502 ' HZ2' ' CG ' ' A' ' 22' ' ' ASP . 9.5 mtmp? -93.91 -16.77 23.68 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.97 0.414 . . . . 0.0 111.368 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -82.54 137.72 34.5 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.396 177.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 47.0 m -68.98 -22.66 64.09 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 120.77 0.319 . . . . 0.0 111.463 179.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.435 ' HA3' ' HG3' ' A' ' 15' ' ' ARG . . . 108.44 23.5 6.59 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 121.274 -0.488 . . . . 0.0 114.194 177.081 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -104.51 6.22 34.6 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 117.388 0.594 . . . . 0.0 111.799 178.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -130.79 130.76 44.11 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.011 -178.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.464 ' HE2' ' HB2' ' A' ' 17' ' ' PHE . 48.2 ttm -125.81 133.88 51.86 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.987 0.422 . . . . 0.0 111.99 -179.156 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.445 ' OD1' ' HB3' ' A' ' 33' ' ' LYS . 9.8 p30 -90.93 168.35 11.75 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.987 0.422 . . . . 0.0 111.605 178.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -66.04 -28.72 73.9 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-N 116.164 -0.471 . . . . 0.0 114.041 -179.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.445 ' HB3' ' OD1' ' A' ' 31' ' ' ASN . 39.6 ttmt -67.46 -48.8 66.14 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 117.006 0.403 . . . . 0.0 111.316 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -68.71 -35.22 76.88 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.803 0.335 . . . . 0.0 111.013 175.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 47.5 t-105 -58.43 -45.48 88.41 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.283 174.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.52 -38.26 83.83 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.193 0.521 . . . . 0.0 111.528 176.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -70.72 -35.58 72.79 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.364 175.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.7 tt -59.57 -54.45 46.4 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.083 0.468 . . . . 0.0 110.588 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 26.2 p -60.51 -44.42 96.04 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.646 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -67.89 -38.16 82.67 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.847 0.356 . . . . 0.0 111.525 -178.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -67.31 -49.91 62.27 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.236 178.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.557 ' SG ' HG22 ' A' ' 103' ' ' VAL . 68.8 m -80.61 1.43 29.85 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.503 178.097 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp 69.03 20.23 7.82 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.033 0.533 . . . . 0.0 112.144 172.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.543 ' HA ' ' NH1' ' A' ' 86' ' ' ARG . 40.0 t -70.04 -26.94 30.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 120.926 0.394 . . . . 0.0 110.561 175.196 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.16 78.04 0.51 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.651 0.739 . . . . 0.0 109.972 172.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.486 ' HB3' ' H ' ' A' ' 50' ' ' VAL . 38.7 t70 -54.99 -30.12 58.62 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 114.601 -1.181 . . . . 0.0 113.978 -169.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.26 -36.44 1.53 Allowed Glycine 0 CA--C 1.531 1.065 0 C-N-CA 121.227 -0.511 . . . . 0.0 113.31 -177.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.7 mttp -82.59 -46.94 12.69 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.161 0.505 . . . . 0.0 110.093 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 73.1 m -108.55 -50.43 3.03 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.564 174.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.486 ' H ' ' HB3' ' A' ' 46' ' ' ASP . 43.1 t -93.76 110.25 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -178.22 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 76.5 p -96.44 173.93 7.12 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 120.689 0.281 . . . . 0.0 111.519 177.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -58.06 -44.05 94.85 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 121.083 -0.58 . . . . 0.0 112.443 177.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.562 ' O ' HG13 ' A' ' 57' ' ' ILE . 44.5 p -51.21 -50.64 58.71 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.325 0.583 . . . . 0.0 110.361 172.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.06 -38.42 70.61 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.04 -176.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.2 t -59.22 -40.56 81.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.173 176.063 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -68.06 -37.66 81.55 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.98 0.419 . . . . 0.0 110.84 175.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.562 HG13 ' O ' ' A' ' 53' ' ' THR . 6.5 mt -62.73 -46.76 95.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.146 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 76.5 t -59.99 -42.48 89.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 120.979 0.419 . . . . 0.0 111.07 177.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -62.36 -23.32 66.73 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-O 121.153 0.502 . . . . 0.0 110.999 176.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 23.1 t -87.0 -34.79 19.13 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.836 0.35 . . . . 0.0 111.254 175.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -60.86 -44.69 96.69 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 29.4 m -78.97 -22.64 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -177.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? -73.97 150.01 41.02 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.905 0.383 . . . . 0.0 111.789 -175.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -70.18 -98.67 0.05 OUTLIER Glycine 0 CA--C 1.53 0.993 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.161 174.063 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -141.88 -64.73 0.43 Allowed 'General case' 0 N--CA 1.471 0.607 0 O-C-N 122.423 -0.457 . . . . 0.0 111.216 174.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 43.5 t -92.77 91.3 7.42 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.862 0.363 . . . . 0.0 110.825 177.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -160.57 146.56 15.08 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.231 0.538 . . . . 0.0 112.089 -178.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 68' ' ' ARG . 32.5 mtm-85 -104.36 -37.76 7.1 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.393 0.616 . . . . 0.0 110.716 177.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.3 m -124.82 158.56 32.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.208 -178.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 42.1 pt -118.49 159.77 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.091 177.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 18.0 p30 -103.61 177.81 4.73 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.412 ' OH ' ' HB3' ' A' ' 6' ' ' ASP . 84.7 t80 -54.01 -40.62 67.17 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -174.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -56.22 -51.47 67.95 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.266 0.555 . . . . 0.0 111.281 178.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -64.52 -32.87 74.69 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.068 177.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.407 ' HB3' ' O ' ' A' ' 72' ' ' TYR . 61.0 t80 -58.82 -43.72 90.68 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.025 174.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp -54.95 -49.53 71.14 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.186 0.517 . . . . 0.0 111.066 173.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -61.18 -35.13 76.32 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.173 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.47 -43.38 81.16 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.012 0.434 . . . . 0.0 111.449 176.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 80.8 mt -64.89 -35.4 81.01 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.103 177.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -59.94 -49.94 75.7 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.134 0.492 . . . . 0.0 110.325 176.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -57.4 -56.7 18.43 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.152 175.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 87.1 mt -60.27 -35.24 75.08 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -178.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.5 ' HB2' HG21 ' A' ' 99' ' ' ILE . . . -64.15 -48.04 77.58 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.108 0.48 . . . . 0.0 111.057 178.279 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 65.7 p -74.67 -9.26 58.39 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.846 -0.616 . . . . 0.0 112.161 -179.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -101.6 -28.32 12.58 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 173.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.543 ' NH1' ' HA ' ' A' ' 44' ' ' VAL . 14.3 tpt180 -83.26 -54.26 5.14 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.695 0.76 . . . . 0.0 110.575 178.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -86.55 144.58 27.14 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.752 178.033 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.464 ' HB3' ' NZ ' ' A' ' 88' ' ' LYS . 0.5 OUTLIER -81.64 -164.71 0.82 Allowed 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -178.555 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -55.3 81.97 0.01 OUTLIER Glycine 0 CA--C 1.531 1.035 0 N-CA-C 114.633 0.613 . . . . 0.0 114.633 -176.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -126.3 177.15 6.6 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 122.885 0.474 . . . . 0.0 110.749 176.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 65.9 m -62.72 125.44 23.96 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 120.767 0.318 . . . . 0.0 111.161 176.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -54.84 -40.31 69.48 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 116.134 -0.485 . . . . 0.0 112.303 -174.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -62.59 -59.93 4.23 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.653 0.263 . . . . 0.0 110.98 178.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -53.82 -39.47 65.57 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 120.725 0.297 . . . . 0.0 111.432 -179.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.24 -42.73 95.91 Favored 'General case' 0 CA--C 1.541 0.635 0 CA-C-O 120.706 0.288 . . . . 0.0 111.468 177.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -67.59 -50.2 59.44 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.222 178.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -57.32 -42.03 81.07 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 120.727 0.298 . . . . 0.0 111.456 178.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.67 -54.22 45.71 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 112.041 0.385 . . . . 0.0 112.041 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.5 HG21 ' HB2' ' A' ' 83' ' ' ALA . 12.7 tt -59.29 -36.12 61.84 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-O 121.096 0.474 . . . . 0.0 110.793 179.252 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 81.6 m -68.04 -38.69 82.8 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.135 176.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -58.42 -31.49 67.76 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.061 0.458 . . . . 0.0 111.486 177.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 92.9 mt -60.79 -41.11 94.96 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.879 176.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.557 HG22 ' SG ' ' A' ' 42' ' ' CYS . 16.3 t -96.76 -31.63 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 CA-C-O 121.044 0.449 . . . . 0.0 112.176 -174.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.03 124.67 21.7 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -173.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 85.78 -11.56 61.73 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 116.123 -0.49 . . . . 0.0 113.44 177.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -86.67 153.33 21.83 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 122.5 -0.412 . . . . 0.0 111.293 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.538 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 0.4 OUTLIER -86.42 163.27 42.79 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.294 173.901 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.538 ' HD2' ' HB2' ' A' ' 107' ' ' GLU . 59.3 Cg_endo -69.73 -149.38 0.02 OUTLIER 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.052 1.835 . . . . 0.0 111.922 177.119 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' A' ' 111' ' ' VAL . . . -48.53 118.94 2.74 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 169.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.475 ' O ' ' HB ' ' A' ' 111' ' ' VAL . 19.4 p30 -53.49 72.09 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -170.475 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.518 ' N ' ' O ' ' A' ' 109' ' ' ALA . 12.4 p 166.63 -36.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.614 0.766 . . . . 0.0 110.684 -178.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 94.47 -67.19 1.4 Allowed Glycine 0 CA--C 1.526 0.725 0 CA-C-N 116.336 -0.393 . . . . 0.0 112.193 -176.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 11.4 p -106.09 150.22 8.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 122.385 0.274 . . . . 0.0 110.638 175.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 58.3 m -49.96 144.5 6.6 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.464 0.173 . . . . 0.0 111.314 178.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -50.98 93.0 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.614 0.721 . . . . 0.0 112.645 -174.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -152.25 -81.33 0.1 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.36 173.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 64.9 tttp 66.21 -21.75 0.1 Allowed 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 170.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 78.9 p -79.84 30.92 0.25 Allowed 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -175.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -66.03 -76.2 0.36 Allowed Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.843 179.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 53.02 32.15 41.67 Favored Glycine 0 CA--C 1.529 0.936 0 N-CA-C 114.478 0.551 . . . . 0.0 114.478 176.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -150.77 161.54 42.44 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 117.004 0.402 . . . . 0.0 111.677 -178.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 65.0 t 69.17 -61.99 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 123.014 0.526 . . . . 0.0 111.785 -178.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 22.3 t70 67.62 -73.68 0.08 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.113 0.565 . . . . 0.0 111.894 176.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 46.2 ttp180 68.17 73.78 0.29 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.476 0.711 . . . . 0.0 111.914 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.478 ' CD1' ' H ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -79.69 -5.75 55.8 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.668 171.889 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 15.2 m -59.56 95.48 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.6 -0.727 . . . . 0.0 112.446 -178.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -77.43 178.54 7.11 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.161 175.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 13.5 t -61.68 176.69 0.49 Allowed 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.114 0.412 . . . . 0.0 112.114 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 45.2 t -49.58 127.62 15.96 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -177.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.424 HH11 ' HD2' ' A' ' 130' ' ' ARG . 61.6 mtt180 -72.31 -16.23 61.89 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.266 178.385 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -81.57 63.52 5.89 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.24 0.543 . . . . 0.0 110.491 177.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 81.0 p 45.84 79.93 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.274 -0.875 . . . . 0.0 113.078 -176.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -81.97 67.64 3.64 Favored Glycine 0 CA--C 1.523 0.538 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.156 175.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 39.6 t -49.16 152.49 1.14 Allowed 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -175.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 74.6 m-70 71.13 -64.38 0.38 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.728 0.811 . . . . 0.0 111.582 -176.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 89.1 tttt 57.26 -93.23 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 122.773 0.429 . . . . 0.0 111.439 -178.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.42 ' O ' ' HB3' ' A' ' 138' ' ' ARG . 18.2 mm-40 -135.96 124.59 23.72 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 122.188 0.195 . . . . 0.0 110.95 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.42 ' HB3' ' O ' ' A' ' 137' ' ' GLU . 30.8 ttt180 72.66 -42.11 0.52 Allowed 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 176.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -76.26 155.43 34.37 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -172.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 61.55 98.8 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.458 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -55.57 122.47 11.39 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.551 176.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 66.8 m -69.26 80.8 0.36 Allowed 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -171.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 51.59 -137.41 30.73 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-N 115.892 -0.594 . . . . 0.0 114.543 173.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.515 ' HE3' ' HA3' ' A' ' 147' ' ' GLY . 46.8 tttp -110.15 108.92 19.24 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 122.58 0.352 . . . . 0.0 110.449 179.008 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.451 ' O ' ' NZ ' ' A' ' 175' ' ' LYS . . . -55.67 -81.32 0.07 OUTLIER Glycine 0 CA--C 1.526 0.761 0 C-N-CA 121.203 -0.522 . . . . 0.0 112.853 178.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -122.49 -44.52 2.24 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 122.431 -0.452 . . . . 0.0 110.895 172.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.515 ' HA3' ' HE3' ' A' ' 144' ' ' LYS . . . 67.65 35.69 86.43 Favored Glycine 0 CA--C 1.521 0.453 0 C-N-CA 121.195 -0.526 . . . . 0.0 112.717 -178.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 10.4 tt -84.98 122.8 38.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-O 121.128 0.49 . . . . 0.0 111.702 -177.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -84.86 78.06 9.97 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.31 0.576 . . . . 0.0 110.856 177.026 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.461 ' C ' ' HD2' ' A' ' 151' ' ' ARG . . . -159.73 177.42 36.24 Favored Glycine 0 CA--C 1.524 0.637 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.84 -179.26 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.461 ' HD2' ' C ' ' A' ' 150' ' ' GLY . 3.5 mpt_? -116.51 138.23 51.55 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.985 0.421 . . . . 0.0 111.418 178.435 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -77.86 85.04 4.14 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.409 178.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -74.99 -12.85 60.43 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.947 0.403 . . . . 0.0 111.375 176.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 7.7 tt -61.73 104.94 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 121.277 0.56 . . . . 0.0 110.554 172.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 92.0 mt -91.57 86.3 5.98 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.939 0.4 . . . . 0.0 111.518 -176.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -70.7 129.55 39.44 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.76 175.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -72.2 77.46 0.97 Allowed 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.794 0.807 . . . . 0.0 110.676 175.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 39.5 t -81.53 94.5 6.89 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.429 -178.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -139.04 -72.45 0.05 OUTLIER Glycine 0 CA--C 1.524 0.636 0 C-N-CA 121.417 -0.421 . . . . 0.0 112.33 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -117.61 120.55 38.39 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.865 0.364 . . . . 0.0 111.072 178.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 16.7 m -78.1 99.52 2.81 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-O 121.402 0.62 . . . . 0.0 111.956 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 62.9 p -90.48 126.9 36.06 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.425 175.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 72.02 113.18 0.06 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.115 0.566 . . . . 0.0 111.081 -174.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -97.11 -83.61 0.39 Allowed 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -172.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 30.5 mmtm 57.92 -89.56 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -174.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 7.4 t30 47.95 76.36 0.11 Allowed 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.133 0.492 . . . . 0.0 111.243 -174.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -74.06 -31.96 63.08 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -174.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 69.35 46.78 55.28 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.119 -176.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.539 HG22 ' HD2' ' A' ' 170' ' ' TYR . 35.1 m -51.76 105.12 0.1 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.493 0.717 . . . . 0.0 112.688 -175.595 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' TYR . . . . . 0.539 ' HD2' HG22 ' A' ' 169' ' ' THR . 93.9 m-85 58.34 16.39 4.04 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 179.317 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 17.5 t70 67.56 161.92 0.18 Allowed 'General case' 0 CA--C 1.547 0.859 0 CA-C-O 121.372 0.606 . . . . 0.0 111.565 -178.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -83.99 9.7 11.7 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.427 0.528 . . . . 0.0 112.427 -178.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.431 ' NZ ' ' HB3' ' A' ' 173' ' ' LYS . 5.8 ttpm? -77.52 51.65 0.91 Allowed 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 121.565 0.697 . . . . 0.0 111.691 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 35.1 m -76.96 -2.84 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-O 121.454 0.645 . . . . 0.0 110.785 173.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.451 ' NZ ' ' O ' ' A' ' 145' ' ' GLY . 11.9 mmmm -83.3 38.02 0.59 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.589 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 7.9 ptmm? -52.29 139.19 24.83 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -172.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 86.8 mt -78.74 1.73 22.12 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.96 -177.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 . . . . . 0 CA--C 1.542 0.671 0 CA-C-O 120.845 0.355 . . . . 0.0 110.276 176.843 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.7 mmt . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 64.78 -74.44 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 178.234 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -58.24 104.82 0.23 Allowed 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -176.28 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 42.7 t 64.9 100.58 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.07 0.548 . . . . 0.0 111.516 -177.067 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 94.4 m -128.96 99.06 5.14 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.578 178.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -78.98 118.08 20.64 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.948 176.226 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.479 HG12 ' H ' ' A' ' 9' ' ' GLY . 10.8 tt -56.72 131.33 20.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 CA-C-O 121.138 0.494 . . . . 0.0 112.014 -178.321 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -53.19 -34.3 56.39 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -177.116 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.479 ' H ' HG12 ' A' ' 7' ' ' ILE . . . -60.75 -34.48 86.9 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 121.41 -0.424 . . . . 0.0 113.487 177.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 38.8 tp -73.76 -43.69 58.32 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.363 0.601 . . . . 0.0 110.656 178.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -59.17 -36.25 74.98 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.501 174.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -66.9 -51.03 60.34 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.457 174.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.5 p -60.74 -43.24 98.16 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -177.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -57.61 -55.96 28.08 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.026 0.441 . . . . 0.0 110.492 175.072 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.46 ' O ' HG12 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -56.91 -34.65 68.14 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.541 177.198 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -63.89 -48.28 77.25 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 120.901 0.381 . . . . 0.0 111.765 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.443 ' HA ' ' HB2' ' A' ' 20' ' ' HIS . 49.9 m-85 -77.72 -23.17 49.48 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.725 -0.216 . . . . 0.0 111.479 176.071 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.78 -47.79 71.04 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 120.913 0.387 . . . . 0.0 111.09 176.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.46 HG12 ' O ' ' A' ' 15' ' ' ARG . 26.3 pt -86.47 1.61 5.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.869 178.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.443 ' HB2' ' HA ' ' A' ' 17' ' ' PHE . 34.6 t-80 -51.8 96.91 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.41 0.624 . . . . 0.0 111.737 -178.106 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 135.31 -50.32 0.86 Allowed Glycine 0 CA--C 1.525 0.705 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.068 -175.56 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -126.97 111.04 21.9 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 122.443 0.297 . . . . 0.0 111.283 179.001 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -68.4 -5.08 14.19 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 122.569 2.179 . . . . 0.0 112.417 178.362 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.3 pttt -93.36 0.06 56.77 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.844 177.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.86 158.94 26.62 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.052 0.454 . . . . 0.0 111.842 -178.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 31.2 p -67.14 -71.23 0.21 Allowed 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.077 -178.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 109.75 14.34 14.21 Favored Glycine 0 CA--C 1.532 1.099 0 N-CA-C 114.674 0.63 . . . . 0.0 114.674 175.372 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 -97.86 4.19 49.7 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 117.617 0.709 . . . . 0.0 111.468 176.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.585 ' HB3' HG21 ' A' ' 69' ' ' VAL . 31.8 mt-10 -144.9 143.53 30.62 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.042 0.537 . . . . 0.0 110.888 177.429 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.518 ' O ' ' HB ' ' A' ' 69' ' ' VAL . 49.4 ttm -128.8 140.69 51.59 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.06 0.457 . . . . 0.0 111.997 -177.398 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 27.2 p30 -93.18 164.21 13.33 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.084 0.469 . . . . 0.0 111.868 178.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.455 ' HA2' ' HB3' ' A' ' 35' ' ' TRP . . . -61.72 -25.96 66.25 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 121.386 -0.435 . . . . 0.0 113.224 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -59.08 -57.38 13.32 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 121.196 0.522 . . . . 0.0 111.474 177.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -75.94 -26.37 56.83 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.49 179.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.455 ' HB3' ' HA2' ' A' ' 32' ' ' GLY . 51.7 t-105 -62.52 -45.5 92.71 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.136 0.493 . . . . 0.0 110.875 173.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.72 -45.25 94.78 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.111 176.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -68.71 -31.25 70.2 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.653 177.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.2 tt -58.44 -56.79 17.58 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.171 0.51 . . . . 0.0 110.522 178.132 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.637 ' HA ' ' SG ' ' A' ' 42' ' ' CYS . 28.9 p -63.98 -35.9 82.22 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.613 -179.303 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -68.42 -41.42 80.42 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.804 0.335 . . . . 0.0 111.443 178.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -73.59 -31.86 63.82 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.637 ' SG ' ' HA ' ' A' ' 39' ' ' CYS . 27.9 p -89.8 -5.97 56.38 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.96 0.409 . . . . 0.0 110.711 173.703 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt 55.94 25.66 8.93 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.299 0.852 . . . . 0.0 113.299 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.525 HG23 ' SG ' ' A' ' 42' ' ' CYS . 79.1 t -67.54 -37.32 78.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 169.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.92 115.46 7.46 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.925 171.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -131.43 84.53 2.18 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.393 -173.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -33.18 -30.69 0.01 OUTLIER Glycine 0 CA--C 1.537 1.458 0 N-CA-C 116.011 1.165 . . . . 0.0 116.011 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -62.89 -44.6 95.67 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 118.042 0.921 . . . . 0.0 111.1 175.151 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.5 t -107.61 -55.66 2.32 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.026 176.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 40.9 t -109.37 109.46 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 122.788 0.435 . . . . 0.0 111.788 -177.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 66.1 p -79.58 151.91 30.38 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -56.41 -30.69 58.94 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 121.395 -0.431 . . . . 0.0 112.59 176.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.596 ' O ' HG13 ' A' ' 57' ' ' ILE . 89.2 m -61.92 -50.58 71.58 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 122.867 -0.196 . . . . 0.0 110.845 174.546 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.442 ' O ' HG23 ' A' ' 58' ' ' VAL . 26.7 t70 -58.22 -41.42 84.07 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.876 0.369 . . . . 0.0 110.951 179.255 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.1 t -58.64 -35.14 53.74 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 CA-C-O 121.183 0.516 . . . . 0.0 111.408 175.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -73.3 -38.28 65.91 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.205 0.526 . . . . 0.0 110.305 179.415 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.596 HG13 ' O ' ' A' ' 53' ' ' THR . 9.1 mt -62.5 -45.72 98.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.777 177.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 54' ' ' ASP . 94.2 t -58.03 -42.13 82.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.794 177.522 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -54.91 -43.88 73.67 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 121.178 0.514 . . . . 0.0 111.252 176.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 60.1 p -80.65 -17.48 51.09 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.834 -177.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.433 ' HD3' ' HA ' ' A' ' 61' ' ' LYS . 31.7 mmtp -84.54 -33.12 23.53 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 178.371 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.515 ' HB ' ' HB3' ' A' ' 74' ' ' GLU . 34.5 m -82.82 -19.63 10.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-O 121.135 0.493 . . . . 0.0 110.729 173.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.4 ttmm -61.2 127.27 30.71 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.285 177.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -71.85 152.12 48.48 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 120.94 -0.648 . . . . 0.0 111.919 171.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -53.53 -44.13 68.94 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -175.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 95.0 p -93.4 4.95 53.13 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 120.849 0.357 . . . . 0.0 111.806 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -88.66 117.58 27.72 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 120.865 0.364 . . . . 0.0 111.671 -178.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 66.3 mtp180 -70.25 -34.37 72.75 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.565 0.698 . . . . 0.0 110.227 178.252 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.585 HG21 ' HB3' ' A' ' 29' ' ' GLU . 32.4 m -124.82 -160.99 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.486 177.226 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 47.4 pt -119.9 150.02 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 O-C-N 122.051 -0.406 . . . . 0.0 111.28 173.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -102.57 169.62 8.54 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 120.778 0.323 . . . . 0.0 111.461 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -54.19 -40.68 67.81 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -175.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -55.81 -43.53 76.98 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.819 0.342 . . . . 0.0 111.353 176.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.621 ' HA ' ' HD3' ' A' ' 77' ' ' LYS . 11.0 mm-40 -71.99 -31.69 66.49 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.009 0.433 . . . . 0.0 110.75 178.441 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -58.09 -43.7 87.23 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.098 176.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -54.9 -49.49 71.11 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.524 0.678 . . . . 0.0 110.987 173.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.621 ' HD3' ' HA ' ' A' ' 74' ' ' GLU . 51.0 mtpt -62.97 -36.66 84.23 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.684 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.7 -47.05 70.49 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.581 178.015 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 75.8 mt -59.35 -47.47 85.31 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.817 0.341 . . . . 0.0 111.195 177.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -54.22 -40.89 68.08 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 121.114 0.483 . . . . 0.0 111.224 178.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -61.18 -61.42 2.57 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.016 0.436 . . . . 0.0 111.164 176.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 80.9 mt -58.29 -30.87 66.97 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.963 0.411 . . . . 0.0 111.54 -179.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.03 -51.36 67.08 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.983 176.215 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 68.0 p -65.65 -17.21 64.43 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -72.22 -55.81 6.6 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 120.756 0.313 . . . . 0.0 111.593 174.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 62.5 mtp180 -81.35 -47.26 13.51 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.872 0.368 . . . . 0.0 111.668 -178.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -84.9 144.91 28.07 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.793 0.33 . . . . 0.0 110.519 177.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 41.6 mtpt -81.53 157.55 24.77 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.308 0.575 . . . . 0.0 112.096 -177.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -78.22 60.89 3.88 Favored Glycine 0 CA--C 1.528 0.897 0 CA-C-N 116.019 -0.537 . . . . 0.0 114.298 -173.216 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 58.7 pttt -96.3 -34.79 11.47 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.239 0.543 . . . . 0.0 110.488 173.113 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 32.3 t -167.26 115.8 0.81 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.141 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -65.68 -25.86 67.53 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 120.783 0.325 . . . . 0.0 110.707 174.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -57.22 -58.46 8.11 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.145 177.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -70.12 -37.7 75.39 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.305 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.51 -41.79 95.08 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.847 0.356 . . . . 0.0 111.54 178.166 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -67.8 -40.49 83.91 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.441 178.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -55.16 -52.67 62.57 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.421 0.629 . . . . 0.0 110.776 174.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.33 -52.62 62.92 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 115.166 -0.925 . . . . 0.0 112.581 -176.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.0 tt -59.65 -38.01 73.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 O-C-N 121.903 -0.498 . . . . 0.0 110.772 178.289 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 83.0 m -73.68 -24.15 59.92 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.177 175.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -62.94 -34.29 77.17 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.503 0.668 . . . . 0.0 109.81 175.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 94.4 mt -80.3 -25.99 39.07 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.487 177.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 76.6 t -100.57 -53.62 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -175.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -51.56 125.99 16.2 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -176.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 69.93 0.65 28.08 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-N 115.861 -0.609 . . . . 0.0 114.257 178.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.48 ' HD3' ' N ' ' A' ' 107' ' ' GLU . 11.7 tmtt? -87.79 134.63 33.64 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 121.382 0.61 . . . . 0.0 111.057 -176.04 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.48 ' N ' ' HD3' ' A' ' 106' ' ' LYS . 0.9 OUTLIER -89.12 154.61 49.49 Favored Pre-proline 0 CA--C 1.547 0.854 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -174.347 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -62.62 120.21 7.63 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 122.526 2.151 . . . . 0.0 112.37 175.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -98.04 -53.75 3.29 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -175.116 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 62.52 97.93 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 122.664 0.385 . . . . 0.0 111.024 -176.02 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 66.8 t 71.87 -58.44 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 123.246 0.619 . . . . 0.0 110.965 -174.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 109.07 74.89 0.84 Allowed Glycine 0 CA--C 1.525 0.658 0 C-N-CA 121.238 -0.506 . . . . 0.0 113.477 175.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.6 p -74.44 -39.88 48.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 O-C-N 122.555 -0.379 . . . . 0.0 110.947 176.293 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 40.2 m -68.02 102.19 1.26 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.942 176.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.54 ' HB3' ' NZ ' ' A' ' 115' ' ' LYS . 0.3 OUTLIER -137.84 7.71 2.74 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.816 0.341 . . . . 0.0 111.731 178.699 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.415 ' O ' ' HB2' ' A' ' 117' ' ' LYS . . . -64.39 102.29 0.52 Allowed 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.83 176.18 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.568 ' HB2' ' NZ ' ' A' ' 117' ' ' LYS . 8.3 mtmp? 71.95 81.22 0.15 Allowed 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.238 0.542 . . . . 0.0 110.686 -174.128 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 82.4 m -75.14 126.41 30.96 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.507 -177.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -81.41 150.95 30.59 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 121.205 -0.521 . . . . 0.0 113.601 -179.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 83.38 -55.61 5.03 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 121.275 -0.488 . . . . 0.0 113.574 177.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 69.93 172.73 0.3 Allowed 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.1 p -78.53 135.29 26.27 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 CA-C-O 121.33 0.586 . . . . 0.0 112.354 -178.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -83.72 45.99 1.12 Allowed 'General case' 0 CA--C 1.548 0.878 0 CA-C-O 121.245 0.545 . . . . 0.0 111.518 178.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -77.24 115.43 17.01 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -177.013 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 9.6 mp -112.67 -53.54 2.7 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.52 170.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 26.2 p 62.42 -65.69 0.09 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.611 1.164 . . . . 0.0 112.972 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -76.62 151.65 36.15 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.051 0.453 . . . . 0.0 111.715 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 74.3 p -77.3 95.38 4.35 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 120.942 0.401 . . . . 0.0 112.009 -176.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 29.0 t -59.23 137.62 57.9 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.575 174.204 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 9.2 mmm-85 -65.47 -18.21 65.15 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -176.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -84.69 90.3 7.68 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.538 0.685 . . . . 0.0 110.958 175.276 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 9.1 t -111.31 3.89 18.66 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.487 -0.778 . . . . 0.0 111.625 -178.011 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 129.36 -86.45 0.31 Allowed Glycine 0 CA--C 1.523 0.585 0 C-N-CA 121.411 -0.423 . . . . 0.0 112.766 -176.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 21.2 t 62.26 -76.1 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.012 0.525 . . . . 0.0 111.579 179.276 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -157.81 86.69 0.92 Allowed 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.071 0.462 . . . . 0.0 111.511 172.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 50.6 pttt -72.35 136.34 46.13 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.979 171.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -116.58 100.98 8.22 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -173.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.455 HH11 ' HD3' ' A' ' 138' ' ' ARG . 7.3 tpp180 -117.9 20.64 13.25 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-O 121.576 0.703 . . . . 0.0 110.414 175.248 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -83.28 32.7 0.45 Allowed 'General case' 0 CA--C 1.545 0.787 0 CA-C-O 121.501 0.667 . . . . 0.0 111.329 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -85.11 106.82 16.85 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.516 0.674 . . . . 0.0 111.141 177.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -94.33 45.52 1.13 Allowed 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.38 -177.086 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 46.6 t -90.37 148.63 22.71 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 120.862 0.363 . . . . 0.0 111.936 -176.131 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -89.87 -138.6 7.14 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 121.46 -0.4 . . . . 0.0 113.355 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -88.65 78.58 7.71 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 122.219 -0.577 . . . . 0.0 111.197 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -98.0 -159.43 30.43 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.159 -0.543 . . . . 0.0 113.308 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -78.61 -16.55 57.24 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 122.362 -0.493 . . . . 0.0 111.804 -179.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -79.81 20.35 5.5 Favored Glycine 0 CA--C 1.53 1.01 0 N-CA-C 114.341 0.496 . . . . 0.0 114.341 -175.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 37.1 pt -77.25 32.39 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 O-C-N 122.243 -0.563 . . . . 0.0 112.481 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -82.17 16.95 1.77 Allowed 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -176.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -158.1 146.53 13.49 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 121.334 -0.46 . . . . 0.0 112.621 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 75.8 mtm180 -134.36 163.77 28.92 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.873 0.368 . . . . 0.0 111.45 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 61.4 mm-40 -86.18 -167.61 1.93 Allowed 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.291 0.567 . . . . 0.0 111.895 179.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -53.6 -28.85 34.68 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.355 176.417 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 9.2 tt -54.45 123.11 4.8 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 179.394 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -110.69 -44.95 3.57 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.287 0.565 . . . . 0.0 109.987 176.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -75.75 157.62 33.29 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.832 177.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 15.6 t70 71.35 164.63 0.28 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 122.65 0.38 . . . . 0.0 110.803 -175.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 51.7 m 73.06 -43.84 0.57 Allowed 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 179.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -59.0 108.85 1.76 Allowed Glycine 0 CA--C 1.531 1.087 0 C-N-CA 121.527 -0.368 . . . . 0.0 113.581 178.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 39.8 t80 60.63 103.47 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.169 0.587 . . . . 0.0 111.851 -177.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.589 HG23 ' HB2' ' A' ' 164' ' ' TYR . 7.2 p -79.24 121.51 32.59 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -177.116 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 72.4 m -139.11 92.53 2.6 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.145 170.199 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 64.55 77.26 0.32 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.22 -172.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.589 ' HB2' HG23 ' A' ' 161' ' ' VAL . 0.9 OUTLIER -83.36 56.82 3.71 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.572 0.701 . . . . 0.0 110.587 -176.931 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -130.4 141.67 50.54 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.217 -176.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -62.99 134.13 55.68 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -178.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -153.22 -60.46 0.14 Allowed 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.163 177.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 73.26 -69.56 1.34 Allowed Glycine 0 CA--C 1.528 0.872 0 C-N-CA 121.195 -0.526 . . . . 0.0 113.244 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 8.9 t -99.64 159.44 15.04 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.988 0.423 . . . . 0.0 111.425 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -118.75 168.64 10.54 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.891 0.377 . . . . 0.0 111.728 -177.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -70.37 125.28 26.35 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.117 0.484 . . . . 0.0 111.482 -177.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -148.45 124.32 10.6 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.621 177.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.453 ' O ' HG22 ' A' ' 174' ' ' VAL . 37.4 mtmm 63.65 32.66 13.72 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.108 -175.378 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.453 HG22 ' O ' ' A' ' 173' ' ' LYS . 15.6 m 52.79 127.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 125.186 1.394 . . . . 0.0 114.41 179.073 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -98.5 126.88 44.21 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.544 179.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 30.3 mtpp -74.83 124.39 26.76 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 122.185 -0.322 . . . . 0.0 111.198 176.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 81.0 mt -87.91 167.47 13.73 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.976 0.417 . . . . 0.0 111.765 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 . . . . . 0 N--CA 1.47 0.558 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.702 179.709 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.2 mtt . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.07 0.462 . . . . 0.0 111.313 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -139.93 130.08 25.09 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.133 -178.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -175.72 -53.96 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.192 0.52 . . . . 0.0 111.346 -177.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 75.6 m -144.96 -21.53 0.5 Allowed 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.633 177.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 44.2 p -75.04 0.9 14.45 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 177.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -65.37 -171.03 0.07 Allowed 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 121.103 0.477 . . . . 0.0 111.958 177.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.521 ' N ' HD12 ' A' ' 7' ' ' ILE . 2.9 mp -73.91 96.65 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 CA-C-O 120.788 0.328 . . . . 0.0 111.004 -177.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.64 -26.4 65.32 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.264 0.554 . . . . 0.0 111.404 179.047 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -55.76 -28.46 52.36 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.381 175.382 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 34.4 tp -58.33 -38.79 77.84 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.954 0.407 . . . . 0.0 110.704 178.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -67.85 -44.11 77.92 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 120.865 0.364 . . . . 0.0 110.246 173.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 20.5 tp10 -54.75 -47.0 74.39 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 178.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.505 ' HB3' ' HA2' ' A' ' 105' ' ' GLY . 53.9 p -67.49 -52.34 40.34 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -53.04 -47.13 68.62 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.273 0.559 . . . . 0.0 111.211 175.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -60.38 -36.14 77.36 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.261 177.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -73.34 -38.17 65.85 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.552 -178.516 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -74.28 -38.3 63.45 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 120.609 0.243 . . . . 0.0 111.388 176.37 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.94 -49.81 72.47 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.517 ' HA ' ' HB3' ' A' ' 25' ' ' ALA . 33.9 pt -78.67 6.06 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -178.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -90.73 146.07 24.29 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.984 0.421 . . . . 0.0 111.837 -177.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 79.15 -60.88 4.2 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 121.164 -0.541 . . . . 0.0 112.533 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -96.59 105.66 24.52 Favored Pre-proline 0 CA--C 1.542 0.657 0 CA-C-O 120.892 0.377 . . . . 0.0 111.115 177.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.14 -7.31 20.53 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.596 2.197 . . . . 0.0 113.387 -178.433 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -97.88 11.76 36.3 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 178.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.517 ' HB3' ' HA ' ' A' ' 19' ' ' ILE . . . -77.21 161.08 28.44 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.288 0.566 . . . . 0.0 112.356 -178.444 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 96.6 p -87.95 -45.15 10.48 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.978 -178.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.05 -19.93 31.79 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 121.393 -0.432 . . . . 0.0 112.481 -175.009 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 56.4 tp60 -96.54 -21.36 17.73 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.95 0.405 . . . . 0.0 110.841 177.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -125.25 129.49 50.15 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.54 178.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 54.7 ttp -125.29 148.91 48.5 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.118 0.485 . . . . 0.0 112.196 -177.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.489 ' OD1' ' HB3' ' A' ' 33' ' ' LYS . 16.9 p30 -93.07 172.09 8.53 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -177.661 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.547 ' HA2' ' HB3' ' A' ' 35' ' ' TRP . . . -60.83 -27.06 66.11 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-N 116.21 -0.45 . . . . 0.0 112.871 176.729 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.489 ' HB3' ' OD1' ' A' ' 31' ' ' ASN . 87.1 tttt -50.81 -64.47 0.8 Allowed 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 123.941 0.897 . . . . 0.0 112.117 175.393 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -77.42 -25.08 50.38 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.972 -0.455 . . . . 0.0 111.51 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.547 ' HB3' ' HA2' ' A' ' 32' ' ' GLY . 55.8 t-105 -59.76 -38.61 82.27 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.203 0.525 . . . . 0.0 110.462 171.158 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.92 -43.62 87.58 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.75 174.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -53.6 -48.75 68.97 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.647 174.003 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.6 mt -52.59 -49.65 64.59 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.027 0.441 . . . . 0.0 111.644 177.059 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 73.8 m -55.9 -42.55 76.19 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.674 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -75.34 -39.86 58.91 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.071 0.462 . . . . 0.0 111.92 -178.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.605 ' HA ' HD21 ' A' ' 110' ' ' ASN . 24.7 t0 -70.83 -42.51 70.1 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 122.144 -0.348 . . . . 0.0 111.277 -177.443 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.592 ' SG ' HG22 ' A' ' 103' ' ' VAL . 62.9 m -83.41 -12.38 56.5 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.44 176.081 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? 64.7 37.94 7.26 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.179 0.592 . . . . 0.0 111.957 179.016 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.484 HG11 HD13 ' A' ' 82' ' ' LEU . 51.6 t -75.32 -34.93 31.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-O 121.155 0.503 . . . . 0.0 110.079 173.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.72 82.09 2.08 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.481 0.657 . . . . 0.0 111.054 177.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -65.47 -40.26 92.94 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.483 -178.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.97 -38.55 3.23 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 121.392 -0.432 . . . . 0.0 112.806 -176.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -96.52 -48.08 5.69 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.18 0.514 . . . . 0.0 111.15 178.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.4 t -90.17 -44.54 9.7 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.318 178.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 54.0 t -121.51 108.88 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.499 177.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.412 ' O ' HG23 ' A' ' 55' ' ' VAL . 68.2 p -94.06 163.31 13.53 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -175.559 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -56.15 -44.41 88.74 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 121.19 -0.528 . . . . 0.0 112.744 176.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.592 ' O ' HG12 ' A' ' 57' ' ' ILE . 7.8 t -61.86 -41.04 97.35 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 122.53 -0.394 . . . . 0.0 110.69 175.719 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -59.85 -37.71 80.02 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.009 0.433 . . . . 0.0 110.584 176.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 51' ' ' THR . 76.3 t -59.39 -35.16 56.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.147 174.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -76.26 -34.39 59.15 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.817 0.817 . . . . 0.0 109.754 178.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.592 HG12 ' O ' ' A' ' 53' ' ' THR . 9.7 mm -60.61 -54.51 34.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.009 175.591 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.411 ' HA ' ' HB3' ' A' ' 61' ' ' LYS . 74.3 t -57.96 -40.3 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-O 120.728 0.299 . . . . 0.0 111.557 178.545 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -61.71 -44.13 97.51 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.045 0.45 . . . . 0.0 110.512 178.37 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 78.3 p -80.33 -15.06 57.77 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.108 0.48 . . . . 0.0 111.452 178.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.411 ' HB3' ' HA ' ' A' ' 58' ' ' VAL . 24.8 tptp -74.78 -49.98 18.92 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.166 0.587 . . . . 0.0 111.709 178.048 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.7 m -85.02 -24.56 7.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -179.102 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -57.7 131.54 50.57 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 179.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -77.68 -162.86 19.01 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-O 121.291 0.384 . . . . 0.0 113.994 179.358 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 21.3 ttpp -82.06 148.16 28.75 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -177.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 48.5 p 51.18 17.91 0.53 Allowed 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 173.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -110.64 146.49 36.08 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.878 0.371 . . . . 0.0 110.811 177.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 7.4 ptp85 -114.97 15.37 17.26 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.271 0.557 . . . . 0.0 110.862 178.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 22.2 m -145.72 169.86 6.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.661 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 37.2 pt -122.37 143.09 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-O 120.681 0.277 . . . . 0.0 110.885 175.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -100.72 177.79 4.89 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 120.888 0.375 . . . . 0.0 111.467 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -55.76 -27.33 50.23 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 113.159 0.799 . . . . 0.0 113.159 -175.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -70.7 -59.79 2.62 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.782 -0.574 . . . . 0.0 111.076 174.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -56.82 -32.42 65.7 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.436 0.636 . . . . 0.0 110.627 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -60.61 -51.54 68.98 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.733 176.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 37.5 mtmm -60.95 -42.72 98.78 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -59.43 -40.9 88.25 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 120.997 0.427 . . . . 0.0 110.839 175.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.02 -43.37 98.98 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.42 177.237 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 85.0 mt -57.7 -43.12 84.94 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.725 178.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -60.11 -46.42 89.69 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 120.722 0.296 . . . . 0.0 111.241 177.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.466 ' O ' ' HG3' ' A' ' 85' ' ' LYS . 52.5 mt-10 -59.24 -50.56 73.53 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.548 0.213 . . . . 0.0 111.274 177.601 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.484 HD13 HG11 ' A' ' 44' ' ' VAL . 95.9 mt -58.88 -40.32 84.02 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.023 0.439 . . . . 0.0 111.381 176.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.87 -51.41 70.16 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.807 178.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 56.2 p -65.99 -22.17 66.45 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -178.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.466 ' HG3' ' O ' ' A' ' 81' ' ' GLU . 96.9 mttt -78.23 -43.24 28.86 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 120.887 0.375 . . . . 0.0 111.225 174.338 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 26.7 tpt180 -81.32 -63.93 1.29 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.026 0.441 . . . . 0.0 111.133 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -79.16 88.18 4.87 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.361 0.6 . . . . 0.0 110.527 178.355 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 53.1 mttm -80.01 87.86 5.39 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.421 -173.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.402 ' O ' ' HB3' ' A' ' 90' ' ' LYS . . . -156.46 4.53 0.19 Allowed Glycine 0 CA--C 1.533 1.212 0 C-N-CA 120.86 -0.686 . . . . 0.0 114.468 178.518 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.402 ' HB3' ' O ' ' A' ' 89' ' ' GLY . 82.8 tttt 72.86 -43.71 0.57 Allowed 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 33.7 p -46.19 105.04 0.06 Allowed 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -175.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 46.4 mttm -60.37 -63.15 1.4 Allowed 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -176.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -54.32 -48.06 71.77 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -175.03 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -66.71 -44.38 81.79 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -178.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.65 -41.01 93.06 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.011 0.434 . . . . 0.0 111.426 179.415 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -68.75 -37.18 79.2 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.043 178.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -62.17 -49.37 76.11 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.373 0.606 . . . . 0.0 110.001 174.435 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -58.87 -49.89 76.07 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.296 -0.866 . . . . 0.0 112.669 -179.033 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.4 tp -60.89 -38.69 79.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-O 121.149 0.499 . . . . 0.0 110.904 178.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 75.0 m -73.65 -25.36 60.24 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.105 176.155 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -72.75 -32.4 65.64 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.024 0.44 . . . . 0.0 110.616 177.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 90.4 mt -64.16 -55.2 23.48 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.077 0.465 . . . . 0.0 110.924 173.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.592 HG22 ' SG ' ' A' ' 42' ' ' CYS . 41.2 t -69.34 -65.15 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.004 178.36 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 48.95 -100.46 0.07 Allowed 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.494 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.505 ' HA2' ' HB3' ' A' ' 13' ' ' SER . . . -151.13 44.18 0.68 Allowed Glycine 0 CA--C 1.523 0.54 0 C-N-CA 121.199 -0.524 . . . . 0.0 112.407 -179.36 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 49.6 tttm -74.37 155.33 38.24 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-O 121.141 0.496 . . . . 0.0 112.337 -177.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -66.56 137.55 95.23 Favored Pre-proline 0 CA--C 1.545 0.756 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.769 173.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -66.54 147.14 81.69 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.564 2.176 . . . . 0.0 113.898 -173.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 75.64 162.65 0.25 Allowed 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.686 177.15 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.605 HD21 ' HA ' ' A' ' 41' ' ' ASP . 4.0 m120 -92.88 117.07 29.63 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.728 -174.425 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 31.0 m -87.08 134.13 28.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 170.491 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 80.85 64.24 1.82 Allowed Glycine 0 CA--C 1.528 0.871 0 C-N-CA 120.697 -0.763 . . . . 0.0 111.582 -173.131 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 49.0 t -59.73 -43.66 92.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -172.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 87.0 m -114.82 108.28 16.54 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.19 0.519 . . . . 0.0 112.051 -177.192 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.577 ' HA ' ' NH2' ' A' ' 124' ' ' ARG . 58.8 pttt -115.76 -35.9 4.36 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.011 174.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.491 ' HA ' HG21 ' A' ' 122' ' ' VAL . . . -166.2 105.46 0.66 Allowed 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.229 178.043 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -125.78 -63.16 1.14 Allowed 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.992 0.425 . . . . 0.0 111.107 179.189 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 91.8 m -86.28 95.77 9.73 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.084 0.468 . . . . 0.0 110.416 176.496 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 97.72 144.12 16.35 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.347 -176.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -68.0 -40.42 88.77 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 120.817 -0.706 . . . . 0.0 113.253 -179.059 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -106.34 85.14 2.13 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.166 0.507 . . . . 0.0 111.726 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.491 HG21 ' HA ' ' A' ' 116' ' ' ALA . 59.3 t -83.02 161.76 3.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.517 175.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.424 ' N ' HG12 ' A' ' 122' ' ' VAL . 8.6 m-20 -56.84 91.36 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -175.24 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.577 ' NH2' ' HA ' ' A' ' 115' ' ' LYS . 48.9 mmt-85 -120.72 -171.97 2.29 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.855 171.204 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 34.5 tp 66.12 15.78 10.2 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.852 0.834 . . . . 0.0 109.73 -170.273 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 65.4 p -99.54 -38.73 8.65 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.572 -176.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 66.29 -65.36 0.19 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.157 0.583 . . . . 0.0 111.834 -176.103 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 59.4 m 66.83 93.64 0.07 Allowed 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 174.222 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 63.8 p -96.64 135.82 38.03 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.994 173.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 130' ' ' ARG . 1.0 OUTLIER -91.87 -6.28 51.81 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -172.333 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 22.3 p90 39.1 35.66 0.14 Allowed 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 175.277 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 93.8 m -143.11 -55.41 0.4 Allowed 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.838 0.351 . . . . 0.0 111.198 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -172.63 163.04 34.91 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 120.918 -0.658 . . . . 0.0 113.27 -179.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 73.9 p -80.15 -177.63 6.16 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.25 0.548 . . . . 0.0 111.865 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 77.5 m-70 -78.08 80.37 4.51 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.079 0.466 . . . . 0.0 110.99 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -84.66 144.89 28.28 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.058 0.456 . . . . 0.0 111.91 -177.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -155.92 95.58 1.65 Allowed 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.432 176.016 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -84.95 106.73 16.67 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.296 179.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -56.5 128.78 37.83 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 174.064 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -57.77 -22.94 49.7 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -171.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -84.48 -67.87 0.76 Allowed 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 120.525 0.203 . . . . 0.0 111.082 175.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 75.7 m 71.65 -47.43 0.66 Allowed 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 112.848 0.685 . . . . 0.0 112.848 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -60.44 125.96 39.97 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 121.495 -0.383 . . . . 0.0 113.313 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -67.77 107.93 2.77 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.212 0.53 . . . . 0.0 110.817 178.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -81.64 65.5 4.01 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 114.716 0.646 . . . . 0.0 114.716 -170.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 43.2 tttm -91.22 126.8 36.42 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 122.273 -0.545 . . . . 0.0 111.069 173.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -74.09 143.63 32.31 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.725 178.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 14.3 tt -65.14 -30.59 50.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 121.176 0.512 . . . . 0.0 111.571 -178.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -83.08 -13.67 55.26 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.408 177.15 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -81.66 87.06 1.4 Allowed Glycine 0 CA--C 1.526 0.751 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.185 177.321 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.422 HH11 ' HD3' ' A' ' 151' ' ' ARG . 41.3 mtt180 -84.37 141.3 30.97 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -174.524 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -116.93 61.04 0.74 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.29 0.566 . . . . 0.0 110.418 173.34 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -68.11 129.57 40.31 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.543 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 46.6 mm -88.1 94.98 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-O 121.364 0.602 . . . . 0.0 111.213 -177.171 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 27.2 tp -128.41 4.81 5.68 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.097 175.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -67.92 157.48 34.87 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.897 -177.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -88.01 96.09 10.38 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -175.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 37.5 t -92.92 137.6 32.22 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.593 174.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 173.42 -27.62 0.09 OUTLIER Glycine 0 CA--C 1.525 0.692 0 C-N-CA 120.253 -0.975 . . . . 0.0 113.969 -178.03 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 70.56 -24.02 0.17 Allowed 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 178.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 31.5 m -59.58 126.92 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -176.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 34.9 t 176.2 -22.5 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.157 178.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -69.02 74.37 0.3 Allowed 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.32 0.581 . . . . 0.0 111.872 178.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -102.99 -16.46 15.81 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.357 178.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -99.13 125.86 44.77 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.11 -178.011 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -86.32 121.03 28.33 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 120.924 0.393 . . . . 0.0 111.691 -178.34 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -109.69 82.86 1.66 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.114 0.483 . . . . 0.0 111.084 177.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -93.52 -138.58 9.0 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 121.09 -0.576 . . . . 0.0 113.724 -177.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 68.8 p -95.09 116.91 29.33 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.897 0.379 . . . . 0.0 111.877 -177.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -142.04 144.73 33.76 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.066 178.248 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -71.83 72.95 0.83 Allowed 'General case' 0 CA--C 1.546 0.799 0 CA-C-O 121.663 0.744 . . . . 0.0 111.217 177.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.49 -26.65 62.77 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -175.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -159.94 -36.29 0.06 Allowed 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.465 0.542 . . . . 0.0 112.465 -176.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 88.8 t 70.15 -65.06 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 122.843 0.457 . . . . 0.0 112.178 -179.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -73.26 161.43 30.53 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.361 0.6 . . . . 0.0 111.991 -178.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -127.99 117.01 20.94 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.761 175.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 58.0 tp -52.42 97.69 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -173.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 . . . . . 0 CA--C 1.539 0.531 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 175.792 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.4 mtm . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.489 0.185 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.08 149.64 33.88 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.759 0.314 . . . . 0.0 111.742 179.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -104.5 142.67 34.21 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.363 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 37.6 m -81.75 172.55 13.25 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.466 0.651 . . . . 0.0 112.179 -177.079 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 77.4 p -97.02 -160.06 0.78 Allowed 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.476 177.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -69.45 -152.4 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.956 0 CA-C-O 120.702 0.287 . . . . 0.0 111.434 175.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.498 ' H ' HD12 ' A' ' 7' ' ' ILE . 3.5 mp -71.69 97.66 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 CA-C-O 121.181 0.515 . . . . 0.0 111.696 -172.409 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.16 -34.95 78.72 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-O 121.329 0.585 . . . . 0.0 111.607 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -59.98 -19.95 52.13 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.698 176.327 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.646 HD22 ' SG ' ' A' ' 100' ' ' CYS . 43.6 tp -74.9 -38.85 61.75 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 120.713 0.292 . . . . 0.0 110.405 177.412 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -59.09 -41.23 87.55 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.009 173.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.542 ' O ' ' HG3' ' A' ' 16' ' ' LYS . 42.5 mt-10 -55.34 -54.45 43.5 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.207 175.391 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 41.7 t -55.37 -54.94 37.35 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.752 -178.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -53.55 -43.33 68.34 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.28 0.562 . . . . 0.0 110.771 176.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 63.8 ttt180 -62.36 -32.74 73.57 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.112 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.542 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 95.8 mttt -74.83 -39.37 61.67 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.564 178.719 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.864 ' HB3' ' SD ' ' A' ' 30' ' ' MET . 18.2 m-85 -69.67 -38.78 77.2 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 120.896 0.379 . . . . 0.0 111.43 175.669 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.2 -40.46 97.56 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -178.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.47 HG22 ' O ' ' A' ' 25' ' ' ALA . 29.2 pt -86.85 13.13 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-O 120.874 0.369 . . . . 0.0 111.839 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 37.6 t-80 -109.13 95.69 5.8 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.812 0.339 . . . . 0.0 111.652 -175.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 108.78 -46.55 1.15 Allowed Glycine 0 CA--C 1.521 0.457 0 C-N-CA 121.147 -0.549 . . . . 0.0 111.895 -175.383 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -74.3 108.34 4.97 Favored Pre-proline 0 CA--C 1.544 0.741 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 171.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -56.92 -38.73 95.26 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.752 2.301 . . . . 0.0 114.298 -169.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.5 mtpt -124.79 28.78 6.39 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -172.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.47 ' O ' HG22 ' A' ' 19' ' ' ILE . . . -74.93 123.56 25.32 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.772 0.32 . . . . 0.0 111.272 179.428 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 55.4 m -69.45 -2.02 10.03 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.52 -1.53 66.57 Favored Glycine 0 CA--C 1.523 0.593 0 C-N-CA 121.402 -0.428 . . . . 0.0 112.94 -178.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -86.35 -37.77 18.12 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.99 0.424 . . . . 0.0 111.775 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -116.66 131.58 56.91 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.86 -175.178 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.864 ' SD ' ' HB3' ' A' ' 17' ' ' PHE . 58.2 ttp -127.64 140.75 51.9 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.988 0.423 . . . . 0.0 111.801 178.28 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.463 ' OD1' ' HB3' ' A' ' 33' ' ' LYS . 10.9 p30 -74.79 167.69 21.34 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 121.249 0.547 . . . . 0.0 112.241 -178.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -70.95 -21.59 78.27 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-N 116.075 -0.511 . . . . 0.0 114.033 -178.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.463 ' HB3' ' OD1' ' A' ' 31' ' ' ASN . 61.5 tttp -70.88 -44.22 66.77 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 117.314 0.557 . . . . 0.0 111.052 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -72.34 -26.43 61.93 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 122.179 -0.326 . . . . 0.0 110.938 174.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 49.7 t-105 -65.45 -52.35 53.75 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 120.885 0.374 . . . . 0.0 111.167 173.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.93 -42.54 85.06 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.411 0.624 . . . . 0.0 110.583 174.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -61.04 -40.12 92.39 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.985 174.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.6 tt -55.22 -46.95 75.95 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.713 -178.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.595 ' SG ' HG21 ' A' ' 55' ' ' VAL . 15.7 p -66.1 -49.33 67.9 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.671 0.272 . . . . 0.0 111.467 -179.747 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.439 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 88.7 tttt -67.64 -34.62 77.31 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 120.904 0.383 . . . . 0.0 111.525 -175.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 49.0 t0 -77.8 -36.96 49.72 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 120.869 0.366 . . . . 0.0 110.824 179.023 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.575 ' SG ' ' HD3' ' A' ' 106' ' ' LYS . 77.7 m -87.12 4.11 43.54 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 178.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm 74.61 15.01 3.38 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 172.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 55.3 t -69.04 -32.67 55.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-O 120.788 0.328 . . . . 0.0 111.087 178.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.1 98.12 6.41 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 120.919 0.39 . . . . 0.0 111.32 178.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -90.79 -37.75 13.44 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -178.182 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 111.97 -25.87 12.3 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 121.286 -0.483 . . . . 0.0 113.608 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -88.87 -53.47 4.59 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.102 0.477 . . . . 0.0 110.72 178.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 64.6 m -98.22 -41.58 7.82 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.226 179.272 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.3 t -111.37 102.5 14.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 121.108 0.48 . . . . 0.0 110.691 175.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 48.5 p -93.4 15.02 16.74 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -176.291 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.6 -52.37 4.69 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.573 -173.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.595 ' O ' HG13 ' A' ' 57' ' ' ILE . 49.1 m -50.53 -46.44 57.35 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.131 0.491 . . . . 0.0 109.949 172.477 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -53.31 -35.31 60.01 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.109 176.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.595 HG21 ' SG ' ' A' ' 39' ' ' CYS . 56.3 t -66.01 -36.88 78.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 120.895 0.378 . . . . 0.0 110.74 177.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -69.79 -37.93 76.49 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.37 0.605 . . . . 0.0 109.886 175.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.595 HG13 ' O ' ' A' ' 53' ' ' THR . 6.8 mt -63.89 -50.42 77.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.191 178.138 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 71.3 t -58.55 -38.15 69.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-O 120.87 0.367 . . . . 0.0 111.34 177.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -59.11 -45.31 91.21 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.215 0.531 . . . . 0.0 110.022 176.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.441 ' HA ' ' HE2' ' A' ' 63' ' ' LYS . 80.7 p -79.14 -12.64 59.99 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.574 177.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.421 ' HE3' ' OE2' ' A' ' 81' ' ' GLU . 61.0 tttp -85.53 -21.96 28.36 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 121.303 0.573 . . . . 0.0 110.763 178.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.492 ' HB ' ' HB3' ' A' ' 74' ' ' GLU . 28.4 m -103.52 -18.85 6.49 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.564 171.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.441 ' HE2' ' HA ' ' A' ' 60' ' ' SER . 37.7 ttpt -71.77 93.37 1.29 Allowed 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 120.974 0.416 . . . . 0.0 111.53 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -93.72 -12.53 56.73 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 121.356 -0.449 . . . . 0.0 113.187 -177.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.534 ' HG2' ' N ' ' A' ' 66' ' ' SER . 22.6 ttmm -111.83 164.7 12.79 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 122.622 0.369 . . . . 0.0 110.359 178.548 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.534 ' N ' ' HG2' ' A' ' 65' ' ' LYS . 86.0 p -74.55 59.6 0.84 Allowed 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.373 0.606 . . . . 0.0 109.649 169.658 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.499 ' HB2' ' HD2' ' A' ' 65' ' ' LYS . . . -114.72 150.23 35.61 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.446 -171.42 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 35.0 mtp180 -90.98 -2.7 57.67 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.305 174.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 27.0 m -135.96 144.43 33.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -173.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 27.6 pt -103.21 158.86 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.964 173.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -103.42 179.42 4.28 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.172 0.511 . . . . 0.0 111.743 -178.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -67.47 -36.3 80.87 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -64.55 -57.11 10.07 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 179.153 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.492 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 0.9 OUTLIER -64.96 -20.46 66.49 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 122.123 -0.361 . . . . 0.0 111.312 177.034 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -63.94 -43.15 96.72 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 120.781 0.324 . . . . 0.0 110.962 173.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -55.16 -46.32 75.74 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 121.178 0.514 . . . . 0.0 110.594 174.106 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.431 ' O ' ' HG3' ' A' ' 81' ' ' GLU . 59.7 tttm -61.49 -50.85 71.09 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.402 177.665 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -53.2 -43.71 67.41 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.119 -178.173 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.512 HD12 HD21 ' A' ' 10' ' ' LEU . 79.9 mt -68.26 -39.86 82.09 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 178.496 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.512 ' O ' HG23 ' A' ' 84' ' ' THR . 38.0 tt0 -55.51 -47.2 76.62 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.309 0.576 . . . . 0.0 110.748 176.291 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.431 ' HG3' ' O ' ' A' ' 77' ' ' LYS . 38.0 mt-10 -65.41 -52.84 50.53 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.444 -179.13 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 58.9 mt -55.55 -36.72 67.09 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 122.252 -0.28 . . . . 0.0 111.428 174.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.16 -45.64 84.11 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 111.661 0.245 . . . . 0.0 111.661 179.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.512 HG23 ' O ' ' A' ' 80' ' ' GLU . 70.7 p -61.19 -29.5 69.84 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 38.4 mtpt -84.57 -48.47 9.5 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 122.026 -0.421 . . . . 0.0 111.967 173.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 32.4 tpt85 -60.05 -56.99 14.79 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.355 0.598 . . . . 0.0 111.873 -176.016 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -86.06 172.72 10.4 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.055 -178.068 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -79.58 171.43 15.16 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.259 -0.428 . . . . 0.0 112.137 -174.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -71.79 67.48 1.06 Allowed Glycine 0 CA--C 1.528 0.858 0 CA-C-N 116.034 -0.53 . . . . 0.0 113.186 178.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -119.81 174.6 6.34 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 45.9 t -44.97 123.32 3.76 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 178.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -52.2 -35.48 49.26 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.662 -178.077 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 -50.06 -62.84 1.34 Allowed 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.327 177.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -58.64 -42.04 87.37 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.787 0.327 . . . . 0.0 111.435 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.76 -37.41 81.74 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.079 0.466 . . . . 0.0 111.59 179.312 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -73.51 -46.49 47.51 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.759 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -58.45 -33.65 69.96 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.855 0.36 . . . . 0.0 110.832 174.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.457 ' O ' ' HB3' ' A' ' 101' ' ' GLN . . . -64.45 -55.34 21.49 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.867 178.112 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 19.1 tt -63.94 -34.03 65.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-O 121.033 0.445 . . . . 0.0 110.856 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' CYS . . . . . 0.646 ' SG ' HD22 ' A' ' 10' ' ' LEU . 99.2 m -66.77 -36.75 83.16 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.809 0.337 . . . . 0.0 110.858 173.611 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.457 ' HB3' ' O ' ' A' ' 98' ' ' ALA . 59.9 tt0 -55.95 -38.64 70.61 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.197 0.522 . . . . 0.0 110.791 175.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 91.1 mt -68.04 -50.97 51.97 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.322 177.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 39.0 t -83.98 -45.97 18.18 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -171.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -52.58 136.89 31.69 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 -173.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 79.44 -35.2 2.01 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-N 116.282 -0.417 . . . . 0.0 113.763 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.575 ' HD3' ' SG ' ' A' ' 42' ' ' CYS . 63.4 tttp -59.77 159.51 8.74 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.349 0.66 . . . . 0.0 112.669 -177.731 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -124.77 151.02 67.45 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.989 179.123 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -64.47 120.84 8.25 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 122.573 2.182 . . . . 0.0 113.231 178.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.11 149.29 48.85 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.214 0.53 . . . . 0.0 112.154 178.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -144.0 163.54 33.2 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.987 177.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 13.1 p -161.48 -30.71 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -177.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 101.61 98.86 2.38 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 121.373 -0.441 . . . . 0.0 112.385 -177.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 35.9 m -85.3 140.78 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-O 121.045 0.45 . . . . 0.0 111.902 -177.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 31.1 m -126.62 96.17 4.58 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.23 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 47.0 mtpt 69.46 -61.25 0.44 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.478 0.711 . . . . 0.0 112.64 178.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 74.6 -57.57 0.61 Allowed 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 176.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -74.58 19.67 0.13 Allowed 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -175.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 58.1 m -69.6 101.3 1.6 Allowed 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.09 0.471 . . . . 0.0 110.112 175.229 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -76.59 65.66 2.79 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 116.039 -0.528 . . . . 0.0 114.409 -173.246 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -84.36 55.19 4.99 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 121.185 -0.531 . . . . 0.0 112.833 177.016 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.36 133.45 50.53 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.738 0.304 . . . . 0.0 111.789 -178.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 33.9 m -111.68 -13.6 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -176.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -141.58 140.44 33.37 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.136 0.493 . . . . 0.0 112.129 -178.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 124' ' ' ARG . 36.7 mtm180 -104.75 -14.89 15.4 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.688 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 97.7 mt -78.84 104.99 9.85 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.454 0.645 . . . . 0.0 112.547 -172.029 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 5.9 t -138.25 45.65 2.08 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.912 178.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -65.24 -12.32 50.26 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.432 -176.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 85.0 m 76.52 -45.53 0.5 Allowed 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 177.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 71.5 m 65.19 97.27 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 121.039 0.447 . . . . 0.0 111.07 -174.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 90.4 mtt-85 -55.81 -33.66 64.64 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -172.152 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -87.01 -13.72 43.66 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -179.158 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.457 HG22 ' O ' ' A' ' 132' ' ' THR . 8.4 m -127.5 20.63 6.67 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 121.071 0.462 . . . . 0.0 111.629 -175.198 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -74.47 -55.89 5.34 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.814 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 73.3 m -90.7 109.52 20.7 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.876 0.37 . . . . 0.0 110.555 176.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -88.73 -174.72 4.64 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.982 0.42 . . . . 0.0 111.715 -176.268 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.414 ' HB3' ' NZ ' ' A' ' 136' ' ' LYS . 9.6 mtpm? -93.51 -163.16 1.01 Allowed 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 120.873 0.368 . . . . 0.0 111.805 -179.377 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -57.99 121.87 11.63 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -176.086 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 138' ' ' ARG . 0.0 OUTLIER -123.55 123.78 41.36 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 176.877 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -60.03 139.9 57.15 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.112 0.482 . . . . 0.0 111.73 -177.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -64.99 88.72 0.07 Allowed 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -171.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.419 ' O ' ' HG3' ' A' ' 141' ' ' GLU . 5.5 pt-20 -98.22 103.74 15.71 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.216 0.532 . . . . 0.0 111.014 172.224 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 42.1 m -65.24 -15.76 62.82 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.912 0.387 . . . . 0.0 111.216 176.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.8 -155.39 48.1 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 121.283 -0.484 . . . . 0.0 112.969 179.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 40.2 mmtm -126.37 19.04 7.53 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 120.971 0.415 . . . . 0.0 110.516 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 81.22 57.46 2.79 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 111.13 -0.788 . . . . 0.0 111.13 -169.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -101.74 126.28 48.57 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -172.079 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 60.41 18.32 50.09 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-N 115.797 -0.638 . . . . 0.0 114.291 176.452 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.522 ' O ' HG22 ' A' ' 148' ' ' ILE . 37.8 mm 52.85 15.44 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.22 0 CA-C-O 121.399 0.619 . . . . 0.0 111.7 -177.566 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . 62.57 18.23 10.3 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.046 0.539 . . . . 0.0 112.37 -176.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -119.6 132.03 9.28 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 121.223 -0.513 . . . . 0.0 113.637 -177.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 47.5 mtp180 -104.81 -18.69 14.15 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 120.982 0.42 . . . . 0.0 111.293 177.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -152.93 -9.98 0.17 Allowed 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.64 -179.563 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 66.47 166.27 0.21 Allowed 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.458 0.647 . . . . 0.0 112.548 -174.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 29.6 pt -109.11 137.4 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.184 175.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 86.9 mt -82.0 88.72 6.38 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.156 0.503 . . . . 0.0 111.694 -178.318 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -46.48 136.09 7.8 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.991 170.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -54.52 102.38 0.06 Allowed 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.468 0.651 . . . . 0.0 112.193 -177.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 24.5 t -109.77 -157.91 0.63 Allowed 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.271 -177.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -59.34 179.23 1.86 Allowed Glycine 0 CA--C 1.532 1.101 0 N-CA-C 114.544 0.578 . . . . 0.0 114.544 -178.49 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -76.93 84.82 3.47 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.223 0.535 . . . . 0.0 112.106 -175.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 27.6 m -108.43 -27.58 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.257 175.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 49.6 m -87.1 -20.92 26.4 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.052 0.453 . . . . 0.0 110.904 176.168 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -121.48 130.88 53.83 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.75 176.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -102.65 15.41 29.37 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 120.956 0.408 . . . . 0.0 111.669 -176.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -77.47 147.34 35.94 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.025 0.44 . . . . 0.0 111.886 -176.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -104.22 154.05 20.23 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -171.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 66.73 88.07 0.11 Allowed 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.733 0.813 . . . . 0.0 112.965 178.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.406 ' C ' ' HG1' ' A' ' 169' ' ' THR . . . -69.8 88.57 0.29 Allowed Glycine 0 CA--C 1.528 0.872 0 C-N-CA 121.096 -0.573 . . . . 0.0 112.54 176.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.406 ' HG1' ' C ' ' A' ' 168' ' ' GLY . 82.5 p 52.1 64.29 1.91 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.257 0.623 . . . . 0.0 111.825 -177.528 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 4.1 t80 72.06 130.15 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.501 0.72 . . . . 0.0 111.506 -177.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -94.51 10.61 33.94 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 113.982 1.104 . . . . 0.0 113.982 -169.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -83.06 -105.0 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.832 0 O-C-N 121.834 -0.541 . . . . 0.0 111.643 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 87.6 mttt 59.1 24.76 13.12 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 174.189 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 7.9 p -91.84 131.47 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 O-C-N 122.119 -0.363 . . . . 0.0 111.563 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.426 ' HG2' ' O ' ' A' ' 175' ' ' LYS . 25.1 ttpp 68.66 -0.3 2.36 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.004 0.521 . . . . 0.0 112.011 179.137 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -74.93 -97.68 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.919 0 O-C-N 122.166 -0.334 . . . . 0.0 111.844 -173.233 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 87.5 mt 41.32 -118.63 0.39 Allowed 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 176.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 . . . . . 0 N--CA 1.476 0.839 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 173.113 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 120.696 0.284 . . . . 0.0 111.119 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.18 84.06 1.35 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.443 178.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -162.26 117.52 1.91 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.104 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 43.3 t -80.74 104.73 11.46 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 170.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.4 t -95.97 16.33 18.11 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -170.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -123.95 -101.53 0.39 Allowed 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.906 -0.496 . . . . 0.0 112.29 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.428 HG22 ' H ' ' A' ' 10' ' ' LEU . 41.3 mm -134.41 122.97 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 O-C-N 121.969 -0.457 . . . . 0.0 112.063 -173.462 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.42 -45.86 57.76 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.012 0.434 . . . . 0.0 111.485 178.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.24 -18.45 35.37 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 121.223 -0.513 . . . . 0.0 112.863 177.139 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.438 HD11 HD11 ' A' ' 79' ' ' LEU . 34.1 tp -74.48 -36.83 63.3 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.895 0.379 . . . . 0.0 110.132 175.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -59.03 -43.18 91.58 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.437 0.637 . . . . 0.0 109.533 173.304 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 56.3 tt0 -58.53 -55.87 29.5 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.236 176.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 73.7 m -54.58 -47.44 73.3 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.628 179.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.409 ' CD1' ' HE3' ' A' ' 30' ' ' MET . 73.4 t80 -58.38 -44.16 88.77 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.005 0.431 . . . . 0.0 110.781 176.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 47.9 ttt180 -60.85 -47.41 86.5 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.719 -179.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -65.25 -40.28 93.78 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.619 178.381 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.429 ' HB3' ' HE2' ' A' ' 30' ' ' MET . 6.2 m-85 -73.07 -29.69 63.14 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 177.53 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.09 -47.03 78.68 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.112 0.482 . . . . 0.0 111.078 178.011 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 17.7 pt -88.88 5.94 4.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-O 121.208 0.527 . . . . 0.0 111.798 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -69.45 93.12 0.64 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.03 0.443 . . . . 0.0 110.806 177.391 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 81.26 45.89 7.25 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 -170.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.471 ' CB ' ' HB2' ' A' ' 25' ' ' ALA . 11.3 p-10 -64.16 120.83 67.89 Favored Pre-proline 0 CA--C 1.542 0.649 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -168.172 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -84.63 -26.39 1.66 Allowed 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.107 1.871 . . . . 0.0 111.96 166.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 47.7 mttp -157.02 67.14 0.53 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.596 0.758 . . . . 0.0 110.095 176.087 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.471 ' HB2' ' CB ' ' A' ' 22' ' ' ASP . . . -55.34 91.29 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 179.047 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 66.4 m -104.31 -29.39 10.8 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 120.968 0.413 . . . . 0.0 110.202 169.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.43 22.73 6.94 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 121.214 -0.517 . . . . 0.0 114.243 173.249 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -146.11 0.78 0.84 Allowed 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 117.363 0.582 . . . . 0.0 112.213 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 20.5 mp0 -114.29 121.48 43.78 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 120.683 0.278 . . . . 0.0 111.74 -175.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.429 ' HE2' ' HB3' ' A' ' 17' ' ' PHE . 52.0 ttm -119.85 134.34 55.27 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.876 0.369 . . . . 0.0 111.406 175.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 18.5 p30 -95.22 165.32 12.45 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.065 0.46 . . . . 0.0 111.702 178.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.78 -31.92 77.35 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 121.321 -0.466 . . . . 0.0 113.255 178.485 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -58.41 -53.62 56.22 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 177.278 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -70.42 -33.73 71.68 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 111.595 0.22 . . . . 0.0 111.595 179.103 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 40.0 t-105 -58.07 -47.13 84.09 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.122 0.487 . . . . 0.0 111.565 175.186 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.25 -49.37 72.15 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.982 0.42 . . . . 0.0 111.351 178.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -68.28 -22.35 64.74 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 178.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.6 tt -62.55 -52.39 63.6 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.542 0.687 . . . . 0.0 109.475 172.062 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 81.9 m -58.34 -38.6 77.49 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.211 177.215 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.1 ttmp? -68.69 -44.08 74.73 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 111.919 0.341 . . . . 0.0 111.919 177.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -67.85 -33.19 74.29 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -173.045 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.964 ' SG ' ' HB3' ' A' ' 102' ' ' LEU . 52.2 t -107.45 1.04 23.25 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-O 121.104 0.478 . . . . 0.0 110.75 175.526 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.446 ' N ' ' HD2' ' A' ' 43' ' ' LYS . 0.1 OUTLIER 63.09 38.2 10.95 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.793 -0.639 . . . . 0.0 112.155 175.83 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 48.5 t -62.89 -27.7 43.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-O 121.343 0.592 . . . . 0.0 110.386 173.186 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.563 ' HB1' HG11 ' A' ' 50' ' ' VAL . . . -57.58 115.75 2.96 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.101 170.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.564 ' C ' HG22 ' A' ' 50' ' ' VAL . 11.0 t70 -144.22 -50.14 0.29 Allowed 'General case' 0 C--O 1.221 -0.444 0 CA-C-O 119.311 -0.376 . . . . 0.0 111.662 -170.26 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -2.45 47.81 0.0 OUTLIER Glycine 0 N--CA 1.475 1.239 0 N-CA-C 116.389 1.316 . . . . 0.0 116.389 -164.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.546 ' N ' ' O ' ' A' ' 46' ' ' ASP . 25.0 ttpp 56.42 3.75 0.12 Allowed 'General case' 0 CA--C 1.552 1.046 0 CA-C-O 121.297 0.57 . . . . 0.0 111.704 -177.334 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.8 m 171.98 -27.35 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.92 1.288 . . . . 0.0 109.163 -168.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.564 HG22 ' C ' ' A' ' 46' ' ' ASP . 0.2 OUTLIER 63.58 158.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 124.994 1.317 . . . . 0.0 111.855 -179.541 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.22 -12.32 6.31 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.67 -177.582 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.79 -67.89 1.63 Allowed Glycine 0 CA--C 1.526 0.759 0 C-N-CA 121.361 -0.447 . . . . 0.0 112.47 -175.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.555 ' O ' HG12 ' A' ' 57' ' ' ILE . 51.8 m -48.57 -38.45 20.62 Favored 'General case' 0 C--O 1.223 -0.309 0 C-N-CA 122.275 0.23 . . . . 0.0 111.138 175.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.435 ' O ' HG23 ' A' ' 58' ' ' VAL . 24.1 t70 -51.87 -47.4 64.52 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.991 0.424 . . . . 0.0 111.148 176.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.6 t -61.74 -35.45 67.64 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 CA-C-O 121.186 0.517 . . . . 0.0 110.788 177.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -73.42 -30.24 63.1 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.6 0.714 . . . . 0.0 110.244 178.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.555 HG12 ' O ' ' A' ' 53' ' ' THR . 5.5 mm -70.31 -41.94 78.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.02 177.297 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 54' ' ' ASP . 88.8 t -58.83 -43.8 89.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 120.777 0.322 . . . . 0.0 110.9 176.172 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -58.13 -41.69 84.23 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.206 0.527 . . . . 0.0 110.44 174.29 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 28.9 t -73.63 -24.01 59.96 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.769 176.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 55.3 tttp -71.88 -38.57 70.0 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 122.901 0.48 . . . . 0.0 111.248 -176.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.3 m -91.1 -9.52 10.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-O 121.018 0.437 . . . . 0.0 111.34 174.425 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.582 ' HG3' ' HB3' ' A' ' 67' ' ' ALA . 39.7 ttmt -68.92 118.86 12.38 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.776 179.386 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -75.52 63.47 2.63 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 121.306 -0.473 . . . . 0.0 113.318 178.08 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.6 mttt 60.66 101.93 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 178.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.0 t 63.66 11.96 6.18 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 175.078 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.582 ' HB3' ' HG3' ' A' ' 63' ' ' LYS . . . -69.39 98.75 1.12 Allowed 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.983 0.42 . . . . 0.0 110.912 177.031 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 58.3 mtm180 -64.5 -16.42 62.48 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -177.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 31.2 m -136.14 148.65 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-O 120.793 0.33 . . . . 0.0 111.318 177.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 35.3 pt -115.23 166.07 9.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 121.024 0.44 . . . . 0.0 111.864 178.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.404 ' OD1' ' HB2' ' A' ' 73' ' ' GLU . 8.5 p30 -111.52 172.15 7.06 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.187 179.566 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.513 ' O ' ' HG3' ' A' ' 76' ' ' LYS . 59.6 t80 -61.62 -42.99 99.66 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -178.463 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.404 ' HB2' ' OD1' ' A' ' 71' ' ' ASN . 6.4 mp0 -55.54 -55.57 30.39 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -177.558 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.57 -30.62 68.45 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 122.276 -0.265 . . . . 0.0 111.664 177.179 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -55.1 -38.71 68.49 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.059 0.457 . . . . 0.0 111.032 175.047 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.513 ' HG3' ' O ' ' A' ' 72' ' ' TYR . 6.5 mtpm? -55.95 -47.82 76.9 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.979 175.508 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.428 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 4.3 mptp? -67.46 -34.36 77.02 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.477 178.597 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.6 -39.73 92.27 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.125 0.488 . . . . 0.0 111.113 175.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.438 HD11 HD11 ' A' ' 10' ' ' LEU . 69.8 mt -66.64 -41.06 88.87 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.408 175.646 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -51.94 -44.9 64.13 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 120.966 0.413 . . . . 0.0 111.357 176.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.595 ' O ' ' HG2' ' A' ' 85' ' ' LYS . 1.2 tm-20 -60.98 -66.5 0.52 Allowed 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.442 177.661 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.422 ' O ' ' HG3' ' A' ' 86' ' ' ARG . 73.6 mt -52.37 -31.52 34.15 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.476 ' HB2' HG21 ' A' ' 99' ' ' ILE . . . -62.95 -51.92 65.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.934 0.397 . . . . 0.0 111.114 177.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.6 ' HB ' ' HA2' ' A' ' 89' ' ' GLY . 69.3 p -62.45 -31.55 72.29 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.244 178.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.595 ' HG2' ' O ' ' A' ' 81' ' ' GLU . 6.2 mmmm -61.71 -29.22 69.96 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.356 176.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.422 ' HG3' ' O ' ' A' ' 82' ' ' LEU . 60.6 mtp180 -96.02 -63.83 1.11 Allowed 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.371 0.605 . . . . 0.0 111.915 179.589 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.422 ' O ' ' HB2' ' A' ' 88' ' ' LYS . 64.3 m-85 -84.83 46.18 1.23 Allowed 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.839 -0.618 . . . . 0.0 112.39 -170.731 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.524 ' NZ ' ' HB2' ' A' ' 88' ' ' LYS . 8.4 mtmp? 70.79 114.89 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.962 0.505 . . . . 0.0 111.725 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.6 ' HA2' ' HB ' ' A' ' 84' ' ' THR . . . -65.69 78.81 0.09 OUTLIER Glycine 0 CA--C 1.526 0.778 0 CA-C-N 116.018 -0.537 . . . . 0.0 113.604 -178.473 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 47.0 tttm -159.51 -77.27 0.07 Allowed 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 48.1 m -75.22 108.2 7.82 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -172.107 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 20.0 ttmm -60.35 -45.6 92.89 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.778 177.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.46 ' H ' ' CD ' ' A' ' 93' ' ' GLU . 21.6 mp0 -60.86 -57.67 11.68 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.313 0.578 . . . . 0.0 111.108 -175.035 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -55.87 -52.01 65.56 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.761 179.077 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.38 -45.32 91.8 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.987 -178.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -65.6 -48.09 73.46 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.651 -0.249 . . . . 0.0 111.524 -178.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -55.56 -47.34 76.53 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.902 0.382 . . . . 0.0 111.702 177.236 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.42 -51.42 65.82 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.476 HG21 ' HB2' ' A' ' 83' ' ' ALA . 16.5 tt -63.57 -33.97 64.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 O-C-N 122.006 -0.434 . . . . 0.0 111.385 -178.151 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 96.5 m -68.7 -37.08 79.27 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.86 0.362 . . . . 0.0 110.593 173.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -59.12 -28.23 66.34 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 121.216 0.532 . . . . 0.0 110.734 176.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.964 ' HB3' ' SG ' ' A' ' 42' ' ' CYS . 53.6 mt -79.74 -58.11 3.34 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.86 175.483 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.6 t -79.22 -51.11 17.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -173.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.53 119.4 7.45 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -172.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 93.89 -16.34 61.08 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-N 116.183 -0.462 . . . . 0.0 113.825 179.099 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.443 ' O ' ' HG2' ' A' ' 107' ' ' GLU . 60.1 tttm -74.01 -49.12 25.75 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 117.183 0.491 . . . . 0.0 112.173 -178.092 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.443 ' HG2' ' O ' ' A' ' 106' ' ' LYS . 7.1 pt-20 54.4 161.16 0.06 OUTLIER Pre-proline 0 CA--C 1.557 1.228 0 C-N-CA 124.295 1.038 . . . . 0.0 112.397 -174.147 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -51.48 118.56 4.5 Favored 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 122.414 2.076 . . . . 0.0 113.641 -176.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -65.59 95.71 0.24 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.312 0.577 . . . . 0.0 111.968 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -98.01 28.36 4.02 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.398 0.618 . . . . 0.0 110.988 176.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 61.2 t -65.12 -50.09 76.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.104 -177.065 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -119.68 138.09 12.97 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 120.993 -0.622 . . . . 0.0 113.286 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 32.6 m -109.53 165.08 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-O 121.07 0.462 . . . . 0.0 111.945 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 61.1 p -77.19 114.84 16.43 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.555 179.113 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -85.84 40.53 0.86 Allowed 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 121.08 0.467 . . . . 0.0 111.809 -177.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -145.83 -177.51 5.63 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.27 -178.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.499 ' O ' ' HD2' ' A' ' 117' ' ' LYS . 0.0 OUTLIER -141.67 142.55 33.37 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -179.4 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.8 t 39.91 98.88 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.703 1.201 . . . . 0.0 113.821 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -67.34 -51.78 35.51 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-N 116.031 -0.531 . . . . 0.0 113.766 -177.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -110.9 11.5 29.62 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.847 -176.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 65.26 17.18 10.91 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 120.995 0.426 . . . . 0.0 111.936 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 30.8 m -142.2 17.28 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 CA-C-O 121.183 0.515 . . . . 0.0 110.74 178.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -76.07 -40.12 53.9 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -171.457 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 51.3 ttp180 73.43 -34.9 0.3 Allowed 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.604 0.762 . . . . 0.0 111.062 -171.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.678 HD23 HG23 ' A' ' 126' ' ' THR . 8.9 tt -67.56 146.1 54.24 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 167.349 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.678 HG23 HD23 ' A' ' 125' ' ' LEU . 31.3 p 54.63 38.68 30.37 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -173.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -73.59 -161.51 0.11 Allowed 'General case' 0 CA--C 1.547 0.832 0 CA-C-O 120.741 0.305 . . . . 0.0 110.52 169.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 79.8 p -65.18 78.57 0.05 Allowed 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.201 0.524 . . . . 0.0 111.313 174.314 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 70.9 m -145.24 146.63 31.77 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.976 0.417 . . . . 0.0 111.732 -177.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 48.7 ttt180 -73.38 -43.58 60.31 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.38 176.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -117.82 128.53 54.94 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.304 172.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 8.9 t -98.63 21.74 10.89 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.036 0.446 . . . . 0.0 111.557 178.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -167.98 -169.5 31.55 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 121.135 -0.555 . . . . 0.0 113.063 -178.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 67.2 m 68.88 154.4 0.11 Allowed 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 121.317 0.579 . . . . 0.0 112.088 -178.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 79.0 m-70 -124.2 104.39 8.8 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.155 0.502 . . . . 0.0 111.87 176.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 47.2 tttp -106.71 5.26 28.61 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.64 0.733 . . . . 0.0 109.928 178.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -80.41 43.4 0.64 Allowed 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.981 -175.32 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -83.62 49.61 1.63 Allowed 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -175.323 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 62.44 122.38 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 175.093 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.469 ' O ' ' HB3' ' A' ' 141' ' ' GLU . 4.9 t70 -68.31 154.86 40.93 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 172.515 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.718 ' HG2' ' H ' ' A' ' 143' ' ' GLY . 40.5 tt0 73.62 145.16 0.08 Allowed 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 121.263 0.554 . . . . 0.0 111.478 -174.128 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 84.8 p -85.58 7.6 22.54 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -177.147 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.718 ' H ' ' HG2' ' A' ' 141' ' ' GLU . . . -69.51 169.94 43.44 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 121.402 -0.428 . . . . 0.0 113.36 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 61.8 mttp 70.75 -34.86 0.31 Allowed 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.7 111.66 3.93 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 121.246 -0.502 . . . . 0.0 112.871 177.087 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 63.9 pttt 43.53 -156.42 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.057 0.943 . . . . 0.0 112.993 -177.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 73.51 -78.3 0.86 Allowed Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 -170.265 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 14.8 tt -108.58 -20.35 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 CA-C-O 121.121 0.486 . . . . 0.0 109.988 166.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . 67.79 -179.15 0.22 Allowed 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.545 179.023 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -68.95 78.62 0.27 Allowed Glycine 0 CA--C 1.528 0.861 0 C-N-CA 121.19 -0.529 . . . . 0.0 112.889 178.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 26.5 tpt180 -72.99 103.35 3.75 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.313 0.577 . . . . 0.0 111.664 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -132.12 -165.69 1.62 Allowed 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.072 179.436 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -87.24 117.87 26.29 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.575 175.36 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.475 HD12 ' N ' ' A' ' 154' ' ' ILE . 2.3 mp -82.28 106.93 13.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-O 121.02 0.438 . . . . 0.0 111.319 -178.491 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.494 ' O ' HD23 ' A' ' 155' ' ' LEU . 6.0 tt -80.2 -38.56 30.92 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.134 0.492 . . . . 0.0 110.57 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -65.95 135.83 55.26 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.415 0.626 . . . . 0.0 112.613 -176.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -124.5 92.19 3.61 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.39 168.338 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 49.6 p -37.11 106.74 0.05 Allowed 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -174.187 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.476 ' O ' ' N ' ' A' ' 161' ' ' VAL . . . 152.89 -33.6 0.8 Allowed Glycine 0 CA--C 1.527 0.798 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.822 -177.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 37.1 p90 44.65 -72.4 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 178.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.476 ' N ' ' O ' ' A' ' 159' ' ' GLY . 59.1 t 65.25 100.36 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 123.634 0.773 . . . . 0.0 112.178 -176.714 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 98.1 p -104.24 -65.0 1.05 Allowed 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.126 0.488 . . . . 0.0 110.775 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -91.74 124.8 36.15 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.457 175.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -77.23 53.99 1.05 Allowed 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -177.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? 53.79 34.57 19.46 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 173.377 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -104.05 -178.97 3.81 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 73.59 127.69 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.304 0.641 . . . . 0.0 112.075 -178.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -129.37 -46.53 0.17 Allowed Glycine 0 CA--C 1.527 0.826 0 C-N-CA 121.336 -0.459 . . . . 0.0 113.573 -177.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 72.4 p -68.71 88.2 0.36 Allowed 'General case' 0 N--CA 1.47 0.555 0 O-C-N 122.397 -0.473 . . . . 0.0 111.596 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 79.7 t80 -110.37 -24.34 10.68 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.979 0.419 . . . . 0.0 111.631 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -73.18 -12.2 60.8 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.253 -0.431 . . . . 0.0 112.102 -177.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -81.19 145.51 30.95 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.024 0.44 . . . . 0.0 112.034 -178.478 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.433 ' HG2' ' O ' ' A' ' 173' ' ' LYS . 54.8 tttm 70.72 7.96 6.4 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 174.309 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 85.7 t -63.33 -29.0 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 O-C-N 121.961 -0.462 . . . . 0.0 111.536 177.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt 73.1 116.68 0.05 Allowed 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.333 0.653 . . . . 0.0 112.521 178.011 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 57.5 pttt -98.86 145.03 27.4 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.733 174.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.472 ' N ' HD22 ' A' ' 177' ' ' LEU . 2.6 mm? -92.17 128.56 38.07 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.995 0.426 . . . . 0.0 111.76 -176.385 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 23.6 mp0 . . . . . 0 CA--C 1.54 0.56 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.605 178.736 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.585 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.551 0.215 . . . . 0.0 110.714 . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.83 53.27 1.62 Allowed 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.114 0.483 . . . . 0.0 111.953 -178.423 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -163.69 152.31 13.73 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.118 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 43.7 t -135.0 -46.92 0.72 Allowed 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.104 0.478 . . . . 0.0 111.405 179.194 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.4 t -132.8 46.12 2.66 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.485 0.66 . . . . 0.0 110.999 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 63.34 -97.61 0.06 Allowed 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.113 -175.064 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.5 mp -138.82 110.37 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-O 120.903 0.383 . . . . 0.0 110.677 176.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.96 -44.88 78.91 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.039 0.447 . . . . 0.0 111.543 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.44 -25.78 63.4 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 121.127 -0.559 . . . . 0.0 113.168 177.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 45.4 tp -72.57 -42.6 64.44 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 122.535 -0.391 . . . . 0.0 110.659 178.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -57.56 -47.47 81.96 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.909 0.385 . . . . 0.0 110.783 175.432 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.603 ' O ' ' HD3' ' A' ' 16' ' ' LYS . 44.6 mt-10 -62.79 -43.28 99.22 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.491 177.035 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.533 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . 38.7 t -54.65 -54.07 46.52 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 120.768 0.318 . . . . 0.0 111.428 178.456 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -56.73 -42.83 79.9 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.212 0.529 . . . . 0.0 110.844 175.182 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 33.5 ttt180 -56.57 -45.91 81.03 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.712 -179.235 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.603 ' HD3' ' O ' ' A' ' 12' ' ' GLU . 5.0 mptp? -66.52 -55.64 14.6 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 178.483 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -64.04 -28.37 69.75 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -178.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.08 -54.15 45.39 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.986 0.422 . . . . 0.0 111.333 177.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 29.1 pt -80.81 4.56 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 CA-C-N 116.147 -0.478 . . . . 0.0 112.026 -178.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -61.83 -36.39 81.04 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -175.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -125.89 0.1 7.75 Favored Glycine 0 N--CA 1.465 0.58 0 C-N-CA 120.852 -0.689 . . . . 0.0 113.079 -179.183 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -155.43 89.89 2.95 Favored Pre-proline 0 CA--C 1.542 0.653 0 CA-C-O 121.192 0.52 . . . . 0.0 111.006 -178.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -52.23 -29.71 38.97 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.086 2.524 . . . . 0.0 113.965 -177.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -80.41 3.83 20.03 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.083 0.468 . . . . 0.0 111.654 -176.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.409 ' HB1' ' O ' ' A' ' 29' ' ' GLU . . . -63.9 -31.8 73.1 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.71 170.04 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 30.6 t 58.69 20.12 7.48 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.499 176.105 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 70.25 11.82 68.15 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.793 -176.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -93.44 -38.31 11.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.231 0.539 . . . . 0.0 110.834 177.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.453 ' HB3' ' CG2' ' A' ' 69' ' ' VAL . 39.3 mt-10 -131.53 154.24 49.0 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.425 -172.706 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 52.1 ttm -137.88 136.31 36.98 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.809 0.338 . . . . 0.0 111.176 177.253 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.537 ' HA ' HG12 ' A' ' 69' ' ' VAL . 10.8 p30 -89.73 166.44 13.57 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.134 0.492 . . . . 0.0 111.916 -179.492 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.62 -21.86 69.34 Favored Glycine 0 CA--C 1.531 1.046 0 CA-C-N 116.024 -0.535 . . . . 0.0 114.283 -177.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.434 ' HB3' ' OD1' ' A' ' 31' ' ' ASN . 62.8 tttp -74.22 -52.43 12.42 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 117.413 0.607 . . . . 0.0 111.151 179.305 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -63.67 -38.36 90.82 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.811 0.338 . . . . 0.0 110.687 176.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.439 ' CD1' ' HB2' ' A' ' 59' ' ' PHE . 43.3 t-105 -60.24 -38.78 84.5 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.425 174.585 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.21 -45.45 93.14 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.482 177.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -74.13 -32.72 63.29 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 120.866 -0.334 . . . . 0.0 111.102 176.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.7 tt -51.33 -51.35 55.19 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.035 0.445 . . . . 0.0 110.399 177.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 75.0 m -69.13 -49.94 52.42 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.11 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -64.7 -47.55 77.94 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 112.041 0.385 . . . . 0.0 112.041 -176.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -64.88 -34.64 78.87 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 121.033 0.444 . . . . 0.0 110.956 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.809 ' HA ' ' HE2' ' A' ' 106' ' ' LYS . 68.5 m -90.07 1.61 56.16 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.352 174.408 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 52.1 mttm 53.07 34.39 17.08 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 176.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.616 ' HA ' HH11 ' A' ' 86' ' ' ARG . 49.0 t -64.89 -37.58 80.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 121.566 0.698 . . . . 0.0 109.556 167.795 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -98.83 51.36 0.97 Allowed 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.51 173.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -64.99 -27.92 69.16 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 116.072 -0.513 . . . . 0.0 112.023 -175.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 138.2 -62.51 0.57 Allowed Glycine 0 CA--C 1.527 0.823 0 C-N-CA 121.046 -0.597 . . . . 0.0 113.497 -178.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.677 ' HD2' ' H ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -71.19 20.03 0.05 Allowed 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -175.653 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 49.2 m -153.71 -64.58 0.14 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.214 0.531 . . . . 0.0 110.887 176.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.58 HG11 HD22 ' A' ' 82' ' ' LEU . 58.8 t -121.18 151.92 24.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.863 -179.768 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 71.4 p -118.59 154.32 32.82 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 122.343 0.257 . . . . 0.0 111.121 177.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -52.18 -41.64 54.1 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 121.398 -0.429 . . . . 0.0 113.349 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.412 ' O ' HG12 ' A' ' 57' ' ' ILE . 63.0 m -55.84 -49.31 73.65 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.097 0.475 . . . . 0.0 110.834 176.004 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.4 ' O ' HG23 ' A' ' 58' ' ' VAL . 24.6 t70 -62.01 -37.33 84.47 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.928 178.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 70.0 t -57.34 -36.3 52.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.85 176.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -69.27 -43.91 72.95 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 122.01 0.91 . . . . 0.0 109.583 178.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.412 HG12 ' O ' ' A' ' 53' ' ' THR . 7.9 mm -62.22 -45.53 98.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-N 114.584 -1.189 . . . . 0.0 111.621 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.478 ' O ' HG12 ' A' ' 62' ' ' VAL . 73.9 t -56.91 -47.82 82.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.525 177.051 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.439 ' HB2' ' CD1' ' A' ' 35' ' ' TRP . 80.0 t80 -50.85 -51.05 55.03 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.026 0.441 . . . . 0.0 111.183 177.657 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 29.2 t -71.01 -29.34 65.26 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.572 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -64.78 -36.95 85.96 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.536 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.508 HG21 ' HB2' ' A' ' 77' ' ' LYS . 3.7 p -94.93 -22.14 5.49 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 178.328 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -56.45 134.79 54.2 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -67.96 83.49 0.17 Allowed Glycine 0 CA--C 1.532 1.113 0 C-N-CA 121.333 -0.461 . . . . 0.0 113.816 176.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 61.9 mttp 53.13 -90.47 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 175.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 36.5 t -128.22 29.62 5.33 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.983 0.42 . . . . 0.0 111.212 -174.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -73.97 5.76 3.96 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 179.287 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 44.5 mtp180 68.36 -64.48 0.3 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.531 0.733 . . . . 0.0 112.125 -176.001 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.537 HG12 ' HA ' ' A' ' 31' ' ' ASN . 24.4 m -117.92 170.04 7.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.134 -172.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.417 ' HB ' ' HB2' ' A' ' 74' ' ' GLU . 39.4 pt -109.75 152.79 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.293 178.073 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -92.36 178.45 5.83 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.045 0.45 . . . . 0.0 111.381 175.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.5 ' O ' ' HB3' ' A' ' 75' ' ' PHE . 75.5 t80 -58.45 -41.87 86.09 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -174.823 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -70.51 -34.05 71.88 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.993 -0.442 . . . . 0.0 111.384 -178.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.417 ' HB2' ' HB ' ' A' ' 70' ' ' ILE . 52.3 mt-10 -68.9 -34.29 75.18 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.434 0.635 . . . . 0.0 110.012 174.765 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.5 ' HB3' ' O ' ' A' ' 72' ' ' TYR . 61.1 t80 -58.22 -43.03 87.52 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.823 170.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.481 ' HG3' ' O ' ' A' ' 72' ' ' TYR . 47.0 mtpt -60.03 -37.86 81.02 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.743 0.306 . . . . 0.0 111.021 176.042 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.508 ' HB2' HG21 ' A' ' 62' ' ' VAL . 94.6 mttt -65.0 -38.45 91.01 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.159 0.504 . . . . 0.0 110.89 177.424 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.98 -39.73 93.91 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.058 176.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 84.2 mt -61.36 -49.78 75.55 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.832 175.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -51.56 -44.39 62.71 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.2 0.524 . . . . 0.0 111.605 175.132 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -60.53 -63.7 1.21 Allowed 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.511 178.006 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.58 HD22 HG11 ' A' ' 50' ' ' VAL . 75.1 mt -58.71 -38.18 77.76 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -178.077 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.4 ' HB1' ' HB1' ' A' ' 95' ' ' ALA . . . -61.78 -47.74 83.8 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.607 0.241 . . . . 0.0 111.546 178.598 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 50.5 p -65.84 -19.56 65.93 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 178.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -81.28 -38.41 26.89 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 120.774 0.321 . . . . 0.0 111.444 172.183 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.616 HH11 ' HA ' ' A' ' 44' ' ' VAL . 36.7 mtp180 -79.28 -58.73 3.07 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.407 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -98.3 -164.46 1.14 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.393 -173.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -62.71 119.58 9.56 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -178.172 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -72.34 61.56 1.47 Allowed Glycine 0 CA--C 1.528 0.901 0 C-N-CA 120.902 -0.666 . . . . 0.0 111.555 171.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -163.29 -50.68 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.93 0.395 . . . . 0.0 111.099 -169.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 48.4 t -94.45 120.95 35.47 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.611 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -75.82 -60.77 2.17 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -178.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -61.76 -36.74 81.9 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -174.445 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -62.21 -60.15 3.99 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.088 0.471 . . . . 0.0 111.428 177.04 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.4 ' HB1' ' HB1' ' A' ' 83' ' ' ALA . . . -58.07 -42.39 85.43 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.913 -178.384 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -70.52 -40.37 73.52 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.412 -177.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -62.79 -53.52 53.04 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.125 0.488 . . . . 0.0 110.354 177.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -55.94 -52.54 63.77 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.644 -178.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 14.4 tt -60.92 -39.84 83.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 O-C-N 122.115 -0.366 . . . . 0.0 111.23 -179.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 95.9 m -70.56 -30.24 66.91 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.829 0.347 . . . . 0.0 111.042 176.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -64.42 -30.27 71.31 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.231 0.539 . . . . 0.0 110.762 178.413 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 82.8 mt -77.82 -18.42 56.35 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 177.413 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.464 HG13 ' SG ' ' A' ' 42' ' ' CYS . 41.3 t -114.56 -54.54 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -172.03 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.533 ' HA ' ' HB2' ' A' ' 13' ' ' SER . . . -52.12 112.08 0.73 Allowed 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -172.722 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 81.98 -2.99 82.24 Favored Glycine 0 CA--C 1.527 0.814 0 CA-C-N 115.908 -0.587 . . . . 0.0 114.463 173.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.809 ' HE2' ' HA ' ' A' ' 42' ' ' CYS . 22.1 ttpp -70.64 -28.05 64.52 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 117.602 0.701 . . . . 0.0 112.22 -178.454 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.521 ' HG2' ' O ' ' A' ' 106' ' ' LYS . 1.5 pt-20 72.7 155.46 0.16 Allowed Pre-proline 0 N--CA 1.481 1.079 0 C-N-CA 124.049 0.94 . . . . 0.0 111.904 -178.581 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -73.08 113.04 3.67 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 122.808 2.338 . . . . 0.0 111.628 174.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.403 ' O ' ' HB3' ' A' ' 110' ' ' ASN . . . -172.29 -28.93 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -174.411 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.403 ' HB3' ' O ' ' A' ' 109' ' ' ALA . 8.2 t30 65.37 173.51 0.22 Allowed 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 -169.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.403 HG13 ' O ' ' A' ' 111' ' ' VAL . 6.1 p -59.24 88.1 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 CA-C-O 121.793 0.806 . . . . 0.0 112.436 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -92.37 -33.05 7.82 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.607 174.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.425 ' O ' ' N ' ' A' ' 115' ' ' LYS . 60.9 t -74.29 136.42 25.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 122.287 0.235 . . . . 0.0 111.586 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.404 HG23 ' N ' ' A' ' 115' ' ' LYS . 12.9 t 53.7 -60.12 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 125.403 1.481 . . . . 0.0 114.602 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.425 ' N ' ' O ' ' A' ' 113' ' ' VAL . 88.4 tttt 73.48 -24.87 0.2 Allowed 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.309 0.644 . . . . 0.0 112.556 177.57 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.36 -23.91 58.3 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -178.206 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 51.6 pttt -72.92 81.61 1.19 Allowed 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 121.5 0.667 . . . . 0.0 111.645 178.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 66.8 p -115.18 173.87 6.28 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.805 -178.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 103.63 -59.93 0.48 Allowed Glycine 0 CA--C 1.526 0.728 0 C-N-CA 121.219 -0.515 . . . . 0.0 112.83 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 84.47 31.67 24.24 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 121.173 -0.537 . . . . 0.0 112.979 179.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -80.78 107.43 13.59 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 121.019 0.438 . . . . 0.0 111.487 -179.331 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.6 p -120.28 106.41 18.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-O 121.263 0.554 . . . . 0.0 111.873 -179.054 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -91.81 141.58 28.52 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.061 176.112 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -113.23 101.74 9.7 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.924 0.392 . . . . 0.0 111.378 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 83.5 mt -98.29 11.19 38.74 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.05 0.452 . . . . 0.0 111.076 176.183 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 28.5 m -64.62 101.15 0.43 Allowed 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.375 178.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -52.74 142.21 19.27 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-O 120.82 0.343 . . . . 0.0 110.418 173.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 11.7 t -137.81 9.29 2.83 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -176.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 77.7 p -70.15 -65.82 0.68 Allowed 'General case' 0 N--CA 1.473 0.701 0 O-C-N 122.141 -0.349 . . . . 0.0 111.064 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 31.4 ttm180 71.96 -51.69 0.7 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.74 0.816 . . . . 0.0 113.14 177.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 59.62 -159.3 0.3 Allowed 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 120.766 0.317 . . . . 0.0 110.398 -170.069 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 11.5 m -113.9 -17.93 11.9 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 121.914 -0.491 . . . . 0.0 111.014 173.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -85.28 -150.04 12.56 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 121.34 -0.457 . . . . 0.0 113.645 -179.172 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 19.5 m -94.86 143.56 26.36 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.012 0.434 . . . . 0.0 111.72 -176.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -121.76 123.43 41.8 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.883 178.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.539 ' NZ ' ' HB2' ' A' ' 136' ' ' LYS . 3.2 ttmp? -63.45 123.18 18.09 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.013 0.435 . . . . 0.0 111.973 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -78.44 105.21 9.54 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.733 175.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 138' ' ' ARG . 36.2 ttp-105 -116.8 7.06 13.28 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 120.941 0.4 . . . . 0.0 111.445 -177.583 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -107.77 -177.73 3.42 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 120.901 0.382 . . . . 0.0 111.789 -178.013 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -124.95 149.28 47.82 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.996 179.065 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -149.38 67.76 1.02 Allowed 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.516 0.674 . . . . 0.0 110.656 178.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 63.2 m -81.32 64.01 5.88 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.234 -175.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 63.89 -84.29 0.05 OUTLIER Glycine 0 CA--C 1.527 0.829 0 CA-C-N 116.27 -0.423 . . . . 0.0 113.542 179.154 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 4.9 ttmp? -163.62 78.43 0.41 Allowed 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 120.844 0.354 . . . . 0.0 111.731 -179.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 73.89 -65.32 1.86 Allowed Glycine 0 CA--C 1.534 1.24 0 N-CA-C 114.942 0.737 . . . . 0.0 114.942 171.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -54.29 -25.68 24.99 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -173.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 85.39 136.88 3.96 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.628 -177.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 11.5 tt -123.56 135.38 63.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-O 121.139 0.495 . . . . 0.0 112.04 -176.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -124.29 -10.63 7.51 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.491 175.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -169.33 167.94 40.87 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-N 116.335 -0.393 . . . . 0.0 112.475 179.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 28.3 ptt180 -88.88 84.88 6.65 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.536 0.684 . . . . 0.0 111.808 -178.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -90.63 -13.17 34.86 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.497 178.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -70.61 2.12 4.43 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -173.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 11.0 tt -68.08 98.24 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 CA-C-O 121.589 0.709 . . . . 0.0 111.794 -179.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.408 ' O ' ' HG ' ' A' ' 155' ' ' LEU . 31.1 tp -117.01 25.54 10.43 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-O 121.118 0.485 . . . . 0.0 111.097 -178.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 34.1 t0 53.97 32.2 14.93 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.838 0.828 . . . . 0.0 110.981 -176.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -76.66 36.99 0.17 Allowed 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.561 177.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 60.1 p -76.56 88.97 3.28 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.455 0.645 . . . . 0.0 111.29 -177.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -80.78 -45.46 7.76 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 114.335 0.494 . . . . 0.0 114.335 -174.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -76.52 11.42 1.63 Allowed 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -173.11 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 87.4 t -63.12 134.64 28.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-O 121.049 0.452 . . . . 0.0 111.891 179.198 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 48.8 p -71.86 82.83 0.92 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.234 0.54 . . . . 0.0 111.495 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -90.97 16.28 9.84 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -178.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 57.27 52.48 8.78 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -62.22 111.7 2.08 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.088 0.47 . . . . 0.0 110.973 177.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' ASN . . . . . 0.583 ' ND2' ' HB3' ' A' ' 170' ' ' TYR . 54.8 t30 65.8 19.3 11.33 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.646 -177.458 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 64.26 25.52 13.57 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 174.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 137.27 -102.98 0.4 Allowed Glycine 0 CA--C 1.526 0.735 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.942 178.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 66.8 p -121.72 -76.66 0.58 Allowed 'General case' 0 N--CA 1.473 0.689 0 O-C-N 122.502 -0.411 . . . . 0.0 110.864 176.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' TYR . . . . . 0.583 ' HB3' ' ND2' ' A' ' 166' ' ' ASN . 50.3 t80 67.2 -58.35 0.41 Allowed 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.75 0.82 . . . . 0.0 112.459 -179.413 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -52.68 116.66 2.42 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 176.26 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -75.7 119.03 19.16 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.776 0.322 . . . . 0.0 110.646 175.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -68.23 -17.0 64.19 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 -172.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.456 HG13 ' N ' ' A' ' 175' ' ' LYS . 7.3 p -156.13 -55.45 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 175.542 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.577 ' HD3' ' HA ' ' A' ' 178' ' ' GLU . 57.7 tttm -178.47 137.9 0.17 Allowed 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 122.32 0.248 . . . . 0.0 111.039 -176.607 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.438 ' HB3' ' NZ ' ' A' ' 176' ' ' LYS . 7.7 mtpm? -59.05 -42.4 90.21 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 120.976 0.417 . . . . 0.0 111.598 -179.24 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 63.2 tp -138.35 105.38 5.43 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.41 174.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.577 ' HA ' ' HD3' ' A' ' 175' ' ' LYS . 1.2 tm-20 . . . . . 0 CA--C 1.539 0.547 0 CA-C-O 121.41 0.624 . . . . 0.0 111.851 -175.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.611 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.486 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.06 76.1 8.96 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.967 0.413 . . . . 0.0 110.922 178.053 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 57.74 69.74 0.71 Allowed 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.866 -176.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.4 ' O ' HG22 ' A' ' 5' ' ' THR . 68.4 m -81.91 43.16 0.75 Allowed 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 -176.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.4 HG22 ' O ' ' A' ' 4' ' ' SER . 5.4 t 48.35 -166.09 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 175.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -71.63 175.95 5.21 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -177.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.2 tp -100.1 118.12 46.29 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 CA-C-O 121.225 0.535 . . . . 0.0 111.255 177.107 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -49.22 -41.46 37.36 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -175.123 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.84 -36.59 80.64 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 121.03 -0.605 . . . . 0.0 113.51 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.589 HD13 ' HB2' ' A' ' 104' ' ' ALA . 24.7 tp -78.24 -39.99 38.59 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 122.46 -0.435 . . . . 0.0 110.868 -179.37 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.584 ' HB3' ' NH2' ' A' ' 15' ' ' ARG . 45.3 mt-10 -55.77 -42.26 75.22 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.428 0.632 . . . . 0.0 110.657 173.665 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.481 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 8.7 tp10 -57.13 -55.57 33.08 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.389 177.721 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.429 ' HB3' ' O ' ' A' ' 108' ' ' PRO . 75.0 m -47.06 -51.23 18.06 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.324 174.132 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.413 ' N ' ' HB3' ' A' ' 109' ' ' ALA . 62.4 t80 -51.32 -46.35 62.56 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.696 -0.627 . . . . 0.0 111.196 -178.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.584 ' NH2' ' HB3' ' A' ' 11' ' ' GLU . 0.5 OUTLIER -70.02 -46.15 65.69 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 111.849 0.315 . . . . 0.0 111.849 177.838 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.524 ' O ' ' HB2' ' A' ' 20' ' ' HIS . 75.8 mmtt -53.99 -42.78 69.41 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.164 0.507 . . . . 0.0 110.854 178.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.624 ' CD1' ' HA ' ' A' ' 108' ' ' PRO . 0.2 OUTLIER -73.58 -34.39 65.09 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.859 -177.114 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.672 ' HA ' ' SD ' ' A' ' 30' ' ' MET . . . -66.98 -58.13 5.54 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.155 0.502 . . . . 0.0 112.048 -177.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 30.7 pt -80.49 -0.09 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 121.432 0.634 . . . . 0.0 111.052 -178.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.524 ' HB2' ' O ' ' A' ' 16' ' ' LYS . 37.2 t-80 -52.16 -45.59 65.11 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.316 -0.856 . . . . 0.0 112.289 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -112.14 10.03 26.94 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.771 -0.728 . . . . 0.0 114.516 -173.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -157.23 127.31 3.34 Favored Pre-proline 0 CA--C 1.545 0.78 0 CA-C-N 117.628 0.714 . . . . 0.0 111.438 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.54 -26.65 13.8 Favored 'Trans proline' 0 CA--C 1.544 0.992 0 C-N-CA 122.754 2.303 . . . . 0.0 113.611 -178.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -96.3 0.98 51.59 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -176.201 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.73 134.25 51.37 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 120.832 0.349 . . . . 0.0 111.846 178.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.4 t -57.43 -34.46 68.96 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.474 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.72 15.1 76.45 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 121.246 -0.502 . . . . 0.0 113.126 177.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 -124.85 -26.15 3.81 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.199 0.523 . . . . 0.0 110.987 178.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -122.81 128.25 50.19 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.694 -178.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.672 ' SD ' ' HA ' ' A' ' 18' ' ' ALA . 10.9 tpp -114.08 152.29 31.28 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -176.3 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.522 ' ND2' ' HB2' ' A' ' 33' ' ' LYS . 13.7 p-10 -97.27 164.4 12.49 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -179.617 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.75 -29.03 69.15 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-N 116.069 -0.514 . . . . 0.0 113.959 -179.087 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.522 ' HB2' ' ND2' ' A' ' 31' ' ' ASN . 5.2 mmmm -51.75 -45.05 63.54 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 175.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.516 ' ND2' ' SD ' ' A' ' 30' ' ' MET . 4.5 m-20 -72.94 -25.71 61.13 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.777 -179.158 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.413 ' CE3' ' O ' ' A' ' 110' ' ' ASN . 40.0 t-105 -66.88 -45.0 79.42 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.042 0.448 . . . . 0.0 111.0 175.291 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.2 -47.76 84.65 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.233 0.539 . . . . 0.0 110.945 175.303 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -63.83 -32.79 74.42 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.689 177.094 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.597 HD11 ' HA ' ' A' ' 109' ' ' ALA . 2.6 tt -58.16 -55.22 37.82 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.221 0.534 . . . . 0.0 110.263 179.06 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.58 ' SG ' ' HB2' ' A' ' 45' ' ' ALA . 45.9 t -58.86 -43.95 90.95 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.529 -179.417 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 28.9 ttpp -66.78 -41.51 87.53 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 120.878 0.37 . . . . 0.0 111.562 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -63.0 -48.59 78.17 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.274 0.559 . . . . 0.0 110.822 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.44 ' SG ' HG22 ' A' ' 103' ' ' VAL . 83.9 m -82.32 -3.28 55.04 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.675 179.329 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt 59.92 28.3 17.78 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.199 0.523 . . . . 0.0 112.02 175.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 47.9 t -67.36 -33.35 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.695 174.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.58 ' HB2' ' SG ' ' A' ' 39' ' ' CYS . . . -61.95 86.77 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.395 0.616 . . . . 0.0 111.079 175.651 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -63.69 -47.45 81.12 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.473 -178.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 125.13 -33.51 3.65 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 121.126 -0.559 . . . . 0.0 113.186 -178.447 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.5 pttt -129.32 -28.64 2.31 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 177.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 90.9 p -88.55 -39.82 13.86 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 121.055 0.455 . . . . 0.0 110.377 171.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 91.2 t -132.99 116.62 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.776 174.007 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 27.1 p -111.8 175.72 5.31 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.874 0.369 . . . . 0.0 111.088 178.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -58.92 -29.11 64.41 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.105 172.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.64 ' O ' HG13 ' A' ' 57' ' ' ILE . 44.3 m -61.51 -57.72 11.0 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 110.318 -0.253 . . . . 0.0 110.318 174.689 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -48.61 -42.51 34.26 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.96 0.41 . . . . 0.0 111.618 178.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 95.5 t -56.35 -45.71 81.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.625 177.202 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -71.79 -32.76 67.96 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 120.837 0.351 . . . . 0.0 111.275 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.64 HG13 ' O ' ' A' ' 53' ' ' THR . 9.3 mt -66.23 -54.44 26.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.721 178.642 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.442 HG11 ' CD1' ' A' ' 82' ' ' LEU . 93.9 t -54.2 -47.37 67.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 120.805 0.336 . . . . 0.0 111.68 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.513 ' O ' ' HG2' ' A' ' 63' ' ' LYS . 55.2 t80 -56.99 -38.28 72.83 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 120.803 0.335 . . . . 0.0 110.638 178.277 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 37.5 m -81.33 -18.78 44.51 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 178.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.435 ' HG2' ' O ' ' A' ' 57' ' ' ILE . 32.4 mmtp -73.26 -43.88 60.34 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 179.05 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.51 HG11 ' HB2' ' A' ' 78' ' ' ALA . 7.1 m -70.03 -45.0 77.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.513 ' HG2' ' O ' ' A' ' 59' ' ' PHE . 22.2 ptmt -81.2 166.34 20.69 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.369 0.604 . . . . 0.0 112.509 -176.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -104.18 -94.36 2.32 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.165 174.051 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -131.84 -57.56 0.98 Allowed 'General case' 0 N--CA 1.473 0.706 0 O-C-N 122.426 -0.455 . . . . 0.0 111.832 176.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 37.8 m -77.45 65.27 2.96 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -176.084 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -160.79 111.86 1.82 Allowed 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.977 0.418 . . . . 0.0 111.676 179.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.86 -26.9 17.44 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.794 0.33 . . . . 0.0 110.822 175.682 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.696 HG23 HG21 ' A' ' 114' ' ' THR . 26.0 m -120.57 174.07 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 121.102 0.477 . . . . 0.0 111.955 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.821 HD11 ' HB2' ' A' ' 110' ' ' ASN . 2.9 pp -135.39 165.76 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -172.368 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.6 ' OD1' ' HB2' ' A' ' 74' ' ' GLU . 24.7 p-10 -111.79 -179.82 3.81 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.231 -178.365 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.622 ' O ' ' HB3' ' A' ' 75' ' ' PHE . 65.9 t80 -85.84 -46.18 10.87 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -176.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -62.05 -31.5 71.92 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.462 -0.774 . . . . 0.0 111.472 -175.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.6 ' HB2' ' OD1' ' A' ' 71' ' ' ASN . 0.4 OUTLIER -73.12 -36.27 66.68 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.751 -0.204 . . . . 0.0 111.134 171.822 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.739 ' HD1' HG12 ' A' ' 111' ' ' VAL . 41.7 t80 -46.09 -41.95 12.95 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 172.378 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -57.84 -41.74 82.95 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 121.238 0.542 . . . . 0.0 111.658 174.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -72.09 -43.6 64.54 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 121.13 0.49 . . . . 0.0 111.082 -179.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.697 ' HB3' HG13 ' A' ' 111' ' ' VAL . . . -60.92 -44.61 96.96 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.843 177.21 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.468 HD11 ' CZ ' ' A' ' 75' ' ' PHE . 34.1 mt -52.32 -46.0 65.83 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 122.079 -0.388 . . . . 0.0 111.61 172.599 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -54.15 -38.25 65.3 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 121.094 0.473 . . . . 0.0 110.94 177.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.439 ' HB3' ' O ' ' A' ' 78' ' ' ALA . 16.6 tp10 -59.47 -51.23 70.76 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.995 174.779 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.442 ' CD1' HG11 ' A' ' 58' ' ' VAL . 8.8 mp -60.63 -47.62 85.42 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 111.841 0.312 . . . . 0.0 111.841 178.386 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.36 -46.28 69.51 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.851 0.358 . . . . 0.0 111.867 -178.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 69.2 p -67.55 -34.59 77.37 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.19 -0.459 . . . . 0.0 112.115 179.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.452 ' HZ2' ' HB3' ' A' ' 85' ' ' LYS . 8.3 mtpm? -80.11 -28.55 38.98 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 179.177 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -85.85 -55.26 4.05 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.07 0.462 . . . . 0.0 110.73 -176.319 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -96.75 50.52 1.12 Allowed 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.45 -177.033 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -59.64 99.82 0.07 Allowed 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.304 0.573 . . . . 0.0 111.483 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 136.14 -30.61 2.71 Favored Glycine 0 CA--C 1.521 0.43 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.774 -176.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -86.01 144.04 27.8 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 122.796 0.439 . . . . 0.0 110.585 176.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 43.6 t -59.07 134.78 57.29 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 122.412 -0.18 . . . . 0.0 111.345 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -52.2 -36.69 52.75 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -174.395 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -66.03 -51.61 56.7 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 120.869 0.366 . . . . 0.0 111.242 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -64.39 -37.21 86.71 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 121.072 0.463 . . . . 0.0 111.366 176.173 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.69 -43.97 91.81 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.994 0.425 . . . . 0.0 111.561 178.595 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -62.81 -39.28 93.81 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.114 0.483 . . . . 0.0 110.758 177.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -60.16 -51.62 68.81 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.534 176.343 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.82 -51.87 67.46 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.247 -178.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.3 tt -58.73 -42.97 86.74 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 CA-C-O 120.808 0.337 . . . . 0.0 111.119 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 74.7 m -68.96 -28.72 66.88 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.727 0.299 . . . . 0.0 111.267 177.387 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -64.41 -33.0 74.85 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.07 0.462 . . . . 0.0 110.989 178.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 81.0 mt -77.12 -20.41 55.67 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 116.176 -0.465 . . . . 0.0 112.062 178.082 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.44 HG22 ' SG ' ' A' ' 42' ' ' CYS . 60.2 t -105.91 -61.5 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -173.513 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.589 ' HB2' HD13 ' A' ' 10' ' ' LEU . . . -57.73 147.9 26.46 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -175.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 98.01 -35.9 4.28 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 121.157 -0.544 . . . . 0.0 113.265 177.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -79.04 -77.33 0.17 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 117.029 0.414 . . . . 0.0 111.525 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.524 ' CG ' ' HD3' ' A' ' 108' ' ' PRO . 11.1 pt-20 -176.29 -33.65 0.0 OUTLIER Pre-proline 0 CA--C 1.553 1.088 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 -179.367 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.624 ' HA ' ' CD1' ' A' ' 17' ' ' PHE . 50.6 Cg_exo -68.08 142.77 57.29 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 122.553 2.169 . . . . 0.0 115.646 176.613 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.597 ' HA ' HD11 ' A' ' 38' ' ' LEU . . . 168.35 115.52 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 115.054 -0.975 . . . . 0.0 112.107 179.397 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.821 ' HB2' HD11 ' A' ' 70' ' ' ILE . 7.9 p30 170.06 127.93 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 177.603 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.739 HG12 ' HD1' ' A' ' 75' ' ' PHE . 4.3 p 170.27 135.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 C-N-CA 123.926 0.891 . . . . 0.0 110.73 166.258 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.498 ' H ' HG21 ' A' ' 70' ' ' ILE . . . 164.66 -130.98 2.29 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 119.739 -1.219 . . . . 0.0 115.261 -176.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.489 HG12 ' N ' ' A' ' 114' ' ' THR . 11.8 t -137.77 165.01 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 O-C-N 122.564 -0.374 . . . . 0.0 111.638 -175.36 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.696 HG21 HG23 ' A' ' 69' ' ' VAL . 12.3 p -140.27 87.14 2.12 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 121.118 0.485 . . . . 0.0 111.92 173.011 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -148.37 -60.96 0.25 Allowed 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.873 175.057 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.474 ' O ' ' HB2' ' A' ' 117' ' ' LYS . . . 59.08 -161.55 0.26 Allowed 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 173.483 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.474 ' HB2' ' O ' ' A' ' 116' ' ' ALA . 34.1 mtmm 89.39 59.29 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.915 1.286 . . . . 0.0 112.364 -177.325 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 34.1 m 61.66 -75.58 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 173.129 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 177.43 -50.13 0.1 Allowed Glycine 0 CA--C 1.525 0.705 0 C-N-CA 121.026 -0.607 . . . . 0.0 113.245 -176.202 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -78.4 47.45 2.96 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 121.266 -0.492 . . . . 0.0 112.994 177.456 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.474 ' HB1' ' HE2' ' A' ' 117' ' ' LYS . . . -89.86 96.34 10.64 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 122.541 -0.388 . . . . 0.0 111.725 -177.119 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 35.1 m -91.11 -2.56 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-O 120.726 0.298 . . . . 0.0 111.296 175.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 62.87 -176.65 0.14 Allowed 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.876 -178.29 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -96.06 -82.04 0.4 Allowed 'General case' 0 CA--C 1.539 0.522 0 O-C-N 122.09 -0.381 . . . . 0.0 111.909 -176.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 5.1 tt -178.7 -77.73 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 120.846 0.355 . . . . 0.0 110.503 -176.169 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 52.4 m -95.22 -14.09 24.36 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 120.922 0.392 . . . . 0.0 111.551 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 66.72 170.55 0.25 Allowed 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.753 0.787 . . . . 0.0 112.628 -178.135 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 81.7 p -127.88 175.13 8.59 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.367 176.218 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 63.1 m -59.81 126.85 29.18 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.717 0.294 . . . . 0.0 110.696 175.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 33.4 mmt180 -61.27 -17.12 51.88 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -176.001 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -52.94 -25.41 11.78 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.166 0.586 . . . . 0.0 111.571 174.33 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 8.5 t -121.57 30.32 6.78 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.301 0.572 . . . . 0.0 111.333 178.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -70.63 -0.47 32.18 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 121.281 -0.485 . . . . 0.0 114.125 -178.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.462 ' O ' ' HG3' ' A' ' 136' ' ' LYS . 40.6 t 63.7 -86.53 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 179.054 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 52.9 t-80 63.5 1.31 0.98 Allowed 'General case' 0 CA--C 1.549 0.932 0 CA-C-O 120.957 0.408 . . . . 0.0 111.809 -175.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.462 ' HG3' ' O ' ' A' ' 134' ' ' SER . 54.7 mtpt -87.43 12.9 11.05 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -172.494 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -118.15 88.75 2.98 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.959 0.409 . . . . 0.0 111.77 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 57.2 ttp180 -88.37 107.41 18.83 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.906 0.384 . . . . 0.0 110.781 176.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -73.24 118.98 16.85 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.043 0.449 . . . . 0.0 111.322 -179.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -68.66 89.07 0.37 Allowed 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.562 0.696 . . . . 0.0 110.806 175.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -60.13 -46.43 89.67 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.516 -178.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 55.6 m 65.88 -74.77 0.06 Allowed 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.24 178.088 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -67.31 96.83 0.35 Allowed Glycine 0 CA--C 1.528 0.864 0 C-N-CA 121.33 -0.462 . . . . 0.0 113.704 -178.076 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -121.57 145.8 47.61 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.794 0.331 . . . . 0.0 111.177 175.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -78.05 111.65 3.3 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 121.266 -0.492 . . . . 0.0 113.861 -175.355 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 10.0 mtmp? -81.65 30.42 0.36 Allowed 'General case' 0 N--CA 1.473 0.723 0 O-C-N 122.377 -0.484 . . . . 0.0 111.46 177.154 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 75.28 56.06 4.88 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.886 -176.021 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 8.8 tt -49.99 -44.01 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-O 121.109 0.48 . . . . 0.0 111.97 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -172.27 -74.93 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.013 178.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -159.33 49.97 0.4 Allowed Glycine 0 CA--C 1.521 0.411 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 175.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 20.7 mtt180 60.68 -156.38 0.35 Allowed 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -171.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 86.3 mm-40 -72.53 115.73 12.15 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 167.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -49.58 107.75 0.16 Allowed 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -171.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 61.3 mt -68.27 130.44 33.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.319 178.299 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.405 ' N ' HD12 ' A' ' 155' ' ' LEU . 6.9 mp -85.21 84.72 7.59 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.145 177.136 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -51.5 139.87 19.18 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.916 -179.049 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -61.34 -41.54 97.21 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.449 0.642 . . . . 0.0 110.62 175.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 48.1 t -141.96 109.68 5.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.963 171.43 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -76.06 63.82 2.8 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 121.177 -0.535 . . . . 0.0 113.56 -177.519 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 50.9 t80 64.05 10.05 5.1 Favored 'General case' 0 CA--C 1.551 0.992 0 CA-C-O 121.199 0.523 . . . . 0.0 112.399 176.368 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 26.9 m -88.59 -33.38 6.34 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -176.333 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.465 ' O ' ' NZ ' ' A' ' 175' ' ' LYS . 66.2 m -77.06 104.71 7.71 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 121.991 -0.443 . . . . 0.0 112.145 -176.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 60.36 98.45 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 176.028 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -78.57 -63.51 1.39 Allowed 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.519 0.676 . . . . 0.0 110.322 174.13 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -89.68 94.5 9.87 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.203 175.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -68.22 116.03 8.35 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.014 0.435 . . . . 0.0 111.782 -178.014 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -88.65 -16.95 31.1 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.874 178.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -76.65 65.85 2.79 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 121.312 -0.471 . . . . 0.0 113.444 -178.133 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 40.4 m -65.99 -52.91 45.21 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.118 0.485 . . . . 0.0 111.975 -176.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -111.55 10.67 21.24 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.289 0.566 . . . . 0.0 111.065 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -89.53 23.09 2.72 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.053 -176.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . 69.82 -6.58 1.03 Allowed 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -82.05 76.35 8.94 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.579 0.704 . . . . 0.0 109.519 176.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 34.4 m -78.12 29.09 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -168.307 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.465 ' NZ ' ' O ' ' A' ' 162' ' ' SER . 87.4 tttt -73.2 95.12 2.06 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.942 -0.473 . . . . 0.0 110.798 176.271 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 47.3 mttp -97.77 95.67 7.71 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.683 0.278 . . . . 0.0 110.674 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 42.9 tp -74.09 87.11 1.88 Allowed 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.484 0.659 . . . . 0.0 111.743 -177.032 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 . . . . . 0 N--CA 1.467 0.419 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.607 175.588 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.5 mtt . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 120.484 0.183 . . . . 0.0 110.799 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.63 116.53 6.3 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 169.426 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 64.25 -168.89 0.2 Allowed 'General case' 0 CA--C 1.542 0.643 0 O-C-N 123.212 0.32 . . . . 0.0 110.954 -171.394 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 66.5 m -67.42 161.74 24.61 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.08 0.467 . . . . 0.0 111.436 178.295 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.5 t -68.08 178.76 1.73 Allowed 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.624 177.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -39.98 -69.44 0.13 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.207 0.603 . . . . 0.0 112.306 178.064 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.553 HD11 ' HB3' ' A' ' 100' ' ' CYS . 30.3 pt -143.28 128.31 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-O 121.226 0.536 . . . . 0.0 111.681 174.022 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.77 -31.92 70.12 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.909 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.8 -31.76 64.81 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 121.215 -0.517 . . . . 0.0 113.028 177.107 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 36.8 tp -70.89 -43.77 67.67 Favored 'General case' 0 N--CA 1.467 0.383 0 O-C-N 122.73 -0.277 . . . . 0.0 110.773 178.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.2 tm-20 -57.78 -46.87 83.99 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.273 175.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.419 ' O ' ' HB2' ' A' ' 16' ' ' LYS . 33.5 tt0 -57.24 -49.61 75.5 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.575 177.504 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 56.9 m -63.36 -50.02 71.57 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -178.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -54.88 -48.53 72.85 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.216 0.531 . . . . 0.0 110.558 176.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.484 ' HG3' ' HA3' ' A' ' 27' ' ' GLY . 23.2 ttt180 -63.7 -37.95 89.27 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.084 178.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.419 ' HB2' ' O ' ' A' ' 12' ' ' GLU . 32.6 ttmt -59.32 -42.12 90.65 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.041 -178.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -79.9 -32.2 40.25 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 174.532 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.52 -34.35 75.38 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -178.149 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 27.9 pt -95.7 14.22 3.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-O 120.98 0.419 . . . . 0.0 111.685 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 75.1 t60 -64.75 -16.81 63.49 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -176.467 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -105.35 -38.57 2.42 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 120.959 -0.639 . . . . 0.0 113.396 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -162.18 148.98 11.05 Favored Pre-proline 0 CA--C 1.541 0.618 0 O-C-N 122.688 -0.301 . . . . 0.0 111.652 -175.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.12 -2.9 12.74 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.651 2.234 . . . . 0.0 113.401 -178.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -85.97 -18.74 31.78 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.068 0.461 . . . . 0.0 110.862 178.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -76.54 54.19 0.92 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.353 170.315 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 38.0 t -25.58 -53.43 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 -170.528 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.484 ' HA3' ' HG3' ' A' ' 15' ' ' ARG . . . 147.95 58.93 0.01 OUTLIER Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.629 -179.408 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 19.4 tm0? -134.95 -19.17 1.79 Allowed 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 120.751 0.31 . . . . 0.0 111.5 -178.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -152.72 151.87 31.03 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -171.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.441 ' O ' HD13 ' A' ' 70' ' ' ILE . 42.8 ttm -136.58 149.63 48.16 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.61 -179.569 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -97.36 168.35 10.46 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.119 0.485 . . . . 0.0 111.948 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.08 -32.77 81.56 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-N 116.185 -0.461 . . . . 0.0 114.181 -177.053 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -62.51 -52.26 64.16 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 117.053 0.426 . . . . 0.0 111.732 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -69.13 -40.3 78.35 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.594 0.235 . . . . 0.0 110.999 177.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.498 ' NE1' ' HB2' ' A' ' 59' ' ' PHE . 24.9 t-105 -56.36 -42.27 77.52 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.113 0.482 . . . . 0.0 111.747 175.34 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.07 -51.93 65.97 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.572 179.028 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -69.32 -27.41 65.35 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.19 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.0 tt -57.38 -56.91 15.77 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.058 0.456 . . . . 0.0 110.198 176.129 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 86.3 m -60.49 -47.83 84.4 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.997 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -67.48 -41.71 84.15 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -176.26 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.407 ' OD2' ' NZ ' ' A' ' 106' ' ' LYS . 37.5 t70 -77.51 -29.96 52.7 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 120.741 0.305 . . . . 0.0 111.623 -178.641 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 62.2 m -90.7 -0.44 57.7 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 120.697 0.284 . . . . 0.0 111.429 176.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt 71.47 22.06 4.31 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 173.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 50.7 t -68.02 -28.45 41.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 CA-C-O 121.144 0.497 . . . . 0.0 110.99 174.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -89.65 121.03 31.45 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.254 174.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -79.48 -66.19 0.9 Allowed 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -173.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.432 ' O ' ' HB2' ' A' ' 48' ' ' LYS . . . 130.34 119.46 2.13 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 -168.653 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.432 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 75.2 mmtt 80.74 -15.94 0.7 Allowed 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.646 0.779 . . . . 0.0 111.936 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 42.4 t -122.03 -83.23 0.66 Allowed 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 173.246 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 84.1 t -87.56 111.7 22.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 120.894 0.378 . . . . 0.0 110.617 172.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.442 ' O ' HG23 ' A' ' 55' ' ' VAL . 72.8 p -125.58 -179.93 4.86 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.935 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -50.78 -35.44 31.11 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 121.031 -0.604 . . . . 0.0 113.195 178.496 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.578 ' O ' HG13 ' A' ' 57' ' ' ILE . 27.6 m -60.8 -58.41 8.57 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.738 0.304 . . . . 0.0 110.797 176.62 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -53.34 -41.45 65.78 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.976 179.193 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 51' ' ' THR . 93.6 t -56.91 -39.51 65.67 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.74 177.549 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -73.82 -37.84 64.75 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.292 0.568 . . . . 0.0 110.4 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.578 HG13 ' O ' ' A' ' 53' ' ' THR . 11.4 mt -60.33 -48.42 88.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.943 178.603 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 89.7 t -62.48 -43.69 98.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.64 177.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.498 ' HB2' ' NE1' ' A' ' 35' ' ' TRP . 86.7 t80 -50.23 -47.66 54.9 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.109 0.481 . . . . 0.0 111.938 178.368 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 35.8 t -82.04 -16.7 49.29 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.06 0.457 . . . . 0.0 111.614 -179.167 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -76.09 -38.22 57.24 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.95 -179.114 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.1 m -87.07 -5.92 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -176.029 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.6 pttp -119.88 -176.92 3.28 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.09 0.472 . . . . 0.0 111.692 -178.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -105.1 -178.03 24.36 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-N 116.291 -0.413 . . . . 0.0 113.424 177.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -75.49 -39.79 58.1 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -178.564 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 43.4 t -66.47 -35.95 81.54 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 120.917 0.389 . . . . 0.0 111.868 -178.14 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -93.4 122.44 35.82 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 120.967 0.413 . . . . 0.0 111.327 178.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 70.7 mtp180 -94.25 5.64 51.14 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.112 0.482 . . . . 0.0 110.683 175.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.9 m -129.63 159.91 41.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.921 179.161 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.502 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -114.4 150.7 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-O 120.967 0.413 . . . . 0.0 111.297 175.946 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.413 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 2.9 p-10 -104.78 172.25 6.89 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.296 178.517 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -46.49 -54.18 9.78 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -169.021 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.403 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 0.7 OUTLIER -64.46 -44.86 89.76 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 120.983 0.421 . . . . 0.0 111.347 -176.035 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -65.71 -33.96 77.1 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.203 0.525 . . . . 0.0 110.838 179.378 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -57.62 -44.09 85.25 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.6 172.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.403 ' HE2' ' HA ' ' A' ' 73' ' ' GLU . 52.8 mtmt -69.08 -33.7 73.94 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.231 176.649 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -60.54 -37.92 82.79 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.251 0.548 . . . . 0.0 110.292 173.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.08 -41.91 97.15 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.745 172.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 88.6 mt -62.31 -33.7 75.19 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.398 175.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -61.07 -49.64 76.52 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 120.735 0.302 . . . . 0.0 110.833 175.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -55.56 -58.01 9.54 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.111 0.482 . . . . 0.0 111.085 174.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 94.0 mt -56.71 -44.46 81.6 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.036 -179.129 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.69 -45.2 87.64 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -179.189 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 81.8 p -72.44 -12.29 61.04 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -178.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -93.72 -47.45 6.78 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 120.685 0.279 . . . . 0.0 111.502 172.169 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 76.7 mtp180 -70.63 -49.87 42.88 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 121.176 0.512 . . . . 0.0 111.85 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -106.55 38.59 2.02 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.881 -177.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -57.87 90.97 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.97 -178.507 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -160.8 44.81 0.41 Allowed Glycine 0 CA--C 1.526 0.772 0 C-N-CA 121.076 -0.583 . . . . 0.0 113.446 179.067 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 60.9 mttm 70.71 -60.68 0.5 Allowed 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 177.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 25.6 m -56.78 87.91 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -175.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -66.36 -43.48 85.88 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.703 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -54.03 -61.07 2.54 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.836 0.35 . . . . 0.0 110.886 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -56.72 -41.6 77.74 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.691 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.24 -43.5 92.39 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.924 0.393 . . . . 0.0 111.282 177.437 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -68.69 -49.06 62.01 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.963 -179.441 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.532 ' O ' ' HG3' ' A' ' 101' ' ' GLN . 1.5 m-20 -55.5 -44.54 76.66 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 111.545 0.202 . . . . 0.0 111.545 175.772 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.67 -57.55 11.55 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.019 0.437 . . . . 0.0 112.108 -179.193 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.0 tt -57.62 -29.74 35.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-O 121.245 0.545 . . . . 0.0 110.474 178.132 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' CYS . . . . . 0.553 ' HB3' HD11 ' A' ' 7' ' ' ILE . 90.6 m -82.26 -18.98 40.53 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.963 175.503 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.532 ' HG3' ' O ' ' A' ' 97' ' ' ASP . 73.2 mt-30 -64.91 -33.94 77.23 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 121.669 -0.644 . . . . 0.0 109.853 171.259 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 81.1 mt -75.58 -11.1 59.95 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.557 177.183 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.411 ' O ' ' HB3' ' A' ' 106' ' ' LYS . 64.5 t -121.48 -51.16 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -173.276 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -49.45 113.8 0.9 Allowed 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -175.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.39 -31.25 5.85 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 121.401 -0.428 . . . . 0.0 113.293 -179.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.411 ' HB3' ' O ' ' A' ' 103' ' ' VAL . 26.3 tptp -47.02 133.21 11.52 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.571 0.748 . . . . 0.0 112.602 -178.429 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -83.48 155.82 65.82 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.319 178.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -79.83 139.34 13.82 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.589 2.193 . . . . 0.0 113.17 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 57.24 54.47 6.73 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.214 0.531 . . . . 0.0 111.301 178.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -80.25 29.34 0.29 Allowed 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.366 0.603 . . . . 0.0 111.86 -174.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.434 HG13 ' N ' ' A' ' 112' ' ' GLY . 5.3 p -104.55 -53.12 7.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.902 176.117 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.434 ' N ' HG13 ' A' ' 111' ' ' VAL . . . 49.41 73.05 0.39 Allowed Glycine 0 C--N 1.339 0.728 0 C-N-CA 121.505 -0.379 . . . . 0.0 112.822 -178.715 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 47.3 t -61.59 93.73 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-O 121.398 0.618 . . . . 0.0 111.459 -177.229 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 60.5 m -133.54 141.35 47.69 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.196 -177.143 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 25.8 ttpp -68.18 104.74 1.88 Allowed 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.317 178.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 67.16 91.68 0.09 Allowed 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 121.22 0.533 . . . . 0.0 111.699 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -139.34 39.56 2.08 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.297 -176.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 33.5 m -59.68 -39.9 86.05 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 121.158 0.504 . . . . 0.0 111.234 178.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -80.26 105.03 2.31 Favored Glycine 0 CA--C 1.526 0.768 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.561 176.17 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -73.78 68.2 1.6 Allowed Glycine 0 CA--C 1.531 1.051 0 C-N-CA 121.395 -0.431 . . . . 0.0 113.604 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 58.62 -84.95 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 20.8 m -102.88 112.17 35.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 121.437 0.637 . . . . 0.0 112.04 -175.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -85.82 -2.82 58.62 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -178.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 53.4 mtm180 -57.73 126.11 25.96 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 120.891 0.377 . . . . 0.0 111.55 176.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.43 ' N ' HD12 ' A' ' 125' ' ' LEU . 6.4 mp -79.59 69.03 5.8 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 121.345 0.593 . . . . 0.0 111.562 -177.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 8.8 t -113.96 3.65 15.45 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.136 0.493 . . . . 0.0 111.348 177.635 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -88.69 143.34 26.99 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.534 -178.162 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 24.5 m -83.92 65.91 8.88 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.436 0.636 . . . . 0.0 111.187 -178.401 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 33.7 t -83.1 -47.66 11.41 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.962 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 19.8 mtp180 70.63 -21.69 0.19 Allowed 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 68.96 -11.86 0.42 Allowed 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 177.451 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.564 ' OG1' ' HB2' ' A' ' 135' ' ' HIS . 46.6 p 52.46 18.95 1.04 Allowed 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 174.01 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 48.09 -110.33 0.64 Allowed Glycine 0 CA--C 1.531 1.08 0 N-CA-C 115.471 0.949 . . . . 0.0 115.471 173.494 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 42.2 m -65.96 -3.6 5.54 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -173.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.564 ' HB2' ' OG1' ' A' ' 132' ' ' THR . 73.4 m80 -83.0 6.71 17.84 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 120.834 0.35 . . . . 0.0 111.554 178.102 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 34.1 ttmt -69.69 73.72 0.4 Allowed 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.355 0.597 . . . . 0.0 110.62 175.372 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -85.44 92.61 8.54 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.268 0.556 . . . . 0.0 111.621 -177.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -110.8 113.16 25.54 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.96 173.154 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 59.9 t80 54.63 72.98 0.43 Allowed 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.423 0.63 . . . . 0.0 111.526 -174.505 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -86.82 127.87 35.02 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.13 -0.487 . . . . 0.0 109.825 178.277 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -57.29 130.17 45.03 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -170.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 48.8 m 65.6 -74.24 0.06 Allowed 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.641 175.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 102.55 -139.82 14.59 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 121.19 -0.528 . . . . 0.0 113.319 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -105.46 -8.4 18.12 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -176.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -68.75 77.52 0.28 Allowed Glycine 0 CA--C 1.533 1.158 0 N-CA-C 114.677 0.631 . . . . 0.0 114.677 -175.145 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -147.42 133.82 19.65 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 120.993 0.425 . . . . 0.0 110.977 174.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 69.58 -163.31 51.73 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 121.254 -0.498 . . . . 0.0 113.011 -177.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.506 ' N ' HD12 ' A' ' 148' ' ' ILE . 2.7 mp -80.32 -46.73 21.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 120.805 0.336 . . . . 0.0 110.122 175.591 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . 60.32 -80.43 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 172.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -57.61 -44.25 93.99 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 114.552 0.581 . . . . 0.0 114.552 -171.12 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' A' ' 151' ' ' ARG . 4.1 ptp85 -118.6 -178.07 3.45 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 122.448 -0.443 . . . . 0.0 111.457 -177.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -100.49 142.99 31.19 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.954 0.407 . . . . 0.0 111.462 -178.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -82.03 -69.45 0.62 Allowed 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.037 0.446 . . . . 0.0 111.191 179.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 7.3 tp -82.62 136.29 23.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.731 176.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 87.9 mt -75.89 65.99 2.06 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.709 0.29 . . . . 0.0 111.718 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.9 p30 39.56 25.27 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 178.216 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -62.47 -31.97 72.79 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 121.078 0.466 . . . . 0.0 111.352 179.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 80.4 p -75.68 14.13 0.69 Allowed 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -97.27 -8.07 56.71 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 121.478 -0.391 . . . . 0.0 112.691 173.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -106.8 -54.52 2.46 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.094 0.473 . . . . 0.0 111.953 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 7.1 p -99.65 126.09 53.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -172.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 61.5 m 65.27 139.71 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 173.223 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 61.2 85.05 0.12 Allowed 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.034 -176.378 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -74.67 -20.99 59.65 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.947 -173.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 73.7 mttt 60.49 -164.61 0.23 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.066 0.46 . . . . 0.0 111.804 174.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -118.88 163.87 16.27 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.809 0.338 . . . . 0.0 110.718 174.426 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -79.48 15.99 1.15 Allowed 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -177.436 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 93.29 65.8 1.07 Allowed Glycine 0 CA--C 1.524 0.625 0 C-N-CA 121.252 -0.499 . . . . 0.0 112.401 -177.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.497 HG23 ' HA ' ' A' ' 173' ' ' LYS . 2.7 t -91.51 128.07 37.2 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.054 0.454 . . . . 0.0 111.959 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -88.74 -14.92 36.06 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.878 178.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -77.27 82.71 3.74 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 121.13 0.49 . . . . 0.0 111.513 -178.468 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . 56.64 9.52 0.58 Allowed 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 175.517 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.497 ' HA ' HG23 ' A' ' 169' ' ' THR . 66.9 mttm 56.86 82.69 0.11 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 122.401 0.28 . . . . 0.0 111.283 -176.445 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.405 HG13 ' O ' ' A' ' 174' ' ' VAL . 9.7 p 41.25 93.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 CA-C-O 121.989 0.899 . . . . 0.0 112.703 -176.369 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 51.4 tttp -89.41 86.0 6.69 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.66 -175.195 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.402 ' O ' ' HB2' ' A' ' 177' ' ' LEU . 27.5 tptp -107.64 -39.8 5.5 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 116.554 -0.293 . . . . 0.0 111.356 -179.384 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.458 ' O ' ' HB3' ' A' ' 178' ' ' GLU . 8.4 mp 73.87 -59.3 0.56 Allowed 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 176.181 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.458 ' HB3' ' O ' ' A' ' 177' ' ' LEU . 40.5 tt0 . . . . . 0 N--CA 1.475 0.803 0 C-N-CA 123.331 0.653 . . . . 0.0 110.825 -169.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.6 tpt . . . . . 0 N--CA 1.489 1.486 0 CA-C-O 120.712 0.292 . . . . 0.0 111.414 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.4 175.87 9.22 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.223 0.535 . . . . 0.0 112.223 -178.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -92.21 -156.75 0.48 Allowed 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.363 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 69.4 m -57.47 101.34 0.07 Allowed 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 120.996 0.427 . . . . 0.0 111.287 175.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 71.9 p -78.03 -177.11 4.86 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.716 0.635 . . . . 0.0 112.716 -176.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -68.19 -179.34 1.24 Allowed 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.866 176.552 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.474 ' N ' HD12 ' A' ' 7' ' ' ILE . 2.3 mp -66.43 96.13 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-O 121.264 0.554 . . . . 0.0 110.797 178.428 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.41 -35.65 72.36 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.329 -177.23 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -56.66 -31.4 60.47 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 121.131 -0.557 . . . . 0.0 113.131 179.215 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.453 HD11 ' HE2' ' A' ' 75' ' ' PHE . 54.7 tp -70.45 -53.73 15.22 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 120.776 0.322 . . . . 0.0 111.314 178.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -63.36 -39.01 93.36 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 122.185 -0.322 . . . . 0.0 111.533 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -57.79 -56.52 20.92 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.831 0.348 . . . . 0.0 111.095 175.167 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.707 ' HB3' ' HB2' ' A' ' 107' ' ' GLU . 65.7 m -67.79 -44.34 77.61 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -176.625 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -50.01 -51.94 38.0 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 121.187 0.518 . . . . 0.0 111.145 171.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.418 HH11 ' HD3' ' A' ' 15' ' ' ARG . 32.1 ttt180 -60.55 -44.23 96.35 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.832 179.542 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.569 ' HD3' HD11 ' A' ' 19' ' ' ILE . 0.1 OUTLIER -68.85 -27.89 66.22 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.844 -179.441 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -78.52 -33.12 48.25 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.177 0.513 . . . . 0.0 110.199 177.775 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.38 -38.35 77.98 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.447 177.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.569 HD11 ' HD3' ' A' ' 16' ' ' LYS . 27.0 pt -94.11 14.45 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 120.877 0.37 . . . . 0.0 111.039 178.236 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -52.85 97.3 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.101 0.477 . . . . 0.0 111.477 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 120.73 -36.2 3.44 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.656 -176.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.445 ' O ' ' HB ' ' A' ' 19' ' ' ILE . 11.7 m-20 -121.54 91.4 48.41 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 122.76 0.424 . . . . 0.0 111.946 -178.413 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -71.35 -2.87 11.9 Favored 'Trans proline' 0 CA--C 1.545 1.026 0 C-N-CA 122.517 2.145 . . . . 0.0 113.549 -178.223 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 8.7 mtpm? -88.35 -7.0 57.38 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -178.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.414 ' HB3' HG22 ' A' ' 19' ' ' ILE . . . -93.73 157.57 16.09 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.615 0.245 . . . . 0.0 111.321 178.163 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 28.3 t -88.36 -19.16 27.02 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 120.989 0.423 . . . . 0.0 110.776 177.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.438 ' HA3' HG23 ' A' ' 19' ' ' ILE . . . 63.87 56.6 17.82 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 115.606 1.002 . . . . 0.0 115.606 170.693 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -96.57 -8.56 31.53 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.518 0.675 . . . . 0.0 109.793 169.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.583 ' HB3' HG21 ' A' ' 69' ' ' VAL . 50.9 mt-10 -113.08 111.61 22.42 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.432 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 42.3 ttm -98.86 133.32 43.32 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.146 0.498 . . . . 0.0 111.553 176.011 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.416 ' ND2' ' HB2' ' A' ' 33' ' ' LYS . 13.9 p-10 -86.86 156.92 19.67 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.531 179.664 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -58.25 -28.2 61.32 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-N 116.24 -0.437 . . . . 0.0 113.212 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.416 ' HB2' ' ND2' ' A' ' 31' ' ' ASN . 47.4 mmtm -57.7 -59.5 5.11 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.045 0.45 . . . . 0.0 111.336 176.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.403 ' O ' ' HB2' ' A' ' 38' ' ' LEU . 87.7 m-20 -64.66 -38.76 92.1 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.872 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 45.5 t-105 -56.17 -49.06 75.06 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 120.901 0.382 . . . . 0.0 111.798 177.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.04 -47.08 86.33 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.205 0.526 . . . . 0.0 111.751 178.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.455 ' HB3' ' NZ ' ' A' ' 37' ' ' LYS . 7.8 mtpm? -67.26 -29.98 69.74 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.336 179.33 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.403 ' HB2' ' O ' ' A' ' 34' ' ' ASN . 5.1 tt -62.3 -49.3 76.18 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.169 0.509 . . . . 0.0 110.081 177.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 78.9 m -58.53 -44.28 89.52 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.442 178.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -69.9 -33.66 72.48 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 120.992 0.425 . . . . 0.0 111.388 179.008 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -64.1 -38.66 91.88 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.418 0.628 . . . . 0.0 110.822 177.257 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.491 ' HA ' ' HE2' ' A' ' 106' ' ' LYS . 59.1 m -99.2 0.76 43.98 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.039 -177.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.432 ' N ' ' HD2' ' A' ' 43' ' ' LYS . 3.3 mptp? 59.2 31.28 21.1 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.337 176.26 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.455 HG11 ' HB3' ' A' ' 82' ' ' LEU . 32.5 t -70.3 -37.44 71.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-O 121.486 0.66 . . . . 0.0 109.39 170.098 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.19 85.46 6.8 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.505 169.249 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -169.76 78.68 0.1 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.785 -171.156 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -176.72 37.29 0.09 OUTLIER Glycine 0 CA--C 1.522 0.506 0 C-N-CA 120.708 -0.758 . . . . 0.0 113.434 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.1 mtpm? 50.23 14.67 0.16 Allowed 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 178.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.7 m -150.54 -60.08 0.19 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.885 0.374 . . . . 0.0 110.509 -175.496 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 41.0 t -68.29 90.36 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 172.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 49.2 p -129.0 -171.09 2.39 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.103 -178.165 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -48.04 -36.86 15.58 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 121.476 -0.392 . . . . 0.0 113.686 -178.347 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.58 ' O ' HG12 ' A' ' 57' ' ' ILE . 4.8 t -64.32 -55.85 18.49 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 122.334 -0.51 . . . . 0.0 111.358 178.37 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.414 ' N ' HG23 ' A' ' 53' ' ' THR . 12.9 t70 -62.7 -40.03 95.87 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.04 0.448 . . . . 0.0 110.994 -177.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 84.3 t -61.69 -31.03 49.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.417 176.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -82.03 -30.91 31.23 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.334 0.588 . . . . 0.0 109.55 179.095 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.58 HG12 ' O ' ' A' ' 53' ' ' THR . 10.4 mm -61.24 -52.38 62.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.9 174.233 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.8 t -58.53 -42.74 85.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 120.919 0.39 . . . . 0.0 110.945 176.218 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -57.82 -40.82 80.9 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.355 0.598 . . . . 0.0 110.869 175.142 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 37.3 m -82.59 -11.72 58.21 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.486 178.413 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.678 ' HA ' ' HE2' ' A' ' 61' ' ' LYS . 0.6 OUTLIER -76.95 -50.41 13.28 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.838 176.972 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 31.4 m -67.63 -25.94 34.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.548 175.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -69.34 104.98 2.4 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.829 174.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -91.15 -61.35 1.27 Allowed Glycine 0 CA--C 1.526 0.778 0 C-N-CA 121.081 -0.581 . . . . 0.0 113.299 -178.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 10.3 mtmp? -121.55 -152.63 0.52 Allowed 'General case' 0 CA--C 1.542 0.66 0 O-C-N 122.524 -0.398 . . . . 0.0 111.014 -178.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 39.3 t -62.72 91.19 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.425 0.631 . . . . 0.0 111.917 -176.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -160.12 108.51 1.7 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.771 178.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.7 ttm-85 -70.36 -44.64 67.71 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.349 0.595 . . . . 0.0 111.113 -177.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.583 HG21 ' HB3' ' A' ' 29' ' ' GLU . 27.6 m -95.64 170.92 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.385 -175.398 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 34.6 pt -121.22 149.63 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.394 176.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -99.46 171.4 7.97 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.93 0.395 . . . . 0.0 111.389 178.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -57.99 -35.49 71.3 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -176.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.5 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 39.5 mm-40 -61.39 -53.27 58.81 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.799 0.333 . . . . 0.0 111.499 178.66 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -65.97 -28.06 68.62 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.907 0.384 . . . . 0.0 110.939 178.008 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.453 ' HE2' HD11 ' A' ' 10' ' ' LEU . 88.5 t80 -60.7 -47.99 83.78 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.183 175.05 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.5 ' HE2' ' HA ' ' A' ' 73' ' ' GLU . 53.4 mtmt -58.01 -47.08 84.1 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.919 0.39 . . . . 0.0 110.782 176.325 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -56.75 -42.9 80.13 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.154 0.502 . . . . 0.0 111.249 175.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.21 -42.87 99.35 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.375 177.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 88.2 mt -58.32 -41.57 84.83 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.294 177.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -63.76 -36.6 84.41 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 120.88 0.372 . . . . 0.0 111.192 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -63.76 -61.06 2.55 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 120.634 0.254 . . . . 0.0 111.122 172.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.455 ' HB3' HG11 ' A' ' 44' ' ' VAL . 11.2 mp -50.71 -40.49 54.3 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.196 0.522 . . . . 0.0 111.851 179.001 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.96 -53.33 59.29 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.743 175.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 69.2 p -74.32 -10.4 59.55 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -86.96 -45.86 10.4 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.105 0.479 . . . . 0.0 111.414 174.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.4 -49.04 9.05 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.882 -176.494 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -82.61 -178.45 7.08 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.156 0.503 . . . . 0.0 111.068 179.322 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -93.96 142.02 27.85 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.848 177.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -76.19 56.33 3.21 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 121.356 -0.449 . . . . 0.0 114.177 -176.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 29.0 ttpp -83.59 -31.78 26.12 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.208 0.527 . . . . 0.0 110.323 175.103 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.529 ' HB3' ' HB3' ' A' ' 94' ' ' GLU . 30.8 t -162.37 126.16 3.06 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.812 178.587 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 50.7 tttm -69.31 -47.09 65.5 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.777 0.323 . . . . 0.0 111.811 -178.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -64.47 -40.9 96.57 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 120.78 0.324 . . . . 0.0 110.986 178.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.529 ' HB3' ' HB3' ' A' ' 91' ' ' SER . 34.5 tt0 -65.67 -43.48 89.2 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.803 0.335 . . . . 0.0 111.257 177.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.95 -35.52 73.28 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.885 0.374 . . . . 0.0 110.978 175.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -64.87 -42.66 94.64 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.864 176.08 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -64.69 -38.51 91.26 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 120.933 0.396 . . . . 0.0 110.972 176.265 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.59 -51.31 60.65 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.679 179.398 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 16.5 tt -62.6 -33.2 58.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-O 120.941 0.4 . . . . 0.0 110.343 177.028 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' CYS . . . . . 0.506 ' SG ' ' HB3' ' A' ' 104' ' ' ALA . 39.7 t -65.43 -34.12 77.55 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.82 0.343 . . . . 0.0 110.851 172.154 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -69.7 -22.32 63.42 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.506 178.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 80.4 mt -95.55 -36.61 11.21 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.059 0.457 . . . . 0.0 111.987 175.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 81.9 t -96.8 -65.69 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 112.554 0.575 . . . . 0.0 112.554 -174.157 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.506 ' HB3' ' SG ' ' A' ' 100' ' ' CYS . . . -51.38 109.38 0.34 Allowed 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -168.074 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 107.25 -38.09 3.5 Favored Glycine 0 CA--C 1.522 0.479 0 C-N-CA 121.174 -0.536 . . . . 0.0 112.849 178.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.491 ' HE2' ' HA ' ' A' ' 42' ' ' CYS . 14.7 ttpp -78.86 -63.37 1.43 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.836 0.35 . . . . 0.0 110.549 178.281 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.707 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 25.6 mt-10 29.72 -88.03 0.0 OUTLIER Pre-proline 0 CA--C 1.557 1.219 0 N-CA-C 115.161 1.541 . . . . 0.0 115.161 177.121 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.65 ' HD3' ' HB2' ' A' ' 107' ' ' GLU . 6.8 Cg_exo -74.22 79.22 2.45 Favored 'Trans proline' 0 C--N 1.367 1.552 0 CA-C-N 123.306 2.216 . . . . 0.0 112.004 177.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -127.56 -51.31 1.38 Allowed 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -177.067 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -77.92 73.58 4.48 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 121.702 0.763 . . . . 0.0 112.143 -172.488 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 35.3 m -90.28 -4.3 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-O 121.314 0.578 . . . . 0.0 110.824 173.609 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -172.66 -107.76 0.21 Allowed Glycine 0 CA--C 1.527 0.834 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.848 178.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 65.0 t -113.55 130.72 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-O 120.99 0.424 . . . . 0.0 111.356 177.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 9.6 t -81.54 135.15 35.58 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.895 0.379 . . . . 0.0 111.181 177.013 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 44.6 tptt -84.32 163.93 19.3 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.652 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 68.28 122.63 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 122.913 0.485 . . . . 0.0 111.868 -177.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt 66.58 16.14 10.31 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 122.954 0.502 . . . . 0.0 111.66 -176.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 18.6 m -58.69 -40.55 83.92 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.932 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 148.41 -125.33 2.05 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 121.394 -0.432 . . . . 0.0 112.598 -178.279 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 88.34 -81.84 1.56 Allowed Glycine 0 CA--C 1.525 0.686 0 C-N-CA 121.333 -0.46 . . . . 0.0 112.842 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -72.65 146.43 46.57 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.939 0.399 . . . . 0.0 111.629 178.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.476 HG23 ' HB2' ' A' ' 125' ' ' LEU . 15.5 m -67.01 81.33 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -178.673 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 58.86 -81.13 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.913 175.195 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -159.91 18.34 0.16 Allowed 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 121.196 0.522 . . . . 0.0 110.339 -178.101 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.476 ' HB2' HG23 ' A' ' 122' ' ' VAL . 88.4 mt -81.8 139.28 34.88 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.48 0.657 . . . . 0.0 112.457 -173.707 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 87.8 m -119.97 85.19 2.34 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.546 175.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -71.85 151.67 43.23 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.301 174.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 93.5 m 67.33 110.03 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 112.451 0.538 . . . . 0.0 112.451 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 54.8 m 66.87 111.48 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 121.14 0.495 . . . . 0.0 111.894 178.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 130' ' ' ARG . 14.5 mmt85 -107.83 12.78 26.95 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -173.024 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -63.61 -6.06 4.81 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -179.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 75.3 p -74.26 149.91 40.51 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -177.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.83 74.66 1.24 Allowed Glycine 0 CA--C 1.528 0.857 0 C-N-CA 121.21 -0.519 . . . . 0.0 113.069 179.443 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 50.7 m -107.94 13.8 25.87 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -177.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 10.0 p-80 -163.37 131.17 3.61 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -178.189 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 55.8 tttm -80.25 -41.33 25.25 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.069 0.461 . . . . 0.0 111.028 177.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -75.06 141.87 43.79 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 120.79 0.328 . . . . 0.0 110.589 175.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 34.2 tpt85 -176.82 -35.5 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.12 0.486 . . . . 0.0 111.164 -170.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -124.6 163.93 20.91 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.281 -176.579 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -66.67 -165.15 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 121.47 0.652 . . . . 0.0 111.807 176.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -82.65 -179.05 7.31 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 120.959 0.409 . . . . 0.0 110.888 174.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 49.7 m -65.76 143.56 57.44 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.379 174.112 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -63.71 90.88 0.08 OUTLIER Glycine 0 CA--C 1.528 0.895 0 C-N-CA 121.157 -0.544 . . . . 0.0 113.692 -175.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -73.15 -36.5 66.67 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.082 0.468 . . . . 0.0 110.725 176.072 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 71.58 -120.66 8.35 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.817 -178.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -161.93 24.17 0.11 Allowed 'General case' 0 CA--C 1.545 0.752 0 CA-C-O 121.282 0.563 . . . . 0.0 110.822 179.264 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 105.8 82.18 1.52 Allowed Glycine 0 CA--C 1.522 0.474 0 C-N-CA 121.224 -0.512 . . . . 0.0 112.117 -176.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 45.6 mm 64.17 -68.31 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 123.222 0.609 . . . . 0.0 111.615 -174.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -139.8 -54.5 0.55 Allowed 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 78.34 65.08 1.9 Allowed Glycine 0 CA--C 1.526 0.775 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.913 -174.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.408 ' HG3' ' H ' ' A' ' 152' ' ' GLN . 12.2 ptm180 53.9 -59.75 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 125.592 1.557 . . . . 0.0 113.585 -172.535 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' GLN . . . . . 0.408 ' H ' ' HG3' ' A' ' 151' ' ' ARG . 25.6 tp60 71.74 107.26 0.07 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.447 0.641 . . . . 0.0 112.033 176.782 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -102.9 144.53 31.09 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.082 173.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 2.7 pp -92.32 162.69 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -174.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 48.3 tp 73.21 -47.64 0.67 Allowed 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 176.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -55.41 -56.1 24.07 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 120.804 0.335 . . . . 0.0 111.689 -178.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.443 ' O ' ' HB3' ' A' ' 158' ' ' SER . 28.6 t0 -129.25 165.25 21.77 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.493 176.188 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.443 ' HB3' ' O ' ' A' ' 157' ' ' ASP . 37.5 t 73.62 -49.87 0.69 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.173 0.589 . . . . 0.0 111.864 -176.355 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -55.36 105.04 0.34 Allowed Glycine 0 CA--C 1.528 0.875 0 C-N-CA 121.614 -0.327 . . . . 0.0 113.318 179.014 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -67.81 96.88 0.6 Allowed 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.361 0.6 . . . . 0.0 111.764 -178.573 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 7.9 p -162.9 140.46 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.513 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 91.8 p -136.5 124.0 22.17 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.867 -0.419 . . . . 0.0 109.867 176.126 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -150.43 127.87 11.45 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -175.24 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 76.7 t80 -147.47 87.24 1.64 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.92 174.178 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 83.7 tttt 55.12 39.9 31.65 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-O 121.725 0.774 . . . . 0.0 110.783 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -83.76 -172.12 3.98 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.172 -175.447 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -64.89 98.76 0.3 Allowed 'General case' 0 CA--C 1.539 0.522 0 O-C-N 122.085 -0.384 . . . . 0.0 111.493 177.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -66.08 -69.27 1.39 Allowed Glycine 0 CA--C 1.526 0.731 0 C-N-CA 121.338 -0.458 . . . . 0.0 112.836 178.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 39.5 p 48.43 48.98 18.76 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.024 0.53 . . . . 0.0 112.298 178.139 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -84.92 37.55 0.67 Allowed 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -175.148 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -94.44 127.85 40.61 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 122.101 -0.374 . . . . 0.0 110.153 176.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -89.32 -10.27 47.37 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -174.242 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -70.49 -42.91 70.74 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.044 0.45 . . . . 0.0 111.342 -177.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 4.9 p -74.28 94.71 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 CA-C-O 121.462 0.649 . . . . 0.0 111.437 178.107 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -84.64 120.68 26.66 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.709 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.675 ' HG3' ' H ' ' A' ' 177' ' ' LEU . 38.7 tptt -109.88 -161.52 0.76 Allowed 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 173.4 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.675 ' H ' ' HG3' ' A' ' 176' ' ' LYS . 87.3 mt -75.0 67.17 1.67 Allowed 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -174.77 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 . . . . . 0 N--CA 1.484 1.23 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 172.46 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.551 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 120.723 0.296 . . . . 0.0 111.277 . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.41 80.73 0.25 Allowed 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.002 0.43 . . . . 0.0 111.649 -178.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -176.16 -23.21 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.408 -177.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 32.9 m -71.06 -56.99 4.98 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.979 0.419 . . . . 0.0 111.827 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.629 HG23 ' HB2' ' A' ' 8' ' ' ALA . 84.8 m -108.79 98.83 8.26 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.031 0.443 . . . . 0.0 111.703 -178.808 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -83.63 -63.39 1.36 Allowed 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.205 0.526 . . . . 0.0 111.067 176.056 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.7 mm -122.17 -31.41 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.465 175.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.629 ' HB2' HG23 ' A' ' 5' ' ' THR . . . 66.23 -68.41 0.13 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.166 0.586 . . . . 0.0 112.098 -178.454 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -51.15 -28.56 18.89 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 121.615 -0.326 . . . . 0.0 113.496 178.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 51.6 tp -64.56 -38.48 91.17 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 120.719 0.295 . . . . 0.0 111.052 176.298 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.615 ' O ' ' HD3' ' A' ' 15' ' ' ARG . 39.9 tt0 -67.09 -46.14 75.14 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 177.806 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.454 ' O ' ' HG3' ' A' ' 16' ' ' LYS . 1.1 mp0 -51.79 -46.22 64.13 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.744 0.307 . . . . 0.0 111.156 172.64 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 70.6 m -58.95 -41.68 88.04 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.684 -0.234 . . . . 0.0 111.253 176.308 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -58.29 -46.85 85.32 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.645 176.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.615 ' HD3' ' O ' ' A' ' 11' ' ' GLU . 1.8 mpt_? -54.93 -55.85 26.1 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.121 175.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.454 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 67.1 mttm -54.32 -45.14 72.56 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -176.037 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -69.75 -39.49 76.69 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 111.728 0.27 . . . . 0.0 111.728 176.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.69 -53.6 38.83 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -177.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.53 HG12 ' O ' ' A' ' 15' ' ' ARG . 25.8 pt -78.8 -1.84 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 -176.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -56.06 -33.98 65.51 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.082 0.467 . . . . 0.0 110.656 175.281 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.57 59.83 4.93 Favored Glycine 0 CA--C 1.522 0.516 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.838 175.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 68.57 124.05 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 123.199 0.6 . . . . 0.0 111.338 -173.7 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.522 ' HA ' ' HB ' ' A' ' 19' ' ' ILE . 81.8 Cg_exo -47.57 -30.62 12.45 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 123.145 2.564 . . . . 0.0 114.237 -178.463 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -75.35 3.33 9.25 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 178.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.36 -52.04 66.97 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 111.868 0.321 . . . . 0.0 111.868 179.123 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 99.7 p 177.74 -70.55 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.004 0.431 . . . . 0.0 111.563 -179.218 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 107.46 -26.08 19.44 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 111.925 -0.47 . . . . 0.0 111.925 -174.226 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -115.88 -15.91 11.2 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.028 0.531 . . . . 0.0 111.101 178.386 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.456 ' HB3' HG21 ' A' ' 69' ' ' VAL . 8.7 mm-40 -111.9 145.7 39.07 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.715 -176.198 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 53.1 ttm -133.87 135.29 43.59 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 120.556 0.217 . . . . 0.0 111.146 178.087 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 36.1 p30 -94.13 168.85 10.67 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.17 0.51 . . . . 0.0 112.277 -178.389 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.15 -27.6 70.81 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-N 116.033 -0.531 . . . . 0.0 113.768 -179.058 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -62.89 -58.94 5.66 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.39 0.614 . . . . 0.0 111.199 178.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -64.18 -35.83 82.09 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.164 178.145 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 50.3 t-105 -62.2 -42.92 99.73 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.625 175.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.11 -45.72 86.77 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 121.131 0.491 . . . . 0.0 111.309 177.348 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.4 mtpp -64.83 -45.04 87.83 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.298 175.32 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.3 tt -46.02 -43.88 14.71 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.134 0.492 . . . . 0.0 111.182 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 79.3 m -68.48 -46.4 69.8 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 120.979 0.418 . . . . 0.0 111.588 176.464 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -65.91 -52.86 46.29 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.785 0.326 . . . . 0.0 111.84 -177.029 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -55.27 -38.47 68.62 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 122.954 0.502 . . . . 0.0 111.257 176.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.687 ' SG ' ' HA ' ' A' ' 103' ' ' VAL . 83.4 m -85.94 -4.12 59.09 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 175.639 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.9 mtmm 52.76 41.3 31.56 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 178.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 57.9 t -78.34 -35.4 19.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 121.316 0.579 . . . . 0.0 110.32 171.121 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -102.56 79.22 1.79 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.637 178.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -60.35 -27.09 67.1 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.5 -29.33 12.75 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 121.196 -0.526 . . . . 0.0 111.977 -172.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -74.05 -61.65 1.78 Allowed 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 120.937 0.398 . . . . 0.0 110.9 176.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 69.0 p -90.05 -74.01 0.5 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.088 0.471 . . . . 0.0 110.506 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 89.0 t -89.19 135.27 26.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.365 174.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 43.6 p -124.05 173.53 8.21 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 120.883 0.373 . . . . 0.0 111.538 -177.53 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -54.84 -34.29 56.95 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 121.24 -0.505 . . . . 0.0 112.753 177.158 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.655 ' O ' HG13 ' A' ' 57' ' ' ILE . 89.3 m -53.61 -57.56 10.33 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 122.382 0.273 . . . . 0.0 111.102 176.443 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -52.43 -42.99 64.59 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.252 179.152 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 80.1 t -55.93 -43.96 76.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.851 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -73.55 -33.31 64.62 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.04 0.448 . . . . 0.0 111.115 -179.378 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.655 HG13 ' O ' ' A' ' 53' ' ' THR . 7.8 mt -64.42 -49.13 82.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.626 177.736 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 93.0 t -60.84 -43.38 95.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-O 120.786 0.327 . . . . 0.0 111.435 178.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -58.15 -35.16 71.13 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.17 0.509 . . . . 0.0 111.261 178.092 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 38.9 t -87.83 -21.84 24.81 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.743 177.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -68.13 -41.22 81.99 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 122.631 0.372 . . . . 0.0 111.969 -176.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.6 m -82.44 -21.26 9.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-O 121.245 0.545 . . . . 0.0 111.533 177.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.452 ' HD3' ' O ' ' A' ' 67' ' ' ALA . 39.4 ttmt -74.08 156.7 37.17 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -175.566 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -91.58 -128.02 4.11 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 121.538 -0.363 . . . . 0.0 113.184 175.258 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -100.54 -77.79 0.53 Allowed 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 81.2 p -76.94 -4.92 46.42 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -172.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.452 ' O ' ' HD3' ' A' ' 63' ' ' LYS . . . -68.88 121.06 15.8 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.106 0.479 . . . . 0.0 111.501 178.814 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 67.3 mtt180 -85.3 -32.31 22.58 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.198 0.523 . . . . 0.0 110.882 178.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.456 HG21 ' HB3' ' A' ' 29' ' ' GLU . 30.9 m -127.34 171.46 15.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.706 -176.526 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 36.3 pt -117.49 170.58 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 CA-C-O 120.581 0.229 . . . . 0.0 111.032 177.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 14.9 p30 -126.82 -179.97 5.08 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 -179.405 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.502 ' O ' ' HB3' ' A' ' 75' ' ' PHE . 70.6 t80 -34.73 -62.66 0.35 Allowed 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 -174.567 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -64.61 -38.57 91.46 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 121.798 -0.564 . . . . 0.0 112.014 -175.372 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -62.41 -37.22 84.97 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.219 0.533 . . . . 0.0 110.333 176.29 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.502 ' HB3' ' O ' ' A' ' 72' ' ' TYR . 60.8 t80 -57.03 -45.98 82.72 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.586 176.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.438 ' HE3' ' CZ ' ' A' ' 72' ' ' TYR . 81.2 mttt -61.39 -38.74 88.15 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.859 0.361 . . . . 0.0 111.7 178.243 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -71.69 -30.46 65.7 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.712 0.292 . . . . 0.0 111.531 176.441 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.31 -46.71 85.41 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.123 0.487 . . . . 0.0 110.687 173.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 86.9 mt -63.74 -34.95 79.01 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.107 175.332 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -62.0 -43.62 98.45 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 121.089 0.471 . . . . 0.0 110.93 178.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -59.79 -58.98 6.23 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.028 0.442 . . . . 0.0 111.284 173.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 90.9 mt -56.12 -42.01 76.17 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.949 -178.194 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.58 -51.78 68.44 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.799 0.333 . . . . 0.0 111.633 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 68.6 p -66.37 -20.7 66.14 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -178.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -102.38 -13.97 17.08 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 48.7 tpt85 -98.38 -60.79 1.48 Allowed 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.196 0.522 . . . . 0.0 110.975 177.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -77.38 -178.98 5.46 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.918 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 19.8 tptm -62.29 133.87 55.73 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.612 177.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -77.07 61.72 3.39 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 121.174 -0.536 . . . . 0.0 114.129 -173.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -165.77 153.52 10.67 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.979 0.389 . . . . 0.0 111.51 176.043 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 44.1 t 65.47 86.76 0.13 Allowed 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.91 -175.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 55.0 tttp -45.73 -41.78 11.07 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.295 175.116 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -57.38 -60.83 3.05 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.7 178.374 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -59.97 -43.75 94.88 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.82 0.343 . . . . 0.0 111.845 -176.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.61 -48.21 80.41 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.038 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -66.69 -48.11 70.3 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.278 -178.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.461 ' O ' ' HG3' ' A' ' 101' ' ' GLN . 4.2 m-20 -54.58 -49.36 70.57 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.748 0.309 . . . . 0.0 111.376 176.266 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -55.32 -51.94 65.1 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -178.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.8 tt -66.67 -33.16 61.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 CA-C-O 120.885 0.374 . . . . 0.0 111.235 -179.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 86.5 m -65.27 -34.82 79.24 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.824 0.345 . . . . 0.0 110.8 173.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.461 ' HG3' ' O ' ' A' ' 97' ' ' ASP . 78.4 mt-30 -64.78 -31.09 72.16 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.33 175.731 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 87.8 mt -72.91 -38.38 66.9 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 176.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.687 ' HA ' ' SG ' ' A' ' 42' ' ' CYS . 58.4 t -92.18 -57.4 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -174.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.91 98.41 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -170.273 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 85.17 5.39 85.68 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 114.99 0.756 . . . . 0.0 114.99 170.407 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 50.5 tttp -83.41 -2.04 54.89 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 118.015 0.908 . . . . 0.0 111.856 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 74.04 148.34 0.12 Allowed Pre-proline 0 N--CA 1.478 0.964 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 173.574 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -74.92 81.95 2.09 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.844 2.363 . . . . 0.0 112.168 176.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 53.28 -149.68 0.39 Allowed 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.863 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -69.49 105.58 2.68 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.732 0.301 . . . . 0.0 110.397 176.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 10.7 p -66.74 -35.91 75.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -178.096 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -118.81 -100.11 1.94 Allowed Glycine 0 CA--C 1.526 0.732 0 C-N-CA 121.354 -0.451 . . . . 0.0 112.646 179.088 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 8.2 p -74.71 135.38 27.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-O 121.014 0.435 . . . . 0.0 111.349 176.246 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 11.3 t -79.93 155.41 27.73 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.062 0.458 . . . . 0.0 112.227 -178.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.468 ' O ' HG23 ' A' ' 118' ' ' THR . 73.0 mmtt 64.6 -80.77 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 178.046 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 69.22 -61.07 0.44 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 122.765 0.426 . . . . 0.0 110.682 -169.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 55.8 tttp -164.57 -57.33 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 120.652 0.263 . . . . 0.0 110.967 173.314 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.468 HG23 ' O ' ' A' ' 115' ' ' LYS . 73.0 p 51.36 23.44 1.74 Allowed 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 175.611 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 78.11 11.96 84.84 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 120.892 -0.67 . . . . 0.0 113.98 178.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -60.63 -14.15 34.61 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 121.48 -0.39 . . . . 0.0 113.882 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -83.63 -43.06 16.01 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 120.802 0.334 . . . . 0.0 111.753 178.05 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 34.7 m -96.19 11.22 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -177.192 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -57.2 118.63 5.26 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.4 178.237 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 21.7 mtm180 -91.89 -174.32 3.77 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.566 0.698 . . . . 0.0 112.03 -177.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 85.4 mt -114.14 -149.84 0.45 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.614 178.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 48.8 p -64.45 93.09 0.09 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.349 0.595 . . . . 0.0 112.078 -177.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -67.45 158.3 32.13 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.097 175.257 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 80.6 p -85.98 -63.35 1.33 Allowed 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.323 0.582 . . . . 0.0 110.576 174.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 84.6 p -150.68 138.39 19.81 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.686 172.622 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 49.5 mtm-85 -66.78 -49.49 65.71 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.476 0.655 . . . . 0.0 110.55 -178.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -174.59 24.12 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 114.904 -1.043 . . . . 0.0 108.759 176.259 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 14.8 m -103.08 122.83 45.47 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.109 -0.95 . . . . 0.0 113.355 -163.276 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -98.8 167.29 21.88 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 166.103 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 66.0 m -57.72 96.11 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 117.677 0.738 . . . . 0.0 111.229 178.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 44.7 t-80 -78.4 90.37 4.42 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -175.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -111.62 -10.29 14.11 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.369 0.604 . . . . 0.0 109.702 167.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -58.36 152.34 17.86 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.612 178.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.657 ' HG3' ' H ' ' A' ' 139' ' ' PHE . 24.4 tpt180 -112.73 -173.28 2.22 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.94 -178.018 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.657 ' H ' ' HG3' ' A' ' 138' ' ' ARG . 95.1 m-85 76.89 23.63 0.97 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.827 0.851 . . . . 0.0 112.073 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -84.02 -12.19 55.59 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.963 172.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -72.9 144.96 47.18 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.08 -0.964 . . . . 0.0 112.433 -175.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 30.1 t -149.47 -57.07 0.19 Allowed 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.03 178.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 96.28 -56.03 1.49 Allowed Glycine 0 CA--C 1.528 0.858 0 C-N-CA 121.135 -0.555 . . . . 0.0 113.571 177.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -102.88 -166.84 1.32 Allowed 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 120.848 0.356 . . . . 0.0 111.296 -178.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -61.87 165.53 19.81 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.659 174.495 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 22.1 tptp -67.11 -22.11 65.82 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 122.265 -0.55 . . . . 0.0 111.911 -176.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -128.14 174.27 18.79 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-N 116.502 -0.317 . . . . 0.0 112.529 179.385 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 9.5 tt -146.19 137.94 19.44 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 O-C-N 122.263 -0.551 . . . . 0.0 112.171 -177.567 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . 74.36 -57.85 0.6 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.575 0.75 . . . . 0.0 112.996 175.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -59.91 -83.86 0.05 OUTLIER Glycine 0 CA--C 1.528 0.874 0 C-N-CA 121.353 -0.451 . . . . 0.0 114.087 -176.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -82.25 119.9 24.69 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 122.301 -0.529 . . . . 0.0 111.245 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -85.86 134.07 33.93 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.552 0.215 . . . . 0.0 111.184 177.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 37.62 -94.76 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -174.102 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 9.8 tt -160.56 116.9 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-O 121.295 0.569 . . . . 0.0 112.236 -176.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 86.1 mt -95.58 -35.95 11.45 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.178 0.513 . . . . 0.0 111.477 176.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -94.08 117.69 30.47 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.3 0.572 . . . . 0.0 112.135 -176.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -95.26 173.34 7.59 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.909 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 51.1 m -56.3 115.06 2.25 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -178.447 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -121.61 -141.17 6.04 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.364 176.594 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 63.84 -74.33 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.969 0 CA-C-O 121.389 0.614 . . . . 0.0 112.429 178.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 85.5 t -89.39 138.04 20.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.28 -175.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 38.4 t -77.45 58.54 1.73 Allowed 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.199 0.523 . . . . 0.0 111.046 177.097 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -80.57 34.22 0.32 Allowed 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -176.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 64.65 86.87 0.12 Allowed 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.29 0.567 . . . . 0.0 112.169 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -72.18 152.71 42.08 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.516 176.51 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -86.91 -172.76 4.14 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 120.926 0.393 . . . . 0.0 111.433 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -55.85 119.46 5.83 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -179.096 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.0 173.67 52.36 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 121.142 -0.552 . . . . 0.0 112.936 177.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 4.4 m -78.39 38.87 0.31 Allowed 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -175.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 57.12 18.41 4.09 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 173.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 31.3 t70 64.09 105.61 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 121.248 0.547 . . . . 0.0 111.537 -178.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.19 93.62 1.47 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.101 0.477 . . . . 0.0 111.18 178.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 36.1 tttp -91.12 95.19 9.95 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.608 -177.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 31.5 m -137.19 161.93 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -175.002 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.537 ' O ' ' HD3' ' A' ' 175' ' ' LYS . 6.0 tmtm? -80.7 -18.35 48.17 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 121.006 0.432 . . . . 0.0 110.544 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -42.32 129.96 3.82 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.532 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.435 HD12 ' N ' ' A' ' 177' ' ' LEU . 6.3 mp -59.63 -84.11 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.549 -178.357 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 . . . . . 0 CA--C 1.534 0.336 0 CA-C-O 121.006 0.431 . . . . 0.0 112.146 178.436 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.529 ' SD ' ' N ' ' A' ' 2' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.529 ' N ' ' SD ' ' A' ' 1' ' ' MET . . . -100.6 -37.43 8.78 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.003 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -173.85 -36.21 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.777 -177.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 73.4 m 75.09 -33.11 0.23 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.227 0.611 . . . . 0.0 112.37 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 55.9 m 65.99 98.21 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 122.765 0.426 . . . . 0.0 111.2 -179.232 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 67.69 -69.32 0.14 Allowed 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.142 0.577 . . . . 0.0 111.14 -175.293 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.429 HG12 ' H ' ' A' ' 9' ' ' GLY . 9.0 tt -163.4 124.35 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.158 176.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -52.62 -33.81 48.28 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.022 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.429 ' H ' HG12 ' A' ' 7' ' ' ILE . . . -60.2 -37.08 92.39 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 121.224 -0.513 . . . . 0.0 112.921 178.644 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.423 ' HB2' HG23 ' A' ' 7' ' ' ILE . 46.7 tp -60.89 -42.72 98.53 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.947 0.403 . . . . 0.0 110.522 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -57.33 -44.95 84.67 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.133 174.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.608 ' O ' ' HG3' ' A' ' 16' ' ' LYS . 32.3 mt-10 -61.44 -49.38 77.06 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.594 0.235 . . . . 0.0 110.954 179.285 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.457 ' HA ' ' HD2' ' A' ' 16' ' ' LYS . 47.4 m -57.48 -45.97 84.23 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.065 0.459 . . . . 0.0 111.312 178.703 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -58.77 -44.64 90.68 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.175 0.512 . . . . 0.0 110.408 175.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.742 HH11 ' HA3' ' A' ' 27' ' ' GLY . 3.0 tpt180 -56.16 -43.4 78.29 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.202 177.569 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.608 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 88.7 mttt -58.88 -54.67 44.49 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.036 -178.674 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -70.51 -33.4 71.17 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.93 -15.92 63.83 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -177.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.442 HG12 ' O ' ' A' ' 15' ' ' ARG . 31.9 pt -113.95 20.12 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-O 121.468 0.652 . . . . 0.0 111.126 175.811 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 50.0 t60 -67.9 -17.37 64.45 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -177.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -101.1 -42.83 2.33 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 120.933 -0.651 . . . . 0.0 113.558 -179.377 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.53 ' HB2' ' HB2' ' A' ' 25' ' ' ALA . 5.0 m-20 -116.41 157.26 46.06 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 122.733 0.413 . . . . 0.0 110.893 -177.591 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -69.91 -13.73 34.69 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.306 2.004 . . . . 0.0 113.198 -178.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -132.79 -38.85 0.99 Allowed 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.006 0.432 . . . . 0.0 110.374 172.165 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.53 ' HB2' ' HB2' ' A' ' 22' ' ' ASP . . . 47.07 -87.68 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -179.548 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 70.0 m -163.69 -56.73 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.384 0.612 . . . . 0.0 110.433 -175.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.742 ' HA3' HH11 ' A' ' 15' ' ' ARG . . . 92.26 -34.51 4.41 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-N 115.934 -0.576 . . . . 0.0 113.238 -178.454 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -99.97 0.92 42.04 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 121.079 0.466 . . . . 0.0 111.001 177.167 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.46 ' HB3' HG21 ' A' ' 69' ' ' VAL . 44.9 mt-10 -124.88 112.34 16.52 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.162 -179.299 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 50.6 ttm -107.68 145.08 33.86 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.78 0.324 . . . . 0.0 111.109 178.128 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -109.73 168.63 9.27 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.154 0.502 . . . . 0.0 112.095 -177.065 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -59.88 -37.24 92.28 Favored Glycine 0 CA--C 1.529 0.936 0 N-CA-C 114.555 0.582 . . . . 0.0 114.555 -174.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -64.21 -53.69 45.22 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -174.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 13.1 p30 -74.33 -28.94 61.38 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 29.0 t-105 -60.42 -44.86 95.34 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.091 0.472 . . . . 0.0 111.231 170.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.43 -49.08 78.28 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.928 0.394 . . . . 0.0 111.135 176.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -64.81 -31.65 72.98 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.425 178.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.9 tt -58.21 -54.81 42.72 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.049 0.452 . . . . 0.0 110.147 177.05 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 67.4 m -58.07 -45.98 86.2 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.192 178.054 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -66.34 -33.2 75.19 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -74.23 -47.09 37.48 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.146 0.498 . . . . 0.0 110.188 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 85.7 m -75.19 -2.21 26.83 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.233 173.034 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt 54.78 35.65 24.59 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 175.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 61.7 t -68.55 -28.12 39.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.784 174.429 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.39 124.22 21.68 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.21 0.529 . . . . 0.0 111.622 178.124 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.443 ' H ' ' HB ' ' A' ' 50' ' ' VAL . 32.0 t70 -75.29 -22.99 57.31 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.929 -176.462 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.12 -47.63 3.87 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 121.252 -0.499 . . . . 0.0 112.853 -179.269 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 42.0 mtmt -77.69 -57.83 3.6 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.465 0.65 . . . . 0.0 110.745 176.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.7 p -97.26 -72.07 0.66 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.497 179.354 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.443 ' HB ' ' H ' ' A' ' 46' ' ' ASP . 49.4 t -76.43 114.29 16.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-O 121.067 0.461 . . . . 0.0 111.475 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.7 t -140.59 -175.16 4.18 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.623 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -45.23 -45.82 10.55 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 113.793 0.277 . . . . 0.0 113.793 -177.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.599 ' O ' HG12 ' A' ' 57' ' ' ILE . 67.8 m -53.88 -56.6 16.19 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.823 0.344 . . . . 0.0 111.37 175.697 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -58.16 -43.26 87.3 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 121.129 0.49 . . . . 0.0 111.016 -178.213 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 71.4 t -61.85 -26.92 41.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-O 121.224 0.535 . . . . 0.0 111.438 178.5 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -82.88 -39.36 21.67 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.522 0.677 . . . . 0.0 109.989 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.599 HG12 ' O ' ' A' ' 53' ' ' THR . 16.4 mm -55.95 -46.76 80.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.593 174.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 87.1 t -61.62 -47.48 93.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.294 176.685 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -54.5 -44.28 72.56 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.068 0.461 . . . . 0.0 111.617 178.488 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 35.6 t -74.92 -35.23 62.2 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.044 0.449 . . . . 0.0 111.636 178.286 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -62.9 -55.66 24.07 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -177.199 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 22.6 m -66.49 -24.38 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-O 121.124 0.488 . . . . 0.0 111.6 -178.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.527 ' HB2' HG22 ' A' ' 70' ' ' ILE . 22.0 ttpp -105.64 82.86 1.86 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.634 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -101.45 -10.58 41.01 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 121.049 -0.596 . . . . 0.0 114.586 -173.063 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 48.2 tptt -84.76 45.66 1.17 Allowed 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 117.81 0.805 . . . . 0.0 112.035 -177.228 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 39.6 t 53.68 16.02 0.9 Allowed 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 176.469 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -76.5 166.75 22.97 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.027 0.441 . . . . 0.0 111.647 -178.555 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.432 HH11 ' HD3' ' A' ' 68' ' ' ARG . 40.6 ttp-105 -105.13 -36.56 7.23 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.045 0.45 . . . . 0.0 111.252 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.46 HG21 ' HB3' ' A' ' 29' ' ' GLU . 33.9 m -110.36 165.0 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.805 178.356 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.527 HG22 ' HB2' ' A' ' 63' ' ' LYS . 33.5 pt -111.93 146.53 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.012 175.649 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 30.1 p30 -100.46 -179.81 4.22 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.609 0.242 . . . . 0.0 111.379 177.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -56.45 -39.07 72.54 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -174.005 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -66.57 -49.25 66.99 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.792 0.33 . . . . 0.0 111.24 179.11 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -62.42 -35.37 79.01 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.058 0.456 . . . . 0.0 110.885 178.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.423 ' O ' ' HG ' ' A' ' 79' ' ' LEU . 89.1 t80 -58.63 -45.24 89.68 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.495 172.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -60.88 -41.81 96.71 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.542 176.06 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -60.05 -40.76 90.53 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.237 0.541 . . . . 0.0 110.727 174.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.76 -40.32 96.91 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.227 177.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' A' ' 75' ' ' PHE . 76.5 mt -62.23 -37.64 86.14 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.233 177.043 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -61.66 -42.72 99.29 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.085 0.469 . . . . 0.0 110.672 176.171 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.449 ' O ' ' HG2' ' A' ' 85' ' ' LYS . 61.7 mm-40 -59.92 -55.08 38.57 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.202 175.655 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 91.5 mt -59.68 -37.81 79.79 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.862 0.363 . . . . 0.0 111.448 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.424 ' HB1' ' HB1' ' A' ' 95' ' ' ALA . . . -58.67 -55.02 40.43 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.878 0.37 . . . . 0.0 111.424 177.684 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 36.3 p -63.52 -24.01 67.63 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.044 178.415 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.449 ' HG2' ' O ' ' A' ' 81' ' ' GLU . 33.3 mmtp -73.97 -42.26 60.75 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 120.884 0.373 . . . . 0.0 111.728 174.409 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 30.9 mmm180 -90.63 -57.32 2.87 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -174.573 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -99.37 25.76 6.66 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -171.358 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt 62.7 -175.06 0.15 Allowed 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.834 -178.239 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -98.05 17.58 58.48 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 121.042 -0.599 . . . . 0.0 113.36 178.692 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -74.77 96.42 3.06 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 122.421 -0.458 . . . . 0.0 111.077 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 24.6 t 65.3 110.09 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.009 0.523 . . . . 0.0 112.327 -178.17 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -57.21 -34.63 68.72 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.589 0.233 . . . . 0.0 111.417 175.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -60.19 -52.69 64.23 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 120.696 0.284 . . . . 0.0 111.684 -178.293 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -69.2 -42.61 75.56 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 120.711 0.291 . . . . 0.0 111.641 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.424 ' HB1' ' HB1' ' A' ' 83' ' ' ALA . . . -60.62 -47.36 86.58 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 120.955 0.407 . . . . 0.0 111.649 177.346 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.47 ' HA ' HG22 ' A' ' 99' ' ' ILE . 49.0 t80 -66.39 -37.04 84.35 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.017 0.437 . . . . 0.0 110.74 179.11 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -58.23 -51.76 68.43 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.508 0.67 . . . . 0.0 110.566 174.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.3 -41.46 94.08 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.814 -176.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.47 HG22 ' HA ' ' A' ' 96' ' ' PHE . 10.1 tp -64.87 -37.68 80.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 O-C-N 121.936 -0.478 . . . . 0.0 110.42 177.292 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 87.1 m -69.75 -30.07 67.58 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.673 172.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 3.6 tp-100 -60.12 -35.56 75.52 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.104 0.478 . . . . 0.0 111.028 178.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 88.3 mt -67.85 -22.58 65.13 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.944 177.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 47.7 t -111.45 -70.02 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-O 120.775 0.321 . . . . 0.0 111.241 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 53.7 -86.74 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 177.09 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -143.57 27.71 2.07 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.739 -176.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -73.3 -172.59 1.16 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.575 0.702 . . . . 0.0 112.745 -176.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -136.51 151.71 73.43 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.374 178.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -57.6 95.7 0.07 OUTLIER 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 122.219 1.946 . . . . 0.0 113.077 -179.21 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 61.98 -79.13 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.443 0.697 . . . . 0.0 112.221 -177.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -165.18 114.01 1.04 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 122.684 0.394 . . . . 0.0 110.259 -178.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 17.4 m -96.6 174.46 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-O 120.917 0.389 . . . . 0.0 111.593 -177.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -60.12 150.36 40.37 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.773 175.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.7 m -70.26 -6.0 6.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -178.378 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 6.6 t -55.28 127.06 27.61 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.935 0.397 . . . . 0.0 111.362 176.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.441 ' HE3' ' HA ' ' A' ' 118' ' ' THR . 65.1 tttp -75.26 113.04 12.17 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.036 0.446 . . . . 0.0 111.911 -175.739 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -80.86 160.29 24.81 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.341 178.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 60.2 tttm 66.06 -70.61 0.1 Allowed 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 122.798 0.439 . . . . 0.0 111.232 -178.163 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.441 ' HA ' ' HE3' ' A' ' 115' ' ' LYS . 68.2 m 51.35 -95.34 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 176.498 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 50.9 -150.24 6.38 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.158 -170.084 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -80.89 -68.83 1.44 Allowed Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 166.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -137.37 -63.72 0.58 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 169.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.5 p -108.09 10.18 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.162 174.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 18.5 t70 76.86 152.55 0.13 Allowed 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.362 -177.47 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.4 tpm_? -76.22 104.28 6.67 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 112.735 0.642 . . . . 0.0 112.735 -172.339 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 97.7 mt -114.5 -161.56 0.78 Allowed 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.266 173.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 48.0 p 54.33 21.09 2.99 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 175.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -87.95 -154.96 0.28 Allowed 'General case' 0 CA--C 1.547 0.832 0 CA-C-O 121.109 0.481 . . . . 0.0 111.879 -175.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 37.1 m -74.45 -36.35 63.35 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -176.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 90.5 p -56.16 122.44 11.72 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -174.42 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -76.34 -47.56 23.05 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.486 174.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 81.0 t80 70.2 -42.55 0.52 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.743 0.817 . . . . 0.0 112.986 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 13.9 t -58.45 -11.01 2.46 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -178.477 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -161.82 121.15 1.0 Allowed Glycine 0 CA--C 1.523 0.54 0 C-N-CA 121.538 -0.363 . . . . 0.0 112.732 177.236 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 66.2 m -67.4 -25.26 65.86 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.01 0.434 . . . . 0.0 111.106 178.11 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -83.11 71.49 10.15 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.322 0.582 . . . . 0.0 109.767 172.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 56.8 pttt -65.81 -43.96 87.06 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.774 -176.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -98.32 79.63 2.56 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.79 0.805 . . . . 0.0 110.759 177.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.461 ' O ' ' HB2' ' A' ' 139' ' ' PHE . 33.8 ttp-105 -98.43 -77.96 0.5 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.506 -177.104 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.461 ' HB2' ' O ' ' A' ' 138' ' ' ARG . 68.2 t80 170.57 81.63 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.828 177.202 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -72.83 130.77 41.19 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 120.916 0.389 . . . . 0.0 111.04 178.037 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.476 ' O ' ' N ' ' A' ' 143' ' ' GLY . 1.5 tm-20 -147.54 -86.6 0.09 Allowed 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.309 -178.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 86.0 p 40.48 -81.21 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.743 0.817 . . . . 0.0 113.059 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 141' ' ' GLU . . . -136.02 -25.45 0.48 Allowed Glycine 0 CA--C 1.529 0.933 0 CA-C-N 116.368 -0.378 . . . . 0.0 112.715 177.388 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 88.2 tttt 63.98 -66.71 0.11 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.591 0.756 . . . . 0.0 112.085 -176.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -82.72 61.36 4.76 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 121.266 -0.493 . . . . 0.0 112.502 176.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -69.57 136.87 51.85 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 122.757 -0.261 . . . . 0.0 111.396 179.655 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 82.33 62.26 1.9 Allowed Glycine 0 CA--C 1.524 0.605 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.339 -178.623 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 10.7 tt -72.72 137.43 23.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 120.933 0.397 . . . . 0.0 111.516 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -67.14 94.27 0.34 Allowed 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.08 0.467 . . . . 0.0 111.559 178.525 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -154.36 -133.09 1.73 Allowed Glycine 0 CA--C 1.524 0.612 0 CA-C-N 116.196 -0.456 . . . . 0.0 112.93 179.262 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -122.04 163.11 19.96 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.032 0.444 . . . . 0.0 111.576 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.43 110.84 16.26 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 173.319 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -91.79 171.52 9.09 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 121.343 0.592 . . . . 0.0 112.085 -172.272 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 2.5 pp -97.33 178.87 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.055 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 48.1 tp 63.22 92.65 0.06 Allowed 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 176.171 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -76.59 147.69 37.47 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.378 169.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -62.88 139.81 58.76 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.267 0.556 . . . . 0.0 111.915 -173.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 71.5 m -98.31 54.98 1.1 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.126 0.489 . . . . 0.0 110.685 174.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -66.85 -33.29 83.63 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-N 116.079 -0.51 . . . . 0.0 113.443 179.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -75.19 81.69 2.33 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.372 0.606 . . . . 0.0 110.981 178.01 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 25.7 m -87.3 32.88 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -177.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 36.3 m -66.88 -13.91 62.17 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 122.301 -0.25 . . . . 0.0 111.613 178.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 63.88 -76.63 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 175.215 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -89.11 -38.06 14.62 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.287 0.565 . . . . 0.0 111.216 -177.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -87.2 135.66 33.22 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.768 -172.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -85.8 155.67 20.9 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.845 0.355 . . . . 0.0 111.385 179.177 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -70.89 -36.65 72.85 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -63.62 122.09 25.57 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 121.41 -0.424 . . . . 0.0 113.232 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 6.1 t -149.32 144.93 26.76 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.235 0.54 . . . . 0.0 112.405 -176.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -143.23 108.47 5.0 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.842 175.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ASP . . . . . 0.532 ' HB2' ' H ' ' A' ' 178' ' ' GLU . 5.6 p-10 -68.26 -33.51 74.5 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -173.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 171' ' ' ASP . . . 77.99 -174.99 0.09 Allowed 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 176.393 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -109.91 -55.77 2.4 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -177.089 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 47.8 t -66.6 98.8 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -170.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.0 mttt 66.76 -64.6 0.23 Allowed 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.543 0.737 . . . . 0.0 112.223 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 38.1 mtmm -60.05 114.89 3.08 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.399 174.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 5.7 tt -169.58 124.27 0.81 Allowed 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.07 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.532 ' H ' ' HB2' ' A' ' 171' ' ' ASP . 3.4 tm-20 . . . . . 0 CA--C 1.542 0.636 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.41 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 52.6 mt . . . . . 0 CA--C 1.542 0.636 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 70.17 -70.42 0.15 Allowed 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -56.46 -45.28 89.68 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 121.455 -0.403 . . . . 0.0 113.315 -177.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.64 HD22 ' SG ' ' A' ' 100' ' ' CYS . 45.3 tp -57.57 -46.14 84.34 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.232 0.539 . . . . 0.0 110.836 175.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -61.42 -34.45 75.4 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.06 178.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -66.43 -50.89 61.89 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.614 177.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.6 m -60.28 -34.18 73.39 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.36 177.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -57.67 -49.99 74.66 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.793 0.33 . . . . 0.0 110.154 174.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.551 ' O ' HG12 ' A' ' 19' ' ' ILE . 76.6 mtm-85 -57.16 -47.1 82.02 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.299 176.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.412 ' HB3' ' HD3' ' A' ' 108' ' ' PRO . 75.3 mmtt -44.93 -48.46 11.32 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 176.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -84.82 -26.97 27.11 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.9 -53.05 23.27 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.976 0.417 . . . . 0.0 111.938 -178.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.551 HG12 ' O ' ' A' ' 15' ' ' ARG . 29.9 pt -77.95 7.33 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -178.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -62.13 89.91 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.232 0.539 . . . . 0.0 110.596 176.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 125.23 -54.48 0.75 Allowed Glycine 0 CA--C 1.527 0.785 0 CA-C-N 115.888 -0.597 . . . . 0.0 112.64 -176.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -127.03 109.79 21.79 Favored Pre-proline 0 CA--C 1.547 0.835 0 O-C-N 122.626 -0.338 . . . . 0.0 110.933 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -76.39 -5.78 16.48 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 122.845 2.363 . . . . 0.0 113.644 -178.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 30.7 mtmm -89.5 -11.77 41.97 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.932 0.396 . . . . 0.0 110.945 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.86 -20.34 66.2 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.607 176.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 59.9 m 73.11 -53.72 0.7 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.582 0.753 . . . . 0.0 112.213 177.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 137.86 47.25 0.07 OUTLIER Glycine 0 CA--C 1.524 0.609 0 CA-C-N 116.41 -0.359 . . . . 0.0 112.309 -177.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -95.16 -34.78 12.13 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.643 0.259 . . . . 0.0 111.506 -178.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.08 178.92 6.59 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.341 0.591 . . . . 0.0 112.488 -175.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 52.7 ttm -157.41 133.9 9.81 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.63 176.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -86.38 167.75 14.45 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.094 0.473 . . . . 0.0 112.134 -178.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -58.13 -33.19 68.87 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-N 115.749 -0.659 . . . . 0.0 114.432 -176.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -69.22 -54.12 16.38 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.331 0.586 . . . . 0.0 110.976 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -60.57 -40.29 91.12 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.425 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 30.5 t-105 -63.51 -42.84 98.46 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 120.998 0.428 . . . . 0.0 111.492 175.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.18 -44.63 96.99 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 121.001 0.429 . . . . 0.0 111.183 176.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 43.2 tttm -66.36 -39.43 89.14 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.784 177.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.7 tt -51.69 -47.5 63.86 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.084 0.469 . . . . 0.0 110.792 178.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 79.5 m -63.44 -41.26 98.66 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.324 176.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -62.7 -57.3 11.48 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.815 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -53.69 -39.42 65.14 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 122.731 0.412 . . . . 0.0 111.795 178.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.587 ' SG ' HG13 ' A' ' 103' ' ' VAL . 57.0 m -91.85 -0.7 57.53 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? 50.15 31.75 5.32 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.1 t -68.78 -38.14 78.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-O 121.263 0.554 . . . . 0.0 109.586 171.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.47 79.69 3.97 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.02 171.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.0 p30 -76.79 -14.28 59.93 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.914 -173.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.61 -27.43 7.14 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 121.168 -0.539 . . . . 0.0 113.23 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -85.01 -37.81 19.96 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 122.478 -0.425 . . . . 0.0 111.448 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.8 t -112.46 -51.13 2.86 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.128 0.49 . . . . 0.0 110.549 176.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 34.1 t -112.81 110.46 32.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.065 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.504 ' O ' HG23 ' A' ' 55' ' ' VAL . 81.9 p -97.52 166.72 11.38 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.527 179.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -50.02 -55.49 15.02 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 121.368 -0.444 . . . . 0.0 113.079 178.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.574 ' O ' HG12 ' A' ' 57' ' ' ILE . 94.0 m -53.08 -48.56 67.66 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.599 0.237 . . . . 0.0 111.493 178.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.488 ' O ' HG23 ' A' ' 58' ' ' VAL . 18.0 t70 -58.48 -36.82 74.32 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 120.726 0.298 . . . . 0.0 110.872 -178.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 51' ' ' THR . 88.6 t -61.87 -37.92 79.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.375 175.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -73.52 -34.73 65.39 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.399 0.619 . . . . 0.0 110.137 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.574 HG12 ' O ' ' A' ' 53' ' ' THR . 8.0 mm -60.48 -52.73 58.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.999 176.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 54' ' ' ASP . 91.8 t -52.49 -48.5 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 121.04 0.448 . . . . 0.0 111.12 177.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -59.94 -41.28 91.49 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.009 178.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 28.3 t -72.95 -20.22 61.09 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 116.156 -0.474 . . . . 0.0 112.051 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.456 ' HG3' ' O ' ' A' ' 57' ' ' ILE . 53.6 mtmt -84.49 -57.12 3.28 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.087 0.47 . . . . 0.0 111.953 178.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.3 m -61.19 -31.95 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 -173.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.646 ' HD3' ' O ' ' A' ' 66' ' ' SER . 17.2 ptpt -56.55 -52.44 64.78 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -175.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 72.74 -64.78 1.48 Allowed Glycine 0 CA--C 1.537 1.46 0 N-CA-C 114.55 0.58 . . . . 0.0 114.55 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.622 ' H ' ' HD2' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -78.52 53.43 1.3 Allowed 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -172.569 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.646 ' O ' ' HD3' ' A' ' 63' ' ' LYS . 88.5 p 54.23 -77.61 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.148 0.579 . . . . 0.0 110.928 -173.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.559 ' HB2' ' HG2' ' A' ' 65' ' ' LYS . . . 46.88 117.88 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 115.859 1.799 . . . . 0.0 115.859 164.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 57.2 ttp180 -66.52 -18.3 65.29 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 121.355 0.598 . . . . 0.0 110.684 169.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.413 ' O ' ' HB1' ' A' ' 67' ' ' ALA . 33.8 m -135.15 159.21 41.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.902 -173.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 39.3 pt -115.27 147.56 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-O 120.699 0.285 . . . . 0.0 110.929 174.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -86.47 157.55 19.77 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -40.25 -48.6 2.63 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 -175.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.529 ' HA ' ' HE3' ' A' ' 76' ' ' LYS . 46.5 mm-40 -52.15 -46.42 65.43 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 120.935 0.398 . . . . 0.0 111.77 178.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -76.56 -19.36 57.98 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 120.97 0.414 . . . . 0.0 110.99 -178.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -70.56 -49.68 45.42 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.118 174.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.529 ' HE3' ' HA ' ' A' ' 73' ' ' GLU . 22.8 pttp -69.58 -22.54 63.51 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.322 177.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -71.81 -41.35 68.35 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.165 0.507 . . . . 0.0 110.251 170.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.467 ' O ' ' HB3' ' A' ' 81' ' ' GLU . . . -63.61 -37.8 88.72 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.33 175.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 84.9 mt -59.69 -43.44 94.04 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.326 175.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -54.85 -43.97 73.55 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 121.029 0.443 . . . . 0.0 110.891 174.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.467 ' HB3' ' O ' ' A' ' 78' ' ' ALA . 6.9 tp10 -54.28 -64.33 0.86 Allowed 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.057 175.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.5 ' HA ' ' HG3' ' A' ' 85' ' ' LYS . 9.1 mp -57.71 -33.25 68.22 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.153 0.502 . . . . 0.0 111.936 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.422 ' HB2' HG21 ' A' ' 99' ' ' ILE . . . -60.84 -48.47 81.66 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.146 175.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.47 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 76.1 p -70.41 -19.06 63.02 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 120.827 0.346 . . . . 0.0 111.699 179.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.5 ' HG3' ' HA ' ' A' ' 82' ' ' LEU . 46.9 mmtt -67.29 -41.64 85.1 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 121.088 0.471 . . . . 0.0 111.013 174.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 23.4 mtp180 -106.25 -57.38 2.06 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -176.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -88.85 29.33 1.04 Allowed 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -171.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.47 ' HB3' ' O ' ' A' ' 84' ' ' THR . 22.7 pttp -71.8 150.58 44.22 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.079 0.466 . . . . 0.0 111.406 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 98.84 -28.5 14.86 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.908 -178.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -86.62 -177.48 6.15 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.05 0.453 . . . . 0.0 111.423 176.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 35.6 t -63.7 135.13 56.48 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.058 177.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -48.76 -48.03 41.25 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 122.98 0.512 . . . . 0.0 111.856 -178.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.432 ' HG3' ' N ' ' A' ' 94' ' ' GLU . 9.9 pt-20 -60.9 -48.45 81.77 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.461 178.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.432 ' N ' ' HG3' ' A' ' 93' ' ' GLU . 63.5 tt0 -58.58 -47.15 85.24 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.635 0.255 . . . . 0.0 111.354 -178.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.81 -44.81 86.61 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 120.951 0.405 . . . . 0.0 111.711 178.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -68.37 -50.29 54.15 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.422 -178.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -62.01 -31.55 71.94 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 120.725 0.298 . . . . 0.0 111.57 177.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -66.65 -54.94 17.86 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.422 HG21 ' HB2' ' A' ' 83' ' ' ALA . 11.5 tt -58.43 -39.75 75.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 120.929 0.395 . . . . 0.0 110.99 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' CYS . . . . . 0.64 ' SG ' HD22 ' A' ' 10' ' ' LEU . 79.0 m -64.17 -37.58 87.96 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.847 0.356 . . . . 0.0 110.998 175.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -60.15 -29.31 68.57 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.536 177.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 79.0 mt -77.18 -13.46 59.94 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 177.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.587 HG13 ' SG ' ' A' ' 42' ' ' CYS . 58.3 t -110.62 -54.18 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -175.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -41.36 126.21 2.74 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 -172.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 109.11 -32.84 6.54 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 121.321 -0.466 . . . . 0.0 114.219 173.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 38.0 mtmm -82.06 169.12 17.07 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -174.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.547 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 12.1 pt-20 -126.89 165.37 29.12 Favored Pre-proline 0 CA--C 1.55 0.967 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.464 -178.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.547 ' HD2' ' HB2' ' A' ' 107' ' ' GLU . 55.5 Cg_endo -68.37 71.97 0.91 Allowed 'Trans proline' 0 CA--C 1.545 1.031 0 C-N-CA 122.635 2.223 . . . . 0.0 113.889 -178.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.673 0 C-N-CA 122.672 0.389 . . . . 0.0 111.8 -179.061 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.0 mt . . . . . 0 N--CA 1.472 0.654 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.55 -31.07 69.04 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.382 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.73 -17.06 48.48 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 121.225 -0.512 . . . . 0.0 113.164 175.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 53.0 tp -71.85 -58.44 3.46 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.783 0.291 . . . . 0.0 110.899 177.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -55.43 -39.63 70.5 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 177.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -61.47 -57.08 13.61 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.573 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.3 t -57.32 -44.91 84.59 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.134 0.492 . . . . 0.0 110.868 178.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -58.34 -40.97 83.59 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.435 176.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.482 ' O ' HG12 ' A' ' 19' ' ' ILE . 58.4 ttt180 -67.48 -44.21 79.1 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 120.678 0.275 . . . . 0.0 110.985 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -62.8 -34.37 77.15 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.237 178.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -72.28 -49.72 32.56 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.365 173.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.73 -46.96 81.0 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -176.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.482 HG12 ' O ' ' A' ' 15' ' ' ARG . 23.1 pt -83.58 5.58 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-O 121.018 0.437 . . . . 0.0 111.974 -177.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 37.1 t60 -78.96 105.22 10.13 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.937 0.399 . . . . 0.0 110.291 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.461 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . 88.82 -64.31 3.42 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.27 -174.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -90.13 97.33 1.07 Allowed Pre-proline 0 CA--C 1.547 0.839 0 CA-C-O 120.865 0.364 . . . . 0.0 110.608 175.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' A' ' 21' ' ' GLY . 74.4 Cg_endo -73.33 -30.79 9.91 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 122.546 2.164 . . . . 0.0 114.183 -170.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.46 2.42 13.75 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -173.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.405 ' HB1' ' O ' ' A' ' 29' ' ' GLU . . . -65.79 -37.16 85.54 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.974 0.416 . . . . 0.0 111.288 176.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 27.1 t 55.76 16.43 2.01 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 175.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 75.86 13.95 82.61 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 120.883 -0.675 . . . . 0.0 113.87 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -95.78 -36.65 11.08 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.268 0.556 . . . . 0.0 110.461 175.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.405 ' O ' ' HB1' ' A' ' 25' ' ' ALA . 26.3 mt-10 -137.44 142.74 41.6 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.926 -178.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.41 ' HE2' ' HA ' ' A' ' 35' ' ' TRP . 27.2 ttt -123.97 142.51 51.1 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.983 0.421 . . . . 0.0 111.667 -175.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -103.46 164.79 11.43 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -174.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -58.71 -32.27 69.25 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-N 115.725 -0.67 . . . . 0.0 113.7 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.522 ' HB2' ' HZ2' ' A' ' 33' ' ' LYS . 3.6 ttmp? -47.75 -61.9 1.72 Allowed 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 121.62 0.724 . . . . 0.0 111.395 176.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -79.81 -20.36 46.31 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.125 -175.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.41 ' HA ' ' HE2' ' A' ' 30' ' ' MET . 62.0 t-105 -69.91 -50.22 44.36 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 120.882 0.373 . . . . 0.0 111.218 177.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.13 -43.85 95.35 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-O 121.403 0.62 . . . . 0.0 110.203 174.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.405 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 41.3 tttm -57.16 -46.73 82.52 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.593 174.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.4 tt -51.91 -46.82 64.76 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 122.895 0.478 . . . . 0.0 111.057 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.704 ' SG ' HG11 ' A' ' 55' ' ' VAL . 73.7 m -56.29 -50.5 71.21 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.218 177.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -71.73 -28.99 64.04 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 121.113 0.482 . . . . 0.0 111.914 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.405 ' HB2' ' O ' ' A' ' 37' ' ' LYS . 5.8 t70 -75.37 -44.8 42.99 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.427 0.632 . . . . 0.0 111.158 -173.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 65.4 m -103.08 2.25 34.48 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.68 178.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp 62.36 34.95 15.34 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.321 0.581 . . . . 0.0 111.348 178.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 59.9 t -68.21 -42.21 84.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.443 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.09 91.91 2.12 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.266 0.555 . . . . 0.0 111.123 178.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.634 ' HB2' ' HG2' ' A' ' 86' ' ' ARG . 26.9 t70 -51.86 -26.61 10.44 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.72 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.11 -55.99 4.59 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 121.302 -0.475 . . . . 0.0 112.27 -177.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.506 ' NZ ' ' HB3' ' A' ' 48' ' ' LYS . 5.9 ttpm? -64.08 -32.97 74.73 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 121.124 0.487 . . . . 0.0 111.128 176.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 13.8 m -110.15 -19.47 13.02 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.52 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 5.8 p -160.3 113.88 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-O 121.005 0.431 . . . . 0.0 112.131 -176.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.4 ' O ' HG23 ' A' ' 55' ' ' VAL . 58.5 p -95.69 172.48 8.02 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 120.818 0.342 . . . . 0.0 111.768 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -51.65 -36.42 39.96 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-N 116.19 -0.459 . . . . 0.0 113.686 177.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.537 ' O ' HG13 ' A' ' 57' ' ' ILE . 21.6 p -62.06 -54.38 42.29 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.972 0.415 . . . . 0.0 110.234 177.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -58.2 -38.48 76.82 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.52 -176.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.704 HG11 ' SG ' ' A' ' 39' ' ' CYS . 88.6 t -58.21 -39.1 72.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.595 174.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -70.42 -36.17 73.86 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 121.296 0.57 . . . . 0.0 110.318 178.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.572 ' O ' ' HG3' ' A' ' 61' ' ' LYS . 8.7 mt -61.49 -46.43 96.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.578 176.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 89.7 t -60.91 -45.13 98.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-O 121.08 0.467 . . . . 0.0 110.73 177.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.522 ' O ' ' HB2' ' A' ' 63' ' ' LYS . 76.5 t80 -59.39 -30.92 68.78 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.874 175.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.552 ' HA ' ' HE3' ' A' ' 63' ' ' LYS . 67.8 m -82.5 -25.15 33.74 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.722 177.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.572 ' HG3' ' O ' ' A' ' 57' ' ' ILE . 95.4 mttt -66.47 -55.3 16.28 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 120.98 0.419 . . . . 0.0 111.338 177.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.537 ' HB ' ' HB3' ' A' ' 74' ' ' GLU . 27.6 m -83.72 6.99 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 CA-C-N 116.064 -0.516 . . . . 0.0 112.198 -177.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.552 ' HE3' ' HA ' ' A' ' 60' ' ' SER . 39.6 ttmt -78.01 143.86 37.17 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.766 -179.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -73.01 177.98 41.24 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 121.022 -0.609 . . . . 0.0 113.203 177.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -50.98 100.35 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -177.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 60.6 p 52.04 23.95 2.45 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.368 0.667 . . . . 0.0 112.335 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.454 ' O ' ' HD3' ' A' ' 63' ' ' LYS . . . -70.29 176.23 4.08 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -177.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.523 ' HG3' HG13 ' A' ' 69' ' ' VAL . 16.8 ptt180 -116.48 -9.48 11.43 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.523 HG13 ' HG3' ' A' ' 68' ' ' ARG . 33.1 m -136.57 172.18 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-O 121.084 0.469 . . . . 0.0 112.0 -178.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 37.8 pt -128.18 145.61 35.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.097 175.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 -79.92 158.89 26.54 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 120.736 0.303 . . . . 0.0 111.729 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.532 ' O ' ' HB3' ' A' ' 75' ' ' PHE . 30.1 t80 -48.4 -46.8 37.73 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -175.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 22.7 mp0 -60.81 -43.96 97.49 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 122.113 -0.367 . . . . 0.0 111.418 -178.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.537 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 32.5 mm-40 -71.96 -27.19 62.61 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.887 0.375 . . . . 0.0 111.078 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.532 ' HB3' ' O ' ' A' ' 72' ' ' TYR . 61.6 t80 -57.22 -39.67 75.93 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.396 0.617 . . . . 0.0 110.349 170.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.529 ' HG3' ' O ' ' A' ' 72' ' ' TYR . 32.3 mtpt -67.12 -35.62 80.14 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.825 177.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.429 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 15.1 tppt? -66.88 -39.65 87.54 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.346 0.593 . . . . 0.0 110.653 176.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.09 -46.47 90.51 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.807 174.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 79.4 mt -60.75 -32.32 71.62 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.114 174.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.429 ' HB3' ' O ' ' A' ' 77' ' ' LYS . 32.9 tt0 -56.66 -51.32 69.19 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 120.704 0.288 . . . . 0.0 110.934 177.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -61.68 -53.71 52.52 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.408 175.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 82.0 mt -54.21 -38.36 65.59 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -178.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.76 -52.16 40.61 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.907 0.384 . . . . 0.0 111.62 177.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 70.1 p -66.65 -16.14 63.98 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -90.5 -49.3 6.58 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 122.077 -0.39 . . . . 0.0 111.02 173.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.634 ' HG2' ' HB2' ' A' ' 46' ' ' ASP . 2.2 tmt_? -59.77 -51.2 70.78 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.003 0.43 . . . . 0.0 110.687 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -94.24 24.18 4.58 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.145 0.498 . . . . 0.0 111.923 -177.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 56.0 mttm 59.46 -179.81 0.08 Allowed 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.925 178.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -77.25 58.69 3.64 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 121.309 -0.472 . . . . 0.0 114.051 -175.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -98.43 -162.16 0.93 Allowed 'General case' 0 CA--C 1.543 0.697 0 O-C-N 122.618 -0.342 . . . . 0.0 110.634 176.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.417 ' HB3' ' HB3' ' A' ' 94' ' ' GLU . 28.5 t -56.28 120.56 7.79 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 122.182 -0.323 . . . . 0.0 111.402 176.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -57.59 -44.56 85.5 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.877 0.37 . . . . 0.0 111.373 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.5 mp0 -59.1 -50.01 75.68 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.933 177.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.417 ' HB3' ' HB3' ' A' ' 91' ' ' SER . 36.3 tt0 -58.25 -47.05 84.79 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.667 177.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.54 -36.73 83.54 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.917 0.389 . . . . 0.0 111.448 178.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -65.87 -42.75 89.96 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.83 178.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -60.94 -42.79 98.87 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.195 0.521 . . . . 0.0 110.591 175.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.541 ' O ' ' HB3' ' A' ' 101' ' ' GLN . . . -61.44 -49.34 77.24 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 179.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.1 tt -64.51 -33.37 62.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 O-C-N 121.886 -0.508 . . . . 0.0 110.937 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 97.6 m -66.12 -38.55 88.46 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.88 0.371 . . . . 0.0 110.581 172.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.541 ' HB3' ' O ' ' A' ' 98' ' ' ALA . 6.7 tt0 -54.95 -34.09 62.93 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 121.045 0.45 . . . . 0.0 111.409 174.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 75.6 mt -78.09 -36.68 47.81 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 112.694 0.628 . . . . 0.0 112.694 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 54.9 t -100.71 -49.73 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -172.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.17 134.34 56.9 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -174.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 68.66 33.39 76.03 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.292 -0.48 . . . . 0.0 113.037 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -142.91 133.71 25.37 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 122.922 0.489 . . . . 0.0 110.807 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.406 ' HA ' ' HD3' ' A' ' 108' ' ' PRO . 38.9 mt-10 -85.94 154.6 58.19 Favored Pre-proline 0 N--CA 1.474 0.767 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -175.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 107' ' ' GLU . 22.8 Cg_exo -65.9 84.64 0.24 Allowed 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 123.076 2.518 . . . . 0.0 112.866 176.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.784 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 174.715 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.9 mm . . . . . 0 CA--C 1.539 0.541 0 CA-C-O 121.122 0.487 . . . . 0.0 110.959 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.42 -38.45 66.28 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.18 -177.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -69.02 -26.69 74.52 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 121.144 -0.551 . . . . 0.0 113.257 177.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 50.7 tp -74.9 -51.29 14.21 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 122.523 -0.398 . . . . 0.0 110.882 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -62.33 -30.22 71.01 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.719 0.295 . . . . 0.0 111.047 176.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -63.56 -51.94 63.21 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.837 0.351 . . . . 0.0 110.377 175.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.5 m -62.78 -39.47 94.31 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.57 177.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -54.14 -51.66 63.57 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.862 0.363 . . . . 0.0 110.492 176.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.607 ' O ' HG12 ' A' ' 19' ' ' ILE . 81.6 mtt85 -63.26 -44.2 95.81 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.962 0.411 . . . . 0.0 111.232 175.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.657 ' HD2' ' HA ' ' A' ' 107' ' ' GLU . 26.9 ttmt -52.43 -34.32 48.03 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.414 -178.058 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -93.04 -38.8 11.44 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 116.167 -0.47 . . . . 0.0 112.098 173.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.07 -41.7 83.95 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -175.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.607 HG12 ' O ' ' A' ' 15' ' ' ARG . 46.5 pt -83.73 10.58 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -178.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 22.8 t60 -82.64 129.15 34.9 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 120.894 0.378 . . . . 0.0 110.8 177.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.408 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . 83.49 -49.29 4.2 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.548 -177.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -93.19 100.78 4.57 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-O 120.741 0.305 . . . . 0.0 111.242 175.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 21' ' ' GLY . 89.8 Cg_endo -76.85 4.64 5.52 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 122.584 2.189 . . . . 0.0 113.229 -177.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -113.83 4.26 15.82 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.708 0.29 . . . . 0.0 111.707 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.405 ' HB3' ' HA ' ' A' ' 19' ' ' ILE . . . -74.99 132.05 41.09 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.788 0.328 . . . . 0.0 111.72 -179.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.6 m -76.81 -36.05 57.19 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.865 0.364 . . . . 0.0 111.473 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.524 ' HA3' ' HG2' ' A' ' 15' ' ' ARG . . . 126.71 15.67 2.61 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 120.881 -0.676 . . . . 0.0 114.229 176.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -113.95 -7.84 13.13 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 117.228 0.514 . . . . 0.0 111.833 177.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -123.79 137.13 54.73 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 122.418 0.287 . . . . 0.0 110.995 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 51.2 ttm -133.54 137.43 45.55 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.867 0.365 . . . . 0.0 111.404 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 31.0 p30 -92.12 171.22 9.23 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.261 0.553 . . . . 0.0 112.267 -179.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.55 -29.1 72.57 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-N 115.885 -0.598 . . . . 0.0 113.603 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -60.13 -55.06 38.54 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.031 0.443 . . . . 0.0 111.356 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -69.99 -29.16 66.18 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.496 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 53.8 t-105 -61.59 -42.63 99.13 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.275 0.559 . . . . 0.0 110.605 173.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.61 -42.62 99.13 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.119 174.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.421 ' HE2' ' OD2' ' A' ' 41' ' ' ASP . 13.2 mmmm -61.87 -44.05 97.61 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.205 175.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.498 HD13 ' HE1' ' A' ' 75' ' ' PHE . 11.1 mt -48.83 -54.28 15.84 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 177.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 24.6 p -62.06 -45.88 91.57 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.664 -178.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.5 ttpm? -68.72 -49.2 60.82 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.074 0.464 . . . . 0.0 111.661 -176.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.421 ' OD2' ' HE2' ' A' ' 37' ' ' LYS . 12.4 m-20 -69.14 -38.37 78.78 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.563 -176.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.472 ' SG ' ' HA ' ' A' ' 103' ' ' VAL . 73.4 m -85.35 -4.04 59.03 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 176.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt 62.0 35.53 16.03 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.265 0.555 . . . . 0.0 112.284 175.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 41.7 t -80.04 -23.84 11.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.472 174.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -92.62 96.92 10.48 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.574 179.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -56.73 -30.43 63.52 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.946 0.403 . . . . 0.0 111.532 178.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 98.04 -48.63 1.43 Allowed Glycine 0 CA--C 1.524 0.63 0 C-N-CA 121.536 -0.364 . . . . 0.0 112.655 -178.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -84.87 -21.11 29.9 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.965 0.412 . . . . 0.0 111.704 178.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 78.7 p -113.7 -72.53 0.7 Allowed 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.957 0.408 . . . . 0.0 110.551 176.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 59.3 t -88.14 122.03 39.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.172 174.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.408 ' O ' HG23 ' A' ' 55' ' ' VAL . 5.5 t -140.6 178.56 7.24 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.416 -176.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -44.83 -52.36 7.82 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 114.189 0.436 . . . . 0.0 114.189 -175.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.597 ' O ' HG12 ' A' ' 57' ' ' ILE . 84.7 m -57.88 -51.67 68.65 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 122.561 -0.376 . . . . 0.0 111.303 177.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -55.86 -42.99 76.68 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 121.263 0.554 . . . . 0.0 111.123 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 51' ' ' THR . 83.7 t -65.8 -29.19 46.18 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.562 177.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -78.05 -33.84 50.73 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.592 0.711 . . . . 0.0 109.732 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.597 HG12 ' O ' ' A' ' 53' ' ' THR . 11.0 mm -64.13 -47.36 90.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.684 175.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.537 ' HA ' ' HD2' ' A' ' 61' ' ' LYS . 80.8 t -57.63 -45.91 86.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.323 175.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -57.36 -43.35 83.42 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.145 0.498 . . . . 0.0 110.579 174.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 23.0 t -65.48 -34.36 78.08 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.766 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.537 ' HD2' ' HA ' ' A' ' 58' ' ' VAL . 64.6 mttm -58.75 -51.96 67.74 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.333 0.587 . . . . 0.0 111.308 176.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.515 ' HB ' ' HB3' ' A' ' 74' ' ' GLU . 25.9 m -84.31 -6.6 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.039 -177.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.42 ' NZ ' ' HB3' ' A' ' 63' ' ' LYS . 6.3 ttpm? -65.69 153.55 41.38 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 120.922 0.392 . . . . 0.0 111.83 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -79.37 -161.46 21.87 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.683 175.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -62.38 -38.63 90.36 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 122.48 -0.424 . . . . 0.0 111.918 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 21.2 t -154.08 17.44 0.49 Allowed 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 120.824 0.345 . . . . 0.0 111.235 177.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.06 138.81 58.56 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -179.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 62.4 mtt180 -94.12 -8.58 39.15 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.232 178.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 36.0 m -132.17 152.03 35.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.807 -178.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.494 HG21 HG23 ' A' ' 62' ' ' VAL . 35.2 pt -117.58 151.63 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.087 176.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -100.38 173.03 6.78 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -177.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.501 ' O ' ' HB3' ' A' ' 75' ' ' PHE . 34.5 t80 -53.17 -50.65 64.18 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -170.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -63.43 -42.82 98.71 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -176.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.515 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 0.8 OUTLIER -69.93 -30.72 68.18 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.984 0.421 . . . . 0.0 110.537 176.653 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.501 ' HB3' ' O ' ' A' ' 72' ' ' TYR . 50.5 t80 -58.53 -43.25 89.14 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.163 0.506 . . . . 0.0 110.55 171.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.486 ' HG3' ' O ' ' A' ' 72' ' ' TYR . 55.2 mtpt -60.95 -40.14 92.17 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.7 175.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.401 ' HD3' ' HA ' ' A' ' 77' ' ' LYS . 72.1 mmtt -70.01 -28.26 65.36 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.528 175.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.85 -42.74 80.91 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.036 0.446 . . . . 0.0 110.546 173.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 79.9 mt -64.71 -41.72 95.79 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.716 173.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -56.95 -45.07 83.07 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.319 0.58 . . . . 0.0 110.665 174.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.418 ' O ' ' HG3' ' A' ' 85' ' ' LYS . 16.4 tp10 -58.65 -59.82 4.79 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.029 176.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.409 ' O ' ' HG3' ' A' ' 86' ' ' ARG . 87.6 mt -56.13 -36.69 68.51 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.556 178.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.99 -58.31 9.23 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.72 -0.218 . . . . 0.0 111.276 177.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 80.5 p -53.79 -33.8 57.12 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.418 ' HG3' ' O ' ' A' ' 81' ' ' GLU . 7.2 mtpm? -72.71 -35.62 67.62 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.518 178.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.409 ' HG3' ' O ' ' A' ' 82' ' ' LEU . 48.1 mtp180 -96.82 -65.91 0.94 Allowed 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 120.88 0.372 . . . . 0.0 111.528 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.41 ' HB2' ' HB1' ' A' ' 95' ' ' ALA . 51.7 m-85 -87.37 111.63 21.3 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.859 0.361 . . . . 0.0 110.436 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 15.5 pttm -141.93 31.64 1.6 Allowed 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -171.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -78.85 43.04 2.35 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 120.97 -0.634 . . . . 0.0 113.182 175.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.5 ttpp 72.04 -45.92 0.63 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.036 0.935 . . . . 0.0 112.964 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.4 m -72.62 110.4 6.95 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 122.071 -0.393 . . . . 0.0 111.759 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -81.62 -34.52 30.85 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 178.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -47.12 -70.55 0.09 Allowed 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 120.994 0.426 . . . . 0.0 111.409 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -66.64 -28.82 68.78 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -177.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.41 ' HB1' ' HB2' ' A' ' 87' ' ' PHE . . . -59.2 -42.88 91.95 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.307 0.575 . . . . 0.0 110.696 174.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -68.16 -40.3 82.37 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.539 176.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -57.78 -40.31 79.52 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.791 0.329 . . . . 0.0 111.513 174.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.574 ' O ' ' HB3' ' A' ' 101' ' ' GLN . . . -63.8 -47.45 80.81 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.036 0.446 . . . . 0.0 112.093 -178.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.9 tt -70.46 -31.14 45.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 O-C-N 121.998 -0.439 . . . . 0.0 110.752 178.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 84.8 m -68.06 -33.88 75.4 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.788 0.328 . . . . 0.0 110.613 171.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.574 ' HB3' ' O ' ' A' ' 98' ' ' ALA . 28.2 tt0 -56.53 -39.93 74.22 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.284 0.564 . . . . 0.0 110.526 173.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 88.8 mt -68.18 -39.15 82.59 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.405 176.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.472 ' HA ' ' SG ' ' A' ' 42' ' ' CYS . 67.7 t -93.53 -59.08 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -174.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -51.28 125.02 13.03 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 112.546 0.572 . . . . 0.0 112.546 -177.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.67 -42.13 2.81 Favored Glycine 0 CA--C 1.528 0.869 0 CA-C-N 116.172 -0.467 . . . . 0.0 112.745 -177.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -51.44 132.64 29.8 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -176.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.657 ' HA ' ' HD2' ' A' ' 16' ' ' LYS . 10.4 pt-20 -95.76 155.05 38.91 Favored Pre-proline 0 CA--C 1.542 0.657 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.902 174.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -56.87 130.14 38.27 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.545 2.163 . . . . 0.0 113.025 -178.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.737 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.224 -177.045 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 48.3 mm . . . . . 0 CA--C 1.538 0.51 0 CA-C-O 120.749 0.309 . . . . 0.0 110.709 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.94 -47.97 81.32 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -178.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.05 -29.83 59.88 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 121.1 -0.572 . . . . 0.0 113.047 177.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 50.6 tp -71.78 -45.1 62.7 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.778 0.323 . . . . 0.0 110.705 177.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -59.08 -46.72 87.57 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.017 0.437 . . . . 0.0 111.282 177.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.557 ' HG3' ' HE2' ' A' ' 16' ' ' LYS . 14.1 tp10 -56.91 -47.59 80.21 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.128 179.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.5 m -64.35 -42.44 96.23 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.795 177.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -53.97 -46.06 71.54 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.265 176.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.55 ' O ' HG12 ' A' ' 19' ' ' ILE . 94.5 mtt180 -59.28 -55.74 30.97 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.61 176.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.557 ' HE2' ' HG3' ' A' ' 12' ' ' GLU . 50.4 mttm -55.43 -32.5 62.76 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -175.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.713 ' HB3' ' HE3' ' A' ' 30' ' ' MET . 11.7 m-85 -81.68 -48.65 11.42 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 122.192 -0.317 . . . . 0.0 111.443 173.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.474 ' HA ' ' HG3' ' A' ' 30' ' ' MET . . . -55.39 -40.47 71.43 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -177.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.55 HG12 ' O ' ' A' ' 15' ' ' ARG . 16.6 pt -99.41 12.82 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 121.426 0.631 . . . . 0.0 110.957 -177.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 37.4 t-80 -58.64 92.93 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.014 -176.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.73 -6.3 57.1 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 121.11 -0.567 . . . . 0.0 113.376 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -134.9 92.85 18.27 Favored Pre-proline 0 CA--C 1.539 0.552 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -63.6 -12.95 33.66 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.348 2.032 . . . . 0.0 111.667 170.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -96.05 7.24 46.93 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.174 178.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.6 -97.25 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -176.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 59.1 m -164.12 -72.05 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 120.913 0.387 . . . . 0.0 111.092 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.59 -31.44 5.57 Favored Glycine 0 N--CA 1.464 0.537 0 C-N-CA 121.185 -0.531 . . . . 0.0 112.052 179.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -100.74 -11.97 19.49 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 120.663 0.268 . . . . 0.0 111.435 174.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -126.5 140.14 52.68 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.827 178.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.713 ' HE3' ' HB3' ' A' ' 17' ' ' PHE . 26.7 ttt -126.15 148.4 49.41 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.765 -173.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.403 ' OD1' ' HB3' ' A' ' 33' ' ' LYS . 10.4 p30 -98.15 174.9 6.3 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 120.933 0.396 . . . . 0.0 111.964 -177.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.4 -26.13 64.24 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 121.368 -0.444 . . . . 0.0 114.119 -176.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.403 ' HB3' ' OD1' ' A' ' 31' ' ' ASN . 39.2 ttpt -63.83 -58.05 8.01 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 122.385 -0.479 . . . . 0.0 111.65 -177.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -74.03 -18.7 60.81 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 120.753 0.311 . . . . 0.0 111.603 178.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.45 ' NE1' HG12 ' A' ' 55' ' ' VAL . 58.8 t-105 -65.75 -47.6 74.69 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 121.142 0.496 . . . . 0.0 110.927 172.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.34 -36.97 79.21 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.181 0.515 . . . . 0.0 110.771 174.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 25.2 tptp -66.57 -44.73 81.46 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.842 176.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.429 HD12 ' HE1' ' A' ' 30' ' ' MET . 5.0 tt -53.86 -56.44 17.59 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.625 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.721 ' HA ' ' SG ' ' A' ' 42' ' ' CYS . 23.9 p -64.45 -32.64 74.35 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.694 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 50.5 tptt -72.7 -36.7 67.89 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 120.589 0.233 . . . . 0.0 111.481 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -73.45 -40.09 64.44 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 120.614 0.245 . . . . 0.0 111.473 177.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.721 ' SG ' ' HA ' ' A' ' 39' ' ' CYS . 27.6 p -79.27 -4.72 52.07 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.403 0.62 . . . . 0.0 110.386 172.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 22.4 mtpp 57.51 23.4 9.11 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.147 -0.933 . . . . 0.0 113.463 173.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.563 HG23 ' SG ' ' A' ' 42' ' ' CYS . 93.9 t -57.08 -42.9 80.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 168.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.599 ' HB2' HG21 ' A' ' 55' ' ' VAL . . . -86.59 65.86 9.22 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.637 177.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -155.62 11.09 0.31 Allowed 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.316 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -92.22 37.17 3.45 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 114.683 0.633 . . . . 0.0 114.683 -170.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt 54.2 13.29 0.58 Allowed 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 117.402 0.601 . . . . 0.0 112.337 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 42.8 t -156.75 -57.03 0.09 Allowed 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.277 0.561 . . . . 0.0 109.578 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.461 HG22 ' HB3' ' A' ' 85' ' ' LYS . 9.3 t -70.88 110.24 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.59 170.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.423 ' H ' ' HB3' ' A' ' 54' ' ' ASP . 68.5 p -135.67 176.1 8.99 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.004 -177.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -48.19 -42.66 24.77 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 121.339 -0.458 . . . . 0.0 113.468 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.578 ' O ' HG12 ' A' ' 57' ' ' ILE . 99.0 m -64.41 -51.18 64.49 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 122.506 -0.408 . . . . 0.0 111.243 177.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.423 ' HB3' ' H ' ' A' ' 51' ' ' THR . 37.1 t70 -56.94 -39.26 74.21 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.17 0.509 . . . . 0.0 111.18 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.599 HG21 ' HB2' ' A' ' 45' ' ' ALA . 64.0 t -72.68 -23.89 21.13 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.684 178.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -79.14 -32.51 44.42 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.601 0.715 . . . . 0.0 109.565 178.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.578 HG12 ' O ' ' A' ' 53' ' ' THR . 16.1 mm -58.51 -47.99 86.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.276 171.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 55.5 t -60.45 -42.85 92.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.849 175.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -57.21 -39.99 76.56 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.083 0.468 . . . . 0.0 110.64 174.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 33.5 t -69.4 -35.82 76.16 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.941 177.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.425 ' HG2' ' O ' ' A' ' 57' ' ' ILE . 11.9 mmmm -61.29 -31.44 71.27 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.234 0.54 . . . . 0.0 111.535 177.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.533 HG21 ' HB2' ' A' ' 78' ' ' ALA . 20.0 m -113.11 20.82 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.943 -178.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.506 ' HA ' HG22 ' A' ' 70' ' ' ILE . 40.1 ttmt -73.84 123.17 23.68 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 120.895 0.379 . . . . 0.0 111.991 -178.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -57.74 86.66 0.01 OUTLIER Glycine 0 CA--C 1.529 0.928 0 CA-C-N 116.057 -0.52 . . . . 0.0 113.121 176.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 61.3 mttm 64.95 -78.33 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.275 0.63 . . . . 0.0 111.464 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 81.1 p -146.54 3.93 0.88 Allowed 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.447 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -69.82 151.04 46.2 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -173.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.542 ' HG3' HG13 ' A' ' 69' ' ' VAL . 1.8 ptm180 -73.13 -6.98 49.27 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.187 174.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.542 HG13 ' HG3' ' A' ' 68' ' ' ARG . 30.6 m -125.71 142.84 41.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-O 121.113 0.482 . . . . 0.0 112.221 -178.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.506 HG22 ' HA ' ' A' ' 63' ' ' LYS . 35.3 pt -113.3 151.49 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.595 176.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -86.9 169.83 12.16 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.075 0.464 . . . . 0.0 111.868 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.438 ' O ' ' HB3' ' A' ' 75' ' ' PHE . 86.9 t80 -52.07 -38.36 56.93 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -175.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.484 ' O ' ' HG3' ' A' ' 77' ' ' LYS . 33.7 tt0 -70.14 -41.36 73.99 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.445 -0.784 . . . . 0.0 110.765 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -64.78 -33.28 75.61 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.248 0.547 . . . . 0.0 110.341 177.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.438 ' HB3' ' O ' ' A' ' 72' ' ' TYR . 67.7 t80 -55.86 -46.35 78.25 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.987 171.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 23.0 mtmt -64.36 -39.37 93.74 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.886 0.374 . . . . 0.0 111.455 176.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.484 ' HG3' ' O ' ' A' ' 73' ' ' GLU . 60.7 mttm -60.18 -39.83 87.85 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.314 0.578 . . . . 0.0 110.363 176.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.533 ' HB2' HG21 ' A' ' 62' ' ' VAL . . . -63.53 -46.88 83.98 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.136 176.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 86.2 mt -58.61 -34.17 70.84 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.86 0.362 . . . . 0.0 111.228 175.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.457 ' HB3' ' O ' ' A' ' 77' ' ' LYS . 10.4 tp10 -55.47 -59.82 4.29 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.533 0.682 . . . . 0.0 110.838 176.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.58 ' O ' ' HG2' ' A' ' 85' ' ' LYS . 47.2 mt-10 -61.18 -47.98 83.65 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.409 178.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 69.5 mt -56.8 -33.75 67.0 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 178.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.36 -48.58 81.12 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 120.906 0.384 . . . . 0.0 110.86 175.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 31.0 p -72.72 -8.56 56.0 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 116.194 -0.457 . . . . 0.0 112.072 177.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.58 ' HG2' ' O ' ' A' ' 81' ' ' GLU . 73.1 mmtt -79.82 -51.58 8.97 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.133 0.492 . . . . 0.0 110.697 174.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 8.2 mmt180 -82.55 -58.07 3.07 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -178.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -86.59 56.88 4.2 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -170.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 66.3 mttm 61.81 175.85 0.12 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.357 0.599 . . . . 0.0 111.989 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -96.87 29.53 10.41 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.669 176.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -143.44 169.19 18.14 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 122.75 0.42 . . . . 0.0 110.861 -178.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 46.4 t 55.62 47.0 21.66 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.153 0.502 . . . . 0.0 111.529 177.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.469 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 22.0 pttp -64.19 -20.22 65.87 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -174.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -63.08 -59.53 4.67 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.296 0.57 . . . . 0.0 109.871 172.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -57.3 -43.75 83.49 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.452 175.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.469 ' HB3' ' HA ' ' A' ' 92' ' ' LYS . . . -58.51 -46.2 87.24 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.026 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -61.04 -53.79 52.81 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.944 0.402 . . . . 0.0 111.212 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -57.15 -37.9 72.75 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 120.808 0.337 . . . . 0.0 111.842 176.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.24 -49.82 68.2 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -179.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 12.5 tt -63.7 -39.94 87.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-O 121.111 0.481 . . . . 0.0 110.874 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 36.5 t -61.3 -39.33 90.07 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.037 0.446 . . . . 0.0 110.927 174.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -60.75 -39.35 88.39 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.677 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 93.1 mt -66.8 -36.02 81.41 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.706 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 49.9 t -83.15 -37.07 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -178.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -57.21 104.09 0.15 Allowed 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -174.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 94.81 13.56 52.83 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-N 116.154 -0.475 . . . . 0.0 113.678 174.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 46.2 tttp -86.3 161.35 18.79 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.973 0.416 . . . . 0.0 111.273 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -73.28 136.11 78.99 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.777 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.61 73.46 2.3 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.468 2.112 . . . . 0.0 112.015 175.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.49 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.781 -175.149 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.7 tp . . . . . 0 CA--C 1.544 0.713 0 CA-C-O 120.895 0.378 . . . . 0.0 110.925 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -49.49 -37.67 27.28 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -176.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.35 -29.92 60.87 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 121.417 -0.42 . . . . 0.0 113.74 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 30.9 tp -73.75 -48.38 32.18 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 122.324 -0.515 . . . . 0.0 111.031 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -65.87 -30.05 70.59 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.766 0.317 . . . . 0.0 110.642 176.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -59.27 -55.24 37.33 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.743 0.306 . . . . 0.0 110.444 174.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.7 m -57.94 -42.28 84.54 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.236 176.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -55.73 -56.07 24.87 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.875 0.369 . . . . 0.0 111.064 176.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 57.3 ttt180 -56.19 -51.13 69.14 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.396 0.617 . . . . 0.0 110.87 177.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -52.91 -37.11 60.36 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 114.903 -1.044 . . . . 0.0 112.213 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -85.51 -32.51 22.17 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.697 176.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.76 -39.61 65.51 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -175.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.522 HD13 ' H ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -103.74 7.45 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -178.927 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 60.0 t60 -35.46 -48.7 0.5 Allowed 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -174.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -138.27 22.44 3.06 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 120.286 -0.959 . . . . 0.0 113.604 -178.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.573 ' HB2' ' HB2' ' A' ' 25' ' ' ALA . 8.9 m-20 -121.55 118.7 29.6 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 116.886 0.343 . . . . 0.0 110.863 -176.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -46.02 -46.49 15.95 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 123.406 2.737 . . . . 0.0 114.102 -176.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -105.29 -34.09 7.99 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.703 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.573 ' HB2' ' HB2' ' A' ' 22' ' ' ASP . . . 36.99 -90.11 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -172.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 28.0 t 167.76 -45.36 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.825 0.85 . . . . 0.0 110.099 -174.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 88.28 -52.18 4.04 Favored Glycine 0 C--N 1.334 0.462 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.257 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 20.4 tp60 -91.26 -13.26 33.04 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 120.818 0.342 . . . . 0.0 111.376 178.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -128.03 143.99 51.09 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.788 175.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 49.2 ttm -115.24 143.39 45.32 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.285 0.564 . . . . 0.0 112.324 -175.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.48 HD22 ' HB2' ' A' ' 33' ' ' LYS . 0.8 OUTLIER -93.78 154.75 17.59 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.892 175.23 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -55.52 -26.64 45.92 Favored Glycine 0 CA--C 1.53 0.97 0 CA-C-N 116.122 -0.49 . . . . 0.0 114.104 -176.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.48 ' HB2' HD22 ' A' ' 31' ' ' ASN . 91.1 mttt -51.07 -60.86 2.65 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 122.026 0.917 . . . . 0.0 110.809 175.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 63.4 m-20 -73.1 -33.97 65.9 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 114.51 -1.223 . . . . 0.0 111.553 -174.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 41.1 t-105 -58.62 -45.21 89.7 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.054 0.454 . . . . 0.0 111.341 174.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.518 ' HA ' HG11 ' A' ' 55' ' ' VAL . . . -60.52 -47.99 83.74 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 120.974 0.416 . . . . 0.0 111.337 176.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -60.7 -37.32 81.26 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.492 176.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.3 tt -59.23 -45.42 91.18 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.336 178.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.665 ' SG ' ' HB ' ' A' ' 44' ' ' VAL . 44.4 t -54.33 -44.41 72.07 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.945 0.402 . . . . 0.0 111.038 175.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.535 ' NZ ' ' HB3' ' A' ' 40' ' ' LYS . 4.5 ttpm? -58.98 -54.64 44.8 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.746 176.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -65.55 -35.77 81.84 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -175.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.571 ' SG ' ' HB3' ' A' ' 102' ' ' LEU . 6.0 t -77.84 -9.87 59.27 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 120.799 0.333 . . . . 0.0 111.452 173.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm 69.05 26.95 5.48 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.197 0.599 . . . . 0.0 112.139 174.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.665 ' HB ' ' SG ' ' A' ' 39' ' ' CYS . 60.1 t -68.15 -35.77 72.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 121.054 0.454 . . . . 0.0 111.212 178.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.63 100.39 7.8 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.007 0.432 . . . . 0.0 111.683 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -99.91 -25.67 14.26 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.679 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 134.89 -78.99 0.33 Allowed Glycine 0 CA--C 1.529 0.921 0 C-N-CA 120.964 -0.636 . . . . 0.0 113.624 178.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -92.06 -7.32 49.06 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -174.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.4 t -102.35 -49.55 3.85 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.181 0.515 . . . . 0.0 110.041 173.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.457 HG11 HG12 ' A' ' 44' ' ' VAL . 99.1 t -139.65 130.94 33.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.948 176.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.459 ' O ' HG23 ' A' ' 55' ' ' VAL . 8.9 t -139.19 -177.86 5.1 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 116.766 -0.197 . . . . 0.0 110.68 173.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -46.19 -46.46 15.75 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 121.579 -0.344 . . . . 0.0 113.847 -177.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.54 ' O ' HG12 ' A' ' 57' ' ' ILE . 41.6 m -51.52 -54.81 23.4 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.035 0.445 . . . . 0.0 111.517 176.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -58.93 -34.56 71.86 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.392 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.518 HG11 ' HA ' ' A' ' 36' ' ' ALA . 65.5 t -60.21 -35.72 63.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.286 177.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -74.48 -38.5 62.9 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.562 0.696 . . . . 0.0 110.17 178.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.54 HG12 ' O ' ' A' ' 53' ' ' THR . 12.1 mm -61.41 -51.82 68.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.903 178.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 87.8 t -57.69 -41.87 80.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-O 120.912 0.387 . . . . 0.0 111.125 177.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -56.76 -42.26 79.06 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 120.915 0.388 . . . . 0.0 110.563 175.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.403 ' HA ' ' HE3' ' A' ' 63' ' ' LYS . 47.6 t -69.33 -36.76 77.26 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.392 177.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.534 ' HG2' ' O ' ' A' ' 57' ' ' ILE . 1.8 mmmp? -56.33 -35.67 67.86 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.875 0.369 . . . . 0.0 111.261 178.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.506 HG21 ' HB2' ' A' ' 78' ' ' ALA . 22.4 m -107.42 -2.7 10.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -177.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.403 ' HE3' ' HA ' ' A' ' 60' ' ' SER . 26.3 ttpp -70.74 101.5 2.1 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.024 0.44 . . . . 0.0 112.142 -178.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -133.98 -146.9 5.55 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-N 116.216 -0.447 . . . . 0.0 113.285 177.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 62.1 mttp 53.37 -103.05 0.15 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.842 0.457 . . . . 0.0 112.031 -176.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 88.0 p -109.0 -1.87 18.63 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.735 0.302 . . . . 0.0 110.899 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 66.0 -168.89 0.2 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.641 -177.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 20.3 tpp180 73.06 -51.56 0.71 Allowed 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.375 0.607 . . . . 0.0 111.034 -176.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 12.6 m -132.51 149.07 31.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.862 -178.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 37.5 pt -113.13 140.6 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-O 120.668 0.271 . . . . 0.0 111.113 177.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -85.37 177.73 7.7 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.9 -0.5 . . . . 0.0 111.341 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -55.1 -37.05 66.35 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -177.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.572 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 42.5 mt-10 -61.08 -53.34 58.34 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.189 0.519 . . . . 0.0 111.497 177.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -69.43 -20.77 63.77 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.243 0.544 . . . . 0.0 110.791 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -69.84 -54.87 11.56 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.959 173.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.572 ' HE2' ' HA ' ' A' ' 73' ' ' GLU . 63.8 pttt -62.54 -30.4 71.27 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.091 0.472 . . . . 0.0 110.533 177.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -64.42 -40.56 96.0 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.851 173.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.506 ' HB2' HG21 ' A' ' 62' ' ' VAL . . . -67.73 -38.73 83.95 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.03 0.443 . . . . 0.0 111.374 175.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 80.7 mt -59.98 -41.09 91.23 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.103 176.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -60.29 -42.49 95.58 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 120.664 0.269 . . . . 0.0 111.021 176.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -54.14 -62.81 1.42 Allowed 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.041 0.448 . . . . 0.0 110.769 174.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.537 HD13 HG11 ' A' ' 44' ' ' VAL . 90.5 mt -52.43 -43.98 65.18 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.434 178.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.13 -54.33 47.17 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.85 -0.613 . . . . 0.0 112.21 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.461 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 63.4 p -64.18 -20.55 66.09 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -177.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -96.72 -23.1 16.59 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 65.5 mtp85 -97.1 -50.63 4.52 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 121.797 -0.564 . . . . 0.0 111.744 175.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -86.75 31.45 0.69 Allowed 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.029 0.442 . . . . 0.0 111.331 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.461 ' HB3' ' O ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -71.63 172.55 9.47 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -177.857 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 78.62 24.36 62.85 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 121.063 -0.589 . . . . 0.0 113.183 -178.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -168.86 -168.75 0.9 Allowed 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 120.826 0.346 . . . . 0.0 111.155 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 65.8 m -56.07 120.72 7.94 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -177.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -55.96 -33.21 64.56 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.321 175.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -54.76 -56.11 22.8 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.204 0.526 . . . . 0.0 110.97 174.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -63.91 -29.75 70.9 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.537 -178.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.53 -57.44 12.67 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.961 0.41 . . . . 0.0 111.017 176.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.523 ' O ' HG22 ' A' ' 99' ' ' ILE . 80.8 t80 -64.94 -35.99 82.95 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.218 0.532 . . . . 0.0 110.791 177.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -55.08 -47.5 74.8 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.461 0.648 . . . . 0.0 111.052 176.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -71.78 -42.08 67.57 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.518 -177.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.523 HG22 ' O ' ' A' ' 96' ' ' PHE . 7.3 tp -61.62 -34.02 60.01 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 CA-C-O 121.351 0.596 . . . . 0.0 110.214 178.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 35.8 t -64.67 -42.71 95.19 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.946 173.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -55.41 -35.12 65.01 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.123 0.487 . . . . 0.0 111.846 176.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.571 ' HB3' ' SG ' ' A' ' 42' ' ' CYS . 97.5 mt -73.29 -48.02 37.97 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 49.1 t -86.67 -53.59 9.93 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -173.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.22 127.39 24.27 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -171.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.59 -39.32 3.1 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-N 116.035 -0.529 . . . . 0.0 113.841 176.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 58.9 tttp -63.05 162.19 11.94 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-O 121.504 0.668 . . . . 0.0 112.799 -174.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.463 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 0.3 OUTLIER -124.48 161.94 45.2 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.679 175.019 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.463 ' HD2' ' HB2' ' A' ' 107' ' ' GLU . 19.0 Cg_endo -58.17 155.69 33.33 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.515 2.143 . . . . 0.0 112.922 176.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.56 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -179.105 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.522 ' HB ' ' HB2' ' A' ' 10' ' ' LEU . 42.6 mm . . . . . 0 CA--C 1.545 0.755 0 CA-C-O 120.629 0.252 . . . . 0.0 111.512 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 72.37 -58.93 0.58 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.463 0.705 . . . . 0.0 110.812 -175.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -63.79 -16.73 59.61 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 120.955 -0.641 . . . . 0.0 112.393 172.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.522 ' HB2' ' HB ' ' A' ' 7' ' ' ILE . 53.7 tp -70.95 -54.7 10.41 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 122.693 -0.298 . . . . 0.0 111.198 178.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.462 ' HG3' ' N ' ' A' ' 12' ' ' GLU . 7.7 pt-20 -61.33 -42.22 98.32 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.788 0.328 . . . . 0.0 110.82 177.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.462 ' N ' ' HG3' ' A' ' 11' ' ' GLU . 1.7 tm-20 -64.5 -34.24 77.75 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-O 120.962 0.411 . . . . 0.0 110.921 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.2 t -72.4 -44.12 62.93 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 120.744 0.307 . . . . 0.0 111.143 176.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -56.1 -50.5 70.87 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.141 0.496 . . . . 0.0 110.067 175.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.489 ' O ' HG12 ' A' ' 19' ' ' ILE . 11.2 ttt85 -53.55 -43.04 68.13 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.706 172.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.436 ' HB2' ' HE2' ' A' ' 16' ' ' LYS . 9.6 tppt? -54.0 -46.21 71.68 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.053 0.454 . . . . 0.0 111.581 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -79.93 -33.63 39.53 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 177.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.13 -38.41 91.08 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.893 0.377 . . . . 0.0 111.781 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.489 HG12 ' O ' ' A' ' 15' ' ' ARG . 23.8 pt -83.26 -7.86 11.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 121.016 0.436 . . . . 0.0 111.689 178.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -64.69 86.7 0.05 Allowed 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.295 0.569 . . . . 0.0 110.748 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 142.02 -40.25 1.31 Allowed Glycine 0 CA--C 1.524 0.613 0 CA-C-N 115.685 -0.688 . . . . 0.0 112.048 -178.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -128.63 111.39 19.09 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-O 120.727 0.298 . . . . 0.0 110.806 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.46 -0.19 9.83 Favored 'Trans proline' 0 CA--C 1.546 1.079 0 C-N-CA 122.5 2.133 . . . . 0.0 114.425 -176.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.419 ' HE2' ' HB2' ' A' ' 24' ' ' LYS . 2.8 mppt? -100.35 -28.38 12.98 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 121.855 -0.528 . . . . 0.0 111.04 178.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.69 134.96 55.17 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 43.1 m -65.54 -35.21 80.19 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.73 178.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.07 45.88 2.52 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-N 116.203 -0.453 . . . . 0.0 113.81 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -103.56 -16.32 15.56 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 122.374 -0.486 . . . . 0.0 111.326 179.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -136.56 154.23 50.76 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.008 -174.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 49.1 ttm -143.6 143.59 31.56 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 120.92 0.39 . . . . 0.0 112.003 -174.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 23.5 p30 -90.09 166.02 13.66 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.063 0.459 . . . . 0.0 111.52 177.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.42 -20.31 61.0 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 121.251 -0.499 . . . . 0.0 113.236 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.433 ' HA ' ' HD3' ' A' ' 33' ' ' LYS . 41.1 mmtm -69.07 -55.38 10.95 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.729 0.3 . . . . 0.0 111.619 177.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -65.67 -34.78 79.02 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.156 176.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 41.2 t-105 -62.45 -48.28 80.34 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 122.602 0.361 . . . . 0.0 111.597 175.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.46 -46.48 89.94 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.117 0.484 . . . . 0.0 111.112 177.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 57.6 tttp -64.46 -35.03 79.62 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.975 178.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.3 tt -59.16 -45.06 91.98 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.311 175.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 73.9 m -60.08 -46.01 91.0 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.407 177.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -60.33 -52.43 65.3 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.578 0.228 . . . . 0.0 111.586 177.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -53.66 -41.68 67.09 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.102 0.477 . . . . 0.0 111.012 177.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.703 ' SG ' ' HA ' ' A' ' 103' ' ' VAL . 58.7 m -89.73 1.09 56.52 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.983 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp 55.56 33.25 20.74 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 122.88 0.472 . . . . 0.0 112.104 177.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.46 ' HA ' ' NH1' ' A' ' 86' ' ' ARG . 55.5 t -72.69 -29.52 30.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.735 178.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -97.36 102.54 14.33 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.815 0.341 . . . . 0.0 111.778 -179.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -57.59 -50.46 73.05 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.484 0.659 . . . . 0.0 112.194 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.02 -16.72 60.62 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 -166.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.42 ' HB3' ' NZ ' ' A' ' 48' ' ' LYS . 6.8 ttpm? -96.44 -64.09 1.08 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.239 0.616 . . . . 0.0 110.618 176.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 45.6 p -95.75 -66.53 0.9 Allowed 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.692 177.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 52.3 t -82.92 98.9 5.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 170.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 80.9 p -89.65 -84.54 0.22 Allowed 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -169.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -152.89 -39.05 0.03 OUTLIER Glycine 0 C--O 1.236 0.229 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.651 ' O ' HG13 ' A' ' 57' ' ' ILE . 26.9 p -48.95 -53.96 17.58 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.012 0.434 . . . . 0.0 109.911 172.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.504 ' O ' HG23 ' A' ' 58' ' ' VAL . 6.2 m-20 -48.43 -49.17 36.25 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.231 -175.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.3 t -60.5 -40.08 83.21 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.277 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -75.35 -43.74 48.94 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.582 0.706 . . . . 0.0 110.196 -176.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.651 HG13 ' O ' ' A' ' 53' ' ' THR . 8.0 mt -62.49 -45.24 99.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.117 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 54' ' ' ASP . 79.4 t -59.66 -41.88 86.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-O 120.554 0.216 . . . . 0.0 111.183 176.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.43 ' O ' ' HG3' ' A' ' 63' ' ' LYS . 76.1 t80 -55.2 -40.93 71.35 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.898 0.38 . . . . 0.0 111.5 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 51.6 p -80.77 -34.13 34.44 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.206 0.527 . . . . 0.0 110.998 177.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 55.3 tttp -65.81 -31.3 72.19 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.234 -174.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.7 m -88.33 -3.7 9.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.582 ' HD3' ' O ' ' A' ' 66' ' ' SER . 96.7 mttt -72.12 163.28 28.18 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -178.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -105.07 -98.92 2.57 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.981 176.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -80.08 75.46 6.84 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 122.44 -0.447 . . . . 0.0 111.132 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.582 ' O ' ' HD3' ' A' ' 63' ' ' LYS . 55.0 m 59.76 -79.09 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 122.334 0.254 . . . . 0.0 110.819 -175.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 64.28 129.3 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 114.09 1.144 . . . . 0.0 114.09 173.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.2 ptm85 -81.95 -21.67 37.1 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.255 173.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 28.3 m -136.41 151.72 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.076 -178.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 39.4 pt -99.6 161.46 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-O 120.589 0.233 . . . . 0.0 110.776 176.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -110.79 166.97 10.59 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.09 0.471 . . . . 0.0 111.49 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.404 ' O ' ' HB3' ' A' ' 75' ' ' PHE . 16.6 t80 -46.46 -36.79 6.96 Favored 'General case' 0 CA--C 1.554 1.133 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -177.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -73.3 -36.67 66.32 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 121.619 -0.676 . . . . 0.0 112.029 -178.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -72.28 -29.91 64.33 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.356 0.598 . . . . 0.0 109.981 174.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.404 ' HB3' ' O ' ' A' ' 72' ' ' TYR . 73.2 t80 -58.64 -44.31 90.04 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.587 176.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -47.7 -61.05 2.13 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.162 0.506 . . . . 0.0 111.604 174.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -64.88 -29.38 70.33 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.309 -176.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.26 -49.86 75.38 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.25 0.548 . . . . 0.0 110.98 173.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 62.2 mt -64.5 -41.7 96.28 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.486 176.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.521 ' O ' HG23 ' A' ' 84' ' ' THR . 31.8 tt0 -60.33 -40.74 91.7 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.54 -178.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -62.31 -59.2 5.35 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 120.85 0.357 . . . . 0.0 110.347 177.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 90.4 mt -57.03 -29.52 63.44 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.974 0.416 . . . . 0.0 111.394 178.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.41 -39.34 90.36 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.648 174.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.521 HG23 ' O ' ' A' ' 80' ' ' GLU . 8.6 p -68.63 -34.56 75.95 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 121.066 0.46 . . . . 0.0 110.986 178.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -69.53 -36.26 76.22 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.71 175.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.46 ' NH1' ' HA ' ' A' ' 44' ' ' VAL . 3.3 tpt180 -85.58 -62.24 1.57 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.341 0.591 . . . . 0.0 111.494 -177.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -96.67 93.44 6.73 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.387 -176.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -92.12 27.92 2.03 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 121.231 0.538 . . . . 0.0 110.653 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -60.03 -78.73 0.13 Allowed Glycine 0 CA--C 1.529 0.921 0 CA-C-N 116.028 -0.533 . . . . 0.0 113.957 -175.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.9 pttp -162.79 -60.62 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -177.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 54.7 m -91.32 132.9 35.86 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -173.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -64.95 -34.92 79.57 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.031 0.443 . . . . 0.0 110.718 176.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -57.2 -52.92 63.37 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.238 0.542 . . . . 0.0 110.484 171.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -55.73 -46.26 77.82 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.287 177.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.48 -48.94 79.13 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.97 0.414 . . . . 0.0 111.274 177.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -65.49 -36.54 84.15 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.022 178.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.465 ' O ' ' HG3' ' A' ' 101' ' ' GLN . 23.6 t70 -57.02 -62.18 1.93 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.391 0.615 . . . . 0.0 110.964 176.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -53.47 -46.85 70.09 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.607 -178.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.482 ' O ' HG23 ' A' ' 103' ' ' VAL . 16.7 tt -66.53 -38.45 81.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 O-C-N 122.056 -0.403 . . . . 0.0 111.232 -179.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 93.5 m -64.46 -35.96 82.62 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.783 0.325 . . . . 0.0 111.043 176.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.465 ' HG3' ' O ' ' A' ' 97' ' ' ASP . 88.1 mt-30 -63.69 -31.87 73.18 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 120.985 0.422 . . . . 0.0 111.09 176.014 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.9 mt -77.7 -9.62 59.09 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.918 177.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.703 ' HA ' ' SG ' ' A' ' 42' ' ' CYS . 69.4 t -108.79 -43.79 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -177.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -50.03 87.37 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 -170.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 48.1 65.27 2.58 Favored Glycine 0 CA--C 1.531 1.035 0 N-CA-C 115.084 0.794 . . . . 0.0 115.084 170.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm -79.22 -82.33 0.1 Allowed 'General case' 0 N--CA 1.471 0.612 0 O-C-N 122.273 -0.545 . . . . 0.0 111.845 178.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.532 ' N ' ' HD3' ' A' ' 108' ' ' PRO . 10.9 pt-20 -149.65 32.38 0.07 OUTLIER Pre-proline 0 CA--C 1.554 1.128 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.532 ' HD3' ' N ' ' A' ' 107' ' ' GLU . 71.7 Cg_endo -76.32 149.75 31.87 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.001 1.801 . . . . 0.0 113.424 -173.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.759 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 178.754 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.441 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 36.3 pt . . . . . 0 N--CA 1.468 0.457 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 7' ' ' ILE . . . 74.81 -48.56 0.65 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.205 0.602 . . . . 0.0 111.424 -176.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.2 -22.89 45.29 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 121.445 -0.407 . . . . 0.0 113.091 175.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.687 HD22 ' SG ' ' A' ' 100' ' ' CYS . 56.6 tp -74.65 -43.1 56.99 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 122.477 -0.425 . . . . 0.0 110.602 176.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -59.26 -42.32 90.89 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.307 0.575 . . . . 0.0 110.26 175.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.521 ' HG2' ' HE2' ' A' ' 16' ' ' LYS . 34.1 tt0 -61.38 -55.31 32.96 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.141 174.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.8 t -58.39 -35.14 71.55 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.439 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -59.49 -46.44 88.81 Favored 'General case' 0 C--O 1.225 -0.231 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.859 177.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.522 ' O ' HG12 ' A' ' 19' ' ' ILE . 97.8 mtt180 -60.48 -45.63 93.04 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.561 176.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.521 ' HE2' ' HG2' ' A' ' 12' ' ' GLU . 67.7 mttm -54.87 -37.72 66.6 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.891 0.377 . . . . 0.0 111.774 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -83.17 -36.56 24.6 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.599 174.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.03 -51.55 67.55 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -175.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.522 HG12 ' O ' ' A' ' 15' ' ' ARG . 29.1 pt -82.62 4.49 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 CA-C-O 121.056 0.455 . . . . 0.0 111.609 -178.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 39.5 t-80 -65.08 107.1 1.43 Allowed 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.903 177.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 115.51 -14.63 17.81 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 121.295 -0.478 . . . . 0.0 112.997 -177.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -154.68 118.1 2.53 Favored Pre-proline 0 CA--C 1.542 0.649 0 O-C-N 122.547 -0.384 . . . . 0.0 110.577 176.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -66.09 -14.55 44.91 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.459 2.106 . . . . 0.0 113.992 -174.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.401 ' HE3' ' HB2' ' A' ' 24' ' ' LYS . 45.3 mtmt -100.07 -52.85 3.3 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 120.74 0.305 . . . . 0.0 110.923 178.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.498 ' HB3' HG22 ' A' ' 19' ' ' ILE . . . 33.56 -115.14 0.07 Allowed 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.897 -175.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 63.8 m -157.93 -56.5 0.07 Allowed 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 122.768 0.427 . . . . 0.0 110.674 176.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.43 7.7 8.11 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 120.635 -0.793 . . . . 0.0 114.687 173.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -136.65 7.35 3.01 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 117.533 0.666 . . . . 0.0 111.531 178.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.447 ' HB3' HG21 ' A' ' 69' ' ' VAL . 33.9 mp0 -122.4 148.21 45.37 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 122.893 0.477 . . . . 0.0 111.536 -175.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.536 ' SD ' ' HB2' ' A' ' 34' ' ' ASN . 39.0 tpp -137.74 131.68 31.67 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.974 178.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 22.1 p30 -92.14 163.3 13.99 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.77 0.319 . . . . 0.0 111.59 178.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -55.88 -29.04 54.33 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 121.163 -0.542 . . . . 0.0 113.111 178.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -57.8 -61.35 2.59 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.072 0.463 . . . . 0.0 111.886 176.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.536 ' HB2' ' SD ' ' A' ' 30' ' ' MET . 24.7 m-20 -68.71 -34.37 75.53 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.358 -179.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.441 ' CD1' ' HB2' ' A' ' 59' ' ' PHE . 56.1 t-105 -60.11 -49.38 77.89 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.976 0.417 . . . . 0.0 111.631 178.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.92 -43.7 94.73 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 121.032 0.444 . . . . 0.0 111.228 177.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -66.57 -38.72 87.67 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.003 177.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.2 tt -56.38 -55.01 38.88 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.282 0.563 . . . . 0.0 110.592 -178.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 26.7 p -66.81 -40.88 88.22 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.782 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 58.0 tttp -76.35 -20.61 57.05 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-O 121.008 0.432 . . . . 0.0 111.715 -177.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -80.29 -41.72 24.43 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.326 0.584 . . . . 0.0 110.478 177.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.637 ' SG ' ' HA ' ' A' ' 103' ' ' VAL . 33.9 m -89.98 -6.83 55.23 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.689 -178.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.5 55.67 2.76 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.634 0.731 . . . . 0.0 111.418 -178.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 56.2 t -92.54 -36.77 7.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.476 173.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -107.18 78.44 1.22 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.221 0.534 . . . . 0.0 111.108 177.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.8 p-10 -152.66 4.03 0.35 Allowed 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.21 -174.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -79.79 47.04 3.22 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 121.094 -0.574 . . . . 0.0 113.534 -178.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt 50.53 21.53 0.88 Allowed 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 177.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 60.2 p -146.93 -63.44 0.29 Allowed 'General case' 0 N--CA 1.469 0.499 0 O-C-N 121.775 -0.578 . . . . 0.0 110.633 -176.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.421 HG22 ' H ' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -48.24 -83.31 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.887 0 CA-C-N 115.221 -0.9 . . . . 0.0 112.514 174.039 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.535 ' O ' HG23 ' A' ' 55' ' ' VAL . 12.4 p 58.33 -174.94 0.08 Allowed 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.418 0.687 . . . . 0.0 112.455 177.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -56.79 -29.5 58.57 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 121.35 -0.452 . . . . 0.0 113.279 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.542 ' O ' HG13 ' A' ' 57' ' ' ILE . 83.7 m -58.01 -58.92 6.27 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 122.626 -0.338 . . . . 0.0 111.377 178.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -63.3 -39.04 93.46 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.616 -0.265 . . . . 0.0 110.927 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 51' ' ' THR . 74.5 t -48.3 -41.13 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 N-CA-C 112.249 0.462 . . . . 0.0 112.249 175.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -74.17 -38.21 63.74 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.01 0.433 . . . . 0.0 110.591 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.542 HG13 ' O ' ' A' ' 53' ' ' THR . 10.1 mt -62.06 -45.41 98.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.102 178.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.515 HG22 ' HG2' ' A' ' 81' ' ' GLU . 86.9 t -63.19 -49.69 82.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.89 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.441 ' HB2' ' CD1' ' A' ' 35' ' ' TRP . 77.2 t80 -58.11 -48.34 80.5 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.188 0.518 . . . . 0.0 110.853 -179.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 90.5 p -68.15 -30.19 69.26 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.146 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -64.58 -46.64 81.83 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.574 177.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.432 HG23 HG21 ' A' ' 70' ' ' ILE . 35.7 m -88.58 -13.77 9.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -178.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -74.71 138.91 43.08 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.92 0.39 . . . . 0.0 111.562 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -66.96 167.05 39.44 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.836 176.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -64.77 -47.97 76.21 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 122.531 -0.394 . . . . 0.0 111.921 -178.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.5 m -99.53 3.75 45.64 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 120.85 0.357 . . . . 0.0 111.584 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -80.26 135.29 36.21 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 120.947 0.403 . . . . 0.0 111.808 -178.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? -87.01 -20.01 27.85 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.057 0.456 . . . . 0.0 110.85 175.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.447 HG21 ' HB3' ' A' ' 29' ' ' GLU . 29.3 m -137.62 174.54 11.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.579 -176.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.432 HG21 HG23 ' A' ' 62' ' ' VAL . 36.4 pt -111.6 144.12 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.711 173.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -94.01 156.61 16.51 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 120.858 0.361 . . . . 0.0 111.777 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.484 ' O ' ' HB3' ' A' ' 75' ' ' PHE . 49.9 t80 -49.04 -39.86 28.95 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -173.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -60.94 -41.91 97.17 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 122.11 -0.369 . . . . 0.0 111.659 178.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -73.18 -28.1 62.02 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.213 0.53 . . . . 0.0 110.519 176.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.484 ' HB3' ' O ' ' A' ' 72' ' ' TYR . 85.3 t80 -58.99 -36.55 75.08 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.969 175.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -61.29 -43.41 98.93 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.462 0.172 . . . . 0.0 111.17 175.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 28.3 mtmm -64.07 -38.1 89.85 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.997 0.427 . . . . 0.0 110.947 175.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.404 ' HB1' ' CH2' ' A' ' 35' ' ' TRP . . . -61.71 -41.07 97.12 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.256 176.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 86.4 mt -64.09 -44.42 92.41 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.105 175.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -56.48 -45.99 80.67 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.173 0.511 . . . . 0.0 110.555 176.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.515 ' HG2' HG22 ' A' ' 58' ' ' VAL . 37.7 tp10 -55.45 -58.74 6.51 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.573 176.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 86.4 mt -62.68 -44.84 95.22 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -178.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.26 -44.27 92.41 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.672 ' HA ' ' HE3' ' A' ' 90' ' ' LYS . 40.1 p -64.54 -35.4 80.86 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -89.93 -20.08 23.77 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 112.991 0.738 . . . . 0.0 112.991 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 33.5 tpt85 -82.97 -53.6 5.71 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.689 0.757 . . . . 0.0 110.826 178.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -94.52 117.89 30.82 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.156 175.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -82.05 -62.64 1.57 Allowed 'General case' 0 CA--C 1.539 0.557 0 O-C-N 122.292 -0.255 . . . . 0.0 111.386 -177.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -82.16 94.53 1.69 Allowed Glycine 0 CA--C 1.528 0.901 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.463 176.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.672 ' HE3' ' HA ' ' A' ' 84' ' ' THR . 0.3 OUTLIER -157.51 171.7 19.88 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -174.725 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 46.7 t -110.53 179.45 4.07 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.182 169.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -59.95 -76.43 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 120.946 0.403 . . . . 0.0 111.841 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 -60.87 -36.21 78.58 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.882 -176.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -56.78 -47.4 80.23 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.829 0.347 . . . . 0.0 111.577 177.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.56 -40.31 73.43 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.868 0.366 . . . . 0.0 111.315 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -63.37 -47.33 82.52 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.907 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -56.38 -49.56 74.11 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.452 0.168 . . . . 0.0 111.063 172.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -53.62 -54.39 38.36 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 15.2 tt -62.33 -33.35 58.59 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-O 120.94 0.4 . . . . 0.0 111.435 -179.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' CYS . . . . . 0.687 ' SG ' HD22 ' A' ' 10' ' ' LEU . 97.2 m -68.6 -38.06 80.31 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.925 0.393 . . . . 0.0 111.083 176.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -67.53 -31.19 71.13 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.706 179.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 96.7 mt -60.86 -35.46 76.65 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.255 0.55 . . . . 0.0 110.774 176.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.637 ' HA ' ' SG ' ' A' ' 42' ' ' CYS . 19.3 t -87.69 -78.07 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.785 178.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 41.05 26.72 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 178.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 61.1 45.59 96.25 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 121.282 -0.485 . . . . 0.0 113.798 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.554 ' HG3' ' HG2' ' A' ' 107' ' ' GLU . 21.9 pttp -70.85 -40.75 72.18 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.754 0.649 . . . . 0.0 112.754 -177.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.554 ' HG2' ' HG3' ' A' ' 106' ' ' LYS . 14.7 pt-20 -167.88 50.44 0.19 Allowed Pre-proline 0 N--CA 1.477 0.884 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -177.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.488 ' HD3' ' N ' ' A' ' 107' ' ' GLU . 64.1 Cg_exo -42.87 120.86 2.01 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 123.225 2.617 . . . . 0.0 113.634 -174.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.653 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.732 -172.331 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.453 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 26.3 pt . . . . . 0 CA--C 1.534 0.334 0 CA-C-O 120.412 0.148 . . . . 0.0 111.037 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 7' ' ' ILE . . . 71.26 -43.22 0.56 Allowed 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 120.792 0.329 . . . . 0.0 110.464 -166.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -73.82 -34.84 55.6 Favored Glycine 0 C--N 1.337 0.613 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 171.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.567 HD22 ' SG ' ' A' ' 100' ' ' CYS . 59.1 tp -62.66 -37.28 85.76 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.091 -0.555 . . . . 0.0 110.273 170.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -68.06 -40.92 82.67 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.821 176.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -54.07 -58.17 8.33 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.032 0.444 . . . . 0.0 110.577 173.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.6 m -59.83 -42.37 93.4 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.511 178.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 94.0 t80 -53.79 -46.75 71.13 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.059 176.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.54 ' O ' HG12 ' A' ' 19' ' ' ILE . 21.7 ttt180 -66.3 -46.19 77.78 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.224 178.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 39.4 mtpt -57.84 -27.06 62.85 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 116.301 -0.408 . . . . 0.0 112.067 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -86.34 -44.66 11.9 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.495 172.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.08 -43.69 74.15 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -177.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.54 HG12 ' O ' ' A' ' 15' ' ' ARG . 29.0 pt -101.05 14.91 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-O 120.976 0.417 . . . . 0.0 111.594 -178.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.42 ' CD2' ' HG2' ' A' ' 108' ' ' PRO . 27.4 t-80 -66.5 -33.31 75.4 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -175.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -135.54 22.9 3.47 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.838 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -138.3 101.6 8.29 Favored Pre-proline 0 CA--C 1.542 0.654 0 CA-C-O 120.871 0.367 . . . . 0.0 110.878 -177.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.21 -19.96 43.88 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 122.683 2.255 . . . . 0.0 113.955 -174.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 49.2 mmtm -100.6 6.6 44.18 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -178.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -81.5 138.46 35.47 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.13 0.49 . . . . 0.0 111.736 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 93.2 p -70.2 -60.43 2.29 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.437 0.637 . . . . 0.0 111.1 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 145.99 -26.73 1.75 Allowed Glycine 0 CA--C 1.522 0.48 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.245 -178.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -85.84 -15.55 41.53 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 111.752 0.278 . . . . 0.0 111.752 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.533 ' HB3' HG21 ' A' ' 69' ' ' VAL . 50.3 mt-10 -111.13 116.46 31.15 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.747 0.308 . . . . 0.0 111.375 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 48.1 ttm -107.22 139.49 41.59 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.179 0.514 . . . . 0.0 111.846 178.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.602 ' OD1' ' HB3' ' A' ' 33' ' ' LYS . 7.6 p30 -95.58 165.74 12.18 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.351 177.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.46 -30.22 73.81 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 121.562 -0.352 . . . . 0.0 113.842 -177.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.602 ' HB3' ' OD1' ' A' ' 31' ' ' ASN . 29.7 ttpt -58.39 -61.21 2.75 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.036 0.446 . . . . 0.0 111.565 177.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 64.2 m-20 -68.24 -31.96 71.82 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 122.281 -0.262 . . . . 0.0 111.57 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 32.2 t-105 -61.99 -38.89 90.31 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-O 120.953 0.406 . . . . 0.0 111.273 175.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.533 ' HA ' HG11 ' A' ' 55' ' ' VAL . . . -61.59 -48.85 79.07 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 120.984 0.421 . . . . 0.0 110.897 175.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.3 mtpp -67.6 -30.55 70.17 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.957 177.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.9 tt -56.9 -46.68 81.79 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.98 0.419 . . . . 0.0 110.169 177.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 79.0 m -64.32 -44.93 90.0 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.049 0.452 . . . . 0.0 111.623 176.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -68.17 -58.31 4.66 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -177.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.31 -23.84 64.51 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 178.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 86.0 m -95.86 -5.05 42.53 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 122.044 -0.41 . . . . 0.0 111.471 173.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt 62.41 28.94 17.1 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 173.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 43.2 t -78.79 -32.99 16.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.439 177.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.425 ' HA ' HG13 ' A' ' 50' ' ' VAL . . . -91.54 102.47 15.12 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.833 0.349 . . . . 0.0 111.9 -178.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -77.31 -44.99 27.68 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.699 0.762 . . . . 0.0 111.687 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.422 ' HA2' HG22 ' A' ' 51' ' ' THR . . . 107.63 -37.63 3.73 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 -163.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.9 ttpm? -43.11 -56.16 3.52 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.66 0.784 . . . . 0.0 112.199 173.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 78.4 p -125.91 -0.85 7.25 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 120.878 0.37 . . . . 0.0 111.755 178.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.425 HG13 ' HA ' ' A' ' 45' ' ' ALA . 3.8 p -156.74 111.75 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-O 121.1 0.476 . . . . 0.0 111.868 -174.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.43 ' O ' HG23 ' A' ' 55' ' ' VAL . 68.6 p -106.23 -177.78 3.46 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.104 178.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -55.64 -38.46 71.97 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.531 175.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.543 ' O ' HG12 ' A' ' 57' ' ' ILE . 88.8 m -58.0 -49.94 75.11 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 122.703 -0.292 . . . . 0.0 110.627 176.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.435 ' O ' HG23 ' A' ' 58' ' ' VAL . 7.1 m-20 -53.76 -38.61 64.59 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.991 0.424 . . . . 0.0 111.266 175.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.533 HG11 ' HA ' ' A' ' 36' ' ' ALA . 95.9 t -59.67 -39.6 80.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.507 178.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -76.02 -34.04 59.67 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.454 0.645 . . . . 0.0 110.535 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.543 HG12 ' O ' ' A' ' 53' ' ' THR . 9.9 mm -59.05 -53.16 51.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.059 175.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 54' ' ' ASP . 56.5 t -61.12 -42.42 93.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.286 178.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -55.22 -40.63 71.05 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.147 0.499 . . . . 0.0 111.289 175.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 50.6 m -78.38 -29.23 47.22 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.387 178.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -69.33 -56.91 6.14 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.903 -178.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.418 HG12 ' HG3' ' A' ' 77' ' ' LYS . 33.9 m -65.0 -34.15 68.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -173.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.602 ' HG3' ' H ' ' A' ' 65' ' ' LYS . 0.1 OUTLIER -65.94 -21.87 66.46 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.91 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 64.22 25.56 69.81 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 121.27 -0.49 . . . . 0.0 113.056 -178.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.602 ' H ' ' HG3' ' A' ' 63' ' ' LYS . 9.7 mtpm? 68.22 167.74 0.26 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.187 0.595 . . . . 0.0 111.889 -176.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 65.5 m 72.47 -47.95 0.67 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.324 0.65 . . . . 0.0 112.335 -178.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.452 ' O ' ' HD3' ' A' ' 63' ' ' LYS . . . -74.72 107.72 7.01 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 122.22 -0.3 . . . . 0.0 111.166 175.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -62.88 -48.71 77.82 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 121.378 0.609 . . . . 0.0 111.289 -177.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.533 HG21 ' HB3' ' A' ' 29' ' ' GLU . 30.2 m -93.23 -166.06 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.271 178.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 31.5 pt -134.93 144.7 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 122.417 0.287 . . . . 0.0 111.102 174.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -97.94 -179.57 4.46 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 120.815 0.34 . . . . 0.0 111.559 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -57.62 -43.38 84.73 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -175.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.623 ' HA ' ' HG3' ' A' ' 76' ' ' LYS . 15.7 pt-20 -80.25 -28.73 38.42 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.529 -0.732 . . . . 0.0 111.881 -176.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -69.03 -30.06 68.35 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.501 0.667 . . . . 0.0 109.43 170.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -69.17 -49.38 57.31 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.47 176.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.623 ' HG3' ' HA ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -64.97 -27.57 68.93 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 120.753 0.311 . . . . 0.0 111.289 177.948 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.418 ' HG3' HG12 ' A' ' 62' ' ' VAL . 17.7 tppt? -68.75 -39.35 80.33 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.8 0.333 . . . . 0.0 110.336 170.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.02 -43.76 86.93 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.184 0.516 . . . . 0.0 110.61 173.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 80.8 mt -58.97 -37.07 75.95 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.3 176.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.409 ' O ' HG23 ' A' ' 84' ' ' THR . 54.9 mt-10 -62.69 -47.39 83.83 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.862 0.363 . . . . 0.0 111.352 175.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -57.59 -55.93 28.41 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.893 0.378 . . . . 0.0 110.828 176.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 11.3 mp -54.4 -49.54 69.67 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.279 176.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -52.34 -48.5 65.46 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.409 HG23 ' O ' ' A' ' 80' ' ' GLU . 75.3 p -62.58 -33.97 76.03 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 -179.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -94.77 -2.08 51.65 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 176.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 31.4 tpt85 -104.8 -63.76 1.19 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.043 0.449 . . . . 0.0 111.727 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -103.77 118.85 37.66 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.721 -177.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -79.01 58.68 2.48 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 121.429 0.633 . . . . 0.0 110.868 176.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -90.16 -11.21 63.32 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-N 115.817 -0.629 . . . . 0.0 114.024 -176.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp 59.74 23.4 12.28 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 177.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 48.2 t -149.17 155.77 41.15 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 122.059 -0.401 . . . . 0.0 111.09 176.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -83.1 -58.57 2.8 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.549 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -52.57 -58.14 7.74 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.584 0.586 . . . . 0.0 112.584 -176.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -57.37 -55.13 38.74 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -176.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.7 -36.36 74.11 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.771 0.319 . . . . 0.0 111.766 179.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -67.28 -52.62 38.41 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.326 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.47 ' O ' ' HG3' ' A' ' 101' ' ' GLN . 7.1 m-20 -58.0 -39.48 78.39 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 120.488 0.185 . . . . 0.0 111.421 176.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.16 -60.21 4.23 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 120.817 0.341 . . . . 0.0 111.593 176.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 17.6 tt -63.16 -28.84 45.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-O 121.039 0.447 . . . . 0.0 111.077 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' CYS . . . . . 0.567 ' SG ' HD22 ' A' ' 10' ' ' LEU . 39.6 t -66.54 -44.95 80.98 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.019 173.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.47 ' HG3' ' O ' ' A' ' 97' ' ' ASP . 46.2 mt-30 -60.71 -29.0 69.08 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 179.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 83.3 mt -63.69 -23.67 67.47 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 120.799 0.333 . . . . 0.0 111.833 176.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 43.3 t -112.98 -34.39 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -177.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.58 115.1 3.98 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -174.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 85.01 14.42 69.51 Favored Glycine 0 CA--C 1.523 0.561 0 CA-C-N 116.103 -0.499 . . . . 0.0 112.531 -178.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 24.3 tptm -102.77 156.31 17.73 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.344 0.592 . . . . 0.0 111.268 -178.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -132.3 158.24 76.14 Favored Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.248 174.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.42 ' HG2' ' CD2' ' A' ' 20' ' ' HIS . 25.6 Cg_exo -62.68 -179.06 0.44 Allowed 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.111 1.874 . . . . 0.0 112.537 178.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.53 0 CA-C-O 121.017 0.437 . . . . 0.0 111.025 174.756 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.432 HG12 ' H ' ' A' ' 9' ' ' GLY . 13.4 tt . . . . . 0 CA--C 1.541 0.623 0 N-CA-C 111.801 0.296 . . . . 0.0 111.801 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -49.16 -36.01 18.23 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.432 ' H ' HG12 ' A' ' 7' ' ' ILE . . . -57.94 -33.6 69.26 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 121.274 -0.488 . . . . 0.0 113.131 176.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 50.0 tp -70.88 -40.68 72.09 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.943 0.401 . . . . 0.0 110.546 177.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -63.27 -36.31 83.25 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.697 175.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -60.03 -56.51 20.79 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.025 0.44 . . . . 0.0 110.895 175.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.3 m -53.15 -51.24 62.62 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.46 178.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -56.12 -50.07 72.12 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.458 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 29.9 ttt180 -62.94 -42.56 99.84 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.875 0.369 . . . . 0.0 111.677 -176.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.407 ' HD3' ' HB3' ' A' ' 107' ' ' GLU . 99.0 mttt -65.22 -34.32 78.08 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.515 ' HA ' ' HB2' ' A' ' 20' ' ' HIS . 41.0 m-85 -79.84 -23.61 41.86 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 120.826 0.346 . . . . 0.0 111.28 173.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.47 -11.56 60.26 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.172 0.511 . . . . 0.0 111.278 175.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.448 HG23 ' HA2' ' A' ' 27' ' ' GLY . 32.8 pt -117.79 15.78 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-O 121.055 0.455 . . . . 0.0 110.67 171.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.515 ' HB2' ' HA ' ' A' ' 17' ' ' PHE . 48.8 t-80 -63.24 100.73 0.25 Allowed 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 120.94 0.4 . . . . 0.0 111.448 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 126.88 -46.9 1.05 Allowed Glycine 0 CA--C 1.526 0.753 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.089 -176.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.478 ' HB2' ' HB2' ' A' ' 25' ' ' ALA . 19.7 m-20 -138.98 127.87 14.02 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 122.757 0.423 . . . . 0.0 110.815 179.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_exo -47.54 -32.64 16.17 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 123.215 2.61 . . . . 0.0 114.232 -178.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -120.9 31.42 6.41 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.875 0.369 . . . . 0.0 111.566 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.478 ' HB2' ' HB2' ' A' ' 22' ' ' ASP . . . -53.44 -60.1 3.73 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 67.5 m -152.9 -43.85 0.1 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.071 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.448 ' HA2' HG23 ' A' ' 19' ' ' ILE . . . 79.1 -34.83 1.94 Allowed Glycine 0 CA--C 1.528 0.904 0 C-N-CA 121.168 -0.539 . . . . 0.0 114.358 173.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -125.72 -21.59 4.4 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 117.033 0.417 . . . . 0.0 111.667 -178.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -99.16 138.66 35.95 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 122.113 -0.367 . . . . 0.0 110.519 173.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 49.8 ttm -125.55 131.19 52.81 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.843 0.354 . . . . 0.0 111.929 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.494 ' ND2' ' HB2' ' A' ' 33' ' ' LYS . 17.8 p-10 -91.71 158.43 16.38 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.89 0.376 . . . . 0.0 111.592 178.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -56.64 -29.17 57.58 Favored Glycine 0 N--CA 1.465 0.626 0 CA-C-N 116.302 -0.408 . . . . 0.0 113.253 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.494 ' HB2' ' ND2' ' A' ' 31' ' ' ASN . 98.7 mttt -57.93 -56.06 26.85 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 120.938 0.399 . . . . 0.0 111.464 175.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -71.21 -29.15 64.8 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 122.342 -0.224 . . . . 0.0 111.412 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.467 ' CD1' ' HB2' ' A' ' 59' ' ' PHE . 25.8 t-105 -64.32 -45.27 88.63 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 120.879 0.371 . . . . 0.0 111.26 175.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.472 ' HA ' HG11 ' A' ' 55' ' ' VAL . . . -58.74 -46.3 87.73 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.183 0.516 . . . . 0.0 111.007 177.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -66.94 -39.25 87.24 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.779 176.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.2 tt -49.88 -45.26 50.46 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.24 0.543 . . . . 0.0 110.618 177.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 64.6 m -70.44 -38.58 74.55 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.715 178.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -70.96 -47.92 56.27 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -176.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -53.46 -48.86 68.46 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.065 0.46 . . . . 0.0 111.073 172.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 63.3 m -77.09 -6.07 51.39 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.722 178.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 47.0 mttp 59.45 26.41 15.34 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 175.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 42.8 t -74.24 -32.63 32.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 121.397 0.618 . . . . 0.0 110.347 173.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.545 ' HB1' ' HA ' ' A' ' 51' ' ' THR . . . -87.85 91.96 8.95 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.669 -176.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -174.52 17.55 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.831 0 CA-C-O 120.971 0.415 . . . . 0.0 111.688 175.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -86.93 18.93 32.61 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.69 -0.767 . . . . 0.0 113.446 -175.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.5 ' HD2' ' N ' ' A' ' 48' ' ' LYS . 12.0 mptt 57.51 20.05 5.79 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 121.738 0.78 . . . . 0.0 111.51 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 65.4 m -147.0 -30.92 0.34 Allowed 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.494 175.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.655 HG11 ' HG ' ' A' ' 82' ' ' LEU . 93.3 t -125.46 96.71 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.95 166.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.545 ' HA ' ' HB1' ' A' ' 45' ' ' ALA . 5.0 t -156.55 125.06 5.79 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.803 0.335 . . . . 0.0 111.854 176.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 50.47 -90.6 0.01 OUTLIER Glycine 0 CA--C 1.53 0.995 0 CA-C-N 116.413 -0.358 . . . . 0.0 113.776 178.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.595 ' O ' HG13 ' A' ' 57' ' ' ILE . 58.0 m -52.04 -55.01 23.27 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.788 0.328 . . . . 0.0 111.199 179.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.49 ' HB2' ' HA ' ' A' ' 50' ' ' VAL . 9.2 m-20 -57.53 -34.02 68.69 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.553 -177.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.472 HG11 ' HA ' ' A' ' 36' ' ' ALA . 43.8 t -64.06 -38.2 81.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-O 120.939 0.4 . . . . 0.0 111.032 178.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -72.12 -31.25 65.85 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.171 0.51 . . . . 0.0 110.004 177.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.595 HG13 ' O ' ' A' ' 53' ' ' THR . 9.8 mt -68.01 -48.31 75.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.896 176.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 76.1 t -54.04 -51.32 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-O 121.022 0.439 . . . . 0.0 110.849 174.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.467 ' HB2' ' CD1' ' A' ' 35' ' ' TRP . 72.0 t80 -53.06 -51.19 62.58 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.763 175.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.595 ' HA ' ' HE3' ' A' ' 63' ' ' LYS . 59.3 m -68.23 -21.65 64.83 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.028 -178.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 43.9 tttp -83.11 -39.87 20.55 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 120.747 0.308 . . . . 0.0 111.402 -178.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 26.9 m -82.22 -24.88 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 CA-C-O 120.783 0.325 . . . . 0.0 111.377 177.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.595 ' HE3' ' HA ' ' A' ' 60' ' ' SER . 26.3 ttpp -53.84 126.83 23.68 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.964 178.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -45.78 -62.26 3.41 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-N 116.088 -0.505 . . . . 0.0 113.294 179.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 48.4 tptt -152.02 -86.3 0.07 Allowed 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 117.085 0.442 . . . . 0.0 111.782 174.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 88.4 p -110.09 -7.04 14.96 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -173.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.43 107.1 1.03 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.725 0.297 . . . . 0.0 111.2 178.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 83.8 mtm-85 -72.48 2.32 6.49 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -176.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 28.2 m -125.71 132.98 70.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-O 120.894 0.378 . . . . 0.0 110.73 174.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.54 ' HB ' ' HB2' ' A' ' 74' ' ' GLU . 30.6 pt -100.63 148.06 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 121.077 0.465 . . . . 0.0 111.878 179.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.445 ' ND2' ' HB2' ' A' ' 73' ' ' GLU . 1.7 p-10 -89.18 167.93 12.71 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.153 174.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.492 ' O ' ' HG3' ' A' ' 76' ' ' LYS . 24.9 t80 -52.12 -37.46 54.34 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.922 0.391 . . . . 0.0 111.866 -173.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.445 ' HB2' ' ND2' ' A' ' 71' ' ' ASN . 19.5 mp0 -60.4 -47.98 83.75 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.288 178.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.54 ' HB2' ' HB ' ' A' ' 70' ' ' ILE . 48.7 mt-10 -65.4 -37.3 86.54 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.18 0.514 . . . . 0.0 110.296 176.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -59.6 -41.11 89.57 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.222 175.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.492 ' HG3' ' O ' ' A' ' 72' ' ' TYR . 27.7 mtpp -55.75 -47.85 76.28 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.691 0.281 . . . . 0.0 110.969 176.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.444 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 54.9 tttp -68.91 -32.99 73.02 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.384 177.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.446 ' O ' HD13 ' A' ' 82' ' ' LEU . . . -56.9 -40.84 77.02 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.111 0.481 . . . . 0.0 110.407 173.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 88.2 mt -67.79 -43.26 80.13 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.87 173.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -49.4 -47.62 47.74 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 120.975 0.417 . . . . 0.0 111.104 175.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.634 ' O ' ' HG2' ' A' ' 85' ' ' LYS . 32.0 mm-40 -58.94 -68.67 0.25 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.916 177.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.655 ' HG ' HG11 ' A' ' 50' ' ' VAL . 11.0 mp -47.77 -43.73 27.71 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -178.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.01 -48.02 83.1 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.692 177.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 74.0 p -75.01 -7.24 53.11 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -178.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.634 ' HG2' ' O ' ' A' ' 81' ' ' GLU . 54.7 mmtt -97.75 -35.4 10.56 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.292 0.568 . . . . 0.0 110.172 172.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 9.9 mmt180 -78.35 -70.2 0.51 Allowed 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.722 176.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -98.83 86.47 3.52 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.192 0.52 . . . . 0.0 111.144 -172.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.559 ' NZ ' ' HB2' ' A' ' 88' ' ' LYS . 9.4 mtmp? -94.07 36.29 1.13 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.3 0.571 . . . . 0.0 110.999 -177.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -78.53 35.95 1.81 Allowed Glycine 0 CA--C 1.531 1.054 0 CA-C-N 116.044 -0.526 . . . . 0.0 113.853 -177.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 76.9 tttt 70.83 -60.87 0.49 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.666 0.786 . . . . 0.0 112.253 178.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 53.5 m -63.73 105.69 0.85 Allowed 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 120.824 0.345 . . . . 0.0 111.558 176.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.407 ' HE2' ' OE2' ' A' ' 93' ' ' GLU . 11.3 ttpt -73.6 -49.05 28.13 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -173.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.407 ' OE2' ' HE2' ' A' ' 92' ' ' LYS . 2.8 mp0 -53.17 -49.59 66.33 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 111.671 0.248 . . . . 0.0 111.671 -178.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -60.71 -33.46 72.91 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.889 0.376 . . . . 0.0 111.402 178.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.21 -39.56 94.97 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.139 0.495 . . . . 0.0 110.645 173.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -63.41 -39.04 93.43 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.326 175.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.47 ' O ' ' HB3' ' A' ' 100' ' ' CYS . 20.2 m-20 -60.25 -49.81 76.14 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.654 0.264 . . . . 0.0 111.057 172.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -53.58 -50.57 65.32 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -177.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 17.3 tt -65.6 -30.56 50.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-O 121.083 0.468 . . . . 0.0 110.819 177.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' CYS . . . . . 0.47 ' HB3' ' O ' ' A' ' 97' ' ' ASP . 35.8 t -63.41 -42.01 98.75 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.968 173.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -57.4 -39.54 76.35 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.776 0.322 . . . . 0.0 111.128 175.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 96.6 mt -65.96 -44.6 84.5 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 178.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 60.9 t -97.8 -54.2 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -172.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.77 127.82 33.53 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -171.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 100.24 -8.78 59.12 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 115.888 -0.596 . . . . 0.0 113.62 177.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -105.08 173.98 6.07 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.467 0.651 . . . . 0.0 112.15 -179.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.523 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 10.9 pt-20 -143.83 160.92 48.47 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.657 179.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.523 ' HD2' ' HB2' ' A' ' 107' ' ' GLU . 42.2 Cg_exo -32.38 106.6 0.04 OUTLIER 'Trans proline' 0 C--N 1.36 1.158 0 C-N-CA 123.711 2.94 . . . . 0.0 114.622 -177.024 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.432 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.817 -177.203 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.638 HG12 ' H ' ' A' ' 9' ' ' GLY . 7.9 tt . . . . . 0 CA--C 1.547 0.848 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.04 -27.9 48.07 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -178.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.638 ' H ' HG12 ' A' ' 7' ' ' ILE . . . -60.06 -28.42 66.36 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 121.229 -0.51 . . . . 0.0 113.049 177.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 44.8 tp -73.24 -35.28 66.22 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.116 0.484 . . . . 0.0 110.524 177.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -62.69 -45.46 92.66 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.849 175.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.498 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 35.1 tt0 -65.89 -45.85 80.51 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.53 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 79.6 p -58.0 -46.41 85.27 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.045 0.45 . . . . 0.0 110.818 178.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -54.14 -48.71 70.53 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.219 0.533 . . . . 0.0 110.685 172.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.435 ' HG3' ' HA3' ' A' ' 27' ' ' GLY . 49.4 ttt180 -58.51 -37.21 75.12 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.37 -179.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.498 ' HG2' ' O ' ' A' ' 12' ' ' GLU . 75.6 mmtt -60.39 -50.19 74.58 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.823 178.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.464 ' HB2' ' HE2' ' A' ' 30' ' ' MET . 81.7 m-85 -72.89 -21.1 60.97 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.739 0.304 . . . . 0.0 111.524 177.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.68 -54.31 12.34 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 120.862 0.363 . . . . 0.0 111.877 179.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 32.8 pt -73.78 -10.68 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-O 120.989 0.423 . . . . 0.0 111.882 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 -58.85 87.95 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.12 0.486 . . . . 0.0 111.745 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 132.84 -34.4 2.47 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-N 116.136 -0.484 . . . . 0.0 113.125 -179.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.502 ' CG ' ' HZ2' ' A' ' 24' ' ' LYS . 12.2 t70 -133.04 114.59 13.9 Favored Pre-proline 0 CA--C 1.544 0.746 0 O-C-N 122.462 -0.434 . . . . 0.0 111.337 -177.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -80.86 0.03 10.29 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.585 2.19 . . . . 0.0 113.562 -179.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.502 ' HZ2' ' CG ' ' A' ' 22' ' ' ASP . 9.5 mtmp? -93.91 -16.77 23.68 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.97 0.414 . . . . 0.0 111.368 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -82.54 137.72 34.5 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.396 177.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 47.0 m -68.98 -22.66 64.09 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 120.77 0.319 . . . . 0.0 111.463 179.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.435 ' HA3' ' HG3' ' A' ' 15' ' ' ARG . . . 108.44 23.5 6.59 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 121.274 -0.488 . . . . 0.0 114.194 177.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -104.51 6.22 34.6 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 117.388 0.594 . . . . 0.0 111.799 178.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -130.79 130.76 44.11 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.011 -178.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.464 ' HE2' ' HB2' ' A' ' 17' ' ' PHE . 48.2 ttm -125.81 133.88 51.86 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.987 0.422 . . . . 0.0 111.99 -179.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.523 HD21 ' ND2' ' A' ' 34' ' ' ASN . 9.8 p30 -90.93 168.35 11.75 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.987 0.422 . . . . 0.0 111.605 178.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -66.04 -28.72 73.9 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-N 116.164 -0.471 . . . . 0.0 114.041 -179.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.445 ' HB3' ' OD1' ' A' ' 31' ' ' ASN . 39.6 ttmt -67.46 -48.8 66.14 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 117.006 0.403 . . . . 0.0 111.316 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.523 ' ND2' HD21 ' A' ' 31' ' ' ASN . 87.4 m-20 -68.71 -35.22 76.88 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.803 0.335 . . . . 0.0 111.013 175.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 47.5 t-105 -58.43 -45.48 88.41 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.283 174.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.52 -38.26 83.83 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.193 0.521 . . . . 0.0 111.528 176.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -70.72 -35.58 72.79 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.364 175.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.7 tt -59.57 -54.45 46.4 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.083 0.468 . . . . 0.0 110.588 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 26.2 p -60.51 -44.42 96.04 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.646 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -67.89 -38.16 82.67 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.847 0.356 . . . . 0.0 111.525 -178.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -67.31 -49.91 62.27 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.236 178.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.557 ' SG ' HG22 ' A' ' 103' ' ' VAL . 68.8 m -80.61 1.43 29.85 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.503 178.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp 69.03 20.23 7.82 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.033 0.533 . . . . 0.0 112.144 172.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.543 ' HA ' ' NH1' ' A' ' 86' ' ' ARG . 40.0 t -70.04 -26.94 30.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 120.926 0.394 . . . . 0.0 110.561 175.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.16 78.04 0.51 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.651 0.739 . . . . 0.0 109.972 172.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.486 ' HB3' ' H ' ' A' ' 50' ' ' VAL . 38.7 t70 -54.99 -30.12 58.62 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 114.601 -1.181 . . . . 0.0 113.978 -169.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.26 -36.44 1.53 Allowed Glycine 0 CA--C 1.531 1.065 0 C-N-CA 121.227 -0.511 . . . . 0.0 113.31 -177.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.7 mttp -82.59 -46.94 12.69 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.161 0.505 . . . . 0.0 110.093 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 73.1 m -108.55 -50.43 3.03 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.564 174.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.486 ' H ' ' HB3' ' A' ' 46' ' ' ASP . 43.1 t -93.76 110.25 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -178.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 76.5 p -96.44 173.93 7.12 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 120.689 0.281 . . . . 0.0 111.519 177.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -58.06 -44.05 94.85 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 121.083 -0.58 . . . . 0.0 112.443 177.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.562 ' O ' HG13 ' A' ' 57' ' ' ILE . 44.5 p -51.21 -50.64 58.71 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.325 0.583 . . . . 0.0 110.361 172.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.06 -38.42 70.61 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.04 -176.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.2 t -59.22 -40.56 81.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.173 176.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -68.06 -37.66 81.55 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.98 0.419 . . . . 0.0 110.84 175.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.562 HG13 ' O ' ' A' ' 53' ' ' THR . 6.5 mt -62.73 -46.76 95.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.146 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 76.5 t -59.99 -42.48 89.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 120.979 0.419 . . . . 0.0 111.07 177.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -62.36 -23.32 66.73 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-O 121.153 0.502 . . . . 0.0 110.999 176.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 23.1 t -87.0 -34.79 19.13 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.836 0.35 . . . . 0.0 111.254 175.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -60.86 -44.69 96.69 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 29.4 m -78.97 -22.64 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -177.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? -73.97 150.01 41.02 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.905 0.383 . . . . 0.0 111.789 -175.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -70.18 -98.67 0.05 OUTLIER Glycine 0 CA--C 1.53 0.993 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.161 174.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -141.88 -64.73 0.43 Allowed 'General case' 0 N--CA 1.471 0.607 0 O-C-N 122.423 -0.457 . . . . 0.0 111.216 174.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 43.5 t -92.77 91.3 7.42 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.862 0.363 . . . . 0.0 110.825 177.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -160.57 146.56 15.08 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.231 0.538 . . . . 0.0 112.089 -178.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 68' ' ' ARG . 32.5 mtm-85 -104.36 -37.76 7.1 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.393 0.616 . . . . 0.0 110.716 177.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.3 m -124.82 158.56 32.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.208 -178.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 42.1 pt -118.49 159.77 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.091 177.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -103.61 177.81 4.73 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.407 ' O ' ' HB3' ' A' ' 75' ' ' PHE . 84.7 t80 -54.01 -40.62 67.17 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -174.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -56.22 -51.47 67.95 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.266 0.555 . . . . 0.0 111.281 178.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -64.52 -32.87 74.69 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.068 177.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.407 ' HB3' ' O ' ' A' ' 72' ' ' TYR . 61.0 t80 -58.82 -43.72 90.68 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.025 174.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp -54.95 -49.53 71.14 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.186 0.517 . . . . 0.0 111.066 173.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -61.18 -35.13 76.32 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.173 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.47 -43.38 81.16 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.012 0.434 . . . . 0.0 111.449 176.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 80.8 mt -64.89 -35.4 81.01 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.103 177.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -59.94 -49.94 75.7 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.134 0.492 . . . . 0.0 110.325 176.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -57.4 -56.7 18.43 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.152 175.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 87.1 mt -60.27 -35.24 75.08 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -178.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.5 ' HB2' HG21 ' A' ' 99' ' ' ILE . . . -64.15 -48.04 77.58 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.108 0.48 . . . . 0.0 111.057 178.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 65.7 p -74.67 -9.26 58.39 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.846 -0.616 . . . . 0.0 112.161 -179.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -101.6 -28.32 12.58 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 173.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.543 ' NH1' ' HA ' ' A' ' 44' ' ' VAL . 14.3 tpt180 -83.26 -54.26 5.14 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.695 0.76 . . . . 0.0 110.575 178.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -86.55 144.58 27.14 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.752 178.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.464 ' HB3' ' NZ ' ' A' ' 88' ' ' LYS . 0.5 OUTLIER -81.64 -164.71 0.82 Allowed 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -178.555 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -55.3 81.97 0.01 OUTLIER Glycine 0 CA--C 1.531 1.035 0 N-CA-C 114.633 0.613 . . . . 0.0 114.633 -176.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -126.3 177.15 6.6 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 122.885 0.474 . . . . 0.0 110.749 176.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 65.9 m -62.72 125.44 23.96 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 120.767 0.318 . . . . 0.0 111.161 176.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -54.84 -40.31 69.48 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 116.134 -0.485 . . . . 0.0 112.303 -174.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -62.59 -59.93 4.23 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.653 0.263 . . . . 0.0 110.98 178.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -53.82 -39.47 65.57 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 120.725 0.297 . . . . 0.0 111.432 -179.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.24 -42.73 95.91 Favored 'General case' 0 CA--C 1.541 0.635 0 CA-C-O 120.706 0.288 . . . . 0.0 111.468 177.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -67.59 -50.2 59.44 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.222 178.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -57.32 -42.03 81.07 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 120.727 0.298 . . . . 0.0 111.456 178.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.67 -54.22 45.71 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 112.041 0.385 . . . . 0.0 112.041 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.5 HG21 ' HB2' ' A' ' 83' ' ' ALA . 12.7 tt -59.29 -36.12 61.84 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-O 121.096 0.474 . . . . 0.0 110.793 179.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 81.6 m -68.04 -38.69 82.8 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.135 176.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -58.42 -31.49 67.76 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.061 0.458 . . . . 0.0 111.486 177.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 92.9 mt -60.79 -41.11 94.96 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.879 176.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.557 HG22 ' SG ' ' A' ' 42' ' ' CYS . 16.3 t -96.76 -31.63 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 CA-C-O 121.044 0.449 . . . . 0.0 112.176 -174.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.03 124.67 21.7 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -173.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 85.78 -11.56 61.73 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 116.123 -0.49 . . . . 0.0 113.44 177.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -86.67 153.33 21.83 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 122.5 -0.412 . . . . 0.0 111.293 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.538 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 0.4 OUTLIER -86.42 163.27 42.79 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.294 173.901 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.538 ' HD2' ' HB2' ' A' ' 107' ' ' GLU . 59.3 Cg_endo -69.73 -149.38 0.02 OUTLIER 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.052 1.835 . . . . 0.0 111.922 177.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.376 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 169.805 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.479 HG12 ' H ' ' A' ' 9' ' ' GLY . 10.8 tt . . . . . 0 CA--C 1.542 0.642 0 CA-C-O 121.138 0.494 . . . . 0.0 112.014 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -53.19 -34.3 56.39 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -177.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.479 ' H ' HG12 ' A' ' 7' ' ' ILE . . . -60.75 -34.48 86.9 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 121.41 -0.424 . . . . 0.0 113.487 177.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 38.8 tp -73.76 -43.69 58.32 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.363 0.601 . . . . 0.0 110.656 178.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -59.17 -36.25 74.98 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.501 174.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -66.9 -51.03 60.34 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.457 174.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.5 p -60.74 -43.24 98.16 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -177.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -57.61 -55.96 28.08 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.026 0.441 . . . . 0.0 110.492 175.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.46 ' O ' HG12 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -56.91 -34.65 68.14 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.541 177.198 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -63.89 -48.28 77.25 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 120.901 0.381 . . . . 0.0 111.765 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.443 ' HA ' ' HB2' ' A' ' 20' ' ' HIS . 49.9 m-85 -77.72 -23.17 49.48 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.725 -0.216 . . . . 0.0 111.479 176.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.78 -47.79 71.04 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 120.913 0.387 . . . . 0.0 111.09 176.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.46 HG12 ' O ' ' A' ' 15' ' ' ARG . 26.3 pt -86.47 1.61 5.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.869 178.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.443 ' HB2' ' HA ' ' A' ' 17' ' ' PHE . 34.6 t-80 -51.8 96.91 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.41 0.624 . . . . 0.0 111.737 -178.106 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 135.31 -50.32 0.86 Allowed Glycine 0 CA--C 1.525 0.705 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.068 -175.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -126.97 111.04 21.9 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 122.443 0.297 . . . . 0.0 111.283 179.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -68.4 -5.08 14.19 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 122.569 2.179 . . . . 0.0 112.417 178.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.3 pttt -93.36 0.06 56.77 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.844 177.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.86 158.94 26.62 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.052 0.454 . . . . 0.0 111.842 -178.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 31.2 p -67.14 -71.23 0.21 Allowed 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.077 -178.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 109.75 14.34 14.21 Favored Glycine 0 CA--C 1.532 1.099 0 N-CA-C 114.674 0.63 . . . . 0.0 114.674 175.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 -97.86 4.19 49.7 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 117.617 0.709 . . . . 0.0 111.468 176.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.585 ' HB3' HG21 ' A' ' 69' ' ' VAL . 31.8 mt-10 -144.9 143.53 30.62 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.042 0.537 . . . . 0.0 110.888 177.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.518 ' O ' ' HB ' ' A' ' 69' ' ' VAL . 49.4 ttm -128.8 140.69 51.59 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.06 0.457 . . . . 0.0 111.997 -177.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 27.2 p30 -93.18 164.21 13.33 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.084 0.469 . . . . 0.0 111.868 178.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.455 ' HA2' ' HB3' ' A' ' 35' ' ' TRP . . . -61.72 -25.96 66.25 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 121.386 -0.435 . . . . 0.0 113.224 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -59.08 -57.38 13.32 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 121.196 0.522 . . . . 0.0 111.474 177.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -75.94 -26.37 56.83 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.49 179.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.455 ' HB3' ' HA2' ' A' ' 32' ' ' GLY . 51.7 t-105 -62.52 -45.5 92.71 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.136 0.493 . . . . 0.0 110.875 173.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.72 -45.25 94.78 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.111 176.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -68.71 -31.25 70.2 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.653 177.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.2 tt -58.44 -56.79 17.58 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.171 0.51 . . . . 0.0 110.522 178.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.637 ' HA ' ' SG ' ' A' ' 42' ' ' CYS . 28.9 p -63.98 -35.9 82.22 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.613 -179.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -68.42 -41.42 80.42 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.804 0.335 . . . . 0.0 111.443 178.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -73.59 -31.86 63.82 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.637 ' SG ' ' HA ' ' A' ' 39' ' ' CYS . 27.9 p -89.8 -5.97 56.38 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.96 0.409 . . . . 0.0 110.711 173.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt 55.94 25.66 8.93 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.299 0.852 . . . . 0.0 113.299 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.525 HG23 ' SG ' ' A' ' 42' ' ' CYS . 79.1 t -67.54 -37.32 78.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 169.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.92 115.46 7.46 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.925 171.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -131.43 84.53 2.18 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.393 -173.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -33.18 -30.69 0.01 OUTLIER Glycine 0 CA--C 1.537 1.458 0 N-CA-C 116.011 1.165 . . . . 0.0 116.011 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -62.89 -44.6 95.67 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 118.042 0.921 . . . . 0.0 111.1 175.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.5 t -107.61 -55.66 2.32 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.026 176.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 40.9 t -109.37 109.46 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 122.788 0.435 . . . . 0.0 111.788 -177.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 66.1 p -79.58 151.91 30.38 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -56.41 -30.69 58.94 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 121.395 -0.431 . . . . 0.0 112.59 176.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.596 ' O ' HG13 ' A' ' 57' ' ' ILE . 89.2 m -61.92 -50.58 71.58 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 122.867 -0.196 . . . . 0.0 110.845 174.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.442 ' O ' HG23 ' A' ' 58' ' ' VAL . 26.7 t70 -58.22 -41.42 84.07 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.876 0.369 . . . . 0.0 110.951 179.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.1 t -58.64 -35.14 53.74 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 CA-C-O 121.183 0.516 . . . . 0.0 111.408 175.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -73.3 -38.28 65.91 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.205 0.526 . . . . 0.0 110.305 179.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.596 HG13 ' O ' ' A' ' 53' ' ' THR . 9.1 mt -62.5 -45.72 98.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.777 177.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 54' ' ' ASP . 94.2 t -58.03 -42.13 82.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.794 177.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -54.91 -43.88 73.67 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 121.178 0.514 . . . . 0.0 111.252 176.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 60.1 p -80.65 -17.48 51.09 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.834 -177.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.433 ' HD3' ' HA ' ' A' ' 61' ' ' LYS . 31.7 mmtp -84.54 -33.12 23.53 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 178.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.515 ' HB ' ' HB3' ' A' ' 74' ' ' GLU . 34.5 m -82.82 -19.63 10.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-O 121.135 0.493 . . . . 0.0 110.729 173.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.4 ttmm -61.2 127.27 30.71 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.285 177.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -71.85 152.12 48.48 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 120.94 -0.648 . . . . 0.0 111.919 171.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -53.53 -44.13 68.94 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -175.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 95.0 p -93.4 4.95 53.13 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 120.849 0.357 . . . . 0.0 111.806 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -88.66 117.58 27.72 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 120.865 0.364 . . . . 0.0 111.671 -178.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 66.3 mtp180 -70.25 -34.37 72.75 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.565 0.698 . . . . 0.0 110.227 178.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.585 HG21 ' HB3' ' A' ' 29' ' ' GLU . 32.4 m -124.82 -160.99 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.486 177.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 47.4 pt -119.9 150.02 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 O-C-N 122.051 -0.406 . . . . 0.0 111.28 173.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.48 ' ND2' ' HB2' ' A' ' 73' ' ' GLU . 4.2 p-10 -102.57 169.62 8.54 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 120.778 0.323 . . . . 0.0 111.461 179.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -54.19 -40.68 67.81 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -175.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.48 ' HB2' ' ND2' ' A' ' 71' ' ' ASN . 43.0 mt-10 -55.81 -43.53 76.98 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.819 0.342 . . . . 0.0 111.353 176.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.621 ' HA ' ' HD3' ' A' ' 77' ' ' LYS . 11.0 mm-40 -71.99 -31.69 66.49 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.009 0.433 . . . . 0.0 110.75 178.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -58.09 -43.7 87.23 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.098 176.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -54.9 -49.49 71.11 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.524 0.678 . . . . 0.0 110.987 173.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.621 ' HD3' ' HA ' ' A' ' 74' ' ' GLU . 51.0 mtpt -62.97 -36.66 84.23 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.684 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.7 -47.05 70.49 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.581 178.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 75.8 mt -59.35 -47.47 85.31 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.817 0.341 . . . . 0.0 111.195 177.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -54.22 -40.89 68.08 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 121.114 0.483 . . . . 0.0 111.224 178.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -61.18 -61.42 2.57 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.016 0.436 . . . . 0.0 111.164 176.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 80.9 mt -58.29 -30.87 66.97 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.963 0.411 . . . . 0.0 111.54 -179.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.03 -51.36 67.08 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.983 176.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 68.0 p -65.65 -17.21 64.43 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -72.22 -55.81 6.6 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 120.756 0.313 . . . . 0.0 111.593 174.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 62.5 mtp180 -81.35 -47.26 13.51 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.872 0.368 . . . . 0.0 111.668 -178.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -84.9 144.91 28.07 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.793 0.33 . . . . 0.0 110.519 177.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 41.6 mtpt -81.53 157.55 24.77 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.308 0.575 . . . . 0.0 112.096 -177.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -78.22 60.89 3.88 Favored Glycine 0 CA--C 1.528 0.897 0 CA-C-N 116.019 -0.537 . . . . 0.0 114.298 -173.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 58.7 pttt -96.3 -34.79 11.47 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.239 0.543 . . . . 0.0 110.488 173.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 32.3 t -167.26 115.8 0.81 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.141 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -65.68 -25.86 67.53 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 120.783 0.325 . . . . 0.0 110.707 174.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -57.22 -58.46 8.11 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.145 177.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -70.12 -37.7 75.39 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.305 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.51 -41.79 95.08 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.847 0.356 . . . . 0.0 111.54 178.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -67.8 -40.49 83.91 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.441 178.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -55.16 -52.67 62.57 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.421 0.629 . . . . 0.0 110.776 174.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.33 -52.62 62.92 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 115.166 -0.925 . . . . 0.0 112.581 -176.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.0 tt -59.65 -38.01 73.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 O-C-N 121.903 -0.498 . . . . 0.0 110.772 178.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 83.0 m -73.68 -24.15 59.92 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.177 175.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.94 -34.29 77.17 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.503 0.668 . . . . 0.0 109.81 175.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 94.4 mt -80.3 -25.99 39.07 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.487 177.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 76.6 t -100.57 -53.62 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -175.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -51.56 125.99 16.2 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -176.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 69.93 0.65 28.08 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-N 115.861 -0.609 . . . . 0.0 114.257 178.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.48 ' HD3' ' N ' ' A' ' 107' ' ' GLU . 11.7 tmtt? -87.79 134.63 33.64 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 121.382 0.61 . . . . 0.0 111.057 -176.04 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.48 ' N ' ' HD3' ' A' ' 106' ' ' LYS . 0.9 OUTLIER -89.12 154.61 49.49 Favored Pre-proline 0 CA--C 1.547 0.854 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -174.347 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -62.62 120.21 7.63 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 122.526 2.151 . . . . 0.0 112.37 175.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.389 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -175.116 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.521 ' N ' HD12 ' A' ' 7' ' ' ILE . 2.9 mp . . . . . 0 CA--C 1.544 0.733 0 CA-C-O 120.788 0.328 . . . . 0.0 111.004 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.64 -26.4 65.32 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.264 0.554 . . . . 0.0 111.404 179.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -55.76 -28.46 52.36 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.381 175.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 34.4 tp -58.33 -38.79 77.84 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.954 0.407 . . . . 0.0 110.704 178.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -67.85 -44.11 77.92 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 120.865 0.364 . . . . 0.0 110.246 173.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 20.5 tp10 -54.75 -47.0 74.39 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 178.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.505 ' HB3' ' HA2' ' A' ' 105' ' ' GLY . 53.9 p -67.49 -52.34 40.34 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -53.04 -47.13 68.62 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.273 0.559 . . . . 0.0 111.211 175.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -60.38 -36.14 77.36 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.261 177.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -73.34 -38.17 65.85 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.552 -178.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -74.28 -38.3 63.45 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 120.609 0.243 . . . . 0.0 111.388 176.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.94 -49.81 72.47 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.517 ' HA ' ' HB3' ' A' ' 25' ' ' ALA . 33.9 pt -78.67 6.06 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -178.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -90.73 146.07 24.29 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.984 0.421 . . . . 0.0 111.837 -177.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 79.15 -60.88 4.2 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 121.164 -0.541 . . . . 0.0 112.533 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -96.59 105.66 24.52 Favored Pre-proline 0 CA--C 1.542 0.657 0 CA-C-O 120.892 0.377 . . . . 0.0 111.115 177.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.14 -7.31 20.53 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.596 2.197 . . . . 0.0 113.387 -178.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -97.88 11.76 36.3 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 178.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.517 ' HB3' ' HA ' ' A' ' 19' ' ' ILE . . . -77.21 161.08 28.44 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.288 0.566 . . . . 0.0 112.356 -178.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 96.6 p -87.95 -45.15 10.48 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.978 -178.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.05 -19.93 31.79 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 121.393 -0.432 . . . . 0.0 112.481 -175.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 56.4 tp60 -96.54 -21.36 17.73 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.95 0.405 . . . . 0.0 110.841 177.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -125.25 129.49 50.15 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.54 178.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 54.7 ttp -125.29 148.91 48.5 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.118 0.485 . . . . 0.0 112.196 -177.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.489 ' OD1' ' HB3' ' A' ' 33' ' ' LYS . 16.9 p30 -93.07 172.09 8.53 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -177.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.547 ' HA2' ' HB3' ' A' ' 35' ' ' TRP . . . -60.83 -27.06 66.11 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-N 116.21 -0.45 . . . . 0.0 112.871 176.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.489 ' HB3' ' OD1' ' A' ' 31' ' ' ASN . 87.1 tttt -50.81 -64.47 0.8 Allowed 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 123.941 0.897 . . . . 0.0 112.117 175.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -77.42 -25.08 50.38 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.972 -0.455 . . . . 0.0 111.51 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.547 ' HB3' ' HA2' ' A' ' 32' ' ' GLY . 55.8 t-105 -59.76 -38.61 82.27 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.203 0.525 . . . . 0.0 110.462 171.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.92 -43.62 87.58 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.75 174.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -53.6 -48.75 68.97 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.647 174.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.6 mt -52.59 -49.65 64.59 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.027 0.441 . . . . 0.0 111.644 177.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 73.8 m -55.9 -42.55 76.19 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.674 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -75.34 -39.86 58.91 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.071 0.462 . . . . 0.0 111.92 -178.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -70.83 -42.51 70.1 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 122.144 -0.348 . . . . 0.0 111.277 -177.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.592 ' SG ' HG22 ' A' ' 103' ' ' VAL . 62.9 m -83.41 -12.38 56.5 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.44 176.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? 64.7 37.94 7.26 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.179 0.592 . . . . 0.0 111.957 179.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.484 HG11 HD13 ' A' ' 82' ' ' LEU . 51.6 t -75.32 -34.93 31.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-O 121.155 0.503 . . . . 0.0 110.079 173.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.72 82.09 2.08 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.481 0.657 . . . . 0.0 111.054 177.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -65.47 -40.26 92.94 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.483 -178.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.97 -38.55 3.23 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 121.392 -0.432 . . . . 0.0 112.806 -176.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -96.52 -48.08 5.69 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.18 0.514 . . . . 0.0 111.15 178.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.4 t -90.17 -44.54 9.7 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.318 178.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 54.0 t -121.51 108.88 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.499 177.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.412 ' O ' HG23 ' A' ' 55' ' ' VAL . 68.2 p -94.06 163.31 13.53 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -175.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -56.15 -44.41 88.74 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 121.19 -0.528 . . . . 0.0 112.744 176.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.592 ' O ' HG12 ' A' ' 57' ' ' ILE . 7.8 t -61.86 -41.04 97.35 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 122.53 -0.394 . . . . 0.0 110.69 175.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -59.85 -37.71 80.02 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.009 0.433 . . . . 0.0 110.584 176.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 51' ' ' THR . 76.3 t -59.39 -35.16 56.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.147 174.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -76.26 -34.39 59.15 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.817 0.817 . . . . 0.0 109.754 178.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.592 HG12 ' O ' ' A' ' 53' ' ' THR . 9.7 mm -60.61 -54.51 34.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.009 175.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.411 ' HA ' ' HB3' ' A' ' 61' ' ' LYS . 74.3 t -57.96 -40.3 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-O 120.728 0.299 . . . . 0.0 111.557 178.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -61.71 -44.13 97.51 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.045 0.45 . . . . 0.0 110.512 178.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 78.3 p -80.33 -15.06 57.77 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.108 0.48 . . . . 0.0 111.452 178.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.411 ' HB3' ' HA ' ' A' ' 58' ' ' VAL . 24.8 tptp -74.78 -49.98 18.92 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.166 0.587 . . . . 0.0 111.709 178.048 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.7 m -85.02 -24.56 7.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -179.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -57.7 131.54 50.57 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 179.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -77.68 -162.86 19.01 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-O 121.291 0.384 . . . . 0.0 113.994 179.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 21.3 ttpp -82.06 148.16 28.75 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -177.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 48.5 p 51.18 17.91 0.53 Allowed 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 173.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -110.64 146.49 36.08 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.878 0.371 . . . . 0.0 110.811 177.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 7.4 ptp85 -114.97 15.37 17.26 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.271 0.557 . . . . 0.0 110.862 178.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 22.2 m -145.72 169.86 6.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.661 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 37.2 pt -122.37 143.09 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-O 120.681 0.277 . . . . 0.0 110.885 175.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -100.72 177.79 4.89 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 120.888 0.375 . . . . 0.0 111.467 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -55.76 -27.33 50.23 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 113.159 0.799 . . . . 0.0 113.159 -175.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -70.7 -59.79 2.62 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.782 -0.574 . . . . 0.0 111.076 174.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -56.82 -32.42 65.7 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.436 0.636 . . . . 0.0 110.627 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -60.61 -51.54 68.98 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.733 176.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 37.5 mtmm -60.95 -42.72 98.78 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -59.43 -40.9 88.25 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 120.997 0.427 . . . . 0.0 110.839 175.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.02 -43.37 98.98 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.42 177.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 85.0 mt -57.7 -43.12 84.94 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.725 178.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -60.11 -46.42 89.69 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 120.722 0.296 . . . . 0.0 111.241 177.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.466 ' O ' ' HG3' ' A' ' 85' ' ' LYS . 52.5 mt-10 -59.24 -50.56 73.53 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.548 0.213 . . . . 0.0 111.274 177.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.484 HD13 HG11 ' A' ' 44' ' ' VAL . 95.9 mt -58.88 -40.32 84.02 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.023 0.439 . . . . 0.0 111.381 176.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.87 -51.41 70.16 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.807 178.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 56.2 p -65.99 -22.17 66.45 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -178.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.466 ' HG3' ' O ' ' A' ' 81' ' ' GLU . 96.9 mttt -78.23 -43.24 28.86 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 120.887 0.375 . . . . 0.0 111.225 174.338 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 26.7 tpt180 -81.32 -63.93 1.29 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.026 0.441 . . . . 0.0 111.133 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -79.16 88.18 4.87 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.361 0.6 . . . . 0.0 110.527 178.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 53.1 mttm -80.01 87.86 5.39 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.421 -173.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.402 ' O ' ' HB3' ' A' ' 90' ' ' LYS . . . -156.46 4.53 0.19 Allowed Glycine 0 CA--C 1.533 1.212 0 C-N-CA 120.86 -0.686 . . . . 0.0 114.468 178.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.402 ' HB3' ' O ' ' A' ' 89' ' ' GLY . 82.8 tttt 72.86 -43.71 0.57 Allowed 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 33.7 p -46.19 105.04 0.06 Allowed 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -175.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 46.4 mttm -60.37 -63.15 1.4 Allowed 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -176.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -54.32 -48.06 71.77 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -175.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -66.71 -44.38 81.79 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -178.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.65 -41.01 93.06 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.011 0.434 . . . . 0.0 111.426 179.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -68.75 -37.18 79.2 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.043 178.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -62.17 -49.37 76.11 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.373 0.606 . . . . 0.0 110.001 174.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -58.87 -49.89 76.07 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.296 -0.866 . . . . 0.0 112.669 -179.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.4 tp -60.89 -38.69 79.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-O 121.149 0.499 . . . . 0.0 110.904 178.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 75.0 m -73.65 -25.36 60.24 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.105 176.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -72.75 -32.4 65.64 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.024 0.44 . . . . 0.0 110.616 177.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 90.4 mt -64.16 -55.2 23.48 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.077 0.465 . . . . 0.0 110.924 173.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.592 HG22 ' SG ' ' A' ' 42' ' ' CYS . 41.2 t -69.34 -65.15 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.004 178.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 48.95 -100.46 0.07 Allowed 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.494 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.505 ' HA2' ' HB3' ' A' ' 13' ' ' SER . . . -151.13 44.18 0.68 Allowed Glycine 0 CA--C 1.523 0.54 0 C-N-CA 121.199 -0.524 . . . . 0.0 112.407 -179.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 49.6 tttm -74.37 155.33 38.24 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-O 121.141 0.496 . . . . 0.0 112.337 -177.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -66.56 137.55 95.23 Favored Pre-proline 0 CA--C 1.545 0.756 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.769 173.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -66.54 147.14 81.69 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.564 2.176 . . . . 0.0 113.898 -173.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.716 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.686 177.15 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.484 ' N ' HD12 ' A' ' 7' ' ' ILE . 3.5 mp . . . . . 0 CA--C 1.546 0.796 0 CA-C-O 121.181 0.515 . . . . 0.0 111.696 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.16 -34.95 78.72 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-O 121.329 0.585 . . . . 0.0 111.607 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -59.98 -19.95 52.13 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.698 176.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.646 HD22 ' SG ' ' A' ' 100' ' ' CYS . 43.6 tp -74.9 -38.85 61.75 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 120.713 0.292 . . . . 0.0 110.405 177.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -59.09 -41.23 87.55 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.009 173.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.542 ' O ' ' HG3' ' A' ' 16' ' ' LYS . 42.5 mt-10 -55.34 -54.45 43.5 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.207 175.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 41.7 t -55.37 -54.94 37.35 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.752 -178.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -53.55 -43.33 68.34 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.28 0.562 . . . . 0.0 110.771 176.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 63.8 ttt180 -62.36 -32.74 73.57 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.112 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.542 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 95.8 mttt -74.83 -39.37 61.67 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.564 178.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.864 ' HB3' ' SD ' ' A' ' 30' ' ' MET . 18.2 m-85 -69.67 -38.78 77.2 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 120.896 0.379 . . . . 0.0 111.43 175.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.2 -40.46 97.56 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -178.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.47 HG22 ' O ' ' A' ' 25' ' ' ALA . 29.2 pt -86.85 13.13 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-O 120.874 0.369 . . . . 0.0 111.839 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 37.6 t-80 -109.13 95.69 5.8 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.812 0.339 . . . . 0.0 111.652 -175.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 108.78 -46.55 1.15 Allowed Glycine 0 CA--C 1.521 0.457 0 C-N-CA 121.147 -0.549 . . . . 0.0 111.895 -175.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -74.3 108.34 4.97 Favored Pre-proline 0 CA--C 1.544 0.741 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 171.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -56.92 -38.73 95.26 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.752 2.301 . . . . 0.0 114.298 -169.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.5 mtpt -124.79 28.78 6.39 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -172.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.47 ' O ' HG22 ' A' ' 19' ' ' ILE . . . -74.93 123.56 25.32 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.772 0.32 . . . . 0.0 111.272 179.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 55.4 m -69.45 -2.02 10.03 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.52 -1.53 66.57 Favored Glycine 0 CA--C 1.523 0.593 0 C-N-CA 121.402 -0.428 . . . . 0.0 112.94 -178.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -86.35 -37.77 18.12 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.99 0.424 . . . . 0.0 111.775 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -116.66 131.58 56.91 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.86 -175.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.864 ' SD ' ' HB3' ' A' ' 17' ' ' PHE . 58.2 ttp -127.64 140.75 51.9 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.988 0.423 . . . . 0.0 111.801 178.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.463 ' OD1' ' HB3' ' A' ' 33' ' ' LYS . 10.9 p30 -74.79 167.69 21.34 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 121.249 0.547 . . . . 0.0 112.241 -178.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -70.95 -21.59 78.27 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-N 116.075 -0.511 . . . . 0.0 114.033 -178.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.463 ' HB3' ' OD1' ' A' ' 31' ' ' ASN . 61.5 tttp -70.88 -44.22 66.77 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 117.314 0.557 . . . . 0.0 111.052 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -72.34 -26.43 61.93 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 122.179 -0.326 . . . . 0.0 110.938 174.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 49.7 t-105 -65.45 -52.35 53.75 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 120.885 0.374 . . . . 0.0 111.167 173.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.93 -42.54 85.06 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.411 0.624 . . . . 0.0 110.583 174.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -61.04 -40.12 92.39 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.985 174.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.6 tt -55.22 -46.95 75.95 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.713 -178.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.595 ' SG ' HG21 ' A' ' 55' ' ' VAL . 15.7 p -66.1 -49.33 67.9 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.671 0.272 . . . . 0.0 111.467 -179.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.439 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 88.7 tttt -67.64 -34.62 77.31 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 120.904 0.383 . . . . 0.0 111.525 -175.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 49.0 t0 -77.8 -36.96 49.72 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 120.869 0.366 . . . . 0.0 110.824 179.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.575 ' SG ' ' HD3' ' A' ' 106' ' ' LYS . 77.7 m -87.12 4.11 43.54 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 178.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm 74.61 15.01 3.38 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 172.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 55.3 t -69.04 -32.67 55.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-O 120.788 0.328 . . . . 0.0 111.087 178.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.1 98.12 6.41 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 120.919 0.39 . . . . 0.0 111.32 178.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -90.79 -37.75 13.44 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -178.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 111.97 -25.87 12.3 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 121.286 -0.483 . . . . 0.0 113.608 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -88.87 -53.47 4.59 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.102 0.477 . . . . 0.0 110.72 178.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 64.6 m -98.22 -41.58 7.82 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.226 179.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.3 t -111.37 102.5 14.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 121.108 0.48 . . . . 0.0 110.691 175.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 48.5 p -93.4 15.02 16.74 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -176.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.6 -52.37 4.69 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.573 -173.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.595 ' O ' HG13 ' A' ' 57' ' ' ILE . 49.1 m -50.53 -46.44 57.35 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.131 0.491 . . . . 0.0 109.949 172.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -53.31 -35.31 60.01 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.109 176.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.595 HG21 ' SG ' ' A' ' 39' ' ' CYS . 56.3 t -66.01 -36.88 78.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 120.895 0.378 . . . . 0.0 110.74 177.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -69.79 -37.93 76.49 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.37 0.605 . . . . 0.0 109.886 175.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.595 HG13 ' O ' ' A' ' 53' ' ' THR . 6.8 mt -63.89 -50.42 77.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.191 178.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 71.3 t -58.55 -38.15 69.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-O 120.87 0.367 . . . . 0.0 111.34 177.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -59.11 -45.31 91.21 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.215 0.531 . . . . 0.0 110.022 176.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.441 ' HA ' ' HE2' ' A' ' 63' ' ' LYS . 80.7 p -79.14 -12.64 59.99 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.574 177.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.421 ' HE3' ' OE2' ' A' ' 81' ' ' GLU . 61.0 tttp -85.53 -21.96 28.36 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 121.303 0.573 . . . . 0.0 110.763 178.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.492 ' HB ' ' HB3' ' A' ' 74' ' ' GLU . 28.4 m -103.52 -18.85 6.49 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.564 171.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.441 ' HE2' ' HA ' ' A' ' 60' ' ' SER . 37.7 ttpt -71.77 93.37 1.29 Allowed 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 120.974 0.416 . . . . 0.0 111.53 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -93.72 -12.53 56.73 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 121.356 -0.449 . . . . 0.0 113.187 -177.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.534 ' HG2' ' N ' ' A' ' 66' ' ' SER . 22.6 ttmm -111.83 164.7 12.79 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 122.622 0.369 . . . . 0.0 110.359 178.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.534 ' N ' ' HG2' ' A' ' 65' ' ' LYS . 86.0 p -74.55 59.6 0.84 Allowed 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.373 0.606 . . . . 0.0 109.649 169.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.499 ' HB2' ' HD2' ' A' ' 65' ' ' LYS . . . -114.72 150.23 35.61 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.446 -171.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 35.0 mtp180 -90.98 -2.7 57.67 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.305 174.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 27.0 m -135.96 144.43 33.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -173.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 27.6 pt -103.21 158.86 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.964 173.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -103.42 179.42 4.28 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.172 0.511 . . . . 0.0 111.743 -178.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -67.47 -36.3 80.87 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -64.55 -57.11 10.07 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 179.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.492 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 0.9 OUTLIER -64.96 -20.46 66.49 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 122.123 -0.361 . . . . 0.0 111.312 177.034 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -63.94 -43.15 96.72 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 120.781 0.324 . . . . 0.0 110.962 173.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -55.16 -46.32 75.74 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 121.178 0.514 . . . . 0.0 110.594 174.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.431 ' O ' ' HG3' ' A' ' 81' ' ' GLU . 59.7 tttm -61.49 -50.85 71.09 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.402 177.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -53.2 -43.71 67.41 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.119 -178.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.512 HD12 HD21 ' A' ' 10' ' ' LEU . 79.9 mt -68.26 -39.86 82.09 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 178.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.512 ' O ' HG23 ' A' ' 84' ' ' THR . 38.0 tt0 -55.51 -47.2 76.62 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.309 0.576 . . . . 0.0 110.748 176.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.431 ' HG3' ' O ' ' A' ' 77' ' ' LYS . 38.0 mt-10 -65.41 -52.84 50.53 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.444 -179.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 58.9 mt -55.55 -36.72 67.09 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 122.252 -0.28 . . . . 0.0 111.428 174.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.16 -45.64 84.11 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 111.661 0.245 . . . . 0.0 111.661 179.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.512 HG23 ' O ' ' A' ' 80' ' ' GLU . 70.7 p -61.19 -29.5 69.84 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 38.4 mtpt -84.57 -48.47 9.5 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 122.026 -0.421 . . . . 0.0 111.967 173.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 32.4 tpt85 -60.05 -56.99 14.79 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.355 0.598 . . . . 0.0 111.873 -176.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -86.06 172.72 10.4 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.055 -178.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -79.58 171.43 15.16 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.259 -0.428 . . . . 0.0 112.137 -174.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -71.79 67.48 1.06 Allowed Glycine 0 CA--C 1.528 0.858 0 CA-C-N 116.034 -0.53 . . . . 0.0 113.186 178.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -119.81 174.6 6.34 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 45.9 t -44.97 123.32 3.76 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 178.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -52.2 -35.48 49.26 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.662 -178.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 -50.06 -62.84 1.34 Allowed 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.327 177.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -58.64 -42.04 87.37 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.787 0.327 . . . . 0.0 111.435 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.76 -37.41 81.74 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.079 0.466 . . . . 0.0 111.59 179.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -73.51 -46.49 47.51 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.759 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -58.45 -33.65 69.96 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.855 0.36 . . . . 0.0 110.832 174.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.457 ' O ' ' HB3' ' A' ' 101' ' ' GLN . . . -64.45 -55.34 21.49 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.867 178.112 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 19.1 tt -63.94 -34.03 65.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-O 121.033 0.445 . . . . 0.0 110.856 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' CYS . . . . . 0.646 ' SG ' HD22 ' A' ' 10' ' ' LEU . 99.2 m -66.77 -36.75 83.16 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.809 0.337 . . . . 0.0 110.858 173.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.457 ' HB3' ' O ' ' A' ' 98' ' ' ALA . 8.4 tt0 -55.95 -38.64 70.61 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.197 0.522 . . . . 0.0 110.791 175.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 91.1 mt -68.04 -50.97 51.97 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.322 177.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 39.0 t -83.98 -45.97 18.18 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -171.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -52.58 136.89 31.69 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 -173.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 79.44 -35.2 2.01 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-N 116.282 -0.417 . . . . 0.0 113.763 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.575 ' HD3' ' SG ' ' A' ' 42' ' ' CYS . 63.4 tttp -59.77 159.51 8.74 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.349 0.66 . . . . 0.0 112.669 -177.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -124.77 151.02 67.45 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.989 179.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -64.47 120.84 8.25 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 122.573 2.182 . . . . 0.0 113.231 178.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.498 0 CA-C-O 121.214 0.53 . . . . 0.0 112.154 178.786 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.428 HG22 ' H ' ' A' ' 10' ' ' LEU . 41.3 mm . . . . . 0 N--CA 1.478 0.927 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.42 -45.86 57.76 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.012 0.434 . . . . 0.0 111.485 178.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.24 -18.45 35.37 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 121.223 -0.513 . . . . 0.0 112.863 177.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.438 HD11 HD11 ' A' ' 79' ' ' LEU . 34.1 tp -74.48 -36.83 63.3 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.895 0.379 . . . . 0.0 110.132 175.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -59.03 -43.18 91.58 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.437 0.637 . . . . 0.0 109.533 173.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 56.3 tt0 -58.53 -55.87 29.5 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.236 176.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 73.7 m -54.58 -47.44 73.3 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.628 179.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.409 ' CD1' ' HE3' ' A' ' 30' ' ' MET . 73.4 t80 -58.38 -44.16 88.77 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.005 0.431 . . . . 0.0 110.781 176.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 47.9 ttt180 -60.85 -47.41 86.5 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.719 -179.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -65.25 -40.28 93.78 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.619 178.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.429 ' HB3' ' HE2' ' A' ' 30' ' ' MET . 6.2 m-85 -73.07 -29.69 63.14 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 177.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.09 -47.03 78.68 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.112 0.482 . . . . 0.0 111.078 178.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 17.7 pt -88.88 5.94 4.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-O 121.208 0.527 . . . . 0.0 111.798 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -69.45 93.12 0.64 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.03 0.443 . . . . 0.0 110.806 177.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 81.26 45.89 7.25 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 -170.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.471 ' CB ' ' HB2' ' A' ' 25' ' ' ALA . 11.3 p-10 -64.16 120.83 67.89 Favored Pre-proline 0 CA--C 1.542 0.649 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -168.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -84.63 -26.39 1.66 Allowed 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.107 1.871 . . . . 0.0 111.96 166.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 47.7 mttp -157.02 67.14 0.53 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.596 0.758 . . . . 0.0 110.095 176.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.471 ' HB2' ' CB ' ' A' ' 22' ' ' ASP . . . -55.34 91.29 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 179.047 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 66.4 m -104.31 -29.39 10.8 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 120.968 0.413 . . . . 0.0 110.202 169.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.43 22.73 6.94 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 121.214 -0.517 . . . . 0.0 114.243 173.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -146.11 0.78 0.84 Allowed 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 117.363 0.582 . . . . 0.0 112.213 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 20.5 mp0 -114.29 121.48 43.78 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 120.683 0.278 . . . . 0.0 111.74 -175.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.429 ' HE2' ' HB3' ' A' ' 17' ' ' PHE . 52.0 ttm -119.85 134.34 55.27 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.876 0.369 . . . . 0.0 111.406 175.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 18.5 p30 -95.22 165.32 12.45 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.065 0.46 . . . . 0.0 111.702 178.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.78 -31.92 77.35 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 121.321 -0.466 . . . . 0.0 113.255 178.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -58.41 -53.62 56.22 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 177.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -70.42 -33.73 71.68 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 111.595 0.22 . . . . 0.0 111.595 179.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 40.0 t-105 -58.07 -47.13 84.09 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.122 0.487 . . . . 0.0 111.565 175.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.25 -49.37 72.15 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.982 0.42 . . . . 0.0 111.351 178.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -68.28 -22.35 64.74 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 178.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.6 tt -62.55 -52.39 63.6 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.542 0.687 . . . . 0.0 109.475 172.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 81.9 m -58.34 -38.6 77.49 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.211 177.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.1 ttmp? -68.69 -44.08 74.73 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 111.919 0.341 . . . . 0.0 111.919 177.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -67.85 -33.19 74.29 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -173.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.964 ' SG ' ' HB3' ' A' ' 102' ' ' LEU . 52.2 t -107.45 1.04 23.25 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-O 121.104 0.478 . . . . 0.0 110.75 175.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.446 ' N ' ' HD2' ' A' ' 43' ' ' LYS . 0.1 OUTLIER 63.09 38.2 10.95 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.793 -0.639 . . . . 0.0 112.155 175.83 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 48.5 t -62.89 -27.7 43.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-O 121.343 0.592 . . . . 0.0 110.386 173.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.563 ' HB1' HG11 ' A' ' 50' ' ' VAL . . . -57.58 115.75 2.96 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.101 170.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.564 ' C ' HG22 ' A' ' 50' ' ' VAL . 11.0 t70 -144.22 -50.14 0.29 Allowed 'General case' 0 C--O 1.221 -0.444 0 CA-C-O 119.311 -0.376 . . . . 0.0 111.662 -170.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -2.45 47.81 0.0 OUTLIER Glycine 0 N--CA 1.475 1.239 0 N-CA-C 116.389 1.316 . . . . 0.0 116.389 -164.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.546 ' N ' ' O ' ' A' ' 46' ' ' ASP . 25.0 ttpp 56.42 3.75 0.12 Allowed 'General case' 0 CA--C 1.552 1.046 0 CA-C-O 121.297 0.57 . . . . 0.0 111.704 -177.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.8 m 171.98 -27.35 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.92 1.288 . . . . 0.0 109.163 -168.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.564 HG22 ' C ' ' A' ' 46' ' ' ASP . 0.2 OUTLIER 63.58 158.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 124.994 1.317 . . . . 0.0 111.855 -179.541 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.22 -12.32 6.31 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.67 -177.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.79 -67.89 1.63 Allowed Glycine 0 CA--C 1.526 0.759 0 C-N-CA 121.361 -0.447 . . . . 0.0 112.47 -175.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.555 ' O ' HG12 ' A' ' 57' ' ' ILE . 51.8 m -48.57 -38.45 20.62 Favored 'General case' 0 C--O 1.223 -0.309 0 C-N-CA 122.275 0.23 . . . . 0.0 111.138 175.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.435 ' O ' HG23 ' A' ' 58' ' ' VAL . 24.1 t70 -51.87 -47.4 64.52 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.991 0.424 . . . . 0.0 111.148 176.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.6 t -61.74 -35.45 67.64 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 CA-C-O 121.186 0.517 . . . . 0.0 110.788 177.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -73.42 -30.24 63.1 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.6 0.714 . . . . 0.0 110.244 178.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.555 HG12 ' O ' ' A' ' 53' ' ' THR . 5.5 mm -70.31 -41.94 78.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.02 177.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 54' ' ' ASP . 88.8 t -58.83 -43.8 89.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 120.777 0.322 . . . . 0.0 110.9 176.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -58.13 -41.69 84.23 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.206 0.527 . . . . 0.0 110.44 174.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 28.9 t -73.63 -24.01 59.96 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.769 176.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 55.3 tttp -71.88 -38.57 70.0 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 122.901 0.48 . . . . 0.0 111.248 -176.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.3 m -91.1 -9.52 10.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-O 121.018 0.437 . . . . 0.0 111.34 174.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.582 ' HG3' ' HB3' ' A' ' 67' ' ' ALA . 39.7 ttmt -68.92 118.86 12.38 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.776 179.386 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -75.52 63.47 2.63 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 121.306 -0.473 . . . . 0.0 113.318 178.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.6 mttt 60.66 101.93 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 178.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.0 t 63.66 11.96 6.18 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 175.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.582 ' HB3' ' HG3' ' A' ' 63' ' ' LYS . . . -69.39 98.75 1.12 Allowed 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.983 0.42 . . . . 0.0 110.912 177.031 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 58.3 mtm180 -64.5 -16.42 62.48 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -177.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 31.2 m -136.14 148.65 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-O 120.793 0.33 . . . . 0.0 111.318 177.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 35.3 pt -115.23 166.07 9.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 121.024 0.44 . . . . 0.0 111.864 178.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.404 ' OD1' ' HB2' ' A' ' 73' ' ' GLU . 8.5 p30 -111.52 172.15 7.06 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.187 179.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.513 ' O ' ' HG3' ' A' ' 76' ' ' LYS . 59.6 t80 -61.62 -42.99 99.66 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -178.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.404 ' HB2' ' OD1' ' A' ' 71' ' ' ASN . 6.4 mp0 -55.54 -55.57 30.39 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -177.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.57 -30.62 68.45 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 122.276 -0.265 . . . . 0.0 111.664 177.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -55.1 -38.71 68.49 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.059 0.457 . . . . 0.0 111.032 175.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.513 ' HG3' ' O ' ' A' ' 72' ' ' TYR . 6.5 mtpm? -55.95 -47.82 76.9 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.979 175.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.428 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 4.3 mptp? -67.46 -34.36 77.02 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.477 178.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.6 -39.73 92.27 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.125 0.488 . . . . 0.0 111.113 175.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.438 HD11 HD11 ' A' ' 10' ' ' LEU . 69.8 mt -66.64 -41.06 88.87 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.408 175.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -51.94 -44.9 64.13 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 120.966 0.413 . . . . 0.0 111.357 176.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.595 ' O ' ' HG2' ' A' ' 85' ' ' LYS . 1.2 tm-20 -60.98 -66.5 0.52 Allowed 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.442 177.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.422 ' O ' ' HG3' ' A' ' 86' ' ' ARG . 73.6 mt -52.37 -31.52 34.15 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.476 ' HB2' HG21 ' A' ' 99' ' ' ILE . . . -62.95 -51.92 65.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.934 0.397 . . . . 0.0 111.114 177.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.6 ' HB ' ' HA2' ' A' ' 89' ' ' GLY . 69.3 p -62.45 -31.55 72.29 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.244 178.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.595 ' HG2' ' O ' ' A' ' 81' ' ' GLU . 6.2 mmmm -61.71 -29.22 69.96 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.356 176.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.422 ' HG3' ' O ' ' A' ' 82' ' ' LEU . 60.6 mtp180 -96.02 -63.83 1.11 Allowed 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.371 0.605 . . . . 0.0 111.915 179.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.422 ' O ' ' HB2' ' A' ' 88' ' ' LYS . 64.3 m-85 -84.83 46.18 1.23 Allowed 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.839 -0.618 . . . . 0.0 112.39 -170.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.524 ' NZ ' ' HB2' ' A' ' 88' ' ' LYS . 8.4 mtmp? 70.79 114.89 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.962 0.505 . . . . 0.0 111.725 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.6 ' HA2' ' HB ' ' A' ' 84' ' ' THR . . . -65.69 78.81 0.09 OUTLIER Glycine 0 CA--C 1.526 0.778 0 CA-C-N 116.018 -0.537 . . . . 0.0 113.604 -178.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 47.0 tttm -159.51 -77.27 0.07 Allowed 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 48.1 m -75.22 108.2 7.82 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -172.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 20.0 ttmm -60.35 -45.6 92.89 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.778 177.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.46 ' CD ' ' H ' ' A' ' 93' ' ' GLU . 21.6 mp0 -60.86 -57.67 11.68 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.313 0.578 . . . . 0.0 111.108 -175.035 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -55.87 -52.01 65.56 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.761 179.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.38 -45.32 91.8 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.987 -178.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -65.6 -48.09 73.46 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.651 -0.249 . . . . 0.0 111.524 -178.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -55.56 -47.34 76.53 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.902 0.382 . . . . 0.0 111.702 177.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.42 -51.42 65.82 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.476 HG21 ' HB2' ' A' ' 83' ' ' ALA . 16.5 tt -63.57 -33.97 64.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 O-C-N 122.006 -0.434 . . . . 0.0 111.385 -178.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 96.5 m -68.7 -37.08 79.27 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.86 0.362 . . . . 0.0 110.593 173.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -59.12 -28.23 66.34 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 121.216 0.532 . . . . 0.0 110.734 176.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.964 ' HB3' ' SG ' ' A' ' 42' ' ' CYS . 53.6 mt -79.74 -58.11 3.34 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.86 175.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.6 t -79.22 -51.11 17.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -173.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.53 119.4 7.45 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -172.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 93.89 -16.34 61.08 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-N 116.183 -0.462 . . . . 0.0 113.825 179.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.443 ' O ' ' HG2' ' A' ' 107' ' ' GLU . 60.1 tttm -74.01 -49.12 25.75 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 117.183 0.491 . . . . 0.0 112.173 -178.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.443 ' HG2' ' O ' ' A' ' 106' ' ' LYS . 7.1 pt-20 54.4 161.16 0.06 OUTLIER Pre-proline 0 CA--C 1.557 1.228 0 C-N-CA 124.295 1.038 . . . . 0.0 112.397 -174.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -51.48 118.56 4.5 Favored 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 122.414 2.076 . . . . 0.0 113.641 -176.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.488 0 CA-C-O 121.312 0.577 . . . . 0.0 111.968 179.586 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.5 mp . . . . . 0 N--CA 1.475 0.812 0 CA-C-O 120.903 0.383 . . . . 0.0 110.677 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.96 -44.88 78.91 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.039 0.447 . . . . 0.0 111.543 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.44 -25.78 63.4 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 121.127 -0.559 . . . . 0.0 113.168 177.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 45.4 tp -72.57 -42.6 64.44 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 122.535 -0.391 . . . . 0.0 110.659 178.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -57.56 -47.47 81.96 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.909 0.385 . . . . 0.0 110.783 175.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.603 ' O ' ' HD3' ' A' ' 16' ' ' LYS . 44.6 mt-10 -62.79 -43.28 99.22 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.491 177.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.533 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . 38.7 t -54.65 -54.07 46.52 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 120.768 0.318 . . . . 0.0 111.428 178.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -56.73 -42.83 79.9 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.212 0.529 . . . . 0.0 110.844 175.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 33.5 ttt180 -56.57 -45.91 81.03 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.712 -179.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.603 ' HD3' ' O ' ' A' ' 12' ' ' GLU . 5.0 mptp? -66.52 -55.64 14.6 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 178.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -64.04 -28.37 69.75 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -178.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.08 -54.15 45.39 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.986 0.422 . . . . 0.0 111.333 177.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 29.1 pt -80.81 4.56 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 CA-C-N 116.147 -0.478 . . . . 0.0 112.026 -178.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -61.83 -36.39 81.04 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -175.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -125.89 0.1 7.75 Favored Glycine 0 N--CA 1.465 0.58 0 C-N-CA 120.852 -0.689 . . . . 0.0 113.079 -179.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -155.43 89.89 2.95 Favored Pre-proline 0 CA--C 1.542 0.653 0 CA-C-O 121.192 0.52 . . . . 0.0 111.006 -178.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -52.23 -29.71 38.97 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.086 2.524 . . . . 0.0 113.965 -177.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -80.41 3.83 20.03 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.083 0.468 . . . . 0.0 111.654 -176.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.409 ' HB1' ' O ' ' A' ' 29' ' ' GLU . . . -63.9 -31.8 73.1 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.71 170.04 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 30.6 t 58.69 20.12 7.48 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.499 176.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 70.25 11.82 68.15 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.793 -176.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.405 HE21 ' HB3' ' A' ' 28' ' ' GLN . 6.2 tt0 -93.44 -38.31 11.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.231 0.539 . . . . 0.0 110.834 177.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.453 ' HB3' ' CG2' ' A' ' 69' ' ' VAL . 39.3 mt-10 -131.53 154.24 49.0 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.425 -172.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 52.1 ttm -137.88 136.31 36.98 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.809 0.338 . . . . 0.0 111.176 177.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.544 HD21 ' ND2' ' A' ' 34' ' ' ASN . 10.8 p30 -89.73 166.44 13.57 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.134 0.492 . . . . 0.0 111.916 -179.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.62 -21.86 69.34 Favored Glycine 0 CA--C 1.531 1.046 0 CA-C-N 116.024 -0.535 . . . . 0.0 114.283 -177.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.434 ' HB3' ' OD1' ' A' ' 31' ' ' ASN . 62.8 tttp -74.22 -52.43 12.42 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 117.413 0.607 . . . . 0.0 111.151 179.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.544 ' ND2' HD21 ' A' ' 31' ' ' ASN . 71.8 m-20 -63.67 -38.36 90.82 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.811 0.338 . . . . 0.0 110.687 176.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.439 ' CD1' ' HB2' ' A' ' 59' ' ' PHE . 43.3 t-105 -60.24 -38.78 84.5 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.425 174.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.21 -45.45 93.14 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.482 177.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -74.13 -32.72 63.29 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 120.866 -0.334 . . . . 0.0 111.102 176.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.7 tt -51.33 -51.35 55.19 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.035 0.445 . . . . 0.0 110.399 177.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 75.0 m -69.13 -49.94 52.42 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.11 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -64.7 -47.55 77.94 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 112.041 0.385 . . . . 0.0 112.041 -176.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -64.88 -34.64 78.87 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 121.033 0.444 . . . . 0.0 110.956 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.809 ' HA ' ' HE2' ' A' ' 106' ' ' LYS . 68.5 m -90.07 1.61 56.16 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.352 174.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 52.1 mttm 53.07 34.39 17.08 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 176.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.616 ' HA ' HH11 ' A' ' 86' ' ' ARG . 49.0 t -64.89 -37.58 80.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 121.566 0.698 . . . . 0.0 109.556 167.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -98.83 51.36 0.97 Allowed 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.51 173.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -64.99 -27.92 69.16 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 116.072 -0.513 . . . . 0.0 112.023 -175.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 138.2 -62.51 0.57 Allowed Glycine 0 CA--C 1.527 0.823 0 C-N-CA 121.046 -0.597 . . . . 0.0 113.497 -178.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.677 ' H ' ' HD2' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -71.19 20.03 0.05 Allowed 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -175.653 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 49.2 m -153.71 -64.58 0.14 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.214 0.531 . . . . 0.0 110.887 176.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.58 HG11 HD22 ' A' ' 82' ' ' LEU . 58.8 t -121.18 151.92 24.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.863 -179.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 71.4 p -118.59 154.32 32.82 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 122.343 0.257 . . . . 0.0 111.121 177.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -52.18 -41.64 54.1 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 121.398 -0.429 . . . . 0.0 113.349 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.412 ' O ' HG12 ' A' ' 57' ' ' ILE . 63.0 m -55.84 -49.31 73.65 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.097 0.475 . . . . 0.0 110.834 176.004 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.4 ' O ' HG23 ' A' ' 58' ' ' VAL . 24.6 t70 -62.01 -37.33 84.47 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.928 178.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 70.0 t -57.34 -36.3 52.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.85 176.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -69.27 -43.91 72.95 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 122.01 0.91 . . . . 0.0 109.583 178.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.412 HG12 ' O ' ' A' ' 53' ' ' THR . 7.9 mm -62.22 -45.53 98.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-N 114.584 -1.189 . . . . 0.0 111.621 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.478 ' O ' HG12 ' A' ' 62' ' ' VAL . 73.9 t -56.91 -47.82 82.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.525 177.051 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.439 ' HB2' ' CD1' ' A' ' 35' ' ' TRP . 80.0 t80 -50.85 -51.05 55.03 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.026 0.441 . . . . 0.0 111.183 177.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 29.2 t -71.01 -29.34 65.26 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.572 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -64.78 -36.95 85.96 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.536 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.508 HG21 ' HB2' ' A' ' 77' ' ' LYS . 3.7 p -94.93 -22.14 5.49 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 178.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -56.45 134.79 54.2 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -67.96 83.49 0.17 Allowed Glycine 0 CA--C 1.532 1.113 0 C-N-CA 121.333 -0.461 . . . . 0.0 113.816 176.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 61.9 mttp 53.13 -90.47 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 175.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 36.5 t -128.22 29.62 5.33 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.983 0.42 . . . . 0.0 111.212 -174.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -73.97 5.76 3.96 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 179.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 44.5 mtp180 68.36 -64.48 0.3 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.531 0.733 . . . . 0.0 112.125 -176.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.537 HG12 ' HA ' ' A' ' 31' ' ' ASN . 24.4 m -117.92 170.04 7.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.134 -172.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.417 ' HB ' ' HB2' ' A' ' 74' ' ' GLU . 39.4 pt -109.75 152.79 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.293 178.073 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -92.36 178.45 5.83 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.045 0.45 . . . . 0.0 111.381 175.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.5 ' O ' ' HB3' ' A' ' 75' ' ' PHE . 75.5 t80 -58.45 -41.87 86.09 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -174.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -70.51 -34.05 71.88 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.993 -0.442 . . . . 0.0 111.384 -178.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.417 ' HB2' ' HB ' ' A' ' 70' ' ' ILE . 52.3 mt-10 -68.9 -34.29 75.18 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.434 0.635 . . . . 0.0 110.012 174.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.5 ' HB3' ' O ' ' A' ' 72' ' ' TYR . 61.1 t80 -58.22 -43.03 87.52 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.823 170.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.481 ' HG3' ' O ' ' A' ' 72' ' ' TYR . 47.0 mtpt -60.03 -37.86 81.02 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.743 0.306 . . . . 0.0 111.021 176.042 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.508 ' HB2' HG21 ' A' ' 62' ' ' VAL . 94.6 mttt -65.0 -38.45 91.01 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.159 0.504 . . . . 0.0 110.89 177.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.98 -39.73 93.91 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.058 176.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 84.2 mt -61.36 -49.78 75.55 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.832 175.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -51.56 -44.39 62.71 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.2 0.524 . . . . 0.0 111.605 175.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -60.53 -63.7 1.21 Allowed 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.511 178.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.58 HD22 HG11 ' A' ' 50' ' ' VAL . 75.1 mt -58.71 -38.18 77.76 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -178.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.4 ' HB1' ' HB1' ' A' ' 95' ' ' ALA . . . -61.78 -47.74 83.8 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.607 0.241 . . . . 0.0 111.546 178.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 50.5 p -65.84 -19.56 65.93 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 178.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -81.28 -38.41 26.89 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 120.774 0.321 . . . . 0.0 111.444 172.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.616 HH11 ' HA ' ' A' ' 44' ' ' VAL . 36.7 mtp180 -79.28 -58.73 3.07 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -98.3 -164.46 1.14 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.393 -173.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -62.71 119.58 9.56 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -178.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -72.34 61.56 1.47 Allowed Glycine 0 CA--C 1.528 0.901 0 C-N-CA 120.902 -0.666 . . . . 0.0 111.555 171.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -163.29 -50.68 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.93 0.395 . . . . 0.0 111.099 -169.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 48.4 t -94.45 120.95 35.47 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.611 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -75.82 -60.77 2.17 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -178.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -61.76 -36.74 81.9 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -174.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -62.21 -60.15 3.99 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.088 0.471 . . . . 0.0 111.428 177.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.4 ' HB1' ' HB1' ' A' ' 83' ' ' ALA . . . -58.07 -42.39 85.43 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.913 -178.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -70.52 -40.37 73.52 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.412 -177.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -62.79 -53.52 53.04 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.125 0.488 . . . . 0.0 110.354 177.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -55.94 -52.54 63.77 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.644 -178.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 14.4 tt -60.92 -39.84 83.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 O-C-N 122.115 -0.366 . . . . 0.0 111.23 -179.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 95.9 m -70.56 -30.24 66.91 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.829 0.347 . . . . 0.0 111.042 176.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -64.42 -30.27 71.31 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.231 0.539 . . . . 0.0 110.762 178.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 82.8 mt -77.82 -18.42 56.35 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 177.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.464 HG13 ' SG ' ' A' ' 42' ' ' CYS . 41.3 t -114.56 -54.54 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -172.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.533 ' HA ' ' HB2' ' A' ' 13' ' ' SER . . . -52.12 112.08 0.73 Allowed 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -172.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 81.98 -2.99 82.24 Favored Glycine 0 CA--C 1.527 0.814 0 CA-C-N 115.908 -0.587 . . . . 0.0 114.463 173.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.809 ' HE2' ' HA ' ' A' ' 42' ' ' CYS . 22.1 ttpp -70.64 -28.05 64.52 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 117.602 0.701 . . . . 0.0 112.22 -178.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.521 ' HG2' ' O ' ' A' ' 106' ' ' LYS . 1.5 pt-20 72.7 155.46 0.16 Allowed Pre-proline 0 N--CA 1.481 1.079 0 C-N-CA 124.049 0.94 . . . . 0.0 111.904 -178.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -73.08 113.04 3.67 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 122.808 2.338 . . . . 0.0 111.628 174.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.62 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -174.411 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.2 tp . . . . . 0 CA--C 1.547 0.828 0 CA-C-O 121.225 0.535 . . . . 0.0 111.255 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -49.22 -41.46 37.36 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -175.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.84 -36.59 80.64 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 121.03 -0.605 . . . . 0.0 113.51 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.589 HD13 ' HB2' ' A' ' 104' ' ' ALA . 24.7 tp -78.24 -39.99 38.59 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 122.46 -0.435 . . . . 0.0 110.868 -179.37 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.584 ' HB3' ' NH2' ' A' ' 15' ' ' ARG . 45.3 mt-10 -55.77 -42.26 75.22 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.428 0.632 . . . . 0.0 110.657 173.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.481 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 8.7 tp10 -57.13 -55.57 33.08 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.389 177.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.429 ' HB3' ' O ' ' A' ' 108' ' ' PRO . 75.0 m -47.06 -51.23 18.06 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.324 174.132 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.413 ' N ' ' HB3' ' A' ' 109' ' ' ALA . 62.4 t80 -51.32 -46.35 62.56 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.696 -0.627 . . . . 0.0 111.196 -178.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.584 ' NH2' ' HB3' ' A' ' 11' ' ' GLU . 0.5 OUTLIER -70.02 -46.15 65.69 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 111.849 0.315 . . . . 0.0 111.849 177.838 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.524 ' O ' ' HB2' ' A' ' 20' ' ' HIS . 75.8 mmtt -53.99 -42.78 69.41 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.164 0.507 . . . . 0.0 110.854 178.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.624 ' CD1' ' HA ' ' A' ' 108' ' ' PRO . 0.2 OUTLIER -73.58 -34.39 65.09 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.859 -177.114 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.672 ' HA ' ' SD ' ' A' ' 30' ' ' MET . . . -66.98 -58.13 5.54 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.155 0.502 . . . . 0.0 112.048 -177.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 30.7 pt -80.49 -0.09 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 121.432 0.634 . . . . 0.0 111.052 -178.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.524 ' HB2' ' O ' ' A' ' 16' ' ' LYS . 37.2 t-80 -52.16 -45.59 65.11 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.316 -0.856 . . . . 0.0 112.289 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -112.14 10.03 26.94 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.771 -0.728 . . . . 0.0 114.516 -173.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -157.23 127.31 3.34 Favored Pre-proline 0 CA--C 1.545 0.78 0 CA-C-N 117.628 0.714 . . . . 0.0 111.438 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.54 -26.65 13.8 Favored 'Trans proline' 0 CA--C 1.544 0.992 0 C-N-CA 122.754 2.303 . . . . 0.0 113.611 -178.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -96.3 0.98 51.59 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -176.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.73 134.25 51.37 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 120.832 0.349 . . . . 0.0 111.846 178.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.4 t -57.43 -34.46 68.96 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.474 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.72 15.1 76.45 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 121.246 -0.502 . . . . 0.0 113.126 177.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -124.85 -26.15 3.81 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.199 0.523 . . . . 0.0 110.987 178.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -122.81 128.25 50.19 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.694 -178.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.672 ' SD ' ' HA ' ' A' ' 18' ' ' ALA . 10.9 tpp -114.08 152.29 31.28 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -176.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.522 ' ND2' ' HB2' ' A' ' 33' ' ' LYS . 13.7 p-10 -97.27 164.4 12.49 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -179.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.75 -29.03 69.15 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-N 116.069 -0.514 . . . . 0.0 113.959 -179.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.522 ' HB2' ' ND2' ' A' ' 31' ' ' ASN . 5.2 mmmm -51.75 -45.05 63.54 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 175.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.516 ' ND2' ' SD ' ' A' ' 30' ' ' MET . 4.5 m-20 -72.94 -25.71 61.13 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.777 -179.158 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 40.0 t-105 -66.88 -45.0 79.42 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.042 0.448 . . . . 0.0 111.0 175.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.2 -47.76 84.65 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.233 0.539 . . . . 0.0 110.945 175.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -63.83 -32.79 74.42 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.689 177.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.597 HD11 ' HA ' ' A' ' 109' ' ' ALA . 2.6 tt -58.16 -55.22 37.82 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.221 0.534 . . . . 0.0 110.263 179.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.58 ' SG ' ' HB2' ' A' ' 45' ' ' ALA . 45.9 t -58.86 -43.95 90.95 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.529 -179.417 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 28.9 ttpp -66.78 -41.51 87.53 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 120.878 0.37 . . . . 0.0 111.562 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -63.0 -48.59 78.17 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.274 0.559 . . . . 0.0 110.822 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.44 ' SG ' HG22 ' A' ' 103' ' ' VAL . 83.9 m -82.32 -3.28 55.04 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.675 179.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt 59.92 28.3 17.78 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.199 0.523 . . . . 0.0 112.02 175.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 47.9 t -67.36 -33.35 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.695 174.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.58 ' HB2' ' SG ' ' A' ' 39' ' ' CYS . . . -61.95 86.77 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.395 0.616 . . . . 0.0 111.079 175.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -63.69 -47.45 81.12 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.473 -178.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 125.13 -33.51 3.65 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 121.126 -0.559 . . . . 0.0 113.186 -178.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.5 pttt -129.32 -28.64 2.31 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 177.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 90.9 p -88.55 -39.82 13.86 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 121.055 0.455 . . . . 0.0 110.377 171.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 91.2 t -132.99 116.62 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.776 174.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 27.1 p -111.8 175.72 5.31 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.874 0.369 . . . . 0.0 111.088 178.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -58.92 -29.11 64.41 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.105 172.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.64 ' O ' HG13 ' A' ' 57' ' ' ILE . 44.3 m -61.51 -57.72 11.0 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 110.318 -0.253 . . . . 0.0 110.318 174.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -48.61 -42.51 34.26 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.96 0.41 . . . . 0.0 111.618 178.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 95.5 t -56.35 -45.71 81.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.625 177.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -71.79 -32.76 67.96 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 120.837 0.351 . . . . 0.0 111.275 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.64 HG13 ' O ' ' A' ' 53' ' ' THR . 9.3 mt -66.23 -54.44 26.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.721 178.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.442 HG11 ' CD1' ' A' ' 82' ' ' LEU . 93.9 t -54.2 -47.37 67.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 120.805 0.336 . . . . 0.0 111.68 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.513 ' O ' ' HG2' ' A' ' 63' ' ' LYS . 55.2 t80 -56.99 -38.28 72.83 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 120.803 0.335 . . . . 0.0 110.638 178.277 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 37.5 m -81.33 -18.78 44.51 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 178.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.435 ' HG2' ' O ' ' A' ' 57' ' ' ILE . 32.4 mmtp -73.26 -43.88 60.34 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 179.05 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.51 HG11 ' HB2' ' A' ' 78' ' ' ALA . 7.1 m -70.03 -45.0 77.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.513 ' HG2' ' O ' ' A' ' 59' ' ' PHE . 22.2 ptmt -81.2 166.34 20.69 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.369 0.604 . . . . 0.0 112.509 -176.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -104.18 -94.36 2.32 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.165 174.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -131.84 -57.56 0.98 Allowed 'General case' 0 N--CA 1.473 0.706 0 O-C-N 122.426 -0.455 . . . . 0.0 111.832 176.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 37.8 m -77.45 65.27 2.96 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -176.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -160.79 111.86 1.82 Allowed 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.977 0.418 . . . . 0.0 111.676 179.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.86 -26.9 17.44 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.794 0.33 . . . . 0.0 110.822 175.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 26.0 m -120.57 174.07 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 121.102 0.477 . . . . 0.0 111.955 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.9 pp -135.39 165.76 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -172.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.6 ' OD1' ' HB2' ' A' ' 74' ' ' GLU . 24.7 p-10 -111.79 -179.82 3.81 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.231 -178.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.622 ' O ' ' HB3' ' A' ' 75' ' ' PHE . 65.9 t80 -85.84 -46.18 10.87 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -176.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -62.05 -31.5 71.92 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.462 -0.774 . . . . 0.0 111.472 -175.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.6 ' HB2' ' OD1' ' A' ' 71' ' ' ASN . 0.4 OUTLIER -73.12 -36.27 66.68 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.751 -0.204 . . . . 0.0 111.134 171.822 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.622 ' HB3' ' O ' ' A' ' 72' ' ' TYR . 41.7 t80 -46.09 -41.95 12.95 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 172.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -57.84 -41.74 82.95 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 121.238 0.542 . . . . 0.0 111.658 174.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -72.09 -43.6 64.54 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 121.13 0.49 . . . . 0.0 111.082 -179.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.51 ' HB2' HG11 ' A' ' 62' ' ' VAL . . . -60.92 -44.61 96.96 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.843 177.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.468 HD11 ' CZ ' ' A' ' 75' ' ' PHE . 34.1 mt -52.32 -46.0 65.83 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 122.079 -0.388 . . . . 0.0 111.61 172.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -54.15 -38.25 65.3 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 121.094 0.473 . . . . 0.0 110.94 177.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.439 ' HB3' ' O ' ' A' ' 78' ' ' ALA . 16.6 tp10 -59.47 -51.23 70.76 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.995 174.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.442 ' CD1' HG11 ' A' ' 58' ' ' VAL . 8.8 mp -60.63 -47.62 85.42 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 111.841 0.312 . . . . 0.0 111.841 178.386 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.36 -46.28 69.51 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.851 0.358 . . . . 0.0 111.867 -178.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 69.2 p -67.55 -34.59 77.37 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.19 -0.459 . . . . 0.0 112.115 179.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.452 ' HB3' ' HZ2' ' A' ' 85' ' ' LYS . 8.3 mtpm? -80.11 -28.55 38.98 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 179.177 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -85.85 -55.26 4.05 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.07 0.462 . . . . 0.0 110.73 -176.319 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -96.75 50.52 1.12 Allowed 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.45 -177.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -59.64 99.82 0.07 Allowed 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.304 0.573 . . . . 0.0 111.483 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 136.14 -30.61 2.71 Favored Glycine 0 CA--C 1.521 0.43 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.774 -176.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -86.01 144.04 27.8 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 122.796 0.439 . . . . 0.0 110.585 176.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 43.6 t -59.07 134.78 57.29 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 122.412 -0.18 . . . . 0.0 111.345 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -52.2 -36.69 52.75 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -174.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -66.03 -51.61 56.7 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 120.869 0.366 . . . . 0.0 111.242 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -64.39 -37.21 86.71 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 121.072 0.463 . . . . 0.0 111.366 176.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.69 -43.97 91.81 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.994 0.425 . . . . 0.0 111.561 178.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -62.81 -39.28 93.81 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.114 0.483 . . . . 0.0 110.758 177.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -60.16 -51.62 68.81 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.534 176.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.82 -51.87 67.46 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.247 -178.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.3 tt -58.73 -42.97 86.74 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 CA-C-O 120.808 0.337 . . . . 0.0 111.119 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 74.7 m -68.96 -28.72 66.88 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.727 0.299 . . . . 0.0 111.267 177.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -64.41 -33.0 74.85 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.07 0.462 . . . . 0.0 110.989 178.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 81.0 mt -77.12 -20.41 55.67 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 116.176 -0.465 . . . . 0.0 112.062 178.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.44 HG22 ' SG ' ' A' ' 42' ' ' CYS . 60.2 t -105.91 -61.5 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -173.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.589 ' HB2' HD13 ' A' ' 10' ' ' LEU . . . -57.73 147.9 26.46 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -175.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 98.01 -35.9 4.28 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 121.157 -0.544 . . . . 0.0 113.265 177.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -79.04 -77.33 0.17 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 117.029 0.414 . . . . 0.0 111.525 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.524 ' CG ' ' HD3' ' A' ' 108' ' ' PRO . 11.1 pt-20 -176.29 -33.65 0.0 OUTLIER Pre-proline 0 CA--C 1.553 1.088 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 -179.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.624 ' HA ' ' CD1' ' A' ' 17' ' ' PHE . 50.6 Cg_exo -68.08 142.77 57.29 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 122.553 2.169 . . . . 0.0 115.646 176.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.597 ' HA ' HD11 ' A' ' 38' ' ' LEU . . . . . . . . 0 N--CA 1.489 1.501 0 CA-C-N 115.054 -0.975 . . . . 0.0 112.107 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.553 HD11 ' HB3' ' A' ' 100' ' ' CYS . 30.3 pt . . . . . 0 N--CA 1.472 0.642 0 CA-C-O 121.226 0.536 . . . . 0.0 111.681 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.77 -31.92 70.12 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.909 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.8 -31.76 64.81 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 121.215 -0.517 . . . . 0.0 113.028 177.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 36.8 tp -70.89 -43.77 67.67 Favored 'General case' 0 N--CA 1.467 0.383 0 O-C-N 122.73 -0.277 . . . . 0.0 110.773 178.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.2 tm-20 -57.78 -46.87 83.99 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.273 175.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.419 ' O ' ' HB2' ' A' ' 16' ' ' LYS . 33.5 tt0 -57.24 -49.61 75.5 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.575 177.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 56.9 m -63.36 -50.02 71.57 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -178.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -54.88 -48.53 72.85 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.216 0.531 . . . . 0.0 110.558 176.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.484 ' HG3' ' HA3' ' A' ' 27' ' ' GLY . 23.2 ttt180 -63.7 -37.95 89.27 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.084 178.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.419 ' HB2' ' O ' ' A' ' 12' ' ' GLU . 32.6 ttmt -59.32 -42.12 90.65 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.041 -178.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -79.9 -32.2 40.25 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 174.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.52 -34.35 75.38 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -178.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 27.9 pt -95.7 14.22 3.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-O 120.98 0.419 . . . . 0.0 111.685 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 75.1 t60 -64.75 -16.81 63.49 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -176.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -105.35 -38.57 2.42 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 120.959 -0.639 . . . . 0.0 113.396 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -162.18 148.98 11.05 Favored Pre-proline 0 CA--C 1.541 0.618 0 O-C-N 122.688 -0.301 . . . . 0.0 111.652 -175.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.12 -2.9 12.74 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.651 2.234 . . . . 0.0 113.401 -178.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -85.97 -18.74 31.78 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.068 0.461 . . . . 0.0 110.862 178.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -76.54 54.19 0.92 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.353 170.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 38.0 t -25.58 -53.43 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 -170.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.484 ' HA3' ' HG3' ' A' ' 15' ' ' ARG . . . 147.95 58.93 0.01 OUTLIER Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.629 -179.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -134.95 -19.17 1.79 Allowed 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 120.751 0.31 . . . . 0.0 111.5 -178.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -152.72 151.87 31.03 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -171.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.441 ' O ' HD13 ' A' ' 70' ' ' ILE . 42.8 ttm -136.58 149.63 48.16 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.61 -179.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -97.36 168.35 10.46 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.119 0.485 . . . . 0.0 111.948 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.08 -32.77 81.56 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-N 116.185 -0.461 . . . . 0.0 114.181 -177.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -62.51 -52.26 64.16 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 117.053 0.426 . . . . 0.0 111.732 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -69.13 -40.3 78.35 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.594 0.235 . . . . 0.0 110.999 177.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.498 ' NE1' ' HB2' ' A' ' 59' ' ' PHE . 24.9 t-105 -56.36 -42.27 77.52 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.113 0.482 . . . . 0.0 111.747 175.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.07 -51.93 65.97 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.572 179.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -69.32 -27.41 65.35 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.19 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.0 tt -57.38 -56.91 15.77 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.058 0.456 . . . . 0.0 110.198 176.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 86.3 m -60.49 -47.83 84.4 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.997 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -67.48 -41.71 84.15 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -176.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.407 ' OD2' ' NZ ' ' A' ' 106' ' ' LYS . 37.5 t70 -77.51 -29.96 52.7 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 120.741 0.305 . . . . 0.0 111.623 -178.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 62.2 m -90.7 -0.44 57.7 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 120.697 0.284 . . . . 0.0 111.429 176.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt 71.47 22.06 4.31 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 173.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 50.7 t -68.02 -28.45 41.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 CA-C-O 121.144 0.497 . . . . 0.0 110.99 174.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -89.65 121.03 31.45 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.254 174.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -79.48 -66.19 0.9 Allowed 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -173.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.432 ' O ' ' HB2' ' A' ' 48' ' ' LYS . . . 130.34 119.46 2.13 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 -168.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.432 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 75.2 mmtt 80.74 -15.94 0.7 Allowed 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.646 0.779 . . . . 0.0 111.936 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 42.4 t -122.03 -83.23 0.66 Allowed 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 173.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 84.1 t -87.56 111.7 22.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 120.894 0.378 . . . . 0.0 110.617 172.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.442 ' O ' HG23 ' A' ' 55' ' ' VAL . 72.8 p -125.58 -179.93 4.86 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.935 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -50.78 -35.44 31.11 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 121.031 -0.604 . . . . 0.0 113.195 178.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.578 ' O ' HG13 ' A' ' 57' ' ' ILE . 27.6 m -60.8 -58.41 8.57 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.738 0.304 . . . . 0.0 110.797 176.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -53.34 -41.45 65.78 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.976 179.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 51' ' ' THR . 93.6 t -56.91 -39.51 65.67 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.74 177.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -73.82 -37.84 64.75 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.292 0.568 . . . . 0.0 110.4 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.578 HG13 ' O ' ' A' ' 53' ' ' THR . 11.4 mt -60.33 -48.42 88.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.943 178.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 89.7 t -62.48 -43.69 98.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.64 177.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.498 ' HB2' ' NE1' ' A' ' 35' ' ' TRP . 86.7 t80 -50.23 -47.66 54.9 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.109 0.481 . . . . 0.0 111.938 178.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 35.8 t -82.04 -16.7 49.29 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.06 0.457 . . . . 0.0 111.614 -179.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -76.09 -38.22 57.24 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.95 -179.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.1 m -87.07 -5.92 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -176.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.6 pttp -119.88 -176.92 3.28 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.09 0.472 . . . . 0.0 111.692 -178.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -105.1 -178.03 24.36 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-N 116.291 -0.413 . . . . 0.0 113.424 177.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -75.49 -39.79 58.1 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -178.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 43.4 t -66.47 -35.95 81.54 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 120.917 0.389 . . . . 0.0 111.868 -178.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -93.4 122.44 35.82 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 120.967 0.413 . . . . 0.0 111.327 178.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 70.7 mtp180 -94.25 5.64 51.14 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.112 0.482 . . . . 0.0 110.683 175.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.9 m -129.63 159.91 41.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.921 179.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.502 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -114.4 150.7 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-O 120.967 0.413 . . . . 0.0 111.297 175.946 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.413 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 2.9 p-10 -104.78 172.25 6.89 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.296 178.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -46.49 -54.18 9.78 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -169.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.403 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 0.7 OUTLIER -64.46 -44.86 89.76 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 120.983 0.421 . . . . 0.0 111.347 -176.035 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -65.71 -33.96 77.1 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.203 0.525 . . . . 0.0 110.838 179.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -57.62 -44.09 85.25 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.6 172.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.403 ' HE2' ' HA ' ' A' ' 73' ' ' GLU . 52.8 mtmt -69.08 -33.7 73.94 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.231 176.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -60.54 -37.92 82.79 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.251 0.548 . . . . 0.0 110.292 173.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.08 -41.91 97.15 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.745 172.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 88.6 mt -62.31 -33.7 75.19 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.398 175.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -61.07 -49.64 76.52 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 120.735 0.302 . . . . 0.0 110.833 175.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -55.56 -58.01 9.54 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.111 0.482 . . . . 0.0 111.085 174.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 94.0 mt -56.71 -44.46 81.6 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.036 -179.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.69 -45.2 87.64 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -179.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 81.8 p -72.44 -12.29 61.04 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -178.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -93.72 -47.45 6.78 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 120.685 0.279 . . . . 0.0 111.502 172.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 76.7 mtp180 -70.63 -49.87 42.88 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 121.176 0.512 . . . . 0.0 111.85 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -106.55 38.59 2.02 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.881 -177.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -57.87 90.97 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.97 -178.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -160.8 44.81 0.41 Allowed Glycine 0 CA--C 1.526 0.772 0 C-N-CA 121.076 -0.583 . . . . 0.0 113.446 179.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 60.9 mttm 70.71 -60.68 0.5 Allowed 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 177.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 25.6 m -56.78 87.91 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -175.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -66.36 -43.48 85.88 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.703 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -54.03 -61.07 2.54 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.836 0.35 . . . . 0.0 110.886 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -56.72 -41.6 77.74 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.691 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.24 -43.5 92.39 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.924 0.393 . . . . 0.0 111.282 177.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -68.69 -49.06 62.01 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.963 -179.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.532 ' O ' ' HG3' ' A' ' 101' ' ' GLN . 1.5 m-20 -55.5 -44.54 76.66 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 111.545 0.202 . . . . 0.0 111.545 175.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.67 -57.55 11.55 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.019 0.437 . . . . 0.0 112.108 -179.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.0 tt -57.62 -29.74 35.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-O 121.245 0.545 . . . . 0.0 110.474 178.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' CYS . . . . . 0.553 ' HB3' HD11 ' A' ' 7' ' ' ILE . 90.6 m -82.26 -18.98 40.53 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.963 175.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.532 ' HG3' ' O ' ' A' ' 97' ' ' ASP . 24.4 mt-30 -64.91 -33.94 77.23 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 121.669 -0.644 . . . . 0.0 109.853 171.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 81.1 mt -75.58 -11.1 59.95 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.557 177.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.411 ' O ' ' HB3' ' A' ' 106' ' ' LYS . 64.5 t -121.48 -51.16 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -173.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -49.45 113.8 0.9 Allowed 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -175.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.39 -31.25 5.85 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 121.401 -0.428 . . . . 0.0 113.293 -179.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.411 ' HB3' ' O ' ' A' ' 103' ' ' VAL . 26.3 tptp -47.02 133.21 11.52 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.571 0.748 . . . . 0.0 112.602 -178.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -83.48 155.82 65.82 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.319 178.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -79.83 139.34 13.82 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.589 2.193 . . . . 0.0 113.17 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.509 0 CA-C-O 121.214 0.531 . . . . 0.0 111.301 178.913 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.474 ' N ' HD12 ' A' ' 7' ' ' ILE . 2.3 mp . . . . . 0 CA--C 1.543 0.683 0 CA-C-O 121.264 0.554 . . . . 0.0 110.797 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.41 -35.65 72.36 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.329 -177.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -56.66 -31.4 60.47 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 121.131 -0.557 . . . . 0.0 113.131 179.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.453 HD11 ' HE2' ' A' ' 75' ' ' PHE . 54.7 tp -70.45 -53.73 15.22 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 120.776 0.322 . . . . 0.0 111.314 178.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -63.36 -39.01 93.36 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 122.185 -0.322 . . . . 0.0 111.533 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -57.79 -56.52 20.92 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.831 0.348 . . . . 0.0 111.095 175.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.707 ' HB3' ' HB2' ' A' ' 107' ' ' GLU . 65.7 m -67.79 -44.34 77.61 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -176.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -50.01 -51.94 38.0 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 121.187 0.518 . . . . 0.0 111.145 171.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.418 HH11 ' HD3' ' A' ' 15' ' ' ARG . 32.1 ttt180 -60.55 -44.23 96.35 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.832 179.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.569 ' HD3' HD11 ' A' ' 19' ' ' ILE . 0.1 OUTLIER -68.85 -27.89 66.22 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.844 -179.441 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -78.52 -33.12 48.25 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.177 0.513 . . . . 0.0 110.199 177.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.38 -38.35 77.98 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.447 177.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.569 HD11 ' HD3' ' A' ' 16' ' ' LYS . 27.0 pt -94.11 14.45 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 120.877 0.37 . . . . 0.0 111.039 178.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -52.85 97.3 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.101 0.477 . . . . 0.0 111.477 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 120.73 -36.2 3.44 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.656 -176.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.445 ' O ' ' HB ' ' A' ' 19' ' ' ILE . 11.7 m-20 -121.54 91.4 48.41 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 122.76 0.424 . . . . 0.0 111.946 -178.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -71.35 -2.87 11.9 Favored 'Trans proline' 0 CA--C 1.545 1.026 0 C-N-CA 122.517 2.145 . . . . 0.0 113.549 -178.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 8.7 mtpm? -88.35 -7.0 57.38 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -178.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.414 ' HB3' HG22 ' A' ' 19' ' ' ILE . . . -93.73 157.57 16.09 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.615 0.245 . . . . 0.0 111.321 178.163 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 28.3 t -88.36 -19.16 27.02 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 120.989 0.423 . . . . 0.0 110.776 177.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.438 ' HA3' HG23 ' A' ' 19' ' ' ILE . . . 63.87 56.6 17.82 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 115.606 1.002 . . . . 0.0 115.606 170.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -96.57 -8.56 31.53 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.518 0.675 . . . . 0.0 109.793 169.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.583 ' HB3' HG21 ' A' ' 69' ' ' VAL . 50.9 mt-10 -113.08 111.61 22.42 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.432 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 42.3 ttm -98.86 133.32 43.32 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.146 0.498 . . . . 0.0 111.553 176.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.416 ' ND2' ' HB2' ' A' ' 33' ' ' LYS . 13.9 p-10 -86.86 156.92 19.67 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.531 179.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -58.25 -28.2 61.32 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-N 116.24 -0.437 . . . . 0.0 113.212 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.416 ' HB2' ' ND2' ' A' ' 31' ' ' ASN . 47.4 mmtm -57.7 -59.5 5.11 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.045 0.45 . . . . 0.0 111.336 176.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.403 ' O ' ' HB2' ' A' ' 38' ' ' LEU . 87.7 m-20 -64.66 -38.76 92.1 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.872 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 45.5 t-105 -56.17 -49.06 75.06 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 120.901 0.382 . . . . 0.0 111.798 177.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.04 -47.08 86.33 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.205 0.526 . . . . 0.0 111.751 178.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.455 ' NZ ' ' HB3' ' A' ' 37' ' ' LYS . 7.8 mtpm? -67.26 -29.98 69.74 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.336 179.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.403 ' HB2' ' O ' ' A' ' 34' ' ' ASN . 5.1 tt -62.3 -49.3 76.18 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.169 0.509 . . . . 0.0 110.081 177.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 78.9 m -58.53 -44.28 89.52 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.442 178.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -69.9 -33.66 72.48 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 120.992 0.425 . . . . 0.0 111.388 179.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -64.1 -38.66 91.88 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.418 0.628 . . . . 0.0 110.822 177.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.491 ' HA ' ' HE2' ' A' ' 106' ' ' LYS . 59.1 m -99.2 0.76 43.98 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.039 -177.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.432 ' N ' ' HD2' ' A' ' 43' ' ' LYS . 3.3 mptp? 59.2 31.28 21.1 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.337 176.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.455 HG11 ' HB3' ' A' ' 82' ' ' LEU . 32.5 t -70.3 -37.44 71.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-O 121.486 0.66 . . . . 0.0 109.39 170.098 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.19 85.46 6.8 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.505 169.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -169.76 78.68 0.1 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.785 -171.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -176.72 37.29 0.09 OUTLIER Glycine 0 CA--C 1.522 0.506 0 C-N-CA 120.708 -0.758 . . . . 0.0 113.434 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.1 mtpm? 50.23 14.67 0.16 Allowed 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 178.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.7 m -150.54 -60.08 0.19 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.885 0.374 . . . . 0.0 110.509 -175.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 41.0 t -68.29 90.36 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 172.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 49.2 p -129.0 -171.09 2.39 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.103 -178.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -48.04 -36.86 15.58 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 121.476 -0.392 . . . . 0.0 113.686 -178.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.58 ' O ' HG12 ' A' ' 57' ' ' ILE . 4.8 t -64.32 -55.85 18.49 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 122.334 -0.51 . . . . 0.0 111.358 178.37 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.414 ' N ' HG23 ' A' ' 53' ' ' THR . 12.9 t70 -62.7 -40.03 95.87 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.04 0.448 . . . . 0.0 110.994 -177.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 84.3 t -61.69 -31.03 49.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.417 176.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -82.03 -30.91 31.23 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.334 0.588 . . . . 0.0 109.55 179.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.58 HG12 ' O ' ' A' ' 53' ' ' THR . 10.4 mm -61.24 -52.38 62.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.9 174.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.8 t -58.53 -42.74 85.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 120.919 0.39 . . . . 0.0 110.945 176.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -57.82 -40.82 80.9 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.355 0.598 . . . . 0.0 110.869 175.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 37.3 m -82.59 -11.72 58.21 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.486 178.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.678 ' HE2' ' HA ' ' A' ' 61' ' ' LYS . 0.6 OUTLIER -76.95 -50.41 13.28 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.838 176.972 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 31.4 m -67.63 -25.94 34.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.548 175.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -69.34 104.98 2.4 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.829 174.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -91.15 -61.35 1.27 Allowed Glycine 0 CA--C 1.526 0.778 0 C-N-CA 121.081 -0.581 . . . . 0.0 113.299 -178.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 10.3 mtmp? -121.55 -152.63 0.52 Allowed 'General case' 0 CA--C 1.542 0.66 0 O-C-N 122.524 -0.398 . . . . 0.0 111.014 -178.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 39.3 t -62.72 91.19 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.425 0.631 . . . . 0.0 111.917 -176.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -160.12 108.51 1.7 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.771 178.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.7 ttm-85 -70.36 -44.64 67.71 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.349 0.595 . . . . 0.0 111.113 -177.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.583 HG21 ' HB3' ' A' ' 29' ' ' GLU . 27.6 m -95.64 170.92 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.385 -175.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 34.6 pt -121.22 149.63 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.394 176.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -99.46 171.4 7.97 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.93 0.395 . . . . 0.0 111.389 178.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -57.99 -35.49 71.3 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -176.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.5 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 39.5 mm-40 -61.39 -53.27 58.81 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.799 0.333 . . . . 0.0 111.499 178.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -65.97 -28.06 68.62 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.907 0.384 . . . . 0.0 110.939 178.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.453 ' HE2' HD11 ' A' ' 10' ' ' LEU . 88.5 t80 -60.7 -47.99 83.78 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.183 175.05 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.5 ' HE2' ' HA ' ' A' ' 73' ' ' GLU . 53.4 mtmt -58.01 -47.08 84.1 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.919 0.39 . . . . 0.0 110.782 176.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -56.75 -42.9 80.13 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.154 0.502 . . . . 0.0 111.249 175.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.21 -42.87 99.35 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.375 177.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 88.2 mt -58.32 -41.57 84.83 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.294 177.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -63.76 -36.6 84.41 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 120.88 0.372 . . . . 0.0 111.192 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -63.76 -61.06 2.55 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 120.634 0.254 . . . . 0.0 111.122 172.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.455 ' HB3' HG11 ' A' ' 44' ' ' VAL . 11.2 mp -50.71 -40.49 54.3 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.196 0.522 . . . . 0.0 111.851 179.001 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.96 -53.33 59.29 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.743 175.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 69.2 p -74.32 -10.4 59.55 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -86.96 -45.86 10.4 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.105 0.479 . . . . 0.0 111.414 174.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.4 -49.04 9.05 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.882 -176.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -82.61 -178.45 7.08 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.156 0.503 . . . . 0.0 111.068 179.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -93.96 142.02 27.85 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.848 177.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -76.19 56.33 3.21 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 121.356 -0.449 . . . . 0.0 114.177 -176.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 29.0 ttpp -83.59 -31.78 26.12 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.208 0.527 . . . . 0.0 110.323 175.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.529 ' HB3' ' HB3' ' A' ' 94' ' ' GLU . 30.8 t -162.37 126.16 3.06 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.812 178.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 50.7 tttm -69.31 -47.09 65.5 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.777 0.323 . . . . 0.0 111.811 -178.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -64.47 -40.9 96.57 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 120.78 0.324 . . . . 0.0 110.986 178.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.529 ' HB3' ' HB3' ' A' ' 91' ' ' SER . 34.5 tt0 -65.67 -43.48 89.2 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.803 0.335 . . . . 0.0 111.257 177.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.95 -35.52 73.28 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.885 0.374 . . . . 0.0 110.978 175.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -64.87 -42.66 94.64 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.864 176.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -64.69 -38.51 91.26 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 120.933 0.396 . . . . 0.0 110.972 176.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.59 -51.31 60.65 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.679 179.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 16.5 tt -62.6 -33.2 58.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-O 120.941 0.4 . . . . 0.0 110.343 177.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' CYS . . . . . 0.506 ' SG ' ' HB3' ' A' ' 104' ' ' ALA . 39.7 t -65.43 -34.12 77.55 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.82 0.343 . . . . 0.0 110.851 172.154 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -69.7 -22.32 63.42 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.506 178.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 80.4 mt -95.55 -36.61 11.21 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.059 0.457 . . . . 0.0 111.987 175.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 81.9 t -96.8 -65.69 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 112.554 0.575 . . . . 0.0 112.554 -174.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.506 ' HB3' ' SG ' ' A' ' 100' ' ' CYS . . . -51.38 109.38 0.34 Allowed 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -168.074 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 107.25 -38.09 3.5 Favored Glycine 0 CA--C 1.522 0.479 0 C-N-CA 121.174 -0.536 . . . . 0.0 112.849 178.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.491 ' HE2' ' HA ' ' A' ' 42' ' ' CYS . 14.7 ttpp -78.86 -63.37 1.43 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.836 0.35 . . . . 0.0 110.549 178.281 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.707 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 25.6 mt-10 29.72 -88.03 0.0 OUTLIER Pre-proline 0 CA--C 1.557 1.219 0 N-CA-C 115.161 1.541 . . . . 0.0 115.161 177.121 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.65 ' HD3' ' HB2' ' A' ' 107' ' ' GLU . 6.8 Cg_exo -74.22 79.22 2.45 Favored 'Trans proline' 0 C--N 1.367 1.552 0 CA-C-N 123.306 2.216 . . . . 0.0 112.004 177.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.763 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -177.067 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.7 mm . . . . . 0 CA--C 1.539 0.522 0 CA-C-O 120.745 0.307 . . . . 0.0 110.465 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 66.23 -68.41 0.13 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.166 0.586 . . . . 0.0 112.098 -178.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -51.15 -28.56 18.89 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 121.615 -0.326 . . . . 0.0 113.496 178.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 51.6 tp -64.56 -38.48 91.17 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 120.719 0.295 . . . . 0.0 111.052 176.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.615 ' O ' ' HD3' ' A' ' 15' ' ' ARG . 39.9 tt0 -67.09 -46.14 75.14 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 177.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.454 ' O ' ' HG3' ' A' ' 16' ' ' LYS . 1.1 mp0 -51.79 -46.22 64.13 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.744 0.307 . . . . 0.0 111.156 172.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 70.6 m -58.95 -41.68 88.04 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.684 -0.234 . . . . 0.0 111.253 176.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -58.29 -46.85 85.32 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.645 176.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.615 ' HD3' ' O ' ' A' ' 11' ' ' GLU . 1.8 mpt_? -54.93 -55.85 26.1 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.121 175.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.454 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 67.1 mttm -54.32 -45.14 72.56 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -176.037 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -69.75 -39.49 76.69 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 111.728 0.27 . . . . 0.0 111.728 176.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.69 -53.6 38.83 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -177.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.53 HG12 ' O ' ' A' ' 15' ' ' ARG . 25.8 pt -78.8 -1.84 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 -176.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -56.06 -33.98 65.51 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.082 0.467 . . . . 0.0 110.656 175.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.57 59.83 4.93 Favored Glycine 0 CA--C 1.522 0.516 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.838 175.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 68.57 124.05 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 123.199 0.6 . . . . 0.0 111.338 -173.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.522 ' HA ' ' HB ' ' A' ' 19' ' ' ILE . 81.8 Cg_exo -47.57 -30.62 12.45 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 123.145 2.564 . . . . 0.0 114.237 -178.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -75.35 3.33 9.25 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 178.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.36 -52.04 66.97 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 111.868 0.321 . . . . 0.0 111.868 179.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 99.7 p 177.74 -70.55 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.004 0.431 . . . . 0.0 111.563 -179.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 107.46 -26.08 19.44 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 111.925 -0.47 . . . . 0.0 111.925 -174.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -115.88 -15.91 11.2 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.028 0.531 . . . . 0.0 111.101 178.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.456 ' HB3' HG21 ' A' ' 69' ' ' VAL . 8.7 mm-40 -111.9 145.7 39.07 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.715 -176.198 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 53.1 ttm -133.87 135.29 43.59 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 120.556 0.217 . . . . 0.0 111.146 178.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 36.1 p30 -94.13 168.85 10.67 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.17 0.51 . . . . 0.0 112.277 -178.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.15 -27.6 70.81 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-N 116.033 -0.531 . . . . 0.0 113.768 -179.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -62.89 -58.94 5.66 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.39 0.614 . . . . 0.0 111.199 178.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -64.18 -35.83 82.09 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.164 178.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 50.3 t-105 -62.2 -42.92 99.73 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.625 175.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.11 -45.72 86.77 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 121.131 0.491 . . . . 0.0 111.309 177.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.4 mtpp -64.83 -45.04 87.83 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.298 175.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.3 tt -46.02 -43.88 14.71 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.134 0.492 . . . . 0.0 111.182 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 79.3 m -68.48 -46.4 69.8 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 120.979 0.418 . . . . 0.0 111.588 176.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -65.91 -52.86 46.29 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.785 0.326 . . . . 0.0 111.84 -177.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -55.27 -38.47 68.62 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 122.954 0.502 . . . . 0.0 111.257 176.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.687 ' SG ' ' HA ' ' A' ' 103' ' ' VAL . 83.4 m -85.94 -4.12 59.09 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 175.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.9 mtmm 52.76 41.3 31.56 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 178.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 57.9 t -78.34 -35.4 19.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 121.316 0.579 . . . . 0.0 110.32 171.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -102.56 79.22 1.79 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.637 178.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -60.35 -27.09 67.1 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.5 -29.33 12.75 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 121.196 -0.526 . . . . 0.0 111.977 -172.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -74.05 -61.65 1.78 Allowed 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 120.937 0.398 . . . . 0.0 110.9 176.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 69.0 p -90.05 -74.01 0.5 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.088 0.471 . . . . 0.0 110.506 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 89.0 t -89.19 135.27 26.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.365 174.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 43.6 p -124.05 173.53 8.21 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 120.883 0.373 . . . . 0.0 111.538 -177.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -54.84 -34.29 56.95 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 121.24 -0.505 . . . . 0.0 112.753 177.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.655 ' O ' HG13 ' A' ' 57' ' ' ILE . 89.3 m -53.61 -57.56 10.33 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 122.382 0.273 . . . . 0.0 111.102 176.443 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -52.43 -42.99 64.59 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.252 179.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 80.1 t -55.93 -43.96 76.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.851 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -73.55 -33.31 64.62 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.04 0.448 . . . . 0.0 111.115 -179.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.655 HG13 ' O ' ' A' ' 53' ' ' THR . 7.8 mt -64.42 -49.13 82.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.626 177.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 93.0 t -60.84 -43.38 95.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-O 120.786 0.327 . . . . 0.0 111.435 178.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -58.15 -35.16 71.13 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.17 0.509 . . . . 0.0 111.261 178.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 38.9 t -87.83 -21.84 24.81 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.743 177.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -68.13 -41.22 81.99 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 122.631 0.372 . . . . 0.0 111.969 -176.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.6 m -82.44 -21.26 9.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-O 121.245 0.545 . . . . 0.0 111.533 177.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.452 ' HD3' ' O ' ' A' ' 67' ' ' ALA . 39.4 ttmt -74.08 156.7 37.17 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -175.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -91.58 -128.02 4.11 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 121.538 -0.363 . . . . 0.0 113.184 175.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -100.54 -77.79 0.53 Allowed 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 81.2 p -76.94 -4.92 46.42 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -172.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.452 ' O ' ' HD3' ' A' ' 63' ' ' LYS . . . -68.88 121.06 15.8 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.106 0.479 . . . . 0.0 111.501 178.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 67.3 mtt180 -85.3 -32.31 22.58 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.198 0.523 . . . . 0.0 110.882 178.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.456 HG21 ' HB3' ' A' ' 29' ' ' GLU . 30.9 m -127.34 171.46 15.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.706 -176.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 36.3 pt -117.49 170.58 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 CA-C-O 120.581 0.229 . . . . 0.0 111.032 177.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -126.82 -179.97 5.08 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 -179.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.502 ' O ' ' HB3' ' A' ' 75' ' ' PHE . 70.6 t80 -34.73 -62.66 0.35 Allowed 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 -174.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -64.61 -38.57 91.46 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 121.798 -0.564 . . . . 0.0 112.014 -175.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -62.41 -37.22 84.97 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.219 0.533 . . . . 0.0 110.333 176.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.502 ' HB3' ' O ' ' A' ' 72' ' ' TYR . 60.8 t80 -57.03 -45.98 82.72 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.586 176.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.438 ' HE3' ' CZ ' ' A' ' 72' ' ' TYR . 81.2 mttt -61.39 -38.74 88.15 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.859 0.361 . . . . 0.0 111.7 178.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -71.69 -30.46 65.7 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.712 0.292 . . . . 0.0 111.531 176.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.31 -46.71 85.41 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.123 0.487 . . . . 0.0 110.687 173.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 86.9 mt -63.74 -34.95 79.01 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.107 175.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -62.0 -43.62 98.45 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 121.089 0.471 . . . . 0.0 110.93 178.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -59.79 -58.98 6.23 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.028 0.442 . . . . 0.0 111.284 173.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 90.9 mt -56.12 -42.01 76.17 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.949 -178.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.58 -51.78 68.44 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.799 0.333 . . . . 0.0 111.633 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 68.6 p -66.37 -20.7 66.14 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -178.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -102.38 -13.97 17.08 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 48.7 tpt85 -98.38 -60.79 1.48 Allowed 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.196 0.522 . . . . 0.0 110.975 177.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -77.38 -178.98 5.46 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.918 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 19.8 tptm -62.29 133.87 55.73 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.612 177.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -77.07 61.72 3.39 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 121.174 -0.536 . . . . 0.0 114.129 -173.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -165.77 153.52 10.67 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.979 0.389 . . . . 0.0 111.51 176.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 44.1 t 65.47 86.76 0.13 Allowed 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.91 -175.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 55.0 tttp -45.73 -41.78 11.07 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.295 175.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -57.38 -60.83 3.05 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.7 178.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -59.97 -43.75 94.88 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.82 0.343 . . . . 0.0 111.845 -176.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.61 -48.21 80.41 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -66.69 -48.11 70.3 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.278 -178.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.461 ' O ' ' HG3' ' A' ' 101' ' ' GLN . 4.2 m-20 -54.58 -49.36 70.57 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.748 0.309 . . . . 0.0 111.376 176.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -55.32 -51.94 65.1 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -178.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.8 tt -66.67 -33.16 61.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 CA-C-O 120.885 0.374 . . . . 0.0 111.235 -179.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 86.5 m -65.27 -34.82 79.24 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.824 0.345 . . . . 0.0 110.8 173.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.461 ' HG3' ' O ' ' A' ' 97' ' ' ASP . 28.9 mt-30 -64.78 -31.09 72.16 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.33 175.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 87.8 mt -72.91 -38.38 66.9 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 176.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.687 ' HA ' ' SG ' ' A' ' 42' ' ' CYS . 58.4 t -92.18 -57.4 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -174.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.91 98.41 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -170.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 85.17 5.39 85.68 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 114.99 0.756 . . . . 0.0 114.99 170.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 50.5 tttp -83.41 -2.04 54.89 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 118.015 0.908 . . . . 0.0 111.856 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 74.04 148.34 0.12 Allowed Pre-proline 0 N--CA 1.478 0.964 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 173.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -74.92 81.95 2.09 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.844 2.363 . . . . 0.0 112.168 176.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.718 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.863 179.676 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.429 HG12 ' H ' ' A' ' 9' ' ' GLY . 9.0 tt . . . . . 0 CA--C 1.541 0.623 0 CA-C-O 120.941 0.4 . . . . 0.0 111.158 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -52.62 -33.81 48.28 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.429 ' H ' HG12 ' A' ' 7' ' ' ILE . . . -60.2 -37.08 92.39 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 121.224 -0.513 . . . . 0.0 112.921 178.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.423 ' HB2' HG23 ' A' ' 7' ' ' ILE . 46.7 tp -60.89 -42.72 98.53 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.947 0.403 . . . . 0.0 110.522 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -57.33 -44.95 84.67 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.133 174.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.608 ' O ' ' HG3' ' A' ' 16' ' ' LYS . 32.3 mt-10 -61.44 -49.38 77.06 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.594 0.235 . . . . 0.0 110.954 179.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.457 ' HA ' ' HD2' ' A' ' 16' ' ' LYS . 47.4 m -57.48 -45.97 84.23 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.065 0.459 . . . . 0.0 111.312 178.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -58.77 -44.64 90.68 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.175 0.512 . . . . 0.0 110.408 175.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.742 HH11 ' HA3' ' A' ' 27' ' ' GLY . 3.0 tpt180 -56.16 -43.4 78.29 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.202 177.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.608 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 88.7 mttt -58.88 -54.67 44.49 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.036 -178.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -70.51 -33.4 71.17 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.93 -15.92 63.83 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -177.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.442 HG12 ' O ' ' A' ' 15' ' ' ARG . 31.9 pt -113.95 20.12 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-O 121.468 0.652 . . . . 0.0 111.126 175.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 50.0 t60 -67.9 -17.37 64.45 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -177.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -101.1 -42.83 2.33 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 120.933 -0.651 . . . . 0.0 113.558 -179.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.53 ' HB2' ' HB2' ' A' ' 25' ' ' ALA . 5.0 m-20 -116.41 157.26 46.06 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 122.733 0.413 . . . . 0.0 110.893 -177.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -69.91 -13.73 34.69 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.306 2.004 . . . . 0.0 113.198 -178.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -132.79 -38.85 0.99 Allowed 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.006 0.432 . . . . 0.0 110.374 172.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.53 ' HB2' ' HB2' ' A' ' 22' ' ' ASP . . . 47.07 -87.68 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -179.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 70.0 m -163.69 -56.73 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.384 0.612 . . . . 0.0 110.433 -175.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.742 ' HA3' HH11 ' A' ' 15' ' ' ARG . . . 92.26 -34.51 4.41 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-N 115.934 -0.576 . . . . 0.0 113.238 -178.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -99.97 0.92 42.04 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 121.079 0.466 . . . . 0.0 111.001 177.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.46 ' HB3' HG21 ' A' ' 69' ' ' VAL . 44.9 mt-10 -124.88 112.34 16.52 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.162 -179.299 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 50.6 ttm -107.68 145.08 33.86 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.78 0.324 . . . . 0.0 111.109 178.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -109.73 168.63 9.27 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.154 0.502 . . . . 0.0 112.095 -177.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -59.88 -37.24 92.28 Favored Glycine 0 CA--C 1.529 0.936 0 N-CA-C 114.555 0.582 . . . . 0.0 114.555 -174.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -64.21 -53.69 45.22 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -174.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 13.1 p30 -74.33 -28.94 61.38 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 29.0 t-105 -60.42 -44.86 95.34 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.091 0.472 . . . . 0.0 111.231 170.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.43 -49.08 78.28 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.928 0.394 . . . . 0.0 111.135 176.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -64.81 -31.65 72.98 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.425 178.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.9 tt -58.21 -54.81 42.72 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.049 0.452 . . . . 0.0 110.147 177.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 67.4 m -58.07 -45.98 86.2 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.192 178.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -66.34 -33.2 75.19 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -74.23 -47.09 37.48 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.146 0.498 . . . . 0.0 110.188 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 85.7 m -75.19 -2.21 26.83 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.233 173.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt 54.78 35.65 24.59 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 175.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 61.7 t -68.55 -28.12 39.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.784 174.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.39 124.22 21.68 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.21 0.529 . . . . 0.0 111.622 178.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.443 ' H ' ' HB ' ' A' ' 50' ' ' VAL . 32.0 t70 -75.29 -22.99 57.31 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.929 -176.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.12 -47.63 3.87 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 121.252 -0.499 . . . . 0.0 112.853 -179.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 42.0 mtmt -77.69 -57.83 3.6 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.465 0.65 . . . . 0.0 110.745 176.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.7 p -97.26 -72.07 0.66 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.497 179.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.443 ' HB ' ' H ' ' A' ' 46' ' ' ASP . 49.4 t -76.43 114.29 16.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-O 121.067 0.461 . . . . 0.0 111.475 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.7 t -140.59 -175.16 4.18 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.623 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -45.23 -45.82 10.55 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 113.793 0.277 . . . . 0.0 113.793 -177.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.599 ' O ' HG12 ' A' ' 57' ' ' ILE . 67.8 m -53.88 -56.6 16.19 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.823 0.344 . . . . 0.0 111.37 175.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -58.16 -43.26 87.3 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 121.129 0.49 . . . . 0.0 111.016 -178.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 71.4 t -61.85 -26.92 41.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-O 121.224 0.535 . . . . 0.0 111.438 178.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -82.88 -39.36 21.67 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.522 0.677 . . . . 0.0 109.989 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.599 HG12 ' O ' ' A' ' 53' ' ' THR . 16.4 mm -55.95 -46.76 80.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.593 174.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 87.1 t -61.62 -47.48 93.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.294 176.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -54.5 -44.28 72.56 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.068 0.461 . . . . 0.0 111.617 178.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 35.6 t -74.92 -35.23 62.2 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.044 0.449 . . . . 0.0 111.636 178.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -62.9 -55.66 24.07 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -177.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 22.6 m -66.49 -24.38 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-O 121.124 0.488 . . . . 0.0 111.6 -178.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.527 ' HB2' HG22 ' A' ' 70' ' ' ILE . 22.0 ttpp -105.64 82.86 1.86 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.634 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -101.45 -10.58 41.01 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 121.049 -0.596 . . . . 0.0 114.586 -173.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 48.2 tptt -84.76 45.66 1.17 Allowed 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 117.81 0.805 . . . . 0.0 112.035 -177.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 39.6 t 53.68 16.02 0.9 Allowed 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 176.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -76.5 166.75 22.97 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.027 0.441 . . . . 0.0 111.647 -178.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.432 HH11 ' HD3' ' A' ' 68' ' ' ARG . 40.6 ttp-105 -105.13 -36.56 7.23 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.045 0.45 . . . . 0.0 111.252 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.46 HG21 ' HB3' ' A' ' 29' ' ' GLU . 33.9 m -110.36 165.0 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.805 178.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.527 HG22 ' HB2' ' A' ' 63' ' ' LYS . 33.5 pt -111.93 146.53 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.012 175.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 30.1 p30 -100.46 -179.81 4.22 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.609 0.242 . . . . 0.0 111.379 177.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -56.45 -39.07 72.54 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -174.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -66.57 -49.25 66.99 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.792 0.33 . . . . 0.0 111.24 179.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -62.42 -35.37 79.01 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.058 0.456 . . . . 0.0 110.885 178.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.423 ' O ' ' HG ' ' A' ' 79' ' ' LEU . 89.1 t80 -58.63 -45.24 89.68 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.495 172.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -60.88 -41.81 96.71 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.542 176.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -60.05 -40.76 90.53 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.237 0.541 . . . . 0.0 110.727 174.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.76 -40.32 96.91 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.227 177.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' A' ' 75' ' ' PHE . 76.5 mt -62.23 -37.64 86.14 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.233 177.043 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -61.66 -42.72 99.29 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.085 0.469 . . . . 0.0 110.672 176.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.449 ' O ' ' HG2' ' A' ' 85' ' ' LYS . 61.7 mm-40 -59.92 -55.08 38.57 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.202 175.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 91.5 mt -59.68 -37.81 79.79 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.862 0.363 . . . . 0.0 111.448 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.424 ' HB1' ' HB1' ' A' ' 95' ' ' ALA . . . -58.67 -55.02 40.43 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.878 0.37 . . . . 0.0 111.424 177.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 36.3 p -63.52 -24.01 67.63 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.044 178.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.449 ' HG2' ' O ' ' A' ' 81' ' ' GLU . 33.3 mmtp -73.97 -42.26 60.75 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 120.884 0.373 . . . . 0.0 111.728 174.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 30.9 mmm180 -90.63 -57.32 2.87 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -174.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -99.37 25.76 6.66 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -171.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt 62.7 -175.06 0.15 Allowed 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.834 -178.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -98.05 17.58 58.48 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 121.042 -0.599 . . . . 0.0 113.36 178.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -74.77 96.42 3.06 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 122.421 -0.458 . . . . 0.0 111.077 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 24.6 t 65.3 110.09 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.009 0.523 . . . . 0.0 112.327 -178.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -57.21 -34.63 68.72 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.589 0.233 . . . . 0.0 111.417 175.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -60.19 -52.69 64.23 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 120.696 0.284 . . . . 0.0 111.684 -178.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -69.2 -42.61 75.56 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 120.711 0.291 . . . . 0.0 111.641 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.424 ' HB1' ' HB1' ' A' ' 83' ' ' ALA . . . -60.62 -47.36 86.58 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 120.955 0.407 . . . . 0.0 111.649 177.346 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.47 ' HA ' HG22 ' A' ' 99' ' ' ILE . 49.0 t80 -66.39 -37.04 84.35 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.017 0.437 . . . . 0.0 110.74 179.11 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -58.23 -51.76 68.43 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.508 0.67 . . . . 0.0 110.566 174.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.3 -41.46 94.08 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.814 -176.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.47 HG22 ' HA ' ' A' ' 96' ' ' PHE . 10.1 tp -64.87 -37.68 80.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 O-C-N 121.936 -0.478 . . . . 0.0 110.42 177.292 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 87.1 m -69.75 -30.07 67.58 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.673 172.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 3.6 tp-100 -60.12 -35.56 75.52 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.104 0.478 . . . . 0.0 111.028 178.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 88.3 mt -67.85 -22.58 65.13 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.944 177.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 47.7 t -111.45 -70.02 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-O 120.775 0.321 . . . . 0.0 111.241 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 53.7 -86.74 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 177.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -143.57 27.71 2.07 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.739 -176.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -73.3 -172.59 1.16 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.575 0.702 . . . . 0.0 112.745 -176.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -136.51 151.71 73.43 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.374 178.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -57.6 95.7 0.07 OUTLIER 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 122.219 1.946 . . . . 0.0 113.077 -179.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.737 0 C-N-CA 123.443 0.697 . . . . 0.0 112.221 -177.891 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.582 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 120.43 0.157 . . . . 0.0 111.103 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 64.07 96.07 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 120.981 0.419 . . . . 0.0 112.032 -177.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -74.08 68.8 1.44 Allowed 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.231 0.539 . . . . 0.0 111.874 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 66.1 p 176.98 -68.25 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.375 -177.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 62.7 p -101.38 74.65 1.56 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.485 0.659 . . . . 0.0 110.605 174.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -72.97 -63.02 1.26 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.412 -0.813 . . . . 0.0 113.06 -172.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 52.6 mt -110.54 -31.13 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -170.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 70.17 -70.42 0.15 Allowed 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -56.46 -45.28 89.68 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 121.455 -0.403 . . . . 0.0 113.315 -177.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.64 HD22 ' SG ' ' A' ' 100' ' ' CYS . 45.3 tp -57.57 -46.14 84.34 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.232 0.539 . . . . 0.0 110.836 175.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -61.42 -34.45 75.4 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.06 178.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -66.43 -50.89 61.89 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.614 177.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.6 m -60.28 -34.18 73.39 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.36 177.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -57.67 -49.99 74.66 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.793 0.33 . . . . 0.0 110.154 174.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.551 ' O ' HG12 ' A' ' 19' ' ' ILE . 76.6 mtm-85 -57.16 -47.1 82.02 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.299 176.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.412 ' HB3' ' HD3' ' A' ' 108' ' ' PRO . 75.3 mmtt -44.93 -48.46 11.32 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 176.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -84.82 -26.97 27.11 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.9 -53.05 23.27 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.976 0.417 . . . . 0.0 111.938 -178.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.551 HG12 ' O ' ' A' ' 15' ' ' ARG . 29.9 pt -77.95 7.33 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -178.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -62.13 89.91 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.232 0.539 . . . . 0.0 110.596 176.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 125.23 -54.48 0.75 Allowed Glycine 0 CA--C 1.527 0.785 0 CA-C-N 115.888 -0.597 . . . . 0.0 112.64 -176.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -127.03 109.79 21.79 Favored Pre-proline 0 CA--C 1.547 0.835 0 O-C-N 122.626 -0.338 . . . . 0.0 110.933 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -76.39 -5.78 16.48 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 122.845 2.363 . . . . 0.0 113.644 -178.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 30.7 mtmm -89.5 -11.77 41.97 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.932 0.396 . . . . 0.0 110.945 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.86 -20.34 66.2 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.607 176.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 59.9 m 73.11 -53.72 0.7 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.582 0.753 . . . . 0.0 112.213 177.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 137.86 47.25 0.07 OUTLIER Glycine 0 CA--C 1.524 0.609 0 CA-C-N 116.41 -0.359 . . . . 0.0 112.309 -177.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -95.16 -34.78 12.13 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.643 0.259 . . . . 0.0 111.506 -178.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.08 178.92 6.59 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.341 0.591 . . . . 0.0 112.488 -175.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 52.7 ttm -157.41 133.9 9.81 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.63 176.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -86.38 167.75 14.45 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.094 0.473 . . . . 0.0 112.134 -178.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -58.13 -33.19 68.87 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-N 115.749 -0.659 . . . . 0.0 114.432 -176.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -69.22 -54.12 16.38 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.331 0.586 . . . . 0.0 110.976 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -60.57 -40.29 91.12 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.425 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 30.5 t-105 -63.51 -42.84 98.46 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 120.998 0.428 . . . . 0.0 111.492 175.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.18 -44.63 96.99 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 121.001 0.429 . . . . 0.0 111.183 176.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 43.2 tttm -66.36 -39.43 89.14 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.784 177.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.7 tt -51.69 -47.5 63.86 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.084 0.469 . . . . 0.0 110.792 178.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 79.5 m -63.44 -41.26 98.66 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.324 176.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -62.7 -57.3 11.48 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.815 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.574 ' HA ' HD21 ' A' ' 110' ' ' ASN . 2.1 m-20 -53.69 -39.42 65.14 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 122.731 0.412 . . . . 0.0 111.795 178.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.587 ' SG ' HG13 ' A' ' 103' ' ' VAL . 57.0 m -91.85 -0.7 57.53 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? 50.15 31.75 5.32 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.1 t -68.78 -38.14 78.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-O 121.263 0.554 . . . . 0.0 109.586 171.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.47 79.69 3.97 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.02 171.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.0 p30 -76.79 -14.28 59.93 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.914 -173.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.61 -27.43 7.14 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 121.168 -0.539 . . . . 0.0 113.23 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -85.01 -37.81 19.96 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 122.478 -0.425 . . . . 0.0 111.448 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.8 t -112.46 -51.13 2.86 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.128 0.49 . . . . 0.0 110.549 176.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 34.1 t -112.81 110.46 32.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.065 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.504 ' O ' HG23 ' A' ' 55' ' ' VAL . 81.9 p -97.52 166.72 11.38 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.527 179.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -50.02 -55.49 15.02 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 121.368 -0.444 . . . . 0.0 113.079 178.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.574 ' O ' HG12 ' A' ' 57' ' ' ILE . 94.0 m -53.08 -48.56 67.66 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.599 0.237 . . . . 0.0 111.493 178.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.488 ' O ' HG23 ' A' ' 58' ' ' VAL . 18.0 t70 -58.48 -36.82 74.32 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 120.726 0.298 . . . . 0.0 110.872 -178.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 51' ' ' THR . 88.6 t -61.87 -37.92 79.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.375 175.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -73.52 -34.73 65.39 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.399 0.619 . . . . 0.0 110.137 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.574 HG12 ' O ' ' A' ' 53' ' ' THR . 8.0 mm -60.48 -52.73 58.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.999 176.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 54' ' ' ASP . 91.8 t -52.49 -48.5 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 121.04 0.448 . . . . 0.0 111.12 177.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -59.94 -41.28 91.49 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.009 178.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 28.3 t -72.95 -20.22 61.09 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 116.156 -0.474 . . . . 0.0 112.051 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.456 ' HG3' ' O ' ' A' ' 57' ' ' ILE . 53.6 mtmt -84.49 -57.12 3.28 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.087 0.47 . . . . 0.0 111.953 178.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.3 m -61.19 -31.95 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 -173.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.646 ' HD3' ' O ' ' A' ' 66' ' ' SER . 17.2 ptpt -56.55 -52.44 64.78 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -175.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 72.74 -64.78 1.48 Allowed Glycine 0 CA--C 1.537 1.46 0 N-CA-C 114.55 0.58 . . . . 0.0 114.55 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.622 ' H ' ' HD2' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -78.52 53.43 1.3 Allowed 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -172.569 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.646 ' O ' ' HD3' ' A' ' 63' ' ' LYS . 88.5 p 54.23 -77.61 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.148 0.579 . . . . 0.0 110.928 -173.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.559 ' HB2' ' HG2' ' A' ' 65' ' ' LYS . . . 46.88 117.88 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 115.859 1.799 . . . . 0.0 115.859 164.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 57.2 ttp180 -66.52 -18.3 65.29 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 121.355 0.598 . . . . 0.0 110.684 169.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.413 ' O ' ' HB1' ' A' ' 67' ' ' ALA . 33.8 m -135.15 159.21 41.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.902 -173.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 39.3 pt -115.27 147.56 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-O 120.699 0.285 . . . . 0.0 110.929 174.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -86.47 157.55 19.77 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -40.25 -48.6 2.63 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 -175.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.529 ' HA ' ' HE3' ' A' ' 76' ' ' LYS . 46.5 mm-40 -52.15 -46.42 65.43 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 120.935 0.398 . . . . 0.0 111.77 178.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -76.56 -19.36 57.98 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 120.97 0.414 . . . . 0.0 110.99 -178.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -70.56 -49.68 45.42 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.118 174.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.529 ' HE3' ' HA ' ' A' ' 73' ' ' GLU . 22.8 pttp -69.58 -22.54 63.51 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.322 177.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -71.81 -41.35 68.35 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.165 0.507 . . . . 0.0 110.251 170.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.467 ' O ' ' HB3' ' A' ' 81' ' ' GLU . . . -63.61 -37.8 88.72 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.33 175.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 84.9 mt -59.69 -43.44 94.04 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.326 175.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -54.85 -43.97 73.55 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 121.029 0.443 . . . . 0.0 110.891 174.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.467 ' HB3' ' O ' ' A' ' 78' ' ' ALA . 6.9 tp10 -54.28 -64.33 0.86 Allowed 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.057 175.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.5 ' HA ' ' HG3' ' A' ' 85' ' ' LYS . 9.1 mp -57.71 -33.25 68.22 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.153 0.502 . . . . 0.0 111.936 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.422 ' HB2' HG21 ' A' ' 99' ' ' ILE . . . -60.84 -48.47 81.66 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.146 175.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.47 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 76.1 p -70.41 -19.06 63.02 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 120.827 0.346 . . . . 0.0 111.699 179.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.5 ' HG3' ' HA ' ' A' ' 82' ' ' LEU . 46.9 mmtt -67.29 -41.64 85.1 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 121.088 0.471 . . . . 0.0 111.013 174.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 23.4 mtp180 -106.25 -57.38 2.06 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -176.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -88.85 29.33 1.04 Allowed 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -171.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.47 ' HB3' ' O ' ' A' ' 84' ' ' THR . 22.7 pttp -71.8 150.58 44.22 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.079 0.466 . . . . 0.0 111.406 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 98.84 -28.5 14.86 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.908 -178.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -86.62 -177.48 6.15 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.05 0.453 . . . . 0.0 111.423 176.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 35.6 t -63.7 135.13 56.48 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.058 177.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -48.76 -48.03 41.25 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 122.98 0.512 . . . . 0.0 111.856 -178.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.432 ' HG3' ' N ' ' A' ' 94' ' ' GLU . 9.9 pt-20 -60.9 -48.45 81.77 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.461 178.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.432 ' N ' ' HG3' ' A' ' 93' ' ' GLU . 63.5 tt0 -58.58 -47.15 85.24 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.635 0.255 . . . . 0.0 111.354 -178.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.81 -44.81 86.61 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 120.951 0.405 . . . . 0.0 111.711 178.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -68.37 -50.29 54.15 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.422 -178.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -62.01 -31.55 71.94 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 120.725 0.298 . . . . 0.0 111.57 177.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -66.65 -54.94 17.86 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.422 HG21 ' HB2' ' A' ' 83' ' ' ALA . 11.5 tt -58.43 -39.75 75.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 120.929 0.395 . . . . 0.0 110.99 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . 0.64 ' SG ' HD22 ' A' ' 10' ' ' LEU . 79.0 m -64.17 -37.58 87.96 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.847 0.356 . . . . 0.0 110.998 175.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -60.15 -29.31 68.57 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.536 177.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 79.0 mt -77.18 -13.46 59.94 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 177.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.587 HG13 ' SG ' ' A' ' 42' ' ' CYS . 58.3 t -110.62 -54.18 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -175.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -41.36 126.21 2.74 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 -172.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 109.11 -32.84 6.54 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 121.321 -0.466 . . . . 0.0 114.219 173.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 38.0 mtmm -82.06 169.12 17.07 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -174.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.547 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 12.1 pt-20 -126.89 165.37 29.12 Favored Pre-proline 0 CA--C 1.55 0.967 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.464 -178.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.547 ' HD2' ' HB2' ' A' ' 107' ' ' GLU . 55.5 Cg_endo -68.37 71.97 0.91 Allowed 'Trans proline' 0 CA--C 1.545 1.031 0 C-N-CA 122.635 2.223 . . . . 0.0 113.889 -178.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 177.28 112.98 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 122.672 0.389 . . . . 0.0 111.8 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.574 HD21 ' HA ' ' A' ' 41' ' ' ASP . 18.5 m120 -77.93 82.21 4.3 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 122.313 -0.242 . . . . 0.0 110.389 174.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 76.5 t 65.77 -67.45 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.205 -174.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -89.54 146.86 19.14 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 121.41 -0.424 . . . . 0.0 112.79 175.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 33.1 m -81.63 156.88 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-O 121.154 0.502 . . . . 0.0 111.532 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 73.2 p -83.31 109.36 17.2 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -178.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -64.0 111.42 2.51 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.743 175.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -130.6 10.34 5.16 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -177.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -67.64 100.03 0.85 Allowed 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.633 0.73 . . . . 0.0 111.518 -178.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.5 t 178.57 -28.52 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.716 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -71.94 114.13 4.88 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.399 175.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -60.02 105.12 0.7 Allowed Glycine 0 CA--C 1.526 0.763 0 C-N-CA 121.354 -0.451 . . . . 0.0 113.166 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -103.99 20.49 18.11 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.206 0.527 . . . . 0.0 111.24 177.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 35.5 m -87.51 14.6 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.138 -177.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -75.04 27.68 0.09 Allowed 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -177.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 54.7 mtm-85 -66.35 84.07 0.09 Allowed 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.373 0.606 . . . . 0.0 111.435 -177.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 26.8 tp -97.13 10.37 39.56 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.093 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 11.2 p 70.84 -49.03 0.67 Allowed 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.609 1.163 . . . . 0.0 111.885 -174.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -53.15 -35.23 59.51 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 120.907 0.384 . . . . 0.0 111.65 172.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 43.4 p -60.18 111.85 1.68 Allowed 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.786 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 27.7 t 66.2 -67.53 0.15 Allowed 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.194 0.597 . . . . 0.0 110.636 -172.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 70.88 -26.1 0.17 Allowed 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 174.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 54.16 -85.6 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 122.867 0.467 . . . . 0.0 111.968 -175.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 24.4 m -77.38 93.84 4.13 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.172 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 133.84 -20.37 4.08 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 120.965 -0.636 . . . . 0.0 113.987 178.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 81.9 p -82.41 -85.94 0.11 Allowed 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 117.592 0.696 . . . . 0.0 111.565 -178.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 43.7 p-80 -171.61 142.95 1.66 Allowed 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.054 0.454 . . . . 0.0 111.895 178.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -124.89 157.83 35.0 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 174.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -60.51 122.23 14.12 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 121.201 0.524 . . . . 0.0 112.133 -178.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 53.2 ttp180 -73.1 153.78 40.65 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.906 178.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -67.46 80.42 0.16 Allowed 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.634 0.731 . . . . 0.0 112.051 -178.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -126.55 26.08 6.37 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.73 0.776 . . . . 0.0 109.619 172.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.574 ' HA ' ' NZ ' ' A' ' 144' ' ' LYS . 50.6 mt-10 -75.61 -28.92 59.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.87 -178.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 61.8 p -77.9 -53.02 7.94 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.514 178.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -104.62 82.47 0.36 Allowed Glycine 0 CA--C 1.53 0.994 0 C-N-CA 120.887 -0.673 . . . . 0.0 114.08 -178.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.574 ' NZ ' ' HA ' ' A' ' 141' ' ' GLU . 50.8 mttp -102.39 171.58 7.37 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.291 0.567 . . . . 0.0 111.723 174.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -84.54 119.43 4.98 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-N 115.932 -0.576 . . . . 0.0 113.324 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -68.49 106.8 2.67 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 120.963 0.411 . . . . 0.0 110.296 176.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 72.11 36.57 60.35 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.161 -171.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 81.5 mt 64.44 -71.93 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 123.448 0.699 . . . . 0.0 111.999 -179.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -150.42 -71.86 0.17 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.98 0.419 . . . . 0.0 110.921 178.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -108.99 32.16 7.11 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 121.103 -0.57 . . . . 0.0 113.593 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.454 HH11 ' HD2' ' A' ' 151' ' ' ARG . 42.8 ttm180 72.77 -53.54 0.7 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.12 0.568 . . . . 0.0 111.875 178.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 40.64 97.72 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 169.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -116.9 -82.71 0.63 Allowed 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.863 174.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 18.6 pt -137.09 134.24 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-O 121.083 0.468 . . . . 0.0 111.743 -179.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 90.2 mt -113.44 32.44 5.78 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.146 0.498 . . . . 0.0 110.988 178.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -62.72 133.06 54.24 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.116 -177.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -117.85 165.98 13.02 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 121.177 0.513 . . . . 0.0 111.449 -179.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 55.4 p -57.52 -25.64 60.16 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 176.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 137.16 11.41 1.04 Allowed Glycine 0 CA--C 1.529 0.959 0 C-N-CA 120.969 -0.634 . . . . 0.0 113.835 178.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 59.1 93.79 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 122.862 0.465 . . . . 0.0 112.219 178.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 42.0 t -95.6 126.17 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-O 120.848 0.356 . . . . 0.0 111.867 -177.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 85.0 p -103.11 139.71 38.27 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.309 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -62.21 113.42 2.87 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -177.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 58.18 23.39 10.19 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 177.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 97.4 mttt 62.65 -164.47 0.25 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 122.612 0.365 . . . . 0.0 111.618 -176.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 11.5 m120 66.72 -75.61 0.06 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 122.833 0.453 . . . . 0.0 111.656 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 55.86 -80.54 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.336 0.655 . . . . 0.0 112.742 178.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -146.65 85.31 0.17 Allowed Glycine 0 CA--C 1.521 0.415 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.407 ' O ' ' HB2' ' A' ' 170' ' ' TYR . 44.0 p 51.57 50.69 18.26 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 121.193 0.52 . . . . 0.0 111.201 -172.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . 0.407 ' HB2' ' O ' ' A' ' 169' ' ' THR . 41.4 m-85 72.4 -175.82 0.17 Allowed 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.905 -179.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -70.42 75.44 0.55 Allowed 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.648 0.737 . . . . 0.0 112.54 -175.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.424 ' HB1' ' HB3' ' A' ' 175' ' ' LYS . . . -79.41 71.14 5.96 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.279 177.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -65.83 103.44 0.91 Allowed 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.34 -178.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 22.7 m 42.55 34.96 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 123.716 0.806 . . . . 0.0 112.184 -175.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.424 ' HB3' ' HB1' ' A' ' 172' ' ' ALA . 86.9 tttt -75.68 85.18 2.7 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.601 -178.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm 58.29 -76.54 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.266 0.626 . . . . 0.0 112.409 178.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.414 HD12 ' N ' ' A' ' 177' ' ' LEU . 6.9 mp -79.49 116.9 19.98 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.963 0.411 . . . . 0.0 110.769 178.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.545 0.751 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.395 -174.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.7 mmt . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 120.532 0.206 . . . . 0.0 110.92 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 63.16 -77.44 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 174.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.16 -32.71 72.23 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -178.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 30.2 t 59.45 -166.17 0.18 Allowed 'General case' 0 N--CA 1.475 0.824 0 CA-C-O 121.104 0.478 . . . . 0.0 111.849 179.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 96.1 m -119.12 106.35 12.3 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.793 0.33 . . . . 0.0 111.027 178.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -56.61 129.07 39.41 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.794 178.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.0 mt -56.71 124.31 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -170.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.55 -31.07 69.04 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.382 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.73 -17.06 48.48 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 121.225 -0.512 . . . . 0.0 113.164 175.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 53.0 tp -71.85 -58.44 3.46 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.783 0.291 . . . . 0.0 110.899 177.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -55.43 -39.63 70.5 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 177.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -61.47 -57.08 13.61 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.573 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.3 t -57.32 -44.91 84.59 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.134 0.492 . . . . 0.0 110.868 178.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -58.34 -40.97 83.59 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.435 176.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.482 ' O ' HG12 ' A' ' 19' ' ' ILE . 58.4 ttt180 -67.48 -44.21 79.1 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 120.678 0.275 . . . . 0.0 110.985 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -62.8 -34.37 77.15 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.237 178.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -72.28 -49.72 32.56 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.365 173.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.73 -46.96 81.0 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -176.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.482 HG12 ' O ' ' A' ' 15' ' ' ARG . 23.1 pt -83.58 5.58 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-O 121.018 0.437 . . . . 0.0 111.974 -177.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 37.1 t60 -78.96 105.22 10.13 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.937 0.399 . . . . 0.0 110.291 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.461 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . 88.82 -64.31 3.42 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.27 -174.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -90.13 97.33 1.07 Allowed Pre-proline 0 CA--C 1.547 0.839 0 CA-C-O 120.865 0.364 . . . . 0.0 110.608 175.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' A' ' 21' ' ' GLY . 74.4 Cg_endo -73.33 -30.79 9.91 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 122.546 2.164 . . . . 0.0 114.183 -170.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.46 2.42 13.75 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -173.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.405 ' HB1' ' O ' ' A' ' 29' ' ' GLU . . . -65.79 -37.16 85.54 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.974 0.416 . . . . 0.0 111.288 176.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 27.1 t 55.76 16.43 2.01 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 175.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 75.86 13.95 82.61 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 120.883 -0.675 . . . . 0.0 113.87 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -95.78 -36.65 11.08 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.268 0.556 . . . . 0.0 110.461 175.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.405 ' O ' ' HB1' ' A' ' 25' ' ' ALA . 26.3 mt-10 -137.44 142.74 41.6 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.926 -178.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.41 ' HE2' ' HA ' ' A' ' 35' ' ' TRP . 27.2 ttt -123.97 142.51 51.1 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.983 0.421 . . . . 0.0 111.667 -175.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -103.46 164.79 11.43 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -174.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -58.71 -32.27 69.25 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-N 115.725 -0.67 . . . . 0.0 113.7 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.522 ' HB2' ' HZ2' ' A' ' 33' ' ' LYS . 3.6 ttmp? -47.75 -61.9 1.72 Allowed 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 121.62 0.724 . . . . 0.0 111.395 176.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -79.81 -20.36 46.31 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.125 -175.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.41 ' HA ' ' HE2' ' A' ' 30' ' ' MET . 62.0 t-105 -69.91 -50.22 44.36 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 120.882 0.373 . . . . 0.0 111.218 177.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.13 -43.85 95.35 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-O 121.403 0.62 . . . . 0.0 110.203 174.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.405 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 41.3 tttm -57.16 -46.73 82.52 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.593 174.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.4 tt -51.91 -46.82 64.76 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 122.895 0.478 . . . . 0.0 111.057 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.704 ' SG ' HG11 ' A' ' 55' ' ' VAL . 73.7 m -56.29 -50.5 71.21 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.218 177.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -71.73 -28.99 64.04 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 121.113 0.482 . . . . 0.0 111.914 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.405 ' HB2' ' O ' ' A' ' 37' ' ' LYS . 5.8 t70 -75.37 -44.8 42.99 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.427 0.632 . . . . 0.0 111.158 -173.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 65.4 m -103.08 2.25 34.48 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.68 178.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp 62.36 34.95 15.34 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.321 0.581 . . . . 0.0 111.348 178.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 59.9 t -68.21 -42.21 84.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.443 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.09 91.91 2.12 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.266 0.555 . . . . 0.0 111.123 178.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.634 ' HB2' ' HG2' ' A' ' 86' ' ' ARG . 26.9 t70 -51.86 -26.61 10.44 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.72 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.11 -55.99 4.59 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 121.302 -0.475 . . . . 0.0 112.27 -177.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.506 ' NZ ' ' HB3' ' A' ' 48' ' ' LYS . 5.9 ttpm? -64.08 -32.97 74.73 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 121.124 0.487 . . . . 0.0 111.128 176.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 13.8 m -110.15 -19.47 13.02 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.52 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 5.8 p -160.3 113.88 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-O 121.005 0.431 . . . . 0.0 112.131 -176.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.4 ' O ' HG23 ' A' ' 55' ' ' VAL . 58.5 p -95.69 172.48 8.02 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 120.818 0.342 . . . . 0.0 111.768 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -51.65 -36.42 39.96 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-N 116.19 -0.459 . . . . 0.0 113.686 177.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.537 ' O ' HG13 ' A' ' 57' ' ' ILE . 21.6 p -62.06 -54.38 42.29 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.972 0.415 . . . . 0.0 110.234 177.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -58.2 -38.48 76.82 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.52 -176.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.704 HG11 ' SG ' ' A' ' 39' ' ' CYS . 88.6 t -58.21 -39.1 72.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.595 174.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -70.42 -36.17 73.86 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 121.296 0.57 . . . . 0.0 110.318 178.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.572 ' O ' ' HG3' ' A' ' 61' ' ' LYS . 8.7 mt -61.49 -46.43 96.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.578 176.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 89.7 t -60.91 -45.13 98.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-O 121.08 0.467 . . . . 0.0 110.73 177.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.522 ' O ' ' HB2' ' A' ' 63' ' ' LYS . 76.5 t80 -59.39 -30.92 68.78 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.874 175.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.552 ' HA ' ' HE3' ' A' ' 63' ' ' LYS . 67.8 m -82.5 -25.15 33.74 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.722 177.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.572 ' HG3' ' O ' ' A' ' 57' ' ' ILE . 95.4 mttt -66.47 -55.3 16.28 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 120.98 0.419 . . . . 0.0 111.338 177.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.537 ' HB ' ' HB3' ' A' ' 74' ' ' GLU . 27.6 m -83.72 6.99 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 CA-C-N 116.064 -0.516 . . . . 0.0 112.198 -177.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.552 ' HE3' ' HA ' ' A' ' 60' ' ' SER . 39.6 ttmt -78.01 143.86 37.17 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.766 -179.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -73.01 177.98 41.24 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 121.022 -0.609 . . . . 0.0 113.203 177.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -50.98 100.35 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -177.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 60.6 p 52.04 23.95 2.45 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.368 0.667 . . . . 0.0 112.335 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.454 ' O ' ' HD3' ' A' ' 63' ' ' LYS . . . -70.29 176.23 4.08 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -177.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.523 ' HG3' HG13 ' A' ' 69' ' ' VAL . 16.8 ptt180 -116.48 -9.48 11.43 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.523 HG13 ' HG3' ' A' ' 68' ' ' ARG . 33.1 m -136.57 172.18 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-O 121.084 0.469 . . . . 0.0 112.0 -178.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 37.8 pt -128.18 145.61 35.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.097 175.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 -79.92 158.89 26.54 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 120.736 0.303 . . . . 0.0 111.729 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.532 ' O ' ' HB3' ' A' ' 75' ' ' PHE . 30.1 t80 -48.4 -46.8 37.73 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -175.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 22.7 mp0 -60.81 -43.96 97.49 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 122.113 -0.367 . . . . 0.0 111.418 -178.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.537 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 32.5 mm-40 -71.96 -27.19 62.61 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.887 0.375 . . . . 0.0 111.078 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.532 ' HB3' ' O ' ' A' ' 72' ' ' TYR . 61.6 t80 -57.22 -39.67 75.93 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.396 0.617 . . . . 0.0 110.349 170.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.529 ' HG3' ' O ' ' A' ' 72' ' ' TYR . 32.3 mtpt -67.12 -35.62 80.14 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.825 177.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.429 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 15.1 tppt? -66.88 -39.65 87.54 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.346 0.593 . . . . 0.0 110.653 176.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.09 -46.47 90.51 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.807 174.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 79.4 mt -60.75 -32.32 71.62 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.114 174.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.429 ' HB3' ' O ' ' A' ' 77' ' ' LYS . 32.9 tt0 -56.66 -51.32 69.19 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 120.704 0.288 . . . . 0.0 110.934 177.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -61.68 -53.71 52.52 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.408 175.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 82.0 mt -54.21 -38.36 65.59 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -178.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.76 -52.16 40.61 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.907 0.384 . . . . 0.0 111.62 177.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 70.1 p -66.65 -16.14 63.98 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -90.5 -49.3 6.58 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 122.077 -0.39 . . . . 0.0 111.02 173.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.634 ' HG2' ' HB2' ' A' ' 46' ' ' ASP . 2.2 tmt_? -59.77 -51.2 70.78 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.003 0.43 . . . . 0.0 110.687 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -94.24 24.18 4.58 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.145 0.498 . . . . 0.0 111.923 -177.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 56.0 mttm 59.46 -179.81 0.08 Allowed 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.925 178.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -77.25 58.69 3.64 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 121.309 -0.472 . . . . 0.0 114.051 -175.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -98.43 -162.16 0.93 Allowed 'General case' 0 CA--C 1.543 0.697 0 O-C-N 122.618 -0.342 . . . . 0.0 110.634 176.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.417 ' HB3' ' HB3' ' A' ' 94' ' ' GLU . 28.5 t -56.28 120.56 7.79 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 122.182 -0.323 . . . . 0.0 111.402 176.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -57.59 -44.56 85.5 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.877 0.37 . . . . 0.0 111.373 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.5 mp0 -59.1 -50.01 75.68 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.933 177.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.417 ' HB3' ' HB3' ' A' ' 91' ' ' SER . 36.3 tt0 -58.25 -47.05 84.79 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.667 177.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.54 -36.73 83.54 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.917 0.389 . . . . 0.0 111.448 178.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -65.87 -42.75 89.96 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.83 178.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -60.94 -42.79 98.87 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.195 0.521 . . . . 0.0 110.591 175.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.541 ' O ' ' HB3' ' A' ' 101' ' ' GLN . . . -61.44 -49.34 77.24 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 179.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.1 tt -64.51 -33.37 62.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 O-C-N 121.886 -0.508 . . . . 0.0 110.937 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 97.6 m -66.12 -38.55 88.46 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.88 0.371 . . . . 0.0 110.581 172.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.541 ' HB3' ' O ' ' A' ' 98' ' ' ALA . 6.7 tt0 -54.95 -34.09 62.93 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 121.045 0.45 . . . . 0.0 111.409 174.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 75.6 mt -78.09 -36.68 47.81 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 112.694 0.628 . . . . 0.0 112.694 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 54.9 t -100.71 -49.73 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -172.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.17 134.34 56.9 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -174.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 68.66 33.39 76.03 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.292 -0.48 . . . . 0.0 113.037 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -142.91 133.71 25.37 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 122.922 0.489 . . . . 0.0 110.807 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.406 ' HA ' ' HD3' ' A' ' 108' ' ' PRO . 38.9 mt-10 -85.94 154.6 58.19 Favored Pre-proline 0 N--CA 1.474 0.767 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -175.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 107' ' ' GLU . 22.8 Cg_exo -65.9 84.64 0.24 Allowed 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 123.076 2.518 . . . . 0.0 112.866 176.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 64.86 25.19 12.83 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 174.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -112.09 158.26 19.81 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 110.251 -0.278 . . . . 0.0 110.251 174.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 61.0 t -63.39 88.24 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 121.399 0.618 . . . . 0.0 111.005 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -178.54 92.36 0.08 OUTLIER Glycine 0 CA--C 1.526 0.72 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.338 -178.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.442 HG13 ' N ' ' A' ' 114' ' ' THR . 4.0 p -162.9 -53.2 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 122.581 0.352 . . . . 0.0 111.141 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.442 ' N ' HG13 ' A' ' 113' ' ' VAL . 76.4 p -78.09 113.87 16.43 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.957 0.408 . . . . 0.0 110.772 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 16.8 pttm -136.05 146.68 47.35 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 120.734 0.302 . . . . 0.0 111.812 -175.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 72.44 -73.65 0.1 Allowed 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.299 0.64 . . . . 0.0 112.424 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -179.22 -40.85 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 120.987 0.422 . . . . 0.0 111.077 -179.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.8 t -80.01 -178.06 6.32 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.89 0.376 . . . . 0.0 111.062 175.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 79.49 -58.29 4.44 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.527 -177.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -64.03 -22.0 66.36 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 121.32 -0.467 . . . . 0.0 112.616 175.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -138.48 153.55 48.8 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 122.595 0.358 . . . . 0.0 110.892 178.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 11.4 p -128.44 145.71 35.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 121.054 0.454 . . . . 0.0 111.81 -177.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -88.0 151.79 22.52 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.873 177.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 17.7 ttm180 -80.95 109.99 16.06 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.25 0.548 . . . . 0.0 111.938 -179.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 8.7 mp -83.15 58.94 4.69 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.059 175.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 15.2 t 38.47 37.58 0.18 Allowed 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 124.112 0.965 . . . . 0.0 113.398 -176.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -68.04 135.99 53.13 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.168 0.508 . . . . 0.0 111.596 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 6.7 t -119.03 142.56 47.72 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.839 177.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.51 ' O ' HG22 ' A' ' 132' ' ' THR . 47.9 t -81.65 -69.6 0.6 Allowed 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.692 0.282 . . . . 0.0 111.44 -178.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 62.34 3.29 1.02 Allowed 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 176.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 42.6 t80 56.83 28.32 14.27 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 121.457 0.646 . . . . 0.0 110.686 -175.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.51 HG22 ' O ' ' A' ' 129' ' ' SER . 5.0 t -71.1 76.62 0.68 Allowed 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.47 0.652 . . . . 0.0 112.632 -176.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -81.16 70.5 3.07 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 121.048 -0.596 . . . . 0.0 111.662 173.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 34.0 t 64.7 -166.38 0.23 Allowed 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 120.865 0.364 . . . . 0.0 110.647 -173.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -149.96 46.02 0.92 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.377 0.608 . . . . 0.0 110.864 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -81.52 63.51 5.84 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.073 -176.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 67.15 -79.69 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.2 0.6 . . . . 0.0 112.31 176.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 19.9 tpt180 -177.4 -48.36 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.978 -175.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -112.78 157.88 20.8 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.411 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -84.65 -64.68 1.11 Allowed 'General case' 0 CA--C 1.545 0.786 0 CA-C-O 120.756 0.312 . . . . 0.0 111.4 177.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -155.75 4.08 0.18 Allowed 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 122.323 0.249 . . . . 0.0 111.275 -179.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 94.7 p 53.35 -85.26 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.335 0.654 . . . . 0.0 111.073 -168.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.443 ' O ' ' HB3' ' A' ' 144' ' ' LYS . . . 77.38 -51.03 3.25 Favored Glycine 0 CA--C 1.53 1.003 0 N-CA-C 114.363 0.505 . . . . 0.0 114.363 176.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.443 ' HB3' ' O ' ' A' ' 143' ' ' GLY . 23.6 ttmm 70.71 -61.11 0.48 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.262 0.625 . . . . 0.0 111.084 -174.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -115.53 79.7 0.29 Allowed Glycine 0 CA--C 1.527 0.817 0 C-N-CA 121.25 -0.5 . . . . 0.0 112.627 176.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -66.77 90.25 0.17 Allowed 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 116.806 0.303 . . . . 0.0 111.192 178.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 142.85 143.65 4.18 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 121.05 -0.595 . . . . 0.0 113.663 177.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 48.9 mm -105.0 124.95 60.0 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 O-C-N 122.524 -0.398 . . . . 0.0 112.03 -178.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . 61.23 14.73 5.8 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 175.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -86.7 82.2 1.65 Allowed Glycine 0 CA--C 1.524 0.594 0 C-N-CA 121.015 -0.612 . . . . 0.0 113.682 -177.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 151' ' ' ARG . 24.5 ttm-85 -145.84 -55.35 0.29 Allowed 'General case' 0 CA--C 1.54 0.586 0 O-C-N 122.481 -0.423 . . . . 0.0 111.553 177.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -71.09 146.63 49.13 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.538 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -108.74 -163.52 0.88 Allowed 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.498 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 41.2 pt -66.94 126.88 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-O 121.192 0.52 . . . . 0.0 112.069 -178.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 75.5 mt -135.48 86.67 2.26 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.6 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 17.3 t70 75.91 -48.75 0.6 Allowed 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 169.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -53.84 121.26 7.57 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -174.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 26.7 p -83.03 -33.17 26.55 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.192 177.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 124.21 107.01 1.73 Allowed Glycine 0 CA--C 1.527 0.786 0 C-N-CA 121.031 -0.604 . . . . 0.0 113.616 175.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -65.66 162.98 17.3 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.231 0.539 . . . . 0.0 112.14 175.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.444 ' O ' ' HB3' ' A' ' 162' ' ' SER . 11.8 p -112.73 26.57 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.928 0 CA-C-O 121.451 0.643 . . . . 0.0 110.409 177.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.444 ' HB3' ' O ' ' A' ' 161' ' ' VAL . 28.9 t 73.06 132.82 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.198 -176.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -58.12 136.12 57.16 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.955 178.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -81.04 59.73 3.94 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.375 0.607 . . . . 0.0 111.531 -176.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -94.77 -77.85 0.46 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.991 -0.549 . . . . 0.0 112.189 177.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 22.2 p-10 -158.41 -55.15 0.07 Allowed 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -176.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.87 109.31 0.62 Allowed 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -174.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -85.56 73.3 2.6 Favored Glycine 0 CA--C 1.524 0.596 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.766 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 59.1 m -67.09 83.62 0.13 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.216 0.531 . . . . 0.0 111.226 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -105.79 134.54 48.75 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.719 178.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -78.18 84.21 4.41 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.758 0.79 . . . . 0.0 111.917 -177.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -120.03 -62.26 1.5 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.037 176.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 51.6 tttp -84.52 31.7 0.52 Allowed 'General case' 0 CA--C 1.548 0.887 0 CA-C-O 121.395 0.617 . . . . 0.0 111.3 -178.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 54.1 t -80.02 87.54 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-O 121.462 0.648 . . . . 0.0 110.826 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 57.5 tttm -151.56 55.53 0.86 Allowed 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.833 0.825 . . . . 0.0 109.248 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 34.1 mtmt -105.37 -83.23 0.51 Allowed 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.601 -171.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.426 HD12 ' N ' ' A' ' 177' ' ' LEU . 6.7 mp -84.19 -79.88 0.2 Allowed 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 178.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 . . . . . 0 N--CA 1.476 0.861 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 166.806 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.4 tpt . . . . . 0 N--CA 1.488 1.44 0 CA-C-O 120.683 0.278 . . . . 0.0 110.861 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.62 102.34 0.9 Allowed 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -176.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -84.8 85.97 7.4 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.27 0.557 . . . . 0.0 110.764 174.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.0 t -66.05 149.81 49.68 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -176.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 75.6 p -84.03 94.77 8.38 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.303 173.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.7 t70 62.31 -164.36 0.25 Allowed 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.518 -176.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.9 mm -75.15 104.42 3.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 O-C-N 121.904 -0.497 . . . . 0.0 110.959 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.42 -38.45 66.28 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.18 -177.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -69.02 -26.69 74.52 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 121.144 -0.551 . . . . 0.0 113.257 177.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 50.7 tp -74.9 -51.29 14.21 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 122.523 -0.398 . . . . 0.0 110.882 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -62.33 -30.22 71.01 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.719 0.295 . . . . 0.0 111.047 176.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -63.56 -51.94 63.21 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.837 0.351 . . . . 0.0 110.377 175.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.5 m -62.78 -39.47 94.31 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.57 177.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -54.14 -51.66 63.57 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.862 0.363 . . . . 0.0 110.492 176.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.607 ' O ' HG12 ' A' ' 19' ' ' ILE . 81.6 mtt85 -63.26 -44.2 95.81 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.962 0.411 . . . . 0.0 111.232 175.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.657 ' HD2' ' HA ' ' A' ' 107' ' ' GLU . 26.9 ttmt -52.43 -34.32 48.03 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.414 -178.058 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -93.04 -38.8 11.44 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 116.167 -0.47 . . . . 0.0 112.098 173.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.07 -41.7 83.95 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -175.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.607 HG12 ' O ' ' A' ' 15' ' ' ARG . 46.5 pt -83.73 10.58 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -178.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 22.8 t60 -82.64 129.15 34.9 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 120.894 0.378 . . . . 0.0 110.8 177.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.408 ' O ' ' HD3' ' A' ' 23' ' ' PRO . . . 83.49 -49.29 4.2 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.548 -177.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -93.19 100.78 4.57 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-O 120.741 0.305 . . . . 0.0 111.242 175.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 21' ' ' GLY . 89.8 Cg_endo -76.85 4.64 5.52 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 122.584 2.189 . . . . 0.0 113.229 -177.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -113.83 4.26 15.82 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.708 0.29 . . . . 0.0 111.707 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.405 ' HB3' ' HA ' ' A' ' 19' ' ' ILE . . . -74.99 132.05 41.09 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.788 0.328 . . . . 0.0 111.72 -179.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 49.6 m -76.81 -36.05 57.19 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.865 0.364 . . . . 0.0 111.473 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.524 ' HA3' ' HG2' ' A' ' 15' ' ' ARG . . . 126.71 15.67 2.61 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 120.881 -0.676 . . . . 0.0 114.229 176.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -113.95 -7.84 13.13 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 117.228 0.514 . . . . 0.0 111.833 177.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -123.79 137.13 54.73 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 122.418 0.287 . . . . 0.0 110.995 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 51.2 ttm -133.54 137.43 45.55 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.867 0.365 . . . . 0.0 111.404 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 31.0 p30 -92.12 171.22 9.23 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.261 0.553 . . . . 0.0 112.267 -179.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.55 -29.1 72.57 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-N 115.885 -0.598 . . . . 0.0 113.603 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -60.13 -55.06 38.54 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.031 0.443 . . . . 0.0 111.356 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -69.99 -29.16 66.18 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.496 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 53.8 t-105 -61.59 -42.63 99.13 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.275 0.559 . . . . 0.0 110.605 173.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.61 -42.62 99.13 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.119 174.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.421 ' HE2' ' OD2' ' A' ' 41' ' ' ASP . 13.2 mmmm -61.87 -44.05 97.61 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.205 175.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.498 HD13 ' HE1' ' A' ' 75' ' ' PHE . 11.1 mt -48.83 -54.28 15.84 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 177.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 24.6 p -62.06 -45.88 91.57 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.664 -178.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.5 ttpm? -68.72 -49.2 60.82 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.074 0.464 . . . . 0.0 111.661 -176.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.421 ' OD2' ' HE2' ' A' ' 37' ' ' LYS . 12.4 m-20 -69.14 -38.37 78.78 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.563 -176.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.472 ' SG ' ' HA ' ' A' ' 103' ' ' VAL . 73.4 m -85.35 -4.04 59.03 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 176.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt 62.0 35.53 16.03 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.265 0.555 . . . . 0.0 112.284 175.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 41.7 t -80.04 -23.84 11.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.472 174.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -92.62 96.92 10.48 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.574 179.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -56.73 -30.43 63.52 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.946 0.403 . . . . 0.0 111.532 178.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 98.04 -48.63 1.43 Allowed Glycine 0 CA--C 1.524 0.63 0 C-N-CA 121.536 -0.364 . . . . 0.0 112.655 -178.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -84.87 -21.11 29.9 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.965 0.412 . . . . 0.0 111.704 178.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 78.7 p -113.7 -72.53 0.7 Allowed 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.957 0.408 . . . . 0.0 110.551 176.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 59.3 t -88.14 122.03 39.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.172 174.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.408 ' O ' HG23 ' A' ' 55' ' ' VAL . 5.5 t -140.6 178.56 7.24 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.416 -176.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -44.83 -52.36 7.82 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 114.189 0.436 . . . . 0.0 114.189 -175.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.597 ' O ' HG12 ' A' ' 57' ' ' ILE . 84.7 m -57.88 -51.67 68.65 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 122.561 -0.376 . . . . 0.0 111.303 177.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -55.86 -42.99 76.68 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 121.263 0.554 . . . . 0.0 111.123 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 51' ' ' THR . 83.7 t -65.8 -29.19 46.18 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.562 177.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -78.05 -33.84 50.73 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.592 0.711 . . . . 0.0 109.732 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.597 HG12 ' O ' ' A' ' 53' ' ' THR . 11.0 mm -64.13 -47.36 90.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.684 175.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.537 ' HA ' ' HD2' ' A' ' 61' ' ' LYS . 80.8 t -57.63 -45.91 86.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.323 175.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -57.36 -43.35 83.42 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.145 0.498 . . . . 0.0 110.579 174.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 23.0 t -65.48 -34.36 78.08 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.766 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.537 ' HD2' ' HA ' ' A' ' 58' ' ' VAL . 64.6 mttm -58.75 -51.96 67.74 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.333 0.587 . . . . 0.0 111.308 176.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.515 ' HB ' ' HB3' ' A' ' 74' ' ' GLU . 25.9 m -84.31 -6.6 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.039 -177.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.42 ' NZ ' ' HB3' ' A' ' 63' ' ' LYS . 6.3 ttpm? -65.69 153.55 41.38 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 120.922 0.392 . . . . 0.0 111.83 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -79.37 -161.46 21.87 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.683 175.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -62.38 -38.63 90.36 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 122.48 -0.424 . . . . 0.0 111.918 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 21.2 t -154.08 17.44 0.49 Allowed 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 120.824 0.345 . . . . 0.0 111.235 177.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.06 138.81 58.56 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -179.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 62.4 mtt180 -94.12 -8.58 39.15 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.232 178.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 36.0 m -132.17 152.03 35.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.807 -178.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.494 HG21 HG23 ' A' ' 62' ' ' VAL . 35.2 pt -117.58 151.63 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.087 176.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -100.38 173.03 6.78 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -177.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.501 ' O ' ' HB3' ' A' ' 75' ' ' PHE . 34.5 t80 -53.17 -50.65 64.18 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -170.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -63.43 -42.82 98.71 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -176.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.515 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 0.8 OUTLIER -69.93 -30.72 68.18 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.984 0.421 . . . . 0.0 110.537 176.653 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.501 ' HB3' ' O ' ' A' ' 72' ' ' TYR . 50.5 t80 -58.53 -43.25 89.14 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.163 0.506 . . . . 0.0 110.55 171.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.486 ' HG3' ' O ' ' A' ' 72' ' ' TYR . 55.2 mtpt -60.95 -40.14 92.17 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.7 175.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.401 ' HD3' ' HA ' ' A' ' 77' ' ' LYS . 72.1 mmtt -70.01 -28.26 65.36 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.528 175.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.85 -42.74 80.91 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.036 0.446 . . . . 0.0 110.546 173.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 79.9 mt -64.71 -41.72 95.79 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.716 173.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -56.95 -45.07 83.07 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.319 0.58 . . . . 0.0 110.665 174.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.418 ' O ' ' HG3' ' A' ' 85' ' ' LYS . 16.4 tp10 -58.65 -59.82 4.79 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.029 176.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.409 ' O ' ' HG3' ' A' ' 86' ' ' ARG . 87.6 mt -56.13 -36.69 68.51 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.556 178.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.99 -58.31 9.23 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.72 -0.218 . . . . 0.0 111.276 177.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 80.5 p -53.79 -33.8 57.12 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.418 ' HG3' ' O ' ' A' ' 81' ' ' GLU . 7.2 mtpm? -72.71 -35.62 67.62 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.518 178.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.409 ' HG3' ' O ' ' A' ' 82' ' ' LEU . 48.1 mtp180 -96.82 -65.91 0.94 Allowed 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 120.88 0.372 . . . . 0.0 111.528 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.41 ' HB2' ' HB1' ' A' ' 95' ' ' ALA . 51.7 m-85 -87.37 111.63 21.3 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.859 0.361 . . . . 0.0 110.436 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 15.5 pttm -141.93 31.64 1.6 Allowed 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -171.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -78.85 43.04 2.35 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 120.97 -0.634 . . . . 0.0 113.182 175.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.5 ttpp 72.04 -45.92 0.63 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.036 0.935 . . . . 0.0 112.964 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.4 m -72.62 110.4 6.95 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 122.071 -0.393 . . . . 0.0 111.759 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -81.62 -34.52 30.85 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 178.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -47.12 -70.55 0.09 Allowed 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 120.994 0.426 . . . . 0.0 111.409 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -66.64 -28.82 68.78 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -177.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.41 ' HB1' ' HB2' ' A' ' 87' ' ' PHE . . . -59.2 -42.88 91.95 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.307 0.575 . . . . 0.0 110.696 174.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -68.16 -40.3 82.37 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.539 176.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -57.78 -40.31 79.52 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.791 0.329 . . . . 0.0 111.513 174.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.574 ' O ' ' HB3' ' A' ' 101' ' ' GLN . . . -63.8 -47.45 80.81 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.036 0.446 . . . . 0.0 112.093 -178.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.9 tt -70.46 -31.14 45.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 O-C-N 121.998 -0.439 . . . . 0.0 110.752 178.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 84.8 m -68.06 -33.88 75.4 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.788 0.328 . . . . 0.0 110.613 171.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.574 ' HB3' ' O ' ' A' ' 98' ' ' ALA . 28.2 tt0 -56.53 -39.93 74.22 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.284 0.564 . . . . 0.0 110.526 173.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 88.8 mt -68.18 -39.15 82.59 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.405 176.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.472 ' HA ' ' SG ' ' A' ' 42' ' ' CYS . 67.7 t -93.53 -59.08 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -174.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -51.28 125.02 13.03 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 112.546 0.572 . . . . 0.0 112.546 -177.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.67 -42.13 2.81 Favored Glycine 0 CA--C 1.528 0.869 0 CA-C-N 116.172 -0.467 . . . . 0.0 112.745 -177.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -51.44 132.64 29.8 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -176.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.657 ' HA ' ' HD2' ' A' ' 16' ' ' LYS . 10.4 pt-20 -95.76 155.05 38.91 Favored Pre-proline 0 CA--C 1.542 0.657 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.902 174.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -56.87 130.14 38.27 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.545 2.163 . . . . 0.0 113.025 -178.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 60.27 -105.24 0.21 Allowed 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.224 -177.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 8.4 t30 59.01 122.1 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 121.304 0.573 . . . . 0.0 112.313 -175.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 41.0 t -73.81 75.65 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-O 121.5 0.667 . . . . 0.0 111.001 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -112.53 83.47 0.33 Allowed Glycine 0 CA--C 1.521 0.439 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.989 178.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 62.0 t -100.79 119.28 48.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -176.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 70.4 m -70.19 100.96 1.76 Allowed 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 172.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -74.99 125.87 29.82 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.296 0.57 . . . . 0.0 112.482 -173.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -100.62 -70.79 0.73 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.012 174.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -114.09 99.8 7.91 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.081 0.467 . . . . 0.0 112.137 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 41.7 p -78.2 -173.04 3.04 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.315 176.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 96.13 134.54 7.99 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.348 -177.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 154.72 -89.16 0.12 Allowed Glycine 0 CA--C 1.523 0.544 0 C-N-CA 121.269 -0.491 . . . . 0.0 112.421 -178.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.2 172.37 18.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.96 0.41 . . . . 0.0 111.416 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 28.8 m -76.7 128.29 37.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-O 121.071 0.463 . . . . 0.0 110.923 176.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -104.38 92.73 4.45 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 120.964 0.412 . . . . 0.0 110.918 -179.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 66.3 mtm180 57.84 16.62 3.71 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 175.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 7.5 mp 62.54 87.02 0.11 Allowed 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.116 0.484 . . . . 0.0 111.782 -177.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 53.2 p -116.84 12.12 14.68 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -86.77 21.12 2.32 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -175.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 66.2 p -79.71 69.19 5.98 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 122.093 -0.38 . . . . 0.0 111.302 178.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.52 ' HB3' ' HB3' ' A' ' 135' ' ' HIS . 82.8 p 50.12 106.33 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.827 0.851 . . . . 0.0 112.593 -176.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 63.9 mtt180 -55.46 -42.52 74.42 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.773 -176.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -171.66 29.41 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.888 0.851 . . . . 0.0 109.827 172.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 24.3 m -82.55 -25.73 33.07 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.603 -178.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 78.03 -61.32 3.77 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 121.156 -0.545 . . . . 0.0 112.02 -172.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 49.5 m -67.52 114.2 5.98 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 122.359 0.264 . . . . 0.0 110.957 175.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.52 ' HB3' ' HB3' ' A' ' 129' ' ' SER . 39.4 p-80 -140.03 -2.83 1.45 Allowed 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -178.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -77.54 -18.73 56.7 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.733 0.777 . . . . 0.0 109.733 173.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.52 ' O ' ' N ' ' A' ' 139' ' ' PHE . 0.0 OUTLIER -138.68 -175.39 4.12 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.555 172.652 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.693 ' HG3' ' H ' ' A' ' 139' ' ' PHE . 13.7 ptm180 34.17 -73.85 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.189 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 -174.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.693 ' H ' ' HG3' ' A' ' 138' ' ' ARG . 36.3 p90 46.42 177.14 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -178.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -90.46 151.29 21.46 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.785 -176.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -74.66 142.6 44.5 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.059 174.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 22.9 t -62.92 98.02 0.12 Allowed 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.101 0.477 . . . . 0.0 111.06 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -61.91 -29.04 71.32 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-N 116.008 -0.542 . . . . 0.0 113.316 -178.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 96.2 mttt 59.28 101.08 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.388 0.613 . . . . 0.0 111.658 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -90.7 -173.81 44.28 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 121.074 -0.584 . . . . 0.0 113.552 -176.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -107.05 144.95 32.97 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.759 0.314 . . . . 0.0 110.708 177.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -68.56 78.97 0.24 Allowed Glycine 0 CA--C 1.527 0.83 0 C-N-CA 121.426 -0.416 . . . . 0.0 113.506 -177.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.435 ' O ' HG12 ' A' ' 148' ' ' ILE . 15.4 tt -146.91 9.56 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 CA-C-O 121.391 0.615 . . . . 0.0 111.384 179.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -73.26 82.3 1.35 Allowed 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.12 0.486 . . . . 0.0 111.648 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 145.58 123.93 1.62 Allowed Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.235 -0.507 . . . . 0.0 112.899 178.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 62.7 ttt-85 -118.63 95.99 5.09 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 120.884 0.373 . . . . 0.0 110.993 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -109.58 20.49 18.09 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.003 0.43 . . . . 0.0 111.025 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 62.53 -166.65 0.22 Allowed 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.19 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.524 HG13 ' H ' ' A' ' 156' ' ' ASP . 35.5 pt -91.46 176.67 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-O 121.079 0.466 . . . . 0.0 111.71 178.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 75.2 mt -89.64 19.35 4.69 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.814 -179.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.524 ' H ' HG13 ' A' ' 154' ' ' ILE . 10.1 m-20 63.85 -84.44 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.114 0.566 . . . . 0.0 111.938 -177.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 3.9 p30 40.37 -67.5 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -177.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.523 ' N ' ' O ' ' A' ' 156' ' ' ASP . 50.9 m -57.76 87.26 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.223 0.609 . . . . 0.0 112.19 -178.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 159.44 108.91 0.25 Allowed Glycine 0 CA--C 1.526 0.74 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.667 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -68.15 112.55 5.16 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 117.109 0.455 . . . . 0.0 111.951 -173.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.411 HG22 ' O ' ' A' ' 161' ' ' VAL . 11.2 p -135.4 19.77 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 CA-C-O 121.527 0.679 . . . . 0.0 111.146 177.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 76.7 p -95.19 20.14 9.61 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -69.67 108.57 3.93 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 122.139 -0.35 . . . . 0.0 111.656 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 35.9 t80 73.19 -53.39 0.7 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.96 0.904 . . . . 0.0 111.317 -178.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 62.6 tttm 72.88 -57.24 0.64 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.101 0.96 . . . . 0.0 113.349 174.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -60.88 91.65 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -175.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -176.52 167.26 2.73 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.385 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -87.32 -44.69 5.52 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.288 175.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 95.9 m 72.82 -41.03 0.49 Allowed 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 176.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . 0.45 ' HA ' ' HE3' ' A' ' 175' ' ' LYS . 80.3 m-85 -73.18 94.18 1.93 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.308 0.575 . . . . 0.0 111.413 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . 0.406 ' O ' ' HB3' ' A' ' 172' ' ' ALA . 12.1 p-10 -95.53 -8.04 36.29 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.527 -0.761 . . . . 0.0 112.257 -178.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.406 ' HB3' ' O ' ' A' ' 171' ' ' ASP . . . 75.31 -42.15 0.47 Allowed 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -178.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 44.2 mmtm -62.16 -63.99 1.07 Allowed 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -176.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 9.1 p -166.33 146.02 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 120.782 0.325 . . . . 0.0 111.621 -175.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.45 ' HE3' ' HA ' ' A' ' 170' ' ' TYR . 41.2 mmtm -97.04 52.37 1.15 Allowed 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -179.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp 60.36 106.91 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 176.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.782 ' H ' HD23 ' A' ' 177' ' ' LEU . 2.3 pt? -87.64 14.57 8.18 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 . . . . . 0 N--CA 1.471 0.618 0 CA-C-O 121.175 0.512 . . . . 0.0 111.357 176.664 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.3 mtt . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 120.671 0.272 . . . . 0.0 111.129 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.23 -58.77 2.8 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.19 0.519 . . . . 0.0 110.194 173.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -86.18 97.18 10.2 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.766 173.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 95.4 p -80.67 -59.06 2.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.48 -177.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.3 m 55.15 58.35 4.78 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.555 0.693 . . . . 0.0 111.032 -178.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -82.98 -170.92 3.27 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.56 -177.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 48.3 mm -98.32 113.34 32.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-O 120.749 0.309 . . . . 0.0 110.709 177.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.94 -47.97 81.32 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -178.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.05 -29.83 59.88 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 121.1 -0.572 . . . . 0.0 113.047 177.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 50.6 tp -71.78 -45.1 62.7 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.778 0.323 . . . . 0.0 110.705 177.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -59.08 -46.72 87.57 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.017 0.437 . . . . 0.0 111.282 177.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.557 ' HG3' ' HE2' ' A' ' 16' ' ' LYS . 14.1 tp10 -56.91 -47.59 80.21 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.128 179.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.5 m -64.35 -42.44 96.23 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.795 177.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -53.97 -46.06 71.54 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.265 176.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.55 ' O ' HG12 ' A' ' 19' ' ' ILE . 94.5 mtt180 -59.28 -55.74 30.97 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.61 176.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.557 ' HE2' ' HG3' ' A' ' 12' ' ' GLU . 50.4 mttm -55.43 -32.5 62.76 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -175.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.713 ' HB3' ' HE3' ' A' ' 30' ' ' MET . 11.7 m-85 -81.68 -48.65 11.42 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 122.192 -0.317 . . . . 0.0 111.443 173.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.474 ' HA ' ' HG3' ' A' ' 30' ' ' MET . . . -55.39 -40.47 71.43 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -177.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.55 HG12 ' O ' ' A' ' 15' ' ' ARG . 16.6 pt -99.41 12.82 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 121.426 0.631 . . . . 0.0 110.957 -177.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 37.4 t-80 -58.64 92.93 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.014 -176.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.73 -6.3 57.1 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 121.11 -0.567 . . . . 0.0 113.376 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -134.9 92.85 18.27 Favored Pre-proline 0 CA--C 1.539 0.552 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -63.6 -12.95 33.66 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.348 2.032 . . . . 0.0 111.667 170.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -96.05 7.24 46.93 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.174 178.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.6 -97.25 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -176.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 59.1 m -164.12 -72.05 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 120.913 0.387 . . . . 0.0 111.092 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.59 -31.44 5.57 Favored Glycine 0 N--CA 1.464 0.537 0 C-N-CA 121.185 -0.531 . . . . 0.0 112.052 179.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -100.74 -11.97 19.49 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 120.663 0.268 . . . . 0.0 111.435 174.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -126.5 140.14 52.68 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.827 178.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.713 ' HE3' ' HB3' ' A' ' 17' ' ' PHE . 26.7 ttt -126.15 148.4 49.41 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.765 -173.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.403 ' OD1' ' HB3' ' A' ' 33' ' ' LYS . 10.4 p30 -98.15 174.9 6.3 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 120.933 0.396 . . . . 0.0 111.964 -177.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.4 -26.13 64.24 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 121.368 -0.444 . . . . 0.0 114.119 -176.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.403 ' HB3' ' OD1' ' A' ' 31' ' ' ASN . 39.2 ttpt -63.83 -58.05 8.01 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 122.385 -0.479 . . . . 0.0 111.65 -177.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -74.03 -18.7 60.81 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 120.753 0.311 . . . . 0.0 111.603 178.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.45 ' NE1' HG12 ' A' ' 55' ' ' VAL . 58.8 t-105 -65.75 -47.6 74.69 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 121.142 0.496 . . . . 0.0 110.927 172.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.34 -36.97 79.21 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.181 0.515 . . . . 0.0 110.771 174.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 25.2 tptp -66.57 -44.73 81.46 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.842 176.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.429 HD12 ' HE1' ' A' ' 30' ' ' MET . 5.0 tt -53.86 -56.44 17.59 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.625 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.721 ' HA ' ' SG ' ' A' ' 42' ' ' CYS . 23.9 p -64.45 -32.64 74.35 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.694 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 50.5 tptt -72.7 -36.7 67.89 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 120.589 0.233 . . . . 0.0 111.481 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -73.45 -40.09 64.44 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 120.614 0.245 . . . . 0.0 111.473 177.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.721 ' SG ' ' HA ' ' A' ' 39' ' ' CYS . 27.6 p -79.27 -4.72 52.07 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.403 0.62 . . . . 0.0 110.386 172.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 22.4 mtpp 57.51 23.4 9.11 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.147 -0.933 . . . . 0.0 113.463 173.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.563 HG23 ' SG ' ' A' ' 42' ' ' CYS . 93.9 t -57.08 -42.9 80.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 168.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.599 ' HB2' HG21 ' A' ' 55' ' ' VAL . . . -86.59 65.86 9.22 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.637 177.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -155.62 11.09 0.31 Allowed 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.316 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -92.22 37.17 3.45 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 114.683 0.633 . . . . 0.0 114.683 -170.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt 54.2 13.29 0.58 Allowed 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 117.402 0.601 . . . . 0.0 112.337 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 42.8 t -156.75 -57.03 0.09 Allowed 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.277 0.561 . . . . 0.0 109.578 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.461 HG22 ' HB3' ' A' ' 85' ' ' LYS . 9.3 t -70.88 110.24 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.59 170.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.423 ' H ' ' HB3' ' A' ' 54' ' ' ASP . 68.5 p -135.67 176.1 8.99 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.004 -177.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -48.19 -42.66 24.77 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 121.339 -0.458 . . . . 0.0 113.468 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.578 ' O ' HG12 ' A' ' 57' ' ' ILE . 99.0 m -64.41 -51.18 64.49 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 122.506 -0.408 . . . . 0.0 111.243 177.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.423 ' HB3' ' H ' ' A' ' 51' ' ' THR . 37.1 t70 -56.94 -39.26 74.21 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.17 0.509 . . . . 0.0 111.18 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.599 HG21 ' HB2' ' A' ' 45' ' ' ALA . 64.0 t -72.68 -23.89 21.13 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.684 178.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -79.14 -32.51 44.42 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.601 0.715 . . . . 0.0 109.565 178.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.578 HG12 ' O ' ' A' ' 53' ' ' THR . 16.1 mm -58.51 -47.99 86.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.276 171.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 55.5 t -60.45 -42.85 92.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.849 175.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -57.21 -39.99 76.56 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.083 0.468 . . . . 0.0 110.64 174.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 33.5 t -69.4 -35.82 76.16 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.941 177.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.425 ' HG2' ' O ' ' A' ' 57' ' ' ILE . 11.9 mmmm -61.29 -31.44 71.27 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.234 0.54 . . . . 0.0 111.535 177.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.533 HG21 ' HB2' ' A' ' 78' ' ' ALA . 20.0 m -113.11 20.82 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.943 -178.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.506 ' HA ' HG22 ' A' ' 70' ' ' ILE . 40.1 ttmt -73.84 123.17 23.68 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 120.895 0.379 . . . . 0.0 111.991 -178.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -57.74 86.66 0.01 OUTLIER Glycine 0 CA--C 1.529 0.928 0 CA-C-N 116.057 -0.52 . . . . 0.0 113.121 176.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 61.3 mttm 64.95 -78.33 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.275 0.63 . . . . 0.0 111.464 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 81.1 p -146.54 3.93 0.88 Allowed 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.447 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -69.82 151.04 46.2 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -173.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.542 ' HG3' HG13 ' A' ' 69' ' ' VAL . 1.8 ptm180 -73.13 -6.98 49.27 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.187 174.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.542 HG13 ' HG3' ' A' ' 68' ' ' ARG . 30.6 m -125.71 142.84 41.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-O 121.113 0.482 . . . . 0.0 112.221 -178.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.506 HG22 ' HA ' ' A' ' 63' ' ' LYS . 35.3 pt -113.3 151.49 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.595 176.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -86.9 169.83 12.16 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.075 0.464 . . . . 0.0 111.868 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.438 ' O ' ' HB3' ' A' ' 75' ' ' PHE . 86.9 t80 -52.07 -38.36 56.93 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -175.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.484 ' O ' ' HG3' ' A' ' 77' ' ' LYS . 33.7 tt0 -70.14 -41.36 73.99 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.445 -0.784 . . . . 0.0 110.765 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -64.78 -33.28 75.61 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.248 0.547 . . . . 0.0 110.341 177.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.438 ' HB3' ' O ' ' A' ' 72' ' ' TYR . 67.7 t80 -55.86 -46.35 78.25 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.987 171.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 23.0 mtmt -64.36 -39.37 93.74 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.886 0.374 . . . . 0.0 111.455 176.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.484 ' HG3' ' O ' ' A' ' 73' ' ' GLU . 60.7 mttm -60.18 -39.83 87.85 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.314 0.578 . . . . 0.0 110.363 176.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.533 ' HB2' HG21 ' A' ' 62' ' ' VAL . . . -63.53 -46.88 83.98 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.136 176.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 86.2 mt -58.61 -34.17 70.84 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.86 0.362 . . . . 0.0 111.228 175.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.457 ' HB3' ' O ' ' A' ' 77' ' ' LYS . 10.4 tp10 -55.47 -59.82 4.29 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.533 0.682 . . . . 0.0 110.838 176.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.58 ' O ' ' HG2' ' A' ' 85' ' ' LYS . 47.2 mt-10 -61.18 -47.98 83.65 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.409 178.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 69.5 mt -56.8 -33.75 67.0 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 178.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.36 -48.58 81.12 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 120.906 0.384 . . . . 0.0 110.86 175.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 31.0 p -72.72 -8.56 56.0 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 116.194 -0.457 . . . . 0.0 112.072 177.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.58 ' HG2' ' O ' ' A' ' 81' ' ' GLU . 73.1 mmtt -79.82 -51.58 8.97 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.133 0.492 . . . . 0.0 110.697 174.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 8.2 mmt180 -82.55 -58.07 3.07 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -178.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -86.59 56.88 4.2 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -170.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 66.3 mttm 61.81 175.85 0.12 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.357 0.599 . . . . 0.0 111.989 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -96.87 29.53 10.41 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.669 176.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -143.44 169.19 18.14 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 122.75 0.42 . . . . 0.0 110.861 -178.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 46.4 t 55.62 47.0 21.66 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.153 0.502 . . . . 0.0 111.529 177.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.469 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 22.0 pttp -64.19 -20.22 65.87 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -174.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -63.08 -59.53 4.67 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.296 0.57 . . . . 0.0 109.871 172.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -57.3 -43.75 83.49 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.452 175.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.469 ' HB3' ' HA ' ' A' ' 92' ' ' LYS . . . -58.51 -46.2 87.24 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.026 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -61.04 -53.79 52.81 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.944 0.402 . . . . 0.0 111.212 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -57.15 -37.9 72.75 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 120.808 0.337 . . . . 0.0 111.842 176.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.24 -49.82 68.2 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -179.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 12.5 tt -63.7 -39.94 87.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-O 121.111 0.481 . . . . 0.0 110.874 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 36.5 t -61.3 -39.33 90.07 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.037 0.446 . . . . 0.0 110.927 174.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -60.75 -39.35 88.39 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.677 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 93.1 mt -66.8 -36.02 81.41 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.706 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 49.9 t -83.15 -37.07 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -178.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -57.21 104.09 0.15 Allowed 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -174.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 94.81 13.56 52.83 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-N 116.154 -0.475 . . . . 0.0 113.678 174.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 46.2 tttp -86.3 161.35 18.79 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.973 0.416 . . . . 0.0 111.273 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -73.28 136.11 78.99 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.777 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.61 73.46 2.3 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.468 2.112 . . . . 0.0 112.015 175.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 62.65 93.18 0.05 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.781 -175.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 14.8 p30 -75.59 73.49 2.59 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 121.855 0.836 . . . . 0.0 111.973 -178.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 7.4 p -166.37 -36.81 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.718 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -63.03 122.26 27.03 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 121.251 -0.499 . . . . 0.0 112.951 176.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 50.0 t -88.74 110.66 21.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 O-C-N 122.471 -0.429 . . . . 0.0 111.584 -178.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 91.2 m -127.19 -49.48 1.44 Allowed 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.683 176.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 67.2 mttm 66.01 -78.45 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.612 176.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.45 157.69 36.61 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -172.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -133.49 108.02 8.39 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.482 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 89.6 m -87.23 -77.78 0.32 Allowed 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -174.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -133.74 166.78 23.83 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 120.466 -0.873 . . . . 0.0 114.109 -173.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -89.74 -24.79 29.32 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 121.552 -0.356 . . . . 0.0 113.484 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 63.56 15.26 8.72 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 177.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.41 ' O ' ' HB2' ' A' ' 123' ' ' ASP . 22.6 m -94.7 -167.07 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -177.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.41 ' HB2' ' O ' ' A' ' 122' ' ' VAL . 16.2 m-20 76.07 -33.08 0.21 Allowed 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 178.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 63.8 ttt180 -59.16 -55.36 36.03 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -91.58 38.48 0.98 Allowed 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -173.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.1 t -151.68 96.37 2.24 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.175 0.512 . . . . 0.0 112.312 179.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -54.25 142.94 24.5 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.601 174.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 79.8 p -58.34 106.2 0.36 Allowed 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.005 0.431 . . . . 0.0 111.246 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 96.2 p -160.1 145.7 15.29 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.885 -178.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? -90.1 -14.36 33.87 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.852 -176.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -109.92 -84.37 0.55 Allowed 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 -177.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 8.8 t -153.36 21.56 0.55 Allowed 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 121.007 0.432 . . . . 0.0 112.049 -175.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 148.09 166.88 13.06 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 121.128 -0.558 . . . . 0.0 112.611 -176.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 82.7 p -147.35 -168.99 3.2 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 122.764 -0.256 . . . . 0.0 110.785 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 12.2 m80 68.84 -77.27 0.05 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 122.738 0.415 . . . . 0.0 111.045 -177.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -141.99 130.97 23.11 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.912 0.387 . . . . 0.0 110.433 176.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -79.15 -51.89 8.92 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.312 0.577 . . . . 0.0 111.897 -173.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 85.2 mtt180 -120.05 112.89 19.7 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.497 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -82.64 179.83 7.66 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 120.473 0.178 . . . . 0.0 110.526 174.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -72.69 136.75 45.66 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 122.166 -0.334 . . . . 0.0 110.592 177.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -67.02 101.72 0.89 Allowed 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -174.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 32.0 t -91.19 -153.3 0.31 Allowed 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.159 175.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -75.6 48.12 2.2 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 120.968 -0.634 . . . . 0.0 113.602 177.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -89.76 113.69 25.27 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 122.401 -0.47 . . . . 0.0 110.533 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 78.78 -66.37 3.35 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.133 -177.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 12.1 ptmm? -58.73 -45.19 90.16 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.021 0.439 . . . . 0.0 111.26 175.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 68.1 142.01 0.08 OUTLIER Glycine 0 CA--C 1.529 0.958 0 N-CA-C 115.058 0.783 . . . . 0.0 115.058 175.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 49.6 mm -82.64 -50.86 15.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 169.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -98.48 105.38 17.51 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 166.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -128.04 -96.08 0.87 Allowed Glycine 0 CA--C 1.525 0.7 0 C-N-CA 120.466 -0.874 . . . . 0.0 115.019 -168.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 23.1 ttp180 -92.77 122.58 35.3 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -168.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -79.67 148.49 31.58 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 165.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -53.1 127.23 23.41 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -171.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 37.6 pt -120.63 175.75 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.328 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 78.6 mt -79.84 80.88 6.19 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.979 0.419 . . . . 0.0 111.752 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -74.06 53.81 0.5 Allowed 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.49 175.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -75.31 83.3 2.44 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.01 0.433 . . . . 0.0 111.827 -174.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 26.8 m -172.75 156.31 3.45 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.402 0.681 . . . . 0.0 110.489 177.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.403 ' O ' ' N ' ' A' ' 161' ' ' VAL . . . -54.97 117.98 9.17 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 120.322 -0.942 . . . . 0.0 110.953 169.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -59.05 82.7 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 -170.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.403 ' N ' ' O ' ' A' ' 159' ' ' GLY . 7.5 p -111.19 -40.03 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.953 171.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 36.8 t -176.37 -177.91 0.9 Allowed 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.133 178.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -68.0 -37.25 81.25 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.731 0.301 . . . . 0.0 111.363 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 85.4 t80 74.35 -55.18 0.66 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.864 0.865 . . . . 0.0 112.767 175.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -58.17 -40.3 81.09 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.03 0.443 . . . . 0.0 111.688 -176.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -105.95 122.18 45.62 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.525 177.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -58.87 123.27 15.92 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.002 0.429 . . . . 0.0 111.525 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -93.97 -155.44 31.76 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 121.221 -0.514 . . . . 0.0 113.543 -175.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 71.2 p -109.5 -166.71 1.12 Allowed 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 120.988 0.423 . . . . 0.0 111.488 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -79.23 18.03 0.73 Allowed 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 112.554 0.575 . . . . 0.0 112.554 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 37.9 t70 69.47 116.34 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.308 0.575 . . . . 0.0 111.627 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -125.3 87.79 2.76 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.122 0.487 . . . . 0.0 112.138 -177.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 49.7 mttp -86.18 -11.55 52.21 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.715 174.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 16.2 m 46.84 14.59 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 N-CA-C 115.441 1.645 . . . . 0.0 115.441 171.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.663 ' HD3' ' HG3' ' A' ' 178' ' ' GLU . 74.7 mmtt -76.46 66.66 2.53 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 121.681 -0.637 . . . . 0.0 110.886 176.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -133.09 -64.38 0.74 Allowed 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.256 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.494 ' H ' HD23 ' A' ' 177' ' ' LEU . 1.9 pt? -104.1 17.92 23.11 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.378 0.609 . . . . 0.0 109.968 173.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.663 ' HG3' ' HD3' ' A' ' 175' ' ' LYS . 1.8 tm-20 . . . . . 0 CA--C 1.546 0.812 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.433 -171.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.4 mtt . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 120.684 0.278 . . . . 0.0 110.462 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -54.89 143.16 26.87 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -179.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 63.48 -90.94 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.451 178.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 39.0 t 176.93 -64.01 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 120.904 0.383 . . . . 0.0 111.935 -175.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.0 t -101.42 -174.87 2.7 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -173.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -83.47 123.77 30.04 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -175.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.7 tp -61.6 118.81 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-O 120.895 0.378 . . . . 0.0 110.925 173.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -49.49 -37.67 27.28 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -176.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.35 -29.92 60.87 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 121.417 -0.42 . . . . 0.0 113.74 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 30.9 tp -73.75 -48.38 32.18 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 122.324 -0.515 . . . . 0.0 111.031 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -65.87 -30.05 70.59 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.766 0.317 . . . . 0.0 110.642 176.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -59.27 -55.24 37.33 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.743 0.306 . . . . 0.0 110.444 174.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.7 m -57.94 -42.28 84.54 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.236 176.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -55.73 -56.07 24.87 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.875 0.369 . . . . 0.0 111.064 176.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 57.3 ttt180 -56.19 -51.13 69.14 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.396 0.617 . . . . 0.0 110.87 177.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -52.91 -37.11 60.36 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 114.903 -1.044 . . . . 0.0 112.213 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -85.51 -32.51 22.17 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.697 176.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.76 -39.61 65.51 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -175.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.522 HD13 ' H ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -103.74 7.45 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -178.927 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 60.0 t60 -35.46 -48.7 0.5 Allowed 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -174.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -138.27 22.44 3.06 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 120.286 -0.959 . . . . 0.0 113.604 -178.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.573 ' HB2' ' HB2' ' A' ' 25' ' ' ALA . 8.9 m-20 -121.55 118.7 29.6 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 116.886 0.343 . . . . 0.0 110.863 -176.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -46.02 -46.49 15.95 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 123.406 2.737 . . . . 0.0 114.102 -176.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -105.29 -34.09 7.99 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.703 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.573 ' HB2' ' HB2' ' A' ' 22' ' ' ASP . . . 36.99 -90.11 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -172.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 28.0 t 167.76 -45.36 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.825 0.85 . . . . 0.0 110.099 -174.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 88.28 -52.18 4.04 Favored Glycine 0 C--N 1.334 0.462 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.257 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 20.4 tp60 -91.26 -13.26 33.04 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 120.818 0.342 . . . . 0.0 111.376 178.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -128.03 143.99 51.09 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.788 175.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 49.2 ttm -115.24 143.39 45.32 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.285 0.564 . . . . 0.0 112.324 -175.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.48 HD22 ' HB2' ' A' ' 33' ' ' LYS . 0.8 OUTLIER -93.78 154.75 17.59 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.892 175.23 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -55.52 -26.64 45.92 Favored Glycine 0 CA--C 1.53 0.97 0 CA-C-N 116.122 -0.49 . . . . 0.0 114.104 -176.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.48 ' HB2' HD22 ' A' ' 31' ' ' ASN . 91.1 mttt -51.07 -60.86 2.65 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 122.026 0.917 . . . . 0.0 110.809 175.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 63.4 m-20 -73.1 -33.97 65.9 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 114.51 -1.223 . . . . 0.0 111.553 -174.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 41.1 t-105 -58.62 -45.21 89.7 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.054 0.454 . . . . 0.0 111.341 174.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.518 ' HA ' HG11 ' A' ' 55' ' ' VAL . . . -60.52 -47.99 83.74 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 120.974 0.416 . . . . 0.0 111.337 176.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -60.7 -37.32 81.26 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.492 176.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.3 tt -59.23 -45.42 91.18 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.336 178.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.665 ' SG ' ' HB ' ' A' ' 44' ' ' VAL . 44.4 t -54.33 -44.41 72.07 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.945 0.402 . . . . 0.0 111.038 175.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.535 ' NZ ' ' HB3' ' A' ' 40' ' ' LYS . 4.5 ttpm? -58.98 -54.64 44.8 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.746 176.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -65.55 -35.77 81.84 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -175.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.571 ' SG ' ' HB3' ' A' ' 102' ' ' LEU . 6.0 t -77.84 -9.87 59.27 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 120.799 0.333 . . . . 0.0 111.452 173.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm 69.05 26.95 5.48 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.197 0.599 . . . . 0.0 112.139 174.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.665 ' HB ' ' SG ' ' A' ' 39' ' ' CYS . 60.1 t -68.15 -35.77 72.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 121.054 0.454 . . . . 0.0 111.212 178.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.63 100.39 7.8 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.007 0.432 . . . . 0.0 111.683 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -99.91 -25.67 14.26 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.679 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 134.89 -78.99 0.33 Allowed Glycine 0 CA--C 1.529 0.921 0 C-N-CA 120.964 -0.636 . . . . 0.0 113.624 178.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -92.06 -7.32 49.06 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -174.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.4 t -102.35 -49.55 3.85 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.181 0.515 . . . . 0.0 110.041 173.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.457 HG11 HG12 ' A' ' 44' ' ' VAL . 99.1 t -139.65 130.94 33.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.948 176.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.459 ' O ' HG23 ' A' ' 55' ' ' VAL . 8.9 t -139.19 -177.86 5.1 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 116.766 -0.197 . . . . 0.0 110.68 173.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -46.19 -46.46 15.75 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 121.579 -0.344 . . . . 0.0 113.847 -177.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.54 ' O ' HG12 ' A' ' 57' ' ' ILE . 41.6 m -51.52 -54.81 23.4 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.035 0.445 . . . . 0.0 111.517 176.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -58.93 -34.56 71.86 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.392 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.518 HG11 ' HA ' ' A' ' 36' ' ' ALA . 65.5 t -60.21 -35.72 63.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.286 177.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -74.48 -38.5 62.9 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.562 0.696 . . . . 0.0 110.17 178.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.54 HG12 ' O ' ' A' ' 53' ' ' THR . 12.1 mm -61.41 -51.82 68.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.903 178.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 87.8 t -57.69 -41.87 80.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-O 120.912 0.387 . . . . 0.0 111.125 177.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -56.76 -42.26 79.06 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 120.915 0.388 . . . . 0.0 110.563 175.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.403 ' HA ' ' HE3' ' A' ' 63' ' ' LYS . 47.6 t -69.33 -36.76 77.26 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.392 177.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.534 ' HG2' ' O ' ' A' ' 57' ' ' ILE . 1.8 mmmp? -56.33 -35.67 67.86 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.875 0.369 . . . . 0.0 111.261 178.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.506 HG21 ' HB2' ' A' ' 78' ' ' ALA . 22.4 m -107.42 -2.7 10.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -177.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.403 ' HE3' ' HA ' ' A' ' 60' ' ' SER . 26.3 ttpp -70.74 101.5 2.1 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.024 0.44 . . . . 0.0 112.142 -178.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -133.98 -146.9 5.55 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-N 116.216 -0.447 . . . . 0.0 113.285 177.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 62.1 mttp 53.37 -103.05 0.15 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.842 0.457 . . . . 0.0 112.031 -176.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 88.0 p -109.0 -1.87 18.63 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.735 0.302 . . . . 0.0 110.899 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 66.0 -168.89 0.2 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.641 -177.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 20.3 tpp180 73.06 -51.56 0.71 Allowed 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.375 0.607 . . . . 0.0 111.034 -176.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 12.6 m -132.51 149.07 31.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.862 -178.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 37.5 pt -113.13 140.6 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-O 120.668 0.271 . . . . 0.0 111.113 177.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -85.37 177.73 7.7 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.9 -0.5 . . . . 0.0 111.341 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -55.1 -37.05 66.35 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -177.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.572 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 42.5 mt-10 -61.08 -53.34 58.34 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.189 0.519 . . . . 0.0 111.497 177.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -69.43 -20.77 63.77 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.243 0.544 . . . . 0.0 110.791 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -69.84 -54.87 11.56 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.959 173.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.572 ' HE2' ' HA ' ' A' ' 73' ' ' GLU . 63.8 pttt -62.54 -30.4 71.27 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.091 0.472 . . . . 0.0 110.533 177.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -64.42 -40.56 96.0 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.851 173.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.506 ' HB2' HG21 ' A' ' 62' ' ' VAL . . . -67.73 -38.73 83.95 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.03 0.443 . . . . 0.0 111.374 175.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 80.7 mt -59.98 -41.09 91.23 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.103 176.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -60.29 -42.49 95.58 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 120.664 0.269 . . . . 0.0 111.021 176.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -54.14 -62.81 1.42 Allowed 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.041 0.448 . . . . 0.0 110.769 174.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.537 HD13 HG11 ' A' ' 44' ' ' VAL . 90.5 mt -52.43 -43.98 65.18 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.434 178.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.13 -54.33 47.17 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.85 -0.613 . . . . 0.0 112.21 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.461 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 63.4 p -64.18 -20.55 66.09 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -177.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -96.72 -23.1 16.59 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 65.5 mtp85 -97.1 -50.63 4.52 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 121.797 -0.564 . . . . 0.0 111.744 175.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -86.75 31.45 0.69 Allowed 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.029 0.442 . . . . 0.0 111.331 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.461 ' HB3' ' O ' ' A' ' 84' ' ' THR . 0.0 OUTLIER -71.63 172.55 9.47 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -177.857 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 78.62 24.36 62.85 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 121.063 -0.589 . . . . 0.0 113.183 -178.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -168.86 -168.75 0.9 Allowed 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 120.826 0.346 . . . . 0.0 111.155 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 65.8 m -56.07 120.72 7.94 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -177.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -55.96 -33.21 64.56 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.321 175.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -54.76 -56.11 22.8 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.204 0.526 . . . . 0.0 110.97 174.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -63.91 -29.75 70.9 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.537 -178.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.53 -57.44 12.67 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.961 0.41 . . . . 0.0 111.017 176.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.523 ' O ' HG22 ' A' ' 99' ' ' ILE . 80.8 t80 -64.94 -35.99 82.95 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.218 0.532 . . . . 0.0 110.791 177.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -55.08 -47.5 74.8 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.461 0.648 . . . . 0.0 111.052 176.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -71.78 -42.08 67.57 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.518 -177.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.523 HG22 ' O ' ' A' ' 96' ' ' PHE . 7.3 tp -61.62 -34.02 60.01 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 CA-C-O 121.351 0.596 . . . . 0.0 110.214 178.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 35.8 t -64.67 -42.71 95.19 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.946 173.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -55.41 -35.12 65.01 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.123 0.487 . . . . 0.0 111.846 176.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.571 ' HB3' ' SG ' ' A' ' 42' ' ' CYS . 97.5 mt -73.29 -48.02 37.97 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 49.1 t -86.67 -53.59 9.93 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -173.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.22 127.39 24.27 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -171.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.59 -39.32 3.1 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-N 116.035 -0.529 . . . . 0.0 113.841 176.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 58.9 tttp -63.05 162.19 11.94 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-O 121.504 0.668 . . . . 0.0 112.799 -174.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.463 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 0.3 OUTLIER -124.48 161.94 45.2 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.679 175.019 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.463 ' HD2' ' HB2' ' A' ' 107' ' ' GLU . 19.0 Cg_endo -58.17 155.69 33.33 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.515 2.143 . . . . 0.0 112.922 176.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -54.74 98.64 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -179.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.504 HD22 ' N ' ' A' ' 110' ' ' ASN . 0.8 OUTLIER 70.01 103.98 0.06 Allowed 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.556 0.693 . . . . 0.0 112.757 175.47 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.9 t -70.31 -25.96 28.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.814 176.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 65.21 -134.65 36.63 Favored Glycine 0 CA--C 1.525 0.659 0 CA-C-N 116.129 -0.487 . . . . 0.0 113.124 177.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 6.3 p -65.84 109.94 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-O 121.384 0.611 . . . . 0.0 111.444 177.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 62.1 p -66.91 116.43 7.76 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.372 -176.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 52.4 mttp -98.03 107.06 19.45 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.256 179.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -87.71 108.36 19.07 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -172.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.569 ' HD3' ' O ' ' A' ' 117' ' ' LYS . 7.8 tmtm? -92.97 -19.14 21.91 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.453 175.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 69.6 p -48.98 -57.57 6.29 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -176.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -77.95 48.19 2.96 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 121.253 -0.498 . . . . 0.0 113.425 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -112.06 26.6 11.19 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 121.355 -0.45 . . . . 0.0 113.018 177.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.537 ' O ' HG22 ' A' ' 122' ' ' VAL . . . 67.7 -6.59 0.67 Allowed 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 176.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.537 HG22 ' O ' ' A' ' 121' ' ' ALA . 2.9 m 53.76 156.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 C-N-CA 124.489 1.116 . . . . 0.0 113.53 -178.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -138.35 132.47 31.58 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.846 -0.534 . . . . 0.0 112.067 -177.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.62 57.83 3.93 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.568 0.699 . . . . 0.0 111.309 176.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.432 ' H ' ' HG ' ' A' ' 125' ' ' LEU . 1.3 pp -77.34 21.69 0.25 Allowed 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -176.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 62.7 p -74.62 102.27 4.51 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.801 0.334 . . . . 0.0 110.79 176.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -53.74 132.78 41.74 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 121.114 0.483 . . . . 0.0 111.965 178.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.2 t -73.65 75.74 1.52 Allowed 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.362 0.601 . . . . 0.0 111.798 178.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.482 ' HB3' ' HD2' ' A' ' 131' ' ' TYR . 66.9 m -63.68 -52.37 60.96 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.871 -179.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.429 ' HB3' ' OG ' ' A' ' 134' ' ' SER . 9.8 mtp180 68.91 -15.18 0.26 Allowed 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 174.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.482 ' HD2' ' HB3' ' A' ' 129' ' ' SER . 98.7 m-85 -45.01 122.01 3.09 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -177.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 32.1 p 70.19 -33.29 0.26 Allowed 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.446 1.099 . . . . 0.0 113.093 178.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -67.36 -25.69 73.64 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.654 176.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.494 ' O ' ' HB2' ' A' ' 135' ' ' HIS . 81.9 p -133.13 52.53 2.08 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 122.604 0.362 . . . . 0.0 110.658 175.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.494 ' HB2' ' O ' ' A' ' 134' ' ' SER . 82.8 m-70 71.72 -168.36 0.14 Allowed 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.219 0.533 . . . . 0.0 111.725 -175.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -82.13 107.84 15.14 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.527 178.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -70.84 65.51 0.34 Allowed 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.477 0.656 . . . . 0.0 110.366 174.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -92.97 -81.58 0.35 Allowed 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.902 -171.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 58.33 96.11 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.151 0.581 . . . . 0.0 112.313 177.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -101.51 -63.76 1.11 Allowed 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 121.133 0.492 . . . . 0.0 111.745 -176.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 62.01 -83.07 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.726 -174.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 72.7 p 179.27 -37.52 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 120.843 0.354 . . . . 0.0 111.56 -174.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -57.35 134.71 52.22 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-N 116.354 -0.385 . . . . 0.0 114.039 -177.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.434 ' HE2' ' HB3' ' A' ' 144' ' ' LYS . 38.6 mtpt 63.86 32.74 13.14 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 178.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -71.69 73.22 0.81 Allowed Glycine 0 CA--C 1.532 1.121 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.629 174.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm 62.68 -73.77 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.719 0.808 . . . . 0.0 112.35 -175.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 72.74 -166.22 54.33 Favored Glycine 0 CA--C 1.529 0.906 0 C-N-CA 121.366 -0.445 . . . . 0.0 113.249 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.447 ' N ' HD12 ' A' ' 148' ' ' ILE . 2.8 mp 59.76 122.03 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 CA-C-O 121.391 0.615 . . . . 0.0 112.177 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -80.46 94.58 6.23 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 122.05 -0.406 . . . . 0.0 111.478 179.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 61.85 -139.89 46.77 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 121.256 -0.497 . . . . 0.0 112.697 -178.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 47.0 mtt180 59.42 30.08 19.72 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 174.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -87.53 173.86 8.83 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.176 0.512 . . . . 0.0 111.925 -176.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -65.04 115.04 5.02 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 -176.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 67.1 mt -76.99 131.43 34.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 170.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.493 ' N ' HD12 ' A' ' 155' ' ' LEU . 5.5 mp -83.2 40.27 0.7 Allowed 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -173.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 63.22 -72.21 0.05 Allowed 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -61.18 85.64 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.254 0.549 . . . . 0.0 111.795 -178.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 57.3 p -94.11 -11.15 31.14 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.703 178.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 102.87 -107.56 3.11 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 121.263 -0.494 . . . . 0.0 113.044 178.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 81.1 t80 66.96 156.18 0.11 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.148 0.579 . . . . 0.0 112.058 178.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 57.1 t -56.08 96.43 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 121.366 0.603 . . . . 0.0 111.225 177.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 68.1 m -112.56 25.33 11.58 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.004 -175.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -55.25 -35.48 65.02 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.338 0.589 . . . . 0.0 111.313 174.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -98.92 10.58 41.09 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.429 176.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.504 ' HG3' ' OH ' ' A' ' 170' ' ' TYR . 75.5 mmtt 67.26 123.07 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.438 0.695 . . . . 0.0 112.362 -177.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -82.87 133.67 35.12 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 120.808 0.337 . . . . 0.0 111.137 178.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 68.81 -4.71 1.13 Allowed 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 176.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 54.87 37.57 62.57 Favored Glycine 0 CA--C 1.531 1.077 0 N-CA-C 114.418 0.527 . . . . 0.0 114.418 177.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 86.9 m -76.74 85.97 3.36 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.279 0.561 . . . . 0.0 111.799 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . 0.504 ' OH ' ' HG3' ' A' ' 165' ' ' LYS . 65.1 m-85 -107.96 -9.22 15.72 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.677 172.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 31.6 t70 56.74 71.64 0.56 Allowed 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.145 -177.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -129.72 16.11 5.86 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.613 0.72 . . . . 0.0 109.944 172.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 46.5 mttm -91.31 25.46 2.55 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.608 -171.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 14.6 p -62.52 -24.52 35.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -176.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -66.59 83.64 0.1 Allowed 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.485 0.659 . . . . 0.0 111.915 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -96.48 -27.16 15.01 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.974 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 85.2 mt -64.56 -53.34 49.35 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -172.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.526 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -176.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.0 mmt . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 120.574 0.226 . . . . 0.0 111.136 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.41 -63.17 1.16 Allowed 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -176.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 55.04 -152.82 0.34 Allowed 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.071 -177.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 67.6 m -63.02 88.94 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.098 0.475 . . . . 0.0 110.123 171.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 71.1 p -58.24 116.33 3.51 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 113.415 0.895 . . . . 0.0 113.415 -172.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -129.36 163.31 26.04 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.517 173.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.522 ' HB ' ' HB2' ' A' ' 10' ' ' LEU . 42.6 mm -86.78 -10.38 11.12 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 CA-C-O 120.629 0.252 . . . . 0.0 111.512 -178.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 72.37 -58.93 0.58 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.463 0.705 . . . . 0.0 110.812 -175.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -63.79 -16.73 59.61 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 120.955 -0.641 . . . . 0.0 112.393 172.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.522 ' HB2' ' HB ' ' A' ' 7' ' ' ILE . 53.7 tp -70.95 -54.7 10.41 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 122.693 -0.298 . . . . 0.0 111.198 178.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.462 ' HG3' ' N ' ' A' ' 12' ' ' GLU . 7.7 pt-20 -61.33 -42.22 98.32 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.788 0.328 . . . . 0.0 110.82 177.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.462 ' N ' ' HG3' ' A' ' 11' ' ' GLU . 1.7 tm-20 -64.5 -34.24 77.75 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-O 120.962 0.411 . . . . 0.0 110.921 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.2 t -72.4 -44.12 62.93 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 120.744 0.307 . . . . 0.0 111.143 176.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -56.1 -50.5 70.87 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.141 0.496 . . . . 0.0 110.067 175.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.489 ' O ' HG12 ' A' ' 19' ' ' ILE . 11.2 ttt85 -53.55 -43.04 68.13 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.706 172.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.436 ' HB2' ' HE2' ' A' ' 16' ' ' LYS . 9.6 tppt? -54.0 -46.21 71.68 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.053 0.454 . . . . 0.0 111.581 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -79.93 -33.63 39.53 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 177.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.13 -38.41 91.08 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.893 0.377 . . . . 0.0 111.781 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.604 HD12 ' HD2' ' A' ' 115' ' ' LYS . 23.8 pt -83.26 -7.86 11.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 121.016 0.436 . . . . 0.0 111.689 178.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -64.69 86.7 0.05 Allowed 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.295 0.569 . . . . 0.0 110.748 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 142.02 -40.25 1.31 Allowed Glycine 0 CA--C 1.524 0.613 0 CA-C-N 115.685 -0.688 . . . . 0.0 112.048 -178.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -128.63 111.39 19.09 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-O 120.727 0.298 . . . . 0.0 110.806 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.46 -0.19 9.83 Favored 'Trans proline' 0 CA--C 1.546 1.079 0 C-N-CA 122.5 2.133 . . . . 0.0 114.425 -176.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.419 ' HE2' ' HB2' ' A' ' 24' ' ' LYS . 2.8 mppt? -100.35 -28.38 12.98 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 121.855 -0.528 . . . . 0.0 111.04 178.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.69 134.96 55.17 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 43.1 m -65.54 -35.21 80.19 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.73 178.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.07 45.88 2.52 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-N 116.203 -0.453 . . . . 0.0 113.81 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -103.56 -16.32 15.56 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 122.374 -0.486 . . . . 0.0 111.326 179.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -136.56 154.23 50.76 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.008 -174.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 49.1 ttm -143.6 143.59 31.56 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 120.92 0.39 . . . . 0.0 112.003 -174.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 23.5 p30 -90.09 166.02 13.66 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.063 0.459 . . . . 0.0 111.52 177.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.42 -20.31 61.0 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 121.251 -0.499 . . . . 0.0 113.236 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.433 ' HA ' ' HD3' ' A' ' 33' ' ' LYS . 41.1 mmtm -69.07 -55.38 10.95 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.729 0.3 . . . . 0.0 111.619 177.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -65.67 -34.78 79.02 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.156 176.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 41.2 t-105 -62.45 -48.28 80.34 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 122.602 0.361 . . . . 0.0 111.597 175.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.46 -46.48 89.94 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.117 0.484 . . . . 0.0 111.112 177.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 57.6 tttp -64.46 -35.03 79.62 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.975 178.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.3 tt -59.16 -45.06 91.98 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.311 175.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 73.9 m -60.08 -46.01 91.0 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.407 177.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -60.33 -52.43 65.3 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.578 0.228 . . . . 0.0 111.586 177.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -53.66 -41.68 67.09 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.102 0.477 . . . . 0.0 111.012 177.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.703 ' SG ' ' HA ' ' A' ' 103' ' ' VAL . 58.7 m -89.73 1.09 56.52 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.983 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp 55.56 33.25 20.74 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 122.88 0.472 . . . . 0.0 112.104 177.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.46 ' HA ' ' NH1' ' A' ' 86' ' ' ARG . 55.5 t -72.69 -29.52 30.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.735 178.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -97.36 102.54 14.33 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.815 0.341 . . . . 0.0 111.778 -179.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -57.59 -50.46 73.05 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.484 0.659 . . . . 0.0 112.194 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.02 -16.72 60.62 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 -166.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.42 ' NZ ' ' HB3' ' A' ' 48' ' ' LYS . 6.8 ttpm? -96.44 -64.09 1.08 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.239 0.616 . . . . 0.0 110.618 176.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 45.6 p -95.75 -66.53 0.9 Allowed 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.692 177.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 52.3 t -82.92 98.9 5.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 170.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 80.9 p -89.65 -84.54 0.22 Allowed 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -169.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -152.89 -39.05 0.03 OUTLIER Glycine 0 C--O 1.236 0.229 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.651 ' O ' HG13 ' A' ' 57' ' ' ILE . 26.9 p -48.95 -53.96 17.58 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.012 0.434 . . . . 0.0 109.911 172.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.504 ' O ' HG23 ' A' ' 58' ' ' VAL . 6.2 m-20 -48.43 -49.17 36.25 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.231 -175.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.3 t -60.5 -40.08 83.21 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.277 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -75.35 -43.74 48.94 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.582 0.706 . . . . 0.0 110.196 -176.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.651 HG13 ' O ' ' A' ' 53' ' ' THR . 8.0 mt -62.49 -45.24 99.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.117 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 54' ' ' ASP . 79.4 t -59.66 -41.88 86.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-O 120.554 0.216 . . . . 0.0 111.183 176.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.43 ' O ' ' HG3' ' A' ' 63' ' ' LYS . 76.1 t80 -55.2 -40.93 71.35 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.898 0.38 . . . . 0.0 111.5 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 51.6 p -80.77 -34.13 34.44 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.206 0.527 . . . . 0.0 110.998 177.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 55.3 tttp -65.81 -31.3 72.19 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.234 -174.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.7 m -88.33 -3.7 9.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.582 ' HD3' ' O ' ' A' ' 66' ' ' SER . 96.7 mttt -72.12 163.28 28.18 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -178.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -105.07 -98.92 2.57 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.981 176.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -80.08 75.46 6.84 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 122.44 -0.447 . . . . 0.0 111.132 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.582 ' O ' ' HD3' ' A' ' 63' ' ' LYS . 55.0 m 59.76 -79.09 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 122.334 0.254 . . . . 0.0 110.819 -175.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 64.28 129.3 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 114.09 1.144 . . . . 0.0 114.09 173.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.2 ptm85 -81.95 -21.67 37.1 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.255 173.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 28.3 m -136.41 151.72 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.076 -178.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 39.4 pt -99.6 161.46 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-O 120.589 0.233 . . . . 0.0 110.776 176.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -110.79 166.97 10.59 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.09 0.471 . . . . 0.0 111.49 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.404 ' O ' ' HB3' ' A' ' 75' ' ' PHE . 16.6 t80 -46.46 -36.79 6.96 Favored 'General case' 0 CA--C 1.554 1.133 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -177.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -73.3 -36.67 66.32 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 121.619 -0.676 . . . . 0.0 112.029 -178.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -72.28 -29.91 64.33 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.356 0.598 . . . . 0.0 109.981 174.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.404 ' HB3' ' O ' ' A' ' 72' ' ' TYR . 73.2 t80 -58.64 -44.31 90.04 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.587 176.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -47.7 -61.05 2.13 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.162 0.506 . . . . 0.0 111.604 174.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -64.88 -29.38 70.33 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.309 -176.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.26 -49.86 75.38 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.25 0.548 . . . . 0.0 110.98 173.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 62.2 mt -64.5 -41.7 96.28 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.486 176.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.521 ' O ' HG23 ' A' ' 84' ' ' THR . 31.8 tt0 -60.33 -40.74 91.7 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.54 -178.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -62.31 -59.2 5.35 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 120.85 0.357 . . . . 0.0 110.347 177.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 90.4 mt -57.03 -29.52 63.44 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.974 0.416 . . . . 0.0 111.394 178.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.41 -39.34 90.36 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.648 174.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.521 HG23 ' O ' ' A' ' 80' ' ' GLU . 8.6 p -68.63 -34.56 75.95 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 121.066 0.46 . . . . 0.0 110.986 178.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -69.53 -36.26 76.22 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.71 175.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.46 ' NH1' ' HA ' ' A' ' 44' ' ' VAL . 3.3 tpt180 -85.58 -62.24 1.57 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.341 0.591 . . . . 0.0 111.494 -177.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -96.67 93.44 6.73 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.387 -176.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -92.12 27.92 2.03 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 121.231 0.538 . . . . 0.0 110.653 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -60.03 -78.73 0.13 Allowed Glycine 0 CA--C 1.529 0.921 0 CA-C-N 116.028 -0.533 . . . . 0.0 113.957 -175.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.9 pttp -162.79 -60.62 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -177.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 54.7 m -91.32 132.9 35.86 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -173.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -64.95 -34.92 79.57 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.031 0.443 . . . . 0.0 110.718 176.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -57.2 -52.92 63.37 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.238 0.542 . . . . 0.0 110.484 171.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -55.73 -46.26 77.82 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.287 177.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.48 -48.94 79.13 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.97 0.414 . . . . 0.0 111.274 177.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -65.49 -36.54 84.15 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.022 178.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.465 ' O ' ' HG3' ' A' ' 101' ' ' GLN . 23.6 t70 -57.02 -62.18 1.93 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.391 0.615 . . . . 0.0 110.964 176.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -53.47 -46.85 70.09 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.607 -178.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.482 ' O ' HG23 ' A' ' 103' ' ' VAL . 16.7 tt -66.53 -38.45 81.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 O-C-N 122.056 -0.403 . . . . 0.0 111.232 -179.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 93.5 m -64.46 -35.96 82.62 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.783 0.325 . . . . 0.0 111.043 176.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.465 ' HG3' ' O ' ' A' ' 97' ' ' ASP . 88.1 mt-30 -63.69 -31.87 73.18 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 120.985 0.422 . . . . 0.0 111.09 176.014 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.9 mt -77.7 -9.62 59.09 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.918 177.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.703 ' HA ' ' SG ' ' A' ' 42' ' ' CYS . 69.4 t -108.79 -43.79 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -177.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -50.03 87.37 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 -170.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 48.1 65.27 2.58 Favored Glycine 0 CA--C 1.531 1.035 0 N-CA-C 115.084 0.794 . . . . 0.0 115.084 170.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm -79.22 -82.33 0.1 Allowed 'General case' 0 N--CA 1.471 0.612 0 O-C-N 122.273 -0.545 . . . . 0.0 111.845 178.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.532 ' N ' ' HD3' ' A' ' 108' ' ' PRO . 10.9 pt-20 -149.65 32.38 0.07 OUTLIER Pre-proline 0 CA--C 1.554 1.128 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.532 ' HD3' ' N ' ' A' ' 107' ' ' GLU . 71.7 Cg_endo -76.32 149.75 31.87 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.001 1.801 . . . . 0.0 113.424 -173.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 72.83 -54.83 0.69 Allowed 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.523 HD22 HG23 ' A' ' 111' ' ' VAL . 8.2 t30 68.0 166.26 0.24 Allowed 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.111 0.564 . . . . 0.0 111.07 -176.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.523 HG23 HD22 ' A' ' 110' ' ' ASN . 60.8 t 60.12 88.12 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-O 121.382 0.611 . . . . 0.0 110.258 -172.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -68.92 77.68 0.28 Allowed Glycine 0 CA--C 1.527 0.782 0 CA-C-N 115.85 -0.613 . . . . 0.0 114.393 -172.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 30.9 m -70.17 130.21 34.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 CA-C-O 121.022 0.439 . . . . 0.0 110.707 172.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 77.3 p -62.57 161.76 11.55 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.223 0.535 . . . . 0.0 112.443 -175.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.604 ' HD2' HD12 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -147.2 153.92 40.43 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.038 0.447 . . . . 0.0 111.714 -177.961 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.413 ' N ' ' HG3' ' A' ' 115' ' ' LYS . . . -65.99 152.89 43.6 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 178.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -60.7 142.81 55.4 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.196 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 90.0 m -75.31 134.4 41.06 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.069 175.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 146.75 -170.18 27.77 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 121.042 -0.599 . . . . 0.0 113.028 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 115.93 -51.78 0.7 Allowed Glycine 0 CA--C 1.527 0.806 0 C-N-CA 121.467 -0.397 . . . . 0.0 113.074 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 66.34 177.73 0.22 Allowed 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 121.108 0.48 . . . . 0.0 112.168 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 33.1 m -87.83 135.77 24.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.426 177.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -101.21 -38.72 7.98 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -177.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 53.7 ttt180 -72.76 83.08 1.17 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.714 0.769 . . . . 0.0 112.647 -173.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 90.7 mt -131.37 18.9 4.83 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.188 168.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 71.3 p -92.35 13.18 20.16 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.857 -176.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -74.51 48.13 0.33 Allowed 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 121.173 0.511 . . . . 0.0 111.011 174.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 78.0 p -89.97 -10.41 45.11 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.249 -0.432 . . . . 0.0 112.13 -175.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 38.8 m -66.93 86.81 0.13 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.032 0.444 . . . . 0.0 110.853 177.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 -59.56 -28.76 67.41 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.344 -176.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -106.79 4.34 27.46 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 120.665 0.269 . . . . 0.0 111.304 -178.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 92.9 m 62.7 -69.5 0.06 Allowed 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 122.98 0.512 . . . . 0.0 111.277 -171.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -118.25 148.54 18.51 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 121.533 -0.365 . . . . 0.0 112.51 176.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 87.8 p -118.21 -60.81 1.75 Allowed 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.097 0.475 . . . . 0.0 110.895 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -78.35 -33.14 49.24 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.149 0.5 . . . . 0.0 110.081 173.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -104.13 134.45 47.37 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.186 172.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -70.55 -51.64 27.21 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.843 0.83 . . . . 0.0 110.943 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 17.7 ptt-85 -110.39 -178.68 3.56 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.669 -1.15 . . . . 0.0 110.914 -178.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -63.41 138.78 58.65 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 167.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -59.46 91.46 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.73 0 CA-C-O 121.207 0.527 . . . . 0.0 112.378 -173.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 59.96 -179.77 0.09 Allowed 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.259 -0.882 . . . . 0.0 113.083 178.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 23.0 t -126.53 -14.38 5.8 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.775 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.92 123.73 1.69 Allowed Glycine 0 CA--C 1.528 0.871 0 C-N-CA 121.028 -0.606 . . . . 0.0 113.152 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.453 ' HD2' ' N ' ' A' ' 144' ' ' LYS . 12.0 mptt -83.06 83.19 7.93 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.248 0.547 . . . . 0.0 110.66 178.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 169.28 129.58 1.11 Allowed Glycine 0 CA--C 1.527 0.835 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.611 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -157.34 -27.88 0.09 Allowed 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -49.15 100.6 0.03 OUTLIER Glycine 0 CA--C 1.529 0.936 0 C-N-CA 121.511 -0.376 . . . . 0.0 113.653 -177.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.402 ' N ' HD12 ' A' ' 148' ' ' ILE . 2.0 mp 71.83 -17.11 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.11 0 C-N-CA 123.399 0.679 . . . . 0.0 112.469 177.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -63.34 138.93 58.7 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -178.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -154.65 63.51 0.34 Allowed Glycine 0 CA--C 1.531 1.054 0 C-N-CA 120.897 -0.668 . . . . 0.0 113.702 -179.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 14.7 mtm-85 64.51 -82.96 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.149 0.579 . . . . 0.0 111.26 178.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -99.55 98.68 9.54 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 171.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -68.56 78.93 0.28 Allowed 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.221 0.534 . . . . 0.0 111.553 -174.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 34.8 pt -106.73 -179.68 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.775 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 45.8 tp -89.73 -27.1 20.29 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.903 -177.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -73.16 85.59 1.37 Allowed 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -178.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 26.3 t70 55.22 -101.4 0.13 Allowed 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.801 172.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 56.5 m -166.92 -36.87 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.272 0.629 . . . . 0.0 109.925 -174.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 136.91 -111.04 0.82 Allowed Glycine 0 CA--C 1.527 0.841 0 C-N-CA 120.938 -0.648 . . . . 0.0 113.59 176.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 62.0 t80 67.46 -62.34 0.33 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.668 0.787 . . . . 0.0 111.467 -173.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.49 ' O ' ' HE2' ' A' ' 165' ' ' LYS . 33.9 m -61.18 -23.47 30.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 121.086 0.469 . . . . 0.0 111.026 174.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.421 ' O ' ' HB3' ' A' ' 163' ' ' ALA . 37.7 t -114.79 173.67 6.36 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.067 172.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 162' ' ' SER . . . 73.61 -49.75 0.69 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.132 0.573 . . . . 0.0 111.949 -176.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -76.48 49.02 0.57 Allowed 'General case' 0 CA--C 1.545 0.773 0 CA-C-O 121.207 0.527 . . . . 0.0 111.2 175.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.49 ' HE2' ' O ' ' A' ' 161' ' ' VAL . 74.9 mmtt -104.9 179.91 4.13 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.081 0.467 . . . . 0.0 111.375 -178.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -75.91 128.49 35.19 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.624 174.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 61.75 18.1 9.36 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 120.959 0.409 . . . . 0.0 112.06 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.19 62.24 4.66 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 121.311 -0.471 . . . . 0.0 112.795 -179.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 9.7 t -93.64 25.96 3.29 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.938 0.399 . . . . 0.0 112.062 -177.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -59.36 -30.52 68.46 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 121.236 0.541 . . . . 0.0 110.737 174.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -138.48 139.09 38.66 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 172.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -61.97 159.46 14.17 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -175.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -56.62 111.85 1.12 Allowed 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.572 176.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 5.2 p -41.75 119.93 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-O 121.827 0.822 . . . . 0.0 112.969 -173.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.401 ' O ' ' HB2' ' A' ' 176' ' ' LYS . 29.1 pttt -51.37 146.18 7.41 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 114.803 -1.089 . . . . 0.0 113.001 -178.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 175' ' ' LYS . 48.1 mmtm 75.18 -12.68 0.93 Allowed 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 177.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 60.9 tp -73.1 -52.52 13.95 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.901 -0.5 . . . . 0.0 111.38 176.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 . . . . . 0 N--CA 1.471 0.621 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.644 179.766 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ptm . . . . . 0 N--CA 1.493 1.714 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.88 174.39 15.58 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.727 0.299 . . . . 0.0 111.669 -178.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -148.42 -81.46 0.13 Allowed 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 120.824 0.345 . . . . 0.0 111.615 178.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 42.8 t -72.93 85.17 1.26 Allowed 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.201 0.524 . . . . 0.0 111.314 177.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.2 t -170.86 -4.79 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.983 179.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.3 t70 71.96 163.0 0.26 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.496 0.719 . . . . 0.0 111.785 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.441 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 36.3 pt -86.71 -4.4 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.9 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 7' ' ' ILE . . . 74.81 -48.56 0.65 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.205 0.602 . . . . 0.0 111.424 -176.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.2 -22.89 45.29 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 121.445 -0.407 . . . . 0.0 113.091 175.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.687 HD22 ' SG ' ' A' ' 100' ' ' CYS . 56.6 tp -74.65 -43.1 56.99 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 122.477 -0.425 . . . . 0.0 110.602 176.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -59.26 -42.32 90.89 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.307 0.575 . . . . 0.0 110.26 175.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.521 ' HG2' ' HE2' ' A' ' 16' ' ' LYS . 34.1 tt0 -61.38 -55.31 32.96 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.141 174.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.8 t -58.39 -35.14 71.55 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.439 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -59.49 -46.44 88.81 Favored 'General case' 0 C--O 1.225 -0.231 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.859 177.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.522 ' O ' HG12 ' A' ' 19' ' ' ILE . 97.8 mtt180 -60.48 -45.63 93.04 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.561 176.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.521 ' HE2' ' HG2' ' A' ' 12' ' ' GLU . 67.7 mttm -54.87 -37.72 66.6 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.891 0.377 . . . . 0.0 111.774 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -83.17 -36.56 24.6 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.599 174.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.03 -51.55 67.55 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -175.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.522 HG12 ' O ' ' A' ' 15' ' ' ARG . 29.1 pt -82.62 4.49 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 CA-C-O 121.056 0.455 . . . . 0.0 111.609 -178.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 39.5 t-80 -65.08 107.1 1.43 Allowed 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.903 177.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 115.51 -14.63 17.81 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 121.295 -0.478 . . . . 0.0 112.997 -177.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -154.68 118.1 2.53 Favored Pre-proline 0 CA--C 1.542 0.649 0 O-C-N 122.547 -0.384 . . . . 0.0 110.577 176.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -66.09 -14.55 44.91 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.459 2.106 . . . . 0.0 113.992 -174.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.401 ' HE3' ' HB2' ' A' ' 24' ' ' LYS . 45.3 mtmt -100.07 -52.85 3.3 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 120.74 0.305 . . . . 0.0 110.923 178.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.498 ' HB3' HG22 ' A' ' 19' ' ' ILE . . . 33.56 -115.14 0.07 Allowed 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.897 -175.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 63.8 m -157.93 -56.5 0.07 Allowed 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 122.768 0.427 . . . . 0.0 110.674 176.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.43 7.7 8.11 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 120.635 -0.793 . . . . 0.0 114.687 173.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -136.65 7.35 3.01 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 117.533 0.666 . . . . 0.0 111.531 178.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.447 ' HB3' HG21 ' A' ' 69' ' ' VAL . 33.9 mp0 -122.4 148.21 45.37 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 122.893 0.477 . . . . 0.0 111.536 -175.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.536 ' SD ' ' HB2' ' A' ' 34' ' ' ASN . 39.0 tpp -137.74 131.68 31.67 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.974 178.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 22.1 p30 -92.14 163.3 13.99 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.77 0.319 . . . . 0.0 111.59 178.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -55.88 -29.04 54.33 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 121.163 -0.542 . . . . 0.0 113.111 178.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -57.8 -61.35 2.59 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.072 0.463 . . . . 0.0 111.886 176.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.536 ' HB2' ' SD ' ' A' ' 30' ' ' MET . 24.7 m-20 -68.71 -34.37 75.53 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.358 -179.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.441 ' CD1' ' HB2' ' A' ' 59' ' ' PHE . 56.1 t-105 -60.11 -49.38 77.89 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.976 0.417 . . . . 0.0 111.631 178.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.92 -43.7 94.73 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 121.032 0.444 . . . . 0.0 111.228 177.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -66.57 -38.72 87.67 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.003 177.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.2 tt -56.38 -55.01 38.88 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.282 0.563 . . . . 0.0 110.592 -178.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 26.7 p -66.81 -40.88 88.22 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.782 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 58.0 tttp -76.35 -20.61 57.05 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-O 121.008 0.432 . . . . 0.0 111.715 -177.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -80.29 -41.72 24.43 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.326 0.584 . . . . 0.0 110.478 177.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.637 ' SG ' ' HA ' ' A' ' 103' ' ' VAL . 33.9 m -89.98 -6.83 55.23 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.689 -178.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.5 55.67 2.76 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.634 0.731 . . . . 0.0 111.418 -178.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 56.2 t -92.54 -36.77 7.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.476 173.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -107.18 78.44 1.22 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.221 0.534 . . . . 0.0 111.108 177.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.8 p-10 -152.66 4.03 0.35 Allowed 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.21 -174.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -79.79 47.04 3.22 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 121.094 -0.574 . . . . 0.0 113.534 -178.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt 50.53 21.53 0.88 Allowed 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 177.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 60.2 p -146.93 -63.44 0.29 Allowed 'General case' 0 N--CA 1.469 0.499 0 O-C-N 121.775 -0.578 . . . . 0.0 110.633 -176.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.421 HG22 ' H ' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -48.24 -83.31 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.887 0 CA-C-N 115.221 -0.9 . . . . 0.0 112.514 174.039 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.535 ' O ' HG23 ' A' ' 55' ' ' VAL . 12.4 p 58.33 -174.94 0.08 Allowed 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.418 0.687 . . . . 0.0 112.455 177.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -56.79 -29.5 58.57 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 121.35 -0.452 . . . . 0.0 113.279 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.542 ' O ' HG13 ' A' ' 57' ' ' ILE . 83.7 m -58.01 -58.92 6.27 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 122.626 -0.338 . . . . 0.0 111.377 178.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -63.3 -39.04 93.46 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.616 -0.265 . . . . 0.0 110.927 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 51' ' ' THR . 74.5 t -48.3 -41.13 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 N-CA-C 112.249 0.462 . . . . 0.0 112.249 175.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -74.17 -38.21 63.74 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.01 0.433 . . . . 0.0 110.591 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.542 HG13 ' O ' ' A' ' 53' ' ' THR . 10.1 mt -62.06 -45.41 98.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.102 178.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.515 HG22 ' HG2' ' A' ' 81' ' ' GLU . 86.9 t -63.19 -49.69 82.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.89 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.441 ' HB2' ' CD1' ' A' ' 35' ' ' TRP . 77.2 t80 -58.11 -48.34 80.5 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.188 0.518 . . . . 0.0 110.853 -179.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 90.5 p -68.15 -30.19 69.26 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.146 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -64.58 -46.64 81.83 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.574 177.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.432 HG23 HG21 ' A' ' 70' ' ' ILE . 35.7 m -88.58 -13.77 9.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -178.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -74.71 138.91 43.08 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.92 0.39 . . . . 0.0 111.562 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -66.96 167.05 39.44 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.836 176.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -64.77 -47.97 76.21 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 122.531 -0.394 . . . . 0.0 111.921 -178.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.5 m -99.53 3.75 45.64 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 120.85 0.357 . . . . 0.0 111.584 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -80.26 135.29 36.21 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 120.947 0.403 . . . . 0.0 111.808 -178.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? -87.01 -20.01 27.85 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.057 0.456 . . . . 0.0 110.85 175.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.447 HG21 ' HB3' ' A' ' 29' ' ' GLU . 29.3 m -137.62 174.54 11.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.579 -176.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.432 HG21 HG23 ' A' ' 62' ' ' VAL . 36.4 pt -111.6 144.12 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.711 173.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -94.01 156.61 16.51 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 120.858 0.361 . . . . 0.0 111.777 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.484 ' O ' ' HB3' ' A' ' 75' ' ' PHE . 49.9 t80 -49.04 -39.86 28.95 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -173.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -60.94 -41.91 97.17 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 122.11 -0.369 . . . . 0.0 111.659 178.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -73.18 -28.1 62.02 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.213 0.53 . . . . 0.0 110.519 176.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.484 ' HB3' ' O ' ' A' ' 72' ' ' TYR . 85.3 t80 -58.99 -36.55 75.08 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.969 175.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -61.29 -43.41 98.93 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.462 0.172 . . . . 0.0 111.17 175.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 28.3 mtmm -64.07 -38.1 89.85 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.997 0.427 . . . . 0.0 110.947 175.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.404 ' HB1' ' CH2' ' A' ' 35' ' ' TRP . . . -61.71 -41.07 97.12 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.256 176.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 86.4 mt -64.09 -44.42 92.41 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.105 175.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -56.48 -45.99 80.67 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.173 0.511 . . . . 0.0 110.555 176.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.515 ' HG2' HG22 ' A' ' 58' ' ' VAL . 37.7 tp10 -55.45 -58.74 6.51 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.573 176.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 86.4 mt -62.68 -44.84 95.22 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -178.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.26 -44.27 92.41 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.672 ' HA ' ' HE3' ' A' ' 90' ' ' LYS . 40.1 p -64.54 -35.4 80.86 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -89.93 -20.08 23.77 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 112.991 0.738 . . . . 0.0 112.991 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 33.5 tpt85 -82.97 -53.6 5.71 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.689 0.757 . . . . 0.0 110.826 178.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -94.52 117.89 30.82 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.156 175.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -82.05 -62.64 1.57 Allowed 'General case' 0 CA--C 1.539 0.557 0 O-C-N 122.292 -0.255 . . . . 0.0 111.386 -177.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -82.16 94.53 1.69 Allowed Glycine 0 CA--C 1.528 0.901 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.463 176.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.672 ' HE3' ' HA ' ' A' ' 84' ' ' THR . 0.3 OUTLIER -157.51 171.7 19.88 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -174.725 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 46.7 t -110.53 179.45 4.07 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.182 169.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -59.95 -76.43 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 120.946 0.403 . . . . 0.0 111.841 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 -60.87 -36.21 78.58 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.882 -176.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -56.78 -47.4 80.23 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.829 0.347 . . . . 0.0 111.577 177.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.56 -40.31 73.43 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.868 0.366 . . . . 0.0 111.315 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -63.37 -47.33 82.52 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.907 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -56.38 -49.56 74.11 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.452 0.168 . . . . 0.0 111.063 172.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -53.62 -54.39 38.36 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 15.2 tt -62.33 -33.35 58.59 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-O 120.94 0.4 . . . . 0.0 111.435 -179.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . 0.687 ' SG ' HD22 ' A' ' 10' ' ' LEU . 97.2 m -68.6 -38.06 80.31 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.925 0.393 . . . . 0.0 111.083 176.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -67.53 -31.19 71.13 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.706 179.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 96.7 mt -60.86 -35.46 76.65 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.255 0.55 . . . . 0.0 110.774 176.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.637 ' HA ' ' SG ' ' A' ' 42' ' ' CYS . 19.3 t -87.69 -78.07 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.785 178.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 41.05 26.72 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 178.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 61.1 45.59 96.25 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 121.282 -0.485 . . . . 0.0 113.798 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.554 ' HG3' ' HG2' ' A' ' 107' ' ' GLU . 21.9 pttp -70.85 -40.75 72.18 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.754 0.649 . . . . 0.0 112.754 -177.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.554 ' HG2' ' HG3' ' A' ' 106' ' ' LYS . 14.7 pt-20 -167.88 50.44 0.19 Allowed Pre-proline 0 N--CA 1.477 0.884 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -177.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.488 ' HD3' ' N ' ' A' ' 107' ' ' GLU . 64.1 Cg_exo -42.87 120.86 2.01 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 123.225 2.617 . . . . 0.0 113.634 -174.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 69.41 -69.03 0.17 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.732 -172.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 177.61 116.59 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.716 174.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 18.3 m -113.59 1.77 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-O 121.077 0.465 . . . . 0.0 110.679 171.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 154.67 -125.44 1.7 Allowed Glycine 0 CA--C 1.527 0.797 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.75 -178.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 11.8 p -164.04 144.8 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 120.681 0.277 . . . . 0.0 110.989 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 5.9 t -75.4 127.26 32.73 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.213 0.53 . . . . 0.0 111.696 179.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -92.19 -8.33 45.81 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.296 -0.411 . . . . 0.0 112.09 -179.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -178.78 -25.76 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -63.56 107.82 1.23 Allowed 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.164 0.507 . . . . 0.0 111.859 -176.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 62.0 p -109.57 -177.03 3.17 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.398 179.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -131.13 -77.77 0.16 Allowed Glycine 0 CA--C 1.53 0.988 0 C-N-CA 120.894 -0.67 . . . . 0.0 113.591 -176.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -66.84 84.06 0.11 Allowed Glycine 0 CA--C 1.529 0.937 0 C-N-CA 121.215 -0.517 . . . . 0.0 113.435 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -73.33 -8.26 55.1 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 60.0 t 70.6 135.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.249 0.62 . . . . 0.0 112.181 -179.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -83.39 175.61 9.72 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-O 120.858 0.361 . . . . 0.0 110.842 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.661 ' HD3' ' H ' ' A' ' 124' ' ' ARG . 0.0 OUTLIER -113.65 -26.99 8.0 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -175.746 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 60.9 tp 65.44 133.77 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 176.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 67.7 p -119.83 -43.06 2.58 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -78.47 38.19 0.3 Allowed 'General case' 0 CA--C 1.547 0.835 0 CA-C-O 121.199 0.523 . . . . 0.0 112.372 -177.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.8 t -68.5 88.41 0.33 Allowed 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -179.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 34.0 t -108.41 -177.63 3.38 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.006 0.432 . . . . 0.0 111.495 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 71.6 mtp180 -80.02 -18.55 49.88 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.739 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -151.04 89.17 1.5 Allowed 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.193 0.521 . . . . 0.0 110.956 -179.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 41.0 p -83.5 70.09 10.18 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.271 0.557 . . . . 0.0 111.586 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -152.3 54.75 0.46 Allowed Glycine 0 CA--C 1.524 0.638 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.602 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 15.2 m -76.13 163.6 26.93 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.872 0.367 . . . . 0.0 111.955 -178.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 69.0 m-70 67.32 82.09 0.19 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.161 0.585 . . . . 0.0 111.132 -177.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.576 ' HD3' ' HG3' ' A' ' 141' ' ' GLU . 94.3 mttt -101.63 -58.19 1.93 Allowed 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.058 -176.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.737 ' HG3' ' HG3' ' A' ' 138' ' ' ARG . 9.3 tp10 60.62 -85.83 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.171 -172.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.737 ' HG3' ' HG3' ' A' ' 137' ' ' GLU . 51.7 mtt-85 -112.01 -92.55 0.47 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 122.953 0.501 . . . . 0.0 110.958 177.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 47.31 26.52 0.73 Allowed 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 172.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 46.34 31.17 1.18 Allowed 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 175.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.576 ' HG3' ' HD3' ' A' ' 136' ' ' LYS . 0.9 OUTLIER -61.43 123.69 18.53 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.055 0.455 . . . . 0.0 111.433 -176.068 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 47.0 t -165.0 -28.89 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.426 -177.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 97.89 19.48 24.2 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 121.216 -0.516 . . . . 0.0 113.198 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 61.2 mttm 62.56 -79.64 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -141.09 131.94 5.13 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 121.186 -0.531 . . . . 0.0 112.756 -177.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm -72.45 77.39 1.04 Allowed 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.247 0.546 . . . . 0.0 111.271 -178.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.447 ' O ' ' N ' ' A' ' 149' ' ' ALA . . . 145.37 -51.45 0.6 Allowed Glycine 0 CA--C 1.53 0.978 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.035 -178.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.515 HG23 ' H ' ' A' ' 149' ' ' ALA . 12.2 tt 43.79 -71.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 N-CA-C 115.506 1.669 . . . . 0.0 115.506 175.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.515 ' H ' HG23 ' A' ' 148' ' ' ILE . . . -113.77 111.06 21.16 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 121.558 -0.713 . . . . 0.0 112.834 -170.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -97.87 5.64 61.87 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 121.43 -0.414 . . . . 0.0 113.011 173.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -90.78 157.52 17.35 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.037 0.446 . . . . 0.0 111.787 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -66.51 -43.28 85.71 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.64 0.733 . . . . 0.0 110.0 171.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -138.29 132.95 32.45 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.946 174.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 9.5 tt -145.33 131.62 14.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-O 121.261 0.553 . . . . 0.0 111.696 -177.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 92.0 mt -88.34 64.09 7.42 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.092 0.472 . . . . 0.0 111.229 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -90.11 0.75 57.0 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.733 176.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 37.2 t70 76.01 -36.0 0.27 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.646 0.778 . . . . 0.0 112.132 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 56.5 m 57.1 39.51 29.02 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.978 0.418 . . . . 0.0 112.053 178.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -69.22 86.3 0.24 Allowed Glycine 0 CA--C 1.527 0.801 0 C-N-CA 121.172 -0.537 . . . . 0.0 112.859 176.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -65.59 162.69 17.72 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.741 0.305 . . . . 0.0 111.69 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 67.4 t 71.46 -57.8 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.183 0.593 . . . . 0.0 111.994 -177.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 91.7 p 52.5 33.73 13.94 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 177.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -95.37 41.89 1.09 Allowed 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 178.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -82.33 -0.52 46.1 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -177.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -88.69 -5.94 57.79 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -175.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -83.17 -39.61 20.8 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -172.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 61.37 102.07 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 121.113 0.482 . . . . 0.0 112.232 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -66.28 171.44 28.5 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 121.318 -0.468 . . . . 0.0 114.046 -178.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.446 HG22 ' O ' ' A' ' 169' ' ' THR . 12.3 m -72.76 2.59 6.38 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -177.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 66.7 t80 64.68 9.5 5.23 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 121.999 -0.438 . . . . 0.0 111.788 178.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 59.13 21.77 9.84 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 122.747 0.419 . . . . 0.0 111.82 179.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -53.93 118.52 4.06 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.689 0.625 . . . . 0.0 112.689 -176.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 64.6 mmtt -84.84 94.12 8.66 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 120.982 0.42 . . . . 0.0 111.812 177.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.421 ' O ' ' HB3' ' A' ' 175' ' ' LYS . 7.5 p -84.43 119.23 33.05 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.265 173.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.421 ' HB3' ' O ' ' A' ' 174' ' ' VAL . 5.0 ttmp? 71.71 90.17 0.09 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.482 0.713 . . . . 0.0 110.52 -168.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -91.47 1.12 57.35 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.555 -178.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 56.0 tp 68.87 111.13 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.033 0.533 . . . . 0.0 111.298 -177.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 . . . . . 0 CA--C 1.544 0.718 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.202 179.866 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptm . . . . . 0 N--CA 1.492 1.626 0 N-CA-C 111.438 0.162 . . . . 0.0 111.438 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 58.04 96.25 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 177.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -175.15 -86.83 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 122.473 0.309 . . . . 0.0 110.994 178.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.1 m -117.72 -3.63 11.25 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 121.142 0.496 . . . . 0.0 110.658 175.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 40.1 p -118.0 98.25 6.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.859 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -70.65 -24.31 62.68 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.493 -177.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.453 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 26.3 pt -57.08 158.11 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.037 173.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 7' ' ' ILE . . . 71.26 -43.22 0.56 Allowed 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 120.792 0.329 . . . . 0.0 110.464 -166.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -73.82 -34.84 55.6 Favored Glycine 0 C--N 1.337 0.613 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 171.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.567 HD22 ' SG ' ' A' ' 100' ' ' CYS . 59.1 tp -62.66 -37.28 85.76 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.091 -0.555 . . . . 0.0 110.273 170.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -68.06 -40.92 82.67 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.821 176.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -54.07 -58.17 8.33 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.032 0.444 . . . . 0.0 110.577 173.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.6 m -59.83 -42.37 93.4 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.511 178.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 94.0 t80 -53.79 -46.75 71.13 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.059 176.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.54 ' O ' HG12 ' A' ' 19' ' ' ILE . 21.7 ttt180 -66.3 -46.19 77.78 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.224 178.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 39.4 mtpt -57.84 -27.06 62.85 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 116.301 -0.408 . . . . 0.0 112.067 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -86.34 -44.66 11.9 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.495 172.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.08 -43.69 74.15 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -177.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.54 HG12 ' O ' ' A' ' 15' ' ' ARG . 29.0 pt -101.05 14.91 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-O 120.976 0.417 . . . . 0.0 111.594 -178.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.42 ' CD2' ' HG2' ' A' ' 108' ' ' PRO . 27.4 t-80 -66.5 -33.31 75.4 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -175.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -135.54 22.9 3.47 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.838 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -138.3 101.6 8.29 Favored Pre-proline 0 CA--C 1.542 0.654 0 CA-C-O 120.871 0.367 . . . . 0.0 110.878 -177.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.21 -19.96 43.88 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 122.683 2.255 . . . . 0.0 113.955 -174.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 49.2 mmtm -100.6 6.6 44.18 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -178.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -81.5 138.46 35.47 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.13 0.49 . . . . 0.0 111.736 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 93.2 p -70.2 -60.43 2.29 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.437 0.637 . . . . 0.0 111.1 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 145.99 -26.73 1.75 Allowed Glycine 0 CA--C 1.522 0.48 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.245 -178.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -85.84 -15.55 41.53 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 111.752 0.278 . . . . 0.0 111.752 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.533 ' HB3' HG21 ' A' ' 69' ' ' VAL . 50.3 mt-10 -111.13 116.46 31.15 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.747 0.308 . . . . 0.0 111.375 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 48.1 ttm -107.22 139.49 41.59 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.179 0.514 . . . . 0.0 111.846 178.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.602 ' OD1' ' HB3' ' A' ' 33' ' ' LYS . 7.6 p30 -95.58 165.74 12.18 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.351 177.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.46 -30.22 73.81 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 121.562 -0.352 . . . . 0.0 113.842 -177.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.602 ' HB3' ' OD1' ' A' ' 31' ' ' ASN . 29.7 ttpt -58.39 -61.21 2.75 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.036 0.446 . . . . 0.0 111.565 177.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 64.2 m-20 -68.24 -31.96 71.82 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 122.281 -0.262 . . . . 0.0 111.57 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 32.2 t-105 -61.99 -38.89 90.31 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-O 120.953 0.406 . . . . 0.0 111.273 175.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.533 ' HA ' HG11 ' A' ' 55' ' ' VAL . . . -61.59 -48.85 79.07 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 120.984 0.421 . . . . 0.0 110.897 175.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.3 mtpp -67.6 -30.55 70.17 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.957 177.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.9 tt -56.9 -46.68 81.79 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.98 0.419 . . . . 0.0 110.169 177.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 79.0 m -64.32 -44.93 90.0 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.049 0.452 . . . . 0.0 111.623 176.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -68.17 -58.31 4.66 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -177.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.31 -23.84 64.51 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 178.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 86.0 m -95.86 -5.05 42.53 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 122.044 -0.41 . . . . 0.0 111.471 173.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt 62.41 28.94 17.1 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 173.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 43.2 t -78.79 -32.99 16.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.439 177.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.425 ' HA ' HG13 ' A' ' 50' ' ' VAL . . . -91.54 102.47 15.12 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.833 0.349 . . . . 0.0 111.9 -178.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -77.31 -44.99 27.68 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.699 0.762 . . . . 0.0 111.687 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.422 ' HA2' HG22 ' A' ' 51' ' ' THR . . . 107.63 -37.63 3.73 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 -163.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.9 ttpm? -43.11 -56.16 3.52 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.66 0.784 . . . . 0.0 112.199 173.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 78.4 p -125.91 -0.85 7.25 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 120.878 0.37 . . . . 0.0 111.755 178.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.425 HG13 ' HA ' ' A' ' 45' ' ' ALA . 3.8 p -156.74 111.75 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-O 121.1 0.476 . . . . 0.0 111.868 -174.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.43 ' O ' HG23 ' A' ' 55' ' ' VAL . 68.6 p -106.23 -177.78 3.46 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.104 178.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -55.64 -38.46 71.97 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.531 175.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.543 ' O ' HG12 ' A' ' 57' ' ' ILE . 88.8 m -58.0 -49.94 75.11 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 122.703 -0.292 . . . . 0.0 110.627 176.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.435 ' O ' HG23 ' A' ' 58' ' ' VAL . 7.1 m-20 -53.76 -38.61 64.59 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.991 0.424 . . . . 0.0 111.266 175.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.533 HG11 ' HA ' ' A' ' 36' ' ' ALA . 95.9 t -59.67 -39.6 80.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.507 178.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -76.02 -34.04 59.67 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.454 0.645 . . . . 0.0 110.535 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.543 HG12 ' O ' ' A' ' 53' ' ' THR . 9.9 mm -59.05 -53.16 51.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.059 175.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 54' ' ' ASP . 56.5 t -61.12 -42.42 93.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.286 178.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -55.22 -40.63 71.05 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.147 0.499 . . . . 0.0 111.289 175.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 50.6 m -78.38 -29.23 47.22 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.387 178.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -69.33 -56.91 6.14 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.903 -178.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.418 HG12 ' HG3' ' A' ' 77' ' ' LYS . 33.9 m -65.0 -34.15 68.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -173.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.602 ' HG3' ' H ' ' A' ' 65' ' ' LYS . 0.1 OUTLIER -65.94 -21.87 66.46 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.91 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 64.22 25.56 69.81 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 121.27 -0.49 . . . . 0.0 113.056 -178.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.602 ' H ' ' HG3' ' A' ' 63' ' ' LYS . 9.7 mtpm? 68.22 167.74 0.26 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.187 0.595 . . . . 0.0 111.889 -176.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 65.5 m 72.47 -47.95 0.67 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.324 0.65 . . . . 0.0 112.335 -178.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.452 ' O ' ' HD3' ' A' ' 63' ' ' LYS . . . -74.72 107.72 7.01 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 122.22 -0.3 . . . . 0.0 111.166 175.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -62.88 -48.71 77.82 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 121.378 0.609 . . . . 0.0 111.289 -177.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.533 HG21 ' HB3' ' A' ' 29' ' ' GLU . 30.2 m -93.23 -166.06 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.271 178.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 31.5 pt -134.93 144.7 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 122.417 0.287 . . . . 0.0 111.102 174.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -97.94 -179.57 4.46 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 120.815 0.34 . . . . 0.0 111.559 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -57.62 -43.38 84.73 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -175.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.623 ' HA ' ' HG3' ' A' ' 76' ' ' LYS . 15.7 pt-20 -80.25 -28.73 38.42 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.529 -0.732 . . . . 0.0 111.881 -176.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -69.03 -30.06 68.35 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.501 0.667 . . . . 0.0 109.43 170.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -69.17 -49.38 57.31 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.47 176.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.623 ' HG3' ' HA ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -64.97 -27.57 68.93 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 120.753 0.311 . . . . 0.0 111.289 177.948 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.418 ' HG3' HG12 ' A' ' 62' ' ' VAL . 17.7 tppt? -68.75 -39.35 80.33 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.8 0.333 . . . . 0.0 110.336 170.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.02 -43.76 86.93 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.184 0.516 . . . . 0.0 110.61 173.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 80.8 mt -58.97 -37.07 75.95 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.3 176.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.409 ' O ' HG23 ' A' ' 84' ' ' THR . 54.9 mt-10 -62.69 -47.39 83.83 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.862 0.363 . . . . 0.0 111.352 175.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -57.59 -55.93 28.41 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.893 0.378 . . . . 0.0 110.828 176.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 11.3 mp -54.4 -49.54 69.67 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.279 176.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -52.34 -48.5 65.46 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.409 HG23 ' O ' ' A' ' 80' ' ' GLU . 75.3 p -62.58 -33.97 76.03 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 -179.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -94.77 -2.08 51.65 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 176.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 31.4 tpt85 -104.8 -63.76 1.19 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.043 0.449 . . . . 0.0 111.727 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -103.77 118.85 37.66 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.721 -177.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -79.01 58.68 2.48 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 121.429 0.633 . . . . 0.0 110.868 176.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -90.16 -11.21 63.32 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-N 115.817 -0.629 . . . . 0.0 114.024 -176.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp 59.74 23.4 12.28 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 177.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 48.2 t -149.17 155.77 41.15 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 122.059 -0.401 . . . . 0.0 111.09 176.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -83.1 -58.57 2.8 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.549 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -52.57 -58.14 7.74 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.584 0.586 . . . . 0.0 112.584 -176.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -57.37 -55.13 38.74 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -176.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.7 -36.36 74.11 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.771 0.319 . . . . 0.0 111.766 179.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -67.28 -52.62 38.41 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.326 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.47 ' O ' ' HG3' ' A' ' 101' ' ' GLN . 7.1 m-20 -58.0 -39.48 78.39 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 120.488 0.185 . . . . 0.0 111.421 176.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.16 -60.21 4.23 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 120.817 0.341 . . . . 0.0 111.593 176.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 17.6 tt -63.16 -28.84 45.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-O 121.039 0.447 . . . . 0.0 111.077 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . 0.567 ' SG ' HD22 ' A' ' 10' ' ' LEU . 39.6 t -66.54 -44.95 80.98 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.019 173.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.47 ' HG3' ' O ' ' A' ' 97' ' ' ASP . 46.2 mt-30 -60.71 -29.0 69.08 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 179.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 83.3 mt -63.69 -23.67 67.47 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 120.799 0.333 . . . . 0.0 111.833 176.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 43.3 t -112.98 -34.39 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -177.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.58 115.1 3.98 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -174.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 85.01 14.42 69.51 Favored Glycine 0 CA--C 1.523 0.561 0 CA-C-N 116.103 -0.499 . . . . 0.0 112.531 -178.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 24.3 tptm -102.77 156.31 17.73 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.344 0.592 . . . . 0.0 111.268 -178.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -132.3 158.24 76.14 Favored Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.248 174.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.42 ' HG2' ' CD2' ' A' ' 20' ' ' HIS . 25.6 Cg_exo -62.68 -179.06 0.44 Allowed 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.111 1.874 . . . . 0.0 112.537 178.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -53.75 -60.73 2.94 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.017 0.437 . . . . 0.0 111.025 174.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.513 HD22 ' N ' ' A' ' 110' ' ' ASN . 0.8 OUTLIER -97.53 135.6 39.14 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.453 173.075 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 14.3 p -134.56 154.98 38.1 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-O 120.794 0.33 . . . . 0.0 111.428 -177.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -87.21 -165.28 41.13 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 121.147 -0.549 . . . . 0.0 113.13 178.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.6 p -101.8 121.32 52.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-O 121.071 0.462 . . . . 0.0 111.582 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 10.0 t -101.36 173.8 6.28 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 121.232 0.539 . . . . 0.0 112.284 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -98.76 -161.85 0.91 Allowed 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.833 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -76.65 163.4 26.9 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.138 173.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -70.71 80.24 0.61 Allowed 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.143 0.497 . . . . 0.0 111.74 -178.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 82.3 p -103.25 -30.51 10.61 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.918 177.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -77.12 52.93 3.4 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 113.975 0.35 . . . . 0.0 113.975 -177.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -90.03 98.24 2.42 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 121.168 -0.539 . . . . 0.0 112.221 176.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -55.3 140.53 39.04 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -177.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.8 p -144.39 6.96 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 CA-C-O 121.52 0.676 . . . . 0.0 111.023 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -75.65 -174.33 2.5 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.922 -177.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 124' ' ' ARG . 11.0 ptp180 -132.7 172.78 12.1 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 120.668 0.271 . . . . 0.0 111.107 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.417 ' O ' HD12 ' A' ' 125' ' ' LEU . 4.1 pp -74.66 145.4 43.22 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 120.912 0.386 . . . . 0.0 111.299 177.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 8.8 t -159.74 23.66 0.18 Allowed 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.416 0.627 . . . . 0.0 110.987 -179.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -78.13 179.49 6.82 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.184 -177.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 8.0 t -146.8 125.78 12.81 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.749 178.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 59.8 m 50.75 93.66 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' A' ' 130' ' ' ARG . 48.3 mtm180 -107.41 0.56 23.0 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.884 174.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.439 ' O ' ' N ' ' A' ' 133' ' ' GLY . 8.9 t80 63.83 -81.73 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.915 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 82.0 p 48.55 -75.66 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 174.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 131' ' ' TYR . . . -56.67 157.29 11.03 Favored Glycine 0 CA--C 1.532 1.105 0 N-CA-C 115.153 0.821 . . . . 0.0 115.153 -173.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 89.5 p -111.23 -163.02 0.82 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 122.951 0.5 . . . . 0.0 110.779 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -89.33 66.0 7.37 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.187 0.518 . . . . 0.0 110.843 178.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.433 ' O ' ' HB3' ' A' ' 137' ' ' GLU . 59.5 mttp 61.34 -80.88 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -178.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.433 ' HB3' ' O ' ' A' ' 136' ' ' LYS . 43.5 tt0 71.99 -46.39 0.64 Allowed 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.345 0.658 . . . . 0.0 110.698 -168.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 28.9 ttt180 -53.58 141.46 25.62 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.209 173.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -83.29 -173.02 4.47 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.375 0.607 . . . . 0.0 112.474 -176.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -74.92 -177.02 3.13 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 121.806 0.812 . . . . 0.0 112.858 -175.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -64.29 143.51 57.83 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.246 -0.888 . . . . 0.0 112.077 178.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 22.1 m -86.58 32.55 0.65 Allowed 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 120.829 0.347 . . . . 0.0 111.7 178.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -75.22 -30.15 59.27 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 114.11 0.404 . . . . 0.0 114.11 -176.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 96.6 mttt 69.39 19.1 7.77 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 122.863 0.465 . . . . 0.0 112.083 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 98.95 -62.57 0.77 Allowed Glycine 0 CA--C 1.527 0.798 0 C-N-CA 121.272 -0.49 . . . . 0.0 113.064 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -155.5 179.05 9.55 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 122.575 -0.368 . . . . 0.0 111.093 178.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -66.29 76.38 0.13 Allowed Glycine 0 CA--C 1.528 0.868 0 C-N-CA 121.39 -0.433 . . . . 0.0 113.142 178.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 61.8 mt -66.07 -34.36 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 121.335 0.588 . . . . 0.0 110.812 178.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -89.3 163.21 15.45 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.622 171.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -73.62 64.83 1.79 Allowed Glycine 0 CA--C 1.528 0.903 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.862 178.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 18.9 mmm180 -132.66 168.41 18.33 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.107 0.479 . . . . 0.0 111.98 -175.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -73.86 -178.25 3.15 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.798 177.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -97.34 166.89 11.33 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.793 176.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 48.1 mm -83.13 87.42 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-O 121.477 0.656 . . . . 0.0 110.798 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 79.1 mt -87.75 80.97 7.75 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.617 -176.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -111.22 115.42 29.32 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.992 0.425 . . . . 0.0 111.586 178.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -89.58 100.07 12.94 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.056 0.455 . . . . 0.0 109.972 173.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 70.6 m -72.38 -167.43 0.33 Allowed 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 116.015 -0.539 . . . . 0.0 112.291 -176.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -72.9 66.94 1.4 Allowed Glycine 0 CA--C 1.53 1.011 0 N-CA-C 114.371 0.509 . . . . 0.0 114.371 -175.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -92.07 103.64 16.12 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 122.552 -0.381 . . . . 0.0 110.093 174.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 49.3 t 57.58 76.79 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 121.58 0.705 . . . . 0.0 110.204 -170.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 31.8 t 61.91 -87.39 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.551 -173.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 58.38 17.53 4.86 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -177.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -94.0 66.28 3.57 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.455 0.645 . . . . 0.0 111.371 -177.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 21.4 pttm -61.33 141.29 57.69 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.788 175.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -68.51 122.83 19.28 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.949 0.405 . . . . 0.0 111.859 -177.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -106.71 97.21 7.03 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.08 0.467 . . . . 0.0 111.537 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 106.48 154.33 20.48 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 121.137 -0.554 . . . . 0.0 113.173 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 16.2 p 55.84 -176.24 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.893 0.877 . . . . 0.0 112.423 -178.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 9.8 t80 63.29 24.82 14.45 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-O 121.547 0.689 . . . . 0.0 110.719 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -62.18 -56.92 13.88 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.726 -175.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -78.49 31.49 0.19 Allowed 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -175.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.526 ' HG3' HG13 ' A' ' 174' ' ' VAL . 61.4 pttt -60.88 -51.74 68.03 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.526 HG13 ' HG3' ' A' ' 173' ' ' LYS . 34.2 m -71.81 -32.2 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -174.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 55.5 mttp 68.9 -66.59 0.24 Allowed 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 177.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 96.7 mttt 67.88 -71.45 0.11 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.521 0.728 . . . . 0.0 111.556 -178.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 42.0 tp -144.09 70.95 1.3 Allowed 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.137 0.494 . . . . 0.0 111.099 178.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 . . . . . 0 CA--C 1.545 0.762 0 CA-C-N 115.503 -0.771 . . . . 0.0 113.073 175.968 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.0 mmt . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 120.597 0.237 . . . . 0.0 110.967 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.85 81.87 1.64 Allowed 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.208 0.528 . . . . 0.0 110.839 174.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -72.67 -48.05 42.36 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.782 -177.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 61.4 p -110.83 102.61 11.12 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.216 0.532 . . . . 0.0 112.028 -178.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 89.8 m -69.83 -23.54 63.32 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.313 0.577 . . . . 0.0 110.277 173.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -67.49 92.71 0.31 Allowed 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.187 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.432 HG12 ' H ' ' A' ' 9' ' ' GLY . 13.4 tt -62.47 150.08 9.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.801 -179.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -49.16 -36.01 18.23 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.432 ' H ' HG12 ' A' ' 7' ' ' ILE . . . -57.94 -33.6 69.26 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 121.274 -0.488 . . . . 0.0 113.131 176.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 50.0 tp -70.88 -40.68 72.09 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.943 0.401 . . . . 0.0 110.546 177.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -63.27 -36.31 83.25 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.697 175.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -60.03 -56.51 20.79 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.025 0.44 . . . . 0.0 110.895 175.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.3 m -53.15 -51.24 62.62 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.46 178.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -56.12 -50.07 72.12 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.458 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 29.9 ttt180 -62.94 -42.56 99.84 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.875 0.369 . . . . 0.0 111.677 -176.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.407 ' HD3' ' HB3' ' A' ' 107' ' ' GLU . 99.0 mttt -65.22 -34.32 78.08 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.515 ' HA ' ' HB2' ' A' ' 20' ' ' HIS . 41.0 m-85 -79.84 -23.61 41.86 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 120.826 0.346 . . . . 0.0 111.28 173.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.47 -11.56 60.26 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.172 0.511 . . . . 0.0 111.278 175.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.448 HG23 ' HA2' ' A' ' 27' ' ' GLY . 32.8 pt -117.79 15.78 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-O 121.055 0.455 . . . . 0.0 110.67 171.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.515 ' HB2' ' HA ' ' A' ' 17' ' ' PHE . 48.8 t-80 -63.24 100.73 0.25 Allowed 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 120.94 0.4 . . . . 0.0 111.448 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 126.88 -46.9 1.05 Allowed Glycine 0 CA--C 1.526 0.753 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.089 -176.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.478 ' HB2' ' HB2' ' A' ' 25' ' ' ALA . 19.7 m-20 -138.98 127.87 14.02 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 122.757 0.423 . . . . 0.0 110.815 179.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_exo -47.54 -32.64 16.17 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 123.215 2.61 . . . . 0.0 114.232 -178.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -120.9 31.42 6.41 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.875 0.369 . . . . 0.0 111.566 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.478 ' HB2' ' HB2' ' A' ' 22' ' ' ASP . . . -53.44 -60.1 3.73 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 67.5 m -152.9 -43.85 0.1 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.071 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.448 ' HA2' HG23 ' A' ' 19' ' ' ILE . . . 79.1 -34.83 1.94 Allowed Glycine 0 CA--C 1.528 0.904 0 C-N-CA 121.168 -0.539 . . . . 0.0 114.358 173.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -125.72 -21.59 4.4 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 117.033 0.417 . . . . 0.0 111.667 -178.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -99.16 138.66 35.95 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 122.113 -0.367 . . . . 0.0 110.519 173.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 49.8 ttm -125.55 131.19 52.81 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.843 0.354 . . . . 0.0 111.929 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.494 ' ND2' ' HB2' ' A' ' 33' ' ' LYS . 17.8 p-10 -91.71 158.43 16.38 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.89 0.376 . . . . 0.0 111.592 178.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -56.64 -29.17 57.58 Favored Glycine 0 N--CA 1.465 0.626 0 CA-C-N 116.302 -0.408 . . . . 0.0 113.253 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.494 ' HB2' ' ND2' ' A' ' 31' ' ' ASN . 98.7 mttt -57.93 -56.06 26.85 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 120.938 0.399 . . . . 0.0 111.464 175.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -71.21 -29.15 64.8 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 122.342 -0.224 . . . . 0.0 111.412 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.467 ' CD1' ' HB2' ' A' ' 59' ' ' PHE . 25.8 t-105 -64.32 -45.27 88.63 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 120.879 0.371 . . . . 0.0 111.26 175.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.472 ' HA ' HG11 ' A' ' 55' ' ' VAL . . . -58.74 -46.3 87.73 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.183 0.516 . . . . 0.0 111.007 177.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -66.94 -39.25 87.24 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.779 176.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.2 tt -49.88 -45.26 50.46 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.24 0.543 . . . . 0.0 110.618 177.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 64.6 m -70.44 -38.58 74.55 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.715 178.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -70.96 -47.92 56.27 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -176.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -53.46 -48.86 68.46 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.065 0.46 . . . . 0.0 111.073 172.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 63.3 m -77.09 -6.07 51.39 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.722 178.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 47.0 mttp 59.45 26.41 15.34 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 175.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 42.8 t -74.24 -32.63 32.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 121.397 0.618 . . . . 0.0 110.347 173.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.545 ' HB1' ' HA ' ' A' ' 51' ' ' THR . . . -87.85 91.96 8.95 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.669 -176.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -174.52 17.55 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.831 0 CA-C-O 120.971 0.415 . . . . 0.0 111.688 175.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -86.93 18.93 32.61 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.69 -0.767 . . . . 0.0 113.446 -175.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.5 ' HD2' ' N ' ' A' ' 48' ' ' LYS . 12.0 mptt 57.51 20.05 5.79 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 121.738 0.78 . . . . 0.0 111.51 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 65.4 m -147.0 -30.92 0.34 Allowed 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.494 175.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.655 HG11 ' HG ' ' A' ' 82' ' ' LEU . 93.3 t -125.46 96.71 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.95 166.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.545 ' HA ' ' HB1' ' A' ' 45' ' ' ALA . 5.0 t -156.55 125.06 5.79 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.803 0.335 . . . . 0.0 111.854 176.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 50.47 -90.6 0.01 OUTLIER Glycine 0 CA--C 1.53 0.995 0 CA-C-N 116.413 -0.358 . . . . 0.0 113.776 178.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.595 ' O ' HG13 ' A' ' 57' ' ' ILE . 58.0 m -52.04 -55.01 23.27 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.788 0.328 . . . . 0.0 111.199 179.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.49 ' HB2' ' HA ' ' A' ' 50' ' ' VAL . 9.2 m-20 -57.53 -34.02 68.69 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.553 -177.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.472 HG11 ' HA ' ' A' ' 36' ' ' ALA . 43.8 t -64.06 -38.2 81.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-O 120.939 0.4 . . . . 0.0 111.032 178.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -72.12 -31.25 65.85 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.171 0.51 . . . . 0.0 110.004 177.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.595 HG13 ' O ' ' A' ' 53' ' ' THR . 9.8 mt -68.01 -48.31 75.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.896 176.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 76.1 t -54.04 -51.32 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-O 121.022 0.439 . . . . 0.0 110.849 174.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.467 ' HB2' ' CD1' ' A' ' 35' ' ' TRP . 72.0 t80 -53.06 -51.19 62.58 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.763 175.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.595 ' HA ' ' HE3' ' A' ' 63' ' ' LYS . 59.3 m -68.23 -21.65 64.83 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.028 -178.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 43.9 tttp -83.11 -39.87 20.55 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 120.747 0.308 . . . . 0.0 111.402 -178.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 26.9 m -82.22 -24.88 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 CA-C-O 120.783 0.325 . . . . 0.0 111.377 177.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.595 ' HE3' ' HA ' ' A' ' 60' ' ' SER . 26.3 ttpp -53.84 126.83 23.68 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.964 178.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -45.78 -62.26 3.41 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-N 116.088 -0.505 . . . . 0.0 113.294 179.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 48.4 tptt -152.02 -86.3 0.07 Allowed 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 117.085 0.442 . . . . 0.0 111.782 174.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 88.4 p -110.09 -7.04 14.96 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -173.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.43 107.1 1.03 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.725 0.297 . . . . 0.0 111.2 178.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 83.8 mtm-85 -72.48 2.32 6.49 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -176.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 28.2 m -125.71 132.98 70.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-O 120.894 0.378 . . . . 0.0 110.73 174.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.54 ' HB ' ' HB2' ' A' ' 74' ' ' GLU . 30.6 pt -100.63 148.06 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-O 121.077 0.465 . . . . 0.0 111.878 179.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.445 ' ND2' ' HB2' ' A' ' 73' ' ' GLU . 1.7 p-10 -89.18 167.93 12.71 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.153 174.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.492 ' O ' ' HG3' ' A' ' 76' ' ' LYS . 24.9 t80 -52.12 -37.46 54.34 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.922 0.391 . . . . 0.0 111.866 -173.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.445 ' HB2' ' ND2' ' A' ' 71' ' ' ASN . 19.5 mp0 -60.4 -47.98 83.75 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.288 178.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.54 ' HB2' ' HB ' ' A' ' 70' ' ' ILE . 48.7 mt-10 -65.4 -37.3 86.54 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.18 0.514 . . . . 0.0 110.296 176.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -59.6 -41.11 89.57 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.222 175.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.492 ' HG3' ' O ' ' A' ' 72' ' ' TYR . 27.7 mtpp -55.75 -47.85 76.28 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.691 0.281 . . . . 0.0 110.969 176.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.444 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 54.9 tttp -68.91 -32.99 73.02 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.384 177.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.446 ' O ' HD13 ' A' ' 82' ' ' LEU . . . -56.9 -40.84 77.02 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.111 0.481 . . . . 0.0 110.407 173.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 88.2 mt -67.79 -43.26 80.13 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.87 173.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -49.4 -47.62 47.74 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 120.975 0.417 . . . . 0.0 111.104 175.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.634 ' O ' ' HG2' ' A' ' 85' ' ' LYS . 32.0 mm-40 -58.94 -68.67 0.25 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.916 177.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.655 ' HG ' HG11 ' A' ' 50' ' ' VAL . 11.0 mp -47.77 -43.73 27.71 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -178.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.01 -48.02 83.1 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.692 177.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 74.0 p -75.01 -7.24 53.11 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -178.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.634 ' HG2' ' O ' ' A' ' 81' ' ' GLU . 54.7 mmtt -97.75 -35.4 10.56 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.292 0.568 . . . . 0.0 110.172 172.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 9.9 mmt180 -78.35 -70.2 0.51 Allowed 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.722 176.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -98.83 86.47 3.52 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.192 0.52 . . . . 0.0 111.144 -172.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.559 ' NZ ' ' HB2' ' A' ' 88' ' ' LYS . 9.4 mtmp? -94.07 36.29 1.13 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.3 0.571 . . . . 0.0 110.999 -177.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -78.53 35.95 1.81 Allowed Glycine 0 CA--C 1.531 1.054 0 CA-C-N 116.044 -0.526 . . . . 0.0 113.853 -177.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 76.9 tttt 70.83 -60.87 0.49 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.666 0.786 . . . . 0.0 112.253 178.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 53.5 m -63.73 105.69 0.85 Allowed 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 120.824 0.345 . . . . 0.0 111.558 176.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.407 ' HE2' ' OE2' ' A' ' 93' ' ' GLU . 11.3 ttpt -73.6 -49.05 28.13 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -173.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.407 ' OE2' ' HE2' ' A' ' 92' ' ' LYS . 2.8 mp0 -53.17 -49.59 66.33 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 111.671 0.248 . . . . 0.0 111.671 -178.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -60.71 -33.46 72.91 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.889 0.376 . . . . 0.0 111.402 178.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.21 -39.56 94.97 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.139 0.495 . . . . 0.0 110.645 173.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -63.41 -39.04 93.43 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.326 175.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.47 ' O ' ' HB3' ' A' ' 100' ' ' CYS . 20.2 m-20 -60.25 -49.81 76.14 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.654 0.264 . . . . 0.0 111.057 172.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -53.58 -50.57 65.32 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -177.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 17.3 tt -65.6 -30.56 50.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-O 121.083 0.468 . . . . 0.0 110.819 177.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . 0.47 ' HB3' ' O ' ' A' ' 97' ' ' ASP . 35.8 t -63.41 -42.01 98.75 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.968 173.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -57.4 -39.54 76.35 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.776 0.322 . . . . 0.0 111.128 175.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 96.6 mt -65.96 -44.6 84.5 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 178.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 60.9 t -97.8 -54.2 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -172.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.77 127.82 33.53 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -171.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 100.24 -8.78 59.12 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 115.888 -0.596 . . . . 0.0 113.62 177.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -105.08 173.98 6.07 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.467 0.651 . . . . 0.0 112.15 -179.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.523 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 10.9 pt-20 -143.83 160.92 48.47 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.657 179.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.523 ' HD2' ' HB2' ' A' ' 107' ' ' GLU . 42.2 Cg_exo -32.38 106.6 0.04 OUTLIER 'Trans proline' 0 C--N 1.36 1.158 0 C-N-CA 123.711 2.94 . . . . 0.0 114.622 -177.024 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -93.62 -24.5 17.89 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.817 -177.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -98.22 100.92 12.25 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.095 0.474 . . . . 0.0 111.032 178.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 60.6 t -83.55 -48.16 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 121.07 0.462 . . . . 0.0 111.662 -177.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -174.53 107.0 0.23 Allowed Glycine 0 CA--C 1.525 0.697 0 C-N-CA 121.329 -0.462 . . . . 0.0 112.549 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 49.0 t -75.34 -64.67 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 O-C-N 122.604 -0.351 . . . . 0.0 111.882 -178.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 90.5 m 70.02 -61.73 0.45 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.215 0.606 . . . . 0.0 112.235 -178.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -68.25 176.67 2.63 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -178.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 69.26 -67.43 0.22 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.315 0.646 . . . . 0.0 112.714 178.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -67.8 -30.16 69.52 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -177.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.5 t -51.35 130.95 28.14 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.27 0.557 . . . . 0.0 112.276 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 136.93 -124.67 3.18 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.175 -177.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -75.78 70.95 1.95 Allowed Glycine 0 CA--C 1.529 0.964 0 C-N-CA 121.405 -0.426 . . . . 0.0 113.052 178.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -136.66 153.3 50.95 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 122.545 0.338 . . . . 0.0 111.057 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 24.3 m -96.59 111.49 26.77 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 CA-C-O 121.726 0.774 . . . . 0.0 112.526 -177.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -89.28 -42.99 11.27 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.493 0.663 . . . . 0.0 109.274 172.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 53.9 ttt85 -97.43 117.99 32.92 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.979 172.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.764 ' H ' HD23 ' A' ' 125' ' ' LEU . 1.9 pt? -121.34 137.83 54.52 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.113 0.483 . . . . 0.0 111.801 -174.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 76.5 p -88.91 3.42 51.45 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.586 0.588 . . . . 0.0 112.586 -177.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -160.25 155.76 25.37 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-O 120.7 0.286 . . . . 0.0 110.638 -178.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 10.0 t -114.73 0.1 13.74 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 121.155 0.502 . . . . 0.0 111.307 178.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 41.1 t -142.37 -55.69 0.44 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.26 -178.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 12.6 tpt180 64.71 7.27 3.72 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 121.289 0.566 . . . . 0.0 111.234 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -145.85 161.34 40.22 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.635 -176.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 94.3 m -125.18 123.49 39.73 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 120.924 0.392 . . . . 0.0 111.908 178.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -74.51 114.23 4.36 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 121.364 -0.446 . . . . 0.0 113.412 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 41.1 t -160.18 110.68 1.86 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 122.624 0.37 . . . . 0.0 110.48 177.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 38.3 m80 60.53 175.28 0.1 Allowed 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 120.989 0.423 . . . . 0.0 111.831 -175.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt 71.66 -26.41 0.17 Allowed 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 172.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -49.0 -49.35 41.28 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -177.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 138' ' ' ARG . 2.8 tmm_? 61.28 101.09 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.425 -175.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 25.3 p90 -128.33 135.4 49.55 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.011 0.434 . . . . 0.0 111.585 -176.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -84.54 126.67 33.51 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.178 0.513 . . . . 0.0 111.123 177.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -63.96 91.77 0.07 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.547 0.689 . . . . 0.0 111.463 -178.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 78.4 p -104.94 26.39 9.29 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.254 -176.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -179.1 -158.98 22.5 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 120.046 -1.073 . . . . 0.0 114.088 -178.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 64.5 tttp 63.48 -87.11 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.278 0.631 . . . . 0.0 111.631 -176.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 42.94 -119.91 2.41 Favored Glycine 0 CA--C 1.531 1.057 0 N-CA-C 114.34 0.496 . . . . 0.0 114.34 177.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -122.3 35.09 4.97 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.953 0.406 . . . . 0.0 110.958 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -72.57 40.0 0.76 Allowed Glycine 0 CA--C 1.536 1.363 0 N-CA-C 114.777 0.671 . . . . 0.0 114.777 -175.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 34.2 mm -98.48 -14.19 7.84 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-O 121.225 0.536 . . . . 0.0 111.078 178.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -73.03 115.39 12.28 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 120.99 0.424 . . . . 0.0 111.918 -177.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 105.29 100.87 2.66 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 121.415 -0.421 . . . . 0.0 112.598 -178.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -123.52 87.44 2.74 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 122.53 -0.394 . . . . 0.0 111.994 -176.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -173.95 -28.93 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.601 175.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 65.13 -77.41 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.206 0.602 . . . . 0.0 112.232 178.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 32.4 pt -133.61 151.34 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-O 120.979 0.419 . . . . 0.0 111.521 -177.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 74.5 mt -98.31 37.13 1.49 Allowed 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 120.893 0.378 . . . . 0.0 111.222 -178.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 60.14 24.8 14.1 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.601 -177.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -60.16 120.99 10.81 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.358 0.599 . . . . 0.0 111.338 179.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 19.6 t -71.05 128.74 36.98 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.146 -172.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -74.32 127.54 10.01 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 121.181 -0.533 . . . . 0.0 112.844 178.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -69.6 128.49 36.65 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 120.893 0.377 . . . . 0.0 111.691 -177.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 35.0 m -76.67 142.5 14.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-O 121.145 0.497 . . . . 0.0 111.804 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 73.0 p -76.32 108.55 9.35 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.034 177.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 67.01 -165.37 0.22 Allowed 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.027 0.441 . . . . 0.0 111.703 -178.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -83.01 14.93 3.01 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -177.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp 68.72 -59.34 0.46 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.16 0.584 . . . . 0.0 111.638 -175.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -103.57 179.25 4.32 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.102 0.477 . . . . 0.0 110.919 175.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -70.0 92.99 0.75 Allowed 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.143 0.497 . . . . 0.0 111.379 177.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -80.8 42.4 2.67 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 121.3 -0.476 . . . . 0.0 113.205 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 73.7 p -139.25 176.54 8.62 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.023 0.439 . . . . 0.0 110.858 -179.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -86.1 48.72 1.65 Allowed 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 121.075 0.464 . . . . 0.0 111.04 178.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 10.6 t70 65.79 -72.91 0.07 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.688 0.795 . . . . 0.0 112.617 178.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -59.45 161.28 5.93 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -177.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -64.03 127.67 32.45 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.82 173.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 58.0 t -50.16 91.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-O 121.098 0.475 . . . . 0.0 112.127 -176.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 51.5 mtpt 54.18 31.07 13.29 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.009 178.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 58.8 mttm 62.17 17.86 9.57 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 122.956 0.502 . . . . 0.0 112.277 178.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 84.1 mt 68.02 98.95 0.05 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.132 0.573 . . . . 0.0 111.726 -178.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 . . . . . 0 N--CA 1.476 0.868 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -178.497 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.6 tpt . . . . . 0 N--CA 1.487 1.425 0 CA-C-O 120.552 0.215 . . . . 0.0 110.759 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.15 165.34 3.48 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 177.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 69.82 101.14 0.06 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.006 0.523 . . . . 0.0 111.309 -176.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.8 t -81.33 126.47 31.62 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.993 0.425 . . . . 0.0 112.093 -174.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.432 ' O ' ' HB2' ' A' ' 6' ' ' ASP . 74.6 p -70.27 114.73 8.69 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.177 172.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.432 ' HB2' ' O ' ' A' ' 5' ' ' THR . 2.1 m-20 68.45 101.48 0.05 Allowed 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.193 0.52 . . . . 0.0 111.25 -174.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.638 HG12 ' H ' ' A' ' 9' ' ' GLY . 7.9 tt -49.28 129.06 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 CA-C-N 115.947 -0.569 . . . . 0.0 112.308 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.04 -27.9 48.07 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -178.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.638 ' H ' HG12 ' A' ' 7' ' ' ILE . . . -60.06 -28.42 66.36 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 121.229 -0.51 . . . . 0.0 113.049 177.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 44.8 tp -73.24 -35.28 66.22 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.116 0.484 . . . . 0.0 110.524 177.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -62.69 -45.46 92.66 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.849 175.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.498 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 35.1 tt0 -65.89 -45.85 80.51 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.53 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 79.6 p -58.0 -46.41 85.27 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.045 0.45 . . . . 0.0 110.818 178.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -54.14 -48.71 70.53 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.219 0.533 . . . . 0.0 110.685 172.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.435 ' HG3' ' HA3' ' A' ' 27' ' ' GLY . 49.4 ttt180 -58.51 -37.21 75.12 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.37 -179.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.498 ' HG2' ' O ' ' A' ' 12' ' ' GLU . 75.6 mmtt -60.39 -50.19 74.58 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.823 178.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.464 ' HB2' ' HE2' ' A' ' 30' ' ' MET . 81.7 m-85 -72.89 -21.1 60.97 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.739 0.304 . . . . 0.0 111.524 177.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.68 -54.31 12.34 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 120.862 0.363 . . . . 0.0 111.877 179.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 32.8 pt -73.78 -10.68 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-O 120.989 0.423 . . . . 0.0 111.882 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 -58.85 87.95 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.12 0.486 . . . . 0.0 111.745 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 132.84 -34.4 2.47 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-N 116.136 -0.484 . . . . 0.0 113.125 -179.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.502 ' CG ' ' HZ2' ' A' ' 24' ' ' LYS . 12.2 t70 -133.04 114.59 13.9 Favored Pre-proline 0 CA--C 1.544 0.746 0 O-C-N 122.462 -0.434 . . . . 0.0 111.337 -177.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -80.86 0.03 10.29 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.585 2.19 . . . . 0.0 113.562 -179.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.502 ' HZ2' ' CG ' ' A' ' 22' ' ' ASP . 9.5 mtmp? -93.91 -16.77 23.68 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.97 0.414 . . . . 0.0 111.368 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -82.54 137.72 34.5 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.396 177.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 47.0 m -68.98 -22.66 64.09 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 120.77 0.319 . . . . 0.0 111.463 179.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.435 ' HA3' ' HG3' ' A' ' 15' ' ' ARG . . . 108.44 23.5 6.59 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 121.274 -0.488 . . . . 0.0 114.194 177.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -104.51 6.22 34.6 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 117.388 0.594 . . . . 0.0 111.799 178.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -130.79 130.76 44.11 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.011 -178.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.464 ' HE2' ' HB2' ' A' ' 17' ' ' PHE . 48.2 ttm -125.81 133.88 51.86 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.987 0.422 . . . . 0.0 111.99 -179.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.523 HD21 ' ND2' ' A' ' 34' ' ' ASN . 9.8 p30 -90.93 168.35 11.75 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.987 0.422 . . . . 0.0 111.605 178.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -66.04 -28.72 73.9 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-N 116.164 -0.471 . . . . 0.0 114.041 -179.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.445 ' HB3' ' OD1' ' A' ' 31' ' ' ASN . 39.6 ttmt -67.46 -48.8 66.14 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 117.006 0.403 . . . . 0.0 111.316 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.523 ' ND2' HD21 ' A' ' 31' ' ' ASN . 87.4 m-20 -68.71 -35.22 76.88 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.803 0.335 . . . . 0.0 111.013 175.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 47.5 t-105 -58.43 -45.48 88.41 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.283 174.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.52 -38.26 83.83 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.193 0.521 . . . . 0.0 111.528 176.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -70.72 -35.58 72.79 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.364 175.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.7 tt -59.57 -54.45 46.4 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.083 0.468 . . . . 0.0 110.588 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 26.2 p -60.51 -44.42 96.04 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.646 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -67.89 -38.16 82.67 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.847 0.356 . . . . 0.0 111.525 -178.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -67.31 -49.91 62.27 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.236 178.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.557 ' SG ' HG22 ' A' ' 103' ' ' VAL . 68.8 m -80.61 1.43 29.85 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.503 178.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp 69.03 20.23 7.82 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.033 0.533 . . . . 0.0 112.144 172.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.543 ' HA ' ' NH1' ' A' ' 86' ' ' ARG . 40.0 t -70.04 -26.94 30.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 120.926 0.394 . . . . 0.0 110.561 175.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.16 78.04 0.51 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.651 0.739 . . . . 0.0 109.972 172.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.486 ' HB3' ' H ' ' A' ' 50' ' ' VAL . 38.7 t70 -54.99 -30.12 58.62 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 114.601 -1.181 . . . . 0.0 113.978 -169.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.26 -36.44 1.53 Allowed Glycine 0 CA--C 1.531 1.065 0 C-N-CA 121.227 -0.511 . . . . 0.0 113.31 -177.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.7 mttp -82.59 -46.94 12.69 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.161 0.505 . . . . 0.0 110.093 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 73.1 m -108.55 -50.43 3.03 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.564 174.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.486 ' H ' ' HB3' ' A' ' 46' ' ' ASP . 43.1 t -93.76 110.25 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -178.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 76.5 p -96.44 173.93 7.12 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 120.689 0.281 . . . . 0.0 111.519 177.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -58.06 -44.05 94.85 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 121.083 -0.58 . . . . 0.0 112.443 177.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.562 ' O ' HG13 ' A' ' 57' ' ' ILE . 44.5 p -51.21 -50.64 58.71 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.325 0.583 . . . . 0.0 110.361 172.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.06 -38.42 70.61 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.04 -176.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.2 t -59.22 -40.56 81.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.173 176.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -68.06 -37.66 81.55 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.98 0.419 . . . . 0.0 110.84 175.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.562 HG13 ' O ' ' A' ' 53' ' ' THR . 6.5 mt -62.73 -46.76 95.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.146 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 76.5 t -59.99 -42.48 89.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 120.979 0.419 . . . . 0.0 111.07 177.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -62.36 -23.32 66.73 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-O 121.153 0.502 . . . . 0.0 110.999 176.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 23.1 t -87.0 -34.79 19.13 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.836 0.35 . . . . 0.0 111.254 175.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -60.86 -44.69 96.69 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 29.4 m -78.97 -22.64 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -177.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? -73.97 150.01 41.02 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.905 0.383 . . . . 0.0 111.789 -175.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -70.18 -98.67 0.05 OUTLIER Glycine 0 CA--C 1.53 0.993 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.161 174.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -141.88 -64.73 0.43 Allowed 'General case' 0 N--CA 1.471 0.607 0 O-C-N 122.423 -0.457 . . . . 0.0 111.216 174.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 43.5 t -92.77 91.3 7.42 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.862 0.363 . . . . 0.0 110.825 177.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -160.57 146.56 15.08 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.231 0.538 . . . . 0.0 112.089 -178.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 68' ' ' ARG . 32.5 mtm-85 -104.36 -37.76 7.1 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.393 0.616 . . . . 0.0 110.716 177.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.3 m -124.82 158.56 32.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.208 -178.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 42.1 pt -118.49 159.77 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.091 177.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -103.61 177.81 4.73 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.412 ' OH ' ' HB3' ' A' ' 6' ' ' ASP . 84.7 t80 -54.01 -40.62 67.17 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -174.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -56.22 -51.47 67.95 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.266 0.555 . . . . 0.0 111.281 178.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -64.52 -32.87 74.69 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.068 177.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.407 ' HB3' ' O ' ' A' ' 72' ' ' TYR . 61.0 t80 -58.82 -43.72 90.68 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.025 174.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp -54.95 -49.53 71.14 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.186 0.517 . . . . 0.0 111.066 173.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -61.18 -35.13 76.32 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.173 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.47 -43.38 81.16 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.012 0.434 . . . . 0.0 111.449 176.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 80.8 mt -64.89 -35.4 81.01 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.103 177.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -59.94 -49.94 75.7 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.134 0.492 . . . . 0.0 110.325 176.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -57.4 -56.7 18.43 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.152 175.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 87.1 mt -60.27 -35.24 75.08 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -178.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.5 ' HB2' HG21 ' A' ' 99' ' ' ILE . . . -64.15 -48.04 77.58 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.108 0.48 . . . . 0.0 111.057 178.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 65.7 p -74.67 -9.26 58.39 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.846 -0.616 . . . . 0.0 112.161 -179.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -101.6 -28.32 12.58 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 173.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.543 ' NH1' ' HA ' ' A' ' 44' ' ' VAL . 14.3 tpt180 -83.26 -54.26 5.14 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.695 0.76 . . . . 0.0 110.575 178.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -86.55 144.58 27.14 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.752 178.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.464 ' HB3' ' NZ ' ' A' ' 88' ' ' LYS . 0.5 OUTLIER -81.64 -164.71 0.82 Allowed 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -178.555 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -55.3 81.97 0.01 OUTLIER Glycine 0 CA--C 1.531 1.035 0 N-CA-C 114.633 0.613 . . . . 0.0 114.633 -176.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -126.3 177.15 6.6 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 122.885 0.474 . . . . 0.0 110.749 176.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 65.9 m -62.72 125.44 23.96 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 120.767 0.318 . . . . 0.0 111.161 176.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -54.84 -40.31 69.48 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 116.134 -0.485 . . . . 0.0 112.303 -174.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -62.59 -59.93 4.23 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.653 0.263 . . . . 0.0 110.98 178.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -53.82 -39.47 65.57 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 120.725 0.297 . . . . 0.0 111.432 -179.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.24 -42.73 95.91 Favored 'General case' 0 CA--C 1.541 0.635 0 CA-C-O 120.706 0.288 . . . . 0.0 111.468 177.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -67.59 -50.2 59.44 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.222 178.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -57.32 -42.03 81.07 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 120.727 0.298 . . . . 0.0 111.456 178.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.67 -54.22 45.71 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 112.041 0.385 . . . . 0.0 112.041 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.5 HG21 ' HB2' ' A' ' 83' ' ' ALA . 12.7 tt -59.29 -36.12 61.84 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-O 121.096 0.474 . . . . 0.0 110.793 179.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 81.6 m -68.04 -38.69 82.8 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.135 176.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -58.42 -31.49 67.76 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.061 0.458 . . . . 0.0 111.486 177.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 92.9 mt -60.79 -41.11 94.96 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.879 176.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.557 HG22 ' SG ' ' A' ' 42' ' ' CYS . 16.3 t -96.76 -31.63 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 CA-C-O 121.044 0.449 . . . . 0.0 112.176 -174.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.03 124.67 21.7 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -173.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 85.78 -11.56 61.73 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 116.123 -0.49 . . . . 0.0 113.44 177.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -86.67 153.33 21.83 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 122.5 -0.412 . . . . 0.0 111.293 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.538 ' HB2' ' HD2' ' A' ' 108' ' ' PRO . 0.4 OUTLIER -86.42 163.27 42.79 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.294 173.901 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.538 ' HD2' ' HB2' ' A' ' 107' ' ' GLU . 59.3 Cg_endo -69.73 -149.38 0.02 OUTLIER 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.052 1.835 . . . . 0.0 111.922 177.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' A' ' 111' ' ' VAL . . . -48.53 118.94 2.74 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 169.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.475 ' O ' ' HB ' ' A' ' 111' ' ' VAL . 19.4 p30 -53.49 72.09 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -170.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.518 ' N ' ' O ' ' A' ' 109' ' ' ALA . 12.4 p 166.63 -36.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.614 0.766 . . . . 0.0 110.684 -178.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 94.47 -67.19 1.4 Allowed Glycine 0 CA--C 1.526 0.725 0 CA-C-N 116.336 -0.393 . . . . 0.0 112.193 -176.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 11.4 p -106.09 150.22 8.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 122.385 0.274 . . . . 0.0 110.638 175.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 58.3 m -49.96 144.5 6.6 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.464 0.173 . . . . 0.0 111.314 178.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -50.98 93.0 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.614 0.721 . . . . 0.0 112.645 -174.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -152.25 -81.33 0.1 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.36 173.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 64.9 tttp 66.21 -21.75 0.1 Allowed 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 170.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 78.9 p -79.84 30.92 0.25 Allowed 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -175.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -66.03 -76.2 0.36 Allowed Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.843 179.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 53.02 32.15 41.67 Favored Glycine 0 CA--C 1.529 0.936 0 N-CA-C 114.478 0.551 . . . . 0.0 114.478 176.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -150.77 161.54 42.44 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 117.004 0.402 . . . . 0.0 111.677 -178.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 65.0 t 69.17 -61.99 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 123.014 0.526 . . . . 0.0 111.785 -178.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 22.3 t70 67.62 -73.68 0.08 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.113 0.565 . . . . 0.0 111.894 176.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 46.2 ttp180 68.17 73.78 0.29 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.476 0.711 . . . . 0.0 111.914 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.478 ' CD1' ' H ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -79.69 -5.75 55.8 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.668 171.889 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 15.2 m -59.56 95.48 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.6 -0.727 . . . . 0.0 112.446 -178.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -77.43 178.54 7.11 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.161 175.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 13.5 t -61.68 176.69 0.49 Allowed 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.114 0.412 . . . . 0.0 112.114 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 45.2 t -49.58 127.62 15.96 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -177.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.424 HH11 ' HD2' ' A' ' 130' ' ' ARG . 61.6 mtt180 -72.31 -16.23 61.89 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.266 178.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -81.57 63.52 5.89 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.24 0.543 . . . . 0.0 110.491 177.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 81.0 p 45.84 79.93 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.274 -0.875 . . . . 0.0 113.078 -176.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -81.97 67.64 3.64 Favored Glycine 0 CA--C 1.523 0.538 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.156 175.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 39.6 t -49.16 152.49 1.14 Allowed 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -175.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 74.6 m-70 71.13 -64.38 0.38 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.728 0.811 . . . . 0.0 111.582 -176.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 89.1 tttt 57.26 -93.23 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 122.773 0.429 . . . . 0.0 111.439 -178.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.42 ' O ' ' HB3' ' A' ' 138' ' ' ARG . 18.2 mm-40 -135.96 124.59 23.72 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 122.188 0.195 . . . . 0.0 110.95 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.42 ' HB3' ' O ' ' A' ' 137' ' ' GLU . 30.8 ttt180 72.66 -42.11 0.52 Allowed 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 176.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -76.26 155.43 34.37 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -172.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 61.55 98.8 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.458 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -55.57 122.47 11.39 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.551 176.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 66.8 m -69.26 80.8 0.36 Allowed 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -171.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 51.59 -137.41 30.73 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-N 115.892 -0.594 . . . . 0.0 114.543 173.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.515 ' HE3' ' HA3' ' A' ' 147' ' ' GLY . 46.8 tttp -110.15 108.92 19.24 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 122.58 0.352 . . . . 0.0 110.449 179.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.451 ' O ' ' NZ ' ' A' ' 175' ' ' LYS . . . -55.67 -81.32 0.07 OUTLIER Glycine 0 CA--C 1.526 0.761 0 C-N-CA 121.203 -0.522 . . . . 0.0 112.853 178.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -122.49 -44.52 2.24 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 122.431 -0.452 . . . . 0.0 110.895 172.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.515 ' HA3' ' HE3' ' A' ' 144' ' ' LYS . . . 67.65 35.69 86.43 Favored Glycine 0 CA--C 1.521 0.453 0 C-N-CA 121.195 -0.526 . . . . 0.0 112.717 -178.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 10.4 tt -84.98 122.8 38.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-O 121.128 0.49 . . . . 0.0 111.702 -177.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -84.86 78.06 9.97 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.31 0.576 . . . . 0.0 110.856 177.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.461 ' C ' ' HD2' ' A' ' 151' ' ' ARG . . . -159.73 177.42 36.24 Favored Glycine 0 CA--C 1.524 0.637 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.84 -179.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.461 ' HD2' ' C ' ' A' ' 150' ' ' GLY . 3.5 mpt_? -116.51 138.23 51.55 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.985 0.421 . . . . 0.0 111.418 178.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -77.86 85.04 4.14 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.409 178.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -74.99 -12.85 60.43 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.947 0.403 . . . . 0.0 111.375 176.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 7.7 tt -61.73 104.94 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 121.277 0.56 . . . . 0.0 110.554 172.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 92.0 mt -91.57 86.3 5.98 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.939 0.4 . . . . 0.0 111.518 -176.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -70.7 129.55 39.44 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.76 175.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -72.2 77.46 0.97 Allowed 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.794 0.807 . . . . 0.0 110.676 175.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 39.5 t -81.53 94.5 6.89 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.429 -178.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -139.04 -72.45 0.05 OUTLIER Glycine 0 CA--C 1.524 0.636 0 C-N-CA 121.417 -0.421 . . . . 0.0 112.33 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -117.61 120.55 38.39 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.865 0.364 . . . . 0.0 111.072 178.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 16.7 m -78.1 99.52 2.81 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-O 121.402 0.62 . . . . 0.0 111.956 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 62.9 p -90.48 126.9 36.06 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.425 175.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 72.02 113.18 0.06 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.115 0.566 . . . . 0.0 111.081 -174.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -97.11 -83.61 0.39 Allowed 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -172.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 30.5 mmtm 57.92 -89.56 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -174.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 7.4 t30 47.95 76.36 0.11 Allowed 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.133 0.492 . . . . 0.0 111.243 -174.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -74.06 -31.96 63.08 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -174.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 69.35 46.78 55.28 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.119 -176.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.539 HG22 ' HD2' ' A' ' 170' ' ' TYR . 35.1 m -51.76 105.12 0.1 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.493 0.717 . . . . 0.0 112.688 -175.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . 0.539 ' HD2' HG22 ' A' ' 169' ' ' THR . 93.9 m-85 58.34 16.39 4.04 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 179.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 17.5 t70 67.56 161.92 0.18 Allowed 'General case' 0 CA--C 1.547 0.859 0 CA-C-O 121.372 0.606 . . . . 0.0 111.565 -178.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -83.99 9.7 11.7 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.427 0.528 . . . . 0.0 112.427 -178.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.431 ' NZ ' ' HB3' ' A' ' 173' ' ' LYS . 5.8 ttpm? -77.52 51.65 0.91 Allowed 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 121.565 0.697 . . . . 0.0 111.691 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 35.1 m -76.96 -2.84 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-O 121.454 0.645 . . . . 0.0 110.785 173.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.451 ' NZ ' ' O ' ' A' ' 145' ' ' GLY . 11.9 mmmm -83.3 38.02 0.59 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.589 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 7.9 ptmm? -52.29 139.19 24.83 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -172.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 86.8 mt -78.74 1.73 22.12 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.96 -177.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 . . . . . 0 CA--C 1.542 0.671 0 CA-C-O 120.845 0.355 . . . . 0.0 110.276 176.843 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.7 mmt . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 64.78 -74.44 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 178.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -58.24 104.82 0.23 Allowed 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -176.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 42.7 t 64.9 100.58 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.07 0.548 . . . . 0.0 111.516 -177.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 94.4 m -128.96 99.06 5.14 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.578 178.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -78.98 118.08 20.64 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.948 176.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.479 HG12 ' H ' ' A' ' 9' ' ' GLY . 10.8 tt -56.72 131.33 20.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 CA-C-O 121.138 0.494 . . . . 0.0 112.014 -178.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -53.19 -34.3 56.39 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -177.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.479 ' H ' HG12 ' A' ' 7' ' ' ILE . . . -60.75 -34.48 86.9 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 121.41 -0.424 . . . . 0.0 113.487 177.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 38.8 tp -73.76 -43.69 58.32 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.363 0.601 . . . . 0.0 110.656 178.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -59.17 -36.25 74.98 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.501 174.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -66.9 -51.03 60.34 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.457 174.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.5 p -60.74 -43.24 98.16 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -177.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -57.61 -55.96 28.08 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.026 0.441 . . . . 0.0 110.492 175.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.46 ' O ' HG12 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -56.91 -34.65 68.14 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.541 177.198 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -63.89 -48.28 77.25 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 120.901 0.381 . . . . 0.0 111.765 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.443 ' HA ' ' HB2' ' A' ' 20' ' ' HIS . 49.9 m-85 -77.72 -23.17 49.48 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.725 -0.216 . . . . 0.0 111.479 176.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.78 -47.79 71.04 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 120.913 0.387 . . . . 0.0 111.09 176.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.46 HG12 ' O ' ' A' ' 15' ' ' ARG . 26.3 pt -86.47 1.61 5.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.869 178.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.443 ' HB2' ' HA ' ' A' ' 17' ' ' PHE . 34.6 t-80 -51.8 96.91 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.41 0.624 . . . . 0.0 111.737 -178.106 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 135.31 -50.32 0.86 Allowed Glycine 0 CA--C 1.525 0.705 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.068 -175.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -126.97 111.04 21.9 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 122.443 0.297 . . . . 0.0 111.283 179.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -68.4 -5.08 14.19 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 122.569 2.179 . . . . 0.0 112.417 178.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.3 pttt -93.36 0.06 56.77 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.844 177.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.86 158.94 26.62 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.052 0.454 . . . . 0.0 111.842 -178.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 31.2 p -67.14 -71.23 0.21 Allowed 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.077 -178.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 109.75 14.34 14.21 Favored Glycine 0 CA--C 1.532 1.099 0 N-CA-C 114.674 0.63 . . . . 0.0 114.674 175.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 -97.86 4.19 49.7 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 117.617 0.709 . . . . 0.0 111.468 176.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.585 ' HB3' HG21 ' A' ' 69' ' ' VAL . 31.8 mt-10 -144.9 143.53 30.62 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.042 0.537 . . . . 0.0 110.888 177.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.518 ' O ' ' HB ' ' A' ' 69' ' ' VAL . 49.4 ttm -128.8 140.69 51.59 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.06 0.457 . . . . 0.0 111.997 -177.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 27.2 p30 -93.18 164.21 13.33 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.084 0.469 . . . . 0.0 111.868 178.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.455 ' HA2' ' HB3' ' A' ' 35' ' ' TRP . . . -61.72 -25.96 66.25 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 121.386 -0.435 . . . . 0.0 113.224 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -59.08 -57.38 13.32 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 121.196 0.522 . . . . 0.0 111.474 177.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -75.94 -26.37 56.83 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.49 179.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.455 ' HB3' ' HA2' ' A' ' 32' ' ' GLY . 51.7 t-105 -62.52 -45.5 92.71 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.136 0.493 . . . . 0.0 110.875 173.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.72 -45.25 94.78 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.111 176.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -68.71 -31.25 70.2 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.653 177.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.2 tt -58.44 -56.79 17.58 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.171 0.51 . . . . 0.0 110.522 178.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.637 ' HA ' ' SG ' ' A' ' 42' ' ' CYS . 28.9 p -63.98 -35.9 82.22 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.613 -179.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -68.42 -41.42 80.42 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.804 0.335 . . . . 0.0 111.443 178.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -73.59 -31.86 63.82 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.637 ' SG ' ' HA ' ' A' ' 39' ' ' CYS . 27.9 p -89.8 -5.97 56.38 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.96 0.409 . . . . 0.0 110.711 173.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt 55.94 25.66 8.93 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.299 0.852 . . . . 0.0 113.299 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.525 HG23 ' SG ' ' A' ' 42' ' ' CYS . 79.1 t -67.54 -37.32 78.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 169.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.92 115.46 7.46 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.925 171.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -131.43 84.53 2.18 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.393 -173.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -33.18 -30.69 0.01 OUTLIER Glycine 0 CA--C 1.537 1.458 0 N-CA-C 116.011 1.165 . . . . 0.0 116.011 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -62.89 -44.6 95.67 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 118.042 0.921 . . . . 0.0 111.1 175.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.5 t -107.61 -55.66 2.32 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.026 176.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 40.9 t -109.37 109.46 28.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 122.788 0.435 . . . . 0.0 111.788 -177.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 66.1 p -79.58 151.91 30.38 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -56.41 -30.69 58.94 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 121.395 -0.431 . . . . 0.0 112.59 176.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.596 ' O ' HG13 ' A' ' 57' ' ' ILE . 89.2 m -61.92 -50.58 71.58 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 122.867 -0.196 . . . . 0.0 110.845 174.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.442 ' O ' HG23 ' A' ' 58' ' ' VAL . 26.7 t70 -58.22 -41.42 84.07 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.876 0.369 . . . . 0.0 110.951 179.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.1 t -58.64 -35.14 53.74 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 CA-C-O 121.183 0.516 . . . . 0.0 111.408 175.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -73.3 -38.28 65.91 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.205 0.526 . . . . 0.0 110.305 179.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.596 HG13 ' O ' ' A' ' 53' ' ' THR . 9.1 mt -62.5 -45.72 98.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.777 177.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 54' ' ' ASP . 94.2 t -58.03 -42.13 82.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.794 177.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -54.91 -43.88 73.67 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 121.178 0.514 . . . . 0.0 111.252 176.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 60.1 p -80.65 -17.48 51.09 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.834 -177.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.433 ' HD3' ' HA ' ' A' ' 61' ' ' LYS . 31.7 mmtp -84.54 -33.12 23.53 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 178.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.515 ' HB ' ' HB3' ' A' ' 74' ' ' GLU . 34.5 m -82.82 -19.63 10.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-O 121.135 0.493 . . . . 0.0 110.729 173.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.4 ttmm -61.2 127.27 30.71 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.285 177.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -71.85 152.12 48.48 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 120.94 -0.648 . . . . 0.0 111.919 171.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -53.53 -44.13 68.94 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -175.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 95.0 p -93.4 4.95 53.13 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 120.849 0.357 . . . . 0.0 111.806 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -88.66 117.58 27.72 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 120.865 0.364 . . . . 0.0 111.671 -178.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 66.3 mtp180 -70.25 -34.37 72.75 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.565 0.698 . . . . 0.0 110.227 178.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.585 HG21 ' HB3' ' A' ' 29' ' ' GLU . 32.4 m -124.82 -160.99 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.486 177.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 47.4 pt -119.9 150.02 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 O-C-N 122.051 -0.406 . . . . 0.0 111.28 173.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.48 ' ND2' ' HB2' ' A' ' 73' ' ' GLU . 4.2 p-10 -102.57 169.62 8.54 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 120.778 0.323 . . . . 0.0 111.461 179.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -54.19 -40.68 67.81 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -175.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.48 ' HB2' ' ND2' ' A' ' 71' ' ' ASN . 43.0 mt-10 -55.81 -43.53 76.98 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.819 0.342 . . . . 0.0 111.353 176.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.621 ' HA ' ' HD3' ' A' ' 77' ' ' LYS . 11.0 mm-40 -71.99 -31.69 66.49 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.009 0.433 . . . . 0.0 110.75 178.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -58.09 -43.7 87.23 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.098 176.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -54.9 -49.49 71.11 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.524 0.678 . . . . 0.0 110.987 173.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.621 ' HD3' ' HA ' ' A' ' 74' ' ' GLU . 51.0 mtpt -62.97 -36.66 84.23 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.684 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.7 -47.05 70.49 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.581 178.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 75.8 mt -59.35 -47.47 85.31 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.817 0.341 . . . . 0.0 111.195 177.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -54.22 -40.89 68.08 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 121.114 0.483 . . . . 0.0 111.224 178.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -61.18 -61.42 2.57 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.016 0.436 . . . . 0.0 111.164 176.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 80.9 mt -58.29 -30.87 66.97 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.963 0.411 . . . . 0.0 111.54 -179.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.03 -51.36 67.08 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.983 176.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 68.0 p -65.65 -17.21 64.43 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -72.22 -55.81 6.6 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 120.756 0.313 . . . . 0.0 111.593 174.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 62.5 mtp180 -81.35 -47.26 13.51 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.872 0.368 . . . . 0.0 111.668 -178.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -84.9 144.91 28.07 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.793 0.33 . . . . 0.0 110.519 177.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 41.6 mtpt -81.53 157.55 24.77 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.308 0.575 . . . . 0.0 112.096 -177.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -78.22 60.89 3.88 Favored Glycine 0 CA--C 1.528 0.897 0 CA-C-N 116.019 -0.537 . . . . 0.0 114.298 -173.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 58.7 pttt -96.3 -34.79 11.47 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.239 0.543 . . . . 0.0 110.488 173.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 32.3 t -167.26 115.8 0.81 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.141 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -65.68 -25.86 67.53 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 120.783 0.325 . . . . 0.0 110.707 174.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -57.22 -58.46 8.11 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.145 177.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -70.12 -37.7 75.39 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.305 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.51 -41.79 95.08 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.847 0.356 . . . . 0.0 111.54 178.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -67.8 -40.49 83.91 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.441 178.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -55.16 -52.67 62.57 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.421 0.629 . . . . 0.0 110.776 174.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.33 -52.62 62.92 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 115.166 -0.925 . . . . 0.0 112.581 -176.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.0 tt -59.65 -38.01 73.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 O-C-N 121.903 -0.498 . . . . 0.0 110.772 178.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 83.0 m -73.68 -24.15 59.92 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.177 175.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.94 -34.29 77.17 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.503 0.668 . . . . 0.0 109.81 175.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 94.4 mt -80.3 -25.99 39.07 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.487 177.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 76.6 t -100.57 -53.62 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -175.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -51.56 125.99 16.2 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -176.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 69.93 0.65 28.08 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-N 115.861 -0.609 . . . . 0.0 114.257 178.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.48 ' HD3' ' N ' ' A' ' 107' ' ' GLU . 11.7 tmtt? -87.79 134.63 33.64 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 121.382 0.61 . . . . 0.0 111.057 -176.04 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.48 ' N ' ' HD3' ' A' ' 106' ' ' LYS . 0.9 OUTLIER -89.12 154.61 49.49 Favored Pre-proline 0 CA--C 1.547 0.854 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -174.347 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -62.62 120.21 7.63 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 122.526 2.151 . . . . 0.0 112.37 175.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -98.04 -53.75 3.29 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -175.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.526 HD22 ' N ' ' A' ' 110' ' ' ASN . 0.8 OUTLIER 62.52 97.93 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 122.664 0.385 . . . . 0.0 111.024 -176.02 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 66.8 t 71.87 -58.44 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 123.246 0.619 . . . . 0.0 110.965 -174.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 109.07 74.89 0.84 Allowed Glycine 0 CA--C 1.525 0.658 0 C-N-CA 121.238 -0.506 . . . . 0.0 113.477 175.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.6 p -74.44 -39.88 48.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 O-C-N 122.555 -0.379 . . . . 0.0 110.947 176.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 40.2 m -68.02 102.19 1.26 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.942 176.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.54 ' NZ ' ' HB3' ' A' ' 115' ' ' LYS . 0.3 OUTLIER -137.84 7.71 2.74 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.816 0.341 . . . . 0.0 111.731 178.699 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.415 ' O ' ' HB2' ' A' ' 117' ' ' LYS . . . -64.39 102.29 0.52 Allowed 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.83 176.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.568 ' HB2' ' NZ ' ' A' ' 117' ' ' LYS . 8.3 mtmp? 71.95 81.22 0.15 Allowed 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.238 0.542 . . . . 0.0 110.686 -174.128 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 82.4 m -75.14 126.41 30.96 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.507 -177.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -81.41 150.95 30.59 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 121.205 -0.521 . . . . 0.0 113.601 -179.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 83.38 -55.61 5.03 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 121.275 -0.488 . . . . 0.0 113.574 177.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 69.93 172.73 0.3 Allowed 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.1 p -78.53 135.29 26.27 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 CA-C-O 121.33 0.586 . . . . 0.0 112.354 -178.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -83.72 45.99 1.12 Allowed 'General case' 0 CA--C 1.548 0.878 0 CA-C-O 121.245 0.545 . . . . 0.0 111.518 178.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -77.24 115.43 17.01 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -177.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 9.6 mp -112.67 -53.54 2.7 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.52 170.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 26.2 p 62.42 -65.69 0.09 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.611 1.164 . . . . 0.0 112.972 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -76.62 151.65 36.15 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.051 0.453 . . . . 0.0 111.715 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 74.3 p -77.3 95.38 4.35 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 120.942 0.401 . . . . 0.0 112.009 -176.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 29.0 t -59.23 137.62 57.9 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.575 174.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 9.2 mmm-85 -65.47 -18.21 65.15 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -176.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -84.69 90.3 7.68 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.538 0.685 . . . . 0.0 110.958 175.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 9.1 t -111.31 3.89 18.66 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.487 -0.778 . . . . 0.0 111.625 -178.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 129.36 -86.45 0.31 Allowed Glycine 0 CA--C 1.523 0.585 0 C-N-CA 121.411 -0.423 . . . . 0.0 112.766 -176.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 21.2 t 62.26 -76.1 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.012 0.525 . . . . 0.0 111.579 179.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -157.81 86.69 0.92 Allowed 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.071 0.462 . . . . 0.0 111.511 172.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 50.6 pttt -72.35 136.34 46.13 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.979 171.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -116.58 100.98 8.22 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -173.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.455 HH11 ' HD3' ' A' ' 138' ' ' ARG . 7.3 tpp180 -117.9 20.64 13.25 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-O 121.576 0.703 . . . . 0.0 110.414 175.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -83.28 32.7 0.45 Allowed 'General case' 0 CA--C 1.545 0.787 0 CA-C-O 121.501 0.667 . . . . 0.0 111.329 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -85.11 106.82 16.85 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.516 0.674 . . . . 0.0 111.141 177.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -94.33 45.52 1.13 Allowed 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.38 -177.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 46.6 t -90.37 148.63 22.71 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 120.862 0.363 . . . . 0.0 111.936 -176.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -89.87 -138.6 7.14 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 121.46 -0.4 . . . . 0.0 113.355 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -88.65 78.58 7.71 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 122.219 -0.577 . . . . 0.0 111.197 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -98.0 -159.43 30.43 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.159 -0.543 . . . . 0.0 113.308 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -78.61 -16.55 57.24 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 122.362 -0.493 . . . . 0.0 111.804 -179.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -79.81 20.35 5.5 Favored Glycine 0 CA--C 1.53 1.01 0 N-CA-C 114.341 0.496 . . . . 0.0 114.341 -175.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 37.1 pt -77.25 32.39 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 O-C-N 122.243 -0.563 . . . . 0.0 112.481 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -82.17 16.95 1.77 Allowed 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -176.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -158.1 146.53 13.49 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 121.334 -0.46 . . . . 0.0 112.621 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 75.8 mtm180 -134.36 163.77 28.92 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.873 0.368 . . . . 0.0 111.45 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 9.0 mm100 -86.18 -167.61 1.93 Allowed 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.291 0.567 . . . . 0.0 111.895 179.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -53.6 -28.85 34.68 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.355 176.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 9.2 tt -54.45 123.11 4.8 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 179.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -110.69 -44.95 3.57 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.287 0.565 . . . . 0.0 109.987 176.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -75.75 157.62 33.29 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.832 177.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 15.6 t70 71.35 164.63 0.28 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 122.65 0.38 . . . . 0.0 110.803 -175.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 51.7 m 73.06 -43.84 0.57 Allowed 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 179.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -59.0 108.85 1.76 Allowed Glycine 0 CA--C 1.531 1.087 0 C-N-CA 121.527 -0.368 . . . . 0.0 113.581 178.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 39.8 t80 60.63 103.47 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.169 0.587 . . . . 0.0 111.851 -177.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.589 HG23 ' HB2' ' A' ' 164' ' ' TYR . 7.2 p -79.24 121.51 32.59 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -177.116 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 72.4 m -139.11 92.53 2.6 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.145 170.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 64.55 77.26 0.32 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.22 -172.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.589 ' HB2' HG23 ' A' ' 161' ' ' VAL . 0.9 OUTLIER -83.36 56.82 3.71 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.572 0.701 . . . . 0.0 110.587 -176.931 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -130.4 141.67 50.54 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.217 -176.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -62.99 134.13 55.68 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -178.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -153.22 -60.46 0.14 Allowed 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.163 177.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 73.26 -69.56 1.34 Allowed Glycine 0 CA--C 1.528 0.872 0 C-N-CA 121.195 -0.526 . . . . 0.0 113.244 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 8.9 t -99.64 159.44 15.04 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.988 0.423 . . . . 0.0 111.425 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -118.75 168.64 10.54 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.891 0.377 . . . . 0.0 111.728 -177.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -70.37 125.28 26.35 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.117 0.484 . . . . 0.0 111.482 -177.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -148.45 124.32 10.6 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.621 177.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.453 ' O ' HG22 ' A' ' 174' ' ' VAL . 37.4 mtmm 63.65 32.66 13.72 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.108 -175.378 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.453 HG22 ' O ' ' A' ' 173' ' ' LYS . 15.6 m 52.79 127.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 125.186 1.394 . . . . 0.0 114.41 179.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -98.5 126.88 44.21 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.544 179.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 30.3 mtpp -74.83 124.39 26.76 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 122.185 -0.322 . . . . 0.0 111.198 176.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 81.0 mt -87.91 167.47 13.73 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.976 0.417 . . . . 0.0 111.765 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 . . . . . 0 N--CA 1.47 0.558 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.702 179.709 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.2 mtt . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.07 0.462 . . . . 0.0 111.313 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -139.93 130.08 25.09 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.133 -178.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -175.72 -53.96 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.192 0.52 . . . . 0.0 111.346 -177.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 75.6 m -144.96 -21.53 0.5 Allowed 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.633 177.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 44.2 p -75.04 0.9 14.45 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 177.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -65.37 -171.03 0.07 Allowed 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 121.103 0.477 . . . . 0.0 111.958 177.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.521 ' N ' HD12 ' A' ' 7' ' ' ILE . 2.9 mp -73.91 96.65 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 CA-C-O 120.788 0.328 . . . . 0.0 111.004 -177.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.64 -26.4 65.32 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.264 0.554 . . . . 0.0 111.404 179.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -55.76 -28.46 52.36 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.381 175.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 34.4 tp -58.33 -38.79 77.84 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.954 0.407 . . . . 0.0 110.704 178.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -67.85 -44.11 77.92 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 120.865 0.364 . . . . 0.0 110.246 173.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 20.5 tp10 -54.75 -47.0 74.39 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 178.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.505 ' HB3' ' HA2' ' A' ' 105' ' ' GLY . 53.9 p -67.49 -52.34 40.34 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -53.04 -47.13 68.62 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.273 0.559 . . . . 0.0 111.211 175.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -60.38 -36.14 77.36 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.261 177.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -73.34 -38.17 65.85 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.552 -178.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -74.28 -38.3 63.45 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 120.609 0.243 . . . . 0.0 111.388 176.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.94 -49.81 72.47 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.517 ' HA ' ' HB3' ' A' ' 25' ' ' ALA . 33.9 pt -78.67 6.06 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -178.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -90.73 146.07 24.29 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.984 0.421 . . . . 0.0 111.837 -177.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 79.15 -60.88 4.2 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 121.164 -0.541 . . . . 0.0 112.533 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -96.59 105.66 24.52 Favored Pre-proline 0 CA--C 1.542 0.657 0 CA-C-O 120.892 0.377 . . . . 0.0 111.115 177.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.14 -7.31 20.53 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.596 2.197 . . . . 0.0 113.387 -178.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -97.88 11.76 36.3 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 178.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.517 ' HB3' ' HA ' ' A' ' 19' ' ' ILE . . . -77.21 161.08 28.44 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.288 0.566 . . . . 0.0 112.356 -178.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 96.6 p -87.95 -45.15 10.48 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.978 -178.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.05 -19.93 31.79 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 121.393 -0.432 . . . . 0.0 112.481 -175.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 56.4 tp60 -96.54 -21.36 17.73 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.95 0.405 . . . . 0.0 110.841 177.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -125.25 129.49 50.15 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.54 178.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 54.7 ttp -125.29 148.91 48.5 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.118 0.485 . . . . 0.0 112.196 -177.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.489 ' OD1' ' HB3' ' A' ' 33' ' ' LYS . 16.9 p30 -93.07 172.09 8.53 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -177.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.547 ' HA2' ' HB3' ' A' ' 35' ' ' TRP . . . -60.83 -27.06 66.11 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-N 116.21 -0.45 . . . . 0.0 112.871 176.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.489 ' HB3' ' OD1' ' A' ' 31' ' ' ASN . 87.1 tttt -50.81 -64.47 0.8 Allowed 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 123.941 0.897 . . . . 0.0 112.117 175.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -77.42 -25.08 50.38 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.972 -0.455 . . . . 0.0 111.51 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.547 ' HB3' ' HA2' ' A' ' 32' ' ' GLY . 55.8 t-105 -59.76 -38.61 82.27 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.203 0.525 . . . . 0.0 110.462 171.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.92 -43.62 87.58 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.75 174.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -53.6 -48.75 68.97 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.647 174.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.6 mt -52.59 -49.65 64.59 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.027 0.441 . . . . 0.0 111.644 177.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 73.8 m -55.9 -42.55 76.19 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.674 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -75.34 -39.86 58.91 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.071 0.462 . . . . 0.0 111.92 -178.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.605 ' HA ' HD21 ' A' ' 110' ' ' ASN . 24.7 t0 -70.83 -42.51 70.1 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 122.144 -0.348 . . . . 0.0 111.277 -177.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.592 ' SG ' HG22 ' A' ' 103' ' ' VAL . 62.9 m -83.41 -12.38 56.5 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.44 176.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? 64.7 37.94 7.26 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.179 0.592 . . . . 0.0 111.957 179.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.484 HG11 HD13 ' A' ' 82' ' ' LEU . 51.6 t -75.32 -34.93 31.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-O 121.155 0.503 . . . . 0.0 110.079 173.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.72 82.09 2.08 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.481 0.657 . . . . 0.0 111.054 177.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -65.47 -40.26 92.94 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.483 -178.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.97 -38.55 3.23 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 121.392 -0.432 . . . . 0.0 112.806 -176.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -96.52 -48.08 5.69 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.18 0.514 . . . . 0.0 111.15 178.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.4 t -90.17 -44.54 9.7 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.318 178.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 54.0 t -121.51 108.88 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.499 177.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.412 ' O ' HG23 ' A' ' 55' ' ' VAL . 68.2 p -94.06 163.31 13.53 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -175.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -56.15 -44.41 88.74 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 121.19 -0.528 . . . . 0.0 112.744 176.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.592 ' O ' HG12 ' A' ' 57' ' ' ILE . 7.8 t -61.86 -41.04 97.35 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 122.53 -0.394 . . . . 0.0 110.69 175.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -59.85 -37.71 80.02 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.009 0.433 . . . . 0.0 110.584 176.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 51' ' ' THR . 76.3 t -59.39 -35.16 56.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.147 174.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -76.26 -34.39 59.15 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.817 0.817 . . . . 0.0 109.754 178.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.592 HG12 ' O ' ' A' ' 53' ' ' THR . 9.7 mm -60.61 -54.51 34.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.009 175.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.411 ' HA ' ' HB3' ' A' ' 61' ' ' LYS . 74.3 t -57.96 -40.3 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-O 120.728 0.299 . . . . 0.0 111.557 178.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -61.71 -44.13 97.51 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.045 0.45 . . . . 0.0 110.512 178.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 78.3 p -80.33 -15.06 57.77 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.108 0.48 . . . . 0.0 111.452 178.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.411 ' HB3' ' HA ' ' A' ' 58' ' ' VAL . 24.8 tptp -74.78 -49.98 18.92 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.166 0.587 . . . . 0.0 111.709 178.048 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.7 m -85.02 -24.56 7.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -179.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -57.7 131.54 50.57 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 179.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -77.68 -162.86 19.01 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-O 121.291 0.384 . . . . 0.0 113.994 179.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 21.3 ttpp -82.06 148.16 28.75 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -177.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 48.5 p 51.18 17.91 0.53 Allowed 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 173.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -110.64 146.49 36.08 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.878 0.371 . . . . 0.0 110.811 177.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 7.4 ptp85 -114.97 15.37 17.26 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.271 0.557 . . . . 0.0 110.862 178.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 22.2 m -145.72 169.86 6.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.661 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 37.2 pt -122.37 143.09 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-O 120.681 0.277 . . . . 0.0 110.885 175.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -100.72 177.79 4.89 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 120.888 0.375 . . . . 0.0 111.467 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -55.76 -27.33 50.23 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 113.159 0.799 . . . . 0.0 113.159 -175.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -70.7 -59.79 2.62 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.782 -0.574 . . . . 0.0 111.076 174.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -56.82 -32.42 65.7 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.436 0.636 . . . . 0.0 110.627 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -60.61 -51.54 68.98 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.733 176.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 37.5 mtmm -60.95 -42.72 98.78 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -59.43 -40.9 88.25 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 120.997 0.427 . . . . 0.0 110.839 175.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.02 -43.37 98.98 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.42 177.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 85.0 mt -57.7 -43.12 84.94 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.725 178.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -60.11 -46.42 89.69 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 120.722 0.296 . . . . 0.0 111.241 177.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.466 ' O ' ' HG3' ' A' ' 85' ' ' LYS . 52.5 mt-10 -59.24 -50.56 73.53 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.548 0.213 . . . . 0.0 111.274 177.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.484 HD13 HG11 ' A' ' 44' ' ' VAL . 95.9 mt -58.88 -40.32 84.02 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.023 0.439 . . . . 0.0 111.381 176.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.87 -51.41 70.16 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.807 178.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 56.2 p -65.99 -22.17 66.45 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -178.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.466 ' HG3' ' O ' ' A' ' 81' ' ' GLU . 96.9 mttt -78.23 -43.24 28.86 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 120.887 0.375 . . . . 0.0 111.225 174.338 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 26.7 tpt180 -81.32 -63.93 1.29 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.026 0.441 . . . . 0.0 111.133 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -79.16 88.18 4.87 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.361 0.6 . . . . 0.0 110.527 178.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 53.1 mttm -80.01 87.86 5.39 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.421 -173.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.402 ' O ' ' HB3' ' A' ' 90' ' ' LYS . . . -156.46 4.53 0.19 Allowed Glycine 0 CA--C 1.533 1.212 0 C-N-CA 120.86 -0.686 . . . . 0.0 114.468 178.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.402 ' HB3' ' O ' ' A' ' 89' ' ' GLY . 82.8 tttt 72.86 -43.71 0.57 Allowed 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 33.7 p -46.19 105.04 0.06 Allowed 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -175.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 46.4 mttm -60.37 -63.15 1.4 Allowed 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -176.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -54.32 -48.06 71.77 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -175.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -66.71 -44.38 81.79 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -178.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.65 -41.01 93.06 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.011 0.434 . . . . 0.0 111.426 179.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -68.75 -37.18 79.2 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.043 178.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -62.17 -49.37 76.11 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.373 0.606 . . . . 0.0 110.001 174.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -58.87 -49.89 76.07 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.296 -0.866 . . . . 0.0 112.669 -179.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.4 tp -60.89 -38.69 79.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-O 121.149 0.499 . . . . 0.0 110.904 178.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 75.0 m -73.65 -25.36 60.24 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.105 176.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -72.75 -32.4 65.64 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.024 0.44 . . . . 0.0 110.616 177.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 90.4 mt -64.16 -55.2 23.48 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.077 0.465 . . . . 0.0 110.924 173.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.592 HG22 ' SG ' ' A' ' 42' ' ' CYS . 41.2 t -69.34 -65.15 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.004 178.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 48.95 -100.46 0.07 Allowed 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.494 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.505 ' HA2' ' HB3' ' A' ' 13' ' ' SER . . . -151.13 44.18 0.68 Allowed Glycine 0 CA--C 1.523 0.54 0 C-N-CA 121.199 -0.524 . . . . 0.0 112.407 -179.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 49.6 tttm -74.37 155.33 38.24 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-O 121.141 0.496 . . . . 0.0 112.337 -177.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -66.56 137.55 95.23 Favored Pre-proline 0 CA--C 1.545 0.756 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.769 173.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -66.54 147.14 81.69 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.564 2.176 . . . . 0.0 113.898 -173.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 75.64 162.65 0.25 Allowed 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.686 177.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.605 HD21 ' HA ' ' A' ' 41' ' ' ASP . 4.0 m120 -92.88 117.07 29.63 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.728 -174.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 31.0 m -87.08 134.13 28.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 170.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 80.85 64.24 1.82 Allowed Glycine 0 CA--C 1.528 0.871 0 C-N-CA 120.697 -0.763 . . . . 0.0 111.582 -173.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 49.0 t -59.73 -43.66 92.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -172.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 87.0 m -114.82 108.28 16.54 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.19 0.519 . . . . 0.0 112.051 -177.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.577 ' HA ' ' NH2' ' A' ' 124' ' ' ARG . 58.8 pttt -115.76 -35.9 4.36 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.011 174.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.491 ' HA ' HG21 ' A' ' 122' ' ' VAL . . . -166.2 105.46 0.66 Allowed 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.229 178.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -125.78 -63.16 1.14 Allowed 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.992 0.425 . . . . 0.0 111.107 179.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 91.8 m -86.28 95.77 9.73 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.084 0.468 . . . . 0.0 110.416 176.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 97.72 144.12 16.35 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.347 -176.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -68.0 -40.42 88.77 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 120.817 -0.706 . . . . 0.0 113.253 -179.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -106.34 85.14 2.13 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.166 0.507 . . . . 0.0 111.726 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.491 HG21 ' HA ' ' A' ' 116' ' ' ALA . 59.3 t -83.02 161.76 3.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.517 175.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.424 ' N ' HG12 ' A' ' 122' ' ' VAL . 8.6 m-20 -56.84 91.36 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -175.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.577 ' NH2' ' HA ' ' A' ' 115' ' ' LYS . 48.9 mmt-85 -120.72 -171.97 2.29 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.855 171.204 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 34.5 tp 66.12 15.78 10.2 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.852 0.834 . . . . 0.0 109.73 -170.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 65.4 p -99.54 -38.73 8.65 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.572 -176.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 66.29 -65.36 0.19 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.157 0.583 . . . . 0.0 111.834 -176.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 59.4 m 66.83 93.64 0.07 Allowed 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 174.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 63.8 p -96.64 135.82 38.03 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.994 173.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 130' ' ' ARG . 1.0 OUTLIER -91.87 -6.28 51.81 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -172.333 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 22.3 p90 39.1 35.66 0.14 Allowed 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 175.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 93.8 m -143.11 -55.41 0.4 Allowed 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.838 0.351 . . . . 0.0 111.198 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -172.63 163.04 34.91 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 120.918 -0.658 . . . . 0.0 113.27 -179.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 73.9 p -80.15 -177.63 6.16 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.25 0.548 . . . . 0.0 111.865 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 77.5 m-70 -78.08 80.37 4.51 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.079 0.466 . . . . 0.0 110.99 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -84.66 144.89 28.28 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.058 0.456 . . . . 0.0 111.91 -177.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -155.92 95.58 1.65 Allowed 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.432 176.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -84.95 106.73 16.67 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.296 179.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -56.5 128.78 37.83 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 174.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -57.77 -22.94 49.7 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -171.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -84.48 -67.87 0.76 Allowed 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 120.525 0.203 . . . . 0.0 111.082 175.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 75.7 m 71.65 -47.43 0.66 Allowed 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 112.848 0.685 . . . . 0.0 112.848 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -60.44 125.96 39.97 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 121.495 -0.383 . . . . 0.0 113.313 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -67.77 107.93 2.77 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.212 0.53 . . . . 0.0 110.817 178.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -81.64 65.5 4.01 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 114.716 0.646 . . . . 0.0 114.716 -170.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 43.2 tttm -91.22 126.8 36.42 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 122.273 -0.545 . . . . 0.0 111.069 173.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -74.09 143.63 32.31 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.725 178.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 14.3 tt -65.14 -30.59 50.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 121.176 0.512 . . . . 0.0 111.571 -178.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -83.08 -13.67 55.26 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.408 177.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -81.66 87.06 1.4 Allowed Glycine 0 CA--C 1.526 0.751 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.185 177.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.422 HH11 ' HD3' ' A' ' 151' ' ' ARG . 41.3 mtt180 -84.37 141.3 30.97 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -174.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -116.93 61.04 0.74 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.29 0.566 . . . . 0.0 110.418 173.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -68.11 129.57 40.31 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.543 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 46.6 mm -88.1 94.98 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-O 121.364 0.602 . . . . 0.0 111.213 -177.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 27.2 tp -128.41 4.81 5.68 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.097 175.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -67.92 157.48 34.87 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.897 -177.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -88.01 96.09 10.38 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -175.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 37.5 t -92.92 137.6 32.22 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.593 174.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 173.42 -27.62 0.09 OUTLIER Glycine 0 CA--C 1.525 0.692 0 C-N-CA 120.253 -0.975 . . . . 0.0 113.969 -178.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 70.56 -24.02 0.17 Allowed 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 178.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 31.5 m -59.58 126.92 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -176.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 34.9 t 176.2 -22.5 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.157 178.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -69.02 74.37 0.3 Allowed 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.32 0.581 . . . . 0.0 111.872 178.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -102.99 -16.46 15.81 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.357 178.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -99.13 125.86 44.77 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.11 -178.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -86.32 121.03 28.33 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 120.924 0.393 . . . . 0.0 111.691 -178.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -109.69 82.86 1.66 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.114 0.483 . . . . 0.0 111.084 177.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -93.52 -138.58 9.0 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 121.09 -0.576 . . . . 0.0 113.724 -177.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 68.8 p -95.09 116.91 29.33 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.897 0.379 . . . . 0.0 111.877 -177.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -142.04 144.73 33.76 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.066 178.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -71.83 72.95 0.83 Allowed 'General case' 0 CA--C 1.546 0.799 0 CA-C-O 121.663 0.744 . . . . 0.0 111.217 177.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.49 -26.65 62.77 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -175.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -159.94 -36.29 0.06 Allowed 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.465 0.542 . . . . 0.0 112.465 -176.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 88.8 t 70.15 -65.06 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 122.843 0.457 . . . . 0.0 112.178 -179.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -73.26 161.43 30.53 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.361 0.6 . . . . 0.0 111.991 -178.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -127.99 117.01 20.94 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.761 175.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 58.0 tp -52.42 97.69 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -173.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 . . . . . 0 CA--C 1.539 0.531 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 175.792 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.4 mtm . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.489 0.185 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.08 149.64 33.88 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.759 0.314 . . . . 0.0 111.742 179.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -104.5 142.67 34.21 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.363 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 37.6 m -81.75 172.55 13.25 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.466 0.651 . . . . 0.0 112.179 -177.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 77.4 p -97.02 -160.06 0.78 Allowed 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.476 177.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -69.45 -152.4 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.956 0 CA-C-O 120.702 0.287 . . . . 0.0 111.434 175.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.498 ' H ' HD12 ' A' ' 7' ' ' ILE . 3.5 mp -71.69 97.66 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 CA-C-O 121.181 0.515 . . . . 0.0 111.696 -172.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.16 -34.95 78.72 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-O 121.329 0.585 . . . . 0.0 111.607 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -59.98 -19.95 52.13 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.698 176.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.646 HD22 ' SG ' ' A' ' 100' ' ' CYS . 43.6 tp -74.9 -38.85 61.75 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 120.713 0.292 . . . . 0.0 110.405 177.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -59.09 -41.23 87.55 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.009 173.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.542 ' O ' ' HG3' ' A' ' 16' ' ' LYS . 42.5 mt-10 -55.34 -54.45 43.5 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.207 175.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 41.7 t -55.37 -54.94 37.35 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.752 -178.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -53.55 -43.33 68.34 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.28 0.562 . . . . 0.0 110.771 176.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 63.8 ttt180 -62.36 -32.74 73.57 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.112 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.542 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 95.8 mttt -74.83 -39.37 61.67 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.564 178.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.864 ' HB3' ' SD ' ' A' ' 30' ' ' MET . 18.2 m-85 -69.67 -38.78 77.2 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 120.896 0.379 . . . . 0.0 111.43 175.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.2 -40.46 97.56 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -178.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.47 HG22 ' O ' ' A' ' 25' ' ' ALA . 29.2 pt -86.85 13.13 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-O 120.874 0.369 . . . . 0.0 111.839 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 37.6 t-80 -109.13 95.69 5.8 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.812 0.339 . . . . 0.0 111.652 -175.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 108.78 -46.55 1.15 Allowed Glycine 0 CA--C 1.521 0.457 0 C-N-CA 121.147 -0.549 . . . . 0.0 111.895 -175.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -74.3 108.34 4.97 Favored Pre-proline 0 CA--C 1.544 0.741 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 171.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -56.92 -38.73 95.26 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.752 2.301 . . . . 0.0 114.298 -169.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.5 mtpt -124.79 28.78 6.39 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -172.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.47 ' O ' HG22 ' A' ' 19' ' ' ILE . . . -74.93 123.56 25.32 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.772 0.32 . . . . 0.0 111.272 179.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 55.4 m -69.45 -2.02 10.03 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.52 -1.53 66.57 Favored Glycine 0 CA--C 1.523 0.593 0 C-N-CA 121.402 -0.428 . . . . 0.0 112.94 -178.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -86.35 -37.77 18.12 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.99 0.424 . . . . 0.0 111.775 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -116.66 131.58 56.91 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.86 -175.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.864 ' SD ' ' HB3' ' A' ' 17' ' ' PHE . 58.2 ttp -127.64 140.75 51.9 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.988 0.423 . . . . 0.0 111.801 178.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.463 ' OD1' ' HB3' ' A' ' 33' ' ' LYS . 10.9 p30 -74.79 167.69 21.34 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 121.249 0.547 . . . . 0.0 112.241 -178.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -70.95 -21.59 78.27 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-N 116.075 -0.511 . . . . 0.0 114.033 -178.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.463 ' HB3' ' OD1' ' A' ' 31' ' ' ASN . 61.5 tttp -70.88 -44.22 66.77 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 117.314 0.557 . . . . 0.0 111.052 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -72.34 -26.43 61.93 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 122.179 -0.326 . . . . 0.0 110.938 174.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 49.7 t-105 -65.45 -52.35 53.75 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 120.885 0.374 . . . . 0.0 111.167 173.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.93 -42.54 85.06 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.411 0.624 . . . . 0.0 110.583 174.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -61.04 -40.12 92.39 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.985 174.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.6 tt -55.22 -46.95 75.95 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.713 -178.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.595 ' SG ' HG21 ' A' ' 55' ' ' VAL . 15.7 p -66.1 -49.33 67.9 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.671 0.272 . . . . 0.0 111.467 -179.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.439 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 88.7 tttt -67.64 -34.62 77.31 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 120.904 0.383 . . . . 0.0 111.525 -175.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 49.0 t0 -77.8 -36.96 49.72 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 120.869 0.366 . . . . 0.0 110.824 179.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.575 ' SG ' ' HD3' ' A' ' 106' ' ' LYS . 77.7 m -87.12 4.11 43.54 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 178.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm 74.61 15.01 3.38 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 172.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 55.3 t -69.04 -32.67 55.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-O 120.788 0.328 . . . . 0.0 111.087 178.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.1 98.12 6.41 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 120.919 0.39 . . . . 0.0 111.32 178.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -90.79 -37.75 13.44 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -178.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 111.97 -25.87 12.3 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 121.286 -0.483 . . . . 0.0 113.608 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -88.87 -53.47 4.59 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.102 0.477 . . . . 0.0 110.72 178.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 64.6 m -98.22 -41.58 7.82 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.226 179.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.3 t -111.37 102.5 14.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 121.108 0.48 . . . . 0.0 110.691 175.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 48.5 p -93.4 15.02 16.74 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -176.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.6 -52.37 4.69 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.573 -173.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.595 ' O ' HG13 ' A' ' 57' ' ' ILE . 49.1 m -50.53 -46.44 57.35 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.131 0.491 . . . . 0.0 109.949 172.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -53.31 -35.31 60.01 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.109 176.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.595 HG21 ' SG ' ' A' ' 39' ' ' CYS . 56.3 t -66.01 -36.88 78.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 120.895 0.378 . . . . 0.0 110.74 177.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -69.79 -37.93 76.49 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.37 0.605 . . . . 0.0 109.886 175.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.595 HG13 ' O ' ' A' ' 53' ' ' THR . 6.8 mt -63.89 -50.42 77.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.191 178.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 71.3 t -58.55 -38.15 69.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-O 120.87 0.367 . . . . 0.0 111.34 177.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -59.11 -45.31 91.21 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.215 0.531 . . . . 0.0 110.022 176.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.441 ' HA ' ' HE2' ' A' ' 63' ' ' LYS . 80.7 p -79.14 -12.64 59.99 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.574 177.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.421 ' HE3' ' OE2' ' A' ' 81' ' ' GLU . 61.0 tttp -85.53 -21.96 28.36 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 121.303 0.573 . . . . 0.0 110.763 178.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.492 ' HB ' ' HB3' ' A' ' 74' ' ' GLU . 28.4 m -103.52 -18.85 6.49 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.564 171.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.441 ' HE2' ' HA ' ' A' ' 60' ' ' SER . 37.7 ttpt -71.77 93.37 1.29 Allowed 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 120.974 0.416 . . . . 0.0 111.53 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -93.72 -12.53 56.73 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 121.356 -0.449 . . . . 0.0 113.187 -177.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.534 ' HG2' ' N ' ' A' ' 66' ' ' SER . 22.6 ttmm -111.83 164.7 12.79 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 122.622 0.369 . . . . 0.0 110.359 178.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.534 ' N ' ' HG2' ' A' ' 65' ' ' LYS . 86.0 p -74.55 59.6 0.84 Allowed 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.373 0.606 . . . . 0.0 109.649 169.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.499 ' HB2' ' HD2' ' A' ' 65' ' ' LYS . . . -114.72 150.23 35.61 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.446 -171.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 35.0 mtp180 -90.98 -2.7 57.67 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.305 174.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 27.0 m -135.96 144.43 33.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -173.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 27.6 pt -103.21 158.86 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.964 173.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -103.42 179.42 4.28 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.172 0.511 . . . . 0.0 111.743 -178.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -67.47 -36.3 80.87 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -64.55 -57.11 10.07 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 179.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.492 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 0.9 OUTLIER -64.96 -20.46 66.49 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 122.123 -0.361 . . . . 0.0 111.312 177.034 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -63.94 -43.15 96.72 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 120.781 0.324 . . . . 0.0 110.962 173.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -55.16 -46.32 75.74 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 121.178 0.514 . . . . 0.0 110.594 174.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.431 ' O ' ' HG3' ' A' ' 81' ' ' GLU . 59.7 tttm -61.49 -50.85 71.09 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.402 177.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -53.2 -43.71 67.41 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.119 -178.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.512 HD12 HD21 ' A' ' 10' ' ' LEU . 79.9 mt -68.26 -39.86 82.09 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 178.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.512 ' O ' HG23 ' A' ' 84' ' ' THR . 38.0 tt0 -55.51 -47.2 76.62 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.309 0.576 . . . . 0.0 110.748 176.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.431 ' HG3' ' O ' ' A' ' 77' ' ' LYS . 38.0 mt-10 -65.41 -52.84 50.53 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.444 -179.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 58.9 mt -55.55 -36.72 67.09 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 122.252 -0.28 . . . . 0.0 111.428 174.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.16 -45.64 84.11 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 111.661 0.245 . . . . 0.0 111.661 179.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.512 HG23 ' O ' ' A' ' 80' ' ' GLU . 70.7 p -61.19 -29.5 69.84 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 38.4 mtpt -84.57 -48.47 9.5 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 122.026 -0.421 . . . . 0.0 111.967 173.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 32.4 tpt85 -60.05 -56.99 14.79 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.355 0.598 . . . . 0.0 111.873 -176.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -86.06 172.72 10.4 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.055 -178.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -79.58 171.43 15.16 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.259 -0.428 . . . . 0.0 112.137 -174.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -71.79 67.48 1.06 Allowed Glycine 0 CA--C 1.528 0.858 0 CA-C-N 116.034 -0.53 . . . . 0.0 113.186 178.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -119.81 174.6 6.34 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 45.9 t -44.97 123.32 3.76 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 178.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -52.2 -35.48 49.26 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.662 -178.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 -50.06 -62.84 1.34 Allowed 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.327 177.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -58.64 -42.04 87.37 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.787 0.327 . . . . 0.0 111.435 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.76 -37.41 81.74 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.079 0.466 . . . . 0.0 111.59 179.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -73.51 -46.49 47.51 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.759 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -58.45 -33.65 69.96 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.855 0.36 . . . . 0.0 110.832 174.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.457 ' O ' ' HB3' ' A' ' 101' ' ' GLN . . . -64.45 -55.34 21.49 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.867 178.112 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 19.1 tt -63.94 -34.03 65.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-O 121.033 0.445 . . . . 0.0 110.856 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . 0.646 ' SG ' HD22 ' A' ' 10' ' ' LEU . 99.2 m -66.77 -36.75 83.16 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.809 0.337 . . . . 0.0 110.858 173.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.457 ' HB3' ' O ' ' A' ' 98' ' ' ALA . 8.4 tt0 -55.95 -38.64 70.61 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.197 0.522 . . . . 0.0 110.791 175.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 91.1 mt -68.04 -50.97 51.97 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.322 177.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 39.0 t -83.98 -45.97 18.18 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -171.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -52.58 136.89 31.69 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 -173.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 79.44 -35.2 2.01 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-N 116.282 -0.417 . . . . 0.0 113.763 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.575 ' HD3' ' SG ' ' A' ' 42' ' ' CYS . 63.4 tttp -59.77 159.51 8.74 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.349 0.66 . . . . 0.0 112.669 -177.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -124.77 151.02 67.45 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.989 179.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -64.47 120.84 8.25 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 122.573 2.182 . . . . 0.0 113.231 178.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.11 149.29 48.85 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.214 0.53 . . . . 0.0 112.154 178.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -144.0 163.54 33.2 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.987 177.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 13.1 p -161.48 -30.71 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -177.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 101.61 98.86 2.38 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 121.373 -0.441 . . . . 0.0 112.385 -177.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 35.9 m -85.3 140.78 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-O 121.045 0.45 . . . . 0.0 111.902 -177.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 31.1 m -126.62 96.17 4.58 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.23 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 47.0 mtpt 69.46 -61.25 0.44 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.478 0.711 . . . . 0.0 112.64 178.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 74.6 -57.57 0.61 Allowed 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 176.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -74.58 19.67 0.13 Allowed 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -175.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 58.1 m -69.6 101.3 1.6 Allowed 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.09 0.471 . . . . 0.0 110.112 175.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -76.59 65.66 2.79 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 116.039 -0.528 . . . . 0.0 114.409 -173.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -84.36 55.19 4.99 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 121.185 -0.531 . . . . 0.0 112.833 177.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.36 133.45 50.53 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.738 0.304 . . . . 0.0 111.789 -178.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 33.9 m -111.68 -13.6 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -176.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -141.58 140.44 33.37 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.136 0.493 . . . . 0.0 112.129 -178.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 124' ' ' ARG . 36.7 mtm180 -104.75 -14.89 15.4 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.688 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 97.7 mt -78.84 104.99 9.85 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.454 0.645 . . . . 0.0 112.547 -172.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 5.9 t -138.25 45.65 2.08 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.912 178.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -65.24 -12.32 50.26 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.432 -176.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 85.0 m 76.52 -45.53 0.5 Allowed 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 177.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 71.5 m 65.19 97.27 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 121.039 0.447 . . . . 0.0 111.07 -174.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 90.4 mtt-85 -55.81 -33.66 64.64 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -172.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -87.01 -13.72 43.66 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -179.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.457 HG22 ' O ' ' A' ' 132' ' ' THR . 8.4 m -127.5 20.63 6.67 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 121.071 0.462 . . . . 0.0 111.629 -175.198 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -74.47 -55.89 5.34 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.814 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 73.3 m -90.7 109.52 20.7 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.876 0.37 . . . . 0.0 110.555 176.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -88.73 -174.72 4.64 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.982 0.42 . . . . 0.0 111.715 -176.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.414 ' NZ ' ' HB3' ' A' ' 136' ' ' LYS . 9.6 mtpm? -93.51 -163.16 1.01 Allowed 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 120.873 0.368 . . . . 0.0 111.805 -179.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -57.99 121.87 11.63 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -176.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 138' ' ' ARG . 0.0 OUTLIER -123.55 123.78 41.36 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 176.877 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -60.03 139.9 57.15 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.112 0.482 . . . . 0.0 111.73 -177.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -64.99 88.72 0.07 Allowed 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -171.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.419 ' O ' ' HG3' ' A' ' 141' ' ' GLU . 5.5 pt-20 -98.22 103.74 15.71 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.216 0.532 . . . . 0.0 111.014 172.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 42.1 m -65.24 -15.76 62.82 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.912 0.387 . . . . 0.0 111.216 176.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.8 -155.39 48.1 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 121.283 -0.484 . . . . 0.0 112.969 179.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 40.2 mmtm -126.37 19.04 7.53 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 120.971 0.415 . . . . 0.0 110.516 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 81.22 57.46 2.79 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 111.13 -0.788 . . . . 0.0 111.13 -169.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -101.74 126.28 48.57 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -172.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 60.41 18.32 50.09 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-N 115.797 -0.638 . . . . 0.0 114.291 176.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.522 HG22 ' O ' ' A' ' 148' ' ' ILE . 37.8 mm 52.85 15.44 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.22 0 CA-C-O 121.399 0.619 . . . . 0.0 111.7 -177.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . 62.57 18.23 10.3 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.046 0.539 . . . . 0.0 112.37 -176.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -119.6 132.03 9.28 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 121.223 -0.513 . . . . 0.0 113.637 -177.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 47.5 mtp180 -104.81 -18.69 14.15 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 120.982 0.42 . . . . 0.0 111.293 177.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -152.93 -9.98 0.17 Allowed 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.64 -179.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 66.47 166.27 0.21 Allowed 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.458 0.647 . . . . 0.0 112.548 -174.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 29.6 pt -109.11 137.4 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.184 175.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 86.9 mt -82.0 88.72 6.38 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.156 0.503 . . . . 0.0 111.694 -178.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -46.48 136.09 7.8 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.991 170.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -54.52 102.38 0.06 Allowed 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.468 0.651 . . . . 0.0 112.193 -177.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 24.5 t -109.77 -157.91 0.63 Allowed 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.271 -177.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -59.34 179.23 1.86 Allowed Glycine 0 CA--C 1.532 1.101 0 N-CA-C 114.544 0.578 . . . . 0.0 114.544 -178.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -76.93 84.82 3.47 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.223 0.535 . . . . 0.0 112.106 -175.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 27.6 m -108.43 -27.58 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.257 175.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 49.6 m -87.1 -20.92 26.4 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.052 0.453 . . . . 0.0 110.904 176.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -121.48 130.88 53.83 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.75 176.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -102.65 15.41 29.37 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 120.956 0.408 . . . . 0.0 111.669 -176.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -77.47 147.34 35.94 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.025 0.44 . . . . 0.0 111.886 -176.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -104.22 154.05 20.23 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -171.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 66.73 88.07 0.11 Allowed 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.733 0.813 . . . . 0.0 112.965 178.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.406 ' C ' ' HG1' ' A' ' 169' ' ' THR . . . -69.8 88.57 0.29 Allowed Glycine 0 CA--C 1.528 0.872 0 C-N-CA 121.096 -0.573 . . . . 0.0 112.54 176.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.406 ' HG1' ' C ' ' A' ' 168' ' ' GLY . 82.5 p 52.1 64.29 1.91 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.257 0.623 . . . . 0.0 111.825 -177.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 4.1 t80 72.06 130.15 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.501 0.72 . . . . 0.0 111.506 -177.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -94.51 10.61 33.94 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 113.982 1.104 . . . . 0.0 113.982 -169.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -83.06 -105.0 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.832 0 O-C-N 121.834 -0.541 . . . . 0.0 111.643 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 87.6 mttt 59.1 24.76 13.12 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 174.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 7.9 p -91.84 131.47 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 O-C-N 122.119 -0.363 . . . . 0.0 111.563 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.426 ' O ' ' HG2' ' A' ' 175' ' ' LYS . 25.1 ttpp 68.66 -0.3 2.36 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.004 0.521 . . . . 0.0 112.011 179.137 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -74.93 -97.68 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.919 0 O-C-N 122.166 -0.334 . . . . 0.0 111.844 -173.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 87.5 mt 41.32 -118.63 0.39 Allowed 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 176.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 . . . . . 0 N--CA 1.476 0.839 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 173.113 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 120.696 0.284 . . . . 0.0 111.119 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.18 84.06 1.35 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.443 178.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -162.26 117.52 1.91 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 43.3 t -80.74 104.73 11.46 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 170.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.4 t -95.97 16.33 18.11 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -170.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -123.95 -101.53 0.39 Allowed 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.906 -0.496 . . . . 0.0 112.29 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.428 HG22 ' H ' ' A' ' 10' ' ' LEU . 41.3 mm -134.41 122.97 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 O-C-N 121.969 -0.457 . . . . 0.0 112.063 -173.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.42 -45.86 57.76 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.012 0.434 . . . . 0.0 111.485 178.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.24 -18.45 35.37 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 121.223 -0.513 . . . . 0.0 112.863 177.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.438 HD11 HD11 ' A' ' 79' ' ' LEU . 34.1 tp -74.48 -36.83 63.3 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.895 0.379 . . . . 0.0 110.132 175.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -59.03 -43.18 91.58 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.437 0.637 . . . . 0.0 109.533 173.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 56.3 tt0 -58.53 -55.87 29.5 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.236 176.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 73.7 m -54.58 -47.44 73.3 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.628 179.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.409 ' CD1' ' HE3' ' A' ' 30' ' ' MET . 73.4 t80 -58.38 -44.16 88.77 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.005 0.431 . . . . 0.0 110.781 176.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 47.9 ttt180 -60.85 -47.41 86.5 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.719 -179.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -65.25 -40.28 93.78 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.619 178.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.429 ' HB3' ' HE2' ' A' ' 30' ' ' MET . 6.2 m-85 -73.07 -29.69 63.14 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 177.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.09 -47.03 78.68 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.112 0.482 . . . . 0.0 111.078 178.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 17.7 pt -88.88 5.94 4.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-O 121.208 0.527 . . . . 0.0 111.798 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -69.45 93.12 0.64 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.03 0.443 . . . . 0.0 110.806 177.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 81.26 45.89 7.25 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 -170.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.471 ' CB ' ' HB2' ' A' ' 25' ' ' ALA . 11.3 p-10 -64.16 120.83 67.89 Favored Pre-proline 0 CA--C 1.542 0.649 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -168.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -84.63 -26.39 1.66 Allowed 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.107 1.871 . . . . 0.0 111.96 166.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 47.7 mttp -157.02 67.14 0.53 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.596 0.758 . . . . 0.0 110.095 176.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.471 ' HB2' ' CB ' ' A' ' 22' ' ' ASP . . . -55.34 91.29 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 179.047 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 66.4 m -104.31 -29.39 10.8 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 120.968 0.413 . . . . 0.0 110.202 169.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.43 22.73 6.94 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 121.214 -0.517 . . . . 0.0 114.243 173.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -146.11 0.78 0.84 Allowed 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 117.363 0.582 . . . . 0.0 112.213 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 20.5 mp0 -114.29 121.48 43.78 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 120.683 0.278 . . . . 0.0 111.74 -175.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.429 ' HE2' ' HB3' ' A' ' 17' ' ' PHE . 52.0 ttm -119.85 134.34 55.27 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.876 0.369 . . . . 0.0 111.406 175.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 18.5 p30 -95.22 165.32 12.45 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.065 0.46 . . . . 0.0 111.702 178.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.78 -31.92 77.35 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 121.321 -0.466 . . . . 0.0 113.255 178.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -58.41 -53.62 56.22 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 177.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -70.42 -33.73 71.68 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 111.595 0.22 . . . . 0.0 111.595 179.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 40.0 t-105 -58.07 -47.13 84.09 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.122 0.487 . . . . 0.0 111.565 175.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.25 -49.37 72.15 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.982 0.42 . . . . 0.0 111.351 178.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -68.28 -22.35 64.74 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 178.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.6 tt -62.55 -52.39 63.6 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.542 0.687 . . . . 0.0 109.475 172.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 81.9 m -58.34 -38.6 77.49 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.211 177.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.1 ttmp? -68.69 -44.08 74.73 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 111.919 0.341 . . . . 0.0 111.919 177.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -67.85 -33.19 74.29 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -173.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.964 ' SG ' ' HB3' ' A' ' 102' ' ' LEU . 52.2 t -107.45 1.04 23.25 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-O 121.104 0.478 . . . . 0.0 110.75 175.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.446 ' N ' ' HD2' ' A' ' 43' ' ' LYS . 0.1 OUTLIER 63.09 38.2 10.95 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.793 -0.639 . . . . 0.0 112.155 175.83 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 48.5 t -62.89 -27.7 43.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-O 121.343 0.592 . . . . 0.0 110.386 173.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.563 ' HB1' HG11 ' A' ' 50' ' ' VAL . . . -57.58 115.75 2.96 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.101 170.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.564 ' C ' HG22 ' A' ' 50' ' ' VAL . 11.0 t70 -144.22 -50.14 0.29 Allowed 'General case' 0 C--O 1.221 -0.444 0 CA-C-O 119.311 -0.376 . . . . 0.0 111.662 -170.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -2.45 47.81 0.0 OUTLIER Glycine 0 N--CA 1.475 1.239 0 N-CA-C 116.389 1.316 . . . . 0.0 116.389 -164.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.546 ' N ' ' O ' ' A' ' 46' ' ' ASP . 25.0 ttpp 56.42 3.75 0.12 Allowed 'General case' 0 CA--C 1.552 1.046 0 CA-C-O 121.297 0.57 . . . . 0.0 111.704 -177.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.8 m 171.98 -27.35 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.92 1.288 . . . . 0.0 109.163 -168.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.564 HG22 ' C ' ' A' ' 46' ' ' ASP . 0.2 OUTLIER 63.58 158.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 124.994 1.317 . . . . 0.0 111.855 -179.541 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.22 -12.32 6.31 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.67 -177.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.79 -67.89 1.63 Allowed Glycine 0 CA--C 1.526 0.759 0 C-N-CA 121.361 -0.447 . . . . 0.0 112.47 -175.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.555 ' O ' HG12 ' A' ' 57' ' ' ILE . 51.8 m -48.57 -38.45 20.62 Favored 'General case' 0 C--O 1.223 -0.309 0 C-N-CA 122.275 0.23 . . . . 0.0 111.138 175.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.435 ' O ' HG23 ' A' ' 58' ' ' VAL . 24.1 t70 -51.87 -47.4 64.52 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.991 0.424 . . . . 0.0 111.148 176.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.6 t -61.74 -35.45 67.64 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 CA-C-O 121.186 0.517 . . . . 0.0 110.788 177.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -73.42 -30.24 63.1 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.6 0.714 . . . . 0.0 110.244 178.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.555 HG12 ' O ' ' A' ' 53' ' ' THR . 5.5 mm -70.31 -41.94 78.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.02 177.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 54' ' ' ASP . 88.8 t -58.83 -43.8 89.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 120.777 0.322 . . . . 0.0 110.9 176.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -58.13 -41.69 84.23 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.206 0.527 . . . . 0.0 110.44 174.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 28.9 t -73.63 -24.01 59.96 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.769 176.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 55.3 tttp -71.88 -38.57 70.0 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 122.901 0.48 . . . . 0.0 111.248 -176.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.3 m -91.1 -9.52 10.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-O 121.018 0.437 . . . . 0.0 111.34 174.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.582 ' HG3' ' HB3' ' A' ' 67' ' ' ALA . 39.7 ttmt -68.92 118.86 12.38 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.776 179.386 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -75.52 63.47 2.63 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 121.306 -0.473 . . . . 0.0 113.318 178.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.6 mttt 60.66 101.93 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 178.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.0 t 63.66 11.96 6.18 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 175.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.582 ' HB3' ' HG3' ' A' ' 63' ' ' LYS . . . -69.39 98.75 1.12 Allowed 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.983 0.42 . . . . 0.0 110.912 177.031 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 58.3 mtm180 -64.5 -16.42 62.48 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -177.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 31.2 m -136.14 148.65 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-O 120.793 0.33 . . . . 0.0 111.318 177.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 35.3 pt -115.23 166.07 9.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 121.024 0.44 . . . . 0.0 111.864 178.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.404 ' OD1' ' HB2' ' A' ' 73' ' ' GLU . 8.5 p30 -111.52 172.15 7.06 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.187 179.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.513 ' O ' ' HG3' ' A' ' 76' ' ' LYS . 59.6 t80 -61.62 -42.99 99.66 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -178.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.404 ' HB2' ' OD1' ' A' ' 71' ' ' ASN . 6.4 mp0 -55.54 -55.57 30.39 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -177.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.57 -30.62 68.45 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 122.276 -0.265 . . . . 0.0 111.664 177.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -55.1 -38.71 68.49 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.059 0.457 . . . . 0.0 111.032 175.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.513 ' HG3' ' O ' ' A' ' 72' ' ' TYR . 6.5 mtpm? -55.95 -47.82 76.9 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.979 175.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.428 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 4.3 mptp? -67.46 -34.36 77.02 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.477 178.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.6 -39.73 92.27 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.125 0.488 . . . . 0.0 111.113 175.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.438 HD11 HD11 ' A' ' 10' ' ' LEU . 69.8 mt -66.64 -41.06 88.87 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.408 175.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -51.94 -44.9 64.13 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 120.966 0.413 . . . . 0.0 111.357 176.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.595 ' O ' ' HG2' ' A' ' 85' ' ' LYS . 1.2 tm-20 -60.98 -66.5 0.52 Allowed 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.442 177.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.422 ' O ' ' HG3' ' A' ' 86' ' ' ARG . 73.6 mt -52.37 -31.52 34.15 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.476 ' HB2' HG21 ' A' ' 99' ' ' ILE . . . -62.95 -51.92 65.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.934 0.397 . . . . 0.0 111.114 177.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.6 ' HB ' ' HA2' ' A' ' 89' ' ' GLY . 69.3 p -62.45 -31.55 72.29 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.244 178.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.595 ' HG2' ' O ' ' A' ' 81' ' ' GLU . 6.2 mmmm -61.71 -29.22 69.96 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.356 176.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.422 ' HG3' ' O ' ' A' ' 82' ' ' LEU . 60.6 mtp180 -96.02 -63.83 1.11 Allowed 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.371 0.605 . . . . 0.0 111.915 179.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.422 ' O ' ' HB2' ' A' ' 88' ' ' LYS . 64.3 m-85 -84.83 46.18 1.23 Allowed 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.839 -0.618 . . . . 0.0 112.39 -170.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.524 ' NZ ' ' HB2' ' A' ' 88' ' ' LYS . 8.4 mtmp? 70.79 114.89 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.962 0.505 . . . . 0.0 111.725 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.6 ' HA2' ' HB ' ' A' ' 84' ' ' THR . . . -65.69 78.81 0.09 OUTLIER Glycine 0 CA--C 1.526 0.778 0 CA-C-N 116.018 -0.537 . . . . 0.0 113.604 -178.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 47.0 tttm -159.51 -77.27 0.07 Allowed 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 48.1 m -75.22 108.2 7.82 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -172.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 20.0 ttmm -60.35 -45.6 92.89 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.778 177.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.46 ' CD ' ' H ' ' A' ' 93' ' ' GLU . 21.6 mp0 -60.86 -57.67 11.68 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.313 0.578 . . . . 0.0 111.108 -175.035 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -55.87 -52.01 65.56 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.761 179.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.38 -45.32 91.8 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.987 -178.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -65.6 -48.09 73.46 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.651 -0.249 . . . . 0.0 111.524 -178.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -55.56 -47.34 76.53 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.902 0.382 . . . . 0.0 111.702 177.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.42 -51.42 65.82 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.476 HG21 ' HB2' ' A' ' 83' ' ' ALA . 16.5 tt -63.57 -33.97 64.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 O-C-N 122.006 -0.434 . . . . 0.0 111.385 -178.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 96.5 m -68.7 -37.08 79.27 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.86 0.362 . . . . 0.0 110.593 173.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -59.12 -28.23 66.34 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 121.216 0.532 . . . . 0.0 110.734 176.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.964 ' HB3' ' SG ' ' A' ' 42' ' ' CYS . 53.6 mt -79.74 -58.11 3.34 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.86 175.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.6 t -79.22 -51.11 17.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -173.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.53 119.4 7.45 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -172.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 93.89 -16.34 61.08 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-N 116.183 -0.462 . . . . 0.0 113.825 179.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.443 ' O ' ' HG2' ' A' ' 107' ' ' GLU . 60.1 tttm -74.01 -49.12 25.75 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 117.183 0.491 . . . . 0.0 112.173 -178.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.443 ' HG2' ' O ' ' A' ' 106' ' ' LYS . 7.1 pt-20 54.4 161.16 0.06 OUTLIER Pre-proline 0 CA--C 1.557 1.228 0 C-N-CA 124.295 1.038 . . . . 0.0 112.397 -174.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -51.48 118.56 4.5 Favored 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 122.414 2.076 . . . . 0.0 113.641 -176.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -65.59 95.71 0.24 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.312 0.577 . . . . 0.0 111.968 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -98.01 28.36 4.02 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.398 0.618 . . . . 0.0 110.988 176.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 61.2 t -65.12 -50.09 76.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.104 -177.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -119.68 138.09 12.97 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 120.993 -0.622 . . . . 0.0 113.286 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 32.6 m -109.53 165.08 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-O 121.07 0.462 . . . . 0.0 111.945 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 61.1 p -77.19 114.84 16.43 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.555 179.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -85.84 40.53 0.86 Allowed 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 121.08 0.467 . . . . 0.0 111.809 -177.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -145.83 -177.51 5.63 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.27 -178.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.499 ' O ' ' HD2' ' A' ' 117' ' ' LYS . 0.0 OUTLIER -141.67 142.55 33.37 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -179.4 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.8 t 39.91 98.88 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.703 1.201 . . . . 0.0 113.821 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -67.34 -51.78 35.51 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-N 116.031 -0.531 . . . . 0.0 113.766 -177.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -110.9 11.5 29.62 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.847 -176.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 65.26 17.18 10.91 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 120.995 0.426 . . . . 0.0 111.936 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 30.8 m -142.2 17.28 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 CA-C-O 121.183 0.515 . . . . 0.0 110.74 178.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -76.07 -40.12 53.9 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -171.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 51.3 ttp180 73.43 -34.9 0.3 Allowed 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.604 0.762 . . . . 0.0 111.062 -171.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.678 HD23 HG23 ' A' ' 126' ' ' THR . 8.9 tt -67.56 146.1 54.24 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 167.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.678 HG23 HD23 ' A' ' 125' ' ' LEU . 31.3 p 54.63 38.68 30.37 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -173.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -73.59 -161.51 0.11 Allowed 'General case' 0 CA--C 1.547 0.832 0 CA-C-O 120.741 0.305 . . . . 0.0 110.52 169.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 79.8 p -65.18 78.57 0.05 Allowed 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.201 0.524 . . . . 0.0 111.313 174.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 70.9 m -145.24 146.63 31.77 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.976 0.417 . . . . 0.0 111.732 -177.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 48.7 ttt180 -73.38 -43.58 60.31 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.38 176.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -117.82 128.53 54.94 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.304 172.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 8.9 t -98.63 21.74 10.89 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.036 0.446 . . . . 0.0 111.557 178.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -167.98 -169.5 31.55 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 121.135 -0.555 . . . . 0.0 113.063 -178.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 67.2 m 68.88 154.4 0.11 Allowed 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 121.317 0.579 . . . . 0.0 112.088 -178.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 79.0 m-70 -124.2 104.39 8.8 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.155 0.502 . . . . 0.0 111.87 176.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 47.2 tttp -106.71 5.26 28.61 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.64 0.733 . . . . 0.0 109.928 178.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -80.41 43.4 0.64 Allowed 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.981 -175.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -83.62 49.61 1.63 Allowed 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -175.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 62.44 122.38 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 175.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.469 ' O ' ' HB3' ' A' ' 141' ' ' GLU . 4.9 t70 -68.31 154.86 40.93 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 172.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.718 ' HG2' ' H ' ' A' ' 143' ' ' GLY . 40.5 tt0 73.62 145.16 0.08 Allowed 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 121.263 0.554 . . . . 0.0 111.478 -174.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 84.8 p -85.58 7.6 22.54 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -177.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.718 ' H ' ' HG2' ' A' ' 141' ' ' GLU . . . -69.51 169.94 43.44 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 121.402 -0.428 . . . . 0.0 113.36 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 61.8 mttp 70.75 -34.86 0.31 Allowed 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.7 111.66 3.93 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 121.246 -0.502 . . . . 0.0 112.871 177.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 63.9 pttt 43.53 -156.42 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.057 0.943 . . . . 0.0 112.993 -177.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 73.51 -78.3 0.86 Allowed Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 -170.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 14.8 tt -108.58 -20.35 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 CA-C-O 121.121 0.486 . . . . 0.0 109.988 166.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . 67.79 -179.15 0.22 Allowed 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.545 179.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -68.95 78.62 0.27 Allowed Glycine 0 CA--C 1.528 0.861 0 C-N-CA 121.19 -0.529 . . . . 0.0 112.889 178.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 26.5 tpt180 -72.99 103.35 3.75 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.313 0.577 . . . . 0.0 111.664 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -132.12 -165.69 1.62 Allowed 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.072 179.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -87.24 117.87 26.29 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.575 175.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.475 HD12 ' N ' ' A' ' 154' ' ' ILE . 2.3 mp -82.28 106.93 13.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-O 121.02 0.438 . . . . 0.0 111.319 -178.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.494 ' O ' HD23 ' A' ' 155' ' ' LEU . 6.0 tt -80.2 -38.56 30.92 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.134 0.492 . . . . 0.0 110.57 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -65.95 135.83 55.26 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.415 0.626 . . . . 0.0 112.613 -176.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -124.5 92.19 3.61 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.39 168.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 49.6 p -37.11 106.74 0.05 Allowed 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -174.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.476 ' O ' ' N ' ' A' ' 161' ' ' VAL . . . 152.89 -33.6 0.8 Allowed Glycine 0 CA--C 1.527 0.798 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.822 -177.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 37.1 p90 44.65 -72.4 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 178.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.476 ' N ' ' O ' ' A' ' 159' ' ' GLY . 59.1 t 65.25 100.36 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 123.634 0.773 . . . . 0.0 112.178 -176.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 98.1 p -104.24 -65.0 1.05 Allowed 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.126 0.488 . . . . 0.0 110.775 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -91.74 124.8 36.15 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.457 175.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -77.23 53.99 1.05 Allowed 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -177.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? 53.79 34.57 19.46 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 173.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -104.05 -178.97 3.81 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 73.59 127.69 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.304 0.641 . . . . 0.0 112.075 -178.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -129.37 -46.53 0.17 Allowed Glycine 0 CA--C 1.527 0.826 0 C-N-CA 121.336 -0.459 . . . . 0.0 113.573 -177.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 72.4 p -68.71 88.2 0.36 Allowed 'General case' 0 N--CA 1.47 0.555 0 O-C-N 122.397 -0.473 . . . . 0.0 111.596 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 79.7 t80 -110.37 -24.34 10.68 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.979 0.419 . . . . 0.0 111.631 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -73.18 -12.2 60.8 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.253 -0.431 . . . . 0.0 112.102 -177.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -81.19 145.51 30.95 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.024 0.44 . . . . 0.0 112.034 -178.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.433 ' O ' ' HG2' ' A' ' 173' ' ' LYS . 54.8 tttm 70.72 7.96 6.4 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 174.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 85.7 t -63.33 -29.0 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 O-C-N 121.961 -0.462 . . . . 0.0 111.536 177.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt 73.1 116.68 0.05 Allowed 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.333 0.653 . . . . 0.0 112.521 178.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 57.5 pttt -98.86 145.03 27.4 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.733 174.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.472 HD22 ' N ' ' A' ' 177' ' ' LEU . 2.6 mm? -92.17 128.56 38.07 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.995 0.426 . . . . 0.0 111.76 -176.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 23.6 mp0 . . . . . 0 CA--C 1.54 0.56 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.605 178.736 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.585 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.551 0.215 . . . . 0.0 110.714 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.83 53.27 1.62 Allowed 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.114 0.483 . . . . 0.0 111.953 -178.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -163.69 152.31 13.73 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.118 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 43.7 t -135.0 -46.92 0.72 Allowed 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.104 0.478 . . . . 0.0 111.405 179.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.4 t -132.8 46.12 2.66 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.485 0.66 . . . . 0.0 110.999 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 63.34 -97.61 0.06 Allowed 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.113 -175.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.5 mp -138.82 110.37 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-O 120.903 0.383 . . . . 0.0 110.677 176.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.96 -44.88 78.91 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.039 0.447 . . . . 0.0 111.543 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.44 -25.78 63.4 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 121.127 -0.559 . . . . 0.0 113.168 177.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 45.4 tp -72.57 -42.6 64.44 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 122.535 -0.391 . . . . 0.0 110.659 178.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -57.56 -47.47 81.96 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.909 0.385 . . . . 0.0 110.783 175.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.603 ' O ' ' HD3' ' A' ' 16' ' ' LYS . 44.6 mt-10 -62.79 -43.28 99.22 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.491 177.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.533 ' HB2' ' HA ' ' A' ' 104' ' ' ALA . 38.7 t -54.65 -54.07 46.52 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 120.768 0.318 . . . . 0.0 111.428 178.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -56.73 -42.83 79.9 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.212 0.529 . . . . 0.0 110.844 175.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 33.5 ttt180 -56.57 -45.91 81.03 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.712 -179.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.603 ' HD3' ' O ' ' A' ' 12' ' ' GLU . 5.0 mptp? -66.52 -55.64 14.6 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 178.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -64.04 -28.37 69.75 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -178.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.08 -54.15 45.39 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.986 0.422 . . . . 0.0 111.333 177.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 29.1 pt -80.81 4.56 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 CA-C-N 116.147 -0.478 . . . . 0.0 112.026 -178.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -61.83 -36.39 81.04 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -175.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -125.89 0.1 7.75 Favored Glycine 0 N--CA 1.465 0.58 0 C-N-CA 120.852 -0.689 . . . . 0.0 113.079 -179.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -155.43 89.89 2.95 Favored Pre-proline 0 CA--C 1.542 0.653 0 CA-C-O 121.192 0.52 . . . . 0.0 111.006 -178.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -52.23 -29.71 38.97 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.086 2.524 . . . . 0.0 113.965 -177.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -80.41 3.83 20.03 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.083 0.468 . . . . 0.0 111.654 -176.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.409 ' HB1' ' O ' ' A' ' 29' ' ' GLU . . . -63.9 -31.8 73.1 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.71 170.04 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 30.6 t 58.69 20.12 7.48 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.499 176.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 70.25 11.82 68.15 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.793 -176.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.405 HE21 ' HB3' ' A' ' 28' ' ' GLN . 6.2 tt0 -93.44 -38.31 11.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.231 0.539 . . . . 0.0 110.834 177.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.453 ' HB3' ' CG2' ' A' ' 69' ' ' VAL . 39.3 mt-10 -131.53 154.24 49.0 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.425 -172.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 52.1 ttm -137.88 136.31 36.98 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.809 0.338 . . . . 0.0 111.176 177.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.544 HD21 ' ND2' ' A' ' 34' ' ' ASN . 10.8 p30 -89.73 166.44 13.57 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.134 0.492 . . . . 0.0 111.916 -179.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.62 -21.86 69.34 Favored Glycine 0 CA--C 1.531 1.046 0 CA-C-N 116.024 -0.535 . . . . 0.0 114.283 -177.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.434 ' HB3' ' OD1' ' A' ' 31' ' ' ASN . 62.8 tttp -74.22 -52.43 12.42 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 117.413 0.607 . . . . 0.0 111.151 179.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.544 ' ND2' HD21 ' A' ' 31' ' ' ASN . 71.8 m-20 -63.67 -38.36 90.82 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.811 0.338 . . . . 0.0 110.687 176.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.439 ' CD1' ' HB2' ' A' ' 59' ' ' PHE . 43.3 t-105 -60.24 -38.78 84.5 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.425 174.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.21 -45.45 93.14 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.482 177.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -74.13 -32.72 63.29 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 120.866 -0.334 . . . . 0.0 111.102 176.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.7 tt -51.33 -51.35 55.19 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.035 0.445 . . . . 0.0 110.399 177.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 75.0 m -69.13 -49.94 52.42 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.11 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -64.7 -47.55 77.94 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 112.041 0.385 . . . . 0.0 112.041 -176.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -64.88 -34.64 78.87 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 121.033 0.444 . . . . 0.0 110.956 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.809 ' HA ' ' HE2' ' A' ' 106' ' ' LYS . 68.5 m -90.07 1.61 56.16 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.352 174.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 52.1 mttm 53.07 34.39 17.08 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 176.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.616 ' HA ' HH11 ' A' ' 86' ' ' ARG . 49.0 t -64.89 -37.58 80.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 121.566 0.698 . . . . 0.0 109.556 167.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -98.83 51.36 0.97 Allowed 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.51 173.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -64.99 -27.92 69.16 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 116.072 -0.513 . . . . 0.0 112.023 -175.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 138.2 -62.51 0.57 Allowed Glycine 0 CA--C 1.527 0.823 0 C-N-CA 121.046 -0.597 . . . . 0.0 113.497 -178.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.677 ' H ' ' HD2' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -71.19 20.03 0.05 Allowed 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -175.653 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 49.2 m -153.71 -64.58 0.14 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.214 0.531 . . . . 0.0 110.887 176.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.58 HG11 HD22 ' A' ' 82' ' ' LEU . 58.8 t -121.18 151.92 24.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.863 -179.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 71.4 p -118.59 154.32 32.82 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 122.343 0.257 . . . . 0.0 111.121 177.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -52.18 -41.64 54.1 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 121.398 -0.429 . . . . 0.0 113.349 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.412 ' O ' HG12 ' A' ' 57' ' ' ILE . 63.0 m -55.84 -49.31 73.65 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.097 0.475 . . . . 0.0 110.834 176.004 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.4 ' O ' HG23 ' A' ' 58' ' ' VAL . 24.6 t70 -62.01 -37.33 84.47 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.928 178.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 70.0 t -57.34 -36.3 52.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.85 176.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -69.27 -43.91 72.95 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 122.01 0.91 . . . . 0.0 109.583 178.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.412 HG12 ' O ' ' A' ' 53' ' ' THR . 7.9 mm -62.22 -45.53 98.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-N 114.584 -1.189 . . . . 0.0 111.621 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.478 ' O ' HG12 ' A' ' 62' ' ' VAL . 73.9 t -56.91 -47.82 82.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.525 177.051 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.439 ' HB2' ' CD1' ' A' ' 35' ' ' TRP . 80.0 t80 -50.85 -51.05 55.03 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.026 0.441 . . . . 0.0 111.183 177.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 29.2 t -71.01 -29.34 65.26 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.572 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -64.78 -36.95 85.96 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.536 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.508 HG21 ' HB2' ' A' ' 77' ' ' LYS . 3.7 p -94.93 -22.14 5.49 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 178.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -56.45 134.79 54.2 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -67.96 83.49 0.17 Allowed Glycine 0 CA--C 1.532 1.113 0 C-N-CA 121.333 -0.461 . . . . 0.0 113.816 176.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 61.9 mttp 53.13 -90.47 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 175.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 36.5 t -128.22 29.62 5.33 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.983 0.42 . . . . 0.0 111.212 -174.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -73.97 5.76 3.96 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 179.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 44.5 mtp180 68.36 -64.48 0.3 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.531 0.733 . . . . 0.0 112.125 -176.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.537 HG12 ' HA ' ' A' ' 31' ' ' ASN . 24.4 m -117.92 170.04 7.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.134 -172.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.417 ' HB ' ' HB2' ' A' ' 74' ' ' GLU . 39.4 pt -109.75 152.79 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.293 178.073 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -92.36 178.45 5.83 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.045 0.45 . . . . 0.0 111.381 175.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.5 ' O ' ' HB3' ' A' ' 75' ' ' PHE . 75.5 t80 -58.45 -41.87 86.09 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -174.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -70.51 -34.05 71.88 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.993 -0.442 . . . . 0.0 111.384 -178.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.417 ' HB2' ' HB ' ' A' ' 70' ' ' ILE . 52.3 mt-10 -68.9 -34.29 75.18 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.434 0.635 . . . . 0.0 110.012 174.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.5 ' HB3' ' O ' ' A' ' 72' ' ' TYR . 61.1 t80 -58.22 -43.03 87.52 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.823 170.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.481 ' HG3' ' O ' ' A' ' 72' ' ' TYR . 47.0 mtpt -60.03 -37.86 81.02 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.743 0.306 . . . . 0.0 111.021 176.042 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.508 ' HB2' HG21 ' A' ' 62' ' ' VAL . 94.6 mttt -65.0 -38.45 91.01 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.159 0.504 . . . . 0.0 110.89 177.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.98 -39.73 93.91 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.058 176.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 84.2 mt -61.36 -49.78 75.55 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.832 175.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -51.56 -44.39 62.71 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.2 0.524 . . . . 0.0 111.605 175.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -60.53 -63.7 1.21 Allowed 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.511 178.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.58 HD22 HG11 ' A' ' 50' ' ' VAL . 75.1 mt -58.71 -38.18 77.76 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -178.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.4 ' HB1' ' HB1' ' A' ' 95' ' ' ALA . . . -61.78 -47.74 83.8 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.607 0.241 . . . . 0.0 111.546 178.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 50.5 p -65.84 -19.56 65.93 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 178.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -81.28 -38.41 26.89 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 120.774 0.321 . . . . 0.0 111.444 172.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.616 HH11 ' HA ' ' A' ' 44' ' ' VAL . 36.7 mtp180 -79.28 -58.73 3.07 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -98.3 -164.46 1.14 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.393 -173.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -62.71 119.58 9.56 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -178.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -72.34 61.56 1.47 Allowed Glycine 0 CA--C 1.528 0.901 0 C-N-CA 120.902 -0.666 . . . . 0.0 111.555 171.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -163.29 -50.68 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.93 0.395 . . . . 0.0 111.099 -169.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 48.4 t -94.45 120.95 35.47 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.611 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -75.82 -60.77 2.17 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -178.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -61.76 -36.74 81.9 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -174.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -62.21 -60.15 3.99 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.088 0.471 . . . . 0.0 111.428 177.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.4 ' HB1' ' HB1' ' A' ' 83' ' ' ALA . . . -58.07 -42.39 85.43 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.913 -178.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -70.52 -40.37 73.52 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.412 -177.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -62.79 -53.52 53.04 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.125 0.488 . . . . 0.0 110.354 177.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -55.94 -52.54 63.77 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.644 -178.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 14.4 tt -60.92 -39.84 83.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 O-C-N 122.115 -0.366 . . . . 0.0 111.23 -179.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 95.9 m -70.56 -30.24 66.91 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.829 0.347 . . . . 0.0 111.042 176.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -64.42 -30.27 71.31 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.231 0.539 . . . . 0.0 110.762 178.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 82.8 mt -77.82 -18.42 56.35 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 177.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.464 HG13 ' SG ' ' A' ' 42' ' ' CYS . 41.3 t -114.56 -54.54 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -172.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.533 ' HA ' ' HB2' ' A' ' 13' ' ' SER . . . -52.12 112.08 0.73 Allowed 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -172.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 81.98 -2.99 82.24 Favored Glycine 0 CA--C 1.527 0.814 0 CA-C-N 115.908 -0.587 . . . . 0.0 114.463 173.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.809 ' HE2' ' HA ' ' A' ' 42' ' ' CYS . 22.1 ttpp -70.64 -28.05 64.52 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 117.602 0.701 . . . . 0.0 112.22 -178.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.521 ' HG2' ' O ' ' A' ' 106' ' ' LYS . 1.5 pt-20 72.7 155.46 0.16 Allowed Pre-proline 0 N--CA 1.481 1.079 0 C-N-CA 124.049 0.94 . . . . 0.0 111.904 -178.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -73.08 113.04 3.67 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 122.808 2.338 . . . . 0.0 111.628 174.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.403 ' O ' ' HB3' ' A' ' 110' ' ' ASN . . . -172.29 -28.93 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -174.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.403 ' HB3' ' O ' ' A' ' 109' ' ' ALA . 8.2 t30 65.37 173.51 0.22 Allowed 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 -169.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.403 HG13 ' O ' ' A' ' 111' ' ' VAL . 6.1 p -59.24 88.1 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 CA-C-O 121.793 0.806 . . . . 0.0 112.436 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -92.37 -33.05 7.82 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.607 174.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.425 ' O ' ' N ' ' A' ' 115' ' ' LYS . 60.9 t -74.29 136.42 25.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 122.287 0.235 . . . . 0.0 111.586 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.404 HG23 ' N ' ' A' ' 115' ' ' LYS . 12.9 t 53.7 -60.12 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 125.403 1.481 . . . . 0.0 114.602 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.425 ' N ' ' O ' ' A' ' 113' ' ' VAL . 88.4 tttt 73.48 -24.87 0.2 Allowed 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.309 0.644 . . . . 0.0 112.556 177.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.36 -23.91 58.3 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -178.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 51.6 pttt -72.92 81.61 1.19 Allowed 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 121.5 0.667 . . . . 0.0 111.645 178.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 66.8 p -115.18 173.87 6.28 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.805 -178.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 103.63 -59.93 0.48 Allowed Glycine 0 CA--C 1.526 0.728 0 C-N-CA 121.219 -0.515 . . . . 0.0 112.83 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 84.47 31.67 24.24 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 121.173 -0.537 . . . . 0.0 112.979 179.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -80.78 107.43 13.59 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 121.019 0.438 . . . . 0.0 111.487 -179.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.6 p -120.28 106.41 18.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-O 121.263 0.554 . . . . 0.0 111.873 -179.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -91.81 141.58 28.52 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.061 176.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -113.23 101.74 9.7 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.924 0.392 . . . . 0.0 111.378 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 83.5 mt -98.29 11.19 38.74 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.05 0.452 . . . . 0.0 111.076 176.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 28.5 m -64.62 101.15 0.43 Allowed 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.375 178.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -52.74 142.21 19.27 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-O 120.82 0.343 . . . . 0.0 110.418 173.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 11.7 t -137.81 9.29 2.83 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -176.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 77.7 p -70.15 -65.82 0.68 Allowed 'General case' 0 N--CA 1.473 0.701 0 O-C-N 122.141 -0.349 . . . . 0.0 111.064 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 31.4 ttm180 71.96 -51.69 0.7 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.74 0.816 . . . . 0.0 113.14 177.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 59.62 -159.3 0.3 Allowed 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 120.766 0.317 . . . . 0.0 110.398 -170.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 11.5 m -113.9 -17.93 11.9 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 121.914 -0.491 . . . . 0.0 111.014 173.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -85.28 -150.04 12.56 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 121.34 -0.457 . . . . 0.0 113.645 -179.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 19.5 m -94.86 143.56 26.36 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.012 0.434 . . . . 0.0 111.72 -176.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -121.76 123.43 41.8 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.883 178.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.539 ' NZ ' ' HB2' ' A' ' 136' ' ' LYS . 3.2 ttmp? -63.45 123.18 18.09 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.013 0.435 . . . . 0.0 111.973 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -78.44 105.21 9.54 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.733 175.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 138' ' ' ARG . 36.2 ttp-105 -116.8 7.06 13.28 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 120.941 0.4 . . . . 0.0 111.445 -177.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -107.77 -177.73 3.42 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 120.901 0.382 . . . . 0.0 111.789 -178.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -124.95 149.28 47.82 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.996 179.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -149.38 67.76 1.02 Allowed 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.516 0.674 . . . . 0.0 110.656 178.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 63.2 m -81.32 64.01 5.88 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.234 -175.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 63.89 -84.29 0.05 OUTLIER Glycine 0 CA--C 1.527 0.829 0 CA-C-N 116.27 -0.423 . . . . 0.0 113.542 179.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 4.9 ttmp? -163.62 78.43 0.41 Allowed 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 120.844 0.354 . . . . 0.0 111.731 -179.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 73.89 -65.32 1.86 Allowed Glycine 0 CA--C 1.534 1.24 0 N-CA-C 114.942 0.737 . . . . 0.0 114.942 171.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -54.29 -25.68 24.99 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -173.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 85.39 136.88 3.96 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.628 -177.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 11.5 tt -123.56 135.38 63.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-O 121.139 0.495 . . . . 0.0 112.04 -176.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -124.29 -10.63 7.51 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.491 175.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -169.33 167.94 40.87 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-N 116.335 -0.393 . . . . 0.0 112.475 179.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 28.3 ptt180 -88.88 84.88 6.65 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.536 0.684 . . . . 0.0 111.808 -178.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -90.63 -13.17 34.86 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.497 178.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -70.61 2.12 4.43 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -173.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 11.0 tt -68.08 98.24 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 CA-C-O 121.589 0.709 . . . . 0.0 111.794 -179.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 155' ' ' LEU . 31.1 tp -117.01 25.54 10.43 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-O 121.118 0.485 . . . . 0.0 111.097 -178.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 34.1 t0 53.97 32.2 14.93 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.838 0.828 . . . . 0.0 110.981 -176.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -76.66 36.99 0.17 Allowed 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.561 177.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 60.1 p -76.56 88.97 3.28 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.455 0.645 . . . . 0.0 111.29 -177.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -80.78 -45.46 7.76 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 114.335 0.494 . . . . 0.0 114.335 -174.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -76.52 11.42 1.63 Allowed 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -173.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 87.4 t -63.12 134.64 28.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-O 121.049 0.452 . . . . 0.0 111.891 179.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 48.8 p -71.86 82.83 0.92 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.234 0.54 . . . . 0.0 111.495 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -90.97 16.28 9.84 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -178.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 57.27 52.48 8.78 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -62.22 111.7 2.08 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.088 0.47 . . . . 0.0 110.973 177.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . 0.583 ' ND2' ' HB3' ' A' ' 170' ' ' TYR . 54.8 t30 65.8 19.3 11.33 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.646 -177.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 64.26 25.52 13.57 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 174.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 137.27 -102.98 0.4 Allowed Glycine 0 CA--C 1.526 0.735 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.942 178.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 66.8 p -121.72 -76.66 0.58 Allowed 'General case' 0 N--CA 1.473 0.689 0 O-C-N 122.502 -0.411 . . . . 0.0 110.864 176.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . 0.583 ' HB3' ' ND2' ' A' ' 166' ' ' ASN . 50.3 t80 67.2 -58.35 0.41 Allowed 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.75 0.82 . . . . 0.0 112.459 -179.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -52.68 116.66 2.42 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 176.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -75.7 119.03 19.16 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.776 0.322 . . . . 0.0 110.646 175.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -68.23 -17.0 64.19 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 -172.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.456 HG13 ' N ' ' A' ' 175' ' ' LYS . 7.3 p -156.13 -55.45 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 175.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.577 ' HD3' ' HA ' ' A' ' 178' ' ' GLU . 57.7 tttm -178.47 137.9 0.17 Allowed 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 122.32 0.248 . . . . 0.0 111.039 -176.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.438 ' NZ ' ' HB3' ' A' ' 176' ' ' LYS . 7.7 mtpm? -59.05 -42.4 90.21 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 120.976 0.417 . . . . 0.0 111.598 -179.24 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 63.2 tp -138.35 105.38 5.43 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.41 174.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.577 ' HA ' ' HD3' ' A' ' 175' ' ' LYS . 1.2 tm-20 . . . . . 0 CA--C 1.539 0.547 0 CA-C-O 121.41 0.624 . . . . 0.0 111.851 -175.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.611 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.486 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.06 76.1 8.96 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.967 0.413 . . . . 0.0 110.922 178.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 57.74 69.74 0.71 Allowed 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.866 -176.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.4 ' O ' HG22 ' A' ' 5' ' ' THR . 68.4 m -81.91 43.16 0.75 Allowed 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 -176.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.4 HG22 ' O ' ' A' ' 4' ' ' SER . 5.4 t 48.35 -166.09 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 175.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -71.63 175.95 5.21 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -177.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.2 tp -100.1 118.12 46.29 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 CA-C-O 121.225 0.535 . . . . 0.0 111.255 177.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -49.22 -41.46 37.36 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -175.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.84 -36.59 80.64 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 121.03 -0.605 . . . . 0.0 113.51 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.589 HD13 ' HB2' ' A' ' 104' ' ' ALA . 24.7 tp -78.24 -39.99 38.59 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 122.46 -0.435 . . . . 0.0 110.868 -179.37 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.584 ' HB3' ' NH2' ' A' ' 15' ' ' ARG . 45.3 mt-10 -55.77 -42.26 75.22 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.428 0.632 . . . . 0.0 110.657 173.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.481 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 8.7 tp10 -57.13 -55.57 33.08 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.389 177.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.429 ' HB3' ' O ' ' A' ' 108' ' ' PRO . 75.0 m -47.06 -51.23 18.06 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.324 174.132 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.413 ' N ' ' HB3' ' A' ' 109' ' ' ALA . 62.4 t80 -51.32 -46.35 62.56 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.696 -0.627 . . . . 0.0 111.196 -178.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.584 ' NH2' ' HB3' ' A' ' 11' ' ' GLU . 0.5 OUTLIER -70.02 -46.15 65.69 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 111.849 0.315 . . . . 0.0 111.849 177.838 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.524 ' O ' ' HB2' ' A' ' 20' ' ' HIS . 75.8 mmtt -53.99 -42.78 69.41 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.164 0.507 . . . . 0.0 110.854 178.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.624 ' CD1' ' HA ' ' A' ' 108' ' ' PRO . 0.2 OUTLIER -73.58 -34.39 65.09 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.859 -177.114 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.672 ' HA ' ' SD ' ' A' ' 30' ' ' MET . . . -66.98 -58.13 5.54 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.155 0.502 . . . . 0.0 112.048 -177.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 30.7 pt -80.49 -0.09 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 121.432 0.634 . . . . 0.0 111.052 -178.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.524 ' HB2' ' O ' ' A' ' 16' ' ' LYS . 37.2 t-80 -52.16 -45.59 65.11 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.316 -0.856 . . . . 0.0 112.289 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -112.14 10.03 26.94 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.771 -0.728 . . . . 0.0 114.516 -173.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -157.23 127.31 3.34 Favored Pre-proline 0 CA--C 1.545 0.78 0 CA-C-N 117.628 0.714 . . . . 0.0 111.438 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.54 -26.65 13.8 Favored 'Trans proline' 0 CA--C 1.544 0.992 0 C-N-CA 122.754 2.303 . . . . 0.0 113.611 -178.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -96.3 0.98 51.59 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -176.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.73 134.25 51.37 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 120.832 0.349 . . . . 0.0 111.846 178.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.4 t -57.43 -34.46 68.96 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.474 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.72 15.1 76.45 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 121.246 -0.502 . . . . 0.0 113.126 177.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -124.85 -26.15 3.81 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.199 0.523 . . . . 0.0 110.987 178.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -122.81 128.25 50.19 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.694 -178.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.672 ' SD ' ' HA ' ' A' ' 18' ' ' ALA . 10.9 tpp -114.08 152.29 31.28 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -176.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.522 ' ND2' ' HB2' ' A' ' 33' ' ' LYS . 13.7 p-10 -97.27 164.4 12.49 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -179.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.75 -29.03 69.15 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-N 116.069 -0.514 . . . . 0.0 113.959 -179.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.522 ' HB2' ' ND2' ' A' ' 31' ' ' ASN . 5.2 mmmm -51.75 -45.05 63.54 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 175.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.516 ' ND2' ' SD ' ' A' ' 30' ' ' MET . 4.5 m-20 -72.94 -25.71 61.13 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.777 -179.158 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.413 ' CE3' ' O ' ' A' ' 110' ' ' ASN . 40.0 t-105 -66.88 -45.0 79.42 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.042 0.448 . . . . 0.0 111.0 175.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.2 -47.76 84.65 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.233 0.539 . . . . 0.0 110.945 175.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -63.83 -32.79 74.42 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.689 177.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.597 HD11 ' HA ' ' A' ' 109' ' ' ALA . 2.6 tt -58.16 -55.22 37.82 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.221 0.534 . . . . 0.0 110.263 179.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.58 ' SG ' ' HB2' ' A' ' 45' ' ' ALA . 45.9 t -58.86 -43.95 90.95 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.529 -179.417 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 28.9 ttpp -66.78 -41.51 87.53 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 120.878 0.37 . . . . 0.0 111.562 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -63.0 -48.59 78.17 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.274 0.559 . . . . 0.0 110.822 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.44 ' SG ' HG22 ' A' ' 103' ' ' VAL . 83.9 m -82.32 -3.28 55.04 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.675 179.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt 59.92 28.3 17.78 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.199 0.523 . . . . 0.0 112.02 175.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 47.9 t -67.36 -33.35 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.695 174.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.58 ' HB2' ' SG ' ' A' ' 39' ' ' CYS . . . -61.95 86.77 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.395 0.616 . . . . 0.0 111.079 175.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -63.69 -47.45 81.12 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.473 -178.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 125.13 -33.51 3.65 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 121.126 -0.559 . . . . 0.0 113.186 -178.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.5 pttt -129.32 -28.64 2.31 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 177.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 90.9 p -88.55 -39.82 13.86 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 121.055 0.455 . . . . 0.0 110.377 171.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 91.2 t -132.99 116.62 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.776 174.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 27.1 p -111.8 175.72 5.31 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.874 0.369 . . . . 0.0 111.088 178.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -58.92 -29.11 64.41 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.105 172.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.64 ' O ' HG13 ' A' ' 57' ' ' ILE . 44.3 m -61.51 -57.72 11.0 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 110.318 -0.253 . . . . 0.0 110.318 174.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -48.61 -42.51 34.26 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.96 0.41 . . . . 0.0 111.618 178.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 95.5 t -56.35 -45.71 81.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.625 177.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -71.79 -32.76 67.96 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 120.837 0.351 . . . . 0.0 111.275 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.64 HG13 ' O ' ' A' ' 53' ' ' THR . 9.3 mt -66.23 -54.44 26.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.721 178.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.442 HG11 ' CD1' ' A' ' 82' ' ' LEU . 93.9 t -54.2 -47.37 67.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 120.805 0.336 . . . . 0.0 111.68 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.513 ' O ' ' HG2' ' A' ' 63' ' ' LYS . 55.2 t80 -56.99 -38.28 72.83 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 120.803 0.335 . . . . 0.0 110.638 178.277 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 37.5 m -81.33 -18.78 44.51 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 178.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.435 ' HG2' ' O ' ' A' ' 57' ' ' ILE . 32.4 mmtp -73.26 -43.88 60.34 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 179.05 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.51 HG11 ' HB2' ' A' ' 78' ' ' ALA . 7.1 m -70.03 -45.0 77.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.513 ' HG2' ' O ' ' A' ' 59' ' ' PHE . 22.2 ptmt -81.2 166.34 20.69 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.369 0.604 . . . . 0.0 112.509 -176.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -104.18 -94.36 2.32 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.165 174.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -131.84 -57.56 0.98 Allowed 'General case' 0 N--CA 1.473 0.706 0 O-C-N 122.426 -0.455 . . . . 0.0 111.832 176.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 37.8 m -77.45 65.27 2.96 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -176.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -160.79 111.86 1.82 Allowed 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.977 0.418 . . . . 0.0 111.676 179.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.86 -26.9 17.44 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.794 0.33 . . . . 0.0 110.822 175.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.696 HG23 HG21 ' A' ' 114' ' ' THR . 26.0 m -120.57 174.07 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 121.102 0.477 . . . . 0.0 111.955 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.821 HD11 ' HB2' ' A' ' 110' ' ' ASN . 2.9 pp -135.39 165.76 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -172.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.6 ' OD1' ' HB2' ' A' ' 74' ' ' GLU . 24.7 p-10 -111.79 -179.82 3.81 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.231 -178.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.622 ' O ' ' HB3' ' A' ' 75' ' ' PHE . 65.9 t80 -85.84 -46.18 10.87 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -176.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -62.05 -31.5 71.92 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.462 -0.774 . . . . 0.0 111.472 -175.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.6 ' HB2' ' OD1' ' A' ' 71' ' ' ASN . 0.4 OUTLIER -73.12 -36.27 66.68 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.751 -0.204 . . . . 0.0 111.134 171.822 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.739 ' HD1' HG12 ' A' ' 111' ' ' VAL . 41.7 t80 -46.09 -41.95 12.95 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 172.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -57.84 -41.74 82.95 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 121.238 0.542 . . . . 0.0 111.658 174.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -72.09 -43.6 64.54 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 121.13 0.49 . . . . 0.0 111.082 -179.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.697 ' HB3' HG13 ' A' ' 111' ' ' VAL . . . -60.92 -44.61 96.96 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.843 177.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.468 HD11 ' CZ ' ' A' ' 75' ' ' PHE . 34.1 mt -52.32 -46.0 65.83 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 122.079 -0.388 . . . . 0.0 111.61 172.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -54.15 -38.25 65.3 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 121.094 0.473 . . . . 0.0 110.94 177.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.439 ' HB3' ' O ' ' A' ' 78' ' ' ALA . 16.6 tp10 -59.47 -51.23 70.76 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.995 174.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.442 ' CD1' HG11 ' A' ' 58' ' ' VAL . 8.8 mp -60.63 -47.62 85.42 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 111.841 0.312 . . . . 0.0 111.841 178.386 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.36 -46.28 69.51 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.851 0.358 . . . . 0.0 111.867 -178.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 69.2 p -67.55 -34.59 77.37 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.19 -0.459 . . . . 0.0 112.115 179.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.452 ' HB3' ' HZ2' ' A' ' 85' ' ' LYS . 8.3 mtpm? -80.11 -28.55 38.98 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 179.177 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -85.85 -55.26 4.05 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.07 0.462 . . . . 0.0 110.73 -176.319 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -96.75 50.52 1.12 Allowed 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.45 -177.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -59.64 99.82 0.07 Allowed 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.304 0.573 . . . . 0.0 111.483 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 136.14 -30.61 2.71 Favored Glycine 0 CA--C 1.521 0.43 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.774 -176.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -86.01 144.04 27.8 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 122.796 0.439 . . . . 0.0 110.585 176.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 43.6 t -59.07 134.78 57.29 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 122.412 -0.18 . . . . 0.0 111.345 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -52.2 -36.69 52.75 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -174.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -66.03 -51.61 56.7 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 120.869 0.366 . . . . 0.0 111.242 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -64.39 -37.21 86.71 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 121.072 0.463 . . . . 0.0 111.366 176.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.69 -43.97 91.81 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.994 0.425 . . . . 0.0 111.561 178.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -62.81 -39.28 93.81 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.114 0.483 . . . . 0.0 110.758 177.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -60.16 -51.62 68.81 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.534 176.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.82 -51.87 67.46 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.247 -178.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.3 tt -58.73 -42.97 86.74 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 CA-C-O 120.808 0.337 . . . . 0.0 111.119 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 74.7 m -68.96 -28.72 66.88 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.727 0.299 . . . . 0.0 111.267 177.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -64.41 -33.0 74.85 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.07 0.462 . . . . 0.0 110.989 178.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 81.0 mt -77.12 -20.41 55.67 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 116.176 -0.465 . . . . 0.0 112.062 178.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.44 HG22 ' SG ' ' A' ' 42' ' ' CYS . 60.2 t -105.91 -61.5 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -173.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.589 ' HB2' HD13 ' A' ' 10' ' ' LEU . . . -57.73 147.9 26.46 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -175.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 98.01 -35.9 4.28 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 121.157 -0.544 . . . . 0.0 113.265 177.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -79.04 -77.33 0.17 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 117.029 0.414 . . . . 0.0 111.525 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.524 ' CG ' ' HD3' ' A' ' 108' ' ' PRO . 11.1 pt-20 -176.29 -33.65 0.0 OUTLIER Pre-proline 0 CA--C 1.553 1.088 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 -179.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.624 ' HA ' ' CD1' ' A' ' 17' ' ' PHE . 50.6 Cg_exo -68.08 142.77 57.29 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 122.553 2.169 . . . . 0.0 115.646 176.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.597 ' HA ' HD11 ' A' ' 38' ' ' LEU . . . 168.35 115.52 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 115.054 -0.975 . . . . 0.0 112.107 179.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.821 ' HB2' HD11 ' A' ' 70' ' ' ILE . 7.9 p30 170.06 127.93 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 177.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.739 HG12 ' HD1' ' A' ' 75' ' ' PHE . 4.3 p 170.27 135.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 C-N-CA 123.926 0.891 . . . . 0.0 110.73 166.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.498 ' H ' HG21 ' A' ' 70' ' ' ILE . . . 164.66 -130.98 2.29 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 119.739 -1.219 . . . . 0.0 115.261 -176.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.489 HG12 ' N ' ' A' ' 114' ' ' THR . 11.8 t -137.77 165.01 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 O-C-N 122.564 -0.374 . . . . 0.0 111.638 -175.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.696 HG21 HG23 ' A' ' 69' ' ' VAL . 12.3 p -140.27 87.14 2.12 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 121.118 0.485 . . . . 0.0 111.92 173.011 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -148.37 -60.96 0.25 Allowed 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.873 175.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.474 ' O ' ' HB2' ' A' ' 117' ' ' LYS . . . 59.08 -161.55 0.26 Allowed 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 173.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.474 ' HB2' ' O ' ' A' ' 116' ' ' ALA . 34.1 mtmm 89.39 59.29 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.915 1.286 . . . . 0.0 112.364 -177.325 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 34.1 m 61.66 -75.58 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 173.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 177.43 -50.13 0.1 Allowed Glycine 0 CA--C 1.525 0.705 0 C-N-CA 121.026 -0.607 . . . . 0.0 113.245 -176.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -78.4 47.45 2.96 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 121.266 -0.492 . . . . 0.0 112.994 177.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.474 ' HB1' ' HE2' ' A' ' 117' ' ' LYS . . . -89.86 96.34 10.64 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 122.541 -0.388 . . . . 0.0 111.725 -177.119 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 35.1 m -91.11 -2.56 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-O 120.726 0.298 . . . . 0.0 111.296 175.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 62.87 -176.65 0.14 Allowed 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.876 -178.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -96.06 -82.04 0.4 Allowed 'General case' 0 CA--C 1.539 0.522 0 O-C-N 122.09 -0.381 . . . . 0.0 111.909 -176.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 5.1 tt -178.7 -77.73 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 120.846 0.355 . . . . 0.0 110.503 -176.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 52.4 m -95.22 -14.09 24.36 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 120.922 0.392 . . . . 0.0 111.551 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 66.72 170.55 0.25 Allowed 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.753 0.787 . . . . 0.0 112.628 -178.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 81.7 p -127.88 175.13 8.59 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.367 176.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 63.1 m -59.81 126.85 29.18 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.717 0.294 . . . . 0.0 110.696 175.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 33.4 mmt180 -61.27 -17.12 51.88 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -176.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -52.94 -25.41 11.78 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.166 0.586 . . . . 0.0 111.571 174.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 8.5 t -121.57 30.32 6.78 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.301 0.572 . . . . 0.0 111.333 178.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -70.63 -0.47 32.18 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 121.281 -0.485 . . . . 0.0 114.125 -178.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.462 ' O ' ' HG3' ' A' ' 136' ' ' LYS . 40.6 t 63.7 -86.53 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 179.054 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 52.9 t-80 63.5 1.31 0.98 Allowed 'General case' 0 CA--C 1.549 0.932 0 CA-C-O 120.957 0.408 . . . . 0.0 111.809 -175.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.462 ' HG3' ' O ' ' A' ' 134' ' ' SER . 54.7 mtpt -87.43 12.9 11.05 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -172.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -118.15 88.75 2.98 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.959 0.409 . . . . 0.0 111.77 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 57.2 ttp180 -88.37 107.41 18.83 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.906 0.384 . . . . 0.0 110.781 176.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -73.24 118.98 16.85 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.043 0.449 . . . . 0.0 111.322 -179.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -68.66 89.07 0.37 Allowed 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.562 0.696 . . . . 0.0 110.806 175.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -60.13 -46.43 89.67 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.516 -178.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 55.6 m 65.88 -74.77 0.06 Allowed 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.24 178.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -67.31 96.83 0.35 Allowed Glycine 0 CA--C 1.528 0.864 0 C-N-CA 121.33 -0.462 . . . . 0.0 113.704 -178.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -121.57 145.8 47.61 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.794 0.331 . . . . 0.0 111.177 175.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -78.05 111.65 3.3 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 121.266 -0.492 . . . . 0.0 113.861 -175.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 10.0 mtmp? -81.65 30.42 0.36 Allowed 'General case' 0 N--CA 1.473 0.723 0 O-C-N 122.377 -0.484 . . . . 0.0 111.46 177.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 75.28 56.06 4.88 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.886 -176.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 8.8 tt -49.99 -44.01 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-O 121.109 0.48 . . . . 0.0 111.97 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -172.27 -74.93 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.013 178.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -159.33 49.97 0.4 Allowed Glycine 0 CA--C 1.521 0.411 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 175.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 20.7 mtt180 60.68 -156.38 0.35 Allowed 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -171.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 86.3 mm-40 -72.53 115.73 12.15 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 167.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -49.58 107.75 0.16 Allowed 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -171.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 61.3 mt -68.27 130.44 33.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.319 178.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.405 ' N ' HD12 ' A' ' 155' ' ' LEU . 6.9 mp -85.21 84.72 7.59 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.145 177.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -51.5 139.87 19.18 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.916 -179.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -61.34 -41.54 97.21 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.449 0.642 . . . . 0.0 110.62 175.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 48.1 t -141.96 109.68 5.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.963 171.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -76.06 63.82 2.8 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 121.177 -0.535 . . . . 0.0 113.56 -177.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 50.9 t80 64.05 10.05 5.1 Favored 'General case' 0 CA--C 1.551 0.992 0 CA-C-O 121.199 0.523 . . . . 0.0 112.399 176.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 26.9 m -88.59 -33.38 6.34 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -176.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.465 ' O ' ' NZ ' ' A' ' 175' ' ' LYS . 66.2 m -77.06 104.71 7.71 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 121.991 -0.443 . . . . 0.0 112.145 -176.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 60.36 98.45 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 176.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -78.57 -63.51 1.39 Allowed 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.519 0.676 . . . . 0.0 110.322 174.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -89.68 94.5 9.87 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.203 175.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -68.22 116.03 8.35 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.014 0.435 . . . . 0.0 111.782 -178.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -88.65 -16.95 31.1 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.874 178.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -76.65 65.85 2.79 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 121.312 -0.471 . . . . 0.0 113.444 -178.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 40.4 m -65.99 -52.91 45.21 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.118 0.485 . . . . 0.0 111.975 -176.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -111.55 10.67 21.24 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.289 0.566 . . . . 0.0 111.065 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -89.53 23.09 2.72 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.053 -176.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . 69.82 -6.58 1.03 Allowed 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -82.05 76.35 8.94 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.579 0.704 . . . . 0.0 109.519 176.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 34.4 m -78.12 29.09 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -168.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.465 ' NZ ' ' O ' ' A' ' 162' ' ' SER . 87.4 tttt -73.2 95.12 2.06 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.942 -0.473 . . . . 0.0 110.798 176.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 47.3 mttp -97.77 95.67 7.71 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.683 0.278 . . . . 0.0 110.674 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 42.9 tp -74.09 87.11 1.88 Allowed 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.484 0.659 . . . . 0.0 111.743 -177.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 . . . . . 0 N--CA 1.467 0.419 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.607 175.588 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.5 mtt . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 120.484 0.183 . . . . 0.0 110.799 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.63 116.53 6.3 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 169.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 64.25 -168.89 0.2 Allowed 'General case' 0 CA--C 1.542 0.643 0 O-C-N 123.212 0.32 . . . . 0.0 110.954 -171.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 66.5 m -67.42 161.74 24.61 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.08 0.467 . . . . 0.0 111.436 178.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.5 t -68.08 178.76 1.73 Allowed 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.624 177.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -39.98 -69.44 0.13 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.207 0.603 . . . . 0.0 112.306 178.064 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.553 HD11 ' HB3' ' A' ' 100' ' ' CYS . 30.3 pt -143.28 128.31 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-O 121.226 0.536 . . . . 0.0 111.681 174.022 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.77 -31.92 70.12 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.909 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.8 -31.76 64.81 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 121.215 -0.517 . . . . 0.0 113.028 177.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 36.8 tp -70.89 -43.77 67.67 Favored 'General case' 0 N--CA 1.467 0.383 0 O-C-N 122.73 -0.277 . . . . 0.0 110.773 178.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.2 tm-20 -57.78 -46.87 83.99 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.273 175.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.419 ' O ' ' HB2' ' A' ' 16' ' ' LYS . 33.5 tt0 -57.24 -49.61 75.5 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.575 177.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 56.9 m -63.36 -50.02 71.57 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -178.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -54.88 -48.53 72.85 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.216 0.531 . . . . 0.0 110.558 176.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.484 ' HG3' ' HA3' ' A' ' 27' ' ' GLY . 23.2 ttt180 -63.7 -37.95 89.27 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.084 178.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.419 ' HB2' ' O ' ' A' ' 12' ' ' GLU . 32.6 ttmt -59.32 -42.12 90.65 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.041 -178.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -79.9 -32.2 40.25 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 174.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.52 -34.35 75.38 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -178.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 27.9 pt -95.7 14.22 3.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-O 120.98 0.419 . . . . 0.0 111.685 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 75.1 t60 -64.75 -16.81 63.49 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -176.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -105.35 -38.57 2.42 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 120.959 -0.639 . . . . 0.0 113.396 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -162.18 148.98 11.05 Favored Pre-proline 0 CA--C 1.541 0.618 0 O-C-N 122.688 -0.301 . . . . 0.0 111.652 -175.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.12 -2.9 12.74 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.651 2.234 . . . . 0.0 113.401 -178.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -85.97 -18.74 31.78 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.068 0.461 . . . . 0.0 110.862 178.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -76.54 54.19 0.92 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.353 170.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 38.0 t -25.58 -53.43 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 -170.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.484 ' HA3' ' HG3' ' A' ' 15' ' ' ARG . . . 147.95 58.93 0.01 OUTLIER Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.629 -179.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -134.95 -19.17 1.79 Allowed 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 120.751 0.31 . . . . 0.0 111.5 -178.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -152.72 151.87 31.03 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -171.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.441 ' O ' HD13 ' A' ' 70' ' ' ILE . 42.8 ttm -136.58 149.63 48.16 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.61 -179.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -97.36 168.35 10.46 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.119 0.485 . . . . 0.0 111.948 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.08 -32.77 81.56 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-N 116.185 -0.461 . . . . 0.0 114.181 -177.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -62.51 -52.26 64.16 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 117.053 0.426 . . . . 0.0 111.732 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -69.13 -40.3 78.35 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.594 0.235 . . . . 0.0 110.999 177.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.498 ' NE1' ' HB2' ' A' ' 59' ' ' PHE . 24.9 t-105 -56.36 -42.27 77.52 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.113 0.482 . . . . 0.0 111.747 175.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.07 -51.93 65.97 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.572 179.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -69.32 -27.41 65.35 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.19 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.0 tt -57.38 -56.91 15.77 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.058 0.456 . . . . 0.0 110.198 176.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 86.3 m -60.49 -47.83 84.4 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.997 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -67.48 -41.71 84.15 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -176.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.407 ' OD2' ' NZ ' ' A' ' 106' ' ' LYS . 37.5 t70 -77.51 -29.96 52.7 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 120.741 0.305 . . . . 0.0 111.623 -178.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 62.2 m -90.7 -0.44 57.7 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 120.697 0.284 . . . . 0.0 111.429 176.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt 71.47 22.06 4.31 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 173.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 50.7 t -68.02 -28.45 41.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 CA-C-O 121.144 0.497 . . . . 0.0 110.99 174.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -89.65 121.03 31.45 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.254 174.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -79.48 -66.19 0.9 Allowed 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -173.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.432 ' O ' ' HB2' ' A' ' 48' ' ' LYS . . . 130.34 119.46 2.13 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 -168.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.432 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 75.2 mmtt 80.74 -15.94 0.7 Allowed 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.646 0.779 . . . . 0.0 111.936 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 42.4 t -122.03 -83.23 0.66 Allowed 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 173.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 84.1 t -87.56 111.7 22.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 120.894 0.378 . . . . 0.0 110.617 172.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.442 ' O ' HG23 ' A' ' 55' ' ' VAL . 72.8 p -125.58 -179.93 4.86 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.935 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -50.78 -35.44 31.11 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 121.031 -0.604 . . . . 0.0 113.195 178.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.578 ' O ' HG13 ' A' ' 57' ' ' ILE . 27.6 m -60.8 -58.41 8.57 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.738 0.304 . . . . 0.0 110.797 176.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -53.34 -41.45 65.78 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.976 179.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 51' ' ' THR . 93.6 t -56.91 -39.51 65.67 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.74 177.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -73.82 -37.84 64.75 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.292 0.568 . . . . 0.0 110.4 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.578 HG13 ' O ' ' A' ' 53' ' ' THR . 11.4 mt -60.33 -48.42 88.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.943 178.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 89.7 t -62.48 -43.69 98.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.64 177.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.498 ' HB2' ' NE1' ' A' ' 35' ' ' TRP . 86.7 t80 -50.23 -47.66 54.9 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.109 0.481 . . . . 0.0 111.938 178.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 35.8 t -82.04 -16.7 49.29 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.06 0.457 . . . . 0.0 111.614 -179.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -76.09 -38.22 57.24 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.95 -179.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.1 m -87.07 -5.92 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -176.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.6 pttp -119.88 -176.92 3.28 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.09 0.472 . . . . 0.0 111.692 -178.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -105.1 -178.03 24.36 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-N 116.291 -0.413 . . . . 0.0 113.424 177.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -75.49 -39.79 58.1 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -178.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 43.4 t -66.47 -35.95 81.54 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 120.917 0.389 . . . . 0.0 111.868 -178.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -93.4 122.44 35.82 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 120.967 0.413 . . . . 0.0 111.327 178.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 70.7 mtp180 -94.25 5.64 51.14 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.112 0.482 . . . . 0.0 110.683 175.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.9 m -129.63 159.91 41.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.921 179.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.502 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -114.4 150.7 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-O 120.967 0.413 . . . . 0.0 111.297 175.946 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.413 ' OD1' ' N ' ' A' ' 71' ' ' ASN . 2.9 p-10 -104.78 172.25 6.89 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.296 178.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -46.49 -54.18 9.78 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -169.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.403 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 0.7 OUTLIER -64.46 -44.86 89.76 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 120.983 0.421 . . . . 0.0 111.347 -176.035 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -65.71 -33.96 77.1 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.203 0.525 . . . . 0.0 110.838 179.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -57.62 -44.09 85.25 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.6 172.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.403 ' HE2' ' HA ' ' A' ' 73' ' ' GLU . 52.8 mtmt -69.08 -33.7 73.94 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.231 176.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -60.54 -37.92 82.79 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.251 0.548 . . . . 0.0 110.292 173.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.08 -41.91 97.15 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.745 172.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 88.6 mt -62.31 -33.7 75.19 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.398 175.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -61.07 -49.64 76.52 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 120.735 0.302 . . . . 0.0 110.833 175.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -55.56 -58.01 9.54 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.111 0.482 . . . . 0.0 111.085 174.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 94.0 mt -56.71 -44.46 81.6 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.036 -179.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.69 -45.2 87.64 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -179.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 81.8 p -72.44 -12.29 61.04 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -178.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -93.72 -47.45 6.78 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 120.685 0.279 . . . . 0.0 111.502 172.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 76.7 mtp180 -70.63 -49.87 42.88 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 121.176 0.512 . . . . 0.0 111.85 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -106.55 38.59 2.02 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.881 -177.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -57.87 90.97 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.97 -178.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -160.8 44.81 0.41 Allowed Glycine 0 CA--C 1.526 0.772 0 C-N-CA 121.076 -0.583 . . . . 0.0 113.446 179.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 60.9 mttm 70.71 -60.68 0.5 Allowed 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 177.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 25.6 m -56.78 87.91 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -175.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -66.36 -43.48 85.88 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.703 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -54.03 -61.07 2.54 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.836 0.35 . . . . 0.0 110.886 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -56.72 -41.6 77.74 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.691 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.24 -43.5 92.39 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.924 0.393 . . . . 0.0 111.282 177.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -68.69 -49.06 62.01 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.963 -179.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.532 ' O ' ' HG3' ' A' ' 101' ' ' GLN . 1.5 m-20 -55.5 -44.54 76.66 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 111.545 0.202 . . . . 0.0 111.545 175.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.67 -57.55 11.55 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.019 0.437 . . . . 0.0 112.108 -179.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.0 tt -57.62 -29.74 35.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-O 121.245 0.545 . . . . 0.0 110.474 178.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . 0.553 ' HB3' HD11 ' A' ' 7' ' ' ILE . 90.6 m -82.26 -18.98 40.53 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.963 175.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.532 ' HG3' ' O ' ' A' ' 97' ' ' ASP . 24.4 mt-30 -64.91 -33.94 77.23 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 121.669 -0.644 . . . . 0.0 109.853 171.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 81.1 mt -75.58 -11.1 59.95 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.557 177.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.411 ' O ' ' HB3' ' A' ' 106' ' ' LYS . 64.5 t -121.48 -51.16 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -173.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -49.45 113.8 0.9 Allowed 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -175.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.39 -31.25 5.85 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 121.401 -0.428 . . . . 0.0 113.293 -179.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.411 ' HB3' ' O ' ' A' ' 103' ' ' VAL . 26.3 tptp -47.02 133.21 11.52 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.571 0.748 . . . . 0.0 112.602 -178.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -83.48 155.82 65.82 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.319 178.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -79.83 139.34 13.82 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.589 2.193 . . . . 0.0 113.17 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 57.24 54.47 6.73 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.214 0.531 . . . . 0.0 111.301 178.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -80.25 29.34 0.29 Allowed 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.366 0.603 . . . . 0.0 111.86 -174.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.434 HG13 ' N ' ' A' ' 112' ' ' GLY . 5.3 p -104.55 -53.12 7.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.902 176.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.434 ' N ' HG13 ' A' ' 111' ' ' VAL . . . 49.41 73.05 0.39 Allowed Glycine 0 C--N 1.339 0.728 0 C-N-CA 121.505 -0.379 . . . . 0.0 112.822 -178.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 47.3 t -61.59 93.73 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-O 121.398 0.618 . . . . 0.0 111.459 -177.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 60.5 m -133.54 141.35 47.69 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.196 -177.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 25.8 ttpp -68.18 104.74 1.88 Allowed 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.317 178.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 67.16 91.68 0.09 Allowed 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 121.22 0.533 . . . . 0.0 111.699 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -139.34 39.56 2.08 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.297 -176.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 33.5 m -59.68 -39.9 86.05 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 121.158 0.504 . . . . 0.0 111.234 178.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -80.26 105.03 2.31 Favored Glycine 0 CA--C 1.526 0.768 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.561 176.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -73.78 68.2 1.6 Allowed Glycine 0 CA--C 1.531 1.051 0 C-N-CA 121.395 -0.431 . . . . 0.0 113.604 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 58.62 -84.95 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 20.8 m -102.88 112.17 35.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 121.437 0.637 . . . . 0.0 112.04 -175.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -85.82 -2.82 58.62 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -178.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 53.4 mtm180 -57.73 126.11 25.96 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 120.891 0.377 . . . . 0.0 111.55 176.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.43 HD12 ' N ' ' A' ' 125' ' ' LEU . 6.4 mp -79.59 69.03 5.8 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 121.345 0.593 . . . . 0.0 111.562 -177.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 8.8 t -113.96 3.65 15.45 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.136 0.493 . . . . 0.0 111.348 177.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -88.69 143.34 26.99 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.534 -178.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 24.5 m -83.92 65.91 8.88 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.436 0.636 . . . . 0.0 111.187 -178.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 33.7 t -83.1 -47.66 11.41 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.962 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 19.8 mtp180 70.63 -21.69 0.19 Allowed 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 68.96 -11.86 0.42 Allowed 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 177.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.564 ' OG1' ' HB2' ' A' ' 135' ' ' HIS . 46.6 p 52.46 18.95 1.04 Allowed 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 174.01 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 48.09 -110.33 0.64 Allowed Glycine 0 CA--C 1.531 1.08 0 N-CA-C 115.471 0.949 . . . . 0.0 115.471 173.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 42.2 m -65.96 -3.6 5.54 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -173.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.564 ' HB2' ' OG1' ' A' ' 132' ' ' THR . 73.4 m80 -83.0 6.71 17.84 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 120.834 0.35 . . . . 0.0 111.554 178.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 34.1 ttmt -69.69 73.72 0.4 Allowed 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.355 0.597 . . . . 0.0 110.62 175.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -85.44 92.61 8.54 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.268 0.556 . . . . 0.0 111.621 -177.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -110.8 113.16 25.54 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.96 173.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 59.9 t80 54.63 72.98 0.43 Allowed 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.423 0.63 . . . . 0.0 111.526 -174.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -86.82 127.87 35.02 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.13 -0.487 . . . . 0.0 109.825 178.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -57.29 130.17 45.03 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -170.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 48.8 m 65.6 -74.24 0.06 Allowed 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.641 175.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 102.55 -139.82 14.59 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 121.19 -0.528 . . . . 0.0 113.319 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -105.46 -8.4 18.12 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -176.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -68.75 77.52 0.28 Allowed Glycine 0 CA--C 1.533 1.158 0 N-CA-C 114.677 0.631 . . . . 0.0 114.677 -175.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -147.42 133.82 19.65 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 120.993 0.425 . . . . 0.0 110.977 174.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 69.58 -163.31 51.73 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 121.254 -0.498 . . . . 0.0 113.011 -177.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.506 ' N ' HD12 ' A' ' 148' ' ' ILE . 2.7 mp -80.32 -46.73 21.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 120.805 0.336 . . . . 0.0 110.122 175.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . 60.32 -80.43 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 172.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -57.61 -44.25 93.99 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 114.552 0.581 . . . . 0.0 114.552 -171.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' A' ' 151' ' ' ARG . 4.1 ptp85 -118.6 -178.07 3.45 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 122.448 -0.443 . . . . 0.0 111.457 -177.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -100.49 142.99 31.19 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.954 0.407 . . . . 0.0 111.462 -178.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -82.03 -69.45 0.62 Allowed 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.037 0.446 . . . . 0.0 111.191 179.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 7.3 tp -82.62 136.29 23.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.731 176.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 87.9 mt -75.89 65.99 2.06 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.709 0.29 . . . . 0.0 111.718 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.9 p30 39.56 25.27 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 178.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -62.47 -31.97 72.79 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 121.078 0.466 . . . . 0.0 111.352 179.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 80.4 p -75.68 14.13 0.69 Allowed 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -97.27 -8.07 56.71 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 121.478 -0.391 . . . . 0.0 112.691 173.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -106.8 -54.52 2.46 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.094 0.473 . . . . 0.0 111.953 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 7.1 p -99.65 126.09 53.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -172.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 61.5 m 65.27 139.71 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 173.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 61.2 85.05 0.12 Allowed 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.034 -176.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -74.67 -20.99 59.65 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.947 -173.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 73.7 mttt 60.49 -164.61 0.23 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.066 0.46 . . . . 0.0 111.804 174.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -118.88 163.87 16.27 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.809 0.338 . . . . 0.0 110.718 174.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -79.48 15.99 1.15 Allowed 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -177.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 93.29 65.8 1.07 Allowed Glycine 0 CA--C 1.524 0.625 0 C-N-CA 121.252 -0.499 . . . . 0.0 112.401 -177.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.497 HG23 ' HA ' ' A' ' 173' ' ' LYS . 2.7 t -91.51 128.07 37.2 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.054 0.454 . . . . 0.0 111.959 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -88.74 -14.92 36.06 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.878 178.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -77.27 82.71 3.74 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 121.13 0.49 . . . . 0.0 111.513 -178.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . 56.64 9.52 0.58 Allowed 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 175.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.497 ' HA ' HG23 ' A' ' 169' ' ' THR . 66.9 mttm 56.86 82.69 0.11 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 122.401 0.28 . . . . 0.0 111.283 -176.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.405 HG13 ' O ' ' A' ' 174' ' ' VAL . 9.7 p 41.25 93.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 CA-C-O 121.989 0.899 . . . . 0.0 112.703 -176.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 51.4 tttp -89.41 86.0 6.69 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.66 -175.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.402 ' O ' ' HB2' ' A' ' 177' ' ' LEU . 27.5 tptp -107.64 -39.8 5.5 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 116.554 -0.293 . . . . 0.0 111.356 -179.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.458 ' O ' ' HB3' ' A' ' 178' ' ' GLU . 8.4 mp 73.87 -59.3 0.56 Allowed 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 176.181 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.458 ' HB3' ' O ' ' A' ' 177' ' ' LEU . 40.5 tt0 . . . . . 0 N--CA 1.475 0.803 0 C-N-CA 123.331 0.653 . . . . 0.0 110.825 -169.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.6 tpt . . . . . 0 N--CA 1.489 1.486 0 CA-C-O 120.712 0.292 . . . . 0.0 111.414 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.4 175.87 9.22 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.223 0.535 . . . . 0.0 112.223 -178.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -92.21 -156.75 0.48 Allowed 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.363 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 69.4 m -57.47 101.34 0.07 Allowed 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 120.996 0.427 . . . . 0.0 111.287 175.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 71.9 p -78.03 -177.11 4.86 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.716 0.635 . . . . 0.0 112.716 -176.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -68.19 -179.34 1.24 Allowed 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.866 176.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.474 ' N ' HD12 ' A' ' 7' ' ' ILE . 2.3 mp -66.43 96.13 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-O 121.264 0.554 . . . . 0.0 110.797 178.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.41 -35.65 72.36 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.329 -177.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -56.66 -31.4 60.47 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 121.131 -0.557 . . . . 0.0 113.131 179.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.453 HD11 ' HE2' ' A' ' 75' ' ' PHE . 54.7 tp -70.45 -53.73 15.22 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 120.776 0.322 . . . . 0.0 111.314 178.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -63.36 -39.01 93.36 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 122.185 -0.322 . . . . 0.0 111.533 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -57.79 -56.52 20.92 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.831 0.348 . . . . 0.0 111.095 175.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.707 ' HB3' ' HB2' ' A' ' 107' ' ' GLU . 65.7 m -67.79 -44.34 77.61 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -176.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -50.01 -51.94 38.0 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 121.187 0.518 . . . . 0.0 111.145 171.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.418 HH11 ' HD3' ' A' ' 15' ' ' ARG . 32.1 ttt180 -60.55 -44.23 96.35 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.832 179.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.569 ' HD3' HD11 ' A' ' 19' ' ' ILE . 0.1 OUTLIER -68.85 -27.89 66.22 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.844 -179.441 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -78.52 -33.12 48.25 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.177 0.513 . . . . 0.0 110.199 177.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.38 -38.35 77.98 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.447 177.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.569 HD11 ' HD3' ' A' ' 16' ' ' LYS . 27.0 pt -94.11 14.45 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 120.877 0.37 . . . . 0.0 111.039 178.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -52.85 97.3 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.101 0.477 . . . . 0.0 111.477 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 120.73 -36.2 3.44 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.656 -176.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.445 ' O ' ' HB ' ' A' ' 19' ' ' ILE . 11.7 m-20 -121.54 91.4 48.41 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 122.76 0.424 . . . . 0.0 111.946 -178.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -71.35 -2.87 11.9 Favored 'Trans proline' 0 CA--C 1.545 1.026 0 C-N-CA 122.517 2.145 . . . . 0.0 113.549 -178.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 8.7 mtpm? -88.35 -7.0 57.38 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -178.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.414 ' HB3' HG22 ' A' ' 19' ' ' ILE . . . -93.73 157.57 16.09 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.615 0.245 . . . . 0.0 111.321 178.163 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 28.3 t -88.36 -19.16 27.02 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 120.989 0.423 . . . . 0.0 110.776 177.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.438 ' HA3' HG23 ' A' ' 19' ' ' ILE . . . 63.87 56.6 17.82 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 115.606 1.002 . . . . 0.0 115.606 170.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -96.57 -8.56 31.53 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.518 0.675 . . . . 0.0 109.793 169.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.583 ' HB3' HG21 ' A' ' 69' ' ' VAL . 50.9 mt-10 -113.08 111.61 22.42 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.432 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 42.3 ttm -98.86 133.32 43.32 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.146 0.498 . . . . 0.0 111.553 176.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.416 ' ND2' ' HB2' ' A' ' 33' ' ' LYS . 13.9 p-10 -86.86 156.92 19.67 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.531 179.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -58.25 -28.2 61.32 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-N 116.24 -0.437 . . . . 0.0 113.212 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.416 ' HB2' ' ND2' ' A' ' 31' ' ' ASN . 47.4 mmtm -57.7 -59.5 5.11 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.045 0.45 . . . . 0.0 111.336 176.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.403 ' O ' ' HB2' ' A' ' 38' ' ' LEU . 87.7 m-20 -64.66 -38.76 92.1 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.872 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 45.5 t-105 -56.17 -49.06 75.06 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 120.901 0.382 . . . . 0.0 111.798 177.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.04 -47.08 86.33 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.205 0.526 . . . . 0.0 111.751 178.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.455 ' NZ ' ' HB3' ' A' ' 37' ' ' LYS . 7.8 mtpm? -67.26 -29.98 69.74 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.336 179.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.403 ' HB2' ' O ' ' A' ' 34' ' ' ASN . 5.1 tt -62.3 -49.3 76.18 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.169 0.509 . . . . 0.0 110.081 177.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 78.9 m -58.53 -44.28 89.52 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.442 178.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -69.9 -33.66 72.48 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 120.992 0.425 . . . . 0.0 111.388 179.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -64.1 -38.66 91.88 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.418 0.628 . . . . 0.0 110.822 177.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.491 ' HA ' ' HE2' ' A' ' 106' ' ' LYS . 59.1 m -99.2 0.76 43.98 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.039 -177.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.432 ' N ' ' HD2' ' A' ' 43' ' ' LYS . 3.3 mptp? 59.2 31.28 21.1 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.337 176.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.455 HG11 ' HB3' ' A' ' 82' ' ' LEU . 32.5 t -70.3 -37.44 71.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-O 121.486 0.66 . . . . 0.0 109.39 170.098 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.19 85.46 6.8 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.505 169.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -169.76 78.68 0.1 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.785 -171.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -176.72 37.29 0.09 OUTLIER Glycine 0 CA--C 1.522 0.506 0 C-N-CA 120.708 -0.758 . . . . 0.0 113.434 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.1 mtpm? 50.23 14.67 0.16 Allowed 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 178.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.7 m -150.54 -60.08 0.19 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.885 0.374 . . . . 0.0 110.509 -175.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 41.0 t -68.29 90.36 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 172.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 49.2 p -129.0 -171.09 2.39 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.103 -178.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -48.04 -36.86 15.58 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 121.476 -0.392 . . . . 0.0 113.686 -178.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.58 ' O ' HG12 ' A' ' 57' ' ' ILE . 4.8 t -64.32 -55.85 18.49 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 122.334 -0.51 . . . . 0.0 111.358 178.37 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.414 ' N ' HG23 ' A' ' 53' ' ' THR . 12.9 t70 -62.7 -40.03 95.87 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.04 0.448 . . . . 0.0 110.994 -177.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 84.3 t -61.69 -31.03 49.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.417 176.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -82.03 -30.91 31.23 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.334 0.588 . . . . 0.0 109.55 179.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.58 HG12 ' O ' ' A' ' 53' ' ' THR . 10.4 mm -61.24 -52.38 62.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.9 174.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.8 t -58.53 -42.74 85.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 120.919 0.39 . . . . 0.0 110.945 176.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -57.82 -40.82 80.9 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.355 0.598 . . . . 0.0 110.869 175.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 37.3 m -82.59 -11.72 58.21 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.486 178.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.678 ' HE2' ' HA ' ' A' ' 61' ' ' LYS . 0.6 OUTLIER -76.95 -50.41 13.28 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.838 176.972 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 31.4 m -67.63 -25.94 34.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.548 175.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -69.34 104.98 2.4 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.829 174.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -91.15 -61.35 1.27 Allowed Glycine 0 CA--C 1.526 0.778 0 C-N-CA 121.081 -0.581 . . . . 0.0 113.299 -178.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 10.3 mtmp? -121.55 -152.63 0.52 Allowed 'General case' 0 CA--C 1.542 0.66 0 O-C-N 122.524 -0.398 . . . . 0.0 111.014 -178.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 39.3 t -62.72 91.19 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.425 0.631 . . . . 0.0 111.917 -176.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -160.12 108.51 1.7 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.771 178.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.7 ttm-85 -70.36 -44.64 67.71 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.349 0.595 . . . . 0.0 111.113 -177.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.583 HG21 ' HB3' ' A' ' 29' ' ' GLU . 27.6 m -95.64 170.92 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.385 -175.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 34.6 pt -121.22 149.63 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.394 176.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -99.46 171.4 7.97 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.93 0.395 . . . . 0.0 111.389 178.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -57.99 -35.49 71.3 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -176.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.5 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 39.5 mm-40 -61.39 -53.27 58.81 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.799 0.333 . . . . 0.0 111.499 178.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -65.97 -28.06 68.62 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.907 0.384 . . . . 0.0 110.939 178.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.453 ' HE2' HD11 ' A' ' 10' ' ' LEU . 88.5 t80 -60.7 -47.99 83.78 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.183 175.05 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.5 ' HE2' ' HA ' ' A' ' 73' ' ' GLU . 53.4 mtmt -58.01 -47.08 84.1 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.919 0.39 . . . . 0.0 110.782 176.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -56.75 -42.9 80.13 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.154 0.502 . . . . 0.0 111.249 175.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.21 -42.87 99.35 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.375 177.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 88.2 mt -58.32 -41.57 84.83 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.294 177.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -63.76 -36.6 84.41 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 120.88 0.372 . . . . 0.0 111.192 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -63.76 -61.06 2.55 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 120.634 0.254 . . . . 0.0 111.122 172.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.455 ' HB3' HG11 ' A' ' 44' ' ' VAL . 11.2 mp -50.71 -40.49 54.3 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.196 0.522 . . . . 0.0 111.851 179.001 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.96 -53.33 59.29 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.743 175.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 69.2 p -74.32 -10.4 59.55 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -86.96 -45.86 10.4 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.105 0.479 . . . . 0.0 111.414 174.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.4 -49.04 9.05 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.882 -176.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -82.61 -178.45 7.08 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.156 0.503 . . . . 0.0 111.068 179.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -93.96 142.02 27.85 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.848 177.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -76.19 56.33 3.21 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 121.356 -0.449 . . . . 0.0 114.177 -176.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 29.0 ttpp -83.59 -31.78 26.12 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.208 0.527 . . . . 0.0 110.323 175.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.529 ' HB3' ' HB3' ' A' ' 94' ' ' GLU . 30.8 t -162.37 126.16 3.06 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.812 178.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 50.7 tttm -69.31 -47.09 65.5 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.777 0.323 . . . . 0.0 111.811 -178.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -64.47 -40.9 96.57 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 120.78 0.324 . . . . 0.0 110.986 178.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.529 ' HB3' ' HB3' ' A' ' 91' ' ' SER . 34.5 tt0 -65.67 -43.48 89.2 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.803 0.335 . . . . 0.0 111.257 177.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.95 -35.52 73.28 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.885 0.374 . . . . 0.0 110.978 175.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -64.87 -42.66 94.64 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.864 176.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -64.69 -38.51 91.26 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 120.933 0.396 . . . . 0.0 110.972 176.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.59 -51.31 60.65 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.679 179.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 16.5 tt -62.6 -33.2 58.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-O 120.941 0.4 . . . . 0.0 110.343 177.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . 0.506 ' SG ' ' HB3' ' A' ' 104' ' ' ALA . 39.7 t -65.43 -34.12 77.55 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.82 0.343 . . . . 0.0 110.851 172.154 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -69.7 -22.32 63.42 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.506 178.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 80.4 mt -95.55 -36.61 11.21 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.059 0.457 . . . . 0.0 111.987 175.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 81.9 t -96.8 -65.69 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 112.554 0.575 . . . . 0.0 112.554 -174.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.506 ' HB3' ' SG ' ' A' ' 100' ' ' CYS . . . -51.38 109.38 0.34 Allowed 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -168.074 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 107.25 -38.09 3.5 Favored Glycine 0 CA--C 1.522 0.479 0 C-N-CA 121.174 -0.536 . . . . 0.0 112.849 178.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.491 ' HE2' ' HA ' ' A' ' 42' ' ' CYS . 14.7 ttpp -78.86 -63.37 1.43 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.836 0.35 . . . . 0.0 110.549 178.281 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.707 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 25.6 mt-10 29.72 -88.03 0.0 OUTLIER Pre-proline 0 CA--C 1.557 1.219 0 N-CA-C 115.161 1.541 . . . . 0.0 115.161 177.121 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.65 ' HD3' ' HB2' ' A' ' 107' ' ' GLU . 6.8 Cg_exo -74.22 79.22 2.45 Favored 'Trans proline' 0 C--N 1.367 1.552 0 CA-C-N 123.306 2.216 . . . . 0.0 112.004 177.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -127.56 -51.31 1.38 Allowed 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -177.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -77.92 73.58 4.48 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 121.702 0.763 . . . . 0.0 112.143 -172.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 35.3 m -90.28 -4.3 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-O 121.314 0.578 . . . . 0.0 110.824 173.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -172.66 -107.76 0.21 Allowed Glycine 0 CA--C 1.527 0.834 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.848 178.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 65.0 t -113.55 130.72 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-O 120.99 0.424 . . . . 0.0 111.356 177.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 9.6 t -81.54 135.15 35.58 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.895 0.379 . . . . 0.0 111.181 177.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 44.6 tptt -84.32 163.93 19.3 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.652 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 68.28 122.63 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 122.913 0.485 . . . . 0.0 111.868 -177.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt 66.58 16.14 10.31 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 122.954 0.502 . . . . 0.0 111.66 -176.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 18.6 m -58.69 -40.55 83.92 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.932 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 148.41 -125.33 2.05 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 121.394 -0.432 . . . . 0.0 112.598 -178.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 88.34 -81.84 1.56 Allowed Glycine 0 CA--C 1.525 0.686 0 C-N-CA 121.333 -0.46 . . . . 0.0 112.842 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -72.65 146.43 46.57 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.939 0.399 . . . . 0.0 111.629 178.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.476 HG23 ' HB2' ' A' ' 125' ' ' LEU . 15.5 m -67.01 81.33 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -178.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 58.86 -81.13 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.913 175.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -159.91 18.34 0.16 Allowed 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 121.196 0.522 . . . . 0.0 110.339 -178.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.476 ' HB2' HG23 ' A' ' 122' ' ' VAL . 88.4 mt -81.8 139.28 34.88 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.48 0.657 . . . . 0.0 112.457 -173.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 87.8 m -119.97 85.19 2.34 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.546 175.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -71.85 151.67 43.23 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.301 174.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 93.5 m 67.33 110.03 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 112.451 0.538 . . . . 0.0 112.451 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 54.8 m 66.87 111.48 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 121.14 0.495 . . . . 0.0 111.894 178.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 130' ' ' ARG . 14.5 mmt85 -107.83 12.78 26.95 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -173.024 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -63.61 -6.06 4.81 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -179.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 75.3 p -74.26 149.91 40.51 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -177.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.83 74.66 1.24 Allowed Glycine 0 CA--C 1.528 0.857 0 C-N-CA 121.21 -0.519 . . . . 0.0 113.069 179.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 50.7 m -107.94 13.8 25.87 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -177.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 10.0 p-80 -163.37 131.17 3.61 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -178.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 55.8 tttm -80.25 -41.33 25.25 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.069 0.461 . . . . 0.0 111.028 177.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -75.06 141.87 43.79 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 120.79 0.328 . . . . 0.0 110.589 175.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 34.2 tpt85 -176.82 -35.5 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.12 0.486 . . . . 0.0 111.164 -170.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -124.6 163.93 20.91 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.281 -176.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -66.67 -165.15 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 121.47 0.652 . . . . 0.0 111.807 176.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -82.65 -179.05 7.31 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 120.959 0.409 . . . . 0.0 110.888 174.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 49.7 m -65.76 143.56 57.44 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.379 174.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -63.71 90.88 0.08 OUTLIER Glycine 0 CA--C 1.528 0.895 0 C-N-CA 121.157 -0.544 . . . . 0.0 113.692 -175.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -73.15 -36.5 66.67 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.082 0.468 . . . . 0.0 110.725 176.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 71.58 -120.66 8.35 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.817 -178.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -161.93 24.17 0.11 Allowed 'General case' 0 CA--C 1.545 0.752 0 CA-C-O 121.282 0.563 . . . . 0.0 110.822 179.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 105.8 82.18 1.52 Allowed Glycine 0 CA--C 1.522 0.474 0 C-N-CA 121.224 -0.512 . . . . 0.0 112.117 -176.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 45.6 mm 64.17 -68.31 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 123.222 0.609 . . . . 0.0 111.615 -174.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -139.8 -54.5 0.55 Allowed 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 78.34 65.08 1.9 Allowed Glycine 0 CA--C 1.526 0.775 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.913 -174.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.408 ' HG3' ' H ' ' A' ' 152' ' ' GLN . 12.2 ptm180 53.9 -59.75 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 125.592 1.557 . . . . 0.0 113.585 -172.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . 0.408 ' H ' ' HG3' ' A' ' 151' ' ' ARG . 25.6 tp60 71.74 107.26 0.07 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.447 0.641 . . . . 0.0 112.033 176.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -102.9 144.53 31.09 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.082 173.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 2.7 pp -92.32 162.69 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -174.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 48.3 tp 73.21 -47.64 0.67 Allowed 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 176.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -55.41 -56.1 24.07 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 120.804 0.335 . . . . 0.0 111.689 -178.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.443 ' O ' ' HB3' ' A' ' 158' ' ' SER . 28.6 t0 -129.25 165.25 21.77 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.493 176.188 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.443 ' HB3' ' O ' ' A' ' 157' ' ' ASP . 37.5 t 73.62 -49.87 0.69 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.173 0.589 . . . . 0.0 111.864 -176.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -55.36 105.04 0.34 Allowed Glycine 0 CA--C 1.528 0.875 0 C-N-CA 121.614 -0.327 . . . . 0.0 113.318 179.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -67.81 96.88 0.6 Allowed 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.361 0.6 . . . . 0.0 111.764 -178.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 7.9 p -162.9 140.46 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.513 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 91.8 p -136.5 124.0 22.17 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.867 -0.419 . . . . 0.0 109.867 176.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -150.43 127.87 11.45 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -175.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 76.7 t80 -147.47 87.24 1.64 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.92 174.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 83.7 tttt 55.12 39.9 31.65 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-O 121.725 0.774 . . . . 0.0 110.783 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -83.76 -172.12 3.98 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.172 -175.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -64.89 98.76 0.3 Allowed 'General case' 0 CA--C 1.539 0.522 0 O-C-N 122.085 -0.384 . . . . 0.0 111.493 177.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -66.08 -69.27 1.39 Allowed Glycine 0 CA--C 1.526 0.731 0 C-N-CA 121.338 -0.458 . . . . 0.0 112.836 178.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 39.5 p 48.43 48.98 18.76 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.024 0.53 . . . . 0.0 112.298 178.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -84.92 37.55 0.67 Allowed 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -175.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -94.44 127.85 40.61 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 122.101 -0.374 . . . . 0.0 110.153 176.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -89.32 -10.27 47.37 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -174.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -70.49 -42.91 70.74 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.044 0.45 . . . . 0.0 111.342 -177.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 4.9 p -74.28 94.71 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 CA-C-O 121.462 0.649 . . . . 0.0 111.437 178.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -84.64 120.68 26.66 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.709 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.675 ' HG3' ' H ' ' A' ' 177' ' ' LEU . 38.7 tptt -109.88 -161.52 0.76 Allowed 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 173.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.675 ' H ' ' HG3' ' A' ' 176' ' ' LYS . 87.3 mt -75.0 67.17 1.67 Allowed 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -174.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 . . . . . 0 N--CA 1.484 1.23 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 172.46 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.551 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 120.723 0.296 . . . . 0.0 111.277 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.41 80.73 0.25 Allowed 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.002 0.43 . . . . 0.0 111.649 -178.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -176.16 -23.21 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.408 -177.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 32.9 m -71.06 -56.99 4.98 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.979 0.419 . . . . 0.0 111.827 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.629 HG23 ' HB2' ' A' ' 8' ' ' ALA . 84.8 m -108.79 98.83 8.26 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.031 0.443 . . . . 0.0 111.703 -178.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -83.63 -63.39 1.36 Allowed 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.205 0.526 . . . . 0.0 111.067 176.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.7 mm -122.17 -31.41 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.465 175.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.629 ' HB2' HG23 ' A' ' 5' ' ' THR . . . 66.23 -68.41 0.13 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.166 0.586 . . . . 0.0 112.098 -178.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -51.15 -28.56 18.89 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 121.615 -0.326 . . . . 0.0 113.496 178.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 51.6 tp -64.56 -38.48 91.17 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 120.719 0.295 . . . . 0.0 111.052 176.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.615 ' O ' ' HD3' ' A' ' 15' ' ' ARG . 39.9 tt0 -67.09 -46.14 75.14 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 177.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.454 ' O ' ' HG3' ' A' ' 16' ' ' LYS . 1.1 mp0 -51.79 -46.22 64.13 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.744 0.307 . . . . 0.0 111.156 172.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 70.6 m -58.95 -41.68 88.04 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.684 -0.234 . . . . 0.0 111.253 176.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -58.29 -46.85 85.32 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.645 176.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.615 ' HD3' ' O ' ' A' ' 11' ' ' GLU . 1.8 mpt_? -54.93 -55.85 26.1 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.121 175.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.454 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 67.1 mttm -54.32 -45.14 72.56 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -176.037 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -69.75 -39.49 76.69 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 111.728 0.27 . . . . 0.0 111.728 176.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.69 -53.6 38.83 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -177.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.53 HG12 ' O ' ' A' ' 15' ' ' ARG . 25.8 pt -78.8 -1.84 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 -176.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -56.06 -33.98 65.51 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.082 0.467 . . . . 0.0 110.656 175.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.57 59.83 4.93 Favored Glycine 0 CA--C 1.522 0.516 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.838 175.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 68.57 124.05 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 123.199 0.6 . . . . 0.0 111.338 -173.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.522 ' HA ' ' HB ' ' A' ' 19' ' ' ILE . 81.8 Cg_exo -47.57 -30.62 12.45 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 123.145 2.564 . . . . 0.0 114.237 -178.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -75.35 3.33 9.25 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 178.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.36 -52.04 66.97 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 111.868 0.321 . . . . 0.0 111.868 179.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 99.7 p 177.74 -70.55 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.004 0.431 . . . . 0.0 111.563 -179.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 107.46 -26.08 19.44 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 111.925 -0.47 . . . . 0.0 111.925 -174.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -115.88 -15.91 11.2 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.028 0.531 . . . . 0.0 111.101 178.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.456 ' HB3' HG21 ' A' ' 69' ' ' VAL . 8.7 mm-40 -111.9 145.7 39.07 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.715 -176.198 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 53.1 ttm -133.87 135.29 43.59 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 120.556 0.217 . . . . 0.0 111.146 178.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 36.1 p30 -94.13 168.85 10.67 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.17 0.51 . . . . 0.0 112.277 -178.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.15 -27.6 70.81 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-N 116.033 -0.531 . . . . 0.0 113.768 -179.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -62.89 -58.94 5.66 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.39 0.614 . . . . 0.0 111.199 178.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -64.18 -35.83 82.09 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.164 178.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 50.3 t-105 -62.2 -42.92 99.73 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.625 175.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.11 -45.72 86.77 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 121.131 0.491 . . . . 0.0 111.309 177.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.4 mtpp -64.83 -45.04 87.83 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.298 175.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.3 tt -46.02 -43.88 14.71 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.134 0.492 . . . . 0.0 111.182 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 79.3 m -68.48 -46.4 69.8 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 120.979 0.418 . . . . 0.0 111.588 176.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -65.91 -52.86 46.29 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.785 0.326 . . . . 0.0 111.84 -177.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -55.27 -38.47 68.62 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 122.954 0.502 . . . . 0.0 111.257 176.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.687 ' SG ' ' HA ' ' A' ' 103' ' ' VAL . 83.4 m -85.94 -4.12 59.09 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 175.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.9 mtmm 52.76 41.3 31.56 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 178.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 57.9 t -78.34 -35.4 19.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 121.316 0.579 . . . . 0.0 110.32 171.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -102.56 79.22 1.79 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.637 178.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -60.35 -27.09 67.1 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.5 -29.33 12.75 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 121.196 -0.526 . . . . 0.0 111.977 -172.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -74.05 -61.65 1.78 Allowed 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 120.937 0.398 . . . . 0.0 110.9 176.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 69.0 p -90.05 -74.01 0.5 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.088 0.471 . . . . 0.0 110.506 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 89.0 t -89.19 135.27 26.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.365 174.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 43.6 p -124.05 173.53 8.21 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 120.883 0.373 . . . . 0.0 111.538 -177.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -54.84 -34.29 56.95 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 121.24 -0.505 . . . . 0.0 112.753 177.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.655 ' O ' HG13 ' A' ' 57' ' ' ILE . 89.3 m -53.61 -57.56 10.33 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 122.382 0.273 . . . . 0.0 111.102 176.443 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -52.43 -42.99 64.59 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.252 179.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 80.1 t -55.93 -43.96 76.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.851 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -73.55 -33.31 64.62 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.04 0.448 . . . . 0.0 111.115 -179.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.655 HG13 ' O ' ' A' ' 53' ' ' THR . 7.8 mt -64.42 -49.13 82.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.626 177.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 93.0 t -60.84 -43.38 95.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-O 120.786 0.327 . . . . 0.0 111.435 178.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -58.15 -35.16 71.13 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.17 0.509 . . . . 0.0 111.261 178.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 38.9 t -87.83 -21.84 24.81 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.743 177.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -68.13 -41.22 81.99 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 122.631 0.372 . . . . 0.0 111.969 -176.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.6 m -82.44 -21.26 9.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-O 121.245 0.545 . . . . 0.0 111.533 177.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.452 ' HD3' ' O ' ' A' ' 67' ' ' ALA . 39.4 ttmt -74.08 156.7 37.17 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -175.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -91.58 -128.02 4.11 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 121.538 -0.363 . . . . 0.0 113.184 175.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -100.54 -77.79 0.53 Allowed 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 81.2 p -76.94 -4.92 46.42 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -172.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.452 ' O ' ' HD3' ' A' ' 63' ' ' LYS . . . -68.88 121.06 15.8 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.106 0.479 . . . . 0.0 111.501 178.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 67.3 mtt180 -85.3 -32.31 22.58 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.198 0.523 . . . . 0.0 110.882 178.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.456 HG21 ' HB3' ' A' ' 29' ' ' GLU . 30.9 m -127.34 171.46 15.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.706 -176.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 36.3 pt -117.49 170.58 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 CA-C-O 120.581 0.229 . . . . 0.0 111.032 177.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -126.82 -179.97 5.08 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 -179.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.502 ' O ' ' HB3' ' A' ' 75' ' ' PHE . 70.6 t80 -34.73 -62.66 0.35 Allowed 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 -174.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -64.61 -38.57 91.46 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 121.798 -0.564 . . . . 0.0 112.014 -175.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -62.41 -37.22 84.97 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.219 0.533 . . . . 0.0 110.333 176.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.502 ' HB3' ' O ' ' A' ' 72' ' ' TYR . 60.8 t80 -57.03 -45.98 82.72 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.586 176.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.438 ' HE3' ' CZ ' ' A' ' 72' ' ' TYR . 81.2 mttt -61.39 -38.74 88.15 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.859 0.361 . . . . 0.0 111.7 178.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -71.69 -30.46 65.7 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.712 0.292 . . . . 0.0 111.531 176.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.31 -46.71 85.41 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.123 0.487 . . . . 0.0 110.687 173.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 86.9 mt -63.74 -34.95 79.01 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.107 175.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -62.0 -43.62 98.45 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 121.089 0.471 . . . . 0.0 110.93 178.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -59.79 -58.98 6.23 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.028 0.442 . . . . 0.0 111.284 173.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 90.9 mt -56.12 -42.01 76.17 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.949 -178.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.58 -51.78 68.44 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.799 0.333 . . . . 0.0 111.633 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 68.6 p -66.37 -20.7 66.14 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -178.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -102.38 -13.97 17.08 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 48.7 tpt85 -98.38 -60.79 1.48 Allowed 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.196 0.522 . . . . 0.0 110.975 177.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -77.38 -178.98 5.46 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.918 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 19.8 tptm -62.29 133.87 55.73 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.612 177.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -77.07 61.72 3.39 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 121.174 -0.536 . . . . 0.0 114.129 -173.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -165.77 153.52 10.67 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.979 0.389 . . . . 0.0 111.51 176.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 44.1 t 65.47 86.76 0.13 Allowed 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.91 -175.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 55.0 tttp -45.73 -41.78 11.07 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.295 175.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -57.38 -60.83 3.05 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.7 178.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -59.97 -43.75 94.88 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.82 0.343 . . . . 0.0 111.845 -176.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.61 -48.21 80.41 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -66.69 -48.11 70.3 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.278 -178.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.461 ' O ' ' HG3' ' A' ' 101' ' ' GLN . 4.2 m-20 -54.58 -49.36 70.57 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.748 0.309 . . . . 0.0 111.376 176.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -55.32 -51.94 65.1 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -178.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.8 tt -66.67 -33.16 61.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 CA-C-O 120.885 0.374 . . . . 0.0 111.235 -179.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 86.5 m -65.27 -34.82 79.24 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.824 0.345 . . . . 0.0 110.8 173.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.461 ' HG3' ' O ' ' A' ' 97' ' ' ASP . 28.9 mt-30 -64.78 -31.09 72.16 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.33 175.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 87.8 mt -72.91 -38.38 66.9 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 176.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.687 ' HA ' ' SG ' ' A' ' 42' ' ' CYS . 58.4 t -92.18 -57.4 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -174.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.91 98.41 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -170.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 85.17 5.39 85.68 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 114.99 0.756 . . . . 0.0 114.99 170.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 50.5 tttp -83.41 -2.04 54.89 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 118.015 0.908 . . . . 0.0 111.856 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 74.04 148.34 0.12 Allowed Pre-proline 0 N--CA 1.478 0.964 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 173.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -74.92 81.95 2.09 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.844 2.363 . . . . 0.0 112.168 176.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 53.28 -149.68 0.39 Allowed 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.863 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -69.49 105.58 2.68 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.732 0.301 . . . . 0.0 110.397 176.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 10.7 p -66.74 -35.91 75.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -178.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -118.81 -100.11 1.94 Allowed Glycine 0 CA--C 1.526 0.732 0 C-N-CA 121.354 -0.451 . . . . 0.0 112.646 179.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 8.2 p -74.71 135.38 27.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-O 121.014 0.435 . . . . 0.0 111.349 176.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 11.3 t -79.93 155.41 27.73 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.062 0.458 . . . . 0.0 112.227 -178.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.468 ' O ' HG23 ' A' ' 118' ' ' THR . 73.0 mmtt 64.6 -80.77 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 178.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 69.22 -61.07 0.44 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 122.765 0.426 . . . . 0.0 110.682 -169.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 55.8 tttp -164.57 -57.33 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 120.652 0.263 . . . . 0.0 110.967 173.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.468 HG23 ' O ' ' A' ' 115' ' ' LYS . 73.0 p 51.36 23.44 1.74 Allowed 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 175.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 78.11 11.96 84.84 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 120.892 -0.67 . . . . 0.0 113.98 178.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -60.63 -14.15 34.61 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 121.48 -0.39 . . . . 0.0 113.882 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -83.63 -43.06 16.01 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 120.802 0.334 . . . . 0.0 111.753 178.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 34.7 m -96.19 11.22 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -177.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -57.2 118.63 5.26 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.4 178.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 21.7 mtm180 -91.89 -174.32 3.77 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.566 0.698 . . . . 0.0 112.03 -177.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 85.4 mt -114.14 -149.84 0.45 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.614 178.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 48.8 p -64.45 93.09 0.09 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.349 0.595 . . . . 0.0 112.078 -177.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -67.45 158.3 32.13 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.097 175.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 80.6 p -85.98 -63.35 1.33 Allowed 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.323 0.582 . . . . 0.0 110.576 174.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 84.6 p -150.68 138.39 19.81 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.686 172.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 49.5 mtm-85 -66.78 -49.49 65.71 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.476 0.655 . . . . 0.0 110.55 -178.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -174.59 24.12 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 114.904 -1.043 . . . . 0.0 108.759 176.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 14.8 m -103.08 122.83 45.47 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.109 -0.95 . . . . 0.0 113.355 -163.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -98.8 167.29 21.88 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 166.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 66.0 m -57.72 96.11 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 117.677 0.738 . . . . 0.0 111.229 178.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 44.7 t-80 -78.4 90.37 4.42 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -175.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -111.62 -10.29 14.11 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.369 0.604 . . . . 0.0 109.702 167.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -58.36 152.34 17.86 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.612 178.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.657 ' HG3' ' H ' ' A' ' 139' ' ' PHE . 24.4 tpt180 -112.73 -173.28 2.22 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.94 -178.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.657 ' H ' ' HG3' ' A' ' 138' ' ' ARG . 95.1 m-85 76.89 23.63 0.97 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.827 0.851 . . . . 0.0 112.073 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -84.02 -12.19 55.59 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.963 172.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -72.9 144.96 47.18 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.08 -0.964 . . . . 0.0 112.433 -175.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 30.1 t -149.47 -57.07 0.19 Allowed 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.03 178.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 96.28 -56.03 1.49 Allowed Glycine 0 CA--C 1.528 0.858 0 C-N-CA 121.135 -0.555 . . . . 0.0 113.571 177.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -102.88 -166.84 1.32 Allowed 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 120.848 0.356 . . . . 0.0 111.296 -178.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -61.87 165.53 19.81 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.659 174.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 22.1 tptp -67.11 -22.11 65.82 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 122.265 -0.55 . . . . 0.0 111.911 -176.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -128.14 174.27 18.79 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-N 116.502 -0.317 . . . . 0.0 112.529 179.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 9.5 tt -146.19 137.94 19.44 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 O-C-N 122.263 -0.551 . . . . 0.0 112.171 -177.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . 74.36 -57.85 0.6 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.575 0.75 . . . . 0.0 112.996 175.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -59.91 -83.86 0.05 OUTLIER Glycine 0 CA--C 1.528 0.874 0 C-N-CA 121.353 -0.451 . . . . 0.0 114.087 -176.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -82.25 119.9 24.69 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 122.301 -0.529 . . . . 0.0 111.245 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -85.86 134.07 33.93 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.552 0.215 . . . . 0.0 111.184 177.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 37.62 -94.76 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -174.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 9.8 tt -160.56 116.9 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-O 121.295 0.569 . . . . 0.0 112.236 -176.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 86.1 mt -95.58 -35.95 11.45 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.178 0.513 . . . . 0.0 111.477 176.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -94.08 117.69 30.47 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.3 0.572 . . . . 0.0 112.135 -176.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -95.26 173.34 7.59 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.909 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 51.1 m -56.3 115.06 2.25 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -178.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -121.61 -141.17 6.04 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.364 176.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 63.84 -74.33 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.969 0 CA-C-O 121.389 0.614 . . . . 0.0 112.429 178.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 85.5 t -89.39 138.04 20.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.28 -175.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 38.4 t -77.45 58.54 1.73 Allowed 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.199 0.523 . . . . 0.0 111.046 177.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -80.57 34.22 0.32 Allowed 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -176.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 64.65 86.87 0.12 Allowed 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.29 0.567 . . . . 0.0 112.169 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -72.18 152.71 42.08 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.516 176.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -86.91 -172.76 4.14 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 120.926 0.393 . . . . 0.0 111.433 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -55.85 119.46 5.83 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -179.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.0 173.67 52.36 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 121.142 -0.552 . . . . 0.0 112.936 177.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 4.4 m -78.39 38.87 0.31 Allowed 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -175.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 57.12 18.41 4.09 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 173.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 31.3 t70 64.09 105.61 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 121.248 0.547 . . . . 0.0 111.537 -178.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.19 93.62 1.47 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.101 0.477 . . . . 0.0 111.18 178.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 36.1 tttp -91.12 95.19 9.95 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.608 -177.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 31.5 m -137.19 161.93 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -175.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.537 ' HD3' ' O ' ' A' ' 175' ' ' LYS . 6.0 tmtm? -80.7 -18.35 48.17 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 121.006 0.432 . . . . 0.0 110.544 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -42.32 129.96 3.82 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.435 ' N ' HD12 ' A' ' 177' ' ' LEU . 6.3 mp -59.63 -84.11 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.549 -178.357 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 . . . . . 0 CA--C 1.534 0.336 0 CA-C-O 121.006 0.431 . . . . 0.0 112.146 178.436 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.529 ' SD ' ' N ' ' A' ' 2' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.529 ' N ' ' SD ' ' A' ' 1' ' ' MET . . . -100.6 -37.43 8.78 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.003 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -173.85 -36.21 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.777 -177.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 73.4 m 75.09 -33.11 0.23 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.227 0.611 . . . . 0.0 112.37 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 55.9 m 65.99 98.21 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 122.765 0.426 . . . . 0.0 111.2 -179.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 67.69 -69.32 0.14 Allowed 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.142 0.577 . . . . 0.0 111.14 -175.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.429 HG12 ' H ' ' A' ' 9' ' ' GLY . 9.0 tt -163.4 124.35 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.158 176.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -52.62 -33.81 48.28 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.429 ' H ' HG12 ' A' ' 7' ' ' ILE . . . -60.2 -37.08 92.39 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 121.224 -0.513 . . . . 0.0 112.921 178.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.423 ' HB2' HG23 ' A' ' 7' ' ' ILE . 46.7 tp -60.89 -42.72 98.53 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.947 0.403 . . . . 0.0 110.522 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -57.33 -44.95 84.67 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.133 174.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.608 ' O ' ' HG3' ' A' ' 16' ' ' LYS . 32.3 mt-10 -61.44 -49.38 77.06 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.594 0.235 . . . . 0.0 110.954 179.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.457 ' HA ' ' HD2' ' A' ' 16' ' ' LYS . 47.4 m -57.48 -45.97 84.23 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.065 0.459 . . . . 0.0 111.312 178.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -58.77 -44.64 90.68 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.175 0.512 . . . . 0.0 110.408 175.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.742 HH11 ' HA3' ' A' ' 27' ' ' GLY . 3.0 tpt180 -56.16 -43.4 78.29 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.202 177.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.608 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 88.7 mttt -58.88 -54.67 44.49 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.036 -178.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -70.51 -33.4 71.17 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.93 -15.92 63.83 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -177.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.442 HG12 ' O ' ' A' ' 15' ' ' ARG . 31.9 pt -113.95 20.12 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-O 121.468 0.652 . . . . 0.0 111.126 175.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 50.0 t60 -67.9 -17.37 64.45 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -177.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -101.1 -42.83 2.33 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 120.933 -0.651 . . . . 0.0 113.558 -179.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.53 ' HB2' ' HB2' ' A' ' 25' ' ' ALA . 5.0 m-20 -116.41 157.26 46.06 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 122.733 0.413 . . . . 0.0 110.893 -177.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -69.91 -13.73 34.69 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.306 2.004 . . . . 0.0 113.198 -178.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -132.79 -38.85 0.99 Allowed 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.006 0.432 . . . . 0.0 110.374 172.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.53 ' HB2' ' HB2' ' A' ' 22' ' ' ASP . . . 47.07 -87.68 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -179.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 70.0 m -163.69 -56.73 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.384 0.612 . . . . 0.0 110.433 -175.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.742 ' HA3' HH11 ' A' ' 15' ' ' ARG . . . 92.26 -34.51 4.41 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-N 115.934 -0.576 . . . . 0.0 113.238 -178.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -99.97 0.92 42.04 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 121.079 0.466 . . . . 0.0 111.001 177.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.46 ' HB3' HG21 ' A' ' 69' ' ' VAL . 44.9 mt-10 -124.88 112.34 16.52 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.162 -179.299 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 50.6 ttm -107.68 145.08 33.86 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.78 0.324 . . . . 0.0 111.109 178.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -109.73 168.63 9.27 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.154 0.502 . . . . 0.0 112.095 -177.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -59.88 -37.24 92.28 Favored Glycine 0 CA--C 1.529 0.936 0 N-CA-C 114.555 0.582 . . . . 0.0 114.555 -174.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -64.21 -53.69 45.22 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -174.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 13.1 p30 -74.33 -28.94 61.38 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 29.0 t-105 -60.42 -44.86 95.34 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.091 0.472 . . . . 0.0 111.231 170.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.43 -49.08 78.28 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.928 0.394 . . . . 0.0 111.135 176.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -64.81 -31.65 72.98 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.425 178.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.9 tt -58.21 -54.81 42.72 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.049 0.452 . . . . 0.0 110.147 177.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 67.4 m -58.07 -45.98 86.2 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.192 178.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -66.34 -33.2 75.19 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -74.23 -47.09 37.48 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.146 0.498 . . . . 0.0 110.188 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 85.7 m -75.19 -2.21 26.83 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.233 173.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt 54.78 35.65 24.59 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 175.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 61.7 t -68.55 -28.12 39.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.784 174.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.39 124.22 21.68 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.21 0.529 . . . . 0.0 111.622 178.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.443 ' H ' ' HB ' ' A' ' 50' ' ' VAL . 32.0 t70 -75.29 -22.99 57.31 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.929 -176.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.12 -47.63 3.87 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 121.252 -0.499 . . . . 0.0 112.853 -179.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 42.0 mtmt -77.69 -57.83 3.6 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.465 0.65 . . . . 0.0 110.745 176.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.7 p -97.26 -72.07 0.66 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.497 179.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.443 ' HB ' ' H ' ' A' ' 46' ' ' ASP . 49.4 t -76.43 114.29 16.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-O 121.067 0.461 . . . . 0.0 111.475 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.7 t -140.59 -175.16 4.18 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.623 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -45.23 -45.82 10.55 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 113.793 0.277 . . . . 0.0 113.793 -177.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.599 ' O ' HG12 ' A' ' 57' ' ' ILE . 67.8 m -53.88 -56.6 16.19 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.823 0.344 . . . . 0.0 111.37 175.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -58.16 -43.26 87.3 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 121.129 0.49 . . . . 0.0 111.016 -178.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 71.4 t -61.85 -26.92 41.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-O 121.224 0.535 . . . . 0.0 111.438 178.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -82.88 -39.36 21.67 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.522 0.677 . . . . 0.0 109.989 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.599 HG12 ' O ' ' A' ' 53' ' ' THR . 16.4 mm -55.95 -46.76 80.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.593 174.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 87.1 t -61.62 -47.48 93.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.294 176.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -54.5 -44.28 72.56 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.068 0.461 . . . . 0.0 111.617 178.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 35.6 t -74.92 -35.23 62.2 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.044 0.449 . . . . 0.0 111.636 178.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -62.9 -55.66 24.07 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -177.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 22.6 m -66.49 -24.38 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-O 121.124 0.488 . . . . 0.0 111.6 -178.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.527 ' HB2' HG22 ' A' ' 70' ' ' ILE . 22.0 ttpp -105.64 82.86 1.86 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.634 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -101.45 -10.58 41.01 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 121.049 -0.596 . . . . 0.0 114.586 -173.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 48.2 tptt -84.76 45.66 1.17 Allowed 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 117.81 0.805 . . . . 0.0 112.035 -177.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 39.6 t 53.68 16.02 0.9 Allowed 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 176.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -76.5 166.75 22.97 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.027 0.441 . . . . 0.0 111.647 -178.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.432 HH11 ' HD3' ' A' ' 68' ' ' ARG . 40.6 ttp-105 -105.13 -36.56 7.23 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.045 0.45 . . . . 0.0 111.252 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.46 HG21 ' HB3' ' A' ' 29' ' ' GLU . 33.9 m -110.36 165.0 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.805 178.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.527 HG22 ' HB2' ' A' ' 63' ' ' LYS . 33.5 pt -111.93 146.53 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.012 175.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 30.1 p30 -100.46 -179.81 4.22 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.609 0.242 . . . . 0.0 111.379 177.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -56.45 -39.07 72.54 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -174.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -66.57 -49.25 66.99 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.792 0.33 . . . . 0.0 111.24 179.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -62.42 -35.37 79.01 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.058 0.456 . . . . 0.0 110.885 178.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.423 ' O ' ' HG ' ' A' ' 79' ' ' LEU . 89.1 t80 -58.63 -45.24 89.68 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.495 172.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -60.88 -41.81 96.71 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.542 176.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -60.05 -40.76 90.53 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.237 0.541 . . . . 0.0 110.727 174.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.76 -40.32 96.91 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.227 177.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' A' ' 75' ' ' PHE . 76.5 mt -62.23 -37.64 86.14 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.233 177.043 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -61.66 -42.72 99.29 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.085 0.469 . . . . 0.0 110.672 176.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.449 ' O ' ' HG2' ' A' ' 85' ' ' LYS . 61.7 mm-40 -59.92 -55.08 38.57 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.202 175.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 91.5 mt -59.68 -37.81 79.79 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.862 0.363 . . . . 0.0 111.448 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.424 ' HB1' ' HB1' ' A' ' 95' ' ' ALA . . . -58.67 -55.02 40.43 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.878 0.37 . . . . 0.0 111.424 177.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 36.3 p -63.52 -24.01 67.63 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.044 178.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.449 ' HG2' ' O ' ' A' ' 81' ' ' GLU . 33.3 mmtp -73.97 -42.26 60.75 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 120.884 0.373 . . . . 0.0 111.728 174.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 30.9 mmm180 -90.63 -57.32 2.87 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -174.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -99.37 25.76 6.66 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -171.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt 62.7 -175.06 0.15 Allowed 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.834 -178.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -98.05 17.58 58.48 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 121.042 -0.599 . . . . 0.0 113.36 178.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -74.77 96.42 3.06 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 122.421 -0.458 . . . . 0.0 111.077 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 24.6 t 65.3 110.09 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.009 0.523 . . . . 0.0 112.327 -178.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -57.21 -34.63 68.72 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.589 0.233 . . . . 0.0 111.417 175.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -60.19 -52.69 64.23 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 120.696 0.284 . . . . 0.0 111.684 -178.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -69.2 -42.61 75.56 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 120.711 0.291 . . . . 0.0 111.641 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.424 ' HB1' ' HB1' ' A' ' 83' ' ' ALA . . . -60.62 -47.36 86.58 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 120.955 0.407 . . . . 0.0 111.649 177.346 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.47 ' HA ' HG22 ' A' ' 99' ' ' ILE . 49.0 t80 -66.39 -37.04 84.35 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.017 0.437 . . . . 0.0 110.74 179.11 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -58.23 -51.76 68.43 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.508 0.67 . . . . 0.0 110.566 174.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.3 -41.46 94.08 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.814 -176.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.47 HG22 ' HA ' ' A' ' 96' ' ' PHE . 10.1 tp -64.87 -37.68 80.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 O-C-N 121.936 -0.478 . . . . 0.0 110.42 177.292 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 87.1 m -69.75 -30.07 67.58 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.673 172.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 3.6 tp-100 -60.12 -35.56 75.52 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.104 0.478 . . . . 0.0 111.028 178.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 88.3 mt -67.85 -22.58 65.13 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.944 177.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 47.7 t -111.45 -70.02 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-O 120.775 0.321 . . . . 0.0 111.241 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 53.7 -86.74 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 177.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -143.57 27.71 2.07 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.739 -176.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -73.3 -172.59 1.16 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.575 0.702 . . . . 0.0 112.745 -176.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -136.51 151.71 73.43 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.374 178.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -57.6 95.7 0.07 OUTLIER 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 122.219 1.946 . . . . 0.0 113.077 -179.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 61.98 -79.13 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.443 0.697 . . . . 0.0 112.221 -177.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -165.18 114.01 1.04 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 122.684 0.394 . . . . 0.0 110.259 -178.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 17.4 m -96.6 174.46 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-O 120.917 0.389 . . . . 0.0 111.593 -177.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -60.12 150.36 40.37 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.773 175.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.7 m -70.26 -6.0 6.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -178.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 6.6 t -55.28 127.06 27.61 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.935 0.397 . . . . 0.0 111.362 176.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.441 ' HE3' ' HA ' ' A' ' 118' ' ' THR . 65.1 tttp -75.26 113.04 12.17 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.036 0.446 . . . . 0.0 111.911 -175.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -80.86 160.29 24.81 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.341 178.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 60.2 tttm 66.06 -70.61 0.1 Allowed 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 122.798 0.439 . . . . 0.0 111.232 -178.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.441 ' HA ' ' HE3' ' A' ' 115' ' ' LYS . 68.2 m 51.35 -95.34 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 176.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 50.9 -150.24 6.38 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.158 -170.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -80.89 -68.83 1.44 Allowed Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 166.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -137.37 -63.72 0.58 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 169.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.5 p -108.09 10.18 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.162 174.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 18.5 t70 76.86 152.55 0.13 Allowed 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.362 -177.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.4 tpm_? -76.22 104.28 6.67 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 112.735 0.642 . . . . 0.0 112.735 -172.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 97.7 mt -114.5 -161.56 0.78 Allowed 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.266 173.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 48.0 p 54.33 21.09 2.99 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 175.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -87.95 -154.96 0.28 Allowed 'General case' 0 CA--C 1.547 0.832 0 CA-C-O 121.109 0.481 . . . . 0.0 111.879 -175.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 37.1 m -74.45 -36.35 63.35 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -176.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 90.5 p -56.16 122.44 11.72 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -174.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -76.34 -47.56 23.05 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.486 174.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 81.0 t80 70.2 -42.55 0.52 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.743 0.817 . . . . 0.0 112.986 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 13.9 t -58.45 -11.01 2.46 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -178.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -161.82 121.15 1.0 Allowed Glycine 0 CA--C 1.523 0.54 0 C-N-CA 121.538 -0.363 . . . . 0.0 112.732 177.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 66.2 m -67.4 -25.26 65.86 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.01 0.434 . . . . 0.0 111.106 178.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -83.11 71.49 10.15 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.322 0.582 . . . . 0.0 109.767 172.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 56.8 pttt -65.81 -43.96 87.06 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.774 -176.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -98.32 79.63 2.56 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.79 0.805 . . . . 0.0 110.759 177.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.461 ' O ' ' HB2' ' A' ' 139' ' ' PHE . 33.8 ttp-105 -98.43 -77.96 0.5 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.506 -177.104 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.461 ' HB2' ' O ' ' A' ' 138' ' ' ARG . 68.2 t80 170.57 81.63 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.828 177.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -72.83 130.77 41.19 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 120.916 0.389 . . . . 0.0 111.04 178.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.476 ' O ' ' N ' ' A' ' 143' ' ' GLY . 1.5 tm-20 -147.54 -86.6 0.09 Allowed 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.309 -178.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 86.0 p 40.48 -81.21 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.743 0.817 . . . . 0.0 113.059 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 141' ' ' GLU . . . -136.02 -25.45 0.48 Allowed Glycine 0 CA--C 1.529 0.933 0 CA-C-N 116.368 -0.378 . . . . 0.0 112.715 177.388 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 88.2 tttt 63.98 -66.71 0.11 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.591 0.756 . . . . 0.0 112.085 -176.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -82.72 61.36 4.76 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 121.266 -0.493 . . . . 0.0 112.502 176.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -69.57 136.87 51.85 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 122.757 -0.261 . . . . 0.0 111.396 179.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 82.33 62.26 1.9 Allowed Glycine 0 CA--C 1.524 0.605 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.339 -178.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 10.7 tt -72.72 137.43 23.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 120.933 0.397 . . . . 0.0 111.516 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -67.14 94.27 0.34 Allowed 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.08 0.467 . . . . 0.0 111.559 178.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -154.36 -133.09 1.73 Allowed Glycine 0 CA--C 1.524 0.612 0 CA-C-N 116.196 -0.456 . . . . 0.0 112.93 179.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -122.04 163.11 19.96 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.032 0.444 . . . . 0.0 111.576 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.43 110.84 16.26 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 173.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -91.79 171.52 9.09 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 121.343 0.592 . . . . 0.0 112.085 -172.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 2.5 pp -97.33 178.87 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.055 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 48.1 tp 63.22 92.65 0.06 Allowed 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 176.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -76.59 147.69 37.47 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.378 169.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -62.88 139.81 58.76 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.267 0.556 . . . . 0.0 111.915 -173.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 71.5 m -98.31 54.98 1.1 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.126 0.489 . . . . 0.0 110.685 174.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -66.85 -33.29 83.63 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-N 116.079 -0.51 . . . . 0.0 113.443 179.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -75.19 81.69 2.33 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.372 0.606 . . . . 0.0 110.981 178.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 25.7 m -87.3 32.88 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -177.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 36.3 m -66.88 -13.91 62.17 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 122.301 -0.25 . . . . 0.0 111.613 178.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 63.88 -76.63 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 175.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -89.11 -38.06 14.62 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.287 0.565 . . . . 0.0 111.216 -177.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -87.2 135.66 33.22 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.768 -172.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . 0.544 HD22 ' N ' ' A' ' 166' ' ' ASN . 0.8 OUTLIER -85.8 155.67 20.9 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.845 0.355 . . . . 0.0 111.385 179.177 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -70.89 -36.65 72.85 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -63.62 122.09 25.57 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 121.41 -0.424 . . . . 0.0 113.232 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 6.1 t -149.32 144.93 26.76 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.235 0.54 . . . . 0.0 112.405 -176.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -143.23 108.47 5.0 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.842 175.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . 0.532 ' HB2' ' H ' ' A' ' 178' ' ' GLU . 5.6 p-10 -68.26 -33.51 74.5 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -173.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 171' ' ' ASP . . . 77.99 -174.99 0.09 Allowed 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 176.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -109.91 -55.77 2.4 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -177.089 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 47.8 t -66.6 98.8 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -170.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.0 mttt 66.76 -64.6 0.23 Allowed 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.543 0.737 . . . . 0.0 112.223 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 38.1 mtmm -60.05 114.89 3.08 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.399 174.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 5.7 tt -169.58 124.27 0.81 Allowed 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.07 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.532 ' H ' ' HB2' ' A' ' 171' ' ' ASP . 3.4 tm-20 . . . . . 0 CA--C 1.542 0.636 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.41 179.795 . . . . . . . . 1 1 . 1 stop_ save_